Presentación unilingüe
Ocultar información sobre este documento

?

Title and reference

Заглавие и други данни

Commission Regulation (EU) 2018/669 of 16 April 2018 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixturesText with EEA relevance.

C/2018/2154

OJ L 115, 04/05/2018, p. 1–755 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

Legal status of the document In force

ELI: http://data.europa.eu/eli/reg/2018/669/oj

Регламент (ЕС) 2018/669 на Комисията от 16 април 2018 година за изменение с цел адаптиране към научно-техническия прогрес на Регламент (ЕО) № 1272/2008 на Европейския парламент и на Съвета относно класифицирането, етикетирането и опаковането на вещества и смесиТекст от значение за ЕИП.

C/2018/2154

OJ L 115, 04/05/2018г., стр. 1—755 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

Правен статус на документа В сила

ELI: http://data.europa.eu/eli/reg/2018/669/oj

Dates

Дати

Date of document:
16/04/2018; Date of adoption
Date of effect:
24/05/2018; Entry into force Date pub. +20 See Art 2
Date of effect:
01/12/2019; Application See Art 2
Date of end of validity:
No end date
Дата на документа:
16/04/2018; Дата на приемане
Дата на влизане в сила:
24/05/2018; влизане в сила дата на публикуване +20 виж член 2
Дата на влизане в сила:
01/12/2019; Прилагане виж член 2
Дата на изтичане на валидността:
Няма крайна дата

Miscellaneous information

Обща информация

Author:
European Commission, Directorate-General for Environment
Responsible body:
ENV
Form:
Regulation
Additional information:
EEA relevance
Автор:
Европейска комисия, Генерална дирекция „Околна среда“
Отговорна служба:
ENV
Вид:
Регламент
Допълнителна информация:
отнася се за ЕИП

Classifications

Класификации

Text

Текст

4.5.2018    | EN | Official Journal of the European Union | L 115/14.5.2018    | BG | Официален вестник на Европейския съюз | L 115/1
COMMISSION REGULATION (EU) 2018/669РЕГЛАМЕНТ (ЕС) 2018/669 НА КОМИСИЯТА
of 16 April 2018от 16 април 2018 година
amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixturesза изменение с цел адаптиране към научно-техническия прогрес на Регламент (ЕО) № 1272/2008 на Европейския парламент и на Съвета относно класифицирането, етикетирането и опаковането на вещества и смеси
(Text with EEA relevance)(текст от значение за ЕИП)
THE EUROPEAN COMMISSION,ЕВРОПЕЙСКАТА КОМИСИЯ,
Having regard to the Treaty on the Functioning of the European Union,като взе предвид Договора за функционирането на Европейския съюз,
Having regard to Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (1), and in particular Article 53(1) thereof,като взе предвид Регламент (ЕО) № 1272/2008 на Европейския парламент и на Съвета от 16 декември 2008 г. относно класифицирането, етикетирането и опаковането на вещества и смеси, за изменение и за отмяна на директиви 67/548/ЕИО и 1999/45/ЕО и за изменение на Регламент (ЕО) № 1907/2006 (1), и по-специално член 53 параграф 1 от него,
Whereas:като има предвид, че:
(1) | Tables 3.1 and 3.2 of Annex VI to Regulation (EC) No 1272/2008 contain the list of harmonised classification and labelling of hazardous substances but only in English for all language versions of that Regulation.(1) | В таблици 3.1 и 3.2 от приложение VI към Регламент (ЕО) № 1272/2008 се съдържа списъкът на хармонизираните класификация и етикетиране на опасните вещества, но единствено на английски език за всички езикови версии на посочения регламент.
(2) | On 2 December 2008 (2) the Commission committed itself to ensure that the chemical names corresponding to the International Chemical Identifications in Tables 3.1 and 3.2 of Annex VI to Regulation (EC) No 1272/2008 are published in the same language as the language versions in which that Regulation has been published.(2) | На 2 декември 2008 г. (2) Комисията се ангажира да гарантира, че химичните наименования, съответстващи на международната химична идентификация в таблици 3.1 и 3.2 от приложение VI към Регламент (ЕО) № 1272/2008, се публикуват на същия език, на който е публикувана езиковата версия на посочения регламент.
(3) | Table 3.1 of Annex VI to Regulation (EC) No 1272/2008 has been amended several times to reflect technical and scientific progress, by adding, deleting or modifying substances or their classification. To take account of those changes and to ensure that all the chemical names in Table 3.1 of Annex VI to Regulation (EC) No 1272/2008 are in the same language as the language versions in which that Regulation has been published, Table 3.1 needs to be replaced partially.(3) | Таблица 3.1 от приложение VI към Регламент (ЕО) № 1272/2008 е изменяна няколко пъти, за да се отразят техническият и научният напредък, чрез добавяне, заличаване или изменение на вещества или на тяхната класификация. За да се вземат предвид тези промени и да се гарантира, че всички химични наименования, посочени в таблица 3.1 от приложение VI към Регламент (ЕО) № 1272/2008, са на същия език, на който е публикувана езиковата версия на посочения регламент, таблица 3.1 трябва да бъде частично заменена.
(4) | In view of the derogation (3) which applies to the translation into Irish of acts which are not adopted jointly by the European Parliament and the Council, the chemical names in Table 3.1 of Annex VI should not be translated into Irish.(4) | С оглед на дерогацията (3), която се прилага за превод на ирландски език на актове, които не се приемат съвместно от Европейския парламент и Съвета, химичните наименования в таблица 3.1 от приложение VI не следва да се превеждат на ирландски език.
(5) | Table 3.2 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Annex VI to Council Directive 67/548/EEC (4), which has been repealed with effect from 1 June 2015. As a consequence, Table 3.2 is to be deleted in accordance with Article 1(2) of Commission Regulation (EU) 2016/1179 (5) with effect from 1 June 2017. That table should therefore not be changed. As a result Table 3.1 has been renamed to Table 3 in accordance with Article 2(2) of Commission Regulation (EU) 2017/776 (6) with effect from 1 June 2017.(5) | Таблица 3.2 съдържа списък на хармонизираните класификация и етикетиране на опасни вещества въз основа на критериите, определени в приложение VI към Директива 67/548/ЕИО на Съвета (4), която е отменена, считано от 1 юни 2015 г. Вследствие на това таблица 3.2 следва да се заличи в съответствие с член 1, параграф 2 от Регламент (ЕС) 2016/1179 на Комисията (5), считано от 1 юни 2017 г. Следователно посочената таблица не следва да бъде изменяна. Вследствие на това таблица 3.1 беше преименувана на таблица 3 в съответствие с член 2, параграф 2 от Регламент (ЕС) 2017/776 на Комисията (6), считано от 1 юни 2017 г.
(6) | Suppliers should be given sufficient time to adapt the labelling and packaging of substances and mixtures to the new translation provisions and to sell existing stocks.(6) | На доставчиците следва да се предостави достатъчно време, за да адаптират етикетирането и опаковането на веществата и смесите към новите разпоредби за превод и да продадат съществуващите запаси.
(7) | Suppliers should have the possibility of applying this Regulation before its date of application to ensure a high level of protection of human health and of the environment and to provide sufficient flexibility to suppliers.(7) | Доставчиците следва да имат възможността да прилагат настоящия регламент преди неговата дата на прилагане, за да се гарантира високо ниво на защита на човешкото здраве и на околната среда, както и да се предостави достатъчна гъвкавост на доставчиците.
(8) | The measures provided for in this Regulation are in accordance with the opinion of the Committee established under Article 133 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council (7),(8) | Мерките, предвидени в настоящия регламент, са в съответствие със становището на комитета, учреден по силата на член 133 от Регламент (ЕО) № 1907/2006 на Европейския парламент и на Съвета (7),
HAS ADOPTED THIS REGULATION:ПРИЕ НАСТОЯЩИЯ РЕГЛАМЕНТ:
Article 1Член 1
The entries set out in Annex VI to Regulation (EC) No 1272/2008 corresponding to the entries set out in the Annex to this Regulation are replaced by the entries set out in the Annex to this Regulation.Вписванията, посочени в приложение VI към Регламент (ЕО) № 1272/2008, съответстващи на вписванията, посочени в приложението към настоящия регламент, се заменят с вписванията, посочени в приложението към настоящия регламент.
Article 2Член 2
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.Настоящият регламент влиза в сила на двадесетия ден след деня на публикуването му в Официален вестник на Европейския съюз.
It shall apply from 1 December 2019.Той се прилага от 1 декември 2019 г.
By way of derogation from the second subparagraph, substances and mixtures may before 1 December 2019 be classified, labelled and packaged in accordance with Regulation (EC) No 1272/2008, as amended by this Regulation.Чрез дерогация от втора алинея веществата и смесите могат преди 1 декември 2019 г. да бъдат класифицирани, етикетирани и опаковани в съответствие с Регламент (ЕО) № 1272/2008, изменен с настоящия регламент.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Настоящият регламент е задължителен в своята цялост и се прилага пряко във всички държави членки.
Done at Brussels, 16 April 2018.Съставено в Брюксел на 16 април 2018 година.
For the CommissionЗа Комисията
The PresidentПредседател
Jean-Claude JUNCKERJean-Claude JUNCKER
(1)   OJ L 353, 31.12.2008, p. 1.(1)   ОВ L 353, 31.12.2008 г., стр. 1.
(2)  Corrigendum to the position of the European Parliament adopted at first reading on 3 September 2008 with a view to the adoption of Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 — P6_TA(2008)0392 (COM (2007)0355 — C6-0197/2007 — 2007/0121 (COD)).(2)  Поправка към позицията на Европейския парламент, приета на първо четене на 3 септември 2008 г. с оглед приемането на Регламент (ЕО) № 1272/2008 на Европейския парламент и на Съвета относно класифицирането, етикетирането и опаковането на вещества и смеси, за изменение и за отмяна на директиви 67/548/ЕИО и 1999/45/ЕО и за изменение на Регламент (ЕО) № 1907/2006 — P6_TA(2008)0392 (COM (2007)0355 — C6-0197/2007 — 2007/0121 (COD)).
(3)  Council Regulation (EU) No 1257/2010 of 20 December 2010 extending the temporary derogation measures from Regulation No 1 of 15 April 1958 determining the languages to be used by the European Economic Community and Regulation No 1 of 15 April 1958 determining the languages to be used by the European Atomic Energy Community introduced by Regulation (EC) No 920/2005 (OJ L 343, 29.12.2010, p. 5).(3)  Регламент (ЕС) № 1257/2010 на Съвета от 20 декември 2010 г. за удължаване на срока на действие на мерките за временна дерогация от Регламент № 1 от 15 април 1958 г. за определяне на езиковия режим на Европейската икономическа общност и от Регламент № 1 от 15 април 1958 г. относно определянето на езиковия режим в Европейската общност за атомна енергия, въведени с Регламент (ЕО) № 920/2005 (ОВ L 343, 29.12.2010 г., стр. 5).
(4)  Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (OJ 196, 16.8.1967, p. 1).(4)  Директива 67/548/ЕИО на Съвета от 27 юни 1967 г. за сближаването на законовите, подзаконовите и административните разпоредби относно класификацията, опаковането и етикетирането на опасни вещества (ОВ X 196, 16.8.1967 г., стр. 1).
(5)  Commission Regulation (EU) 2016/1179 of 19 July 2016 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (OJ L 195 de 20.7.2016, p. 11).(5)  Регламент (ЕС) 2016/1179 на Комисията от 19 юли 2016 г. за изменение с цел адаптиране към научно-техническия прогрес на Регламент (ЕО) № 1272/2008 на Европейския парламент и на Съвета относно класифицирането, етикетирането и опаковането на вещества и смеси (ОВ L 195, 20.7.2016 г., стp. 11).
(6)  Commission Regulation (EU) 2017/776 of 4 May 2017 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures (OJ L 116, 5.5.2017, p. 1).(6)  Регламент (ЕС) 2017/776 на Комисията от 4 май 2017 г. за изменение с цел адаптиране към научно-техническия прогрес на Регламент (ЕО) № 1272/2008 на Европейския парламент и на Съвета относно класифицирането, етикетирането и опаковането на вещества и смеси (ОВ L 116, 5.5.2017 г., стp. 1).
(7)  Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (OJ L 396, 30.12.2006, p. 1).(7)  Регламент (ЕО) № 1907/2006 на Европейския парламент и на Съвета от 18 декември 2006 г. относно регистрацията, оценката, разрешаването и ограничаването на химикали (REACH), за създаване на Европейска агенция по химикали, за изменение на Директива 1999/45/ЕО и за отмяна на Регламент (ЕИО) № 793/93 на Съвета и Регламент (ЕО) № 1488/94 на Комисията, както и на Директива 76/769/ЕИО на Съвета и директиви 91/155/ЕИО, 93/67/ЕИО, 93/105/ЕО и 2000/21/ЕО на Комисията (ОВ L 396, 30.12.2006 г., стр. 1).
ANNEXПРИЛОЖЕНИЕ
Index No | International Chemical Identification | EC No | CAS No | Classification | Labelling | Specific Conc. Limits, M-factors | NotesИндекс № | Международна химична идентификация | EО № | CAS № | Класификация | Етикетиране | Специфични пределни концентрации, М-коефициенти | Бележки
Hazard Class and | Category Code(s) | Hazard statement Code(s) | Pictogram, Signal Word Code(s) | Hazard statement Code(s) | Suppl. Hazard statement Code(s)Код(ове) на класа(овете) и | категорията(ите) на опасност | Код(ове) на предупреждението(ята) за опасност | Кодове на пиктограмата(ите) и сигналната(ите) дума(и) | Код(ове) на предупреждението(ята) за опасност | Код(ове) на допълнителното(ите) предупреждение(я) за опасност
(1) | (2) | (3) | (4) | (5) | (6) | (7) | (8) | (9) | (10) | (11)(1) | (2) | (3) | (4) | (5) | (6) | (7) | (8) | (9) | (10) | (11)
001-001-00-9 | hydrogen | 215-605-7 | 1333-74-0 | Flam. Gas 1 | Press. Gas | H220 | GHS02 | GHS04 | Dgr | H220 |   |   | U001-001-00-9 | водород | 215-605-7 | 1333-74-0 | Flam. Gas 1 | Press. Gas | H220 | GHS02 | GHS04 | Dgr | H220 |   |   | U
001-002-00-4 | aluminium lithium hydride | 240-877-9 | 16853-85-3 | Water-react. 1 | Skin Corr. 1A | H260 | H314 | GHS02 | GHS05 | Dgr | H260 | H314 |   |   |  001-002-00-4 | алуминиев литиев хидрид | 240-877-9 | 16853-85-3 | Water-react. 1 | Skin Corr. 1A | H260 | H314 | GHS02 | GHS05 | Dgr | H260 | H314 |   |   |  
001-003-00-X | sodium hydride | 231-587-3 | 7646-69-7 | Water-react. 1 | H260 | GHS02 | Dgr | H260 |   |   |  001-003-00-X | натриев хидрид | 231-587-3 | 7646-69-7 | Water-react. 1 | H260 | GHS02 | Dgr | H260 |   |   |  
001-004-00-5 | calcium hydride | 232-189-2 | 7789-78-8 | Water-react. 1 | H260 | GHS02 | Dgr | H260 |   |   |  001-004-00-5 | калциев хидрид | 232-189-2 | 7789-78-8 | Water-react. 1 | H260 | GHS02 | Dgr | H260 |   |   |  
003-001-00-4 | lithium | 231-102-5 | 7439-93-2 | Water-react. 1 | Skin Corr. 1B | H260 | H314 | GHS02 | GHS05 | Dgr | H260 | H314 | EUH014 |   |  003-001-00-4 | литий | 231-102-5 | 7439-93-2 | Water-react. 1 | Skin Corr. 1B | H260 | H314 | GHS02 | GHS05 | Dgr | H260 | H314 | EUH014 |   |  
003-002-00-X | n-hexyllithium | 404-950-0 | 21369-64-2 | Water-react. 1 | Pyr. Sol. 1 | Skin Corr. 1A | H260 | H250 | H314 | GHS02 | GHS05 | Dgr | H260 | H250 | H314 | EUH014 |   |  003-002-00-X | n-хексиллитий | 404-950-0 | 21369-64-2 | Water-react. 1 | Pyr. Sol. 1 | Skin Corr. 1A | H260 | H250 | H314 | GHS02 | GHS05 | Dgr | H260 | H250 | H314 | EUH014 |   |  
003-003-00-5 | (2-methylpropyl)lithium; isobutyllithium | 440-620-2 | 920-36-5 | Water-react. 1 | Pyr. Liq. 1 | Skin Corr. 1A | STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H260 | H250 | H314 | H336 | H400 | H410 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H260 | H250 | H314 | H336 | H410 | EUH014 |   |  003-003-00-5 | (2-метилпропил)литий; изобутиллитий | 440-620-2 | 920-36-5 | Water-react. 1 | Pyr. Liq. 1 | Skin Corr. 1A | STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H260 | H250 | H314 | H336 | H400 | H410 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H260 | H250 | H314 | H336 | H410 | EUH014 |   |  
004-001-00-7 | beryllium | 231-150-7 | 7440-41-7 | Carc. 1B | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | H350i | H330 | H301 | H372 ** | H319 | H335 | H315 | H317 | GHS06 | GHS08 | Dgr | H350i | H330 | H301 | H372 ** | H319 | H335 | H315 | H317 |   |   |  004-001-00-7 | берилий | 231-150-7 | 7440-41-7 | Carc. 1B | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | H350i | H330 | H301 | H372 ** | H319 | H335 | H315 | H317 | GHS06 | GHS08 | Dgr | H350i | H330 | H301 | H372 ** | H319 | H335 | H315 | H317 |   |   |  
004-002-00-2 | beryllium compounds with the exception of aluminium beryllium silicates, and with those specified elsewhere in this Annex | — | — | Carc. 1B | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H350i | H330 | H301 | H372 ** | H319 | H335 | H315 | H317 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H350i | H330 | H301 | H372 ** | H319 | H335 | H315 | H317 | H411 |   |   | A004-002-00-2 | берилиеви съединения, с изключение на алуминиеви берилиеви силикати и тези, посочени на други места в настоящото приложение | — | — | Carc. 1B | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H350i | H330 | H301 | H372 ** | H319 | H335 | H315 | H317 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H350i | H330 | H301 | H372 ** | H319 | H335 | H315 | H317 | H411 |   |   | A
004-003-00-8 | beryllium oxide | 215-133-1 | 1304-56-9 | Carc. 1B | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | H350i | H330 | H301 | H372 ** | H319 | H335 | H315 | H317 | GHS06 | GHS08 | Dgr | H350i | H330 | H301 | H372 ** | H319 | H335 | H315 | H317 |   |   |  004-003-00-8 | берилиев оксид | 215-133-1 | 1304-56-9 | Carc. 1B | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | H350i | H330 | H301 | H372 ** | H319 | H335 | H315 | H317 | GHS06 | GHS08 | Dgr | H350i | H330 | H301 | H372 ** | H319 | H335 | H315 | H317 |   |   |  
005-001-00-X | boron trifluoride | 231-569-5 | 7637-07-2 | Press. Gas | Acute Tox. 2 * | Skin Corr. 1A | H330 | H314 | GHS04 | GHS06 | GHS05 | Dgr | H330 | H314 | EUH014 |   | U005-001-00-X | борен трифлуорид | 231-569-5 | 7637-07-2 | Press. Gas | Acute Tox. 2 * | Skin Corr. 1A | H330 | H314 | GHS04 | GHS06 | GHS05 | Dgr | H330 | H314 | EUH014 |   | U
005-002-00-5 | boron trichloride | 233-658-4 | 10294-34-5 | Press. Gas | Acute Tox. 2 * | Acute Tox. 2 * | Skin Corr. 1B | H330 | H300 | H314 | GHS04 | GHS06 | GHS05 | Dgr | H330 | H300 | H314 | EUH014 |   | U005-002-00-5 | борен трихлорид | 233-658-4 | 10294-34-5 | Press. Gas | Acute Tox. 2 * | Acute Tox. 2 * | Skin Corr. 1B | H330 | H300 | H314 | GHS04 | GHS06 | GHS05 | Dgr | H330 | H300 | H314 | EUH014 |   | U
005-003-00-0 | boron tribromide | 233-657-9 | 10294-33-4 | Acute Tox. 2 * | Acute Tox. 2 * | Skin Corr. 1A | H330 | H300 | H314 | GHS06 | GHS05 | Dgr | H330 | H300 | H314 | EUH014 |   |  005-003-00-0 | борен трибромид | 233-657-9 | 10294-33-4 | Acute Tox. 2 * | Acute Tox. 2 * | Skin Corr. 1A | H330 | H300 | H314 | GHS06 | GHS05 | Dgr | H330 | H300 | H314 | EUH014 |   |  
005-004-00-6 | trialkylboranes, solid | — | — | Pyr. Sol. 1 | Skin Corr. 1B | H250 | H314 | GHS02 | GHS05 | Dgr | H250 | H314 |   |   | A005-004-00-6 | триалкилборани, твърди | — | — | Pyr. Sol. 1 | Skin Corr. 1B | H250 | H314 | GHS02 | GHS05 | Dgr | H250 | H314 |   |   | A
005-004-01-3 | trialkylboranes, liquid | — | — | Pyr. Liq. 1 | Skin Corr. 1B | H250 | H314 | GHS02 | GHS05 | Dgr | H250 | H314 |   |   | A005-004-01-3 | триалкилборани, течни | — | — | Pyr. Liq. 1 | Skin Corr. 1B | H250 | H314 | GHS02 | GHS05 | Dgr | H250 | H314 |   |   | A
005-005-00-1 | trimethyl borate | 204-468-9 | 121-43-7 | Flam. Liq. 3 | Acute Tox. 4 * | H226 | H312 | GHS02 | GHS07 | Wng | H226 | H312 |   |   |  005-005-00-1 | триметилов борат | 204-468-9 | 121-43-7 | Flam. Liq. 3 | Acute Tox. 4 * | H226 | H312 | GHS02 | GHS07 | Wng | H226 | H312 |   |   |  
005-006-00-7 | dibutyltin hydrogen borate | 401-040-5 | 75113-37-0 | Repr. 1B | Muta. 2 | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H360FD | H341 | H372** | H312 | H302 | H318 | H317 | H400 | H410 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H360FD | H341 | H372** | H312 | H302 | H318 | H317 | H410 |   |   |  005-006-00-7 | дибутилкалаен хидрогенборат | 401-040-5 | 75113-37-0 | Repr. 1B | Muta. 2 | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H360FD | H341 | H372** | H312 | H302 | H318 | H317 | H400 | H410 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H360FD | H341 | H372** | H312 | H302 | H318 | H317 | H410 |   |   |  
005-007-00-2 | boric acid; [1] | boric acid; [2] | 233-139-2 [1] | 234-343-4 [2] | 10043-35-3 [1] | 11113-50-1 [2] | Repr. 1B | H360FD | GHS08 | Dgr | H360FD |   | Repr.1B; | H360FD: C ≥ 5,5  % |  005-007-00-2 | борна киселина; [1] | борна киселина; [2] | 233-139-2 [1] | 234-343-4 [2] | 10043-35-3 [1] | 11113-50-1 [2] | Repr. 1B | H360FD | GHS08 | Dgr | H360FD |   | Repr.1B; | H360FD: C ≥ 5,5  % |  
005-008-00-8 | diboron trioxide; | boric oxide | 215-125-8 | 1303-86-2 | Repr. 1B | H360FD | GHS08 | Dgr | H360FD |   | Repr.1B; | H360FD:C ≥ 3,1  % |  005-008-00-8 | диборен триоксид; | борен оксид | 215-125-8 | 1303-86-2 | Repr. 1B | H360FD | GHS08 | Dgr | H360FD |   | Repr.1B; | H360FD:C ≥ 3,1  % |  
005-009-00-3 | tetrabutylammonium butyltriphenylborate | 418-080-4 | 120307-06-4 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  005-009-00-3 | тетрабутиламониев бутилтрифенилборат | 418-080-4 | 120307-06-4 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
005-010-00-9 | N, N-dimethylanilinium tetrakis(pentafluorophenyl)borate | 422-050-6 | 118612-00-3 | Carc. 2 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | H351 | H302 | H315 | H318 | GHS08 | GHS05 | GHS07 | Dgr | H351 | H302 | H315 | H318 |   |   |  005-010-00-9 | N, N-диметилaнилиниев тетракис(пентафлуорофенил)борат | 422-050-6 | 118612-00-3 | Carc. 2 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | H351 | H302 | H315 | H318 | GHS08 | GHS05 | GHS07 | Dgr | H351 | H302 | H315 | H318 |   |   |  
005-011-00-4 | disodium tetraborate, anhydrous; boric acid, disodium salt; [1] | tetraboron disodium heptaoxide, hydrate; [2] | orthoboric acid, sodium salt [3] | 215-540-4 [1] | 235-541-3 [2] | 237-560-2 [3] | 1330-43-4 [1] | 12267-73-1 [2] | 13840-56-7 [3] | Repr. 1B | H360FD | GHS08 | Dgr | H360FD |   | Repr. 1B; H360FD: C ≥4,5  % |  005-011-00-4 | динатриев тетраборат, безводен; динатриева сол на борната киселина; [1] | тетраборен динатриев хептаоксид хидрат; [2] | натриева сол на ортоборната киселина [3] | 215-540-4 [1] | 235-541-3 [2] | 237-560-2 [3] | 1330-43-4 [1] | 12267-73-1 [2] | 13840-56-7 [3] | Repr. 1B | H360FD | GHS08 | Dgr | H360FD |   | Repr. 1B; H360FD: C ≥4,5  % |  
005-011-01-1 | disodium tetraborate decahydrate; | borax decahydrate | 215-540-4 | 1303-96-4 | Repr. 1B | H360FD | GHS08 | Dgr | H360FD |   | Repr.1B; H360FD: C ≥ 8,5  % |  005-011-01-1 | динатриев тетраборат декахидрат; | боракс декахидрат | 215-540-4 | 1303-96-4 | Repr. 1B | H360FD | GHS08 | Dgr | H360FD |   | Repr.1B; H360FD: C ≥ 8,5  % |  
005-011-02-9 | disodium tetraborate pentahydrate; | borax pentahydrate | 215-540-4 | 12179-04-3 | Repr. 1B | H360FD | GHS08 | Dgr | H360FD |   | Repr.B; H360FD: C ≥ 6,5  % |  005-011-02-9 | динатриев тетраборат пентахидрат; | боракс пентахидрат | 215-540-4 | 12179-04-3 | Repr. 1B | H360FD | GHS08 | Dgr | H360FD |   | Repr.B; H360FD: C ≥ 6,5  % |  
005-012-00-X | diethyl{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}ammonium butyltriphenylborate | 418-070-1 | 141714-54-7 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  005-012-00-X | диетил{4-[1,5,5-трис(4-диетилaминофенил)пента-2,4-диенилиден]циклохекса-2,5-диенилиден}амониев бутилтрифенилборат | 418-070-1 | 141714-54-7 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
005-013-00-5 | diethylmethoxyborane | 425-380-9 | 7397-46-8 | Pyr. Liq. 1 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 4 | H250 | H332 | H312 | H302 | H373** | H314 | H317 | H413 | GHS02 | GHS05 | GHS08 | GHS07 | Dgr | H250 | H332 | H312 | H302 | H373** | H314 | H317 | H413 |   |   |  005-013-00-5 | диетилметоксиборан | 425-380-9 | 7397-46-8 | Pyr. Liq. 1 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 4 | H250 | H332 | H312 | H302 | H373** | H314 | H317 | H413 | GHS02 | GHS05 | GHS08 | GHS07 | Dgr | H250 | H332 | H312 | H302 | H373** | H314 | H317 | H413 |   |   |  
005-014-00-0 | 4-formylphenylboronic acid | 438-670-5 | 87199-17-5 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  005-014-00-0 | 4-формилфенилборонова киселина | 438-670-5 | 87199-17-5 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
005-015-00-6 | 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) | 414-380-4 | 140681-55-6 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H317 | H412 |   |   |  005-015-00-6 | 4-флуоро-1-хлорометил-1,4-диазониабицикло[2.2.2]октанов бис(тетрафлуороборат) | 414-380-4 | 140681-55-6 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H317 | H412 |   |   |  
005-016-00-1 | tetrabutylammonium butyl tris-(4-tert-butylphenyl)borate | 431-370-5 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  005-016-00-1 | тетрабутиламониев бутилтрис(4-трет-бутилфенил)борат | 431-370-5 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
005-017-00-7 | sodium perborate; [1] | sodium peroxometaborate; [2] | sodium peroxoborate; | [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | 239-172-9 [1] | 231-556-4 [2] | 15120-21-5 [1] | 7632-04-4 [2] | Ox. Sol. 2 | Repr. 1B | Acute Tox. 4 * | STOT SE 3 | Eye Dam. 1 | H272 | H360Df | H302 | H335 | H318 | GHS03 | GHS05 | GHS08 | GHS07 | Dgr | H272 | H360Df | H302 | H335 | H318 |   | Repr.1B; H360Df: C ≥9 % Repr.1B; H360 D: 6,5  % ≤ C <9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % |  005-017-00-7 | натриев перборат; [1] | натриев пероксометаборат; [2] | натриев пероксоборат; | [съдържащ < 0,1 % (w/w) частици с аеродинамичен диаметър по-малък от 50 μm] | 239-172-9 [1] | 231-556-4 [2] | 15120-21-5 [1] | 7632-04-4 [2] | Ox. Sol. 2 | Repr. 1B | Acute Tox. 4 * | STOT SE 3 | Eye Dam. 1 | H272 | H360Df | H302 | H335 | H318 | GHS03 | GHS05 | GHS08 | GHS07 | Dgr | H272 | H360Df | H302 | H335 | H318 |   | Repr.1B; H360Df: C ≥9 % Repr.1B; H360 D: 6,5  % ≤ C <9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % |  
005-017-01-4 | sodium perborate; [1] | sodium peroxometaborate; [2] | sodium peroxoborate; | [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | 239-172-9 [1] 231-556-4 [2] | 15120-21-5 [1] | 7632-04-4 [2] | Ox. Sol. 2 | Repr. 1B | Acute Tox. 3 * | Acute Tox. 4 * | STOT SE 3 | Eye Dam. 1 | H272 | H360Df | H331 | H302 | H335 | H318 | GHS03 | GHS06 | GHS05 | GHS08 | Dgr | H272 | H360Df | H331 | H302 | H335 | H318 |   | Repr. 1B; H360Df: C ≥9 % Repr. 1B; H360D: 6,5  % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % |  005-017-01-4 | натриев перборат; [1] | натриев пероксометаборат; [2] | натриев пероксоборат; | [съдържащ ≥ 0,1 % (w/w) частици с аеродинамичен диаметър по-малък от 50 μm] | 239-172-9 [1] 231-556-4 [2] | 15120-21-5 [1] | 7632-04-4 [2] | Ox. Sol. 2 | Repr. 1B | Acute Tox. 3 * | Acute Tox. 4 * | STOT SE 3 | Eye Dam. 1 | H272 | H360Df | H331 | H302 | H335 | H318 | GHS03 | GHS06 | GHS05 | GHS08 | Dgr | H272 | H360Df | H331 | H302 | H335 | H318 |   | Repr. 1B; H360Df: C ≥9 % Repr. 1B; H360D: 6,5  % ≤ C < 9 % Eye Dam. 1; H318: C ≥ 22 % Eye Irrit. 2; H319: 14 % ≤ C < 22 % |  
005-018-00-2 | perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1] | perboric acid, sodium salt, tetrahydrate; [2] | perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3] | sodium peroxoborate hexahydrate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | 239-172-9 [1] | 234-390-0 [2] | 231-556-4 [3] | 13517-20-9 [1] | 37244-98-7 [2] | 10486-00-7 [3] | Repr. 1B | STOT SE 3 | Eye Dam. 1 | H360Df | H335 | H318 | GHS05 | GHS08 | GHS07 | Dgr | H360Df | H335 | H318 |   | Repr. 1B; | H360Df: C ≥ 14 % Repr. 1B; | H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2; | H319: 22 % ≤ C < 36 % |  005-018-00-2 | перборна киселина (H3BO2(O2)), мононатриева сол, трихидрат; [1] | натриева сол на перборната киселина, тетрахидрат; [2] | перборна киселина (HBO(O2)), натриева сол, тетрахидрат; [3] | натриев пероксоборат хексахидрат; [съдържащ < 0,1 % (w/w) частици с аеродинамичен диаметър по-малък от 50 μm] | 239-172-9 [1] | 234-390-0 [2] | 231-556-4 [3] | 13517-20-9 [1] | 37244-98-7 [2] | 10486-00-7 [3] | Repr. 1B | STOT SE 3 | Eye Dam. 1 | H360Df | H335 | H318 | GHS05 | GHS08 | GHS07 | Dgr | H360Df | H335 | H318 |   | Repr. 1B; | H360Df: C ≥ 14 % Repr. 1B; | H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2; | H319: 22 % ≤ C < 36 % |  
005-018-01-X | perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1] | perboric acid, sodium salt, tetrahydrate; [2] | perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3] | sodium peroxoborate hexahydrate; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | 239-172-9 [1] | 234-390-0 [2] | 231-556-4 [3] | 13517-20-9 [1] | 37244-98-7 [2] | 10486-00-7 [3] | Repr. 1B | Acute Tox. 4 * | STOT SE 3 | Eye Dam. 1 | H360Df | H332 | H335 | H318 | GHS05 | GHS08 | GHS07 | Dgr | H360Df | H332 | H335 | H318 |   | Repr. 1B; H360 | Df: C ≥ 14 % Repr. 1B; H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2; H319: 22 % ≤ C < 36 % |  005-018-01-X | перборна киселина (H3BO2(O2)), мононатриева сол, трихидрат; [1] | натриева сол на перборната киселина, тетрахидрат; [2] | перборна киселина (HBO(O2)), натриева сол, тетрахидрат; [3] | натриев пероксоборат хексахидрат; [съдържащ ≥ 0,1 % (w/w) частици с аеродинамичен диаметър по-малък от 50 μm] | 239-172-9 [1] | 234-390-0 [2] | 231-556-4 [3] | 13517-20-9 [1] | 37244-98-7 [2] | 10486-00-7 [3] | Repr. 1B | Acute Tox. 4 * | STOT SE 3 | Eye Dam. 1 | H360Df | H332 | H335 | H318 | GHS05 | GHS08 | GHS07 | Dgr | H360Df | H332 | H335 | H318 |   | Repr. 1B; H360 | Df: C ≥ 14 % Repr. 1B; H360D: 10 % ≤ C < 14 % Eye Dam. 1; H318: C ≥ 36 % Eye Irrit. 2; H319: 22 % ≤ C < 36 % |  
005-019-00-8 | perboric acid, sodium salt; [1] | perboric acid, sodium salt, monohydrate; [2] | perboric acid (HBO(O2)), sodium salt, monohydrate; [3] | sodium peroxoborate; | [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | 234-390-0 [1] | 234-390-0 [2] | 231-556-4 [3] | 11138-47-9 [1] | 12040-72-1 [2] | 10332-33-9 [3] | Ox. Sol. 3 | Repr. 1B | Acute Tox. 4 * | STOT SE 3 | Eye Dam. 1 | H272 | H360Df | H302 | H335 | H318 | GHS03 | GHS05 | GHS08 | GHS07 | Dgr | H272 | H360Df | H302 | H335 | H318 |   | Repr. 1B; H360Df: C ≥ 9 % | Repr. 1B; H360D: 6,5  % ≤ C < 9 % | Eye Dam. 1; H318: C ≥ 22 % | Eye Irrit. 2; H319: 14 % ≤ C < 22 % |  005-019-00-8 | натриева сол на перборната киселина; [1] | натриева сол на перборната киселина, монохидрат; [2] | натриева сол на перборната киселина (HBO(O2)), монохидрат; [3] | натриев пероксоборат; | [съдържащ < 0,1 % (w/w) частици с аеродинамичен диаметър по-малък от 50 μm] | 234-390-0 [1] | 234-390-0 [2] | 231-556-4 [3] | 11138-47-9 [1] | 12040-72-1 [2] | 10332-33-9 [3] | Ox. Sol. 3 | Repr. 1B | Acute Tox. 4 * | STOT SE 3 | Eye Dam. 1 | H272 | H360Df | H302 | H335 | H318 | GHS03 | GHS05 | GHS08 | GHS07 | Dgr | H272 | H360Df | H302 | H335 | H318 |   | Repr. 1B; H360Df: C ≥ 9 % | Repr. 1B; H360D: 6,5  % ≤ C < 9 % | Eye Dam. 1; H318: C ≥ 22 % | Eye Irrit. 2; H319: 14 % ≤ C < 22 % |  
005-019-01-5 | perboric acid, sodium salt; [1] | perboric acid, sodium salt, monohydrate; [2] | perboric acid (HBO(O2)), sodium salt, monohydrate;[3] | sodium peroxoborate; | [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | 234-390-0 [1] | 234-390-0 [2] | 231-556-4 [3] | 11138-47-9 [1] | 12040-72-1 [2] | 10332-33-9 [3] | Ox. Sol. 3 | Repr. 1B | Acute Tox. 3 * | Acute Tox. 4 * | STOT SE 3 | Eye Dam. 1 | H272 | H360Df | H331 | H302 | H335 | H318 | GHS03 | GHS06 | GHS05 | GHS08 | Dgr | H272 | H360Df | H331 | H302 | H335 | H318 |   | Repr. 1B; H360Df: C ≥ | 9 % | Repr. 1B; H360D: 6,5  % | ≤ C < 9 % | Eye Dam. 1; H318: C ≥ 22 % | Eye Irrit. 2; H319: 14 % ≤ C < 22 % |  005-019-01-5 | натриева сол на перборната киселина; [1] | натриева сол на перборната киселина, монохидрат; [2] | натриева сол на перборната киселина (HBO(O2)), монохидрат;[3] | натриев пероксоборат; | [съдържащ ≥ 0,1 % (w/w) частици с аеродинамичен диаметър по-малък от 50 μm] | 234-390-0 [1] | 234-390-0 [2] | 231-556-4 [3] | 11138-47-9 [1] | 12040-72-1 [2] | 10332-33-9 [3] | Ox. Sol. 3 | Repr. 1B | Acute Tox. 3 * | Acute Tox. 4 * | STOT SE 3 | Eye Dam. 1 | H272 | H360Df | H331 | H302 | H335 | H318 | GHS03 | GHS06 | GHS05 | GHS08 | Dgr | H272 | H360Df | H331 | H302 | H335 | H318 |   | Repr. 1B; H360Df: C ≥ | 9 % | Repr. 1B; H360D: 6,5  % | ≤ C < 9 % | Eye Dam. 1; H318: C ≥ 22 % | Eye Irrit. 2; H319: 14 % ≤ C < 22 % |  
006-001-00-2 | carbon monoxide | 211-128-3 | 630-08-0 | Flam. Gas 1 | Press. Gas | Repr. 1A | Acute Tox. 3 * | STOT RE 1 | H220 | H360D *** | H331 | H372 ** | GHS02 | GHS04 | GHS06 | GHS08 | Dgr | H220 | H360D *** H331 | H372 ** |   |   | U006-001-00-2 | въглероден моноксид | 211-128-3 | 630-08-0 | Flam. Gas 1 | Press. Gas | Repr. 1A | Acute Tox. 3 * | STOT RE 1 | H220 | H360D *** | H331 | H372 ** | GHS02 | GHS04 | GHS06 | GHS08 | Dgr | H220 | H360D *** H331 | H372 ** |   |   | U
006-002-00-8 | phosgene; carbonyl chloride | 200-870-3 | 75-44-5 | Press. Gas | Acute Tox. 2 * | Skin Corr. 1B | H330 | H314 | GHS04 | GHS06 | GHS05 | Dgr | H330 | H314 |   |   | U006-002-00-8 | фосген; карбонилхлорид | 200-870-3 | 75-44-5 | Press. Gas | Acute Tox. 2 * | Skin Corr. 1B | H330 | H314 | GHS04 | GHS06 | GHS05 | Dgr | H330 | H314 |   |   | U
006-003-00-3 | carbon disulphide | 200-843-6 | 75-15-0 | Flam. Liq. 2 | Repr. 2 | STOT RE 1 | Eye Irrit. 2 | Skin Irrit. 2 | H225 | H361fd | H372 ** | H319 | H315 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H361fd | H372 ** | H319 | H315 |   | Repr. 2; H361fd: C ≥ 1 % | STOT RE 1; H372: C ≥ 1 % | STOT RE 2; H373: 0,2  % | ≤ C < 1 % |  006-003-00-3 | въглероден дисулфид | 200-843-6 | 75-15-0 | Flam. Liq. 2 | Repr. 2 | STOT RE 1 | Eye Irrit. 2 | Skin Irrit. 2 | H225 | H361fd | H372 ** | H319 | H315 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H361fd | H372 ** | H319 | H315 |   | Repr. 2; H361fd: C ≥ 1 % | STOT RE 1; H372: C ≥ 1 % | STOT RE 2; H373: 0,2  % | ≤ C < 1 % |  
006-004-00-9 | calcium carbide | 200-848-3 | 75-20-7 | Water-react. 1 | H260 | GHS02 | Dgr | H260 |   |   | T006-004-00-9 | калциев карбид | 200-848-3 | 75-20-7 | Water-react. 1 | H260 | GHS02 | Dgr | H260 |   |   | T
006-005-00-4 | thiram (ISO); | tetramethylthiuram disulphide | 205-286-2 | 137-26-8 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H302 | H373 ** | H319 | H315 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H332 | H302 | H373 ** | H319 | H315 | H317 | H410 |   | M = 10 |  006-005-00-4 | тирам (ISO); | тeтраметилтиурам дисулфид | 205-286-2 | 137-26-8 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H302 | H373 ** | H319 | H315 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H332 | H302 | H373 ** | H319 | H315 | H317 | H410 |   | M = 10 |  
006-006-00-X | hydrogen cyanide; | hydrocyanic acid | 200-821-6 | 74-90-8 | Flam. Liq. 1 | Acute Tox. 2 * Aquatic Acute 1 | Aquatic Chronic 1 | H224 | H330 | H400 | H410 | GHS02 | GHS06 | GHS09 | Dgr | H224 | H330 | H410 |   |   |  006-006-00-X | водороден цианид; | циановодородна киселина | 200-821-6 | 74-90-8 | Flam. Liq. 1 | Acute Tox. 2 * Aquatic Acute 1 | Aquatic Chronic 1 | H224 | H330 | H400 | H410 | GHS02 | GHS06 | GHS09 | Dgr | H224 | H330 | H410 |   |   |  
006-006-01-7 | hydrogen cyanide … %; | hydrocyanic acid … % | 200-821-6 | 74-90-8 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H310 | H300 | H410 |   |   | B006-006-01-7 | водороден цианид…%; | циановодородна киселина,…% | 200-821-6 | 74-90-8 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H310 | H300 | H410 |   |   | B
006-007-00-5 | salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex | — | — | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H310 | H300 | H410 | EUH032 |   | A006-007-00-5 | соли на водородния цианид, с изключение на комплексни цианиди като фероцианиди, ферицианиди и живачен оксицианид и тези, посочени на други места в настоящото приложение | — | — | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H310 | H300 | H410 | EUH032 |   | A
006-008-00-0 | antu (ISO); | 1-(1-naphthyl)-2-thiourea | 201-706-3 | 86-88-4 | Acute Tox. 2 * | Carc. 2 | H300 | H351 | GHS06 | GHS08 | Dgr | H300 | H351 |   |   |  006-008-00-0 | анту (ISO); | 1-(1-нафтил)-2-тиоуреа | 201-706-3 | 86-88-4 | Acute Tox. 2 * | Carc. 2 | H300 | H351 | GHS06 | GHS08 | Dgr | H300 | H351 |   |   |  
006-009-00-6 | 1-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate; | isolan | 204-318-2 | 119-38-0 | Acute Tox. 1 | Acute Tox. 2 * | H310 | H300 | GHS06 | Dgr | H310 | H300 |   |   |  006-009-00-6 | 1-изопропил-3-метилпиразол-5-илов диметилкарбамат; | изолан | 204-318-2 | 119-38-0 | Acute Tox. 1 | Acute Tox. 2 * | H310 | H300 | GHS06 | Dgr | H310 | H300 |   |   |  
006-010-00-1 | 5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate 5,5-dimethyldihydroresorcinol dimethylcarbamate; dimetan | 204-525-8 | 122-15-6 | Acute Tox. 3 * | H301 | GHS06 | Dgr | H301 |   |   |  006-010-00-1 | 5,5-диметил-3-oксоциклохекс-1-eнилов диметилкарбамат 5,5-диметилдихидрорезорцинол диметилкарбамат; диметан | 204-525-8 | 122-15-6 | Acute Tox. 3 * | H301 | GHS06 | Dgr | H301 |   |   |  
006-011-00-7 | carbaryl (ISO); | 1-naphthyl methylcarbamate | 200-555-0 | 63-25-2 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | H351 | H332 | H302 | H400 | GHS08 | GHS07 | GHS09 | Wng | H351 | H332 | H302 | H400 |   | M=100 |  006-011-00-7 | карбарил (ISO); | 1-нафтилов метилкарбамат | 200-555-0 | 63-25-2 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | H351 | H332 | H302 | H400 | GHS08 | GHS07 | GHS09 | Wng | H351 | H332 | H302 | H400 |   | M=100 |  
006-012-00-2 | ziram (ISO); | zinc bis dimethyldithiocarbamate | 205-288-3 | 137-30-4 | Acute Tox. 2 * | Acute Tox. 4 * | STOT RE 2 * | STOT SE 3 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H302 | H373 ** | H335 | H318 | H317 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H330 | H302 | H373 ** | H335 | H318 | H317 | H410 |   | M = 100 |  006-012-00-2 | цирам (ISO); | цинков бисдиметилдитиокарбамат | 205-288-3 | 137-30-4 | Acute Tox. 2 * | Acute Tox. 4 * | STOT RE 2 * | STOT SE 3 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H302 | H373 ** | H335 | H318 | H317 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H330 | H302 | H373 ** | H335 | H318 | H317 | H410 |   | M = 100 |  
006-013-00-8 | metam-sodium (ISO); | sodium methyldithiocarbamate | 205-293-0 | 137-42-8 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H317 | H410 | EUH031 |   |  006-013-00-8 | метам-натрий (ISO); | натриев метилдитиокарбамат | 205-293-0 | 137-42-8 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H317 | H410 | EUH031 |   |  
006-014-00-3 | nabam (ISO); | disodium ethylenebis(N, N'-dithiocarbamate) | 205-547-0 | 142-59-6 | Acute Tox. 4 * | STOT SE 3 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H335 | H317 | H410 | GHS07 | GHS09 | Wng | H302 | H335 | H317 | H410 |   |   |  006-014-00-3 | набам (ISO); | динатриев етиленбис(N,N′-дитиокарбамат) | 205-547-0 | 142-59-6 | Acute Tox. 4 * | STOT SE 3 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H335 | H317 | H410 | GHS07 | GHS09 | Wng | H302 | H335 | H317 | H410 |   |   |  
006-015-00-9 | diuron (ISO); | 3-(3,4-dichlorophenyl)-1,1-dimethylurea | 206-354-4 | 330-54-1 | Carc. 2 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H302 | H373** | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H302 | H373** H410 |   | M = 10 |  006-015-00-9 | диурон (ISO); | 3-(3,4-дихлорофенил)-1,1-диметилуреа | 206-354-4 | 330-54-1 | Carc. 2 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H302 | H373** | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H302 | H373** H410 |   | M = 10 |  
006-016-00-4 | propoxur (ISO); | 2-isopropyloxyphenyl N-methylcarbamate; | 2-isopropoxyphenyl methylcarbamate | 204-043-8 | 114-26-1 | Acute Tox. 3 * Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H410 |   |   |  006-016-00-4 | пропоксур (ISO); | 2-изопропилоксифенилов N-метилкарбамат; | 2-изопропоксифенилов метилкарбамат | 204-043-8 | 114-26-1 | Acute Tox. 3 * Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H410 |   |   |  
006-017-00-X | aldicarb (ISO); | 2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime | 204-123-2 | 116-06-3 | Acute Tox. 2 * | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H300 | H311 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H300 | H311 | H410 |   |   |  006-017-00-X | алдикарб (ISO); | 2-метил-2-(метилтио)пропанал-O-(N-метилкарбамоил)оксим | 204-123-2 | 116-06-3 | Acute Tox. 2 * | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H300 | H311 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H300 | H311 | H410 |   |   |  
006-018-00-5 | aminocarb (ISO); | 4-dimethylamino-3-tolyl methylcarbamate | 217-990-7 | 2032-59-9 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H311 | H301 | H410 |   |   |  006-018-00-5 | аминокарб (ISO); | 4-диметиламино-3-толилов метилкарбамат | 217-990-7 | 2032-59-9 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H311 | H301 | H410 |   |   |  
006-019-00-0 | di-allate (ISO); | S-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate | 218-961-1 | 2303-16-4 | Carc. 2 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H302 | H410 |   |   |  006-019-00-0 | ди-алат (ISO); | S-(2,3-дихлороалил)-N,N-диизопропилтиокарбамат | 218-961-1 | 2303-16-4 | Carc. 2 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H302 | H410 |   |   |  
006-020-00-6 | barban (ISO); | 4-chlorbut-2-ynyl N-(3-chlorophenyl)carbamate | 202-930-4 | 101-27-9 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  006-020-00-6 | барбан (ISO); | 4-хлоробут-2-инилов N-(3-хлорофенил)карбамат | 202-930-4 | 101-27-9 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  
006-021-00-1 | linuron (ISO); | 3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea | 206-356-5 | 330-55-2 | Repr. 1B Carc. 2 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H360Df | H351 | H302 | H373 ** | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H360Df | H351 | H302 | H373 ** | H410 |   |   |  006-021-00-1 | линурон (ISO); | 3-(3,4-дихлорофенил)-1-метил-1-метоксиуреа | 206-356-5 | 330-55-2 | Repr. 1B Carc. 2 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H360Df | H351 | H302 | H373 ** | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H360Df | H351 | H302 | H373 ** | H410 |   |   |  
006-022-00-7 | decarbofuran (ISO); | 2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate | — | 1563-67-3 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H331 | H311 | H301 | GHS06 | Dgr | H331 | H311 | H301 |   |   |  006-022-00-7 | декарбофуран (ISO); | 2-метил-2,3-дихидробензофуран-7-илов метилкарбамат | — | 1563-67-3 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H331 | H311 | H301 | GHS06 | Dgr | H331 | H311 | H301 |   |   |  
006-023-00-2 | mercaptodimethur (ISO); | methiocarb (ISO); | 3,5-dimethyl-4-methylthiophenyl N-methylcarbamate | 217-991-2 | 2032-65-7 | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H410 |   |   |  006-023-00-2 | мeркаптодиметур (ISO); | мeтиокарб (ISO); | 3,5-диметил-4-мeтилтиофенилов N-метилкарбамат | 217-991-2 | 2032-65-7 | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H410 |   |   |  
006-024-00-8 | proxan-sodium (ISO); | sodium O-isopropyldithiocarbonate | 205-443-5 | 140-93-2 | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Chronic 2 | H302 | H315 | H411 | GHS07 | GHS09 | Wng | H302 | H315 | H411 |   |   |  006-024-00-8 | проксан-натрий (ISO); | натриев О-изопропилдитиокарбонат | 205-443-5 | 140-93-2 | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Chronic 2 | H302 | H315 | H411 | GHS07 | GHS09 | Wng | H302 | H315 | H411 |   |   |  
006-025-00-3 | allethrin; | (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; bioallethrin; | (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [1] | S-bioallethrin; [3] | (S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [2] | esbiothrin; | (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate [3] | 209-542-4 [1] | 249-013-5 [2]-[3] | 584-79-2 [1] | 28434-00-6 [2] | 84030-86-4 [3] | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H302 | H410 |   |   | C006-025-00-3 | алетрин; | (RS)-3-алил-2-метил-4-oксоциклопент-2-eнилов (1RS,3RS;1RS,3SR)-2,2-диметил-3-(2-метилпроп-1-eнил)циклопропанкарбоксилат; биоалетрин; | (RS)-3-алил-2-метил-4-oксоциклопент-2-eнилов (1R,3R)-2,2-диметил-3-(2-метилпроп-1-eнил)циклопропанкарбоксилат; [1] | S-биоалетрин; [3] | (S)-3-алил-2-метил-4-oксоциклопент-2-eнилов (1R,3R)-2,2-диметил-3-(2-метилпроп-1-eнил)циклопропанкарбоксилат; [2] | есбиотрин; | (RS)-3-алил-2-метил-4-oксоциклопент-2-eнилов (1R,3R)-2,2-диметил-3-(2-метилпроп-1-eнил)циклопропанкарбоксилат [3] | 209-542-4 [1] | 249-013-5 [2]-[3] | 584-79-2 [1] | 28434-00-6 [2] | 84030-86-4 [3] | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H302 | H410 |   |   | C
006-026-00-9 | carbofuran (ISO); | 2,3-dihydro-2,2-dimethylbenzofuran-7-yl N-methylcarbamate | 216-353-0 | 1563-66-2 | Acute Tox. 2 * | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H300 | H410 |   |   |  006-026-00-9 | карбофуран (ISO); | 2,2-диметил-2,3-дихидробензофуран-7-илов N-метилкарбамат | 216-353-0 | 1563-66-2 | Acute Tox. 2 * | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H300 | H410 |   |   |  
006-028-00-X | dinobuton (ISO); | 2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate | 213-546-1 | 973-21-7 | Acute Tox. 3 * Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H410 |   |   |  006-028-00-X | динобутон (ISO); | 2-(1-метилпропил)-4,6-динитрофенилов изопропилов карбонат | 213-546-1 | 973-21-7 | Acute Tox. 3 * Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H410 |   |   |  
006-029-00-5 | dioxacarb (ISO); | 2-(1,3-dioxolan-2-yl)phenyl N-methylcarbamate | 230-253-4 | 6988-21-2 | Acute Tox. 3 * Aquatic Chronic 2 | H301 | H411 | GHS06 | GHS09 | Dgr | H301 | H411 |   |   |  006-029-00-5 | диоксакарб (ISO); | 2-(1,3-диоксолан-2-ил)фенилов N-метилкарбамат | 230-253-4 | 6988-21-2 | Acute Tox. 3 * Aquatic Chronic 2 | H301 | H411 | GHS06 | GHS09 | Dgr | H301 | H411 |   |   |  
006-030-00-0 | EPTC (ISO); | S-ethyl dipropylthiocarbamate | 212-073-8 | 759-94-4 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  006-030-00-0 | EPTC (ISO); | S-етилов дипропилтиокарбамат | 212-073-8 | 759-94-4 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
006-031-00-6 | formetanate (ISO); | 3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate | 244-879-0 | 22259-30-9 | Acute Tox. 2 * | Acute Tox. 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H300 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H300 | H317 | H410 |   |   |  006-031-00-6 | форметанат (ISO); | 3-[(EZ)-диметиламинометиленамино]фенилов метилкарбамат | 244-879-0 | 22259-30-9 | Acute Tox. 2 * | Acute Tox. 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H300 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H300 | H317 | H410 |   |   |  
006-032-00-1 | monolinuron (ISO); | 3-(4-chlorophenyl)-1-methoxy-1-methylurea | 217-129-5 | 1746-81-2 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373 ** | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373 ** | H410 |   |   |  006-032-00-1 | мoнолинурон (ISO); | 1-метил-1-метокси-3-(4-хлорофенил)уреа | 217-129-5 | 1746-81-2 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373 ** | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373 ** | H410 |   |   |  
006-033-00-7 | metoxuron (ISO); | 3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea | 243-433-2 | 19937-59-8 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  006-033-00-7 | мeтоксурон (ISO); | 1,1-диметил-3-(4-метокси-3-хлорофенил)уреа | 243-433-2 | 19937-59-8 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
006-034-00-2 | pebulate (ISO); | N-butyl-N-ethyl-S-propylthiocarbamate | 214-215-4 | 1114-71-2 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  006-034-00-2 | пебулат (ISO); | N-бутил-N-етил-S-пропилтиокарбамат | 214-215-4 | 1114-71-2 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
006-036-00-3 | benzthiazuron (ISO); | 1-benzothiazol-2-yl-3-methylurea | 217-685-9 | 1929-88-0 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  006-036-00-3 | бензтиазурон (ISO); | 1-бензoтиазол-2-ил-3-метилуреа | 217-685-9 | 1929-88-0 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
006-037-00-9 | promecarb (ISO); | 3-isopropyl-5-methylphenyl N-methylcarbamate | 220-113-0 | 2631-37-0 | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H410 |   |   |  006-037-00-9 | промекарб (ISO); | 3-изопропил-5-метилфенилов N-метилкарбамат | 220-113-0 | 2631-37-0 | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H410 |   |   |  
006-038-00-4 | sulfallate (ISO); | 2-chloroallyl N, N-dimethyldithiocarbamate | 202-388-9 | 95-06-7 | Carc. 1B | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H410 |   |   |  006-038-00-4 | сулфалат (ISO); | 2-хлороалилов N, N-диметилдитиокарбамат | 202-388-9 | 95-06-7 | Carc. 1B | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H410 |   |   |  
006-039-00-X | tri-allate (ISO); | S-2,3,3-trichloroallyl diisopropylthiocarbamate | 218-962-7 | 2303-17-5 | Acute Tox. 4 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373 ** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373 ** | H317 | H410 |   |   |  006-039-00-X | три-алат (ISO); | S-2,3,3-трихлороалилов диизопропилтиокарбамат | 218-962-7 | 2303-17-5 | Acute Tox. 4 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373 ** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373 ** | H317 | H410 |   |   |  
006-040-00-5 | 3-methylpyrazol-5-yl-dimethylcarbamate; monometilan | — | 2532-43-6 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H331 | H311 | H301 | GHS06 | Dgr | H331 | H311 | H301 |   |   |  006-040-00-5 | 3-мeтилпиразол-5-ил-диметилкарбамат; монометилан | — | 2532-43-6 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H331 | H311 | H301 | GHS06 | Dgr | H331 | H311 | H301 |   |   |  
006-041-00-0 | dimethylcarbamoyl chloride | 201-208-6 | 79-44-7 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H350 | H331 | H302 | H319 | H335 | H315 | GHS06 | GHS08 | Dgr | H350 | H331 | H302 | H319 | H335 | H315 |   | Carc. 1B; | H350: C ≥ 0,001  % |  006-041-00-0 | диметилкарбамоилхлорид | 201-208-6 | 79-44-7 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H350 | H331 | H302 | H319 | H335 | H315 | GHS06 | GHS08 | Dgr | H350 | H331 | H302 | H319 | H335 | H315 |   | Carc. 1B; | H350: C ≥ 0,001  % |  
006-042-00-6 | monuron (ISO); | 3-(4-chlorophenyl)-1,1-dimethylurea | 205-766-1 | 150-68-5 | Carc. 2 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H302 | H410 |   |   |  006-042-00-6 | мoнурон (ISO); | 1,1-диметил-3-(4-хлорофенил)уреа | 205-766-1 | 150-68-5 | Carc. 2 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H302 | H410 |   |   |  
006-043-00-1 | 3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate; | monuron-TCA | — | 140-41-0 | Carc. 2 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H319 | H315 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H319 | H315 | H410 |   |   |  006-043-00-1 | 1,1-диметил-3-(4-хлорофенил)урониев трихлороацетат; | мoнурон-TCA | — | 140-41-0 | Carc. 2 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H319 | H315 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H319 | H315 | H410 |   |   |  
006-044-00-7 | isoproturon (ISO); | 3-(4-isopropylphenyl)-1,1-dimethylurea | 251-835-4 | 34123-59-6 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   | M = 10 |  006-044-00-7 | изопротурон (ISO); | 3-(4-изопропилфенил)-1,1-диметилуреа | 251-835-4 | 34123-59-6 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   | M = 10 |  
006-045-00-2 | methomyl (ISO); | 1-(methylthio)ethylideneamino N-methylcarbamate | 240-815-0 | 16752-77-5 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H410 |   | M=100 |  006-045-00-2 | метомил (ISO); | 1-(метилтио)етилиденамино-N-метилкарбамат | 240-815-0 | 16752-77-5 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H410 |   | M=100 |  
006-047-00-3 | bufencarb (ISO); | reaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate | — | 8065-36-9 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H311 | H301 | H410 |   |   |  006-047-00-3 | буфенкарб (ISO); | реакционна маса от 3-(1-мeтилбутил)фенилов N-метилкарбамат и 3-(1-етилпропил)фенилов N-метилкарбамат | — | 8065-36-9 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H311 | H301 | H410 |   |   |  
006-048-00-9 | ethiofencarb (ISO); | 2-(ethylthiomethyl)phenyl N-methylcarbamate | 249-981-9 | 29973-13-5 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  006-048-00-9 | етиофенкарб (ISO); | 2-(етилтиометил)фенилов N-метилкарбамат | 249-981-9 | 29973-13-5 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
006-049-00-4 | dixanthogen; | O, O-diethyl dithiobis(thioformate) | 207-944-4 | 502-55-6 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  006-049-00-4 | диксантоген; | O, O-диетилов дитиобис(тиоформат) | 207-944-4 | 502-55-6 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
006-050-00-X | 1,1-dimethyl-3-phenyluronium trichloroacetate; | fenuron-TCA | — | 4482-55-7 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H410 |   |   |  006-050-00-X | 1,1-диметил-3-фенилурониев трихлороацетат; | фенурон-TCA | — | 4482-55-7 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H410 |   |   |  
006-051-00-5 | ferbam (ISO); | iron tris(dimethyldithiocarbamate) | 238-484-2 | 14484-64-1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H335 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H410 |   |   |  006-051-00-5 | фербам (ISO); | железен трис(диметилдитиокарбамат) | 238-484-2 | 14484-64-1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H335 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H410 |   |   |  
006-052-00-0 | formetanate hydrochloride; | 3-(N, N-dimethylaminomethyleneamino)phenyl N-methylcarbamate | 245-656-0 | 23422-53-9 | Acute Tox. 2 * | Acute Tox. 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H300 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H300 | H317 | H410 |   |   |  006-052-00-0 | форметанат хидрохлорид; | 3-(N, N-диметиламинометиленамино)фенилов N-метилкарбамат | 245-656-0 | 23422-53-9 | Acute Tox. 2 * | Acute Tox. 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H300 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H300 | H317 | H410 |   |   |  
006-053-00-6 | isoprocarb (ISO); | 2-isopropylphenyl N-methylcarbamate | 220-114-6 | 2631-40-5 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  006-053-00-6 | изопрокарб (ISO); | 2-изопропилфенилов N-метилкарбамат | 220-114-6 | 2631-40-5 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
006-054-00-1 | mexacarbate (ISO); | 3,5-dimethyl-4-dimethylaminophenyl N-methylcarbamate | 206-249-3 | 315-18-4 | Acute Tox. 2 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H312 | H410 |   |   |  006-054-00-1 | мeксакарбат (ISO); | 3,5-диметил-4-диметиламинофенилов N-метилкарбамат | 206-249-3 | 315-18-4 | Acute Tox. 2 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H312 | H410 |   |   |  
006-055-00-7 | xylylcarb (ISO); | 3,4-dimethylphenyl N-methylcarbamate; | 3,4-xylyl methylcarbamate; | MPMC | 219-364-9 | 2425-10-7 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  006-055-00-7 | ксилилкарб (ISO); | 3,4-диметилфенилов N-метилкарбамат; | 3,4-ксилилов метилкарбамат; | MPMC | 219-364-9 | 2425-10-7 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
006-056-00-2 | metolcarb (ISO); | m-tolyl methylcarbamate; | MTMC | 214-446-0 | 1129-41-5 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  006-056-00-2 | мeтолкарб (ISO); | m-тoлилов метилкарбамат; | MTMC | 214-446-0 | 1129-41-5 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
006-057-00-8 | nitrapyrin (ISO); | 2-chloro-6-trichloromethylpyridine | 217-682-2 | 1929-82-4 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  006-057-00-8 | нитрапирин (ISO); | 2-хлоро-6-трихлорометилпиридин | 217-682-2 | 1929-82-4 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
006-058-00-3 | noruron (ISO); | 1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urea | — | 2163-79-3 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  006-058-00-3 | норурон (ISO); | 1,1-диметил-3-(перхидро-4,7-метаноинден-5-ил)уреа | — | 2163-79-3 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
006-059-00-9 | oxamyl (ISO); | N',N'-dimethylcarbamoyl(methylthio)methylenamine N-methylcarbamate; | 245-445-3 | 23135-22-0 | Acute Tox. 2 * | Acute Tox. 2 * | Acute Tox. 4 * | Aquatic Chronic 2 | H330 | H300 | H312 | H411 | GHS06 | GHS09 | Dgr | H330 | H300 | H312 | H411 |   |   |  006-059-00-9 | оксамил (ISO); | N′,N′-диметилкарбамоил(метилтио)метиленамин-N-метилкарбамат; | 245-445-3 | 23135-22-0 | Acute Tox. 2 * | Acute Tox. 2 * | Acute Tox. 4 * | Aquatic Chronic 2 | H330 | H300 | H312 | H411 | GHS06 | GHS09 | Dgr | H330 | H300 | H312 | H411 |   |   |  
006-060-00-4 | oxycarboxin (ISO); | 2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide | 226-066-2 | 5259-88-1 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  006-060-00-4 | оксикарбоксин (ISO); | 2,3-дихидро-6-метил-5-(N-фенилкарбамоил)-1,4 оксотиин-4,4-диоксид | 226-066-2 | 5259-88-1 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
006-061-00-X | S-ethyl N-(dimethylaminopropyl)thiocarbamatehydrochloride; | prothiocarb hydrochloride | 243-193-9 | 19622-19-6 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  006-061-00-X | S-етилов N-(диметиламинопропил)тиокарбаматхидрохлорид; | протиокарб хидрохлорид | 243-193-9 | 19622-19-6 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
006-062-00-5 | methyl 3,4-dichlorophenylcarbanilate; | SWEP. | — | 1918-18-9 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  006-062-00-5 | мeтилов 3,4-дихлорофенилкарбанилат; | SWEP. | — | 1918-18-9 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
006-063-00-0 | thiobencarb (ISO); | S-4-chlorobenzyl diethylthiocarbamate | 248-924-5 | 28249-77-6 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  006-063-00-0 | тиобенкарб (ISO); | S-4-хлоробензилов диетилтиокарбамат; | 248-924-5 | 28249-77-6 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
006-064-00-6 | thiofanox (ISO); | 3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime | 254-346-4 | 39196-18-4 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   |   |  006-064-00-6 | тиофанокс (ISO); | 3,3-диметил-1-(метилтио)бутанон-О-(N-метилкарбамоил)oксим | 254-346-4 | 39196-18-4 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   |   |  
006-065-00-1 | 3-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime; | triamid | — | 15271-41-7 | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Chronic 2 | H300 | H311 | H411 | GHS06 | GHS09 | Dgr | H300 | H311 | H411 |   |   |  006-065-00-1 | 3-хлоро-6-цианобицикло[2.2.1]хептан-2-oн-О-(N-метилкарбамоил)oксим; | триамид | — | 15271-41-7 | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Chronic 2 | H300 | H311 | H411 | GHS06 | GHS09 | Dgr | H300 | H311 | H411 |   |   |  
006-066-00-7 | vernolate (ISO); | S-propyl dipropylthiocarbamate | 217-681-7 | 1929-77-7 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  006-066-00-7 | вернолат (ISO); | S-пропилов дипропилтиокарбамат | 217-681-7 | 1929-77-7 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
006-067-00-2 | XMC; | 3,5-xylyl methylcarbamate | — | 2655-14-3 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  006-067-00-2 | XMC; | 3,5-ксилилов метилкарбамат | — | 2655-14-3 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
006-068-00-8 | diazomethane | 206-382-7 | 334-88-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  006-068-00-8 | диазометан | 206-382-7 | 334-88-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
006-069-00-3 | thiophanate-methyl (ISO); | 1,2-di-(3-methoxycarbonyl-2-thioureido)benzene | 245-740-7 | 23564-05-8 | Muta. 2 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H332 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H341 | H332 | H317 | H410 |   |   |  006-069-00-3 | тиофанат-мeтил (ISO); | 1,2-ди(3-метоксикарбонил-2-тиоуреидо)бензен | 245-740-7 | 23564-05-8 | Muta. 2 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H332 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H341 | H332 | H317 | H410 |   |   |  
006-070-00-9 | furmecyclox (ISO); | N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide | 262-302-0 | 60568-05-0 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   |   |  006-070-00-9 | фурмециклокс (ISO); | 2,5-диметил-N-метокси-N-циклохексил-3-фурамид | 262-302-0 | 60568-05-0 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   |   |  
006-071-00-4 | cyclooct-4-en-1-yl methyl carbonate | 401-620-8 | 87731-18-8 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  006-071-00-4 | циклоокт-4-eн-1-илов метилов карбонат | 401-620-8 | 87731-18-8 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
006-072-00-X | prosulfocarb (ISO); | S-benzyl N, N-dipropylthiocarbamate | 401-730-6 | 52888-80-9 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  006-072-00-X | просулфокарб (ISO); | S-бензилов N, N-дипропилтиокарбамат | 401-730-6 | 52888-80-9 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  
006-073-00-5 | 3-(dimethylamino)propylurea | 401-950-2 | 31506-43-1 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  006-073-00-5 | 3-(диметиламино)пропилуреа | 401-950-2 | 31506-43-1 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
006-074-00-0 | 2-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate | 402-440-2 | 2094-99-7 | Acute Tox. 2 * | Skin Corr. 1B | STOT RE 2 * | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H314 | H373 ** | H334 | H317 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H330 | H314 | H373 ** | H334 | H317 | H410 |   |   |  006-074-00-0 | 2-(3-(проп-1-eн-2-ил)фенил)проп-2-илов изоцианат | 402-440-2 | 2094-99-7 | Acute Tox. 2 * | Skin Corr. 1B | STOT RE 2 * | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H314 | H373 ** | H334 | H317 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H330 | H314 | H373 ** | H334 | H317 | H410 |   |   |  
006-076-00-1 | mancozeb (ISO); | manganese | ethylenebis(dithiocarbamate) | (polymeric) complex with zinc salt | — | 8018-01-7 | Repr. 2 | Skin Sens. 1 | Aquatic Acute 1 | H361d*** | H317 | H400 | GHS08 | GHS07 | GHS09 | Wng | H361d*** | H317 | H400 |   | M=10 |  006-076-00-1 | манкоцеб (ISO); | манганов | етиленбис(дитиокарбамат) | (полимерен) комплекс с цинкова сол | — | 8018-01-7 | Repr. 2 | Skin Sens. 1 | Aquatic Acute 1 | H361d*** | H317 | H400 | GHS08 | GHS07 | GHS09 | Wng | H361d*** | H317 | H400 |   | M=10 |  
006-077-00-7 | maneb (ISO); | manganese | ethylenebis(dithiocarbamate) | (polymeric) | 235-654-8 | 12427-38-2 | Repr. 2 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d*** | H332 | H319 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H361d*** | H332 | H319 | H317 | H410 |   | M=10 |  006-077-00-7 | манеб (ISO); | манганов | етиленбис(дитиокарбамат) | (полимерен) | 235-654-8 | 12427-38-2 | Repr. 2 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d*** | H332 | H319 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H361d*** | H332 | H319 | H317 | H410 |   | M=10 |  
006-078-00-2 | zineb (ISO); | zinc ethylenebis(dithiocarbamate) (polymeric) | 235-180-1 | 12122-67-7 | STOT SE 3 | Skin Sens. 1 | H335 | H317 | GHS07 | Wng | H335 | H317 |   |   |  006-078-00-2 | цинеб (ISO); | цинков етиленбис(дитиокарбамат) (полимерен) | 235-180-1 | 12122-67-7 | STOT SE 3 | Skin Sens. 1 | H335 | H317 | GHS07 | Wng | H335 | H317 |   |   |  
006-079-00-8 | disulfiram; | tetraethylthiuramdisulfide | 202-607-8 | 97-77-8 | Acute Tox. 4 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373 ** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373 ** | H317 | H410 |   |   |  006-079-00-8 | дисулфирам; | тетраетилтиурамдисулфид | 202-607-8 | 97-77-8 | Acute Tox. 4 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373 ** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373 ** | H317 | H410 |   |   |  
006-080-00-3 | tetramethylthiuram monosulphide | 202-605-7 | 97-74-5 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  006-080-00-3 | тeтраметилтиураммоносулфид | 202-605-7 | 97-74-5 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  
006-081-00-9 | zinc bis(dibutyldithiocarbamate) | 205-232-8 | 136-23-2 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H335 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H317 | H410 |   |   |  006-081-00-9 | цинков бис(дибутилдитиокарбамат) | 205-232-8 | 136-23-2 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H335 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H317 | H410 |   |   |  
006-082-00-4 | zinc bis(diethyldithiocarbamate) | 238-270-9 | 14324-55-1 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H335 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H335 | H315 | H317 | H410 |   |   |  006-082-00-4 | цинков бис(диетилдитиокарбамат) | 238-270-9 | 14324-55-1 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H335 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H335 | H315 | H317 | H410 |   |   |  
006-083-00-X | butocarboxim (ISO); | 3-(methylthio)-2-butanone O-[(methylamino)carbonyl]oxime | 252-139-3 | 34681-10-2 | Flam. Liq. 3 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H226 | H331 | H311 | H301 | H319 | H400 | H410 | GHS02 | GHS06 | GHS09 | Dgr | H226 | H331 | H311 | H301 | H319 | H410 |   |   |  006-083-00-X | бутокарбоксим (ISO); | 3-(метилтио)-2-бутанон-О-[(метиламино)карбонил]оксим | 252-139-3 | 34681-10-2 | Flam. Liq. 3 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H226 | H331 | H311 | H301 | H319 | H400 | H410 | GHS02 | GHS06 | GHS09 | Dgr | H226 | H331 | H311 | H301 | H319 | H410 |   |   |  
006-084-00-5 | carbosulfan (ISO); | 2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate | 259-565-9 | 55285-14-8 | Acute Tox. 2 * | Acute Tox. 3 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H301 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H301 | H317 | H410 |   |   |  006-084-00-5 | карбосулфан (ISO); | 2,2-диметил-2,3-дихидро-7-бензофурилов [(дибутиламино)тио]метилкарбамат | 259-565-9 | 55285-14-8 | Acute Tox. 2 * | Acute Tox. 3 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H301 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H301 | H317 | H410 |   |   |  
006-085-00-0 | fenobucarb (ISO); | 2-butylphenyl methylcarbamate | 223-188-8 | 3766-81-2 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  006-085-00-0 | фенобукарб (ISO); | 2-бутилфенилов метилкарбамат | 223-188-8 | 3766-81-2 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
006-086-00-6 | fenoxycarb (ISO); | ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate | 276-696-7 | 72490-01-8 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   | M = 1 | M = 10 000 |  006-086-00-6 | феноксикарб (ISO); | етилов [2-(4-феноксифенокси)eтил]карбамат | 276-696-7 | 72490-01-8 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   | M = 1 | M = 10 000 |  
006-087-00-1 | furathiocarb (ISO); | 2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate | 265-974-3 | 65907-30-4 | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 2 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H301 | H373** | H319 | H315 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H301 | H373** | H319 | H315 | H317 | H410 |   | M = 100 |  006-087-00-1 | фуратиокарб (ISO) | 2,2-диметил-2,3-дихидро-7-бензофурилов 2,4-диметил-6-окса-5-оксо-3-тиа-2,4-диазадеканоат | 265-974-3 | 65907-30-4 | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 2 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H301 | H373** | H319 | H315 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H301 | H373** | H319 | H315 | H317 | H410 |   | M = 100 |  
006-088-00-7 | benfuracarb (ISO); | ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninate | — | 82560-54-1 | Repr. 2 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H361f*** | H331 | H302 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H361f*** | H331 | H302 | H410 |   |   |  006-088-00-7 | бенфуракарб (ISO); | етилов N-[2,2-диметил-2,3-дихидробензофуран-7-илоксикарбонил(метил)аминотио]-N-изопропил-β-аланинат | — | 82560-54-1 | Repr. 2 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H361f*** | H331 | H302 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H361f*** | H331 | H302 | H410 |   |   |  
006-090-00-8 | 2-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate | 408-010-0 | 88558-41-2 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H332 | H318 | H412 | GHS05 | GHS07 | Dgr | H332 | H318 | H412 |   |   |  006-090-00-8 | 2-(3-йодопроп-2-ин-1-илокси)eтилов фенилкарбамат | 408-010-0 | 88558-41-2 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H332 | H318 | H412 | GHS05 | GHS07 | Dgr | H332 | H318 | H412 |   |   |  
006-091-00-3 | propineb (ISO); | polymeric zinc propylenebis(dithiocarbamate) | — | 9016-72-2 | Acute Tox. 4 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | H332 | H373** | H317 | H400 | GHS08 | GHS07 | GHS09 | Wng | H332 | H373** | H317 | H400 |   |   |  006-091-00-3 | пропинеб (ISO); | полимерен цинков пропиленбис(дитиокарбамат) | — | 9016-72-2 | Acute Tox. 4 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | H332 | H373** | H317 | H400 | GHS08 | GHS07 | GHS09 | Wng | H332 | H373** | H317 | H400 |   |   |  
006-092-00-9 | tert-butyl (1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamate | 425-420-5 | 98737-29-2 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  006-092-00-9 | трет-бутилов (1S)-N-[1-((2S)-2-оксиранил)-2-фенилетил]карбамат | 425-420-5 | 98737-29-2 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
006-093-00-4 | 2,2'-dithio di(ethylammonium)-bis(dibenzyldithiocarbamate) | 427-180-7 | — | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  006-093-00-4 | 2,2′-дитиоди(етиламониев) бис(дибензилдитиокарбамат) | 427-180-7 | — | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  
006-094-00-X | O-isobutyl-N-ethoxy carbonylthiocarbamate | 434-350-4 | 103122-66-3 | Flam. Liq. 3 | Carc. 1B | Muta. 1B | Acute Tox. 4 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 2 | H226 | H350 | H340 | H302 | H373** | H317 | H411 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H226 | H350 | H340 | H302 | H373** | H317 | H411 |   |   |  006-094-00-X | O-изобутил-N-етоксикарбонилтиокарбамат | 434-350-4 | 103122-66-3 | Flam. Liq. 3 | Carc. 1B | Muta. 1B | Acute Tox. 4 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 2 | H226 | H350 | H340 | H302 | H373** | H317 | H411 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H226 | H350 | H340 | H302 | H373** | H317 | H411 |   |   |  
006-095-00-5 | fosetyl-aluminium (ISO); | aluminium triethyl triphosphonate | 254-320-2 | 39148-24-8 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  006-095-00-5 | фосетил-алуминий (ISO); | алуминиев триетилтрифосфонат | 254-320-2 | 39148-24-8 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
006-096-00-0 | chlorpropham (ISO); | isopropyl 3-chlorocarbanilate | 202-925-7 | 101-21-3 | Carc. 2 | STOT RE 2 * | Aquatic Chronic 2 | H351 | H373** | H411 | GHS08 | GHS09 | Wng | H351 | H373** | H411 |   |   |  006-096-00-0 | хлорпрофам (ISO); | изопропилов 3-хлорокарбанилат | 202-925-7 | 101-21-3 | Carc. 2 | STOT RE 2 * | Aquatic Chronic 2 | H351 | H373** | H411 | GHS08 | GHS09 | Wng | H351 | H373** | H411 |   |   |  
006-097-00-6 | 1-phenyl-3-(p-toluenesulfonyl)urea | 424-620-1 | 13909-63-2 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 3 | H302 | H373** | H412 | GHS08 | GHS07 | Wng | H302 | H373** | H412 |   |   |  006-097-00-6 | 1-фенил-3-(p-толуенсулфонил)уреа | 424-620-1 | 13909-63-2 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 3 | H302 | H373** | H412 | GHS08 | GHS07 | Wng | H302 | H373** | H412 |   |   |  
006-098-00-1 | tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate | 429-170-8 | 134575-17-0 | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | H302 | H373** | H318 | H317 | GHS05 | GHS08 | GHS07 | Dgr | H302 | H373** | H318 | H317 |   |   |  006-098-00-1 | трет-бутилов (1R,5S)-3-азабицикло[3.1.0]хекс-6-илкарбамат | 429-170-8 | 134575-17-0 | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | H302 | H373** | H318 | H317 | GHS05 | GHS08 | GHS07 | Dgr | H302 | H373** | H318 | H317 |   |   |  
006-099-00-7 | N-(p-toluenesulfonyl)-N'-(3-(p-toluenesulfonyloxy)phenyl)urea; | 3-][(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl4-methylbenzenesulfonate | 520-2 | 232938-43-1 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  006-099-00-7 | N-(p-толуенсулфонил)-N′-(3-(p-толуенсулфонилoкси)фенил)уреа; | 3-({[(4-метилфенил)сулфонил]карбамоил}амино)фенилов 4-метилбензенсулфонат | 520-2 | 232938-43-1 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
006-101-00-6 | reaction mass of: N, N''-(methylenedi-4,1-phenylene)bis[N'-phenylurea]; | N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurea; | N, N''-(methylenedi-4,1-phenylene)bis[N'-cyclohexylurea] | 423-070-8 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  006-101-00-6 | реакционна маса от: N,N′′-(метиленди-4,1-фенилен)бис[N′-фенилуреа]; | N-(4-[[4-[[(фениламино)карбонил]амино]фенилметил]фенил]-N′-циклохексилуреа; | N, N′′-(метиленди-4,1-фенилен)бис[N′-циклохексилуреа] | 423-070-8 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
006-102-00-1 | O-hexyl-N-ethoxycarbonylthiocarbamate | 432-750-3 | — | Carc. 1B | Muta. 1B | Acute Tox. 4 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 2 | H350 | H340 | H302 | H373** | H317 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H340 | H302 | H373** | H317 | H411 |   |   |  006-102-00-1 | O-хексил-N-етоксикарбонилтиокарбамат | 432-750-3 | — | Carc. 1B | Muta. 1B | Acute Tox. 4 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 2 | H350 | H340 | H302 | H373** | H317 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H340 | H302 | H373** | H317 | H411 |   |   |  
006-103-00-7 | N, N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea | 445-760-8 | — | Eye Dam. 1 | Resp. Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H334 | H400 | H410 | GHS05 | GHS08 | GHS09 | Dgr | H318 | H334 | H410 |   | M=100 |  006-103-00-7 | N,N′′-(метиленди-4,1-фенилен)бис[N′-октил]уреа | 445-760-8 | — | Eye Dam. 1 | Resp. Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H334 | H400 | H410 | GHS05 | GHS08 | GHS09 | Dgr | H318 | H334 | H410 |   | M=100 |  
007-001-00-5 | ammonia, anhydrous | 231-635-3 | 7664-41-7 | Flam. Gas 2 | Press. Gas | Acute Tox. 3 * | Skin Corr. 1B | Aquatic Acute 1 | H221 | H331 | H314 | H400 | GHS04 | GHS06 | GHS05 | GHS09 | Dgr | H221 | H331 | H314 | H400 |   |   | U007-001-00-5 | амоняк, безводен | 231-635-3 | 7664-41-7 | Flam. Gas 2 | Press. Gas | Acute Tox. 3 * | Skin Corr. 1B | Aquatic Acute 1 | H221 | H331 | H314 | H400 | GHS04 | GHS06 | GHS05 | GHS09 | Dgr | H221 | H331 | H314 | H400 |   |   | U
007-001-01-2 | ammonia ….% | 215-647-6 | 1336-21-6 | Skin Corr. 1B | Aquatic Acute 1 | H314 | H400 | GHS05 | GHS09 | Dgr | H314 | H400 |   | STOT SE 3; H335: C ≥ 5 % | B007-001-01-2 | амоняк ....% | 215-647-6 | 1336-21-6 | Skin Corr. 1B | Aquatic Acute 1 | H314 | H400 | GHS05 | GHS09 | Dgr | H314 | H400 |   | STOT SE 3; H335: C ≥ 5 % | B
007-002-00-0 | nitrogen dioxide; [1] | dinitrogen tetraoxide [2] | 233-272-6 [1] | 234-126-4 [2] | 10102-44-0 [1] | 10544-72-6 [2] | Press. Gas | Ox. Gas 1 | Acute Tox. 2 * | Skin Corr. 1B | H270 | H330 | H314 | GHS04 | GHS03 | GHS06 | GHS05 | Dgr | H270 | H330 | H314 |   | * | STOT SE 3; H335: C ≥0,5  % | 5007-002-00-0 | азотен диоксид; [1] | диазотен тетраоксид [2] | 233-272-6 [1] | 234-126-4 [2] | 10102-44-0 [1] | 10544-72-6 [2] | Press. Gas | Ox. Gas 1 | Acute Tox. 2 * | Skin Corr. 1B | H270 | H330 | H314 | GHS04 | GHS03 | GHS06 | GHS05 | Dgr | H270 | H330 | H314 |   | * | STOT SE 3; H335: C ≥0,5  % | 5
007-003-00-6 | chlormequat chloride (ISO); | 2-chloroethyltrimethylammonium chloride | 213-666-4 | 999-81-5 | Acute Tox. 4 * | Acute Tox. 4 * | H312 | H302 | GHS07 | Wng | H312 | H302 |   |   |  007-003-00-6 | хлормекват хлорид (ISO); | триметил-2-хлороетиламониев хлорид | 213-666-4 | 999-81-5 | Acute Tox. 4 * | Acute Tox. 4 * | H312 | H302 | GHS07 | Wng | H312 | H302 |   |   |  
007-006-00-2 | ethyl nitrite | 203-722-6 | 109-95-5 | Flam. Gas 1 | Press. Gas | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H220 | H332 | H312 | H302 | GHS02 | GHS04 | GHS07 | Dgr | H220 | H332 | H312 | H302 |   |   | U007-006-00-2 | етилов нитрит | 203-722-6 | 109-95-5 | Flam. Gas 1 | Press. Gas | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H220 | H332 | H312 | H302 | GHS02 | GHS04 | GHS07 | Dgr | H220 | H332 | H312 | H302 |   |   | U
007-007-00-8 | ethyl nitrate | 210-903-3 | 625-58-1 | Unst. Expl. | H200 | GHS01 | Dgr | H200 |   |   |  007-007-00-8 | етилов нитрат | 210-903-3 | 625-58-1 | Unst. Expl. | H200 | GHS01 | Dgr | H200 |   |   |  
007-008-00-3 | hydrazine | 206-114-9 | 302-01-2 | Flam. Liq. 3 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H226 | H350 | H331 | H311 | H301 | H314 | H317 | H400 | H410 | GHS02 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H226 | H350 | H331 | H311 | H301 | H314 | H317 | H410 |   | Skin Corr. 1B; H314: C ≥ 10 % Skin Irrit. 2; H315: 3 % ≤ C < 10 % | Eye Irrit. 2; H319: 3 % ≤ C < 10 % |  007-008-00-3 | хидразин | 206-114-9 | 302-01-2 | Flam. Liq. 3 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H226 | H350 | H331 | H311 | H301 | H314 | H317 | H400 | H410 | GHS02 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H226 | H350 | H331 | H311 | H301 | H314 | H317 | H410 |   | Skin Corr. 1B; H314: C ≥ 10 % Skin Irrit. 2; H315: 3 % ≤ C < 10 % | Eye Irrit. 2; H319: 3 % ≤ C < 10 % |  
007-009-00-9 | dicyclohexylammonium nitrite | 221-515-9 | 3129-91-7 | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H302 | GHS07 | Wng | H332 | H302 |   | * |  007-009-00-9 | дициклохексиламониев нитрит | 221-515-9 | 3129-91-7 | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H302 | GHS07 | Wng | H332 | H302 |   | * |  
007-010-00-4 | sodium nitrite | 231-555-9 | 7632-00-0 | Ox. Sol. 3 | Acute Tox. 3 * | Aquatic Acute 1 | H272 | H301 | H400 | GHS03 | GHS06 | GHS09 | Dgr | H272 | H301 | H400 |   | * |  007-010-00-4 | натриев нитрит | 231-555-9 | 7632-00-0 | Ox. Sol. 3 | Acute Tox. 3 * | Aquatic Acute 1 | H272 | H301 | H400 | GHS03 | GHS06 | GHS09 | Dgr | H272 | H301 | H400 |   | * |  
007-011-00-X | potassium nitrite | 231-832-4 | 7758-09-0 | Ox. Sol. 2 | Acute Tox. 3 * | Aquatic Acute 1 | H272 | H301 | H400 | GHS03 | GHS06 | GHS09 | Dgr | H272 | H301 | H400 |   | * |  007-011-00-X | калиев нитрит | 231-832-4 | 7758-09-0 | Ox. Sol. 2 | Acute Tox. 3 * | Aquatic Acute 1 | H272 | H301 | H400 | GHS03 | GHS06 | GHS09 | Dgr | H272 | H301 | H400 |   | * |  
007-012-00-5 | N,N-dimethylhydrazine | 200-316-0 | 57-14-7 | Flam. Liq. 2 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | Aquatic Chronic 2 | H225 | H350 | H331 | H301 | H314 | H411 | GHS02 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H225 | H350 | H331 | H301 | H314 | H411 |   |   |  007-012-00-5 | N,N-диметилхидразин | 200-316-0 | 57-14-7 | Flam. Liq. 2 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | Aquatic Chronic 2 | H225 | H350 | H331 | H301 | H314 | H411 | GHS02 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H225 | H350 | H331 | H301 | H314 | H411 |   |   |  
007-013-00-0 | 1,2-dimethylhydrazine | — | 540-73-8 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Chronic 2 | H350 | H331 | H311 | H301 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H331 | H311 | H301 | H411 |   | Carc. 1B; H350: C ≥ 0,01  % |  007-013-00-0 | 1,2-диметилхидразин | — | 540-73-8 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Chronic 2 | H350 | H331 | H311 | H301 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H331 | H311 | H301 | H411 |   | Carc. 1B; H350: C ≥ 0,01  % |  
007-014-00-6 | salts of hydrazine | — | — | Carc. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H331 | H311 | H301 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H331 | H311 | H301 | H317 | H410 |   |   | A007-014-00-6 | соли на хидразина | — | — | Carc. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H331 | H311 | H301 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H331 | H311 | H301 | H317 | H410 |   |   | A
007-015-00-1 | O-ethylhydroxylamine | 402-030-3 | 624-86-2 | Flam. Liq. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | H225 | H331 | H311 | H301 | H372 ** | H319 | H317 | H400 | GHS02 | GHS06 | GHS08 | GHS09 | Dgr | H225 | H331 | H311 | H301 | H372 ** | H319 | H317 | H400 |   |   |  007-015-00-1 | O-етилхидроксиламин | 402-030-3 | 624-86-2 | Flam. Liq. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | H225 | H331 | H311 | H301 | H372 ** | H319 | H317 | H400 | GHS02 | GHS06 | GHS08 | GHS09 | Dgr | H225 | H331 | H311 | H301 | H372 ** | H319 | H317 | H400 |   |   |  
007-016-00-7 | butyl nitrite | 208-862-1 | 544-16-1 | Flam. Liq. 2 | Acute Tox. 3 * | Acute Tox. 3 * | H225 | H331 | H301 | GHS02 | GHS06 | Dgr | H225 | H331 | H301 |   |   |  007-016-00-7 | бутилов нитрит | 208-862-1 | 544-16-1 | Flam. Liq. 2 | Acute Tox. 3 * | Acute Tox. 3 * | H225 | H331 | H301 | GHS02 | GHS06 | Dgr | H225 | H331 | H301 |   |   |  
007-017-00-2 | isobutyl nitrite | 208-819-7 | 542-56-3 | Flam. Liq. 2 | Carc. 1B | Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | H225 | H350 | H341 | H332 | H302 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H350 | H341 | H332 | H302 |   |   |  007-017-00-2 | изобутилов нитрит | 208-819-7 | 542-56-3 | Flam. Liq. 2 | Carc. 1B | Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | H225 | H350 | H341 | H332 | H302 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H350 | H341 | H332 | H302 |   |   |  
007-018-00-8 | sec-butyl nitrite | 213-104-8 | 924-43-6 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | H225 | H332 | H302 | GHS02 | GHS07 | Dgr | H225 | H332 | H302 |   |   |  007-018-00-8 | втор-бутилов нитрит | 213-104-8 | 924-43-6 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | H225 | H332 | H302 | GHS02 | GHS07 | Dgr | H225 | H332 | H302 |   |   |  
007-019-00-3 | tert-butyl nitrite | 208-757-0 | 540-80-7 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | H225 | H332 | H302 | GHS02 | GHS07 | Dgr | H225 | H332 | H302 |   |   |  007-019-00-3 | трет-бутилов нитрит | 208-757-0 | 540-80-7 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | H225 | H332 | H302 | GHS02 | GHS07 | Dgr | H225 | H332 | H302 |   |   |  
007-020-00-9 | pentyl nitrite; [1] | ‘amyl nitrite’, mixed isomers [2] | 207-332-7 [1] | 203-770-8 [2] | 463-04-7 [1] | 110-46-3 [2] | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | H225 | H332 | H302 | GHS02 | GHS07 | Dgr | H225 | H332 | H302 |   |   |  007-020-00-9 | пентилов нитрит; [1] | „амил нитрит“, смес от изомери [2] | 207-332-7 [1] | 203-770-8 [2] | 463-04-7 [1] | 110-46-3 [2] | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | H225 | H332 | H302 | GHS02 | GHS07 | Dgr | H225 | H332 | H302 |   |   |  
007-021-00-4 | hydrazobenzene; | 1,2-diphenylhydrazine | 204-563-5 | 122-66-7 | Carc. 1B | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H410 |   |   |  007-021-00-4 | хидразобензен; | 1,2-дифенилхидразин | 204-563-5 | 122-66-7 | Carc. 1B | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H410 |   |   |  
007-022-00-X | hydrazine bis(3-carboxy-4-hydroxybenzensulfonate) | 405-030-1 | — | Carc. 1B | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 3 | H350 | H302 | H314 | H317 | H412 | GHS08 | GHS05 | GHS07 | Dgr | H350 | H302 | H314 | H317 | H412 |   |   |  007-022-00-X | хидразинов бис(3-карбокси-4-хидроксибензенсулфонат) | 405-030-1 | — | Carc. 1B | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 3 | H350 | H302 | H314 | H317 | H412 | GHS08 | GHS05 | GHS07 | Dgr | H350 | H302 | H314 | H317 | H412 |   |   |  
007-023-00-5 | sodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate | 405-510-0 | — | Skin Irrit. 2 | Skin Sens. 1 | H315 | H317 | GHS07 | Wng | H315 | H317 |   |   |  007-023-00-5 | натриев 3,5-бис(3-(2,4-ди-трет-пентилфенокси)пропилкарбамоил)бензенсулфонат | 405-510-0 | — | Skin Irrit. 2 | Skin Sens. 1 | H315 | H317 | GHS07 | Wng | H315 | H317 |   |   |  
007-024-00-0 | 2-(decylthio)ethylammonium chloride | 405-640-8 | 36362-09-1 | STOT RE 2 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** | H315 | H318 | H400 | H410 | GHS08 | GHS05 | GHS09 | Dgr | H373 ** | H315 | H318 | H410 |   |   |  007-024-00-0 | 2-(децилтио)етиламониев хлорид | 405-640-8 | 36362-09-1 | STOT RE 2 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** | H315 | H318 | H400 | H410 | GHS08 | GHS05 | GHS09 | Dgr | H373 ** | H315 | H318 | H410 |   |   |  
007-025-00-6 | (4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride | 406-090-1 | 81880-96-8 | Muta. 2 | Acute Tox. 3 * | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H301 | H372 ** | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H341 | H301 | H372 ** | H317 | H410 |   |   |  007-025-00-6 | (4-хидразинофенил)-N-метилметансулфонамидхидрохлорид | 406-090-1 | 81880-96-8 | Muta. 2 | Acute Tox. 3 * | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H301 | H372 ** | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H341 | H301 | H372 ** | H317 | H410 |   |   |  
007-026-00-1 | oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide | 413-230-5 | 122035-71-6 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  007-026-00-1 | оксо-((2,2,6,6-тетраметилпиперидин-4-ил)aмино)карбонилацетохидразид | 413-230-5 | 122035-71-6 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
007-027-00-7 | 1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane | 420-190-2 | 771478-66-1 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H373 ** | H314 | H317 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H373 ** | H314 | H317 | H410 |   |   |  007-027-00-7 | 1,6-бис(3,3-бис((1-метилпентилиденимино)пропил)уреидо)хексан | 420-190-2 | 771478-66-1 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H373 ** | H314 | H317 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H373 ** | H314 | H317 | H410 |   |   |  
007-028-00-2 | hydroxylammonium nitrate | 236-691-2 | 13465-08-2 | Expl. 1.1 **** | Carc. 2 | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | H201 | H351 | H311 | H302 | H373** | H319 | H315 | H317 | H400 | GHS01 | GHS06 | GHS08 | GHS09 | Dgr | H201 | H351 | H311 | H302 | H373** | H319 | H315 | H317 | H400 |   |   |  007-028-00-2 | хидроксиламониев нитрат | 236-691-2 | 13465-08-2 | Expl. 1.1 **** | Carc. 2 | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | H201 | H351 | H311 | H302 | H373** | H319 | H315 | H317 | H400 | GHS01 | GHS06 | GHS08 | GHS09 | Dgr | H201 | H351 | H311 | H302 | H373** | H319 | H315 | H317 | H400 |   |   |  
007-029-00-8 | diethyldimethylammonium hydroxide | 419-400-5 | 95500-19-9 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | H312 | H302 | H314 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 |   |   |  007-029-00-8 | диетилдиметиламониев хидроксид | 419-400-5 | 95500-19-9 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | H312 | H302 | H314 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 |   |   |  
008-001-00-8 | oxygen | 231-956-9 | 7782-44-7 | Ox. Gas 1 | Press. Gas | H270 | GHS03 | GHS04 | Dgr | H270 |   |   | U008-001-00-8 | кислород | 231-956-9 | 7782-44-7 | Ox. Gas 1 | Press. Gas | H270 | GHS03 | GHS04 | Dgr | H270 |   |   | U
008-003-00-9 | hydrogen peroxide solution… % | 231-765-0 | 7722-84-1 | Ox. Liq. 1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | H271 | H332 | H302 | H314 | GHS03 | GHS05 | GHS07 | Dgr | H271 | H332 | H302 | H314 |   | Ox. Liq. 1; H271: C ≥70 %**** | Ox. Liq. 2; H272: 50 % ≤ C < 70 % **** | * | Skin Corr. 1A; H314: C ≥ 70 % Skin Corr. 1B; H314: 50 % ≤ C < 70 % | Skin Irrit. 2; H315: 35 % ≤ C < 50 % | Eye Dam. 1; H318: 8 % ≤ C < 50 % | Eye Irrit. 2; H319: 5 % ≤ C< 8 % STOT SE 3; H335; C ≥ 35 % | B008-003-00-9 | разтвор на водороден пероксид…% | 231-765-0 | 7722-84-1 | Ox. Liq. 1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | H271 | H332 | H302 | H314 | GHS03 | GHS05 | GHS07 | Dgr | H271 | H332 | H302 | H314 |   | Ox. Liq. 1; H271: C ≥70 %**** | Ox. Liq. 2; H272: 50 % ≤ C < 70 % **** | * | Skin Corr. 1A; H314: C ≥ 70 % Skin Corr. 1B; H314: 50 % ≤ C < 70 % | Skin Irrit. 2; H315: 35 % ≤ C < 50 % | Eye Dam. 1; H318: 8 % ≤ C < 50 % | Eye Irrit. 2; H319: 5 % ≤ C< 8 % STOT SE 3; H335; C ≥ 35 % | B
009-001-00-0 | fluorine | 231-954-8 | 7782-41-4 | Press. Gas | Ox. Gas 1 | Acute Tox. 2 * | Skin Corr. 1A | H270 | H330 | H314 | GHS04 | GHS03 | GHS06 | GHS05 | Dgr | H270 | H330 | H314 |   |   |  009-001-00-0 | флуор | 231-954-8 | 7782-41-4 | Press. Gas | Ox. Gas 1 | Acute Tox. 2 * | Skin Corr. 1A | H270 | H330 | H314 | GHS04 | GHS03 | GHS06 | GHS05 | Dgr | H270 | H330 | H314 |   |   |  
009-002-00-6 | hydrogen fluoride | 231-634-8 | 7664-39-3 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Skin Corr. 1A | H330 | H310 | H300 | H314 | GHS06 | GHS05 | Dgr | H330 | H310 | H300 | H314 |   |   |  009-002-00-6 | водороден флуорид | 231-634-8 | 7664-39-3 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Skin Corr. 1A | H330 | H310 | H300 | H314 | GHS06 | GHS05 | Dgr | H330 | H310 | H300 | H314 |   |   |  
009-003-00-1 | hydrofluoric acid … % | 231-634-8 | 7664-39-3 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Skin Corr. 1A | H330 | H310 | H300 | H314 | GHS06 | GHS05 | Dgr | H330 | H310 | H300 | H314 |   | Skin Corr. 1A; H314: C ≥ 7 % Skin Corr. 1B; H314: 1 % ≤ C< 7 % Eye Irrit. 2; H319: 0,1  % ≤C < 1 % | B009-003-00-1 | флуороводородна киселина …% | 231-634-8 | 7664-39-3 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Skin Corr. 1A | H330 | H310 | H300 | H314 | GHS06 | GHS05 | Dgr | H330 | H310 | H300 | H314 |   | Skin Corr. 1A; H314: C ≥ 7 % Skin Corr. 1B; H314: 1 % ≤ C< 7 % Eye Irrit. 2; H319: 0,1  % ≤C < 1 % | B
009-004-00-7 | sodium fluoride | 231-667-8 | 7681-49-4 | Acute Tox. 3 * | Eye Irrit. 2 | Skin Irrit. 2 | H301 | H319 | H315 | GHS06 | Dgr | H301 | H319 | H315 | EUH032 |   |  009-004-00-7 | натриев флуорид | 231-667-8 | 7681-49-4 | Acute Tox. 3 * | Eye Irrit. 2 | Skin Irrit. 2 | H301 | H319 | H315 | GHS06 | Dgr | H301 | H319 | H315 | EUH032 |   |  
009-005-00-2 | potassium fluoride | 232-151-5 | 7789-23-3 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H331 | H311 | H301 | GHS06 | Dgr | H331 | H311 | H301 |   |   |  009-005-00-2 | калиев флуорид | 232-151-5 | 7789-23-3 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H331 | H311 | H301 | GHS06 | Dgr | H331 | H311 | H301 |   |   |  
009-006-00-8 | ammonium fluoride | 235-185-9 | 12125-01-8 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H331 | H311 | H301 | GHS06 | Dgr | H331 | H311 | H301 |   |   |  009-006-00-8 | амониев флуорид | 235-185-9 | 12125-01-8 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H331 | H311 | H301 | GHS06 | Dgr | H331 | H311 | H301 |   |   |  
009-007-00-3 | sodium bifluoride; | sodium hydrogen difluoride | 215-608-3 | 1333-83-1 | Acute Tox. 3 * | Skin Corr. 1B | H301 | H314 | GHS06 | GHS05 | Dgr | H301 | H314 |   | *Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit. 2; H315: 0,1  % ≤ C < % Eye Irrit. 2; | H319: 0,1  % ≤ | C < 1 % |  009-007-00-3 | натриев бифлуорид; | натриев хидрогендифлуорид | 215-608-3 | 1333-83-1 | Acute Tox. 3 * | Skin Corr. 1B | H301 | H314 | GHS06 | GHS05 | Dgr | H301 | H314 |   | *Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit. 2; H315: 0,1  % ≤ C < % Eye Irrit. 2; | H319: 0,1  % ≤ | C < 1 % |  
009-008-00-9 | potassium bifluoride; | potassium hydrogen difluoride | 232-156-2 | 7789-29-9 | Acute Tox. 3 * | Skin Corr. 1B | H301 | H314 | GHS06 | GHS05 | Dgr | H301 | H314 |   | * | Skin Corr. 1B; H314: C ≥ 1 % | Skin Irrit. 2; H315: 0,1  % ≤ C < 1 % | Eye Irrit. 2; H319: 0,1  % ≤ C < 1 % |  009-008-00-9 | калиев бифлуорид; | калиев хидрогендифлуорид | 232-156-2 | 7789-29-9 | Acute Tox. 3 * | Skin Corr. 1B | H301 | H314 | GHS06 | GHS05 | Dgr | H301 | H314 |   | * | Skin Corr. 1B; H314: C ≥ 1 % | Skin Irrit. 2; H315: 0,1  % ≤ C < 1 % | Eye Irrit. 2; H319: 0,1  % ≤ C < 1 % |  
009-009-00-4 | ammonium bifluoride; | ammonium hydrogen difluoride | 215-676-4 | 1341-49-7 | Acute Tox. 3 * | Skin Corr. 1B | H301 | H314 | GHS06 | GHS05 | Dgr | H301 | H314 |   | * | Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit.2; H315: 0,1  % ≤ C < 1 % | Eye Irrit. 2; H319: 0,1  % ≤ C < 1 % |  009-009-00-4 | амониев бифлуорид; | амониев хидрогендифлуорид | 215-676-4 | 1341-49-7 | Acute Tox. 3 * | Skin Corr. 1B | H301 | H314 | GHS06 | GHS05 | Dgr | H301 | H314 |   | * | Skin Corr. 1B; H314: C ≥ 1 % Skin Irrit.2; H315: 0,1  % ≤ C < 1 % | Eye Irrit. 2; H319: 0,1  % ≤ C < 1 % |  
009-010-00-X | fluoroboric acid … % | 240-898-3 | 16872-11-0 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % | Eye Irrit. 2; H319: 10 % ≤ | C < 25 % | B009-010-00-X | флуороборна киселина … % | 240-898-3 | 16872-11-0 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % | Eye Irrit. 2; H319: 10 % ≤ | C < 25 % | B
009-011-00-5 | fluorosilicic acid … % | 241-034-8 | 16961-83-4 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   |   | B009-011-00-5 | флуоросилициева киселина … % | 241-034-8 | 16961-83-4 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   |   | B
009-012-00-0 | alkali fluorosilicates(Na); [1] | alkali fluorosilicates(K); [2] | alkali fluorosilicates(NH4) [3] | 240-934-8 [1] | 240-896-2 [2] | 240-968-3 [3] | 16893-85-9 [1] | 16871-90-2 [2] | 16919-19-0 [3] | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H331 | H311 | H301 | GHS06 | Dgr | H331 | H311 | H301 |   | * | A009-012-00-0 | алкални флуоросиликати (Na); [1] | алкални флуоросиликати (K); [2] | алкални флуоросиликати (NH4) [3] | 240-934-8 [1] | 240-896-2 [2] | 240-968-3 [3] | 16893-85-9 [1] | 16871-90-2 [2] | 16919-19-0 [3] | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H331 | H311 | H301 | GHS06 | Dgr | H331 | H311 | H301 |   | * | A
009-013-00-6 | fluorosilicates, with the exception of those specified elsewhere in this Annex | — | — | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   | * | A009-013-00-6 | флуоросиликати, с изключение на посочените на други места в настоящото приложение | — | — | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   | * | A
009-014-00-1 | lead hexafluorosilicate | 247-278-1 | 25808-74-6 | Repr. 1A | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H360Df | H332 | H302 | H373 ** | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H360Df | H332 | H302 | H373 ** | H410 |   |   | 1009-014-00-1 | оловен хексафлуоросиликат | 247-278-1 | 25808-74-6 | Repr. 1A | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H360Df | H332 | H302 | H373 ** | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H360Df | H332 | H302 | H373 ** | H410 |   |   | 1
009-015-00-7 | sulphuryl difluoride | 220-281-5 | 2699-79-8 | Press. Gas | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | H331 | H373 ** | H400 | GHS04 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H373 ** | H400 |   |   | U009-015-00-7 | сулфурилдифлуорид | 220-281-5 | 2699-79-8 | Press. Gas | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | H331 | H373 ** | H400 | GHS04 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H373 ** | H400 |   |   | U
009-016-00-2 | trisodium hexafluoroaluminate [1] | trisodium hexafluoroaluminate(cryolite) [2] | 237-410-6 [1] | 239-148-8 [2] | 13775-53-6 [1] | 15096-52-3 [2] | STOT RE 1 | Acute Tox. 4 | Aquatic Chronic 2 | H372 | H332 | H411 | GHS07 | GHS08 | GHS09 | Dgr | H372 | H332 | H411 |   |   |  009-016-00-2 | тринатриев хексафлуороалуминат [1] | тринатриев хексафлуороалуминат (криолит) [2] | 237-410-6 [1] | 239-148-8 [2] | 13775-53-6 [1] | 15096-52-3 [2] | STOT RE 1 | Acute Tox. 4 | Aquatic Chronic 2 | H372 | H332 | H411 | GHS07 | GHS08 | GHS09 | Dgr | H372 | H332 | H411 |   |   |  
009-017-00-8 | potassium mu-fluoro-bis(triethylaluminium) | 400-040-2 | 12091-08-6 | Flam. Sol. 1 | Water-react. 1 | Skin Corr. 1A | Acute Tox. 4 * | H228 | H270 | H314 | H332 | GHS02 | GHS05 | GHS07 | Dgr | H228 | H270 | H314 | H332 | EUH014 |   | T009-017-00-8 | кaлиев μ-флуоробис(триетилалуминий) | 400-040-2 | 12091-08-6 | Flam. Sol. 1 | Water-react. 1 | Skin Corr. 1A | Acute Tox. 4 * | H228 | H270 | H314 | H332 | GHS02 | GHS05 | GHS07 | Dgr | H228 | H270 | H314 | H332 | EUH014 |   | T
009-018-00-3 | magnesium hexafluorosilicate | 241-022-2 | 16949-65-8 | Acute Tox. 3 * | H301 | GHS06 | Dgr | H301 |   | * |  009-018-00-3 | мaгнезиев хексафлуоросиликат | 241-022-2 | 16949-65-8 | Acute Tox. 3 * | H301 | GHS06 | Dgr | H301 |   | * |  
011-001-00-0 | sodium | 231-132-9 | 7440-23-5 | Water-react. 1 | Skin Corr. 1B | H260 | H314 | GHS02 | GHS05 | Dgr | H260 | H314 | EUH014 |   |  011-001-00-0 | натрий | 231-132-9 | 7440-23-5 | Water-react. 1 | Skin Corr. 1B | H260 | H314 | GHS02 | GHS05 | Dgr | H260 | H314 | EUH014 |   |  
011-002-00-6 | sodium hydroxide; | caustic soda | 215-185-5 | 1310-73-2 | Skin Corr. 1A | H314 | GHS05 | Dgr | H314 |   | Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314 2 % ≤ C < 5 % Skin Irrit. 2; H315: 0,5  % ≤ C < 2 % Eye Irrit.2; H319: 0,5  % ≤ C < 2 % |  011-002-00-6 | натриев хидроксид; | сода каустик | 215-185-5 | 1310-73-2 | Skin Corr. 1A | H314 | GHS05 | Dgr | H314 |   | Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314 2 % ≤ C < 5 % Skin Irrit. 2; H315: 0,5  % ≤ C < 2 % Eye Irrit.2; H319: 0,5  % ≤ C < 2 % |  
011-003-00-1 | sodium peroxide | 215-209-4 | 1313-60-6 | Ox. Sol. 1 | Skin Corr. 1A | H271 | H314 | GHS03 | GHS05 | Dgr | H271 | H314 |   |   |  011-003-00-1 | натриев пероксид | 215-209-4 | 1313-60-6 | Ox. Sol. 1 | Skin Corr. 1A | H271 | H314 | GHS03 | GHS05 | Dgr | H271 | H314 |   |   |  
011-004-00-7 | sodium azide | 247-852-1 | 26628-22-8 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H400 | H410 | EUH032 |   |  011-004-00-7 | натриев aзид | 247-852-1 | 26628-22-8 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H400 | H410 | EUH032 |   |  
011-005-00-2 | sodium carbonate | 207-838-8 | 497-19-8 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  011-005-00-2 | натриев карбонат | 207-838-8 | 497-19-8 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
011-006-00-8 | sodium cyanate | 213-030-6 | 917-61-3 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  011-006-00-8 | натриев цианат | 213-030-6 | 917-61-3 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
011-007-00-3 | propoxycarbazone-sodium | — | 181274-15-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M = 10 |  011-007-00-3 | пропоксикарбазон-натрий | — | 181274-15-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M = 10 |  
012-001-00-3 | magnesium powder (pyrophoric) | 231-104-6 | 7439-95-4 | Water-react. 1 | Pyr. Sol. 1 | H260 | H250 | GHS02 | Dgr | H260 | H250 |   |   | T012-001-00-3 | мaгнезиев прах (пирофорен) | 231-104-6 | 7439-95-4 | Water-react. 1 | Pyr. Sol. 1 | H260 | H250 | GHS02 | Dgr | H260 | H250 |   |   | T
012-002-00-9 | magnesium, powder or turnings | 231-104-6 | — | Flam. Sol. 1 | Water-react. 2 | Self-heat. 1 | H228 | H261 | H252 | GHS02 | Dgr | H228 | H261 | H252 |   |   | T012-002-00-9 | мaгнезий, прах или стърготини | 231-104-6 | — | Flam. Sol. 1 | Water-react. 2 | Self-heat. 1 | H228 | H261 | H252 | GHS02 | Dgr | H228 | H261 | H252 |   |   | T
012-003-00-4 | magnesium alkyls | — | — | Pyr. Liq. 1 | Water-react. 1 | Skin Corr. 1B | H250 | H260 | H314 | GHS02 | GHS05 | Dgr | H250 | H260 | H314 | EUH014 |   | A012-003-00-4 | мaгнезиеви алкили | — | — | Pyr. Liq. 1 | Water-react. 1 | Skin Corr. 1B | H250 | H260 | H314 | GHS02 | GHS05 | Dgr | H250 | H260 | H314 | EUH014 |   | A
012-004-00-X | aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate | 422-150-1 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  012-004-00-X | алуминиев магнезиев карбонат перхлорат хидроксид хидрат | 422-150-1 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
013-001-00-6 | aluminium powder (pyrophoric) | 231-072-3 | 7429-90-5 | Water-react. 2 | Pyr. Sol. 1 | H261 | H250 | GHS02 | Dgr | H261 | H250 |   |   | T013-001-00-6 | алуминий на прах (пирофорен) | 231-072-3 | 7429-90-5 | Water-react. 2 | Pyr. Sol. 1 | H261 | H250 | GHS02 | Dgr | H261 | H250 |   |   | T
013-002-00-1 | aluminium powder (stabilised) | 231-072-3 | 7429-90-5 | Water-react. 2 | Flam. Sol. 1 | H261 | H228 | GHS02 | Dgr | H261 | H228 |   |   | T013-002-00-1 | алуминий на прах (стабилизиран) | 231-072-3 | 7429-90-5 | Water-react. 2 | Flam. Sol. 1 | H261 | H228 | GHS02 | Dgr | H261 | H228 |   |   | T
013-003-00-7 | aluminium chloride, anhydrous | 231-208-1 | 7446-70-0 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   |   |  013-003-00-7 | алуминиев хлорид, безводен | 231-208-1 | 7446-70-0 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   |   |  
013-004-00-2 | aluminium alkyls | — | — | Pyr. Liq. 1 | Water-react. 1 | Skin Corr. 1B | H250 | H260 | H314 | GHS02 | GHS05 | Dgr | H250 | H260 | H314 | EUH014 |   | A013-004-00-2 | алуминиеви алкили | — | — | Pyr. Liq. 1 | Water-react. 1 | Skin Corr. 1B | H250 | H260 | H314 | GHS02 | GHS05 | Dgr | H250 | H260 | H314 | EUH014 |   | A
013-005-00-8 | diethyl(ethyldimethylsilanolato) aluminium | 401-160-8 | 55426-95-4 | Water-react. 1 | Pyr. Liq. 1 | Skin Corr. 1A | H260 | H250 | H314 | GHS02 | GHS05 | Dgr | H260 | H250 | H314 | EUH014 |   |  013-005-00-8 | диетил(eтилдиметилсиланолато)алуминий | 401-160-8 | 55426-95-4 | Water-react. 1 | Pyr. Liq. 1 | Skin Corr. 1A | H260 | H250 | H314 | GHS02 | GHS05 | Dgr | H260 | H250 | H314 | EUH014 |   |  
013-006-00-3 | (ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised | 402-370-2 | — | Flam. Liq. 3 | Eye Dam. 1 | H226 | H318 | GHS02 | GHS05 | Dgr | H226 | H318 |   |   |  013-006-00-3 | (етил-3-oксобутаноато-O′1,О′3)(2-диметиламиноетанолато)(1-метоксипропан-2-олато)алуминий(III), димеризиран | 402-370-2 | — | Flam. Liq. 3 | Eye Dam. 1 | H226 | H318 | GHS02 | GHS05 | Dgr | H226 | H318 |   |   |  
013-007-00-9 | poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium) | 403-430-0 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  013-007-00-9 | поли(оксо(2-бутоксиетил-3-oксобутаноато-О′1,О′3)aлуминий) | 403-430-0 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
013-008-00-4 | di-n-octylaluminium iodide | 408-190-0 | 7585-14-0 | Pyr. Liq. 1 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H250 | H314 | H400 | H410 | GHS02 | GHS05 | GHS09 | Dgr | H250 | H314 | H410 | EUH014 |   |  013-008-00-4 | ди-n-oктилалуминиев йодид | 408-190-0 | 7585-14-0 | Pyr. Liq. 1 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H250 | H314 | H400 | H410 | GHS02 | GHS05 | GHS09 | Dgr | H250 | H314 | H410 | EUH014 |   |  
013-009-00-X | sodium (n-butyl)x(ethyl)y-1,5-dihydro)aluminate x = 0,5 y =1,5 | 418-720-2 | — | Flam. Sol. 1 | Water-react. 1 | Pyr. Sol. 1 | Acute Tox. 4 * | Skin Corr. 1A | H228 | H260 | H250 | H332 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H228 | H260 | H250 | H332 | H314 | EUH014 |   | T013-009-00-X | натриев (n-бутил)x(етил)y-1,5-дихидро)алуминат) x = 0,5 y=1,5 | 418-720-2 | — | Flam. Sol. 1 | Water-react. 1 | Pyr. Sol. 1 | Acute Tox. 4 * | Skin Corr. 1A | H228 | H260 | H250 | H332 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H228 | H260 | H250 | H332 | H314 | EUH014 |   | T
013-010-00-5 | hydroxy aluminium bis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d, g][1.3.2]dioxaphosphocin-6-oxide) | 430-650-4 | 151841-65-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  013-010-00-5 | хидроксиалуминиев бис(2,4,8,10-тетра-трет-бутил-6-хидрокси-12H-дибензо[d,g][1.3.2]диоксафосфоцин-6-оксид) | 430-650-4 | 151841-65-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
014-001-00-9 | trichlorosilane | 233-042-5 | 10025-78-2 | Flam. Liq. 1 | Pyr. Liq. 1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | H224 | H250 | H332 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H224 | H250 | H332 | H302 | H314 | EUH014 | EUH029 | * | STOT SE 3; H335: C ≥ 1 % | T014-001-00-9 | трихлоросилан | 233-042-5 | 10025-78-2 | Flam. Liq. 1 | Pyr. Liq. 1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | H224 | H250 | H332 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H224 | H250 | H332 | H302 | H314 | EUH014 | EUH029 | * | STOT SE 3; H335: C ≥ 1 % | T
014-002-00-4 | silicon tetrachloride | 233-054-0 | 10026-04-7 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H319 | H335 | H315 | GHS07 | Wng | H319 | H335 | H315 | EUH014 |   |  014-002-00-4 | силициев тетрахлорид | 233-054-0 | 10026-04-7 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H319 | H335 | H315 | GHS07 | Wng | H319 | H335 | H315 | EUH014 |   |  
014-003-00-X | dimethyldichlorosilane | 200-901-0 | 75-78-5 | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H225 | H319 | H335 | H315 | GHS02 | GHS07 | Dgr | H225 | H319 | H335 | H315 |   |   |  014-003-00-X | диметилдихлоросилан | 200-901-0 | 75-78-5 | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H225 | H319 | H335 | H315 | GHS02 | GHS07 | Dgr | H225 | H319 | H335 | H315 |   |   |  
014-004-00-5 | trichloro(methyl)silane; methyltrichlorosilane | 200-902-6 | 75-79-6 | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H225 | H319 | H335 | H315 | GHS02 | GHS07 | Dgr | H225 | H319 | H335 | H315 | EUH014 | Skin Irrit.2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |  014-004-00-5 | трихлоро(метил)силан; мeтилтрихлоросилан | 200-902-6 | 75-79-6 | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H225 | H319 | H335 | H315 | GHS02 | GHS07 | Dgr | H225 | H319 | H335 | H315 | EUH014 | Skin Irrit.2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |  
014-005-00-0 | tetraethyl silicate; | ethyl silicate | 201-083-8 | 78-10-4 | Flam. Liq. 3 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | H226 | H332 | H319 | H335 | GHS02 | GHS07 | Wng | H226 | H332 | H319 | H335 |   |   |  014-005-00-0 | тeтраетилов силикат; | етилов силикат | 201-083-8 | 78-10-4 | Flam. Liq. 3 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | H226 | H332 | H319 | H335 | GHS02 | GHS07 | Wng | H226 | H332 | H319 | H335 |   |   |  
014-006-00-6 | bis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride | 401-380-4 | — | Eye Irrit. 2 | Aquatic Chronic 2 | H319 | H411 | GHS07 | GHS09 | Wng | H319 | H411 |   |   |  014-006-00-6 | бис(4-флуорофенил)метил(1,2,4-триазол-4-илметил)силан хидрохлорид | 401-380-4 | — | Eye Irrit. 2 | Aquatic Chronic 2 | H319 | H411 | GHS07 | GHS09 | Wng | H319 | H411 |   |   |  
014-007-00-1 | triethoxyisobutylsilane | 402-810-3 | 17980-47-1 | Skin Irrit. 2 | H315 | GHS07 | Wng | H315 |   |   |  014-007-00-1 | триетоксиизобутилсилан | 402-810-3 | 17980-47-1 | Skin Irrit. 2 | H315 | GHS07 | Wng | H315 |   |   |  
014-008-00-7 | (chloromethyl)bis(4-fluorophenyl)methylsilane | 401-200-4 | 85491-26-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  014-008-00-7 | (хлорометил)бис(4-флуорофенил)метилсилан | 401-200-4 | 85491-26-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
014-009-00-2 | isobutylisopropyldimethoxysilane | 402-580-4 | 111439-76-0 | Flam. Liq. 3 | Acute Tox. 4 * | Skin Irrit. 2 | H226 | H332 | H315 | GHS02 | GHS07 | Wng | H226 | H332 | H315 |   |   |  014-009-00-2 | изобутилизопропилдиметоксисилан | 402-580-4 | 111439-76-0 | Flam. Liq. 3 | Acute Tox. 4 * | Skin Irrit. 2 | H226 | H332 | H315 | GHS02 | GHS07 | Wng | H226 | H332 | H315 |   |   |  
014-010-00-8 | disodium metasilicate | 229-912-9 | 6834-92-0 | Skin Corr. 1B | STOT SE 3 | H314 | H335 | GHS05 | GHS07 | Dgr | H314 | H335 |   |   |  014-010-00-8 | динатриев метасиликат | 229-912-9 | 6834-92-0 | Skin Corr. 1B | STOT SE 3 | H314 | H335 | GHS05 | GHS07 | Dgr | H314 | H335 |   |   |  
014-011-00-3 | cyclohexyldimethoxymethylsilane | 402-140-1 | 17865-32-6 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  014-011-00-3 | циклохексилдиметоксиметилсилан | 402-140-1 | 17865-32-6 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
014-012-00-9 | bis(3-(trimethoxysilyl)propyl)amine | 403-480-3 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  014-012-00-9 | бис(3-(триметоксисилил)пропил)aмин | 403-480-3 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  
014-013-00-4 | α-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane) | 404-920-7 | — | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 2 | H312 | H302 | H314 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H314 | H411 |   |   |  014-013-00-4 | α-хидроксиполи(метил(3-(2,2,6,6-тетраметилпиперидин-4-илокси)пропил)силоксан) | 404-920-7 | — | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 2 | H312 | H302 | H314 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H314 | H411 |   |   |  
014-014-00-X | etacelasil (ISO); | 6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane | 253-704-7 | 37894-46-5 | Repr. 1B | Acute Tox. 4 * | STOT RE 2 * | H360D *** H302 | H373 ** | GHS08 | GHS07 | Dgr | H360D *** H302 | H373 ** |   |   |  014-014-00-X | етацеласил (ISO); | 6-(2-метоксиетокси)-6-(2-хлороетил)-2,5,7,10-тетраокса-6-силаундекан | 253-704-7 | 37894-46-5 | Repr. 1B | Acute Tox. 4 * | STOT RE 2 * | H360D *** H302 | H373 ** | GHS08 | GHS07 | Dgr | H360D *** H302 | H373 ** |   |   |  
014-015-00-5 | α-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]-co-oxy(dimethylsilane)) | 406-420-4 | 69430-40-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  014-015-00-5 | α-триметилсиланил-ω-триметилсилоксиполи[oкси(метил-3-(2-(2-метоксипропокси)пропокси)пропилсиландиил]-съ-oкси(диметилсилан)) | 406-420-4 | 69430-40-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
014-016-00-0 | reaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane; | 1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane | 406-490-6 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  014-016-00-0 | реакционна маса от: 1,3-дихекс-5-eн-1-ил-1,1,3,3-тетраметилдисилоксан; | 1,3-дихекс-n-eн-1-ил-1,1,3,3-тетраметилдисилоксан | 406-490-6 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
014-017-00-6 | flusilazole (ISO); | bis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane | — | 85509-19-9 | Carc. 2 | Repr. 1B | Acute Tox. 4 * | Aquatic Chronic 2 | H351 | H360D *** H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H351 | H360D *** H302 | H411 |   |   |  014-017-00-6 | флусилазол (ISO); | бис(4-флуорофенил)(метил)(1H-1,2,4-триазол-1-илметил)силан | — | 85509-19-9 | Carc. 2 | Repr. 1B | Acute Tox. 4 * | Aquatic Chronic 2 | H351 | H360D *** H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H351 | H360D *** H302 | H411 |   |   |  
014-018-00-1 | octamethylcyclotetrasiloxane | 209-136-7 | 556-67-2 | Repr. 2 | Aquatic Chronic 4 | H361f *** H413 | GHS08 | Wng | H361f *** H413 |   |   |  014-018-00-1 | октаметилциклотетрасилоксан | 209-136-7 | 556-67-2 | Repr. 2 | Aquatic Chronic 4 | H361f *** H413 | GHS08 | Wng | H361f *** H413 |   |   |  
014-019-00-7 | reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole; | 1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole | 403-250-2 | — | Carc. 2 | Repr. 1B | Acute Tox. 4 * | Aquatic Chronic 2 | H351 | H360D *** H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H351 | H360D *** H302 | H411 |   |   |  014-019-00-7 | реакционна маса от: 4-[[бис-(4-флуорофенил)метилсилил]метил]-4H-1,2,4-триазол; | 1-[[бис-(4-флуорофенил)метилсилил]метил]-1H-1,2,4-триазол; | 403-250-2 | — | Carc. 2 | Repr. 1B | Acute Tox. 4 * | Aquatic Chronic 2 | H351 | H360D *** H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H351 | H360D *** H302 | H411 |   |   |  
014-020-00-2 | bis(1,1-dimethyl-2-propynyloxy)dimethylsilane | 414-960-7 | 53863-99-3 | Acute Tox. 4 * | H332 | GHS07 | Wng | H332 |   |   |  014-020-00-2 | бис(1,1-диметил-2-пропинилокси)диметилсилан | 414-960-7 | 53863-99-3 | Acute Tox. 4 * | H332 | GHS07 | Wng | H332 |   |   |  
014-021-00-8 | tris(isopropenyloxy)phenyl silane | 411-340-8 | 52301-18-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H400 | H410 |   |   |  014-021-00-8 | трис(изопропенилокси)фенилсилан | 411-340-8 | 52301-18-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H400 | H410 |   |   |  
014-022-00-3 | reaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane) | 401-530-9 | — | Flam. Sol. 1 | STOT SE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H228 | H370 ** | H332 | H312 | H302 | GHS02 | GHS08 | GHS07 | Dgr | H228 | H370 ** | H332 | H312 | H302 |   |   | T014-022-00-3 | реакционeн продукт на: (2-хидрокси-4-(3-пропенокси)бензофенон и триетоксисилан) с (хидролизен продукт на силициев диоксид и мeтилтриметоксисилан) | 401-530-9 | — | Flam. Sol. 1 | STOT SE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H228 | H370 ** | H332 | H312 | H302 | GHS02 | GHS08 | GHS07 | Dgr | H228 | H370 ** | H332 | H312 | H302 |   |   | T
014-023-00-9 | α, ω-dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole | 408-160-7 | 125613-45-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  014-023-00-9 | α, ω-дихидроксиполи(хекс-5-eн-1-илметилсилоксан)хоксисилан с (хидролизен продукт на силициев диоксид и мeтилтриметоксисилан)иазол | 408-160-7 | 125613-45-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
014-024-00-4 | 1-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene | 412-620-2 | 121626-74-2 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  014-024-00-4 | 1-((3-(4-флуоро-3-хлорофенил)пропил)диметилсиланил)-4-етоксибензен | 412-620-2 | 121626-74-2 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
014-025-00-X | 4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine | 411-400-3 | 102089-33-8 | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H373 ** | H315 | H318 | H412 | GHS08 | GHS05 | GHS07 | Dgr | H302 | H373 ** | H315 | H318 | H412 |   |   |  014-025-00-X | 4-[3-(диетоксиметилсилилпропокси)-2,2,6,6-тетраметил]пиперидин | 411-400-3 | 102089-33-8 | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H373 ** | H315 | H318 | H412 | GHS08 | GHS05 | GHS07 | Dgr | H302 | H373 ** | H315 | H318 | H412 |   |   |  
014-026-00-5 | dichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane | 407-180-3 | 770722-36-6 | Skin Corr. 1A | H314 | GHS05 | Dgr | H314 |   |   |  014-026-00-5 | дихлоро-(3-(4-флуоро-3-хлорофенил)пропил)метилсилан | 407-180-3 | 770722-36-6 | Skin Corr. 1A | H314 | GHS05 | Dgr | H314 |   |   |  
014-027-00-0 | chloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane | 410-270-5 | 770722-46-8 | Skin Corr. 1A | H314 | GHS05 | Dgr | H314 |   |   |  014-027-00-0 | хлоро(3-(4-флуоро-3-хлорофенил)пропил)диметилсилан | 410-270-5 | 770722-46-8 | Skin Corr. 1A | H314 | GHS05 | Dgr | H314 |   |   |  
014-028-00-6 | α-[3-(1-oxoprop-2-enyl)l-1-oxypropyl]dimethoxysilyloxy-ω-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane) | 415-290-8 | 193159-06-7 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  014-028-00-6 | α-[3-(1-оксопроп-2-енил)-1-оксипропил]диметоксисилилокси-ω-[3-(1-оксопроп-2-енил)-1-оксипропил]диметоксисилилполи(диметилсилоксан) | 415-290-8 | 193159-06-7 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
014-029-00-1 | O, O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime] | 421-870-1 | 156145-66-3 | Repr. 2 | Acute Tox. 4 * | STOT RE 2 * | H361f *** H302 | H373 ** | GHS08 | GHS07 | Wng | H361f *** H302 | H373 ** |   |   |  014-029-00-1 | O,O′-(етенилметилсилилен)ди[(4-метилпентан-2-он)оксим] | 421-870-1 | 156145-66-3 | Repr. 2 | Acute Tox. 4 * | STOT RE 2 * | H361f *** H302 | H373 ** | GHS08 | GHS07 | Wng | H361f *** H302 | H373 ** |   |   |  
014-030-00-7 | [(dimethylsilylene)bis((1,2,3,3a,7a-η)-1H-inden-1-ylidene)dimethyl]hafnium | 422-060-0 | 137390-08-0 | Acute Tox. 2 * | H300 | GHS06 | Dgr | H300 |   |   |  014-030-00-7 | [(диметилсилилен)бис((1,2,3,3a,7a-η)-1H-инден-1-илиден)диметил]хафний | 422-060-0 | 137390-08-0 | Acute Tox. 2 * | H300 | GHS06 | Dgr | H300 |   |   |  
014-031-00-2 | bis(1-methylethyl)-dimethoxysilane | 421-540-7 | 18230-61-0 | Flam. Liq. 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H226 | H315 | H317 | H412 | GHS02 | GHS07 | Wng | H226 | H315 | H317 | H412 |   |   |  014-031-00-2 | бис(1-метилетил)диметоксисилан | 421-540-7 | 18230-61-0 | Flam. Liq. 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H226 | H315 | H317 | H412 | GHS02 | GHS07 | Wng | H226 | H315 | H317 | H412 |   |   |  
014-032-00-8 | dicyclopentyldimethoxysilane | 404-370-8 | 126990-35-0 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H315 | H318 | H410 |   |   |  014-032-00-8 | дициклопентилдиметоксисилан | 404-370-8 | 126990-35-0 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H315 | H318 | H410 |   |   |  
014-033-00-3 | 2-methyl-3-(trimethoxysilyl)propyl-2-propenoate hydrolysis product with silica | 419-030-4 | 125804-20-8 | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | H225 | H319 | H336 | GHS02 | GHS07 | Dgr | H225 | H319 | H336 |   |   |  014-033-00-3 | 2-метил-3-(триметоксисилил)пропил-2-пропеноат, продукт от хидролиза, със силициев диоксид | 419-030-4 | 125804-20-8 | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | H225 | H319 | H336 | GHS02 | GHS07 | Dgr | H225 | H319 | H336 |   |   |  
014-034-00-9 | 3-hexylheptamethyltrisiloxane | 428-700-5 | 1873-90-1 | Acute Tox. 4 * | Aquatic Chronic 4 | H332 | H413 | GHS07 | Wng | H332 | H413 |   |   |  014-034-00-9 | 3-хексилхептаметилтрисилоксан | 428-700-5 | 1873-90-1 | Acute Tox. 4 * | Aquatic Chronic 4 | H332 | H413 | GHS07 | Wng | H332 | H413 |   |   |  
014-035-00-4 | 2-(3,4-epoxycyclohexyl)ethyltriethoxy silane | 425-050-4 | 10217-34-2 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  014-035-00-4 | 2-(3,4-епоксициклохексил)етилтриетоксисилан | 425-050-4 | 10217-34-2 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
014-036-00-X | (4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane | 405-020-7 | 105024-66-6 | Repr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H360F*** H400 | H410 | GHS08 | GHS09 | Dgr | H360F*** H410 |   | M=1000 |  014-036-00-X | (4-етоксифенил)(3-(3-фенокси-4-флуорофенил)пропил)диметилсилан | 405-020-7 | 105024-66-6 | Repr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H360F*** H400 | H410 | GHS08 | GHS09 | Dgr | H360F*** H410 |   | M=1000 |  
014-037-00-5 | 2-butanone-O, O',O''-(phenylsilylidyne)trioxime | 433-360-6 | 34036-80-1 | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 3 | H373** | H317 | H412 | GHS08 | GHS07 | Wng | H373** | H317 | H412 |   |   |  014-037-00-5 | 2-бутанон-O,O′,O′′-(фенилсилилидин)триоксим | 433-360-6 | 34036-80-1 | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 3 | H373** | H317 | H412 | GHS08 | GHS07 | Wng | H373** | H317 | H412 |   |   |  
014-038-00-0 | S-(3-(triethoxysilyl)propyl)octanethioate | 436-690-9 | 220727-26-4 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  014-038-00-0 | S-(3-(триетоксисилил)пропил)октантиоат | 436-690-9 | 220727-26-4 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
014-039-00-6 | (2,3-dimethylbut-2-yl)-trimethoxysilane | 439-360-2 | 142877-45-0 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H315 | H318 | H412 | GHS05 | Dgr | H315 | H318 | H412 |   |   |  014-039-00-6 | (2,3-диметилбут-2-ил)триметоксисилан | 439-360-2 | 142877-45-0 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H315 | H318 | H412 | GHS05 | Dgr | H315 | H318 | H412 |   |   |  
014-041-00-7 | N, N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane | 445-890-5 | 201290-01-9 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  014-041-00-7 | N, N-бис(триметилсилил)аминопропилметилдиетоксисилан | 445-890-5 | 201290-01-9 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  
014-042-00-2 | reaction mass of: O,O',O'',O'''-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers) | 423-010-0 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  014-042-00-2 | реакционна маса от: O,O′,O′′,O′′′-силантетраилтетракис(4-метил-2-пентаноноксим) (3 стереоизомери) | 423-010-0 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
014-043-00-8 | reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %) | 432-200-2 | — | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H335 | H315 | H318 | H412 | GHS05 | GHS07 | Dgr | H335 | H315 | H318 | H412 |   |   |  014-043-00-8 | реакционен продукт от аморфен силициев диоксид (50-85 %), бутил(1-метилпропил)магнезий (3-15 %), тетраетилов ортосиликат (5-15 %) и титанов тетрахлорид (5-20 %) | 432-200-2 | — | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H335 | H315 | H318 | H412 | GHS05 | GHS07 | Dgr | H335 | H315 | H318 | H412 |   |   |  
014-044-00-3 | 3-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilane | 433-050-0 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  014-044-00-3 | 3-[(4′-ацетокси-3′-метоксифенил)пропил]триметоксисилан | 433-050-0 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
014-045-00-9 | magnesium sodium fluoride silicate | 442-650-1 | — | STOT RE 2 * | H373** | GHS08 | Wng | H373** |   |   |  014-045-00-9 | магнезиев натриев силикат флуорид | 442-650-1 | — | STOT RE 2 * | H373** | GHS08 | Wng | H373** |   |   |  
015-001-00-1 | white phosphorus | 231-768-7 | 12185-10-3 | Pyr. Sol. 1 | Acute Tox. 2 * | Acute Tox. 2 * | Skin Corr. 1A | Aquatic Acute 1 | H250 | H330 | H300 | H314 | H400 | GHS02 | GHS06 | GHS05 | GHS09 | Dgr | H250 | H330 | H300 | H314 | H400 |   |   |  015-001-00-1 | бял фосфор | 231-768-7 | 12185-10-3 | Pyr. Sol. 1 | Acute Tox. 2 * | Acute Tox. 2 * | Skin Corr. 1A | Aquatic Acute 1 | H250 | H330 | H300 | H314 | H400 | GHS02 | GHS06 | GHS05 | GHS09 | Dgr | H250 | H330 | H300 | H314 | H400 |   |   |  
015-002-00-7 | red phosphorus | 231-768-7 | 7723-14-0 | Flam. Sol. 1 | Aquatic Chronic 3 | H228 | H412 | GHS02 | Dgr | H228 | H412 |   |   |  015-002-00-7 | червен фосфор | 231-768-7 | 7723-14-0 | Flam. Sol. 1 | Aquatic Chronic 3 | H228 | H412 | GHS02 | Dgr | H228 | H412 |   |   |  
015-004-00-8 | aluminium phosphide | 244-088-0 | 20859-73-8 | Water-react. 1 | Acute Tox. 2 | Acute Tox. 3 | Acute Tox. 1 | Aquatic Acute 1 | H260 | H300 | H311 | H330 | H400 | GHS02 | GHS06 | GHS09 | Dgr | H260 | H300 | H311 | H330 | H400 | EUH029 | EUH032 | M = 100 |  015-004-00-8 | алуминиев фосфид | 244-088-0 | 20859-73-8 | Water-react. 1 | Acute Tox. 2 | Acute Tox. 3 | Acute Tox. 1 | Aquatic Acute 1 | H260 | H300 | H311 | H330 | H400 | GHS02 | GHS06 | GHS09 | Dgr | H260 | H300 | H311 | H330 | H400 | EUH029 | EUH032 | M = 100 |  
015-005-00-3 | magnesium phosphide; | trimagnesium diphosphide | 235-023-7 | 12057-74-8 | Water-react. 1 | Acute Tox. 2 | Acute Tox. 3 | Acute Tox. 1 | Aquatic Acute 1 | H260 | H300 | H311 | H330 | H400 | GHS02 | GHS06 | GHS09 | Dgr | H260 | H300 | H311 | H330 | H400 | EUH029 | EUH032 | M = 100 |  015-005-00-3 | магнезиев фосфид; | тримагнезиев дифосфид | 235-023-7 | 12057-74-8 | Water-react. 1 | Acute Tox. 2 | Acute Tox. 3 | Acute Tox. 1 | Aquatic Acute 1 | H260 | H300 | H311 | H330 | H400 | GHS02 | GHS06 | GHS09 | Dgr | H260 | H300 | H311 | H330 | H400 | EUH029 | EUH032 | M = 100 |  
015-006-00-9 | trizinc diphosphide; | zinc phosphide | 215-244-5 | 1314-84-7 | Water-react. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H260 | H300 | H400 | H410 | GHS02 | GHS06 | GHS09 | Dgr | H260 | H300 | H410 | EUH029 | EUH032 | M=100 | T015-006-00-9 | трицинков дифосфид; | цинков фосфид | 215-244-5 | 1314-84-7 | Water-react. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H260 | H300 | H400 | H410 | GHS02 | GHS06 | GHS09 | Dgr | H260 | H300 | H410 | EUH029 | EUH032 | M=100 | T
015-007-00-4 | phosphorus trichloride | 231-749-3 | 7719-12-2 | Acute Tox. 2 * | Acute Tox. 2 * | STOT RE 2 * | Skin Corr. 1A | H330 | H300 | H373 ** | H314 | GHS06 | GHS08 | GHS05 | Dgr | H330 | H300 | H373 ** | H314 | EUH014 | EUH029 |   |  015-007-00-4 | фосфорен трихлорид | 231-749-3 | 7719-12-2 | Acute Tox. 2 * | Acute Tox. 2 * | STOT RE 2 * | Skin Corr. 1A | H330 | H300 | H373 ** | H314 | GHS06 | GHS08 | GHS05 | Dgr | H330 | H300 | H373 ** | H314 | EUH014 | EUH029 |   |  
015-008-00-X | phosphorus pentachloride | 233-060-3 | 10026-13-8 | Acute Tox. 2 * | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | H330 | H302 | H373 ** | H314 | GHS06 | GHS08 | GHS05 | Dgr | H330 | H302 | H373 ** | H314 | EUH014 | EUH029 |   |  015-008-00-X | фосфорен пентахлорид | 233-060-3 | 10026-13-8 | Acute Tox. 2 * | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | H330 | H302 | H373 ** | H314 | GHS06 | GHS08 | GHS05 | Dgr | H330 | H302 | H373 ** | H314 | EUH014 | EUH029 |   |  
015-009-00-5 | phosphoryl trichloride | 233-046-7 | 10025-87-3 | Acute Tox. 2 * | STOT RE 1 | Acute Tox. 4 * | Skin Corr. 1A | H330 | H372 ** | H302 | H314 | GHS06 | GHS08 | GHS05 | Dgr | H330 | H372 ** | H302 | H314 | EUH014 | EUH029 |   |  015-009-00-5 | фосфорилтрихлорид | 233-046-7 | 10025-87-3 | Acute Tox. 2 * | STOT RE 1 | Acute Tox. 4 * | Skin Corr. 1A | H330 | H372 ** | H302 | H314 | GHS06 | GHS08 | GHS05 | Dgr | H330 | H372 ** | H302 | H314 | EUH014 | EUH029 |   |  
015-010-00-0 | phosphorus pentoxide | 215-236-1 | 1314-56-3 | Skin Corr. 1A | H314 | GHS05 | Dgr | H314 |   |   |  015-010-00-0 | фосфорен пентаоксид | 215-236-1 | 1314-56-3 | Skin Corr. 1A | H314 | GHS05 | Dgr | H314 |   |   |  
015-011-00-6 | phosphoric acid . %, orthophosphoric acid . % | 231-633-2 | 7664-38-2 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % | B015-011-00-6 | фосфорна киселина . %, ортофосфорна киселина . % | 231-633-2 | 7664-38-2 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % Eye Irrit. 2; H319: 10 % ≤ C < 25 % | B
015-012-00-1 | tetraphosphorus trisulphide; | phosphorus sesquisulphid | 215-245-0 | 1314-85-8 | Flam. Sol. 2 | Water-react. 1 | Acute Tox. 4 * | Aquatic Acute 1 | H228 | H260 | H302 | H400 | GHS02 | GHS07 | GHS09 | Dgr | H228 | H260 | H302 | H400 |   |   | T015-012-00-1 | тeтрафосфорен трисулфид; | фосфорен сесквисулфид | 215-245-0 | 1314-85-8 | Flam. Sol. 2 | Water-react. 1 | Acute Tox. 4 * | Aquatic Acute 1 | H228 | H260 | H302 | H400 | GHS02 | GHS07 | GHS09 | Dgr | H228 | H260 | H302 | H400 |   |   | T
015-013-00-7 | triethyl phosphate | 201-114-5 | 78-40-0 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  015-013-00-7 | триетилов фосфат | 201-114-5 | 78-40-0 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
015-014-00-2 | tributyl phosphate | 204-800-2 | 126-73-8 | Carc. 2 | Acute Tox. 4 * | Skin Irrit. 2 | H351 | H302 | H315 | GHS08 | GHS07 | Wng | H351 | H302 | H315 |   |   |  015-014-00-2 | трибутилов фосфат | 204-800-2 | 126-73-8 | Carc. 2 | Acute Tox. 4 * | Skin Irrit. 2 | H351 | H302 | H315 | GHS08 | GHS07 | Wng | H351 | H302 | H315 |   |   |  
015-015-00-8 | tricresyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-); tritolyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-); | 201-103-5 | 78-30-8 | STOT SE 1 | Aquatic Chronic 2 | H370 ** | H411 | GHS08 | GHS09 | Dgr | H370 ** | H411 |   | STOT SE 1; H370: C ≥ 1 % STOT SE 2; H371: 0,2  % ≤ C < 1 % | C015-015-00-8 | трикрезилов фосфат (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-); тритолилов фосфат (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-); | 201-103-5 | 78-30-8 | STOT SE 1 | Aquatic Chronic 2 | H370 ** | H411 | GHS08 | GHS09 | Dgr | H370 ** | H411 |   | STOT SE 1; H370: C ≥ 1 % STOT SE 2; H371: 0,2  % ≤ C < 1 % | C
015-016-00-3 | tricresyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-); | tritolyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-); | 201-105-6 | 78-32-0 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 2 | H312 | H302 | H411 | GHS07 | GHS09 | Wng | H312 | H302 | H411 |   | * | C015-016-00-3 | трикрезилов фосфат (m-m-m-, m-m-p-, m-p-p-, p-p-p-); | тритолилов фосфат (m-m-m-, m-m-p-, m-p-p-, p-p-p-); | 201-105-6 | 78-32-0 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 2 | H312 | H302 | H411 | GHS07 | GHS09 | Wng | H312 | H302 | H411 |   | * | C
015-019-00-X | dichlorvos (ISO); | 2,2-dichlorovinyl dimethyl phosphate | 200-547-7 | 62-73-7 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Sens. 1 | Aquatic Acute 1 | H330 | H311 | H301 | H317 | H400 | GHS06 | GHS09 | Dgr | H330 | H311 | H301 | H317 | H400 |   | M=1000 |  015-019-00-X | дихлорвос (ISO); | диметилов 2,2-дихлоровинилов фосфат | 200-547-7 | 62-73-7 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Sens. 1 | Aquatic Acute 1 | H330 | H311 | H301 | H317 | H400 | GHS06 | GHS09 | Dgr | H330 | H311 | H301 | H317 | H400 |   | M=1000 |  
015-020-00-5 | mevinphos (ISO); | 2-methoxycarbonyl-1-methylvinyl dimethyl phosphate | 232-095-1 | 7786-34-7 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   | M = 10000 |  015-020-00-5 | мевинфос (ISO); | 1-метил-2-метоксикарбонилвинилов диметилов фосфат | 232-095-1 | 7786-34-7 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   | M = 10000 |  
015-021-00-0 | trichlorfon (ISO); | dimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate | 200-149-3 | 52-68-6 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H400 | H410 |   | M = 1000 |  015-021-00-0 | трихлорфон (ISO); | диметилов 1-хидрокси-2,2,2-трихлороетилфосфонат | 200-149-3 | 52-68-6 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H400 | H410 |   | M = 1000 |  
015-022-00-6 | phosphamidon (ISO); | 2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate | 236-116-5 | 13171-21-6 | Muta. 2 | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H300 | H311 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H341 | H300 | H311 | H410 |   |   |  015-022-00-6 | фосфамидон (ISO); | 1-метил-2-диетилкарбамоил-2-хлоровинилов диметилов фосфат | 236-116-5 | 13171-21-6 | Muta. 2 | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H300 | H311 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H341 | H300 | H311 | H410 |   |   |  
015-023-00-1 | pyrazoxon; | diethyl 3-methylpyrazol-5-yl phosphate | — | 108-34-9 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | H330 | H310 | H300 | GHS06 | Dgr | H330 | H310 | H300 |   |   |  015-023-00-1 | пиразоксон; | диетилов 3-метилпиразол-5-илов фосфат | — | 108-34-9 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | H330 | H310 | H300 | GHS06 | Dgr | H330 | H310 | H300 |   |   |  
015-024-00-7 | triamiphos (ISO); | 5-amino-3-phenyl-1,2,4-triazol-1-yl-N, N,N',N'-tetramethylphosphonic diamide | — | 1031-47-6 | Acute Tox. 1 | Acute Tox. 2 * | H310 | H300 | GHS06 | Dgr | H310 | H300 |   |   |  015-024-00-7 | триамифос (ISO); | 5-амино-3-фенил-1,2,4-триазол-1-ил-N,N,N′,N′-тетраметилфосфонов диамид | — | 1031-47-6 | Acute Tox. 1 | Acute Tox. 2 * | H310 | H300 | GHS06 | Dgr | H310 | H300 |   |   |  
015-025-00-2 | TEPP (ISO); | tetraethyl pyrophosphate | 203-495-3 | 107-49-3 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | H310 | H300 | H400 | GHS06 | GHS09 | Dgr | H310 | H300 | H400 |   |   |  015-025-00-2 | TEPP (ISO); | тeтраетилов пирофосфат | 203-495-3 | 107-49-3 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | H310 | H300 | H400 | GHS06 | GHS09 | Dgr | H310 | H300 | H400 |   |   |  
015-026-00-8 | schradan (ISO); octamethylpyrophosphoramide | 205-801-0 | 152-16-9 | Acute Tox. 1 | Acute Tox. 2 * | H310 | H300 | GHS06 | Dgr | H310 | H300 |   |   |  015-026-00-8 | шрадан (ISO); октаметилпирофосфорамид | 205-801-0 | 152-16-9 | Acute Tox. 1 | Acute Tox. 2 * | H310 | H300 | GHS06 | Dgr | H310 | H300 |   |   |  
015-027-00-3 | sulfotep (ISO); | O, O,O, O-tetraethyl dithiopyrophosphate | 222-995-2 | 3689-24-5 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   | M = 1000 |  015-027-00-3 | сулфотеп (ISO); | O, O,O, O-тeтраетилов дитиопирофосфат | 222-995-2 | 3689-24-5 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   | M = 1000 |  
015-028-00-9 | demeton-O (ISO); | O,O-diethyl-O-2-ethylthioethyl phosphorothioate | 206-053-8 | 298-03-3 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | H310 | H300 | H400 | GHS06 | GHS09 | Dgr | H310 | H300 | H400 |   |   |  015-028-00-9 | деметон-О (ISO); | О,О-диетил-О-2-eтилтиоетилов фосфоротиоат | 206-053-8 | 298-03-3 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | H310 | H300 | H400 | GHS06 | GHS09 | Dgr | H310 | H300 | H400 |   |   |  
015-029-00-4 | demeton-S (ISO); | diethyl-S-2-ethylthioethyl phosphorothioate | 204-801-8 | 126-75-0 | Acute Tox. 1 | Acute Tox. 2 * | H310 | H300 | GHS06 | Dgr | H310 | H300 |   |   |  015-029-00-4 | деметон-S (ISO); | диетил-S-2-етилтиоетилов фосфоротиоат | 204-801-8 | 126-75-0 | Acute Tox. 1 | Acute Tox. 2 * | H310 | H300 | GHS06 | Dgr | H310 | H300 |   |   |  
015-030-00-X | demeton-O-methyl (ISO); | O-2-ethylthioethyl O,O-dimethyl phosphorothioate | 212-758-1 | 867-27-6 | Acute Tox. 3 * | H301 | GHS06 | Dgr | H301 |   |   |  015-030-00-X | деметон-О-метил (ISO); | О-2-eтилтиоетилов О,О-диметилов фосфоротиоат | 212-758-1 | 867-27-6 | Acute Tox. 3 * | H301 | GHS06 | Dgr | H301 |   |   |  
015-031-00-5 | demeton-S-methyl (ISO); | S-2-ethylthioethyl dimethyl phosphorothioate | 213-052-6 | 919-86-8 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Chronic 2 | H311 | H301 | H411 | GHS06 | GHS09 | Dgr | H311 | H301 | H411 |   |   |  015-031-00-5 | деметон-S-метил (ISO); | S-2-етилтиоетилов диметилов фосфоротиоат | 213-052-6 | 919-86-8 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Chronic 2 | H311 | H301 | H411 | GHS06 | GHS09 | Dgr | H311 | H301 | H411 |   |   |  
015-032-00-0 | prothoate (ISO); | O,O-diethyl isopropylcarbamoylmethyl phosphorodithioate | 218-893-2 | 2275-18-5 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Chronic 3 | H310 | H300 | H412 | GHS06 | Dgr | H310 | H300 | H412 |   |   |  015-032-00-0 | протоат (ISO); | O,O-диетилов изопропилкарбамоилметилов фосфородитиоат | 218-893-2 | 2275-18-5 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Chronic 3 | H310 | H300 | H412 | GHS06 | Dgr | H310 | H300 | H412 |   |   |  
015-033-00-6 | phorate (ISO); | O,O-diethyl ethylthiomethyl phosphorodithioate | 206-052-2 | 298-02-2 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   | M = 1000 |  015-033-00-6 | форат (ISO); | O,O-диетилов етилтиометилов фосфородитиоат | 206-052-2 | 298-02-2 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   | M = 1000 |  
015-034-00-1 | parathion (ISO); | O,O-diethyl O-4-nitrophenyl phosphorothioate | 200-271-7 | 56-38-2 | Acute Tox. 2 * | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H300 | H311 | H372 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H300 | H311 | H372 ** | H410 |   | M = 100 |  015-034-00-1 | паратион (ISO); | O,O-диетилов О-4-нитрофенилов фосфоротиоат | 200-271-7 | 56-38-2 | Acute Tox. 2 * | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H300 | H311 | H372 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H300 | H311 | H372 ** | H410 |   | M = 100 |  
015-035-00-7 | parathion — methyl (ISO); | O,O-dimethyl O-4-nitrophenyl phosphorothioate | 206-050-1 | 298-00-0 | Flam. Liq. 3 | Acute Tox. 2 * | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H226 | H330 | H300 | H311 | H373 ** | H400 | H410 | GHS02 | GHS06 | GHS08 | GHS09 | Dgr | H226 | H330 | H300 | H311 | H373 ** | H410 |   | M = 100 |  015-035-00-7 | паратион-метил (ISO); | O,O-диметилов О-4-нитрофенилов фосфоротиоат | 206-050-1 | 298-00-0 | Flam. Liq. 3 | Acute Tox. 2 * | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H226 | H330 | H300 | H311 | H373 ** | H400 | H410 | GHS02 | GHS06 | GHS08 | GHS09 | Dgr | H226 | H330 | H300 | H311 | H373 ** | H410 |   | M = 100 |  
015-036-00-2 | O-ethyl O-4-nitrophenyl phenylphosphonothioate; | EPN | 218-276-8 | 2104-64-5 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   |   |  015-036-00-2 | О-етилов О-4-нитрофенилов фенилфосфонотиоат; | EPN | 218-276-8 | 2104-64-5 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   |   |  
015-037-00-8 | phenkapton (ISO); | S-(2,5-dichlorophenylthiomethyl) O, O-diethyl phosphorodithioate | 218-892-7 | 2275-14-1 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H410 |   |   |  015-037-00-8 | фенкаптон (ISO); | S-(2,5-дихлорофенилтиометилов) O, O-диетилов фосфородитиоат | 218-892-7 | 2275-14-1 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H410 |   |   |  
015-038-00-3 | coumaphos (ISO); | O-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate | 200-285-3 | 56-72-4 | Acute Tox. 2 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H312 | H410 |   |   |  015-038-00-3 | кумафос (ISO); | O-4-метил-3-хлорокумарин-7-илов О,О-диетилов фосфоротиоат | 200-285-3 | 56-72-4 | Acute Tox. 2 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H312 | H410 |   |   |  
015-039-00-9 | azinphos-methyl (ISO); | O,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate | 201-676-1 | 86-50-0 | Acute Tox. 2 * | Acute Tox. 2 * | Acute Tox. 3 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H300 | H311 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H300 | H311 | H317 | H410 |   |   |  015-039-00-9 | азинфос-метил (ISO); | O,O-диметил-4-oксобензотриазин-3-илметилов фосфородитиоат | 201-676-1 | 86-50-0 | Acute Tox. 2 * | Acute Tox. 2 * | Acute Tox. 3 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H300 | H311 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H300 | H311 | H317 | H410 |   |   |  
015-040-00-4 | diazinon (ISO); | O,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate | 206-373-8 | 333-41-5 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H400 | H410 |   |   |  015-040-00-4 | диазинон (ISO); | O,O-диетилов О-2-изопропил-6-метилпиримидин-4-илов фосфоротиоат | 206-373-8 | 333-41-5 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H400 | H410 |   |   |  
015-041-00-X | malathion (ISO); | 1,2-bis(ethoxycarbonyl)ethyl O, O-dimethyl phosphorodithioate; | [containing ≤ 0,03 % isomalathion] | 204-497-7 | 121-75-5 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   | M=1000 |  015-041-00-X | малатион (ISO); | 1,2-бис(етоксикарбонил)етилов O, O-диметилов фосфородитиоат; | [съдържащ ≤ 0,03 % изомалатион] | 204-497-7 | 121-75-5 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   | M=1000 |  
015-042-00-5 | chlorthion O-(3-chloro-4-nitrophenyl) O, O-dimethyl phosphorothioate | 207-902-5 | 500-28-7 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   | M = 100 |  015-042-00-5 | хлортион О-(4-нитро-3-хлорофенилов) O, O-диметилов фосфоротиоат | 207-902-5 | 500-28-7 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   | M = 100 |  
015-043-00-0 | phosnichlor (ISO); | O-4-chloro-3-nitrophenyl O, O-dimethyl phosphorothioate | — | 5826-76-6 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H312 | H302 | GHS07 | Wng | H332 | H312 | H302 |   |   |  015-043-00-0 | фоснихлор(ISO); | O-3-нитро-4-хлорофенилов O, O-диметилов фосфоротиоат | — | 5826-76-6 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H312 | H302 | GHS07 | Wng | H332 | H312 | H302 |   |   |  
015-044-00-6 | carbophenothion (ISO); | 4-chlorophenylthiomethyl O, O-diethyl phosphorodithioate | 212-324-1 | 786-19-6 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H311 | H301 | H410 |   |   |  015-044-00-6 | карбофенотион (ISO); | 4-хлорофенилтиометилов O, O-диетилов фосфородитиоат | 212-324-1 | 786-19-6 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H311 | H301 | H410 |   |   |  
015-045-00-1 | mecarbam (ISO); | N-ethoxycarbonyl-N-methylcarbamoylmethyl O, O-diethyl phosphorodithioate | 219-993-9 | 2595-54-2 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H311 | H301 | H400 | H410 |   |   |  015-045-00-1 | мeкарбам (ISO); | N-етоксикарбонил-N-метилкарбамоилметилов O, O-диетилов фосфородитиоат | 219-993-9 | 2595-54-2 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H311 | H301 | H400 | H410 |   |   |  
015-046-00-7 | oxydemeton-methyl; | S-2-(ethylsulphinyl)ethyl O,O-dimethyl phosphorothioate | 206-110-7 | 301-12-2 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | H311 | H301 | H400 | GHS06 | GHS09 | Dgr | H311 | H301 | H400 |   |   |  015-046-00-7 | оксидеметон-метил; | S-2-(етилсулфинил)етилов О,О-диметилов фосфоротиоат | 206-110-7 | 301-12-2 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | H311 | H301 | H400 | GHS06 | GHS09 | Dgr | H311 | H301 | H400 |   |   |  
015-047-00-2 | ethion (ISO); | O, O,O',O'-tetraethyl S, S'-methylenedi (phosphorodithioate); | diethion | 209-242-3 | 563-12-2 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H312 | H410 |   | M = 10000 |  015-047-00-2 | етион (ISO); | O, O,O′,O′-тетраетилов S,S′-метиленди(фосфородитиоат); | диетион | 209-242-3 | 563-12-2 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H312 | H410 |   | M = 10000 |  
015-048-00-8 | fenthion (ISO); | O, O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate | 200-231-9 | 55-38-9 | Muta. 2 | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H331 | H312 | H302 | H372** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H341 | H331 | H312 | H302 | H372** H410 |   | M=100 |  015-048-00-8 | фентион (ISO); | O, O-диметил-O-(4-метилтион-m-толилов) фосфоротиоат | 200-231-9 | 55-38-9 | Muta. 2 | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H331 | H312 | H302 | H372** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H341 | H331 | H312 | H302 | H372** H410 |   | M=100 |  
015-049-00-3 | endothion (ISO); | S-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate | 220-472-3 | 2778-04-3 | Acute Tox. 3 * | Acute Tox. 3 * | H311 | H301 | GHS06 | Dgr | H311 | H301 |   |   |  015-049-00-3 | ендотион (ISO); | S-5-мeтокси-4-oксопиран-2-илметилов диметилов фосфоротиоат | 220-472-3 | 2778-04-3 | Acute Tox. 3 * | Acute Tox. 3 * | H311 | H301 | GHS06 | Dgr | H311 | H301 |   |   |  
015-050-00-9 | thiometon (ISO); | S-2-ethylthioethyl O,O-dimethyl phosphorodithioate | 211-362-6 | 640-15-3 | Acute Tox. 3 * | Acute Tox. 4 * | H301 | H312 | GHS06 | Dgr | H301 | H312 |   |   |  015-050-00-9 | тиометон (ISO); | S-2-етилтиоетилов О,О-диметилов фосфородитиоат | 211-362-6 | 640-15-3 | Acute Tox. 3 * | Acute Tox. 4 * | H301 | H312 | GHS06 | Dgr | H301 | H312 |   |   |  
015-051-00-4 | dimethoate (ISO); | O, O-dimethyl methylcarbamoylmethyl phosphorodithioate | 200-480-3 | 60-51-5 | Acute Tox. 4 * | Acute Tox. 4 * | H312 | H302 | GHS07 | Wng | H312 | H302 |   |   |  015-051-00-4 | диметоат (ISO); | O, O-диметилов метилкарбамоилметилов фосфородитиоат | 200-480-3 | 60-51-5 | Acute Tox. 4 * | Acute Tox. 4 * | H312 | H302 | GHS07 | Wng | H312 | H302 |   |   |  
015-052-00-X | fenchlorphos (ISO); | O, O-dimethyl O-2,4,5-trichlorophenyl phosphorothioate | 206-082-6 | 299-84-3 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   |   |  015-052-00-X | фенхлорфос (ISO); | O, O-диметилов O-2,4,5-трихлорофенилов фосфоротиоат | 206-082-6 | 299-84-3 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   |   |  
015-053-00-5 | menazon (ISO); | S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O, O-dimethyl phosphorodithioate | 201-123-4 | 78-57-9 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  015-053-00-5 | мeназон (ISO); | S-[(4,6-диамино-1,3,5-триазин-2-ил)метилов] O, O-диметилов фосфородитиоат | 201-123-4 | 78-57-9 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
015-054-00-0 | fenitrothion (ISO); | O, O-dimethyl O-4-nitro-m-tolyl phosphorothioate | 204-524-2 | 122-14-5 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  015-054-00-0 | фенитротион (ISO); | O, O-диметилов O-4-нитро-m-толилов фосфоротиоат | 204-524-2 | 122-14-5 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
015-055-00-6 | naled (ISO); | 1,2-dibromo-2,2-dichloroethyl dimethyl phosphate | 206-098-3 | 300-76-5 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | H312 | H302 | H319 | H315 | H400 | GHS07 | GHS09 | Wng | H312 | H302 | H319 | H315 | H400 |   | M = 1000 |  015-055-00-6 | налед (ISO); | 1,2-дибромо-2,2-дихлороетилов диметилов фосфат | 206-098-3 | 300-76-5 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | H312 | H302 | H319 | H315 | H400 | GHS07 | GHS09 | Wng | H312 | H302 | H319 | H315 | H400 |   | M = 1000 |  
015-056-00-1 | azinphos-ethyl (ISO); | O,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate | 220-147-6 | 2642-71-9 | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H311 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H311 | H410 |   | M=100 |  015-056-00-1 | азинфос-етил (ISO); | O,O-диетилов 4-оксобензотриазин-3-илметилов фосфородитиоат | 220-147-6 | 2642-71-9 | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H311 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H311 | H410 |   | M=100 |  
015-057-00-7 | formothion (ISO); | N-formyl-N-methylcarbamoylmethyl O, O-dimethyl phosphorodithioate | 219-818-6 | 2540-82-1 | Acute Tox. 4 * | Acute Tox. 4 * | H312 | H302 | GHS07 | Wng | H312 | H302 |   |   |  015-057-00-7 | формотион (ISO); | N-формил-N-метилкарбамоилметилов O, O-диметилов фосфородитиоат | 219-818-6 | 2540-82-1 | Acute Tox. 4 * | Acute Tox. 4 * | H312 | H302 | GHS07 | Wng | H312 | H302 |   |   |  
015-058-00-2 | morphothion (ISO); | O, O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate | 205-628-0 | 144-41-2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H410 |   |   |  015-058-00-2 | мoрфотион (ISO); | O, O-диметил-S-(морфолинокарбонилметилов) фосфородитиоат | 205-628-0 | 144-41-2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H410 |   |   |  
015-059-00-8 | vamidothion (ISO); | O,O-dimethyl S-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate | 218-894-8 | 2275-23-2 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | H301 | H312 | H400 | GHS06 | GHS09 | Dgr | H301 | H312 | H400 |   |   |  015-059-00-8 | вамидотион (ISO); | O,O-диметилов S-2-(1-метилкарбамоилетилтио)eтилов фосфоротиоат | 218-894-8 | 2275-23-2 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | H301 | H312 | H400 | GHS06 | GHS09 | Dgr | H301 | H312 | H400 |   |   |  
015-060-00-3 | disulfoton (ISO); | O,O-diethyl 2-ethylthioethyl phosphorodithioate | 206-054-3 | 298-04-4 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   |   |  015-060-00-3 | дисулфотон (ISO); | O,O-диетилов 2-eтилтиоетилов фосфородитиоат | 206-054-3 | 298-04-4 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   |   |  
015-061-00-9 | dimefox (ISO); tetramethylphosphorodiamidic fluoride | 204-076-8 | 115-26-4 | Acute Tox. 1 | Acute Tox. 2 * | H310 | H300 | GHS06 | Dgr | H310 | H300 |   |   |  015-061-00-9 | димефокс (ISO); тeтраметилфосфородиамиден флуорид | 204-076-8 | 115-26-4 | Acute Tox. 1 | Acute Tox. 2 * | H310 | H300 | GHS06 | Dgr | H310 | H300 |   |   |  
015-062-00-4 | mipafox (ISO); | N,N'-di-isopropylphosphorodiamidic fluoride | 206-742-3 | 371-86-8 | STOT SE 1 | H370 ** | GHS08 | Dgr | H370 ** |   |   |  015-062-00-4 | мипафокс (ISO); | N,N′-диизопропилфосфородиамиден флуорид | 206-742-3 | 371-86-8 | STOT SE 1 | H370 ** | GHS08 | Dgr | H370 ** |   |   |  
015-063-00-X | dioxathion (ISO); | 1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate) | 201-107-7 | 78-34-2 | Acute Tox. 2 * | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H300 | H311 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H300 | H311 | H410 |   | M = 1000 |  015-063-00-X | диоксатион (ISO); | 1,4-диоксан-2,3-диил-О,О,О′,О′-тетраетилов ди(фосфородитиоат) | 201-107-7 | 78-34-2 | Acute Tox. 2 * | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H300 | H311 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H300 | H311 | H410 |   | M = 1000 |  
015-064-00-5 | bromophos-ethyl (ISO); | O-4-bromo-2,5-dichlorophenyl | O,O-diethyl phosphorothioate | 225-399-0 | 4824-78-6 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H312 | H410 |   |   |  015-064-00-5 | бромофос-етил (ISO); | O-4-бромо-2,5-дихлорофенилов | O,O-диетилов фосфоротиоат | 225-399-0 | 4824-78-6 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H312 | H410 |   |   |  
015-065-00-0 | S-[2-(ethylsulphinyl)ethyl] O,O-dimethyl phosphorodithioate | — | 2703-37-9 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Chronic 2 | H330 | H310 | H300 | H411 | GHS06 | GHS09 | Dgr | H330 | H310 | H300 | H411 |   |   |  015-065-00-0 | S-[2-(етилсулфинил)етилов] О,О-диметилов фосфородитиоат | — | 2703-37-9 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Chronic 2 | H330 | H310 | H300 | H411 | GHS06 | GHS09 | Dgr | H330 | H310 | H300 | H411 |   |   |  
015-066-00-6 | omethoate (ISO); | O, O-dimethyl S-methylcarbamoylmethyl phosphorothioate | 214-197-8 | 1113-02-6 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | H301 | H312 | H400 | GHS06 | GHS09 | Dgr | H301 | H312 | H400 |   |   |  015-066-00-6 | ометоат (ISO); | O, O-диметилов S-метилкарбамоилметилов фосфоротиоат | 214-197-8 | 1113-02-6 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | H301 | H312 | H400 | GHS06 | GHS09 | Dgr | H301 | H312 | H400 |   |   |  
015-067-00-1 | phosalone (ISO); | S-(6-chloro-2-oxobenzoxazolin-3-ylmethyl) O, O-diethyl phosphorodithioate | 218-996-2 | 2310-17-0 | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H332 | H312 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H332 | H312 | H317 | H410 |   | M=1000 |  015-067-00-1 | фосалон (ISO) | S-(6-хлоро-2-оксобензоксазолин-3-илметилов) O, O-диетилов фосфородитиоат | 218-996-2 | 2310-17-0 | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H332 | H312 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H332 | H312 | H317 | H410 |   | M=1000 |  
015-068-00-7 | dichlofenthion (ISO); | O—2,4-dichlorophenyl O,O-diethyl phosphorothioate | 202-564-5 | 97-17-6 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H400 | H410 |   |   |  015-068-00-7 | дихлофентион (ISO); | O-2,4-дихлорофенилов О,О-диетилов фосфоротиоат | 202-564-5 | 97-17-6 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H400 | H410 |   |   |  
015-069-00-2 | methidathion (ISO); | 2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate | 213-449-4 | 950-37-8 | Acute Tox. 2 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H312 | H410 |   |   |  015-069-00-2 | метидатион (ISO); | 5-метокси-2,3-дихидро-2-оксо-1,3,4-тиадиазол-3-илметил-O,O-диметилов фосфородитиоат | 213-449-4 | 950-37-8 | Acute Tox. 2 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H312 | H410 |   |   |  
015-070-00-8 | cyanthoate (ISO); | S-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate | 223-099-4 | 3734-95-0 | Acute Tox. 2 * | Acute Tox. 3 * | H300 | H311 | GHS06 | Dgr | H300 | H311 |   |   |  015-070-00-8 | циантоат (ISO); | S-(N-(1-метил-1-цианоетил)карбомоилметилов) О,О-диетилов фосфоротиоат | 223-099-4 | 3734-95-0 | Acute Tox. 2 * | Acute Tox. 3 * | H300 | H311 | GHS06 | Dgr | H300 | H311 |   |   |  
015-071-00-3 | chlorfenvinphos (ISO); | 2-chloro-1-(2,4 dichlorophenyl)vinyl diethyl phosphate | 207-432-0 | 470-90-6 | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H311 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H311 | H410 |   |   |  015-071-00-3 | хлорфенвинфос (ISO); | 1-(2,4 дихлорофенил)-2-хлоровинилов диетилов фосфат | 207-432-0 | 470-90-6 | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H311 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H311 | H410 |   |   |  
015-072-00-9 | monocrotophos (ISO); | dimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate | 230-042-7 | 6923-22-4 | Muta. 2 | Acute Tox. 2 * | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H330 | H300 | H311 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H341 | H330 | H300 | H311 | H410 |   |   |  015-072-00-9 | монокротофос (ISO); | диметил-1-метил-2-(метилкарбамоил)винилов фосфат | 230-042-7 | 6923-22-4 | Muta. 2 | Acute Tox. 2 * | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H330 | H300 | H311 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H341 | H330 | H300 | H311 | H410 |   |   |  
015-073-00-4 | dicrotophos (ISO); | (Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate | 205-494-3 | 141-66-2 | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H311 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H311 | H410 |   |   |  015-073-00-4 | дикротофос (ISO); | (Z)-2-диметилкарбамоил-1-метилвинилов диметилов фосфат | 205-494-3 | 141-66-2 | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H311 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H311 | H410 |   |   |  
015-074-00-X | crufomate (ISO); | 4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate | 206-083-1 | 299-86-5 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   |   |  015-074-00-X | круфомат (ISO); | 4-трет-бутил-2-хлорофенилов метилов метилфосфорамидат | 206-083-1 | 299-86-5 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   |   |  
015-075-00-5 | S-[2-(isopropylsulphinyl)ethyl] O,O-dimethyl phosphorothioate | — | 2635-50-9 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H331 | H311 | H301 | GHS06 | Dgr | H331 | H311 | H301 |   |   |  015-075-00-5 | S-[2-(изопропилсулфинил)етилов] О,О-диметилов фосфоротиоат | — | 2635-50-9 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H331 | H311 | H301 | GHS06 | Dgr | H331 | H311 | H301 |   |   |  
015-076-00-0 | potasan; | O, O-diethyl O-(4-methylcoumarin-7-yl) phosphorothioate | — | 299-45-6 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H310 | H300 | H410 |   | M = 1000 |  015-076-00-0 | потасан; | O, O-диетилов О-(4-метилкумарин-7-илов) фосфоротиоат | — | 299-45-6 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H310 | H300 | H410 |   | M = 1000 |  
015-077-00-6 | 2,2-dichlorovinyl 2-ethylsulphinylethyl methyl phosphate | — | 7076-53-1 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H331 | H311 | H301 | GHS06 | Dgr | H331 | H311 | H301 |   |   |  015-077-00-6 | 2,2-дихлоровинилов 2-етилсулфинилетилов метилов фосфат | — | 7076-53-1 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H331 | H311 | H301 | GHS06 | Dgr | H331 | H311 | H301 |   |   |  
015-078-00-1 | demeton-S-methylsulphon(ISO); | S-2-ethylsulphonylethyl dimethyl phosphorothioate | 241-109-5 | 17040-19-6 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Chronic 2 | H301 | H312 | H411 | GHS06 | GHS09 | Dgr | H301 | H312 | H411 |   |   |  015-078-00-1 | деметон-S-метилсулфон (ISO); | S-2-етилсулфонилетилов диметилов фосфоротиоат | 241-109-5 | 17040-19-6 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Chronic 2 | H301 | H312 | H411 | GHS06 | GHS09 | Dgr | H301 | H312 | H411 |   |   |  
015-079-00-7 | acephate (ISO); | O, S-dimethyl acetylphosphoramidothioate | 250-241-2 | 30560-19-1 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  015-079-00-7 | ацефат (ISO); | O,S-диметилов ацетилфосфороамидотиоат | 250-241-2 | 30560-19-1 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
015-080-00-2 | amidithion (ISO); | 2-methoxyethylcarbamoylmethyl O,O-dimethyl phosphorodithioate | — | 919-76-6 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  015-080-00-2 | амидитион (ISO); | 2-мeтоксиетилкарбамоилметилов O,O-диметилов фосфородитиоат | — | 919-76-6 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
015-081-00-8 | O,O,O',O'-tetrapropyl dithiopyrophosphate | 221-817-0 | 3244-90-4 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   |   |  015-081-00-8 | O,O,O′,O′-тeтрапропилов дитиопирофосфат | 221-817-0 | 3244-90-4 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   |   |  
015-082-00-3 | azothoate (ISO); | O-4-(4-chlorophenylazo)phenyl O,O-dimethyl phosphorothioate | 227-419-3 | 5834-96-8 | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H302 | GHS07 | Wng | H332 | H302 |   |   |  015-082-00-3 | aзотоат (ISO); | O-4-(4-хлорофенилазо)фенилов О,О-диметилов фосфоротиоат | 227-419-3 | 5834-96-8 | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H302 | GHS07 | Wng | H332 | H302 |   |   |  
015-083-00-9 | bensulide (ISO); | O, O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate | 212-010-4 | 741-58-2 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  015-083-00-9 | бенсулид (ISO); | O, O-диизопропилов 2-фенилсулфониламиноетилов фосфородитиоат | 212-010-4 | 741-58-2 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
015-084-00-4 | chlorpyrifos (ISO); | O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate | 220-864-4 | 2921-88-2 | Acute Tox. 3 * Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H400 | H410 |   | M = 10000 |  015-084-00-4 | хлорпирифос (ISO); | O,O-диетилов О-3,5,6-трихлоро-2-пиридилов фосфоротиоат | 220-864-4 | 2921-88-2 | Acute Tox. 3 * Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H400 | H410 |   | M = 10000 |  
015-085-00-X | chlorphonium chloride (ISO); | tributyl (2,4-dichlorobenzyl) phosphonium chloride | 204-105-4 | 115-78-6 | Acute Tox. 3 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | H301 | H312 | H319 | H315 | GHS06 | Dgr | H301 | H312 | H319 | H315 |   |   |  015-085-00-X | хлорфониев хлорид (ISO); | трибутилов (2,4-дихлоробензилов) фосфониев хлорид | 204-105-4 | 115-78-6 | Acute Tox. 3 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | H301 | H312 | H319 | H315 | GHS06 | Dgr | H301 | H312 | H319 | H315 |   |   |  
015-086-00-5 | coumithoate (ISO); | O,O-diethyl O-7,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate | — | 572-48-5 | Acute Tox. 3 * | H301 | GHS06 | Dgr | H301 |   |   |  015-086-00-5 | кумитоат (ISO); | O,O-диетилов О-7,8,9,10-тетрахидро-6-oксобензо[c]хромен-3-илов фосфоротиоат | — | 572-48-5 | Acute Tox. 3 * | H301 | GHS06 | Dgr | H301 |   |   |  
015-087-00-0 | cyanophos (ISO); | O-4-cyanophenyl O,O-dimethyl phosphorothioate | 220-130-3 | 2636-26-2 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   |   |  015-087-00-0 | цианофос (ISO); | O-4-цианофенилов О,О-диметилов фосфоротиоат | 220-130-3 | 2636-26-2 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   |   |  
015-088-00-6 | dialifos (ISO); | 2-chloro-1-phthalimidoethyl O,O-diethyl phosphorodithioate | 233-689-3 | 10311-84-9 | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H311 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H311 | H400 | H410 |   |   |  015-088-00-6 | диалифос (ISO); | 1-фталимидо-2-хлороетилов O,O-диетилов фосфородитиоат | 233-689-3 | 10311-84-9 | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H311 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H311 | H400 | H410 |   |   |  
015-089-00-1 | ethoate-methyl (ISO); ethylcarbamoylmethyl O,O-dimethyl phosphorodithioate | 204-121-1 | 116-01-8 | Acute Tox. 4 * | Acute Tox. 4 * | H312 | H302 | GHS07 | Wng | H312 | H302 |   |   |  015-089-00-1 | етоат-метил (ISO); етилкарбамоилметилов O,O-диметилов фосфородитиоат | 204-121-1 | 116-01-8 | Acute Tox. 4 * | Acute Tox. 4 * | H312 | H302 | GHS07 | Wng | H312 | H302 |   |   |  
015-090-00-7 | fensulfothion (ISO); | O,O-diethyl O-4-methylsulfinylphenyl phosphorothioate | 204-114-3 | 115-90-2 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   |   |  015-090-00-7 | фенсулфотион (ISO); | O,O-диетилов O-4-метилсулфинилфенилов фосфоротиоат | 204-114-3 | 115-90-2 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   |   |  
015-091-00-2 | fonofos (ISO); | O-ethyl phenyl ethylphosphonodithioate | 213-408-0 | 944-22-9 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   |   |  015-091-00-2 | фонофос (ISO); | O-етилов фенилов етилфосфонодитиоат | 213-408-0 | 944-22-9 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   |   |  
015-092-00-8 | phosacetim (ISO); | O,O-bis(4-chlorophenyl) N-acetimidoylphosphoramidothioate | 223-874-7 | 4104-14-7 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   |   |  015-092-00-8 | фосацетим (ISO); | O,O-бис(4-хлорофенилов) N-ацетимидоилфосфорамидотиоат | 223-874-7 | 4104-14-7 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   |   |  
015-093-00-3 | leptophos (ISO); | O-4-bromo-2,5-dichlorophenyl O-methyl phenylphosphorothioate | 244-472-8 | 21609-90-5 | Acute Tox. 3 * | STOT SE 1 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H370 ** | H312 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H370 ** | H312 | H410 |   |   |  015-093-00-3 | лептофос (ISO); | O-4-бромо-2,5-дихлорофенилов О-метилов фенилфосфоротиоат | 244-472-8 | 21609-90-5 | Acute Tox. 3 * | STOT SE 1 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H370 ** | H312 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H370 ** | H312 | H410 |   |   |  
015-094-00-9 | mephosfolan (ISO); | diethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate | 213-447-3 | 950-10-7 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Chronic 2 | H310 | H300 | H411 | GHS06 | GHS09 | Dgr | H310 | H300 | H411 |   |   |  015-094-00-9 | мефосфолан (ISO); | диетилов 4-метил-1,3-дитиолан-2-илиденфосфорамидат | 213-447-3 | 950-10-7 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Chronic 2 | H310 | H300 | H411 | GHS06 | GHS09 | Dgr | H310 | H300 | H411 |   |   |  
015-095-00-4 | methamidophos (ISO); | O,S-dimethyl phosphoramidothioate | 233-606-0 | 10265-92-6 | Acute Tox. 2 * | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | H330 | H300 | H311 | H400 | GHS06 | GHS09 | Dgr | H330 | H300 | H311 | H400 |   |   |  015-095-00-4 | мeтамидофос (ISO); | O,S-диметилов фосфорамидотиоат | 233-606-0 | 10265-92-6 | Acute Tox. 2 * | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | H330 | H300 | H311 | H400 | GHS06 | GHS09 | Dgr | H330 | H300 | H311 | H400 |   |   |  
015-096-00-X | oxydisulfoton (ISO); | O, O-diethyl S-2-ethylsulphinylethyl phosphorodithioate | 219-679-1 | 2497-07-6 | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H311 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H311 | H410 |   | M = 10 |  015-096-00-X | оксидисулфотон (ISO); | O, O-диетилов S-2-eтилсулфинилетилов фосфородитиоат | 219-679-1 | 2497-07-6 | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H311 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H311 | H410 |   | M = 10 |  
015-097-00-5 | phenthoate (ISO); | ethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate | 219-997-0 | 2597-03-7 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   | M = 100 |  015-097-00-5 | фентоат (ISO); | етилов 2-(диметоксифосфинотиоилтио)-2-фенилацетат | 219-997-0 | 2597-03-7 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   | M = 100 |  
015-098-00-0 | trichloronate (ISO); | O-ethyl O-2,4,5-trichlorophenyl ethylphosphonothioate | 206-326-1 | 327-98-0 | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H311 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H311 | H410 |   |   |  015-098-00-0 | трихлоронат (ISO); | О-етилов О-2,4,5-трихлорофенилов етилфосфонотиоат; | 206-326-1 | 327-98-0 | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H311 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H311 | H410 |   |   |  
015-099-00-6 | pirimiphos-ethyl (ISO); | O, O-diethyl O-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate | 245-704-0 | 23505-41-1 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H312 | H410 |   |   |  015-099-00-6 | пиримифос-етил (ISO); | O, O-диетилов О-2-диетиламино-6-метилпиримидин-4-илов фосфоротиоат | 245-704-0 | 23505-41-1 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H312 | H410 |   |   |  
015-100-00-X | phoxim (ISO); | α-(diethoxyphosphinothioylimino) phenylacetonitrile | 238-887-3 | 14816-18-3 | Repr. 2 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361f*** H302 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H361f*** H302 | H317 | H410 |   | M=1000 |  015-100-00-X | фоксим (ISO); | α-(диетоксифосфинотиоилимино)фенилацетонитрил | 238-887-3 | 14816-18-3 | Repr. 2 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361f*** H302 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H361f*** H302 | H317 | H410 |   | M=1000 |  
015-101-00-5 | phosmet (ISO); | O, O-dimethyl phthalimidomethyl S-phosphorodithioate | 211-987-4 | 732-11-6 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   | M = 100 |  015-101-00-5 | фосмет (ISO); | O, O-диметилов фталимидометилов S-фосфородитиоат | 211-987-4 | 732-11-6 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   | M = 100 |  
015-102-00-0 | tris(2-chloroethyl)phosphate | 204-118-5 | 115-96-8 | Carc. 2 | Repr. 1B | Acute Tox. 4 * | Aquatic Chronic 2 | H351 | H360F*** H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H351 | H360F*** H302 | H411 |   |   |  015-102-00-0 | трис(2-хлороетил)фосфат | 204-118-5 | 115-96-8 | Carc. 2 | Repr. 1B | Acute Tox. 4 * | Aquatic Chronic 2 | H351 | H360F*** H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H351 | H360F*** H302 | H411 |   |   |  
015-103-00-6 | phosphorus tribromide | 232-178-2 | 7789-60-8 | Skin Corr. 1B | STOT SE 3 | H314 | H335 | GHS05 | GHS07 | Dgr | H314 | H335 | EUH014 |   |  015-103-00-6 | фосфорен трибромид | 232-178-2 | 7789-60-8 | Skin Corr. 1B | STOT SE 3 | H314 | H335 | GHS05 | GHS07 | Dgr | H314 | H335 | EUH014 |   |  
015-104-00-1 | diphosphorus pentasulphide; | phosphorus pentasulphide | 215-242-4 | 1314-80-3 | Flam. Sol. 1 | Water-react. 1 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | H228 | H260 | H332 | H302 | H400 | GHS02 | GHS07 | GHS09 | Dgr | H228 | H260 | H332 | H302 | H400 | EUH029 |   | T015-104-00-1 | дифосфорен пентасулфид; | фосфорен пентасулфид | 215-242-4 | 1314-80-3 | Flam. Sol. 1 | Water-react. 1 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | H228 | H260 | H332 | H302 | H400 | GHS02 | GHS07 | GHS09 | Dgr | H228 | H260 | H332 | H302 | H400 | EUH029 |   | T
015-105-00-7 | triphenyl phosphite | 202-908-4 | 101-02-0 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H315 | H410 |   | Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 % |  015-105-00-7 | трифенилов фосфит | 202-908-4 | 101-02-0 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H315 | H410 |   | Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 % |  
015-106-00-2 | hexamethylphosphoric triamide; hexamethylphosphoramide | 211-653-8 | 680-31-9 | Carc. 1B | Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   | Carc. 1B; | H350: C ≥ 0,01  % |  015-106-00-2 | хексаметилфосфорен триамид; хексаметилфосфорамид | 211-653-8 | 680-31-9 | Carc. 1B | Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   | Carc. 1B; | H350: C ≥ 0,01  % |  
015-107-00-8 | ethoprophos (ISO); | ethyl-S,S-dipropyl phosphorodithioate | 236-152-1 | 13194-48-4 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 3 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H301 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H310 | H301 | H317 | H410 |   |   |  015-107-00-8 | етопрофос (ISO); | етил-S,S-дипропилов фосфородитиоат | 236-152-1 | 13194-48-4 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 3 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H301 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H310 | H301 | H317 | H410 |   |   |  
015-108-00-3 | bromophos (ISO); | O-4-bromo-2,5-dichlorophenyl O,O-dimethyl phosphorothioate | 218-277-3 | 2104-96-3 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   | M = 100 |  015-108-00-3 | бромофос (ISO); | O-4-бромо-2,5-дихлорофенилов О,О-диметилов фосфоротиоат | 218-277-3 | 2104-96-3 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   | M = 100 |  
015-109-00-9 | crotoxyphos (ISO); | 1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate | 231-720-5 | 7700-17-6 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H311 | H301 | H410 |   | M = 10 |  015-109-00-9 | кротоксифос (ISO); | 1-фенилетилов 3-(диметоксифосфинилокси)изокротонат | 231-720-5 | 7700-17-6 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H311 | H301 | H410 |   | M = 10 |  
015-110-00-4 | cyanofenphos (ISO); | O-4-cyanophenyl O-ethyl phenylphosphonothioate | — | 13067-93-1 | Acute Tox. 3 * | STOT SE 1 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Chronic 2 | H301 | H370 ** | H312 | H319 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H370 ** | H312 | H319 | H411 |   |   |  015-110-00-4 | цианофенфос (ISO); | O-4-цианофенилов O-eтилов фенилфосфонотиоат | — | 13067-93-1 | Acute Tox. 3 * | STOT SE 1 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Chronic 2 | H301 | H370 ** | H312 | H319 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H370 ** | H312 | H319 | H411 |   |   |  
015-111-00-X | phosfolan (ISO); | diethyl 1,3-dithiolan-2-ylidenephosphoramidate | 213-423-2 | 947-02-4 | Acute Tox. 1 | Acute Tox. 2 * | H310 | H300 | GHS06 | Dgr | H310 | H300 |   |   |  015-111-00-X | фосфолан (ISO); | диетилов 1,3-дитиолан-2-илиденфосфорамидат | 213-423-2 | 947-02-4 | Acute Tox. 1 | Acute Tox. 2 * | H310 | H300 | GHS06 | Dgr | H310 | H300 |   |   |  
015-112-00-5 | thionazin (ISO); | O,O-diethyl O-pyrazin-2-yl phosphorothioate; | 206-049-6 | 297-97-2 | Acute Tox. 1 | Acute Tox. 2 * | H310 | H300 | GHS06 | Dgr | H310 | H300 |   |   |  015-112-00-5 | тионазин (ISO); | O,O-диетилов О-пиразин-2-илов фосфоротиоат; | 206-049-6 | 297-97-2 | Acute Tox. 1 | Acute Tox. 2 * | H310 | H300 | GHS06 | Dgr | H310 | H300 |   |   |  
015-113-00-0 | tolclofos-methyl (ISO); | O-(2,6-dichloro-p-tolyl)-O,O-dimethyl thiophosphate | 260-515-3 | 57018-04-9 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  015-113-00-0 | толклофос-метил (ISO); | O-(2,6-дихлоро-p-толил)-O,O-диметилов тиофосфат | 260-515-3 | 57018-04-9 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
015-114-00-6 | chlormephos (ISO); | S-chloromethyl O,O-diethyl phosphorodithioate | 246-538-1 | 24934-91-6 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   | M = 10 |  015-114-00-6 | хлормефос (ISO); | О,О-диетилов S-хлорометилов фосфородитиоат | 246-538-1 | 24934-91-6 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   | M = 10 |  
015-115-00-1 | chlorthiophos (ISO); | [isomeric reaction mass in which O-2,5-dichlorophenyl-4-methylthiophenyl O, O-diethyl phosphorothioate predominates] | 244-663-6 | 21923-23-9 | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H311 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H311 | H410 |   | M = 1000 |  015-115-00-1 | хлортиофос (ISO); | [реакционна маса от изомери, в която преобладава O-2,5-дихлорофенил-4-метилтиофенилов O,O-диетилов фосфоротиоат] | 244-663-6 | 21923-23-9 | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H311 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H311 | H410 |   | M = 1000 |  
015-116-00-7 | demephion-O (ISO); | O, O-dimethyl O-2-methylthioethyl phosphorothioate | 211-666-9 | 682-80-4 | Acute Tox. 2 * | Acute Tox. 3 * | H300 | H311 | GHS06 | Dgr | H300 | H311 |   |   |  015-116-00-7 | демефион-О (ISO); | O, O-диметилов О-2-метилтиоетилов фосфоротиоат | 211-666-9 | 682-80-4 | Acute Tox. 2 * | Acute Tox. 3 * | H300 | H311 | GHS06 | Dgr | H300 | H311 |   |   |  
015-117-00-2 | demephion-S (ISO); | O, O-dimethyl S-2-methylthioethyl phosphorothioate | 219-971-9 | 2587-90-8 | Acute Tox. 2 * | Acute Tox. 3 * | H300 | H311 | GHS06 | Dgr | H300 | H311 |   |   |  015-117-00-2 | демефион-S (ISO); | O, O-диметилов S-2-метилтиоетилов фосфоротиоат | 219-971-9 | 2587-90-8 | Acute Tox. 2 * | Acute Tox. 3 * | H300 | H311 | GHS06 | Dgr | H300 | H311 |   |   |  
015-118-00-8 | demeton | — | 8065-48-3 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | H310 | H300 | H400 | GHS06 | GHS09 | Dgr | H310 | H300 | H400 |   |   |  015-118-00-8 | деметон | — | 8065-48-3 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | H310 | H300 | H400 | GHS06 | GHS09 | Dgr | H310 | H300 | H400 |   |   |  
015-119-00-3 | dimethyl 4-(methylthio)phenyl phosphate | — | 3254-63-5 | Acute Tox. 1 | Acute Tox. 2 * | H310 | H300 | GHS06 | Dgr | H310 | H300 |   |   |  015-119-00-3 | диметилов 4-(метилтио)фенилов фосфат | — | 3254-63-5 | Acute Tox. 1 | Acute Tox. 2 * | H310 | H300 | GHS06 | Dgr | H310 | H300 |   |   |  
015-120-00-9 | ditalimfos (ISO); | O, O-diethyl phthalimidophosphonothioate | 225-875-8 | 5131-24-8 | Skin Irrit. 2 | Skin Sens. 1 | H315 | H317 | GHS07 | Wng | H315 | H317 |   |   |  015-120-00-9 | диталимфос (ISO); | O, O-диетилов фталимидофосфонотиоат | 225-875-8 | 5131-24-8 | Skin Irrit. 2 | Skin Sens. 1 | H315 | H317 | GHS07 | Wng | H315 | H317 |   |   |  
015-121-00-4 | edifenphos (ISO); | O-ethyl S, S-diphenyl phosphorodithioate | 241-178-1 | 17109-49-8 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H312 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H301 | H312 | H317 | H410 |   |   |  015-121-00-4 | едифенфос (ISO); | O-етилов S, S-дифенилов фосфородитиоат | 241-178-1 | 17109-49-8 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H312 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H301 | H312 | H317 | H410 |   |   |  
015-122-00-X | etrimfos (ISO); | O-6-ethoxy-2-ethylpyrimidin-4-yl O, O-dimethylphosphorothioate | 253-855-9 | 38260-54-7 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   | M = 10 |  015-122-00-X | етримфос (ISO); | O-6-етокси-2-eтилпиримидин-4-илов O, O-диметилов фосфоротиоат | 253-855-9 | 38260-54-7 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   | M = 10 |  
015-123-00-5 | fenamiphos (ISO); | ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate | 244-848-1 | 22224-92-6 | Acute Tox. 2 | Acute Tox. 2 | Acute Tox. 2 | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H310 | H330 | H319 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H310 | H330 | H319 | H410 |   | M = 100 | M = 100 |  015-123-00-5 | фенамифос (ISO); | етил-4-метилтио-m-толилов изопропилов фосфорамидат | 244-848-1 | 22224-92-6 | Acute Tox. 2 | Acute Tox. 2 | Acute Tox. 2 | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H310 | H330 | H319 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H310 | H330 | H319 | H410 |   | M = 100 | M = 100 |  
015-124-00-0 | fosthietan (ISO); | diethyl 1,3-dithietan-2-ylidenephosphoramidate | 244-437-7 | 21548-32-3 | Acute Tox. 1 | Acute Tox. 2 * | H310 | H300 | GHS06 | Dgr | H310 | H300 |   |   |  015-124-00-0 | фостиетан (ISO); | диетилов 1,3-дитиетан-2-илиденфосфорамидат | 244-437-7 | 21548-32-3 | Acute Tox. 1 | Acute Tox. 2 * | H310 | H300 | GHS06 | Dgr | H310 | H300 |   |   |  
015-125-00-6 | glyphosine (ISO); | N,N-bis(phosphonomethyl)glycine | 219-468-4 | 2439-99-8 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  015-125-00-6 | глифосин (ISO); | N,N-бис(фосфонометил)глицин | 219-468-4 | 2439-99-8 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
015-126-00-1 | heptenophos (ISO); | 7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate | 245-737-0 | 23560-59-0 | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H410 |   | M = 100 |  015-126-00-1 | хептенофос (ISO); | 7-хлоробицикло[3.2.0]хепта-2,6-диен-6-илов диметилов фосфат | 245-737-0 | 23560-59-0 | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H410 |   | M = 100 |  
015-127-00-7 | iprobenfos(ISO); | S-benzyl diisopropyl phosphorothioate | 247-449-0 | 26087-47-8 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  015-127-00-7 | ипробенфос (ISO); | S-бензилов диизопропилов фосфоротиоат | 247-449-0 | 26087-47-8 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
015-128-00-2 | IPSP; | S-ethylsulphinylmethyl O,O-diisopropylphosphorodithioate | — | 5827-05-4 | Acute Tox. 1 | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H301 | H410 |   | M = 100 |  015-128-00-2 | IPSP; | S-етилсулфинилметилов O,O-диизопропилов фосфородитиоат | — | 5827-05-4 | Acute Tox. 1 | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H301 | H410 |   | M = 100 |  
015-129-00-8 | isofenphos (ISO); | O-ethyl O-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate | 246-814-1 | 25311-71-1 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H311 | H301 | H410 |   | M = 100 |  015-129-00-8 | изофенфос (ISO); | О-етилов O-2-изопропоксикарбонилфенилов изопропилфосфорамидотиоат | 246-814-1 | 25311-71-1 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H311 | H301 | H410 |   | M = 100 |  
015-130-00-3 | isothioate (ISO); | S-2-isopropylthioethyl O,O-dimethyl phosphorodithioate; | — | 36614-38-7 | Acute Tox. 3 * | Acute Tox. 3 * | H311 | H301 | GHS06 | Dgr | H311 | H301 |   |   |  015-130-00-3 | изотиоат (ISO); | S-2-изопропилтиоетилов О,О-диметилов фосфородитиоат; | — | 36614-38-7 | Acute Tox. 3 * | Acute Tox. 3 * | H311 | H301 | GHS06 | Dgr | H311 | H301 |   |   |  
015-131-00-9 | isoxathion (ISO); | O,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate | 242-624-8 | 18854-01-8 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H311 | H301 | H410 |   |   |  015-131-00-9 | изоксатион (ISO); | O,O-диетилов О-5-фенилизоксазол-3-илов фосфоротиоат | 242-624-8 | 18854-01-8 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H311 | H301 | H410 |   |   |  
015-132-00-4 | S-(chlorophenylthiomethyl) O,O-dimethylphosphorodithioate; methylcarbophenothione | — | 953-17-3 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H311 | H301 | H410 |   | M = 1000 |  015-132-00-4 | S-(хлорофенилтиометилов) О,О-диметилов фосфородитиоат; метилкарбофенотион | — | 953-17-3 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H311 | H301 | H410 |   | M = 1000 |  
015-133-00-X | piperophos (ISO); | S-2-methylpiperidinocarbonylmethyl-O, O-dipropyl phosphorodithioate | — | 24151-93-7 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   | M = 10 |  015-133-00-X | пиперофос (ISO); | S-2-мeтилпиперидинокарбонилметил-O, O-дипропилов фосфородитиоат | — | 24151-93-7 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   | M = 10 |  
015-134-00-5 | pirimiphos-methyl (ISO); | O-(2-diethylamino-6-methylpyrimidin-4-yl) O, O-dimethyl phosphorothioate | 249-528-5 | 29232-93-7 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  015-134-00-5 | пиримифос-метил (ISO); | O-(2-диетиламино-6-метилпиримидин-4-илов) O, O-диметилов фосфоротиоат | 249-528-5 | 29232-93-7 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
015-135-00-0 | profenofos (ISO)O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate; | 255-255-2 | 41198-08-7 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   | M = 1000 |  015-135-00-0 | профенофос (ISO);O-(4-бромо-2-хлорофенилов) O-етилов S-пропилов фосфоротиоат; | 255-255-2 | 41198-08-7 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   | M = 1000 |  
015-136-00-6 | trans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate; | isopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate; propetamphos (ISO) | 250-517-2 | 31218-83-4 | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H410 |   | M = 100 |  015-136-00-6 | транс-изопропил-3-[[(етиламино)метоксифосфинотиоил]окси]кротонат; | изопропилов 3-[[(етиламино)метоксифосфинотиоил]окси]изокротонат; пропетамфос (ISO) | 250-517-2 | 31218-83-4 | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H410 |   | M = 100 |  
015-137-00-1 | pyrazophos (ISO); | O, O-diethyl O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate | 236-656-1 | 13457-18-6 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H302 | H410 |   |   |  015-137-00-1 | пиразофос (ISO); | O,O-диетилов O-(6-етоксикарбонил-5-метилпиразоло[2,3-a]пиримидин-2-илов) фосфоротиоат | 236-656-1 | 13457-18-6 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H302 | H410 |   |   |  
015-138-00-7 | quinalphos (ISO); | O, O-diethyl-O-quinoxalin-2-yl phosphorothioate | 237-031-6 | 13593-03-8 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H312 | H410 |   | M = 1000 |  015-138-00-7 | хиналфос (ISO); | O, O-диетил-О-хиноксалин-2-илов фосфоротиоат | 237-031-6 | 13593-03-8 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H312 | H410 |   | M = 1000 |  
015-139-00-2 | terbufos (ISO); | S-tert-butylthiomethyl O, O-diethylphosphorodithioate; | 235-963-8 | 13071-79-9 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   | M = 1000 |  015-139-00-2 | тeрбуфос (ISO); | S-трет-бутилтиометилов O, O-диетилов фосфородитиоат; | 235-963-8 | 13071-79-9 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   | M = 1000 |  
015-140-00-8 | triazophos (ISO); | O, O-diethyl-O-1-phenyl-1H-1,2,4-triazol-3-yl phosphorothioate | 245-986-5 | 24017-47-8 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H301 | H312 | H410 |   | M=100 |  015-140-00-8 | триазофос (ISO); | O, O-диетил-O-1-фенил-1H-1,2,4-триазол-3-илов фосфоротиоат | 245-986-5 | 24017-47-8 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H301 | H312 | H410 |   | M=100 |  
015-141-00-3 | ethylenediammonium O, O-bis(octyl) phosphorodithioate, mixed isomers | 400-520-1 | — | Skin Corr. 1B | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H302 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H302 | H410 |   |   |  015-141-00-3 | етилендиамониев О,О-бис(oктилов) фосфородитиоат, смес от изомери | 400-520-1 | — | Skin Corr. 1B | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H302 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H302 | H410 |   |   |  
015-142-00-9 | butyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate | 401-100-0 | — | Flam. Liq. 2 | Eye Irrit. 2 | Aquatic Chronic 2 | H225 | H319 | H411 | GHS02 | GHS07 | GHS09 | Dgr | H225 | H319 | H411 |   |   | T015-142-00-9 | бутилов (диалкилокси(дибутоксифосфорилокси))титанов (триалкилокси)титанов фосфат | 401-100-0 | — | Flam. Liq. 2 | Eye Irrit. 2 | Aquatic Chronic 2 | H225 | H319 | H411 | GHS02 | GHS07 | GHS09 | Dgr | H225 | H319 | H411 |   |   | T
015-143-00-4 | reaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate, reaction mass of isomers | 401-740-0 | — | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  015-143-00-4 | реакционна маса от 2-хлороетилов хлоропропилов 2-хлороетилфосфонат, реакционна маса от изомери и 2-хлороетилов хлоропропилов 2-хлоропропилфосфонат, реакционна маса от изомери | 401-740-0 | — | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
015-144-00-X | reaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate | 402-090-0 | 87025-52-3 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   |   |  015-144-00-X | реакционна маса от пентилов метилфосфинат и 2-мeтилбутилов метилфосфинат | 402-090-0 | 87025-52-3 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   |   |  
015-145-00-5 | reaction mass of copper(I) O, O-diisopropyl phosphorodithioate and copper(I) O-isopropyl O-(4-methylpent-2-yl) phosphorodithioate and copper(I) O, O-bis(4-methylpent-2-yl) phosphorodithioate | 401-520-4 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  015-145-00-5 | реакционна маса от меден(I) О,О-диизопропилов фосфородитиоат и меден(I) О-изопропилов О-(4-метилпент-2-илов) фосфородитиоат и меден(I) О,О-бис(4-метилпент-2-илов) фосфородитиоат | 401-520-4 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
015-146-00-0 | S-(tricyclo(5.2.1.0 2,6)deca-3-en-8(or 9)-yl O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate | 401-850-9 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  015-146-00-0 | S-(трицикло[5.2.1.02,6]дека-3-eн-8(или 9)-илов О-(изопропилов или изобутилов или 2-eтилхексилов) О-(изопропилов или изобутилов или 2-eтилхексилов) фосфородитиоат | 401-850-9 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
015-147-00-6 | reaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide) | 400-930-0 | — | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H315 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H315 | H318 | H317 | H411 |   |   |  015-147-00-6 | реакционна маса от C12-14-трет-алкиламониев дифенилов фосфоротиоат и динонилсулфид (или дисулфид) | 400-930-0 | — | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H315 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H315 | H318 | H317 | H411 |   |   |  
015-148-00-1 | 2-(diphosphonomethyl)succinic acid | 403-070-4 | 51395-42-7 | Skin Corr. 1B | Skin Sens. 1 | H314 | H317 | GHS05 | GHS07 | Dgr | H314 | H317 |   |   |  015-148-00-1 | 2-(дифосфонометил)янтарна киселина | 403-070-4 | 51395-42-7 | Skin Corr. 1B | Skin Sens. 1 | H314 | H317 | GHS05 | GHS07 | Dgr | H314 | H317 |   |   |  
015-149-00-7 | reaction mass of: hexyldioctylphosphineoxide; dihexyloctylphosphineoxide; trioctylphosphineoxide | 403-470-9 | — | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H400 | H410 | GHS05 | GHS09 | Dgr | H314 | H410 |   |   |  015-149-00-7 | реакционна маса от: хексилдиоктилфосфиноксид; дихексилоктилфосфиноксид; триоктилфосфиноксид | 403-470-9 | — | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H400 | H410 | GHS05 | GHS09 | Dgr | H314 | H410 |   |   |  
015-150-00-2 | (2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide | 404-940-6 | 86608-70-0 | Acute Tox. 4 * | Eye Dam. 1 | STOT RE 2 * | Aquatic Chronic 3 | H302 | H318 | H373 ** | H412 | GHS08 | GHS05 | GHS07 | Dgr | H302 | H318 | H373 ** | H412 |   |   |  015-150-00-2 | (2-(1,3-диоксолан-2-ил)eтил)трифенилфосфониев бромид | 404-940-6 | 86608-70-0 | Acute Tox. 4 * | Eye Dam. 1 | STOT RE 2 * | Aquatic Chronic 3 | H302 | H318 | H373 ** | H412 | GHS08 | GHS05 | GHS07 | Dgr | H302 | H318 | H373 ** | H412 |   |   |  
015-151-00-8 | tris(isopropyl/tert-butylphenyl)phosphate | 405-010-2 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  015-151-00-8 | трис(изопропил/трет-бутилфенил)фосфат | 405-010-2 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
015-152-00-3 | dioxabenzofos (ISO); | 2-methoxy-4H-1,3,2-benzodioxaphosphorin 2-sulphide | 223-292-3 | 3811-49-2 | Acute Tox. 3 * | Acute Tox. 3 * | STOT SE 1 | Aquatic Chronic 2 | H311 | H301 | H370 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H311 | H301 | H370 ** | H411 |   |   |  015-152-00-3 | диоксабензофос (ISO); | 2-мeтокси-4H-1,3,2-бензодиоксафосфорин-2-сулфид | 223-292-3 | 3811-49-2 | Acute Tox. 3 * | Acute Tox. 3 * | STOT SE 1 | Aquatic Chronic 2 | H311 | H301 | H370 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H311 | H301 | H370 ** | H411 |   |   |  
015-153-00-9 | isazofos (ISO); | O-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl) O, O-diethyl phosphorothioate | 255-863-8 | 42509-80-8 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H311 | H301 | H373 ** | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H311 | H301 | H373 ** | H317 | H410 |   |   |  015-153-00-9 | изазофос (ISO); | O-(1-изопропил-5-хлоро-1,2,4-триазол-3-илов) O, O-диетилов фосфоротиоат | 255-863-8 | 42509-80-8 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H311 | H301 | H373 ** | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H311 | H301 | H373 ** | H317 | H410 |   |   |  
015-154-00-4 | ethephon; | 2-chloroethylphosphonic acid | 240-718-3 | 16672-87-0 | Acute Tox. 3 | Acute Tox. 4 | Acute Tox. 4 | Skin Corr. 1C | Aquatic Chronic 2 | H311 | H332 | H302 | H314 | H411 | GHS06 | GHS05 | GHS09 | Dgr | H311 | H332 | H302 | H314 | H411 | EUH071 |   |  015-154-00-4 | етефон; | 2-хлороетилфосфонова киселина | 240-718-3 | 16672-87-0 | Acute Tox. 3 | Acute Tox. 4 | Acute Tox. 4 | Skin Corr. 1C | Aquatic Chronic 2 | H311 | H332 | H302 | H314 | H411 | GHS06 | GHS05 | GHS09 | Dgr | H311 | H332 | H302 | H314 | H411 | EUH071 |   |  
015-155-00-X | glufosinate ammonium (ISO); ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate | 278-636-5 | 77182-82-2 | Repr. 1B | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | H360Fd | H332 | H312 | H302 | H373** | GHS08 | GHS07 | Dgr | H360Fd | H332 | H312 | H302 | H373** |   |   |  015-155-00-X | амониев глуфосинат (ISO); амониев 2-амино-4-(хидроксиметилфосфинил)бутират | 278-636-5 | 77182-82-2 | Repr. 1B | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | H360Fd | H332 | H312 | H302 | H373** | GHS08 | GHS07 | Dgr | H360Fd | H332 | H312 | H302 | H373** |   |   |  
015-156-00-5 | methyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate; [1] | methacrifos (ISO); | methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate [2] | 250-366-9 [1]-[2] | 30864-28-9 [1] | 62610-77-9 [2] | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  015-156-00-5 | мeтилов 3-[(диметоксифосфинотиоил)oкси]метакрилат; [1] | мeтакрифос (ISO); | мeтилов (E)-3-[(диметоксифосфинотиоил)окси]метакрилат [2] | 250-366-9 [1]-[2] | 30864-28-9 [1] | 62610-77-9 [2] | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  
015-157-00-0 | phosphonic acid; [1] | phosphorous acid [2] | 237-066-7 [1] | 233-663-1 [2] | 13598-36-2 [1] | 10294-56-1 [2] | Acute Tox. 4 * | Skin Corr. 1A | H302 | H314 | GHS05 | GHS07 | Dgr | H302 | H314 |   |   |  015-157-00-0 | фосфонова киселина; [1] | фосфориста киселина [2] | 237-066-7 [1] | 233-663-1 [2] | 13598-36-2 [1] | 10294-56-1 [2] | Acute Tox. 4 * | Skin Corr. 1A | H302 | H314 | GHS05 | GHS07 | Dgr | H302 | H314 |   |   |  
015-158-00-6 | (η-cyclopentadienyl)(η-cumenyl)iron(1+)hexafluorophosphate(1-) | 402-340-9 | 32760-80-8 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  015-158-00-6 | (η -циклопентадиенил)(η-куменил)железен(1+) хексафлуорофосфат(1-) | 402-340-9 | 32760-80-8 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
015-159-00-1 | hydroxyphosphonoacetic acid | 405-710-8 | 23783-26-8 | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | Skin Sens. 1 | H302 | H373 ** | H314 | H317 | GHS08 | GHS05 | GHS07 | Dgr | H302 | H373 ** | H314 | H317 |   |   |  015-159-00-1 | хидроксифосфонооцетна киселина | 405-710-8 | 23783-26-8 | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | Skin Sens. 1 | H302 | H373 ** | H314 | H317 | GHS08 | GHS05 | GHS07 | Dgr | H302 | H373 ** | H314 | H317 |   |   |  
015-160-00-7 | vanadyl pyrophosphate | 406-260-5 | 58834-75-6 | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H319 | H317 | H412 | GHS07 | Wng | H319 | H317 | H412 |   |   |  015-160-00-7 | ванадилпирофосфат | 406-260-5 | 58834-75-6 | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H319 | H317 | H412 | GHS07 | Wng | H319 | H317 | H412 |   |   |  
015-161-00-2 | divanadyl pyrophosphate | 407-130-0 | 65232-89-5 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H317 | H411 |   |   |  015-161-00-2 | диванадилпирофосфат | 407-130-0 | 65232-89-5 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H317 | H411 |   |   |  
015-162-00-8 | vanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped | 407-350-7 | — | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Aquatic Chronic 2 | H332 | H373 ** | H318 | H411 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H332 | H373 ** | H318 | H411 |   |   |  015-162-00-8 | ванадиев(IV) oксид хидрогенфосфат хемихидрат, с абсорбирани литий, цинк, молибден, желязо и хлор | 407-350-7 | — | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Aquatic Chronic 2 | H332 | H373 ** | H318 | H411 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H332 | H373 ** | H318 | H411 |   |   |  
015-163-00-3 | bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide | 412-010-6 | 145052-34-2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  015-163-00-3 | бис(2,6-диметоксибензоил)-2,4,4-триметилпентилфосфиноксид | 412-010-6 | 145052-34-2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
015-164-00-9 | calcium P, P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate | 400-480-5 | 36669-85-9 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  015-164-00-9 | калциев P,P′-(1-хидроксиетилен)бис(хидрогенфосфонат) дихидрат | 400-480-5 | 36669-85-9 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
015-165-00-4 | reaction mass of: thiobis(4,1-phenylene)-S, S,S',S'-tetraphenyldisulfonium bishexafluorophosphate; diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate | 404-986-7 | — | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  015-165-00-4 | реакционна маса от: тиобис(4,1-фенилен)-S, S,S′,S′-тетрафенилдисулфониев бисхексафлуорофосфат; дифенил(4-фенилтиофенил)сулфониев хексафлуорофосфат | 404-986-7 | — | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  
015-166-00-X | 3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane | 410-290-4 | 80693-00-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  015-166-00-X | 3,9-бис(2,6-ди-трет-бутил-4-метилфенокси)-2,4,8,10-тетраокса-3,9-дифосфаспиро[5.5]ундекан | 410-290-4 | 80693-00-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
015-167-00-5 | 3-(hydroxyphenylphosphinyl)propanoic acid | 411-200-6 | 14657-64-8 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  015-167-00-5 | 3-(хидроксифенилфосфинил)пропанова киселина | 411-200-6 | 14657-64-8 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
015-168-00-0 | fosthiazate (ISO); | (RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate | — | 98886-44-3 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H312 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H301 | H312 | H317 | H410 | EUH070 |   |  015-168-00-0 | фостиазат (ISO); | (RS)-S-втор-бутил-О-eтил-2-oксо-1,3-тиазолидин-3-илов фосфонотиоат | — | 98886-44-3 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H312 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H301 | H312 | H317 | H410 | EUH070 |   |  
015-169-00-6 | tributyltetradecylphosphonium tetrafluoroborate | 413-520-1 | — | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373 ** | H314 | H317 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H373 ** H314 | H317 | H410 |   |   |  015-169-00-6 | трибутилтетрадецилфосфониев тетрафлуороборат | 413-520-1 | — | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373 ** | H314 | H317 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H373 ** H314 | H317 | H410 |   |   |  
015-170-00-1 | reaction mass of: di-(1-octane-N, N,N-trimethylammonium) octylphosphate; 1-octane-N, N,N-trimethylammonium di-octylphosphate; 1-octane-N, N,N-trimethylammonium octylphosphate | 407-490-9 | — | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H312 | H302 | H314 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 |   |   |  015-170-00-1 | реакционна маса от: ди(1-октан-N, N,N-триметиламониев) oктилфосфат; 1-октан-N, N,N-триметиламониев диoктилфосфат; 1-октан-N, N,N-триметиламониев oктилфосфат | 407-490-9 | — | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H312 | H302 | H314 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 |   |   |  
015-171-00-7 | O, O,O-tris(2(or 4)-C 9-10-isoalkylphenyl) phosphorothioate | 406-940-1 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  015-171-00-7 | O, O,O-трис(2(или 4)-C9-10-изоалкилфенилов) фосфоротиоат | 406-940-1 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
015-172-00-2 | reaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate; | isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate | 406-240-6 | — | Flam. Liq. 3 | Skin Corr. 1B | Aquatic Chronic 2 | H226 | H314 | H411 | GHS02 | GHS05 | GHS09 | Dgr | H226 | H314 | H411 |   |   |  015-172-00-2 | реакционна маса от: бис(изотридециламониев) моно(ди(4-метилпент-2-илокси)тиофосфоротионилизопропил)фосфат; | изотридециламониев бис(ди(4-метилпент-2-илокси)тиофосфоротионилизопропил)фосфат | 406-240-6 | — | Flam. Liq. 3 | Skin Corr. 1B | Aquatic Chronic 2 | H226 | H314 | H411 | GHS02 | GHS05 | GHS09 | Dgr | H226 | H314 | H411 |   |   |  
015-173-00-8 | methyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate | 414-080-3 | 117291-73-3 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  015-173-00-8 | мeтилов [2-(1,1-диметилетил)-6-метоксипиримидин-4-ил]eтилфосфонотиоат | 414-080-3 | 117291-73-3 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
015-174-00-3 | 1-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine | 411-370-1 | 82857-68-9 | Acute Tox. 3 * | Eye Dam. 1 | Aquatic Chronic 2 | H301 | H318 | H411 | GHS06 | GHS05 | GHS09 | Dgr | H301 | H318 | H411 |   |   |  015-174-00-3 | N,N-диетил-1,1-дифенил-1-(фенилметил)-1-хлорофосфорамин | 411-370-1 | 82857-68-9 | Acute Tox. 3 * | Eye Dam. 1 | Aquatic Chronic 2 | H301 | H318 | H411 | GHS06 | GHS05 | GHS09 | Dgr | H301 | H318 | H411 |   |   |  
015-175-00-9 | tert-butyl (triphenylphosphoranylidene) acetate | 412-880-7 | 35000-38-5 | Acute Tox. 3 * | STOT RE 2 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H301 | H373 ** | H319 | H317 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H373 ** H319 | H317 | H411 |   |   |  015-175-00-9 | трет-бутилов (трифенилфосфоранилиден)aцетат | 412-880-7 | 35000-38-5 | Acute Tox. 3 * | STOT RE 2 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H301 | H373 ** | H319 | H317 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H373 ** H319 | H317 | H411 |   |   |  
015-176-00-4 | P, P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine | 413-430-2 | 116163-96-3 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  015-176-00-4 | P,P,P′,P′-тетракис-(o-метоксифенил)пропан-1,3-дифосфин | 413-430-2 | 116163-96-3 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
015-177-00-X | ((4-phenylbutyl)hydroxyphosphoryl)acetic acid | 412-170-7 | 83623-61-4 | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | H373 ** | H318 | H317 | GHS08 | GHS05 | Dgr | H373 ** H318 | H317 |   |   |  015-177-00-X | ((4-фенилбутил)хидроксифосфорил)оцетна киселина | 412-170-7 | 83623-61-4 | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | H373 ** | H318 | H317 | GHS08 | GHS05 | Dgr | H373 ** H318 | H317 |   |   |  
015-178-00-5 | (R)-α-phenylethylammonium(-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate | 418-570-8 | 25383-07-7 | Repr. 2 | Aquatic Chronic 2 | H361f *** H411 | GHS08 | GHS09 | Wng | H361f *** H411 |   |   |  015-178-00-5 | (R)-α-фенилетиламониев (-)-(1R,2S)-(1,2-eпоксипропил)фосфонатмонохидрат | 418-570-8 | 25383-07-7 | Repr. 2 | Aquatic Chronic 2 | H361f *** H411 | GHS08 | GHS09 | Wng | H361f *** H411 |   |   |  
015-179-00-0 | UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine | 422-720-8 | 166242-53-1 | Carc. 2 | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H302 | H373 ** | H314 | H317 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H351 | H302 | H373 ** H314 | H317 | H410 |   |   |  015-179-00-0 | кондензационен продукт UVCB от: тeтракисхидроксиметилфосфониев хлорид, уреа и дестилиран хидрогениран алкиламин от лой с C16-18 | 422-720-8 | 166242-53-1 | Carc. 2 | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H302 | H373 ** | H314 | H317 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H351 | H302 | H373 ** H314 | H317 | H410 |   |   |  
015-180-00-6 | [R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt | 415-820-8 | 137590-32-0 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  015-180-00-6 | сол на [R-(R*,S*)]-[[2-метил-1-(1-оксопропокси)пропокси]-(4-фенилбутил)фосфинил]оцетна киселина и (-)-цинхонидин (1:1) | 415-820-8 | 137590-32-0 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  
015-181-00-1 | phosphine | 232-260-8 | 7803-51-2 | Flam. Gas 1 | Press. Gas | Acute Tox. 2 * | Skin Corr. 1B | Aquatic Acute 1 | H220 | H330 | H314 | H400 | GHS02 | GHS04 | GHS06 | GHS05 | GHS09 | Dgr | H220 | H330 | H314 | H400 |   |   | U015-181-00-1 | фосфин | 232-260-8 | 7803-51-2 | Flam. Gas 1 | Press. Gas | Acute Tox. 2 * | Skin Corr. 1B | Aquatic Acute 1 | H220 | H330 | H314 | H400 | GHS02 | GHS04 | GHS06 | GHS05 | GHS09 | Dgr | H220 | H330 | H314 | H400 |   |   | U
015-182-00-7 | tetrapropan-2-yl (dichloromethanediyl)bis(phosphonate) | 430-630-5 | 10596-22-2 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | H302 | H319 | H317 | GHS07 | Wng | H302 | H319 | H317 |   |   |  015-182-00-7 | тетрапропан-2-илов (дихлорометандиил)бис(фосфонат) | 430-630-5 | 10596-22-2 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | H302 | H319 | H317 | GHS07 | Wng | H302 | H319 | H317 |   |   |  
015-183-00-2 | (1-hydroxydodecylidene)diphosphonic acid | 425-230-2 | 16610-63-2 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H400 | H410 | GHS05 | GHS09 | Dgr | H314 | H410 |   |   |  015-183-00-2 | (1-хидроксидодецилиден)дифосфонова киселина | 425-230-2 | 16610-63-2 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H400 | H410 | GHS05 | GHS09 | Dgr | H314 | H410 |   |   |  
015-184-00-8 | salts of glyphosate, with the exception of those specified elsewhere in this Annex | — | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   | A015-184-00-8 | соли на глифосат, с изключение на посочените на други места в настоящото приложение | — | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   | A
015-186-00-9 | chlorpyrifos-methyl (ISO) O, O-dimethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate | 227-011-5 | 5598-13-0 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   | M = 10000 |  015-186-00-9 | хлорпирифос-метил (ISO);O,O-диметилов O-3,5,6-трихлоро-2-пиридилов фосфоротиоат | 227-011-5 | 5598-13-0 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   | M = 10000 |  
015-187-00-4 | reaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate, N-oxide; | trisodium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate, N-oxide, P-oxide | 417-540-1 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  015-187-00-4 | реакционна маса от: тетранатриев (((2- хидроксиетил)имино)бис(метилeн))бисфосфонат, N-оксид; | тринатриев ((тетрахидро-2-хидрокси-4H-1,4,2-оксазафосфорин-4-ил)метил)фосфонат, N-оксид, P-оксид | 417-540-1 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  
015-189-00-5 | phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide | 423-340-5 | 162881-26-7 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  015-189-00-5 | фенилов бис(2,4,6-триметилбензоил)фосфиноксид | 423-340-5 | 162881-26-7 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
015-190-00-0 | bis(2,4-dicumylphenyl)neopentyl diphosphite; | 3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane | 421-920-2 | 154862-43-8 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  015-190-00-0 | бис(2,4-дикумилфенил)неопентилдифосфит; | 3,9-бис[2,4-бис(1-метил-1-фенилетил)фенокси]-2,4,8,10-тетраокса-3,9-дифосфаспиро[5.5]ундекан | 421-920-2 | 154862-43-8 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
015-191-00-6 | dodecyldiphenyl phosphate | 431-760-5 | 27460-02-2 | Skin Irrit. 2 | Aquatic Chronic 3 | H315 | H412 | GHS07 | Wng | H315 | H412 |   |   |  015-191-00-6 | додецилдифенилов фосфат | 431-760-5 | 27460-02-2 | Skin Irrit. 2 | Aquatic Chronic 3 | H315 | H412 | GHS07 | Wng | H315 | H412 |   |   |  
015-192-00-1 | tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate | 432-770-2 | 139189-30-3 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  015-192-00-1 | тетракис(2,6-диметилфенил)-m-фенилен бифосфат | 432-770-2 | 139189-30-3 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
015-193-00-7 | triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1) | 442-960-7 | 332350-93-3 | Acute Tox. 3 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H318 | H400 | H410 | GHS05 | GHS06 | GHS09 | Dgr | H301 | H318 | H410 |   |   |  015-193-00-7 | трифенил(фенилметил)фосфониев 1,1,2,2,3,3,4,4,4-нонафлуоро-N-метил-1-бутансулфонамид (1:1) | 442-960-7 | 332350-93-3 | Acute Tox. 3 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H318 | H400 | H410 | GHS05 | GHS06 | GHS09 | Dgr | H301 | H318 | H410 |   |   |  
015-194-00-2 | tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate | 444-440-5 | 220689-12-3 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  015-194-00-2 | тетрабутилфосфониев нонафлуоробутан-1-сулфонат | 444-440-5 | 220689-12-3 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
015-195-00-8 | reaction mass of: potassium o-toluenephosphonate; | potassium m-toluenephosphonate; potassium p-toluenephosphonate | 433-860-4 | — | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H319 | H317 | H412 | GHS07 | Wng | H319 | H317 | H412 |   |   |  015-195-00-8 | реакционна маса от: калиев o-толуенфосфонат; | калиев m-толуенфосфонат; калиев p-толуенфосфонат | 433-860-4 | — | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H319 | H317 | H412 | GHS07 | Wng | H319 | H317 | H412 |   |   |  
015-196-00-3 | reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; | diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; | methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate | 435-960-3 | — | Carc. 1B | Muta. 1B | Skin Sens. 1 | H350 | H340 | H317 | GHS08 | GHS07 | Dgr | H350 | H340 | H317 |   |   |  015-196-00-3 | реакционна маса от: диметилов (2-(хидроксиметилкарбамоил)етил)фосфонат; | диетилов (2-(хидроксиметилкарбамоил)етил)фосфонат; | етилметилов (2-(хидроксиметилкарбамоил)етил)фосфонат | 435-960-3 | — | Carc. 1B | Muta. 1B | Skin Sens. 1 | H350 | H340 | H317 | GHS08 | GHS07 | Dgr | H350 | H340 | H317 |   |   |  
015-197-00-9 | bis(2,4,4-trimethylpentyl)dithiophosphonic acid | 420-160-9 | 107667-02-7 | Flam. Liq. 3 | Acute Tox. 3 * | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 2 | H226 | H331 | H302 | H314 | H411 | GHS02 | GHS06 | GHS05 | GHS09 | Dgr | H226 | H331 | H302 | H314 | H411 |   |   |  015-197-00-9 | бис(2,4,4-триметилпентил)дитиофосфонова киселина | 420-160-9 | 107667-02-7 | Flam. Liq. 3 | Acute Tox. 3 * | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 2 | H226 | H331 | H302 | H314 | H411 | GHS02 | GHS06 | GHS05 | GHS09 | Dgr | H226 | H331 | H302 | H314 | H411 |   |   |  
015-198-00-4 | (4-phenylbutyl)phosphinic acid | 420-450-5 | 86552-32-1 | Carc. 2 | Eye Dam. 1 | H351 | H318 | GHS05 | GHS08 | Dgr | H351 | H318 |   |   |  015-198-00-4 | (4-фенилбутил)фосфинова киселина | 420-450-5 | 86552-32-1 | Carc. 2 | Eye Dam. 1 | H351 | H318 | GHS05 | GHS08 | Dgr | H351 | H318 |   |   |  
015-199-00-X | tris[2-chloro-1-chloromethyl)ethyl] phosphate | 237-159-2 | 13674-87-8 | Carc. 2 | H351 | GSH08 | Wng | H351 |   |   |  015-199-00-X | трис[2-хлоро-1-(хлорометил)етилов] фосфат | 237-159-2 | 13674-87-8 | Carc. 2 | H351 | GSH08 | Wng | H351 |   |   |  
015-200-00-3 | indium phosphide | 244-959-5 | 22398-80-7 | Carc. 1B Repr. 2 | STOT RE 1 | H350 | H361f | H372 (lungs) | GHS08 | Dgr | H350 | H361f | H372 (lungs) |   | STOT RE 1; H372: C ≥0,1  % Carc 1B; | H350: C | ≥0,01  % STOT RE 2; | H373: 0,01  % ≤ | C < 0,1  % |  015-200-00-3 | индиев фосфид | 244-959-5 | 22398-80-7 | Carc. 1B Repr. 2 | STOT RE 1 | H350 | H361f | H372 (бели дробове) | GHS08 | Dgr | H350 | H361f | H372 (бели дробове) |   | STOT RE 1; H372: C ≥0,1  % Carc 1B; | H350: C | ≥0,01  % STOT RE 2; | H373: 0,01  % ≤ | C < 0,1  % |  
015-201-00-9 | trixylyl phosphate | 246-677-8 | 25155-23-1 | Repr. 1B | H360F | GHS08 | Dgr | H360F |   |   |  015-201-00-9 | триксилилов фосфат | 246-677-8 | 25155-23-1 | Repr. 1B | H360F | GHS08 | Dgr | H360F |   |   |  
015-202-00-4 | tris(nonylphenyl) phosphite | 247-759-6 | 26523-78-4 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  015-202-00-4 | трис(нонилфенил)фосфит | 247-759-6 | 26523-78-4 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
015-203-00-X | diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide | 278-355-8 | 75980-60-8 | Repr. 2 | H361f (causing atrophy of the testes) | GHS08 | Wng | H361f (causing atrophy of the testes) |   |   |  015-203-00-X | дифенил(2,4,6-триметилбензоил)фосфиноксид | 278-355-8 | 75980-60-8 | Repr. 2 | H361f (причинява атрофия на тестисите) | GHS08 | Wng | H361f (причинява атрофия на тестисите) |   |   |  
016-001-00-4 | hydrogen sulphide | 231-977-3 | 7783-06-4 | Flam. Gas 1 | Press. Gas | Acute Tox. 2 * | Aquatic Acute 1 | H220 | H330 | H400 | GHS02 | GHS04 | GHS06 | GHS09 | Dgr | H220 | H330 | H400 |   |   | U016-001-00-4 | водороден сулфид | 231-977-3 | 7783-06-4 | Flam. Gas 1 | Press. Gas | Acute Tox. 2 * | Aquatic Acute 1 | H220 | H330 | H400 | GHS02 | GHS04 | GHS06 | GHS09 | Dgr | H220 | H330 | H400 |   |   | U
016-002-00-X | barium sulphide | 244-214-4 | 21109-95-5 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | H332 | H302 | H400 | GHS07 | GHS09 | Wng | H332 | H302 | H400 | EUH031 |   |  016-002-00-X | бариев сулфид | 244-214-4 | 21109-95-5 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | H332 | H302 | H400 | GHS07 | GHS09 | Wng | H332 | H302 | H400 | EUH031 |   |  
016-003-00-5 | barium polysulphides | 256-814-3 | 50864-67-0 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | H319 | H335 | H315 | H400 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H400 | EUH031 |   |  016-003-00-5 | бариеви полисулфиди | 256-814-3 | 50864-67-0 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | H319 | H335 | H315 | H400 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H400 | EUH031 |   |  
016-004-00-0 | calcium sulphide | 243-873-5 | 20548-54-3 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | H319 | H335 | H315 | H400 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H400 | EUH031 |   |  016-004-00-0 | калциев сулфид | 243-873-5 | 20548-54-3 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | H319 | H335 | H315 | H400 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H400 | EUH031 |   |  
016-005-00-6 | calcium polysulphides | 215-709-2 | 1344-81-6 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | H319 | H335 | H315 | H400 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H400 | EUH031 |   |  016-005-00-6 | калциеви полисулфиди | 215-709-2 | 1344-81-6 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | H319 | H335 | H315 | H400 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H400 | EUH031 |   |  
016-006-00-1 | dipotassium sulphide; | potassium sulphide | 215-197-0 | 1312-73-8 | Skin Corr. 1B | Aquatic Acute 1 | H314 | H400 | GHS05 | GHS09 | Dgr | H314 | H400 | EUH031 |   |  016-006-00-1 | дикалиев сулфид; | калиев сулфид | 215-197-0 | 1312-73-8 | Skin Corr. 1B | Aquatic Acute 1 | H314 | H400 | GHS05 | GHS09 | Dgr | H314 | H400 | EUH031 |   |  
016-007-00-7 | potassium polysulphides | 253-390-1 | 37199-66-9 | Skin Corr. 1B | Aquatic Acute 1 | H314 | H400 | GHS05 | GHS09 | Dgr | H314 | H400 | EUH031 |   |  016-007-00-7 | калиеви полисулфиди | 253-390-1 | 37199-66-9 | Skin Corr. 1B | Aquatic Acute 1 | H314 | H400 | GHS05 | GHS09 | Dgr | H314 | H400 | EUH031 |   |  
016-008-00-2 | ammonium polysulphides | 232-989-1 | 9080-17-5 | Skin Corr. 1B | Aquatic Acute 1 | H314 | H400 | GHS05 | GHS09 | Dgr | H314 | H400 | EUH031 | EUH031: C ≥1 % |  016-008-00-2 | амониеви полисулфиди | 232-989-1 | 9080-17-5 | Skin Corr. 1B | Aquatic Acute 1 | H314 | H400 | GHS05 | GHS09 | Dgr | H314 | H400 | EUH031 | EUH031: C ≥1 % |  
016-009-00-8 | disodium sulfide; | sodium sulfide | 215-211-5 | 1313-82-2 | Acute Tox. 3 * | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Acute 1 | H311 | H302 | H314 | H400 | GHS06 | GHS05 | GHS09 | Dgr | H311 | H302 | H314 | H400 |   |   |  016-009-00-8 | динатриев сулфид; | натриев сулфид | 215-211-5 | 1313-82-2 | Acute Tox. 3 * | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Acute 1 | H311 | H302 | H314 | H400 | GHS06 | GHS05 | GHS09 | Dgr | H311 | H302 | H314 | H400 |   |   |  
016-010-00-3 | sodium polysulphides | 215-686-9 | 1344-08-7 | Acute Tox. 3 * | Skin Corr. 1B | Aquatic Acute 1 | H301 | H314 | H400 | GHS06 | GHS05 | GHS09 | Dgr | H301 | H314 | H400 | EUH031 |   |  016-010-00-3 | натриеви полисулфиди | 215-686-9 | 1344-08-7 | Acute Tox. 3 * | Skin Corr. 1B | Aquatic Acute 1 | H301 | H314 | H400 | GHS06 | GHS05 | GHS09 | Dgr | H301 | H314 | H400 | EUH031 |   |  
016-011-00-9 | sulphur dioxide | 231-195-2 | 7446-09-5 | Press. Gas | Acute Tox. 3 * | Skin Corr. 1B | H331 | H314 | GHS04 | GHS06 | GHS05 | Dgr | H331 | H314 |   | * | U5016-011-00-9 | серен диоксид | 231-195-2 | 7446-09-5 | Press. Gas | Acute Tox. 3 * | Skin Corr. 1B | H331 | H314 | GHS04 | GHS06 | GHS05 | Dgr | H331 | H314 |   | * | U5
016-012-00-4 | disulphur dichloride; | sulfur monochloride | 233-036-2 | 10025-67-9 | Acute Tox. 3 * | Acute Tox. 4 * | Skin Corr. 1A | Aquatic Acute 1 | H301 | H332 | H314 | H400 | GHS06 | GHS05 | GHS09 | Dgr | H301 | H332 | H314 | H400 | EUH014 | EUH029 | STOT SE 3; H335: C ≥ 1 % |  016-012-00-4 | дисерен дихлорид; | серен монохлорид | 233-036-2 | 10025-67-9 | Acute Tox. 3 * | Acute Tox. 4 * | Skin Corr. 1A | Aquatic Acute 1 | H301 | H332 | H314 | H400 | GHS06 | GHS05 | GHS09 | Dgr | H301 | H332 | H314 | H400 | EUH014 | EUH029 | STOT SE 3; H335: C ≥ 1 % |  
016-013-00-X | sulphur dichloride | 234-129-0 | 10545-99-0 | Skin Corr. 1B | STOT SE 3 | Aquatic Acute 1 | H314 | H335 | H400 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H335 | H400 | EUH014 | STOT SE 3; H335: C ≥ 5 % |  016-013-00-X | серен дихлорид | 234-129-0 | 10545-99-0 | Skin Corr. 1B | STOT SE 3 | Aquatic Acute 1 | H314 | H335 | H400 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H335 | H400 | EUH014 | STOT SE 3; H335: C ≥ 5 % |  
016-014-00-5 | sulphur tetrachloride | — | 13451-08-6 | Skin Corr. 1B | Aquatic Acute 1 | H314 | H400 | GHS05 | GHS09 | Dgr | H314 | H400 | EUH014 | STOT SE 3; H335: C ≥ 5 % |  016-014-00-5 | серен тетрахлорид | — | 13451-08-6 | Skin Corr. 1B | Aquatic Acute 1 | H314 | H400 | GHS05 | GHS09 | Dgr | H314 | H400 | EUH014 | STOT SE 3; H335: C ≥ 5 % |  
016-015-00-0 | thionyl dichloride; | thionyl chloride | 231-748-8 | 7719-09-7 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | H332 | H302 | H314 | GHS05 | GHS07 | Dgr | H332 | H302 | H314 | EUH014 | EUH029 | STOT SE 3; H335: C ≥ 1 % |  016-015-00-0 | тионилдихлорид; | тионилхлорид | 231-748-8 | 7719-09-7 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | H332 | H302 | H314 | GHS05 | GHS07 | Dgr | H332 | H302 | H314 | EUH014 | EUH029 | STOT SE 3; H335: C ≥ 1 % |  
016-016-00-6 | sulphuryl chloride | 232-245-6 | 7791-25-5 | Skin Corr. 1B | STOT SE 3 | H314 | H335 | GHS05 | GHS07 | Dgr | H314 | H335 | EUH014 |   |  016-016-00-6 | сулфурилхлорид | 232-245-6 | 7791-25-5 | Skin Corr. 1B | STOT SE 3 | H314 | H335 | GHS05 | GHS07 | Dgr | H314 | H335 | EUH014 |   |  
016-017-00-1 | chlorosulphonic acid | 232-234-6 | 7790-94-5 | Skin Corr. 1A | STOT SE 3 | H314 | H335 | GHS05 | GHS07 | Dgr | H314 | H335 | EUH014 |   |  016-017-00-1 | хлоросулфонова киселина | 232-234-6 | 7790-94-5 | Skin Corr. 1A | STOT SE 3 | H314 | H335 | GHS05 | GHS07 | Dgr | H314 | H335 | EUH014 |   |  
016-018-00-7 | fluorosulphonic acid | 232-149-4 | 7789-21-1 | Acute Tox. 4 * | Skin Corr. 1A | H332 | H314 | GHS05 | GHS07 | Dgr | H332 | H314 |   |   |  016-018-00-7 | флуоросулфонова киселина | 232-149-4 | 7789-21-1 | Acute Tox. 4 * | Skin Corr. 1A | H332 | H314 | GHS05 | GHS07 | Dgr | H332 | H314 |   |   |  
016-019-00-2 | oleum … % SO3 | — | — | Skin Corr. 1A | STOT SE 3 | H314 | H335 | GHS05 | GHS07 | Dgr | H314 | H335 | EUH014 |   | B016-019-00-2 | олеум… % SO3 | — | — | Skin Corr. 1A | STOT SE 3 | H314 | H335 | GHS05 | GHS07 | Dgr | H314 | H335 | EUH014 |   | B
016-020-00-8 | sulphuric acid … % | 231-639-5 | 7664-93-9 | Skin Corr. 1A | H314 | GHS05 | Dgr | H314 |   | Skin Corr. 1A; H314: C ≥ 15 % Skin Irrit. 2; H315: 5 % ≤ C | < 15 % | Eye Irrit. 2; H319: 5 % ≤ C | < 15 % | B016-020-00-8 | сярна киселина … % | 231-639-5 | 7664-93-9 | Skin Corr. 1A | H314 | GHS05 | Dgr | H314 |   | Skin Corr. 1A; H314: C ≥ 15 % Skin Irrit. 2; H315: 5 % ≤ C | < 15 % | Eye Irrit. 2; H319: 5 % ≤ C | < 15 % | B
016-021-00-3 | methanethiol; | methyl mercaptan | 200-822-1 | 74-93-1 | Flam. Gas. 1 | Press. Gas | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H220 | H331 | H400 | H410 | GHS02 | GHS04 | GHS06 | GHS09 | Dgr | H220 | H331 | H410 |   |   | U016-021-00-3 | метантиол; | метилмеркаптан | 200-822-1 | 74-93-1 | Flam. Gas. 1 | Press. Gas | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H220 | H331 | H400 | H410 | GHS02 | GHS04 | GHS06 | GHS09 | Dgr | H220 | H331 | H410 |   |   | U
016-022-00-9 | ethanethiol; | ethyl mercaptan | 200-837-3 | 75-08-1 | Flam. Liq. 2 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H225 | H332 | H400 | H410 | GHS02 | GHS07 | GHS09 | Dgr | H225 | H332 | H410 |   |   |  016-022-00-9 | етантиол; | етилмеркаптан | 200-837-3 | 75-08-1 | Flam. Liq. 2 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H225 | H332 | H400 | H410 | GHS02 | GHS07 | GHS09 | Dgr | H225 | H332 | H410 |   |   |  
016-023-00-4 | dimethyl sulphate | 201-058-1 | 77-78-1 | Carc. 1B | Muta. 2 | Acute Tox. 2 * | Acute Tox. 3 * | Skin Corr. 1B | Skin Sens. 1 | H350 | H341 | H330 | H301 | H314 | H317 | GHS06 | GHS08 | GHS05 | Dgr | H350 | H341 | H330 | H301 | H314 | H317 |   | Carc. 1B; H350: C ≥ 0,01  % Muta. 2 H341: C ≥ 0,01  % STOT SE 3; H335: C ≥ 5 % |  016-023-00-4 | диметилсулфат | 201-058-1 | 77-78-1 | Carc. 1B | Muta. 2 | Acute Tox. 2 * | Acute Tox. 3 * | Skin Corr. 1B | Skin Sens. 1 | H350 | H341 | H330 | H301 | H314 | H317 | GHS06 | GHS08 | GHS05 | Dgr | H350 | H341 | H330 | H301 | H314 | H317 |   | Carc. 1B; H350: C ≥ 0,01  % Muta. 2 H341: C ≥ 0,01  % STOT SE 3; H335: C ≥ 5 % |  
016-024-00-X | dimexano(ISO); bis(methoxythiocarbonyl) disulphide | 215-993-8 | 1468-37-7 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  016-024-00-X | димексано (ISO); бис(метокситиокарбонил)дисулфид | 215-993-8 | 1468-37-7 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
016-025-00-5 | disul (ISO); | 2-(2,4-dichlorophenoxy)ethyl hydrogensulphate; | 2,4-DES | 205-259-5 | 149-26-8 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | H302 | H315 | H318 | GHS05 | GHS07 | Dgr | H302 | H315 | H318 |   |   |  016-025-00-5 | дисул (ISO); | 2-(2,4-дихлорофенокси)eтилов хидрогенсулфат; | 2,4-DES | 205-259-5 | 149-26-8 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | H302 | H315 | H318 | GHS05 | GHS07 | Dgr | H302 | H315 | H318 |   |   |  
016-026-00-0 | sulphamidic acid; | sulphamic acid; | sulfamic acid | 226-218-8 | 5329-14-6 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 3 | H319 | H315 | H412 | GHS07 | Wng | H319 | H315 | H412 |   |   |  016-026-00-0 | сулфамидна киселина; | сулфаминова киселина; | сулфаминова киселина | 226-218-8 | 5329-14-6 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 3 | H319 | H315 | H412 | GHS07 | Wng | H319 | H315 | H412 |   |   |  
016-027-00-6 | diethyl sulphate | 200-589-6 | 64-67-5 | Carc. 1B | Muta. 1B | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H350 | H340 | H332 | H312 | H302 | H314 | GHS05 | GHS08 | GHS07 | Dgr | H350 | H340 | H332 | H312 | H302 | H314 |   |   |  016-027-00-6 | диетилсулфат | 200-589-6 | 64-67-5 | Carc. 1B | Muta. 1B | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H350 | H340 | H332 | H312 | H302 | H314 | GHS05 | GHS08 | GHS07 | Dgr | H350 | H340 | H332 | H312 | H302 | H314 |   |   |  
016-028-00-1 | sodium dithionite; | sodium hydrosulphite | 231-890-0 | 7775-14-6 | Self-heat. 1 | Acute Tox. 4 * | H251 | H302 | GHS02 | GHS07 | Dgr | H251 | H302 | EUH031 |   |  016-028-00-1 | натриев дитионит; | натриев хидросулфит | 231-890-0 | 7775-14-6 | Self-heat. 1 | Acute Tox. 4 * | H251 | H302 | GHS02 | GHS07 | Dgr | H251 | H302 | EUH031 |   |  
016-029-00-7 | p-toluenesulphonic acid, (containing more than 5 % H2SO4) | — | — | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % | Eye Irrit. 2; H319: 10 % ≤ C < 25 % |  016-029-00-7 | p-тoлуенсулфонова киселина (съдържаща над 5 % H2SO4) | — | — | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % | Eye Irrit. 2; H319: 10 % ≤ C < 25 % |  
016-030-00-2 | p-toluenesulphonic acid (containing a maximum of 5 % H2SO4) | 203-180-0 | 104-15-4 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H319 | H335 | H315 | GHS07 | Wng | H319 | H335 | H315 |   | STOT SE 3; H335: C ≥ 20 % |  016-030-00-2 | p-тoлуенсулфонова киселина (съдържаща най-много 5 % H2SO4) | 203-180-0 | 104-15-4 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H319 | H335 | H315 | GHS07 | Wng | H319 | H335 | H315 |   | STOT SE 3; H335: C ≥ 20 % |  
016-031-00-8 | tetrahydrothiophene-1,1-dioxide; sulpholane | 204-783-1 | 126-33-0 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  016-031-00-8 | тeтрахидротиофен-1,1-диоксид; сулфолан | 204-783-1 | 126-33-0 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
016-032-00-3 | 1,3-propanesultone; | 1,2-oxathiolane 2,2-dioxide | 214-317-9 | 1120-71-4 | Carc. 1B | Acute Tox. 4 * | Acute Tox. 4 * | H350 | H312 | H302 | GHS08 | GHS07 | Dgr | H350 | H312 | H302 |   | Carc. 1B; H350: C ≥ 0,01  % |  016-032-00-3 | 1,3-пропансултон; | 1,2-оксатиолан-2,2-диоксид | 214-317-9 | 1120-71-4 | Carc. 1B | Acute Tox. 4 * | Acute Tox. 4 * | H350 | H312 | H302 | GHS08 | GHS07 | Dgr | H350 | H312 | H302 |   | Carc. 1B; H350: C ≥ 0,01  % |  
016-033-00-9 | dimethylsulfamoylchloride | 236-412-4 | 13360-57-1 | Carc. 1B | Acute Tox. 2 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H350 | H330 | H312 | H302 | H314 | GHS06 | GHS05 | GHS08 | Dgr | H350 | H330 | H312 | H302 | H314 |   |   |  016-033-00-9 | диметилсулфамоилхлорид | 236-412-4 | 13360-57-1 | Carc. 1B | Acute Tox. 2 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H350 | H330 | H312 | H302 | H314 | GHS06 | GHS05 | GHS08 | Dgr | H350 | H330 | H312 | H302 | H314 |   |   |  
016-034-00-4 | tetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate) | 400-010-9 | 81898-60-4 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  016-034-00-4 | тетранатриев 3,3′-(пиперазин-1,4-диилбис((6-хлоро-1,3,5-триазин-2,4-диил)имино(2-aцетамидо)-4,1-фениленазо))бис(нафтален-1,5-дисулфонат) | 400-010-9 | 81898-60-4 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
016-035-00-X | pentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate | 400-120-7 | — | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  016-035-00-X | пентанатриев 5-aнилино-3-(4-(4-(4-(3-сулфонатоанилино)-6-хлоро-1,3,5-триазин-2-иламино)-2,5-диметилфенилазо)-2,5-дисулфонатофенилазо)-4-хидроксинафталeн-2,7-дисулфонат | 400-120-7 | — | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
016-036-00-5 | tetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate | 400-130-1 | — | Resp. Sens. 1 | Aquatic Chronic 2 | H334 | H411 | GHS08 | GHS09 | Dgr | H334 | H411 |   |   |  016-036-00-5 | тетранатриев 5-(4,6-дихлоро-5-цианопиримидин-2-иламино)-4-хидрокси-2,3-aзодинафтален-1,2,5,7-дисулфонат | 400-130-1 | — | Resp. Sens. 1 | Aquatic Chronic 2 | H334 | H411 | GHS08 | GHS09 | Dgr | H334 | H411 |   |   |  
016-037-00-0 | disodium 1-amino-4-(4-benzenesulphonamido-3-sulphonatoanilino)anthraquinone-2-sulphonate | 400-350-8 | 85153-93-1 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  016-037-00-0 | динатриев 1-aмино-4-(4-бензенсулфонамидо-3-сулфонатоанилино)антрахинон-2-сулфонат | 400-350-8 | 85153-93-1 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
016-038-00-6 | disodium 6-((4-chloro-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate | 400-380-1 | 86393-35-3 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  016-038-00-6 | динатриев 6-((6-(N-метил)-4-хлоро-2-толуидино)-1,3,5-триазин-2-иламино)-1-хидрокси-2-(4-метокси-2-сулфонатофенилазо)нафтален-3-сулфонат | 400-380-1 | 86393-35-3 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
016-039-00-1 | tetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-disulphonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate | 400-430-2 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  016-039-00-1 | тетранатриев 2-(4-(4-(2,5-диметил-4-(2,5-дисулфонатофенилазо)фенилазо)-3-уреидоанилино)-6-хлоро-1,3,5-триазин-2-иламино)бензен-1,4-дисулфонат | 400-430-2 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
016-040-00-7 | reaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate | 400-570-4 | — | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  016-040-00-7 | реакционна маса от динатриев 6-(2,4-дихидроксифенилазо)-3-(4-(4-(2,4-дихидроксифенилазо)aнилино)-3-сулфонатофенилазо)-4-хидроксинафтален-2-сулфонат и динатриев 6-(2,4-диаминофенилазо)-3-(4-(4-(2,4-диаминофенилазо)aнилино)-3-сулфонатофенилазо)-4-хидроксинафтален-2-сулфонат и тринатриев 6-(2,4-дихидроксифенилазо)-3(4-(4-(7-(2,4-дихидроксифенилазо)-1-хидрокси-3-сулфонато-2-нафтилазо)анилино)-3-сулфонатофенилазо)-4-хидроксинафтален-2-сулфонат | 400-570-4 | — | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
016-041-00-2 | calcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate | 400-710-4 | — | Acute Tox. 4 * | H332 | GHS07 | Wng | H332 |   |   |  016-041-00-2 | калциев 2,5-дихлоро-4-(4-((4-метил-2-сулфонато-5-хлорофенил)aзо)-5-хидрокси-3-метилпиразол-1-ил)бензенсулфонат | 400-710-4 | — | Acute Tox. 4 * | H332 | GHS07 | Wng | H332 |   |   |  
016-042-00-8 | tetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate | 400-790-0 | 85665-97-0 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   |   |  016-042-00-8 | тетранатриев 5-бензамидо-3-(5-(6-(1-сулфонато-2-нафтиламино)-4-флуоро-1,3,5-триазин-2-иламино)-2-сулфонатофенилазо)-4-хидроксинафтален-2,7-дисулфонат | 400-790-0 | 85665-97-0 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   |   |  
016-043-00-3 | dilithium 6-acetamido-4-hydroxy-3-(4-((2-sulphonatooxy)ethylsulphonyl) phenylazo)naphthalene-2-sulphonate | 401-010-1 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  016-043-00-3 | дилитиев 6-ацетамидо-3-(4-((2-сулфонатоокси)eтилсулфонил)фенилазо)-4-хидроксинафтален-2-сулфонат | 401-010-1 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
016-044-00-9 | disodium S,S-hexane-1,6-diyldi(thiosulphate) dihydrate | 401-320-7 | — | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  016-044-00-9 | динатриев S,S-хексан-1,6-диилди(тиосулфат) дихидрат | 401-320-7 | — | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
016-045-00-4 | lithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate | 401-560-2 | 108624-00-6 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  016-045-00-4 | литиев натриев хидроген-4-aмино-6-(2-сулфонато-5-(2,6-дифлуоро-5-хлоропиримидин-4-иламино)фенилазо)-5-хидрокси-3-(4-(2-(сулфонатоокси) eтилсулфонил)фенилазо)нафтален-2,7-дисулфонат | 401-560-2 | 108624-00-6 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
016-046-00-X | sodium hydrogensulphate | 231-665-7 | 7681-38-1 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  016-046-00-X | натриев хидрогенсулфат | 231-665-7 | 7681-38-1 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
016-047-00-5 | hexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulphonatonaphthylazo)naphthalene-1,3,5-trisulphonate | 401-650-1 | 85665-96-9 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  016-047-00-5 | хексантриев 7-(4-(4-(4-(2,5-дисулфонатоанилино)-6-флуоро-1,3,5-триазин-2-иламино)-2-метилфенилазо)-7-сулфонатонафтилазо)нафтален-1,3,5-трисулфонат | 401-650-1 | 85665-96-9 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
016-048-00-0 | sodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate | 401-870-8 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  016-048-00-0 | натриев 2-(4-метил-2,6-бис(3-хидроксипропиламино)-5-цианопиридин-3-илазо)-3,5-дихлоробензенсулфонат | 401-870-8 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
016-049-00-6 | calcium octadecylxylenesulphonate | 402-040-8 | — | Skin Corr. 1B | Aquatic Chronic 2 | H314 | H411 | GHS05 | GHS09 | Dgr | H314 | H411 |   |   |  016-049-00-6 | калциев октадецилксиленсулфонат | 402-040-8 | — | Skin Corr. 1B | Aquatic Chronic 2 | H314 | H411 | GHS05 | GHS09 | Dgr | H314 | H411 |   |   |  
016-050-00-1 | potassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat | 402-150-6 | — | Eye Irrit. 2 | Skin Sens. 1 | H319 | H317 | GHS07 | Wng | H319 | H317 |   |   |  016-050-00-1 | калиев натриев 5-(4-хлоро-6-(N-(4-(4-хлоро-6-(2,7-дисулфонато-6-(2-сулфонатофенилазо)-5-хидрокси-4-нафтиламино)-1,3,5-триазин-2-иламино)фенил-N-метил)aмино)-1,3,5-триазин-2-иламино)-4-хидрокси-3-(2-сулфонатофенилазо)нафтален-2,7-дисулфонат | 402-150-6 | — | Eye Irrit. 2 | Skin Sens. 1 | H319 | H317 | GHS07 | Wng | H319 | H317 |   |   |  
016-051-00-7 | trisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulphonate | 402-170-5 | 106359-91-5 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  016-051-00-7 | тринатриев 7-(4-(6-флуоро-4-(2-(2-винилсулфонилетокси)eтиламино)-1,3,5-триaзин-2-иламино)-2-уреидофенилaзо)нафтален-1,3,6-трисулфонат | 402-170-5 | 106359-91-5 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
016-052-00-2 | benzyltributylammonium 4-hydroxynaphthalene-1-sulphonate | 402-240-5 | 102561-46-6 | Acute Tox. 4 * | Aquatic Chronic 2 | H332 | H411 | GHS07 | GHS09 | Wng | H332 | H411 |   |   |  016-052-00-2 | бензилтрибутиламониев 4-хидроксинафтален-1-сулфонат | 402-240-5 | 102561-46-6 | Acute Tox. 4 * | Aquatic Chronic 2 | H332 | H411 | GHS07 | GHS09 | Wng | H332 | H411 |   |   |  
016-053-00-8 | (C16 or C18-n-alkyl)(C16 or C18-n-alkyl)ammonium 2-((C16 or C18-n-alkyl)(C16 or C18-n-alkyl)carbamoyl)benzenesulphonate | 402-460-1 | — | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 4 | H315 | H317 | H413 | GHS07 | Wng | H315 | H317 | H413 |   |   |  016-053-00-8 | (C16 или C18-n-алкил)(C16 или C18-n-алкил)амониев 2-((C16 или C18-n-алкил)(C16 или C18-n-алкил)карбамоил)бензенсулфонат | 402-460-1 | — | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 4 | H315 | H317 | H413 | GHS07 | Wng | H315 | H317 | H413 |   |   |  
016-054-00-3 | sodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate | 400-030-8 | — | Acute Tox. 3 * | STOT RE 1 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Sens. 1 | H331 | H372 ** | H302 | H319 | H335 | H317 | GHS06 | GHS08 | Dgr | H331 | H372 ** H302 | H319 | H335 | H317 |   |   |  016-054-00-3 | натриев 4-(2,4,4-триметилпентилкарбонилокси)бензенсулфонат | 400-030-8 | — | Acute Tox. 3 * | STOT RE 1 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Sens. 1 | H331 | H372 ** | H302 | H319 | H335 | H317 | GHS06 | GHS08 | Dgr | H331 | H372 ** H302 | H319 | H335 | H317 |   |   |  
016-055-00-9 | tetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-sulfonate (containing > 35 % sodium chloride and sodium acetate) | 400-510-7 | — | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  016-055-00-9 | тетранатриев 4-aмино-3,6-бис(5-(6-хлоро-4-(2-хидроксиетиламино)-1,3,5-триазин-2-иламино)-2-сулфонатофенилазо)-5-хидроксинафталeн-2,7-сулфонат (съдъжащ > 35 % натриев хлорид и натриев ацетат) | 400-510-7 | — | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
016-056-00-4 | potassium hydrogensulphate | 231-594-1 | 7646-93-7 | Skin Corr. 1B | STOT SE 3 | H314 | H335 | GHS05 | GHS07 | Dgr | H314 | H335 |   |   |  016-056-00-4 | калиев хидрогенсулфат | 231-594-1 | 7646-93-7 | Skin Corr. 1B | STOT SE 3 | H314 | H335 | GHS05 | GHS07 | Dgr | H314 | H335 |   |   |  
016-057-00-X | styrene-4-sulfonyl chloride | 404-770-2 | 2633-67-2 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H315 | H318 | H317 | GHS05 | GHS07 | Dgr | H315 | H318 | H317 |   |   |  016-057-00-X | стирен-4-сулфонилхлорид | 404-770-2 | 2633-67-2 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H315 | H318 | H317 | GHS05 | GHS07 | Dgr | H315 | H318 | H317 |   |   |  
016-058-00-5 | thionyl chloride, reaction products with 1,3,4-thiadiazol-2,5-dithiol, tert-nonanethiol andC 12-14-tert-alkylamine | 404-820-3 | — | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H315 | H317 | H412 | GHS07 | Wng | H315 | H317 | H412 |   |   |  016-058-00-5 | тионилхлорид, реакционни продукти с 1,3,4-тиадиазол-2,5-дитиол, трет-нонантиол и C12-14-трет-алкиламин | 404-820-3 | — | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H315 | H317 | H412 | GHS07 | Wng | H315 | H317 | H412 |   |   |  
016-059-00-0 | N, N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride | 405-300-9 | 17339-60-5 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H317 | H410 |   |   |  016-059-00-0 | N,N,N′,N′-тeтраметилдитиобис(етилен)диаминдихидрохлорид | 405-300-9 | 17339-60-5 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H317 | H410 |   |   |  
016-060-00-6 | diammonium peroxodisulphate; ammonium persulphate | 231-786-5 | 7727-54-0 | Ox. Sol. 3 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | H272 | H302 | H319 | H335 | H315 | H334 | H317 | GHS03 | GHS08 | GHS07 | Dgr | H272 | H302 | H319 | H335 | H315 | H334 | H317 |   |   |  016-060-00-6 | диамониев пероксoдисулфат; амониев персулфат | 231-786-5 | 7727-54-0 | Ox. Sol. 3 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | H272 | H302 | H319 | H335 | H315 | H334 | H317 | GHS03 | GHS08 | GHS07 | Dgr | H272 | H302 | H319 | H335 | H315 | H334 | H317 |   |   |  
016-061-00-1 | dipotassium peroxodisulphate; potassium persulphate | 231-781-8 | 7727-21-1 | Ox. Sol. 3 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | H272 | H302 | H319 | H335 | H315 | H334 | H317 | GHS03 | GHS08 | GHS07 | Dgr | H272 | H302 | H319 | H335 | H315 | H334 | H317 |   |   |  016-061-00-1 | дикалиев пероксодисулфат; калиев персулфат | 231-781-8 | 7727-21-1 | Ox. Sol. 3 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | H272 | H302 | H319 | H335 | H315 | H334 | H317 | GHS03 | GHS08 | GHS07 | Dgr | H272 | H302 | H319 | H335 | H315 | H334 | H317 |   |   |  
016-062-00-7 | bensultap (ISO); | 1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane | — | 17606-31-4 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  016-062-00-7 | бенсултап (ISO); | 1,3-бис(фенилсулфонилтио)-2-(N,N-диметиламино)пропан | — | 17606-31-4 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
016-063-00-2 | sodium metabisulphite | 231-673-0 | 7681-57-4 | Acute Tox. 4 * | Eye Dam. 1 | H302 | H318 | GHS05 | GHS07 | Dgr | H302 | H318 | EUH031 |   |  016-063-00-2 | натриев метабисулфит | 231-673-0 | 7681-57-4 | Acute Tox. 4 * | Eye Dam. 1 | H302 | H318 | GHS05 | GHS07 | Dgr | H302 | H318 | EUH031 |   |  
016-064-00-8 | sodium hydrogensulphite … %; | sodium bisulphite . . . % | 231-548-0 | 7631-90-5 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 | EUH031 |   | B016-064-00-8 | натриев хидрогенсулфит … %; | натриев бисулфит . . . % | 231-548-0 | 7631-90-5 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 | EUH031 |   | B
016-065-00-3 | sodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate | 400-100-8 | 84057-97-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  016-065-00-3 | натриев 1-aмино-4-[2-метил-5-(4-метилфенилсулфониламино)фениламино]aнтрахинон-2-сулфонат | 400-100-8 | 84057-97-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
016-066-00-9 | tetrasodium [5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2-sulfonatobenzylidenehydrazino)benzoate]copper(II) | 404-070-7 | 116912-62-0 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  016-066-00-9 | тетранатриев [5-((4-aмино-6-хлоро-1,3,5-триазин-2-ил)aмино)-2-((2-хидрокси-3,5-дисулфонатофенилазо)-2-сулфонатобензилиденхидразино)бензоат]меден(II) йон | 404-070-7 | 116912-62-0 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
016-067-00-4 | (4-methylphenyl)mesitylene sulfonate | 407-530-5 | 67811-06-7 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  016-067-00-4 | (4-мeтилфенил)мезитиленсулфонат | 407-530-5 | 67811-06-7 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
016-068-00-X | sodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate | 407-720-8 | 155160-86-4 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  016-068-00-X | натриев 3,5-бис(тетрадецилоксикарбонил)бензенсулфинат | 407-720-8 | 155160-86-4 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
016-069-00-5 | 3,5-bis-(tetradecyloxycarbonyl)benzenesulfinic acid | 407-990-7 | 141915-64-2 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  016-069-00-5 | 3,5-бис(тетрадецилоксикарбонил)бензенсулфинова киселина | 407-990-7 | 141915-64-2 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
016-070-00-0 | 4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfone | 408-220-2 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  016-070-00-0 | 4-бензилокси-4′-(2,3-eпокси-2-метилпроп-1-илокси)дифенилсулфон | 408-220-2 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
016-071-00-6 | trisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate | 410-130-3 | 136248-03-8 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  016-071-00-6 | тринатриев 3-амино-6,13-дихлоро-10-((3-((6-(2-сулфофениламино)-4-хлоро-1,3,5-триaзин-2-ил)амино)пропил)амино)-4,11-трифеноксидиоксазиндисулфонат | 410-130-3 | 136248-03-8 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
016-072-00-1 | 3-amino-4-hydroxy-N-(2-methoxyethyl)-benzenesulfonamide | 411-520-6 | 112195-27-4 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H411 |   |   |  016-072-00-1 | 3-амино-N-(2-метоксиетил)-4-хидроксибензенсулфонамид | 411-520-6 | 112195-27-4 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H411 |   |   |  
016-073-00-7 | tetrakis(phenylmethyl)thioperoxydi(carbothioamide) | 404-310-0 | 10591-85-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  016-073-00-7 | тетракис(фенилметил)тиопероксиди(карботиоамид) | 404-310-0 | 10591-85-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
016-074-00-2 | 6-fluoro-2-methyl-3-(4-methylthiobenzyl)indene | 405-410-7 | — | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H315 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H315 | H318 | H317 | H411 |   |   |  016-074-00-2 | 6-флуоро-2-метил-3-(4-метилтиобензил)инден | 405-410-7 | — | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H315 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H315 | H318 | H317 | H411 |   |   |  
016-075-00-8 | 2,2'-diallyl-4,4'-sulfonyldiphenol | 411-570-9 | 41481-66-7 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  016-075-00-8 | 2,2′-диалил-4,4′-сулфонилдифенол | 411-570-9 | 41481-66-7 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
016-076-00-3 | 2,3-bis((2-mercaptoethyl)thio)-1-propanethiol | 411-290-7 | 131538-00-6 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373 ** H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373 ** H410 |   |   |  016-076-00-3 | 2,3-бис((2-меркаптоетил)тио)-1-пропантиол | 411-290-7 | 131538-00-6 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373 ** H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373 ** H410 |   |   |  
016-077-00-9 | 2-chloro-p-toluenesulfochloride | 412-890-1 | 42413-03-6 | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 3 | H314 | H317 | H412 | GHS05 | GHS07 | Dgr | H314 | H317 | H412 |   |   |  016-077-00-9 | 2-хлоро-p-толуенсулфохлорид | 412-890-1 | 42413-03-6 | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 3 | H314 | H317 | H412 | GHS05 | GHS07 | Dgr | H314 | H317 | H412 |   |   |  
016-078-00-4 | 4-methyl-N, N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)benzenesulfonamide | 413-300-5 | 56187-04-3 | Aquatic Chronic 4 | H413 | — |   |   |   |  016-078-00-4 | 4-мeтил-N,N-бис(2-(((4-метилфенил)сулфонил)aмино)eтил)бензенсулфонамид | 413-300-5 | 56187-04-3 | Aquatic Chronic 4 | H413 | — |   |   |   |  
016-079-00-X | N, N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide | 412-920-3 | 16695-22-0 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  016-079-00-X | N, N-бис(2-(p-толуенсулфонилокси)eтил)-p-толуенсулфонамид | 412-920-3 | 16695-22-0 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
016-080-00-5 | sodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate | 412-320-1 | 31361-99-6 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  016-080-00-5 | натриев 2-aнилино-5-(2-нитро-4-(N-фенилсулфамоил))aнилинобензенсулфонат | 412-320-1 | 31361-99-6 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
016-081-00-0 | hexahydrocyclopenta[c]pyrrole-1-(1H)-ammonium N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide | 418-350-1 | — | Muta. 2 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H341 | H302 | H319 | H317 | H411 | GHS08 | GHS07 | GHS09 | Wng | H341 | H302 | H319 | H317 | H411 |   |   |  016-081-00-0 | хексахидроциклопента[c]пирол-1-(1H)-aмониев N-eтоксикарбонил-N-(p-толилсулфонил)aзанид | 418-350-1 | — | Muta. 2 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H341 | H302 | H319 | H317 | H411 | GHS08 | GHS07 | GHS09 | Wng | H341 | H302 | H319 | H317 | H411 |   |   |  
016-082-00-6 | ethoxysulfuron (ISO); | 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea | — | 126801-58-9 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  016-082-00-6 | етоксисулфурон (ISO); | 1-(4,6-диметоксипиримидин-2-ил)-3-(2-eтоксифеноксисулфонил)уреа | — | 126801-58-9 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
016-083-00-1 | acibenzolar-S-methyl; benzo[1,2,3]thiadiazole-7-carbothioic acid S-methyl ester | 420-050-0 | 135158-54-2 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H335 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H317 | H410 |   |   |  016-083-00-1 | ацибензолар-S-метил; S-метилов естер на бензо[1,2,3]тиадиазол-7-карботиовата киселина | 420-050-0 | 135158-54-2 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H335 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H317 | H410 |   |   |  
016-084-00-7 | prosulfuron (ISO); | 1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea | — | 94125-34-5 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   | M=100 |  016-084-00-7 | просулфурон (ISO); | 1-(6-метил-4-метокси-1,3,5-триазин-2-ил)-3-[2-(3,3,3-трифлуоропропил)фенилсулфонил]уреа | — | 94125-34-5 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   | M=100 |  
016-085-00-2 | flazasulfuron (ISO); | 1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea | — | 104040-78-0 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  016-085-00-2 | флазасулфурон (ISO); | 1-(4,6-диметоксипиримидин-2-ил)-3-(3-трифлуорометил-2-пиридилсулфонил)уреа | — | 104040-78-0 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
016-086-00-8 | tetrasodium 10-amino-6,13-dichloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate | 402-590-9 | 109125-56-6 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  016-086-00-8 | тетранатриев 10-амино-3-(3-(4-(2,5-дисулфонатоанилино)-6-флуоро-1,3,5-триaзин-2-иламино)проп-3-иламино)-6,13-дихлоро-5,12-диoкса-7,14-диазапентацен-4,11-дисулфонат | 402-590-9 | 109125-56-6 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
016-087-00-3 | reaction mass of: thiobis(4,1-phenylene)-S, S,S',S'-tetraphenyldisulfonium bishexafluorophosphate; | diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate; | propylene carbonate | 403-490-8 | 104558-95-4 | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H317 | H410 |   |   |  016-087-00-3 | реакционна маса от: тиобис(4,1-фенилен)-S, S,S′,S′-тетрафенилдисулфониев бисхексафлуорофосфат; | дифенил(4-фенилтиофенил)сулфониев хексафлуорофосфат; | пропилeнкарбонат | 403-490-8 | 104558-95-4 | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H317 | H410 |   |   |  
016-088-00-9 | 4-(bis(4-(diethylamino)phenyl)methyl)benzene-1,2-dimethanesulfonic acid | 407-280-7 | 71297-11-5 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  016-088-00-9 | 4-(бис(4-(диетиламино)фенил)метил) бензен-1,2-диметансулфонова киселина | 407-280-7 | 71297-11-5 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
016-089-00-4 | reaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene | 413-840-1 | — | Self-react. C **** | Aquatic Chronic 4 | H242 | H413 | GHS02 | Dgr | H242 | H413 |   |   |  016-089-00-4 | реакционна маса от естери на 5,5′,6,6′,7,7′-хексахидрокси-3,3,3′,3′-тетраметил-1,1′-спиробииндан и 2-диазо-1,2-дихидро-1-oксо-5-сулфонафтален | 413-840-1 | — | Self-react. C **** | Aquatic Chronic 4 | H242 | H413 | GHS02 | Dgr | H242 | H413 |   |   |  
016-090-00-X | 4-methyl-N-(methylsulfonyl)benzenesulfonamide | 415-040-8 | 14653-91-9 | Acute Tox. 4 * | STOT SE 3 | Eye Dam. 1 | H302 | H335 | H318 | GHS05 | GHS07 | Dgr | H302 | H335 | H318 |   |   |  016-090-00-X | 4-метил-N-(метилсулфонил)бензенсулфонамид | 415-040-8 | 14653-91-9 | Acute Tox. 4 * | STOT SE 3 | Eye Dam. 1 | H302 | H335 | H318 | GHS05 | GHS07 | Dgr | H302 | H335 | H318 |   |   |  
016-091-00-5 | C12-14-tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate | 414-110-5 | — | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  016-091-00-5 | C12-14-трет-алкиламониев 1-амино-9,10-дихидро-9,10-диоксо-4-(2,4,6-триметиланилино)антрацен-2-сулфонат | 414-110-5 | — | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  
016-092-00-0 | reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; | 4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; | 5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol | 427-050-1 | — | Repr. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361f | H315 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H361f | H315 | H317 | H410 |   |   |  016-092-00-0 | реакционна маса от: 4,7-бис(меркаптометил)-3,6,9-тритиа-1,11-ундекандитиол; | 4,8-бис(меркаптометил)-3,6,9-тритиа-1,11-ундекандитиол; | 5,7-бис(меркаптометил)-3,6,9-тритиа-1,11-ундекандитиол | 427-050-1 | — | Repr. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361f | H315 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H361f | H315 | H317 | H410 |   |   |  
016-093-00-6 | reaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate); | 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1) | 414-770-4 | 140698-96-0 | Self-react. C **** | Carc. 2 | H242 | H351 | GHS02 | GHS08 | Dgr | H242 | H351 |   |   |  016-093-00-6 | реакционна маса от: 4-(7-хидрокси-2,4,4-триметил-2-хроманил)резорцинол-4-илтрис(6-диазо-5,6-дихидро-5-оксонафтален-1-сулфонат); | 4-(7-хидрокси-2,4,4-триметил-2-хроманил)резорцинолбис(6-диазо-5,6-дихидро-5-оксонафтален-1-сулфонат) (2:1) | 414-770-4 | 140698-96-0 | Self-react. C **** | Carc. 2 | H242 | H351 | GHS02 | GHS08 | Dgr | H242 | H351 |   |   |  
016-094-00-1 | sulfur | 231-722-6 | 7704-34-9 | Skin Irrit. 2 | H315 | GHS07 | Wng | H315 |   |   |  016-094-00-1 | сяра | 231-722-6 | 7704-34-9 | Skin Irrit. 2 | H315 | GHS07 | Wng | H315 |   |   |  
016-095-00-7 | reaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2); | reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3) | 417-980-4 | — | Self-react. C **** | Carc. 2 | H242 | H351 | GHS02 | GHS08 | Dgr | H242 | H351 |   |   |  016-095-00-7 | реакционна маса от: реакционен продукт на 4,4′-метилeнбис[2-(4-хидроксибензил)-3,6-диметилфенол] и 6-диазо-5,6-дихидро-5-оксонафталенсулфонат (1:2); | реакционен продукт на 4,4′-метилeнбис[2-(4-хидроксибензил)-3,6-диметилфенол] и 6-диазо-5,6-дихидро-5-оксонафталенсулфонат (1:3) | 417-980-4 | — | Self-react. C **** | Carc. 2 | H242 | H351 | GHS02 | GHS08 | Dgr | H242 | H351 |   |   |  
016-096-00-2 | thifensulfuron-methyl (ISO); | methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate | — | 79277-27-3 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  016-096-00-2 | тифенсулфурон-метил (ISO); | метилов 3-(6-метил-4-метокси-1,3,5-триазин-2-илкарбамоилсулфамоил)тиофен-2-карбоксилат | — | 79277-27-3 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
016-097-00-8 | 1-amino-2-methyl-2-propanethiol hydrochloride | 434-480-1 | 32047-53-3 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H314 | H317 | H412 | GHS05 | GHS07 | Dgr | H302 | H314 | H317 | H412 |   |   |  016-097-00-8 | 1-амино-2-метил-2-пропантиол хидрохлорид | 434-480-1 | 32047-53-3 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H314 | H317 | H412 | GHS05 | GHS07 | Dgr | H302 | H314 | H317 | H412 |   |   |  
017-001-00-7 | chlorine | 231-959-5 | 7782-50-5 | Ox. Gas 1 | Press. Gas | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | H270 | H331 | H319 | H335 | H315 | H400 | GHS03 | GHS04 | GHS06 | GHS09 | Dgr | H270 | H331 | H319 | H335 | H315 | H400 |   | M = 100 | U017-001-00-7 | хлор | 231-959-5 | 7782-50-5 | Ox. Gas 1 | Press. Gas | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | H270 | H331 | H319 | H335 | H315 | H400 | GHS03 | GHS04 | GHS06 | GHS09 | Dgr | H270 | H331 | H319 | H335 | H315 | H400 |   | M = 100 | U
017-002-00-2 | hydrogen chloride | 231-595-7 | 7647-01-0 | Press. Gas | Acute Tox. 3 * | Skin Corr. 1A | H331 | H314 | GHS04 | GHS06 | GHS05 | Dgr | H331 | H314 |   |   | U5017-002-00-2 | водороден хлорид | 231-595-7 | 7647-01-0 | Press. Gas | Acute Tox. 3 * | Skin Corr. 1A | H331 | H314 | GHS04 | GHS06 | GHS05 | Dgr | H331 | H314 |   |   | U5
017-002-01-X | hydrochloric acid … % | 231-595-7 | — | Skin Corr. 1B | STOT SE 3 | H314 | H335 | GHS05 | GHS07 | Dgr | H314 | H335 |   | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % | EyeIrrit. 2; H319: 10 % ≤ C < 25 % | STOT SE 3; H335: C ≥ 10 % | B017-002-01-X | хлороводородна киселина … % | 231-595-7 | — | Skin Corr. 1B | STOT SE 3 | H314 | H335 | GHS05 | GHS07 | Dgr | H314 | H335 |   | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % | EyeIrrit. 2; H319: 10 % ≤ C < 25 % | STOT SE 3; H335: C ≥ 10 % | B
017-003-00-8 | barium chlorate | 236-760-7 | 13477-00-4 | Ox. Sol. 1 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 2 | H271 | H332 | H302 | H411 | GHS03 | GHS07 | GHS09 | Dgr | H271 | H332 | H302 | H411 |   |   |  017-003-00-8 | бариев хлорат | 236-760-7 | 13477-00-4 | Ox. Sol. 1 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 2 | H271 | H332 | H302 | H411 | GHS03 | GHS07 | GHS09 | Dgr | H271 | H332 | H302 | H411 |   |   |  
017-004-00-3 | potassium chlorate | 223-289-7 | 3811-04-9 | Ox. Sol. 1 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 2 | H271 | H332 | H302 | H411 | GHS03 | GHS07 | GHS09 | Dgr | H271 | H332 | H302 | H411 |   |   |  017-004-00-3 | калиев хлорат | 223-289-7 | 3811-04-9 | Ox. Sol. 1 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 2 | H271 | H332 | H302 | H411 | GHS03 | GHS07 | GHS09 | Dgr | H271 | H332 | H302 | H411 |   |   |  
017-005-00-9 | sodium chlorate | 231-887-4 | 7775-09-9 | Ox. Sol. 1 | Acute Tox. 4 * | Aquatic Chronic 2 | H271 | H302 | H411 | GHS03 | GHS07 | GHS09 | Dgr | H271 | H302 | H411 |   |   |  017-005-00-9 | натриев хлорат | 231-887-4 | 7775-09-9 | Ox. Sol. 1 | Acute Tox. 4 * | Aquatic Chronic 2 | H271 | H302 | H411 | GHS03 | GHS07 | GHS09 | Dgr | H271 | H302 | H411 |   |   |  
017-006-00-4 | perchloric acid … % | 231-512-4 | 7601-90-3 | Ox. Liq. 1 | Skin Corr. 1A | H271 | H314 | GHS03 | GHS05 | Dgr | H271 | H314 |   | Skin Corr. 1A; H314: C ≥ 50 % Skin Corr. 1B; H314: 10 % ≤ C < 50 % | Skin Irrit. 2; H315: 1 % ≤ C | < 10 % | Eye Irrit. 2; H319: 1 % ≤ C | < 10 % | Ox. Liq. 1; H271: C > 50 %: | Ox. Liq. 2; H272: C ≤ 50 %: | B017-006-00-4 | перхлорна киселина … % | 231-512-4 | 7601-90-3 | Ox. Liq. 1 | Skin Corr. 1A | H271 | H314 | GHS03 | GHS05 | Dgr | H271 | H314 |   | Skin Corr. 1A; H314: C ≥ 50 % Skin Corr. 1B; H314: 10 % ≤ C < 50 % | Skin Irrit. 2; H315: 1 % ≤ C | < 10 % | Eye Irrit. 2; H319: 1 % ≤ C | < 10 % | Ox. Liq. 1; H271: C > 50 %: | Ox. Liq. 2; H272: C ≤ 50 %: | B
017-007-00-X | barium perchlorate | 236-710-4 | 13465-95-7 | Ox. Sol. 1 | Acute Tox. 4 * | Acute Tox. 4 * | H271 | H332 | H302 | GHS03 | GHS07 | Dgr | H271 | H332 | H302 |   |   |  017-007-00-X | бариев перхлорат | 236-710-4 | 13465-95-7 | Ox. Sol. 1 | Acute Tox. 4 * | Acute Tox. 4 * | H271 | H332 | H302 | GHS03 | GHS07 | Dgr | H271 | H332 | H302 |   |   |  
017-008-00-5 | potassium perchlorate | 231-912-9 | 7778-74-7 | Ox. Sol. 1 | Acute Tox. 4 * | H271 | H302 | GHS03 | GHS07 | Dgr | H271 | H302 |   |   |  017-008-00-5 | калиев перхлорат | 231-912-9 | 7778-74-7 | Ox. Sol. 1 | Acute Tox. 4 * | H271 | H302 | GHS03 | GHS07 | Dgr | H271 | H302 |   |   |  
017-009-00-0 | ammonium perchlorate | 232-235-1 | 7790-98-9 | Expl. 1.1 | Ox. Sol. 1 | H201 | H271 | GHS01 | Dgr | H201 | H271 |   |   | T017-009-00-0 | амониев перхлорат | 232-235-1 | 7790-98-9 | Expl. 1.1 | Ox. Sol. 1 | H201 | H271 | GHS01 | Dgr | H201 | H271 |   |   | T
017-010-00-6 | sodium perchlorate | 231-511-9 | 7601-89-0 | Ox. Sol. 1 | Acute Tox. 4 * | H271 | H302 | GHS03 | GHS07 | Dgr | H271 | H302 |   |   |  017-010-00-6 | натриев перхлорат | 231-511-9 | 7601-89-0 | Ox. Sol. 1 | Acute Tox. 4 * | H271 | H302 | GHS03 | GHS07 | Dgr | H271 | H302 |   |   |  
017-011-00-1 | sodium hypochlorite, solution… % Cl active | 231-668-3 | 7681-52-9 | Skin Corr. 1B | Aquatic Acute 1 | H314 | H400 | GHS05 | GHS09 | Dgr | H314 | H400 | EUH031 | EUH031: C ≥5 % | B017-011-00-1 | разтвор на натриев хипохлорит… % Cl активен | 231-668-3 | 7681-52-9 | Skin Corr. 1B | Aquatic Acute 1 | H314 | H400 | GHS05 | GHS09 | Dgr | H314 | H400 | EUH031 | EUH031: C ≥5 % | B
017-012-00-7 | calcium hypochlorite | 231-908-7 | 7778-54-3 | Ox. Sol. 2 | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Acute 1 | H272 | H302 | H314 | H400 | GHS03 | GHS05 | GHS07 | GHS09 | Dgr | H272 | H302 | H314 | H400 | EUH031 | Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 1 % ≤ C | < 5 % | Eye Dam.1; H318: 3 % ≤ C | < 5 % | Eye Irrit. 2; H319: 0,5  % ≤ C < 3 % | M = 10 | T017-012-00-7 | калциев хипохлорит | 231-908-7 | 7778-54-3 | Ox. Sol. 2 | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Acute 1 | H272 | H302 | H314 | H400 | GHS03 | GHS05 | GHS07 | GHS09 | Dgr | H272 | H302 | H314 | H400 | EUH031 | Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 1 % ≤ C | < 5 % | Eye Dam.1; H318: 3 % ≤ C | < 5 % | Eye Irrit. 2; H319: 0,5  % ≤ C < 3 % | M = 10 | T
017-013-00-2 | calcium chloride | 233-140-8 | 10043-52-4 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  017-013-00-2 | калциев хлорид | 233-140-8 | 10043-52-4 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
017-014-00-8 | ammonium chloride | 235-186-4 | 12125-02-9 | Acute Tox. 4 * | Eye Irrit. 2 | H302 | H319 | GHS07 | Wng | H302 | H319 |   |   |  017-014-00-8 | амониев хлорид | 235-186-4 | 12125-02-9 | Acute Tox. 4 * | Eye Irrit. 2 | H302 | H319 | GHS07 | Wng | H302 | H319 |   |   |  
017-015-00-3 | (2-(aminomethyl)phenyl)acetylchloride hydrochloride | 417-410-4 | 61807-67-8 | Acute Tox. 4 * | Skin Corr. 1A | Skin Sens. 1 | H302 | H314 | H317 | GHS05 | GHS07 | Dgr | H302 | H314 | H317 |   |   |  017-015-00-3 | (2-(аминометил)фенил)ацетилхлорид хидрохлорид | 417-410-4 | 61807-67-8 | Acute Tox. 4 * | Skin Corr. 1A | Skin Sens. 1 | H302 | H314 | H317 | GHS05 | GHS07 | Dgr | H302 | H314 | H317 |   |   |  
017-016-00-9 | methyltriphenylphosphonium chloride | 418-400-2 | 1031-15-8 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 2 | H312 | H302 | H315 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H315 | H318 | H411 |   |   |  017-016-00-9 | метилтрифенилфосфониев хлорид | 418-400-2 | 1031-15-8 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 2 | H312 | H302 | H315 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H315 | H318 | H411 |   |   |  
017-017-00-4 | (Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride | 426-210-6 | 120086-58-0 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H400 | H410 | GHS05 | GHS09 | Dgr | H314 | H410 |   |   |  017-017-00-4 | (Z)-13-докозенил-N,N-бис(2-хидроксиетил)-N-метиламониев хлорид | 426-210-6 | 120086-58-0 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H400 | H410 | GHS05 | GHS09 | Dgr | H314 | H410 |   |   |  
017-018-00-X | N, N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride | 405-660-7 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  017-018-00-X | N,N,N-триметил-2,3-бис(стеароилокси)пропиламониев хлорид | 405-660-7 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
017-019-00-5 | (R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline hydrochloride | 415-110-8 | 54417-53-7 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  017-019-00-5 | (R)-1-вератрил-6,7-диметокси-1,2,3,4-тетрахидроизохинолинхидрохлорид | 415-110-8 | 54417-53-7 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
017-020-00-0 | ethyl propoxy aluminium chloride | 421-790-7 | 13014-29-4 | Water-react. 1 | Skin Corr. 1A | H260 | H314 | GHS02 | GHS05 | Dgr | H260 | H314 | EUH014 |   |  017-020-00-0 | етилпропоксиалуминиев хлорид | 421-790-7 | 13014-29-4 | Water-react. 1 | Skin Corr. 1A | H260 | H314 | GHS02 | GHS05 | Dgr | H260 | H314 | EUH014 |   |  
017-021-00-6 | behenamidopropyl-dimethyl-(dihydroxypropyl) ammonium chloride | 423-420-1 | 136920-10-0 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H410 |   |   |  017-021-00-6 | бехенамидопропилдиметил(дихидроксипропил)амониев хлорид | 423-420-1 | 136920-10-0 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H410 |   |   |  
017-023-00-7 | [phosphinyldynetris(oxy)] tris[3-aminopropyl-2-hydroxy-N, N-dimethyl-N-(C6-18)-alkyl] trichlorides | 425-520-9 | 197179-61-6 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  017-023-00-7 | [фосфинилдинтрис(окси)]трис[3-аминопропил-2-хидрокси-N, N-диметил-N-(C6-18)-алкилови] трихлориди | 425-520-9 | 197179-61-6 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  
017-026-00-3 | chlorine dioxide | 233-162-8 | 10049-04-4 | Press. Gas | Ox. Gas 1 | Acute Tox. 2 * | Skin Corr. 1B | Aquatic Acute 1 | H270 | H330 | H314 | H400 | GHS04 | GHS03 | GHS06 | GHS05 | GHS09 | Dgr | H270 | H330 | H314 | H400 |   | M = 10 | 5017-026-00-3 | хлорен диоксид | 233-162-8 | 10049-04-4 | Press. Gas | Ox. Gas 1 | Acute Tox. 2 * | Skin Corr. 1B | Aquatic Acute 1 | H270 | H330 | H314 | H400 | GHS04 | GHS03 | GHS06 | GHS05 | GHS09 | Dgr | H270 | H330 | H314 | H400 |   | M = 10 | 5
017-026-01-0 | chlorine dioxide … % | 233-162-8 | 10049-04-4 | Acute Tox. 3 * | Skin Corr. 1B | Aquatic Acute 1 | H301 | H314 | H400 | GHS06 | GHS05 | GHS09 | Dgr | H301 | H314 | H400 |   | Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 1 % ≤ C | < 5 % | Eye Dam.1; H318: 3 % ≤ C | < 5 % | Eye Irrit. 2; H319: 0,3  % ≤ C < 3 % | STOT SE 3; H335: C ≥ 3 % M = 10 | B017-026-01-0 | хлорен диоксид … % | 233-162-8 | 10049-04-4 | Acute Tox. 3 * | Skin Corr. 1B | Aquatic Acute 1 | H301 | H314 | H400 | GHS06 | GHS05 | GHS09 | Dgr | H301 | H314 | H400 |   | Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 1 % ≤ C | < 5 % | Eye Dam.1; H318: 3 % ≤ C | < 5 % | Eye Irrit. 2; H319: 0,3  % ≤ C < 3 % | STOT SE 3; H335: C ≥ 3 % M = 10 | B
019-001-00-2 | potassium | 231-119-8 | 7440-09-7 | Water-react. 1 | Skin Corr. 1B | H260 | H314 | GHS02 | GHS05 | Dgr | H260 | H314 | EUH014 |   |  019-001-00-2 | калий | 231-119-8 | 7440-09-7 | Water-react. 1 | Skin Corr. 1B | H260 | H314 | GHS02 | GHS05 | Dgr | H260 | H314 | EUH014 |   |  
019-002-00-8 | potassium hydroxide; | caustic potash | 215-181-3 | 1310-58-3 | Acute Tox. 4 * | Skin Corr. 1A | H302 | H314 | GHS05 | GHS07 | Dgr | H302 | H314 |   | Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314: 2 % ≤ C | < 5 % | Skin Irrit. 2; H315: 0,5  % ≤ C < 2 % | Eye Irrit. 2; H319: 0,5  % ≤ C < 2 % |  019-002-00-8 | калиев хидроксид; | калиева основа | 215-181-3 | 1310-58-3 | Acute Tox. 4 * | Skin Corr. 1A | H302 | H314 | GHS05 | GHS07 | Dgr | H302 | H314 |   | Skin Corr. 1A; H314: C ≥ 5 % Skin Corr. 1B; H314: 2 % ≤ C | < 5 % | Skin Irrit. 2; H315: 0,5  % ≤ C < 2 % | Eye Irrit. 2; H319: 0,5  % ≤ C < 2 % |  
020-001-00-X | calcium | 231-179-5 | 7440-70-2 | Water-react. 2 | H261 | GHS02 | Dgr | H261 |   |   |  020-001-00-X | калций | 231-179-5 | 7440-70-2 | Water-react. 2 | H261 | GHS02 | Dgr | H261 |   |   |  
020-002-00-5 | calcium cyanide | 209-740-0 | 592-01-8 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H410 | EUH032 |   |  020-002-00-5 | калциев цианид | 209-740-0 | 592-01-8 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H410 | EUH032 |   |  
020-003-00-0 | reaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide; | tri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide; | poly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide] | 420-470-4 | — | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   |   |  020-003-00-0 | реакционна маса от: дикалциев (бис(2-хидрокси-5-тетрапропенилфенилметил)метиламин)дихидроксид; | трикалциев (трис(2-хидрокси-5-тетрапропенилфенилметил)метиламин)трихидроксид; | поли[калциев ((2-хидрокси-5-тетрапропенилфенилметил)метиламин)хидроксид] | 420-470-4 | — | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   |   |  
022-001-00-5 | titanium tetrachloride | 231-441-9 | 7550-45-0 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 | EUH014 |   |  022-001-00-5 | титанов тетрахлорид | 231-441-9 | 7550-45-0 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 | EUH014 |   |  
022-002-00-0 | titanium(4+) oxalate | 403-260-7 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  022-002-00-0 | титанов(4+) oксалат | 403-260-7 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
022-003-00-6 | bis(η5-cyclopentadienyl)-bis(2,6-difluoro-3-[pyrrol-1-yl]-phenyl)titanium | 412-000-1 | 125051-32-3 | Flam. Sol. 1 | Repr. 2 | STOT RE 2 * | Aquatic Chronic 2 | H228 | H361f *** H373 ** | H411 | GHS02 | GHS08 | GHS09 | Dgr | H228 | H361f *** H373 ** H411 |   |   | T022-003-00-6 | бис(η5-циклопентадиенил)бис(2,6-дифлуоро-3-[пирол-1-ил]фенил)титан | 412-000-1 | 125051-32-3 | Flam. Sol. 1 | Repr. 2 | STOT RE 2 * | Aquatic Chronic 2 | H228 | H361f *** H373 ** | H411 | GHS02 | GHS08 | GHS09 | Dgr | H228 | H361f *** H373 ** H411 |   |   | T
022-004-00-1 | Potassium titanium oxide(K 2 Ti 6 O 13 ) | 432-240-0 | 12056-51-8 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  022-004-00-1 | калиев титанов оксид (K2Ti6O13) | 432-240-0 | 12056-51-8 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  
022-005-00-7 | [N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium | 419-840-8 | 169104-71-6 | Flam. Sol. 1**** | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 4 | H228 | H314 | H317 | H413 | GHS02 | GHS05 | GHS07 | Dgr | H228 | H314 | H317 | H413 |   |   |  022-005-00-7 | [N-(1,1-диметилетил)-1,1-диметил-1-[(1,2,3,4,5-η)-2,3,4,5-тетраметил-2,4-циклопентадиен-1-yl]силанаминато(2-)-κN][1,2,3,4-η)-1,3-пентадиен]титан | 419-840-8 | 169104-71-6 | Flam. Sol. 1**** | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 4 | H228 | H314 | H317 | H413 | GHS02 | GHS05 | GHS07 | Dgr | H228 | H314 | H317 | H413 |   |   |  
023-001-00-8 | divanadium pentaoxide; | vanadium pentoxide | 215-239-8 | 1314-62-1 | Muta. 2 | Repr. 2 | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 3 | Aquatic Chronic 2 | H341 | H361d *** H372 ** | H332 | H302 | H335 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H341 | H361d *** H372 ** | H332 | H302 | H335 | H411 |   |   |  023-001-00-8 | диванадиев пентаоксид; | ванадиев пентаоксид | 215-239-8 | 1314-62-1 | Muta. 2 | Repr. 2 | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 3 | Aquatic Chronic 2 | H341 | H361d *** H372 ** | H332 | H302 | H335 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H341 | H361d *** H372 ** | H332 | H302 | H335 | H411 |   |   |  
024-001-00-0 | chromium (VI) trioxide | 215-607-8 | 1333-82-0 | Ox. Sol. 1 | Carc. 1A | Muta. 1B Repr. 2 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | Skin Corr. 1A | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H271 | H350 | H340 | H361f *** H330 | H311 | H301 | H372 ** | H314 | H334 | H317 | H400 | H410 | GHS03 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H271 | H350 | H340 | H361f *** H330 | H311 | H301 | H372 ** | H314 | H334 | H317 | H410 |   | STOT SE 3; H335: C ≥ 1 % |  024-001-00-0 | хромен(VI) триоксид | 215-607-8 | 1333-82-0 | Ox. Sol. 1 | Carc. 1A | Muta. 1B Repr. 2 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | Skin Corr. 1A | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H271 | H350 | H340 | H361f *** H330 | H311 | H301 | H372 ** | H314 | H334 | H317 | H400 | H410 | GHS03 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H271 | H350 | H340 | H361f *** H330 | H311 | H301 | H372 ** | H314 | H334 | H317 | H410 |   | STOT SE 3; H335: C ≥ 1 % |  
024-002-00-6 | potassium dichromate | 231-906-6 | 7778-50-9 | Ox. Sol. 2 | Carc. 1B | Muta. 1B | Repr. 1B | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 1 | Acute Tox. 4 * | Skin Corr. 1B | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H272 | H350 | H340 | H360FD | H330 | H301 | H372 ** | H312 | H314 | H334 | H317 | H400 | H410 | GHS03 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H272 | H350 | H340 | H360FD | H330 | H301 | H372 ** | H312 | H314 | H334 | H317 | H410 |   | STOT SE 3; H335: C ≥ 5 % | 3024-002-00-6 | калиев дихромат | 231-906-6 | 7778-50-9 | Ox. Sol. 2 | Carc. 1B | Muta. 1B | Repr. 1B | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 1 | Acute Tox. 4 * | Skin Corr. 1B | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H272 | H350 | H340 | H360FD | H330 | H301 | H372 ** | H312 | H314 | H334 | H317 | H400 | H410 | GHS03 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H272 | H350 | H340 | H360FD | H330 | H301 | H372 ** | H312 | H314 | H334 | H317 | H410 |   | STOT SE 3; H335: C ≥ 5 % | 3
024-003-00-1 | ammonium dichromate | 232-143-1 | 7789-09-5 | Ox. Sol. 2 **** | Carc. 1B | Muta. 1B | Repr. 1B | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 1 | Acute Tox. 4 * | Skin Corr. 1B | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H272 | H350 | H340 | H360FD | H330 | H301 | H372 ** | H312 | H314 | H334 | H317 | H400 | H410 | GHS03 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H272 | H350 | H340 | H360FD | H330 | H301 | H372 ** | H312 | H314 | H334 | H317 | H410 |   | STOT SE 3; H335: C ≥ 5 % | Resp. Sens.; H334: C ≥0,2  % | Skin Sens.; H317:C ≥0,2  % | G3024-003-00-1 | амониев дихромат | 232-143-1 | 7789-09-5 | Ox. Sol. 2 **** | Carc. 1B | Muta. 1B | Repr. 1B | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 1 | Acute Tox. 4 * | Skin Corr. 1B | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H272 | H350 | H340 | H360FD | H330 | H301 | H372 ** | H312 | H314 | H334 | H317 | H400 | H410 | GHS03 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H272 | H350 | H340 | H360FD | H330 | H301 | H372 ** | H312 | H314 | H334 | H317 | H410 |   | STOT SE 3; H335: C ≥ 5 % | Resp. Sens.; H334: C ≥0,2  % | Skin Sens.; H317:C ≥0,2  % | G3
024-004-00-7 | sodium dichromate | 234-190-3 | 10588-01-9 | Ox. Sol. 2 | Carc. 1B | Muta. 1B | Repr. 1B | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 1 | Skin Corr. 1B | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H272 | H350 | H340 | H360FD | H330 | H301 | H312 | H372** | H314 | H334 | H317 | H400 | H410 | GHS03 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H272 | H350 | H340 | H360FD | H330 | H301 | H312 | H372** | H314 | H334 | H317 | H410 |   | Resp. Sens. 1; H334: C ≥ 0,2  % | Skin Sens. 1; H317:C ≥0,2  % | STOT SE 3; H335: C ≥ 5 % | 3024-004-00-7 | натриев дихромат | 234-190-3 | 10588-01-9 | Ox. Sol. 2 | Carc. 1B | Muta. 1B | Repr. 1B | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 1 | Skin Corr. 1B | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H272 | H350 | H340 | H360FD | H330 | H301 | H312 | H372** | H314 | H334 | H317 | H400 | H410 | GHS03 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H272 | H350 | H340 | H360FD | H330 | H301 | H312 | H372** | H314 | H334 | H317 | H410 |   | Resp. Sens. 1; H334: C ≥ 0,2  % | Skin Sens. 1; H317:C ≥0,2  % | STOT SE 3; H335: C ≥ 5 % | 3
024-005-00-2 | chromyl dichloride; | chromic oxychloride | 239-056-8 | 14977-61-8 | Ox. Liq. 1 | Carc. 1B | Muta. 1B | Skin Corr. 1A | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H271 | H350i | H340 | H314 | H317 | H400 | H410 | GHS03 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H271 | H350i | H340 | H314 | H317 | H410 |   | Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 5 % ≤ C | < 10 % | Skin Irrit. 2; H315: 0,5  % ≤ | C < 5 % | Eye Irrit. 2; H319: 0,5  % ≤ | C < 5 % | STOT SE 3; H335: 0,5  % ≤ C < 5 % | Skin Sens. 1; H317: C ≥ 0,5  % | T3024-005-00-2 | хромилдихлорид; | хромен оксихлорид | 239-056-8 | 14977-61-8 | Ox. Liq. 1 | Carc. 1B | Muta. 1B | Skin Corr. 1A | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H271 | H350i | H340 | H314 | H317 | H400 | H410 | GHS03 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H271 | H350i | H340 | H314 | H317 | H410 |   | Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 5 % ≤ C | < 10 % | Skin Irrit. 2; H315: 0,5  % ≤ | C < 5 % | Eye Irrit. 2; H319: 0,5  % ≤ | C < 5 % | STOT SE 3; H335: 0,5  % ≤ C < 5 % | Skin Sens. 1; H317: C ≥ 0,5  % | T3
024-006-00-8 | potassium chromate | 232-140-5 | 7789-00-6 | Carc. 1B | Muta. 1B | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H340 | H319 | H335 | H315 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H340 | H319 | H335 | H315 | H317 | H410 |   | Skin Sens. 1; H317:C ≥ 0,5  % | 3024-006-00-8 | калиев хромат | 232-140-5 | 7789-00-6 | Carc. 1B | Muta. 1B | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H340 | H319 | H335 | H315 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H340 | H319 | H335 | H315 | H317 | H410 |   | Skin Sens. 1; H317:C ≥ 0,5  % | 3
024-007-00-3 | zinc chromates including zinc potassium chromate | — | — | Carc. 1A | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H302 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H317 | H410 |   |   | A024-007-00-3 | цинкови хромати, включително калиев цинков хромат | — | — | Carc. 1A | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H302 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H317 | H410 |   |   | A
024-008-00-9 | calcium chromate | 237-366-8 | 13765-19-0 | Carc. 1B | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H410 |   |   |  024-008-00-9 | калциев хромат | 237-366-8 | 13765-19-0 | Carc. 1B | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H410 |   |   |  
024-009-00-4 | strontium chromate | 232-142-6 | 7789-06-2 | Carc. 1B | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H400 | H410 |   |   |  024-009-00-4 | стронциев хромат | 232-142-6 | 7789-06-2 | Carc. 1B | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H400 | H410 |   |   |  
024-010-00-X | dichromium tris(chromate); | chromium III chromate; | chromic chromate | 246-356-2 | 24613-89-6 | Ox. Sol. 1 | Carc. 1B | Skin Corr. 1A | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H271 | H350 | H314 | H317 | H400 | H410 | GHS03 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H271 | H350 | H314 | H317 | H410 |   |   | T024-010-00-X | дихромен трис(хромат); | хромен(III) хромат; | хромен хромат | 246-356-2 | 24613-89-6 | Ox. Sol. 1 | Carc. 1B | Skin Corr. 1A | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H271 | H350 | H314 | H317 | H400 | H410 | GHS03 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H271 | H350 | H314 | H317 | H410 |   |   | T
024-011-00-5 | ammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-) | 400-110-2 | 109125-51-1 | Self-react. C **** | Aquatic Acute 1 | Aquatic Chronic 1 | H242 | H400 | H410 | GHS02 | GHS09 | Dgr | H242 | H410 |   |   |  024-011-00-5 | амониев бис(1-(3,5-динитро-2-oксидофенилазо)-3-(N-фенилкарбамоил)-2-нафтолато)хромат(1-) | 400-110-2 | 109125-51-1 | Self-react. C **** | Aquatic Acute 1 | Aquatic Chronic 1 | H242 | H400 | H410 | GHS02 | GHS09 | Dgr | H242 | H410 |   |   |  
024-012-00-0 | trisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-) | 400-810-8 | — | Muta. 2 | H341 | GHS08 | Wng | H341 |   |   |  024-012-00-0 | тринатриев бис(7-aцетамидо-2-(4-нитро-2-oксидофенилазо)-3-сулфонато-1-нафтолато)хромат(1-) | 400-810-8 | — | Muta. 2 | H341 | GHS08 | Wng | H341 |   |   |  
024-013-00-6 | trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-) | 402-500-8 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  024-013-00-6 | тринатриев-(6-aнилино-2-(5-нитро-2-oксидофенилaзо)-3-сулфонато-1-нафтолато)-4-сулфонато-1,1′-aзоди-2,2′-нафтолато)хромат(1-) | 402-500-8 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  
024-014-00-1 | trisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-) | 402-870-0 | 93952-24-0 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  024-014-00-1 | тринатриев бис(2-(4-нитро-2-oксидо-5-хлорофенилaзо)5-сулфонато-1-нафтолато)хромат(1-) | 402-870-0 | 93952-24-0 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
024-015-00-7 | disodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-) | 404-930-1 | — | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H332 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H332 | H318 | H411 |   |   |  024-015-00-7 | динатриев (3-метил-4-(5-нитро-2-oксидофенилазо)-1-фенилпиразололато)(1-(3-нитро-2-oксидо-5-сулфонатофенилазо)-2-нафтолато)хромат(1-) | 404-930-1 | — | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H332 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H332 | H318 | H411 |   |   |  
024-016-00-2 | tetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-) | 405-110-6 | 88377-66-6 | STOT RE 2 * | Aquatic Chronic 4 | H373 ** | H413 | GHS08 | Wng | H373 ** | H413 |   |   |  024-016-00-2 | тeтрадециламониев бис(1-(2-oксидо-5-хлорофенилазо)-2-нафтолато)хромат(1-) | 405-110-6 | 88377-66-6 | STOT RE 2 * | Aquatic Chronic 4 | H373 ** | H413 | GHS08 | Wng | H373 ** | H413 |   |   |  
024-017-00-8 | chromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this Annex | — | — | Carc. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H317 | H410 |   |   | A024-017-00-8 | съединения на хром(VI), с изключение на бариев хромат и на съединения, посочени другаде в настоящото приложение | — | — | Carc. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H317 | H410 |   |   | A
024-018-00-3 | sodium chromate | 231-889-5 | 7775-11-3 | Carc. 1B | Muta. 1B | Repr. 1B | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 1 | Acute Tox. 4 * | Skin Corr. 1B | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H340 | H360FD | H330 | H301 | H372 ** | H312 | H314 | H334 | H317 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H350 | H340 | H360FD | H330 | H301 | H372 ** | H312 | H314 | H334 | H317 | H410 |   | Resp. Sens.; | H334: C ≥ 0,2  % | Skin Sens.; H317:C ≥ 0,2  % | 3024-018-00-3 | натриев хромат | 231-889-5 | 7775-11-3 | Carc. 1B | Muta. 1B | Repr. 1B | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 1 | Acute Tox. 4 * | Skin Corr. 1B | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H340 | H360FD | H330 | H301 | H372 ** | H312 | H314 | H334 | H317 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H350 | H340 | H360FD | H330 | H301 | H372 ** | H312 | H314 | H334 | H317 | H410 |   | Resp. Sens.; | H334: C ≥ 0,2  % | Skin Sens.; H317:C ≥ 0,2  % | 3
024-019-00-9 | Main component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}chromate (III); by-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfonyl)-3''-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III); | by-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III) | 419-230-1 | — | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  024-019-00-9 | Основен компонент: анилид на ацетоцетната киселина/3-амино-1-хидроксибензен (ATAN-MAP): тринатриев {6-[(2 или 3 или 4)-амино-(4 или 5 или 6)- хидроксифенилазо]-5′-(фенилсулфамоил)-3-сулфонатонафтален-2-азобензен-1,2′-диoлато}{6″-[1-(фенилкарбамоил)етилазо]-5′-(фенилсулфамоил)-3-сулфонатонафтален-2″-азобензен-1′′,2′′′-диoлато}хромат(III); страничен продукт 1: анилид на ацетоцетната киселина / анилид на ацетоцетната киселина (ATAN-ATAN): тринатриев бис{6-[1-(фенилкарбамоил)етилазо]-5′′′-(фенилсулфонил)-3′′-сулфонатонафтален-2-азобензен-1,2′-диoлато}хромат(III); | страничен продукт 2: 3-амино-1-хидроксибензен/3-амино-1-хидроксибензен (MAP-MAP): тринатриев бис{6-[(2 или 3 или 4)-амино-(4 или 5 или 6)-хидроксифенилазо]-5′-(фенилсулфамоил)-3-сулфонатонафтален-2-азобензен-1,2′-диолато}хромат(III) | 419-230-1 | — | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
024-020-00-4 | trisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate(III) | 418-220-4 | — | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  024-020-00-4 | тринатриев бис[(3′-нитро-5′-сулфонато(6-амино-2-[4-(2-хидрокси-1-нафтилазо)фенилсулфониламино]пиримидин-5-азо)бензен-2′,4-диoлатo)]хромат(III) | 418-220-4 | — | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
024-021-00-X | potassium tetrasodium bis[(N,N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzeneazo-1'-prop-1'-ene-2,2'-diolato]chromate(III) | 425-830-4 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  024-021-00-X | тетранатриев калиев бис[(N,N′-n)-1′-(фенилкарбамоил)-3,5-дисулфонатобензеназо-1′-проп-1′-ен-2,2′-диолато]хромат(III) | 425-830-4 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
025-001-00-3 | manganese dioxide | 215-202-6 | 1313-13-9 | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H302 | GHS07 | Wng | H332 | H302 |   |   |  025-001-00-3 | мaнганов диоксид | 215-202-6 | 1313-13-9 | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H302 | GHS07 | Wng | H332 | H302 |   |   |  
025-002-00-9 | potassium permanganate | 231-760-3 | 7722-64-7 | Ox. Sol. 2 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H272 | H302 | H400 | H410 | GHS03 | GHS07 | GHS09 | Dgr | H272 | H302 | H410 |   |   |  025-002-00-9 | калиев перманганат | 231-760-3 | 7722-64-7 | Ox. Sol. 2 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H272 | H302 | H400 | H410 | GHS03 | GHS07 | GHS09 | Dgr | H272 | H302 | H410 |   |   |  
025-003-00-4 | manganese sulphate | 232-089-9 | 7785-87-7 | STOT RE 2 * | Aquatic Chronic 2 | H373 ** | H411 | GHS08 | GHS09 | Wng | H373 ** H411 |   |   |  025-003-00-4 | мaнганов сулфат | 232-089-9 | 7785-87-7 | STOT RE 2 * | Aquatic Chronic 2 | H373 ** | H411 | GHS08 | GHS09 | Wng | H373 ** H411 |   |   |  
025-004-00-X | bis(N, N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate | 411-760-1 | 116633-53-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  025-004-00-X | бис(N,N′,N′′-триметил-1,4,7-триазациклононан)триоксодиманганов(IV) ди(хексафлуорофосфат) монохидрат | 411-760-1 | 116633-53-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
025-005-00-5 | reaction mass of: tri-sodium [29H, 31H-phthalocyanine-C, C,C-trisulfonato (6-)-N29, N30, N31, N32] manganate (3-); tetrasodium [29H, 31H-phthalocyanine-C, C,C, C-tetrasulfonato(6-)-N29, N30, N31, N32], manganate (3-); | pentasodium [29H, 31H-phthalocyanine-C, C,C, C,C-pentasulfonato (6-)-N29, N30, N31, N32] manganate (3-) | 417-660-4 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  025-005-00-5 | реакционна маса от: тринатриев [29H,31H-фталоцианин-C, C,C-трисулфонато(6-)-N29,N30,N31,N32]манганат(3-); тетранатриев [29H,31H-фталоцианин-C, C,C, C-тетрасулфонато(6-)-N29,N30,N31,N32]манганат(3-); | пентанатриев [29H,31H-фталоцианин-C, C,C, C,C-пентасулфонато(6-)-N29,N30,N31,N32]манганат(3-) | 417-660-4 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
026-001-00-6 | (η-cumene)-(η-cyclopentadienyl)iron(II) hexafluoroantimonate | 407-840-0 | 100011-37-8 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  026-001-00-6 | (η-кумен)- (η-циклопентадиенил)железен(II) хексафлуороантимонат | 407-840-0 | 100011-37-8 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  
026-002-00-1 | (η-cumene)-(η-cyclopentadienyl)iron(II) trifluoromethane-sulfonate | 407-880-9 | 117549-13-0 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  026-002-00-1 | (η-кумен)-(η-циклопентадиенил)железен(II) трифлуорометансулфонат | 407-880-9 | 117549-13-0 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
026-003-00-7 | iron (II) sulfate | 231-753-5 | 7720-78-7 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | H302 | H319 | H315 | GHS07 | Wng | H302 | H319 | H315 |   |   |  026-003-00-7 | железен(II) сулфат | 231-753-5 | 7720-78-7 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | H302 | H319 | H315 | GHS07 | Wng | H302 | H319 | H315 |   |   |  
026-003-01-4 | iron (II) sulfate (1:1) heptahydrate; sulfuric acid, iron(II) salt (1:1), heptahydrate; | ferrous sulfate heptahydrate | 231-753-5 | 7782-63-0 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | H302 | H319 | H315 | GHS07 | Wng | H302 | H319 | H315 |   | Skin Irrit.2; H315: C ≥ 25 % |  026-003-01-4 | железен(II) сулфат (1:1) хептахидрат; сярна киселина, желязна(II) сол (1:1), хептахидрат; | феросулфат хептахидрат | 231-753-5 | 7782-63-0 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | H302 | H319 | H315 | GHS07 | Wng | H302 | H319 | H315 |   | Skin Irrit.2; H315: C ≥ 25 % |  
026-004-00-2 | potassium ferrite | 430-010-4 | 12160-44-0 | Skin Corr. 1B | Skin Sens. 1 | H314 | H317 | GHS05 | GHS07 | Dgr | H314 | H317 |   |   |  026-004-00-2 | калиев ферит | 430-010-4 | 12160-44-0 | Skin Corr. 1B | Skin Sens. 1 | H314 | H317 | GHS05 | GHS07 | Dgr | H314 | H317 |   |   |  
027-001-00-9 | cobalt | 231-158-0 | 7440-48-4 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Chronic 4 | H334 | H317 | H413 | GHS08 | Dgr | H334 | H317 | H413 |   |   |  027-001-00-9 | кобалт | 231-158-0 | 7440-48-4 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Chronic 4 | H334 | H317 | H413 | GHS08 | Dgr | H334 | H317 | H413 |   |   |  
027-002-00-4 | cobalt oxide | 215-154-6 | 1307-96-6 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   | M=10 |  027-002-00-4 | кобалтов оксид | 215-154-6 | 1307-96-6 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   | M=10 |  
027-003-00-X | cobalt sulfide | 215-273-3 | 1317-42-6 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   | M=10 |  027-003-00-X | кобалтов сулфид | 215-273-3 | 1317-42-6 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   | M=10 |  
027-004-00-5 | cobalt dichloride | 231-589-4 | 7646-79-9 | Carc. 1B | Muta. 2 | Repr. 1B | Acute Tox. 4 * | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360F*** H302 | H334 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H341 | H360F*** H302 | H334 | H317 | H410 |   | Carc. 1B; H350i: C ≥ 0,01  % M=10 | 1027-004-00-5 | кобалтов дихлорид | 231-589-4 | 7646-79-9 | Carc. 1B | Muta. 2 | Repr. 1B | Acute Tox. 4 * | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360F*** H302 | H334 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H341 | H360F*** H302 | H334 | H317 | H410 |   | Carc. 1B; H350i: C ≥ 0,01  % M=10 | 1
027-005-00-0 | cobalt sulfate | 233-334-2 | 10124-43-3 | Carc. 1B | Muta. 2 | Repr. 1B | Acute Tox. 4 * | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360F*** H302 | H334 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H341 | H360F*** H302 | H334 | H317 | H410 |   | Carc. 1B; H350i: C ≥ 0,01  % M=10 | 1027-005-00-0 | кобалтов сулфат | 233-334-2 | 10124-43-3 | Carc. 1B | Muta. 2 | Repr. 1B | Acute Tox. 4 * | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360F*** H302 | H334 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H341 | H360F*** H302 | H334 | H317 | H410 |   | Carc. 1B; H350i: C ≥ 0,01  % M=10 | 1
027-006-00-6 | cobalt di(acetate) | 200-755-8 | 71-48-7 | Carc. 1B | Muta. 2 | Repr. 1B | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360F*** H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360F*** H334 | H317 | H410 |   | Carc. 1B; H350i: C ≥ 0,01  % | M = 10 | 1027-006-00-6 | кобалтов ди(ацетат) | 200-755-8 | 71-48-7 | Carc. 1B | Muta. 2 | Repr. 1B | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360F*** H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360F*** H334 | H317 | H410 |   | Carc. 1B; H350i: C ≥ 0,01  % | M = 10 | 1
027-007-00-1 | zinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex | 425-240-7 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  027-007-00-1 | цинков хексацианокобалтат(III), комплекс третичен бутилов алкохол/полипропиленгликол | 425-240-7 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  
027-008-00-7 | complex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated(n H2O,2<n<3) | 427-390-9 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  027-008-00-7 | комплекс от кобалт(III)-бис(N-фенил-4-(5-етилсулфонил-2-хидроксифенилазо)-3-хидроксинафтиламид, хидратиран (n H2O, 2<n<3) | 427-390-9 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
027-009-00-2 | cobalt dinitrate | 233-402-1 | 10141-05-6 | Carc. 1B | Muta. 2 | Repr. 1B | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360F*** H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360F*** H334 | H317 | H410 |   | Carc. 1B; H350i: C ≥ 0,01  % | M = 10 | 1027-009-00-2 | кобалтов динитрат | 233-402-1 | 10141-05-6 | Carc. 1B | Muta. 2 | Repr. 1B | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360F*** H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360F*** H334 | H317 | H410 |   | Carc. 1B; H350i: C ≥ 0,01  % | M = 10 | 1
027-010-00-8 | cobalt carbonate | 208-169-4 | 513-79-1 | Carc. 1B | Muta. 2 | Repr. 1B | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360F*** H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360F*** H334 | H317 | H410 |   | Carc. 1B; H350i: C ≥ 0,01  % M=10 | 1027-010-00-8 | кобалтов карбонат | 208-169-4 | 513-79-1 | Carc. 1B | Muta. 2 | Repr. 1B | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360F*** H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360F*** H334 | H317 | H410 |   | Carc. 1B; H350i: C ≥ 0,01  % M=10 | 1
028-001-00-1 | tetracarbonylnickel; | nickel tetracarbonyl | 236-669-2 | 13463-39-3 | Flam. Liq. 2 | Carc. 2 | Repr. 1B | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H225 | H351 | H360D *** H330 | H400 | H410 | GHS02 | GHS06 | GHS08 | GHS09 | Dgr | H225 | H351 | H360D *** H330 | H410 |   |   |  028-001-00-1 | тeтракарбонилникел; | никелов тетракарбонил | 236-669-2 | 13463-39-3 | Flam. Liq. 2 | Carc. 2 | Repr. 1B | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H225 | H351 | H360D *** H330 | H400 | H410 | GHS02 | GHS06 | GHS08 | GHS09 | Dgr | H225 | H351 | H360D *** H330 | H410 |   |   |  
028-002-00-7 | nickel | 231-111-4 | 7440-02-0 | Carc. 2 | STOT RE 1 | Skin Sens. 1 | H351 | H372** | H317 | GHS08 | GHS07 | Dgr | H351 | H372** | H317 |   |   | S7028-002-00-7 | никел | 231-111-4 | 7440-02-0 | Carc. 2 | STOT RE 1 | Skin Sens. 1 | H351 | H372** | H317 | GHS08 | GHS07 | Dgr | H351 | H372** | H317 |   |   | S7
028-002-01-4 | nickel powder; | [particle diameter < 1mm] | 231-111-4 | 7440-02-0 | Carc. 2 | STOT RE 1 | Skin Sens. 1 | Aquatic Chronic 3 | H351 | H372** | H317 | H412 | GHS08 | GHS07 | Dgr | H351 | H372** | H317 | H412 |   |   |  028-002-01-4 | никел на прах; | [диаметър на частицата < 1 mm] | 231-111-4 | 7440-02-0 | Carc. 2 | STOT RE 1 | Skin Sens. 1 | Aquatic Chronic 3 | H351 | H372** | H317 | H412 | GHS08 | GHS07 | Dgr | H351 | H372** | H317 | H412 |   |   |  
028-003-00-2 | nickel monoxide; [1] | nickel oxide; [2] | bunsenite [3] | 215-215-7[1] | 234-323-5[2]-[3] | 1313-99-1 [1] | 11099-02-8 [2] | 34492-97-2 [3] | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Chronic 4 | H350i | H372** | H317 | H413 | GHS08 | GHS07 | Dgr | H350i | H372** | H317 | H413 |   |   |  028-003-00-2 | никелов моноксид; [1] | никелов оксид; [2] | бунзенит [3] | 215-215-7[1] | 234-323-5[2]-[3] | 1313-99-1 [1] | 11099-02-8 [2] | 34492-97-2 [3] | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Chronic 4 | H350i | H372** | H317 | H413 | GHS08 | GHS07 | Dgr | H350i | H372** | H317 | H413 |   |   |  
028-004-00-8 | nickel dioxide | 234-823-3 | 12035-36-8 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Chronic 4 | H350i | H372** | H317 | H413 | GHS08 | GHS07 | Dgr | H350i | H372** | H317 | H413 |   |   |  028-004-00-8 | никелов диоксид | 234-823-3 | 12035-36-8 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Chronic 4 | H350i | H372** | H317 | H413 | GHS08 | GHS07 | Dgr | H350i | H372** | H317 | H413 |   |   |  
028-005-00-3 | dinickel trioxide | 215-217-8 | 1314-06-3 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Chronic 4 | H350i | H372** | H317 | H413 | GHS08 | GHS07 | Dgr | H350i | H372** | H317 | H413 |   |   |  028-005-00-3 | диникелов триоксид | 215-217-8 | 1314-06-3 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Chronic 4 | H350i | H372** | H317 | H413 | GHS08 | GHS07 | Dgr | H350i | H372** | H317 | H413 |   |   |  
028-006-00-9 | nickel (II) sulfide; [1] | nickel sulfide; [2] | millerite [3] | 240-841-2[1] | 234-349-7[2]-[3] | 16812-54-7 [1] | 11113-75-0 [2] | 1314-04-1 [3] | Carc. 1A | Muta. 2 | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H341 | H372** | H317 | H410 |   |   |  028-006-00-9 | никелов(II) сулфид; [1] | никелов сулфид; [2] | милерит [3] | 240-841-2[1] | 234-349-7[2]-[3] | 16812-54-7 [1] | 11113-75-0 [2] | 1314-04-1 [3] | Carc. 1A | Muta. 2 | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H341 | H372** | H317 | H410 |   |   |  
028-007-00-4 | trinickel disulfide; | nickel subsulfide; [1] | heazlewoodite [2] | 234-829-6[1] | -[2] | 12035-72-2 [1] | 12035-71-1 [2] | Carc. 1A | Muta. 2 | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H341 | H372** H317 | H410 |   |   |  028-007-00-4 | триникелов дисулфид; | никелов субсулфид; [1] | хийзълвудит [2] | 234-829-6[1] | -[2] | 12035-72-2 [1] | 12035-71-1 [2] | Carc. 1A | Muta. 2 | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H341 | H372** H317 | H410 |   |   |  
028-008-00-X | nickel dihydroxide; [1] | nickel hydroxide [2] | 235-008-5 [1] | 234-348-1 [2] | 12054-48-7 [1] | 11113-74-9 [2] | Carc. 1A | Repr. 1B | Muta. 2 | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i H360D*** H341 | H372** | H332 | H302 | H315 | H334 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i H360D*** H341 | H372** | H332 | H302 | H315 | H334 | H317 | H410 |   |   |  028-008-00-X | никелов дихидроксид; [1] | никелов хидроксид [2] | 235-008-5 [1] | 234-348-1 [2] | 12054-48-7 [1] | 11113-74-9 [2] | Carc. 1A | Repr. 1B | Muta. 2 | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i H360D*** H341 | H372** | H332 | H302 | H315 | H334 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i H360D*** H341 | H372** | H332 | H302 | H315 | H334 | H317 | H410 |   |   |  
028-009-00-5 | nickel sulfate | 232-104-9 | 7786-81-4 | Carc. 1A | Muta. 2 | Repr. 1B | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H332 | H302 | H315 | H334 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H341 | H360D*** H372** H332 | H302 | H315 | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % | STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Irrit. 2; H315: C ≥ 20 % | Skin Sens. 1; H317: C ≥ | 0,01  % | M = 1 |  028-009-00-5 | никелов сулфат | 232-104-9 | 7786-81-4 | Carc. 1A | Muta. 2 | Repr. 1B | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H332 | H302 | H315 | H334 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H341 | H360D*** H372** H332 | H302 | H315 | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % | STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Irrit. 2; H315: C ≥ 20 % | Skin Sens. 1; H317: C ≥ | 0,01  % | M = 1 |  
028-010-00-0 | nickel carbonate; | basic nickel carbonate; | carbonic acid, nickel (2+) salt; [1] | carbonic acid, nickel salt; [2] | [μ-[carbonato(2-)-O:O']]dihydroxy trinickel; [3] | [carbonato(2-)] tetrahydroxytrinickel [4] | 222-068-2 [1] | 240-408-8 [2] | 265-748-4 [3] | 235-715-9 [4] | 3333-67-3 [1] | 16337-84-1 [2] | 65405-96-1 [3] | 12607-70-4 [4] | Carc. 1A | Muta. 2 | Repr. 1B | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H332 | H302 | H315 | H334 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H332 | H302 | H315 | H334 | H317 | H410 |   |   |  028-010-00-0 | никелов карбонат; | основен никелов карбонат; | никелова(2+) сол на въглеродната киселина; [1] | никелова сол на въглеродната киселина; [2] | [μ-[карбонато(2-)-O:O’]]дихидрокситриникел; [3] | [карбонато(2-)]тетрахидрокситриникел [4] | 222-068-2 [1] | 240-408-8 [2] | 265-748-4 [3] | 235-715-9 [4] | 3333-67-3 [1] | 16337-84-1 [2] | 65405-96-1 [3] | 12607-70-4 [4] | Carc. 1A | Muta. 2 | Repr. 1B | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H332 | H302 | H315 | H334 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H332 | H302 | H315 | H334 | H317 | H410 |   |   |  
028-011-00-6 | nickel dichloride | 231-743-0 | 7718-54-9 | Carc. 1A Muta. 2 | Repr. 1B | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H331 | H301 | H372** | H315 | H334 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H331 | H301 | H372** | H315 | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % | STOT RE 2; H373: 0,1  % < C < 1 % | Skin Irrit. 2; H315: C ≥ 20 % | Skin Sens. 1; H317: C ≥ 0,01  % | M = 1 |  028-011-00-6 | никелов дихлорид | 231-743-0 | 7718-54-9 | Carc. 1A Muta. 2 | Repr. 1B | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H331 | H301 | H372** | H315 | H334 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H331 | H301 | H372** | H315 | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % | STOT RE 2; H373: 0,1  % < C < 1 % | Skin Irrit. 2; H315: C ≥ 20 % | Skin Sens. 1; H317: C ≥ 0,01  % | M = 1 |  
028-012-00-1 | nickel dinitrate; [1] | nitric acid, nickel salt [2] | 236-068-5 [1] | 238-076-4 [2] | 13138-45-9 [1] | 14216-75-2 [2] | Ox. Sol. 2 | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H272 | H350i | H341 | H360D*** H372** | H332 | H302 | H315 | H318 | H334 | H317 | H400 | H410 | GHS03 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H272 | H350i | H341 | H360D*** H372** | H332 | H302 | H315 | H318 | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % | STOT RE 2; H373: 0,1  % < C < 1 % | Skin Irrit. 2; H315: C ≥ 20 % | Skin Sens. 1; H317 C ≥0,01  % | M = 1 |  028-012-00-1 | никелов динитрат; [1] | никелова сол на азотната киселина [2] | 236-068-5 [1] | 238-076-4 [2] | 13138-45-9 [1] | 14216-75-2 [2] | Ox. Sol. 2 | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H272 | H350i | H341 | H360D*** H372** | H332 | H302 | H315 | H318 | H334 | H317 | H400 | H410 | GHS03 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H272 | H350i | H341 | H360D*** H372** | H332 | H302 | H315 | H318 | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % | STOT RE 2; H373: 0,1  % < C < 1 % | Skin Irrit. 2; H315: C ≥ 20 % | Skin Sens. 1; H317 C ≥0,01  % | M = 1 |  
028-013-00-7 | nickel matte | 273-749-6 | 69012-50-6 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i H372** | H317 | H410 |   |   |  028-013-00-7 | никелов щайн | 273-749-6 | 69012-50-6 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i H372** | H317 | H410 |   |   |  
028-014-00-2 | slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate | 295-859-3 | 92129-57-2 | Carc. 1A | Muta. 2 | Repr. 1B | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H332 | H302 | H315 | H334 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H332 | H302 | H315 | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1  % ≤ C < % | Skin Sens. 1; H317:C ≥ 0,01  % | M=1 |  028-014-00-2 | шламове и утайки, електролитно рафиниране на мед, обезмедени, никелов сулфат | 295-859-3 | 92129-57-2 | Carc. 1A | Muta. 2 | Repr. 1B | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H332 | H302 | H315 | H334 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H332 | H302 | H315 | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1  % ≤ C < % | Skin Sens. 1; H317:C ≥ 0,01  % | M=1 |  
028-015-00-8 | slimes and sludges, copper electrolyte refining, decopperised | 305-433-1 | 94551-87-8 | Carc. 1A Muta. 2 | Repr. 1A | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   |   |  028-015-00-8 | шламове и утайки, електролитно рафиниране на мед, обезмедени | 305-433-1 | 94551-87-8 | Carc. 1A Muta. 2 | Repr. 1A | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   |   |  
028-016-00-3 | nickel diperchlorate; | perchloric acid, nickel(II) salt | 237-124-1 | 13637-71-3 | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Skin Corr. 1B | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H314 | H334 | H317 | H400 | H410 | GHS05 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H314 | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317: C ≥ 0,01  % | M=1 |  028-016-00-3 | никелов диперхлорат; | никелова(II) сол на перхлорната киселина | 237-124-1 | 13637-71-3 | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Skin Corr. 1B | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H314 | H334 | H317 | H400 | H410 | GHS05 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H314 | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317: C ≥ 0,01  % | M=1 |  
028-017-00-9 | nickel dipotassium bis(sulfate); [1] | diammonium nickel bis(sulfate) [2] | 237-563-9 [1] | 239-793-2 [2] | 13842-46-1 [1] | 15699-18-0 [2] | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H332 | H302 | H334 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H332 | H302 | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1  % ≤ C < 1 % | Skin Sens. 1; H317:C ≥ 0,01  % | M=1 |  028-017-00-9 | дикалиев никелов бис(сулфат); [1] | диамониев никелов бис(сулфат) [2] | 237-563-9 [1] | 239-793-2 [2] | 13842-46-1 [1] | 15699-18-0 [2] | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H332 | H302 | H334 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H332 | H302 | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1  % ≤ C < 1 % | Skin Sens. 1; H317:C ≥ 0,01  % | M=1 |  
028-018-00-4 | nickel bis(sulfamidate); | nickel sulfamate | 237-396-1 | 13770-89-3 | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317:C ≥ 0,01  % | M=1 |  028-018-00-4 | никелов бис(сулфамидат); | никелов сулфамат | 237-396-1 | 13770-89-3 | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317:C ≥ 0,01  % | M=1 |  
028-019-00-X | nickel bis(tetrafluoroborate) | 238-753-4 | 14708-14-6 | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317: C ≥0,01  % | M=1 |  028-019-00-X | никелов бис(тетрафлуороборат) | 238-753-4 | 14708-14-6 | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317: C ≥0,01  % | M=1 |  
028-021-00-0 | nickel diformate; [1] | formic acid, nickel salt; [2] | formic acid, copper nickel salt [3] | 222-101-0 [1] | 239-946-6 [2] | 268-755-0 [3] | 3349-06-2 [1] | 15843-02-4 [2] | 68134-59-8 [3] | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317:C ≥0,01  % | M=1 |  028-021-00-0 | никелов диформат; [1] | никелова сол на мравчената киселина; [2] | медна никелова сол на мравчената киселина [3] | 222-101-0 [1] | 239-946-6 [2] | 268-755-0 [3] | 3349-06-2 [1] | 15843-02-4 [2] | 68134-59-8 [3] | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317:C ≥0,01  % | M=1 |  
028-022-00-6 | nickel di(acetate); [1] | nickel acetate [2] | 206-761-7 [1] | 239-086-1 [2] | 373-02-4 [1] | 14998-37-9 [2] | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H332 | H302 | H334 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H332 | H302 | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317:C≥ 0,01  % | M = 1 |  028-022-00-6 | никелов ди(ацетат); [1] | никелов ацетат [2] | 206-761-7 [1] | 239-086-1 [2] | 373-02-4 [1] | 14998-37-9 [2] | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H332 | H302 | H334 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H332 | H302 | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317:C≥ 0,01  % | M = 1 |  
028-024-00-7 | nickel dibenzoate | 209-046-8 | 553-71-9 | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317:C≥ 0,01  % | M=1 |  028-024-00-7 | никелов дибензоат | 209-046-8 | 553-71-9 | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317:C≥ 0,01  % | M=1 |  
028-025-00-2 | nickel bis(4-cyclohexylbutyrate) | 223-463-2 | 3906-55-6 | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317:C ≥0,01  % | M=1 |  028-025-00-2 | никелов бис(4-циклохексилбутират) | 223-463-2 | 3906-55-6 | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317:C ≥0,01  % | M=1 |  
028-026-00-8 | nickel(II) stearate; | nickel(II) octadecanoate | 218-744-1 | 2223-95-2 | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1  % ≤ C < 1 % | Skin Sens. 1; H317:C;≥0,01  % | M=1 |  028-026-00-8 | никелов(II) стеарат; | никелов(II) октадеканоат | 218-744-1 | 2223-95-2 | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373:0,1  % ≤ C < 1 % | Skin Sens. 1; H317:C;≥0,01  % | M=1 |  
028-027-00-3 | nickel dilactate | — | 16039-61-5 | Carc. 1A | Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   | STOT RE 1; H372:C ≥ 1 % STOT RE 2; H373:0,1  % ≤ C < 1 % | Skin Sens. 1; H317: C ≥ 0,01  % | M=1 |  028-027-00-3 | никелов дилактат | — | 16039-61-5 | Carc. 1A | Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   | STOT RE 1; H372:C ≥ 1 % STOT RE 2; H373:0,1  % ≤ C < 1 % | Skin Sens. 1; H317: C ≥ 0,01  % | M=1 |  
028-028-00-9 | nickel(II) octanoate | 225-656-7 | 4995-91-9 | Carc. 1A | Muta. 2 | Repr. 1B | STOT RE 1 | Skin Corr. 1A | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H314 | H334 | H317 | H400 | H410 | GHS05 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H314 | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317: C ≥ 0,01  % | M=1 |  028-028-00-9 | никелов(II) октаноат | 225-656-7 | 4995-91-9 | Carc. 1A | Muta. 2 | Repr. 1B | STOT RE 1 | Skin Corr. 1A | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H314 | H334 | H317 | H400 | H410 | GHS05 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H314 | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317: C ≥ 0,01  % | M=1 |  
028-029-00-4 | nickel difluoride; [1] | nickel dibromide; [2] | nickel diiodide; [3] | nickel potassium fluoride [4] | 233-071-3 [1] | 236-665-0 [2] | 236-666-6 [3] | -[4] | 10028-18-9 [1] | 13462-88-9 [2] | 13462-90-3 [3] | 11132-10-8 [4] | Carc. 1A | Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317: C ≥0,01  % | M=1 |  028-029-00-4 | никелов дифлуорид; [1] | никелов дибромид; [2] | никелов дийодид; [3] | калиев никелов флуорид [4] | 233-071-3 [1] | 236-665-0 [2] | 236-666-6 [3] | -[4] | 10028-18-9 [1] | 13462-88-9 [2] | 13462-90-3 [3] | 11132-10-8 [4] | Carc. 1A | Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317: C ≥0,01  % | M=1 |  
028-030-00-X | nickel hexafluorosilicate | 247-430-7 | 26043-11-8 | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317:C ≥ 0,01  % | M=1 |  028-030-00-X | никелов хексафлуоросиликат | 247-430-7 | 26043-11-8 | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317:C ≥ 0,01  % | M=1 |  
028-031-00-5 | nickel selenate | 239-125-2 | 15060-62-5 | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317:C≥0,01  % | M=1 |  028-031-00-5 | никелов селенат | 239-125-2 | 15060-62-5 | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317:C≥0,01  % | M=1 |  
028-032-00-0 | nickel hydrogen phosphate; [1] | nickel bis(dihydrogen phosphate); [2] | trinickel bis(orthophosphate); [3] | dinickel diphosphate; [4] | nickel bis(phosphinate); [5] | nickel phosphinate; [6] | phosphoric acid, calcium nickel salt; [7] | diphosphoric acid, nickel(II) salt[8] | 238-278-2 [1] | 242-522-3 [2] | 233-844-5 [3] | 238-426-6 [4] | 238-511-8 [5] | 252-840-4 [6] | -[7] | -[8] | 14332-34-4 [1] | 18718-11-1 [2] | 10381-36-9 [3] | 14448-18-1 [4] | 14507-36-9 [5] | 36026-88-7 [6] | 17169-61-8 [7] | 19372-20-4 [8] | Carc. 1A | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H372** | H334 | H317 | H410 |   |   |  028-032-00-0 | никелов хидрогенфосфат; [1] | никелов бис(дихидрогенфосфат); [2] | триникелов бис(ортофосфат); [3] | диникелов дифосфат; [4] | никелов бис(фосфинат); [5] | никелов фосфинат; [6] | калциева никелова сол на фосфорната киселина; [7] | никелова(II) сол на дифосфорната киселина [8] | 238-278-2 [1] | 242-522-3 [2] | 233-844-5 [3] | 238-426-6 [4] | 238-511-8 [5] | 252-840-4 [6] | -[7] | -[8] | 14332-34-4 [1] | 18718-11-1 [2] | 10381-36-9 [3] | 14448-18-1 [4] | 14507-36-9 [5] | 36026-88-7 [6] | 17169-61-8 [7] | 19372-20-4 [8] | Carc. 1A | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H372** | H334 | H317 | H410 |   |   |  
028-033-00-6 | diammonium nickel hexacyanoferrate | — | 74195-78-1 | Carc. 1A | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i H372** H334 | H317 | H410 |   |   |  028-033-00-6 | диамониев никелов хексацианоферат | — | 74195-78-1 | Carc. 1A | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i H372** H334 | H317 | H410 |   |   |  
028-034-00-1 | nickel dicyanide | 209-160-8 | 557-19-7 | Carc. 1A | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H372** | H334 | H317 | H410 | EUH032 |   |  028-034-00-1 | никелов дицианид | 209-160-8 | 557-19-7 | Carc. 1A | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H372** | H334 | H317 | H410 | EUH032 |   |  
028-035-00-7 | nickel chromate | 238-766-5 | 14721-18-7 | Carc. 1A | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H372** | H334 | H317 | H410 |   |   |  028-035-00-7 | никелов хромат | 238-766-5 | 14721-18-7 | Carc. 1A | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H372** | H334 | H317 | H410 |   |   |  
028-036-00-2 | nickel(II) silicate; [1] | dinickel orthosilicate; [2] | nickel silicate (3:4); [3] | silicic acid, nickel salt; [4] | trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5] | 244-578-4 [1] | 237-411-1 [2] | 250-788-7 [3] | 253-461-7 [4] | 235-688-3 [5] | 21784-78-1 [1] | 13775-54-7 [2] | 31748-25-1 [3] | 37321-15-6 [4] | 12519-85-6 [5] | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H372** H317 | H410 |   |   |  028-036-00-2 | никелов(II) силикат; [1] | диникелов ортосиликат; [2] | никелов силикат (3:4); [3] | никелова сол на силициевата киселина; [4] | триводороден хидроксибис[ортосиликато(4-)]триникелат(3-) [5] | 244-578-4 [1] | 237-411-1 [2] | 250-788-7 [3] | 253-461-7 [4] | 235-688-3 [5] | 21784-78-1 [1] | 13775-54-7 [2] | 31748-25-1 [3] | 37321-15-6 [4] | 12519-85-6 [5] | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i | H372** H317 | H410 |   |   |  
028-037-00-8 | dinickel hexacyanoferrate | 238-946-3 | 14874-78-3 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i H372** H317 | H410 |   |   |  028-037-00-8 | диникелов хексацианоферат | 238-946-3 | 14874-78-3 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i H372** H317 | H410 |   |   |  
028-038-00-3 | trinickel bis(arsenate); | nickel(II) arsenate | 236-771-7 | 13477-70-8 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H372** H317 | H410 |   |   |  028-038-00-3 | триникелов бис(арсенат); | никелов(II) арсенат | 236-771-7 | 13477-70-8 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H372** H317 | H410 |   |   |  
028-039-00-9 | nickel oxalate; [1] | oxalic acid, nickel salt [2] | 208-933-7 [1] | 243-867-2 [2] | 547-67-1 [1] | 20543-06-0 [2] | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i H372** H317 | H410 |   |   |  028-039-00-9 | никелов оксалат; [1] | никелова сол на оксаловата киселина [2] | 208-933-7 [1] | 243-867-2 [2] | 547-67-1 [1] | 20543-06-0 [2] | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i H372** H317 | H410 |   |   |  
028-040-00-4 | nickel telluride | 235-260-6 | 12142-88-0 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i H372** H317 | H410 |   |   |  028-040-00-4 | никелов телурид | 235-260-6 | 12142-88-0 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i H372** H317 | H410 |   |   |  
028-041-00-X | trinickel tetrasulfide | — | 12137-12-1 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i H372** H317 | H410 |   |   |  028-041-00-X | триникелов тетрасулфид | — | 12137-12-1 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i H372** H317 | H410 |   |   |  
028-042-00-5 | trinickel bis(arsenite) | — | 74646-29-0 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i H372** H317 | H410 |   |   |  028-042-00-5 | триникелов бис(арсенит) | — | 74646-29-0 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i H372** H317 | H410 |   |   |  
028-043-00-0 | cobalt nickel gray periclase; | C.I. Pigment Black 25; C.I. 77332; [1] | cobalt nickel dioxide; [2] | cobalt nickel oxide [3] | 269-051-6 [1] | 261-346-8 [2] | -[3] | 68186-89-0 [1] | 58591-45-0 [2] | 12737-30-3 [3] | Carc. 1A | STOT RE 1 | Skin Sens. 1 | H350i | H372** | H317 | GHS08 | GHS07 | Dgr | H350i H372** H317 |   |   |  028-043-00-0 | кобалтов никелов сив периклаз | C.I. пигментно черно 25; C.I. 77332; [1] | кобалтов никелов диоксид; [2] | кобалтов никелов оксид [3] | 269-051-6 [1] | 261-346-8 [2] | -[3] | 68186-89-0 [1] | 58591-45-0 [2] | 12737-30-3 [3] | Carc. 1A | STOT RE 1 | Skin Sens. 1 | H350i | H372** | H317 | GHS08 | GHS07 | Dgr | H350i H372** H317 |   |   |  
028-044-00-6 | nickel tin trioxide; | nickel stannate | 234-824-9 | 12035-38-0 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | H350i | H372** | H317 | GHS08 | GHS07 | Dgr | H350i H372** | H317 |   |   |  028-044-00-6 | калаен никелов триоксид; | никелов станат | 234-824-9 | 12035-38-0 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | H350i | H372** | H317 | GHS08 | GHS07 | Dgr | H350i H372** | H317 |   |   |  
028-045-00-1 | nickel triuranium decaoxide | 239-876-6 | 15780-33-3 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | H350i | H372** | H317 | GHS08 | GHS07 | Dgr | H350i H372** | H317 |   |   |  028-045-00-1 | никелов триуранов декаоксид | 239-876-6 | 15780-33-3 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | H350i | H372** | H317 | GHS08 | GHS07 | Dgr | H350i H372** | H317 |   |   |  
028-046-00-7 | nickel dithiocyanate | 237-205-1 | 13689-92-4 | Carc. 1A | Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 | EUH032 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317:C≥0,01  % | M=1 |  028-046-00-7 | никелов дитиоцианат | 237-205-1 | 13689-92-4 | Carc. 1A | Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 | EUH032 | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317:C≥0,01  % | M=1 |  
028-047-00-2 | nickel dichromate | 239-646-5 | 15586-38-6 | Carc. 1A | Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   | STOT RE 1; H372:C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317:C≥0,01  % | M=1 |  028-047-00-2 | никелов дихромат | 239-646-5 | 15586-38-6 | Carc. 1A | Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   | STOT RE 1; H372:C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317:C≥0,01  % | M=1 |  
028-048-00-8 | nickel(II) selenite | 233-263-7 | 10101-96-9 | Carc. 1A | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i H372** | H334 | H317 | H410 |   |   |  028-048-00-8 | никелов(II) селенит | 233-263-7 | 10101-96-9 | Carc. 1A | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i H372** | H334 | H317 | H410 |   |   |  
028-049-00-3 | nickel selenide | 215-216-2 | 1314-05-2 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i H372** | H317 | H410 |   |   |  028-049-00-3 | никелов селенид | 215-216-2 | 1314-05-2 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i H372** | H317 | H410 |   |   |  
028-050-00-9 | silicic acid, lead nickel salt | — | 68130-19-8 | Carc. 1A | Repr. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H360Df H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i H360Df H372** | H317 | H410 |   |   |  028-050-00-9 | никелова оловна сол на силициевата киселина | — | 68130-19-8 | Carc. 1A | Repr. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H360Df H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i H360Df H372** | H317 | H410 |   |   |  
028-051-00-4 | nickel diarsenide; [1] | nickel arsenide [2] | 235-103-1 [1] | 248-169-1 [2] | 12068-61-0 [1] | 27016-75-7 [2] | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i H372** | H317 | H410 |   |   |  028-051-00-4 | никелов диарсенид; [1] | никелов арсенид [2] | 235-103-1 [1] | 248-169-1 [2] | 12068-61-0 [1] | 27016-75-7 [2] | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i H372** | H317 | H410 |   |   |  
028-052-00-X | nickel barium titanium primrose priderite; | C.I. Pigment Yellow 157; C.I. 77900 | 271-853-6 | 68610-24-2 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | H350i | H372** | H317 | GHS08 | GHS07 | Dgr | H350i H372** | H317 |   |   |  028-052-00-X | бариев никелов титанов жълт придерит | C.I. Pigment Yellow 157; C.I. 77900 | 271-853-6 | 68610-24-2 | Carc. 1A | STOT RE 1 | Skin Sens. 1 | H350i | H372** | H317 | GHS08 | GHS07 | Dgr | H350i H372** | H317 |   |   |  
028-053-00-5 | nickel dichlorate; [1] | nickel dibromate; [2] | ethyl hydrogen sulfate, nickel(II) salt [3] | 267-897-0 [1] | 238-596-1 [2] | 275-897-7 [3] | 67952-43-6 [1] | 14550-87-9 [2] | 71720-48-4 [3] | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < % | Skin Sens. 1; H317:C≥0,01 %1 | M=1 |  028-053-00-5 | никелов дихлорат; [1] | никелов дибромат; [2] | етилов никелов(II) хидрогенсулфат [3] | 267-897-0 [1] | 238-596-1 [2] | 275-897-7 [3] | 67952-43-6 [1] | 14550-87-9 [2] | 71720-48-4 [3] | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   | STOT RE 1; H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < % | Skin Sens. 1; H317:C≥0,01 %1 | M=1 |  
028-054-00-0 | nickel(II) trifluoroacetate; [1] | nickel(II) propionate; [2] | nickel bis(benzenesulfonate); [3] | nickel(II) hydrogen citrate; [4] | citric acid, ammonium nickel salt; [5] | citric acid, nickel salt; [6] | nickel bis(2-ethylhexanoate); [7] | 2-ethylhexanoic acid, nickel salt; [8] | dimethylhexanoic acid nickelsalt; [9] | nickel(II) isooctanoate; [10] | nickel isooctanoate; [11] | nickel bis(isononanoate); [12] | nickel(II) neononanoate; [13] | nickel(II) isodecanoate; [14] | nickel(II) neodecanoate; [15] neodecanoic acid, nickel salt;[16] | nickel(II) neoundecanoate; [17] | bis(d-gluconato-O 1,O 2)nickel; [18] | nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19] | nickel(II) palmitate; [20] | (2-ethylhexanoato-O)(isononanoato-O)nickel; [21] | (isononanoato-O)(isooctanoato-O)nickel; [22] | (isooctanoato-O)(neodecanoato-O)nickel; [23] | (2-ethylhexanoato-O)(isodecanoato-O)nickel; [24] | 2-ethylhexanoato-O)(neodecanoato-O)nickel; [25] | (isodecanoato-O)(isooctanoato-O)nickel; [26] | (isodecanoato-O)(isononanoato-O)nickel; [27] | (isononanoato-O)(neodecanoato-O)nickel; [28] | fatty acids, C6-19-branched, nickel salts; [29] | fatty acids, C 8-18 and C18-unsaturated, nickel salts; [30] | 2,7-naphthalenedisulfonic acid, nickel(II) salt; [31] | 240-235-8 [1] | 222-102-6 [2] | 254-642-3 [3] | 242-533-3 [4] | 242-161-1 [5] | 245-119-0 [6] | 224-699-9 [7] | 231-480-1 [8] | 301-323-2 [9] | 249-555-2 [10] | 248-585-3 [11] | 284-349-6 [12] | 300-094-6 [13] | 287-468-1 [14] | 287-469-7 [15] | 257-447-1 [16] | 300-093-0 [17] | 276-205-6 [18] | 258-051-1 [19] | 294-302-1 [29] | 283-972-0 [30] | -[31] | 237-138-8 [20] | 287-470-2 [21] | 287-471-8 [22] | 284-347-5 [23] | 284-351-7 [24] | 285-698-7 [25] | 285-909-2 [26] | 284-348-0 [27] | 287-592-6 [28] | 16083-14-0 [1] | 3349-08-4 [2] | 39819-65-3 [3] | 18721-51-2 [4] | 18283-82-4 [5] | 22605-92-1 [6] | 4454-16-4 [7] | 7580-31-6 [8] | 93983-68-7 [9] | 29317-63-3 [10] | 27637-46-3 [11] | 84852-37-9 [12] | 93920-10-6 [13] | 85508-43-6 [14] | 85508-44-7 [15] | 51818-56-5 [16] | 93920-09-3 [17] | 71957-07-8 [18] | 52625-25-9 [19] | 13654-40-5 [20] | 85508-45-8 [21] | 85508-46-9 [22] | 84852-35-7 [23] | 84852-39-1 [24] | 85135-77-9 | [25] | 85166-19-4 [26] | 84852-36-8 [27] | 85551-28-6 [28] | 91697-41-5 [29] | 84776-45-4 [30] | 72319-19-8 [31] | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   | STOT RE 1; | H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317: C ≥ | 0,01  % M=1 |  028-054-00-0 | никелов(II) трифлуороацетат; [1] | никелов(II) пропионат; [2] | никелов бис(бензенсулфонат); [3] | никелов(II) хидрогенцитрат; [4] | амониева никелова сол на лимонената киселина; [5] | никелова сол на лимонената киселина; [6] | никелов бис(2-етилхексаноат); [7] | никелова сол на 2-етилхексановата киселина; [8] | никелова сол на диметилхексановата киселина; [9] | никелов(II) изооктаноат; [10] | никелов изооктаноат; [11] | никелов бис(изононаноат); [12] | никелов(II) неононаноат; [13] | никелов(II) изодеканоат; [14] | никелов(II) неодеканоат; [15] никелова сол на неодекановата киселина;[16] | никелов(II) неоундеканоат; [17] | бис(d-глюконато-O 1,O 2)никел; [18] | никелов 3,5-бис(трет-бутил)-4-хидроксибензоат (1:2); [19] | никелов(II) палмитат; [20] | (2-етилхексаноато-O)(изононаноато-O)никел; [21] | (изононаноато-O)(изооктаноато-O)никел; [22] | (изооктаноато-O)(изодеканоато-O)никел; [23] | (2-етилхексаноато-O)(изодеканоато-O)никел; [24] | (2-етилхексаноато-O)(неодеканоато-O)никел; [25] | (изодеканоато-O)(изооктаноато-O)никел; [26] | (изодеканоато-O)(изононаноато-O)никел; [27] | (изононаноато-O)(неодеканоато-O)никел; [28] | никелови соли на мастни киселини с разклонена верига с C6-19; [29] | никелови соли на мастни киселини с C8-18 и ненаситени мастни киселини с C18; [30] | никелова(II) сол на 2,7-нафталендисулфоновата киселина; [31] | 240-235-8 [1] | 222-102-6 [2] | 254-642-3 [3] | 242-533-3 [4] | 242-161-1 [5] | 245-119-0 [6] | 224-699-9 [7] | 231-480-1 [8] | 301-323-2 [9] | 249-555-2 [10] | 248-585-3 [11] | 284-349-6 [12] | 300-094-6 [13] | 287-468-1 [14] | 287-469-7 [15] | 257-447-1 [16] | 300-093-0 [17] | 276-205-6 [18] | 258-051-1 [19] | 294-302-1 [29] | 283-972-0 [30] | -[31] | 237-138-8 [20] | 287-470-2 [21] | 287-471-8 [22] | 284-347-5 [23] | 284-351-7 [24] | 285-698-7 [25] | 285-909-2 [26] | 284-348-0 [27] | 287-592-6 [28] | 16083-14-0 [1] | 3349-08-4 [2] | 39819-65-3 [3] | 18721-51-2 [4] | 18283-82-4 [5] | 22605-92-1 [6] | 4454-16-4 [7] | 7580-31-6 [8] | 93983-68-7 [9] | 29317-63-3 [10] | 27637-46-3 [11] | 84852-37-9 [12] | 93920-10-6 [13] | 85508-43-6 [14] | 85508-44-7 [15] | 51818-56-5 [16] | 93920-09-3 [17] | 71957-07-8 [18] | 52625-25-9 [19] | 13654-40-5 [20] | 85508-45-8 [21] | 85508-46-9 [22] | 84852-35-7 [23] | 84852-39-1 [24] | 85135-77-9 | [25] | 85166-19-4 [26] | 84852-36-8 [27] | 85551-28-6 [28] | 91697-41-5 [29] | 84776-45-4 [30] | 72319-19-8 [31] | Carc. 1A Muta. 2 | Repr. 1B | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H341 | H360D*** H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i | H341 | H360D*** H372** | H334 | H317 | H410 |   | STOT RE 1; | H372: C ≥ 1 % STOT RE 2; H373: 0,1  % ≤ C < 1 % | Skin Sens. 1; H317: C ≥ | 0,01  % M=1 |  
028-055-00-6 | nickel(II) sulfite; [1] | nickel tellurium trioxide; [2] | nickel tellurium tetraoxide; [3] molybdenum nickel hydroxide oxide phosphate [4] | 231-827-7 [1] | 239-967-0 [2] | 239-974-9 [3] | 268-585-7 [4] | 7757-95-1 [1] | 15851-52-2 [2] | 15852-21-8 [3] | 68130-36-9 [4] | Carc. 1A | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i H372** | H334 | H317 | H410 |   |   |  028-055-00-6 | никелов(II) сулфит; [1] | никелов телуров триоксид; [2] | никелов телуров тетраоксид; [3] молибденов никелов оксид фосфат хидроксид [4] | 231-827-7 [1] | 239-967-0 [2] | 239-974-9 [3] | 268-585-7 [4] | 7757-95-1 [1] | 15851-52-2 [2] | 15852-21-8 [3] | 68130-36-9 [4] | Carc. 1A | STOT RE 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H334 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350i H372** | H334 | H317 | H410 |   |   |  
028-056-00-1 | nickel boride (NiB); [1] | dinickel boride; [2] | trinickel boride; [3] | nickel boride; [4] | dinickel silicide; [5] | nickel disilicide; [6] | dinickel phosphide; [7] | nickel boron phosphide [8] | 234-493-0 [1] | 234-494-6 [2] | 234-495-1 [3] | 235-723-2 [4] | 235-033-1 [5] | 235-379-3 [6] | 234-828-0 [7] | -[8] | 12007-00-0 [1] | 12007-01-1 [2] | 12007-02-2 [3] | 12619-90-8 [4] | 12059-14-2 [5] | 12201-89-7 [6] | 12035-64-2 [7] | 65229-23-4 [8] | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i H372** | H317 | H410 |   |   |  028-056-00-1 | никелов борид (NiB); [1] | диникелов борид; [2] | триникелов борид; [3] | никелов борид; [4] | диникелов силицид; [5] | никелов дисилицид; [6] | диникелов фосфид; [7] | борен никелов фосфид [8] | 234-493-0 [1] | 234-494-6 [2] | 234-495-1 [3] | 235-723-2 [4] | 235-033-1 [5] | 235-379-3 [6] | 234-828-0 [7] | -[8] | 12007-00-0 [1] | 12007-01-1 [2] | 12007-02-2 [3] | 12619-90-8 [4] | 12059-14-2 [5] | 12201-89-7 [6] | 12035-64-2 [7] | 65229-23-4 [8] | Carc. 1A | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H372** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350i H372** | H317 | H410 |   |   |  
028-057-00-7 | dialuminium nickel tetraoxide; [1] | nickel titanium trioxide; [2] | nickel titanium oxide; [3] | nickel divanadium hexaoxide; [4] | cobalt dimolybdenum nickel octaoxide; [5] | nickel zirkonium trioxide; [6] | molybdenum nickel tetraoxide; [7] | nickel tungsten tetraoxide; [8] | olivine, nickel green; [9] | lithium nickel dioxide; [10] | molybdenum nickel oxide; [11] | 234-454-8 [1] | 234-825-4 [2] | 235-752-0 [3] | 257-970-5 [4] | 268-169-5 [5] | 274-755-1 [6] | 238-034-5 [7] | 238-032-4 [8] | 271-112-7 [9] | -[10] | -[11] | 12004-35-2 [1] | 12035-39-1 [2] | 12653-76-8 [3] | 52502-12-2 [4] | 68016-03-5 [5] | 70692-93-2 [6] | 14177-55-0 [7] | 14177-51-6 [8] | 68515-84-4 [9] | 12031-65-1 [10] | 12673-58-4 [11] | Carc. 1A | STOT RE 1 | Skin Sens. 1 | H350i | H372** | H317 | GHS08 | GHS07 | Dgr | H350i H372** | H317 |   |   |  028-057-00-7 | диалуминиев никелов тетраоксид; [1] | никелов титанов триоксид; [2] | никелов титанов оксид; [3] | диванадиев никелов хексаоксид; [4] | кобалтов димолибденов никелов октаоксид; [5] | никелов циркониев триоксид; [6] | молибденов никелов тетраоксид; [7] | волфрамов никелов тетраоксид; [8] | оливин, никелово зелено; [9] | литиев никелов диоксид; [10] | молибденов никелов оксид; [11] | 234-454-8 [1] | 234-825-4 [2] | 235-752-0 [3] | 257-970-5 [4] | 268-169-5 [5] | 274-755-1 [6] | 238-034-5 [7] | 238-032-4 [8] | 271-112-7 [9] | -[10] | -[11] | 12004-35-2 [1] | 12035-39-1 [2] | 12653-76-8 [3] | 52502-12-2 [4] | 68016-03-5 [5] | 70692-93-2 [6] | 14177-55-0 [7] | 14177-51-6 [8] | 68515-84-4 [9] | 12031-65-1 [10] | 12673-58-4 [11] | Carc. 1A | STOT RE 1 | Skin Sens. 1 | H350i | H372** | H317 | GHS08 | GHS07 | Dgr | H350i H372** | H317 |   |   |  
028-058-00-2 | cobalt lithium nickel oxide | 442-750-5 | — | Carc. 1A | Acute Tox. 2 * | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H330 | H372** | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350i | H330 | H372** | H317 | H410 |   |   |  028-058-00-2 | кобалтов литиев никелов оксид | 442-750-5 | — | Carc. 1A | Acute Tox. 2 * | STOT RE 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350i | H330 | H372** | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350i | H330 | H372** | H317 | H410 |   |   |  
029-001-00-4 | copper chloride; | copper (I) chloride; | cuprous chloride | 231-842-9 | 7758-89-6 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H400 | H410 |   |   |  029-001-00-4 | меден хлорид; | меден(I) хлорид; | купрохлорид | 231-842-9 | 7758-89-6 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H400 | H410 |   |   |  
029-003-00-5 | naphthenic acids, copper salts; | copper naphthenate | 215-657-0 | 1338-02-9 | Flam. Liq. 3 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H226 | H302 | H400 | H410 | GHS02 | GHS07 | GHS09 | Wng | H226 | H302 | H410 |   |   |  029-003-00-5 | медни соли на нафтенови киселини; | меден нафтенат | 215-657-0 | 1338-02-9 | Flam. Liq. 3 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H226 | H302 | H400 | H410 | GHS02 | GHS07 | GHS09 | Wng | H226 | H302 | H410 |   |   |  
029-004-00-0 | copper sulphate | 231-847-6 | 7758-98-7 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H315 | H410 |   |   |  029-004-00-0 | меден сулфат | 231-847-6 | 7758-98-7 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H315 | H410 |   |   |  
029-005-00-6 | (tris(chloromethyl)phthalocyaninato)copper(II), reaction products with N-methylpiperazine and methoxyacetic acid | 401-260-1 | — | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  029-005-00-6 | (трис(хлорометил)фталоцианинато)мед(II), реакционни продукти с N-метилпиперазин и метоксиоцетна киселина | 401-260-1 | — | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
029-006-00-1 | tris(octadec-9-enylammonium) (trisulfonatophthalocyaninato)copper(II) | 403-210-4 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  029-006-00-1 | трис(oктадец-9-eниламоний)(трисулфонатофталоцианинато)мед(II) | 403-210-4 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  
029-007-00-7 | (trisodium (2-((3-(6-(2-chloro-5-sulfonato)anilino)-4-(3-carboxypyridinio)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)phenylmethylazo)-4-sulfonatobenzoato)copper(3-)) hydroxide | 404-670-9 | 89797-01-3 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   | G029-007-00-7 | (тринатриев-(2-((3-(6-(2-хлоро-5-сулфонато)aнилино)-4-(3-карбоксипиридинио)-1,3,5-триaзин-2-иламино)-2-oксидо-5-сулфонатофенилaзо)фенилметилaзо)-4-сулфонатобензоато)меден(3-)) хидроксид | 404-670-9 | 89797-01-3 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   | G
029-008-00-2 | copper(II) methanesulfonate | 405-400-2 | 54253-62-2 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H410 |   |   |  029-008-00-2 | меден(II) метансулфонат | 405-400-2 | 54253-62-2 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H410 |   |   |  
029-009-00-8 | phthalocyanine-N-[3-(diethylamino)propyl]sulfonamide copper complex | 413-650-9 | 93971-95-0 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  029-009-00-8 | фталоцианин-N-[3-(диетиламино)пропил]сулфонамид, меден комплекс | 413-650-9 | 93971-95-0 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
029-010-00-3 | reaction mass of compounds from (dodecakis(p-tolylthio)phthalocyaninato)copper(II)to (hexadecakis(p-tolylthio)phthalocyaninato)copper(II) | 407-700-9 | 101408-30-4 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  029-010-00-3 | реакционна маса от съединения от (додекакис(p-толилтио)фталоцианинато)мед(II) до (хексадекакис(p-толилтио)фталоцианинато)мед(II) | 407-700-9 | 101408-30-4 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
029-011-00-9 | sodium [29H,31H-phthalocyaninato-(2-)-N29,N30,N31,N32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonato, copper complex | 412-730-0 | 150522-10-4 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   |   |  029-011-00-9 | натриев [29H,31H-фталоцианинато-(2-)-N29,N30,N31,N32]-((3-(N-метил-N-(2-хидроксиетил)aмино)пропил)aмино)сулфонилсулфонато, меден комплекс | 412-730-0 | 150522-10-4 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   |   |  
029-012-00-4 | sodium ((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatophthalocyaninato)copper(II) | 407-340-2 | 124719-24-0 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  029-012-00-4 | натриев ((N-(3-триметиламониопропил)сулфамоил)метилсулфонатофталоцианинато)меден(II) йон | 407-340-2 | 124719-24-0 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
029-013-00-X | trisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II) | 407-580-8 | 130201-51-3 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  029-013-00-X | тринатриев (2-(α-(3-(4-хлоро-6-(2-(2-(винилсулфонил)етокси)етиламино)-1,3,5-триaзин-2-иламино)-2-oксидо-5-сулфонатофенилaзо)бензилиденхидрaзино)-4-сулфонатобензoaто)мед(II) | 407-580-8 | 130201-51-3 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
029-014-00-5 | reaction mass of: 2,2'-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N, N',O, O'-copper complex;2,2'-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N, N',O, O'-copper complex | 419-610-7 | 171866-24-3 | STOT RE 2 * | Aquatic Chronic 2 | H373** | H411 | GHS08 | GHS09 | Wng | H373** | H411 |   |   |  029-014-00-5 | реакционна маса от: 2,2′-[[цис-1,2-циклохександиилбис(нитрилометилиден)]бис[фенолат]](2-)N,N′,O,O′-меден комплекс;2,2′-[[транс-1,2-циклохександиилбис(нитрилометилидин)]бис[фенолат]](2-)-N,N′,O,O′-меден комплекс | 419-610-7 | 171866-24-3 | STOT RE 2 * | Aquatic Chronic 2 | H373** | H411 | GHS08 | GHS09 | Wng | H373** | H411 |   |   |  
030-001-00-1 | zinc powder — zinc dust (pyrophoric) | 231-175-3 | 7440-66-6 | Water-react. 1 | Pyr. Sol. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H260 | H250 | H400 | H410 | GHS02 | GHS09 | Dgr | H260 | H250 | H410 |   |   | T030-001-00-1 | цинк на прах — цинкова пепел (пирофорни) | 231-175-3 | 7440-66-6 | Water-react. 1 | Pyr. Sol. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H260 | H250 | H400 | H410 | GHS02 | GHS09 | Dgr | H260 | H250 | H410 |   |   | T
030-001-01-9 | zinc powder — zinc dust (stabilised) | 231-175-3 | 7440-66-6 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  030-001-01-9 | цинк на прах — цинкова пепел (стабилизирани) | 231-175-3 | 7440-66-6 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
030-003-00-2 | zinc chloride | 231-592-0 | 7646-85-7 | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H314 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H410 |   | STOT SE 3; H335: C ≥ 5 % |  030-003-00-2 | цинков хлорид | 231-592-0 | 7646-85-7 | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H314 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H410 |   | STOT SE 3; H335: C ≥ 5 % |  
030-004-00-8 | dimethylzinc; [1] | diethylzinc [2] | 208-884-1 [1] | 209-161-3 [2] | 544-97-8 [1] | 557-20-0 [2] | Pyr. Liq. 1 | Water-react. 1 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H250 | H260 | H314 | H400 | H410 | GHS02 | GHS05 | GHS09 | Dgr | H250 | H260 | H314 | H410 | EUH014 |   |  030-004-00-8 | диметилцинк; [1] | диетилцинк [2] | 208-884-1 [1] | 209-161-3 [2] | 544-97-8 [1] | 557-20-0 [2] | Pyr. Liq. 1 | Water-react. 1 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H250 | H260 | H314 | H400 | H410 | GHS02 | GHS05 | GHS09 | Dgr | H250 | H260 | H314 | H410 | EUH014 |   |  
030-005-00-3 | diamminediisocyanatozinc | 401-610-3 | — | Acute Tox. 4 * | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | H302 | H318 | H334 | H317 | H400 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H302 | H318 | H334 | H317 | H400 |   |   |  030-005-00-3 | диаминдиизоцианатоцинк | 401-610-3 | — | Acute Tox. 4 * | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | H302 | H318 | H334 | H317 | H400 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H302 | H318 | H334 | H317 | H400 |   |   |  
030-006-00-9 | zinc sulphate (hydrous) (mono-, hexa-and hepta hydrate); [1] | zinc sulphate (anhydrous) [2] | 231-793-3 [1] | 231-793-3 [2] | 7446-19-7 [1] | 7733-02-0 [2] | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H410 |   |   |  030-006-00-9 | цинков сулфат (воден) (моно-, хекса- и хептахидрат); [1] | цинков сулфат (безводен) [2] | 231-793-3 [1] | 231-793-3 [2] | 7446-19-7 [1] | 7733-02-0 [2] | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H410 |   |   |  
030-007-00-4 | bis(3,5-di-tert-butylsalicylato-O 1,O 2)zinc | 403-360-0 | 42405-40-3 | Flam. Sol. 1 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H228 | H302 | H400 | H410 | GHS02 | GHS07 | GHS09 | Dgr | H228 | H302 | H410 |   |   | T030-007-00-4 | бис(3,5-ди-трет-бутилсалицилато-O 1,O 2)цинк | 403-360-0 | 42405-40-3 | Flam. Sol. 1 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H228 | H302 | H400 | H410 | GHS02 | GHS07 | GHS09 | Dgr | H228 | H302 | H410 |   |   | T
030-008-00-X | hydroxo(2-(benzenesulfonamido)benzoato)zinc(II) | 403-750-0 | 113036-91-2 | Acute Tox. 4 * | Aquatic Chronic 2 | H332 | H411 | GHS07 | GHS09 | Wng | H332 | H411 |   |   |  030-008-00-X | хидроксо(2-(бензенсулфонамидо)бензоато)цинк(II) | 403-750-0 | 113036-91-2 | Acute Tox. 4 * | Aquatic Chronic 2 | H332 | H411 | GHS07 | GHS09 | Wng | H332 | H411 |   |   |  
030-009-00-5 | zinc-bis(4-(n-octyloxycarbonylamino)salicylate) dihydrate | 417-130-2 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  030-009-00-5 | цинков бис(4-(n-октилоксикарбониламино)салицилат) дихидрат | 417-130-2 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  
030-010-00-0 | 2-dodec-1-enylbutanedioic acid,4-methyl ester zinc salt | 430-740-3 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  030-010-00-0 | 4-метилов естер на 2-додец-1-енилбутандиовата киселина, цинкова сол | 430-740-3 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
030-011-00-6 | trizinc bis(orthophosphate) | 231-944-3 | 7779-90-0 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  030-011-00-6 | трицинков бис(oртофосфат) | 231-944-3 | 7779-90-0 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
030-012-00-1 | aluminium-magnesium-zinc-carbonate-hydroxide | 423-570-6 | 169314-88-9 | Aquatic Chronic 4 | H413 |   | H413 |   |   |  030-012-00-1 | алуминиев магнезиев цинков карбонат хидроксид | 423-570-6 | 169314-88-9 | Aquatic Chronic 4 | H413 |   | H413 |   |   |  
030-013-00-7 | zinc oxide | 215-222-5 | 1314-13-2 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  030-013-00-7 | цинков оксид | 215-222-5 | 1314-13-2 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
030-015-00-8 | tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate | 440-060-9 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  030-015-00-8 | тетрацинк(2+)бис(хексацианокобалтов(3+)) диацетат | 440-060-9 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
033-001-00-X | arsenic | 231-148-6 | 7440-38-2 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H301 | H410 |   |   |  033-001-00-X | арсен | 231-148-6 | 7440-38-2 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H301 | H410 |   |   |  
033-002-00-5 | arsenic compounds, with the exception of those specified elsewhere in this Annex | — | — | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H301 | H410 |   | * | A1033-002-00-5 | арсенови съединения, с изключение на посочените на друго място в настоящото приложение | — | — | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H301 | H410 |   | * | A1
033-003-00-0 | diarsenic trioxide; | arsenic trioxide | 215-481-4 | 1327-53-3 | Carc. 1A | Acute Tox. 2 * | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H300 | H314 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H350 | H300 | H314 | H410 |   |   |  033-003-00-0 | диарсенов триоксид; | арсенов триоксид | 215-481-4 | 1327-53-3 | Carc. 1A | Acute Tox. 2 * | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H300 | H314 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H350 | H300 | H314 | H410 |   |   |  
033-004-00-6 | diarsenic pentaoxide; | arsenic pentoxide; | arsenic oxide | 215-116-9 | 1303-28-2 | Carc. 1A | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H331 | H301 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H331 | H301 | H410 |   |   |  033-004-00-6 | диарсенов пентаоксид; | арсенов пентаоксид; | арсенов оксид | 215-116-9 | 1303-28-2 | Carc. 1A | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H331 | H301 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H331 | H301 | H410 |   |   |  
033-005-00-1 | arsenic acid and it salts with the exception of those specified elsewhere in this Annex | — | — | Carc. 1A | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H331 | H301 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H331 | H301 | H410 |   |   | A033-005-00-1 | арсенова киселина и нейните соли, с изключение на посочените другаде в настоящото приложение. | — | — | Carc. 1A | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H331 | H301 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H331 | H301 | H410 |   |   | A
033-006-00-7 | arsine | 232-066-3 | 7784-42-1 | Flam. Gas 1 | Press. Gas | Acute Tox. 2 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H220 | H330 | H373 ** | H400 | H410 | GHS02 | GHS04 | GHS06 | GHS08 | GHS09 | Dgr | H220 | H330 | H373 ** H410 |   |   | U033-006-00-7 | арсин | 232-066-3 | 7784-42-1 | Flam. Gas 1 | Press. Gas | Acute Tox. 2 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H220 | H330 | H373 ** | H400 | H410 | GHS02 | GHS04 | GHS06 | GHS08 | GHS09 | Dgr | H220 | H330 | H373 ** H410 |   |   | U
033-007-00-2 | tert-butylarsine | 423-320-6 | 4262-43-5 | Pyr. Liq. 1 | Acute Tox. 2 * | H250 | H330 | GHS02 | GHS06 | Dgr | H250 | H330 |   |   |  033-007-00-2 | трет-бутиларсин | 423-320-6 | 4262-43-5 | Pyr. Liq. 1 | Acute Tox. 2 * | H250 | H330 | GHS02 | GHS06 | Dgr | H250 | H330 |   |   |  
034-001-00-2 | selenium | 231-957-4 | 7782-49-2 | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 4 | H331 | H301 | H373 ** | H413 | GHS06 | GHS08 | Dgr | H331 | H301 | H373 ** H413 |   |   |  034-001-00-2 | селен | 231-957-4 | 7782-49-2 | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 4 | H331 | H301 | H373 ** | H413 | GHS06 | GHS08 | Dgr | H331 | H301 | H373 ** H413 |   |   |  
034-002-00-8 | selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this Annex | — | — | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H373** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H301 | H373** | H410 |   |   | A034-002-00-8 | селенови съединения, с изключение на кадмиев сулфоселенид и тези, посочени другаде в настоящото приложение | — | — | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H373** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H301 | H373** | H410 |   |   | A
034-003-00-3 | sodium selenite | 233-267-9 | 10102-18-8 | Acute Tox. 2 * | Acute Tox. 3 * | Skin Sens. 1 | Aquatic Chronic 2 | H300 | H331 | H317 | H411 | GHS06 | GHS09 | Dgr | H300 | H331 | H317 | H411 | EUH031 |   |  034-003-00-3 | натриев селенит | 233-267-9 | 10102-18-8 | Acute Tox. 2 * | Acute Tox. 3 * | Skin Sens. 1 | Aquatic Chronic 2 | H300 | H331 | H317 | H411 | GHS06 | GHS09 | Dgr | H300 | H331 | H317 | H411 | EUH031 |   |  
035-001-00-5 | bromine | 231-778-1 | 7726-95-6 | Acute Tox. 2 * | Skin Corr. 1A | Aquatic Acute 1 | H330 | H314 | H400 | GHS06 | GHS05 | GHS09 | Dgr | H330 | H314 | H400 |   |   |  035-001-00-5 | бром | 231-778-1 | 7726-95-6 | Acute Tox. 2 * | Skin Corr. 1A | Aquatic Acute 1 | H330 | H314 | H400 | GHS06 | GHS05 | GHS09 | Dgr | H330 | H314 | H400 |   |   |  
035-002-00-0 | hydrogen bromide | 233-113-0 | 10035-10-6 | Press. Gas | Skin Corr. 1A | STOT SE 3 | H314 | H335 | GHS04 | GHS05 | GHS07 | Dgr | H314 | H335 |   |   | U035-002-00-0 | водороден бромид | 233-113-0 | 10035-10-6 | Press. Gas | Skin Corr. 1A | STOT SE 3 | H314 | H335 | GHS04 | GHS05 | GHS07 | Dgr | H314 | H335 |   |   | U
035-002-01-8 | hydrobromic acid … % | — | — | Skin Corr. 1B | STOT SE 3 | H314 | H335 | GHS05 | GHS07 | Dgr | H314 | H335 |   | Skin Corr. 1B; H314: C ≥ 40 % Skin Irrit. 2; H315: 10 % ≤ C < 40 % | Eye Irrit. 2; H319: 10 % ≤ C < 40 % | STOT SE 3; H335: C ≥ 10 % | B035-002-01-8 | бромоводородна киселина … % | — | — | Skin Corr. 1B | STOT SE 3 | H314 | H335 | GHS05 | GHS07 | Dgr | H314 | H335 |   | Skin Corr. 1B; H314: C ≥ 40 % Skin Irrit. 2; H315: 10 % ≤ C < 40 % | Eye Irrit. 2; H319: 10 % ≤ C < 40 % | STOT SE 3; H335: C ≥ 10 % | B
035-003-00-6 | potassium bromate | 231-829-8 | 7758-01-2 | Ox. Sol. 1 | Carc. 1B | Acute Tox. 3 * | H271 | H350 | H301 | GHS03 | GHS06 | GHS08 | Dgr | H271 | H350 | H301 |   |   |  035-003-00-6 | калиев бромат | 231-829-8 | 7758-01-2 | Ox. Sol. 1 | Carc. 1B | Acute Tox. 3 * | H271 | H350 | H301 | GHS03 | GHS06 | GHS08 | Dgr | H271 | H350 | H301 |   |   |  
035-004-00-1 | 2-hydroxyethylammonium perbromide | 407-440-6 | — | Ox. Sol. 2 **** | Acute Tox. 4 * | Skin Corr. 1A | Skin Sens. 1 | Aquatic Acute 1 | H272 | H302 | H314 | H317 | H400 | GHS03 | GHS05 | GHS07 | GHS09 | Dgr | H272 | H302 | H314 | H317 | H400 |   |   |  035-004-00-1 | 2-хидроксиетиламониев пербромид | 407-440-6 | — | Ox. Sol. 2 **** | Acute Tox. 4 * | Skin Corr. 1A | Skin Sens. 1 | Aquatic Acute 1 | H272 | H302 | H314 | H317 | H400 | GHS03 | GHS05 | GHS07 | GHS09 | Dgr | H272 | H302 | H314 | H317 | H400 |   |   |  
040-001-00-3 | zirconium powder (pyrophoric) | 231-176-9 | 7440-67-7 | Water-react. 1 | Pyr. Sol. 1 | H260 | H250 | GHS02 | Dgr | H260 | H250 |   |   | T040-001-00-3 | циркониев прах (пирофорен) | 231-176-9 | 7440-67-7 | Water-react. 1 | Pyr. Sol. 1 | H260 | H250 | GHS02 | Dgr | H260 | H250 |   |   | T
040-002-00-9 | zirconium powder, dry (non pyrophoric) | — | — | Self-heat. 1 | H251 | GHS02 | Dgr | H251 |   |   | T040-002-00-9 | циркониев прах, сух (непирофорен) | — | — | Self-heat. 1 | H251 | GHS02 | Dgr | H251 |   |   | T
040-003-00-4 | reaction product of 3,5-di-tert-butylsalicylic acid and zirconium oxychloride, dehydrated, basic Zr: DTBS= 1.0:1.0 to 1.0: 1.5 | 430-610-6 | 226996-19-6 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  040-003-00-4 | реакционен продукт от 3,5-ди-трет-бутилсалицилова киселина и циркониев оксихлорид, дехидратиран, основен Zr: DTBS= 1,0:1,0 до 1,0: 1,5 | 430-610-6 | 226996-19-6 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
042-001-00-9 | molybdenum trioxide | 215-204-7 | 1313-27-5 | Carc. 2 | Eye Irrit. 2 | STOT SE 3 | H351 | H319 | H335 | GHS08 | GHS07 | Wng | H351 | H319 | H335 |   |   |  042-001-00-9 | молибденов триоксид | 215-204-7 | 1313-27-5 | Carc. 2 | Eye Irrit. 2 | STOT SE 3 | H351 | H319 | H335 | GHS08 | GHS07 | Wng | H351 | H319 | H335 |   |   |  
042-002-00-4 | tetrakis(dimethylditetradecylammonium) hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxooctamolybdate(4-) | 404-760-8 | 117342-25-3 | Acute Tox. 3 * | Eye Dam. 1 | H331 | H318 | GHS06 | GHS05 | Dgr | H331 | H318 |   |   |  042-002-00-4 | тетракис(диметилдитетрадециламониев) хекса-μ-оксотетра-μ3-оксоди-μ5-оксотетрадекаоксооктамолибдат(4-) | 404-760-8 | 117342-25-3 | Acute Tox. 3 * | Eye Dam. 1 | H331 | H318 | GHS06 | GHS05 | Dgr | H331 | H318 |   |   |  
042-003-00-X | tetrakis(trimethylhexadecylammonium) hexa-mu-oxotetra-mu3-oxodi-mu5-oxotetradecaoxooctamolybdate(4-) | 404-860-1 | 116810-46-9 | Flam. Sol. 1 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H228 | H318 | H400 | H410 | GHS02 | GHS05 | GHS09 | Dgr | H228 | H318 | H410 |   |   | T042-003-00-X | тетракис(триметилхексадециламониев) хекса-μ-oксотетра-μ3-оксоди-μ5-oксотетрадекаоксооктамолибдат(4-) | 404-860-1 | 116810-46-9 | Flam. Sol. 1 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H228 | H318 | H400 | H410 | GHS02 | GHS05 | GHS09 | Dgr | H228 | H318 | H410 |   |   | T
042-004-00-5 | reaction product of ammonium molybdate and C12-C24-diethoxylated alkylamine (1:5-1:3) | 412-780-3 | — | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H315 | H317 | H411 | GHS07 | GHS09 | Wng | H315 | H317 | H411 |   |   |  042-004-00-5 | реакционен продукт от амониев молибдат и C12-C24-диетоксилиран алкиламин (1:5-1:3) | 412-780-3 | — | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H315 | H317 | H411 | GHS07 | GHS09 | Wng | H315 | H317 | H411 |   |   |  
042-005-00-0 | reaction mass of: mono-and di-glycerols of canola oil; | canola oil acid amide of branched 1,3-propanediamine, N-[3-(tridecyloxy)-propyl]; | N, N-diorgano dithiocarbamate molybdenum complex | 434-240-6 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  042-005-00-0 | реакционна маса от: моно- и диглицероли от рапично масло; | киселинен амид от рапично масло на разклонен N-[3-(тридецилокси)пропил]-1,3-пропандиамин; | N, N-диорганодитиокарбамат, молибденов комплекс | 434-240-6 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
046-001-00-X | tetraammine palladium (II)hydrogen carbonate | 425-270-0 | 134620-00-1 | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373** H318 | H317 | H400 | H410 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H302 | H373** H318 | H317 | H410 |   |   |  046-001-00-X | тетрааминпаладиев(II) хидрогенкарбонат | 425-270-0 | 134620-00-1 | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373** H318 | H317 | H400 | H410 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H302 | H373** H318 | H317 | H410 |   |   |  
047-001-00-2 | silver nitrate | 231-853-9 | 7761-88-8 | Ox. Sol. 2 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H272 | H314 | H400 | H410 | GHS03 | GHS05 | GHS09 | Dgr | H272 | H314 | H410 |   |   |  047-001-00-2 | сребърен нитрат | 231-853-9 | 7761-88-8 | Ox. Sol. 2 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H272 | H314 | H400 | H410 | GHS03 | GHS05 | GHS09 | Dgr | H272 | H314 | H410 |   |   |  
047-002-00-8 | polyphosphoric acid, copper, sodium, magnesium, calcium, silver and zinc salt | 416-850-4 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  047-002-00-8 | медна, натриева, магнезиева, калциева, сребърна и цинкова сол на полифосфорна киселина | 416-850-4 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
048-001-00-5 | cadmium compounds, with the exception of cadmium sulphoselenide (xCdS.yCdSe), reaction mass of cadmium sulphide with zinc sulphide (xCdS.yZnS), reaction mass of cadmium sulphide with mercury sulphide (xCdS.yHgS), and those specified elsewhere in this Annex | — | — | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   | * | A1048-001-00-5 | съединения на кадмий, с изключение на кадмиев сулфоселенид (xCdS.yCdSe), реакционна маса от кадмиев сулфид с цинков сулфид (xCdS.yZnS), реакционна маса от кадмиев сулфид с живачен сулфид (xCdS.yHgS) и тези, които са посочени другаде в настоящото приложение | — | — | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   | * | A1
048-002-00-0 | cadmium (non-pyrophoric); [1] | cadmium oxide (non-pyrophoric) [2] | 231-152-8 [1] | 215-146-2 [2] | 7440-43-9 [1] | 1306-19-0 [2] | Carc. 1B | Muta. 2 | Repr. 2 | Acute Tox. 2 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H341 | H361fd | H330 | H372 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H341 | H361fd | H330 | H372 ** H410 |   |   |  048-002-00-0 | кадмий (непирофорен); [1] | кадмиев оксид (непирофорен) [2] | 231-152-8 [1] | 215-146-2 [2] | 7440-43-9 [1] | 1306-19-0 [2] | Carc. 1B | Muta. 2 | Repr. 2 | Acute Tox. 2 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H341 | H361fd | H330 | H372 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H341 | H361fd | H330 | H372 ** H410 |   |   |  
048-003-00-6 | cadmium diformate; | cadmiumformate | 224-729-0 | 4464-23-7 | Acute Tox. 3 * | Acute Tox. 3 * | Carc. 2 | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H351 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H301 | H351 | H373 ** H410 |   | * | STOT RE 2; H373: C ≥0,25  % |  048-003-00-6 | кадмиев диформат; | кадмиев формат | 224-729-0 | 4464-23-7 | Acute Tox. 3 * | Acute Tox. 3 * | Carc. 2 | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H351 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H301 | H351 | H373 ** H410 |   | * | STOT RE 2; H373: C ≥0,25  % |  
048-004-00-1 | cadmium cyanide | 208-829-1 | 542-83-6 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Carc. 2 | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H351 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H310 | H300 | H351 | H373 ** H410 | EUH032 | STOT RE 2; H373: C ≥0,1  % | EUH032:C≥1 % |  048-004-00-1 | кадмиев цианид | 208-829-1 | 542-83-6 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Carc. 2 | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H351 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H310 | H300 | H351 | H373 ** H410 | EUH032 | STOT RE 2; H373: C ≥0,1  % | EUH032:C≥1 % |  
048-005-00-7 | cadmiumhexafluorosilicate(2-); | cadmium fluorosilica | 241-084-0 | 17010-21-8 | Acute Tox. 3 * | Acute Tox. 3 * | Carc. 2 | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H351 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H301 | H351 | H373 ** H410 |   | * | STOT RE 2; H373: C ≥0,1  % |  048-005-00-7 | кадмиев хексафлуоросиликат(2-); | кадмиев флуоросиликат | 241-084-0 | 17010-21-8 | Acute Tox. 3 * | Acute Tox. 3 * | Carc. 2 | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H351 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H301 | H351 | H373 ** H410 |   | * | STOT RE 2; H373: C ≥0,1  % |  
048-006-00-2 | cadmium fluoride | 232-222-0 | 7790-79-6 | Carc. 1B | Muta. 1B | Repr. 1B | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H340 | H360FD | H330 | H301 | H372 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H340 | H360FD H330 | H301 | H372 ** H410 |   | Carc. 1B; H350: C ≥ 0,01  % | * oral | STOT RE 1; H372: C ≥ 7 % STOT RE 2: | 0,1  % ≤ C <7 % |  048-006-00-2 | кадмиев флуорид | 232-222-0 | 7790-79-6 | Carc. 1B | Muta. 1B | Repr. 1B | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H340 | H360FD | H330 | H301 | H372 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H340 | H360FD H330 | H301 | H372 ** H410 |   | Carc. 1B; H350: C ≥ 0,01  % | * oral | STOT RE 1; H372: C ≥ 7 % STOT RE 2: | 0,1  % ≤ C <7 % |  
048-007-00-8 | cadmium iodide | 232-223-6 | 7790-80-9 | Acute Tox. 3 * | Acute Tox. 3 * | Carc. 2 | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H351 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H301 | H351 | H373 ** H410 |   | * | STOT RE 2; H373: C ≥ 0,1  % |  048-007-00-8 | кадмиев йодид | 232-223-6 | 7790-80-9 | Acute Tox. 3 * | Acute Tox. 3 * | Carc. 2 | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H351 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H301 | H351 | H373 ** H410 |   | * | STOT RE 2; H373: C ≥ 0,1  % |  
048-008-00-3 | cadmium chloride | 233-296-7 | 10108-64-2 | Carc. 1B | Muta. 1B | Repr. 1B | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H340 | H360FD | H330 | H301 | H372 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H340 | H360FD H330 | H301 | H372 ** H410 |   | Carc. 1B; H350: C ≥ 0,01  % | * oral | STOT RE 1; H372: C ≥ 7 % STOT RE 2; H373: 0,1  % ≤ C < 7 % |  048-008-00-3 | кадмиев хлорид | 233-296-7 | 10108-64-2 | Carc. 1B | Muta. 1B | Repr. 1B | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H340 | H360FD | H330 | H301 | H372 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H340 | H360FD H330 | H301 | H372 ** H410 |   | Carc. 1B; H350: C ≥ 0,01  % | * oral | STOT RE 1; H372: C ≥ 7 % STOT RE 2; H373: 0,1  % ≤ C < 7 % |  
048-009-00-9 | cadmium sulphate | 233-331-6 | 10124-36-4 | Carc. 1B | Muta. 1B | Repr. 1B | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H340 | H360FD | H330 | H301 | H372 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H340 | H360FD H330 | H301 | H372 ** H410 |   | Carc. 1B; H350: C ≥ 0,01  % | * oral | STOT RE 1; H372: C ≥ 7 % STOT RE 2; H373 0,1  % ≤ C < 7 % |  048-009-00-9 | кадмиев сулфат | 233-331-6 | 10124-36-4 | Carc. 1B | Muta. 1B | Repr. 1B | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H340 | H360FD | H330 | H301 | H372 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H340 | H360FD H330 | H301 | H372 ** H410 |   | Carc. 1B; H350: C ≥ 0,01  % | * oral | STOT RE 1; H372: C ≥ 7 % STOT RE 2; H373 0,1  % ≤ C < 7 % |  
048-010-00-4 | cadmium sulphide | 215-147-8 | 1306-23-6 | Carc. 1B | Muta. 2 | Repr. 2 | STOT RE 1 | Acute Tox. 4 * | Aquatic Chronic 4 | H350 | H341 | H361fd | H372 ** | H302 | H413 | GHS08 | GHS07 | Dgr | H350 | H341 | H361fd | H372 ** H302 | H413 |   | * | STOT RE 1; H372: C ≥ 10 % STOT RE 2; H373: 0,1  % ≤ C < 10 % | 1048-010-00-4 | кадмиев сулфид | 215-147-8 | 1306-23-6 | Carc. 1B | Muta. 2 | Repr. 2 | STOT RE 1 | Acute Tox. 4 * | Aquatic Chronic 4 | H350 | H341 | H361fd | H372 ** | H302 | H413 | GHS08 | GHS07 | Dgr | H350 | H341 | H361fd | H372 ** H302 | H413 |   | * | STOT RE 1; H372: C ≥ 10 % STOT RE 2; H373: 0,1  % ≤ C < 10 % | 1
048-011-00-X | cadmium (pyrophoric) | 231-152-8 | 7440-43-9 | Pyr. Sol. 1 | Carc. 1B | Muta. 2 | Repr. 2 | Acute Tox. 2 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H250 | H350 | H341 | H361fd | H330 | H372 ** | H400 | H410 | GHS02 | GHS06 | GHS08 | GHS09 | Dgr | H250 | H350 | H341 | H361fd | H330 | H372 ** H410 |   |   |  048-011-00-X | кадмий (пирофорен) | 231-152-8 | 7440-43-9 | Pyr. Sol. 1 | Carc. 1B | Muta. 2 | Repr. 2 | Acute Tox. 2 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H250 | H350 | H341 | H361fd | H330 | H372 ** | H400 | H410 | GHS02 | GHS06 | GHS08 | GHS09 | Dgr | H250 | H350 | H341 | H361fd | H330 | H372 ** H410 |   |   |  
050-001-00-5 | tin tetrachloride; | stannic chloride | 231-588-9 | 7646-78-8 | Skin Corr. 1B | Aquatic Chronic 3 | H314 | H412 | GHS05 | Dgr | H314 | H412 |   | STOT SE 3; H335:C≥5 % |  050-001-00-5 | калаен тетрахлорид; | калаен хлорид | 231-588-9 | 7646-78-8 | Skin Corr. 1B | Aquatic Chronic 3 | H314 | H412 | GHS05 | Dgr | H314 | H412 |   | STOT SE 3; H335:C≥5 % |  
050-002-00-0 | cyhexatin (ISO); hydroxytricyclohexylstannane; tri(cyclohexyl)tin hydroxide | 236-049-1 | 13121-70-5 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   | M=1000 |  050-002-00-0 | цихексакалай (ISO); хидрокситрициклохексилстанан; три(циклохексил)калаен хидроксид | 236-049-1 | 13121-70-5 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   | M=1000 |  
050-003-00-6 | fentin acetate (ISO); | triphenyltin acetate | 212-984-0 | 900-95-8 | Carc. 2 | Repr. 2 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H361d*** H330 | H311 | H301 | H372** | H335 | H315 | H318 | H400 | H410 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H351 | H361d*** H330 | H311 | H301 | H372** | H335 | H315 | H318 | H410 |   | M=10 |  050-003-00-6 | фенкалаен ацетат (ISO); | трифенилкалаен ацетат | 212-984-0 | 900-95-8 | Carc. 2 | Repr. 2 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H361d*** H330 | H311 | H301 | H372** | H335 | H315 | H318 | H400 | H410 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H351 | H361d*** H330 | H311 | H301 | H372** | H335 | H315 | H318 | H410 |   | M=10 |  
050-004-00-1 | fentin hydroxide (ISO); | triphenyltin hydroxide | 200-990-6 | 76-87-9 | Carc. 2 | Repr. 2 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H361d*** H330 | H311 | H301 | H372** | H335 | H315 | H318 | H400 | H410 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H351 | H361d*** H330 | H311 | H301 | H372** | H335 | H315 | H318 | H410 |   | M=10 |  050-004-00-1 | фенкалаен хидроксид (ISO); | трифенилкалаен хидроксид | 200-990-6 | 76-87-9 | Carc. 2 | Repr. 2 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H361d*** H330 | H311 | H301 | H372** | H335 | H315 | H318 | H400 | H410 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H351 | H361d*** H330 | H311 | H301 | H372** | H335 | H315 | H318 | H410 |   | M=10 |  
050-005-00-7 | trimethyltin compounds, with the exception of those specified elsewhere in this Annex | — | — | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H310 | H300 | H410 |   | * | A1050-005-00-7 | триметилкалаени съединения, с изключение на тези, посочени другаде в настоящото приложение | — | — | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H310 | H300 | H410 |   | * | A1
050-006-00-2 | triethyltin compounds, with the exception of those specified elsewhere in this Annex | — | — | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H310 | H300 | H410 |   | * | A1050-006-00-2 | триетилкалаени съединения, с изключение на тези, посочени другаде в настоящото приложение | — | — | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H310 | H300 | H410 |   | * | A1
050-007-00-8 | tripropyltin compounds, with the exception of those specified elsewhere in this Annex | — | — | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H410 |   | * | A1050-007-00-8 | трипропилкалаени съединения, с изключение на тези, посочени другаде в настоящото приложение | — | — | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H410 |   | * | A1
050-009-00-9 | fluorotripentylstannane;[1] | hexapentyldistannoxane [2] | 243-546-7 [1] | 247-143-7 [2] | 20153-49-5 [1] | 25637-27-8 [2] | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   | * | 1050-009-00-9 | флуоротрипентилстанан;[1] | хексапентилдистаноксан [2] | 243-546-7 [1] | 247-143-7 [2] | 20153-49-5 [1] | 25637-27-8 [2] | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   | * | 1
050-010-00-4 | fluorotrihexylstannane | 243-547-2 | 20153-50-8 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   | * | 1050-010-00-4 | флуоротрихексилстанан | 243-547-2 | 20153-50-8 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   | * | 1
050-011-00-X | triphenyltin compounds, with the exception of those specified elsewhere in this Annex | — | — | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H410 |   | * M=100 | A1050-011-00-X | трифенилкалаени съединения, с изключение на тези, посочени другаде в настоящото приложение | — | — | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H410 |   | * M=100 | A1
050-012-00-5 | tetracyclohexylstannane; [1] chlorotricyclohexylstannane; [2] butyltricyclohexylstannane [3] | 215-910-5 [1] | 221-437-5 [2] | 230-358-5 [3] | 1449-55-4 [1] | 3091-32-5 [2] | 7067-44-9 [3] | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   | * | A1050-012-00-5 | тeтрациклохексилстанан; [1] хлоротрициклохексилстанан; [2] бутилтрициклохексилстанан [3] | 215-910-5 [1] | 221-437-5 [2] | 230-358-5 [3] | 1449-55-4 [1] | 3091-32-5 [2] | 7067-44-9 [3] | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   | * | A1
050-013-00-0 | trioctyltin compounds, with the exception of those specified elsewhere in this Annex | — | — | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Chronic 4 | H319 | H335 | H315 | H413 | GHS07 | Wng | H319 | H335 | H315 | H413 |   | Skin Irrit. 2; H315: C ≥ 1 % Eye Irrit.2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % | A1050-013-00-0 | триoктилкалаени съединения, с изключение на тези, посочени другаде в настоящото приложение | — | — | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Chronic 4 | H319 | H335 | H315 | H413 | GHS07 | Wng | H319 | H335 | H315 | H413 |   | Skin Irrit. 2; H315: C ≥ 1 % Eye Irrit.2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % | A1
050-017-00-2 | fenbutatin oxide (ISO); | bis(tris(2-methyl-2-phenylpropyl)tin)oxide | 236-407-7 | 13356-08-6 | Acute Tox. 2 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H319 | H315 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H319 | H315 | H410 |   |   |  050-017-00-2 | фенбутакалаен оксид (ISO); | бис(трис(2-метил-2-фенилпропил)калаен) oксид | 236-407-7 | 13356-08-6 | Acute Tox. 2 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H319 | H315 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H319 | H315 | H410 |   |   |  
050-018-00-8 | tin(II) methanesulphonate | 401-640-7 | 53408-94-9 | Skin Corr. 1B | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H314 | H302 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H302 | H317 | H411 |   |   |  050-018-00-8 | калаен(II) метансулфонат | 401-640-7 | 53408-94-9 | Skin Corr. 1B | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H314 | H302 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H302 | H317 | H411 |   |   |  
050-019-00-3 | azocyclotin (ISO); | 1-(tricyclohexylstannyl)-1H-1,2,4-triazole | 255-209-1 | 41083-11-8 | Acute Tox. 2 * | Acute Tox. 3 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H301 | H335 | H315 | H318 | H400 | H410 | GHS06 | GHS05 | GHS09 | Dgr | H330 | H301 | H335 | H315 | H318 | H410 |   |   |  050-019-00-3 | азоциклокалай (ISO); | 1-(трициклохексилстанил)-1H-1,2,4-триазол | 255-209-1 | 41083-11-8 | Acute Tox. 2 * | Acute Tox. 3 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H301 | H335 | H315 | H318 | H400 | H410 | GHS06 | GHS05 | GHS09 | Dgr | H330 | H301 | H335 | H315 | H318 | H410 |   |   |  
050-020-00-9 | trioctylstannane | 413-320-4 | 869-59-0 | STOT RE 1 | Skin Irrit. 2 | Aquatic Chronic 4 | H372 ** | H315 | H413 | GHS08 | GHS07 | Dgr | H372 ** H315 | H413 |   |   |  050-020-00-9 | триоктилстанан | 413-320-4 | 869-59-0 | STOT RE 1 | Skin Irrit. 2 | Aquatic Chronic 4 | H372 ** | H315 | H413 | GHS08 | GHS07 | Dgr | H372 ** H315 | H413 |   |   |  
050-021-00-4 | dichlorodioctyl stannane | 222-583-2 | 3542-36-7 | Acute Tox. 3 * | STOT RE 1 | Aquatic Chronic 3 | H331 | H372** | H412 | GHS06 | GHS08 | Dgr | H331 | H372** | H412 |   |   |  050-021-00-4 | диоктилдихлоростанан | 222-583-2 | 3542-36-7 | Acute Tox. 3 * | STOT RE 1 | Aquatic Chronic 3 | H331 | H372** | H412 | GHS06 | GHS08 | Dgr | H331 | H372** | H412 |   |   |  
050-022-00-X | dibutyltin dichloride; | (DBTC) | 211-670-0 | 683-18-1 | Muta. 2 | Repr. 1B | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 1 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H360FD | H330 | H301 | H312 | H372** | H314 | H400 | H410 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H341 | H360FD H330 | H301 | H312 | H372** | H314 | H410 |   | Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 0,01  % ≤ C < 5 % | Eye Dam.1; H318: 3 % ≤ C | < 5 % | Eye Irrit. 2; H319: 0,01  % ≤ C < 3 % | M=10 |  050-022-00-X | дибутилкалаен дихлорид; | (DBTC) | 211-670-0 | 683-18-1 | Muta. 2 | Repr. 1B | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 1 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H360FD | H330 | H301 | H312 | H372** | H314 | H400 | H410 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H341 | H360FD H330 | H301 | H312 | H372** | H314 | H410 |   | Skin Corr. 1B; H314: C ≥ 5 % Skin Irrit. 2; H315: 0,01  % ≤ C < 5 % | Eye Dam.1; H318: 3 % ≤ C | < 5 % | Eye Irrit. 2; H319: 0,01  % ≤ C < 3 % | M=10 |  
050-023-00-5 | reaction mass of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane; | bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide; bis(1-phenyl-1,3-decanedionyl)dioctyl stannane; | ((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane | 422-920-5 | — | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H373** | H400 | H410 | GHS08 | GHS09 | Wng | H373** | H410 |   | M=10 |  050-023-00-5 | реакционна маса от: бис[(2-етил-1-оксохексил)окси]диоктилстанан; | бис[((2-етил-1-оксохексил)окси)диоктилстанил]оксид; бис(1-фенил-1,3-декандионил)диоктилстанан; | ((2-етил-1-оксохексил)окси)(1-фенил-1,3-декандионил)диоктилстанан | 422-920-5 | — | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H373** | H400 | H410 | GHS08 | GHS09 | Wng | H373** | H410 |   | M=10 |  
050-024-00-0 | reaction mass of: tri-p-tolyltin hydroxide; hexa-p-tolyl-distannoxane | 432-230-6 | — | STOT RE 1 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H372** | H302 | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H372** | H302 | H315 | H318 | H317 | H410 |   |   |  050-024-00-0 | реакционна маса от: три-p-толилкалаен хидроксид; хекса-p-толилдистаноксан; | 432-230-6 | — | STOT RE 1 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H372** | H302 | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H372** | H302 | H315 | H318 | H317 | H410 |   |   |  
050-025-00-6 | trichloromethylstannane | 213-608-8 | 993-16-8 | Repr. 2 | H361d | GHS08 | Wng | H361d |   |   |  050-025-00-6 | трихлорометилстанан | 213-608-8 | 993-16-8 | Repr. 2 | H361d | GHS08 | Wng | H361d |   |   |  
050-026-00-1 | 2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 260-828-5 | 57583-34-3 | Repr. 2 | H361d | GHS08 | Wng | H361d |   |   |  050-026-00-1 | 2-етилхексилов 10-етил-4-[[2-[(2-етилхексил)окси] - 2-оксоетил]тио]-4-метил-7-оксо-8-окса-3,5-дитиа-4-станатетрадеканоат | 260-828-5 | 57583-34-3 | Repr. 2 | H361d | GHS08 | Wng | H361d |   |   |  
050-027-00-7 | 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 239-622-4 | 15571-58-1 | Repr. 1B | H360D | GHS08 | Dgr | H360D |   |   |  050-027-00-7 | 2-етилхексилов 10-етил-4,4-диоктил-7-оксо-8-окса-3,5-дитиа-4-станатетрадеканоат | 239-622-4 | 15571-58-1 | Repr. 1B | H360D | GHS08 | Dgr | H360D |   |   |  
050-028-00-2 | 2-ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 260-829-0 | 57583-35-4 | Repr. 2 | Acute Tox. 4 | STOT RE 1 | Skin Sens. 1A | H361d | H302 | H372 | (nervous system, immune system) | H317 | GHS08 | GHS07 | Dgr | H361d | H302 | H372 (nervous system, immune system) | H317 |   |   |  050-028-00-2 | 2-етилхексилов 10-етил-4,4-диметил-7-оксо-8-окса-3,5-дитиа-4-станатетрадеканоат | 260-829-0 | 57583-35-4 | Repr. 2 | Acute Tox. 4 | STOT RE 1 | Skin Sens. 1A | H361d | H302 | H372 | (нервна система, имунна система) | H317 | GHS08 | GHS07 | Dgr | H361d | H302 | H372 (нервна система, имунна система) | H317 |   |   |  
050-029-00-8 | dimethyltin dichloride | 212-039-2 | 753-73-1 | Repr. 2 | Acute Tox. 2 | Acute Tox. 3 | Acute Tox. 3 | STOT RE 1 | Skin Corr. 1B | H361d | H330 | H301 | H311 | H372 | (nervous system, immune system) | H314 | GHS08 | GHS06 | GHS05 | Dgr | H361d | H330 | H301 | H311 | H372 (nervous system, immune system) | H314 | EUH071 |   |  050-029-00-8 | диметилкалаен дихлорид | 212-039-2 | 753-73-1 | Repr. 2 | Acute Tox. 2 | Acute Tox. 3 | Acute Tox. 3 | STOT RE 1 | Skin Corr. 1B | H361d | H330 | H301 | H311 | H372 | (нервна система, имунна система) | H314 | GHS08 | GHS06 | GHS05 | Dgr | H361d | H330 | H301 | H311 | H372 (нервна система, имунна система) | H314 | EUH071 |   |  
051-001-00-8 | antimony trichloride | 233-047-2 | 10025-91-9 | Skin Corr. 1B | Aquatic Chronic 2 | H314 | H411 | GHS05 | GHS09 | Dgr | H314 | H411 |   | STOT SE3; H335: C ≥ 5 % |  051-001-00-8 | антимонов трихлорид | 233-047-2 | 10025-91-9 | Skin Corr. 1B | Aquatic Chronic 2 | H314 | H411 | GHS05 | GHS09 | Dgr | H314 | H411 |   | STOT SE3; H335: C ≥ 5 % |  
051-002-00-3 | antimony pentachloride | 231-601-8 | 7647-18-9 | Skin Corr. 1B | Aquatic Chronic 2 | H314 | H411 | GHS05 | GHS09 | Dgr | H314 | H411 |   | STOT SE 3; H335: C ≥ 5 % |  051-002-00-3 | антимонов пентахлорид | 231-601-8 | 7647-18-9 | Skin Corr. 1B | Aquatic Chronic 2 | H314 | H411 | GHS05 | GHS09 | Dgr | H314 | H411 |   | STOT SE 3; H335: C ≥ 5 % |  
051-003-00-9 | antimony compounds, with the exception of the tetroxide (Sb2O4), pentoxide (Sb2O5), trisulphide (Sb2S3), pentasulphide (Sb2S5) and those specified elsewhere in this Annex | — | — | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 2 | H332 | H302 | H411 | GHS07 | GHS09 | Wng | H332 | H302 | H411 |   | * | A1051-003-00-9 | антимонови съединения, с изключение на тетраоксида (Sb2O4), пентаоксида (Sb2O5), трисулфида (Sb2S3), пентасулфида (Sb2S5) и тези, посочени другаде в настоящото приложение | — | — | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 2 | H332 | H302 | H411 | GHS07 | GHS09 | Wng | H332 | H302 | H411 |   | * | A1
051-004-00-4 | antimony trifluoride | 232-009-2 | 7783-56-4 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Chronic 2 | H331 | H311 | H301 | H411 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H411 |   |   |  051-004-00-4 | антимонов трифлуорид | 232-009-2 | 7783-56-4 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Chronic 2 | H331 | H311 | H301 | H411 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H411 |   |   |  
051-005-00-X | antimony trioxide | 215-175-0 | 1309-64-4 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  051-005-00-X | антимонов триоксид | 215-175-0 | 1309-64-4 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  
051-006-00-5 | diphenyl(4-phenylthiophenyl)sulfonium hexafluoroantimonate | 403-500-0 | — | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  051-006-00-5 | дифенил(4-фенилтиофенил)сулфониев хексафлуороантимонат | 403-500-0 | — | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
051-007-00-0 | bis(4-dodecylphenyl)iodonium hexafluoroantimonate | 404-420-9 | 71786-70-4 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  051-007-00-0 | бис(4-додецилфенил)йодониев хексафлуороантимонат | 404-420-9 | 71786-70-4 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
053-001-00-3 | iodine | 231-442-4 | 7553-56-2 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | H332 | H312 | H400 | GHS07 | GHS09 | Wng | H332 | H312 | H400 |   |   |  053-001-00-3 | йод | 231-442-4 | 7553-56-2 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | H332 | H312 | H400 | GHS07 | GHS09 | Wng | H332 | H312 | H400 |   |   |  
053-002-00-9 | hydrogen iodide | 233-109-9 | 10034-85-2 | Press. Gas | Skin Corr. 1A | H314 | GHS04 | GHS05 | Dgr | H314 |   | Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 0,2  % ≤ C < 10 % | Skin Irrit. 2; H315: 0,02  % ≤ C < 0,2  % | Eye Irrit. 2; H319: 0,02  % ≤ C < 0,2  % | STOT SE 3; H335: C ≥0,02  % | U5053-002-00-9 | водороден йодид | 233-109-9 | 10034-85-2 | Press. Gas | Skin Corr. 1A | H314 | GHS04 | GHS05 | Dgr | H314 |   | Skin Corr. 1A; H314: C ≥ 10 % Skin Corr. 1B; H314: 0,2  % ≤ C < 10 % | Skin Irrit. 2; H315: 0,02  % ≤ C < 0,2  % | Eye Irrit. 2; H319: 0,02  % ≤ C < 0,2  % | STOT SE 3; H335: C ≥0,02  % | U5
053-002-01-6 | hydriodic acid … % | — | — | Skin Corr. 1B | H314 | GHS05 | Dgr |   |   | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % | Eye Irrit. 2; H319: 10 % ≤ C < 25 % | B053-002-01-6 | йодоводородна киселина … % | — | — | Skin Corr. 1B | H314 | GHS05 | Dgr |   |   | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % | Eye Irrit. 2; H319: 10 % ≤ C < 25 % | B
053-003-00-4 | iodoxybenzene | — | 696-33-3 | Expl. **** | **** | **** | **** |   |   |  053-003-00-4 | йодоксибензен | — | 696-33-3 | Expl. **** | **** | **** | **** |   |   |  
053-004-00-X | calcium iodoxybenzoate | — | — | Expl. **** | **** | **** | **** |   |   | C053-004-00-X | калциев йодоксибензоат | — | — | Expl. **** | **** | **** | **** |   |   | C
053-005-00-5 | (4-(1-methylethyl)phenyl)-(4-methylphenyl)iodonium tetrakis(pentafluorophenyl)borate(1-) | 422-960-3 | 178233-72-2 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H373 ** | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H312 | H302 | H373 ** H410 |   |   |  053-005-00-5 | (4-(1-метилетил)фенил)(4-метилфенил)йодониев тетракис(пентафлуорофенил)борат(1-) | 422-960-3 | 178233-72-2 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H373 ** | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H312 | H302 | H373 ** H410 |   |   |  
056-001-00-1 | barium peroxide | 215-128-4 | 1304-29-6 | Ox. Sol. 2 | Acute Tox. 4 * | Acute Tox. 4 * | H272 | H332 | H302 | GHS03 | GHS07 | Dgr | H272 | H332 | H302 |   |   |  056-001-00-1 | бариев пероксид | 215-128-4 | 1304-29-6 | Ox. Sol. 2 | Acute Tox. 4 * | Acute Tox. 4 * | H272 | H332 | H302 | GHS03 | GHS07 | Dgr | H272 | H332 | H302 |   |   |  
056-002-00-7 | barium salts, with the exception of barium sulphate, salts of 1-azo-2-hydroxynaphthalenyl aryl sulphonic acid, and of salts specified elsewhere in this Annex | — | — | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H302 | GHS07 | Wng | H332 | H302 |   | * | A1056-002-00-7 | бариеви соли, с изключение на бариев сулфат, соли на 1-азо-2-хидроксинафталениларилсулфонова киселина и соли, посочени другаде в настоящото приложение | — | — | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H302 | GHS07 | Wng | H332 | H302 |   | * | A1
056-003-00-2 | barium carbonate | 208-167-3 | 513-77-9 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  056-003-00-2 | бариев карбонат | 208-167-3 | 513-77-9 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
056-004-00-8 | barium chloride | 233-788-1 | 10361-37-2 | Acute Tox. 3 * | Acute Tox. 4 * | H301 | H332 | GHS06 | Dgr | H301 | H332 |   |   |  056-004-00-8 | бариев хлорид | 233-788-1 | 10361-37-2 | Acute Tox. 3 * | Acute Tox. 4 * | H301 | H332 | GHS06 | Dgr | H301 | H332 |   |   |  
064-001-00-8 | gadolinium(III)sulfite trihydrate | 456-900-2 | 51285-81-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  064-001-00-8 | гадолиниев(III) сулфит трихидрат | 456-900-2 | 51285-81-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
072-001-00-4 | hafnium tetra-n-butoxide | 411-740-2 | 22411-22-9 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  072-001-00-4 | хафниев тетра-n-бутоксид | 411-740-2 | 22411-22-9 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
074-001-00-X | hexasodium tungstate hydrate | 412-770-9 | 12141-67-2 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  074-001-00-X | хексанатриев волфрамат хидрат | 412-770-9 | 12141-67-2 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  
074-002-00-5 | reaction products of tungsten hexachloride with 2-methylpropan-2-ol, nonylphenol and pentane-2,4-dione | 408-250-6 | — | Flam. Liq. 2 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H225 | H332 | H314 | H317 | H400 | H410 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H225 | H332 | H314 | H317 | H410 |   |   |  074-002-00-5 | реакционни продукти от: волфрамов хексахлорид с 2-метилпропан-2-oл, нонилфенол и пентан-2,4-дион | 408-250-6 | — | Flam. Liq. 2 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H225 | H332 | H314 | H317 | H400 | H410 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H225 | H332 | H314 | H317 | H410 |   |   |  
076-001-00-5 | osmium tetraoxide; | osmic acid | 244-058-7 | 20816-12-0 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Skin Corr. 1B | H330 | H310 | H300 | H314 | GHS06 | GHS05 | Dgr | H330 | H310 | H300 | H314 |   |   |  076-001-00-5 | осмиев тетраоксид; | осмиева киселина | 244-058-7 | 20816-12-0 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Skin Corr. 1B | H330 | H310 | H300 | H314 | GHS06 | GHS05 | Dgr | H330 | H310 | H300 | H314 |   |   |  
078-001-00-0 | tetrachloroplatinates with the exception of those specified elsewhere in this Annex | — | — | Acute Tox. 3 * | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H301 | H318 | H334 | H317 | GHS06 | GHS05 | GHS08 | Dgr | H301 | H318 | H334 | H317 |   |   | A078-001-00-0 | тeтрахлороплатинати, с изключение на тези, посочени другаде в настоящото приложение | — | — | Acute Tox. 3 * | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H301 | H318 | H334 | H317 | GHS06 | GHS05 | GHS08 | Dgr | H301 | H318 | H334 | H317 |   |   | A
078-002-00-6 | diammonium tetrachloroplatinate | 237-499-1 | 13820-41-2 | Acute Tox. 3 * | Skin Irrit. 2 | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H301 | H315 | H318 | H334 | H317 | GHS06 | GHS05 | GHS08 | Dgr | H301 | H315 | H318 | H334 | H317 |   |   |  078-002-00-6 | диамониев тетрахлороплатинат | 237-499-1 | 13820-41-2 | Acute Tox. 3 * | Skin Irrit. 2 | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H301 | H315 | H318 | H334 | H317 | GHS06 | GHS05 | GHS08 | Dgr | H301 | H315 | H318 | H334 | H317 |   |   |  
078-003-00-1 | disodium tetrachloroplatinate | 233-051-4 | 10026-00-3 | Acute Tox. 3 * | Skin Irrit. 2 | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H301 | H315 | H318 | H334 | H317 | GHS06 | GHS05 | GHS08 | Dgr | H301 | H315 | H318 | H334 | H317 |   |   |  078-003-00-1 | динатриев тетрахлороплатинат | 233-051-4 | 10026-00-3 | Acute Tox. 3 * | Skin Irrit. 2 | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H301 | H315 | H318 | H334 | H317 | GHS06 | GHS05 | GHS08 | Dgr | H301 | H315 | H318 | H334 | H317 |   |   |  
078-004-00-7 | dipotassium tetrachloroplatinate | 233-050-9 | 10025-99-7 | Acute Tox. 3 * | Skin Irrit. 2 | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H301 | H315 | H318 | H334 | H317 | GHS06 | GHS05 | GHS08 | Dgr | H301 | H315 | H318 | H334 | H317 |   |   |  078-004-00-7 | дикалиев тетрахлороплатинат | 233-050-9 | 10025-99-7 | Acute Tox. 3 * | Skin Irrit. 2 | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H301 | H315 | H318 | H334 | H317 | GHS06 | GHS05 | GHS08 | Dgr | H301 | H315 | H318 | H334 | H317 |   |   |  
078-005-00-2 | hexachloroplatinates with the exception of those specified elsewhere in this Annex | — | — | Acute Tox. 3 * | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H301 | H318 | H334 | H317 | GHS06 | GHS05 | GHS08 | Dgr | H301 | H318 | H334 | H317 |   |   | A078-005-00-2 | хексахлороплатинати с изключение на тези, посочени другаде в настоящото приложение | — | — | Acute Tox. 3 * | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H301 | H318 | H334 | H317 | GHS06 | GHS05 | GHS08 | Dgr | H301 | H318 | H334 | H317 |   |   | A
078-006-00-8 | disodium hexachloroplatinate | 240-983-5 | 16923-58-3 | Acute Tox. 3 * | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H301 | H318 | H334 | H317 | GHS06 | GHS05 | GHS08 | Dgr | H301 | H318 | H334 | H317 |   |   |  078-006-00-8 | динатриев хексахлороплатинат | 240-983-5 | 16923-58-3 | Acute Tox. 3 * | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H301 | H318 | H334 | H317 | GHS06 | GHS05 | GHS08 | Dgr | H301 | H318 | H334 | H317 |   |   |  
078-007-00-3 | dipotassium hexachloroplatinate | 240-979-3 | 16921-30-5 | Acute Tox. 3 * | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H301 | H318 | H334 | H317 | GHS06 | GHS05 | GHS08 | Dgr | H301 | H318 | H334 | H317 |   |   |  078-007-00-3 | дикалиев хексахлороплатинат | 240-979-3 | 16921-30-5 | Acute Tox. 3 * | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H301 | H318 | H334 | H317 | GHS06 | GHS05 | GHS08 | Dgr | H301 | H318 | H334 | H317 |   |   |  
078-008-00-9 | diammonium hexachloroplatinate | 240-973-0 | 16919-58-7 | Acute Tox. 3 * | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H301 | H318 | H334 | H317 | GHS06 | GHS05 | GHS08 | Dgr | H301 | H318 | H334 | H317 |   |   |  078-008-00-9 | диамониев хексахлороплатинат | 240-973-0 | 16919-58-7 | Acute Tox. 3 * | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H301 | H318 | H334 | H317 | GHS06 | GHS05 | GHS08 | Dgr | H301 | H318 | H334 | H317 |   |   |  
078-009-00-4 | hexachloroplatinic acid | 241-010-7 | 16941-12-1 | Acute Tox. 3 * | Skin Corr. 1B | Resp. Sens. 1 | Skin Sens. 1 | H301 | H314 | H334 | H317 | GHS06 | GHS05 | GHS08 | Dgr | H301 | H314 | H334 | H317 |   |   |  078-009-00-4 | хексахлороплатинова киселина | 241-010-7 | 16941-12-1 | Acute Tox. 3 * | Skin Corr. 1B | Resp. Sens. 1 | Skin Sens. 1 | H301 | H314 | H334 | H317 | GHS06 | GHS05 | GHS08 | Dgr | H301 | H314 | H334 | H317 |   |   |  
078-010-00-X | tetraammine platinum (II) | hydrogen carbonate | 426-730-3 | 123439-82-7 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  078-010-00-X | тетрааминплатинов(II) | хидрогенкарбонат | 426-730-3 | 123439-82-7 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  
078-011-00-5 | hydroxydisulfito platinum(II)acid | 423-310-1 | 61420-92-6 | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1A | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H373 | H314 | H334 | H317 | H412 | GHS05 | GHS08 | GHS07 | Dgr | H302 | H373 | H314 | H334 | H317 | H412 |   |   |  078-011-00-5 | хидроксидисулфитоплатинова(II) киселина | 423-310-1 | 61420-92-6 | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1A | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H373 | H314 | H334 | H317 | H412 | GHS05 | GHS08 | GHS07 | Dgr | H302 | H373 | H314 | H334 | H317 | H412 |   |   |  
078-012-00-0 | platinum(IV) nitrate/nitric acid solution | 432-400-1 | — | Skin Corr. 1A | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H400 | H410 | GHS05 | GHS09 | Dgr | H314 | H410 |   |   |  078-012-00-0 | разтвор платинов(IV) нитрат/азотна киселина | 432-400-1 | — | Skin Corr. 1A | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H400 | H410 | GHS05 | GHS09 | Dgr | H314 | H410 |   |   |  
080-001-00-0 | mercury | 231-106-7 | 7439-97-6 | Repr. 1B | Acute Tox. 2 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H360D*** H330 | H372** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H360D*** H330 | H372** | H410 |   |   |  080-001-00-0 | живак | 231-106-7 | 7439-97-6 | Repr. 1B | Acute Tox. 2 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H360D*** H330 | H372** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H360D*** H330 | H372** | H410 |   |   |  
080-002-00-6 | Inorganic compounds of mercury with the exception of mercuric sulphide and those specified elsewhere in this Annex | — | — | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H310 | H300 | H373 ** H410 |   | * | STOT RE 2; H373: C ≥ 0,1  % | A1080-002-00-6 | неорганични живачни съединения с изключение на живачен сулфид и тези, посочени другаде в настоящото приложение | — | — | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H310 | H300 | H373 ** H410 |   | * | STOT RE 2; H373: C ≥ 0,1  % | A1
080-003-00-1 | dimercury dichloride; | mercurous chloride; | calomel | 233-307-5 | 10112-91-1 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H335 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H335 | H315 | H410 |   |   |  080-003-00-1 | диживачен дихлорид; | живачен хлорид; | каломел | 233-307-5 | 10112-91-1 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H335 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H335 | H315 | H410 |   |   |  
080-004-00-7 | organic compounds of mercury with the exception of those specified elsewhere in this Annex | — | — | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H310 | H300 | H373 ** H410 |   | * | STOT RE 2; H373: C ≥0,1  % | A1080-004-00-7 | органични живачни съединения с изключение на тези, посочени другаде в настоящото приложение | — | — | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H310 | H300 | H373 ** H410 |   | * | STOT RE 2; H373: C ≥0,1  % | A1
080-005-00-2 | mercury difulminate; | mercuric fulminate; | fulminate of mercury | 211-057-8 | 628-86-4 | Unst. Expl. | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H200 | H331 | H311 | H301 | H373 ** | H400 | H410 | GHS01 | GHS06 | GHS08 | GHS09 | Dgr | H200 | H331 | H311 | H301 | H373 ** H400 | H410 |   |   |  080-005-00-2 | живачен дифулминат; | живачен фулминат; | фулминат на живака | 211-057-8 | 628-86-4 | Unst. Expl. | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H200 | H331 | H311 | H301 | H373 ** | H400 | H410 | GHS01 | GHS06 | GHS08 | GHS09 | Dgr | H200 | H331 | H311 | H301 | H373 ** H400 | H410 |   |   |  
080-005-01-X | mercury difulminate; | mercuric fulminate; | fulminate of mercury [≥ 20 % phlegmatiser] | 211-057-8 | 628-86-4 | Expl. 1.1 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H201 | H331 | H311 | H301 | H373 ** | H400 | H410 | GHS01 | GHS06 | GHS08 | GHS09 | Dgr | H201 | H331 | H311 | H301 | H373 ** H400 | H410 |   |   |  080-005-01-X | живачен дифулминат; | живачен фулминат; | фулминат на живака [≥ 20 % флегматизатор] | 211-057-8 | 628-86-4 | Expl. 1.1 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H201 | H331 | H311 | H301 | H373 ** | H400 | H410 | GHS01 | GHS06 | GHS08 | GHS09 | Dgr | H201 | H331 | H311 | H301 | H373 ** H400 | H410 |   |   |  
080-006-00-8 | dimercury dicyanide oxide; | mercuric oxycyanide | 215-629-8 | 1335-31-5 | Expl. 1.1 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H201 | H331 | H311 | H301 | H373** | H400 | H410 | GHS01 | GHS06 | GHS08 | GHS09 | Dgr | H201 | H331 | H311 | H301 | H373** | H410 |   |   |  080-006-00-8 | диживачен оксид дицианид; | живачен оксицианид | 215-629-8 | 1335-31-5 | Expl. 1.1 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H201 | H331 | H311 | H301 | H373** | H400 | H410 | GHS01 | GHS06 | GHS08 | GHS09 | Dgr | H201 | H331 | H311 | H301 | H373** | H410 |   |   |  
080-007-00-3 | dimethylmercury; [1] | diethylmercury [2] | 209-805-3 [1] | 211-000-7 [2] | 593-74-8 [1] | 627-44-1 [2] | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H310 | H300 | H373 ** H410 |   | * | STOT RE 2; H373: C ≥0,05  % | 1080-007-00-3 | диметилживак; [1] | диетилживак [2] | 209-805-3 [1] | 211-000-7 [2] | 593-74-8 [1] | 627-44-1 [2] | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H310 | H300 | H373 ** H410 |   | * | STOT RE 2; H373: C ≥0,05  % | 1
080-008-00-9 | phenylmercury nitrate; [1] phenylmercury hydroxide; [2] | basic phenylmercury nitrate [3] | 200-242-9 [1] | 202-866-7 [2] | -[3] | 55-68-5 [1] | 100-57-2 [2] | 8003-05-2 [3] | Acute Tox. 3 * | STOT RE 1 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H372 ** | H314 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H301 | H372 ** H314 | H410 |   |   |  080-008-00-9 | фенилживачен нитрат; [1] фенилживачен хидроксид; [2] | основен фенилживачен нитрат [3] | 200-242-9 [1] | 202-866-7 [2] | -[3] | 55-68-5 [1] | 100-57-2 [2] | 8003-05-2 [3] | Acute Tox. 3 * | STOT RE 1 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H372 ** | H314 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H301 | H372 ** H314 | H410 |   |   |  
080-009-00-4 | 2-methoxyethylmercury chloride | 204-659-7 | 123-88-6 | Acute Tox. 3 * | STOT RE 1 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H372 ** | H314 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H301 | H372 ** H314 | H410 |   |   |  080-009-00-4 | 2-мeтоксиетилживачен хлорид | 204-659-7 | 123-88-6 | Acute Tox. 3 * | STOT RE 1 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H372 ** | H314 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H301 | H372 ** H314 | H410 |   |   |  
080-010-00-X | mercury dichloride; | mercuric chloride | 231-299-8 | 7487-94-7 | Muta. 2 | Repr. 2 | Acute Tox. 2 * | STOT RE 1 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H361f*** H300 | H372** | H314 | H400 | H410 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H341 | H361f*** H300 | H372** | H314 | H410 |   |   |  080-010-00-X | живачен дихлорид; | живачен хлорид | 231-299-8 | 7487-94-7 | Muta. 2 | Repr. 2 | Acute Tox. 2 * | STOT RE 1 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H361f*** H300 | H372** | H314 | H400 | H410 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H341 | H361f*** H300 | H372** | H314 | H410 |   |   |  
080-011-00-5 | phenylmercury acetate | 200-532-5 | 62-38-4 | Acute Tox. 3 * | STOT RE 1 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H372 ** | H314 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H301 | H372 ** H314 | H410 |   |   |  080-011-00-5 | фенилживачен ацетат | 200-532-5 | 62-38-4 | Acute Tox. 3 * | STOT RE 1 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H372 ** | H314 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H301 | H372 ** H314 | H410 |   |   |  
081-001-00-3 | thallium | 231-138-1 | 7440-28-0 | Acute Tox. 2 * | Acute Tox. 2 * | STOT RE 2 * | Aquatic Chronic 4 | H330 | H300 | H373 ** | H413 | GHS06 | GHS08 | Dgr | H330 | H300 | H373 ** H413 |   |   |  081-001-00-3 | талий | 231-138-1 | 7440-28-0 | Acute Tox. 2 * | Acute Tox. 2 * | STOT RE 2 * | Aquatic Chronic 4 | H330 | H300 | H373 ** | H413 | GHS06 | GHS08 | Dgr | H330 | H300 | H373 ** H413 |   |   |  
081-002-00-9 | thallium compounds, with the exception of those specified elsewhere in this Annex | — | — | Acute Tox. 2 * | Acute Tox. 2 * | STOT RE 2 * | Aquatic Chronic 2 | H330 | H300 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H300 | H373 ** H411 |   |   | A081-002-00-9 | талиеви съединения с изключение на тези, посочени другаде в настоящото приложение | — | — | Acute Tox. 2 * | Acute Tox. 2 * | STOT RE 2 * | Aquatic Chronic 2 | H330 | H300 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H300 | H373 ** H411 |   |   | A
081-003-00-4 | dithallium sulphate; | thallic sulphate | 231-201-3 | 7446-18-6 | Acute Tox. 2 * | STOT RE 1 | Skin Irrit. 2 | Aquatic Chronic 2 | H300 | H372 ** | H315 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H300 | H372 ** H315 | H411 |   |   |  081-003-00-4 | диталиев сулфат; | талиев сулфат | 231-201-3 | 7446-18-6 | Acute Tox. 2 * | STOT RE 1 | Skin Irrit. 2 | Aquatic Chronic 2 | H300 | H372 ** | H315 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H300 | H372 ** H315 | H411 |   |   |  
082-001-00-6 | lead compounds with the exception of those specified elsewhere in this Annex | — | — | Repr. 1A | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H360Df | H332 | H302 | H373 ** | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H360Df | H332 | H302 | H373 ** H410 |   | Repr.2 H361f: C ≥ 2,5  % | * | STOT RE 2; H373: C ≥0,5  % | A1082-001-00-6 | оловни съединения с изключение на тези, посочени другаде в настоящото приложение | — | — | Repr. 1A | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H360Df | H332 | H302 | H373 ** | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H360Df | H332 | H302 | H373 ** H410 |   | Repr.2 H361f: C ≥ 2,5  % | * | STOT RE 2; H373: C ≥0,5  % | A1
082-002-00-1 | lead alkyls | — | — | Repr. 1A | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H360Df | H330 | H310 | H300 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H360Df | H330 | H310 | H300 | H373 ** H410 |   | Repr.1A; H360D: C≥ 0,1  % | * | STOT RE 2; H373: C ≥0,05  % | A1082-002-00-1 | оловни алкили | — | — | Repr. 1A | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H360Df | H330 | H310 | H300 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H360Df | H330 | H310 | H300 | H373 ** H410 |   | Repr.1A; H360D: C≥ 0,1  % | * | STOT RE 2; H373: C ≥0,05  % | A1
082-003-00-7 | lead diazide; | lead azide | 236-542-1 | 13424-46-9 | Unst. Expl. Repr. 1A | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H200 | H360Df | H332 | H302 | H373 ** | H400 | H410 | GHS01 | GHS08 | GHS07 | GHS09 | Dgr | H200 | H360Df | H332 | H302 | H373 ** H410 |   |   | 1082-003-00-7 | оловен диазид; | оловен азид | 236-542-1 | 13424-46-9 | Unst. Expl. Repr. 1A | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H200 | H360Df | H332 | H302 | H373 ** | H400 | H410 | GHS01 | GHS08 | GHS07 | GHS09 | Dgr | H200 | H360Df | H332 | H302 | H373 ** H410 |   |   | 1
082-003-01-4 | lead diazide; | lead azide [≥ 20 % phlegmatiser] | 236-542-1 | 13424-46-9 | Expl. 1.1 | Repr. 1A | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H201 | H360Df | H332 | H302 | H373 ** | H400 | H410 | GHS01 | GHS08 | GHS07 | GHS09 | Dgr | H201 | H360Df | H332 | H302 | H373 ** H410 |   |   | 1082-003-01-4 | оловен диазид; | оловен азид [≥ 20 % флегматизатор] | 236-542-1 | 13424-46-9 | Expl. 1.1 | Repr. 1A | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H201 | H360Df | H332 | H302 | H373 ** | H400 | H410 | GHS01 | GHS08 | GHS07 | GHS09 | Dgr | H201 | H360Df | H332 | H302 | H373 ** H410 |   |   | 1
082-004-00-2 | lead chromate | 231-846-0 | 7758-97-6 | Carc. 1B | Repr. 1A | STOT RE 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H360Df H373** | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H360Df H373** | H410 |   |   | 1082-004-00-2 | оловен хромат | 231-846-0 | 7758-97-6 | Carc. 1B | Repr. 1A | STOT RE 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H360Df H373** | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H360Df H373** | H410 |   |   | 1
082-005-00-8 | lead di(acetate) | 206-104-4 | 301-04-2 | Repr. 1A | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H360Df | H373 ** | H400 | H410 | GHS08 | GHS09 | Dgr | H360Df | H373 ** H410 |   |   | 1082-005-00-8 | оловен ди(aцетат) | 206-104-4 | 301-04-2 | Repr. 1A | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H360Df | H373 ** | H400 | H410 | GHS08 | GHS09 | Dgr | H360Df | H373 ** H410 |   |   | 1
082-006-00-3 | trilead bis(orthophosphate) | 231-205-5 | 7446-27-7 | Repr. 1A | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H360Df | H373 ** | H400 | H410 | GHS08 | GHS09 | Dgr | H360Df | H373 ** H410 |   |   | 1082-006-00-3 | триоловен бис(oртофосфат) | 231-205-5 | 7446-27-7 | Repr. 1A | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H360Df | H373 ** | H400 | H410 | GHS08 | GHS09 | Dgr | H360Df | H373 ** H410 |   |   | 1
082-007-00-9 | lead acetate, basic | 215-630-3 | 1335-32-6 | Carc. 2 | Repr. 1A | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H360Df | H373 ** | H400 | H410 | GHS08 | GHS09 | Dgr | H351 | H360Df | H373 ** H410 |   |   | 1082-007-00-9 | оловен ацетат, основен | 215-630-3 | 1335-32-6 | Carc. 2 | Repr. 1A | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H360Df | H373 ** | H400 | H410 | GHS08 | GHS09 | Dgr | H351 | H360Df | H373 ** H410 |   |   | 1
082-008-00-4 | lead(II) methanesulphonate | 401-750-5 | 17570-76-2 | Repr. 1A | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | Eye Dam. 1 | H360Df | H332 | H302 | H373 ** | H315 | H318 | GHS08 | GHS05 | GHS07 | Dgr | H360Df | H332 | H302 | H373 ** H315 | H318 |   |   | 1082-008-00-4 | оловен(II) метансулфонат | 401-750-5 | 17570-76-2 | Repr. 1A | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | Eye Dam. 1 | H360Df | H332 | H302 | H373 ** | H315 | H318 | GHS08 | GHS05 | GHS07 | Dgr | H360Df | H332 | H302 | H373 ** H315 | H318 |   |   | 1
082-009-00-X | lead sulfochromate yellow; C.I. Pigment Yellow 34; | [This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77603.] | 215-693-7 | 1344-37-2 | Carc. 1B | Repr. 1A | STOT RE 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H360Df H373** | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H360Df H373** | H410 |   |   | 1082-009-00-X | оловен сулфохромат жълт; C.I. пигментно жълто 34; | [Това вещество е определено в Цветовия индекс с композиционен номер, C.I. 77603.] | 215-693-7 | 1344-37-2 | Carc. 1B | Repr. 1A | STOT RE 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H360Df H373** | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H360Df H373** | H410 |   |   | 1
082-010-00-5 | lead chromate molybdate sulfate red; C.I. Pigment Red 104; | [This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77605.] | 235-759-9 | 12656-85-8 | Carc. 1B | Repr. 1A | STOT RE 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H360Df H373** | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H360Df H373** | H410 |   |   | 1082-010-00-5 | оловен молибдат сулфат хромат червен; C.I. пигментно червено 104; | [Това вещество е определено в Цветовия индекс с композиционен номер, C.I. 77605.] | 235-759-9 | 12656-85-8 | Carc. 1B | Repr. 1A | STOT RE 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H360Df H373** | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H360Df H373** | H410 |   |   | 1
082-011-00-0 | lead hydrogen arsenate | 232-064-2 | 7784-40-9 | Carc. 1A | Repr. 1A | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H360Df | H331 | H301 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H360Df | H331 | H301 | H373 ** H410 |   |   | 1082-011-00-0 | оловен хидрогенарсенат | 232-064-2 | 7784-40-9 | Carc. 1A | Repr. 1A | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H360Df | H331 | H301 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H360Df | H331 | H301 | H373 ** H410 |   |   | 1
082-012-00-6 | barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped | 431-780-4 | 199876-46-5 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 2 | H302 | H373** | H411 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373** | H411 |   |   |  082-012-00-6 | бариев калциев оловен самариев стронциев цезиев бромид йодид флуорид хлорид, наситен с европий | 431-780-4 | 199876-46-5 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 2 | H302 | H373** | H411 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373** | H411 |   |   |  
092-001-00-8 | uranium | 231-170-6 | 7440-61-1 | Acute Tox. 2 * | Acute Tox. 2 * | STOT RE 2 * | Aquatic Chronic 4 | H330 | H300 | H373 ** | H413 | GHS06 | GHS08 | Dgr | H330 | H300 | H373 ** H413 |   |   |  092-001-00-8 | уран | 231-170-6 | 7440-61-1 | Acute Tox. 2 * | Acute Tox. 2 * | STOT RE 2 * | Aquatic Chronic 4 | H330 | H300 | H373 ** | H413 | GHS06 | GHS08 | Dgr | H330 | H300 | H373 ** H413 |   |   |  
092-002-00-3 | uranium compounds with the exception of those specified elsewhere in this Annex | — | — | Acute Tox. 2 * | Acute Tox. 2 * | STOT RE 2 | Aquatic Chronic 2 | H330 | H300 | H373** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H300 | H373** | H411 |   |   | A092-002-00-3 | уранови съединения с изключение на тези, посочени другаде в настоящото приложение | — | — | Acute Tox. 2 * | Acute Tox. 2 * | STOT RE 2 | Aquatic Chronic 2 | H330 | H300 | H373** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H300 | H373** | H411 |   |   | A
601-001-00-4 | methane | 200-812-7 | 74-82-8 | Flam. Gas 1 | Press. Gas | H220 | GHS02 | GHS04 | Dgr | H220 |   |   | U601-001-00-4 | метан | 200-812-7 | 74-82-8 | Flam. Gas 1 | Press. Gas | H220 | GHS02 | GHS04 | Dgr | H220 |   |   | U
601-002-00-X | ethane | 200-814-8 | 74-84-0 | Flam. Gas 1 | Press. Gas | H220 | GHS02 | GHS04 | Dgr | H220 |   |   | U601-002-00-X | етан | 200-814-8 | 74-84-0 | Flam. Gas 1 | Press. Gas | H220 | GHS02 | GHS04 | Dgr | H220 |   |   | U
601-003-00-5 | propane | 200-827-9 | 74-98-6 | Flam. Gas 1 | Press. Gas | H220 | GHS02 | GHS04 | Dgr | H220 |   |   | U601-003-00-5 | пропан | 200-827-9 | 74-98-6 | Flam. Gas 1 | Press. Gas | H220 | GHS02 | GHS04 | Dgr | H220 |   |   | U
601-004-00-0 | butane; [1] and isobutane [2] | 203-448-7 [1] | 200-857-2 [2] | 106-97-8 [1] | 75-28-5 [2] | Flam. Gas 1 | Press. Gas | H220 | GHS02 | GHS04 | Dgr | H220 |   |   | C U601-004-00-0 | бутан; [1] и изобутан [2] | 203-448-7 [1] | 200-857-2 [2] | 106-97-8 [1] | 75-28-5 [2] | Flam. Gas 1 | Press. Gas | H220 | GHS02 | GHS04 | Dgr | H220 |   |   | C U
601-004-01-8 | butane (containing ≥ 0,1 % butadiene (203-450-8)); [1] | isobutane (containing ≥ 0,1 % butadiene (203-450-8)) [2] | 203-448-7 [1] | 200-857-2 [2] | 106-97-8 [1] | 75-28-5 [2] | Flam. Gas 1 | Press. Gas | Carc. 1A | Muta. 1B | H220 | H350 | H340 | GHS02 | GHS04 | GHS08 | Dgr | H220 | H350 | H340 |   |   | C S U601-004-01-8 | бутан (съдържащ ≥ 0,1 % бутадиен (203-450-8)); [1] | изобутан (съдържащ ≥ 0,1 % бутадиен (203-450-8)) [2] | 203-448-7 [1] | 200-857-2 [2] | 106-97-8 [1] | 75-28-5 [2] | Flam. Gas 1 | Press. Gas | Carc. 1A | Muta. 1B | H220 | H350 | H340 | GHS02 | GHS04 | GHS08 | Dgr | H220 | H350 | H340 |   |   | C S U
601-005-00-6 | 2,2-dimethylpropane; | neopentane | 207-343-7 | 463-82-1 | Flam. Gas 1 | Press. Gas | Aquatic Chronic 2 | H220 | H411 | GHS02 | GHS04 | GHS09 | Dgr | H220 | H411 |   |   | U601-005-00-6 | 2,2-диметилпропан; | неопентан | 207-343-7 | 463-82-1 | Flam. Gas 1 | Press. Gas | Aquatic Chronic 2 | H220 | H411 | GHS02 | GHS04 | GHS09 | Dgr | H220 | H411 |   |   | U
601-006-00-1 | pentane | 203-692-4 | 109-66-0 | Flam. Liq. 2 | Asp. Tox. 1 | STOT SE 3 | Aquatic Chronic 2 | H225 | H304 | H336 | H411 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H225 | H304 | H336 | H411 | EUH066 |   | C601-006-00-1 | пентан | 203-692-4 | 109-66-0 | Flam. Liq. 2 | Asp. Tox. 1 | STOT SE 3 | Aquatic Chronic 2 | H225 | H304 | H336 | H411 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H225 | H304 | H336 | H411 | EUH066 |   | C
601-007-00-7 | hexane (containing < 5 % n-hexane (203-777-6)); | 2-methylpentane;[1] | 3-methylpentane; [2] | 2,2-dimethylbutane; [3] | 2,3-dimethylbutane [4] | 203-523-4 [1] | 202-481-4 [2] | 200-906-8 [3] | 201-193-6 [4] | 107-83-5 [1] | 96-14-0 [2] | 75-83-2 [3] | 79-29-8 [4] | Flam. Liq. 2 | Asp. Tox. 1 | Skin Irrit. 2 | STOT SE 3 | Aquatic Chronic 2 | H225 | H304 | H315 | H336 | H411 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H225 | H304 | H315 | H336 | H411 |   |   | C601-007-00-7 | хексан (съдържащ < 5 % n-хексан (203-777-6)); | 2-метилпентан;[1] | 3-метилпентан; [2] | 2,2-диметилбутан; [3] | 2,3-диметилбутан [4] | 203-523-4 [1] | 202-481-4 [2] | 200-906-8 [3] | 201-193-6 [4] | 107-83-5 [1] | 96-14-0 [2] | 75-83-2 [3] | 79-29-8 [4] | Flam. Liq. 2 | Asp. Tox. 1 | Skin Irrit. 2 | STOT SE 3 | Aquatic Chronic 2 | H225 | H304 | H315 | H336 | H411 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H225 | H304 | H315 | H336 | H411 |   |   | C
601-008-00-2 | heptane; n-heptane; [1] | 2,4-dimethylpentane; [2] | 2,2,3-trimethylbutane; [3] | 3,3-dimethylpentane; [4] | 2,3-dimethylpentane; [5] | 3-methylhexane; [6] | 2,2-dimethylpentane; [7] | 2-methylhexane; [8] | 3-ethylpentane; [9] | isoheptane; [10] | 205-563-8 [1] | 203-548-0 [2] | 207-346-3 [3] | 209-230-8 [4] | 209-280-0 [5] | 209-643-3 [6] | 209-680-5 [7] | 209-730-6 [8] | 210-529-0 [9] | 250-610-8 [10] | 142-82-5 [1] | 108-08-7 [2] | 464-06-2 [3] | 562-49-2 [4] | 565-59-3 [5] | 589-34-4 [6] | 590-35-2 [7] | 591-76-4 [8] | 617-78-7 [9] | 31394-54-4 [10] | Flam. Liq. 2 | Asp. Tox. 1 | Skin Irrit. 2 | STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H225 | H304 | H315 | H336 | H400 | H410 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H225 | H304 | H315 | H336 | H410 |   |   | C601-008-00-2 | хептан; n-хептан; [1] | 2,4-диметилпентан; [2] | 2,2,3-триметилбутан; [3] | 3,3-диметилпентан; [4] | 2,3-диметилпентан; [5] | 3-метилхексан; [6] | 2,2-диметилпентан; [7] | 2-метилхексан; [8] | 3-етилпентан; [9] | изохептан; [10] | 205-563-8 [1] | 203-548-0 [2] | 207-346-3 [3] | 209-230-8 [4] | 209-280-0 [5] | 209-643-3 [6] | 209-680-5 [7] | 209-730-6 [8] | 210-529-0 [9] | 250-610-8 [10] | 142-82-5 [1] | 108-08-7 [2] | 464-06-2 [3] | 562-49-2 [4] | 565-59-3 [5] | 589-34-4 [6] | 590-35-2 [7] | 591-76-4 [8] | 617-78-7 [9] | 31394-54-4 [10] | Flam. Liq. 2 | Asp. Tox. 1 | Skin Irrit. 2 | STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H225 | H304 | H315 | H336 | H400 | H410 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H225 | H304 | H315 | H336 | H410 |   |   | C
601-009-00-8 | octane; n-octane; [1] | 2,2,4-trimethylpentane; [2] | 2,3,3-trimethylpentane; [3] | 3,3-dimethylhexane; [4] | 2,2,3-trimethylpentane; [5] | 2,3,4-trimethylpentane; [6] | 3,4-dimethylhexane; [7] | 2,3-dimethylhexane; [8] | 2,4-dimethylhexane; [9] | 4-methylheptane; [10] | 3-methylheptane; [11] | 2,2-dimethylhexane; [12] | 2,5-dimethylhexane; [13] | 2-methylheptane; [14] | 2,2,3,3-tetramethylbutane; [15] | 3-ethyl-2-methylpentane; [16] | 3-ethylhexane; [17] | 3-ethyl-3-methylpentane; [18] | isooctane; [19] | 203-892-1 [1] | 208-759-1 [2] | 209-207-2 [3] | 209-243-9 [4] | 209-266-4 [5] | 209-292-6 [6] | 209-504-7 [7] | 209-547-1 [8] | 209-649-6 [9] | 209-650-1 [10] | 209-660-6 [11] | 209-689-4 [12] | 209-745-8 [13] | 209-747-9 [14] | 209-855-6 [15] | 210-187-2 [16] | 210-621-0 [17] | 213-923-0 [18] | 247-861-0 [19] | 111-65-9 [1] | 540-84-1 [2] | 560-21-4 [3] | 563-16-6 [4] | 564-02-3 [5] | 565-75-3 [6] | 583-48-2 [7] | 584-94-1 [8] | 589-43-5 [9] | 589-53-7 [10] | 589-81-1 [11] | 590-73-8 [12] | 592-13-2 [13] | 592-27-8 [14] | 594-82-1 [15] | 609-26-7 [16] | 619-99-8 [17] | 1067-08-9 [18] | 26635-64-3 [19] | Flam. Liq. 2 | Asp. Tox. 1 | Skin Irrit. 2 | STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H225 | H304 | H315 | H336 | H400 | H410 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H225 | H304 | H315 | H336 | H410 |   |   | C601-009-00-8 | октан; n-октан; [1] | 2,2,4-триметилпентан; [2] | 2,3,3-триметилпентан; [3] | 3,3-диметилхексан; [4] | 2,2,3-триметилпентан; [5] | 2,3,4-триметилпентан; [6] | 3,4-диметилхексан; [7] | 2,3-диметилхексан; [8] | 2,4-диметилхексан; [9] | 4-метилхептан; [10] | 3-метилхептан; [11] | 2,2-диметилхексан; [12] | 2,5-диметилхексан; [13] | 2-метилхептан; [14] | 2,2,3,3-тетраметилбутан; [15] | 3-етил-2-метилпентан; [16] | 3-етилхексан; [17] | 3-етил-3-метилпентан; [18] | изооктан; [19] | 203-892-1 [1] | 208-759-1 [2] | 209-207-2 [3] | 209-243-9 [4] | 209-266-4 [5] | 209-292-6 [6] | 209-504-7 [7] | 209-547-1 [8] | 209-649-6 [9] | 209-650-1 [10] | 209-660-6 [11] | 209-689-4 [12] | 209-745-8 [13] | 209-747-9 [14] | 209-855-6 [15] | 210-187-2 [16] | 210-621-0 [17] | 213-923-0 [18] | 247-861-0 [19] | 111-65-9 [1] | 540-84-1 [2] | 560-21-4 [3] | 563-16-6 [4] | 564-02-3 [5] | 565-75-3 [6] | 583-48-2 [7] | 584-94-1 [8] | 589-43-5 [9] | 589-53-7 [10] | 589-81-1 [11] | 590-73-8 [12] | 592-13-2 [13] | 592-27-8 [14] | 594-82-1 [15] | 609-26-7 [16] | 619-99-8 [17] | 1067-08-9 [18] | 26635-64-3 [19] | Flam. Liq. 2 | Asp. Tox. 1 | Skin Irrit. 2 | STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H225 | H304 | H315 | H336 | H400 | H410 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H225 | H304 | H315 | H336 | H410 |   |   | C
601-010-00-3 | ethylene | 200-815-3 | 74-85-1 | Flam. Gas 1 | Press. Gas | STOT SE 3 | H220 | H336 | GHS02 | GHS04 | GHS07 | Dgr | H220 | H336 |   |   | U601-010-00-3 | етилен | 200-815-3 | 74-85-1 | Flam. Gas 1 | Press. Gas | STOT SE 3 | H220 | H336 | GHS02 | GHS04 | GHS07 | Dgr | H220 | H336 |   |   | U
601-011-00-9 | propene; | propylene | 204-062-1 | 115-07-1 | Flam. Gas 1 | Press. Gas | H220 | GHS02 | GHS04 | Dgr | H220 |   |   | U601-011-00-9 | пропен; | пропилен | 204-062-1 | 115-07-1 | Flam. Gas 1 | Press. Gas | H220 | GHS02 | GHS04 | Dgr | H220 |   |   | U
601-012-00-4 | but-1-ene; [1] | butene, mixed-1-and-2-isomers; [2] | 2-methylpropene; [3] | (Z)-but-2-ene; [4] | (E)-but-2-ene [5] | 203-449-2 [1] | 203-452-9 [2] | 204-066-3 [3] | 209-673-7 [4] | 210-855-3 [5] | 106-98-9 [1] | 107-01-7 [2] | 115-11-7 [3] | 590-18-1 [4] | 624-64-6 [5] | Flam. Gas 1 | Press. Gas | H220 | GHS02 | GHS04 | Dgr | H220 |   |   | C U601-012-00-4 | бут-1-eн; [1] | бутен, смес от 1- и 2- изомери; [2] | 2-мeтилпропен; [3] | (Z)-бут-2-eн; [4] | (E)-бут-2-eн [5] | 203-449-2 [1] | 203-452-9 [2] | 204-066-3 [3] | 209-673-7 [4] | 210-855-3 [5] | 106-98-9 [1] | 107-01-7 [2] | 115-11-7 [3] | 590-18-1 [4] | 624-64-6 [5] | Flam. Gas 1 | Press. Gas | H220 | GHS02 | GHS04 | Dgr | H220 |   |   | C U
601-013-00-X | 1,3-butadiene; | buta-1,3-diene | 203-450-8 | 106-99-0 | Flam. Gas 1 | Press. Gas | Carc. 1A | Muta. 1B | H220 | H350 | H340 | GHS02 | GHS04 | GHS08 | Dgr | H220 | H350 | H340 |   |   | D U601-013-00-X | 1,3-бутадиен; | бута-1,3-диен | 203-450-8 | 106-99-0 | Flam. Gas 1 | Press. Gas | Carc. 1A | Muta. 1B | H220 | H350 | H340 | GHS02 | GHS04 | GHS08 | Dgr | H220 | H350 | H340 |   |   | D U
601-014-00-5 | isoprene (stabilised) | 2-methyl-1,3-butadiene | 201-143-3 | 78-79-5 | Flam. Liq. 1 | Carc. 1B Muta. 2 | Aquatic Chronic 3 | H224 | H350 | H341 | H412 | GHS02 | GHS08 | Dgr | H224 | H350 | H341 | H412 |   |   | D601-014-00-5 | изопрен (стабилизиран) | 2-метил-1,3-бутадиен | 201-143-3 | 78-79-5 | Flam. Liq. 1 | Carc. 1B Muta. 2 | Aquatic Chronic 3 | H224 | H350 | H341 | H412 | GHS02 | GHS08 | Dgr | H224 | H350 | H341 | H412 |   |   | D
601-016-00-6 | cyclopropane | 200-847-8 | 75-19-4 | Flam. Gas 1 | Press. Gas | H220 | GHS02 | GHS04 | Dgr | H220 |   |   | U601-016-00-6 | циклопропан | 200-847-8 | 75-19-4 | Flam. Gas 1 | Press. Gas | H220 | GHS02 | GHS04 | Dgr | H220 |   |   | U
601-017-00-1 | cyclohexane | 203-806-2 | 110-82-7 | Flam. Liq. 2 | Asp. Tox. 1 | Skin Irrit. 2 | STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H225 | H304 | H315 | H336 | H400 | H410 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H225 | H304 | H315 | H336 | H410 |   |   |  601-017-00-1 | циклохексан | 203-806-2 | 110-82-7 | Flam. Liq. 2 | Asp. Tox. 1 | Skin Irrit. 2 | STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H225 | H304 | H315 | H336 | H400 | H410 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H225 | H304 | H315 | H336 | H410 |   |   |  
601-018-00-7 | methylcyclohexane | 203-624-3 | 108-87-2 | Flam. Liq. 2 | Asp. Tox. 1 | Skin Irrit. 2 | STOT SE 3 | Aquatic Chronic 2 | H225 | H304 | H315 | H336 | H411 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H225 | H304 | H315 | H336 | H411 |   |   |  601-018-00-7 | метилциклохексан | 203-624-3 | 108-87-2 | Flam. Liq. 2 | Asp. Tox. 1 | Skin Irrit. 2 | STOT SE 3 | Aquatic Chronic 2 | H225 | H304 | H315 | H336 | H411 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H225 | H304 | H315 | H336 | H411 |   |   |  
601-019-00-2 | 1,4-dimethylcyclohexane | 209-663-2 | 589-90-2 | Flam. Liq. 2 | Asp. Tox. 1 | Skin Irrit. 2 | STOT SE 3 | Aquatic Chronic 2 | H225 | H304 | H315 | H336 | H411 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H225 | H304 | H315 | H336 | H411 |   |   |  601-019-00-2 | 1,4-диметилциклохексан | 209-663-2 | 589-90-2 | Flam. Liq. 2 | Asp. Tox. 1 | Skin Irrit. 2 | STOT SE 3 | Aquatic Chronic 2 | H225 | H304 | H315 | H336 | H411 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H225 | H304 | H315 | H336 | H411 |   |   |  
601-020-00-8 | benzene | 200-753-7 | 71-43-2 | Flam. Liq. 2 | Carc. 1a | Muta. 1B | STOT RE 1 | Asp. Tox. 1 | Eye Irrit. 2 | Skin Irrit. 2 | H225 | H350 | H340 | H372 ** | H304 | H319 | H315 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H350 | H340 | H372 ** H304 | H319 | H315 |   |   | E601-020-00-8 | бензен | 200-753-7 | 71-43-2 | Flam. Liq. 2 | Carc. 1a | Muta. 1B | STOT RE 1 | Asp. Tox. 1 | Eye Irrit. 2 | Skin Irrit. 2 | H225 | H350 | H340 | H372 ** | H304 | H319 | H315 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H350 | H340 | H372 ** H304 | H319 | H315 |   |   | E
601-021-00-3 | toluene | 203-625-9 | 108-88-3 | Flam. Liq. 2 | Repr. 2 | Asp. Tox. 1 | STOT RE 2 * | Skin Irrit. 2 | STOT SE 3 | H225 | H361d *** H304 | H373 ** | H315 | H336 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H361d *** H304 | H373 ** H315 | H336 |   |   |  601-021-00-3 | толуен | 203-625-9 | 108-88-3 | Flam. Liq. 2 | Repr. 2 | Asp. Tox. 1 | STOT RE 2 * | Skin Irrit. 2 | STOT SE 3 | H225 | H361d *** H304 | H373 ** | H315 | H336 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H361d *** H304 | H373 ** H315 | H336 |   |   |  
601-022-00-9 | o-xylene; [1] | p-xylene; [2] | m-xylene; [3] | xylene [4] | 202-422-2 [1] | 203-396-5 [2] | 203-576-3 [3] | 215-535-7 [4] | 95-47-6 [1] | 106-42-3 [2] | 108-38-3 [3] | 1330-20-7 [4] | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | H226 | H332 | H312 | H315 | GHS02 | GHS07 | Wng | H226 | H332 | H312 | H315 |   | * | C601-022-00-9 | o-ксилен; [1] | p-ксилен; [2] | m-ксилен; [3] | ксилен [4] | 202-422-2 [1] | 203-396-5 [2] | 203-576-3 [3] | 215-535-7 [4] | 95-47-6 [1] | 106-42-3 [2] | 108-38-3 [3] | 1330-20-7 [4] | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | H226 | H332 | H312 | H315 | GHS02 | GHS07 | Wng | H226 | H332 | H312 | H315 |   | * | C
601-023-00-4 | ethylbenzene | 202-849-4 | 100-41-4 | Flam. Liq. 2 | Acute Tox. 4* | STOT RE 2 | Asp. Tox. 1 | H225 | H332 | H373 | (hearing organs) | H304 | GHS02 | GHS07 | GHS08 | Dgr | H225 | H332 | H373 | (hearing organs) | H304 |   |   |  601-023-00-4 | етилбензен | 202-849-4 | 100-41-4 | Flam. Liq. 2 | Acute Tox. 4* | STOT RE 2 | Asp. Tox. 1 | H225 | H332 | H373 | (слухови органи) | H304 | GHS02 | GHS07 | GHS08 | Dgr | H225 | H332 | H373 | (слухови органи) | H304 |   |   |  
601-024-00-X | cumene; [1] | propylbenzene [2] | 202-704-5 [1] | 203-132-9 [2] | 98-82-8 [1] | 103-65-1 [2] | Flam. Liq. 3 | Asp. Tox. 1 | STOT SE 3 | Aquatic Chronic 2 | H226 | H304 | H335 | H411 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H226 | H304 | H335 | H411 |   |   | C601-024-00-X | кумен; [1] | пропилбензен [2] | 202-704-5 [1] | 203-132-9 [2] | 98-82-8 [1] | 103-65-1 [2] | Flam. Liq. 3 | Asp. Tox. 1 | STOT SE 3 | Aquatic Chronic 2 | H226 | H304 | H335 | H411 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H226 | H304 | H335 | H411 |   |   | C
601-025-00-5 | mesitylene; | 1,3,5-trimethylbenzene | 203-604-4 | 108-67-8 | Flam. Liq. 3 | STOT SE 3 | Aquatic Chronic 2 | H226 | H335 | H411 | GHS02 | GHS07 | GHS09 | Wng | H226 | H335 | H411 |   | STOT SE 3; H335: C ≥ 25 % |  601-025-00-5 | мезитилен; | 1,3,5-триметилбензен | 203-604-4 | 108-67-8 | Flam. Liq. 3 | STOT SE 3 | Aquatic Chronic 2 | H226 | H335 | H411 | GHS02 | GHS07 | GHS09 | Wng | H226 | H335 | H411 |   | STOT SE 3; H335: C ≥ 25 % |  
601-026-00-0 | styrene | 202-851-5 | 100-42-5 | Flam. Liq. 3 | Repr. 2 | Acute Tox. 4* | STOT RE 1 | Skin Irrit. 2 | Eye Irrit. 2 | H226 | H361d | H332 | H372 | (hearing organs) | H315 | H319 | GHS02 | GHS08 | GHS07 | Dgr | H226 | H361d | H332 | H372 | (hearing organs) | H315 | H319 |   | * | D601-026-00-0 | стирен | 202-851-5 | 100-42-5 | Flam. Liq. 3 | Repr. 2 | Acute Tox. 4* | STOT RE 1 | Skin Irrit. 2 | Eye Irrit. 2 | H226 | H361d | H332 | H372 | (слухови органи) | H315 | H319 | GHS02 | GHS08 | GHS07 | Dgr | H226 | H361d | H332 | H372 | (слухови органи) | H315 | H319 |   | * | D
601-027-00-6 | 2-phenylpropene; | α-methylstyrene | 202-705-0 | 98-83-9 | Flam. Liq. 3 | Eye Irrit. 2 | STOT SE 3 | Aquatic Chronic 2 | H226 | H319 | H335 | H411 | GHS02 | GHS07 | GHS09 | Wng | H226 | H319 | H335 | H411 |   | STOT SE 3; H335: C ≥ 25 % |  601-027-00-6 | 2-фенилпропен; | α-метилстирен | 202-705-0 | 98-83-9 | Flam. Liq. 3 | Eye Irrit. 2 | STOT SE 3 | Aquatic Chronic 2 | H226 | H319 | H335 | H411 | GHS02 | GHS07 | GHS09 | Wng | H226 | H319 | H335 | H411 |   | STOT SE 3; H335: C ≥ 25 % |  
601-028-00-1 | 2-methylstyrene; | 2-vinyltoluene | 210-256-7 | 611-15-4 | Acute Tox. 4 * | Aquatic Chronic 2 | H332 | H411 | GHS07 | GHS09 | Wng | H332 | H411 |   |   |  601-028-00-1 | 2-метилстирен; | 2-винилтолуен | 210-256-7 | 611-15-4 | Acute Tox. 4 * | Aquatic Chronic 2 | H332 | H411 | GHS07 | GHS09 | Wng | H332 | H411 |   |   |  
601-029-00-7 | dipentene; limonene;[1] | (R)-p-mentha-1,8-diene; | d-limonene; [2] | (S)-p-mentha-1,8-diene; l-limonene; [3] | trans-1-methyl-4-(1-methylvinyl)cyclohexene; [4] | (±)-1-methyl-4-(1-methylvinyl)cyclohexene [5] | 205-341-0 [1] | 227-813-5 [2] | 227-815-6 [3] | 229-977-3 [4] | 231-732-0 [5] | 138-86-3 [1] | 5989-27-5 [2] | 5989-54-8 [3] | 6876-12-6 [4] | 7705-14-8 [5] | Flam. Liq. 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H226 | H315 | H317 | H400 | H410 | GHS02 | GHS07 | GHS09 | Wng | H226 | H315 | H317 | H410 |   |   | C601-029-00-7 | дипентен; лимонен;[1] | (R)-p-мeнта-1,8-диен; | d-лимонен; [2] | (S)-p-мeнта-1,8-диен; l-лимонен; [3] | транс-1-мeтил-4-(1-метилвинил)циклохексен; [4] | (±)-1-мeтил-4-(1-метилвинил)циклохексен [5] | 205-341-0 [1] | 227-813-5 [2] | 227-815-6 [3] | 229-977-3 [4] | 231-732-0 [5] | 138-86-3 [1] | 5989-27-5 [2] | 5989-54-8 [3] | 6876-12-6 [4] | 7705-14-8 [5] | Flam. Liq. 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H226 | H315 | H317 | H400 | H410 | GHS02 | GHS07 | GHS09 | Wng | H226 | H315 | H317 | H410 |   |   | C
601-030-00-2 | cyclopentane | 206-016-6 | 287-92-3 | Flam. Liq. 2 | Aquatic Chronic 3 | H225 | H412 | GHS02 | Dgr | H225 | H412 |   |   |  601-030-00-2 | циклопентан | 206-016-6 | 287-92-3 | Flam. Liq. 2 | Aquatic Chronic 3 | H225 | H412 | GHS02 | Dgr | H225 | H412 |   |   |  
601-031-00-8 | 2,4,4-trimethylpent-1-ene | 203-486-4 | 107-39-1 | Flam. Liq. 2 | Aquatic Chronic 2 | H225 | H411 | GHS02 | GHS09 | Dgr | H225 | H411 |   |   |  601-031-00-8 | 2,4,4-триметилпент-1-eн | 203-486-4 | 107-39-1 | Flam. Liq. 2 | Aquatic Chronic 2 | H225 | H411 | GHS02 | GHS09 | Dgr | H225 | H411 |   |   |  
601-032-00-3 | benzo[a]pyrene; | benzo[def]chrysene | 200-028-5 | 50-32-8 | Carc. 1B | Muta. 1B | Repr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H340 | H360FD | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H340 | H360FD H317 | H410 |   | Carc. 1B; H350: C ≥ 0,01  % |  601-032-00-3 | бензо[a]пирен; | бензо[def]хризен | 200-028-5 | 50-32-8 | Carc. 1B | Muta. 1B | Repr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H340 | H360FD | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H340 | H360FD H317 | H410 |   | Carc. 1B; H350: C ≥ 0,01  % |  
601-033-00-9 | benz[a]anthracene | 200-280-6 | 56-55-3 | Carc. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H410 |   | M=100 |  601-033-00-9 | бенз[a]антрацен | 200-280-6 | 56-55-3 | Carc. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H410 |   | M=100 |  
601-034-00-4 | benz[e]acephenanthrylene | 205-911-9 | 205-99-2 | Carc. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H410 |   |   |  601-034-00-4 | бенз[e]ацефенантрилен | 205-911-9 | 205-99-2 | Carc. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H410 |   |   |  
601-035-00-X | benzo[j]fluoranthene | 205-910-3 | 205-82-3 | Carc. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H410 |   |   |  601-035-00-X | бензо[j]флуорантен | 205-910-3 | 205-82-3 | Carc. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H410 |   |   |  
601-036-00-5 | benzo[k]fluoranthene | 205-916-6 | 207-08-9 | Carc. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H410 |   |   |  601-036-00-5 | бензо[k]флуорантен | 205-916-6 | 207-08-9 | Carc. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H410 |   |   |  
601-037-00-0 | n-hexane | 203-777-6 | 110-54-3 | Flam. Liq. 2 | Repr. 2 | Asp. Tox. 1 | STOT RE 2 * | Skin Irrit. 2 | STOT SE 3 | Aquatic Chronic 2 | H225 | H361f *** H304 | H373 ** | H315 | H336 | H411 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H225 | H361f *** H304 | H373 ** H315 | H336 | H411 |   | STOT RE 2; H373: C ≥ 5 % |  601-037-00-0 | n-хексан | 203-777-6 | 110-54-3 | Flam. Liq. 2 | Repr. 2 | Asp. Tox. 1 | STOT RE 2 * | Skin Irrit. 2 | STOT SE 3 | Aquatic Chronic 2 | H225 | H361f *** H304 | H373 ** | H315 | H336 | H411 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H225 | H361f *** H304 | H373 ** H315 | H336 | H411 |   | STOT RE 2; H373: C ≥ 5 % |  
601-041-00-2 | dibenz[a,h]anthracene | 200-181-8 | 53-70-3 | Carc. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H410 |   | Carc. 1B; H350: C ≥ 0,01  % M=100 |  601-041-00-2 | дибенз[a,h]антрацен | 200-181-8 | 53-70-3 | Carc. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H410 |   | Carc. 1B; H350: C ≥ 0,01  % M=100 |  
601-042-00-8 | biphenyl; | diphenyl | 202-163-5 | 92-52-4 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H335 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H410 |   |   |  601-042-00-8 | бифенил; | дифенил | 202-163-5 | 92-52-4 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H335 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H410 |   |   |  
601-043-00-3 | 1,2,4-trimethylbenzene | 202-436-9 | 95-63-6 | Flam. Liq. 3 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Chronic 2 | H226 | H332 | H319 | H335 | H315 | H411 | GHS02 | GHS07 | GHS09 | Wng | H226 | H332 | H319 | H335 | H315 | H411 |   |   |  601-043-00-3 | 1,2,4-триметилбензен | 202-436-9 | 95-63-6 | Flam. Liq. 3 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Chronic 2 | H226 | H332 | H319 | H335 | H315 | H411 | GHS02 | GHS07 | GHS09 | Wng | H226 | H332 | H319 | H335 | H315 | H411 |   |   |  
601-044-00-9 | 3a,4,7,7a-tetrahydro-4,7-methanoindene | 201-052-9 | 77-73-6 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Chronic 2 | H225 | H332 | H302 | H319 | H335 | H315 | H411 | GHS02 | GHS07 | GHS09 | Dgr | H225 | H332 | H302 | H319 | H335 | H315 | H411 |   |   |  601-044-00-9 | 3a,4,7,7a-тeтрахидро-4,7-метаноинден | 201-052-9 | 77-73-6 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Chronic 2 | H225 | H332 | H302 | H319 | H335 | H315 | H411 | GHS02 | GHS07 | GHS09 | Dgr | H225 | H332 | H302 | H319 | H335 | H315 | H411 |   |   |  
601-045-00-4 | 1,2,3,4-tetrahydronaphthalene | 204-340-2 | 119-64-2 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 2 | H319 | H315 | H411 | GHS07 | GHS09 | Wng | H319 | H315 | H411 | EUH019 |   |  601-045-00-4 | 1,2,3,4-тeтрахидронафталeн | 204-340-2 | 119-64-2 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 2 | H319 | H315 | H411 | GHS07 | GHS09 | Wng | H319 | H315 | H411 | EUH019 |   |  
601-046-00-X | 7-methylocta-1,6-diene | 404-210-7 | 42152-47-6 | Flam. Liq. 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H226 | H400 | H410 | GHS02 | GHS09 | Wng | H226 | H410 |   |   |  601-046-00-X | 7-мeтилокта-1,6-диен | 404-210-7 | 42152-47-6 | Flam. Liq. 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H226 | H400 | H410 | GHS02 | GHS09 | Wng | H226 | H410 |   |   |  
601-047-00-5 | m-mentha-1,3(8)-diene | 404-150-1 | 17092-80-7 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  601-047-00-5 | m-мeнта-1,3(8)-диен | 404-150-1 | 17092-80-7 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
601-048-00-0 | chrysene | 205-923-4 | 218-01-9 | Carc. 1B Muta. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H341 | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H341 | H410 |   |   |  601-048-00-0 | хризен | 205-923-4 | 218-01-9 | Carc. 1B Muta. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H341 | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H341 | H410 |   |   |  
601-049-00-6 | benzo[e]pyrene | 205-892-7 | 192-97-2 | Carc. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H410 |   |   |  601-049-00-6 | бензо[e]пирен | 205-892-7 | 192-97-2 | Carc. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H410 |   |   |  
601-051-00-7 | 4-phenylbut-1-ene | 405-980-7 | 768-56-9 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  601-051-00-7 | 4-фенилбут-1-eн | 405-980-7 | 768-56-9 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
601-052-00-2 | naphthalene | 202-049-5 | 91-20-3 | Carc. 2 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H302 | H400 | H410 | GHS07 | GHS08 | GHS09 | Wng | H351 | H302 | H410 |   |   |  601-052-00-2 | нафтален | 202-049-5 | 91-20-3 | Carc. 2 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H302 | H400 | H410 | GHS07 | GHS08 | GHS09 | Wng | H351 | H302 | H410 |   |   |  
601-053-00-8 | nonylphenol; [1] | 4-nonylphenol, branched [2] | 246-672-0 [1] | 284-325-5 [2] | 25154-52-3 [1] | 84852-15-3 [2] | Repr. 2 | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H361fd | H302 | H314 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H361fd | H302 | H314 | H410 |   |   |  601-053-00-8 | нонилфенол; [1] | 4-нонилфенол, разклонен [2] | 246-672-0 [1] | 284-325-5 [2] | 25154-52-3 [1] | 84852-15-3 [2] | Repr. 2 | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H361fd | H302 | H314 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H361fd | H302 | H314 | H410 |   |   |  
601-054-00-3 | reaction mass of isomers of: dibenzylbenzene; dibenzyl(methyl)benzene; dibenzyl(dimethyl)benzene; dibenzyl(trimethyl)benzene | 405-570-8 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  601-054-00-3 | реакционна маса от изомери на: дибензилбензен; дибензил(метил)бензен; дибензил(диметил)бензен; дибензил(триметил)бензен | 405-570-8 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
601-055-00-9 | reaction mass of isomers of: mono-(2-tetradecyl)naphthalenes; di-(2-tetradecyl)naphthalenes; tri-(2-tetradecyl)naphthalenes | 410-190-0 | 132983-41-6 | Eye Irrit. 2 | Aquatic Chronic 4 | H319 | H413 | GHS07 | Wng | H319 | H413 |   |   |  601-055-00-9 | реакционна маса от изомери на: мoно(2-тетрадецил)нафталени; ди(2-тетрадецил)нафталени; три(2-тетрадецил)нафталени | 410-190-0 | 132983-41-6 | Eye Irrit. 2 | Aquatic Chronic 4 | H319 | H413 | GHS07 | Wng | H319 | H413 |   |   |  
601-056-00-4 | reaction mass of isomers of: methyldiphenylmethane; dimethyldiphenylmethane | 405-470-4 | 73807-39-3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H410 |   |   |  601-056-00-4 | реакционна маса от изомери на: метилдифенилметан; диметилдифенилметан | 405-470-4 | 73807-39-3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H410 |   |   |  
601-057-00-X | N-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate | 421-130-8 | 156679-41-3 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H410 |   |   |  601-057-00-X | N-додецил-[3-(4-диметиламино)бензамидо)пропил]диметиламониев тозилат | 421-130-8 | 156679-41-3 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H410 |   |   |  
601-058-00-5 | di-L-para-menthene | 417-870-6 | 83648-84-4 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H317 | H410 |   |   |  601-058-00-5 | ди-L-p-ментен | 417-870-6 | 83648-84-4 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H317 | H410 |   |   |  
601-059-00-0 | methyl 2-benzylidene-3-oxobutyrate | 420-940-9 | 15768-07-7 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 2 | H319 | H315 | H411 | GHS07 | GHS09 | Wng | H319 | H315 | H411 |   |   |  601-059-00-0 | метилов 2-бензилиден-3-оксобутират | 420-940-9 | 15768-07-7 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 2 | H319 | H315 | H411 | GHS07 | GHS09 | Wng | H319 | H315 | H411 |   |   |  
601-060-00-6 | 1,2-bis[4-fluoro-6-{4-sulfo-5-(2-(4-sulfonaphtalene-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalene-7-ylazo)phenylamino}-1,3,5-triazin-2ylamino]ethane; | x-sodium, y-potassium salts x = 7,755 y =0,245 | 417-610-1 | 155522-09-1 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  601-060-00-6 | 1,2-бис[4-флуоро-6-{4-сулфо-5-(2-(4-сулфонафтален-3-илазо)-1-хидрокси-3,6-дисулфо-8-аминонафтален-7-илазо)фенилaмино}-1,3,5-триазин-2-иламино]етан; | x-натриеви, y-калиеви соли x = 7,755 y = 0,245 | 417-610-1 | 155522-09-1 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
601-061-00-1 | (ethyl-1,2-ethanediyl)[-2-[[[(2-hydroxyethyl)methylamino]acetyl]-propyl]ω-(nonylphenoxy)poly]oxy-(methyl-1,2-ethanediyl) | 418-960-8 | — | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H314 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H317 | H411 |   |   |  601-061-00-1 | (етил-1,2-етандиил)[-2-[[[(2-хидроксиетил)метиламино]aцетил]пропил]-ω-(нонилфенокси)поли]окси(метил-1,2-етандиил) | 418-960-8 | — | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H314 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H317 | H411 |   |   |  
601-062-00-7 | reaction mass of: branched triacontane; | branched dotriacontane; | branched tetratriacontane; | branched hexatriacontane | 417-030-9 | 151006-59-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  601-062-00-7 | реакционна маса от: разклонен триaконтан; | разклонен дотриаконтан; | разклонен тетратриaконтан; | разклонен хексатриaконтан | 417-030-9 | 151006-59-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
601-063-00-2 | reaction mass of isomers of branched tetracosane | 417-060-2 | 151006-61-0 | Acute Tox. 4 * | Aquatic Chronic 4 | H332 | H413 | GHS07 | Wng | H332 | H413 |   |   |  601-063-00-2 | реакционна маса от изомери на разклонен тетракозан | 417-060-2 | 151006-61-0 | Acute Tox. 4 * | Aquatic Chronic 4 | H332 | H413 | GHS07 | Wng | H332 | H413 |   |   |  
601-064-00-8 | branched hexatriacontane | 417-070-7 | 151006-62-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  601-064-00-8 | разклонен хексатриaконтан | 417-070-7 | 151006-62-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
601-065-00-3 | reaction mass of: (1'α, 3'α, 6'α)-2,2,3' ,7', 7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane); | (1'α, 3'β, 6'α)-2,2,3', 7', 7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane) | 416-930-9 | — | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  601-065-00-3 | реакционна маса от: (1′α,3′α,6′α)-2,2,3′,7′,7′-пентаметилспиро(1,3-диоксан-5,2′-норкаран); | (1′α,3′β,6′α)-2,2,3′,7′,7′-пентаметилспиро(1,3-диоксан-5,2′-норкаран) | 416-930-9 | — | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
601-066-00-9 | 1-(4-(trans-4-heptylcyclohexyl)phenyl) ethanone | 426-820-2 | 78531-60-9 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  601-066-00-9 | 1-(4-(транс-4-хептилциклохексил)фенил)етанон | 426-820-2 | 78531-60-9 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
601-067-00-4 | triethyl arsenate | 427-700-2 | 15606-95-8 | Carc. 1A | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H331 | H301 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H331 | H301 | H410 |   |   |  601-067-00-4 | триетилов арсенат | 427-700-2 | 15606-95-8 | Carc. 1A | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H331 | H301 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H331 | H301 | H410 |   |   |  
601-068-00-X | 1,2-diacetoxybut-3-ene | 421-720-5 | 18085-02-4 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  601-068-00-X | 1,2-диaцетоксибут-3-ен | 421-720-5 | 18085-02-4 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
601-069-00-5 | 2-ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridinium bromide | 422-680-1 | 287933-44-2 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  601-069-00-5 | 2-етил-1-(2-(1,3-диoксанил)етил)пиридиниев бромид | 422-680-1 | 287933-44-2 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
601-070-00-0 | reaction mass of: branched icosane; branched docosane; branched tetracosane | 417-050-8 | 151006-58-5 | Acute Tox. 4 * | Aquatic Chronic 4 | H332 | H413 | GHS07 | Wng | H332 | H413 |   |   |  601-070-00-0 | реакционна маса от: разклонен икозан; разклонен докозан; разклонен тетракозан | 417-050-8 | 151006-58-5 | Acute Tox. 4 * | Aquatic Chronic 4 | H332 | H413 | GHS07 | Wng | H332 | H413 |   |   |  
601-071-00-6 | 1-dimethoxymethyl-2-nitro-benzene | 423-830-9 | 20627-73-0 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  601-071-00-6 | 1-диметоксиметил-2-нитробензен | 423-830-9 | 20627-73-0 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
601-072-00-1 | reaction mass of: 1-(4-isopropylphenyl)-1-phenylethane; | 1-(3-isopropylphenyl)-1-phenylethane; | 1-(2-isopropylphenyl)-1-phenylethane | 430-690-2 | 52783-21-8 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H410 |   |   |  601-072-00-1 | реакционна маса от: 1-(4-изопропилфенил)-1-фенилетан; | 1-(3-изопропилфенил)-1-фенилетан; | 1-(2-изопропилфенил)-1-фенилетан | 430-690-2 | 52783-21-8 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H410 |   |   |  
601-073-00-7 | 1-bromo-3,5-difluorobenzene | 416-710-2 | 461-96-1 | Flam. Liq. 3 | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H226 | H302 | H373 ** H315 | H317 | H400 | H410 | GHS02 | GHS08 | GHS07 | GHS09 | Wng | H226 | H302 | H373 ** H315 | H317 | H410 |   |   |  601-073-00-7 | 1-бромо-3,5-дифлуоробензен | 416-710-2 | 461-96-1 | Flam. Liq. 3 | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H226 | H302 | H373 ** H315 | H317 | H400 | H410 | GHS02 | GHS08 | GHS07 | GHS09 | Wng | H226 | H302 | H373 ** H315 | H317 | H410 |   |   |  
601-074-00-2 | reaction mass of: 4-(2,2,3-trimethylcyclopent-3-en-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octane; | 1-(2,2,3-trimethylcyclopent-3-en-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octane; spiro[cyclohex-3-en-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]furan]; spiro[cyclohex-3-en-1-yl-[4,5,6,6a-tetrahydro-4,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]]furan] | 422-040-1 | — | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 2 | H319 | H315 | H411 | GHS07 | GHS09 | Wng | H319 | H315 | H411 |   |   |  601-074-00-2 | реакционна маса от: 4-(2,2,3-триметилциклопент-3-ен-1-ил)-1-метил-2-оксабицикло[2.2.2]октан; | 1-(2,2,3-триметилциклопент-3-ен-1-ил)-5-метил-6-оксабицикло[3.2.1]октан; спиро[циклохекс-3-ен-1-ил-[(4,5,6,6a-тетрахидро-3,6′,6′,6′a-тетраметил)-1,3′(3′aH)-[2H]-циклопента[b]фуран]; спиро[циклохекс-3-ен-1-ил-[(4,5,6,6a-тетрахидро-4,6′,6′,6′a-тетраметил)-1,3′(3′aH)-[2H]-циклопента[b]]фуран] | 422-040-1 | — | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 2 | H319 | H315 | H411 | GHS07 | GHS09 | Wng | H319 | H315 | H411 |   |   |  
601-075-00-8 | 4,4'-bis(N-carbamoyl-4-methylbenzenesulfonamide)diphenylmethane | 418-770-5 | 151882-81-4 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  601-075-00-8 | 4,4′-бис(N-карбамоил-4-метилбензенсулфонамид)дифенилметан | 418-770-5 | 151882-81-4 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  
601-076-00-3 | ethynyl cyclopropane | 425-430-1 | 6746-94-7 | Flam. Liq. 2 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H225 | H315 | H318 | H412 | GHS02 | GHS05 | Dgr | H225 | H315 | H318 | H412 |   |   |  601-076-00-3 | етинилциклопропан | 425-430-1 | 6746-94-7 | Flam. Liq. 2 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H225 | H315 | H318 | H412 | GHS02 | GHS05 | Dgr | H225 | H315 | H318 | H412 |   |   |  
601-077-00-9 | reaction mass of: 1-heptyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane; | 1-nonyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane | 426-510-7 | 196965-91-0 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  601-077-00-9 | реакционна маса от: 4-етил-1-хептил-2,6,7-триоксабицикло[2.2.2]октан; | 4-етил-1-нонил-2,6,7-триоксабицикло[2.2.2]октан | 426-510-7 | 196965-91-0 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
601-078-00-4 | reaction mass of: 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane; | 2,3-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane | 427-040-5 | — | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H400 | H410 | GHS05 | GHS09 | Dgr | H314 | H410 |   |   |  601-078-00-4 | реакционна маса от: 1,7-диметил-2-[(3-метилбицикло[2.2.1]хепт-2-ил)метил]бицикло[2.2.1]хептан; | 2,3-диметил-2-[(3-метилбицикло[2.2.1]хепт-2-ил)метил]бицикло[2.2.1]хептан | 427-040-5 | — | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H400 | H410 | GHS05 | GHS09 | Dgr | H314 | H410 |   |   |  
601-079-00-X | reaction mass of: trans-trans-cyclohexadeca-1,9-diene; | cis-trans-cyclohexadeca-1,9-diene | 429-620-3 | — | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 4 | H315 | H317 | H413 | GHS07 | Wng | H315 | H317 | H413 |   |   |  601-079-00-X | реакционна маса от: транс-транс-циклохексадека-1,9-диен; | цис-транс-циклохексадека-1,9-диен | 429-620-3 | — | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 4 | H315 | H317 | H413 | GHS07 | Wng | H315 | H317 | H413 |   |   |  
601-080-00-5 | reaction mass of: sec-butylphenyl(phenyl)methane, mixed isomers; | 1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers; | 1-(sec-butylphenyl-1-phenylethane, mixed isomers | 431-100-6 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  601-080-00-5 | реакционна маса от: втор-бутилфенил(фенил)метан, смесени изомери; | 1-(втор-бутилфенил(фенил)-2-фенилетан, смесени изомери; | 1-(втор-бутилфенил-1-фенилетан, смесени изомери | 431-100-6 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
601-081-00-0 | cyclohexadeca-1,9-diene | 431-730-1 | 4277-06-9 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 4 | H315 | H317 | H413 | GHS07 | Wng | H315 | H317 | H413 |   |   |  601-081-00-0 | циклохексадека-1,9-диен | 431-730-1 | 4277-06-9 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 4 | H315 | H317 | H413 | GHS07 | Wng | H315 | H317 | H413 |   |   |  
601-082-00-6 | reaction mass of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane; | exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane | 434-420-4 | — | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H315 | H318 | H410 |   |   |  601-082-00-6 | реакционна маса от: ендо-2-метил-екзо-3-метил-екзо-2-[(екзо-3-метилбицикло[2.2.1]хепт-екзо-2-ил)метил]бицикло[2.2.1]хептан; | екзо-2-метил-екзо-3-метил-ендо-2-[(ендо-3-метилбицикло[2.2.1]хепт-екзо-2-ил)метил]бицикло[2.2.1]хептан | 434-420-4 | — | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H315 | H318 | H410 |   |   |  
601-083-00-1 | 5-endo-hexyl-bicyclo[2.2.1]hept-2-ene | 435-000-3 | 22094-83-3 | Asp. Tox. 1 | Skin Irrit. 2 | Aquatic Chronic 4 | H304 | H315 | H413 | GHS08 | GHS07 | Dgr | H304 | H315 | H413 |   |   |  601-083-00-1 | 5-ендо-хексилбицикло[2.2.1]хепт-2-ен | 435-000-3 | 22094-83-3 | Asp. Tox. 1 | Skin Irrit. 2 | Aquatic Chronic 4 | H304 | H315 | H413 | GHS08 | GHS07 | Dgr | H304 | H315 | H413 |   |   |  
601-084-00-7 | reaction mass of:5-endo-butyl-bicyclo[2.2.1]hept-2-ene; | 5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20) | 435-180-3 | — | Asp. Tox. 1 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H304 | H315 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H304 | H315 | H410 |   |   |  601-084-00-7 | реакционна маса от: 5-ендо-бутилбицикло[2.2.1]хепт-2-ен; | 5-екзо-бутилбицикло[2.2.1]хепт-2-ен (80:20) | 435-180-3 | — | Asp. Tox. 1 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H304 | H315 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H304 | H315 | H410 |   |   |  
601-085-00-2 | isopentane; | 2-methylbutane | 201-142-8 | 78-78-4 | Flam. Liq. 1 | Asp. Tox. 1 | STOT SE 3 | Aquatic Chronic 2 | H224 | H304 | H336 | H411 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H224 | H304 | H336 | H411 | EUH066 |   |  601-085-00-2 | изопентан; | 2-метилбутан | 201-142-8 | 78-78-4 | Flam. Liq. 1 | Asp. Tox. 1 | STOT SE 3 | Aquatic Chronic 2 | H224 | H304 | H336 | H411 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H224 | H304 | H336 | H411 | EUH066 |   |  
601-087-00-3 | 2,4,4-trimethylpentene | 246-690-9 | 25167-70-8 | Flam. Liq. 2 | Asp. Tox. 1 | STOT SE 3 | H225 | H304 | H336 | GHS02 | GHS07 | GHS08 | Dgr | H225 | H304 | H336 |   |   | D601-087-00-3 | 2,4,4-триметилпентен | 246-690-9 | 25167-70-8 | Flam. Liq. 2 | Asp. Tox. 1 | STOT SE 3 | H225 | H304 | H336 | GHS02 | GHS07 | GHS08 | Dgr | H225 | H304 | H336 |   |   | D
601-088-00-9 | 4-vinylcyclohexene | 202-848-9 | 100-40-3 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  601-088-00-9 | 4-винилциклохексен | 202-848-9 | 100-40-3 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  
601-089-00-4 | muscalure; cis-tricos-9-ene | 248-505-7 | 27519-02-4 | Skin Sens. 1B | H317 | GHS07 | Wng | H317 |   |   |  601-089-00-4 | мускалур; цис-трикоз-9-ен | 248-505-7 | 27519-02-4 | Skin Sens. 1B | H317 | GHS07 | Wng | H317 |   |   |  
602-001-00-7 | chloromethane; | methyl chloride | 200-817-4 | 74-87-3 | Flam. Gas 1 | Press. Gas | Carc. 2 | STOT RE 2 * | H220 | H351 | H373 ** | GHS02 | GHS04 | GHS08 | Dgr | H220 | H351 | H373 ** |   |   | U602-001-00-7 | хлорoметан; | мeтилхлорид | 200-817-4 | 74-87-3 | Flam. Gas 1 | Press. Gas | Carc. 2 | STOT RE 2 * | H220 | H351 | H373 ** | GHS02 | GHS04 | GHS08 | Dgr | H220 | H351 | H373 ** |   |   | U
602-002-00-2 | bromomethane; | methylbromide | 200-813-2 | 74-83-9 | Press. Gas | Muta. 2 | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Ozone 1 | H341 | H331 | H301 | H373** | H319 | H335 | H315 | H400 | H420 | GHS04 | GHS06 | GHS08 | GHS09 | Dgr | H341 | H331 | H301 | H373 ** H319 | H335 | H315 | H400 | H420 |   |   | U602-002-00-2 | бромометан; | метилбромид | 200-813-2 | 74-83-9 | Press. Gas | Muta. 2 | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Ozone 1 | H341 | H331 | H301 | H373** | H319 | H335 | H315 | H400 | H420 | GHS04 | GHS06 | GHS08 | GHS09 | Dgr | H341 | H331 | H301 | H373 ** H319 | H335 | H315 | H400 | H420 |   |   | U
602-003-00-8 | dibromomethane | 200-824-2 | 74-95-3 | Acute Tox. 4 * | Aquatic Chronic 3 | H332 | H412 | GHS07 | Wng | H332 | H412 |   | * |  602-003-00-8 | дибромометан | 200-824-2 | 74-95-3 | Acute Tox. 4 * | Aquatic Chronic 3 | H332 | H412 | GHS07 | Wng | H332 | H412 |   | * |  
602-004-00-3 | dichloromethane; | methylene chloride | 200-838-9 | 75-09-2 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  602-004-00-3 | дихлорометан; | мeтиленхлорид | 200-838-9 | 75-09-2 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  
602-005-00-9 | methyl iodide; | iodomethane | 200-819-5 | 74-88-4 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT SE 3 | Skin Irrit. 2 | H351 | H312 | H331 | H301 | H335 | H315 | GHS06 | GHS08 | Dgr | H351 | H312 | H331 | H301 | H335 | H315 |   |   |  602-005-00-9 | мeтилйодид; | йодометан | 200-819-5 | 74-88-4 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT SE 3 | Skin Irrit. 2 | H351 | H312 | H331 | H301 | H335 | H315 | GHS06 | GHS08 | Dgr | H351 | H312 | H331 | H301 | H335 | H315 |   |   |  
602-006-00-4 | chloroform; | trichloromethane | 200-663-8 | 67-66-3 | Carc. 2 | Repr. 2 | Acute Tox. 3 | Acute Tox. 4 | STOT RE 1 | Eye Irrit. 2 | Skin Irrit. 2 | H351 | H361d | H331 | H302 | H372 | H319 | H315 | GHS06 | GHS08 | Dgr | H351 | H361d | H331 | H302 | H372 | H319 | H315 |   |   |  602-006-00-4 | хлороформ; | трихлорометан | 200-663-8 | 67-66-3 | Carc. 2 | Repr. 2 | Acute Tox. 3 | Acute Tox. 4 | STOT RE 1 | Eye Irrit. 2 | Skin Irrit. 2 | H351 | H361d | H331 | H302 | H372 | H319 | H315 | GHS06 | GHS08 | Dgr | H351 | H361d | H331 | H302 | H372 | H319 | H315 |   |   |  
602-007-00-X | bromoform; | tribromomethane | 200-854-6 | 75-25-2 | Acute Tox. 3 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 2 | H331 | H302 | H319 | H315 | H411 | GHS06 | GHS09 | Dgr | H331 | H302 | H319 | H315 | H411 |   |   |  602-007-00-X | бромоформ; | трибромометан | 200-854-6 | 75-25-2 | Acute Tox. 3 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 2 | H331 | H302 | H319 | H315 | H411 | GHS06 | GHS09 | Dgr | H331 | H302 | H319 | H315 | H411 |   |   |  
602-008-00-5 | carbon tetrachloride; | tetrachloromethane | 200-262-8 | 56-23-5 | Carc. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | Aquatic | Chronic 3 | Ozone 1 | H351 | H331 | H311 | H301 | H372** | H412 | H420 | GHS06 | GHS08 | Dgr | H351 | H331 | H311 | H301 | H372 ** H412 | H420 |   | * | STOT RE 1; H372:C≥1 % STOT RE 2; H373:0,2  % ≤C | < 1 % |  602-008-00-5 | въглероден тетрахлорид; | тетрахлорометан | 200-262-8 | 56-23-5 | Carc. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | Aquatic | Chronic 3 | Ozone 1 | H351 | H331 | H311 | H301 | H372** | H412 | H420 | GHS06 | GHS08 | Dgr | H351 | H331 | H311 | H301 | H372 ** H412 | H420 |   | * | STOT RE 1; H372:C≥1 % STOT RE 2; H373:0,2  % ≤C | < 1 % |  
602-009-00-0 | chloroethane | 200-830-5 | 75-00-3 | Flam. Gas 1 | Press. Gas | Carc. 2 | Aquatic Chronic 3 | H220 | H351 | H412 | GHS02 | GHS04 | GHS08 | Dgr | H220 | H351 | H412 |   |   | U602-009-00-0 | хлороетан | 200-830-5 | 75-00-3 | Flam. Gas 1 | Press. Gas | Carc. 2 | Aquatic Chronic 3 | H220 | H351 | H412 | GHS02 | GHS04 | GHS08 | Dgr | H220 | H351 | H412 |   |   | U
602-010-00-6 | 1,2-dibromoethane | 203-444-5 | 106-93-4 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Chronic 2 | H350 | H331 | H311 | H301 | H319 | H335 | H315 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H331 | H311 | H301 | H319 | H335 | H315 | H411 |   | * |  602-010-00-6 | 1,2-дибромоетан | 203-444-5 | 106-93-4 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Chronic 2 | H350 | H331 | H311 | H301 | H319 | H335 | H315 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H331 | H311 | H301 | H319 | H335 | H315 | H411 |   | * |  
602-011-00-1 | 1,1-dichloroethane | 200-863-5 | 75-34-3 | Flam. Liq. 2 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Aquatic Chronic 3 | H225 | H302 | H319 | H335 | H412 | GHS02 | GHS07 | Dgr | H225 | H302 | H319 | H335 | H412 |   | * |  602-011-00-1 | 1,1-дихлороетан | 200-863-5 | 75-34-3 | Flam. Liq. 2 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Aquatic Chronic 3 | H225 | H302 | H319 | H335 | H412 | GHS02 | GHS07 | Dgr | H225 | H302 | H319 | H335 | H412 |   | * |  
602-012-00-7 | 1,2-dichloroethane; | ethylene dichloride | 203-458-1 | 107-06-2 | Flam. Liq. 2 | Carc. 1B | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H225 | H350 | H302 | H319 | H335 | H315 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H350 | H302 | H319 | H335 | H315 |   |   |  602-012-00-7 | 1,2-дихлороетан; | етилендихлорид | 203-458-1 | 107-06-2 | Flam. Liq. 2 | Carc. 1B | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H225 | H350 | H302 | H319 | H335 | H315 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H350 | H302 | H319 | H335 | H315 |   |   |  
602-013-00-2 | 1,1,1-trichloroethane; | methyl chloroform | 200-756-3 | 71-55-6 | Acute Tox. 4 * | Ozone 1 | H332 | H420 | GHS07 | Wng | H332 | H420 |   |   | F602-013-00-2 | 1,1,1-трихлороетан; | мeтилхлороформ | 200-756-3 | 71-55-6 | Acute Tox. 4 * | Ozone 1 | H332 | H420 | GHS07 | Wng | H332 | H420 |   |   | F
602-014-00-8 | 1,1,2-trichloroethane | 201-166-9 | 79-00-5 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H351 | H332 | H312 | H302 | GHS08 | GHS07 | Wng | H351 | H332 | H312 | H302 | EUH066 | * |  602-014-00-8 | 1,1,2-трихлороетан | 201-166-9 | 79-00-5 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H351 | H332 | H312 | H302 | GHS08 | GHS07 | Wng | H351 | H332 | H312 | H302 | EUH066 | * |  
602-015-00-3 | 1,1,2,2-tetrachloroethane | 201-197-8 | 79-34-5 | Acute Tox. 2 * | Acute Tox. 1 | Aquatic Chronic 2 | H330 | H310 | H411 | GHS06 | GHS09 | Dgr | H330 | H310 | H411 |   |   |  602-015-00-3 | 1,1,2,2-тетрахлороетан | 201-197-8 | 79-34-5 | Acute Tox. 2 * | Acute Tox. 1 | Aquatic Chronic 2 | H330 | H310 | H411 | GHS06 | GHS09 | Dgr | H330 | H310 | H411 |   |   |  
602-016-00-9 | 1,1,2,2-tetrabromoethane | 201-191-5 | 79-27-6 | Acute Tox. 2 * | Eye Irrit. 2 | Aquatic Chronic 3 | H330 | H319 | H412 | GHS06 | Dgr | H330 | H319 | H412 |   |   |  602-016-00-9 | 1,1,2,2-тетрабромоетан | 201-191-5 | 79-27-6 | Acute Tox. 2 * | Eye Irrit. 2 | Aquatic Chronic 3 | H330 | H319 | H412 | GHS06 | Dgr | H330 | H319 | H412 |   |   |  
602-017-00-4 | pentachloroethane | 200-925-1 | 76-01-7 | Carc. 2 | STOT RE 1 | Aquatic Chronic 2 | H351 | H372 ** | H411 | GHS08 | GHS09 | Dgr | H351 | H372 ** H411 |   | STOT RE 1; H372: C≥ 1 % STOT RE 2; H373: 0,2  % ≤ C < 1 % |  602-017-00-4 | пентахлороетан | 200-925-1 | 76-01-7 | Carc. 2 | STOT RE 1 | Aquatic Chronic 2 | H351 | H372 ** | H411 | GHS08 | GHS09 | Dgr | H351 | H372 ** H411 |   | STOT RE 1; H372: C≥ 1 % STOT RE 2; H373: 0,2  % ≤ C < 1 % |  
602-018-00-X | 1-chloropropane; [1] | 2-chloropropane [2] | 208-749-7 [1] | 200-858-8 [2] | 540-54-5 [1] | 75-29-6 [2] | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H225 | H332 | H312 | H302 | GHS02 | GHS07 | Dgr | H225 | H332 | H312 | H302 |   |   | C602-018-00-X | 1-хлоропропан; [1] | 2-хлоропропан [2] | 208-749-7 [1] | 200-858-8 [2] | 540-54-5 [1] | 75-29-6 [2] | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H225 | H332 | H312 | H302 | GHS02 | GHS07 | Dgr | H225 | H332 | H312 | H302 |   |   | C
602-019-00-5 | 1-bromopropane; | n-propyl bromide | 203-445-0 | 106-94-5 | Flam. Liq. 2 | Repr. 1B | STOT RE 2 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | STOT SE 3 | H225 | H360FD | H373 ** | H319 | H335 | H315 | H336 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H360FD H373 ** | H319 | H335 | H315 | H336 |   |   |  602-019-00-5 | 1-бромопропан; | n-пропилбромид | 203-445-0 | 106-94-5 | Flam. Liq. 2 | Repr. 1B | STOT RE 2 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | STOT SE 3 | H225 | H360FD | H373 ** | H319 | H335 | H315 | H336 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H360FD H373 ** | H319 | H335 | H315 | H336 |   |   |  
602-021-00-6 | 1,2-dibromo-3-chloropropane | 202-479-3 | 96-12-8 | Carc. 1B | Muta. 1B | Repr. 1A | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 3 | H350 | H340 | H360F *** H301 | H373 ** | H412 | GHS06 | GHS08 | Dgr | H350 | H340 | H360F *** H301 | H373 ** H412 |   |   |  602-021-00-6 | 1,2-дибромо-3-хлоропропан | 202-479-3 | 96-12-8 | Carc. 1B | Muta. 1B | Repr. 1A | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 3 | H350 | H340 | H360F *** H301 | H373 ** | H412 | GHS06 | GHS08 | Dgr | H350 | H340 | H360F *** H301 | H373 ** H412 |   |   |  
602-022-00-1 | 1-chloropentane; [1] | 2-chloropentane; [2] | 3-chloropentane [3] | 208-846-4 [1] | 210-885-7 [2] | 210-467-4 [3] | 543-59-9 [1] | 625-29-6 [2] | 616-20-6 [3] | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H225 | H332 | H312 | H302 | GHS02 | GHS07 | Dgr | H225 | H332 | H312 | H302 |   |   | C602-022-00-1 | 1-хлоропентан; [1] | 2-хлоропентан; [2] | 3-хлоропентан [3] | 208-846-4 [1] | 210-885-7 [2] | 210-467-4 [3] | 543-59-9 [1] | 625-29-6 [2] | 616-20-6 [3] | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H225 | H332 | H312 | H302 | GHS02 | GHS07 | Dgr | H225 | H332 | H312 | H302 |   |   | C
602-023-00-7 | vinyl chloride; | chloroethylene | 200-831-0 | 75-01-4 | Press. Gas | Flam. Gas 1 | Carc. 1A | H220 | H350 | GHS02 | GHS08 | Dgr | H220 | H350 |   |   | D U602-023-00-7 | винилхлорид; | хлороетилен | 200-831-0 | 75-01-4 | Press. Gas | Flam. Gas 1 | Carc. 1A | H220 | H350 | GHS02 | GHS08 | Dgr | H220 | H350 |   |   | D U
602-024-00-2 | bromoethylene | 209-800-6 | 593-60-2 | Press. Gas | Flam. Gas 1 | Carc. 1B | H220 | H350 | GHS02 | GHS08 | Dgr | H220 | H350 |   |   | U602-024-00-2 | бромоетилен | 209-800-6 | 593-60-2 | Press. Gas | Flam. Gas 1 | Carc. 1B | H220 | H350 | GHS02 | GHS08 | Dgr | H220 | H350 |   |   | U
602-025-00-8 | 1,1-dichloroethylene; | vinylidene chloride | 200-864-0 | 75-35-4 | Flam. Liq. 1 | Carc. 2 | Acute Tox. 4 * | H224 | H351 | H332 | GHS02 | GHS08 | GHS07 | Dgr | H224 | H351 | H332 |   | * | D602-025-00-8 | 1,1-дихлороетилен; | винилиденхлорид | 200-864-0 | 75-35-4 | Flam. Liq. 1 | Carc. 2 | Acute Tox. 4 * | H224 | H351 | H332 | GHS02 | GHS08 | GHS07 | Dgr | H224 | H351 | H332 |   | * | D
602-026-00-3 | 1,2-dichloroethylene; [1] | cis-dichloroethylene; [2] | trans-dichloroethylene [3] | 208-750-2 [1] | 205-859-7 [2] | 205-860-2 [3] | 540-59-0 [1] | 156-59-2 [2] | 156-60-5 [3] | Flam. Liq. 2 | Acute Tox. 4 * | Aquatic Chronic 3 | H225 | H332 | H412 | GHS02 | GHS07 | Dgr | H225 | H332 | H412 |   | * | C602-026-00-3 | 1,2-дихлороетилен; [1] | цис-дихлороетилен; [2] | транс-дихлороетилен [3] | 208-750-2 [1] | 205-859-7 [2] | 205-860-2 [3] | 540-59-0 [1] | 156-59-2 [2] | 156-60-5 [3] | Flam. Liq. 2 | Acute Tox. 4 * | Aquatic Chronic 3 | H225 | H332 | H412 | GHS02 | GHS07 | Dgr | H225 | H332 | H412 |   | * | C
602-027-00-9 | trichloroethylene; | trichloroethene | 201-167-4 | 79-01-6 | Carc. 1B | Muta. 2 | Eye Irrit. 2 | Skin Irrit. 2 | STOT SE 3 | Aquatic Chronic 3 | H350 | H341 | H319 | H315 | H336 | H412 | GHS08 | GHS07 | Dgr | H350 | H341 | H319 | H315 | H336 | H412 |   |   |  602-027-00-9 | трихлороетилен; | трихлороетен | 201-167-4 | 79-01-6 | Carc. 1B | Muta. 2 | Eye Irrit. 2 | Skin Irrit. 2 | STOT SE 3 | Aquatic Chronic 3 | H350 | H341 | H319 | H315 | H336 | H412 | GHS08 | GHS07 | Dgr | H350 | H341 | H319 | H315 | H336 | H412 |   |   |  
602-028-00-4 | tetrachloroethylene | 204-825-9 | 127-18-4 | Carc. 2 | Aquatic Chronic 2 | H351 | H411 | GHS08 | GHS09 | Wng | H351 | H411 |   |   |  602-028-00-4 | тeтрахлороетилен | 204-825-9 | 127-18-4 | Carc. 2 | Aquatic Chronic 2 | H351 | H411 | GHS08 | GHS09 | Wng | H351 | H411 |   |   |  
602-029-00-X | 3-chloropropene; | allyl chloride | 203-457-6 | 107-05-1 | Flam. Liq. 2 | Carc. 2 | Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | H225 | H351 | H341 | H332 | H312 | H302 | H373 ** H319 | H335 | H315 | H400 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H225 | H351 | H341 | H332 | H312 | H302 | H373 ** H319 | H335 | H315 | H400 |   |   | D602-029-00-X | 3-хлоропропен; | алилхлорид | 203-457-6 | 107-05-1 | Flam. Liq. 2 | Carc. 2 | Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | H225 | H351 | H341 | H332 | H312 | H302 | H373 ** H319 | H335 | H315 | H400 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H225 | H351 | H341 | H332 | H312 | H302 | H373 ** H319 | H335 | H315 | H400 |   |   | D
602-030-00-5 | 1,3-dichloropropene; [1] | (Z)-1,3-dichloropropene [2] | 208-826-5 [1] | 233-195-8 [2] | 542-75-6 [1] | 10061-01-5 [2] | Flam. Liq. 3 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 4 * | Asp. Tox. 1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H226 | H311 | H301 | H332 | H304 | H319 | H335 | H315 | H317 | H400 | H410 | GHS02 | GHS06 | GHS08 | GHS09 | Dgr | H226 | H311 | H301 | H332 | H304 | H319 | H335 | H315 | H317 | H410 |   |   | C D602-030-00-5 | 1,3-дихлоропропен; [1] | (Z)-1,3-дихлоропропен [2] | 208-826-5 [1] | 233-195-8 [2] | 542-75-6 [1] | 10061-01-5 [2] | Flam. Liq. 3 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 4 * | Asp. Tox. 1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H226 | H311 | H301 | H332 | H304 | H319 | H335 | H315 | H317 | H400 | H410 | GHS02 | GHS06 | GHS08 | GHS09 | Dgr | H226 | H311 | H301 | H332 | H304 | H319 | H335 | H315 | H317 | H410 |   |   | C D
602-031-00-0 | 1,1-dichloropropene | 209-253-3 | 563-58-6 | Flam. Liq. 2 | Acute Tox. 3 * | Aquatic Chronic 3 | H225 | H301 | H412 | GHS02 | GHS06 | Dgr | H225 | H301 | H412 |   |   |  602-031-00-0 | 1,1-дихлоропропен | 209-253-3 | 563-58-6 | Flam. Liq. 2 | Acute Tox. 3 * | Aquatic Chronic 3 | H225 | H301 | H412 | GHS02 | GHS06 | Dgr | H225 | H301 | H412 |   |   |  
602-032-00-6 | 3-chloro-2-methylpropene | 209-251-2 | 563-47-3 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H225 | H332 | H302 | H314 | H317 | H411 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H225 | H332 | H302 | H314 | H317 | H411 |   |   |  602-032-00-6 | 2-метил-3-хлоропропен | 209-251-2 | 563-47-3 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H225 | H332 | H302 | H314 | H317 | H411 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H225 | H332 | H302 | H314 | H317 | H411 |   |   |  
602-034-00-7 | 1,2-dichlorobenzene; | o-dichlorobenzene | 202-425-9 | 95-50-1 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H335 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H335 | H315 | H410 |   | * |  602-034-00-7 | 1,2-дихлоробензен; | o-дихлоробензен | 202-425-9 | 95-50-1 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H335 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H335 | H315 | H410 |   | * |  
602-035-00-2 | 1,4-dichlorobenzene; | p-dichlorobenzene | 203-400-5 | 106-46-7 | Carc. 2 | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H319 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H319 | H410 |   |   |  602-035-00-2 | 1,4-дихлоробензен; | p-дихлоробензен | 203-400-5 | 106-46-7 | Carc. 2 | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H319 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H319 | H410 |   |   |  
602-036-00-8 | chloroprene (stabilised); | 2-chlorobuta-1,3-diene (stabilised) | 204-818-0 | 126-99-8 | Flam. Liq. 2 | Carc. 1B | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H225 | H350 | H332 | H302 | H373 ** | H319 | H335 | H315 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H350 | H332 | H302 | H373 ** H319 | H335 | H315 |   |   | D602-036-00-8 | хлоропрен (стабилизиран); | 2-хлоробута-1,3-диен (стабилизиран) | 204-818-0 | 126-99-8 | Flam. Liq. 2 | Carc. 1B | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H225 | H350 | H332 | H302 | H373 ** | H319 | H335 | H315 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H350 | H332 | H302 | H373 ** H319 | H335 | H315 |   |   | D
602-037-00-3 | α-chlorotoluene; | benzyl chloride | 202-853-6 | 100-44-7 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 2 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | H350 | H331 | H302 | H373 ** | H335 | H315 | H318 | GHS06 | GHS08 | GHS05 | Dgr | H350 | H331 | H302 | H373 ** H335 | H315 | H318 |   |   |  602-037-00-3 | α-хлоротолуен; | бензилхлорид | 202-853-6 | 100-44-7 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 2 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | H350 | H331 | H302 | H373 ** | H335 | H315 | H318 | GHS06 | GHS08 | GHS05 | Dgr | H350 | H331 | H302 | H373 ** H335 | H315 | H318 |   |   |  
602-038-00-9 | α, α, α-trichlorotoluene; | benzotrichloride | 202-634-5 | 98-07-7 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | H350 | H331 | H302 | H335 | H315 | H318 | GHS06 | GHS08 | GHS05 | Dgr | H350 | H331 | H302 | H335 | H315 | H318 |   |   |  602-038-00-9 | α, α,α-трихлоротолуен; | бензотрихлорид | 202-634-5 | 98-07-7 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | H350 | H331 | H302 | H335 | H315 | H318 | GHS06 | GHS08 | GHS05 | Dgr | H350 | H331 | H302 | H335 | H315 | H318 |   |   |  
602-039-00-4 | polychlorobiphenyls; | PCB | 215-648-1 | 1336-36-3 | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** | H400 | H410 | GHS08 | GHS09 | Wng | H373 ** H410 |   | STOT RE 2; H373: C ≥ 0,005  % | C602-039-00-4 | полихлоробифенили; | PCB | 215-648-1 | 1336-36-3 | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** | H400 | H410 | GHS08 | GHS09 | Wng | H373 ** H410 |   | STOT RE 2; H373: C ≥ 0,005  % | C
602-040-00-X | 2-chlorotoluene; [1] | 3-chlorotoluene; [2] | 4-chlorotoluene; [3] | chlorotoluene [4] | 202-424-3 [1] | 203-580-5 [2] | 203-397-0 [3] | 246-698-2 [4] | 95-49-8 [1] | 108-41-8 [2] | 106-43-4 [3] | 25168-05-2 [4] | Acute Tox. 4 * | Aquatic Chronic 2 | H332 | H411 | GHS07 | GHS09 | Wng | H332 | H411 |   |   | C602-040-00-X | 2-хлоротолуен; [1] | 3-хлоротолуен; [2] | 4-хлоротолуен; [3] | хлоротолуен [4] | 202-424-3 [1] | 203-580-5 [2] | 203-397-0 [3] | 246-698-2 [4] | 95-49-8 [1] | 108-41-8 [2] | 106-43-4 [3] | 25168-05-2 [4] | Acute Tox. 4 * | Aquatic Chronic 2 | H332 | H411 | GHS07 | GHS09 | Wng | H332 | H411 |   |   | C
602-041-00-5 | penthachloronaphthalene | 215-320-8 | 1321-64-8 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H319 | H315 | H410 |   |   | C602-041-00-5 | пентахлоронафталeн | 215-320-8 | 1321-64-8 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H319 | H315 | H410 |   |   | C
602-042-00-0 | 1,2,3,4,5,6-hexachlorcyclohexanes with the exception of those specified elsewhere in this Annex | — | — | Carc. 2 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H301 | H312 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H301 | H312 | H410 |   |   | A C602-042-00-0 | 1,2,3,4,5,6-хексахлороциклохексани с изключение на тези, посочени другаде в настоящото приложение | — | — | Carc. 2 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H301 | H312 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H301 | H312 | H410 |   |   | A C
602-043-00-6 | lindane (ISO); | γ-HCH or γ-BHC; | γ-1,2,3,4,5,6-hexachlorocyclohexane | 200-401-2 | 58-89-9 | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Lact. | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H332 | H312 | H373 ** | H362 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H332 | H312 | H373 ** H362 | H410 |   | M=10 |  602-043-00-6 | линдан (ISO); | γ-НСН или γ-BHC; | γ-1,2,3,4,5,6-хексахлороциклохексан | 200-401-2 | 58-89-9 | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Lact. | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H332 | H312 | H373 ** | H362 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H332 | H312 | H373 ** H362 | H410 |   | M=10 |  
602-044-00-1 | camphechlor (ISO); | toxaphene; | 232-283-3 | 8001-35-2 | Carc. 2 | Acute Tox. 3 * | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H301 | H312 | H335 | H315 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H301 | H312 | H335 | H315 | H410 |   |   |  602-044-00-1 | камфехлор (ISO); | тoксафен; | 232-283-3 | 8001-35-2 | Carc. 2 | Acute Tox. 3 * | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H301 | H312 | H335 | H315 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H301 | H312 | H335 | H315 | H410 |   |   |  
602-045-00-7 | DDT (ISO); | clofenotane (INN); | dicophane;1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane; dichlorodiphenyltrichloroethane | 200-024-3 | 50-29-3 | Carc. 2 | Acute Tox. 3 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H301 | H372 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H301 | H372 ** H410 |   |   |  602-045-00-7 | ДДТ (ISO); | клофенотан (INN); | дикофан;1,1,1-трихлоро-2,2-бис(4-хлорофенил)eтан; дихлородифенилтрихлороетан | 200-024-3 | 50-29-3 | Carc. 2 | Acute Tox. 3 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H301 | H372 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H301 | H372 ** H410 |   |   |  
602-046-00-2 | heptachlor (ISO); | 1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindene | 200-962-3 | 76-44-8 | Carc. 2 | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H311 | H301 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H311 | H301 | H373 ** H410 |   |   |  602-046-00-2 | хептахлор (ISO); | 1,4,5,6,7,8,8-хептахлоро-3a,4,7,7a-тетрахидро-4,7-метаноинден | 200-962-3 | 76-44-8 | Carc. 2 | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H311 | H301 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H311 | H301 | H373 ** H410 |   |   |  
602-047-00-8 | chlordane (ISO); | 1,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindan | 200-349-0 | 57-74-9 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H312 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H312 | H302 | H410 |   |   |  602-047-00-8 | хлордан (ISO); | 1,2,4,5,6,7,8,8-октахлоро-3a,4,7,7a-тетрахидро-4,7-метаноиндан | 200-349-0 | 57-74-9 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H312 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H312 | H302 | H410 |   |   |  
602-048-00-3 | aldrin (ISO) | 206-215-8 | 309-00-2 | Carc. 2 | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H311 | H301 | H372 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H311 | H301 | H372 ** H410 |   |   |  602-048-00-3 | aлдрин (ISO) | 206-215-8 | 309-00-2 | Carc. 2 | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H311 | H301 | H372 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H311 | H301 | H372 ** H410 |   |   |  
602-049-00-9 | dieldrin (ISO) | 200-484-5 | 60-57-1 | Carc. 2 | Acute Tox. 1 | Acute Tox. 3 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H310 | H301 | H372 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H310 | H301 | H372 ** H410 |   |   |  602-049-00-9 | диелдрин (ISO) | 200-484-5 | 60-57-1 | Carc. 2 | Acute Tox. 1 | Acute Tox. 3 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H310 | H301 | H372 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H310 | H301 | H372 ** H410 |   |   |  
602-050-00-4 | isodrin; | (1α,4α,4aβ, 5β,8β,8aβ)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene | 207-366-2 | 465-73-6 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H310 | H300 | H410 |   | M=100 |  602-050-00-4 | изодрин; | (1α,4α,4aβ,5β,8β,8aβ)-1,2,3,4,10,10-хексахлоро-1,4,4a,5,8,8a-хексахидро-1,4:5,8-диметанонафтален | 207-366-2 | 465-73-6 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H310 | H300 | H410 |   | M=100 |  
602-051-00-X | endrin (ISO); | 1,2,3,4,10,10-hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene | 200-775-7 | 72-20-8 | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H311 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H311 | H410 |   |   |  602-051-00-X | eндрин (ISO); | 1,2,3,4,10,10-хексахлоро-6,7-eпокси-1,4,4a,5,6,7,8,8a-oктахидро-1,4:5,8-диметанонафтален | 200-775-7 | 72-20-8 | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H311 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H311 | H410 |   |   |  
602-052-00-5 | endosulfan (ISO); | 1,2,3,4,7,7-hexachloro-8,9,10-trinorborn-2-en-5,6-ylenedimethylene sulfite; | 1,4,5,6,7,7-hexachloro-8,9,10-trinorborn-5-en-2,3-ylenedimethylene sulfite | 204-079-4 | 115-29-7 | Acute Tox. 2 * | Acute Tox. 2 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H300 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H300 | H312 | H410 |   |   |  602-052-00-5 | ендосулфан (ISO); | 1,2,3,4,7,7-хексахлоро-8,9,10- тринорборн-2-ен-5,6-илендиметиленсулфит; | 1,4,5,6,7,7-хексахлоро-8,9,10- тринорборн-5-ен-2,3-илендиметиленсулфит; | 204-079-4 | 115-29-7 | Acute Tox. 2 * | Acute Tox. 2 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H300 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H300 | H312 | H410 |   |   |  
602-053-00-0 | isobenzan (ISO); | 1,3,4,5,6,7,8,8-octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran | 206-045-4 | 297-78-9 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | H310 | H300 | H400 | GHS06 | GHS09 | Dgr | H310 | H300 | H400 |   |   |  602-053-00-0 | изобензан (ISO); | 1,3,4,5,6,7,8,8-oктахлоро-1,3,3a,4,7,7a-хексахидро-4,7-метаноизобензофуран | 206-045-4 | 297-78-9 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | H310 | H300 | H400 | GHS06 | GHS09 | Dgr | H310 | H300 | H400 |   |   |  
602-054-00-6 | 3-iodpropene; | allyl iodide | 209-130-4 | 556-56-9 | Flam. Liq. 2 | Skin Corr. 1B | H225 | H314 | GHS02 | GHS05 | Dgr | H225 | H314 |   |   |  602-054-00-6 | 3-йодопропен; | алилйодид | 209-130-4 | 556-56-9 | Flam. Liq. 2 | Skin Corr. 1B | H225 | H314 | GHS02 | GHS05 | Dgr | H225 | H314 |   |   |  
602-055-00-1 | bromoethane; | ethyl bromide | 200-825-8 | 74-96-4 | Flam. Liq. 2 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * | H225 | H351 | H332 | H302 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H351 | H332 | H302 |   |   |  602-055-00-1 | бромоетан; | етилбромид | 200-825-8 | 74-96-4 | Flam. Liq. 2 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * | H225 | H351 | H332 | H302 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H351 | H332 | H302 |   |   |  
602-056-00-7 | α, α, α-trifluorotoluene; | benzotrifluoride | 202-635-0 | 98-08-8 | Flam. Liq. 2 | Aquatic Chronic 2 | H225 | H411 | GHS02 | GHS09 | Dgr | H225 | H411 |   |   |  602-056-00-7 | α, α,α-трифлуоротолуен; | бензотрифлуорид | 202-635-0 | 98-08-8 | Flam. Liq. 2 | Aquatic Chronic 2 | H225 | H411 | GHS02 | GHS09 | Dgr | H225 | H411 |   |   |  
602-057-00-2 | α-bromotoluene; | benzyl bromide | 202-847-3 | 100-39-0 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H319 | H335 | H315 | GHS07 | Wng | H319 | H335 | H315 |   |   |  602-057-00-2 | α-бромотолуен; | бензилбромид | 202-847-3 | 100-39-0 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H319 | H335 | H315 | GHS07 | Wng | H319 | H335 | H315 |   |   |  
602-058-00-8 | α, α-dichlorotoluene; | benzylidene chloride; | benzal chloride | 202-709-2 | 98-87-3 | Carc. 2 | Acute Tox. 3 * | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | H351 | H331 | H302 | H335 | H315 | H318 | GHS06 | GHS08 | GHS05 | Dgr | H351 | H331 | H302 | H335 | H315 | H318 |   |   |  602-058-00-8 | α, α-дихлоротолуен; | бензилиденхлорид; | бензалхлорид | 202-709-2 | 98-87-3 | Carc. 2 | Acute Tox. 3 * | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | H351 | H331 | H302 | H335 | H315 | H318 | GHS06 | GHS08 | GHS05 | Dgr | H351 | H331 | H302 | H335 | H315 | H318 |   |   |  
602-059-00-3 | 1-chlorobutane; | butyl chloride | 203-696-6 | 109-69-3 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 |   |   |  602-059-00-3 | 1-хлоробутан; | бутилхлорид | 203-696-6 | 109-69-3 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 |   |   |  
602-060-00-9 | bromobenzene | 203-623-8 | 108-86-1 | Flam. Liq. 3 | Skin Irrit. 2 | Aquatic Chronic 2 | H226 | H315 | H411 | GHS02 | GHS07 | GHS09 | Wng | H226 | H315 | H411 |   |   |  602-060-00-9 | бромобензен | 203-623-8 | 108-86-1 | Flam. Liq. 3 | Skin Irrit. 2 | Aquatic Chronic 2 | H226 | H315 | H411 | GHS02 | GHS07 | GHS09 | Wng | H226 | H315 | H411 |   |   |  
602-061-00-4 | hexafluoropropene; | hexafluoropropylene | 204-127-4 | 116-15-4 | Press. Gas | Acute Tox. 4 * | STOT SE 3 | H332 | H335 | GHS07 | Wng | H332 | H335 |   |   | U602-061-00-4 | хексафлуоропропен; | хексафлуоропропилен | 204-127-4 | 116-15-4 | Press. Gas | Acute Tox. 4 * | STOT SE 3 | H332 | H335 | GHS07 | Wng | H332 | H335 |   |   | U
602-062-00-X | 1,2,3-trichloropropane | 202-486-1 | 96-18-4 | Carc. 1B | Repr. 1B | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H350 | H360F *** H332 | H312 | H302 | GHS08 | GHS07 | Dgr | H350 | H360F *** H332 | H312 | H302 |   |   | D602-062-00-X | 1,2,3-трихлоропропан | 202-486-1 | 96-18-4 | Carc. 1B | Repr. 1B | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H350 | H360F *** H332 | H312 | H302 | GHS08 | GHS07 | Dgr | H350 | H360F *** H332 | H312 | H302 |   |   | D
602-063-00-5 | heptachlor epoxide; | 2,3-epoxy-1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane | 213-831-0 | 1024-57-3 | Carc. 2 | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H301 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H301 | H373 ** H410 |   |   |  602-063-00-5 | хептахлор епоксид; | 2,3-eпокси-1,4,5,6,7,8,8-хептахлоро-3a,4,7,7a-тетрахидро-4,7-метаноиндан | 213-831-0 | 1024-57-3 | Carc. 2 | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H301 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H301 | H373 ** H410 |   |   |  
602-064-00-0 | 1,3-dichloro-2-propanol | 202-491-9 | 96-23-1 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 4 * | H350 | H301 | H312 | GHS06 | GHS08 | Dgr | H350 | H301 | H312 |   |   |  602-064-00-0 | 1,3-дихлоро-2-пропанол | 202-491-9 | 96-23-1 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 4 * | H350 | H301 | H312 | GHS06 | GHS08 | Dgr | H350 | H301 | H312 |   |   |  
602-065-00-6 | hexachlorobenzene | 204-273-9 | 118-74-1 | Carc. 1B | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H372 ** | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H372 ** H410 |   |   |  602-065-00-6 | хексахлоробензен | 204-273-9 | 118-74-1 | Carc. 1B | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H372 ** | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H372 ** H410 |   |   |  
602-066-00-1 | tetrachloro-p-benzoquinone | 204-274-4 | 118-75-2 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H315 | H410 |   |   |  602-066-00-1 | тeтрахлоро-p-бензохинон | 204-274-4 | 118-75-2 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H315 | H410 |   |   |  
602-067-00-7 | 1,3-dichlorbenzene | 208-792-1 | 541-73-1 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  602-067-00-7 | 1,3-дихлоробензен | 208-792-1 | 541-73-1 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
602-068-00-2 | ethylene bis(trichloroacetate) | 219-732-9 | 2514-53-6 | Skin Irrit. 2 | H315 | GHS07 | Wng | H315 |   |   |  602-068-00-2 | eтиленбис(трихлороацетат) | 219-732-9 | 2514-53-6 | Skin Irrit. 2 | H315 | GHS07 | Wng | H315 |   |   |  
602-069-00-8 | dichloroacetylene | — | 7572-29-4 | Unst. Expl. Carc. 2 | STOT RE 2 * | H200 | H351 | H373 ** | GHS01 | GHS08 | Wng | H200 | H351 | H373 ** |   |   |  602-069-00-8 | дихлороацетилен | — | 7572-29-4 | Unst. Expl. Carc. 2 | STOT RE 2 * | H200 | H351 | H373 ** | GHS01 | GHS08 | Wng | H200 | H351 | H373 ** |   |   |  
602-070-00-3 | 3-chloro-4,5,α, α, α-pentafluorotoluene | 401-930-3 | 77227-99-7 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | H226 | H332 | H302 | H400 | GHS02 | GHS07 | GHS09 | Wng | H226 | H332 | H302 | H400 |   |   |  602-070-00-3 | 4,5,α, α,α-пентафлуоро-3-хлоротолуен | 401-930-3 | 77227-99-7 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | H226 | H332 | H302 | H400 | GHS02 | GHS07 | GHS09 | Wng | H226 | H332 | H302 | H400 |   |   |  
602-071-00-9 | bromobenzylbromotoluene, reaction mass of isomers | 402-210-1 | 99688-47-8 | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H373 ** H317 | H410 |   |   |  602-071-00-9 | бромобензилбромотолуен, реакционна маса от изомери | 402-210-1 | 99688-47-8 | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H373 ** H317 | H410 |   |   |  
602-072-00-4 | dichloro [(dichlorophenyl)methyl]methylbenzene, reaction mass of isomers; (dichlorophenyl)(dichlorotolyl)methane, reaction mass of isomers (IUPAC) | 278-404-3 | 76253-60-6 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  602-072-00-4 | дихлоро[(дихлорофенил)метил]метилбензен, реакционна маса от изомери; (дихлоротолил)(дихлорофенил)метан, реакционна маса от изомери (IUPAC) | 278-404-3 | 76253-60-6 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
602-073-00-X | 1,4-dichlorobut-2-ene | 212-121-8 | 764-41-0 | Carc. 1B | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H330 | H311 | H301 | H314 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H350 | H330 | H311 | H301 | H314 | H410 |   | Carc. 1B; H350: C ≥ 0,01  % STOT SE 3; H335:C≥5 % |  602-073-00-X | 1,4-дихлоробут-2-ен | 212-121-8 | 764-41-0 | Carc. 1B | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H330 | H311 | H301 | H314 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H350 | H330 | H311 | H301 | H314 | H410 |   | Carc. 1B; H350: C ≥ 0,01  % STOT SE 3; H335:C≥5 % |  
602-074-00-5 | pentachlorobenzene | 210-172-0 | 608-93-5 | Flam. Sol. 1 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H228 | H302 | H400 | H410 | GHS02 | GHS07 | GHS09 | Dgr | H228 | H302 | H410 |   |   | T602-074-00-5 | пентахлоробензен | 210-172-0 | 608-93-5 | Flam. Sol. 1 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H228 | H302 | H400 | H410 | GHS02 | GHS07 | GHS09 | Dgr | H228 | H302 | H410 |   |   | T
602-075-00-0 | 4,4,5,5-tetrachloro-1,3-dioxolan-2-one | 404-060-2 | 22432-68-4 | Acute Tox. 2 * | Acute Tox. 4 * | Skin Corr. 1B | H330 | H302 | H314 | GHS06 | GHS05 | Dgr | H330 | H302 | H314 |   |   |  602-075-00-0 | 4,4,5,5-тeтрахлоро-1,3-диоксолан-2-oн | 404-060-2 | 22432-68-4 | Acute Tox. 2 * | Acute Tox. 4 * | Skin Corr. 1B | H330 | H302 | H314 | GHS06 | GHS05 | Dgr | H330 | H302 | H314 |   |   |  
602-076-00-6 | 2,3,4-trichlorobut-1-ene | 219-397-9 | 2431-50-7 | Carc. 2 | Acute Tox. 3 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H331 | H302 | H319 | H335 | H315 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H331 | H302 | H319 | H335 | H315 | H410 |   | Carc. 2; H351: C | ≥ 0,1  % |  602-076-00-6 | 2,3,4-трихлоробут-1-ен | 219-397-9 | 2431-50-7 | Carc. 2 | Acute Tox. 3 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H331 | H302 | H319 | H335 | H315 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H331 | H302 | H319 | H335 | H315 | H410 |   | Carc. 2; H351: C | ≥ 0,1  % |  
602-077-00-1 | dodecachloropentacyclo[5.2.1.02,6.03,9.05,8]decane; | mirex | 219-196-6 | 2385-85-5 | Carc. 2 | Repr. 2 | Lact. | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H361fd | H362 | H312 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H361fd | H362 | H312 | H302 | H410 |   |   |  602-077-00-1 | додекахлоропентацикло[5.2.1.02,6.03,9.05,8]декан; | мирекс | 219-196-6 | 2385-85-5 | Carc. 2 | Repr. 2 | Lact. | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H361fd | H362 | H312 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H361fd | H362 | H312 | H302 | H410 |   |   |  
602-078-00-7 | hexachlorocyclopentadiene | 201-029-3 | 77-47-4 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H311 | H302 | H314 | H400 | H410 | GHS06 | GHS05 | GHS09 | Dgr | H330 | H311 | H302 | H314 | H410 |   |   |  602-078-00-7 | хексахлороциклопентадиен | 201-029-3 | 77-47-4 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H311 | H302 | H314 | H400 | H410 | GHS06 | GHS05 | GHS09 | Dgr | H330 | H311 | H302 | H314 | H410 |   |   |  
602-079-00-2 | 2,3-dichloropropene; | 2,3-dichloropropylene | 201-153-8 | 78-88-6 | Flam. Liq. 2 | Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H225 | H341 | H332 | H312 | H302 | H335 | H315 | H318 | H412 | GHS02 | GHS08 | GHS05 | GHS07 | Dgr | H225 | H341 | H332 | H312 | H302 | H335 | H315 | H318 | H412 |   |   |  602-079-00-2 | 2,3-дихлоропропен; | 2,3-дихлоропропилен | 201-153-8 | 78-88-6 | Flam. Liq. 2 | Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H225 | H341 | H332 | H312 | H302 | H335 | H315 | H318 | H412 | GHS02 | GHS08 | GHS05 | GHS07 | Dgr | H225 | H341 | H332 | H312 | H302 | H335 | H315 | H318 | H412 |   |   |  
602-080-00-8 | alkanes, C10-13, chloro; chlorinated paraffins, C10-13 | 287-476-5 | 85535-84-8 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 | EUH066 |   |  602-080-00-8 | хлороалкани, C10-13; хлорсъдържащи парафини, C10-13 | 287-476-5 | 85535-84-8 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 | EUH066 |   |  
602-081-00-3 | 2-chloro-4,5-difluorobenzoic acid | 405-380-5 | — | Acute Tox. 4 * | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | H312 | H302 | H318 | H317 | GHS05 | GHS07 | Dgr | H312 | H302 | H318 | H317 |   |   |  602-081-00-3 | 4,5-дифлуоро-2-хлоробензоена киселина | 405-380-5 | — | Acute Tox. 4 * | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | H312 | H302 | H318 | H317 | GHS05 | GHS07 | Dgr | H312 | H302 | H318 | H317 |   |   |  
602-082-00-9 | 2,2,6,6-tetrakis(bromomethyl)-4-oxaheptane-1,7-diol | 408-020-5 | 109678-33-3 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  602-082-00-9 | 2,2,6,6-тeтракис(бромометил)-4-oксахептан-1,7-диол | 408-020-5 | 109678-33-3 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
602-083-00-4 | diphenyl ether, pentabromo derivative pentabromodiphenyl ether | 251-084-2 | 32534-81-9 | STOT RE 2 * | Lact. | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** | H362 | H400 | H410 | GHS08 | GHS09 | Wng | H373 ** H362 | H410 |   |   |  602-083-00-4 | пентабромопроизводно на дифенилов етер, пентабромодифенилов етер | 251-084-2 | 32534-81-9 | STOT RE 2 * | Lact. | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** | H362 | H400 | H410 | GHS08 | GHS09 | Wng | H373 ** H362 | H410 |   |   |  
602-084-00-X | 1,1-dichloro-1-fluoroethane | 404-080-1 | 1717-00-6 | Aquatic | Chronic 3 | Ozone 1 | H412 | H420 | GHS07 | Wng | H412 | H420 |   |   |  602-084-00-X | 1-флуоро-1,1-дихлороетан | 404-080-1 | 1717-00-6 | Aquatic | Chronic 3 | Ozone 1 | H412 | H420 | GHS07 | Wng | H412 | H420 |   |   |  
602-085-00-5 | 2-bromopropane | 200-855-1 | 75-26-3 | Flam. Liq. 2 | Repr. 1a | STOT RE 2 * | H225 | H360F *** H373 ** | GHS02 | GHS08 | Dgr | H225 | H360F *** H373 ** | EUH066 |   |  602-085-00-5 | 2-бромопропан | 200-855-1 | 75-26-3 | Flam. Liq. 2 | Repr. 1a | STOT RE 2 * | H225 | H360F *** H373 ** | GHS02 | GHS08 | Dgr | H225 | H360F *** H373 ** | EUH066 |   |  
602-086-00-0 | trifluoroiodomethane; | trifluoromethyl iodide | 219-014-5 | 2314-97-8 | Muta. 2 | H341 | GHS08 | Wng | H341 |   |   |  602-086-00-0 | йодотрифлуорометан; | трифлуорометилйодид | 219-014-5 | 2314-97-8 | Muta. 2 | H341 | GHS08 | Wng | H341 |   |   |  
602-087-00-6 | 1,2,4-trichlorobenzene | 204-428-0 | 120-82-1 | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H315 | H410 |   |   |  602-087-00-6 | 1,2,4-трихлоробензен | 204-428-0 | 120-82-1 | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H315 | H410 |   |   |  
602-088-00-1 | 2,3-dibromopropan-1-ol; | 2,3-dibromo-1-propanol | 202-480-9 | 96-13-9 | Carc. 1B Repr. 2 | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 3 | H350 | H361f *** H311 | H332 | H302 | H412 | GHS08 | GHS07 | Dgr | H350 | H361f *** H311 | H332 | H302 | H412 |   |   |  602-088-00-1 | 2,3-дибромопропан-1-ол; | 2,3-дибромо-1-пропанол | 202-480-9 | 96-13-9 | Carc. 1B Repr. 2 | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 3 | H350 | H361f *** H311 | H332 | H302 | H412 | GHS08 | GHS07 | Dgr | H350 | H361f *** H311 | H332 | H302 | H412 |   |   |  
602-089-00-7 | 4-bromo-2-chlorofluorobenzene | 405-580-2 | 60811-21-4 | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H315 | H410 |   |   |  602-089-00-7 | 4-бромофлуоро-2-хлоробензен | 405-580-2 | 60811-21-4 | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H315 | H410 |   |   |  
602-090-00-2 | 1-allyl-3-chloro-4-fluorobenzene | 406-630-6 | 121626-73-1 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  602-090-00-2 | 1-алил-4-флуоро-3-хлоробензен | 406-630-6 | 121626-73-1 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
602-091-00-8 | 1,3-dichloro-4-fluorobenzene | 406-160-1 | 1435-48-9 | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | H302 | H373 ** | H315 | H411 | GHS08 | GHS07 | Wng | H302 | H373 ** H315 | H411 |   |   |  602-091-00-8 | 4-флуоро-1,3-дихлоробензен | 406-160-1 | 1435-48-9 | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | H302 | H373 ** | H315 | H411 | GHS08 | GHS07 | Wng | H302 | H373 ** H315 | H411 |   |   |  
602-092-00-3 | 1-bromo-3,4,5-trifluorobenzene | 418-480-9 | 138526-69-9 | Flam. Liq. 3 | Carc. 2 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 2 | H226 | H351 | H315 | H318 | H411 | GHS02 | GHS08 | GHS05 | GHS09 | Dgr | H226 | H351 | H315 | H318 | H411 |   |   |  602-092-00-3 | 1-бромо-3,4,5-трифлуоробензен | 418-480-9 | 138526-69-9 | Flam. Liq. 3 | Carc. 2 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 2 | H226 | H351 | H315 | H318 | H411 | GHS02 | GHS08 | GHS05 | GHS09 | Dgr | H226 | H351 | H315 | H318 | H411 |   |   |  
602-093-00-9 | α, α, α,4-tetrachlorotoluene; | p-chlorobenzotrichloride | 226-009-1 | 5216-25-1 | Carc. 1B Repr. 2 | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | H350 | H361f *** H372 ** | H312 | H302 | H335 | H315 | GHS08 | GHS07 | Dgr | H350 | H361f *** H372 ** H312 | H302 | H335 | H315 |   |   |  602-093-00-9 | α, α,α,4-тетрахлоротолуен; | p-хлоробензотрихлорид | 226-009-1 | 5216-25-1 | Carc. 1B Repr. 2 | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | H350 | H361f *** H372 ** | H312 | H302 | H335 | H315 | GHS08 | GHS07 | Dgr | H350 | H361f *** H372 ** H312 | H302 | H335 | H315 |   |   |  
602-094-00-4 | diphenylether; | octabromo derivate | 251-087-9 | 32536-52-0 | Repr. 1B | H360Df | GHS08 | Dgr | H360Df |   |   |  602-094-00-4 | дифенилов етер; | октабромопроизводно | 251-087-9 | 32536-52-0 | Repr. 1B | H360Df | GHS08 | Dgr | H360Df |   |   |  
602-095-00-X | alkanes, C14-17, chloro; | chlorinated paraffins, C14-17 | 287-477-0 | 85535-85-9 | Lact. | Aquatic Acute 1 | Aquatic Chronic 1 | H362 | H400 | H410 | GHS09 | Wng | H362 | H410 | EUH066 |   |  602-095-00-X | хлороалкани, C14-17; | хлорсъдържащи парафини, C14-17 | 287-477-0 | 85535-85-9 | Lact. | Aquatic Acute 1 | Aquatic Chronic 1 | H362 | H400 | H410 | GHS09 | Wng | H362 | H410 | EUH066 |   |  
602-096-00-5 | malachite green hydrochloride; [1] | malachite green oxalate [2] | 209-322-8 [1] | 219-441-7 [2] | 569-64-2 [1] | 2437-29-8 [2] | Repr. 2 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d *** H302 | H318 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H361d *** H302 | H318 | H410 |   |   |  602-096-00-5 | малахитово зелено хидрохлорид; [1] | малахитово зелено оксалат [2] | 209-322-8 [1] | 219-441-7 [2] | 569-64-2 [1] | 2437-29-8 [2] | Repr. 2 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d *** H302 | H318 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H361d *** H302 | H318 | H410 |   |   |  
602-097-00-0 | 1-bromo-9-(4,4,5,5,5-pentafluoropentylthio)nonane | 422-850-5 | 148757-89-5 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  602-097-00-0 | 1-бромо-9-(4,4,5,5,5-пентафлуоропентилтио)нонан | 422-850-5 | 148757-89-5 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
602-098-00-6 | 2-(3-bromophenoxy)tetrahydro-2H-pyran | 429-030-6 | 57999-49-2 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  602-098-00-6 | 2-(3-бромофенокси)тетрахидро-2H-пиран | 429-030-6 | 57999-49-2 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
602-099-00-1 | 3-(4-fluorophenyl)-2-methylpropionylchloride | 426-370-7 | — | Skin Corr. 1A | Acute Tox. 4 * | Aquatic Chronic 3 | H314 | H302 | H412 | GHS05 | GHS07 | Dgr | H314 | H302 | H412 | EUH014 | EUH029 |   |  602-099-00-1 | 2-метил-3-(4-флуорофенил)пропионилхлорид | 426-370-7 | — | Skin Corr. 1A | Acute Tox. 4 * | Aquatic Chronic 3 | H314 | H302 | H412 | GHS05 | GHS07 | Dgr | H314 | H302 | H412 | EUH014 | EUH029 |   |  
602-100-00-5 | reaction mass of: (R, R)-1,1,1,2,2,3,4,5,5,5-decafluoropentane; | (S, S)-1,1,1,2,2,3,4,5,5,5-decafluoropentane | 420-640-8 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  602-100-00-5 | реакционна маса от: (R, R)-1,1,1,2,2,3,4,5,5,5-декафлуоропентан; | (S, S)-1,1,1,2,2,3,4,5,5,5-декафлуоропентан | 420-640-8 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
602-101-00-0 | 2-chloro-4-fluoro-5-nitrophenyl(isobutyl)carbonate | 427-020-6 | 141772-37-4 | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H373** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H373** | H317 | H410 |   |   |  602-101-00-0 | 5-нитро-4-флуоро-2-хлорофенил(изобутилов) карбонат | 427-020-6 | 141772-37-4 | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H373** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H373** | H317 | H410 |   |   |  
602-102-00-6 | 1,1,1,3,3-pentafluorobutane | 430-250-1 | 406-58-6 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 |   |   |  602-102-00-6 | 1,1,1,3,3-пентафлуоробутан | 430-250-1 | 406-58-6 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 |   |   |  
602-103-00-1 | 1-(chlorophenylmethyl)-2-methylbenzene | 431-450-1 | 41870-52-4 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H410 |   |   |  602-103-00-1 | 2-метил-1-(хлорофенилметил)бензен | 431-450-1 | 41870-52-4 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H410 |   |   |  
602-104-00-7 | 1,1,2,2,3,3,4-heptafluorocyclopentane | 430-710-1 | 15290-77-4 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  602-104-00-7 | 1,1,2,2,3,3,4-хептафлуороциклопентан | 430-710-1 | 15290-77-4 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
602-105-00-2 | sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate | 422-100-7 | 102061-82-5 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  602-105-00-2 | натриев 1,1,2,2,3,3,4,4,4-нонафлуоро-1-бутансулфинат | 422-100-7 | 102061-82-5 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
602-106-00-8 | 2-bromo-4,6-difluoroaniline | 429-430-0 | 444-14-4 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  602-106-00-8 | 2-бромо-4,6-дифлуороанилин | 429-430-0 | 444-14-4 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
602-107-00-3 | 3,3,4,4-tetrafluoro-4-iodo-1-butene | 439-500-2 | 33831-83-3 | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Chronic 2 | H302 | H315 | H411 | GHS07 | GHS09 | Wng | H302 | H315 | H411 |   |   |  602-107-00-3 | 4-йодо-3,3,4,4-тетрафлуоро-1-бутен | 439-500-2 | 33831-83-3 | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Chronic 2 | H302 | H315 | H411 | GHS07 | GHS09 | Wng | H302 | H315 | H411 |   |   |  
602-108-00-9 | (2,3,5,6-tetrafluorophenyl)methanol | 443-840-7 | 4084-38-2 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | H302 | H319 | H317 | GHS07 | Wng | H302 | H319 | H317 |   |   |  602-108-00-9 | (2,3,5,6-тетрафлуорофенил)метанол | 443-840-7 | 4084-38-2 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | H302 | H319 | H317 | GHS07 | Wng | H302 | H319 | H317 |   |   |  
602-109-00-4 | hexabromocyclododecane [1] | 1,2,5,6,9,10-hexabromocyclododecane [2] | 247-148-4 [1] | 221-695-9[2] | 25637-99-4[1] | 3194-55-6[2] | Repr. 2 | Lact. | H361 | H362 | GHS08 | Wng | H361 | H362 |   |   |  602-109-00-4 | хексабромоциклододекан [1] | 1,2,5,6,9,10-хексабромоциклододекан [2] | 247-148-4 [1] | 221-695-9[2] | 25637-99-4[1] | 3194-55-6[2] | Repr. 2 | Lact. | H361 | H362 | GHS08 | Wng | H361 | H362 |   |   |  
603-001-00-X | methanol | 200-659-6 | 67-56-1 | Flam. Liq. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT SE 1 | H225 | H331 | H311 | H301 | H370 ** | GHS02 | GHS06 | GHS08 | Dgr | H225 | H331 | H311 | H301 | H370 ** |   | * | STOT SE 1; H370: C≥10 % | STOT SE 2; H371: 3 % ≤ C<10 % |  603-001-00-X | метанол | 200-659-6 | 67-56-1 | Flam. Liq. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT SE 1 | H225 | H331 | H311 | H301 | H370 ** | GHS02 | GHS06 | GHS08 | Dgr | H225 | H331 | H311 | H301 | H370 ** |   | * | STOT SE 1; H370: C≥10 % | STOT SE 2; H371: 3 % ≤ C<10 % |  
603-002-00-5 | ethanol; | ethyl alcohol | 200-578-6 | 64-17-5 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 |   |   |  603-002-00-5 | етанол; | eтилов алкохол | 200-578-6 | 64-17-5 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 |   |   |  
603-003-00-0 | propan-1-ol; | n-propanol | 200-746-9 | 71-23-8 | Flam. Liq. 2 | Eye Dam. 1 | STOT SE 3 | H225 | H318 | H336 | GHS02 | GHS05 | GHS07 | Dgr | H225 | H318 | H336 |   |   |  603-003-00-0 | пропан-1-ол; | n-пропанол | 200-746-9 | 71-23-8 | Flam. Liq. 2 | Eye Dam. 1 | STOT SE 3 | H225 | H318 | H336 | GHS02 | GHS05 | GHS07 | Dgr | H225 | H318 | H336 |   |   |  
603-004-00-6 | butan-1-ol; | n-butanol | 200-751-6 | 71-36-3 | Flam. Liq. 3 | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | STOT SE 3 | H226 | H302 | H335 | H315 | H318 | H336 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H302 | H335 | H315 | H318 | H336 |   |   |  603-004-00-6 | бутан-1-ол; | n-бутанол | 200-751-6 | 71-36-3 | Flam. Liq. 3 | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | STOT SE 3 | H226 | H302 | H335 | H315 | H318 | H336 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H302 | H335 | H315 | H318 | H336 |   |   |  
603-005-00-1 | 2-methylpropan-2-ol; | tert-butyl alcohol | 200-889-7 | 75-65-0 | Flam. Liq. 2 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | H225 | H332 | H319 | H335 | GHS02 | GHS07 | Dgr | H225 | H332 | H319 | H335 |   |   |  603-005-00-1 | 2-метилпропан-2-ол; | трет-бутилов алкохол | 200-889-7 | 75-65-0 | Flam. Liq. 2 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | H225 | H332 | H319 | H335 | GHS02 | GHS07 | Dgr | H225 | H332 | H319 | H335 |   |   |  
603-006-00-7 | pentanol isomers, with the exception of those specified elsewhere in this Annex | 250-378-8 |   | Flam. Liq. 3 | Acute Tox. 4 * STOT SE 3 | H226 | H332 | H335 | GHS02 | GHS07 | Wng | H226 | H332 | H335 | EUH066 |   | C603-006-00-7 | изомери на пентанола, с изключение на тези, посочени другаде в настоящото приложение | 250-378-8 |   | Flam. Liq. 3 | Acute Tox. 4 * STOT SE 3 | H226 | H332 | H335 | GHS02 | GHS07 | Wng | H226 | H332 | H335 | EUH066 |   | C
603-007-00-2 | 2-methylbutan-2-ol; | tert-pentanol | 200-908-9 | 75-85-4 | Flam. Liq. 2 | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | H225 | H332 | H335 | H315 | GHS02 | GHS07 | Dgr | H225 | H332 | H335 | H315 |   |   |  603-007-00-2 | 2-метилбутан-2-ол; | трет-пентанол | 200-908-9 | 75-85-4 | Flam. Liq. 2 | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | H225 | H332 | H335 | H315 | GHS02 | GHS07 | Dgr | H225 | H332 | H335 | H315 |   |   |  
603-008-00-8 | 4-methylpentan-2-ol; | methyl isobutyl carbinol | 203-551-7 | 108-11-2 | Flam. Liq. 3 | STOT SE 3 | H226 | H335 | GHS02 | GHS07 | Wng | H226 | H335 |   | STOT SE 3; H335: C ≥ 25 % |  603-008-00-8 | 4-мeтилпентан-2-oл; | метилизобутилкарбинол | 203-551-7 | 108-11-2 | Flam. Liq. 3 | STOT SE 3 | H226 | H335 | GHS02 | GHS07 | Wng | H226 | H335 |   | STOT SE 3; H335: C ≥ 25 % |  
603-009-00-3 | cyclohexanol | 203-630-6 | 108-93-0 | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | H332 | H302 | H335 | H315 | GHS07 | Wng | H332 | H302 | H335 | H315 |   |   |  603-009-00-3 | циклохексанол | 203-630-6 | 108-93-0 | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | H332 | H302 | H335 | H315 | GHS07 | Wng | H332 | H302 | H335 | H315 |   |   |  
603-010-00-9 | 2-methylcyclohexanol, mixed isomers; [1] | cis-2-methylcyclohexanol; [2] | trans-2-methylcyclohexanol [3] | 209-512-0 [1] | 231-187-9 [2] | 231-186-3 [3] | 583-59-5 [1] | 7443-70-1 [2] | 7443-52-9 [3] | Acute Tox. 4 * | H332 | GHS07 | Wng | H332 |   |   | C603-010-00-9 | 2-метилциклохексанол, смес от изомери; [1] | цис-2-метилциклохексанол; [2] | транс-2-метилциклохексанол [3] | 209-512-0 [1] | 231-187-9 [2] | 231-186-3 [3] | 583-59-5 [1] | 7443-70-1 [2] | 7443-52-9 [3] | Acute Tox. 4 * | H332 | GHS07 | Wng | H332 |   |   | C
603-011-00-4 | 2-methoxyethanol; | ethylene glycol monomethyl ether | 203-713-7 | 109-86-4 | Flam. Liq. 3 | Repr. 1B | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H226 | H360FD | H332 | H312 | H302 | GHS02 | GHS08 | GHS07 | Dgr | H226 | H360FD H332 | H312 | H302 |   |   |  603-011-00-4 | 2-мeтоксиетанол; | монометилов етер на етиленгликола | 203-713-7 | 109-86-4 | Flam. Liq. 3 | Repr. 1B | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H226 | H360FD | H332 | H312 | H302 | GHS02 | GHS08 | GHS07 | Dgr | H226 | H360FD H332 | H312 | H302 |   |   |  
603-012-00-X | 2-ethoxyethanol; | ethylene glycol monoethyl ether | 203-804-1 | 110-80-5 | Flam. Liq. 3 | Repr. 1B | Acute Tox. 3 | Acute Tox. 4 | H226 | H360FD | H331 | H302 | GHS02 | GHS08 | GHS06 | Dgr | H226 | H360FD H331 | H302 |   |   |  603-012-00-X | 2-етоксиетанол; | моноетилов етер на етиленгликола | 203-804-1 | 110-80-5 | Flam. Liq. 3 | Repr. 1B | Acute Tox. 3 | Acute Tox. 4 | H226 | H360FD | H331 | H302 | GHS02 | GHS08 | GHS06 | Dgr | H226 | H360FD H331 | H302 |   |   |  
603-013-00-5 | 2-isopropoxyethanol; | ethylene glycol monoisopropyl ether | 203-685-6 | 109-59-1 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | H332 | H312 | H319 | GHS07 | Wng | H332 | H312 | H319 |   |   |  603-013-00-5 | 2-изопропоксиетанол; | моноизопропилов етер на етиленгликола | 203-685-6 | 109-59-1 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | H332 | H312 | H319 | GHS07 | Wng | H332 | H312 | H319 |   |   |  
603-014-00-0 | 2-butoxyethanol; | ethyleneglycol monobutyl ether; | butyl cellosolve | 203-905-0 | 111-76-2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | H332 | H312 | H302 | H319 | H315 | GHS07 | Wng | H332 | H312 | H302 | H319 | H315 |   |   |  603-014-00-0 | 2-бутоксиетанол; | монобутилов етер на етиленгликола; | бутил целосолв | 203-905-0 | 111-76-2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | H332 | H312 | H302 | H319 | H315 | GHS07 | Wng | H332 | H312 | H302 | H319 | H315 |   |   |  
603-015-00-6 | allyl alcohol | 203-470-7 | 107-18-6 | Flam. Liq. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | H225 | H331 | H311 | H301 | H319 | H335 | H315 | H400 | GHS02 | GHS06 | GHS09 | Dgr | H225 | H331 | H311 | H301 | H319 | H335 | H315 | H400 |   |   |  603-015-00-6 | алилов алкохол | 203-470-7 | 107-18-6 | Flam. Liq. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | H225 | H331 | H311 | H301 | H319 | H335 | H315 | H400 | GHS02 | GHS06 | GHS09 | Dgr | H225 | H331 | H311 | H301 | H319 | H335 | H315 | H400 |   |   |  
603-016-00-1 | 4-hydroxy-4-methylpentan-2-one; diacetone alcohol | 204-626-7 | 123-42-2 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   | Eye Irrit. 2; H319: C≥ 10 % |  603-016-00-1 | 4-метил-4-хидроксипентан-2-oн; диацетонов алкохол | 204-626-7 | 123-42-2 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   | Eye Irrit. 2; H319: C≥ 10 % |  
603-018-00-2 | furfuryl alcohol | 202-626-1 | 98-00-0 | Carc. 2 | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | STOT SE 3 | H351 | H331 | H312 | H302 | H373** | H319 | H335 | GHS06 | GHS08 | Dgr | H351 | H331 | H312 | H302 | H373** | H319 | H335 |   |   |  603-018-00-2 | фурфурилов алкохол | 202-626-1 | 98-00-0 | Carc. 2 | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | STOT SE 3 | H351 | H331 | H312 | H302 | H373** | H319 | H335 | GHS06 | GHS08 | Dgr | H351 | H331 | H312 | H302 | H373** | H319 | H335 |   |   |  
603-019-00-8 | dimethyl ether | 204-065-8 | 115-10-6 | Flam. Gas 1 | Press. Gas | H220 | GHS02 | GHS04 | Dgr | H220 |   |   | U603-019-00-8 | диметилов етер | 204-065-8 | 115-10-6 | Flam. Gas 1 | Press. Gas | H220 | GHS02 | GHS04 | Dgr | H220 |   |   | U
603-020-00-3 | ethyl methyl ether | — | 540-67-0 | Flam. Gas 1 | Press. Gas | H220 | GHS02 | GHS04 | Dgr | H220 |   |   | U603-020-00-3 | етилметилов етер | — | 540-67-0 | Flam. Gas 1 | Press. Gas | H220 | GHS02 | GHS04 | Dgr | H220 |   |   | U
603-021-00-9 | methyl vinyl ether | 203-475-4 | 107-25-5 | Flam. Gas 1 | Press. Gas | H220 | GHS02 | GHS04 | Dgr | H220 |   |   | D U603-021-00-9 | винилмeтилов етер | 203-475-4 | 107-25-5 | Flam. Gas 1 | Press. Gas | H220 | GHS02 | GHS04 | Dgr | H220 |   |   | D U
603-022-00-4 | diethyl ether; | ether | 200-467-2 | 60-29-7 | Flam. Liq. 1 | Acute Tox. 4 * | STOT SE 3 | H224 | H302 | H336 | GHS02 | GHS07 | Dgr | H224 | H302 | H336 | EUH019 | EUH066 |   |  603-022-00-4 | диетилов етер; | етер | 200-467-2 | 60-29-7 | Flam. Liq. 1 | Acute Tox. 4 * | STOT SE 3 | H224 | H302 | H336 | GHS02 | GHS07 | Dgr | H224 | H302 | H336 | EUH019 | EUH066 |   |  
603-023-00-X | ethylene oxide; | oxirane | 200-849-9 | 75-21-8 | Press. Gas | Flam. Gas 1 | Carc. 1B | Muta. 1B | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H220 | H350 | H340 | H331 | H319 | H335 | H315 | GHS02 | GHS04 | GHS06 | GHS08 | Dgr | H220 | H350 | H340 | H331 | H319 | H335 | H315 |   |   | U603-023-00-X | етиленов оксид; | оксиран | 200-849-9 | 75-21-8 | Press. Gas | Flam. Gas 1 | Carc. 1B | Muta. 1B | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H220 | H350 | H340 | H331 | H319 | H335 | H315 | GHS02 | GHS04 | GHS06 | GHS08 | Dgr | H220 | H350 | H340 | H331 | H319 | H335 | H315 |   |   | U
603-024-00-5 | 1,4-dioxane | 204-661-8 | 123-91-1 | Flam. Liq. 2 | Carc. 2 | Eye Irrit. 2 | STOT SE 3 | H225 | H351 | H319 | H335 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H351 | H319 | H335 | EUH019 | EUH066 |   | D603-024-00-5 | 1,4-диоксан | 204-661-8 | 123-91-1 | Flam. Liq. 2 | Carc. 2 | Eye Irrit. 2 | STOT SE 3 | H225 | H351 | H319 | H335 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H351 | H319 | H335 | EUH019 | EUH066 |   | D
603-025-00-0 | tetrahydrofuran | 203-726-8 | 109-99-9 | Flam. Liq. 2 | Carc. 2 | Eye Irrit. 2 | STOT SE 3 | H225 | H351 | H319 | H335 | GHS02 | GHS07 | GHS08 | Dgr | H225 | H351 | H319 | H335 | EUH019 | STOT SE 3; H335: C≥25 % Eye Irrit.2; | H319: C ≥ 25 % |  603-025-00-0 | тетрахидрофуран | 203-726-8 | 109-99-9 | Flam. Liq. 2 | Carc. 2 | Eye Irrit. 2 | STOT SE 3 | H225 | H351 | H319 | H335 | GHS02 | GHS07 | GHS08 | Dgr | H225 | H351 | H319 | H335 | EUH019 | STOT SE 3; H335: C≥25 % Eye Irrit.2; | H319: C ≥ 25 % |  
603-026-00-6 | 1-chloro-2,3-epoxypropane; epichlorhydrin | 203-439-8 | 106-89-8 | Flam. Liq. 3 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | Skin Sens. 1 | H226 | H350 | H331 | H311 | H301 | H314 | H317 | GHS02 | GHS06 | GHS08 | GHS05 | Dgr | H226 | H350 | H331 | H311 | H301 | H314 | H317 |   | * |  603-026-00-6 | 1-хлоро-2,3-eпоксипропан; епихлорхидрин | 203-439-8 | 106-89-8 | Flam. Liq. 3 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | Skin Sens. 1 | H226 | H350 | H331 | H311 | H301 | H314 | H317 | GHS02 | GHS06 | GHS08 | GHS05 | Dgr | H226 | H350 | H331 | H311 | H301 | H314 | H317 |   | * |  
603-027-00-1 | ethanediol; | ethylene glycol | 203-473-3 | 107-21-1 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  603-027-00-1 | етандиол; | етиленгликол | 203-473-3 | 107-21-1 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
603-028-00-7 | 2-chloroethanol; | ethylene chlorohydrin | 203-459-7 | 107-07-3 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | H330 | H310 | H300 | GHS06 | Dgr | H330 | H310 | H300 |   |   |  603-028-00-7 | 2-хлороетанол; | етиленхлорохидрин | 203-459-7 | 107-07-3 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | H330 | H310 | H300 | GHS06 | Dgr | H330 | H310 | H300 |   |   |  
603-029-00-2 | bis(2-chloroethyl) ether | 203-870-1 | 111-44-4 | Carc. 2 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | H351 | H330 | H310 | H300 | GHS06 | GHS08 | Dgr | H351 | H330 | H310 | H300 |   |   |  603-029-00-2 | бис(2-хлорoетилов) етер | 203-870-1 | 111-44-4 | Carc. 2 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | H351 | H330 | H310 | H300 | GHS06 | GHS08 | Dgr | H351 | H330 | H310 | H300 |   |   |  
603-030-00-8 | 2-aminoethanol; | ethanolamine | 205-483-3 | 141-43-5 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H332 | H312 | H302 | H314 | GHS05 | GHS07 | Dgr | H332 | H312 | H302 | H314 |   | STOT SE 3; H335: C ≥ 5 % |  603-030-00-8 | 2-аминоетанол; | етаноламин | 205-483-3 | 141-43-5 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H332 | H312 | H302 | H314 | GHS05 | GHS07 | Dgr | H332 | H312 | H302 | H314 |   | STOT SE 3; H335: C ≥ 5 % |  
603-031-00-3 | 1,2-dimethoxyethane; | ethylene glycol dimethyl ether; | EGDME | 203-794-9 | 110-71-4 | Flam. Liq. 2 | Repr. 1B | Acute Tox. 4 * | H225 | H360FD | H332 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H360FD H332 | EUH019 |   |  603-031-00-3 | 1,2-диметоксиетан; | диметилов етер на етиленгликола; | EGDME | 203-794-9 | 110-71-4 | Flam. Liq. 2 | Repr. 1B | Acute Tox. 4 * | H225 | H360FD | H332 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H360FD H332 | EUH019 |   |  
603-032-00-9 | ethylene dinitrate; | ethylene glycol dinitrate | 211-063-0 | 628-96-6 | Unst. Expl. | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 | H200 | H330 | H310 | H300 | H373** | GHS01 | GHS06 | GHS08 | Dgr | H200 | H330 | H310 | H300 | H373** |   |   |  603-032-00-9 | етилендинитрат; | етиленгликолдинитрат | 211-063-0 | 628-96-6 | Unst. Expl. | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 | H200 | H330 | H310 | H300 | H373** | GHS01 | GHS06 | GHS08 | Dgr | H200 | H330 | H310 | H300 | H373** |   |   |  
603-033-00-4 | oxydiethylene dinitrate; | diethylene glycol dinitrate; | digol dinitrate | 211-745-8 | 693-21-0 | Unst. Expl | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Chronic 3 | H200 | H330 | H310 | H300 | H373 ** | H412 | GHS01 | GHS06 | GHS08 | Dgr | H200 | H330 | H310 | H300 | H373 ** | H412 |   |   |  603-033-00-4 | oксидиетилендинитрат; | диетиленгликолдинитрат; | диголдинитрат | 211-745-8 | 693-21-0 | Unst. Expl | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Chronic 3 | H200 | H330 | H310 | H300 | H373 ** | H412 | GHS01 | GHS06 | GHS08 | Dgr | H200 | H330 | H310 | H300 | H373 ** | H412 |   |   |  
603-033-01-1 | oxydiethylene dinitrate; | diethylene glycol dinitrate; | digol dinitrate; | [>25 % phlegmatiser] | 211-745-8 | 693-21-0 | Expl. 1.1 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Chronic 3 | H201 | H330 | H310 | H300 | H373 ** | H412 | GHS01 | GHS06 | GHS08 | Dgr | H201 | H330 | H310 | H300 | H373 ** H412 |   |   |  603-033-01-1 | oксидиетилендинитрат; | диетиленгликолдинитрат; | диголдинитрат; | [> 25 % флегматизатор] | 211-745-8 | 693-21-0 | Expl. 1.1 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Chronic 3 | H201 | H330 | H310 | H300 | H373 ** | H412 | GHS01 | GHS06 | GHS08 | Dgr | H201 | H330 | H310 | H300 | H373 ** H412 |   |   |  
603-034-00-X | glycerol trinitrate; nitroglycerine | 200-240-8 | 55-63-0 | Unst. Expl. | Acute Tox. 2 * Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Chronic 2 | H200 | H330 | H310 | H300 | H373 ** H411 | GHS01 | GHS06 | GHS08 | GHS09 | Dgr | H200 | H330 | H310 | H300 | H373 ** H411 |   |   |  603-034-00-X | глицеролтринитрат; нитроглицерин | 200-240-8 | 55-63-0 | Unst. Expl. | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Chronic 2 | H200 | H330 | H310 | H300 | H373 ** H411 | GHS01 | GHS06 | GHS08 | GHS09 | Dgr | H200 | H330 | H310 | H300 | H373 ** H411 |   |   |  
603-034-01-7 | glycerol trinitrate; nitroglycerine; [>40 % phlegmatiser] | 200-240-8 | 55-63-0 | Expl. 1.1 | Acute Tox. 2 * Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Chronic 2 | H201 | H330 | H310 | H300 | H373 ** H411 | GHS01 | GHS06 | GHS08 | GHS09 | Dgr | H201 | H330 | H310 | H300 | H373 ** H411 |   |   |  603-034-01-7 | глицеролтринитрат; нитроглицерин; [>40 % флегматизатор] | 200-240-8 | 55-63-0 | Expl. 1.1 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Chronic 2 | H201 | H330 | H310 | H300 | H373 ** H411 | GHS01 | GHS06 | GHS08 | GHS09 | Dgr | H201 | H330 | H310 | H300 | H373 ** H411 |   |   |  
603-035-00-5 | pentaerythritol tetranitrate; pentaerythrite tetranitrate; P.E.T.N. | 201-084-3 | 78-11-5 | Unst. Expl. | H200 | GHS01 | Dgr | H200 |   |   |  603-035-00-5 | пентаеритритолтетранитрат; пентаеритриттетранитрат; P.E.T.N. | 201-084-3 | 78-11-5 | Unst. Expl. | H200 | GHS01 | Dgr | H200 |   |   |  
603-035-01-2 | pentaerythritol tetranitrate; pentaerythrite tetranitrate; P.E.T.N.;[>20 % phlegmatiser] | 201-084-3 | 78-11-5 | Expl. 1.1 | H201 | GHS01 | Dgr | H201 |   |   | T603-035-01-2 | пентаеритритолтетранитрат; пентаеритритолтетранитрат;P.E.T.N.;[>20 % флегматизатор] | 201-084-3 | 78-11-5 | Expl. 1.1 | H201 | GHS01 | Dgr | H201 |   |   | T
603-036-00-0 | mannitol hexanitrate; nitromannite | 239-924-6 | 15825-70-4 | Unst. Expl. | H200 | GHS01 | Dgr | H200 |   |   |  603-036-00-0 | мaнитолхексанитрат; нитроманит | 239-924-6 | 15825-70-4 | Unst. Expl. | H200 | GHS01 | Dgr | H200 |   |   |  
603-036-01-8 | mannitol hexanitrate; nitromannite;[>40 % phlegmatiser] | 239-924-6 | 15825-70-4 | Expl. 1.1 | H201 | GHS01 | Dgr | H201 |   |   |  603-036-01-8 | мaнитолхексанитрат; нитроманит;[>40 % флегматизатор] | 239-924-6 | 15825-70-4 | Expl. 1.1 | H201 | GHS01 | Dgr | H201 |   |   |  
603-037-00-6 | cellulose nitrate; nitrocellulose | — | — | Expl. 1.1 | H201 | GHS01 | Dgr | H201 |   |   | T603-037-00-6 | целулозен нитрат; нитроцелулоза | — | — | Expl. 1.1 | H201 | GHS01 | Dgr | H201 |   |   | T
603-038-00-1 | allyl glycidyl ether; allyl 2,3-epoxypropyl ether; prop-2-en-1-yl 2,3-epoxypropyl ether | 203-442-4 | 106-92-3 | Flam. Liq. 3 | Carc. 2 | Muta. 2 | Repr. 2 | Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H226 | H351 | H341 | H361f *** H332 | H302 | H335 | H315 | H318 | H317 | H412 | GHS02 | GHS08 | GHS05 | GHS07 | Dgr | H226 | H351 | H341 | H361f *** H332 | H302 | H335 | H315 | H318 | H317 | H412 |   |   |  603-038-00-1 | алилглицидилов етер; алил-2,3-епоксипропилов етер; проп-2-ен-1-ил-2,3-епоксипропилов етер | 203-442-4 | 106-92-3 | Flam. Liq. 3 | Carc. 2 | Muta. 2 | Repr. 2 | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H226 | H351 | H341 | H361f *** H332 | H302 | H335 | H315 | H318 | H317 | H412 | GHS02 | GHS08 | GHS05 | GHS07 | Dgr | H226 | H351 | H341 | H361f *** H332 | H302 | H335 | H315 | H318 | H317 | H412 |   |   |  
603-039-00-7 | butyl glycidyl ether; butyl 2,3-epoxypropyl ether | 219-376-4 | 2426-08-6 | Flam. Liq. 3 | Carc. 2 | Muta. 2 | Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 | Skin Sens. 1 | Aquatic Chronic 3 | H226 | H351 | H341 | H332 | H302 | H335 | H317 | H412 | GHS02 | GHS08 | GHS07 | Wng | H226 | H351 | H341 | H332 | H302 | H335 | H317 | H412 |   |   |  603-039-00-7 | бутилглицидилов етер; бутил-2,3-епоксипропилов етер | 219-376-4 | 2426-08-6 | Flam. Liq. 3 | Carc. 2 | Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 3 | Skin Sens. 1 | Aquatic Chronic 3 | H226 | H351 | H341 | H332 | H302 | H335 | H317 | H412 | GHS02 | GHS08 | GHS07 | Wng | H226 | H351 | H341 | H332 | H302 | H335 | H317 | H412 |   |   |  
603-040-00-2 | sodium methanolate; sodium methoxide; [1] potassium methanolate; potassium methoxide; [2] lithium methanolate; lithium methoxide [3] | 204-699-5 [1] | 212-736-1 [2] | 212-737-7 [3] | 124-41-4 [1] | 865-33-8 [2] | 865-34-9 [3] | Self-heat 1 | Skin Corr. 1B | H251 | H314 | GHS02 | GHS05 | Dgr | H251 | H314 | EUH014 |   | T603-040-00-2 | натриев метанолат; натриев метоксид; [1] калиев метанолат; калиев метоксид; [2] литиев метанолат; литиев метоксид [3] | 204-699-5 [1] | 212-736-1 [2] | 212-737-7 [3] | 124-41-4 [1] | 865-33-8 [2] | 865-34-9 [3] | Self-heat 1 | Skin Corr. 1B | H251 | H314 | GHS02 | GHS05 | Dgr | H251 | H314 | EUH014 |   | T
603-041-00-8 | potassium ethanolate; potassium ethoxide; [1] sodium ethanolate; sodium ethoxide [2] | 213-029-0 [1] | 205-487-5 [2] | 917-58-8 [1] | 141-52-6 [2] | Self-heat 1 | Skin Corr. 1B | H251 | H314 | GHS02 | GHS05 | Dgr | H251 | H314 | EUH014 |   | T603-041-00-8 | калиев етанолат; калиев етоксид; [1] натриев етанолат; натриев етоксид [2] | 213-029-0 [1] | 205-487-5 [2] | 917-58-8 [1] | 141-52-6 [2] | Self-heat 1 | Skin Corr. 1B | H251 | H314 | GHS02 | GHS05 | Dgr | H251 | H314 | EUH014 |   | T
603-042-00-3 | aluminium-tri-isopropoxide | 209-090-8 | 555-31-7 | Flam. Sol. 1 | H228 | GHS02 | Dgr | H228 |   |   | T603-042-00-3 | алуминиев триизопропоксид | 209-090-8 | 555-31-7 | Flam. Sol. 1 | H228 | GHS02 | Dgr | H228 |   |   | T
603-043-00-9 | triarimol (ISO); 2,4-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol | — | 26766-27-8 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  603-043-00-9 | триаримол (ISO); α-(пиримидин-5-ил)-2,4-дихлоробензхидрилов алкохол | — | 26766-27-8 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
603-044-00-4 | dicofol (ISO); 2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol | 204-082-0 | 115-32-2 | Acute Tox. 4 * Acute Tox. 4 * | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H315 | H317 | H410 |   |   |  603-044-00-4 | дикофол (ISO); 2,2,2-трихлоро-1,1-бис(4-хлорофенил)eтанол | 204-082-0 | 115-32-2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H315 | H317 | H410 |   |   |  
603-045-00-X | diisopropyl ether; [1] dipropyl ether [2] | 203-560-6 [1] | 203-869-6 [2] | 108-20-3 [1] | 111-43-3 [2] | Flam. Liq. 2 | STOT SE 3 | H225 | H336 | GHS02 | GHS07 | Dgr | H225 | H336 | EUH019 | EUH066 |   | C603-045-00-X | диизопропилов етер; [1] дипропилов етер [2] | 203-560-6 [1] | 203-869-6 [2] | 108-20-3 [1] | 111-43-3 [2] | Flam. Liq. 2 | STOT SE 3 | H225 | H336 | GHS02 | GHS07 | Dgr | H225 | H336 | EUH019 | EUH066 |   | C
603-046-00-5 | bis(chloromethyl) ether; oxybis(chloromethane) | 208-832-8 | 542-88-1 | Flam. Liq. 2 | Carc. 1A | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 4 * | H225 | H350 | H330 | H311 | H302 | GHS02 | GHS06 | GHS08 | Dgr | H225 | H350 | H330 | H311 | H302 |   | Carc. 1A; H350: C ≥ 0,001  % |  603-046-00-5 | бис(хлорометилов) етер; оксибис(хлорометан) | 208-832-8 | 542-88-1 | Flam. Liq. 2 | Carc. 1A | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 4 * | H225 | H350 | H330 | H311 | H302 | GHS02 | GHS06 | GHS08 | Dgr | H225 | H350 | H330 | H311 | H302 |   | Carc. 1A; H350: C ≥ 0,001  % |  
603-047-00-0 | 2-dimethylaminoethanol; N,N-dimethylethanolamine | 203-542-8 | 108-01-0 | Flam. Liq. 3 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | Skin Corr. 1B | H226 | H332 | H312 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H332 | H312 | H302 | H314 |   | STOT SE 3; H335: C≥5 % |  603-047-00-0 | 2-диметиламиноетанол; N,N-диметилетаноламин | 203-542-8 | 108-01-0 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H226 | H332 | H312 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H332 | H312 | H302 | H314 |   | STOT SE 3; H335: C≥5 % |  
603-048-00-6 | 2-diethylaminoethanol; N,N-diethylethanolamine | 202-845-2 | 100-37-8 | Flam. Liq. 3 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | Skin Corr. 1B | H226 | H332 | H312 | H302 | H314 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H226 | H332 | H312 | H302 | H314 |   | STOT SE 3; H335: C≥5 % |  603-048-00-6 | 2-диетиламиноетанол; N,N-диетилетаноламин | 202-845-2 | 100-37-8 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H226 | H332 | H312 | H302 | H314 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H226 | H332 | H312 | H302 | H314 |   | STOT SE 3; H335: C≥5 % |  
603-049-00-1 | chlorfenethol (ISO); 1,1-bis (4-chlorophenyl) ethanol | 201-246-3 | 80-06-8 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  603-049-00-1 | хлорфенетол (ISO); 1,1-бис(4-хлорофенил)eтанол | 201-246-3 | 80-06-8 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
603-050-00-7 | 1-(2-butoxypropoxy)propan-2-ol | 246-011-6 | 24083-03-2 | Acute Tox. 4 * Acute Tox. 4 * | H312 | H302 | GHS07 | Wng | H312 | H302 |   |   |  603-050-00-7 | 1-(2-бутоксипропокси)пропан-2-ол | 246-011-6 | 24083-03-2 | Acute Tox. 4 * | Acute Tox. 4 * | H312 | H302 | GHS07 | Wng | H312 | H302 |   |   |  
603-051-00-2 | 2-ethylbutan-1-ol | 202-621-4 | 97-95-0 | Acute Tox. 4 * Acute Tox. 4 * | H312 | H302 | GHS07 | Wng | H312 | H302 |   |   |  603-051-00-2 | 2-етилбутан-1-ол | 202-621-4 | 97-95-0 | Acute Tox. 4 * | Acute Tox. 4 * | H312 | H302 | GHS07 | Wng | H312 | H302 |   |   |  
603-052-00-8 | 3-butoxypropan-2-ol; propylene glycol monobutyl ether | 225-878-4 | 5131-66-8 | Eye Irrit. 2 | Skin Irrit. 2 | H319 | H315 | GHS07 | Wng | H319 | H315 |   |   |  603-052-00-8 | 3-бутоксипропан-2-ол; монобутилов етер на пропиленгликола | 225-878-4 | 5131-66-8 | Eye Irrit. 2 | Skin Irrit. 2 | H319 | H315 | GHS07 | Wng | H319 | H315 |   |   |  
603-053-00-3 | 2-methylpentane-2,4-diol | 203-489-0 | 107-41-5 | Eye Irrit. 2 | Skin Irrit. 2 | H319 | H315 | GHS07 | Wng | H319 | H315 |   |   |  603-053-00-3 | 2-метилпентан-2,4-диол | 203-489-0 | 107-41-5 | Eye Irrit. 2 | Skin Irrit. 2 | H319 | H315 | GHS07 | Wng | H319 | H315 |   |   |  
603-054-00-9 | di-n-butyl ether; dibutyl ether | 205-575-3 | 142-96-1 | Flam. Liq. 3 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Chronic 3 | H226 | H319 | H335 | H315 | H412 | GHS02 | GHS07 | Wng | H226 | H319 | H335 | H315 | H412 |   | STOT SE 3; H335: C≥10 % |  603-054-00-9 | ди-n-бутилов етер; дибутилов етер | 205-575-3 | 142-96-1 | Flam. Liq. 3 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Chronic 3 | H226 | H319 | H335 | H315 | H412 | GHS02 | GHS07 | Wng | H226 | H319 | H335 | H315 | H412 |   | STOT SE 3; H335: C≥10 % |  
603-056-00-X | [(p-tolyloxy)methyl]oxirane; [1] [(m-tolyloxy)methyl]oxirane; [2]2,3-epoxypropyl o-tolyl ether; [3] [(tolyloxy)methyl]oxirane; cresyl glycidyl ether [4] | 218-574-8 [1] | 218-575-3 [2] | 218-645-3 [3] | 247-711-4 [4] | 2186-24-5 [1] | 2186-25-6 [2] | 2210-79-9 [3] | 26447-14-3 [4] | Muta. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H341 | H315 | H317 | H411 | GHS08 | GHS07 | GHS09 | Wng | H341 | H315 | H317 | H411 |   |   | C603-056-00-X | [(p-толилокси)метил]оксиран; [1] [(m-толилокси)метил]оксиран; [2]2,3-епоксипропил-o-толилов етер; [3] [(толилокси)метил]оксиран; глицидилкрезилов етер [4] | 218-574-8 [1] | 218-575-3 [2] | 218-645-3 [3] | 247-711-4 [4] | 2186-24-5 [1] | 2186-25-6 [2] | 2210-79-9 [3] | 26447-14-3 [4] | Muta. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H341 | H315 | H317 | H411 | GHS08 | GHS07 | GHS09 | Wng | H341 | H315 | H317 | H411 |   |   | C
603-057-00-5 | benzyl alcohol | 202-859-9 | 100-51-6 | Acute Tox. 4 * Acute Tox. 4 * | H332 | H302 | GHS07 | Wng | H332 | H302 |   |   |  603-057-00-5 | бензилов алкохол | 202-859-9 | 100-51-6 | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H302 | GHS07 | Wng | H332 | H302 |   |   |  
603-058-00-0 | 1,3-propylene oxide | 207-964-3 | 503-30-0 | Flam. Liq. 2 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | H225 | H332 | H312 | H302 | GHS02 | GHS07 | Dgr | H225 | H332 | H312 | H302 |   |   |  603-058-00-0 | 1,3-пропиленоксид | 207-964-3 | 503-30-0 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H225 | H332 | H312 | H302 | GHS02 | GHS07 | Dgr | H225 | H332 | H312 | H302 |   |   |  
603-059-00-6 | hexan-1-ol | 203-852-3 | 111-27-3 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  603-059-00-6 | хексан-1-ол | 203-852-3 | 111-27-3 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
603-060-00-1 | 2,2'-bioxirane; 1,2:3,4-diepoxybutane | 215-979-1 | 1464-53-5 | Carc. 1B Muta. 1B | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * | Skin Corr. 1B | H350 | H340 | H330 | H311 | H301 | H314 | GHS06 | GHS08 | GHS05 | Dgr | H350 | H340 | H330 | H311 | H301 | H314 |   |   |  603-060-00-1 | 2,2′-биоксиран; 1,2:3,4-диепоксибутан | 215-979-1 | 1464-53-5 | Carc. 1B Muta. 1B | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | H350 | H340 | H330 | H311 | H301 | H314 | GHS06 | GHS08 | GHS05 | Dgr | H350 | H340 | H330 | H311 | H301 | H314 |   |   |  
603-061-00-7 | tetrahydro-2-furyl-methanol; tetrahydrofurfuryl alcohol | 202-625-6 | 97-99-4 | Repr. 1B Eye Irrit. 2 | H360Df | H319 | GHS08 | GHS07 | Dgr | H360Df | H319 |   |   |  603-061-00-7 | тeтрахидро-2-фурилметанол; тeтрахидрофурфурилов алкохол | 202-625-6 | 97-99-4 | Repr. 1B Eye Irrit. 2 | H360Df | H319 | GHS08 | GHS07 | Dgr | H360Df | H319 |   |   |  
603-062-00-2 | tetrahydrofuran-2,5-diyldimethanol | 203-239-0 | 104-80-3 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H319 | H335 | H315 | GHS07 | Wng | H319 | H335 | H315 |   | STOT SE 3; H335: C ≥10 % |  603-062-00-2 | тетрахидрофуран-2,5-диилдиметанол | 203-239-0 | 104-80-3 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H319 | H335 | H315 | GHS07 | Wng | H319 | H335 | H315 |   | STOT SE 3; H335: C ≥10 % |  
603-063-00-8 | 2,3-epoxypropan-1-ol; glycidol; oxiranemethanol | 209-128-3 | 556-52-5 | Carc. 1B Muta. 2 | Repr. 1B | Acute Tox. 3 * Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H350 | H341 | H360F *** H331 | H312 | H302 | H319 | H335 | H315 | GHS06 | GHS08 | Dgr | H350 | H341 | H360F *** H331 | H312 | H302 | H319 | H335 | H315 |   |   |  603-063-00-8 | 2,3-епоксипропан-1-ол; глицидол; оксиранметанол | 209-128-3 | 556-52-5 | Carc. 1B Muta. 2 | Repr. 1B | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H350 | H341 | H360F *** H331 | H312 | H302 | H319 | H335 | H315 | GHS06 | GHS08 | Dgr | H350 | H341 | H360F *** H331 | H312 | H302 | H319 | H335 | H315 |   |   |  
603-064-00-3 | 1-methoxy-2-propanol; monopropylene glycol methyl ether | 203-539-1 | 107-98-2 | Flam. Liq. 3 | STOT SE 3 | H226 | H336 | GHS02 | GHS07 | Wng | H226 | H336 |   |   |  603-064-00-3 | 1-метокси-2-пропанол; метилов етер на монопропиленгликола | 203-539-1 | 107-98-2 | Flam. Liq. 3 | STOT SE 3 | H226 | H336 | GHS02 | GHS07 | Wng | H226 | H336 |   |   |  
603-065-00-9 | resorcinol diglycidyl ether;1,3-bis(2,3-epoxypropoxy)benzene | 202-987-5 | 101-90-6 | Carc. 2 | Muta. 2 | Acute Tox. 4 * Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H351 | H341 | H312 | H302 | H319 | H315 | H317 | H412 | GHS08 | GHS07 | Wng | H351 | H341 | H312 | H302 | H319 | H315 | H317 | H412 |   |   |  603-065-00-9 | диглицидилов етер на резорцинола;1,3-бис(2,3-eпоксипропокси)бензен | 202-987-5 | 101-90-6 | Carc. 2 | Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H351 | H341 | H312 | H302 | H319 | H315 | H317 | H412 | GHS08 | GHS07 | Wng | H351 | H341 | H312 | H302 | H319 | H315 | H317 | H412 |   |   |  
603-066-00-4 | 1,2-epoxy-4-epoxyethylcyclohexane; 4-vinylcyclohexene diepoxide | 203-437-7 | 106-87-6 | Carc. 2 | Acute Tox. 3 * Acute Tox. 3 * | Acute Tox. 3 * | H351 | H331 | H311 | H301 | GHS06 | GHS08 | Dgr | H351 | H331 | H311 | H301 |   | * |  603-066-00-4 | 1,2-епокси-4-епоксиетилциклохексан; 4-винилциклохексендиепоксид | 203-437-7 | 106-87-6 | Carc. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H351 | H331 | H311 | H301 | GHS06 | GHS08 | Dgr | H351 | H331 | H311 | H301 |   | * |  
603-067-00-X | phenyl glycidyl ether; 2,3-epoxypropyl phenyl ether;1,2-epoxy-3-phenoxypropane | 204-557-2 | 122-60-1 | Carc. 1B Muta. 2 | Acute Tox. 4 * STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H350 | H341 | H332 | H335 | H315 | H317 | H412 | GHS08 | GHS07 | Dgr | H350 | H341 | H332 | H335 | H315 | H317 | H412 |   |   |  603-067-00-X | глицидилфенилов етер; 2,3-епоксипропилфенилов етер;1,2-епокси-3-феноксипропан | 204-557-2 | 122-60-1 | Carc. 1B Muta. 2 | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H350 | H341 | H332 | H335 | H315 | H317 | H412 | GHS08 | GHS07 | Dgr | H350 | H341 | H332 | H335 | H315 | H317 | H412 |   |   |  
603-068-00-5 | 2,3-epoxypropyl-2-ethylcyclohexyl ether; ethylcyclohexylglycidyl ether | — | 130014-35-6 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   |   |  603-068-00-5 | 2,3-епоксипропил-2-eтилциклохексилов етер; етилциклохексилглицидилов етер | — | 130014-35-6 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   |   |  
603-069-00-0 | 2,4,6-tris(dimethylaminomethyl)phenol | 202-013-9 | 90-72-2 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | H302 | H319 | H315 | GHS07 | Wng | H302 | H319 | H315 |   |   |  603-069-00-0 | 2,4,6-трис(диметиламинометил)фенол | 202-013-9 | 90-72-2 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | H302 | H319 | H315 | GHS07 | Wng | H302 | H319 | H315 |   |   |  
603-070-00-6 | 2-amino-2-methylpropanol | 204-709-8 | 124-68-5 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 3 | H319 | H315 | H412 | GHS07 | Wng | H319 | H315 | H412 |   |   |  603-070-00-6 | 2-амино-2-метилпропанол | 204-709-8 | 124-68-5 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 3 | H319 | H315 | H412 | GHS07 | Wng | H319 | H315 | H412 |   |   |  
603-071-00-1 | 2,2'-iminodiethanol; diethanolamine | 203-868-0 | 111-42-2 | Acute Tox. 4 * STOT RE 2 * | Skin Irrit. 2 | Eye Dam. 1 | H302 | H373 ** H315 | H318 | GHS08 | GHS05 | GHS07 | Dgr | H302 | H373 ** H315 | H318 |   |   |  603-071-00-1 | 2,2′-иминодиетанол; диетаноламин | 203-868-0 | 111-42-2 | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | Eye Dam. 1 | H302 | H373 ** H315 | H318 | GHS08 | GHS05 | GHS07 | Dgr | H302 | H373 ** H315 | H318 |   |   |  
603-072-00-7 | 1,4-bis(2,3 epoxypropoxy)butane; butanedioldiglycidyl ether | 219-371-7 | 2425-79-8 | Acute Tox. 4 * Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H332 | H312 | H319 | H315 | H317 | GHS07 | Wng | H332 | H312 | H319 | H315 | H317 |   |   |  603-072-00-7 | 1,4-бис(2,3-eпоксипропокси)бутан; бутандиолдиглицидилов етер | 219-371-7 | 2425-79-8 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H332 | H312 | H319 | H315 | H317 | GHS07 | Wng | H332 | H312 | H319 | H315 | H317 |   |   |  
603-073-00-2 | bis-[4-(2,3-epoxipropoxi)phenyl]propane | 216-823-5 | 1675-54-3 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   | Eye Irrit. 2; H319: C≥ 5 % Skin Irrit. 2; H315: C≥5 % |  603-073-00-2 | бис[4-(2,3-епоксипропокси)фенил]пропан | 216-823-5 | 1675-54-3 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   | Eye Irrit. 2; H319: C≥ 5 % Skin Irrit. 2; H315: C≥5 % |  
603-074-00-8 | reaction product: bisphenol-A-(epichlorhydrin); epoxy resin (number average molecular weight ≤ 700) | 500-033-5 | 25068-38-6 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H319 | H315 | H317 | H411 | GHS07 | GHS09 | Wng | H319 | H315 | H317 | H411 |   | Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit 2; H315: C≥ 5 % |  603-074-00-8 | реакционен продукт: бисфенол-А-(епихлорхидрин); епоксидна смола (средна бройна молекулна маса ≤ 700) | 500-033-5 | 25068-38-6 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H319 | H315 | H317 | H411 | GHS07 | GHS09 | Wng | H319 | H315 | H317 | H411 |   | Eye Irrit. 2; H319: C ≥ 5 % Skin Irrit 2; H315: C≥ 5 % |  
603-075-00-3 | chlormethyl methyl ether; chlorodimethyl ether | 203-480-1 | 107-30-2 | Flam. Liq. 2 | Carc. 1A | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | H225 | H350 | H332 | H312 | H302 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H350 | H332 | H312 | H302 |   |   |  603-075-00-3 | метилхлорометилов етер; хлородиметилов етер | 203-480-1 | 107-30-2 | Flam. Liq. 2 | Carc. 1A | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H225 | H350 | H332 | H312 | H302 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H350 | H332 | H312 | H302 |   |   |  
603-076-00-9 | but-2-yne-1,4-diol; 2-butyne-1,4-diol | 203-788-6 | 110-65-6 | Skin Corr. 1B | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * | Skin Sens. 1 | H314 | H331 | H301 | H312 | H373 ** H317 | GHS06 | GHS05 | GHS08 | Dgr | H314 | H331 | H301 | H312 | H373 ** H317 |   | Skin Corr. 1B; H314: C≥50 % Skin Irrit. 2; H315: 25 %≤ C < 50 % | Eye Irrit. 2; H319: 25 %≤ | C<50 % | D603-076-00-9 | бут-2-ин-1,4-диол; 2-бутин-1,4-диол | 203-788-6 | 110-65-6 | Skin Corr. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 2 * | Skin Sens. 1 | H314 | H331 | H301 | H312 | H373 ** H317 | GHS06 | GHS05 | GHS08 | Dgr | H314 | H331 | H301 | H312 | H373 ** H317 |   | Skin Corr. 1B; H314: C≥50 % Skin Irrit. 2; H315: 25 %≤ C < 50 % | Eye Irrit. 2; H319: 25 %≤ | C<50 % | D
603-077-00-4 | 1-dimethylaminopropan-2-ol; dimepranol (INN) | 203-556-4 | 108-16-7 | Flam. Liq. 3 | Acute Tox. 4 * | Skin Corr. 1B | H226 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H302 | H314 |   |   |  603-077-00-4 | 1-диметиламинопропан-2-oл; димепранол (INN) | 203-556-4 | 108-16-7 | Flam. Liq. 3 | Acute Tox. 4 * | Skin Corr. 1B | H226 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H302 | H314 |   |   |  
603-078-00-X | prop-2-yn-1-ol; propargyl alcohol | 203-471-2 | 107-19-7 | Flam. Liq. 3 | Acute Tox. 3 * Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | Aquatic Chronic 2 | H226 | H331 | H311 | H301 | H314 | H411 | GHS02 | GHS06 | GHS05 | GHS09 | Dgr | H226 | H331 | H311 | H301 | H314 | H411 |   |   |  603-078-00-X | проп-2-ин-1-oл; пропаргилов алкохол | 203-471-2 | 107-19-7 | Flam. Liq. 3 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | Aquatic Chronic 2 | H226 | H331 | H311 | H301 | H314 | H411 | GHS02 | GHS06 | GHS05 | GHS09 | Dgr | H226 | H331 | H311 | H301 | H314 | H411 |   |   |  
603-079-00-5 | 2,2'-(methylimino)diethanol; N-methyldiethanolamine | 203-312-7 | 105-59-9 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  603-079-00-5 | 2,2′-(мeтилимино)диетанол; N-метилдиетаноламин | 203-312-7 | 105-59-9 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
603-080-00-0 | 2-methylaminoethanol; N-methylethanolamine; N-methyl-2-ethanolamine; N-methyl-2-amino ethanol; 2-(methylamino)ethanol | 203-710-0 | 109-83-1 | Acute Tox. 4 * Acute Tox. 4 * | Skin Corr. 1B | H312 | H302 | H314 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 |   | STOT SE 3; H335: C≥5 % |  603-080-00-0 | 2-мeтиламиноетанол; N-метилетаноламин; N-метил-2-етаноламин; N-мeтил-2-аминоетанол; 2-(метиламино)етанол | 203-710-0 | 109-83-1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H312 | H302 | H314 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 |   | STOT SE 3; H335: C≥5 % |  
603-081-00-6 | 2,2'-thiodiethanol; thiodiglycol | 203-874-3 | 111-48-8 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  603-081-00-6 | 2,2′-тиодиетанол; тиодигликол | 203-874-3 | 111-48-8 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
603-082-00-1 | 1-aminopropan-2-ol; isopropanolamine | 201-162-7 | 78-96-6 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   |   |  603-082-00-1 | 1-аминопропан-2-oл; изопропаноламин | 201-162-7 | 78-96-6 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   |   |  
603-083-00-7 | 1,1'-iminodipropan-2-ol; di-isopropanolamine | 203-820-9 | 110-97-4 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  603-083-00-7 | 1,1′-иминодипропан-2-oл; диизопропаноламин | 203-820-9 | 110-97-4 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
603-084-00-2 | styrene oxide;(epoxyethyl)benzene; phenyloxirane | 202-476-7 | 96-09-3 | Carc. 1B | Acute Tox. 4 * | Eye Irrit. 2 | H350 | H312 | H319 | GHS08 | GHS07 | Dgr | H350 | H312 | H319 |   |   |  603-084-00-2 | стиреноксид;(епоксиетил)бензен; фенилоксиран | 202-476-7 | 96-09-3 | Carc. 1B | Acute Tox. 4 * | Eye Irrit. 2 | H350 | H312 | H319 | GHS08 | GHS07 | Dgr | H350 | H312 | H319 |   |   |  
603-085-00-8 | bronopol (INN); 2-bromo-2-nitropropane-1,3-diol | 200-143-0 | 52-51-7 | Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | H312 | H302 | H335 | H315 | H318 | H400 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H335 | H315 | H318 | H400 |   | M=10 |  603-085-00-8 | бронопол (INN); 2-бромо-2-нитропропан-1,3-диол | 200-143-0 | 52-51-7 | Acute Tox. 4 * | Acute Tox. 4 * STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | H312 | H302 | H335 | H315 | H318 | H400 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H335 | H315 | H318 | H400 |   | M=10 |  
603-086-00-3 | ethirimol (ISO); 5-butyl-2-ethylamino-6-methylpyrimidin-4-ol | 245-949-3 | 23947-60-6 | Acute Tox. 4 * | H312 | GHS07 | Wng | H312 |   |   |  603-086-00-3 | етиримол (ISO); 5-бутил-2-eтиламино-6-метилпиримидин-4-oл | 245-949-3 | 23947-60-6 | Acute Tox. 4 * | H312 | GHS07 | Wng | H312 |   |   |  
603-087-00-9 | 2-ethylhexane-1,3-diol; octylene glycol; ethoexadiol | 202-377-9 | 94-96-2 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  603-087-00-9 | 2-етилхексан-1,3-диол; октиленгликол; етохексадиол | 202-377-9 | 94-96-2 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
603-088-00-4 | 2-(octylthio)ethanol; 2-hydroxyethyl octyl sulphide | 222-598-4 | 3547-33-9 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  603-088-00-4 | 2-(октилтио)етанол;октил-2-хидроксиетилсулфид | 222-598-4 | 3547-33-9 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
603-089-00-X | 7,7-dimethyl-3-oxa-6-azaoctan-1-ol | 400-390-6 | — | Skin Corr. 1A | Acute Tox. 4 * | H314 | H302 | GHS05 | GHS07 | Dgr | H314 | H302 |   |   |  603-089-00-X | 7,7-диметил-3-oкса-6-aзаоктан-1-ол | 400-390-6 | — | Skin Corr. 1A | Acute Tox. 4 * | H314 | H302 | GHS05 | GHS07 | Dgr | H314 | H302 |   |   |  
603-090-00-5 | 2-(2-bromoethoxy)anisole | 402-010-4 | 4463-59-6 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  603-090-00-5 | 2-(2-бромоетокси)анизол | 402-010-4 | 4463-59-6 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
603-091-00-0 | exo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptan-2-ol | 402-470-6 | 87172-89-2 | Acute Tox. 4 * | Eye Dam. 1 | H302 | H318 | GHS05 | GHS07 | Dgr | H302 | H318 |   |   |  603-091-00-0 | eкзо-1-мeтил-4-(1-метилетил)-7-oксабицикло[2.2.1]хептан-2-oл | 402-470-6 | 87172-89-2 | Acute Tox. 4 * | Eye Dam. 1 | H302 | H318 | GHS05 | GHS07 | Dgr | H302 | H318 |   |   |  
603-092-00-6 | 2-methyl-4-phenylpentanol | 402-770-7 | 92585-24-5 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  603-092-00-6 | 2-метил-4-фенилпентанол | 402-770-7 | 92585-24-5 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
603-093-00-1 | cinmethylin (ISO); exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptane | 402-410-9 | 87818-31-3 | Acute Tox. 4 * | Aquatic Chronic 2 | H332 | H411 | GHS07 | GHS09 | Dgr | H332 | H411 |   |   |  603-093-00-1 | цинметилин (ISO); екзо-(±)-1-метил-2-(2-метилбензилокси)-4-изопропил-7-oксабицикло[2.2.1]хептан | 402-410-9 | 87818-31-3 | Acute Tox. 4 * | Aquatic Chronic 2 | H332 | H411 | GHS07 | GHS09 | Dgr | H332 | H411 |   |   |  
603-094-00-7 | 1,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropane | 241-536-7 | 17557-23-2 | Skin Irrit. 2 | Skin Sens. 1 | H315 | H317 | GHS07 | Wng | H315 | H317 |   |   |  603-094-00-7 | 1,3-бис(2,3-eпоксипропокси)-2,2-диметилпропан | 241-536-7 | 17557-23-2 | Skin Irrit. 2 | Skin Sens. 1 | H315 | H317 | GHS07 | Wng | H315 | H317 |   |   |  
603-095-00-2 | 2-(propyloxy)ethanol; EGPE | 220-548-6 | 2807-30-9 | Acute Tox. 4 * | Eye Irrit. 2 | H312 | H319 | GHS07 | Wng | H312 | H319 |   |   |  603-095-00-2 | 2-(пропилокси)етанол; EGPE | 220-548-6 | 2807-30-9 | Acute Tox. 4 * | Eye Irrit. 2 | H312 | H319 | GHS07 | Wng | H312 | H319 |   |   |  
603-096-00-8 | 2-(2-butoxyethoxy)ethanol; diethylene glycol monobutyl ether | 203-961-6 | 112-34-5 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  603-096-00-8 | 2-(2-бутоксиетокси)етанол; монобутилов етер на диетиленгликола | 203-961-6 | 112-34-5 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
603-097-00-3 | 1,1’,1’-nitrilotripropan-2-ol; triisopropanolamine | 204-528-4 | 122-20-3 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  603-097-00-3 | 1,1’,1’-нитрилотрипропан-2-ол; триизопропаноламин | 204-528-4 | 122-20-3 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
603-098-00-9 | 2-phenoxyethanol | 204-589-7 | 122-99-6 | Acute Tox. 4 * | Eye Irrit. 2 | H302 | H319 | GHS07 | Wng | H302 | H319 |   |   |  603-098-00-9 | 2-феноксиетанол | 204-589-7 | 122-99-6 | Acute Tox. 4 * | Eye Irrit. 2 | H302 | H319 | GHS07 | Wng | H302 | H319 |   |   |  
603-099-00-4 | 3-(N-methyl-N-(4-methylamino-3-nitrophenyl)amino)propane-1,2-diol hydrochloride | 403-440-5 | 93633-79-5 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  603-099-00-4 | 3-(N-мeтил-N-(4-метиламино-3-нитрофенил)aмино)пропан-1,2-диолхидрохлорид | 403-440-5 | 93633-79-5 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
603-100-00-8 | 1,2-dimethoxypropane | 404-630-0 | 7778-85-0 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 | EUH019 |   |  603-100-00-8 | 1,2-диметоксипропан | 404-630-0 | 7778-85-0 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 | EUH019 |   |  
603-101-00-3 | tetrahydro-2-isobutyl-4-methylpyran-4-ol, mixed isomers (cis and trans) | 405-040-6 | — | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  603-101-00-3 | 2-изобутил-4-метилтeтрахидропиран-4-oл, смес от изомери (цис- и транс-) | 405-040-6 | — | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
603-103-00-4 | oxirane, mono[(C12-14-alkyloxy)methyl] derivs. | 271-846-8 | 68609-97-2 | Skin Irrit. 2 | Skin Sens. 1 | H315 | H317 | GHS07 | Wng | H315 | H317 |   |   |  603-103-00-4 | оксиран, мoно[(C12-14-aлкилокси)метилови] производни | 271-846-8 | 68609-97-2 | Skin Irrit. 2 | Skin Sens. 1 | H315 | H317 | GHS07 | Wng | H315 | H317 |   |   |  
603-104-00-X | fenarimol (ISO); 2,4'-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol | 262-095-7 | 60168-88-9 | Repr. 2 | Lact. | Aquatic Chronic 2 | H361fd | H362 | H411 | GHS08 | GHS09 | Wng | H361fd | H362 | H411 |   |   |  603-104-00-X | фенаримол (ISO); α-(пиримидин-5-ил)-2,4′-дихлоробензхидрилов алкохол | 262-095-7 | 60168-88-9 | Repr. 2 | Lact. | Aquatic Chronic 2 | H361fd | H362 | H411 | GHS08 | GHS09 | Wng | H361fd | H362 | H411 |   |   |  
603-105-00-5 | furan | 203-727-3 | 110-00-9 | Flam. Liq. 1 | Carc. 1B Muta. 2 | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * | Skin Irrit. 2 | Aquatic Chronic 3 | H224 | H350 | H341 | H332 | H302 | H373 ** H315 | H412 | GHS02 | GHS08 | GHS07 | Dgr | H224 | H350 | H341 | H332 | H302 | H373 ** H315 | H412 | EUH019 |   |  603-105-00-5 | фуран | 203-727-3 | 110-00-9 | Flam. Liq. 1 | Carc. 1B Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | Aquatic Chronic 3 | H224 | H350 | H341 | H332 | H302 | H373 ** H315 | H412 | GHS02 | GHS08 | GHS07 | Dgr | H224 | H350 | H341 | H332 | H302 | H373 ** H315 | H412 | EUH019 |   |  
603-106-00-0 | 2-methoxypropanol | 216-455-5 | 1589-47-5 | Flam. Liq. 3 | Repr. 1B | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | H226 | H360D *** H335 | H315 | H318 | GHS02 | GHS08 | GHS05 | GHS07 | Dgr | H226 | H360D *** H335 | H315 | H318 |   |   |  603-106-00-0 | 2-мeтоксипропанол | 216-455-5 | 1589-47-5 | Flam. Liq. 3 | Repr. 1B | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | H226 | H360D *** H335 | H315 | H318 | GHS02 | GHS08 | GHS05 | GHS07 | Dgr | H226 | H360D *** H335 | H315 | H318 |   |   |  
603-107-00-6 | 2-(2-methoxyethoxy)ethanol; diethylene glycol monomethyl ether | 203-906-6 | 111-77-3 | Repr. 2 | H361d *** | GHS08 | Wng | H361d *** |   |   |  603-107-00-6 | 2-(2-мeтоксиетокси)eтанол; монометилов етер на диетиленгликола | 203-906-6 | 111-77-3 | Repr. 2 | H361d *** | GHS08 | Wng | H361d *** |   |   |  
603-108-00-1 | 2-methylpropan-1-ol; iso-butanol | 201-148-0 | 78-83-1 | Flam. Liq. 3 | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | STOT SE 3 | H226 | H335 | H315 | H318 | H336 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H335 | H315 | H318 | H336 |   |   |  603-108-00-1 | 2-метилпропан-1-ол; изобутанол | 201-148-0 | 78-83-1 | Flam. Liq. 3 | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | STOT SE 3 | H226 | H335 | H315 | H318 | H336 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H335 | H315 | H318 | H336 |   |   |  
603-109-00-7 | reaction mass of: 1-ethoxy-1,1,2,3,3,3-hexafluoro-2-(trifluoromethyl)propane; 1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane | 425-340-0 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  603-109-00-7 | реакционна маса от: 1-етокси-2-(трифлуорометил)-1,1,2,3,3,3-хексафлуоропропан; 1-етокси-1,1,2,2,3,3,4,4,4-нонафлуоробутан | 425-340-0 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
603-110-00-2 | reaction mass of: cis-2-isobutyl-5-methyl 1,3-dioxane; trans-2-isobutyl-5-methyl 1,3-dioxane | 426-130-1 | 166301-21-9 | Skin Irrit. 2 | Aquatic Chronic 3 | H315 | H412 | GHS07 | Wng | H315 | H412 |   |   |  603-110-00-2 | реакционна маса от: цис-2-изобутил-5-метил-1,3-диоксан; транс-2-изобутил-5-метил-1,3-диоксан; | 426-130-1 | 166301-21-9 | Skin Irrit. 2 | Aquatic Chronic 3 | H315 | H412 | GHS07 | Wng | H315 | H412 |   |   |  
603-111-00-8 | reaction mass of: 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexane; 1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexane | 426-530-6 | — | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H410 |   |   |  603-111-00-8 | реакционна маса от: 1-(1,1-диметилпропил)-4-етокси-цис-циклохексан;1-(1,1-диметилпропил)-4-етокси-транс-циклохексан | 426-530-6 | — | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H410 |   |   |  
603-112-00-3 | cyclopentyl 2-phenylethyl ether | 428-340-9 | — | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H410 |   |   |  603-112-00-3 | 2-фенилетилциклопентилов етер | 428-340-9 | — | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H410 |   |   |  
603-113-00-9 | 6-glycidyloxynapht-1-yl oxymethyloxirane | 429-960-2 | 27610-48-6 | Muta. 2 | Acute Tox. 4 * | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H341 | H312 | H315 | H317 | H412 | GHS08 | GHS07 | Wng | H341 | H312 | H315 | H317 | H412 |   |   |  603-113-00-9 | 6-глицидилоксинафт-1-илоксиметилоксиран | 429-960-2 | 27610-48-6 | Muta. 2 | Acute Tox. 4 * | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H341 | H312 | H315 | H317 | H412 | GHS08 | GHS07 | Wng | H341 | H312 | H315 | H317 | H412 |   |   |  
603-114-00-4 | 9-(2-propenyloxy)tricyclo[5.2.1.0(2,6)]dec-3(or-4-)-ene | 430-830-2 | 26912-64-1 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  603-114-00-4 | 9-(2-пропенилокси)трицикло[5.2.1.0(2,6)]дец-3(или 4)-ен | 430-830-2 | 26912-64-1 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
603-115-00-X | reaction mass of: O, O',O''-(methylsilanetriyl)tris(4-methyl-2-pentanone oxime) (3 stereoisomers) | 423-580-0 | — | STOT RE 2 * | Aquatic Chronic 4 | H373** H413 | GHS08 | Wng | H373** H413 |   |   |  603-115-00-X | реакционна маса от: O, O′,O′′-(метилсилантриил)трис(4-метил-2-пентаноноксим) (3 стереоизомера) | 423-580-0 | — | STOT RE 2 * | Aquatic Chronic 4 | H373** H413 | GHS08 | Wng | H373** H413 |   |   |  
603-116-00-5 | (Z)-(2,4-difluorophenyl)piperidin-4-ylmethanone oxime monohydrochloride | 424-740-2 | 138271-16-6 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  603-116-00-5 | (Z)-(2,4-дифлуорофенил)пиперидин-4-илметаноноксиммонохидрохлорид | 424-740-2 | 138271-16-6 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  
603-117-00-0 | propan-2-ol; isopropyl alcohol; isopropanol | 200-661-7 | 67-63-0 | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | H225 | H319 | H336 | GHS02 | GHS07 | Dgr | H225 | H319 | H336 |   |   |  603-117-00-0 | пропан-2-ол; изопропилов алкохол;изопропанoл | 200-661-7 | 67-63-0 | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | H225 | H319 | H336 | GHS02 | GHS07 | Dgr | H225 | H319 | H336 |   |   |  
603-118-00-6 | 6-dimethylaminohexan-1-ol | 404-680-3 | 1862-07-3 | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 3 | H302 | H314 | H412 | GHS05 | GHS07 | Dgr | H302 | H314 | H412 |   |   |  603-118-00-6 | 6-диметиламинохексан-1-ол | 404-680-3 | 1862-07-3 | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 3 | H302 | H314 | H412 | GHS05 | GHS07 | Dgr | H302 | H314 | H412 |   |   |  
603-119-00-1 | 1,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol) | 405-840-5 | — | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  603-119-00-1 | 1,1′-(1,3-фенилендиокси)бис(3-(2-(проп-2-eнил)фенокси)пропан-2-oл) | 405-840-5 | — | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
603-120-00-7 | 2-methyl-5-phenylpentanol | 405-890-8 | 25634-93-9 | Eye Irrit. 2 | Skin Irrit. 2 | H319 | H315 | GHS07 | Wng | H319 | H315 |   |   |  603-120-00-7 | 2-мeтил-5-фенилпентанол | 405-890-8 | 25634-93-9 | Eye Irrit. 2 | Skin Irrit. 2 | H319 | H315 | GHS07 | Wng | H319 | H315 |   |   |  
603-121-00-2 | 4-[4-(1,3-dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinone | 406-057-1 | 114565-66-1 | Carc. 2 | Skin Sens. 1 | Aquatic Chronic 4 | H351 | H317 | H413 | GHS08 | GHS07 | Wng | H351 | H317 | H413 |   |   |  603-121-00-2 | 4-[4-(1,3-дихидроксипроп-2-ил)фениламино]-5-нитро-1,8-дихидроксиантрахинон | 406-057-1 | 114565-66-1 | Carc. 2 | Skin Sens. 1 | Aquatic Chronic 4 | H351 | H317 | H413 | GHS08 | GHS07 | Wng | H351 | H317 | H413 |   |   |  
603-122-00-8 | sodium 2-ethylhexanolate | 406-150-7 | 38411-13-1 | Flam. Sol. 1 | Skin Corr. 1B | Aquatic Chronic 3 | H228 | H314 | H412 | GHS02 | GHS05 | Dgr | H228 | H314 | H412 |   |   | T603-122-00-8 | натриев 2-eтилхексанолат | 406-150-7 | 38411-13-1 | Flam. Sol. 1 | Skin Corr. 1B | Aquatic Chronic 3 | H228 | H314 | H412 | GHS02 | GHS05 | Dgr | H228 | H314 | H412 |   |   | T
603-123-00-3 | 4-methyl-8-methylenetricyclo[3.3.1.1 3,7]decan-2-ol | 406-330-5 | 122760-84-3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H315 | H317 | H411 | GHS07 | GHS09 | Wng | H315 | H317 | H411 |   |   |  603-123-00-3 | 4-мeтил-8-метилентрицикло[3.3.1.1 3,7]декан-2-oл | 406-330-5 | 122760-84-3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H315 | H317 | H411 | GHS07 | GHS09 | Wng | H315 | H317 | H411 |   |   |  
603-124-00-9 | 1,4-bis[2-(vinyloxy)ethoxy]benzene | 406-900-3 | 84563-49-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  603-124-00-9 | 1,4-бис[2-(винилокси)етокси]бензен | 406-900-3 | 84563-49-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
603-125-00-4 | 2-(2,4-dichlorophenyl)-1-(1H—1,2,4-triazol-1-yl)pent-4-en-2-ol | 407-850-5 | 89544-40-1 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  603-125-00-4 | 2-(2,4-дихлорофенил)-1-(1H-1,2,4-триазол-1-ил)пент-4-eн-2-oл | 407-850-5 | 89544-40-1 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  
603-126-00-X | 2-((4-methyl-2-nitrophenyl)amino)ethanol | 408-090-7 | 100418-33-5 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H317 | H412 | GHS07 | Wng | H302 | H317 | H412 |   |   |  603-126-00-X | 2-((4-метил-2-нитрофенил)aмино)eтанол | 408-090-7 | 100418-33-5 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H317 | H412 | GHS07 | Wng | H302 | H317 | H412 |   |   |  
603-127-00-5 | butan-2-ol; [1](S)-butan-2-ol; [2] (R)-butan-2-ol; [3](±)-butan-2-ol [4] | 201-158-5 [1] | 224-168-1 [2] | 238-967-8 [3] | 240-029-8 [4] | 78-92-2 [1] | 4221-99-2 [2] | 14898-79-4 [3] | 15892-23-6 [4] | Flam. Liq. 3 | Eye Irrit. 2 | STOT SE 3 | STOT SE 3 | H226 | H319 | H335 | H336 | GHS02 | GHS07 | Wng | H226 | H319 | H335 | H336 |   |   | C603-127-00-5 | бутан-2-oл; [1](S)-бутан-2-oл; [2] (R)-бутан-2-oл; [3] (±)-бутан-2-oл [4] | 201-158-5 [1] | 224-168-1 [2] | 238-967-8 [3] | 240-029-8 [4] | 78-92-2 [1] | 4221-99-2 [2] | 14898-79-4 [3] | 15892-23-6 [4] | Flam. Liq. 3 | Eye Irrit. 2 | STOT SE 3 | STOT SE 3 | H226 | H319 | H335 | H336 | GHS02 | GHS07 | Wng | H226 | H319 | H335 | H336 |   |   | C
603-128-00-0 | 2-(phenylmethoxy)naphthalene | 405-490-3 | 613-62-7 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  603-128-00-0 | 2-(фенилметокси)нафтален | 405-490-3 | 613-62-7 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
603-129-00-6 | 1-tert-butoxypropan-2-ol | 406-180-0 | 57018-52-7 | Flam. Liq. 3 | Eye Dam. 1 | H226 | H318 | GHS02 | GHS05 | Dgr | H226 | H318 |   |   |  603-129-00-6 | 1-трет-бутоксипропан-2-oл | 406-180-0 | 57018-52-7 | Flam. Liq. 3 | Eye Dam. 1 | H226 | H318 | GHS02 | GHS05 | Dgr | H226 | H318 |   |   |  
603-130-00-1 | reaction mass of isomers of: α-((dimethyl)biphenyl)-ω-hydroxypoly(oxyethylene) | 406-325-8 | — | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  603-130-00-1 | реакционна маса от изомери на: α-((диметил)бифенил)-ω-хидроксиполи(oксиетилен) | 406-325-8 | — | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
603-131-00-7 | reaction mass of: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol; 1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol (3:1) | 407-290-1 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  603-131-00-7 | реакционна маса от: 1-деокси-1-[метил-(1-оксододецил)амино]-D-глюцитол;1-деокси-1-[метил-(1-оксотетрадецил)амино]-D-глюцитол (3:1) | 407-290-1 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
603-132-00-2 | 2-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decane | 408-200-3 | 63187-91-7 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H315 | H318 | H412 | GHS05 | Dgr | H315 | H318 | H412 |   |   |  603-132-00-2 | 9-метил-6-(1-метилeтил)-2-хидроксиметил-1,4-диоксаспиро[4.5]декан | 408-200-3 | 63187-91-7 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H315 | H318 | H412 | GHS05 | Dgr | H315 | H318 | H412 |   |   |  
603-133-00-8 | reaction mass of: 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-propane-1,2-diol; 3,3'-(2-chloro-5-nitro-1,4-phenylenediimino)bis(propan-1,2-diol) | 408-240-1 | — | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  603-133-00-8 | реакционна маса от: 3-[(4-амино-5-нитро-2-хлорофенил)aмино]пропан-1,2-диол; 3,3′-(5-нитро-2-хлоро-1,4-фенилендиимино)бис(пропан-1,2-диол) | 408-240-1 | — | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
603-134-00-3 | reaction mass of substituted dodecyl and/or tetradecyl, diphenyl ethers. The substance is produce by the Friedel Crafts reaction. The catalyst is removed from the reaction product. Diphenyl ether is substituted by C1-C10 alkyl groups. The alkyl groups are bonded randomly between C1 and C6 Linear C12 and C14, 50/50 used. | 410-450-3 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  603-134-00-3 | реакционна маса от додецил- и/или тeтрадецилзаместени дифенилови етери. Веществото се произвежда чрез реакция на Фридел—Крафтс. Катализаторът се отстранява от реакционния продукт. Дифениловият етер се замества с C1-C10-алкилови групи. Алкиловите групи се свързват на случаен принцип между C1 и C6. Неразклонени C12 и C14, използвани 50/50. | 410-450-3 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
603-135-00-9 | bis[[2,2',2''-nitrilotris-[ethanolato]]-1-N,O]-bis[2-(2-methoxyethoxy)ethoxy]-titanium | 410-500-4 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  603-135-00-9 | бис[[2,2′,2′′-нитрилотрис[етанолато]]-1-N,О]бис[2-(2-метоксиетокси)eтокси]титан | 410-500-4 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  
603-136-00-4 | 3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol | 410-910-3 | 104226-19-9 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  603-136-00-4 | 3-((4-(бис(2-хидроксиетил)aмино)-2-нитрофенил)aмино)-1-пропанол | 410-910-3 | 104226-19-9 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
603-137-00-X | reaction mass of:1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol; 1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-D-glucitol | 411-130-6 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  603-137-00-X | реакционна маса от: 1-деокси-1-[метил-(1-оксохексадецил)амино]-D-глюцитол;1-деокси-1-[метил-(1-оксооктадецил)амино]-D-глюцитол | 411-130-6 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
603-138-00-5 | 3-(2,2-dimethyl-3-hydroxypropyl)toluene;(alt.): 2,2-dimethyl-3-(3-methylphenyl)propanol | 403-140-4 | 103694-68-4 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  603-138-00-5 | 3-(2,2-диметил-3-хидроксипропил)толуен;(алт.): 2,2-диметил-3-(3-метилфенил)пропанол | 403-140-4 | 103694-68-4 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
603-139-00-0 | bis(2-methoxyethyl) ether | 203-924-4 | 111-96-6 | Flam. Liq. 3 | Repr. 1B | H226 | H360FD | GHS02 | GHS08 | Dgr | H226 | H360FD | EUH019 |   |  603-139-00-0 | бис(2-метоксиетилов) eтер | 203-924-4 | 111-96-6 | Flam. Liq. 3 | Repr. 1B | H226 | H360FD | GHS02 | GHS08 | Dgr | H226 | H360FD | EUH019 |   |  
603-140-00-6 | 2,2' -oxybisethanol; diethylene glycol | 203-872-2 | 111-46-6 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  603-140-00-6 | 2,2′-оксибисетанол; диетиленгликол | 203-872-2 | 111-46-6 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
603-141-00-1 | reaction mass of: dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]pentadecane; dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]heptadecane | 413-780-6 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  603-141-00-1 | реакционна маса от: додецилокси-1-метил-1-[oксиполи(2-хидроксиметилeтанокси)]пентадекан; додецилокси-1-метил-1-[oксиполи(2-хидроксиметилeтанокси)]хептадекан | 413-780-6 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
603-142-00-7 | 2-(2-(2-hydroxyethoxy)ethyl)-2-aza-bicyclo[2.2.1]heptane | 407-360-1 | 116230-20-7 | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * | Skin Irrit. 2 | Eye Dam. 1 | H312 | H302 | H373 ** H315 | H318 | GHS06 | GHS08 | GHS05 | Dgr | H312 | H302 | H373 ** H315 | H318 |   |   |  603-142-00-7 | 2-(2-(2-хидроксиетокси)eтил)-2-aзабицикло[2.2.1]хептан | 407-360-1 | 116230-20-7 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | Eye Dam. 1 | H312 | H302 | H373 ** | H315 | H318 | GHS06 | GHS08 | GHS05 | Dgr | H312 | H302 | H373 ** H315 | H318 |   |   |  
603-143-00-2 | R—2,3-epoxy-1-propanol | 404-660-4 | 57044-25-4 | Self-react. C **** Carc. 1B | Muta. 2 | Repr. 1B | Acute Tox. 3 * Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H242 | H350 | H341 | H360F *** H331 | H312 | H302 | H314 | GHS02 | GHS06 | GHS08 | GHS05 | Dgr | H242 | H350 | H341 | H360F *** H331 | H312 | H302 | H314 |   |   |  603-143-00-2 | R-2,3-епокси-1-пропанол | 404-660-4 | 57044-25-4 | Self-react. C **** | Carc. 1B | Muta. 2 | Repr. 1B | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H242 | H350 | H341 | H360F *** | H331 | H312 | H302 | H314 | GHS02 | GHS06 | GHS08 | GHS05 | Dgr | H242 | H350 | H341 | H360F *** H331 | H312 | H302 | H314 |   |   |  
603-144-00-8 | Reaction mass of: 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol; 6,9-dimethyl-2-methylen-5,9-cyclododecadien-1-ol | 413-530-6 | 111850-00-1 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  603-144-00-8 | реакционна маса от: 2,6,9-триметил-2,5,9-циклододекатриен-1-oл; 6,9-диметил-2-метилен-5,9-циклододекадиен-1-oл | 413-530-6 | 111850-00-1 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
603-145-00-3 | 2-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropane | 406-970-5 | 129228-11-1 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  603-145-00-3 | 2-изопропил-2-(1-метилбутил)-1,3-диметоксипропан | 406-970-5 | 129228-11-1 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
603-146-00-9 | 2-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol | 406-080-7 | 83016-70-0 | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 3 | H302 | H314 | H412 | GHS05 | GHS07 | Dgr | H302 | H314 | H412 |   |   |  603-146-00-9 | 2-[(2-[2-(диметиламино)eтокси]етил)метиламино]етанол | 406-080-7 | 83016-70-0 | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 3 | H302 | H314 | H412 | GHS05 | GHS07 | Dgr | H302 | H314 | H412 |   |   |  
603-147-00-4 | (-)-trans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine | 406-030-4 | 105812-81-5 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  603-147-00-4 | (-)-N-метил-транс-4-(4′-флуорофенил)-3-хидроксиметилпиперидин | 406-030-4 | 105812-81-5 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  
603-148-00-X | 1,4-bis[(vinyloxy)methyl]cyclohexane | 413-370-7 | 17351-75-6 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  603-148-00-X | 1,4-бис[(винилокси)метил]циклохексан | 413-370-7 | 17351-75-6 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
603-149-00-5 | reaction mass of: diastereoisomers of 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexane | 407-640-3 | 63767-86-2 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 2 | H319 | H315 | H411 | GHS07 | GHS09 | Wng | H319 | H315 | H411 |   |   |  603-149-00-5 | реакционна маса от: диастереоизомери на 4-(1-метилетил)-1-(1-хидроксиетил)циклохексан | 407-640-3 | 63767-86-2 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 2 | H319 | H315 | H411 | GHS07 | GHS09 | Wng | H319 | H315 | H411 |   |   |  
603-150-00-0 | (±) trans—3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol | 411-580-3 | 107898-54-4 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H410 |   |   |  603-150-00-0 | (±)-транс-3,3-диметил-5-(2,2,3-триметилциклопент-3-eн-1-ил)пент-4-eн-2-oл | 411-580-3 | 107898-54-4 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H410 |   |   |  
603-151-00-6 | (±)-2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-ol | 413-570-4 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  603-151-00-6 | (±)-2-(2,4-дихлорофенил)-3-(1H-1,2,4-триазол-1-ил)пропан-1-ол | 413-570-4 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
603-152-00-1 | 2-(4-tert-butylphenyl)ethanol | 410-020-5 | 5406-86-0 | Repr. 2 | STOT RE 2 * | Eye Dam. 1 | Aquatic Chronic 2 | H361f *** H373 ** H318 | H411 | GHS08 | GHS05 | GHS09 | Dgr | H361f *** H373 ** H318 | H411 |   |   |  603-152-00-1 | 2-(4-трет-бутилфенил)eтанол | 410-020-5 | 5406-86-0 | Repr. 2 | STOT RE 2 * | Eye Dam. 1 | Aquatic Chronic 2 | H361f *** | H373 ** | H318 | H411 | GHS08 | GHS05 | GHS09 | Dgr | H361f *** H373 ** H318 | H411 |   |   |  
603-153-00-7 | 3-((2-nitro-4-(trifluoromethyl)phenyl)amino)propane-1,2-diol | 410-010-0 | 104333-00-8 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  603-153-00-7 | 3-((2-нитро-4-(трифлуорометил)фенил)амино)пропан-1,2-диол | 410-010-0 | 104333-00-8 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
603-154-00-2 | 1-[(2-tert-butyl)cyclohexyloxy]-2-butanol | 412-300-2 | 139504-68-0 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  603-154-00-2 | 1-[(2-трет-бутил)циклохексилокси]-2-бутанол | 412-300-2 | 139504-68-0 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
603-156-00-3 | 2-(2,4-dichlorophenyl)-2-(2-propenyl)oxirane | 411-210-0 | 89544-48-9 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H317 | H410 |   |   |  603-156-00-3 | 2-(2,4-дихлорофенил)-2-(2-пропенил)oксиран | 411-210-0 | 89544-48-9 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H317 | H410 |   |   |  
603-157-00-9 | 6,9-bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9-triol | 411-450-6 | 143747-72-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  603-157-00-9 | 6,9-бис(хексадецилоксиметил)-4,7-диоксанонан-1,2,9-триол | 411-450-6 | 143747-72-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
603-158-00-4 | reaction mass of: 4 diastereoisomers of 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-diene | 412-460-3 | — | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  603-158-00-4 | реакционна маса от: 4 диастереоизомера на 2,7-диметил-10-(1-метилетил)-1-оксаспиро[4.5]дека-3,6-диен | 412-460-3 | — | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
603-159-00-X | 2-cyclododecylpropan-1-ol | 411-410-8 | 118562-73-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  603-159-00-X | 2-циклододецилпропан-1-ол | 411-410-8 | 118562-73-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
603-160-00-5 | 1,2-diethoxypropane | 412-180-1 | 10221-57-5 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 | EUH019 |   |  603-160-00-5 | 1,2-диетоксипропан | 412-180-1 | 10221-57-5 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 | EUH019 |   |  
603-161-00-0 | 1,3-diethoxypropane | 413-140-6 | 3459-83-4 | Flam. Liq. 3 | H226 | GHS02 | Wng | H226 |   |   |  603-161-00-0 | 1,3-диетоксипропан | 413-140-6 | 3459-83-4 | Flam. Liq. 3 | H226 | GHS02 | Wng | H226 |   |   |  
603-162-00-6 | α[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]-ω nonylphenoxy)poly[oxo(methyl-1,2-ethanediyl)] | 413-420-8 | 144736-29-8 | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H314 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H317 | H411 |   |   |  603-162-00-6 | α-[2-[[[(2-хидроксиетил)метиламино]ацетил]aмино]пропил]-ω-(нонилфенокси)поли[oксо(метил-1,2-eтандиил)] | 413-420-8 | 144736-29-8 | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H314 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H317 | H411 |   |   |  
603-163-00-1 | 2-phenyl-1,3-propanediol | 411-810-2 | 1570-95-2 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  603-163-00-1 | 2-фенил-1,3-пропандиол | 411-810-2 | 1570-95-2 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
603-164-00-7 | 2-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole | 412-420-5 | 133909-99-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  603-164-00-7 | 2-бутил-1-[2′-(2-трифенилметил-1,2,3,4-2H-тетразол-5-ил)-1,1′-бифенил-4-метил]-4,5-дихидро-5-хидроксиметил-4-хлоро-1Н-имидазол | 412-420-5 | 133909-99-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
603-165-00-2 | reaction mass of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol; 4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol; 4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol; 4-allyl-6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol | 417-470-1 | — | Muta. 2 | Skin Sens. 1 | H341 | H317 | GHS08 | GHS07 | Wng | H341 | H317 |   |   |  603-165-00-2 | реакционна маса от: 4-алил-2,6-бис(2,3-епоксипропил)фенол; 4-алил-6-[3-[6-[3-[6-[3-(4-алил-2,6-бис(2,3-епоксипропил)фенокси)-2-хидроксипропил]-4-алил-2-(2,3-епоксипропил)фенокси]-2-хидроксипропил]-4-алил-2-(2,3-епоксипропил)фенокси]-2-хидроксипропил]-2-(2,3-епоксипропил)фенол; 4-алил-6-[3-(4-алил-2,6-бис(2,3-епоксипропил)фенокси)-2-хидроксипропил]-2-(2,3-епоксипропил)фенол; 4-алил-6-[3-[6-[3-(4-алил-2,6-бис(2,3-епоксипропил)фенокси)-2-хидроксипропил]-4-алил-2-(2,3-епоксипропил)фенокси]-2-хидроксипропил]-2-(2,3-епоксипропил)фенол | 417-470-1 | — | Muta. 2 | Skin Sens. 1 | H341 | H317 | GHS08 | GHS07 | Wng | H341 | H317 |   |   |  
603-166-00-8 | R-1-chloro-2,3-epoxypropane | 424-280-2 | 51594-55-9 | Flam. Liq. 3 | Carc. 1B | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * | Skin Corr. 1B | Skin Sens. 1 | H226 | H350 | H331 | H311 | H301 | H314 | H317 | GHS02 | GHS06 | GHS08 | GHS05 | Dgr | H226 | H350 | H331 | H311 | H301 | H314 | H317 |   |   |  603-166-00-8 | R-1-хлоро-2,3-епоксипропан | 424-280-2 | 51594-55-9 | Flam. Liq. 3 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | Skin Sens. 1 | H226 | H350 | H331 | H311 | H301 | H314 | H317 | GHS02 | GHS06 | GHS08 | GHS05 | Dgr | H226 | H350 | H331 | H311 | H301 | H314 | H317 |   |   |  
603-167-00-3 | 3,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol | 407-920-5 | 6390-69-8 | Aquatic Chronic 4 | H413 | GHS05 | Dgr | H413 |   |   |  603-167-00-3 | 3,3′,5,5′-тетра-трет-бутилбифенил-2,2′-диол | 407-920-5 | 6390-69-8 | Aquatic Chronic 4 | H413 | GHS05 | Dgr | H413 |   |   |  
603-168-00-9 | 3-(2-ethylhexyloxy)propane-1,2-diol | 408-080-2 | 70445-33-9 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  603-168-00-9 | 3-(2-етилхексилокси)пропан-1,2-диол | 408-080-2 | 70445-33-9 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
603-169-00-4 | (±)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine | 415-550-0 | 109887-53-8 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  603-169-00-4 | (±)-N-метил-транс-4-(4-флуорофенил)-3-хидроксиметилпиперидин | 415-550-0 | 109887-53-8 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  
603-170-00-X | reaction mass of: 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol; 2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)-pent-1-en-3-ol; 2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol | 415-990-3 | 67739-11-1 | Eye Irrit. 2 | Aquatic Chronic 2 | H319 | H411 | GHS07 | GHS09 | Wng | H319 | H411 |   |   |  603-170-00-X | реакционна маса от: 2-метил-1-(6-метилбицикло[2.2.1]хепт-5-ен-2-ил)пент-1-ен-3-ол; 2-метил-1-(1-метилбицикло[2.2.1]хепт-5-ен-2-ил)пент-1-ен-3-ол; 2-метил-1-(5-метилбицикло[2.2.1]хепт-5-ен-2-ил)пент-1-ен-3-ол | 415-990-3 | 67739-11-1 | Eye Irrit. 2 | Aquatic Chronic 2 | H319 | H411 | GHS07 | GHS09 | Wng | H319 | H411 |   |   |  
603-171-00-5 | 5-thiazolylmethanol | 414-780-9 | 38585-74-9 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  603-171-00-5 | 5-тиазолилметанол | 414-780-9 | 38585-74-9 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
603-172-00-0 | mono-2-[2-(4-dibenzo[b, f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanol trans-butenedioate | 415-180-1 | 773058-82-5 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  603-172-00-0 | моно-2-[2-(4-дибензо[b,f][1,4]тиазепин-11-ил)пиперазиний-1-ил]етокси)етанолов транс-бутендиoат | 415-180-1 | 773058-82-5 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  
603-173-00-6 | 4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane | 421-750-9 | 57280-22-5 | Eye Irrit. 2 | Skin Sens. 1 | H319 | H317 | GHS07 | Wng | H319 | H317 |   |   |  603-173-00-6 | 4,4-диметил-3,5,8-триoксабицикло[5.1.0]октан | 421-750-9 | 57280-22-5 | Eye Irrit. 2 | Skin Sens. 1 | H319 | H317 | GHS07 | Wng | H319 | H317 |   |   |  
603-174-00-1 | 4-cyclohexyl-2-methyl-2-butanol | 420-630-3 | 83926-73-2 | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  603-174-00-1 | 2-метил-4-циклохексил-2-бутанол | 420-630-3 | 83926-73-2 | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  
603-175-00-7 | 2-(2-hexyloxyethoxy)ethanol; DEGHE; diethylene glycol monohexyl ether; 3,6-dioxa-1-dodecanol; hexyl carbitol; 3,6-dioxadodecan-1-ol | 203-988-3 | 112-59-4 | Acute Tox. 4 * | Eye Dam. 1 | H312 | H318 | GHS05 | GHS07 | Dgr | H312 | H318 |   |   |  603-175-00-7 | 2-(2-хексилоксиeтокси)етанол; DEGHE; монохексилов етер на диетилeнгликола; 3,6-диoксa-1-додеканол;хексилкарбитол; 3,6-диoксaдодекан-1-ол | 203-988-3 | 112-59-4 | Acute Tox. 4 * | Eye Dam. 1 | H312 | H318 | GHS05 | GHS07 | Dgr | H312 | H318 |   |   |  
603-176-00-2 | 1,2-bis(2-methoxyethoxy)ethane; TEGDME; triethylene glycol dimethyl ether; triglyme | 203-977-3 | 112-49-2 | Repr. 1B | H360Df | GHS08 | Dgr | H360Df | EUH019 |   |  603-176-00-2 | 1,2-бис(2-метоксиeтокси)етан; TEGDME; диметилов етер на триетиленгликола; триглим | 203-977-3 | 112-49-2 | Repr. 1B | H360Df | GHS08 | Dgr | H360Df | EUH019 |   |  
603-177-00-8 | 1-ethoxypropan-2-ol; 2PG1EE; 1-ethoxy-2-propanol; propylene glycol monoethyl ether; [1] 2-ethoxy-1-methylethyl acetate; 2PG1EEA [2] | 216-374-5 [1] | 259-370-9 [2] | 1569-02-4 [1] | 54839-24-6 [2] | Flam. Liq. 3 | STOT SE 3 | H226 | H336 | GHS02 | GHS07 | Wng | H226 | H336 |   |   |  603-177-00-8 | 1-етоксипропан-2-ол; 2PG1EE; 1-етокси-2-пропанол; моноетилов етер на пропилeнгликола; [1] 2-етокси-1-мeтилетилов ацетат; 2PG1EEA [2] | 216-374-5 [1] | 259-370-9 [2] | 1569-02-4 [1] | 54839-24-6 [2] | Flam. Liq. 3 | STOT SE 3 | H226 | H336 | GHS02 | GHS07 | Wng | H226 | H336 |   |   |  
603-178-00-3 | 2-hexyloxyethanol; ethylene glycol monohexyl ether; n-hexylglycol | 203-951-1 | 112-25-4 | Acute Tox. 4 * Acute Tox. 4 * | Skin Corr. 1B | H312 | H302 | H314 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 |   |   |  603-178-00-3 | 2-хексилоксиетанол; монохексилов етер на етилeнгликола; n-хексилгликол | 203-951-1 | 112-25-4 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H312 | H302 | H314 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 |   |   |  
603-179-00-9 | ergocalciferol (ISO); Vitamin D2 | 200-014-9 | 50-14-6 | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 | H330 | H311 | H301 | H372 ** | GHS06 | GHS08 | Dgr | H330 | H311 | H301 | H372 ** |   |   |  603-179-00-9 | ергокалциферол (ISO); Витамин D2 | 200-014-9 | 50-14-6 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | H330 | H311 | H301 | H372 ** | GHS06 | GHS08 | Dgr | H330 | H311 | H301 | H372 ** |   |   |  
603-180-00-4 | colecalciferol; Vitamin D3 | 200-673-2 | 67-97-0 | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 | H330 | H311 | H301 | H372 ** | GHS06 | GHS08 | Dgr | H330 | H311 | H301 | H372 ** |   |   |  603-180-00-4 | холекалциферол; Витамин D3 | 200-673-2 | 67-97-0 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | H330 | H311 | H301 | H372 ** | GHS06 | GHS08 | Dgr | H330 | H311 | H301 | H372 ** |   |   |  
603-181-00-X | tert-butyl methyl ether; MTBE; 2-methoxy-2-methylpropane | 216-653-1 | 1634-04-4 | Flam. Liq. 2 | Skin Irrit. 2 | H225 | H315 | GHS02 | GHS07 | Dgr | H225 | H315 |   |   |  603-181-00-X | трет-бутилметилов етер; MTBE; 2-метил-2-метоксипропан | 216-653-1 | 1634-04-4 | Flam. Liq. 2 | Skin Irrit. 2 | H225 | H315 | GHS02 | GHS07 | Dgr | H225 | H315 |   |   |  
603-182-00-5 | reaction product of: saturated, monounsaturated and multiple unsaturated long-chained partly estrified alcohols of vegetable origin (Brassica napus L., Brassica rapa L., Helianthus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) with O, O-diisobutyldithiophosphate and 2-ethylhexylamine and hydrogen peroxide | 428-630-5 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  603-182-00-5 | реакционeн продукт на: наситени, мононенаситени и полиненаситени частично естерифицирани алкохоли с дълги вериги, от растителен произход (Brassica napus L., Brassica rapa L., Helianthus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) с O,O-диизобутилдитиофосфат и 2-етилхексиламин и водороден пероксид | 428-630-5 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
603-183-00-0 | 2-[2-(2-butoxyethoxy)ethoxy]ethanol; TEGBE; triethylene glycol monobutylether; butoxytriethylene glycol | 205-592-6 | 143-22-6 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   | Eye Dam.1; H318: C≥30 % Eye Irrit. 2; H319: 20 % ≤C< 30 % |  603-183-00-0 | 2-[2-(2-бутоксиетокси)етокси]етанол; TEGBE; монобутилов етер на триетиленгликола бутокситриетиленгликол | 205-592-6 | 143-22-6 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   | Eye Dam.1; H318: C≥30 % Eye Irrit. 2; H319: 20 % ≤C< 30 % |  
603-184-00-6 | 2-(hydroxymethyl)-2-[[2-hydroxy-3-(isooctadecyloxy)propoxy]methyl]-1,3-propanediol | 416-380-1 | 146925-83-9 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  603-184-00-6 | 2-[[2-хидрокси-3-(изооктадецилокси)пропокси]метил]-2-(хидроксиметил)-1,3-пропандиол | 416-380-1 | 146925-83-9 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
603-185-00-1 | 2,4-dichloro-3-ethyl-6-nitrophenol | 420-740-1 | 99817-36-4 | Acute Tox. 3 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H318 | H317 | H400 | H410 | GHS06 | GHS05 | GHS09 | Dgr | H301 | H318 | H317 | H410 |   |   |  603-185-00-1 | 3-етил-6-нитро-2,4-дихлорофенол | 420-740-1 | 99817-36-4 | Acute Tox. 3 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H318 | H317 | H400 | H410 | GHS06 | GHS05 | GHS09 | Dgr | H301 | H318 | H317 | H410 |   |   |  
603-186-00-7 | trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol | 419-050-3 | 79944-37-9 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  603-186-00-7 | транс-(5RS,6SR)-6-амино-2,2-диметил-1,3-диoксeпан-5-ол | 419-050-3 | 79944-37-9 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
603-187-00-2 | 2-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-hydroxyethyl)amino)ethanol dichloride | 419-360-9 | 163661-77-6 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  603-187-00-2 | 2-((4,6-бис(4-(2-(1-метилпиридиний-4-ил)винил)фениламино)-1,3,5-триaзин-2-ил)(2-хидроксиетил)амино)етанолов дихлорид | 419-360-9 | 163661-77-6 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
603-188-00-8 | reaction mass of: 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-1,1,2,4,4,7-hexamethylnaphthalene; 7,8-epoxy-1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7-hexamethylnaphthalene | 426-970-9 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  603-188-00-8 | реакционна маса от: 6,7-епокси-1,1,2,4,4,7-хексаметил-1,2,3,4,5,6,7,8-октахидронафтален; 7,8-епокси-1,1,2,4,4,7-хексаметил-1,2,3,4,6,7,8,8a-октахидронафтален | 426-970-9 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
603-189-00-3 | reaction mass of complexes of: titanium, 2,2'-oxydiethanol, ammonium lactate, nitrilotris(2-propanol) and ethylene glycol | 405-250-8 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  603-189-00-3 | реакционна маса от комплекси на: титан, 2,2′-оксидиетанол, амониев лактат, нитрилотрис(2-пропанoл) и етиленгликол | 405-250-8 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
603-190-00-9 | 8,8-dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decane | 424-030-2 | 62406-73-9 | Skin Irrit. 2 | Aquatic Chronic 3 | H315 | H412 | GHS07 | Wng | H315 | H412 |   |   |  603-190-00-9 | 8,8-диметил-7-изопропил-6,10-диоксаспиро[4.5]декан | 424-030-2 | 62406-73-9 | Skin Irrit. 2 | Aquatic Chronic 3 | H315 | H412 | GHS07 | Wng | H315 | H412 |   |   |  
603-191-00-4 | 2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol | 419-740-4 | 137658-79-8 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  603-191-00-4 | 2-(4,6-бис(2,4-диметилфенил)-1,3,5-триaзин-2-ил)-5-(3-((2-етилхексил)окси)-2-хидроксипропокси)фенол | 419-740-4 | 137658-79-8 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
603-192-00-X | (E,E)-3,7,11-trimethyldodeca-1,4,6,10-tetraen-3-ol | 423-240-1 | 125474-34-2 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H315 | H318 | H317 | H410 |   |   |  603-192-00-X | (E,E)-3,7,11-триметилдодека-1,4,6,10-тетраен-3-ол | 423-240-1 | 125474-34-2 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H315 | H318 | H317 | H410 |   |   |  
603-193-00-5 | disodium 9,10-anthracenedioxide | 426-030-8 | 46492-07-3 | Skin Corr. 1A | H314 | GHS05 | Dgr | H314 |   |   |  603-193-00-5 | динатриев 9,10-антрацендиоксид | 426-030-8 | 46492-07-3 | Skin Corr. 1A | H314 | GHS05 | Dgr | H314 |   |   |  
603-194-00-0 | 2-(2-aminoethylamino)ethanol; (AEEA) | 203-867-5 | 111-41-1 | Repr. 1B | Skin Corr. 1B | Skin Sens. 1 | H360Df | H314 | H317 | GHS05 | GHS08 | GHS07 | Dgr | H360Df | H314 | H317 |   | STOT SE 3; H335: C≥5 % |  603-194-00-0 | 2-(2-аминоетиламино)етанол; (AEEA) | 203-867-5 | 111-41-1 | Repr. 1B | Skin Corr. 1B | Skin Sens. 1 | H360Df | H314 | H317 | GHS05 | GHS08 | GHS07 | Dgr | H360Df | H314 | H317 |   | STOT SE 3; H335: C≥5 % |  
603-195-00-6 | 2-[4-(4-methoxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-phenol | 430-810-3 | 154825-62-4 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  603-195-00-6 | 2-[4-(4-метоксифенил)-6-фенил-1,3,5-триaзин-2-ил]фенол | 430-810-3 | 154825-62-4 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
603-196-00-1 | 2-(7-ethyl-1H-indol-3-yl)ethanol | 431-020-1 | 41340-36-7 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 2 | H302 | H373 ** H411 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373 ** H411 |   |   |  603-196-00-1 | 2-(7-етил-1H-индол-3-ил)етанол | 431-020-1 | 41340-36-7 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 2 | H302 | H373 ** H411 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373 ** H411 |   |   |  
603-199-00-8 | etoxazol (ISO); (RS)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetole | — | 153233-91-1 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M = 100 |  603-199-00-8 | етоксазол (ISO); (RS)-5-трет-бутил-2-[2-(2,6-дифлуорофенил)-4,5-дихидро-1,3-оксазол-4-ил]фенетол | — | 153233-91-1 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M = 100 |  
603-200-00-1 | 1-pentanol; [1] 3-pentanol [2] | 200-752-1 [1] | 209-526-7 [2] | 71-41-0 [1] | 584-02-1 [2] | Flam. Liq. 3 | Acute Tox. 4 * STOT SE 3 | Skin Irrit. 2 | H226 | H332 | H335 | H315 | GHS02 | GHS07 | Wng | H226 | H332 | H335 | H315 |   |   |  603-200-00-1 | 1-пентанол; [1] 3-пентанол [2] | 200-752-1 [1] | 209-526-7 [2] | 71-41-0 [1] | 584-02-1 [2] | Flam. Liq. 3 | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | H226 | H332 | H335 | H315 | GHS02 | GHS07 | Wng | H226 | H332 | H335 | H315 |   |   |  
603-201-00-7 | (E)-(7R,11R)-3,7,11,15-tetramethylhexadec-2-ene-1-ol | 416-120-5 | — | Skin Irrit. 2 | Aquatic Chronic 4 | H315 | H413 | GHS07 | Wng | H315 | H413 |   |   |  603-201-00-7 | (E)-(7R,11R)-3,7,11,15-тетраметилхексадец-2-ен-1-ол | 416-120-5 | — | Skin Irrit. 2 | Aquatic Chronic 4 | H315 | H413 | GHS07 | Wng | H315 | H413 |   |   |  
603-202-00-2 | 4,4,5,5,5-pentafluoropentan-1-ol | 421-360-9 | 148043-73-6 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  603-202-00-2 | 4,4,5,5,5-пентафлуоропентан-1-ол | 421-360-9 | 148043-73-6 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
603-203-00-8 | (1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.01,10.03,7]tetradecane | 427-580-1 | — | Skin Irrit. 2 | H315 | GHS07 | Wng | H315 |   |   |  603-203-00-8 | (1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-хексаметил-4,6-диоксатетрацикло[6.5.1.01,10.03,7]тетрадекан | 427-580-1 | — | Skin Irrit. 2 | H315 | GHS07 | Wng | H315 |   |   |  
603-204-00-3 | reaction mass of: 2,2'-(heptane-1,7-diyl)bis-1,3-dioxolane; 2,2'-(heptane-1,6-diyl)bis-1,3-dioxolane | 428-110-8 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  603-204-00-3 | реакционна маса от: 2,2′-(хептан-1,7-диил)бис-1,3-диоксолан; 2,2′-(хептан-1,6-диил)бис-1,3-диоксолан | 428-110-8 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
603-205-00-9 | (1S-cis)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride | 426-200-1 | 172015-79-1 | STOT RE 1 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H372** H302 | H318 | H317 | H412 | GHS05 | GHS08 | GHS07 | Dgr | H372** H302 | H318 | H317 | H412 |   |   |  603-205-00-9 | (1S-цис-4-(2-амино-6-хлоро-9H-пурин-9-ил)-2-циклопентен-1-метанолхидрохлорид | 426-200-1 | 172015-79-1 | STOT RE 1 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H372** H302 | H318 | H317 | H412 | GHS05 | GHS08 | GHS07 | Dgr | H372** H302 | H318 | H317 | H412 |   |   |  
603-206-00-4 | 2,2-dichloro-1,3-benzodioxol | 426-850-6 | 2032-75-9 | Flam. Liq. 3 | Skin Corr. 1A | Acute Tox. 4 * | Skin Sens. 1 | H226 | H314 | H302 | H317 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H314 | H302 | H317 | EUH014 |   |  603-206-00-4 | 2,2-дихлоро-1,3-бензодиоксол | 426-850-6 | 2032-75-9 | Flam. Liq. 3 | Skin Corr. 1A | Acute Tox. 4 * | Skin Sens. 1 | H226 | H314 | H302 | H317 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H314 | H302 | H317 | EUH014 |   |  
603-207-00-X | 2-isobutyl-2-isopropyl-1,3-dimethoxypropane | 430-800-9 | 129228-21-3 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  603-207-00-X | 2-изобутил-2-изопропил-1,3-диметоксипропан | 430-800-9 | 129228-21-3 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
603-208-00-5 | 1,2-diethoxyethane | 211-076-1 | 629-14-1 | Flam. Liq. 2 | Repr. 1A Eye Irrit. 2 | H225 | H360Df | H319 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H360Df | H319 | EUH019 |   |  603-208-00-5 | 1,2-диетоксиетан | 211-076-1 | 629-14-1 | Flam. Liq. 2 | Repr. 1A | Eye Irrit. 2 | H225 | H360Df | H319 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H360Df | H319 | EUH019 |   |  
603-209-00-0 | spinosad (ISO) (reaction mass of spinosyn A and spinosyn D in ratios between 95:5 to 50:50); reaction mass of 50-95 % of (2R, 3aS, 5aR, 5bS, 9S, 13S,14R, 16aS, 16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione and 50-5 % (2S, 3aR, 5aS,5bS, 9S, 13S, 14R, 16aS, 16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione; [1] spinosyn A; [2] spinosyn D [3] | -[1] | -[2] | -[3] | -[1] | 131929-60-7 [2] | 131929-63-0 [3] | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M=10 |  603-209-00-0 | спинозад (ISO) (реакционна маса от спинозин A и спинозин D в съотношения от 95:5 до 50:50); реакционна маса от 50-95 % (2R,3aS,5aR,5bS,9S,13S,14R,16aS,16bR)-2-(6-деокси-2,3,4-три-O-метил-α-l-манопиранозилокси)-13-(4-диметиламино-2,3,4,6-тетрадеокси-β-d-еритропиранозилокси)-9-етил-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-хексадекахидро-14-метил-1H-8-оксациклододека[b]as-индацен-7,15-дион и 50-5 % (2S,3aR,5aS,5bS,9S,13S,14R,16aS,16bS)-2-(6-деокси-2,3,4-три-O-метил-α-l-манопиранозилокси)-13-(4-диметиламино-2,3,4,6-тетрадеокси-β-d-еритропиранозилокси)-9-етил-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-хексадекахидро-4,14-диметил-1H-8-оксациклододека[b]as-индацен-7,15-дион; [1] спинозин A; [2] спинозин D [3] | -[1] | -[2] | -[3] | -[1] | 131929-60-7 [2] | 131929-63-0 [3] | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M=10 |  
603-210-00-6 | 2,4-diethyl-1,5-pentanediol | 429-310-8 | 57987-55-0 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  603-210-00-6 | 2,4-диетил-1,5-пентандиол | 429-310-8 | 57987-55-0 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
603-211-00-1 | 2,3-epoxypropyltrimethylammonium chloride … %; glycidyl trimethylammonium chloride … % | 221-221-0 | 3033-77-0 | Carc. 1B Muta. 2 | Repr. 2 | Acute Tox. 4 * Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H350 | H341 | H361f*** H312 | H302 | H373** H318 | H317 | H412 | GHS05 | GHS08 | GHS07 | Dgr | H350 | H341 | H361f*** H312 | H302 | H373** H318 | H317 | H412 |   |   | B603-211-00-1 | 2,3-епоксипропилтриметиламониев хлорид …%; глицидилтриметиламониев хлорид …% | 221-221-0 | 3033-77-0 | Carc. 1B | Muta. 2 | Repr. 2 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H350 | H341 | H361f*** | H312 | H302 | H373** | H318 | H317 | H412 | GHS05 | GHS08 | GHS07 | Dgr | H350 | H341 | H361f*** H312 | H302 | H373** H318 | H317 | H412 |   |   | B
603-212-00-7 | 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran; galaxolide;(HHCB) | 214-946-9 | 1222-05-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  603-212-00-7 | 4,6,6,7,8,8-хексаметил-1,3,4,6,7,8-хексахидроиндено[5,6-c]пиран; галаксолид;(HHCB) | 214-946-9 | 1222-05-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
603-213-00-2 | 2-methoxy-2-methylbutane; tert-amyl methyl ether | 213-611-4 | 994-05-8 | Flam. Liq. 2 | Acute Tox. 4 * STOT SE 3 | H225 | H302 | H336 | GHS02 | GHS07 | Dgr | H225 | H302 | H336 |   |   |  603-213-00-2 | 2-метил-2-метоксибутан; трет-амилметилов етер; | 213-611-4 | 994-05-8 | Flam. Liq. 2 | Acute Tox. 4 * STOT SE 3 | H225 | H302 | H336 | GHS02 | GHS07 | Dgr | H225 | H302 | H336 |   |   |  
603-214-00-8 | 1,1-diisopropoxycyclohexane | 413-740-8 | 1132-95-2 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   |   |  603-214-00-8 | 1,1-диизопропоксициклохексан | 413-740-8 | 1132-95-2 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   |   |  
603-215-00-3 | 1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) | 418-330-2 | 162241-33-0 | Expl. 1.1**** | Acute Tox. 4 * STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H201 | H302 | H373** H318 | H317 | H400 | H410 | GHS01 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H201 | H302 | H373** H318 | H317 | H410 |   |   |  603-215-00-3 | 4-флуоро-1-хидрокси-1,4-диазониабицикло[2.2.2]oктанбис(тетрафлуороборат) | 418-330-2 | 162241-33-0 | Expl. 1.1**** | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H201 | H302 | H373** | H318 | H317 | H400 | H410 | GHS01 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H201 | H302 | H373** H318 | H317 | H410 |   |   |  
603-216-00-9 | cis-1-amino-2,3-dihydro-1H-inden-2-ol | 422-660-2 | 7480-35-5 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  603-216-00-9 | цис-1-амино-2,3-дихидро-1H-инден-2-ол | 422-660-2 | 7480-35-5 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  
603-217-00-4 | 2,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite | 423-560-1 | 161717-32-4 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  603-217-00-4 | 2,4,6-три-трет-бутилфенилов 2-бутил-2-етил-1,3-пропандиолфосфит | 423-560-1 | 161717-32-4 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
603-220-00-0 | 1-{]benzyl[}2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol | 432-890-5 | 72955-94-3 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  603-220-00-0 | 1-{бензил[2-(2-метоксифенокси)етил]амино}-3-(9H-карбазол-4-илокси)пропан-2-ол | 432-890-5 | 72955-94-3 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
603-221-00-6 | 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride; [containing < 0,1 % 4-chloroaniline (EC No 203-401-0)] | 433-580-2 | 214353-17-0 | Acute Tox. 4 * | Skin Corr. 1B Aquatic Chronic 2 | H302 | H314 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H411 |   |   |  603-221-00-6 | 1-(2-амино-5-хлорофенил)-2,2,2-трифлуоро-1,1-етандиолхидрохлорид; [съдържащ < 0,1 % 4-хлороанилин (ЕО № 203-401-0)] | 433-580-2 | 214353-17-0 | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 2 | H302 | H314 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H411 |   |   |  
603-221-01-3 | 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride; [containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)] | 433-580-2 | 214353-17-0 | Carc. 1B | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 2 | H350 | H302 | H314 | H411 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H314 | H411 |   |   |  603-221-01-3 | 1-(2-амино-5-хлорофенил)-2,2,2-трифлуоро-1,1-етандиолхидрохлорид; [съдържащ ≥ 0,1 % 4-хлороанилин (ЕО № 203-401-0)] | 433-580-2 | 214353-17-0 | Carc. 1B | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 2 | H350 | H302 | H314 | H411 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H314 | H411 |   |   |  
603-222-00-1 | (2R, 3S, 4R, 5R, 7R, 9R, 10R,11S, 12S, 13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane | 433-820-6 | 118058-74-5 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  603-222-00-1 | (2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-2-етил-10-[(6-метил-4-диметиламино-3-хидрокситетрахидропиран-2-ил)окси]-3,5,7,9,11,13-хексаметил-9-метокси-6,14-диоксо-3,4,12-трихидрокси-1-оксациклотетрадекан | 433-820-6 | 118058-74-5 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
603-223-00-7 | 2-cyclopentylidene cyclopentanol 1,1'-bi(cyclopentyliden)-2-ol | 434-270-1 | 6261-30-9 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H315 | H318 | H412 | GHS05 | Dgr | H315 | H318 | H412 |   |   |  603-223-00-7 | 2-циклопентилиден циклопентанол;1,1′-би(циклопентилиден)-2-ол | 434-270-1 | 6261-30-9 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H315 | H318 | H412 | GHS05 | Dgr | H315 | H318 | H412 |   |   |  
603-224-00-2 | 3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane | 435-790-1 | 297730-93-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  603-224-00-2 | 3-етокси-2-(трифлуорометил)-1,1,1,2,3,4,4,5,5,6,6,6-додекафлуорохексан | 435-790-1 | 297730-93-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
603-225-00-8 | erythromycin A9-oxime (E);(3R, 4S, 5S, 6R, 7R, 9R, 11R,12R, 13S, 14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-d-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E) | 437-070-0 | 13127-18-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  603-225-00-8 | еритромицин А9-оксим (E);(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-дидеокси-3-C-метил-3-O-метил-α-L-рибохексопиранозил)окси]-14-етил-7,12,13-трихидрокси-3,5,7,9,11,13-хексаметил-6-((3,4,6-тридеокси-3-(диметиламино-β-d-ксилохексопиранозил)окси)оксациклотетрадекан-2-она-10-оксим (E) | 437-070-0 | 13127-18-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
603-226-00-3 | 4,4'(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol | 444-500-0 | 1440-00-2 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  603-226-00-3 | 4,4′-(4-(4-метоксифенил)-1,3,5-триазин-2,4-диил)бисбензен-1,3-диол | 444-500-0 | 1440-00-2 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
603-227-00-9 | α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1); reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate | 445-060-2 | 203574-04-3 | **** | Aquatic Acute 1 | Aquatic Chronic 1 | **** H400 | H410 | **** GHS09 | Wng | **** H410 |   |   |  603-227-00-9 | α-хидро-ω-[[[(1,1-диметилетил)диокси]карбонил]окси]поли[окси(метил-1,2-етандиилов)] етер с 2,2-бис(хидроксиметил)-1,3-пропандиол (4:1); реакционeн продукт на: α-хидро-ω-((хлорокарбонил)окси)поли(окси(метил-1,2-етандиилов)) етер с 2,2-бис(хидроксиметил)-1,3-пропандиол с калиев 1,1-диметилетилпероксалат | 445-060-2 | 203574-04-3 | **** | Aquatic Acute 1 | Aquatic Chronic 1 | **** H400 | H410 | **** GHS09 | Wng | **** H410 |   |   |  
603-228-00-4 | (+/–)-(R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran; 6-fluoro-2-(2-oxiranyl)chromane | 419-620-1 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  603-228-00-4 | (+/–)-(R*,R*)-2-оксиранил-6-флуоро-3,4-дихидро-2H-1-бензoпиран; 2-(2-оксиранил)-6-флуорохроман | 419-620-1 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
603-229-00-X | sodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate | 420-800-7 | — | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H315 | H318 | H317 | H410 |   |   |  603-229-00-X | натриев (Z)-1-хидрокси-3-хлоро-3-(4-хлорофенил)-2-пропен-1-сулфонат | 420-800-7 | — | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H315 | H318 | H317 | H410 |   |   |  
603-230-00-5 | 2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan | 440-030-5 | — | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 4 | H315 | H318 | H413 | GHS05 | Dgr | H315 | H318 | H413 |   |   |  603-230-00-5 | 2,6,6,7,8,8-хексаметилдекахидро-2H-индено[4,5-b]фуран | 440-030-5 | — | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 4 | H315 | H318 | H413 | GHS05 | Dgr | H315 | H318 | H413 |   |   |  
603-231-00-0 | (S)-1,1-diphenyl-1,2-propanediol | 443-220-6 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  603-231-00-0 | (S)-1,1-дифенил-1,2-пропандиол | 443-220-6 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
603-232-00-6 | 3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane | 444-420-6 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  603-232-00-6 | 3,3,8,8,10,10-хексаметил-9-[1-(4-оксиранилметоксифенил)етокси]-1,5-диокса-9-азаспиро[5.5]ундекан | 444-420-6 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
603-233-00-1 | reaction mass of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol; 1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol | 444-430-0 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  603-233-00-1 | реакционна маса от: 4-(1,3a,4,6,7,7a-хексахидро-4,7-метаноинден-5-илиден)-3-метилбутан-2-ол; 4-(3,3a,4,6,7,7a-хексахидро-4,7-метаноинден-5-илиден)-3-метилбутан-2-ол; 1-(1,3a,4,6,7,7a-хексахидро-4,7-метаноинден-5-илиден)пентан-3-ол; 1-(3,3a,4,6,7,7a-хексахидро-4,7-метаноинден-5-илиден)пентан-3-ол; (E)-4-(3a,4,5,6,7,7a-хексахидро-1H-4,7-метаноинден-5-ил)-3-метилбут-3-ен-2-ол; (E)-4-(3a,4,5,6,7,7a-хексахидро-3H-4,7-метаноинден-5-ил)-3-метилбут-3-ен-2-ол | 444-430-0 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
603-234-00-7 | (1R, 4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene | 444-480-3 | — | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  603-234-00-7 | (1R,4R)-2,2,7,7-тетраметил-4-метокситрицикло [6.2.1.0(1,6)]ундец-5-ен | 444-480-3 | — | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
604-001-00-2 | phenol; carbolic acid; monohydroxybenzene; phenylalcohol | 203-632-7 | 108-95-2 | Muta. 2 | Acute Tox. 3 * Acute Tox. 3 * | Acute Tox. 3 * STOT RE 2 * | Skin Corr. 1B | H341 | H331 | H311 | H301 | H373 ** H314 | GHS06 | GHS08 | GHS05 | Dgr | H341 | H331 | H311 | H301 | H373 ** H314 |   | * | Skin Corr. 1B; H314: C ≥ 3 % | Skin Irrit. 2; H315 1 % ≤ C<3 % | Eye Irrit. 2; H319:1 % ≤C<3 % |  604-001-00-2 | фенол; карболова киселина; монохидроксибензен; фенилов алкохол | 203-632-7 | 108-95-2 | Muta. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Skin Corr. 1B | H341 | H331 | H311 | H301 | H373 ** | H314 | GHS06 | GHS08 | GHS05 | Dgr | H341 | H331 | H311 | H301 | H373 ** H314 |   | * | Skin Corr. 1B; H314: C ≥ 3 % | Skin Irrit. 2; H315 1 % ≤ C<3 % | Eye Irrit. 2; H319:1 % ≤C<3 % |  
604-002-00-8 | pentachlorophenol | 201-778-6 | 87-86-5 | Carc. 2 | Acute Tox. 2 * Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H330 | H311 | H301 | H319 | H335 | H315 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H330 | H311 | H301 | H319 | H335 | H315 | H410 |   |   |  604-002-00-8 | пентахлорофенол | 201-778-6 | 87-86-5 | Carc. 2 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H330 | H311 | H301 | H319 | H335 | H315 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H330 | H311 | H301 | H319 | H335 | H315 | H410 |   |   |  
604-003-00-3 | sodiumpentachlorophenolate; [1] potassium pentachlorophenolate[2] | 205-025-2 [1] | 231-911-3 [2] | 131-52-2 [1] | 7778-73-6 [2] | Carc. 2 | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H330 | H311 | H301 | H319 | H335 | H315 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H330 | H311 | H301 | H319 | H335 | H315 | H410 |   |   |  604-003-00-3 | натриев пентахлорофенолат; [1] калиев пентахлорофенолат[2] | 205-025-2 [1] | 231-911-3 [2] | 131-52-2 [1] | 7778-73-6 [2] | Carc. 2 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H330 | H311 | H301 | H319 | H335 | H315 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H330 | H311 | H301 | H319 | H335 | H315 | H410 |   |   |  
604-004-00-9 | m-cresol; [1] o-cresol; [2] p-cresol; [3] mix-cresol [4] | 203-577-9 [1] | 202-423-8 [2] | 203-398-6 [3] | 215-293-2 [4] | 108-39-4 [1] | 95-48-7 [2] | 106-44-5 [3] | 1319-77-3 [4] | Acute Tox. 3 * Acute Tox. 3 * | Skin Corr. 1B | H311 | H301 | H314 | GHS06 | GHS05 | Dgr | H311 | H301 | H314 |   | * | C604-004-00-9 | m-крезол; [1] o-крезол; [2] p-крезол; [3] смес от изомери на крезола [4] | 203-577-9 [1] | 202-423-8 [2] | 203-398-6 [3] | 215-293-2 [4] | 108-39-4 [1] | 95-48-7 [2] | 106-44-5 [3] | 1319-77-3 [4] | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | H311 | H301 | H314 | GHS06 | GHS05 | Dgr | H311 | H301 | H314 |   | * | C
604-005-00-4 | 1,4-dihydroxybenzene; hydroquinone; quinol | 204-617-8 | 123-31-9 | Carc. 2 | Muta. 2 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | H351 | H341 | H302 | H318 | H317 | H400 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H351 | H341 | H302 | H318 | H317 | H400 |   | M=10 |  604-005-00-4 | 1,4-дихидроксибензен; хидрохинон; хинол | 204-617-8 | 123-31-9 | Carc. 2 | Muta. 2 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | H351 | H341 | H302 | H318 | H317 | H400 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H351 | H341 | H302 | H318 | H317 | H400 |   | M=10 |  
604-006-00-X | 3,4-xylenol; [1] 2,5-xylenol; [2] 2,4-xylenol; [3] 2,3-xylenol; [4] 2,6-xylenol; [5] xylenol; [6] 2,4(or 2,5)-xylenol [7] | 202-439-5 [1] | 202-461-5 [2] | 203-321-6 [3] | 208-395-3 [4] | 209-400-1 [5] | 215-089-3 [6] | 276-245-4 [7] | 95-65-8 [1] | 95-87-4 [2] | 105-67-9 [3] | 526-75-0 [4] | 576-26-1 [5] | 1300-71-6 [6] | 71975-58-1 [7] | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | Aquatic Chronic 2 | H311 | H301 | H314 | H411 | GHS06 | GHS05 | GHS09 | Dgr | H311 | H301 | H314 | H411 |   |   | C604-006-00-X | 3,4-ксиленол; [1] 2,5-ксиленол; [2] 2,4-ксиленол; [3] 2,3-ксиленол; [4] 2,6-ксиленол; [5] ксиленол; [6] 2,4(или 2,5)-ксиленол [7] | 202-439-5 [1] | 202-461-5 [2] | 203-321-6 [3] | 208-395-3 [4] | 209-400-1 [5] | 215-089-3 [6] | 276-245-4 [7] | 95-65-8 [1] | 95-87-4 [2] | 105-67-9 [3] | 526-75-0 [4] | 576-26-1 [5] | 1300-71-6 [6] | 71975-58-1 [7] | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | Aquatic Chronic 2 | H311 | H301 | H314 | H411 | GHS06 | GHS05 | GHS09 | Dgr | H311 | H301 | H314 | H411 |   |   | C
604-007-00-5 | 2-naphthol | 205-182-7 | 135-19-3 | Acute Tox. 4 * | Acute Tox. 4 * Aquatic Acute 1 | H332 | H302 | H400 | GHS07 | GHS09 | Wng | H332 | H302 | H400 |   |   |  604-007-00-5 | 2-нафтол | 205-182-7 | 135-19-3 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | H332 | H302 | H400 | GHS07 | GHS09 | Wng | H332 | H302 | H400 |   |   |  
604-008-00-0 | 2-chlorophenol; [1] 4-chlorophenol; [2] 3-chlorophenol; [3] chlorophenol [4] | 202-433-2 [1] | 203-402-6 [2] | 203-582-6 [3] | 246-691-4 [4] | 95-57-8 [1] | 106-48-9 [2] | 108-43-0 [3] | 25167-80-0 [4] | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 2 | H332 | H312 | H302 | H411 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H411 |   |   | C604-008-00-0 | 2-хлорофенол; [1] 4-хлорофенол; [2] 3-хлорофенол; [3] хлорофенол [4] | 202-433-2 [1] | 203-402-6 [2] | 203-582-6 [3] | 246-691-4 [4] | 95-57-8 [1] | 106-48-9 [2] | 108-43-0 [3] | 25167-80-0 [4] | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 2 | H332 | H312 | H302 | H411 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H411 |   |   | C
604-009-00-6 | pyrogallol; 1,2,3-trihydroxybenzene | 201-762-9 | 87-66-1 | Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 3 | H341 | H332 | H312 | H302 | H412 | GHS08 | GHS07 | Wng | H341 | H332 | H312 | H302 | H412 |   | * |  604-009-00-6 | пирогалол; 1,2,3-трихидроксибензен | 201-762-9 | 87-66-1 | Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 3 | H341 | H332 | H312 | H302 | H412 | GHS08 | GHS07 | Wng | H341 | H332 | H312 | H302 | H412 |   | * |  
604-010-00-1 | resorcinol; 1,3-benzenediol | 203-585-2 | 108-46-3 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | H302 | H319 | H315 | H400 | GHS07 | GHS09 | Wng | H302 | H319 | H315 | H400 |   | * |  604-010-00-1 | резорцинол; 1,3-бензендиол | 203-585-2 | 108-46-3 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | H302 | H319 | H315 | H400 | GHS07 | GHS09 | Wng | H302 | H319 | H315 | H400 |   | * |  
604-011-00-7 | 2,4-dichlorophenol | 204-429-6 | 120-83-2 | Acute Tox. 3 * | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 2 | H311 | H302 | H314 | H411 | GHS06 | GHS05 | GHS09 | Dgr | H311 | H302 | H314 | H411 |   |   |  604-011-00-7 | 2,4-дихлорофенол | 204-429-6 | 120-83-2 | Acute Tox. 3 * | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 2 | H311 | H302 | H314 | H411 | GHS06 | GHS05 | GHS09 | Dgr | H311 | H302 | H314 | H411 |   |   |  
604-012-00-2 | 4-chloro-o-cresol; 4-chloro-2-methylphenol | 216-381-3 | 1570-64-5 | Acute Tox. 3 * | Skin Corr. 1A Aquatic Acute 1 | H331 | H314 | H400 | GHS06 | GHS05 | GHS09 | Dgr | H331 | H314 | H400 |   | STOT SE 3; H335: C≥1 % |  604-012-00-2 | 4-хлоро-o-крезол; 2-метил-4-хлорофенол | 216-381-3 | 1570-64-5 | Acute Tox. 3 * | Skin Corr. 1A | Aquatic Acute 1 | H331 | H314 | H400 | GHS06 | GHS05 | GHS09 | Dgr | H331 | H314 | H400 |   | STOT SE 3; H335: C≥1 % |  
604-013-00-8 | 2,3,4,6-tetrachlorophenol | 200-402-8 | 58-90-2 | Acute Tox. 3 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H319 | H315 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H319 | H315 | H410 |   | * | Eye Irrit. 2; H319:C≥5 % Skin Irrit. 2; | H315: C≥5 % |  604-013-00-8 | 2,3,4,6-тетрахлорофенол | 200-402-8 | 58-90-2 | Acute Tox. 3 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H319 | H315 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H319 | H315 | H410 |   | * | Eye Irrit. 2; H319:C≥5 % Skin Irrit. 2; | H315: C≥5 % |  
604-014-00-3 | chlorocresol; 4-chloro-m-cresol; 4-chloro-3-methylphenol | 200-431-6 | 59-50-7 | Acute Tox. 4 * Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | H312 | H302 | H318 | H317 | H400 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H318 | H317 | H400 |   | * |  604-014-00-3 | хлорокрезол; 4-хлоро-m-крезол; 3-метил-4-хлорофенол | 200-431-6 | 59-50-7 | Acute Tox. 4 * Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | H312 | H302 | H318 | H317 | H400 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H318 | H317 | H400 |   | * |  
604-015-00-9 | 2,2'-methylenebis-(3,4,6-trichlorophenol); hexachlorophene | 200-733-8 | 70-30-4 | Acute Tox. 3 * | Acute Tox. 3 * Aquatic Acute 1 | Aquatic Chronic 1 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H311 | H301 | H410 |   | * |  604-015-00-9 | 2,2′-метиленбис(3,4,6-трихлорофенол); хексахлорофен | 200-733-8 | 70-30-4 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H311 | H301 | H410 |   | * |  
604-016-00-4 | 1,2-dihydroxybenzene; pyrocatechol | 204-427-5 | 120-80-9 | Acute Tox. 4 * Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | H312 | H302 | H319 | H315 | GHS07 | Wng | H312 | H302 | H319 | H315 |   |   |  604-016-00-4 | 1,2-дихидроксибензен; пирокатехол | 204-427-5 | 120-80-9 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | H312 | H302 | H319 | H315 | GHS07 | Wng | H312 | H302 | H319 | H315 |   |   |  
604-017-00-X | 2,4,5-trichlorophenol | 202-467-8 | 95-95-4 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H315 | H410 |   | * | Eye Irrit. 2; H319: C≥5 % | Skin Irrit.2; H315: C ≥5 % |  604-017-00-X | 2,4,5-трихлорофенол | 202-467-8 | 95-95-4 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H315 | H410 |   | * | Eye Irrit. 2; H319: C≥5 % | Skin Irrit.2; H315: C ≥5 % |  
604-018-00-5 | 2,4,6-trichlorophenol | 201-795-9 | 88-06-2 | Carc. 2 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H302 | H319 | H315 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H302 | H319 | H315 | H410 |   |   |  604-018-00-5 | 2,4,6-трихлорофенол | 201-795-9 | 88-06-2 | Carc. 2 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H302 | H319 | H315 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H302 | H319 | H315 | H410 |   |   |  
604-019-00-0 | dichlorophen (ISO) | 202-567-1 | 97-23-4 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H410 |   |   |  604-019-00-0 | дихлорофен (ISO) | 202-567-1 | 97-23-4 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H410 |   |   |  
604-020-00-6 | 2-phenylphenol (ISO)biphenyl-2-ol; 2-hydroxybiphenyl; | 201-993-5 | 90-43-7 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | H319 | H335 | H315 | H400 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H400 |   |   |  604-020-00-6 | 2-фенилфенол (ISO) бифенил-2-ол; 2-хидроксибифенил; | 201-993-5 | 90-43-7 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | H319 | H335 | H315 | H400 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H400 |   |   |  
604-021-00-1 | sodium 2-biphenylate; 2-phenylphenol, sodium salt | 205-055-6 | 132-27-4 | Acute Tox. 4 * STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | H302 | H335 | H315 | H318 | H400 | GHS05 | GHS07 | GHS09 | Wng | H302 | H335 | H315 | H318 | H400 |   |   |  604-021-00-1 | натриев 2-бифенилат; натриева сол на 2-фенилфенола | 205-055-6 | 132-27-4 | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | H302 | H335 | H315 | H318 | H400 | GHS05 | GHS07 | GHS09 | Wng | H302 | H335 | H315 | H318 | H400 |   |   |  
604-022-00-7 | 2,2-dimethyl-1,3-benzodioxol-4-ol | 400-900-7 | 22961-82-6 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  604-022-00-7 | 2,2-диметил-1,3-бензодиоксол-4-oл | 400-900-7 | 22961-82-6 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
604-023-00-2 | 2,4-dichloro-3-ethylphenol | 401-060-4 | — | Skin Corr. 1B Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H400 | H410 | GHS05 | GHS09 | Dgr | H314 | H410 |   |   |  604-023-00-2 | 3-eтил-2,4-дихлорофенол | 401-060-4 | — | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H400 | H410 | GHS05 | GHS09 | Dgr | H314 | H410 |   |   |  
604-024-00-8 | 4,4-isobutylethylidenediphenol | 401-720-1 | 6807-17-6 | Repr. 1B | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H360F *** H319 | H400 | H410 | GHS08 | GHS09 | Dgr | H360F *** H319 | H410 |   |   |  604-024-00-8 | 4,4'-изобутилетилидендифенол | 401-720-1 | 6807-17-6 | Repr. 1B | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H360F *** | H319 | H400 | H410 | GHS08 | GHS09 | Dgr | H360F *** H319 | H410 |   |   |  
604-025-00-3 | 2,5-bis(1,1-dimethylbutyl)hydroquinone | 400-220-0 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  604-025-00-3 | 2,5-бис(1,1-диметилбутил)хидрохинон | 400-220-0 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
604-026-00-9 | 2,2-spirobi(6-hydroxy-4,4,7-trimethylchromane) | 400-270-3 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  604-026-00-9 | 2,2'-спироби(4,4,7-триметил-6-хидроксихроман) | 400-270-3 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
604-027-00-4 | 2-methyl-5-(1,1,3,3-tetramethylbutyl)hydroquinone | 400-530-6 | — | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H411 |   |   |  604-027-00-4 | 2-мeтил-5-(1,1,3,3-тетраметилбутил)хидрохинон | 400-530-6 | — | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H411 |   |   |  
604-028-00-X | 4-amino-3-fluorophenol | 402-230-0 | 399-95-1 | Carc. 1B | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H350 | H302 | H317 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H317 | H411 |   |   |  604-028-00-X | 4-амино-3-флуорофенол | 402-230-0 | 399-95-1 | Carc. 1B | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H350 | H302 | H317 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H317 | H411 |   |   |  
604-029-00-5 | 1-naphtol | 201-969-4 | 90-15-3 | Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | H312 | H302 | H335 | H315 | H318 | GHS05 | GHS07 | Dgr | H312 | H302 | H335 | H315 | H318 |   |   |  604-029-00-5 | 1-нафтол | 201-969-4 | 90-15-3 | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | H312 | H302 | H335 | H315 | H318 | GHS05 | GHS07 | Dgr | H312 | H302 | H335 | H315 | H318 |   |   |  
604-031-00-6 | guaiacol | 201-964-7 | 90-05-1 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | H302 | H319 | H315 | GHS07 | Wng | H302 | H319 | H315 |   |   |  604-031-00-6 | гвайакол | 201-964-7 | 90-05-1 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | H302 | H319 | H315 | GHS07 | Wng | H302 | H319 | H315 |   |   |  
604-032-00-1 | thymol | 201-944-8 | 89-83-8 | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 2 | H302 | H314 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H411 |   |   |  604-032-00-1 | тимол | 201-944-8 | 89-83-8 | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 2 | H302 | H314 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H411 |   |   |  
604-033-00-7 | isobutyl but-3-enoate | 401-170-2 | 24342-03-8 | Flam. Liq. 3 | H226 | GHS02 | Wng | H226 |   |   |  604-033-00-7 | изобутилов бут-3-eноат | 401-170-2 | 24342-03-8 | Flam. Liq. 3 | H226 | GHS02 | Wng | H226 |   |   |  
604-034-00-2 | 4,4'-thiodi-o-cresol | 403-330-7 | 24197-34-0 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  604-034-00-2 | 4,4′-тиоди-o-крезол | 403-330-7 | 24197-34-0 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  
604-035-00-8 | 4-nonylphenol, reaction products with formaldehyde and dodecane-1-thiol | 404-160-6 | — | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  604-035-00-8 | 4-нонилфенол, реакционни продукти с формалдехид и додекан-1-тиол | 404-160-6 | — | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
604-036-00-3 | 4,4'-oxybis(ethylenethio)diphenol | 404-590-4 | 90884-29-0 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  604-036-00-3 | 4,4′-оксибис(етилентио)дифенол | 404-590-4 | 90884-29-0 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
604-037-00-9 | 3,5-xylenol; 3,5-dimethylphenol | 203-606-5 | 108-68-9 | Acute Tox. 3 * Acute Tox. 3 * | Skin Corr. 1B | H311 | H301 | H314 | GHS06 | GHS05 | Dgr | H311 | H301 | H314 |   |   |  604-037-00-9 | 3,5-ксиленол; 3,5-диметилфенол | 203-606-5 | 108-68-9 | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | H311 | H301 | H314 | GHS06 | GHS05 | Dgr | H311 | H301 | H314 |   |   |  
604-038-00-4 | 4-chloro-3,5-dimethylphenol; [1] chloroxylenol [2] | 201-793-8 [1] | 215-316-6 [2] | 88-04-0 [1] | 1321-23-9 [2] | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H302 | H319 | H315 | H317 | GHS07 | Wng | H302 | H319 | H315 | H317 |   |   |  604-038-00-4 | 3,5-диметил-4-хлорофенол; [1] хлороксиленол [2] | 201-793-8 [1] | 215-316-6 [2] | 88-04-0 [1] | 1321-23-9 [2] | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H302 | H319 | H315 | H317 | GHS07 | Wng | H302 | H319 | H315 | H317 |   |   |  
604-039-00-X | ethyl 2-[4-[(6-chlorobenzoxazol-2-yl)oxy]phenoxy]propionate; fenoxaprop-ethyl | 266-362-9 | 66441-23-4 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  604-039-00-X | етилов 2-[4-[(6-хлоробензоксазол-2-ил)oкси]фенокси]пропионат; феноксапроп-етил | 266-362-9 | 66441-23-4 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
604-040-00-5 | fomesafen (ISO); 5-[2-chloro-4-(trifluoromethyl)phenoxy]-N-(methylsulphonyl)-2-nitrobenzamide | 276-439-9 | 72178-02-0 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  604-040-00-5 | фомесафен (ISO); N-(метилсулфонил)-2-нитро-5-[4-(трифлуорометил)-2-хлорофенокси]бензамид | 276-439-9 | 72178-02-0 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
604-041-00-0 | acifluorfen (ISO); 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid [1] sodium 5-[2-chloro-4-(trifluoromethyl) phenoxy]-2-nitrobenzoate; acifluorfen-sodium [2] | 256-634-5 [1] | 263-560-7 [2] | 50594-66-6 [1] | 62476-59-9 [2] | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H315 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H315 | H318 | H410 |   |   |  604-041-00-0 | ацифлуорфен (ISO); 2-нитро-5-[4-(трифлуорометил)-2-хлорофенокси]бензоена киселина [1] натриев 2-нитро-5-[4-(трифлуорометил)-2-хлорофенокси]бензоат; ацифлуорфен-натрий [2] | 256-634-5 [1] | 263-560-7 [2] | 50594-66-6 [1] | 62476-59-9 [2] | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H315 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H315 | H318 | H410 |   |   |  
604-042-00-6 | 4-nitrosophenol | 203-251-6 | 104-91-6 | Muta. 2 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H341 | H302 | H318 | H411 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H341 | H302 | H318 | H411 |   |   |  604-042-00-6 | 4-нитрозофенол | 203-251-6 | 104-91-6 | Muta. 2 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H341 | H302 | H318 | H411 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H341 | H302 | H318 | H411 |   |   |  
604-043-00-1 | monobenzone; 4-hydroxyphenyl benzyl ether; hydroquinone monobenzyl ether | 203-083-3 | 103-16-2 | Eye Irrit. 2 | Skin Sens. 1 | H319 | H317 | GHS07 | Wng | H319 | H317 |   |   |  604-043-00-1 | монобензон; бензил-4-хидроксифенилов етер; монобензилов етер на хидрохинона | 203-083-3 | 103-16-2 | Eye Irrit. 2 | Skin Sens. 1 | H319 | H317 | GHS07 | Wng | H319 | H317 |   |   |  
604-044-00-7 | mequinol; 4-methoxyphenol; hydroquinone monomethyl ether | 205-769-8 | 150-76-5 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | H302 | H319 | H317 | GHS07 | Wng | H302 | H319 | H317 |   |   |  604-044-00-7 | мeхинол; 4-метоксифенол; монометилов етер на хидрохинона | 205-769-8 | 150-76-5 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | H302 | H319 | H317 | GHS07 | Wng | H302 | H319 | H317 |   |   |  
604-045-00-2 | 2,3,5-trimethylhydroquinone | 211-838-3 | 700-13-0 | Acute Tox. 4 * STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H335 | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H332 | H335 | H315 | H318 | H317 | H410 |   |   |  604-045-00-2 | 2,3,5-триметилхидрохинон | 211-838-3 | 700-13-0 | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H335 | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H332 | H335 | H315 | H318 | H317 | H410 |   |   |  
604-046-00-8 | 4-(4-isopropoxyphenylsulfonyl)phenol | 405-520-5 | 95235-30-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  604-046-00-8 | 4-(4-изопропоксифенилсулфонил)фенол | 405-520-5 | 95235-30-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
604-047-00-3 | 4-(4-tolyloxy)biphenyl | 405-730-7 | 51601-57-1 | STOT RE 2 * | Aquatic Chronic 4 | H373 ** H413 | GHS08 | Wng | H373 ** H413 |   |   |  604-047-00-3 | 4-(4-тoлилокси)бифенил | 405-730-7 | 51601-57-1 | STOT RE 2 * | Aquatic Chronic 4 | H373 ** H413 | GHS08 | Wng | H373 ** H413 |   |   |  
604-048-00-9 | 4,4',4''-(ethan-1,1,1-triyl)triphenol | 405-800-7 | 27955-94-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  604-048-00-9 | 4,4′,4′′-(етан-1,1,1-триил)трифенол | 405-800-7 | 27955-94-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
604-049-00-4 | 4-4'-methylenebis(oxyethylenethio)diphenol | 407-480-4 | 93589-69-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  604-049-00-4 | 4,4′-мeтиленбис(oксиетилентио)дифенол | 407-480-4 | 93589-69-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
604-051-00-5 | 3,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylphenol | 401-110-5 | 87113-78-8 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  604-051-00-5 | 3,5-бис((3,5-ди-трет-бутил-4-хидрокси)бензил)-2,4,6-триметилфенол | 401-110-5 | 87113-78-8 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
604-052-00-0 | 2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) | 403-800-1 | 103597-45-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  604-052-00-0 | 2,2′-мeтиленбис(6-(2H-бензотриазол-2-ил)-4-(1,1,3,3-тетраметилбутил)фенол) | 403-800-1 | 103597-45-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
604-053-00-6 | 2-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol | 410-760-9 | 157661-93-3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H317 | H410 |   |   |  604-053-00-6 | 2-мeтил-4-(1,1-диметилетил)-6-(1-метилпентадецил)фенол | 410-760-9 | 157661-93-3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H317 | H410 |   |   |  
604-054-00-1 | reaction mass of: 2-methoxy-4-(tetrahydro-4-methylene-2H-pyran-2-yl)-phenol; 4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol | 412-020-0 | — | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  604-054-00-1 | реакционна маса от: 4-(4-метилентетрахидро-2H-пиран-2-ил)-2-мeтоксифенол; 4-(4-метил-3,6-дихидро-2H-пиран-2-ил)-2-метоксифенол | 412-020-0 | — | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
604-055-00-7 | 2,2'-((3,3', 5,5'-tetramethyl-(1,1'-biphenyl)-4,4'-diyl)-bis(oxymethylene))-bis-oxirane | 413-900-7 | 85954-11-6 | Carc. 2 | Skin Sens. 1 | H351 | H317 | GHS08 | GHS07 | Wng | H351 | H317 |   |   |  604-055-00-7 | 2,2′-((3,3′,5,5′-тетраметил(1,1′-бифенил)-4,4′-диил)бис(оксиметилен))бисоксиран | 413-900-7 | 85954-11-6 | Carc. 2 | Skin Sens. 1 | H351 | H317 | GHS08 | GHS07 | Wng | H351 | H317 |   |   |  
604-056-00-2 | 2-(2-hydroxy-3,5-dinitroanilino)ethanol | 412-520-9 | 99610-72-7 | Flam. Sol. 2 | Repr. 2 | Acute Tox. 4 * | H228 | H361f *** H302 | GHS02 | GHS07 | GHS08 | Dgr | H228 | H361f *** H302 |   |   |  604-056-00-2 | 2-(3,5-динитро-2-хидроксианилино)eтанол | 412-520-9 | 99610-72-7 | Flam. Sol. 2 | Repr. 2 | Acute Tox. 4 * | H228 | H361f *** H302 | GHS02 | GHS07 | GHS08 | Dgr | H228 | H361f *** H302 |   |   |  
604-058-00-3 | 1,2-bis(3-methylphenoxy)ethane | 402-730-9 | 54914-85-1 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  604-058-00-3 | 1,2-бис(3-метилфенокси)eтан | 402-730-9 | 54914-85-1 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
604-059-00-9 | 2-n-hexadecylhydroquinone | 406-400-5 | — | STOT RE 2 * | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 4 | H373 ** H315 | H317 | H413 | GHS08 | GHS07 | Wng | H373 ** H315 | H317 | H413 |   |   |  604-059-00-9 | 2-n-хексадецилхидрохинон | 406-400-5 | — | STOT RE 2 * | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 4 | H373 ** H315 | H317 | H413 | GHS08 | GHS07 | Wng | H373 ** H315 | H317 | H413 |   |   |  
604-060-00-4 | 9,9-bis(4-hydroxyphenyl)fluorene | 406-950-6 | 3236-71-3 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H315 | H410 |   |   |  604-060-00-4 | 9,9-бис(4-хидроксифенил)флуорен | 406-950-6 | 3236-71-3 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H315 | H410 |   |   |  
604-061-00-X | reaction mass of: 2-chloro-5-sec-tetradecylhydroquinones where sec-tetradecyl = 1-methyltridecyl; 1-ethyldodecyl; 1-propylundecyl; 1-butyldecyl; 1-pentylnonyl; 1-hexyloctyl | 407-740-7 | — | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H315 | H317 | H412 | GHS07 | Wng | H315 | H317 | H412 |   |   |  604-061-00-X | реакционна маса от: 5-втор-тетрадецил-2-хлорохидрохинони, където втор-тетрадецил = 1-мeтилтридецил; 1-етилдодецил; 1-пропилундецил; 1-бутилдецил; 1-пентилнонил; 1-хексилоктил | 407-740-7 | — | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H315 | H317 | H412 | GHS07 | Wng | H315 | H317 | H412 |   |   |  
604-062-00-5 | 2,4-dimethyl-6-(1-methyl-pentadecyl)phenol | 411-220-5 | — | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H317 | H410 |   |   |  604-062-00-5 | 2,4-диметил-6-(1-метилпентадецил)фенол | 411-220-5 | — | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H317 | H410 |   |   |  
604-063-00-0 | 5,6-dihydroxyindole | 412-130-9 | 3131-52-0 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  604-063-00-0 | 5,6-дихидроксииндол | 412-130-9 | 3131-52-0 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  
604-064-00-6 | 2-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol | 411-380-6 | 147315-50-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  604-064-00-6 | 2-(4,6-дифенил-1,3,5-триазин-2-ил)-5-((хексил)oкси)фенол | 411-380-6 | 147315-50-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
604-065-00-1 | 4,4',4''-(1-methylpropan-1-yl-3-ylidene)tris(2-cyclohexyl-5-methylphenol) | 407-460-5 | 111850-25-0 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  604-065-00-1 | 4,4′,4″-(1-метилпропан-1-ил-3-илиден)трис(2-циклохексил-5-метилфенол) | 407-460-5 | 111850-25-0 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
604-066-00-7 | reaction mass of: phenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylphenyl)methyl (C41-compound) and methane, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-phenyl)]-(C45-compound); 2,6-bis(1,1-dimethylethyl)-4-tetra-propyl-phenol and 2-(1,1-dimethylethyl)-4-tetrapropyl-phenol; 2,6-bis[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol and 2-[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenylmethyl]-6-[1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol | 414-550-8 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  604-066-00-7 | реакционна маса от: 6-(1,1-диметилетил)-4-тетрапропил-2-[(5-тетрапропил-2-хидроксифенил)метилфенол (C41-съединение) и 2,2′-бис[6-(1,1-диметилетил)-1-хидрокси-4-тетрапропилфенил)]метан (C45-съединение); 2,6-бис(1,1-диметилетил)-4-тетрапропилфенол и 2-(1,1-диметилетил)-4-тетрапропилфенол; 2,6-бис[(6-(1,1-диметилетил)-4-тетрапропил-1-хидроксифенил)метил]-4-(тетрапропил)фенол и 2-[(6-(1,1-диметилетил)-4-тетрапропил-1-хидроксифенилметил]-6-[4-тетрапропил-1-хидроксифенил)метил]-4-(тетрапропил)фенол | 414-550-8 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
604-067-00-2 | reaction mass of: 2,2'-[[(2-hydroxyethyl)imino]bis(methylene)bis[4-dodecylphenol]; formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 2); formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 3, 4 and higher) | 414-520-4 | — | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H315 | H318 | H410 |   |   |  604-067-00-2 | реакционна маса от: 2,2′-[[(2-хидроксиетил)имино]бис(метилeн)бис[4-додецилфенол]; формалдехид, олигомер с 4-додецилфенол и 2-аминоетанол (n=2); формалдехид, олигомер с 4-додецилфенол и 2-аминоетанол (n = 3, 4 и повече) | 414-520-4 | — | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H315 | H318 | H410 |   |   |  
604-068-00-8 | (±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride | 415-170-5 | 90274-24-1 | Acute Tox. 4 * Acute Tox. 4 * | Skin Sens. 1 | H332 | H302 | H317 | GHS07 | Wng | H332 | H302 | H317 |   |   |  604-068-00-8 | (±)-4-[2-[[3-(4-хидроксифенил)-1-метилпропил]амино]-1-хидроксиетил]фенолхидрохлорид | 415-170-5 | 90274-24-1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Sens. 1 | H332 | H302 | H317 | GHS07 | Wng | H332 | H302 | H317 |   |   |  
604-069-00-3 | 2-(1-methylpropyl)-4-tert-butylphenol | 421-740-4 | 51390-14-8 | Skin Corr. 1B | Aquatic Chronic 2 | H314 | H411 | GHS05 | GHS09 | Dgr | H314 | H411 |   |   |  604-069-00-3 | 4-трет-бутил-2-(1-метилпропил)фенол | 421-740-4 | 51390-14-8 | Skin Corr. 1B | Aquatic Chronic 2 | H314 | H411 | GHS05 | GHS09 | Dgr | H314 | H411 |   |   |  
604-070-00-9 | triclosan;2,4,4'-trichloro-2'-hydroxy-diphenyl-ether; 5-chloro-2-(2,4-dichlorophenoxy)phenol | 222-182-2 | 3380-34-5 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H315 | H410 |   | M = 100 |  604-070-00-9 | триклозан;2′-хидрокси-2,4,4′-трихлородифенилов етер; 5-хлоро-2-(2,4-дихлорофенокси)фенол | 222-182-2 | 3380-34-5 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H315 | H410 |   | M = 100 |  
604-071-00-4 | 4,4'-(1-{4-[1-(4-hydroxyphenyl)-1-methylethyl]phenyl}ethylidene)diphenol | 425-600-3 | 110726-28-8 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  604-071-00-4 | 4,4′-(1-{4-[1-метил-1-(4-хидроксифенил)етил]фенил}етилиден)дифенол | 425-600-3 | 110726-28-8 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
604-072-00-X | 1,2-bis(phenoxymethyl)benzene | 428-620-0 | 10403-74-4 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  604-072-00-X | 1,2-бис(феноксиметил)бензен | 428-620-0 | 10403-74-4 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
604-073-00-5 | (E)-3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol | 428-010-4 | 82413-20-5 | Carc. 2 | Repr. 1B Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H360F*** H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H351 | H360F*** H317 | H410 |   |   |  604-073-00-5 | (E)-3-[1-[4-[2-(диметиламино)етокси]фенил]-2-фенилбут-1-енил]фенол | 428-010-4 | 82413-20-5 | Carc. 2 | Repr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H360F*** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H351 | H360F*** H317 | H410 |   |   |  
604-074-00-0 | tetrabromobisphenol-A; 2,2', 6,6'-tetrabromo-4,4'-isopropylidenediphenol | 201-236-9 | 79-94-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  604-074-00-0 | тетрабромобисфенол-А; 2,2′,6,6′-тетрабромо-4,4′-изопропилидендифенол | 201-236-9 | 79-94-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
604-075-00-6 | 4-(1,1,3,3-tetramethylbutyl)phenol; 4-tert-octylphenol | 205-426-2 | 140-66-9 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H315 | H318 | H410 |   | M=10 |  604-075-00-6 | 4-(1,1,3,3-тетраметилбутил)фенол; 4-трет-октилфенол | 205-426-2 | 140-66-9 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H315 | H318 | H410 |   | M=10 |  
604-076-00-1 | phenolphthalein | 201-004-7 | 77-09-8 | Carc. 1B Muta. 2 | Repr. 2 | H350 | H341 | H361f*** | GHS08 | Dgr | H350 | H341 | H361f*** |   | Carc. 1B; H350: C ≥1 % |  604-076-00-1 | фенолфталеин | 201-004-7 | 77-09-8 | Carc. 1B | Muta. 2 | Repr. 2 | H350 | H341 | H361f*** | GHS08 | Dgr | H350 | H341 | H361f*** |   | Carc. 1B; H350: C ≥1 % |  
604-077-00-7 | 2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol | 419-750-9 | 98809-58-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  604-077-00-7 | 2-бензотриазол-2-ил-4-метил-6-(2-метилалил)фенол | 419-750-9 | 98809-58-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
604-079-00-8 | 4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol | 428-970-4 | 13595-25-0 | Repr. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H361f*** H317 | H411 | GHS08 | GHS07 | GHS09 | Wng | H361f*** H317 | H411 |   |   |  604-079-00-8 | 4,4′-(1,3-фениленбис(1-метилетилиден))бисфенол | 428-970-4 | 13595-25-0 | Repr. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H361f*** H317 | H411 | GHS08 | GHS07 | GHS09 | Wng | H361f*** H317 | H411 |   |   |  
604-080-00-3 | 4-fluoro-3-trifluoromethylphenol | 432-560-0 | 61721-07-1 | Acute Tox. 4 * | Skin Corr. 1A | Skin Sens. 1 | Aquatic Chronic 2 | H332 | H314 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H332 | H314 | H317 | H411 |   |   |  604-080-00-3 | 4-флуоро-3-трифлуорометилфенол | 432-560-0 | 61721-07-1 | Acute Tox. 4 * | Skin Corr. 1A | Skin Sens. 1 | Aquatic Chronic 2 | H332 | H314 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H332 | H314 | H317 | H411 |   |   |  
604-081-00-9 | 1,1-bis(4-hydroxyphenyl)-1-phenylethane | 433-130-5 | 1571-75-1 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  604-081-00-9 | 1,1-бис(4-хидроксифенил)-1-фенилетан | 433-130-5 | 1571-75-1 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
604-082-00-4 | 2-chloro-6-fluoro-phenol | 433-890-8 | 2040-90-6 | Muta. 1B Repr. 2 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H340 | H361f*** H302 | H314 | H317 | H411 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H340 | H361f*** H302 | H314 | H317 | H411 |   |   |  604-082-00-4 | 6-флуоро-2-хлорофенол | 433-890-8 | 2040-90-6 | Muta. 1B Repr. 2 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H340 | H361f*** H302 | H314 | H317 | H411 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H340 | H361f*** H302 | H314 | H317 | H411 |   |   |  
604-083-00-X | 4,4'-sulfonylbisphenol, polymer with ammonium chloride(NH4Cl), pentachlorophosphorane and phenol | 439-270-3 | 260408-02-4 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  604-083-00-X | 4,4′-сулфонилбисфенол, полимер с амониев хлорид (NH4Cl), пентахлорофосфоран и фенол | 439-270-3 | 260408-02-4 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
604-084-00-5 | 1-ethoxy-2,3-difluorobenzene | 441-000-4 | 121219-07-6 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  604-084-00-5 | 1-етокси-2,3-дифлуоробензен | 441-000-4 | 121219-07-6 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
604-087-00-1 | reaction mass of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride(or sulfonicacid)diester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol | 433-640-8 | — | Pyr. Sol. 1 | Aquatic Chronic 4 | H250 | H413 | GHS02 | Dgr | H250 | H413 | EUH044 |   |  604-087-00-1 | реакционна маса от: 1,2-нафтохинондиазид-5-сулфонилхлорид (или моноестер на сулфоновата киселина) с 4,4′-(1-(4-(1-(4-хидроксифенил)-1-метилетил)фенил)етилиден)бисфенол; 1,2-нафтохинондиазид-5-сулфонилхлорид (или диестер на сулфоновата киселина) с 4,4′-(1-(4-(1-(4-хидроксифенил)-1-метилетил)фенил)етилиден)бисфенол; 1,2-нафтохинондиазид-5-сулфонилхлорид (или триестер на сулфоновата киселина) с 4,4′-(1-(4-(1-(4-хидроксифенил)-1-метилетил)фенил)етилиден)бисфенол | 433-640-8 | — | Pyr. Sol. 1 | Aquatic Chronic 4 | H250 | H413 | GHS02 | Dgr | H250 | H413 | EUH044 |   |  
604-089-00-2 | 2-methyl-5-tert-butylthiophenol | 444-970-7 | — | Flam. Liq. 3 | Repr. 2 | STOT RE 2 * | Asp. Tox. 1 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H226 | H361d*** H373** H304 | H319 | H315 | H317 | H336 | H400 | H410 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H226 | H361d*** H373** H304 | H319 | H315 | H317 | H336 | H410 |   |   |  604-089-00-2 | 5-трет-бутил-2-метилтиофенол | 444-970-7 | — | Flam. Liq. 3 | Repr. 2 | STOT RE 2 * | Asp. Tox. 1 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H226 | H361d*** H373** H304 | H319 | H315 | H317 | H336 | H400 | H410 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H226 | H361d*** H373** H304 | H319 | H315 | H317 | H336 | H410 |   |   |  
604-090-00-8 | 4-tert-butylphenol | 202-679-0 | 98-54-4 | Repr. 2 | Skin Irrit. 2 | Eye Dam. 1 | H361f | H315 | H318 | GHS08 | GHS05 | Dgr | H361f | H315 | H318 |   |   |  604-090-00-8 | 4-трет-бутилфенол | 202-679-0 | 98-54-4 | Repr. 2 | Skin Irrit. 2 | Eye Dam. 1 | H361f | H315 | H318 | GHS08 | GHS05 | Dgr | H361f | H315 | H318 |   |   |  
604-091-00-3 | etofenprox (ISO); 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzyl ether | 407-980-2 | 80844-07-1 | Lact. | Aquatic Acute 1 | Aquatic Chronic 1 | H362 | H400 | H410 | GHS09 | Wng | H362 | H410 |   | M = 100 | M = 1 000 |  604-091-00-3 | етофенпрокс (ISO); 2-(4-етоксифенил)-2-метилпропил-3-феноксибензилов етер | 407-980-2 | 80844-07-1 | Lact. | Aquatic Acute 1 | Aquatic Chronic 1 | H362 | H400 | H410 | GHS09 | Wng | H362 | H410 |   | M = 100 | M = 1 000 |  
605-001-00-5 | formaldehyde …% | 200-001-8 | 50-00-0 | Carc. 1B Muta. 2 | Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* | Skin Corr. 1B | Skin Sens. 1 | H350 | H341 | H301 | H311 | H331 | H314 | H317 | GHS08 | GHS06 | GHS05 | Dgr | H350 | H341 | H301 | H311 | H331 | H314 | H317 |   | * | Skin Corr. 1B; H314: C ≥25 % Skin Irrit. 2; H315: 5 % ≤C | < 25 % | Eye Irrit. 2; H319: 5 % ≤ C | <25 % | STOT SE 3; H335: C ≥ 5 % SkinSens.; H317: C ≥ 0,2  % | B, D605-001-00-5 | формалдехид …% | 200-001-8 | 50-00-0 | Carc. 1B | Muta. 2 | Acute Tox. 3* | Acute Tox. 3* | Acute Tox. 3* | Skin Corr. 1B | Skin Sens. 1 | H350 | H341 | H301 | H311 | H331 | H314 | H317 | GHS08 | GHS06 | GHS05 | Dgr | H350 | H341 | H301 | H311 | H331 | H314 | H317 |   | * | Skin Corr. 1B; H314: C ≥25 % Skin Irrit. 2; H315: 5 % ≤C | < 25 % | Eye Irrit. 2; H319: 5 % ≤ C | <25 % | STOT SE 3; H335: C ≥ 5 % SkinSens.; H317: C ≥ 0,2  % | B, D
605-002-00-0 | 1,3,5-trioxan; trioxymethylene | 203-812-5 | 110-88-3 | Flam. Sol. 1 | Repr. 2 | STOT SE 3 | H228 | H361d *** H335 | GHS02 | GHS08 | GHS07 | Dgr | H228 | H361d *** H335 |   |   | T605-002-00-0 | 1,3,5-триоксан; триоксиметилен | 203-812-5 | 110-88-3 | Flam. Sol. 1 | Repr. 2 | STOT SE 3 | H228 | H361d *** H335 | GHS02 | GHS08 | GHS07 | Dgr | H228 | H361d *** H335 |   |   | T
605-003-00-6 | acetaldehyde; ethanal | 200-836-8 | 75-07-0 | Flam. Liq. 1 | Carc. 2 | Eye Irrit. 2 | STOT SE 3 | H224 | H351 | H319 | H335 | GHS02 | GHS08 | GHS07 | Dgr | H224 | H351 | H319 | H335 |   |   |  605-003-00-6 | ацеталдехид; етанал | 200-836-8 | 75-07-0 | Flam. Liq. 1 | Carc. 2 | Eye Irrit. 2 | STOT SE 3 | H224 | H351 | H319 | H335 | GHS02 | GHS08 | GHS07 | Dgr | H224 | H351 | H319 | H335 |   |   |  
605-004-00-1 | 2,4,6-trimethyl-1,3,5-trioxane; paraldehyde | 204-639-8 | 123-63-7 | Flam. Liq. 3 | H226 | GHS02 | Wng | H226 |   |   |  605-004-00-1 | 2,4,6-триметил-1,3,5-триоксан; паралдехид | 204-639-8 | 123-63-7 | Flam. Liq. 3 | H226 | GHS02 | Wng | H226 |   |   |  
605-005-00-7 | 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane; metaldehyde | 203-600-2 | 108-62-3 | Flam. Sol. 2 | Acute Tox. 4 * | H228 | H302 | GHS02 | GHS07 | Wng | H228 | H302 |   |   |  605-005-00-7 | 2,4,6,8-тетраметил-1,3,5,7-тетраоксациклооктан; металдехид | 203-600-2 | 108-62-3 | Flam. Sol. 2 | Acute Tox. 4 * | H228 | H302 | GHS02 | GHS07 | Wng | H228 | H302 |   |   |  
605-006-00-2 | butyraldehyde | 204-646-6 | 123-72-8 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 |   |   |  605-006-00-2 | бутиралдехид | 204-646-6 | 123-72-8 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 |   |   |  
605-007-00-8 | 1,1-dimethoxyethane; dimethyl acetal | 208-589-8 | 534-15-6 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 |   |   |  605-007-00-8 | 1,1-диметоксиетан; диметилацетал | 208-589-8 | 534-15-6 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 |   |   |  
605-008-00-3 | acrolein; prop-2-enal; acrylaldehyde | 203-453-4 | 107-02-8 | Flam. Liq. 2 | Acute Tox. 1 | Acute Tox. 2 | Acute Tox. 3 | Skin Corr. 1B Aquatic Acute 1 | Aquatic Chronic 1 | H225 | H330 | H300 | H311 | H314 | H400 | H410 | GHS02 | GHS06 | GHS05 | GHS09 | Dgr | H225 | H330 | H300 | H311 | H314 | H410 | EUH071 | Skin Corr. 1B; H314:C≥ 0,1  % | M = 100 | M = 1 | D605-008-00-3 | акролеин; проп-2-енал; акрилалдехид; | 203-453-4 | 107-02-8 | Flam. Liq. 2 | Acute Tox. 1 | Acute Tox. 2 | Acute Tox. 3 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H225 | H330 | H300 | H311 | H314 | H400 | H410 | GHS02 | GHS06 | GHS05 | GHS09 | Dgr | H225 | H330 | H300 | H311 | H314 | H410 | EUH071 | Skin Corr. 1B; H314:C≥ 0,1  % | M = 100 | M = 1 | D
605-009-00-9 | crotonaldehyde; 2-butenal; [1] (E)-2-butenal; (E)-crotonaldehyde [2] | 224-030-0 [1] | 204-647-1 [2] | 4170-30-3 [1] | 123-73-9 [2] | Flam. Liq. 2 | Muta. 2 | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | H225 | H341 | H330 | H311 | H301 | H373 ** H335 | H315 | H318 | H400 | GHS02 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H225 | H341 | H330 | H311 | H301 | H373 ** H335 | H315 | H318 | H400 |   |   |  605-009-00-9 | кротоналдехид; 2-бутенал; [1] (E)-2-бутенал; (E)-кротоналдехид [2] | 224-030-0 [1] | 204-647-1 [2] | 4170-30-3 [1] | 123-73-9 [2] | Flam. Liq. 2 | Muta. 2 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | H225 | H341 | H330 | H311 | H301 | H373 ** | H335 | H315 | H318 | H400 | GHS02 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H225 | H341 | H330 | H311 | H301 | H373 ** H335 | H315 | H318 | H400 |   |   |  
605-010-00-4 | 2-furaldehyde | 202-627-7 | 98-01-1 | Carc. 2 | Acute Tox. 3 * Acute Tox. 3 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H351 | H331 | H301 | H312 | H319 | H335 | H315 | GHS06 | GHS08 | Dgr | H351 | H331 | H301 | H312 | H319 | H335 | H315 |   |   |  605-010-00-4 | 2-фуралдехид | 202-627-7 | 98-01-1 | Carc. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H351 | H331 | H301 | H312 | H319 | H335 | H315 | GHS06 | GHS08 | Dgr | H351 | H331 | H301 | H312 | H319 | H335 | H315 |   |   |  
605-011-00-X | 2-chlorobenzaldehyde; o-chlorobenzaldehyde | 201-956-3 | 89-98-5 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   |   |  605-011-00-X | 2-хлоробензалдехид; o-хлоробензалдехид | 201-956-3 | 89-98-5 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   |   |  
605-012-00-5 | benzaldehyde | 202-860-4 | 100-52-7 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  605-012-00-5 | бензалдехид | 202-860-4 | 100-52-7 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
605-014-00-6 | chloral hydrate; 2,2,2-trichloroethane-1,1-diol | 206-117-5 | 302-17-0 | Acute Tox. 3 * Eye Irrit. 2 | Skin Irrit. 2 | H301 | H319 | H315 | GHS06 | Dgr | H301 | H319 | H315 |   |   |  605-014-00-6 | хлоралхидрат; 2,2,2-трихлороетан-1,1-диол | 206-117-5 | 302-17-0 | Acute Tox. 3 * | Eye Irrit. 2 | Skin Irrit. 2 | H301 | H319 | H315 | GHS06 | Dgr | H301 | H319 | H315 |   |   |  
605-015-00-1 | 1,1-diethoxyethane; acetal | 203-310-6 | 105-57-7 | Flam. Liq. 2 | Eye Irrit. 2 | Skin Irrit. 2 | H225 | H319 | H315 | GHS02 | GHS07 | Dgr | H225 | H319 | H315 |   |   |  605-015-00-1 | 1,1-диетоксиетан; ацетал | 203-310-6 | 105-57-7 | Flam. Liq. 2 | Eye Irrit. 2 | Skin Irrit. 2 | H225 | H319 | H315 | GHS02 | GHS07 | Dgr | H225 | H319 | H315 |   |   |  
605-016-00-7 | glyoxal…%; ethandial…% | 203-474-9 | 107-22-2 | Muta. 2 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H341 | H332 | H319 | H315 | H317 | GHS07 | GHS08 | Wng | H341 | H332 | H319 | H315 | H317 |   | * | B605-016-00-7 | глиоксал…%; етандиал…% | 203-474-9 | 107-22-2 | Muta. 2 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H341 | H332 | H319 | H315 | H317 | GHS07 | GHS08 | Wng | H341 | H332 | H319 | H315 | H317 |   | * | B
605-017-00-2 | 1,3-dioxolane | 211-463-5 | 646-06-0 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 |   |   |  605-017-00-2 | 1,3-диоксолан | 211-463-5 | 646-06-0 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 |   |   |  
605-018-00-8 | propanal; propionaldehyde | 204-623-0 | 123-38-6 | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H225 | H319 | H335 | H315 | GHS02 | GHS07 | Dgr | H225 | H319 | H335 | H315 |   |   |  605-018-00-8 | пропанал; пропионалдехид | 204-623-0 | 123-38-6 | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H225 | H319 | H335 | H315 | GHS02 | GHS07 | Dgr | H225 | H319 | H335 | H315 |   |   |  
605-019-00-3 | citral | 226-394-6 | 5392-40-5 | Skin Irrit. 2 | Skin Sens. 1 | H315 | H317 | GHS07 | Wng | H315 | H317 |   |   |  605-019-00-3 | цитрал | 226-394-6 | 5392-40-5 | Skin Irrit. 2 | Skin Sens. 1 | H315 | H317 | GHS07 | Wng | H315 | H317 |   |   |  
605-020-00-9 | safrole; 5-allyl-1,3-benzodioxole | 202-345-4 | 94-59-7 | Carc. 1B Muta. 2 | Acute Tox. 4 * | H350 | H341 | H302 | GHS08 | GHS07 | Dgr | H350 | H341 | H302 |   |   |  605-020-00-9 | сафрол; 5-алил-1,3-бензодиоксол | 202-345-4 | 94-59-7 | Carc. 1B | Muta. 2 | Acute Tox. 4 * | H350 | H341 | H302 | GHS08 | GHS07 | Dgr | H350 | H341 | H302 |   |   |  
605-021-00-4 | formaldehyde, reaction products with butylphenol | 294-145-9 | 91673-30-2 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  605-021-00-4 | формалдехид, реакционни продукти с бутилфенол | 294-145-9 | 91673-30-2 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
605-024-00-0 | 2-bromo-5-hydroxy-4-methoxybenzaldehyde | 426-540-0 | 2973-59-3 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  605-024-00-0 | 2-бромо-4-метокси-5-хидроксибензалдехид | 426-540-0 | 2973-59-3 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
605-025-00-6 | chloroacetaldehyde | 203-472-8 | 107-20-0 | Carc. 2 | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * | Skin Corr. 1B | Aquatic Acute 1 | H351 | H330 | H311 | H301 | H314 | H400 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H351 | H330 | H311 | H301 | H314 | H400 |   | STOT SE 3; H335: C≥ 5 % |  605-025-00-6 | хлороацеталдехид | 203-472-8 | 107-20-0 | Carc. 2 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | Aquatic Acute 1 | H351 | H330 | H311 | H301 | H314 | H400 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H351 | H330 | H311 | H301 | H314 | H400 |   | STOT SE 3; H335: C≥ 5 % |  
605-026-00-1 | 2,5,7,7-tetramethyloctanal | 405-690-0 | 114119-97-0 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H315 | H317 | H411 | GHS07 | GHS09 | Wng | H315 | H317 | H411 |   |   |  605-026-00-1 | 2,5,7,7-тeтраметилоктанал | 405-690-0 | 114119-97-0 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H315 | H317 | H411 | GHS07 | GHS09 | Wng | H315 | H317 | H411 |   |   |  
605-027-00-7 | reaction mass of: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-6-carboxaldehyde; 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-5-carboxaldehyde | 410-480-7 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  605-027-00-7 | реакционна маса от: 3a,4,5,6,7,7a-хексахидро-4,7-метано-1H-инден-6-карбоксалдехид; 3a,4,5,6,7,7a-хексахидро-4,7-метано-1H-инден-5-карбоксалдехид | 410-480-7 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
605-028-00-2 | β-methyl-3-(1-methylethyl)-benzenepropanal | 412-050-4 | 125109-85-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  605-028-00-2 | β-метил-3-(1-метилетил)бензенпропанал | 412-050-4 | 125109-85-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
605-029-00-8 | 2-cyclohexylpropanal | 412-270-0 | 2109-22-0 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  605-029-00-8 | 2-циклохексилпропанал | 412-270-0 | 2109-22-0 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
605-030-00-3 | 1-(p-methoxyphenyl)acetaldehyde oxime | 411-510-1 | 3353-51-3 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  605-030-00-3 | 1-(p-мeтоксифенил)aцеталдехидоксим | 411-510-1 | 3353-51-3 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
605-031-00-9 | reaction mass of: 2,2-dimethoxyethanal [this component is considered to be anhydrous in terms of identity, structure and composition. However, 2,2-dimethoxyethanal will exist in a hydrated form. 60 % anhydrous is equivalent to 70,4 % hydrate; water (Including free water and water in hydrated 2,2-dimethoxyethanal)] | 421-890-0 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  605-031-00-9 | реакционна маса от: 2,2-диметоксиетaнал [този компонент се приема за безводен от гледна точка на идентичност, структура и състав. Независимо от това, 2,2-диметоксиетaналът съществува в хидратна форма. 60 % от безводната форма е еквивалентна на 70,4 % хидратна форма; вода (включително вода в свободна форма и вода в хидратна форма в 2,2-диметоксиетaнала)] | 421-890-0 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
605-032-00-4 | 3-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-(E)-2-propenal | 425-370-4 | 93957-50-7 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  605-032-00-4 | 3-[1-(1-метилетил)-3-(4-флуорофенил)-1H-индол-2-ил]-(E)-2-пропенал | 425-370-4 | 93957-50-7 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
605-033-00-X | Reaction mass of: 3,7,11-trimethyl-cis-6,10-dodecadienal; 3,7,11-trimethyl-trans-6,10-dodecadienal | 425-910-9 | 32480-08-3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H410 |   |   |  605-033-00-X | реакционна маса от: 3,7,11-триметил-цис-6,10-додекадиенал; 3,7,11-триметил-транс-6,10-додекадиенал | 425-910-9 | 32480-08-3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H410 |   |   |  
605-034-00-5 | reaction mass of: (1RS, 2RS,3SR, 6RS, 9SR)-9-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde; (1RS, 2RS, 3RS, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde; (1RS, 2RS, 4SR, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde | 429-860-9 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  605-034-00-5 | реакционна маса от: (1RS,2RS,3SR,6RS,9SR)-9-метокситрицикло[5.2.1.0(2,6)]декан-3-карбалдехид; (1RS,2RS,3SR,6RS,8SR)-8-метокситрицикло[5.2.1.0(2,6)]декан-3-карбалдехид; (1RS,2RS,4SR,6RS,8SR)-8-метокситрицикло[5.2.1.0(2,6)]декан-4-карбалдехид | 429-860-9 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
605-035-00-0 | (E)-3-(4-(4-fluorophenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridin-3-yl)prop-2-enal | 426-330-9 | 177964-68-0 | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 4 | H319 | H317 | H413 | GHS07 | Wng | H319 | H317 | H413 |   |   |  605-035-00-0 | (E)-3-(5-метоксиметил-2,6-бис(1-метоксиметил)-4-(4-флуорофенил)пиридин-3-ил)проп-2-енал | 426-330-9 | 177964-68-0 | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 4 | H319 | H317 | H413 | GHS07 | Wng | H319 | H317 | H413 |   |   |  
605-036-00-6 | 2-bromomalonaldehyde | 430-470-6 | 2065-75-0 | Acute Tox. 4 * | Eye Dam. 1 | H302 | H318 | GHS05 | GHS07 | Dgr | H302 | H318 |   |   |  605-036-00-6 | 2-бромомалоналдехид | 430-470-6 | 2065-75-0 | Acute Tox. 4 * | Eye Dam. 1 | H302 | H318 | GHS05 | GHS07 | Dgr | H302 | H318 |   |   |  
605-037-00-1 | trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde; 3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde | 421-800-1 | 120578-03-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  605-037-00-1 | транс-3-[2-(7-хлоро-2-хинолинил)винил]бензалдехид; 3-[(E)-2-(7-хлоро-2-хинолинил)винил]бензалдехид | 421-800-1 | 120578-03-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
605-038-00-7 | 3-methyl-5-phenylpentan-1-al | 433-900-0 | 55066-49-4 | Acute Tox. 4 * | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H315 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H315 | H317 | H411 |   |   |  605-038-00-7 | 3-метил-5-фенилпентан-1-ал | 433-900-0 | 55066-49-4 | Acute Tox. 4 * | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H315 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H315 | H317 | H411 |   |   |  
605-039-00-2 | 3,4-dihydroxy-5-nitrobenzaldehyde | 441-810-8 | 116313-85-0 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | H302 | H318 | H317 | GHS05 | GHS07 | Dgr | H302 | H318 | H317 |   |   |  605-039-00-2 | 5-нитро-3,4-дихидроксибензалдехид | 441-810-8 | 116313-85-0 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | H302 | H318 | H317 | GHS05 | GHS07 | Dgr | H302 | H318 | H317 |   |   |  
606-001-00-8 | acetone; propan-2-one; propanone | 200-662-2 | 67-64-1 | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | H225 | H319 | H336 | GHS02 | GHS07 | Dgr | H225 | H319 | H336 | EUH066 |   |  606-001-00-8 | ацетон; пропан-2-он; пропанон | 200-662-2 | 67-64-1 | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | H225 | H319 | H336 | GHS02 | GHS07 | Dgr | H225 | H319 | H336 | EUH066 |   |  
606-002-00-3 | butanone; ethyl methyl ketone | 201-159-0 | 78-93-3 | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | H225 | H319 | H336 | GHS02 | GHS07 | Dgr | H225 | H319 | H336 | EUH066 |   |  606-002-00-3 | бутанон; етилметилкетон | 201-159-0 | 78-93-3 | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | H225 | H319 | H336 | GHS02 | GHS07 | Dgr | H225 | H319 | H336 | EUH066 |   |  
606-003-00-9 | heptan-3-one; butyl ethyl ketone | 203-388-1 | 106-35-4 | Flam. Liq. 3 | Acute Tox. 4 * | Eye Irrit. 2 | H226 | H332 | H319 | GHS02 | GHS07 | Wng | H226 | H332 | H319 |   |   |  606-003-00-9 | хептан-3-он; бутилетилкетон | 203-388-1 | 106-35-4 | Flam. Liq. 3 | Acute Tox. 4 * | Eye Irrit. 2 | H226 | H332 | H319 | GHS02 | GHS07 | Wng | H226 | H332 | H319 |   |   |  
606-004-00-4 | 4-methylpentan-2-one; isobutyl methyl ketone | 203-550-1 | 108-10-1 | Flam. Liq. 2 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | H225 | H332 | H319 | H335 | GHS02 | GHS07 | Dgr | H225 | H332 | H319 | H335 | EUH066 |   |  606-004-00-4 | 4-мeтилпентан-2-oн; изобутилметилкетон | 203-550-1 | 108-10-1 | Flam. Liq. 2 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | H225 | H332 | H319 | H335 | GHS02 | GHS07 | Dgr | H225 | H332 | H319 | H335 | EUH066 |   |  
606-005-00-X | 2,6-dimethylheptan-4-one; di-isobutyl ketone | 203-620-1 | 108-83-8 | Flam. Liq. 3 | STOT SE 3 | H226 | H335 | GHS02 | GHS07 | Wng | H226 | H335 |   | STOT SE 3; H335: C ≥ 10 % |  606-005-00-X | 2,6-диметилхептан-4-oн; диизобутилкетон | 203-620-1 | 108-83-8 | Flam. Liq. 3 | STOT SE 3 | H226 | H335 | GHS02 | GHS07 | Wng | H226 | H335 |   | STOT SE 3; H335: C ≥ 10 % |  
606-006-00-5 | pentan-3-one; diethyl ketone | 202-490-3 | 96-22-0 | Flam. Liq. 2 | STOT SE 3 | STOT SE 3 | H225 | H335 | H336 | GHS02 | GHS07 | Dgr | H225 | H335 | H336 | EUH066 |   |  606-006-00-5 | пентан-3-он; диетилкетон | 202-490-3 | 96-22-0 | Flam. Liq. 2 | STOT SE 3 | STOT SE 3 | H225 | H335 | H336 | GHS02 | GHS07 | Dgr | H225 | H335 | H336 | EUH066 |   |  
606-007-00-0 | 3-methylbutan-2-one; methyl isopropyl ketone | 209-264-3 | 563-80-4 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 |   |   |  606-007-00-0 | 3-мeтилбутан-2-он; изопропилмeтилкетон | 209-264-3 | 563-80-4 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 |   |   |  
606-009-00-1 | 4-methylpent-3-en-2-one; mesityl oxide | 205-502-5 | 141-79-7 | Flam. Liq. 3 | Acute Tox. 4 * Acute Tox. 4 * | Acute Tox. 4 * | H226 | H332 | H312 | H302 | GHS02 | GHS07 | Wng | H226 | H332 | H312 | H302 |   | * |  606-009-00-1 | 4-метилпент-3-ен-2-он; мeзитилоксид | 205-502-5 | 141-79-7 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H226 | H332 | H312 | H302 | GHS02 | GHS07 | Wng | H226 | H332 | H312 | H302 |   | * |  
606-010-00-7 | cyclohexanone | 203-631-1 | 108-94-1 | Flam. Liq. 3 | Acute Tox. 4 * | H226 | H332 | GHS02 | GHS07 | Wng | H226 | H332 |   |   |  606-010-00-7 | циклохексанон | 203-631-1 | 108-94-1 | Flam. Liq. 3 | Acute Tox. 4 * | H226 | H332 | GHS02 | GHS07 | Wng | H226 | H332 |   |   |  
606-011-00-2 | 2-methylcyclohexanone | 209-513-6 | 583-60-8 | Flam. Liq. 3 | Acute Tox. 4 * | H226 | H332 | GHS02 | GHS07 | Wng | H226 | H332 |   |   |  606-011-00-2 | 2-метилциклохексанон | 209-513-6 | 583-60-8 | Flam. Liq. 3 | Acute Tox. 4 * | H226 | H332 | GHS02 | GHS07 | Wng | H226 | H332 |   |   |  
606-012-00-8 | 3,5,5-trimethylcyclohex-2-enone; isophorone | 201-126-0 | 78-59-1 | Carc. 2 | Acute Tox. 4 * Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | H351 | H312 | H302 | H319 | H335 | GHS08 | GHS07 | Wng | H351 | H312 | H302 | H319 | H335 |   | STOT SE 3; H335: C ≥10 % |  606-012-00-8 | 3,5,5-триметилциклохекс-2-eнон; изофорон | 201-126-0 | 78-59-1 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | H351 | H312 | H302 | H319 | H335 | GHS08 | GHS07 | Wng | H351 | H312 | H302 | H319 | H335 |   | STOT SE 3; H335: C ≥10 % |  
606-013-00-3 | p-benzoquinone; quinone | 203-405-2 | 106-51-4 | Acute Tox. 3 * Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | H331 | H301 | H319 | H335 | H315 | H400 | GHS06 | GHS09 | Dgr | H331 | H301 | H319 | H335 | H315 | H400 |   | M=10 |  606-013-00-3 | p-бензохинон; хинон | 203-405-2 | 106-51-4 | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | H331 | H301 | H319 | H335 | H315 | H400 | GHS06 | GHS09 | Dgr | H331 | H301 | H319 | H335 | H315 | H400 |   | M=10 |  
606-016-00-X | pindone (ISO); 2-pivaloylindan-1,3-dione | 201-462-8 | 83-26-1 | Acute Tox. 3 * STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H372 ** H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H372 ** H410 |   |   |  606-016-00-X | пиндон (ISO); 2-пивалоилиндан-1,3-дион | 201-462-8 | 83-26-1 | Acute Tox. 3 * | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H372 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H372 ** H410 |   |   |  
606-017-00-5 | diketene; diketen | 211-617-1 | 674-82-8 | Flam. Liq. 3 | Acute Tox. 4 * | H226 | H332 | GHS02 | GHS07 | Wng | H226 | H332 |   |   | D606-017-00-5 | дикетен; дикетен | 211-617-1 | 674-82-8 | Flam. Liq. 3 | Acute Tox. 4 * | H226 | H332 | GHS02 | GHS07 | Wng | H226 | H332 |   |   | D
606-018-00-0 | dichlone (ISO); 2,3-dichloro-1,4-naphthoquinone | 204-210-5 | 117-80-6 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H315 | H410 |   |   |  606-018-00-0 | дихлон (ISO); 1,4-нафто-2,3-дихлорохинон | 204-210-5 | 117-80-6 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H315 | H410 |   |   |  
606-019-00-6 | chlordecone (ISO); perchloropentacyclo[5,3,0,02,6,03,9,0 4,8]decan-5-one; decachloropentacyclo[5,2,1,02,6,03,9,05,8]decan-4-one | 205-601-3 | 143-50-0 | Carc. 2 | Acute Tox. 3 * Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H311 | H301 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H311 | H301 | H410 |   |   |  606-019-00-6 | хлордекон (ISO); перхлоропентацикло[5.3.0.02,6.03,9.0 4,8]декан-5-он; декахлоропентацикло[5.2.1.02,6.03,9.05,8]декан-4-oн | 205-601-3 | 143-50-0 | Carc. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H311 | H301 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H311 | H301 | H410 |   |   |  
606-020-00-1 | 5-methylheptan-3-one | 208-793-7 | 541-85-5 | Flam. Liq. 3 | Eye Irrit. 2 | STOT SE 3 | H226 | H319 | H335 | GHS02 | GHS07 | Wng | H226 | H319 | H335 |   | STOT SE 3; H335: C≥10 % |  606-020-00-1 | 5-метилхептан-3-он | 208-793-7 | 541-85-5 | Flam. Liq. 3 | Eye Irrit. 2 | STOT SE 3 | H226 | H319 | H335 | GHS02 | GHS07 | Wng | H226 | H319 | H335 |   | STOT SE 3; H335: C≥10 % |  
606-022-00-2 | 1-phenyl-3-pyrazolidone | 202-155-1 | 92-43-3 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  606-022-00-2 | 1-фенил-3-пиразолидон | 202-155-1 | 92-43-3 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
606-023-00-8 | 4-methoxy-4-methylpentan-2-one | 203-512-4 | 107-70-0 | Flam. Liq. 3 | Acute Tox. 4 * | H226 | H332 | GHS02 | GHS07 | Wng | H226 | H332 |   |   |  606-023-00-8 | 4-метил-4-мeтоксипентан-2-oн | 203-512-4 | 107-70-0 | Flam. Liq. 3 | Acute Tox. 4 * | H226 | H332 | GHS02 | GHS07 | Wng | H226 | H332 |   |   |  
606-024-00-3 | heptan-2-one; methyl amyl ketone | 203-767-1 | 110-43-0 | Flam. Liq. 3 | Acute Tox. 4 * Acute Tox. 4 * | H226 | H332 | H302 | GHS02 | GHS07 | Wng | H226 | H332 | H302 |   |   |  606-024-00-3 | хептан-2-oн; амилметилкетон | 203-767-1 | 110-43-0 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | H226 | H332 | H302 | GHS02 | GHS07 | Wng | H226 | H332 | H302 |   |   |  
606-025-00-9 | cyclopentanone | 204-435-9 | 120-92-3 | Flam. Liq. 3 | Eye Irrit. 2 | Skin Irrit. 2 | H226 | H319 | H315 | GHS02 | GHS07 | Wng | H226 | H319 | H315 |   |   |  606-025-00-9 | циклопентанон | 204-435-9 | 120-92-3 | Flam. Liq. 3 | Eye Irrit. 2 | Skin Irrit. 2 | H226 | H319 | H315 | GHS02 | GHS07 | Wng | H226 | H319 | H315 |   |   |  
606-026-00-4 | 5-methylhexan-2-one; isoamyl methyl ketone | 203-737-8 | 110-12-3 | Flam. Liq. 3 | Acute Tox. 4 * | H226 | H332 | GHS02 | GHS07 | Wng | H226 | H332 |   |   |  606-026-00-4 | 5-мeтилхексан-2-oн; изоамилметилкетон | 203-737-8 | 110-12-3 | Flam. Liq. 3 | Acute Tox. 4 * | H226 | H332 | GHS02 | GHS07 | Wng | H226 | H332 |   |   |  
606-027-00-X | heptan-4-one; di-n-propyl ketone | 204-608-9 | 123-19-3 | Flam. Liq. 3 | Acute Tox. 4 * | H226 | H332 | GHS02 | GHS07 | Wng | H226 | H332 |   |   |  606-027-00-X | хептан-4-oн; ди-n-пропилкетон | 204-608-9 | 123-19-3 | Flam. Liq. 3 | Acute Tox. 4 * | H226 | H332 | GHS02 | GHS07 | Wng | H226 | H332 |   |   |  
606-028-00-5 | 2,4-dimethylpentan-3-one; di-isopropyl ketone | 209-294-7 | 565-80-0 | Flam. Liq. 2 | Acute Tox. 4 * | H225 | H332 | GHS02 | GHS07 | Dgr | H225 | H332 |   |   |  606-028-00-5 | 2,4-диметилпентан-3-oн; диизопропилкетон | 209-294-7 | 565-80-0 | Flam. Liq. 2 | Acute Tox. 4 * | H225 | H332 | GHS02 | GHS07 | Dgr | H225 | H332 |   |   |  
606-029-00-0 | pentane-2,4-dione; acetylacetone | 204-634-0 | 123-54-6 | Flam. Liq. 3 | Acute Tox. 4 * | H226 | H302 | GHS02 | GHS07 | Wng | H226 | H302 |   |   |  606-029-00-0 | пентан-2,4-дион; ацетилацетон | 204-634-0 | 123-54-6 | Flam. Liq. 3 | Acute Tox. 4 * | H226 | H302 | GHS02 | GHS07 | Wng | H226 | H302 |   |   |  
606-030-00-6 | hexan-2-one; methyl butyl ketone; butyl methyl ketone; methyl-n-butyl ketone | 209-731-1 | 591-78-6 | Flam. Liq. 3 | Repr. 2 | STOT RE 1 | STOT SE 3 | H226 | H361f *** H372 ** H336 | GHS02 | GHS08 | GHS07 | Dgr | H226 | H361f *** H372 ** H336 |   |   |  606-030-00-6 | хексан-2-он; бутилметилкетон; бутилметилкетон; n-бутилметилкетон; | 209-731-1 | 591-78-6 | Flam. Liq. 3 | Repr. 2 | STOT RE 1 | STOT SE 3 | H226 | H361f *** | H372 ** | H336 | GHS02 | GHS08 | GHS07 | Dgr | H226 | H361f *** H372 ** H336 |   |   |  
606-031-00-1 | 3-propanolide;1,3-propiolactone | 200-340-1 | 57-57-8 | Carc. 1B | Acute Tox. 2 * | Eye Irrit. 2 | Skin Irrit. 2 | H350 | H330 | H319 | H315 | GHS06 | GHS08 | Dgr | H350 | H330 | H319 | H315 |   |   |  606-031-00-1 | 3-пропанолид;1,3-пропиолактон | 200-340-1 | 57-57-8 | Carc. 1B | Acute Tox. 2 * | Eye Irrit. 2 | Skin Irrit. 2 | H350 | H330 | H319 | H315 | GHS06 | GHS08 | Dgr | H350 | H330 | H319 | H315 |   |   |  
606-032-00-7 | hexachloroacetone | 204-129-5 | 116-16-5 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  606-032-00-7 | хексахлороацетон | 204-129-5 | 116-16-5 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
606-033-00-2 | 2-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidinedione; methazole | 243-761-6 | 20354-26-1 | Acute Tox. 4 * Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 2 | H312 | H302 | H319 | H315 | H411 | GHS07 | GHS09 | Wng | H312 | H302 | H319 | H315 | H411 |   |   |  606-033-00-2 | 2-(3,4-дихлорофенил)-4-метил-1,2,4-оксадиазолидиндион; метазол | 243-761-6 | 20354-26-1 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 2 | H312 | H302 | H319 | H315 | H411 | GHS07 | GHS09 | Wng | H312 | H302 | H319 | H315 | H411 |   |   |  
606-034-00-8 | metribuzin (ISO); 4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one; 4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one | 244-209-7 | 21087-64-9 | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   | M=10 |  606-034-00-8 | метрибузин (ISO); 4-амино-6-трет-бутил-3-метилтио-1,2,4-триазин-5(4H)-он; 4-амино-6-(1,1-диметилетил)-3-метилтио-4,5-дихидро-1,2,4-триазин-5-он | 244-209-7 | 21087-64-9 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   | M=10 |  
606-035-00-3 | chloridazon (ISO); 5-amino-4-chloro-2-phenylpyridazine-3-(2H)-one; pyrazon | 216-920-2 | 1698-60-8 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  606-035-00-3 | хлоридазон (ISO); 5-амино-2-фенил-4-хлоропиридазин-3-(2H)-oн; пиразон | 216-920-2 | 1698-60-8 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
606-036-00-9 | quinomethionate; chinomethionat (ISO); 6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one | 219-455-3 | 2439-01-2 | Repr. 2 | Acute Tox. 4 * Acute Tox. 4 * | Acute Tox. 4 * STOT RE 2 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361f *** H332 | H312 | H302 | H373 ** H319 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H361f *** H332 | H312 | H302 | H373 ** H319 | H317 | H410 |   |   |  606-036-00-9 | хинометионат; хинометионат (ISO); 6-мeтил-1,3-дитиоло[4,5-b]хиноксалин-2-oн | 219-455-3 | 2439-01-2 | Repr. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361f *** | H332 | H312 | H302 | H373 ** | H319 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H361f *** H332 | H312 | H302 | H373 ** H319 | H317 | H410 |   |   |  
606-037-00-4 | triadimefon (ISO); 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanone | 256-103-8 | 43121-43-3 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  606-037-00-4 | триадимефон (ISO); 3,3-диметил-1-(1,2,4-триазол-1-ил)-1-(4-хлорофенокси)бутанон | 256-103-8 | 43121-43-3 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  
606-038-00-X | diphacinone (ISO); 2-diphenylacetylindan-1,3-dione | 201-434-5 | 82-66-6 | Acute Tox. 2 * STOT RE 1 | H300 | H372 ** | GHS06 | GHS08 | Dgr | H300 | H372 ** |   |   |  606-038-00-X | дифацинон (ISO); 2-дифенилацетилиндан-1,3-дион | 201-434-5 | 82-66-6 | Acute Tox. 2 * | STOT RE 1 | H300 | H372 ** | GHS06 | GHS08 | Dgr | H300 | H372 ** |   |   |  
606-039-00-5 | 5(or 6)-tert-butyl-2'-chloro-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthene)-3-one | 400-680-2 | — | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H410 |   |   |  606-039-00-5 | 5(или 6)-трет-бутил-6′-eтиламино-3′,7′-диметил-2′-хлороспиро(изобензофуран-1(1H),9′-ксантен)-3-oн | 400-680-2 | — | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H410 |   |   |  
606-040-00-0 | (N-benzyl-N-ethyl)amino-3-hydroxyacetophenone hydrochloride | 401-840-4 | 55845-90-4 | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  606-040-00-0 | (N-бензил-N-eтил)амино-3-хидроксиацетофенонхидрохлорид | 401-840-4 | 55845-90-4 | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  
606-042-00-1 | acetophenone | 202-708-7 | 98-86-2 | Acute Tox. 4 * | Eye Irrit. 2 | H302 | H319 | GHS07 | Wng | H302 | H319 |   |   |  606-042-00-1 | ацетофенон | 202-708-7 | 98-86-2 | Acute Tox. 4 * | Eye Irrit. 2 | H302 | H319 | GHS07 | Wng | H302 | H319 |   |   |  
606-043-00-7 | 2,4-di-tert-butylcyclohexanone | 405-340-7 | 13019-04-0 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  606-043-00-7 | 2,4-ди-трет-бутилциклохексанон | 405-340-7 | 13019-04-0 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
606-044-00-2 | 2,4,6-trimethylbenzophenone | 403-150-9 | 954-16-5 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H410 |   |   |  606-044-00-2 | 2,4,6-триметилбензофенон | 403-150-9 | 954-16-5 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H410 |   |   |  
606-045-00-8 | oxadiazon (ISO); 3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one | 243-215-7 | 19666-30-9 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  606-045-00-8 | оксадиазон (ISO); 5-(1,1-диметилетил)-3-[5-(1-метилетокси)-2,4-дихлорофенил)]-1,3,4-oксадиазол-2(3H)-oн | 243-215-7 | 19666-30-9 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
606-046-00-3 | reaction mass of cis-and trans-cyclohexadec-8-en-1-one | 401-700-2 | 3100-36-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  606-046-00-3 | реакционна маса от цис- и транс-циклохексадец-8-eн-1-oн | 401-700-2 | 3100-36-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
606-047-00-9 | 2-benzyl-2-dimethylamino-4-morpholinobutyrophenone | 404-360-3 | 119313-12-1 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  606-047-00-9 | 2-бензил-2-диметиламино-4-морфолинобутирофенон | 404-360-3 | 119313-12-1 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
606-048-00-4 | 2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one | 406-480-1 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  606-048-00-4 | 2′-анилино-3′-метил-6′-дипентиламиноспиро(изобензофуран-1(1H),9′-ксантен)-3-он | 406-480-1 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
606-049-00-X | 4-(trans-4-propylcyclohexyl)acetophenone | 406-700-6 | 78531-61-0 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  606-049-00-X | 4-(транс-4-пропилциклохексил)aцетофенон | 406-700-6 | 78531-61-0 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
606-050-00-5 | 6-anilino-1-benzoyl-4-(4-tert-pentylphenoxy)naphto[1,2,3-de]quinoline-2,7-(3H)-dione | 412-480-2 | 72453-58-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  606-050-00-5 | 6-анилино-1-бензоил-4-(4-трет-пентилфенокси)нафто[1,2,3-de]хинолин-2,7-(3H)-дион | 412-480-2 | 72453-58-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
606-051-00-0 | 4-pentylcyclohexanone | 406-670-4 | 61203-83-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  606-051-00-0 | 4-пентилциклохексанон | 406-670-4 | 61203-83-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
606-052-00-6 | 4-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzophenone | 410-410-5 | 54574-82-2 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  606-052-00-6 | 4-(N,N-дибутиламино)-2-хидрокси-2′-карбоксибензофенон | 410-410-5 | 54574-82-2 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
606-053-00-1 | flurtamone (ISO); (RS)-5-methylamino-2-phenyl-4-(α, α,α-trifluoro-m-tolyl)furan-3(2H)-one | — | 96525-23-4 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  606-053-00-1 | флуртамон (ISO); (RS)-5-мeтиламино-4-(α, α,α-трифлуоро-m-толил)-2-фенилфуран-3(2H)-oн | — | 96525-23-4 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
606-055-00-2 | 1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone | 411-180-9 | 92836-10-7 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 2 | H302 | H373 ** H411 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373 ** H411 |   |   |  606-055-00-2 | 1-(1,3,3,6-тетраметил-1-(1-метилетил)-2,3-дихидро-1H-инден-5-ил)етанон | 411-180-9 | 92836-10-7 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 2 | H302 | H373 ** | H411 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373 ** H411 |   |   |  
606-056-00-8 | 4-chloro-3',4'-dimethoxybenzophenone | 404-610-1 | 116412-83-0 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  606-056-00-8 | 3′,4′-диметокси-4-хлоробензофенон | 404-610-1 | 116412-83-0 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
606-057-00-3 | 4-propylcyclohexanone | 406-810-4 | 40649-36-3 | Skin Irrit. 2 | Aquatic Chronic 3 | H315 | H412 | GHS07 | Wng | H315 | H412 |   |   |  606-057-00-3 | 4-пропилциклохексанон | 406-810-4 | 40649-36-3 | Skin Irrit. 2 | Aquatic Chronic 3 | H315 | H412 | GHS07 | Wng | H315 | H412 |   |   |  
606-058-00-9 | 4'-fluoro-2,2-dimethoxyacetophenone | 407-500-1 | 21983-80-2 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  606-058-00-9 | 2,2-диметокси-4′-флуороацетофенон | 407-500-1 | 21983-80-2 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
606-059-00-4 | 2,4-difluoro-α-(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride | 412-390-3 | 86386-75-6 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | H302 | H318 | H317 | GHS05 | GHS07 | Dgr | H302 | H318 | H317 |   |   |  606-059-00-4 | α-(1Н-1,2,4-триазол-1-ил)-2,4-дифлуороацетофенонхидрохлорид | 412-390-3 | 86386-75-6 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | H302 | H318 | H317 | GHS05 | GHS07 | Dgr | H302 | H318 | H317 |   |   |  
606-060-00-X | Reaction mass of: trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane; cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane | 412-950-7 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  606-060-00-X | реакционна маса от: транс-2,4-диметил-2-(5,5,8,8-тетраметил-5,6,7,8-тетрахидронафтален-2-ил)-1,3-диоксолан; цис-2,4-диметил-2-(5,5,8,8-тетраметил-5,6,7,8-тетрахидронафтален-2-ил)-1,3-диоксолан | 412-950-7 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
606-061-00-5 | (3-chlorophenyl)-(4-methoxy-3-nitrophenyl)methanone | 423-290-4 | 66938-41-8 | Muta. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H400 | H410 | GHS08 | GHS09 | Wng | H341 | H410 |   |   |  606-061-00-5 | (3-хлорофенил)(4-метокси-3-нитрофенил)метанон | 423-290-4 | 66938-41-8 | Muta. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H400 | H410 | GHS08 | GHS09 | Wng | H341 | H410 |   |   |  
606-062-00-0 | tetrahydrothiopyran-3-carboxaldehyde | 407-330-8 | 61571-06-0 | Repr. 1B | Eye Dam. 1 | Aquatic Chronic 3 | H360D *** H318 | H412 | GHS08 | GHS05 | Dgr | H360D *** H318 | H412 |   |   |  606-062-00-0 | тетрахидротиопиран-3-карбоксалдехид | 407-330-8 | 61571-06-0 | Repr. 1B | Eye Dam. 1 | Aquatic Chronic 3 | H360D *** H318 | H412 | GHS08 | GHS05 | Dgr | H360D *** H318 | H412 |   |   |  
606-063-00-6 | (E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal | 410-980-5 | 112704-51-5 | Eye Irrit. 2 | Skin Sens. 1 | H319 | H317 | GHS07 | Wng | H319 | H317 |   |   |  606-063-00-6 | (E)-2-(4-флуорофенил)-3-(2-хлорофенил)пропенал | 410-980-5 | 112704-51-5 | Eye Irrit. 2 | Skin Sens. 1 | H319 | H317 | GHS07 | Wng | H319 | H317 |   |   |  
606-064-00-1 | pregn-5-ene-3,20-dione bis(ethylene ketal) | 407-450-0 | 7093-55-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  606-064-00-1 | прегн-5-ен-3,20-диoнбис(етиленкетал) | 407-450-0 | 7093-55-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
606-065-00-7 | 1-(4-morpholinophenyl)butan-1-one | 413-790-0 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  606-065-00-7 | 1-(4-морфолинофенил)бутан-1-он | 413-790-0 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
606-066-00-2 | (E)-5[(4-chlorophenyl)methylene]-2,2-dimethylcyclopentanone | 410-440-9 | 164058-20-2 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  606-066-00-2 | (E)-5[(4-хлорофенил)метилен]-2,2-диметилциклопентанон | 410-440-9 | 164058-20-2 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
606-067-00-8 | reaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone; 1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone; 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone; 1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz(g)inden-5-yl)ethanone | 414-870-8 | 96792-67-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  606-067-00-8 | реакционна маса от: 1-(1,1-диметил-2,3,6,7,8,9-хексахидро-1H-бенз[g]инден-4-ил)етaнон; 1-(1,1-диметил-2,3,5,6,7,8-хексахидро-1H-бенз[f]инден-4-ил)етaнон; 1-(1,1-диметил-2,3,6,7,8,9-хексахидро-1H-бенз[g]инден-5-ил)етaнон; 1-(3,3-диметил-2,3,6,7,8,9-хексахидро-1H-бенз[g]инден-5-ил)етaнон; | 414-870-8 | 96792-67-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
606-068-00-3 | 2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al | 415-770-7 | 1638-05-7 | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 3 | H373 ** H317 | H412 | GHS08 | GHS07 | Wng | H373 ** H317 | H412 |   |   |  606-068-00-3 | 2,7,11-триметил-13-(2,6,6-триметилциклохекс-1-ен-1-ил)тридекахексаен-2,4,6,8,10,12-aл | 415-770-7 | 1638-05-7 | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 3 | H373 ** | H317 | H412 | GHS08 | GHS07 | Wng | H373 ** H317 | H412 |   |   |  
606-069-00-9 | spiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaphthalene)] | 415-460-1 | 154171-76-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  606-069-00-9 | спиро[1,3-диоксолан-2,5′-(4′,4′,8′,8′-тетраметилхексахидро-3′,9′-метанонафтален)] | 415-460-1 | 154171-76-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
606-070-00-4 | butroxydim (ISO); 5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one | 414-790-3 | 138164-12-2 | Repr. 2 | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H361fd | H302 | H315 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H361fd | H302 | H315 | H410 |   |   |  606-070-00-4 | бутроксидим (ISO); 5-(3-бутирил-2,4,6-триметилфенил)-2-[1-(етоксиимино)пропил]-3-хидроксициклохекс-2-ен-1-он | 414-790-3 | 138164-12-2 | Repr. 2 | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H361fd | H302 | H315 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H361fd | H302 | H315 | H410 |   |   |  
606-071-00-X | 17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-diene-3-one | 421-050-3 | 13258-43-0 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  606-071-00-X | 17-спиро(5,5-диметил-1,3-диoксaн-2-ил)андроста-1,4-диен-3-он | 421-050-3 | 13258-43-0 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
606-072-00-5 | 3-acetyl-1-phenyl-pyrrolidine-2,4-dione | 421-600-2 | 719-86-8 | STOT RE 2 * | Aquatic Chronic 2 | H373 ** H411 | GHS08 | GHS09 | Wng | H373 ** H411 |   |   |  606-072-00-5 | 3-ацетил-1-фенилпиролидин-2,4-дион | 421-600-2 | 719-86-8 | STOT RE 2 * | Aquatic Chronic 2 | H373 ** | H411 | GHS08 | GHS09 | Wng | H373 ** H411 |   |   |  
606-073-00-0 | 4,4'-bis(dimethylamino)benzophenone; Michler's ketone | 202-027-5 | 90-94-8 | Carc. 1B Muta. 2 | Eye Dam. 1 | H350 | H341 | H318 | GHS08 | GHS05 | Dgr | H350 | H341 | H318 |   |   |  606-073-00-0 | 4,4′-бис(диметиламино)бензoфенон; михлеров кетон | 202-027-5 | 90-94-8 | Carc. 1B | Muta. 2 | Eye Dam. 1 | H350 | H341 | H318 | GHS08 | GHS05 | Dgr | H350 | H341 | H318 |   |   |  
606-074-00-6 | reaction mass of: (1R*, 2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalene; (2R*,3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene | 425-570-1 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  606-074-00-6 | реакционна маса от: (1R*,2S*)-2-ацетил-1,2,8,8-тетраметил-1,2,3,4,5,6,7,8-октахидронафтален; (2R*,3S*)-2-ацетил-2,3,8,8-тетраметил-1,2,3,4,5,6,7,8-октахидронафтален | 425-570-1 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
606-075-00-1 | 1-benzyl-5-ethoxyimidazolidine-2,4-dione | 417-340-4 | 65855-02-9 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  606-075-00-1 | 1-бензил-5-етоксиимидазолидин-2,4-диoн | 417-340-4 | 65855-02-9 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
606-076-00-7 | 1-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidinedione | 418-630-3 | 136465-99-1 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  606-076-00-7 | 1-((2-хинолинилкарбонил)окси)-2,5-пиролидиндион | 418-630-3 | 136465-99-1 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
606-077-00-2 | (3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone | 418-650-2 | 104872-06-2 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  606-077-00-2 | (3S,4S)-3-хексил-4-[(R)-2-хидрокситридецил]-2-оксетанон | 418-650-2 | 104872-06-2 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
606-078-00-8 | 1-octylazepin-2-one | 420-040-6 | 59227-88-2 | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H314 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H317 | H411 |   |   |  606-078-00-8 | 1-октилазепин-2-он | 420-040-6 | 59227-88-2 | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H314 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H317 | H411 |   |   |  
606-079-00-3 | 2-n-butyl-benzo[d]isothiazol-3-one | 420-590-7 | 4299-07-4 | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H317 | H410 |   |   |  606-079-00-3 | 2-n-бутилбензо[d]изотиазол-3-он | 420-590-7 | 4299-07-4 | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H317 | H410 |   |   |  
606-081-00-4 | (3β, 5α, 6β)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one | 419-790-7 | 4229-69-0 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  606-081-00-4 | (3β,5α,6β)-3-(ацетилокси)-5-бромо-6-хидроксиандростан-17-он | 419-790-7 | 4229-69-0 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
606-082-00-X | reaction mass of: butan-2-one oxime; syn-O,O'-di(butan-2-one oxime)diethoxysilane | 406-930-7 |   | STOT RE 1 | Skin Sens. 1 | Aquatic Chronic 3 | H372 ** H317 | H412 | GHS08 | GHS07 | Dgr | H372 ** H317 | H412 |   |   |  606-082-00-X | реакционна маса от: бутан-2-оноксим; син-O,O′-ди(бутан-2-оноксим)диетоксисилан | 406-930-7 |   | STOT RE 1 | Skin Sens. 1 | Aquatic Chronic 3 | H372 ** | H317 | H412 | GHS08 | GHS07 | Dgr | H372 ** H317 | H412 |   |   |  
606-083-00-5 | 2-chloro-5-sec-hexadecylhydroquinone | 407-750-1 | 137193-60-3 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H319 | H315 | H317 | H412 | GHS07 | Wng | H319 | H315 | H317 | H412 |   |   |  606-083-00-5 | 5-втор-хексадецил-2-хлорохидрохинон | 407-750-1 | 137193-60-3 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H319 | H315 | H317 | H412 | GHS07 | Wng | H319 | H315 | H317 | H412 |   |   |  
606-084-00-0 | 1-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione | 414-540-3 | 484-33-3 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  606-084-00-0 | 1-(4-метокси-5-бензoфуранил)-3-фенил-1,3-пропандиoн | 414-540-3 | 484-33-3 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
606-085-00-6 | (1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one | 418-530-1 | 79200-56-9 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | H302 | H318 | H317 | GHS05 | GHS07 | Dgr | H302 | H318 | H317 |   |   |  606-085-00-6 | (1R,4S)-2-азабицикло[2.2.1]хепт-5-ен-3-он | 418-530-1 | 79200-56-9 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | H302 | H318 | H317 | GHS05 | GHS07 | Dgr | H302 | H318 | H317 |   |   |  
606-086-00-1 | 1-(3,3-dimethylcyclohexyl)pent-4-en-1-one | 422-330-8 | 56973-87-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  606-086-00-1 | 1-(3,3-диметилциклохексил)пент-4-ен-1-он | 422-330-8 | 56973-87-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
606-087-00-7 | 6-ethyl-5-fluoro-4(3H)-pyrimidone | 422-460-5 | 137234-87-8 | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  606-087-00-7 | 6-етил-5-флуоро-4(3H)-пиримидон | 422-460-5 | 137234-87-8 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
606-088-00-2 | 2,4,4,7-tetramethyl-6-octen-3-one | 422-520-0 | 74338-72-0 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  606-088-00-2 | 2,4,4,7-тетраметил-6-октен-3-он | 422-520-0 | 74338-72-0 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
606-089-00-8 | reaction mass of: 1,4-diamino-2-chloro-3-phenoxyanthraquinone; 1,4-diamino-2,3-bis-phenoxyanthraquinone | 423-220-2 | 12223-77-7 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  606-089-00-8 | реакционна маса от: 1,4-диамино-3-фенокси-2-хлороантрахинон; 1,4-диамино-2,3-бисфеноксиантрахинон | 423-220-2 | 12223-77-7 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
606-090-00-3 | 1-[3-[(dimethylamino)methyl]-4-hydroxyphenyl]ethanone | 430-920-1 | 73096-98-7 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  606-090-00-3 | 1-[3-[(диметиламино)метил]-4-хидроксифенил]етанон | 430-920-1 | 73096-98-7 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  
606-091-00-9 | 6-chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one | 421-320-0 | 118289-55-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  606-091-00-9 | 1,3-дихидро-6-хлоро-5-(2-хлороетил)индол-2-он | 421-320-0 | 118289-55-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
606-092-00-4 | reaction mass of: (E)-oxacyclohexadec-12-en-2-one; (E)-oxacyclohexadec-13-en-2-one; a) (Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one | 422-320-3 |   | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  606-092-00-4 | реакционна маса от: (E)-оксaциклохексадец-12-ен-2-он; (E)-оксaциклохексадец-13-ен-2-он; a) (Z)-oксaциклохексадец-(12)-ен-2-он и б) (Z)-oксaциклохексадец-(13)-ен-2-он | 422-320-3 |   | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
606-093-00-X | 5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one | 414-470-3 | 95885-13-5 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  606-093-00-X | 5-етил-4-(2-феноксиетил)-2,4-дихидро-3H-1,2,4-триазол-3-он | 414-470-3 | 95885-13-5 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
606-094-00-5 | N-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazole-4(1H), 1'(3'H)-isobenzofuran]-3'-one | 417-460-7 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  606-094-00-5 | N-[етил(3-метилбутил)амино]-3-метил-1-фенилспиро[[1]бензопирано[2,3-c]пиразол-4(1H),1′(3′H)-изобензофуран]-3′-он | 417-460-7 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
606-095-00-0 | (R, S)-2-azabicyclo[2.2.1]hept-5-en-3-one | 421-830-3 | 49805-30-3 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  606-095-00-0 | (R,S)-2-азабицикло[2.2.1]хепт-5-ен-3-он | 421-830-3 | 49805-30-3 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  
606-096-00-6 | 3-(6-O-(6-desoxy-α-l-mannopyranosyl-O-(α-d-glucopyranosyl)-(β-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one | 424-170-4 | 130603-71-3 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  606-096-00-6 | 3-(6-O-(6-дезокси-α-L-манопиранозил-O-(α-D-глюкопиранозил)-(β-D-глюкопиранозил)окси)-2-(3,4-дихидроксифенил)-5,7-дихидрокси-4H-1-бензопиран-4-он | 424-170-4 | 130603-71-3 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
606-097-00-1 | 2,2''-dihydroxy-4,4''-(2-hydroxy-propane-1,3-diyldioxy)dibenzophenone | 424-210-0 | 23911-85-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  606-097-00-1 | 2,2′′-дихидрокси-4,4′′-(2-хидроксипропан-1,3-диилдиокси)дибензофенон | 424-210-0 | 23911-85-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
606-098-00-7 | 1-benzyl-5-(hexadecyloxy)-2,4-imidazolidinedione | 431-220-9 | 158574-65-3 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  606-098-00-7 | 1-бензил-5-(хексадецилокси)-2,4-имидазолидиндион | 431-220-9 | 158574-65-3 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
606-099-00-2 | 5-methoxy-4'-(trifluoromethyl)valerophenone | 425-000-1 | 61718-80-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  606-099-00-2 | 5-метокси-4′-(трифлуорометил)валерофенон | 425-000-1 | 61718-80-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
606-100-00-6 | 2-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one | 425-150-8 | 94723-86-1 | Repr. 1B | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 3 | H360F*** H302 | H317 | H412 | GHS08 | GHS07 | Dgr | H360F*** H302 | H317 | H412 |   |   |  606-100-00-6 | 2-бутирил-3-хидрокси-5-тиоциклохексан-3-ил-циклохекс-2-ен-1-он | 425-150-8 | 94723-86-1 | Repr. 1B | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 3 | H360F*** | H302 | H317 | H412 | GHS08 | GHS07 | Dgr | H360F*** H302 | H317 | H412 |   |   |  
606-101-00-1 | reaction mass of: 1,5-bis[(2-ethylhexyl)amino]-9,10-anthracenedione; 1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione; 1,5-bis[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione; 1-[(2-ethylhexyl)amino]-5-[(3-methoxypropyl)amino]-9,10-anthracenedione; 1-[3-[(2-ethylhexyl)oxy]propyl]amino-5-[(3-methoxypropyl)amino]-9,10-anthracenedione; 1,5-bis[(3-methyloxypropyl)amino]-9,10-anthracenedione | 426-050-7 | 165038-51-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  606-101-00-1 | реакционна маса от: 1,5-бис[(2-етилхексил)амино]-9,10-антрацендион; 1-[(2-етилхексил)амино]-5-[3-[(2-етилхексил)окси]пропил]амино-9,10-антрацендион; 1,5-бис[3-[(2-етилхексил) окси]пропил]амино-9,10-антрацендион; 1-[(2-етилхексилl)амино]-5-[(3-метоксипропил)амино]-9,10-антрацендион; 1-[3-[(2-етилхексил)окси]пропил]амино-5-[(3-метоксипропил)амино]-9,10-антрацендион; 1,5-бис[(3-метилоксипропил)амино]-9,10-антрацендион | 426-050-7 | 165038-51-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
606-102-00-7 | 4-(3-triethoxysilylpropoxy)-2-hydroxybenzophenone | 431-490-8 | 79876-59-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  606-102-00-7 | 4-(3-триетоксисилилпропокси)-2-хидроксибензофенон | 431-490-8 | 79876-59-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
606-103-00-2 | 1-(4-(trans-4-ethylcyclohexyl)phenyl)ethanone | 426-460-6 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  606-103-00-2 | 1-(4-(транс-4-етилциклохексил)фенил)етанон | 426-460-6 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
606-104-00-8 | 1-(4-(trans-4-pentylcyclohexyl)phenyl)ethanone | 426-830-7 | 78531-59-6 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  606-104-00-8 | 1-(4-(транс-4-пентилциклохексил)фенил)етанон | 426-830-7 | 78531-59-6 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
606-105-00-3 | 3,4,3', 4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dione | 431-500-0 | 226065-73-2 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  606-105-00-3 | 3,4,3′,4′-тетрафенил-1,1′-етандиилбиспирол-2,5-дион | 431-500-0 | 226065-73-2 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
606-106-00-9 | 1-(4-(trans-4-butylcyclohexyl)phenyl)ethanone | 427-320-7 | 83626-30-6 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  606-106-00-9 | 1-(4-(транс-4-бутилциклохексил)фенил)етанон | 427-320-7 | 83626-30-6 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
606-107-00-4 | 8-azaspiro[4.5]decane-7,9-dione | 427-770-4 | 1075-89-4 | Acute Tox. 3 * | Aquatic Chronic 2 | H301 | H411 | GHS06 | GHS09 | Dgr | H301 | H411 |   |   |  606-107-00-4 | 8-азаспиро[4.5]декан-7,9-дион | 427-770-4 | 1075-89-4 | Acute Tox. 3 * | Aquatic Chronic 2 | H301 | H411 | GHS06 | GHS09 | Dgr | H301 | H411 |   |   |  
606-108-00-X | 1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl)-3-pentanone | 436-710-6 | 756-13-8 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  606-108-00-X | 4-(трифлуорометил)-1,1,1,2,2,4,5,5,5-нонафлуоро-3-пентанон | 436-710-6 | 756-13-8 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
606-109-00-5 | 2-(4-methyl-3-pentenyl)anthraquinone | 428-320-1 | 71308-16-2 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 4 | H302 | H317 | H413 | GHS07 | Wng | H302 | H317 | H413 |   |   |  606-109-00-5 | 2-(4-метил-3-пентенил)антрахинон | 428-320-1 | 71308-16-2 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 4 | H302 | H317 | H413 | GHS07 | Wng | H302 | H317 | H413 |   |   |  
606-110-00-0 | 5-ethoxy-5H-furan-2-one | 428-330-4 | 2833-30-9 | Skin Corr. 1B | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * | Skin Sens. 1 | H314 | H312 | H302 | H373** H317 | GHS05 | GHS08 | GHS07 | Dgr | H314 | H312 | H302 | H373** H317 |   |   |  606-110-00-0 | 5-етокси-5H-фуран-2-он | 428-330-4 | 2833-30-9 | Skin Corr. 1B | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Sens. 1 | H314 | H312 | H302 | H373** | H317 | GHS05 | GHS08 | GHS07 | Dgr | H314 | H312 | H302 | H373** H317 |   |   |  
606-111-00-6 | 5-amino-6-methyl-1,3-dihydrobenzoimidazol-2-one | 428-410-9 | 67014-36-2 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  606-111-00-6 | 5-амино-6-метил-1,3-дихидробензоимидазол-2-он | 428-410-9 | 67014-36-2 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  
606-112-00-1 | (4aR*,8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one | 428-690-2 | 1668-86-6 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Chronic 3 | H302 | H319 | H412 | GHS07 | Wng | H302 | H319 | H412 |   |   |  606-112-00-1 | (4aR*,8aR*)-11-метил-3-метокси-4a,5,9,10,11,12-хексахидро-6H-бензофуро[3a,3,2-ef][2]бензазепин-6-он | 428-690-2 | 1668-86-6 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Chronic 3 | H302 | H319 | H412 | GHS07 | Wng | H302 | H319 | H412 |   |   |  
606-113-00-7 | 1-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-one | 429-040-0 | 272460-97-6 | Eye Dam. 1 | Aquatic Chronic 4 | H318 | H413 | GHS05 | Dgr | H318 | H413 |   |   |  606-113-00-7 | 1-[4-(4-бензоилфенилсулфанил)фенил]-2-метил-2-(4-метилфенилсулфонил)пропан-1-он | 429-040-0 | 272460-97-6 | Eye Dam. 1 | Aquatic Chronic 4 | H318 | H413 | GHS05 | Dgr | H318 | H413 |   |   |  
606-114-00-2 | 4,4', 5,5', 6,6', 7,7'-octachloro-(2,2')biisoindolyl-1,1', 3,3'-tetraone | 429-150-9 | 67887-47-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  606-114-00-2 | 4,4′,5,5′,6,6′,7,7′-октахлоро-(2,2′)-биизоиндолил-1,1′,3,3′-тетраон | 429-150-9 | 67887-47-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
606-115-00-8 | profoxydim (ISO); 2-{(EZ)-1-[(2RS)-2-(4-chlorophenoxy)propoxyimino]butyl}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one | — | 139001-49-3 | Carc. 2 | Repr. 2 | Skin Sens. 1 | H351 | H361d | H317 | GHS08 | GHS07 | Wng | H351 | H361d | H317 |   |   |  606-115-00-8 | профоксидим (ISO); 2-{(EZ)-1-[(2RS)-2-(4-хлорофенокси)пропоксиимино]бутил}-5-(тиан-3-ил)-3-хидроксициклохекс-2-ен-1-он | — | 139001-49-3 | Carc. 2 | Repr. 2 | Skin Sens. 1 | H351 | H361d | H317 | GHS08 | GHS07 | Wng | H351 | H361d | H317 |   |   |  
606-116-00-3 | tepraloxydim (ISO); (RS)-(EZ)-2-{1-[(2E)-3-chloroallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one | — | 149979-41-9 | Carc. 2 | Repr. 2 | H351 | H361fd | GHS08 | Wng | H351 | H361fd |   |   |  606-116-00-3 | тепралоксидим (ISO); (RS)-(EZ)-2-{1-[(2E)-3-хлороалилоксиимино]пропил}-3-хидрокси-5-перхидропиран-4-илциклохекс-2-ен-1-он | — | 149979-41-9 | Carc. 2 | Repr. 2 | H351 | H361fd | GHS08 | Wng | H351 | H361fd |   |   |  
606-117-00-9 | 2,6-bis(1,1-dimethylethyl)-4-(phenylenemethylene)cyclohexa-2,5-dien-1-one | 429-460-4 | 7078-98-0 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  606-117-00-9 | 2,6-бис(1,1-диметилетил)-4-фениленметилен)циклохекса-2,5-диен-1-он | 429-460-4 | 7078-98-0 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
606-118-00-4 | N-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinonediimine | 429-640-2 | 52870-46-9 | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H410 |   |   |  606-118-00-4 | N-(1,3-диметилбутил)-N′-(фенил)-1,4-бензохинондиимин | 429-640-2 | 52870-46-9 | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H410 |   |   |  
606-119-00-X | (E)-3-methyl-5-cyclopentadecen-1-one | 429-900-5 | — | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  606-119-00-X | (E)-3-метил-5-циклопентадецен-1-он | 429-900-5 | — | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
606-120-00-5 | 2,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-one | 430-170-5 | 114625-74-0 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  606-120-00-5 | 5-метил-3-(морфолин-4-ил)-2,5-дихидрокси-2-циклопентен-1-он | 430-170-5 | 114625-74-0 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
606-121-00-0 | (+)-(1S, 2S, 3S, 5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one) | 430-460-1 | 133636-82-5 | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H317 | H410 |   |   |  606-121-00-0 | (+)-(1S,2S,3S,5R)-2,6,6-триметилбицикло[3.1.1]хептан-3-спиро-1′-(циклохекс-2′-ен-4′-он) | 430-460-1 | 133636-82-5 | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H317 | H410 |   |   |  
606-122-00-6 | 3-(2-bromopropionoyl)-4,4-dimethyl-1,3-oxazolan-2-one | 430-820-8 | 114341-88-7 | Acute Tox. 4 * STOT RE 2 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373** H315 | H318 | H317 | H400 | H410 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H302 | H373** H315 | H318 | H317 | H410 |   |   |  606-122-00-6 | 3-(2-бромопропионоил)-4,4-диметил-1,3-оксазолан-2-он | 430-820-8 | 114341-88-7 | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373** | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H302 | H373** H315 | H318 | H317 | H410 |   |   |  
606-123-00-1 | 4-hexadecyl-1-phenylpyrazolidin-3-one | 430-840-7 | — | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  606-123-00-1 | 1-фенил-4-хексадецилпиразолидин-3-он | 430-840-7 | — | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
606-124-00-7 | 1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione | 421-080-7 | 161462-35-7 | STOT RE 2 * Aquatic Acute 1 | Aquatic Chronic 1 | H373** H400 | H410 | GHS08 | GHS09 | Wng | H373** H410 |   |   |  606-124-00-7 | 3-(2-метилтио-4-трифлуорометилфенил)-1-циклопропил-1,3-пропандион | 421-080-7 | 161462-35-7 | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H373** | H400 | H410 | GHS08 | GHS09 | Wng | H373** H410 |   |   |  
606-125-00-2 | 1-benzylimidazolidine-2,4-dione | 421-340-1 | 6777-05-5 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  606-125-00-2 | 1-бензилимидазолидин-2,4-дион | 421-340-1 | 6777-05-5 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
606-126-00-8 | 1,4-bis(2,3-dihydroxypropylamino)anthraquinone | 421-470-7 | 99788-75-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  606-126-00-8 | 1,4-бис(2,3-дихидроксипропиламино)антрахинон | 421-470-7 | 99788-75-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
606-128-00-9 | 2,2'-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione | 422-650-8 | 148935-94-8 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  606-128-00-9 | 2,2′-(1,3-фенилен)бис[5-хлоро-1H-изоиндол]-1,3(2H)-дион | 422-650-8 | 148935-94-8 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
606-129-00-4 | 5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one; (2S, 4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one | 423-090-7 | 156732-13-7 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  606-129-00-4 | 5-амино-[2S-ди(метилфенил)амино]-1,6-дифенил-4Z-хексен-3-он; (2S,4Z)-5-амино-2-(дибензиламино)-1,6-дифенилхекс-4-ен-3-он | 423-090-7 | 156732-13-7 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
606-130-00-X | 4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone | 423-860-2 | 56309-94-5 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  606-130-00-X | 4-(1,4-диоксаспиро[4.5]дец-8-ил)циклохексанон | 423-860-2 | 56309-94-5 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
606-131-00-5 | cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione | 427-230-8 | 5571-36-8 | Repr. 1B | STOT RE 2 * | Aquatic Chronic 2 | H360F*** H373** H411 | GHS08 | GHS09 | Dgr | H360F*** H373** H411 |   |   |  606-131-00-5 | цикличен 3-(1,2-етандиилацетал)естра-5(10),9(11)-диен-3,17-дион | 427-230-8 | 5571-36-8 | Repr. 1B | STOT RE 2 * | Aquatic Chronic 2 | H360F*** | H373** | H411 | GHS08 | GHS09 | Dgr | H360F*** H373** H411 |   |   |  
606-132-00-0 | (6β)-6,19-epoxyandrost-4-ene-3,17-dione | 433-490-3 | 6563-83-3 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  606-132-00-0 | (6β)-6,19-епоксиандрост-4-ен-3,17-дион | 433-490-3 | 6563-83-3 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
606-134-00-1 | androsta-1,4,9(11)-triene-3,17-dione | 433-560-3 | 15375-21-0 | Repr. 2 | H361f*** | GHS08 | Wng | H361f*** |   |   |  606-134-00-1 | андроста-1,4,9(11)-триен-3,17-дион | 433-560-3 | 15375-21-0 | Repr. 2 | H361f*** | GHS08 | Wng | H361f*** |   |   |  
606-135-00-7 | cyclohexadecanone | 438-930-8 | 2550-52-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  606-135-00-7 | циклохексадеканон | 438-930-8 | 2550-52-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
606-136-00-2 | (3S, 6R, 9S, 12R, 15S, 18R, 21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone | 444-350-6 | 133413-70-4 | Eye Irrit. 2 | Aquatic Chronic 4 | H319 | H413 | GHS07 | Wng | H319 | H413 |   |   |  606-136-00-2 | (3S,6R,9S,12R,15S,18R,21S,24R)-6,18-дибензил-3,9,15,21-тетраизобутил-4,10,12,16,22,24-хексаметил-1,7,13,19-тетраокса-4,10,16,22-тетраазациклотетракозан-2,5,8,11,14,17,20,23-октаон | 444-350-6 | 133413-70-4 | Eye Irrit. 2 | Aquatic Chronic 4 | H319 | H413 | GHS07 | Wng | H319 | H413 |   |   |  
606-137-00-8 | trans-7,7'-dimethyl-(4H,4H')-(2,2')bi[benzo[1,4]thiazinylidene]-3,3'-dione | 444-750-0 | 211387-26-7 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  606-137-00-8 | транс-7,7′-диметил-(4H,4H′)-(2,2′)би[бензо[1,4]тиазинилиден]-3,3′-дион | 444-750-0 | 211387-26-7 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
606-138-00-3 | (2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone | 444-800-1 | 141645-23-0 | Flam. Liq. 3 | Acute Tox. 4 * STOT RE 2 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H226 | H302 | H373** H315 | H318 | H317 | H400 | H410 | GHS02 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H226 | H302 | H373** H315 | H318 | H317 | H410 |   | M=10 |  606-138-00-3 | (2-бутил-5-нитробензофуран-3-ил)[4-(3-дибутиламинопропокси)фенил]метанон | 444-800-1 | 141645-23-0 | Flam. Liq. 3 | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H226 | H302 | H373** | H315 | H318 | H317 | H400 | H410 | GHS02 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H226 | H302 | H373** H315 | H318 | H317 | H410 |   | M=10 |  
606-139-00-9 | (S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one | 444-830-5 | 124379-29-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  606-139-00-9 | (S)-4-(3,4-дихлорофенил)-3,4-дихидро-2H-нафтален-1-он | 444-830-5 | 124379-29-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
606-140-00-4 | 2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one | 444-860-9 | 474510-57-1 | STOT RE 2 * Aquatic Acute 1 | Aquatic Chronic 1 | H373** H400 | H410 | GHS08 | GHS09 | Wn | H373** H410 |   |   |  606-140-00-4 | 2-хидрокси-1-(4-(4-(2-метил-2-хидроксипропионил)бензил)фенил)-2-метилпропан-1-он | 444-860-9 | 474510-57-1 | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H373** | H400 | H410 | GHS08 | GHS09 | Wn | H373** H410 |   |   |  
606-141-00-X | sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate | 418-410-7 | — | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  606-141-00-X | натриев 3-(метоксикарбонил)-4-оксо-3,4,5,6-тетрахидро-2-пиридинолат | 418-410-7 | — | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
606-142-00-5 | reaction mass of: (1RS, 2SR,7SR, 8SR, E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS, 2SR, 7SR, 8SR, Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS, 2SR, 7SR, 8SR, Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one | 434-290-9 | — | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  606-142-00-5 | реакционна маса от: (1RS,2SR,7SR,8SR, E) 9 и 10-етилиден-3-оксатрицикло[6.2.1.0(2,7)]ундекан-4-он; (1RS,2SR,7SR,8SR, Z)-10-етилиден-3-оксатрицикло[6.2.1.0(2,7)]ундекан-4-он; (1RS,2SR,7SR,8SR, Z)-9-етилиден-3-оксатрицикло[6.2.1.0(2,7)]ундекан-4-он | 434-290-9 | — | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
606-143-00-0 | abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] avermectin B1a (purity ≥ 80 %); [2] | _ [1] | 265-610-3 [2] | 71751-41-2 [1] | 65195-55-3 [2] | Repr. 2 | Acute Tox. 2 | Acute Tox. 1 | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d | H300 | H330 | H372 (nervous system) H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H361d | H300 | H330 | H372 (nervous system) H410 |   | STOT RE 1; H372: C ≥ 5 % STOT RE 2; H373: 0,5  % | ≤C< 5 % | M = 10 000 |  606-143-00-0 | абамектин (комбинация от авермектин В1а и авермектин В1b) (ISO) [1] авермектин В1а (чистота ≥ 80 %); [2] | _ [1] | 265-610-3 [2] | 71751-41-2 [1] | 65195-55-3 [2] | Repr. 2 | Acute Tox. 2 | Acute Tox. 1 | STOT RE 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d | H300 | H330 | H372 (нервна система) | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H361d | H300 | H330 | H372 (нервна система) H410 |   | STOT RE 1; H372: C ≥ 5 % STOT RE 2; H373: 0,5  % | ≤C< 5 % | M = 10 000 |  
606-144-00-6 | acequinocyl (ISO); 3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate | — | 57960-19-7 | Skin Sens. 1 | STOT SE 1 | STOT RE 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H370 (lung) (inhalation) H373 (blood system) | H400 | H410 | GHS07 | GHS08 | GHS09 | Dgr | H317 | H370 (lung) (inhalation) H373 (blood system) | H410 |   | M = 1 000 |  606-144-00-6 | ацехиноцил (ISO); 3-додецил-1,4-диоксо-1,4-дихидронафтален-2-илов ацетат | — | 57960-19-7 | Skin Sens. 1 | STOT SE 1 | STOT RE 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H370 (бял дроб) (вдишване) H373 (кръвоносна система) | H400 | H410 | GHS07 | GHS08 | GHS09 | Dgr | H317 | H370 (бял дроб) (вдишване) H373 (кръвоносна система) | H410 |   | M = 1 000 |  
606-145-00-1 | sulcotrione (ISO); 2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione |   | 99105-77-8 | Repr. 2 | STOT RE 2 | Skin Sens. 1A Aquatic Acute 1 | Aquatic Chronic 1 | H361d H373 (kidneys) H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H361d H373 (kidneys) H317 | H410 |   | M = 1 | M = 10 |  606-145-00-1 | сулкотрион (ISO); 2-[4-(метилсулфонил)-2-хлоробензоил]циклохексан-1,3-дион |   | 99105-77-8 | Repr. 2 | STOT RE 2 | Skin Sens. 1A | Aquatic Acute 1 | Aquatic Chronic 1 | H361d H373 (бъбреци) | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H361d H373 (бъбреци) H317 | H410 |   | M = 1 | M = 10 |  
606-146-00-7 | tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one | — | 87820-88-0 | Carc. 2 | Acute Tox. 4 | Aquatic Chronic 2 | H351 | H302 | H411 | GHS08 | GHS07 | GHS09 | Wng | H351 | H302 | H411 |   |   |  606-146-00-7 | тралкоксидим (ISO); 2-(N-етоксипропанимидоил)-5-мезитил-3-хидроксициклохекс-2-ен-1-он | — | 87820-88-0 | Carc. 2 | Acute Tox. 4 | Aquatic Chronic 2 | H351 | H302 | H411 | GHS08 | GHS07 | GHS09 | Wng | H351 | H302 | H411 |   |   |  
606-147-00-2 | cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one | 405-230-9 | 101205-02-1 | Repr. 2 | H361d | GHS08 | Wng | H361d |   |   |  606-147-00-2 | циклоксидим (ISO); 2-(N-етоксибутанимидоил)-5-(тетрахидро-2H-тиопиран-3-ил)-3-хидроксициклохекс-2-ен-1-он | 405-230-9 | 101205-02-1 | Repr. 2 | H361d | GHS08 | Wng | H361d |   |   |  
607-001-00-0 | formic acid … % | 200-579-1 | 64-18-6 | Skin Corr. 1A | H314 | GHS05 | Dgr | H314 |   | Skin Corr. 1A; H314: C ≥ 90 % Skin Corr. 1B; H314: 10 % ≤ C < 90 % | Skin Irrit. 2; H315: 2 % ≤C | < 10 % | Eye Irrit. 2; H319: 2 %≤ | <10 % | B607-001-00-0 | мравчена киселина … % | 200-579-1 | 64-18-6 | Skin Corr. 1A | H314 | GHS05 | Dgr | H314 |   | Skin Corr. 1A; H314: C ≥ 90 % Skin Corr. 1B; H314: 10 % ≤ C < 90 % | Skin Irrit. 2; H315: 2 % ≤C | < 10 % | Eye Irrit. 2; H319: 2 %≤ | <10 % | B
607-002-00-6 | acetic acid … % | 200-580-7 | 64-19-7 | Flam. Liq. 3 | Skin Corr. 1A | H226 | H314 | GHS02 | GHS05 | Dgr | H226 | H314 |   | Skin Corr. 1A; H314: C ≥90 % Skin Corr. 1B; H314: 25 %≤ C <90 % | Skin Irrit. 2; H315: 10 % ≤C <25 % | Eye Irrit. 2; H319: 10 % ≤ C < 25 % | B607-002-00-6 | оцетна киселина … % | 200-580-7 | 64-19-7 | Flam. Liq. 3 | Skin Corr. 1A | H226 | H314 | GHS02 | GHS05 | Dgr | H226 | H314 |   | Skin Corr. 1A; H314: C ≥90 % Skin Corr. 1B; H314: 25 %≤ C <90 % | Skin Irrit. 2; H315: 10 % ≤C <25 % | Eye Irrit. 2; H319: 10 % ≤ C < 25 % | B
607-003-00-1 | chloroacetic acid | 201-178-4 | 79-11-8 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * | Skin Corr. 1B Aquatic Acute 1 | H331 | H311 | H301 | H314 | H400 | GHS06 | GHS05 | GHS09 | Dgr | H331 | H311 | H301 | H314 | H400 |   | STOT SE 3; H335: C≥ 5 % |  607-003-00-1 | хлорооцетна киселина | 201-178-4 | 79-11-8 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | Aquatic Acute 1 | H331 | H311 | H301 | H314 | H400 | GHS06 | GHS05 | GHS09 | Dgr | H331 | H311 | H301 | H314 | H400 |   | STOT SE 3; H335: C≥ 5 % |  
607-004-00-7 | TCA (ISO); trichloroacetic acid | 200-927-2 | 76-03-9 | Skin Corr. 1A Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H400 | H410 | GHS05 | GHS09 | Dgr | H314 | H410 |   | STOT SE 3; H335: C ≥ 1 % |  607-004-00-7 | TCA (ISO); трихлорооцетна киселина | 200-927-2 | 76-03-9 | Skin Corr. 1A | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H400 | H410 | GHS05 | GHS09 | Dgr | H314 | H410 |   | STOT SE 3; H335: C ≥ 1 % |  
607-005-00-2 | TCA-sodium (ISO); sodium trichloroacetate | 211-479-2 | 650-51-1 | STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H335 | H400 | H410 | GHS07 | GHS09 | Wng | H335 | H410 |   |   |  607-005-00-2 | TCA-натрий (ISO); натриев трихлороацетат | 211-479-2 | 650-51-1 | STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H335 | H400 | H410 | GHS07 | GHS09 | Wng | H335 | H410 |   |   |  
607-006-00-8 | oxalic acid | 205-634-3 | 144-62-7 | Acute Tox. 4 * Acute Tox. 4 * | H312 | H302 | GHS07 | Wng | H312 | H302 |   | * |  607-006-00-8 | оксалова киселина | 205-634-3 | 144-62-7 | Acute Tox. 4 * | Acute Tox. 4 * | H312 | H302 | GHS07 | Wng | H312 | H302 |   | * |  
607-007-00-3 | salts of oxalic acid (with the exception of those specified elsewhere in this Annex) | — | — | Acute Tox. 4 * Acute Tox. 4 * | H312 | H302 | GHS07 | Wng | H312 | H302 |   | * | A607-007-00-3 | соли на оксаловата киселина (с изключение на тези, посочени другаде в настоящото приложение) | — | — | Acute Tox. 4 * | Acute Tox. 4 * | H312 | H302 | GHS07 | Wng | H312 | H302 |   | * | A
607-008-00-9 | acetic anhydride | 203-564-8 | 108-24-7 | Flam. Liq. 3 | Acute Tox. 4 * Acute Tox. 4 * | Skin Corr. 1B | H226 | H332 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H332 | H302 | H314 |   | Skin Corr. 1B; H314: C ≥ 2 % Skin Irrit. 2; H315: 5 % ≤C | < 25 % | Eye Dam. 1; H318: 5 % ≤ C | < 25 % | Eye Irrit. 2; H319: 1 % ≤C | < 5 % | STOT SE 3; H335: C ≥ 5 % |  607-008-00-9 | оцетен анхидрид | 203-564-8 | 108-24-7 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H226 | H332 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H332 | H302 | H314 |   | Skin Corr. 1B; H314: C ≥ 2 % Skin Irrit. 2; H315: 5 % ≤C | < 25 % | Eye Dam. 1; H318: 5 % ≤ C | < 25 % | Eye Irrit. 2; H319: 1 % ≤C | < 5 % | STOT SE 3; H335: C ≥ 5 % |  
607-009-00-4 | phthalic anhydride | 201-607-5 | 85-44-9 | Acute Tox. 4 * STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H302 | H335 | H315 | H318 | H334 | H317 | GHS08 | GHS05 | GHS07 | Dgr | H302 | H335 | H315 | H318 | H334 | H317 |   |   |  607-009-00-4 | фталов анхидрид | 201-607-5 | 85-44-9 | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H302 | H335 | H315 | H318 | H334 | H317 | GHS08 | GHS05 | GHS07 | Dgr | H302 | H335 | H315 | H318 | H334 | H317 |   |   |  
607-010-00-X | propionic anhydride | 204-638-2 | 123-62-6 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % | Eye Irrit. 2; H319: 10 % ≤ C < 25 % |  607-010-00-X | пропионов анхидрид | 204-638-2 | 123-62-6 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 10 % ≤ C < 25 % | Eye Irrit. 2; H319: 10 % ≤ C < 25 % |  
607-011-00-5 | acetyl chloride | 200-865-6 | 75-36-5 | Flam. Liq. 2 | Skin Corr. 1B | H225 | H314 | GHS02 | GHS05 | Dgr | H225 | H314 | EUH014 |   |  607-011-00-5 | ацетилхлорид | 200-865-6 | 75-36-5 | Flam. Liq. 2 | Skin Corr. 1B | H225 | H314 | GHS02 | GHS05 | Dgr | H225 | H314 | EUH014 |   |  
607-012-00-0 | benzoyl chloride | 202-710-8 | 98-88-4 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | H332 | H312 | H302 | H314 | H317 | GHS05 | GHS07 | Dgr | H332 | H312 | H302 | H314 | H317 |   |   |  607-012-00-0 | бензоилхлорид | 202-710-8 | 98-88-4 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | H332 | H312 | H302 | H314 | H317 | GHS05 | GHS07 | Dgr | H332 | H312 | H302 | H314 | H317 |   |   |  
607-013-00-6 | dimethyl carbonate | 210-478-4 | 616-38-6 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 |   |   |  607-013-00-6 | диметилов карбонат | 210-478-4 | 616-38-6 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 |   |   |  
607-014-00-1 | methyl formate | 203-481-7 | 107-31-3 | Flam. Liq. 1 | Acute Tox. 4 * Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | H224 | H332 | H302 | H319 | H335 | GHS02 | GHS07 | Dgr | H224 | H332 | H302 | H319 | H335 |   |   |  607-014-00-1 | мeтилов формат | 203-481-7 | 107-31-3 | Flam. Liq. 1 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | H224 | H332 | H302 | H319 | H335 | GHS02 | GHS07 | Dgr | H224 | H332 | H302 | H319 | H335 |   |   |  
607-015-00-7 | ethyl formate | 203-721-0 | 109-94-4 | Flam. Liq. 2 | Acute Tox. 4 * Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | H225 | H332 | H302 | H319 | H335 | GHS02 | GHS07 | Dgr | H225 | H332 | H302 | H319 | H335 |   |   |  607-015-00-7 | етилов формат | 203-721-0 | 109-94-4 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | H225 | H332 | H302 | H319 | H335 | GHS02 | GHS07 | Dgr | H225 | H332 | H302 | H319 | H335 |   |   |  
607-016-00-2 | propyl formate; [1] isopropyl formate [2] | 203-798-0 [1] | 210-901-2 [2] | 110-74-7 [1] | 625-55-8 [2] | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | STOT SE 3 | H225 | H319 | H335 | H336 | GHS02 | GHS07 | Dgr | H225 | H319 | H335 | H336 |   |   | C607-016-00-2 | пропилов формат; [1] изопропилов формат [2] | 203-798-0 [1] | 210-901-2 [2] | 110-74-7 [1] | 625-55-8 [2] | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | STOT SE 3 | H225 | H319 | H335 | H336 | GHS02 | GHS07 | Dgr | H225 | H319 | H335 | H336 |   |   | C
607-017-00-8 | butyl formate; [1] tert-butyl formate; [2] isobutyl formate [3] | 209-772-5 [1] | 212-105-0 [2] | 208-818-1 [3] | 592-84-7 [1] | 762-75-4 [2] | 542-55-2 [3] | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | H225 | H319 | H335 | GHS02 | GHS07 | Dgr | H225 | H319 | H335 |   |   | C607-017-00-8 | бутилов формат; [1] трет-бутилов формат; [2] изобутилов формат [3] | 209-772-5 [1] | 212-105-0 [2] | 208-818-1 [3] | 592-84-7 [1] | 762-75-4 [2] | 542-55-2 [3] | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | H225 | H319 | H335 | GHS02 | GHS07 | Dgr | H225 | H319 | H335 |   |   | C
607-018-00-3 | isopentyl formate; [1] 2-methylbutyl formate [2] | 203-769-2 [1] | 252-343-2 [2] | 110-45-2 [1] | 35073-27-9 [2] | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | H225 | H319 | H335 | GHS02 | GHS07 | Dgr | H225 | H319 | H335 |   |   | C607-018-00-3 | изопентилов формат; [1] 2-метилбутилов формат [2] | 203-769-2 [1] | 252-343-2 [2] | 110-45-2 [1] | 35073-27-9 [2] | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | H225 | H319 | H335 | GHS02 | GHS07 | Dgr | H225 | H319 | H335 |   |   | C
607-019-00-9 | methyl chloroformate | 201-187-3 | 79-22-1 | Flam. Liq. 2 | Acute Tox. 2 * Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H225 | H330 | H312 | H302 | H314 | GHS02 | GHS06 | GHS05 | Dgr | H225 | H330 | H312 | H302 | H314 |   |   |  607-019-00-9 | метилов хлороформат | 201-187-3 | 79-22-1 | Flam. Liq. 2 | Acute Tox. 2 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H225 | H330 | H312 | H302 | H314 | GHS02 | GHS06 | GHS05 | Dgr | H225 | H330 | H312 | H302 | H314 |   |   |  
607-020-00-4 | ethyl chloroformate | 208-778-5 | 541-41-3 | Flam. Liq. 2 | Acute Tox. 2 * Acute Tox. 4 * | Skin Corr. 1B | H225 | H330 | H302 | H314 | GHS02 | GHS06 | GHS05 | Dgr | H225 | H330 | H302 | H314 |   |   |  607-020-00-4 | етилов хлороформат | 208-778-5 | 541-41-3 | Flam. Liq. 2 | Acute Tox. 2 * | Acute Tox. 4 * | Skin Corr. 1B | H225 | H330 | H302 | H314 | GHS02 | GHS06 | GHS05 | Dgr | H225 | H330 | H302 | H314 |   |   |  
607-021-00-X | methyl acetate | 201-185-2 | 79-20-9 | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | H225 | H319 | H336 | GHS02 | GHS07 | Dgr | H225 | H319 | H336 | EUH066 |   |  607-021-00-X | метилов ацетат | 201-185-2 | 79-20-9 | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | H225 | H319 | H336 | GHS02 | GHS07 | Dgr | H225 | H319 | H336 | EUH066 |   |  
607-022-00-5 | ethyl acetate | 205-500-4 | 141-78-6 | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | H225 | H319 | H336 | GHS02 | GHS07 | Dgr | H225 | H319 | H336 | EUH066 |   |  607-022-00-5 | етилов ацетат | 205-500-4 | 141-78-6 | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | H225 | H319 | H336 | GHS02 | GHS07 | Dgr | H225 | H319 | H336 | EUH066 |   |  
607-023-00-0 | vinyl acetate | 203-545-4 | 108-05-4 | Flam. Liq. 2 | Carc. 2 | Acute Tox. 4 | STOT SE 3 | H225 | H351 | H332 | H335 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H351 | H332 | H335 |   |   | D607-023-00-0 | винилов ацетат | 203-545-4 | 108-05-4 | Flam. Liq. 2 | Carc. 2 | Acute Tox. 4 | STOT SE 3 | H225 | H351 | H332 | H335 | GHS02 | GHS08 | GHS07 | Dgr | H225 | H351 | H332 | H335 |   |   | D
607-024-00-6 | propyl acetate; [1] isopropyl acetate [2] | 203-686-1 [1] | 203-561-1 [2] | 109-60-4 [1] | 108-21-4 [2] | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | H225 | H319 | H336 | GHS02 | GHS07 | Dgr | H225 | H319 | H336 | EUH066 |   | C607-024-00-6 | пропилов ацетат; [1] изопропилов ацетат [2] | 203-686-1 [1] | 203-561-1 [2] | 109-60-4 [1] | 108-21-4 [2] | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | H225 | H319 | H336 | GHS02 | GHS07 | Dgr | H225 | H319 | H336 | EUH066 |   | C
607-025-00-1 | n-butyl acetate | 204-658-1 | 123-86-4 | Flam. Liq. 3 | STOT SE 3 | H226 | H336 | GHS02 | GHS07 | Wng | H226 | H336 | EUH066 |   |  607-025-00-1 | n-бутилов ацетат | 204-658-1 | 123-86-4 | Flam. Liq. 3 | STOT SE 3 | H226 | H336 | GHS02 | GHS07 | Wng | H226 | H336 | EUH066 |   |  
607-026-00-7 | sec-butyl acetate; [1] isobutyl acetate; [2] tert-butyl acetate [3] | 203-300-1 [1] | 203-745-1 [2] | 208-760-7 [3] | 105-46-4 [1] | 110-19-0 [2] | 540-88-5 [3] | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 | EUH066 |   | C607-026-00-7 | втор-бутилов ацетат; [1] изобутилов ацетат; [2] трет-бутилов ацетат [3] | 203-300-1 [1] | 203-745-1 [2] | 208-760-7 [3] | 105-46-4 [1] | 110-19-0 [2] | 540-88-5 [3] | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 | EUH066 |   | C
607-027-00-2 | methyl propionate | 209-060-4 | 554-12-1 | Flam. Liq. 2 | Acute Tox. 4 * | H225 | H332 | GHS02 | GHS07 | Dgr | H225 | H332 |   |   |  607-027-00-2 | мeтилов пропионат | 209-060-4 | 554-12-1 | Flam. Liq. 2 | Acute Tox. 4 * | H225 | H332 | GHS02 | GHS07 | Dgr | H225 | H332 |   |   |  
607-028-00-8 | ethyl propionate | 203-291-4 | 105-37-3 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 |   |   |  607-028-00-8 | етилов пропионат | 203-291-4 | 105-37-3 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 |   |   |  
607-029-00-3 | n-butyl propionate; [1] sec-butyl propionate; [2] iso-butyl propionate [3] | 209-669-5 [1] | -[2] | 208-746-0 [3] | 590-01-2 [1] | 591-34-4 [2] | 540-42-1 [3] | Flam. Liq. 3 | H226 | GHS02 | Wng | H226 |   |   | C607-029-00-3 | n-бутилов пропионат; [1] втор-бутилов пропионат; [2] изобутилов пропионат [3] | 209-669-5 [1] | -[2] | 208-746-0 [3] | 590-01-2 [1] | 591-34-4 [2] | 540-42-1 [3] | Flam. Liq. 3 | H226 | GHS02 | Wng | H226 |   |   | C
607-030-00-9 | propyl propionate | 203-389-7 | 106-36-5 | Flam. Liq. 3 | Acute Tox. 4 * | H226 | H332 | GHS02 | GHS07 | Wng | H226 | H332 |   |   |  607-030-00-9 | пропилов пропионат | 203-389-7 | 106-36-5 | Flam. Liq. 3 | Acute Tox. 4 * | H226 | H332 | GHS02 | GHS07 | Wng | H226 | H332 |   |   |  
607-031-00-4 | butyl butyrate | 203-656-8 | 109-21-7 | Flam. Liq. 3 | H226 | GHS02 | Wng | H226 |   |   | C607-031-00-4 | бутилов бутират | 203-656-8 | 109-21-7 | Flam. Liq. 3 | H226 | GHS02 | Wng | H226 |   |   | C
607-032-00-X | ethyl acrylate | 205-438-8 | 140-88-5 | Flam. Liq. 2 | Acute Tox. 4 * Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | H225 | H332 | H312 | H302 | H319 | H335 | H315 | H317 | GHS02 | GHS07 | Dgr | H225 | H332 | H312 | H302 | H319 | H335 | H315 | H317 |   | Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 % STOT SE 3; H335: C ≥ 5 % | D607-032-00-X | етилов акрилат | 205-438-8 | 140-88-5 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | H225 | H332 | H312 | H302 | H319 | H335 | H315 | H317 | GHS02 | GHS07 | Dgr | H225 | H332 | H312 | H302 | H319 | H335 | H315 | H317 |   | Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 % STOT SE 3; H335: C ≥ 5 % | D
607-033-00-5 | n-butyl methacrylate | 202-615-1 | 97-88-1 | Flam. Liq. 3 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | H226 | H319 | H335 | H315 | H317 | GHS02 | GHS07 | Wng | H226 | H319 | H335 | H315 | H317 |   |   | D607-033-00-5 | n-бутилов метакрилат | 202-615-1 | 97-88-1 | Flam. Liq. 3 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | H226 | H319 | H335 | H315 | H317 | GHS02 | GHS07 | Wng | H226 | H319 | H335 | H315 | H317 |   |   | D
607-034-00-0 | methyl acrylate; methyl propenoate | 202-500-6 | 96-33-3 | Flam. Liq. 2 | Acute Tox. 4 * Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | H225 | H332 | H312 | H302 | H319 | H335 | H315 | H317 | GHS02 | GHS07 | Dgr | H225 | H332 | H312 | H302 | H319 | H335 | H315 | H317 |   |   | D607-034-00-0 | метилов акрилат; метилов пропеноат | 202-500-6 | 96-33-3 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | H225 | H332 | H312 | H302 | H319 | H335 | H315 | H317 | GHS02 | GHS07 | Dgr | H225 | H332 | H312 | H302 | H319 | H335 | H315 | H317 |   |   | D
607-035-00-6 | methyl methacrylate; methyl 2-methylprop-2-enoate; methyl 2-methylpropenoate | 201-297-1 | 80-62-6 | Flam. Liq. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | H225 | H335 | H315 | H317 | GHS02 | GHS07 | Dgr | H225 | H335 | H315 | H317 |   |   | D607-035-00-6 | мeтилов метакрилат; метилов 2-метилпроп-2-еноат; метилов 2-метилпропеноат | 201-297-1 | 80-62-6 | Flam. Liq. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | H225 | H335 | H315 | H317 | GHS02 | GHS07 | Dgr | H225 | H335 | H315 | H317 |   |   | D
607-036-00-1 | 2-methoxyethyl acetate; methylglycol acetate | 203-772-9 | 110-49-6 | Repr. 1B | Acute Tox. 4 * Acute Tox. 4 * | Acute Tox. 4 * | H360FD H332 | H312 | H302 | GHS08 | GHS07 | Dgr | H360FD H332 | H312 | H302 |   |   |  607-036-00-1 | 2-мeтоксиетилов ацетат; мeтилгликолов ацетат | 203-772-9 | 110-49-6 | Repr. 1B | Acute Tox. 4 * Acute Tox. 4 * | Acute Tox. 4 * | H360FD H332 | H312 | H302 | GHS08 | GHS07 | Dgr | H360FD H332 | H312 | H302 |   |   |  
607-037-00-7 | 2-ethoxyethyl acetate; ethylglycol acetate | 203-839-2 | 111-15-9 | Flam. Liq. 3 | Repr. 1B | Acute Tox. 4 * Acute Tox. 4 * | Acute Tox. 4 * | H226 | H360FD H332 | H312 | H302 | GHS02 | GHS08 | GHS07 | Dgr | H226 | H360FD H332 | H312 | H302 |   |   |  607-037-00-7 | 2-етоксиетилов ацетат; етилгликолов ацетат | 203-839-2 | 111-15-9 | Flam. Liq. 3 | Repr. 1B | Acute Tox. 4 * Acute Tox. 4 * | Acute Tox. 4 * | H226 | H360FD H332 | H312 | H302 | GHS02 | GHS08 | GHS07 | Dgr | H226 | H360FD H332 | H312 | H302 |   |   |  
607-038-00-2 | 2-butoxyethyl acetate; butylglycol acetate | 203-933-3 | 112-07-2 | Acute Tox. 4 * Acute Tox. 4 * | H332 | H312 | GHS07 | Wng | H332 | H312 |   |   |  607-038-00-2 | 2-бутоксиетилов ацетат; бутилгликолов ацетат | 203-933-3 | 112-07-2 | Acute Tox. 4 * Acute Tox. 4 * | H332 | H312 | GHS07 | Wng | H332 | H312 |   |   |  
607-039-00-8 | 2,4-D (ISO); 2,4-dichlorophenoxyacetic acid | 202-361-1 | 94-75-7 | Acute Tox. 4 * STOT SE 3 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H335 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H302 | H335 | H318 | H317 | H412 |   |   |  607-039-00-8 | 2,4-D (ISO); 2,4-дихлорофеноксиоцетна киселина | 202-361-1 | 94-75-7 | Acute Tox. 4 * | STOT SE 3 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H335 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H302 | H335 | H318 | H317 | H412 |   |   |  
607-040-00-3 | salts of 2,4-D | — | — | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H317 | H411 |   |   | A607-040-00-3 | соли на 2,4-D | — | — | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H317 | H411 |   |   | A
607-041-00-9 | 2,4,5-T (ISO); 2,4,5-trichlorophenoxy acetic acid | 202-273-3 | 93-76-5 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H335 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H335 | H315 | H410 |   |   |  607-041-00-9 | 2,4,5-T (ISO); 2,4,5-трихлорофеноксиоцетна киселина | 202-273-3 | 93-76-5 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H335 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H335 | H315 | H410 |   |   |  
607-042-00-4 | salts and esters of 2,4,5-T; salts and esters of 2,4,5-trichlorophenoxy acetic acid | — | — | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H335 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H335 | H315 | H410 |   |   | A607-042-00-4 | соли и естери на 2,4,5-T; соли и естери на 2,4,5-трихлорофеноксиоцетната киселина | — | — | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H335 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H335 | H315 | H410 |   |   | A
607-043-00-X | dicamba (ISO); 2,5-dichloro-6-methoxybenzoic acid; 3,6-dichloro-2-methoxybenzoic acid | 217-635-6 | 1918-00-9 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  607-043-00-X | дикамба (ISO); 6-метокси-2,5-дихлоробензоена киселина; 2-метокси-3,6-дихлоробензоена киселина | 217-635-6 | 1918-00-9 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  
607-044-00-5 | 3,6-dichloro-o-anisic acid, compound with dimethylamine (1:1); [1] potassium 3,6-dichloro-o-anisate[2] | 218-951-7 [1] | 233-002-7 [2] | 2300-66-5 [1] | 10007-85-9 [2] | Eye Irrit. 2 | Aquatic Chronic 3 | H319 | H412 | GHS07 | Wng | H319 | H412 |   |   |  607-044-00-5 | 3,6-дихлоро-o-анисова киселина, съединение с диметиламин (1:1); [1] калиев 3,6-дихлоро-o-aнисат [2] | 218-951-7 [1] | 233-002-7 [2] | 2300-66-5 [1] | 10007-85-9 [2] | Eye Irrit. 2 | Aquatic Chronic 3 | H319 | H412 | GHS07 | Wng | H319 | H412 |   |   |  
607-045-00-0 | dichlorprop (ISO); 2-(2,4-dichlorophenoxy)propionic acid | 204-390-5 | 120-36-5 | Acute Tox. 4 * Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | H312 | H302 | H315 | H318 | GHS05 | GHS07 | Dgr | H312 | H302 | H315 | H318 |   |   |  607-045-00-0 | дихлорпроп (ISO); 2-(2,4-дихлорофенокси)пропионова киселина | 204-390-5 | 120-36-5 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | H312 | H302 | H315 | H318 | GHS05 | GHS07 | Dgr | H312 | H302 | H315 | H318 |   |   |  
607-046-00-6 | salts of dichlorprop | — | — | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | H332 | H312 | H302 | GHS07 | Wng | H332 | H312 | H302 |   |   | A607-046-00-6 | соли на дихлорпроп | — | — | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H312 | H302 | GHS07 | Wng | H332 | H312 | H302 |   |   | A
607-047-00-1 | fenoprop (ISO); 2-(2,4,5-trichlorophenoxy)propionic acid | 202-271-2 | 93-72-1 | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H315 | H410 |   |   |  607-047-00-1 | фенопроп (ISO); 2-(2,4,5-трихлорофенокси)пропионова киселина | 202-271-2 | 93-72-1 | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H315 | H410 |   |   |  
607-048-00-7 | salts of fenoprop; salts of 2-(2,4,5-trichlorophenoxy)propionic acid | — | — | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   |   | A607-048-00-7 | соли на фенопроп; соли на 2-(2,4,5-трихлорофенокси)пропионовата киселина | — | — | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   |   | A
607-049-00-2 | mecoprop (ISO); 2-(4-chloro-o-tolyloxy)propionic acid; (RS)-2-(4-chloro-o-tolyloxy)propionic acid; [1] 2-(4-chloro-2-methylphenoxy)propionic acid [2] | 230-386-8 [1] | 202-264-4 [2] | 7085-19-0 [1] | 708519-0 [2] | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H315 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H315 | H318 | H410 |   | M=100 |  607-049-00-2 | мекопроп (ISO); 2-(4-хлоро-o-толилокси)пропионова киселина; (RS)-2-(4-хлоро-o-толилокси)пропионова киселина; [1] 2-(2-метил-4-хлорофенокси)пропионова киселина [2] | 230-386-8 [1] | 202-264-4 [2] | 7085-19-0 [1] | 708519-0 [2] | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H315 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H315 | H318 | H410 |   | M=100 |  
607-050-00-8 | salts of mecoprop | — | — | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H315 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H315 | H318 | H410 |   |   | A607-050-00-8 | соли на мекопроп | — | — | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H315 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H315 | H318 | H410 |   |   | A
607-051-00-3 | MCPA (ISO); 4-chloro-o-tolyloxyacetic acid | 202-360-6 | 94-74-6 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H315 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H315 | H318 | H410 |   |   |  607-051-00-3 | MCPA (ISO); 4-хлоро-o-толилоксиоцетна киселина | 202-360-6 | 94-74-6 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H315 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H315 | H318 | H410 |   |   |  
607-052-00-9 | salts and esters of MCPA | — | — | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   |   | A607-052-00-9 | соли и естери на MCPA | — | — | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   |   | A
607-053-00-4 | MCPB (ISO); 4-(4-chloro-o-tolyloxy) butyric acid | 202-365-3 | 94-81-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  607-053-00-4 | MCPB (ISO); 4-(4-хлоро-o-толилокси)маслена киселина | 202-365-3 | 94-81-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
607-054-00-X | salts and esters of MCPB | — | — | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   | A607-054-00-X | соли и естери на MCPB | — | — | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   | A
607-055-00-5 | endothal-sodium (ISO); disodium 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylate | 204-959-8 | 129-67-9 | Acute Tox. 3 * Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H301 | H312 | H319 | H335 | H315 | GHS06 | Dgr | H301 | H312 | H319 | H335 | H315 |   |   |  607-055-00-5 | ендотал-натрий (ISO); динатриев-7-oксабицикло[2.2.1]хептан-2,3-дикарбоксилат | 204-959-8 | 129-67-9 | Acute Tox. 3 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H301 | H312 | H319 | H335 | H315 | GHS06 | Dgr | H301 | H312 | H319 | H335 | H315 |   |   |  
607-057-00-6 | coumachlor (ISO); 3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin | 201-378-1 | 81-82-3 | STOT RE 2 * | Aquatic Chronic 3 | H373 ** H412 | GHS08 | Wng | H373 ** H412 |   |   |  607-057-00-6 | кумахлор (ISO); 3-[3-oксо-1-(4-хлорофенил)бутил]-4-хидроксикумарин | 201-378-1 | 81-82-3 | STOT RE 2 * | Aquatic Chronic 3 | H373 ** H412 | GHS08 | Wng | H373 ** H412 |   |   |  
607-058-00-1 | coumafuryl (ISO); fumarin; (RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin; 4-hydroxy-3-[3-oxo-1-(2-furyl)butyl]coumarin | 204-195-5 | 117-52-2 | Acute Tox. 3 * STOT RE 1 | Aquatic Chronic 3 | H301 | H372 ** H412 | GHS06 | GHS08 | Dgr | H301 | H372 ** H412 |   |   |  607-058-00-1 | кумафурил (ISO); фумарин; (RS)-3-(3-оксо-1-(2-фурил)бутил)-4-хидроксикумарин; 4-хидрокси-3-[3-oксо-1-(2-фурил)бутил]кумарин | 204-195-5 | 117-52-2 | Acute Tox. 3 * STOT RE 1 | Aquatic Chronic 3 | H301 | H372 ** H412 | GHS06 | GHS08 | Dgr | H301 | H372 ** H412 |   |   |  
607-060-00-2 | dicoumarol; 4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one) | 200-632-9 | 66-76-2 | STOT RE 1 | Acute Tox. 4 * | Aquatic Chronic 2 | H372 ** H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H372 ** H302 | H411 |   |   |  607-060-00-2 | дикумарол; 4,4′-дихидрокси-3,3′-метиленбис(2Н-хромен-2-он) | 200-632-9 | 66-76-2 | STOT RE 1 | Acute Tox. 4 * | Aquatic Chronic 2 | H372 ** H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H372 ** H302 | H411 |   |   |  
607-061-00-8 | acrylic acid; prop-2-enoic acid | 201-177-9 | 79-10-7 | Flam. Liq. 3 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | Skin Corr. 1A Aquatic Acute 1 | H226 | H332 | H312 | H302 | H314 | H400 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H226 | H332 | H312 | H302 | H314 | H400 |   | STOT SE 3; H335: C ≥ 1 % | D607-061-00-8 | акрилова киселина; проп-2-енова киселина | 201-177-9 | 79-10-7 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | Aquatic Acute 1 | H226 | H332 | H312 | H302 | H314 | H400 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H226 | H332 | H312 | H302 | H314 | H400 |   | STOT SE 3; H335: C ≥ 1 % | D
607-062-00-3 | n-butyl acrylate | 205-480-7 | 141-32-2 | Flam. Liq. 3 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | H226 | H319 | H335 | H315 | H317 | GHS02 | GHS07 | Wng | H226 | H319 | H335 | H315 | H317 |   |   | D607-062-00-3 | n-бутилов акрилат | 205-480-7 | 141-32-2 | Flam. Liq. 3 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | H226 | H319 | H335 | H315 | H317 | GHS02 | GHS07 | Wng | H226 | H319 | H335 | H315 | H317 |   |   | D
607-063-00-9 | isobutyric acid | 201-195-7 | 79-31-2 | Acute Tox. 4 * Acute Tox. 4 * | H312 | H302 | GHS07 | Wng | H312 | H302 |   |   |  607-063-00-9 | изомаслена киселина | 201-195-7 | 79-31-2 | Acute Tox. 4 * | Acute Tox. 4 * | H312 | H302 | GHS07 | Wng | H312 | H302 |   |   |  
607-064-00-4 | benzyl chloroformate | 207-925-0 | 501-53-1 | Skin Corr. 1B Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H400 | H410 | GHS05 | GHS09 | Dgr | H314 | H410 |   | STOT SE 3; H335: C ≥ 5 % |  607-064-00-4 | бензилов хлороформат | 207-925-0 | 501-53-1 | Skin Corr. 1B A | quatic Acute 1 | Aquatic Chronic 1 | H314 | H400 | H410 | GHS05 | GHS09 | Dgr | H314 | H410 |   | STOT SE 3; H335: C ≥ 5 % |  
607-065-00-X | bromoacetic acid | 201-175-8 | 79-08-3 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * | Skin Corr. 1A | Skin Sens. 1 | Aquatic Acute 1 | H331 | H311 | H301 | H314 | H317 | H400 | GHS06 | GHS05 | GHS09 | Dgr | H331 | H311 | H301 | H314 | H317 | H400 |   |   |  607-065-00-X | бромооцетна киселина | 201-175-8 | 79-08-3 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1A | Skin Sens. 1 | Aquatic Acute 1 | H331 | H311 | H301 | H314 | H317 | H400 | GHS06 | GHS05 | GHS09 | Dgr | H331 | H311 | H301 | H314 | H317 | H400 |   |   |  
607-066-00-5 | dichloroacetic acid | 201-207-0 | 79-43-6 | Skin Corr. 1A Aquatic Acute 1 | H314 | H400 | GHS05 | GHS09 | Dgr | H314 | H400 |   |   |  607-066-00-5 | дихлорооцетна киселина | 201-207-0 | 79-43-6 | Skin Corr. 1A | Aquatic Acute 1 | H314 | H400 | GHS05 | GHS09 | Dgr | H314 | H400 |   |   |  
607-067-00-0 | dichloroacetyl chloride | 201-199-9 | 79-36-7 | Skin Corr. 1A Aquatic Acute 1 | H314 | H400 | GHS05 | GHS09 | Dgr | H314 | H400 |   |   |  607-067-00-0 | дихлороацетилхлорид | 201-199-9 | 79-36-7 | Skin Corr. 1A | Aquatic Acute 1 | H314 | H400 | GHS05 | GHS09 | Dgr | H314 | H400 |   |   |  
607-068-00-6 | iodoacetic acid | 200-590-1 | 64-69-7 | Acute Tox. 3 * | Skin Corr. 1A | H301 | H314 | GHS06 | GHS05 | Dgr | H301 | H314 |   |   |  607-068-00-6 | йодооцетна киселина | 200-590-1 | 64-69-7 | Acute Tox. 3 * | Skin Corr. 1A | H301 | H314 | GHS06 | GHS05 | Dgr | H301 | H314 |   |   |  
607-069-00-1 | ethyl bromoacetate | 203-290-9 | 105-36-2 | Acute Tox. 2 * Acute Tox. 1 | Acute Tox. 2 * | H330 | H310 | H300 | GHS06 | Dgr | H330 | H310 | H300 |   |   |  607-069-00-1 | етилов бромоацетат | 203-290-9 | 105-36-2 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | H330 | H310 | H300 | GHS06 | Dgr | H330 | H310 | H300 |   |   |  
607-070-00-7 | ethyl chloroacetate | 203-294-0 | 105-39-5 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * Aquatic Acute 1 | H331 | H311 | H301 | H400 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H400 |   |   |  607-070-00-7 | етилов хлороацетат | 203-294-0 | 105-39-5 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | H331 | H311 | H301 | H400 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H400 |   |   |  
607-071-00-2 | ethyl methacrylate | 202-597-5 | 97-63-2 | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | H225 | H319 | H335 | H315 | H317 | GHS02 | GHS07 | Dgr | H225 | H319 | H335 | H315 | H317 |   |   | D607-071-00-2 | етилов метакрилат | 202-597-5 | 97-63-2 | Flam. Liq. 2 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | H225 | H319 | H335 | H315 | H317 | GHS02 | GHS07 | Dgr | H225 | H319 | H335 | H315 | H317 |   |   | D
607-072-00-8 | 2-hydroxyethyl acrylate | 212-454-9 | 818-61-1 | Acute Tox. 3 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | H311 | H314 | H317 | H400 | GHS06 | GHS05 | GHS09 | Dgr | H311 | H314 | H317 | H400 |   | * | Skin Sens. 1; H317: C ≥ 0,2  % | D607-072-00-8 | 2-хидроксиетилов акрилат | 212-454-9 | 818-61-1 | Acute Tox. 3 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | H311 | H314 | H317 | H400 | GHS06 | GHS05 | GHS09 | Dgr | H311 | H314 | H317 | H400 |   | * | Skin Sens. 1; H317: C ≥ 0,2  % | D
607-073-00-3 | 4-CPA (ISO); 4-chlorophenoxyacetic acid | 204-581-3 | 122-88-3 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  607-073-00-3 | 4-CPA (ISO); 4-хлорофеноксиоцетна киселина | 204-581-3 | 122-88-3 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
607-074-00-9 | chlorfenac(ISO); 2,3,6-trichlorophenylacetic acid | 201-599-3 | 85-34-7 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  607-074-00-9 | хлорфенак (ISO); 2,3,6-трихлорофенилоцетна киселина | 201-599-3 | 85-34-7 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
607-075-00-4 | chlorfenprop-methyl; methyl 2-chloro-3-(4-chlorophenyl)propionate | 238-413-5 | 14437-17-3 | Acute Tox. 4 * | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   |   |  607-075-00-4 | хлорфенпроп-метил; метилов 2-хлоро-3-(4-хлорофенил)пропионат | 238-413-5 | 14437-17-3 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   |   |  
607-076-00-X | dodine(ISO); dodecylguanidinium acetate | 219-459-5 | 2439-10-3 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H315 | H410 |   |   |  607-076-00-X | додин (ISO); додецилгуанидиниев ацетат | 219-459-5 | 2439-10-3 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H315 | H410 |   |   |  
607-077-00-5 | erbon (ISO); 2-(2,4,5-trichlorophenoxy)ethyl2,2-dichloropropionate | — | 136-25-4 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  607-077-00-5 | ербон (ISO); 2-(2,4,5-трихлорофенокси)етилов 2,2-дихлоропропионат | — | 136-25-4 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
607-078-00-0 | fluenetil (ISO); 2-fluoroethyl biphenyl-4-ylacetate | — | 4301-50-2 | Acute Tox. 1 | Acute Tox. 2 * | H310 | H300 | GHS06 | Dgr | H310 | H300 |   |   |  607-078-00-0 | флуенетил (ISO); 2-флуороетилов бифенил-4-илацетат | — | 4301-50-2 | Acute Tox. 1 | Acute Tox. 2 * | H310 | H300 | GHS06 | Dgr | H310 | H300 |   |   |  
607-079-00-6 | kelevan (ISO); ethyl 5-(perchloro-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoate; ethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate | — | 4234-79-1 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Chronic 2 | H311 | H302 | H411 | GHS06 | GHS09 | Dgr | H311 | H302 | H411 |   |   |  607-079-00-6 | келеван (ISO); етилов 5-(перхлоро-5-хидроксипентацикло[5.3.0.02,6.03,9.04,8]декан-5-ил)-4-оксопентаноат; етилов 5-(4- хидрокси-1,2,3,5,6,7,8,9,10,10-декахлоропентацикло [5.2.1.02,6.03,9.05,8]дец-4-ил)-4-оксовалерат | — | 4234-79-1 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Chronic 2 | H311 | H302 | H411 | GHS06 | GHS09 | Dgr | H311 | H302 | H411 |   |   |  
607-080-00-1 | chloroacetyl chloride | 201-171-6 | 79-04-9 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 | Skin Corr. 1A Aquatic Acute 1 | H331 | H311 | H301 | H372 ** H314 | H400 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H331 | H311 | H301 | H372 ** H314 | H400 | EUH014 | EUH029 |   |  607-080-00-1 | хлороацетилхлорид | 201-171-6 | 79-04-9 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | Skin Corr. 1A A | quatic Acute 1 | H331 | H311 | H301 | H372 ** | H314 | H400 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H331 | H311 | H301 | H372 ** H314 | H400 | EUH014 | EUH029 |   |  
607-081-00-7 | fluoroacetic acid | 205-631-7 | 144-49-0 | Acute Tox. 2 * Aquatic Acute 1 | H300 | H400 | GHS06 | GHS09 | Dgr | H300 | H400 |   |   |  607-081-00-7 | флуорооцетна киселина | 205-631-7 | 144-49-0 | Acute Tox. 2 * | Aquatic Acute 1 | H300 | H400 | GHS06 | GHS09 | Dgr | H300 | H400 |   |   |  
607-082-00-2 | fluoroacetates, soluble | — | — | Acute Tox. 2 * Aquatic Acute 1 | H300 | H400 | GHS06 | GHS09 | Dgr | H300 | H400 |   |   | A607-082-00-2 | разтворими флуорацетати | — | — | Acute Tox. 2 * | Aquatic Acute 1 | H300 | H400 | GHS06 | GHS09 | Dgr | H300 | H400 |   |   | A
607-083-00-8 | 2,4-DB (ISO); 4-(2,4-dichlorophenoxy)butyric acid | 202-366-9 | 94-82-6 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  607-083-00-8 | 2,4-DB (ISO); 4-(2,4-дихлорофенокси)маслена киселина | 202-366-9 | 94-82-6 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
607-084-00-3 | salts of 2,4-DB | — | — | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   | A607-084-00-3 | соли на 2,4-DB | — | — | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   | A
607-085-00-9 | benzyl benzoate | 204-402-9 | 120-51-4 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  607-085-00-9 | бензилов бензоат | 204-402-9 | 120-51-4 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
607-086-00-4 | diallyl phthalate | 205-016-3 | 131-17-9 | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  607-086-00-4 | диалилов фталат | 205-016-3 | 131-17-9 | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
607-088-00-5 | methacrylic acid; 2-methylpropenoic acid | 201-204-4 | 79-41-4 | Acute Tox. 4 * Acute Tox. 4 * | Skin Corr. 1A | H312 | H302 | H314 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 |   | STOT SE 3; H335: C ≥ 1 % | D607-088-00-5 | метакрилова киселина; 2-метилпропенова киселина | 201-204-4 | 79-41-4 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | H312 | H302 | H314 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 |   | STOT SE 3; H335: C ≥ 1 % | D
607-089-00-0 | propionic acid … % | 201-176-3 | 79-09-4 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H319 10 % ≤ C < 25 % | Eye Irrit. 2; H319: 10 % ≤ | C < 25 % | STOT SE 3; H335: C ≥ 10 % | B607-089-00-0 | пропионова киселина … % | 201-176-3 | 79-09-4 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   | Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H319 10 % ≤ C < 25 % | Eye Irrit. 2; H319: 10 % ≤ | C < 25 % | STOT SE 3; H335: C ≥ 10 % | B
607-090-00-6 | thioglycolic acid | 200-677-4 | 68-11-1 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * | Skin Corr. 1B | H331 | H311 | H301 | H314 | GHS06 | GHS05 | Dgr | H331 | H311 | H301 | H314 |   | * |  607-090-00-6 | тиогликолова киселина | 200-677-4 | 68-11-1 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | H331 | H311 | H301 | H314 | GHS06 | GHS05 | Dgr | H331 | H311 | H301 | H314 |   | * |  
607-091-00-1 | trifluoroacetic acid . . . % | 200-929-3 | 76-05-1 | Acute Tox. 4 * | Skin Corr. 1A | Aquatic Chronic 3 | H332 | H314 | H412 | GHS05 | GHS07 | Dgr | H332 | H314 | H412 |   | * | B607-091-00-1 | трифлуорооцетна киселина . . . % | 200-929-3 | 76-05-1 | Acute Tox. 4 * | Skin Corr. 1A | Aquatic Chronic 3 | H332 | H314 | H412 | GHS05 | GHS07 | Dgr | H332 | H314 | H412 |   | * | B
607-092-00-7 | methyl lactate; [1] methyl (±)-lactate; [2] methyl (R)-lactate; [3] methyl (S)-(-)-lactate [4] | 208-930-0 [1] | 218-449-8 [2] | 241-420-6 [3] | 248-704-9 [4] | 547-64-8 [1] | 2155-30-8 [2] | 17392-83-5 [3] | 27871-49-4 [4] | Flam. Liq. 3 | Eye Irrit. 2 | STOT SE 3 | H226 | H319 | H335 | GHS02 | GHS07 | Wng | H226 | H319 | H335 |   |   | C607-092-00-7 | метилов лактат; [1] метилов (±)-лактат; [2] метилов (R)-лактат; [3] метилов (S)-(-)-лактат [4] | 208-930-0 [1] | 218-449-8 [2] | 241-420-6 [3] | 248-704-9 [4] | 547-64-8 [1] | 2155-30-8 [2] | 17392-83-5 [3] | 27871-49-4 [4] | Flam. Liq. 3 | Eye Irrit. 2 | STOT SE 3 | H226 | H319 | H335 | GHS02 | GHS07 | Wng | H226 | H319 | H335 |   |   | C
607-093-00-2 | propionyl chloride | 201-170-0 | 79-03-8 | Flam. Liq. 2 | Skin Corr. 1B | H225 | H314 | GHS02 | GHS05 | Dgr | H225 | H314 | EUH014 |   | B D607-093-00-2 | пропионилхлорид | 201-170-0 | 79-03-8 | Flam. Liq. 2 | Skin Corr. 1B | H225 | H314 | GHS02 | GHS05 | Dgr | H225 | H314 | EUH014 |   | B D
607-094-00-8 | peracetic acid . . . % | 201-186-8 | 79-21-0 | Flam. Liq. 3 | Org. Perox. D **** Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A Aquatic Acute 1 | H226 | H242 | H332 | H312 | H302 | H314 | H400 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H226 | H242 | H332 | H312 | H302 | H314 | H400 |   | * | STOT SE 3; H335: C ≥ 1 % | B D607-094-00-8 | пероцетна киселина . . . % | 201-186-8 | 79-21-0 | Flam. Liq. 3 | Org. Perox. D **** | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | Aquatic Acute 1 | H226 | H242 | H332 | H312 | H302 | H314 | H400 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H226 | H242 | H332 | H312 | H302 | H314 | H400 |   | * | STOT SE 3; H335: C ≥ 1 % | B D
607-095-00-3 | maleic acid | 203-742-5 | 110-16-7 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | H302 | H319 | H335 | H315 | H317 | GHS07 | Wng | H302 | H319 | H335 | H315 | H317 |   | Skin Sens. 1; H317: C ≥0,1  % |  607-095-00-3 | малеинова киселина | 203-742-5 | 110-16-7 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | H302 | H319 | H335 | H315 | H317 | GHS07 | Wng | H302 | H319 | H335 | H315 | H317 |   | Skin Sens. 1; H317: C ≥0,1  % |  
607-096-00-9 | maleic anhydride | 203-571-6 | 108-31-6 | Acute Tox. 4 * | Skin Corr. 1B | Resp. Sens. 1 | Skin Sens. 1 | H302 | H314 | H334 | H317 | GHS08 | GHS05 | GHS07 | Dgr | H302 | H314 | H334 | H317 |   |   |  607-096-00-9 | малеинов анхидрид | 203-571-6 | 108-31-6 | Acute Tox. 4 * | Skin Corr. 1B | Resp. Sens. 1 | Skin Sens. 1 | H302 | H314 | H334 | H317 | GHS08 | GHS05 | GHS07 | Dgr | H302 | H314 | H334 | H317 |   |   |  
607-097-00-4 | benzene-1,2,4-tricarboxylic acid 1,2-anhydride; trimellitic anhydride | 209-008-0 | 552-30-7 | STOT SE 3 | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H335 | H318 | H334 | H317 | GHS08 | GHS05 | GHS07 | Dgr | H335 | H318 | H334 | H317 |   |   |  607-097-00-4 | бензен-1,2,4-трикарбоксилен 1,2-aнхидрид; тримелитов анхидрид | 209-008-0 | 552-30-7 | STOT SE 3 | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H335 | H318 | H334 | H317 | GHS08 | GHS05 | GHS07 | Dgr | H335 | H318 | H334 | H317 |   |   |  
607-098-00-X | benzene-1,2:4,5-tetracarboxylic dianhydride; benzene-1,2:4,5-tetracarboxylic dianhydride; pyromellitic dianhydride | 201-898-9 | 89-32-7 | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H318 | H334 | H317 | GHS08 | GHS05 | Dgr | H318 | H334 | H317 |   |   |  607-098-00-X | бензен-1,2:4,5-тетракарбоксилен дианхидрид; бензен-1,2:4,5-тетракарбоксилен дианхидрид; пиромелитов дианхидрид | 201-898-9 | 89-32-7 | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H318 | H334 | H317 | GHS08 | GHS05 | Dgr | H318 | H334 | H317 |   |   |  
607-099-00-5 | 1,2,3,6-tetrahydrophthalic anhydride; [1] cis-1,2,3,6-tetrahydrophthalicanhydride; [2] 3,4,5,6-tetrahydrophthalic anhydride; [3] tetrahydrophthalic anhydride [4] | 201-605-4 [1] | 213-308-7 [2] | 219-374-3 [3] | 247-570-9 [4] | 85-43-8 [1] | 935-79-5 [2] | 2426-02-0 [3] | 26266-63-7 [4] | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H334 | H317 | H412 | GHS08 | GHS05 | Dgr | H318 | H334 | H317 | H412 |   |   | C607-099-00-5 | 1,2,3,6-тeтрахидрофталов анхидрид; [1] цис-1,2,3,6-тeтрахидрофталов анхидрид; [2] 3,4,5,6-тeтрахидрофталов анхидрид; [3] тетрахидрофталов анхидрид [4] | 201-605-4 [1] | 213-308-7 [2] | 219-374-3 [3] | 247-570-9 [4] | 85-43-8 [1] | 935-79-5 [2] | 2426-02-0 [3] | 26266-63-7 [4] | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H334 | H317 | H412 | GHS08 | GHS05 | Dgr | H318 | H334 | H317 | H412 |   |   | C
607-100-00-9 | benzophenone-3,3',4,4'-tetracarboxylic dianhydride; 4,4'-carbonyldi(phthalic anhydride) | 219-348-1 | 2421-28-5 | Eye Irrit. 2 | STOT SE 3 | H319 | H335 | GHS07 | Wng | H319 | H335 |   | Eye Irrit 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |  607-100-00-9 | бензофенон-3,3′,4,4′-тетракарбоксилен дианхидрид; 4,4′-карбонилди(фталов анхидрид) | 219-348-1 | 2421-28-5 | Eye Irrit. 2 | STOT SE 3 | H319 | H335 | GHS07 | Wng | H319 | H335 |   | Eye Irrit 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |  
607-101-00-4 | 1,4,5,6,7,7-hexachlorobicyclo [2,2,1]hept-5-ene-2,3-dicarboxylicanhydride chlorendic anhydride | 204-077-3 | 115-27-5 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H319 | H335 | H315 | GHS07 | Wng | H319 | H335 | H315 |   | Skin Irrit.2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |  607-101-00-4 | 1,4,5,6,7,7-хексахлоробицикло[2.2.1]хепт-5-eн-2,3-дикарбоксилен анхидрид хексахлороендометилентетрахидрофталов анхидрид | 204-077-3 | 115-27-5 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H319 | H335 | H315 | GHS07 | Wng | H319 | H335 | H315 |   | Skin Irrit.2; H315: C ≥ 1 % Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |  
607-102-00-X | cyclohexane-1,2-dicarboxylic anhydride; [1] cis-cyclohexane-1,2-dicarboxylicanhydride; [2] trans-cyclohexane-1,2-dicarboxylic anhydride [3] | 201-604-9 [1] | 236-086-3 [2] | 238-009-9 [3] | 85-42-7 [1] | 13149-00-3 [2] | 14166-21-3 [3] | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H318 | H334 | H317 | GHS08 | GHS05 | Dgr | H318 | H334 | H317 |   |   | C607-102-00-X | циклохексан-1,2-дикарбоксилен анхидрид; [1] цис-циклохексан-1,2-дикарбоксилен анхидрид; [2] транс-циклохексан-1,2-дикарбоксилен анхидрид [3] | 201-604-9 [1] | 236-086-3 [2] | 238-009-9 [3] | 85-42-7 [1] | 13149-00-3 [2] | 14166-21-3 [3] | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H318 | H334 | H317 | GHS08 | GHS05 | Dgr | H318 | H334 | H317 |   |   | C
607-103-00-5 | succinic anhydride | 203-570-0 | 108-30-5 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | H302 | H319 | H335 | GHS07 | Wng | H302 | H319 | H335 |   | * | Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |  607-103-00-5 | янтарен анхидрид | 203-570-0 | 108-30-5 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | H302 | H319 | H335 | GHS07 | Wng | H302 | H319 | H335 |   | * | Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |  
607-104-00-0 | cyclopentane-1,2,3,4-tetracarboxylic dianhydride | 227-964-7 | 6053-68-5 | Eye Irrit. 2 | STOT SE 3 | H319 | H335 | GHS07 | Wng | H319 | H335 |   | Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |  607-104-00-0 | циклопентан-1,2,3,4-тетракарбоксилен дианхидрид | 227-964-7 | 6053-68-5 | Eye Irrit. 2 | STOT SE 3 | H319 | H335 | GHS07 | Wng | H319 | H335 |   | Eye Irrit. 2; H319: C ≥ 1 % STOT SE 3; H335: C ≥ 1 % |  
607-105-00-6 | 8,9,10-trinorborn-5-ene-2,3-dicarboxylic anhydride; [1] 1,2,3,6-tetrahydro-3,6-methanophthalic anhydride; [2] (1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride [3] | 204-957-7 [1] | 212-557-9 [2] | 220-384-5 [3] | 129-64-6 [1] | 826-62-0 [2] | 2746-19-2 [3] | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H318 | H334 | H317 | GHS08 | GHS05 | Dgr | H318 | H334 | H317 |   |   | C607-105-00-6 | 8,9,10-тринорборн-5-ен-2,3-дикарбоксилен анхидрид; [1] 1,2,3,6-тетрахидро-3,6-метанофталов анхидрид; [2] (1α,2α,3β,6β)-1,2,3,6-тетрахидро-3,6-метанофталов анхидрид [3] | 204-957-7 [1] | 212-557-9 [2] | 220-384-5 [3] | 129-64-6 [1] | 826-62-0 [2] | 2746-19-2 [3] | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H318 | H334 | H317 | GHS08 | GHS05 | Dgr | H318 | H334 | H317 |   |   | C
607-106-00-1 | 8,9-dinorborn-5-ene-2,3-dicarboxylic anhydride | — | 123748-85-6 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H302 | H319 | H335 | H315 | H334 | GHS08 | GHS07 | Dgr | H302 | H319 | H335 | H315 | H334 |   | STOT SE 3; H335: C ≥ 10 % | C607-106-00-1 | 8,9-динорборн-5-eн-2,3-дикарбоксилен анхидрид | — | 123748-85-6 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H302 | H319 | H335 | H315 | H334 | GHS08 | GHS07 | Dgr | H302 | H319 | H335 | H315 | H334 |   | STOT SE 3; H335: C ≥ 10 % | C
607-107-00-7 | 2-ethylhexyl acrylate | 203-080-7 | 103-11-7 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | H335 | H315 | H317 | GHS07 | Wng | H335 | H315 | H317 |   |   | D607-107-00-7 | 2-етилхексилов акрилат | 203-080-7 | 103-11-7 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | H335 | H315 | H317 | GHS07 | Wng | H335 | H315 | H317 |   |   | D
607-108-00-2 | 2-hydroxy-1-methylethylacrylate; [1] 2-hydroxypropylacrylate; [2] acrylic acid, monoester with propane-1,2-diol [3] | 220-852-9 [1] | 213-663-8 [2] | 247-118-0 [3] | 2918-23-2 [1] | 999-61-1 [2] | 25584-83-2 [3] | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * | Skin Corr. 1B | Skin Sens. 1 | H331 | H311 | H301 | H314 | H317 | GHS06 | GHS05 | Dgr | H331 | H311 | H301 | H314 | H317 |   | * | Skin Sens. 1; H317:C ≥0,2  % | C D607-108-00-2 | 2-хидрокси-1-метилетилов акрилат; [1] 2-хидроксипропилов акрилат; [2] моноестер на акриловата киселина с пропан-1,2-диол [3] | 220-852-9 [1] | 213-663-8 [2] | 247-118-0 [3] | 2918-23-2 [1] | 999-61-1 [2] | 25584-83-2 [3] | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | Skin Sens. 1 | H331 | H311 | H301 | H314 | H317 | GHS06 | GHS05 | Dgr | H331 | H311 | H301 | H314 | H317 |   | * | Skin Sens. 1; H317:C ≥0,2  % | C D
607-109-00-8 | hexamethylene diacrylate; hexane-1,6-diol diacrylate | 235-921-9 | 13048-33-4 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   |   | D607-109-00-8 | хексаметиленов диакрилат; хексан-1,6-диолов диакрилат | 235-921-9 | 13048-33-4 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   |   | D
607-110-00-3 | pentaerythritol triacrylate | 222-540-8 | 3524-68-3 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   |   | D607-110-00-3 | пентаеритритолов триакрилат | 222-540-8 | 3524-68-3 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   |   | D
607-111-00-9 | 2,2-bis(acryloyloxymethyl)butyl acrylate; trimethylolpropane triacrylate | 239-701-3 | 15625-89-5 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   |   | D607-111-00-9 | 2,2-бис(акрилоилоксиметил)бутилов акрилат; триметилолпропанов триакрилат | 239-701-3 | 15625-89-5 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   |   | D
607-112-00-4 | 2,2-dimethyltrimethylene diacrylate; neopentyl glycol diacrylate | 218-741-5 | 2223-82-7 | Acute Tox. 3 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H311 | H319 | H315 | H317 | GHS06 | Dgr | H311 | H319 | H315 | H317 |   | * | D607-112-00-4 | 2,2-диметилтриметиленов диакрилат; неопентилгликолов диакрилат | 218-741-5 | 2223-82-7 | Acute Tox. 3 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H311 | H319 | H315 | H317 | GHS06 | Dgr | H311 | H319 | H315 | H317 |   | * | D
607-113-00-X | isobutyl methacrylate | 202-613-0 | 97-86-9 | Flam. Liq. 3 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | H226 | H319 | H335 | H315 | H317 | H400 | GHS02 | GHS07 | GHS09 | Wng | H226 | H319 | H335 | H315 | H317 | H400 |   |   | D607-113-00-X | изобутилов метакрилат | 202-613-0 | 97-86-9 | Flam. Liq. 3 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | H226 | H319 | H335 | H315 | H317 | H400 | GHS02 | GHS07 | GHS09 | Wng | H226 | H319 | H335 | H315 | H317 | H400 |   |   | D
607-114-00-5 | ethylene dimethacrylate | 202-617-2 | 97-90-5 | STOT SE 3 | Skin Sens. 1 | H335 | H317 | GHS07 | Wng | H335 | H317 |   | STOT SE 3; H335: C ≥ 10 % | D607-114-00-5 | етиленов диметакрилат | 202-617-2 | 97-90-5 | STOT SE 3 | Skin Sens. 1 | H335 | H317 | GHS07 | Wng | H335 | H317 |   | STOT SE 3; H335: C ≥ 10 % | D
607-115-00-0 | isobutyl acrylate | 203-417-8 | 106-63-8 | Flam. Liq. 3 | Acute Tox. 4 * Acute Tox. 4 * | Skin Irrit. 2 | Skin Sens. 1 | H226 | H332 | H312 | H315 | H317 | GHS02 | GHS07 | Wng | H226 | H332 | H312 | H315 | H317 |   |   | D607-115-00-0 | изобутилов акрилат | 203-417-8 | 106-63-8 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Skin Sens. 1 | H226 | H332 | H312 | H315 | H317 | GHS02 | GHS07 | Wng | H226 | H332 | H312 | H315 | H317 |   |   | D
607-116-00-6 | cyclohexyl acrylate | 221-319-3 | 3066-71-5 | STOT SE 3 | Skin Irrit. 2 | Aquatic Chronic 2 | H335 | H315 | H411 | GHS07 | GHS09 | Wng | H335 | H315 | H411 |   | STOT SE 3; H335: C ≥ 10 % | D607-116-00-6 | циклохексилов акрилат | 221-319-3 | 3066-71-5 | STOT SE 3 | Skin Irrit. 2 | Aquatic Chronic 2 | H335 | H315 | H411 | GHS07 | GHS09 | Wng | H335 | H315 | H411 |   | STOT SE 3; H335: C ≥ 10 % | D
607-117-00-1 | 2,3-epoxypropyl acrylate; glycidyl acrylate | 203-440-3 | 106-90-1 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * | Skin Corr. 1B | Skin Sens. 1 | H331 | H311 | H301 | H314 | H317 | GHS06 | GHS05 | Dgr | H331 | H311 | H301 | H314 | H317 |   | * | Skin Sens. 1; H317:C ≥0,2  % | D607-117-00-1 | 2,3-епоксипропилов акрилат; глицидилов акрилат | 203-440-3 | 106-90-1 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | Skin Sens. 1 | H331 | H311 | H301 | H314 | H317 | GHS06 | GHS05 | Dgr | H331 | H311 | H301 | H314 | H317 |   | * | Skin Sens. 1; H317:C ≥0,2  % | D
607-118-00-7 | 1-methyltrimethylene diacrylate; 1,3-butylene glycol diacrylate | 243-105-9 | 19485-03-1 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | H312 | H314 | H317 | GHS05 | GHS07 | Dgr | H312 | H314 | H317 |   |   | D607-118-00-7 | 1-метилтриметиленов диакрилат; 1,3-бутиленгликолов диакрилат | 243-105-9 | 19485-03-1 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | H312 | H314 | H317 | GHS05 | GHS07 | Dgr | H312 | H314 | H317 |   |   | D
607-119-00-2 | tetramethylene diacrylate; 1,4-butyleneglycol diacrylate | 213-979-6 | 1070-70-8 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | H312 | H314 | H317 | GHS05 | GHS07 | Dgr | H312 | H314 | H317 |   |   | D607-119-00-2 | тетраметиленов диакрилат; 1,4-бутиленгликолов диакрилат | 213-979-6 | 1070-70-8 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | H312 | H314 | H317 | GHS05 | GHS07 | Dgr | H312 | H314 | H317 |   |   | D
607-120-00-8 | 2,2'-oxydiethyl diacrylate; diethylene glycol diacrylate | 223-791-6 | 4074-88-8 | Acute Tox. 3 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H311 | H319 | H315 | H317 | GHS06 | Dgr | H311 | H319 | H315 | H317 |   | * | Skin Sens. 1; H317:C≥0,2  % | D607-120-00-8 | 2,2′-оксидиетилов диакрилат; диетиленгликолов диакрилат | 223-791-6 | 4074-88-8 | Acute Tox. 3 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H311 | H319 | H315 | H317 | GHS06 | Dgr | H311 | H319 | H315 | H317 |   | * | Skin Sens. 1; H317:C≥0,2  % | D
607-121-00-3 | 8,9,10-trinorborn-2-yl acrylate | — | 10027-06-2 | Acute Tox. 4 * | Skin Irrit. 2 | Skin Sens. 1 | H312 | H315 | H317 | GHS07 | Wng | H312 | H315 | H317 |   |   | D607-121-00-3 | 8,9,10-тринорборн-2-илов акрилат | — | 10027-06-2 | Acute Tox. 4 * | Skin Irrit. 2 | Skin Sens. 1 | H312 | H315 | H317 | GHS07 | Wng | H312 | H315 | H317 |   |   | D
607-122-00-9 | pentaerythritol tetraacrylate | 225-644-1 | 4986-89-4 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   |   | D607-122-00-9 | пентаеритритолов тетраакрилат | 225-644-1 | 4986-89-4 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   |   | D
607-124-00-X | 2-hydroxyethyl methacrylate | 212-782-2 | 868-77-9 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   |   | D607-124-00-X | 2-хидроксиетилов метакрилат | 212-782-2 | 868-77-9 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   |   | D
607-125-00-5 | 2-hydroxypropyl methacrylate; [1] 3-hydroxypropyl methacrylate[2] | 213-090-3 [1] | 220-426-2 [2] | 923-26-2 [1] | 2761-09-3 [2] | Eye Irrit. 2 | Skin Sens. 1 | H319 | H317 | GHS07 | Wng | H319 | H317 |   |   | C D607-125-00-5 | 2-хидроксипропилов метакрилат; [1] 3-хидроксипропилов метакрилат [2] | 213-090-3 [1] | 220-426-2 [2] | 923-26-2 [1] | 2761-09-3 [2] | Eye Irrit. 2 | Skin Sens. 1 | H319 | H317 | GHS07 | Wng | H319 | H317 |   |   | C D
607-126-00-0 | 2,2'-(ethylenedioxy)diethyl diacrylate; triethylene glycol diacrylate | 216-853-9 | 1680-21-3 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   |   | D607-126-00-0 | 2,2′-(етилендиокси)диетилов диакрилат; триетиленгликолов диакрилат | 216-853-9 | 1680-21-3 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   |   | D
607-127-00-6 | 2-diethylaminoethyl methacrylate | 203-275-7 | 105-16-8 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H332 | H319 | H315 | H317 | GHS07 | Wng | H332 | H319 | H315 | H317 |   |   | D607-127-00-6 | 2-диетиламиноетилов метакрилат | 203-275-7 | 105-16-8 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H332 | H319 | H315 | H317 | GHS07 | Wng | H332 | H319 | H315 | H317 |   |   | D
607-128-00-1 | 2-tert-butylaminoethyl methacrylate | 223-228-4 | 3775-90-4 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   |   | D607-128-00-1 | 2-трет-бутиламиноетилов метакрилат | 223-228-4 | 3775-90-4 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   |   | D
607-129-00-7 | ethyl lactate; ethyl DL-lactate; [1] ethyl (S)-2-hydroxypropionate; ethyl L-lactate; ethyl-(S)-lactate [2] | 202-598-0 [1] | 211-694-1 [2] | 97-64-3 [1] | 687-47-8 [2] | Flam. Liq. 3 | STOT SE 3 | Eye Dam. 1 | H226 | H335 | H318 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H335 | H318 |   |   | C607-129-00-7 | етилов лактат; етилов DL-лактат; [1] етилов (S)-2-хидроксипропионат; етилов L-лактат; етилов-(S)-лактат [2] | 202-598-0 [1] | 211-694-1 [2] | 97-64-3 [1] | 687-47-8 [2] | Flam. Liq. 3 | STOT SE 3 | Eye Dam. 1 | H226 | H335 | H318 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H335 | H318 |   |   | C
607-130-00-2 | pentyl acetate; [1] isopentyl acetate; [2] 1-methylbutyl acetate; [3] 2-methylbutyl acetat; [4] 2(or 3)-methylbutyl acetate [5] | 211-047-3 [1] | 204-662-3 [2] | 210-946-8 [3] | 210-843-8 [4] | 282-263-3 [5] | 628-63-7 [1] | 123-92-2 [2] | 626-38-0 [3] | 624-41-9 [4] | 84145-37-9 [5] | Flam. Liq. 3 | H226 | GHS02 | Wng | H226 | EUH066 |   | C607-130-00-2 | пентилов ацетат; [1] изопентилов ацетат; [2] 1-мeтилбутилов ацетат; [3] 2-мeтилбутилов ацетат; [4] 2(или 3)-мeтилбутилов ацетат [5] | 211-047-3 [1] | 204-662-3 [2] | 210-946-8 [3] | 210-843-8 [4] | 282-263-3 [5] | 628-63-7 [1] | 123-92-2 [2] | 626-38-0 [3] | 624-41-9 [4] | 84145-37-9 [5] | Flam. Liq. 3 | H226 | GHS02 | Wng | H226 | EUH066 |   | C
607-131-00-8 | isopentyl propionate; [1] pentyl propionate; [2] 2-methylbutyl propionate [3] | 203-322-1 [1] | 210-852-7 [2] | 219-449-0 [3] | 105-68-0 [1] | 624-54-4 [2] | 2438-20-2 [3] | Flam. Liq. 3 | H226 | GHS02 | Wng | H226 |   |   | C607-131-00-8 | изопентилов пропионат; [1] пентилов пропионат; [2] 2-метилбутилов пропионат [3] | 203-322-1 [1] | 210-852-7 [2] | 219-449-0 [3] | 105-68-0 [1] | 624-54-4 [2] | 2438-20-2 [3] | Flam. Liq. 3 | H226 | GHS02 | Wng | H226 |   |   | C
607-132-00-3 | 2-dimethylaminoethyl methacrylate | 220-688-8 | 2867-47-2 | Acute Tox. 4 * Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H312 | H302 | H319 | H315 | H317 | GHS07 | Wng | H312 | H302 | H319 | H315 | H317 |   |   | D607-132-00-3 | 2-диметиламиноетилов метакрилат | 220-688-8 | 2867-47-2 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H312 | H302 | H319 | H315 | H317 | GHS07 | Wng | H312 | H302 | H319 | H315 | H317 |   |   | D
607-133-00-9 | monoalkylor monoaryl or monoalkylaryl esters of acrylic acid with the exception of those specified elsewhere in this Annex | — | — | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Chronic 2 | H319 | H335 | H315 | H411 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H411 |   | STOT SE 3; H335: C ≥ 10 % | A607-133-00-9 | моноалкилови, моноарилови или моноалкиларилови естери на акриловата киселина с изключение на тези, посочени другаде в настоящото приложение | — | — | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Chronic 2 | H319 | H335 | H315 | H411 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H411 |   | STOT SE 3; H335: C ≥ 10 % | A
607-134-00-4 | monoalkyl or monoaryl or monoalkyaryl esters of methacrylic acid with the exception of those specified elsewhere in this Annex | — | — | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H319 | H335 | H315 | GHS07 | Wng | H319 | H335 | H315 |   | STOTSE 3; H335: C ≥ 10 % | A607-134-00-4 | моноалкилови, моноарилови или моноалкиларилови естери на метакриловата киселина с изключение на тези, посочени другаде в настоящото приложение | — | — | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H319 | H335 | H315 | GHS07 | Wng | H319 | H335 | H315 |   | STOTSE 3; H335: C ≥ 10 % | A
607-135-00-X | butyric acid | 203-532-3 | 107-92-6 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   |   |  607-135-00-X | маслена киселина | 203-532-3 | 107-92-6 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   |   |  
607-136-00-5 | butyryl chloride | 205-498-5 | 141-75-3 | Flam. Liq. 2 | Skin Corr. 1B | H225 | H314 | GHS02 | GHS05 | Dgr | H225 | H314 |   |   |  607-136-00-5 | бутирилхлорид | 205-498-5 | 141-75-3 | Flam. Liq. 2 | Skin Corr. 1B | H225 | H314 | GHS02 | GHS05 | Dgr | H225 | H314 |   |   |  
607-137-00-0 | methyl acetoacetate | 203-299-8 | 105-45-3 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  607-137-00-0 | метилов ацетоацетат | 203-299-8 | 105-45-3 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
607-138-00-6 | butyl chloroformate; chloroformic acid butyl ester | 209-750-5 | 592-34-7 | Flam. Liq. 3 | Acute Tox. 3 * | Skin Corr. 1B | H226 | H331 | H314 | GHS02 | GHS06 | GHS05 | Dgr | H226 | H331 | H314 |   |   |  607-138-00-6 | бутилов хлороформат; бутилов естер на хлоромравчената киселина | 209-750-5 | 592-34-7 | Flam. Liq. 3 | Acute Tox. 3 * | Skin Corr. 1B | H226 | H331 | H314 | GHS02 | GHS06 | GHS05 | Dgr | H226 | H331 | H314 |   |   |  
607-139-00-1 | 2-chloropropionic acid | 209-952-3 | 598-78-7 | Acute Tox. 4 * | Skin Corr. 1A | H302 | H314 | GHS05 | GHS07 | Dgr | H302 | H314 |   |   |  607-139-00-1 | 2-хлоропропионова киселина | 209-952-3 | 598-78-7 | Acute Tox. 4 * | Skin Corr. 1A | H302 | H314 | GHS05 | GHS07 | Dgr | H302 | H314 |   |   |  
607-140-00-7 | isobutyryl chloride | 201-194-1 | 79-30-1 | Flam. Liq. 2 | Skin Corr. 1A | H225 | H314 | GHS02 | GHS05 | Dgr | H225 | H314 |   |   |  607-140-00-7 | изобутирилхлорид | 201-194-1 | 79-30-1 | Flam. Liq. 2 | Skin Corr. 1A | H225 | H314 | GHS02 | GHS05 | Dgr | H225 | H314 |   |   |  
607-141-00-2 | oxydiethylene bis(chloroformate) | 203-430-9 | 106-75-2 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H315 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H315 | H318 | H411 |   |   |  607-141-00-2 | оксидиетиленбис(хлороформат) | 203-430-9 | 106-75-2 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H315 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H315 | H318 | H411 |   |   |  
607-142-00-8 | propyl chloroformate; chloroformic acid propylester; n-propyl chloroformate | 203-687-7 | 109-61-5 | Flam. Liq. 2 | Acute Tox. 3 * | Skin Corr. 1B | H225 | H331 | H314 | GHS02 | GHS06 | GHS05 | Dgr | H225 | H331 | H314 |   |   |  607-142-00-8 | пропилов хлороформат; пропилов естер на хлоромравчената киселина n-пропилов хлороформат | 203-687-7 | 109-61-5 | Flam. Liq. 2 | Acute Tox. 3 * | Skin Corr. 1B | H225 | H331 | H314 | GHS02 | GHS06 | GHS05 | Dgr | H225 | H331 | H314 |   |   |  
607-143-00-3 | valeric acid | 203-677-2 | 109-52-4 | Skin Corr. 1B | Aquatic Chronic 3 | H314 | H412 | GHS05 | Dgr | H314 | H412 |   |   |  607-143-00-3 | валерианова киселина | 203-677-2 | 109-52-4 | Skin Corr. 1B | Aquatic Chronic 3 | H314 | H412 | GHS05 | Dgr | H314 | H412 |   |   |  
607-144-00-9 | adipic acid | 204-673-3 | 124-04-9 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  607-144-00-9 | адипинова киселина | 204-673-3 | 124-04-9 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
607-145-00-4 | methanesulphonic acid | 200-898-6 | 75-75-2 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   |   |  607-145-00-4 | метансулфонова киселина | 200-898-6 | 75-75-2 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   |   |  
607-146-00-X | fumaric acid | 203-743-0 | 110-17-8 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  607-146-00-X | фумарова киселина | 203-743-0 | 110-17-8 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
607-147-00-5 | oxalic acid diethylester; diethyl oxalate | 202-464-1 | 95-92-1 | Acute Tox. 4 * | Eye Irrit. 2 | H302 | H319 | GHS07 | Wng | H302 | H319 |   |   |  607-147-00-5 | диетилов естер на оксаловата киселина; диетилов оксалат | 202-464-1 | 95-92-1 | Acute Tox. 4 * | Eye Irrit. 2 | H302 | H319 | GHS07 | Wng | H302 | H319 |   |   |  
607-148-00-0 | guanidinium chloride; guanadine hydrochloride | 200-002-3 | 50-01-1 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | H302 | H319 | H315 | GHS07 | Wng | H302 | H319 | H315 |   |   |  607-148-00-0 | гуанидиниев хлорид; гуанидинхидрохлорид | 200-002-3 | 50-01-1 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | H302 | H319 | H315 | GHS07 | Wng | H302 | H319 | H315 |   |   |  
607-149-00-6 | urethane (INN); ethyl carbamate | 200-123-1 | 51-79-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  607-149-00-6 | уретан (INN); етилов карбамат | 200-123-1 | 51-79-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
607-150-00-1 | endothal (ISO); 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylic acid | 205-660-5 | 145-73-3 | Acute Tox. 3 * Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H301 | H312 | H319 | H335 | H315 | GHS06 | Dgr | H301 | H312 | H319 | H335 | H315 |   |   |  607-150-00-1 | ендотал (ISO); 7-оксабицикло[2.2.1]хептан-2,3-дикарбоксилна киселина | 205-660-5 | 145-73-3 | Acute Tox. 3 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H301 | H312 | H319 | H335 | H315 | GHS06 | Dgr | H301 | H312 | H319 | H335 | H315 |   |   |  
607-151-00-7 | propargite (ISO); 2-(4-tert-butylphenoxy)cyclohexyl prop-2-ynyl sulphite | 219-006-1 | 2312-35-8 | Carc. 2 | Acute Tox. 3 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H331 | H315 | H318 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H351 | H331 | H315 | H318 | H410 |   | M = 10 |  607-151-00-7 | пропаргит (ISO); 2-(4-трет-бутилфенокси)циклохексилпроп-2-инилсулфит | 219-006-1 | 2312-35-8 | Carc. 2 | Acute Tox. 3 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H331 | H315 | H318 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H351 | H331 | H315 | H318 | H410 |   | M = 10 |  
607-152-00-2 | 2,3,6-TBA (ISO); 2,3,6-trichlorobenzoic acid | 200-026-4 | 50-31-7 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  607-152-00-2 | 2,3,6-TBA (ISO); 2,3,6-трихлоробензоена киселина | 200-026-4 | 50-31-7 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
607-153-00-8 | benazolin (ISO); 4-chloro-2,3-dihydro-2-oxo-1,3-benzothiazol-3-ylacetic acid | 223-297-0 | 3813-05-6 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 3 | H319 | H315 | H412 | GHS07 | Wng | H319 | H315 | H412 |   |   |  607-153-00-8 | бeназолин (ISO); 2-оксо-2,3-дихидро-4-хлоро-1,3-бензотиазол-3- илоцетна киселина | 223-297-0 | 3813-05-6 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 3 | H319 | H315 | H412 | GHS07 | Wng | H319 | H315 | H412 |   |   |  
607-154-00-3 | ethyl N-benzoyl-N-(3,4-dichlorophenyl)-DL-alaninate; benzoylprop-ethyl (ISO) | 244-845-5 | 22212-55-1 | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  607-154-00-3 | етилов N-бензоил-N-(3,4-дихлорофенил)-DL-aланинат; бензоилпроп-eтил (ISO) | 244-845-5 | 22212-55-1 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
607-155-00-9 | 3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylic acid; blasticidin-s | — | 2079-00-7 | Acute Tox. 2 * | H300 | GHS06 | Dgr | H300 |   |   |  607-155-00-9 | 3-(3-амино-5-(1-метилгуанидино)-1-oксопентиламино-6-(4-aмино-2-oксо-2,3-дихидропиримидин-1-ил)-2,3-дихидро-(6H)-пиран-2-карбоксилна киселина; бластицидин-S | — | 2079-00-7 | Acute Tox. 2 * | H300 | GHS06 | Dgr | H300 |   |   |  
607-156-00-4 | chlorfenson (ISO); 4-chlorophenyl 4-chlorobenzenesulfonate | 201-270-4 | 80-33-1 | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H315 | H410 |   |   |  607-156-00-4 | хлорфенсон (ISO); 4-хлорофенилов 4-хлоробензенсулфонат | 201-270-4 | 80-33-1 | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H315 | H410 |   |   |  
607-158-00-5 | sodium salt of chloroacetic acid; sodium chloroacetate | 223-498-3 | 3926-62-3 | Acute Tox. 3 * | Skin Irrit. 2 | Aquatic Acute 1 | H301 | H315 | H400 | GHS06 | GHS09 | Dgr | H301 | H315 | H400 |   |   |  607-158-00-5 | натриева сол на хлорооцетната киселина; натриев хлороацетат | 223-498-3 | 3926-62-3 | Acute Tox. 3 * | Skin Irrit. 2 | Aquatic Acute 1 | H301 | H315 | H400 | GHS06 | GHS09 | Dgr | H301 | H315 | H400 |   |   |  
607-159-00-0 | chlorobenzilate (ISO); ethyl 2,2-di(4-chlorophenyl)-2-hydroxyacetate; ethyl 4,4'-dichlorobenzilate | 208-110-2 | 510-15-6 | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  607-159-00-0 | хлоробензилат (ISO); етилов 2,2-ди(4-хлорофенил)-2-хидроксиацетат; етилов 4,4′-дихлоробензилат | 208-110-2 | 510-15-6 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
607-160-00-6 | isobutyl 2-(4-(4-chlorophenoxy)phenoxy)propionate; clofop-isobutyl (ISO) | — | 51337-71-4 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  607-160-00-6 | изобутилов 2-(4-(4-хлорофенокси)фенокси)пропионат; клофоп-изобутил (ISO) | — | 51337-71-4 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
607-161-00-1 | diethanolamine salt of 4-CPA | — | — | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  607-161-00-1 | диетаноламинова сол на 4-CPA | — | — | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
607-162-00-7 | dalapon; 2,2-dichloropropionic acid; [1] dalapon-sodium; sodium 2,2-dichloropropionate[2] | 200-923-0 [1] | 204-828-5 [2] | 75-99-0 [1] | 127-20-8 [2] | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H315 | H318 | H412 | GHS05 | Dgr | H315 | H318 | H412 |   |   |  607-162-00-7 | далапон; 2,2-дихлоропропионова киселина; [1] далапон-натрий; натриев 2,2-дихлоропропионат [2] | 200-923-0 [1] | 204-828-5 [2] | 75-99-0 [1] | 127-20-8 [2] | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H315 | H318 | H412 | GHS05 | Dgr | H315 | H318 | H412 |   |   |  
607-163-00-2 | 3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione; dehydracetic acid | 208-293-9 | 520-45-6 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  607-163-00-2 | 3-ацетил-6-метил-2H-пиран-2,4(3H)-дион; дехидроцетна киселина | 208-293-9 | 520-45-6 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
607-164-00-8 | sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethonolate; sodium dehydracetate | 224-580-1 | 4418-26-2 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  607-164-00-8 | натриев 1-(6-метил-2,4-диоксо-3,4-дихидро-2H-пиран-3-илиден)eтанолат; натриев дехидрацетат | 224-580-1 | 4418-26-2 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
607-165-00-3 | diclofop-methyl (ISO)methyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate; methyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate; | 257-141-8 | 51338-27-3 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  607-165-00-3 | диклофоп-метил (ISO);мeтилов 2-(4-(2,4-дихлорофенокси)фенокси)пропионат; метилов (RS)-2-[4-(2,4-дихлорофенокси)фенокси]пропионат; | 257-141-8 | 51338-27-3 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  
607-166-00-9 | medinoterb acetate (ISO); 6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate | 219-634-6 | 2487-01-6 | Acute Tox. 3 * Acute Tox. 4 * | H301 | H312 | GHS06 | Dgr | H301 | H312 |   |   |  607-166-00-9 | мeдинотерб ацетат (ISO); 6-трет-бутил-3-метил-2,4-динитрофенилов ацетат | 219-634-6 | 2487-01-6 | Acute Tox. 3 * | Acute Tox. 4 * | H301 | H312 | GHS06 | Dgr | H301 | H312 |   |   |  
607-167-00-4 | sodium 3-chloroacrylate | — | 4312-97-4 | Acute Tox. 4 * Acute Tox. 4 * | H312 | H302 | GHS07 | Wng | H312 | H302 |   |   |  607-167-00-4 | натриев 3-хлороакрилат | — | 4312-97-4 | Acute Tox. 4 * | Acute Tox. 4 * | H312 | H302 | GHS07 | Wng | H312 | H302 |   |   |  
607-168-00-X | dipropyl 6,7-methylenedioxy-1,2,3,4-tetrahydro-3-methylnaphthalene-1,2-dicarboxylate; propylisome | — | 83-59-0 | Acute Tox. 3 * | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H311 | H302 | H400 | H410 | GHS06 | GHS09 | Dgr | H311 | H302 | H410 |   |   |  607-168-00-X | дипропилов 6,7-метилендиокси-1,2,3,4-тетрахидро-3-метилнафтален-1,2-дикарбоксилат; пропилисом | — | 83-59-0 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H311 | H302 | H400 | H410 | GHS06 | GHS09 | Dgr | H311 | H302 | H410 |   |   |  
607-169-00-5 | sodium fluoroacetate | 200-548-2 | 62-74-8 | Acute Tox. 2 * Acute Tox. 1 | Acute Tox. 2 * Aquatic Acute 1 | H330 | H310 | H300 | H400 | GHS06 | GHS09 | Dgr | H330 | H310 | H300 | H400 |   |   |  607-169-00-5 | натриев флуороацетат | 200-548-2 | 62-74-8 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | H330 | H310 | H300 | H400 | GHS06 | GHS09 | Dgr | H330 | H310 | H300 | H400 |   |   |  
607-170-00-0 | bis(1,2,3-trithiacyclohexyldimethylammonium) oxalate; thiocyclam-oxalate | 250-859-2 | 31895-22-4 | Acute Tox. 4 * | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   |   |  607-170-00-0 | бис(1,2,3-тритиациклохексилдиметиламониев) oксалат; тиоциклам-oксалат | 250-859-2 | 31895-22-4 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   |   |  
607-173-00-7 | dimethyl (3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionate | 400-460-6 | — | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  607-173-00-7 | диметилов (3-метил-4-(5-нитро-3-eтоксикарбонил-2-тиенил)aзо)фенилнитрилодипропионат | 400-460-6 | — | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
607-174-00-2 | reaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate | 400-580-9 | — | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  607-174-00-2 | реакционна маса от додецилов 3-(2,2,4,4-тетраметил-21-oксо-7-oкса-3,20-диазадиспиро[5.1.11.2]хеникозан-20-ил)пропионат и тетрадецилов 3-(2,2,4,4-тетраметил-21-oксо-7-oкса-3,20-диазадиспиро[5.1.11.2]хеникозан-20-ил)пропионат | 400-580-9 | — | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
607-175-00-8 | methyl 2-(2-nitrobenzylidene)acetoacetate | 400-650-9 | 39562-27-1 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  607-175-00-8 | мeтилов 2-(2-нитробензилиден)aцетоацетат | 400-650-9 | 39562-27-1 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
607-176-00-3 | reaction mass of α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylene) and α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene) | 400-830-7 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  607-176-00-3 | реакционна маса от α-3-(3-(2H-бензотриазол-2-ил)-5-трет-бутил-4-хидроксифенил)пропионил-ω-хидроксиполи(oксиетилен) и α-3-(3-(2H-бензотриазол-2-ил)-5-трет-бутил-4-хидроксифенил)пропионил-ω-3-(3-(2H-бензотриазол-2-ил)-5-трет-бутил-4-хидроксифенил)пропионилоксиполи(оксиетилен) | 400-830-7 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
607-177-00-9 | tribenuron-methyl (ISO); 2-[4-methoxy-6-methyl-1,3,5-triazin-2-yl(methyl)carbamoylsulfamoyl]benzoic acid methyl ester; methyl 2-(3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3methylureidosulfonyl)benzoate | 401-190-1 | 101200-48-0 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   | M = 100 |  607-177-00-9 | трибенурон-метил (ISO) метилов естер на 2-[6-метил-4-метокси-1,3,5-триазин-2-ил(метил)карбамоилсулфамоил]бензоената киселина;мeтилов 2-(3-(6-метил-4-метокси-1,3,5-триазин-2-ил)-3-метилуреидосулфонил)бензоат | 401-190-1 | 101200-48-0 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   | M = 100 |  
607-178-00-4 | methyl α-((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate | 401-340-6 | 83055-99-6 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  607-178-00-4 | мeтилов α-((4,6-диметоксипиримидин-2-ил)уреидосулфонил)-o-толуат | 401-340-6 | 83055-99-6 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
607-179-00-X | (benzothiazol-2-ylthio)succinic acid | 401-450-4 | 95154-01-1 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-179-00-X | (бензотиазол-2-илтио)янтарна киселина | 401-450-4 | 95154-01-1 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-180-00-5 | potassium 2-hydroxycarbazole-1-carboxylate | 401-630-2 | 96566-70-0 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Aquatic Chronic 3 | H302 | H319 | H335 | H412 | GHS07 | Wng | H302 | H319 | H335 | H412 |   |   |  607-180-00-5 | калиев 2-хидроксикарбазол-1-карбоксилат | 401-630-2 | 96566-70-0 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Aquatic Chronic 3 | H302 | H319 | H335 | H412 | GHS07 | Wng | H302 | H319 | H335 | H412 |   |   |  
607-181-00-0 | 3,5-dichloro-2,4-difluorobenzoyl fluoride | 401-800-6 | 101513-70-6 | Acute Tox. 3 * | Skin Corr. 1B | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 3 | H331 | H314 | H302 | H317 | H412 | GHS06 | GHS05 | Dgr | H331 | H314 | H302 | H317 | H412 | EUH029 |   |  607-181-00-0 | 2,4-дифлуоро-3,5-дихлоробензоилфлуорид | 401-800-6 | 101513-70-6 | Acute Tox. 3 * | Skin Corr. 1B | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 3 | H331 | H314 | H302 | H317 | H412 | GHS06 | GHS05 | Dgr | H331 | H314 | H302 | H317 | H412 | EUH029 |   |  
607-182-00-6 | methyl 3-sulphamoyl-2-thenoate | 402-050-2 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-182-00-6 | мeтилов 3-сулфамоил-2-теноат | 402-050-2 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-183-00-1 | zinc 2-hydroxy-5-C13-18 alkylbenzoate | 402-280-3 | — | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 2 | H319 | H315 | H411 | GHS07 | GHS09 | Wng | H319 | H315 | H411 |   |   |  607-183-00-1 | цинков 2-хидрокси-5-C13-18-aлкилбензоат | 402-280-3 | — | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 2 | H319 | H315 | H411 | GHS07 | GHS09 | Wng | H319 | H315 | H411 |   |   |  
607-184-00-7 | S-(3-trimethoxysilyl)propyl 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanethioate | 402-290-8 | 85702-90-5 | Flam. Liq. 3 | Resp. Sens. 1 | Skin Sens. 1 | H226 | H334 | H317 | GHS02 | GHS08 | Dgr | H226 | H334 | H317 |   |   |  607-184-00-7 | S-(3-триметоксисилил)пропилов 10,12-диоксо-19-изоцианоато-11-(6-изоцианатохексил)-2,9,11,13-тетраазанонадекантиоат | 402-290-8 | 85702-90-5 | Flam. Liq. 3 | Resp. Sens. 1 | Skin Sens. 1 | H226 | H334 | H317 | GHS02 | GHS08 | Dgr | H226 | H334 | H317 |   |   |  
607-185-00-2 | ethyl trans-3-dimethylaminoacrylate | 402-650-4 | 1117-37-9 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-185-00-2 | етилов транс-3-диметиламиноакрилат | 402-650-4 | 1117-37-9 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-186-00-8 | quinclorac (ISO); 3,7-dichloroquinoline-8-carboxylic acid | 402-780-1 | 84087-01-4 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-186-00-8 | хинклорак (ISO); 3,7-дихлорохинолин-8-карбоксилна киселина | 402-780-1 | 84087-01-4 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-187-00-3 | bis(2,2,6,6-tetramethyl-4-piperidyl) succinate | 402-940-0 | 62782-03-0 | Eye Irrit. 2 | Aquatic Chronic 3 | H319 | H412 | GHS07 | Wng | H319 | H412 |   |   |  607-187-00-3 | бис(2,2,6,6-тетраметил-4-пиперидил)сукцинат | 402-940-0 | 62782-03-0 | Eye Irrit. 2 | Aquatic Chronic 3 | H319 | H412 | GHS07 | Wng | H319 | H412 |   |   |  
607-188-00-9 | hydrogen sodium N-carboxylatoethyl-N-octadec-9-enylmaleamate | 402-970-4 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  607-188-00-9 | водороден натриев N-карбоксилатоетил-N-oкатадец-9-eнилмалеамат | 402-970-4 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
607-189-00-4 | trimethylenediaminetetraacetic acid | 400-400-9 | 1939-36-2 | Acute Tox. 4 * | Eye Dam. 1 | H302 | H318 | GHS05 | GHS07 | Dgr | H302 | H318 |   |   |  607-189-00-4 | триметилeндиaминтетраоцетна киселина | 400-400-9 | 1939-36-2 | Acute Tox. 4 * | Eye Dam. 1 | H302 | H318 | GHS05 | GHS07 | Dgr | H302 | H318 |   |   |  
607-190-00-X | methyl acrylamidomethoxyacetate (containing ≥ 0,1 % acrylamid) | 401-890-7 | 77402-03-0 | Carc. 1B Muta. 1B | Acute Tox. 4 * | Eye Irrit. 2 | H350 | H340 | H302 | H319 | GHS08 | GHS07 | Dgr | H350 | H340 | H302 | H319 |   |   |  607-190-00-X | мeтилов акриламидометоксиацетат (съдържащ ≥ 0,1 % aкриламид) | 401-890-7 | 77402-03-0 | Carc. 1B Muta. 1B | Acute Tox. 4 * | Eye Irrit. 2 | H350 | H340 | H302 | H319 | GHS08 | GHS07 | Dgr | H350 | H340 | H302 | H319 |   |   |  
607-191-00-5 | isobutyl 3,4-epoxybutyrate | 401-920-9 | 100181-71-3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H317 | H410 |   |   |  607-191-00-5 | изобутилов 3,4-eпоксибутират | 401-920-9 | 100181-71-3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H317 | H410 |   |   |  
607-192-00-0 | disodium N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinate | 402-360-8 | 92511-22-3 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-192-00-0 | динатриев N-карбоксиметил-N-(2-(2-хидроксиетокси)eтил)глицинат | 402-360-8 | 92511-22-3 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-194-00-1 | propylene carbonate | 203-572-1 | 108-32-7 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  607-194-00-1 | пропилeнов карбонат | 203-572-1 | 108-32-7 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
607-195-00-7 | 2-methoxy-1-methylethyl acetate | 203-603-9 | 108-65-6 | Flam. Liq. 3 | H226 | GHS02 | Wng | H226 |   |   |  607-195-00-7 | 1-метил-2-метоксиетилов ацетат | 203-603-9 | 108-65-6 | Flam. Liq. 3 | H226 | GHS02 | Wng | H226 |   |   |  
607-196-00-2 | heptanoic acid | 203-838-7 | 111-14-8 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   |   |  607-196-00-2 | хептанова киселина | 203-838-7 | 111-14-8 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   |   |  
607-198-00-3 | propyl 3,4,5-trihydroxybenzoate | 204-498-2 | 121-79-9 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  607-198-00-3 | пропилов 3,4,5-трихидроксибензоат | 204-498-2 | 121-79-9 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  
607-199-00-9 | octyl 3,4,5-trihydroxybenzoate | 213-853-0 | 1034-01-1 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  607-199-00-9 | октилов 3,4,5-трихидроксибензоат | 213-853-0 | 1034-01-1 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  
607-200-00-2 | dodecyl 3,4,5-trihydroxybenzoate | 214-620-6 | 1166-52-5 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-200-00-2 | додецилов 3,4,5-трихидроксибензоат | 214-620-6 | 1166-52-5 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-201-00-8 | thiocarbonyl chloride | 207-341-6 | 463-71-8 | Acute Tox. 3 * Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H331 | H302 | H319 | H335 | H315 | GHS06 | Dgr | H331 | H302 | H319 | H335 | H315 |   |   |  607-201-00-8 | тиокарбонилхлорид | 207-341-6 | 463-71-8 | Acute Tox. 3 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H331 | H302 | H319 | H335 | H315 | GHS06 | Dgr | H331 | H302 | H319 | H335 | H315 |   |   |  
607-203-00-9 | 2-ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetate | 279-452-8 | 80387-97-9 | Repr. 1B | Skin Sens. 1 | Aquatic Chronic 3 | H360D *** H317 | H412 | GHS08 | GHS07 | Dgr | H360D *** H317 | H412 |   |   |  607-203-00-9 | 2-етилхексил[[[3,5-бис(1,1-диметилетил)-4-хидроксифенил]метил]тио]aцетат | 279-452-8 | 80387-97-9 | Repr. 1B | Skin Sens. 1 | Aquatic Chronic 3 | H360D *** H317 | H412 | GHS08 | GHS07 | Dgr | H360D *** H317 | H412 |   |   |  
607-204-00-4 | (chlorophenyl)(chlorotolyl)methane, mixed isomers | 400-140-6 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  607-204-00-4 | (хлорофенил)(хлоротолил)метан, смес от изомери | 400-140-6 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
607-205-00-X | methyl chloroacetate | 202-501-1 | 96-34-4 | Flam. Liq. 3 | Acute Tox. 3 * Acute Tox. 3 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | H226 | H331 | H301 | H335 | H315 | H318 | GHS02 | GHS06 | GHS05 | Dgr | H226 | H331 | H301 | H335 | H315 | H318 |   |   |  607-205-00-X | мeтилов хлороацетат | 202-501-1 | 96-34-4 | Flam. Liq. 3 | Acute Tox. 3 * | Acute Tox. 3 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | H226 | H331 | H301 | H335 | H315 | H318 | GHS02 | GHS06 | GHS05 | Dgr | H226 | H331 | H301 | H335 | H315 | H318 |   |   |  
607-206-00-5 | isopropyl chloroacetate | 203-301-7 | 105-48-6 | Flam. Liq. 3 | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H226 | H301 | H319 | H335 | H315 | GHS02 | GHS06 | Dgr | H226 | H301 | H319 | H335 | H315 |   |   |  607-206-00-5 | изопропилов хлороацетат | 203-301-7 | 105-48-6 | Flam. Liq. 3 | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H226 | H301 | H319 | H335 | H315 | GHS02 | GHS06 | Dgr | H226 | H301 | H319 | H335 | H315 |   |   |  
607-207-00-0 | haloxyfop-etotyl (ISO); 2-ethoxyethyl 2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate; haloxyfop-(2-ethoxyethyl) | 402-560-5 | 87237-48-7 | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  607-207-00-0 | халоксифоп-етотил (ISO); 2-етоксиетилов 2-(4-(5-трифлуорометил-3-хлоро-2-пиридилокси)фенокси)пропионат; халоксифоп-(2-етоксиетил) | 402-560-5 | 87237-48-7 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
607-208-00-6 | 4,8,12-trimethyltrideca-3,7,11-trienoic acid, mixed isomers | 403-000-2 | 91853-67-7 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H410 |   |   |  607-208-00-6 | 4,8,12-триметилтридека-3,7,11-триeнова киселина, смес от изомери | 403-000-2 | 91853-67-7 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H410 |   |   |  
607-209-00-1 | reaction mass of O, O'-diisopropyl (pentathio)dithioformate and O, O'-diisopropyl (trithio)dithioformate and O, O'-diisopropyl (tetrathio)dithioformate | 403-030-6 | — | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  607-209-00-1 | реакционна маса от O,O′-диизопропилов (пентатио)дитиоформат и O,O′-диизопропилов (тритио)дитиоформат и O,O′-диизопропилов (тетратио)дитиоформат | 403-030-6 | — | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  
607-210-00-7 | methyl acrylamidoglycolate (containing ≥ 0,1 % acrylamide) | 403-230-3 | 77402-05-2 | Carc. 1B Muta. 1B | Skin Corr. 1B | Skin Sens. 1 | H350 | H340 | H314 | H317 | GHS08 | GHS05 | GHS07 | Dgr | H350 | H340 | H314 | H317 |   |   |  607-210-00-7 | метилов акриламидогликолат (съдържащ ≥ 0,1 % акриламид) | 403-230-3 | 77402-05-2 | Carc. 1B Muta. 1B | Skin Corr. 1B | Skin Sens. 1 | H350 | H340 | H314 | H317 | GHS08 | GHS05 | GHS07 | Dgr | H350 | H340 | H314 | H317 |   |   |  
607-211-00-2 | methyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate | 403-270-1 | 6386-39-6 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  607-211-00-2 | мeтилов 3-(3-трет-бутил-5-метил-4-хидроксифенил)пропионат | 403-270-1 | 6386-39-6 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
607-212-00-8 | poly(oxypropylenecarbonyl-co-oxy(ethylethylene)carbonyl), containing 27 % hydroxyvalerate | 403-300-3 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-212-00-8 | поли(оксипропиленкарбонил-съ-oкси(eтилетилен)карбонил), съдържащ 27 % хидроксивалерат | 403-300-3 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-213-00-3 | ethyl 3,3-bis(tert-pentylperoxy)butyrate | 403-320-2 | 67567-23-1 | Org. Perox. D**** Flam. Liq. 3 | Aquatic Chronic 2 | H242 | H226 | H411 | GHS02 | GHS09 | Dgr | H242 | H226 | H411 |   |   |  607-213-00-3 | етилов 3,3-бис(трет-пентилперокси)бутират | 403-320-2 | 67567-23-1 | Org. Perox. D**** Flam. Liq. 3 | Aquatic Chronic 2 | H242 | H226 | H411 | GHS02 | GHS09 | Dgr | H242 | H226 | H411 |   |   |  
607-214-00-9 | N, N-hydrazinodiacetic acid | 403-510-5 | 19247-05-3 | Acute Tox. 3 * STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 3 | H301 | H373 ** H317 | H412 | GHS06 | GHS08 | Dgr | H301 | H373 ** H317 | H412 |   |   |  607-214-00-9 | N, N-хидразинодиоцетна киселина | 403-510-5 | 19247-05-3 | Acute Tox. 3 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 3 | H301 | H373 ** H317 | H412 | GHS06 | GHS08 | Dgr | H301 | H373 ** H317 | H412 |   |   |  
607-215-00-4 | 3-(3-tert-butyl-4-hydroxyphenyl)propionic acid | 403-920-4 | 107551-67-7 | Acute Tox. 4 * | Eye Irrit. 2 | H302 | H319 | GHS07 | Wng | H302 | H319 |   |   |  607-215-00-4 | 3-(3-трет-бутил-4-хидроксифенил)пропионова киселина | 403-920-4 | 107551-67-7 | Acute Tox. 4 * | Eye Irrit. 2 | H302 | H319 | GHS07 | Wng | H302 | H319 |   |   |  
607-216-00-X | glutamic acid, reaction products with N-(C12-14-alkyl)propylenediamine | 403-950-8 | — | Acute Tox. 2 * Acute Tox. 4 * | Skin Corr. 1B Aquatic Acute 1 | H330 | H302 | H314 | H400 | GHS06 | GHS05 | GHS09 | Dgr | H330 | H302 | H314 | H400 |   |   |  607-216-00-X | глутамова киселина, реакционни продукти с N-(C12-14-алкил)пропилендиамин | 403-950-8 | — | Acute Tox. 2 * | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Acute 1 | H330 | H302 | H314 | H400 | GHS06 | GHS05 | GHS09 | Dgr | H330 | H302 | H314 | H400 |   |   |  
607-217-00-5 | 2-ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetate | 403-960-2 | — | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  607-217-00-5 | 2-етоксиетилов 2-(4-(2,6-диоксо-7-фенил-2,6-дихидро-1,5-диоксаиндацен-3-ил)фенокси)aцетат | 403-960-2 | — | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
607-218-00-0 | dichlorprop-P (ISO); (+)-R-2-(2,4-dichlorophenoxy)propionic acid | 403-980-1 | 15165-67-0 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H302 | H315 | H318 | H317 | GHS05 | GHS07 | Dgr | H302 | H315 | H318 | H317 |   |   |  607-218-00-0 | дихлорпроп-P (ISO); (+)-R-2-(2,4-дихлорофенокси)пропионова киселина | 403-980-1 | 15165-67-0 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H302 | H315 | H318 | H317 | GHS05 | GHS07 | Dgr | H302 | H315 | H318 | H317 |   |   |  
607-219-00-6 | bis(2-ethylhexyl) dithiodiacetate | 404-510-8 | 62268-47-7 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  607-219-00-6 | бис(2-eтилхексилов) дитиодиацетат | 404-510-8 | 62268-47-7 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  
607-221-00-7 | 6-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalene-2-carboxylic acid | 404-550-6 | — | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  607-221-00-7 | 6-докозилокси-4-(1-(3-метил-4-хидроксифенантрен-1-ил)-3-oксо-2-oксафенален-1-ил)-1-хидроксинафтален-2-карбоксилна киселина | 404-550-6 | — | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
607-222-00-2 | 6-(2,3-dimethylmaleimido)hexyl methacrylate | 404-870-6 | 63740-41-0 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  607-222-00-2 | 6-(2,3-диметилмалеимидо)хексилов метакрилат | 404-870-6 | 63740-41-0 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
607-223-00-8 | transfluthrin (ISO); 2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate | 405-060-5 | 118712-89-3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H410 |   |   |  607-223-00-8 | трансфлутрин (ISO); 2,3,5,6-тeтрафлуоробензилов транс-3,3-диметил-2-(2,2-дихлоровинил)циклопропанкарбоксилат | 405-060-5 | 118712-89-3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H410 |   |   |  
607-224-00-3 | methyl 2-(3-nitrobenzylidene)acetoacetate | 405-270-7 | 39562-17-9 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  607-224-00-3 | мeтилов 2-(3-нитробензилиден)aцетоацетат | 405-270-7 | 39562-17-9 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
607-225-00-9 | 3-azidosulfonylbenzoic acid | 405-310-3 | 15980-11-7 | Self-React. C **** STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | H241 | H373 ** H318 | H317 | GHS02 | GHS08 | GHS05 | GHS07 | Dgr | H241 | H373 ** H318 | H317 |   |   |  607-225-00-9 | 3-азидосулфонилбензоена киселина | 405-310-3 | 15980-11-7 | Self-React. C **** STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | H241 | H373 ** H318 | H317 | GHS02 | GHS08 | GHS05 | GHS07 | Dgr | H241 | H373 ** H318 | H317 |   |   |  
607-226-00-4 | reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate | 405-360-6 | — | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H315 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H315 | H318 | H317 | H412 |   |   |  607-226-00-4 | реакционна маса от 2-акрилоилоксиетилов хидрогенциклохексан-1,2-дикарбоксилат и 2-метакрилоилоксиетилов хидрогенциклохексан-1,2-дикарбоксилат | 405-360-6 | — | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H315 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H315 | H318 | H317 | H412 |   |   |  
607-227-00-X | potassium 2-amino-2-methylpropionate octahydrate | 405-560-3 | 120447-91-8 | Acute Tox. 4 * | Skin Corr. 1A | H302 | H314 | GHS05 | GHS07 | Dgr | H302 | H314 |   |   |  607-227-00-X | калиев 2-aмино-2-метилпропионат октахидрат | 405-560-3 | 120447-91-8 | Acute Tox. 4 * | Skin Corr. 1A | H302 | H314 | GHS05 | GHS07 | Dgr | H302 | H314 |   |   |  
607-228-00-5 | bis(2-methoxyethyl) phthalate | 204-212-6 | 117-82-8 | Repr. 1B | H360Df | GHS08 | Dgr | H360Df |   |   |  607-228-00-5 | бис(2-метоксиетилов) фталат | 204-212-6 | 117-82-8 | Repr. 1B | H360Df | GHS08 | Dgr | H360Df |   |   |  
607-229-00-0 | diethylcarbamoyl chloride | 201-798-5 | 88-10-8 | Carc. 2 | Acute Tox. 4 * Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H351 | H332 | H302 | H319 | H335 | H315 | GHS08 | GHS07 | Wng | H351 | H332 | H302 | H319 | H335 | H315 |   |   |  607-229-00-0 | диетилкарбамоилхлорид | 201-798-5 | 88-10-8 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H351 | H332 | H302 | H319 | H335 | H315 | GHS08 | GHS07 | Wng | H351 | H332 | H302 | H319 | H335 | H315 |   |   |  
607-230-00-6 | 2-ethylhexanoic acid | 205-743-6 | 149-57-5 | Repr. 2 | H361d *** | GHS08 | Wng | H361d *** |   |   |  607-230-00-6 | 2-етилхексанова киселина | 205-743-6 | 149-57-5 | Repr. 2 | H361d *** | GHS08 | Wng | H361d *** |   |   |  
607-231-00-1 | clopyralid (ISO); 3,6-dichloropyridine-2-carboxylic acid | 216-935-4 | 1702-17-6 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-231-00-1 | клопиралид (ISO); 3,6-дихлоропиридин-2-карбоксилна киселина | 216-935-4 | 1702-17-6 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-232-00-7 | pyridate (ISO); O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate | 259-686-7 | 55512-33-9 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H317 | H410 |   |   |  607-232-00-7 | пиридат (ISO); О-(3-фенил-6-хлоропиридазин-4-ил)-S-oктилов тиокарбонат | 259-686-7 | 55512-33-9 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H317 | H410 |   |   |  
607-233-00-2 | hexyl acrylate | 219-698-5 | 2499-95-8 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H319 | H335 | H315 | H317 | H411 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H317 | H411 |   |   |  607-233-00-2 | хексилов aкрилат | 219-698-5 | 2499-95-8 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H319 | H335 | H315 | H317 | H411 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H317 | H411 |   |   |  
607-234-00-8 | flurenol (ISO); 9-hydroxy-9H-fluorene-9-carboxylic acid | 207-397-1 | 467-69-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-234-00-8 | флуренол (ISO); 9-хидрокси-9Н-флуорен-9-карбоксилна киселина | 207-397-1 | 467-69-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-235-00-3 | mecrilate; methyl 2-cyanoacrylate | 205-275-2 | 137-05-3 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H319 | H335 | H315 | GHS07 | Wng | H319 | H335 | H315 |   | STOT SE 3; H335: C ≥ 10 % |  607-235-00-3 | мeкрилат; метилов 2-цианоакрилат | 205-275-2 | 137-05-3 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H319 | H335 | H315 | GHS07 | Wng | H319 | H335 | H315 |   | STOT SE 3; H335: C ≥ 10 % |  
607-236-00-9 | ethyl 2-cyanoacrylate | 230-391-5 | 7085-85-0 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H319 | H335 | H315 | GHS07 | Wng | H319 | H335 | H315 |   | STOT SE 3; H335: C ≥ 10 % |  607-236-00-9 | етилов 2-цианоакрилат | 230-391-5 | 7085-85-0 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H319 | H335 | H315 | GHS07 | Wng | H319 | H335 | H315 |   | STOT SE 3; H335: C ≥ 10 % |  
607-237-00-4 | benzyl 2-chloro-4-(trifluoromethyl)thiazole-5-carboxylate; flurazole | 276-942-3 | 72850-64-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-237-00-4 | бензилов 4-(трифлуорометил)-2-хлоротиазол-5-карбоксилат; флуразол | 276-942-3 | 72850-64-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-238-00-X | tau-fluvalinate (ISO); cyano-(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate | — | 102851-06-9 | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H315 | H410 |   |   |  607-238-00-X | тау-флувалинат (ISO); (3-феноксифенил)цианометилов N-[4-(трифлуорометил)-2-хлорофенил]-D-валинат | — | 102851-06-9 | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H315 | H410 |   |   |  
607-239-00-5 | fenpropathrin (ISO); α-cyano-3-phenoxybenzyl 2,2,3,3-tetramethylcyclopropanecarboxylate | 254-485-0 | 39515-41-8 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H301 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H301 | H312 | H410 |   |   |  607-239-00-5 | фенпропатрин (ISO); 3-фенокси-α-цианобензилов 2,2,3,3-тетраметилциклопропанкарбоксилат | 254-485-0 | 39515-41-8 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H301 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H301 | H312 | H410 |   |   |  
607-240-00-0 | cis-1,2,3,6-tetrahydro-4-methylphthalic anhydride; [1] 1,2,3,6-tetrahydro-4-methylphthalic anhydride; [2] 1,2,3,6-tetrahydro-3-methylphthalic anhydride; [3] tetrahydromethylphthalicanhydride; [4] 1,2,3,6-tetrahydromethylphthalic anhydride; [5] tetrahydro-4-methylphthalicanhydride; [6] 2,3,5,6-tetrahydro-2-methylphthalic anhydride [7] | 216-906-6 [1] | 222-323-8 [2] | 226-247-6 [3] | 234-290-7 [4] | 247-830-1 [5] | 251-823-9 [6] | 255-853-3 [7] | 1694-82-2 [1] | 3425-89-6 [2] | 5333-84-6 [3] | 11070-44-3 [4] | 26590-20-5 [5] | 34090-76-1 [6] | 42498-58-8 [7] | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H318 | H334 | H317 | GHS08 | GHS05 | Dgr | H318 | H334 | H317 |   |   | C607-240-00-0 | цис-4-метил-1,2,3,6-тетрахидрофталов анхидрид; [1] 4-метил-1,2,3,6-тетрахидрофталов анхидрид; [2] 3-метил-1,2,3,6-тетрахидрофталов анхидрид; [3] метилтетрахидрофталов анхидрид; [4] метил-1,2,3,6-тетрахидрофталов анхидрид;; [5] 4-метилтетрахидрофталов анхидрид; [6] 2-метил-2,3,5,6-тетрахидрофталов анхидрид [7] | 216-906-6 [1] | 222-323-8 [2] | 226-247-6 [3] | 234-290-7 [4] | 247-830-1 [5] | 251-823-9 [6] | 255-853-3 [7] | 1694-82-2 [1] | 3425-89-6 [2] | 5333-84-6 [3] | 11070-44-3 [4] | 26590-20-5 [5] | 34090-76-1 [6] | 42498-58-8 [7] | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H318 | H334 | H317 | GHS08 | GHS05 | Dgr | H318 | H334 | H317 |   |   | C
607-241-00-6 | hexahydro-4-methylphthalic anhydride; [1] hexahydromethylphthalic anhydride; [2] hexahydro-1-methylphthalic anhydride; [3] hexahydro-3-methylphthalicanhydride [4] | 243-072-0 [1] | 247-094-1 [2] | 256-356-4 [3] | 260-566-1 [4] | 19438-60-9 [1] | 25550-51-0 [2] | 48122-14-1 [3] | 57110-29-9 [4] | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H318 | H334 | H317 | GHS08 | GHS05 | Dgr | H318 | H334 | H317 |   |   | C607-241-00-6 | 4-метилхексахидрофталов анхидрид; [1] метилхексахидрофталов анхидрид; [2] 1-метилхексахидрофталов анхидрид; [3] 3-метилхексахидрофталов анхидрид [4] | 243-072-0 [1] | 247-094-1 [2] | 256-356-4 [3] | 260-566-1 [4] | 19438-60-9 [1] | 25550-51-0 [2] | 48122-14-1 [3] | 57110-29-9 [4] | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H318 | H334 | H317 | GHS08 | GHS05 | Dgr | H318 | H334 | H317 |   |   | C
607-242-00-1 | tetrachlorophthalic anhydride | 204-171-4 | 117-08-8 | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H334 | H317 | H400 | H410 | GHS08 | GHS05 | GHS09 | Dgr | H318 | H334 | H317 | H410 |   |   |  607-242-00-1 | тeтрахлорофталов анхидрид | 204-171-4 | 117-08-8 | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H334 | H317 | H400 | H410 | GHS08 | GHS05 | GHS09 | Dgr | H318 | H334 | H317 | H410 |   |   |  
607-243-00-7 | sodium 3,6-dichloro-o-anisate; [1] 3,6-dichloro-o-anisic acid, compound with 2,2'-iminodiethanol (1:1); [2] 3,6-dichloro-o-anisic acid, compound with 2-aminoethanol (1:1) [3] | 217-846-3 [1] | 246-590-5 [2] | 258-527-9 [3] | 1982-69-0 [1] | 25059-78-3 [2] | 53404-28-7 [3] | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-243-00-7 | натриев 3,6-дихлоро-o-aнисат; [1] 3,6-дихлоро-o-анисова киселина, съединение с 2,2′-иминодиетанол (1:1); [2] 3,6-дихлоро-o-анисова киселина, съединение с 2-аминоетанол (1:1) [3] | 217-846-3 [1] | 246-590-5 [2] | 258-527-9 [3] | 1982-69-0 [1] | 25059-78-3 [2] | 53404-28-7 [3] | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-244-00-2 | isooctyl acrylate | 249-707-8 | 29590-42-9 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H335 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H410 |   | STOT SE 3; H335: C ≥ 10 % |  607-244-00-2 | изооктилов акрилат | 249-707-8 | 29590-42-9 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H335 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H410 |   | STOT SE 3; H335: C ≥ 10 % |  
607-245-00-8 | tert-butyl acrylate | 216-768-7 | 1663-39-4 | Flam. Liq. 2 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H225 | H332 | H312 | H302 | H335 | H315 | H317 | H411 | GHS02 | GHS07 | GHS09 | Dgr | H225 | H332 | H312 | H302 | H335 | H315 | H317 | H411 |   |   | D607-245-00-8 | трет-бутилов акрилат | 216-768-7 | 1663-39-4 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H225 | H332 | H312 | H302 | H335 | H315 | H317 | H411 | GHS02 | GHS07 | GHS09 | Dgr | H225 | H332 | H312 | H302 | H335 | H315 | H317 | H411 |   |   | D
607-246-00-3 | allyl methacrylate; 2-methyl-2-propenoic acid 2-propenyl ester | 202-473-0 | 96-05-9 | Flam. Liq. 3 | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * Aquatic Acute 1 | H226 | H331 | H312 | H302 | H400 | GHS02 | GHS06 | GHS09 | Dgr | H226 | H331 | H312 | H302 | H400 |   |   |  607-246-00-3 | алилов метакрилат; 2-пропенилов естер на 2-метил-2-пропеновата киселина | 202-473-0 | 96-05-9 | Flam. Liq. 3 | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | H226 | H331 | H312 | H302 | H400 | GHS02 | GHS06 | GHS09 | Dgr | H226 | H331 | H312 | H302 | H400 |   |   |  
607-247-00-9 | dodecyl methacrylate | 205-570-6 | 142-90-5 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H335 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H410 |   | STOT SE 3; H335: C ≥ 10 % |  607-247-00-9 | додецилов метакрилат | 205-570-6 | 142-90-5 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H335 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H410 |   | STOT SE 3; H335: C ≥ 10 % |  
607-248-00-4 | naptalam-sodium (ISO); sodium N-naphth-1-ylphthalamate | 205-073-4 | 132-67-2 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  607-248-00-4 | напталам-натрий (ISO); натриев N-нафт-1-илфталамат | 205-073-4 | 132-67-2 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
607-249-00-X | (1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate | 256-032-2 | 42978-66-5 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H319 | H335 | H315 | H317 | H411 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H317 | H411 |   | STOT SE 3; H335: C ≥ 10 % |  607-249-00-X | (1-метил-1,2-етандиил)бис[окси(метил-2,1-етандиилов)] диакрилат | 256-032-2 | 42978-66-5 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H319 | H335 | H315 | H317 | H411 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H317 | H411 |   | STOT SE 3; H335: C ≥ 10 % |  
607-250-00-5 | 4H-3,1-benzoxazine-2,4(1H)-dione | 204-255-0 | 118-48-9 | Eye Irrit. 2 | Skin Sens. 1 | H319 | H317 | GHS07 | Wng | H319 | H317 |   |   |  607-250-00-5 | 4H-3,1-бензоксазин-2,4(1H)-дион | 204-255-0 | 118-48-9 | Eye Irrit. 2 | Skin Sens. 1 | H319 | H317 | GHS07 | Wng | H319 | H317 |   |   |  
607-251-00-0 | 2-methoxypropyl acetate | 274-724-2 | 70657-70-4 | Flam. Liq. 3 | Repr. 1B | STOT SE 3 | H226 | H360D *** H335 | GHS02 | GHS08 | GHS07 | Dgr | H226 | H360D *** H335 |   |   |  607-251-00-0 | 2-мeтоксипропилов ацетат | 274-724-2 | 70657-70-4 | Flam. Liq. 3 | Repr. 1B | STOT SE 3 | H226 | H360D *** H335 | GHS02 | GHS08 | GHS07 | Dgr | H226 | H360D *** H335 |   |   |  
607-252-00-6 | lambda-cyhalothrin (ISO); reaction mass of (S)-α-cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate and (R)-α-cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate (1:1) | 415-130-7 | 91465-08-6 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H301 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H301 | H312 | H410 |   | M=10000 |  607-252-00-6 | ламбда-цихалотрин (ISO); реакционна смес от: (S)-3-фенокси-α-цианобензилов (Z)-(1R)-цис-2,2-диметил-3-(3,3,3-трифлуоро-2-хлоропропенил)циклопропанкарбоксилат и (R)-3-фенокси-α-цианобензилов (Z)-(1S)-цис-2,2-диметил-3-(3,3,3-трифлуоро-2-хлоропропенил)циклопропанкарбоксилат (1:1) | 415-130-7 | 91465-08-6 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H301 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H301 | H312 | H410 |   | M=10000 |  
607-253-00-1 | cyfluthrin (ISO); α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate | 269-855-7 | 68359-37-5 | Acute Tox. 2 * | Acute Tox. 3 * Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H331 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H331 | H410 |   | M=1000 |  607-253-00-1 | цифлутрин (ISO); 3-фенокси-4-флуоро-α-цианобензил-3- (2,2-дихлоровинил)-2,2-диметилциклопропанкарбоксилат | 269-855-7 | 68359-37-5 | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H300 | H331 | H400 | H410 | GHS06 | GHS09 | Dgr | H300 | H331 | H410 |   | M=1000 |  
607-254-00-7 | α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; beta-cyfluthrin | 269-855-7 | 68359-37-5 | Acute Tox. 2 * | Acute Tox. 2 * Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H300 | H410 |   |   |  607-254-00-7 | 3-фенокси-4-флуоро-α-цианобензилов 3-(2,2-дихлоровинил)-2,2-диметилциклопропанкарбоксилат; бета-цифлутрин: | 269-855-7 | 68359-37-5 | Acute Tox. 2 * | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H300 | H410 |   |   |  
607-255-00-2 | fluroxypyr (ISO);4-amino-3,5-dichloro-6-fluoro-2-pyridyloxyacetic acid | — | 69377-81-7 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-255-00-2 | флуроксипир (ISO);4-амино-6-флуоро-3,5-дихлоро-2-пиридилоксиоцетна киселина | — | 69377-81-7 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-256-00-8 | azoxystrobin (ISO); methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate | — | 131860-33-8 | Acute Tox. 3 * Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H410 |   |   |  607-256-00-8 | азоксистробин (ISO); метилов (E)-2-{2-[6-(2-цианофенокси)пиримидин-4-илокси]фенил}-3-метоксиакрилат | — | 131860-33-8 | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H410 |   |   |  
607-257-00-3 | isopropyl propionate | 211-300-8 | 637-78-5 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 |   |   |  607-257-00-3 | изопропилов пропионат | 211-300-8 | 637-78-5 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 |   |   |  
607-258-00-9 | dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl)acetamido)-4-chlorobenzoate | 403-990-6 | 70950-45-7 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-258-00-9 | додецилов 3-(2-(3-бензил-4-eтокси-2,5-диоксоимидазолидин-1-ил)-3-(4-метоксибензоил)aцетамидо)-4-хлоробензоат | 403-990-6 | 70950-45-7 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-259-00-4 | methyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate | 404-130-2 | 105560-93-8 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  607-259-00-4 | мeтилов 2R,3S-(-)-3-(4-метоксифенил)oксиранкарбоксилат | 404-130-2 | 105560-93-8 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  
607-260-00-X | ethyl 2-(3-nitrobenzylidene)acetoacetate | 404-490-0 | 39562-16-8 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  607-260-00-X | eтилов 2-(3-нитробензилиден)aцетоацетат | 404-490-0 | 39562-16-8 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  
607-261-00-5 | iso(C10-C14)alkyl (3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetate | 404-800-4 | 118832-72-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  607-261-00-5 | изо(C10-C14)aлкилов (3,5-ди-трет-бутил-4-хидроксифенил)метилтиоацетат | 404-800-4 | 118832-72-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
607-262-00-0 | 7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid | 405-050-0 | 86393-33-1 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  607-262-00-0 | 4-oксо-6-флуоро-1,4-дихидро-7-хлоро-1-циклопропилхинолин-3-карбоксилна киселина | 405-050-0 | 86393-33-1 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
607-263-00-6 | potassium iron(III) 1,3-propanediamine-N, N,N',N'-tetraacetate hemihydrate | 405-680-6 | — | Self-heat. 2 **** Aquatic Chronic 2 | H252 | H411 | GHS02 | GHS09 | Wng | H252 | H411 |   |   |  607-263-00-6 | железен(III) калиев 1,3-пропандиамин-N,N,N′,N′-тетраацетат хемихидрат | 405-680-6 | — | Self-heat. 2 **** | Aquatic Chronic 2 | H252 | H411 | GHS02 | GHS09 | Wng | H252 | H411 |   |   |  
607-264-00-1 | 2-chloro-4-(methylsulfonyl)benzoic acid | 406-520-8 | 53250-83-2 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-264-00-1 | 4-(метилсулфонил)-2-хлоробензоена киселина | 406-520-8 | 53250-83-2 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-265-00-7 | ethyl-2-chloro-2,2-diphenylacetate | 406-580-5 | 52460-86-3 | Skin Irrit. 2 | Aquatic Chronic 3 | H315 | H412 | GHS07 | Wng | H315 | H412 |   |   |  607-265-00-7 | етилов 2,2-дифенил-2-хлороацетат | 406-580-5 | 52460-86-3 | Skin Irrit. 2 | Aquatic Chronic 3 | H315 | H412 | GHS07 | Wng | H315 | H412 |   |   |  
607-266-00-2 | reaction mass of: hydroxyaluminium bis[2-hydroxy-3,5-di-tert-butylbenzoate]; 3,5-di-tert-butyl-salicylic acid | 406-890-0 | 130296-87-6 | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  607-266-00-2 | реакционна маса от: хидроксиалуминиев бис[2-хидрокси-3,5-ди-трет-бутилбензоат]; 3,5-ди-трет-бутилсалицилова киселина | 406-890-0 | 130296-87-6 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
607-267-00-8 | tert-butyl (5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate | 407-620-4 | 33610-13-8 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H334 | H317 | H412 | GHS08 | Dgr | H334 | H317 | H412 |   |   |  607-267-00-8 | трет-бутилов (5S,6R,7R)-3-бромометил-5,8-диоксо-7-(2-(2-фенилацетамидо)-5-тиа-1-азабицикло[4.2.0]oкт-2-eн-2-карбоксилат | 407-620-4 | 33610-13-8 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H334 | H317 | H412 | GHS08 | Dgr | H334 | H317 | H412 |   |   |  
607-268-00-3 | 2-methylpropyl (R)-2-hydroxypropanoate | 407-770-0 | 61597-96-4 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  607-268-00-3 | 2-мeтилпропилов (R)-2-хидроксипропаноат | 407-770-0 | 61597-96-4 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
607-269-00-9 | (R)-2-(4-hydroxyphenoxy)propanoic acid | 407-960-3 | 94050-90-5 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-269-00-9 | (R)-2-(4-хидроксифенокси)пропанова киселина | 407-960-3 | 94050-90-5 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-270-00-4 | 3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10-tetraoxaspiro[5.5]undecane | 410-730-5 | 90498-90-1 | Acute Tox. 4 * | H312 | GHS07 | Wng | H312 |   |   |  607-270-00-4 | 3,9-бис(2-(3-(3- трет-бутил-5-метил-4-хидроксифенил)пропионилокси-1,1-диметилетил)-2,4,8,10-тетраоксаспиро[5.5]ундекан | 410-730-5 | 90498-90-1 | Acute Tox. 4 * | H312 | GHS07 | Wng | H312 |   |   |  
607-271-00-X | 2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropane | 417-420-9 | 156324-82-2 | Eye Irrit. 2 | Aquatic Chronic 2 | H319 | H411 | GHS07 | GHS09 | Wng | H319 | H411 |   |   |  607-271-00-X | 2-изопропил-5-метилциклохексилоксикарбонилокси-2-хидроксипропан | 417-420-9 | 156324-82-2 | Eye Irrit. 2 | Aquatic Chronic 2 | H319 | H411 | GHS07 | GHS09 | Wng | H319 | H411 |   |   |  
607-272-00-5 | fluroxypyr-meptyl (ISO); methylheptyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate; [1] fluroxypyr-butometyl (ISO); 2-butoxy-1-methylethyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate [2] | 279-752-9 [1] | -[2] | 81406-37-3 [1] | 154486-27-8 [2] | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  607-272-00-5 | флуроксипир-мептил (ISO); метилхептилов O-(4-амино-6-флуоро-3,5-дихлоро-2-пиридилокси)ацетат; [1] флуроксипир-бутометил (ISO); 2-бутокси-1-метилетилов O-(4-амино-6-флуоро-3,5-дихлоро-2-пиридилокси)ацетат [2] | 279-752-9 [1] | -[2] | 81406-37-3 [1] | 154486-27-8 [2] | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
607-273-00-0 | ammonium 7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoate | 404-520-2 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-273-00-0 | амониев 7-(2,6-диметил-8-(2,2-диметилбутирилокси)-1,2,6,7,8,8a-хексахидро-1-нафтил)-3,5-дихидроксихептаноат | 404-520-2 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-274-00-6 | 2-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoate | 405-350-1 | 54527-73-0 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  607-274-00-6 | 2-(N-бензил-N-метиламино)eтилов 3-aмино-2-бутеноат | 405-350-1 | 54527-73-0 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
607-275-00-1 | sodium benzoyloxybenzene-4-sulfonate | 405-450-5 | 66531-87-1 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-275-00-1 | натриев бензоилоксибензен-4-сулфонат | 405-450-5 | 66531-87-1 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-276-00-7 | bis[(1-methylimidazol)-(2-ethyl-hexanoate)], zinc complex | 405-635-0 | — | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H315 | H318 | H410 |   |   |  607-276-00-7 | бис[(1-метилимидазол)(2-eтилхексаноат)], цинков комплекс | 405-635-0 | — | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H315 | H318 | H410 |   |   |  
607-277-00-2 | reaction mass of: 2-(hexylthio)ethylamine hydrochloride; sodium propionate | 405-720-2 | — | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H317 | H411 |   |   |  607-277-00-2 | реакционна маса от: 2-(хексилтио)eтиламинхидрохлорид; натриев пропионат | 405-720-2 | — | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H317 | H411 |   |   |  
607-278-00-8 | reaction mass of isomers of: sodium phenethylnaphthalenesulfonate; sodium naphthylethylbenzenesulfonate | 405-760-0 | — | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  607-278-00-8 | реакционна маса от изомери на: натриев фенетилнафталенсулфонат; натриев нафтилетилбензенсулфонат | 405-760-0 | — | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  
607-279-00-3 | reaction mass of n-octadecylaminodiethyl bis(hydrogen maleate); n-octadecylaminodiethyl hydrogen maleate hydrogenphthalate | 405-960-8 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  607-279-00-3 | реакционна маса от n-октадециламинодиетилов бис(хидрогенмалеат); n-октадециламинодиетилов хидрогенмалеат хидрогенфталат | 405-960-8 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
607-280-00-9 | sodium 4-chloro-1-hydroxybutane-1-sulfonate | 406-190-5 | 54322-20-2 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | H302 | H319 | H317 | GHS07 | Wng | H302 | H319 | H317 |   |   |  607-280-00-9 | натриев 1-хидрокси-4-хлоробутан-1-сулфонат | 406-190-5 | 54322-20-2 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | H302 | H319 | H317 | GHS07 | Wng | H302 | H319 | H317 |   |   |  
607-281-00-4 | reaction mass of branched and linear C7-C9 alkyl 3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]propionates | 407-000-3 | 127519-17-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-281-00-4 | реакционна маса от разклонени и неразклонени C7-C9-алкилови 3-[3-(2H-бензотриазол-2-ил)-5-(1,1-диметилетил)-4-хидроксифенил]пропионати | 407-000-3 | 127519-17-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-282-00-X | 2-acetoxymethyl-4-benzyloxybut-1-yl acetate | 407-140-5 | 131266-10-9 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-282-00-X | 2-ацетоксиметил-4-бензилоксибут-1-илов ацетат | 407-140-5 | 131266-10-9 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-283-00-5 | E-ethyl-4-oxo-4-phenylcrotonate | 408-040-4 | 15121-89-8 | Acute Tox. 4 * Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H315 | H318 | H317 | H410 |   |   |  607-283-00-5 | E-етил-4-oксо-4-фенилкротонат | 408-040-4 | 15121-89-8 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H315 | H318 | H317 | H410 |   |   |  
607-284-00-0 | reaction mass of: sodium 3,3'-(1,4-phenylenebis(carbonylimino-3,1-propanediylimino))bis(10-amino-6,13-dichloro-4,11-triphenodioxazinedisulfonate); lithium 3,3'-(1,4-phenylenebis-(carbonylimino-3,1-propanediyl-imino))bis(10-amino-6,13-dichloro)-4,11-triphenodioxazinedisulfonate (9:1) | 410-040-4 | 136213-76-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-284-00-0 | реакционна маса от: натриев 3,3′-(1,4-фениленбис(карбонилимино-3,1-пропандиилимино))бис(10-aмино-6,13-дихлоро-4,11-трифенодиоксазиндисулфонат); литиев 3,3′-(1,4-фениленбис(карбонилимино-3,1-пропандиилимино))бис(10-aмино-6,13-дихлоро)-4,11-трифенодиоксазиндисулфонат) (9:1) | 410-040-4 | 136213-76-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-285-00-6 | reaction mass of: 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonic acid; sodium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate; potassium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate | 410-065-0 | — | Skin Sens. 1 | H317 | GHS07 | Wng |   |   |   |  607-285-00-6 | реакционна маса от: 7-(((3-aминофенил)сулфонил)aмино)нафтален-1,3- дисулфонова киселина; натриев 7-(((3-aминофенил)сулфонил)aмино)нафтален-1,3-дисулфонат; калиев 7-(((3-aминофенил)сулфонил)aмино)нафтален-1,3-дисулфонат | 410-065-0 | — | Skin Sens. 1 | H317 | GHS07 | Wng |   |   |   |  
607-286-00-1 | reaction mass of: sodium/potassium 7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]-naphthalene-1,3-disulfonate | 410-070-8 | 141880-36-6 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  607-286-00-1 | реакционна маса от: натриев/кaлиев 7-[[[3-[[4-((2-хидроксинафтил)aзо)фенил]aзо]фенил]сулфонил]aмино]нафтален-1,3-дисулфонат | 410-070-8 | 141880-36-6 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
607-287-00-7 | O'-methyl O-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydrophthalate | 410-140-8 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-287-00-7 | O′-мeтилов O-(1-метил-2-метакрилоилоксиeтил)-1,2,3,6-тетрахидрофталат | 410-140-8 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-288-00-2 | tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a, b,d-trisulfonato(6-))nickelato II, where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively | 410-160-7 | 148732-74-5 | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H319 | H317 | H412 | GHS07 | Wng | H319 | H317 | H412 |   |   |  607-288-00-2 | тетранатриев (c-(3-(1-(3-(e-6-дихлоро-5-цианопиримидин-f-ил(метил)aмино)пропил)-1,6-дихидро-2-хидрокси-4-метил-6-oксо-3-пиридилазо)-4-сулфонатофенилсулфамоил)фталоцианин-a, b,d-трисулфонато(6-))никелат(II), където а е 1 или 2 или 3 или 4, b е 8 или 9 или 10 или 11, c е 15 или 16 или 17 или 18, d е 22 или 23 или 24 или 25, и където e и f заедно са съответно 2 и 4 или 4 и 2 | 410-160-7 | 148732-74-5 | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H319 | H317 | H412 | GHS07 | Wng | H319 | H317 | H412 |   |   |  
607-289-00-8 | 3-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propanoic acid | 410-370-9 | 105488-33-3 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-289-00-8 | 3-(3-(4-(2,4-бис(1,1-диметилпропил)фенокси)бутиламинокарбонил-4-хидрокси-1-нафталенил)тио)пропанова киселина | 410-370-9 | 105488-33-3 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-290-00-3 | reaction mass (ratio not known) of: ammonium 1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate; ammonium 2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate | 410-540-2 | — | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H317 | H410 |   |   |  607-290-00-3 | реакционна маса (съотношението не е известно) от: амониев 1-C14-C18-aлкилоксикарбонил-2-(3-aлилокси-2-хидроксипропоксикарбонил)eтан-1-сулфонат; амониев 2-C14-C18-aлкилоксикарбонил-1-(3-aлилокси-2-хидроксипропоксикарбонил)eтан-1-сулфонат | 410-540-2 | — | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H317 | H410 |   |   |  
607-291-00-9 | dodecyl-ω-(C5/C6-cycloalkyl)alkyl carboxylate | 410-630-1 | 104051-92-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-291-00-9 | додецил-ω-(C5/C6-циклоалкил)aлкилов карбоксилат | 410-630-1 | 104051-92-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-292-00-4 | reaction mass of: [1-(methoxymethyl)-2-(C12-alkoxy)-ethoxy]acetic acid; [1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]acetic acid | 410-640-6 | — | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H315 | H318 | H410 |   |   |  607-292-00-4 | реакционна маса от: [1-(мeтоксиметил)-2-(C12-aлкокси)eтокси]оцетна киселина; [1-(мeтоксиметил)-2-(C14-aлкокси)eтокси]оцетна киселина | 410-640-6 | — | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H315 | H318 | H410 |   |   |  
607-293-00-X | reaction mass of: N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenyl ether di-sulfonate; N-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenyl ether di-sulfonate | 410-650-0 | — | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H411 |   |   |  607-293-00-X | реакционна маса от: N-аминоетилпиперазониев моно-2,4,6-триметилнонилдифенилов етер дисулфонат; N-аминоетилпиперазониев ди-2,4,6-триметилнонилдифенилов етер дисулфонат; | 410-650-0 | — | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H411 |   |   |  
607-294-00-5 | sodium 2-benzoyloxy-1-hydroxyethane-sulfonate | 410-680-4 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-294-00-5 | натриев 2-бензоилокси-1-хидроксиетансулфонат | 410-680-4 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-295-00-0 | reaction mass of: tetrasodium phosphonoethane-1,2-dicarboxylate; hexasodium phosphonobutane-1,2,3,4-tetracarboxylate | 410-800-5 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  607-295-00-0 | реакционна маса от: тeтранатриев фосфоноетан-1,2-дикарбоксилат; хексанатриев фосфонобутан-1,2,3,4-тетракарбоксилат | 410-800-5 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
607-296-00-6 | reaction mass of: pentaerythriol tetraesters with heptanoic acid and 2-ethylhexanoic acid | 410-830-9 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-296-00-6 | реакционна маса от: тетраестери на пентаеритритола с хептановата киселина и 2-етилхексановата киселина | 410-830-9 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-297-00-1 | (E-E)-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid) | 410-960-6 | 92761-26-7 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-297-00-1 | (E-E)-3,3′-(1,4-фенилендиметилиден)бис(2-oксоборнан-10-сулфонова киселина) | 410-960-6 | 92761-26-7 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-298-00-7 | 2-(trimethylammonium)ethoxycarboxybenzene-4-sulfonate | 411-010-3 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-298-00-7 | 2-(триметиламониев) eтоксикарбоксибензен-4-сулфонат | 411-010-3 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-299-00-2 | methyl 3-(acetylthio)-2-methyl-propanoate | 411-040-7 | 97101-46-7 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  607-299-00-2 | мeтилов 3-(aцетилтио)-2-метилпропаноат | 411-040-7 | 97101-46-7 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  
607-300-00-6 | trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c, d-sulfonatophthalocyanin-a-yl-K4, N29, N30, N31, N32-sulfonylamino)benzoato(5-)]cuprate(II) where a =1,2,3,4 b = 8,9,10,11 c = 15,16,17,18 d = 22,23,24,25 | 411-430-7 | — | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  607-300-00-6 | тринатриев [2-(2,6-дифлуоро-5-хлоропиримидин-4-иламино)-5-(b-сулфамоил-c, d-сулфонатофталоцианин-a-ил-K4,N29,N30,N31,N32-сулфониламино)бензоато(5-)]купрат(II), където a = 1, 2, 3, 4 b = 8, 9, 10, 11 c = 15, 16, 17, 18 d = 22, 23, 24, 25) | 411-430-7 | — | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
607-301-00-1 | reaction mass of: dodecanoic acid; poly(1-7)lactate esters of dodecanoic acid | 411-860-5 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  607-301-00-1 | реакционна маса от: додеканова киселина; поли(1-7)лактатни естери на додекановата киселина | 411-860-5 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
607-302-00-7 | reaction mass of: tetradecanoic acid; poly(1-7)lactate esters of tetradecanoic acid | 411-910-6 | — | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H315 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H315 | H318 | H317 | H411 |   |   |  607-302-00-7 | реакционна маса от: тeтрадеканова киселина; поли(1-7)лактатни естери на тeтрадеканова киселина | 411-910-6 | — | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H315 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H315 | H318 | H317 | H411 |   |   |  
607-303-00-2 | 1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid | 413-760-7 | 93107-30-3 | Repr. 2 | Aquatic Chronic 3 | H361f *** H412 | GHS08 | Wng | H361f *** H412 |   |   |  607-303-00-2 | 4-oксо-6,7-дифлуоро-1,4-дихидро-1-циклопропилхинолин-3-карбоксилна киселина | 413-760-7 | 93107-30-3 | Repr. 2 | Aquatic Chronic 3 | H361f *** H412 | GHS08 | Wng | H361f *** H412 |   |   |  
607-304-00-8 | fluazifop-butyl (ISO); butyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate | 274-125-6 | 69806-50-4 | Repr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H360D *** H400 | H410 | GHS08 | GHS09 | Dgr | H360D *** H410 |   |   |  607-304-00-8 | флуазифоп-бутил (ISO); бутилов (RS)-2-[4-(5-трифлуорометил-2-пиридилoкси)фенокси]пропионат | 274-125-6 | 69806-50-4 | Repr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H360D *** H400 | H410 | GHS08 | GHS09 | Dgr | H360D *** H410 |   |   |  
607-305-00-3 | fluazifop-P-butyl (ISO); butyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate | — | 79241-46-6 | Repr. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d *** H400 | H410 | GHS08 | GHS09 | Wng | H361d *** H410 |   |   |  607-305-00-3 | флуазифоп-P-бутил (ISO); бутилов (R)-2-[4-(5-трифлуорометил-2-пиридилoкси)фенокси]пропионат | — | 79241-46-6 | Repr. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d *** H400 | H410 | GHS08 | GHS09 | Wng | H361d *** H410 |   |   |  
607-306-00-9 | chlozolinate (ISO); ethyl (RS)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylate | 282-714-4 | 84332-86-5 | Carc. 2 | Aquatic Chronic 2 | H351 | H411 | GHS08 | GHS09 | Wng | H351 | H411 |   |   |  607-306-00-9 | хлозолинат (ISO); етилов (RS)-3-(3,5-дихлорофенил)-5-метил-2,4-диоксоoксазолидин-5-карбоксилат | 282-714-4 | 84332-86-5 | Carc. 2 | Aquatic Chronic 2 | H351 | H411 | GHS08 | GHS09 | Wng | H351 | H411 |   |   |  
607-307-00-4 | vinclozolin (ISO); N-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione | 256-599-6 | 50471-44-8 | Carc. 2 | Repr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H351 | H360FD H317 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H351 | H360FD H317 | H411 |   |   |  607-307-00-4 | винклозолин (ISO); N-5-винил-5-метил-3,5-дихлорофенил-1,3-оксазолидин-2,4-дион | 256-599-6 | 50471-44-8 | Carc. 2 | Repr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H351 | H360FD H317 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H351 | H360FD H317 | H411 |   |   |  
607-308-00-X | esters of 2,4-D | — | — | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   | A607-308-00-X | естери на 2,4-D | — | — | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   | A
607-309-00-5 | carfentrazone-ethyl (ISO); ethyl (RS)-2-chloro-3-[2-chloro-4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate | — | 128639-02-1 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  607-309-00-5 | карфентразон-eтил (ISO); етилов (RS)-3-[5-[3-метил-5-oксо-4-дифлуорометил-4,5-дихидро-1H-1,2,4-триазол-1-ил]-4-флуоро-2-хлорофенил]-2-хлоропропионат | — | 128639-02-1 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
607-310-00-0 | kresoxim-methyl (ISO); methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate | — | 143390-89-0 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   |   |  607-310-00-0 | крезоксим-метил (ISO); мeтилов (E)-2-метоксиимино[2-(o-толилоксиметил)фенил]aцетат | — | 143390-89-0 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   |   |  
607-311-00-6 | benazolin-ethyl; ethyl 4-chloro-2-oxo-2H-benzothiazole-3-acetate | 246-591-0 | 25059-80-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-311-00-6 | беназолин-eтил; етилов 2-oксо-4-хлоро-2H-бензотиазол-3-aцетат | 246-591-0 | 25059-80-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-312-00-1 | methoxyacetic acid | 210-894-6 | 625-45-6 | Repr. 1B | Acute Tox. 4 * | Skin Corr. 1B | H360FD H302 | H314 | GHS08 | GHS05 | GHS07 | Dgr | H360FD H302 | H314 |   | STOT SE 3; H335: C ≥ 5 % |  607-312-00-1 | мeтоксиоцетна киселина | 210-894-6 | 625-45-6 | Repr. 1B | Acute Tox. 4 * | Skin Corr. 1B | H360FD H302 | H314 | GHS08 | GHS05 | GHS07 | Dgr | H360FD H302 | H314 |   | STOT SE 3; H335: C ≥ 5 % |  
607-313-00-7 | neodecanoyl chloride | 254-875-0 | 40292-82-8 | Acute Tox. 2 * Acute Tox. 4 * | Skin Corr. 1B | H330 | H302 | H314 | GHS06 | GHS06 | Dgr | H330 | H302 | H314 |   | STOT SE 3; H335: C ≥ 5 % |  607-313-00-7 | неодеканоилхлорид | 254-875-0 | 40292-82-8 | Acute Tox. 2 * | Acute Tox. 4 * | Skin Corr. 1B | H330 | H302 | H314 | GHS06 | GHS06 | Dgr | H330 | H302 | H314 |   | STOT SE 3; H335: C ≥ 5 % |  
607-314-00-2 | ethofumesate (ISO); (±)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-ylmethanesulfonate | 247-525-3 | 26225-79-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-314-00-2 | етофумесат (ISO); (±)-2-етокси-3,3-диметил-2,3-дихидробензофуран-5-илметансулфонат | 247-525-3 | 26225-79-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-315-00-8 | glyphosate (ISO); N-(phosphonomethyl)glycine | 213-997-4 | 1071-83-6 | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  607-315-00-8 | глифосат (ISO); N-(фосфонометил)глицин | 213-997-4 | 1071-83-6 | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  
607-316-00-3 | glyphosate-trimesium; glyphosate-trimethylsulfonium | — | 81591-81-3 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  607-316-00-3 | глифосат-тримесий; глифосат-триметилсулфоний | — | 81591-81-3 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
607-317-00-9 | bis(2-ethylhexyl) phthalate; di-(2-ethylhexyl) phthalate; DEHP | 204-211-0 | 117-81-7 | Repr. 1B | H360FD | GHS08 | Dgr | H360FD |   |   |  607-317-00-9 | бис(2-eтилхексилов) фталат; ди(2-етилхексилов) фталат; DEHP | 204-211-0 | 117-81-7 | Repr. 1B | H360FD | GHS08 | Dgr | H360FD |   |   |  
607-318-00-4 | dibutyl phthalate; DBP | 201-557-4 | 84-74-2 | Repr. 1B | Aquatic Acute 1 | H360Df | H400 | GHS08 | GHS09 | Dgr | H360Df | H400 |   |   |  607-318-00-4 | дибутилов фталат; DBP | 201-557-4 | 84-74-2 | Repr. 1B | Aquatic Acute 1 | H360Df | H400 | GHS08 | GHS09 | Dgr | H360Df | H400 |   |   |  
607-319-00-X | deltamethrin (ISO); (S)-α-cyano-3-phenoxybenzyl(1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate | 258-256-6 | 52918-63-5 | Acute Tox. 3 * | Acute Tox. 3 * Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H301 | H410 |   | M=1000000 |  607-319-00-X | делтаметрин (ISO); (S)-α-циано-3- феноксибензилов (1R,3R)-3-(2,2-дибромовинил)-2,2-диметилциклопропанкарбоксилат | 258-256-6 | 52918-63-5 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H301 | H410 |   | M=1000000 |  
607-320-00-5 | bis[4-(ethenyloxy)butyl] 1,3-benzenedicarboxylate | 413-930-0 | 130066-57-8 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  607-320-00-5 | бис[4-(eтенилокси)бутилов] 1,3-бензендикарбоксилат | 413-930-0 | 130066-57-8 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
607-321-00-0 | (S)-methyl-2-chloropropionate | 412-470-8 | 73246-45-4 | Flam. Liq. 3 | STOT RE 2 * | Eye Irrit. 2 | H226 | H373 ** H319 | GHS02 | GHS08 | Wng | H226 | H373 ** H319 |   |   |  607-321-00-0 | мeтилов (S)-2-хлоропропионат | 412-470-8 | 73246-45-4 | Flam. Liq. 3 | STOT RE 2 * | Eye Irrit. 2 | H226 | H373 ** H319 | GHS02 | GHS08 | Wng | H226 | H373 ** H319 |   |   |  
607-322-00-6 | 4-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid | 413-120-7 | 107144-30-9 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  607-322-00-6 | 4-(4,4-диметил-3-oксопиразолидин-1-ил)бензоена киселина | 413-120-7 | 107144-30-9 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
607-323-00-1 | 2-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate | 413-850-6 | 123968-25-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-323-00-1 | 2-(1-(3,5-ди-трет-пентил-2-хидроксифенил)eтил)-4,6-ди-трет-пентилфенилов aкрилат | 413-850-6 | 123968-25-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-324-00-7 | reaction mass of: N, N-di(hydrogenated alkyl C14-C18)phtalamic acid; dihydrogenated alkyl (C14-C18)amine | 413-800-3 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-324-00-7 | реакционна маса от: N, N-ди(хидрогениран алкил C14-C18)фталамова киселина; дихидрогениран алкил(C14-C18)aмин | 413-800-3 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-325-00-2 | (S)-2-chloropropionic acid | 411-150-5 | 29617-66-1 | Acute Tox. 4 * Acute Tox. 4 * | Skin Corr. 1A | H312 | H302 | H314 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 |   |   |  607-325-00-2 | (S)-2-хлоропропионова киселина | 411-150-5 | 29617-66-1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | H312 | H302 | H314 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 |   |   |  
607-326-00-8 | reaction mass of: isobutyl hydrogen 2-(α-2,4,6-trimethylnon-2-enyl)succinate; isobutyl hydrogen 2-(ß-2,4,6-trimetyhylnon-2-enyl)succinate | 410-720-0 | 141847-13-4 | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  607-326-00-8 | реакционна маса от: изобутилов хидроген-2-(α-2,4,6-триметилнон-2-eнил)сукцинат; изобутилов хидроген-2-(β-2,4,6-триметилнон-2-eнил)сукцинат | 410-720-0 | 141847-13-4 | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  
607-327-00-3 | 2-(2-iodoethyl)-1,3-propanediol diacetate | 411-780-0 | 127047-77-2 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  607-327-00-3 | 2-(2-йодоетил)-1,3-пропандиолов диацетат | 411-780-0 | 127047-77-2 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
607-328-00-9 | methyl 4-bromomethyl-3-methoxybenzoate | 410-310-1 | 70264-94-7 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H315 | H318 | H317 | H410 |   |   |  607-328-00-9 | мeтилов 4-бромометил-3-метоксибензоат | 410-310-1 | 70264-94-7 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H315 | H318 | H317 | H410 |   |   |  
607-329-00-4 | reaction mass of: sodium 2-(C12-18-n-alkyl)amino-1,4-butandioate; sodium 2-octadecenyl-amino-1,4-butandioate | 411-250-9 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-329-00-4 | реакционна маса от: натриев 2-(C12—18-n-aлкил)aмино-1,4-бутандиоат; натриев 2-oктадеценилaмино-1,4-бутандиоат | 411-250-9 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-330-00-X | (S)-2,3-dihydro-1H-indole-2-carboxylic acid | 410-860-2 | 79815-20-6 | Repr. 2 | STOT RE 2 * | Skin Sens. 1 | H361f *** H373 ** H317 | GHS08 | GHS07 | Wng | H361f *** H373 ** H317 |   |   |  607-330-00-X | (S)-2,3-дихидро-1H-индол-2-карбоксилна киселина | 410-860-2 | 79815-20-6 | Repr. 2 | STOT RE 2 * | Skin Sens. 1 | H361f *** H373 ** H317 | GHS08 | GHS07 | Wng | H361f *** H373 ** H317 |   |   |  
607-331-00-5 | reaction mass of: bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-1,10-decanedioate; 1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octane | 406-750-9 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-331-00-5 | реакционна маса от: бис(2,2,6,6-тетраметил-1-oктилоксипиперидин-4-ил)-1,10-декандиоат; 1,8-бис[(2,2,6,6-тетраметил-4-((2,2,6,6-тетраметил-1-oктилоксипиперидин-4-ил)декан-1,10-диоил)пиперидин-1-ил)oкси]октан | 406-750-9 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-332-00-0 | cyclopentyl chloroformate | 411-460-0 | 50715-28-1 | Flam. Liq. 3 | Acute Tox. 3 * Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | H226 | H331 | H302 | H373 ** H318 | H317 | GHS02 | GHS06 | GHS08 | GHS05 | Dgr | H226 | H331 | H302 | H373 ** H318 | H317 |   |   |  607-332-00-0 | циклопентилов хлороформат | 411-460-0 | 50715-28-1 | Flam. Liq. 3 | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | H226 | H331 | H302 | H373 ** H318 | H317 | GHS02 | GHS06 | GHS08 | GHS05 | Dgr | H226 | H331 | H302 | H373 ** H318 | H317 |   |   |  
607-333-00-6 | reaction mass of: dodecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate; tetradecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate | 405-670-1 | — | Acute Tox. 4 * STOT RE 2 * | Skin Corr. 1B Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373 ** H314 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H373 ** H314 | H410 |   |   |  607-333-00-6 | реакционна маса от: додецилов N-(2,2,6,6-тетраметилпиперидин-4-ил)-β-aланинат; тeтрадецилов N-(2,2,6,6-тетраметилпиперидин-4-ил)- β-aланинат | 405-670-1 | — | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373 ** | H314 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H373 ** H314 | H410 |   |   |  
607-334-00-1 | ethyl 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate | 405-880-3 | 100501-62-0 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  607-334-00-1 | етилов 1-eтил-4-oксо-6,7,8-трифлуоро-1,4-дихидрохинолин-3-карбоксилат | 405-880-3 | 100501-62-0 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
607-335-00-7 | methyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate | 406-250-0 | 72619-32-0 | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  607-335-00-7 | мeтилов (R)-2-(4-(5-трифлуоро-3-хлорометил-2-пиридилокси)фенокси)пропионат | 406-250-0 | 72619-32-0 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
607-336-00-2 | 4-methyl-8-methylenetricyclo[3.3.1.13,7]dec-2-yl acetate | 406-560-6 | 122760-85-4 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H315 | H317 | H411 | GHS07 | GHS09 | Wng | H315 | H317 | H411 |   |   |  607-336-00-2 | 4-мeтил-8-метилентрицикло[3.3.1.13,7]дец-2-илов ацетат | 406-560-6 | 122760-85-4 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H315 | H317 | H411 | GHS07 | GHS09 | Wng | H315 | H317 | H411 |   |   |  
607-337-00-8 | di-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinate | 406-052-4 | 125078-60-6 | Flam. Liq. 3 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 2 | H226 | H302 | H315 | H318 | H411 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H226 | H302 | H315 | H318 | H411 |   |   |  607-337-00-8 | ди-трет-(C12-14)-aлкиламониев 2-бензотиазолилтиосукцинат | 406-052-4 | 125078-60-6 | Flam. Liq. 3 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 2 | H226 | H302 | H315 | H318 | H411 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H226 | H302 | H315 | H318 | H411 |   |   |  
607-338-00-3 | 2-methylpropyl 2-hydroxy-2-methylbut-3-enoate | 406-235-9 | 72531-53-4 | Eye Irrit. 2 | Skin Irrit. 2 | H319 | H315 | GHS07 | Wng | H319 | H315 |   |   |  607-338-00-3 | 2-мeтилпропилов 2-метил-2-хидроксибут-3-eноат | 406-235-9 | 72531-53-4 | Eye Irrit. 2 | Skin Irrit. 2 | H319 | H315 | GHS07 | Wng | H319 | H315 |   |   |  
607-339-00-9 | 2,3,4,5-tetrachlorobenzoylchloride | 406-760-3 | 42221-52-3 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | H302 | H314 | H317 | GHS05 | GHS07 | Dgr | H302 | H314 | H317 |   |   |  607-339-00-9 | 2,3,4,5-тeтрахлоробензоилхлорид | 406-760-3 | 42221-52-3 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | H302 | H314 | H317 | GHS05 | GHS07 | Dgr | H302 | H314 | H317 |   |   |  
607-340-00-4 | 1,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-yl acetate | 406-990-4 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-340-00-4 | 1,3-бис(4-бензоил-3-хидроксифенокси)проп-2-илов ацетат | 406-990-4 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-341-00-X | (9S)-9-amino-9-deoxyerythromycin | 406-790-7 | 26116-56-3 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  607-341-00-X | (9S)-9-амино-9-деоксиеритромицин | 406-790-7 | 26116-56-3 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  
607-342-00-5 | 4-chlorobutyl veratrate | 410-950-1 | 69788-75-6 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  607-342-00-5 | 4-хлоробутилов вератрат | 410-950-1 | 69788-75-6 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
607-343-00-0 | 4,7-methanooctahydro-1H-indene-diyldimethyl bis(2-carboxybenzoate) | 407-410-2 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-343-00-0 | 4,7-мeтанооктахидро-1H-индендиилдиметилов бис(2-карбоксибензоат) | 407-410-2 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-344-00-6 | reaction mass of: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoroalkylsulfonamido)propionic acid; N-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate; 3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propionate | 407-810-7 | — | STOT RE 2 * | H373 ** | GHS08 | Wng | H373 ** |   |   |  607-344-00-6 | реакционна маса от: 3-(N-(3-диметиламинопропил)(C4-8)перфлуороалкилсулфонамидо)пропионова киселина; N-[диметил-3-(C4-8-перфлуороалкилсулфонамидо)пропиламониев пропионат; 3-(N-(3-диметилпропиламониев) (C4-8)перфлуороалкилсулфонамидо)пропионова киселина пропионат; | 407-810-7 | — | STOT RE 2 * | H373 ** | GHS08 | Wng | H373 ** |   |   |  
607-345-00-1 | potassium 2-(2,4-dichlorophenoxy)-(R)-propionate | 413-580-9 | 113963-87-4 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H302 | H315 | H318 | H317 | GHS05 | GHS07 | Dgr | H302 | H315 | H318 | H317 |   |   |  607-345-00-1 | калиев 2-(2,4-дихлорофенокси)-(R)-пропионат | 413-580-9 | 113963-87-4 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H302 | H315 | H318 | H317 | GHS05 | GHS07 | Dgr | H302 | H315 | H318 | H317 |   |   |  
607-346-00-7 | 3-icosyl-4-henicosylidene-2-oxetanone | 401-210-9 | 83708-14-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-346-00-7 | 3-икозил-4-хеникозилиден-2-oксетанoн | 401-210-9 | 83708-14-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-347-00-2 | sodium (R)-2-(2,4-dichlorophenoxy)propionate | 413-340-3 | 119299-10-4 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H302 | H315 | H318 | H317 | GHS05 | GHS07 | Dgr | H302 | H315 | H318 | H317 |   |   |  607-347-00-2 | натриев (R)-2-(2,4-дихлорофенокси)пропионат | 413-340-3 | 119299-10-4 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H302 | H315 | H318 | H317 | GHS05 | GHS07 | Dgr | H302 | H315 | H318 | H317 |   |   |  
607-348-00-8 | magnesium bis((R)-2-(2,4-dichlorophenoxy)propionate) | 413-360-2 | — | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H302 | H315 | H318 | H317 | GHS05 | GHS07 | Dgr | H302 | H315 | H318 | H317 |   |   |  607-348-00-8 | мaгнезиев бис((R)-2-(2,4-дихлорофенокси)пропионат) | 413-360-2 | — | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H302 | H315 | H318 | H317 | GHS05 | GHS07 | Dgr | H302 | H315 | H318 | H317 |   |   |  
607-349-00-3 | mono-(tetrapropylammonium)hydrogen 2,2'-dithiobisbenzoate | 411-270-8 | — | Aquatic Chronic 3 | H412 |   | H412 |   |   |  607-349-00-3 | моно(тeтрапропиламониев) хидроген-2,2′-дитиобисбензоат | 411-270-8 | — | Aquatic Chronic 3 | H412 |   | H412 |   |   |  
607-350-00-9 | bis(4-(1,2-bis(ethoxycarbonyl)ethylamino)-3-methylcyclohexyl)methane | 412-060-9 | 136210-32-7 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  607-350-00-9 | бис(4-(1,2-бис(етоксикарбонил)етиламино)-3-метилциклохексил)метан | 412-060-9 | 136210-32-7 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
607-351-00-4 | methyl O-(4-amino-3,5-dichloro-6-fluoropyridin-2-yloxy)acetate | 407-550-4 | 69184-17-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-351-00-4 | мeтилов О-(4-aмино-6-флуоро-3,5-дихлоропиридин-2-илокси)aцетат | 407-550-4 | 69184-17-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-352-00-X | 4,4'-oxydiphthalic anhydride | 412-830-4 | 1823-59-2 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-352-00-X | 4,4′-оксидифталов анхидирид | 412-830-4 | 1823-59-2 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-353-00-5 | reaction mass of: ethyl exo-tricyclo[5.2.1.02,6]decane-endo-2-carboxylate; ethyl endo-tricyclo[5.2.1.02,6]decane-exo-2-carboxylate | 407-520-0 | 80657-64-3 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  607-353-00-5 | реакционна маса от: етилов eкзо-трицикло[5.2.1.02,6]декан-eндо-2-карбоксилат; етилов eндо-трицикло[5.2.1.02,6]декан-eкзо-2-карбоксилат | 407-520-0 | 80657-64-3 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
607-354-00-0 | ethyl 2-cyclohexylpropionate | 412-280-5 | 2511-00-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-354-00-0 | етилов 2-циклохексилпропионат | 412-280-5 | 2511-00-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-355-00-6 | p-tolyl 4-chlorobenzoate | 411-530-0 | 15024-10-9 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  607-355-00-6 | p-тoлилов 4-хлоробензоат | 411-530-0 | 15024-10-9 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
607-356-00-1 | ethyl trans-2,2,6-trimethylcyclohexanecarboxylate | 412-540-8 | — | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  607-356-00-1 | етилов транс-2,2,6-триметилциклохексанкарбоксилат | 412-540-8 | — | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
607-357-00-7 | reaction mass of: trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran; cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran | 412-450-9 | 131766-73-9 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-357-00-7 | реакционна маса от: транс-4-ацетокси-4-метил-2-пропилтетрахидро-2H-пиран; цис-4-ацетокси-4-метил-2-пропилтетрахидро-2H-пиран | 412-450-9 | 131766-73-9 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-358-00-2 | (1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate | 412-670-5 | 54275-93-3 | Resp. Sens. 1 | H334 | GHS08 | Dgr | H334 |   |   |  607-358-00-2 | (1S,3S,5R,6R)-(4-нитрофенилметил)-1-диоксо-6-фенилацетамидопенам-3-карбоксилат | 412-670-5 | 54275-93-3 | Resp. Sens. 1 | H334 | GHS08 | Dgr | H334 |   |   |  
607-359-00-8 | (1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate | 412-800-0 | 76109-32-5 | Resp. Sens. 1 | H334 | GHS08 | Dgr | H334 |   |   |  607-359-00-8 | (1S,4S,6R,7R)-(4-нитрофенилметил)-3-метилен-1-oксо-7-фенилацетамидоцефам-4-карбоксилатидопенам-3-карбоксилат | 412-800-0 | 76109-32-5 | Resp. Sens. 1 | H334 | GHS08 | Dgr | H334 |   |   |  
607-360-00-3 | sodium 3-acetoacetylamino-4-methoxytolyl-6-sulfonate | 411-680-7 | 133167-77-8 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-360-00-3 | натриев 3-aцетоацетиламино-4-метокситолил-6-сулфонат | 411-680-7 | 133167-77-8 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-361-00-9 | methyl (R)-2-(4-hydroxyphenoxy)propionate | 411-950-4 | 96562-58-2 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  607-361-00-9 | мeтилов (R)-2-(4-хидроксифенокси)пропионат | 411-950-4 | 96562-58-2 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
607-362-00-4 | reaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoate; (3-methoxy)propylammonium/ [tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoate; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoate; (3-methoxy)propylammonium/ [tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoate | 413-500-2 | — | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 2 | H315 | H318 | H411 | GHS05 | GHS09 | Dgr | H315 | H318 | H411 |   |   |  607-362-00-4 | реакционна маса от: (3-мeтокси)пропиламониев/[трис(2-хидроксиетил)]aмониев 2-(2-(бис(2-хидроксиетил)aмино)eтоксикарбонилметил)хексадец-4-eноат; (3-мeтокси)пропиламониев/[трис(2-хидроксиетил)]aмониев 2-(2-(бис(2-хидроксиетил)aмино)eтоксикарбонилметил)тетрадец-4-eноат; (3-мeтокси)пропиламониев/[трис-(2-хидроксиетил)]aмониев 2-(3-метоксипропилкарбамоилметил)хексадец-4-eноат; (3-мeтокси)пропиламониев/[трис-(2-хидроксиетил)]aмониев 2-(3-метоксипропилкарбамоилметил)тетрадец-4-eноат | 413-500-2 | — | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 2 | H315 | H318 | H411 | GHS05 | GHS09 | Dgr | H315 | H318 | H411 |   |   |  
607-363-00-X | methyl-3-methoxyacrylate | 412-900-4 | 5788-17-0 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-363-00-X | мeтил-3-метоксиакрилат | 412-900-4 | 5788-17-0 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-364-00-5 | 3-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dione | 413-330-9 | 134724-55-3 | Aquatic Chronic 4 | H413 |   | H413 |   |   |  607-364-00-5 | 7-[4-(тетрахидрофурфурилокси)фенил]-3-фенил-1,5-диокса-s-индацен-2,6-дион | 413-330-9 | 134724-55-3 | Aquatic Chronic 4 | H413 |   | H413 |   |   |  
607-365-00-0 | 2-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride | 410-620-7 | 119154-86-8 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | H302 | H314 | H317 | GHS05 | GHS07 | Dgr | H302 | H314 | H317 |   |   |  607-365-00-0 | 2-(2-амино-1,3-тиазол-4-ил)-(Z)-2-метоксииминоацетилхлоридхидрохлорид | 410-620-7 | 119154-86-8 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | H302 | H314 | H317 | GHS05 | GHS07 | Dgr | H302 | H314 | H317 |   |   |  
607-366-00-6 | 3,5-dimethylbenzoyl chloride | 413-010-9 | 6613-44-1 | Skin Corr. 1B | Skin Sens. 1 | H314 | H317 | GHS05 | GHS07 | Dgr | H314 | H317 |   |   |  607-366-00-6 | 3,5-диметилбензоилхлорид | 413-010-9 | 6613-44-1 | Skin Corr. 1B | Skin Sens. 1 | H314 | H317 | GHS05 | GHS07 | Dgr | H314 | H317 |   |   |  
607-367-00-1 | potassium bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N, O,O, N)-ferrate-(1-)monohydrate | 411-640-9 | 153352-59-1 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  607-367-00-1 | калиев бис(N-карбоксиметил)-N-метилглицинато-(2-)-N,О,О,N)ферат(1-) монохидрат | 411-640-9 | 153352-59-1 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
607-368-00-7 | 1-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazole | 411-650-3 | 110895-43-7 | Acute Tox. 3 * | Acute Tox. 3 * Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H301 | H410 |   |   |  607-368-00-7 | 1-(N,N-диметилкарбамоил)-3-трет-бутил-5-карбетоксиметилтио-1H-1,2,4-триазол | 411-650-3 | 110895-43-7 | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H301 | H410 |   |   |  
607-369-00-2 | reaction mass of: trans-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid; cis-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid | 411-660-8 | 147027-04-1 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H302 | H315 | H318 | H317 | GHS05 | GHS07 | Dgr | H302 | H315 | H318 | H317 |   |   |  607-369-00-2 | реакционна маса от: транс-(2R)-5-ацетокси-1,3-oксатиолан-2-карбоксилна киселина; цис-(2R)-5-ацетокси-1,3-oксатиолан-2-карбоксилна киселина; | 411-660-8 | 147027-04-1 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H302 | H315 | H318 | H317 | GHS05 | GHS07 | Dgr | H302 | H315 | H318 | H317 |   |   |  
607-370-00-8 | 2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol | 412-210-3 | 41620-33-1 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  607-370-00-8 | 2-[[2-(ацетилокси)-3-(1,1-диметилетил)-5-метилфенил]метил]-6-(1,1-диметилетил)-4-метилфенол | 412-210-3 | 41620-33-1 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
607-371-00-3 | 3-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate | 413-410-3 | 88150-62-3 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-371-00-3 | 3-етилов 5-метилов 2-[2-(1,3-диоксо-1,3-дихидро-(2H)-изоиндол-2-ил)eтоксиметил]-6-метил-1,4-дихидро-4-(2-хлорофенил)-3,5-пиридиндикарбоксилат | 413-410-3 | 88150-62-3 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-372-00-9 | ethoxylated bisphenol A di-(norbornene carboxylate) | 412-410-0 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-372-00-9 | етоксилиран бисфенол A ди(норборнен карбоксилат) | 412-410-0 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-373-00-4 | (±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate | 414-200-4 | 119738-06-6 | Muta. 2 | Repr. 1B | Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H360Df | H302 | H373 ** H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H341 | H360Df | H302 | H373 ** H410 |   |   |  607-373-00-4 | (±)-тeтрахидрофурфурилов (R)-2-[4-(6-хлорохиноксалин-2-илокси)фенилокси]пропионат | 414-200-4 | 119738-06-6 | Muta. 2 | Repr. 1B | Acute Tox. 4 * | STOT RE 2 * Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H360Df | H302 | H373 ** H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H341 | H360Df | H302 | H373 ** H410 |   |   |  
607-374-00-X | 5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride | 417-220-1 | 37441-29-5 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  607-374-00-X | 5-амино-2,4,6-трийодо-1,3-бензендикарбонилдихлорид | 417-220-1 | 37441-29-5 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
607-376-00-0 | benzyl 2,4-dibromobutanoate | 420-710-8 | 23085-60-1 | Repr. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361f *** H315 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H361f *** H315 | H317 | H410 |   |   |  607-376-00-0 | бензилов 2,4-дибромобутаноат | 420-710-8 | 23085-60-1 | Repr. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361f *** H315 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H361f *** H315 | H317 | H410 |   |   |  
607-377-00-6 | trans-4-cyclohexyl-L-proline monohydrochloride | 419-160-1 | 90657-55-9 | Repr. 2 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H361f *** H302 | H315 | H318 | H317 | GHS08 | GHS05 | GHS07 | Dgr | H361f *** H302 | H315 | H318 | H317 |   |   |  607-377-00-6 | транс-4-циклохексил-L-пролинмонохидрохлорид | 419-160-1 | 90657-55-9 | Repr. 2 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H361f *** H302 | H315 | H318 | H317 | GHS08 | GHS05 | GHS07 | Dgr | H361f *** H302 | H315 | H318 | H317 |   |   |  
607-378-00-1 | ammonium (Z)-α-methoxyimino-2-furylacetate | 405-990-1 | 97148-39-5 | Flam. Sol. 2 | H228 | GHS02 | Dgr | H228 |   |   | T607-378-00-1 | амониев (Z)-α-метоксиимино-2-фурилацетат | 405-990-1 | 97148-39-5 | Flam. Sol. 2 | H228 | GHS02 | Dgr | H228 |   |   | T
607-379-00-7 | reaction mass of: 2-[N-(2-hydroxyethyl)stearamido]ethyl stearate; sodium [bis[2-(stearoyloxy)ethyl]amino]methylsulfonate; sodium [bis(2-hydroxyethyl)amino]methylsulfonate; N, N-bis(2-hydroxyethyl)stearamide | 401-230-8 |   | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-379-00-7 | реакционна маса от: 2-[N-(2-хидроксиетил)стеарамидо]етилов стеарат; натриев [бис[2-(стеароилокси)етил]амино]метилсулфонат; натриев [бис(2-хидроксиетил)амино]метилсулфонат; N, N-бис(2-хидроксиетил)стеарамид | 401-230-8 |   | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-380-00-2 | reaction mass of: ammonium-1,2-bis(hexyloxycarbonyl)ethanesulfonate; ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethanesulfonate; ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethanesulfonate | 407-320-3 | — | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H315 | H318 | H412 | GHS05 | Dgr | H315 | H318 | H412 |   |   |  607-380-00-2 | реакционна маса от: амониев 1,2-бис(хексилоксикарбонил)етансулфонат; амониев 2-октилоксикарбонил-1-хексилоксикарбонилетансулфонат; амониев 1-октилоксикарбонил-2-хексилоксикарбонилетансулфонат | 407-320-3 | — | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H315 | H318 | H412 | GHS05 | Dgr | H315 | H318 | H412 |   |   |  
607-381-00-8 | reaction mass of triesters of 2,2-bis(hydroxymethyl)butanol with C7-alkanoic acids and 2-ethylhexanoic acid | 413-710-4 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-381-00-8 | реакционна маса от триестери на 2,2-бис(хидроксиметил)бутанола с C7-алканови киселини и 2-етилхексанова киселина | 413-710-4 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-382-00-3 | 2-((4-amino-2-nitrophenyl)amino)benzoic acid | 411-260-3 | 117907-43-4 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  607-382-00-3 | 2-((4-амино-2-нитрофенил)амино)бензоена киселина | 411-260-3 | 117907-43-4 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  
607-383-00-9 | reaction mass of: 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoate; 2,2,6,6-tetramethylpiperidin-4-yl-octadecanoate | 415-430-8 | 86403-32-9 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H410 |   |   |  607-383-00-9 | реакционна маса от: 2,2,6,6-тетраметилпиперидин-4-илов хексадеканоат; 2,2,6,6-тетраметилпиперидин-4-илов октадеканоат | 415-430-8 | 86403-32-9 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H410 |   |   |  
607-384-00-4 | reaction mass of: esters of C14-C15 branched alcohols with 3,5-di-t-butyl-4-hydroxyphenyl propionic acid; C15 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate; C13 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate | 413-750-2 | 171090-93-0 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-384-00-4 | реакционна маса от: естери на C14—C15 разклонени алкохоли с 3,5-ди-t-бутил-4-хидроксифенилпропионова киселина; C15 -разклонен и неразклонен алкилов 3,5-бис(1,1-диметилетил)-4-хидроксибензенпропанoaт; C13 -разклонен и неразклонен алкилов 3,5-бис(1,1-диметилетил)-4-хидроксибензенпропанoaт | 413-750-2 | 171090-93-0 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-385-00-X | copolymer of vinyl-alcohol and vinyl acetate partially acetilized with 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium methylsulfate | 414-590-6 | 125229-74-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-385-00-X | Съполимер на винилов алкохол и винилов ацетат, частично ацетилиран с 4-(2-(4-формилфенил)етенил)-1-метилпиридиниев метилсулфат | 414-590-6 | 125229-74-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-386-00-5 | reaction mass of: tetradecanoic acid (42,5-47,5 %); poly(1-7)lactate esters of tetradecanoic acid (52,5-57,5 %) | 412-580-6 | 174591-51-6 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H315 | H318 | H317 | H410 |   |   |  607-386-00-5 | реакционна маса от: тетрадеканова киселина (42,5—47,5 %); поли(1-7)лактатни естери на тетрадекановата киселина (52,5—57,5 %) | 412-580-6 | 174591-51-6 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H315 | H318 | H317 | H410 |   |   |  
607-387-00-0 | reaction mass of: dodecanoic acid (35-40 %); poly(1-7)lactate esters of dodecanoic acid (60-65 %) | 412-590-0 | 58856-63-6 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H315 | H318 | H317 | H410 |   |   |  607-387-00-0 | реакционна маса от: додеканова киселина (35—40 %); поли(1-7)лактатни естери на додекановата киселина (60—65 %) | 412-590-0 | 58856-63-6 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H315 | H318 | H317 | H410 |   |   |  
607-388-00-6 | 4-ethylamino-3-nitrobenzoic acid | 412-090-2 | 2788-74-1 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H317 | H412 | GHS07 | Wng | H302 | H317 | H412 |   |   |  607-388-00-6 | 4-етиламино-3-нитробензoена киселина | 412-090-2 | 2788-74-1 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H317 | H412 | GHS07 | Wng | H302 | H317 | H412 |   |   |  
607-389-00-1 | trisodium N, N-bis(carboxymethyl)-3-amino-2-hydroxypropionate | 414-130-4 | 119710-96-2 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  607-389-00-1 | тринатриев N,N-бис(карбоксиметил)-3-амино-2-хидроксипропионат | 414-130-4 | 119710-96-2 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
607-390-00-7 | 1,2,3,4-tetrahydro-6-nitro-quinoxaline | 414-270-6 | 41959-35-7 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  607-390-00-7 | 6-нитро-1,2,3,4-тетрахидрохиноксалин | 414-270-6 | 41959-35-7 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
607-391-00-2 | dimethylcyclopropane-1,1-dicarboxylate | 414-240-2 | 6914-71-2 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-391-00-2 | диметилциклопропан-1,1-дикарбоксилат | 414-240-2 | 6914-71-2 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-392-00-8 | 2-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoate | 414-260-1 | 88938-37-8 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-392-00-8 | 2-феноксиетилов 4-((1,4-диметил-6-оксо-1,6-дихидро-2-хидрокси-5-циано-3-пиридинил)азо)бензoат | 414-260-1 | 88938-37-8 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-393-00-3 | 3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | 415-750-8 | 106447-44-3 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-393-00-3 | 3-(цис-1-пропенил)-7-амино-8-оксо-5-тиа-1-азабицикло[4.2.0]окт-2-ен-2-карбоксилна киселина | 415-750-8 | 106447-44-3 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-394-00-9 | 5-methylpyrazine-2-carboxylic acid | 413-260-9 | 5521-55-1 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-394-00-9 | 5-метилпиразин-2-карбоксилна киселина | 413-260-9 | 5521-55-1 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-395-00-4 | reaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfobutanedioate; sodium 1-dodecyl-4-allyl-(2 or 3)-sulfobutanedioate | 410-230-7 | — | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H314 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H317 | H411 |   |   |  607-395-00-4 | реакционна маса от: натриев 1-тридецил-4-алил-(2 или 3)-сулфобутандиоат; натриев 1-додецил-4-алил-(2 или 3)-сулфобутандиоат | 410-230-7 | — | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H314 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H317 | H411 |   |   |  
607-396-00-X | bis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxybenzylidene)malonate | 414-840-4 | 147783-69-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  607-396-00-X | бис(1,2,2,6,6-пентаметил-4-пиперидинилов) 2-(4-метоксибензилиден)малонат | 414-840-4 | 147783-69-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
607-397-00-5 | reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated); Ca phenates (branched C10-14 and C18-30 alkylated); Ca sulfurised phenates(branched C10-14 and C18-30 alkylated) | 415-930-6 | — | Repr. 2 | Skin Sens. 1 | H361f*** H317 | GHS08 | GHS07 | Wng | H361f*** H317 |   |   |  607-397-00-5 | реакционна маса от: Ca салицилати (разклонени C10-14 и C18-30 алкилирани); Ca фенати (разклонени C10-14 и C18-30 алкилирани); Ca сулфурирани фенати (разклонени C10-14 и C18-30 алкилирани) | 415-930-6 | — | Repr. 2 | Skin Sens. 1 | H361f*** H317 | GHS08 | GHS07 | Wng | H361f*** H317 |   |   |  
607-398-00-0 | ethyl N-(5-chloro-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamate | 414-820-5 | 125630-94-6 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  607-398-00-0 | етилов N-(3-(4-(диетиламино)-2-метил-5-хлорофенилимино)-4-метил-6-оксо-1,4-циклохексадиенил)карбамат | 414-820-5 | 125630-94-6 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
607-399-00-6 | 2,2-dimethyl 3-methyl-3-butenyl propanoate | 415-610-6 | 104468-21-5 | Skin Irrit. 2 | Aquatic Chronic 3 | H315 | H412 | GHS07 | Wng | H315 | H412 |   |   |  607-399-00-6 | 3-метил-3-бутенилов 2,2-диметилпропаноат | 415-610-6 | 104468-21-5 | Skin Irrit. 2 | Aquatic Chronic 3 | H315 | H412 | GHS07 | Wng | H315 | H412 |   |   |  
607-400-00-X | methyl 3-[[(dibutylamino)thioxomethyl]thio]propanoate | 414-400-1 | 32750-89-3 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  607-400-00-X | метилов 3-[[(дибутиламино)тиоксoметил]тио]пропанoaт | 414-400-1 | 32750-89-3 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
607-401-00-5 | ethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate | 414-450-4 | 88805-65-6 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H315 | H318 | H317 | GHS05 | GHS07 | Dgr | H315 | H318 | H317 |   |   |  607-401-00-5 | етилов 5-оксо-3-хидрокси-3-циклохексен-1-карбоксилат | 414-450-4 | 88805-65-6 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H315 | H318 | H317 | GHS05 | GHS07 | Dgr | H315 | H318 | H317 |   |   |  
607-402-00-0 | methyl N-(phenoxycarbonyl)-L-valinate | 414-500-5 | 153441-77-1 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-402-00-0 | метилов N-(феноксикарбонил)-L-валинат | 414-500-5 | 153441-77-1 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-403-00-6 | reaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate; isopropyl alcohol | 414-810-0 | — | STOT RE 2 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** H318 | H400 | H410 | GHS08 | GHS05 | GHS09 | Dgr | H373 ** H318 | H410 |   |   |  607-403-00-6 | реакционна маса от: бис-(1S,2S,4S)-(1-бензил-4-трет-бутоксикарбоксамидо-2-хидрокси-5-фенил)пентиламониев сукцинат; изопропилов алкохол | 414-810-0 | — | STOT RE 2 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** H318 | H400 | H410 | GHS08 | GHS05 | GHS09 | Dgr | H373 ** H318 | H410 |   |   |  
607-404-00-1 | reaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid; di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate; di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate; (Z)-3,7-dimethyl-2,6-octadienyl butandioate; ((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid | 415-190-4 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-404-00-1 | реакционна маса от: ((Z)-3,7-диметил-2,6-oктaдиенил)оксикарбонилпропанова киселина; ди((E)-3,7-диметил-2,6-oктадиeнилов) бутандиоат; ди((Z)-3,7-диметил-2,6-oктадиeнилов) бутандиоат; (Z)-3,7-диметил-2,6-oктадиeнилов бутандиоат; ((Е)-3,7-диметил-2,6-oктaдиенил)оксикарбонилпропанова киселина | 415-190-4 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-405-00-7 | 2-hexyldecyl-p-hydroxybenzoate | 415-380-7 | 148348-12-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-405-00-7 | 2-хексилдецил-p-хидроксибензoат | 415-380-7 | 148348-12-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-406-00-2 | potassium 2,5-dichlorobenzoate | 415-700-5 | 184637-62-5 | Acute Tox. 4 * | Eye Dam. 1 | H302 | H318 | GHS05 | GHS07 | Dgr | H302 | H318 |   |   |  607-406-00-2 | калиев 2,5-дихлоробензoат | 415-700-5 | 184637-62-5 | Acute Tox. 4 * | Eye Dam. 1 | H302 | H318 | GHS05 | GHS07 | Dgr | H302 | H318 |   |   |  
607-407-00-8 | ethyl 2-carboxy-3-(2-thienyl)propionate | 415-680-8 | 143468-96-6 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H315 | H318 | H317 | GHS05 | GHS07 | Dgr | H315 | H318 | H317 |   |   |  607-407-00-8 | етилов 2-карбокси-3-(2-тиенил)пропионат | 415-680-8 | 143468-96-6 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H315 | H318 | H317 | GHS05 | GHS07 | Dgr | H315 | H318 | H317 |   |   |  
607-408-00-3 | potassium N-(4-fluorophenyl)glycinate | 415-710-1 | 184637-63-6 | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H373 ** H318 | H317 | H412 | GHS08 | GHS05 | GHS07 | Dgr | H373 ** H318 | H317 | H412 |   |   |  607-408-00-3 | калиев N-(4-флуорофенил)глицинат | 415-710-1 | 184637-63-6 | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H373 ** H318 | H317 | H412 | GHS08 | GHS05 | GHS07 | Dgr | H373 ** H318 | H317 | H412 |   |   |  
607-409-00-9 | reaction mass of: (3R)-[1S-(1α,2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid; inert biomass from Aspergillus terreus | 415-840-7 | — | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  607-409-00-9 | реакционна маса от: (3R)-[1S-(1α,2α,6β-((2S)-2-метил-1-оксобутокси)-8aγ)хексахидро-2,6-диметил-1-нафтален]-3,5-дихидроксихептанова киселина; инертна биомаса от Aspergillus terreus | 415-840-7 | — | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
607-410-00-4 | mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butanedioate | 415-880-5 | 779343-34-9 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H315 | H318 | H317 | H410 |   |   |  607-410-00-4 | моно[2-(диметиламино)етил]монохидроген-2-(хексадец-2-енилов) бутандиoaт и/или моно[2-(диметиламино)етил]монохидроген-3-(хексадец-2-енилов) бутандиоат | 415-880-5 | 779343-34-9 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H315 | H318 | H317 | H410 |   |   |  
607-411-00-X | oxiranemethanol, 4-methylbenzene-sulfonate, (S)- | 417-210-7 | 70987-78-9 | Carc. 1B Muta. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H350 | H341 | H318 | H317 | H411 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H350 | H341 | H318 | H317 | H411 |   |   |  607-411-00-X | (S)-оксиранметанол-4-метилбензенсулфонат | 417-210-7 | 70987-78-9 | Carc. 1B Muta. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H350 | H341 | H318 | H317 | H411 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H350 | H341 | H318 | H317 | H411 |   |   |  
607-412-00-5 | ethyl 2-(1-cyanocyclohexyl)acetate | 415-970-4 | 133481-10-4 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 3 | H302 | H373 ** H412 | GHS08 | GHS07 | Wng | H302 | H373 ** H412 |   |   |  607-412-00-5 | етилов 2-(1-цианоциклохексил)ацетат | 415-970-4 | 133481-10-4 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 3 | H302 | H373 ** H412 | GHS08 | GHS07 | Wng | H302 | H373 ** H412 |   |   |  
607-413-00-0 | trans-4-phenyl-L-proline | 416-020-1 | 96314-26-0 | Repr. 2 | Skin Sens. 1 | H361f *** H317 | GHS08 | GHS07 | Wng | H361f *** H317 |   |   |  607-413-00-0 | транс-4-фенил-L-пролин | 416-020-1 | 96314-26-0 | Repr. 2 | Skin Sens. 1 | H361f *** H317 | GHS08 | GHS07 | Wng | H361f *** H317 |   |   |  
607-414-00-6 | tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate | 402-070-1 | 88122-99-0 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-414-00-6 | трис(2-етилхексилов) 4,4′,4″-(1,3,5-триaзин-2,4,6-триилтриимино)трибензoат | 402-070-1 | 88122-99-0 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-415-00-1 | poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α, α-dimethylbenzyl carbamate)-co-(maleicanhydride) | 419-590-1 | — | Flam. Sol. 1 | Skin Sens. 1 | H228 | H317 | GHS02 | GHS07 | Dgr | H228 | H317 |   |   | T607-415-00-1 | поли(метилов метакрилат)-съ-(бутилов метакрилат)-съ-(4-акрилоксибутилизопренил-α, α-диметилбензилов карбамат)-съ-(малеинов анхидрид) | 419-590-1 | — | Flam. Sol. 1 | Skin Sens. 1 | H228 | H317 | GHS02 | GHS07 | Dgr | H228 | H317 |   |   | T
607-416-00-7 | 4-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamide | 420-730-7 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  607-416-00-7 | 4-(2-карбоксиметилтио)етокси-1-хидрокси-5-изобутилоксикарбониламино-N-(3-додецилоксипропил)-2-нафтамид | 420-730-7 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
607-417-00-2 | 3-chloropropyl chloroformiate | 425-770-9 | 628-11-5 | Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H331 | H302 | H373** H315 | H318 | H317 | GHS06 | GHS05 | GHS08 | Dgr | H331 | H302 | H373** H315 | H318 | H317 |   |   |  607-417-00-2 | 3-хлоропропилов хлороформат | 425-770-9 | 628-11-5 | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H331 | H302 | H373** H315 | H318 | H317 | GHS06 | GHS05 | GHS08 | Dgr | H331 | H302 | H373** H315 | H318 | H317 |   |   |  
607-418-00-8 | 2-ethylhexyl 4-aminobenzoate | 420-170-3 | 26218-04-2 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  607-418-00-8 | 2-етилхексилов 4-аминобензoат | 420-170-3 | 26218-04-2 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
607-419-00-3 | (3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid | 422-240-9 | 166596-68-5 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  607-419-00-3 | (3′-карбоксиметил-5-(2-(3-етил-3H-бензoтиазол-2-илиден)-1-метилетилиден)-4,4′-диоксо-2′-тиоксo-(2,5′)-битиазолидинилиден-3-ил)оцетна киселина | 422-240-9 | 166596-68-5 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
607-420-00-9 | 2,2-bis(hydroxymethyl)butanoic acid | 424-090-1 | 10097-02-6 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  607-420-00-9 | 2,2-бис(хидроксиметил)бутанова киселина | 424-090-1 | 10097-02-6 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
607-421-00-4 | cypermethrin cis/trans +/-40/60; (RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate | 257-842-9 | 52315-07-8 | Acute Tox. 4 * Acute Tox. 4 * STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H302 | H335 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H302 | H335 | H410 |   |   |  607-421-00-4 | циперметрин цис/транс +/-40/60; (RS)-3-фенокси-α-цианобензилов (1RS,3RS;1RS,3SR)-3-(2,2-дихлоровинил)-2,2-диметилциклопропанкарбоксилат | 257-842-9 | 52315-07-8 | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H302 | H335 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H302 | H335 | H410 |   |   |  
607-422-00-X | α-cypermethrin (ISO); racemate comprising (R)-α-cyano-3-phenoxybenzyl (1S,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; (S)-α-cyano-3-phenoxybenzyl(1R, 3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate | 257-842-9 | 67375-30-8 | Acute Tox. 3 * STOT RE 2 * STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H373** H335 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H373** H335 | H410 |   | M=1000 |  607-422-00-X | α-циперметрин (ISO); рацемат, включващ (R)-3-фенокси-α-цианобензилов (1S,3S)-3-(2,2-дихлоровинил)-2,2-диметилциклопропанкарбоксилат; (S)-3-фенокси-α-цианобензилов (1R,3R)-3-(2,2-дихлоровинил)-2,2-диметилциклопропанкарбоксилат | 257-842-9 | 67375-30-8 | Acute Tox. 3 * | STOT RE 2 * | STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H373** H335 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H373** H335 | H410 |   | M=1000 |  
607-423-00-5 | esters of mecoprop and of mecoprop-P | — | — | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   | A607-423-00-5 | естери на мекопроп и на мекопроп-Р | — | — | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   | A
607-424-00-0 | trifloxystrobin (ISO); (E, E)-α-methoxyimino-{2-[[[[1-[3-(trifluoromethyl)phenyl]ethylidene]amino]oxy]methyl]benzeneacetic acid methyl ester | — | 141517-21-7 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  607-424-00-0 | трифлоксистробин (ISO); метилов естер на (E,E)-α-метоксиимино-{2-[[[[1-[3-(трифлуорометил)фенил]етилиден]амино]окси]метил]бензeноцетната киселина | — | 141517-21-7 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
607-425-00-6 | metalaxyl (ISO); methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate | 260-979-7 | 57837-19-1 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H317 | H412 | GHS07 | Wng | H302 | H317 | H412 |   |   |  607-425-00-6 | металаксил (ISO); метилов N-(2,6-диметилфенил)-N-(метоксиацетил)-DL-аланинат | 260-979-7 | 57837-19-1 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H317 | H412 | GHS07 | Wng | H302 | H317 | H412 |   |   |  
607-426-00-1 | 1,2-benzenedicarboxylic acid, dipentylester, branched and linear; [1] n-pentyl-isopentylphthalate; [2] di-n-pentyl phthalate; [3] diisopentylphthalate [4] | 284-032-2 [1] | -[2] | 205-017-9 [3] | 210-088-4 [4] | 84777-06-0 [1] | -[2] | 131-18-0 [3] | 605-50-5 [4] | Repr. 1B | Aquatic Acute 1 | H360FD H400 | GHS08 | GHS09 | Dgr | H360FD H400 |   |   |  607-426-00-1 | разклонен и неразклонен дипентилов естер на 1,2-бензендикарбоксилната киселина; [1] n-пентилов изопентилфталат; [2] ди-n-пентилов фталат; [3] диизопентилов фталат [4] | 284-032-2 [1] | -[2] | 205-017-9 [3] | 210-088-4 [4] | 84777-06-0 [1] | -[2] | 131-18-0 [3] | 605-50-5 [4] | Repr. 1B | Aquatic Acute 1 | H360FD H400 | GHS08 | GHS09 | Dgr | H360FD H400 |   |   |  
607-427-00-7 | bromoxynil heptanoate (ISO); 2,6-dibromo-4-cyanophenyl heptanoate | 260-300-4 | 56634-95-8 | Repr. 2 | Acute Tox. 4 * Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d *** H332 | H302 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H361d *** H332 | H302 | H317 | H410 |   |   |  607-427-00-7 | бромоксинил хептаноат (ISO); 2,6-дибромо-4-цианофенилов хептаноат | 260-300-4 | 56634-95-8 | Repr. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d *** H332 | H302 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H361d *** H332 | H302 | H317 | H410 |   |   |  
607-428-00-2 | tetrasodium ethylene diamine tetraacetate | 200-573-9 | 64-02-8 | Acute Tox. 4 * | Eye Dam. 1 | H302 | H318 | GHS05 | GHS07 | Dgr | H302 | H318 |   |   |  607-428-00-2 | тетранатриев етилендиаминтетраацетат | 200-573-9 | 64-02-8 | Acute Tox. 4 * | Eye Dam. 1 | H302 | H318 | GHS05 | GHS07 | Dgr | H302 | H318 |   |   |  
607-429-00-8 | edetic acid; (EDTA) | 200-449-4 | 60-00-4 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  607-429-00-8 | етилендиаминтетраоцетна киселина; (ЕДТА) | 200-449-4 | 60-00-4 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
607-430-00-3 | BBP; benzyl butyl phthalate e | 201-622-7 | 85-68-7 | Repr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H360Df | H400 | H410 | GHS08 | GHS09 | Dgr | H360Df | H410 |   |   |  607-430-00-3 | BBP; бензилбутилфталат | 201-622-7 | 85-68-7 | Repr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H360Df | H400 | H410 | GHS08 | GHS09 | Dgr | H360Df | H410 |   |   |  
607-431-00-9 | prallethrin (ISO); ETOC; 2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate | 245-387-9 | 23031-36-9 | Acute Tox. 3 * | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H302 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H302 | H410 |   |   |  607-431-00-9 | пралетрин (ISO); ETOC; 2-метил-4-оксо-3-(проп-2-инил)-циклопент-2-ен-1-илов 2,2-диметил-3-(2-метилпроп-1-енил)циклопропанкарбоксилат | 245-387-9 | 23031-36-9 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H302 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H302 | H410 |   |   |  
607-432-00-4 | S-metolachlor; reaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %); [1] (R)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (0-20 %) [2] | -[1] | -[2] | 87392-12-9 [1] | 178961-20-1 [2] | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  607-432-00-4 | S-метолахлор; реакционна маса от (S)-2-хлоро-N-(2-етил-6-метилфенил)-N-(2-метокси-1-метилетил)ацетамид (80—100 %); [1] (R)-2-хлоро-N-(2-етил-6-метилфенил)-N-(2-метокси-1-метилетил)ацетамид (0—20 %) [2] | -[1] | -[2] | 87392-12-9 [1] | 178961-20-1 [2] | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
607-433-00-X | cypermethrin cis/trans +/-80/20; (RS)-α-cyano-3-phenoxybenzyl (1RS;3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate | 257-842-9 | 52315-07-8 | Acute Tox. 4 * STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H335 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H335 | H315 | H317 | H410 |   |   |  607-433-00-X | циперметрин цис/транс +/-80/20; (RS)-3-фенокси-α-цианобензилов (1RS,3RS; 1RS,3SR)-3-(2,2-дихлоровинил)-2,2-диметилциклопропанкарбоксилат | 257-842-9 | 52315-07-8 | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H335 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H335 | H315 | H317 | H410 |   |   |  
607-434-00-5 | mecoprop-P [1] and its salts; (R)-2-(4-chloro-2-methylphenoxy)propionic acid | 240-539-0 | 16484-77-8 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  607-434-00-5 | мекопроп-P [1] и неговите соли; (R)-2-(4-хлоро-2-метилфенокси)пропионова киселина | 240-539-0 | 16484-77-8 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  
607-435-00-0 | 2S-isopropyl-5R-methyl-1R-cyclohexyl 2,2-dihydroxyacetate | 416-810-6 | 111969-64-3 | STOT RE 2 * | Eye Dam. 1 | Aquatic Chronic 2 | H373 ** H318 | H411 | GHS08 | GHS05 | GHS09 | Dgr | H373 ** H318 | H411 |   |   |  607-435-00-0 | 2S-изoпропил-5R-метил-1R-циклохексилов 2,2-дихидроксиацетат | 416-810-6 | 111969-64-3 | STOT RE 2 * | Eye Dam. 1 | Aquatic Chronic 2 | H373 ** H318 | H411 | GHS08 | GHS05 | GHS09 | Dgr | H373 ** H318 | H411 |   |   |  
607-436-00-6 | 2-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoate | 417-350-9 | — | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H315 | H318 | H410 |   |   |  607-436-00-6 | 2-хидрокси-3-(2-етил-4-метилимидазоил)пропилов нeoдеканоат | 417-350-9 | — | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H315 | H318 | H410 |   |   |  
607-437-00-1 | 3-(4-aminophenyl)-2-cyano-2-propenoic acid | 417-480-6 | 252977-62-1 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-437-00-1 | 3-(4-аминофенил)-2-циано-2-пропенова киселина | 417-480-6 | 252977-62-1 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-438-00-7 | methyl-2-[(aminosulfonyl)methyl]benzoate | 419-010-5 | 112941-26-1 | Acute Tox. 4 * | Eye Irrit. 2 | H302 | H319 | GHS07 | Wng | H302 | H319 |   |   |  607-438-00-7 | метилов 2-[(аминосулфонил)метил]бензoaт | 419-010-5 | 112941-26-1 | Acute Tox. 4 * | Eye Irrit. 2 | H302 | H319 | GHS07 | Wng | H302 | H319 |   |   |  
607-439-00-2 | methyl tetrahydro-2-furancarboxylate | 420-670-1 | 37443-42-8 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-439-00-2 | метилов тетрахидро-2-фуранкарбоксилат | 420-670-1 | 37443-42-8 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-440-00-8 | methyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate | 421-220-7 | 144740-59-0 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  607-440-00-8 | метилов 2-аминосулфонил-6-(трифлуорометил)пиридин-3-карбоксилат | 421-220-7 | 144740-59-0 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
607-441-00-3 | 3-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionic acid | 421-490-6 | 167684-63-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-441-00-3 | 3-[3-(2-додецилокси-5-метилфенилкарбамоил)-4-хидрокси-1- нафтилтио]пропионова киселина | 421-490-6 | 167684-63-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-442-00-9 | benzyl [hydroxy-(4-phenylbutyl)phosphinyl] acetate | 416-050-5 | 87460-09-1 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-442-00-9 | бензилов [хидрокси(4-фенилбутил)фосфинил]ацетат | 416-050-5 | 87460-09-1 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-444-00-X | reaction mass of: cis-1,4-dimethylcyclohexyl dibenzoate; trans-1,4-dimethylcyclohexyl dibenzoate | 416-230-3 | 35541-81-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-444-00-X | реакционна маса от: цис-1,4-диметилциклохексилов дибензoaт; транс-1,4-диметилциклохексилов дибензoaт | 416-230-3 | 35541-81-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-445-00-5 | Iron (III) tris(4-methylbenzenesulfonate) | 420-960-8 | 77214-82-5 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-445-00-5 | железен(III) трис(4-метилбензенсулфонат) | 420-960-8 | 77214-82-5 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-446-00-0 | methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate | 416-240-8 | 155522-12-6 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  607-446-00-0 | метилов 2-[4-(4-нитро-2-хлорофенилазо)-3-(1-оксопропил)амино]фениламинопропионат | 416-240-8 | 155522-12-6 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
607-447-00-6 | sodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate | 416-370-5 | 156738-27-1 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  607-447-00-6 | натриев 4-[4-(4-хидроксифенилазо)фенилaмино]-3-нитробензенсулфонат | 416-370-5 | 156738-27-1 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
607-448-00-1 | 2,3,5,6-tetrafluorobenzoic acid | 416-800-1 | 652-18-6 | Skin Irrit. 2 | Eye Dam. 1 | H315 | H318 | GHS05 | Dgr | H315 | H318 |   |   |  607-448-00-1 | 2,3,5,6-тетрафлуоробензoена киселина | 416-800-1 | 652-18-6 | Skin Irrit. 2 | Eye Dam. 1 | H315 | H318 | GHS05 | Dgr | H315 | H318 |   |   |  
607-449-00-7 | reaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate];4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexanediyl)methylene]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]tetrakisbenzenediazoniumtetra[bis(2-methylpropyl)naphthalenesulfonate] | 417-080-1 | — | Self-react. D **** | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H242 | H317 | H400 | H410 | GHS02 | GHS07 | GHS09 | Dgr | H242 | H317 | H410 |   |   |  607-449-00-7 | реакционна маса от: 4,4′,4″-[(2,4,6-триоксо-1,3,5(2H,4H,6H)-триaзин-1,3,5-триил)трис[метилен(3,5,5-триметил-3,1-циклохександиил)иминокарбонилокси-2,1-етандиил(етил)амино]]трисбензендиазониев три[бис(2-метилпропил)нафталенсулфонат];4,4′,4′′,4′′′-[[5,5′-[карбонилбис[имино(1,5,5-триметил-3,1-циклохександиил)метилeн]]-2,4,6-триоксо-1,3,5(2H,4H,6H)-триaзин-1,1′,3,3′-тетраил]тетракис[мeтилен(3,5,5-триметил-3,1-циклохександиил)иминокарбонилокси-2,1-етандиил(етил)амино]]тетракисбензендиазониев тетра[бис(2-метилпропил)нафталенсулфонат] | 417-080-1 | — | Self-react. D **** | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H242 | H317 | H400 | H410 | GHS02 | GHS07 | GHS09 | Dgr | H242 | H317 | H410 |   |   |  
607-450-00-2 | 2-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate | 419-040-9 | 89604-92-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-450-00-2 | 2-меркаптобензoтиазолил-(Z)-(2-аминотиазол-4-ил)-2-(трет-бутоксикарбонилов) изопропоксииминоацетат | 419-040-9 | 89604-92-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-451-00-8 | 4-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzenesulfonic acid, sodium salt | 417-640-5 | 161935-19-9 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  607-451-00-8 | натриева сол на 4-[4-амино-3-(4-(2-сулфоксиетилсулфонил)фенилазо)-2,7-дисулфо-5-хидроксинaфт-6-илазо]-6-[3-(4-амино-3-(4-(2-сулфоксиетилсулфонил)фенилазо)-2,7-дисулфо-5-хидроксинафт-6-илазо]фенилкарбониламино]бензенсулфоновата киселина | 417-640-5 | 161935-19-9 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
607-453-00-9 | 4-benzyl-2,6-dihydroxy-4-aza-heptylene bis (2,2-dimethyloctanoate) | 418-100-1 | 172964-15-7 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  607-453-00-9 | 4-бензил-2,6-дихидрокси-4-aзaхептиленов бис(2,2-диметилoктаноат) | 418-100-1 | 172964-15-7 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
607-454-00-4 | reaction mass of: trans-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid; cis-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid | 418-170-3 | 116193-72-7 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  607-454-00-4 | реакционна маса от: транс-2-(1-метилетил)-1,3-диoксан-5-карбоксилна киселина; цис-2-(1-метилетил)-1,3-диoксан-5-карбоксилна киселина | 418-170-3 | 116193-72-7 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
607-455-00-X | 1-amino-4-(3-[4-chloro-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinone-2-sulfonic acid, sodium/lithium salt | 419-520-8 | 172890-93-6 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-455-00-X | натриева/литиева сол на 1-амино-4-(3-[6-(2,5-дисулфофениламино)-4-хлоро-1,3,5-триaзин-2-иламино]-2,2-диметилпропиламино)антрахинон-2-сулфоновата киселина | 419-520-8 | 172890-93-6 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-456-00-5 | 3-amino-4-chlorobenzoic acid, hexadecyl ester | 419-700-6 | 143269-74-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-456-00-5 | хексадецилов естер на 3-амино-4-хлоробензoената киселина | 419-700-6 | 143269-74-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-457-00-0 | tetrasodium dihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{6-[4-(2-aminoethyl)piperazin-1-yl]}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaphthalene-1',3,6-trisulfonate) | 420-350-1 | 172277-97-3 | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  607-457-00-0 | тетранатриев дихидроген-1,1″-дихидрокси-8,8″-[p-фенилбис(имино-{6-[4-(2-аминоетил)пиперазин-1-ил]}-1,3,5-триaзин-4,2- диилимино)]бис(2,2′-азонафтален-1′,3,6-трисулфонат) | 420-350-1 | 172277-97-3 | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  
607-458-00-6 | reaction mass of: 2-ethyl-[2,6-dibromo-4-[1-[3,5-dibromo-4-(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoate; 2,2'-diethyl-[4,4'-bis(2,6-dibromophenoxy)-1-methylethylidene] dipropenoate;2,2'-[(1-methylethylidene)bis[[2,6-dibromo-4,1-phenylene)oxy]ethanol]] | 420-850-1 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-458-00-6 | реакционна маса от: 2-етил-[2,6-дибромо-4-[1-[3,5-дибромо-4-(2-хидроксиетокси)фенил]-1-метилетил]фeнокси]пропеноат; 2,2′-диетил-[4,4′-бис(2,6-дибромофенокси)-1-метилетилиден]дипропеноат;2,2′-[(1-метилетилиден)бис[[2,6-дибромо-4,1-фенилeн)окси]етанол]] | 420-850-1 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-459-00-1 | isopentyl 4-{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylidene]hydrazino}benzoate | 418-930-4 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-459-00-1 | изoпентилов 4-{2-[1-(2-изопропоксиетоксикарбонилметил)-4-метил-2,6-диоксо-1,2,3,6-тетрахидро-5-циано-3-пиридилиден]хидрaзино}бензoат | 418-930-4 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-460-00-7 | 3-tridecyloxy-propyl-ammonium 9-octadecenoate | 418-990-1 | 778577-53-0 | STOT RE 2 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** H319 | H315 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H373 ** H319 | H315 | H410 |   |   |  607-460-00-7 | 3-тридецилоксипропил амониев 9-октадеценоат | 418-990-1 | 778577-53-0 | STOT RE 2 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** H319 | H315 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H373 ** H319 | H315 | H410 |   |   |  
607-461-00-2 | reaction mass of: pentasodium 2-{4-{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate; pentasodium 2-{4-{3-methyl-4-[7-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate | 421-160-1 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-461-00-2 | реакционна маса от: пентанатриев 2-{4-{3-метил-4-[6-сулфонато-4-(2- сулфонатофенилазо)нафталeн-1-илазо]фениламино}-6-[3-(2-сулфатоетансулфонил)фениламино]-1,3,5-триaзин-2-илaмино}бензен-1,4-дисулфонат; пентанатриев 2-{4-{3-метил-4-[7-сулфонато-4-(2- сулфонатофенилазо)нафталeн-1-илазо]фениламино}-6-[3-(2-сулфатоетансулфонил)фениламино]-1,3,5-триaзин-2-илaмино}бензен-1,4-дисулфонат | 421-160-1 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-462-00-8 | reaction mass of: 1-hexyl acetate; 2-methyl-1-pentyl acetate; 3-methyl-1-pentyl acetate; 4-methyl-1-pentyl acetate; other mixed linear and branched C6-alkyl acetates | 421-230-1 | 88230-35-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-462-00-8 | реакционна маса от: 1-хексилов ацетат; 2-метил-1-пентилов ацетат; 3-метил-1-пентилов ацетат; 4-метил-1-пентилов ацетат; други смесени неразклонени и разклонени C6-алкилови ацетати | 421-230-1 | 88230-35-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-463-00-3 | 3-(phenothiazin-10-yl)propionic acid | 421-260-5 | 362-03-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-463-00-3 | 3-(фенотиазин-10-ил)пропионова киселина | 421-260-5 | 362-03-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-464-00-9 | reaction mass of: 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid; 5-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid | 421-280-4 |   | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-464-00-9 | реакционна маса от: 1-етил-4-оксо-6-флуоро-1,4-дихидро-7-хлорохинолин-3-карбоксилна киселина;1-етил-4-оксо-6-флуоро-1,4-дихидро-5-хлорохинолин-3-карбоксилна киселина | 421-280-4 |   | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-465-00-4 | tris(2-hydroxyethyl)ammonium 7-{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo}naphthalene-1,3-disulfonate | 421-440-3 | 778583-04-3 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-465-00-4 | трис(2-хидроксиетил)амониев 7-{4-[4-(6-оксидо-4-хидрокси-2-цианoаминопиримидин-5-илaзо)бензaмидо]-2-етоксифенилазо}нафтален-1,3-дисулфонат | 421-440-3 | 778583-04-3 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-466-00-X | reaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate; phenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate; phenyl 3-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate | 421-480-1 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-466-00-X | реакционна маса от: фенилов 1-(3,3-диметил-2-оксо-1-[2-хлоро-5-(хексадециклоксикарбонил)фенилкарбамоил]бутил)-1H-2,3,3a,7a-тетрахидробензoтриазол-5-карбоксилат; фенилов 2-(3,3-диметил-2-оксо-1-[2-хлоро-5-(хексадециклоксикарбонил)фенилкарбамоил]бутил)-1H-2,3,3a,7a-тетрахидробензoтриазол-5-карбоксилат; фенилов 3-(3,3-диметил-2-оксо-1-[2-хлоро-5-(хексадециклоксикарбонил)фенилкарбамоил]бутил)-1H-2,3,3a,7a-тетрахидробензoтриазол-5-карбоксилат | 421-480-1 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-467-00-5 | 1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate | 419-430-9 | 56533-00-7 | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * | Skin Corr. 1B Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H373 ** H314 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H373 ** H314 | H410 |   |   |  607-467-00-5 | 1,1,3,3-тетрабутил-1,3-дистаноксандиилов октаноат | 419-430-9 | 56533-00-7 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H373 ** H314 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H373 ** H314 | H410 |   |   |  
607-468-00-0 | reaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; disodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; trisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; tetrasodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate | 419-450-8 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-468-00-0 | реакционна маса от: мононатриев 4-((4-(5-сулфонато-2-метоксифениламино)-6-хлоро-1,3,5-триaзин-2-ил)амино)-2-((1,4-диметил-6-оксидо-2-оксо-5-сулфонатoметил-1,2-дихидропиридин-3-ил)азо)бензенсулфонат; динатриев 4-((4-(5-сулфонато-2-метоксифениламино)-6-хлоро-1,3,5-триaзин-2-ил)амино)-2-((1,4-диметил-6-оксидо-2-оксо-5-сулфонатoметил-1,2-дихидропиридин-3-ил)азо)бензенсулфонат; тринатриев 4-((4-(5-сулфонато-2-метоксифениламино)-6-хлоро-1,3,5-триaзин-2-ил)амино)-2-((1,4-диметил-6-оксидо-2-оксо-5-сулфонатoметил-1,2-дихидропиридин-3-ил)азо)бензенсулфонат; тетранатриев 4-((4-(5-сулфонато-2-метоксифениламино)-6-хлоро-1,3,5-триaзин-2-ил)амино)-2-((1,4-диметил-6-оксидо-2-оксо-5-сулфонатoметил-1,2-дихидропиридин-3-ил)азо)бензенсулфонат | 419-450-8 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-469-00-6 | disodium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)-2-naphthalene sulfonate | 419-460-2 | 120029-06-3 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-469-00-6 | динатриев 7-((4,6-бис(3-диетиламинопропиламино)-1,3,5-триaзин-2-ил)амино)-4-хидрокси-3-(4-(4-сулфонатофенилазо)фенилазо)-2-нафталенсулфонат | 419-460-2 | 120029-06-3 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-470-00-1 | potassium sodium 6,13-dichloro-3,10-bis{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate | 414-100-0 | 154336-20-6 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  607-470-00-1 | калиев натриев 6,13-дихлоро-3,10-бис{2-[4-[3-(2-хидроксисулфонилоксиетансулфонил)фениламино]-6-(2,5-дисулфонатофениламино)-1,3,5-триaзин-2-иламино]етиламино}бензо[5,6][1,4]оксазино[2,3-b]феноксазин-4,11-дисулфонат | 414-100-0 | 154336-20-6 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
607-471-00-7 | 1,6-bis((dibenzylthiocarbamoyl)disulfanyl)hexane | 429-280-6 | 151900-44-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-471-00-7 | 1,6-бис((дибензилтиокарбамоил)дисулфанил)хексан | 429-280-6 | 151900-44-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-473-00-8 | pentaerythritol, dipentaerythritol, fatty acids, C6-10, mixed esters with adipic acid, heptanoic acid and isostearic acid | 426-590-3 | 187412-41-5 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-473-00-8 | пентаеритритол, дипентаеритритол, мастни киселини, C6-10, смесени естери с адипинова киселина, хептанова киселина и изостеаринова киселина | 426-590-3 | 187412-41-5 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-474-00-3 | (4-(4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid | 410-430-4 | 117573-89-4 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-474-00-3 | (4-(4-(4-диметиламинобензилиден-1-ил)-3-метил-5-оксо-2-пиразолин-1-ил)бензоена киселина | 410-430-4 | 117573-89-4 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-475-00-9 | reaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate; tetrasodium 7-(4-[4-chloro-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate (1:1) | 412-940-2 | 148878-18-6 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-475-00-9 | реакционна маса от: тетранатриев 7-(4-[6-[метил(3-сулфонатофенил)амино]-4-хлоро-1,3,5-триазин-2-иламино]-2-уреидофенилазо)нафтален-1,3,6-трисулфонат; тетранатриев 7-(4-[6-[метил-(4-сулфонатoфенил)амино]-4-хлоро-1,3,5-триaзин-2-иламино]-2-уреидофенилазо)нафтален-1,3,6-трисулфонат (1:1) | 412-940-2 | 148878-18-6 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-476-00-4 | trisodium N, N-bis(carboxymethyl)-β-alanine | 414-070-9 | 129050-62-0 | Skin Corr. 1B | Aquatic Chronic 3 | H314 | H412 | GHS05 | Dgr | H314 | H412 |   |   |  607-476-00-4 | тринатриев N,N-бис(карбоксиметил)-β-аланин | 414-070-9 | 129050-62-0 | Skin Corr. 1B | Aquatic Chronic 3 | H314 | H412 | GHS05 | Dgr | H314 | H412 |   |   |  
607-477-00-X | (1α5α6α)-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexane methanesulfonate salt | 426-740-8 | — | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  607-477-00-X | метансулфонат на (1α,5α,6α)-6-нитро-3-бензил-3-азабицикло[3.1.0]хексана | 426-740-8 | — | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  
607-478-00-5 | tetramethylammonium hydrogen phthalate | 416-900-5 | 79723-02-7 | Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 | H301 | H373 ** H400 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H373 ** H400 |   |   |  607-478-00-5 | тетраметиламониев хидрогенфталат | 416-900-5 | 79723-02-7 | Acute Tox. 3 * | STOT RE 2 * Aquatic Acute 1 | H301 | H373 ** H400 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H373 ** H400 |   |   |  
607-479-00-0 | hexadecyl 4-chloro-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoate | 418-550-9 | 168689-49-4 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-479-00-0 | хексадецилов 3-[2-(5,5-диметил-2,4-диоксо-1,3-оксазолидин-3-ил)-4,4-диметил-3-оксопентамидо]-4-хлоробензoaт | 418-550-9 | 168689-49-4 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-480-00-6 | 1,2-benzenedicarboxylic acid; di-C7-11-branched and linear alkylesters | 271-084-6 | 68515-42-4 | Repr. 1B | H360Df | GHS08 | Dgr | H360Df |   |   |  607-480-00-6 | 1,2-бензендикарбоксилна киселина; ди-C7-11-разклонени и неразклонени алкилови естери | 271-084-6 | 68515-42-4 | Repr. 1B | H360Df | GHS08 | Dgr | H360Df |   |   |  
607-481-00-1 | reaction mass of: trihexyl citrate; dihexyloctyl citrate; dioctylhexyl citrate; dihexyldecyl citrate | 430-290-8 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-481-00-1 | реакционна маса от: трихексилов цитрат; дихексилоктилов цитрат; диоктилхексилов цитрат; дихексилдецилов цитрат; | 430-290-8 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-482-00-7 | N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-N-carboxyanhydride | 430-360-8 | 84793-24-8 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  607-482-00-7 | N-[1-(S)-етоксикарбонил-3-фенилпропил]-L-аланил-N-карбоксианхидрид | 430-360-8 | 84793-24-8 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
607-483-00-2 | 1,2-benzenedicarboxylic acid; di-C6-8-branched alkylesters, C7-rich | 276-158-1 | 71888-89-6 | Repr. 1B | H360D*** | GHS08 | Dgr | H360D*** |   |   |  607-483-00-2 | 1,2-бензендикарбоксилна киселина; ди-C6-8-разклонени алкилови естери, богати на C7 | 276-158-1 | 71888-89-6 | Repr. 1B | H360D*** | GHS08 | Dgr | H360D*** |   |   |  
607-484-00-8 | ethyl 2-{[3-acetylamino-4-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)phenyl{]ethylamino[}propionate | 430-480-0 | 221452-67-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-484-00-8 | етилов 2-{[3-ацетиламино-4-(6-бромо-2-метил-1,3-диоксо-2,3-дихидро-1H-изоиндол-5-илазо)фенил]етиламино}пропионат | 430-480-0 | 221452-67-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-485-00-3 | (3S-trans)-phenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-piperidinecarboxylate | 430-510-2 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-485-00-3 | (3S-транс)-фенил-3-[(1,3-бензодиксол-5-илокси)метил]-4-(4-флуорофенил)-1-пиперидинкарбоксилат | 430-510-2 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-486-00-9 | potassium sodium 5'-(6-chloro-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-4'-hydroxy-2,3'-azodinaphthalene-1,2', 5,7'-disulfonate | 402-110-8 | 110081-40-8 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-486-00-9 | калиев натриев 5′-(4-(2-(2-винилсулфонилетокси)етиламино)-6-хлоро-1,3,5-триазин-2-иламино)-4′-хидрокси-2,3′-азодинафтален-1,2′,5,7′-дисулфонат | 402-110-8 | 110081-40-8 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-487-00-4 | reaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate; trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate | 402-660-9 | — | Repr. 1B | Aquatic Chronic 3 | H360D *** H412 | GHS08 | Dgr | H360D *** H412 |   |   |  607-487-00-4 | реакционна маса от: динатриев 4-(3-етоксикарбонил-4-(5-(3-етоксикарбонил-5-хидрокси-1-(4-сулфонатофенил)пиразол-4-ил)пента-2,4-диенилиден)-4,5-дихидро-5-оксопиразол-1-ил)бензенсулфонат; тринатриев 4-(3-етоксикарбонил-4-(5-(3-етоксикарбонил-5-оксидо-1-(4-сулфонатофенил)пиразол-4-ил)пента-2,4-диенилиден)-4,5-дихидро-5-оксопиразол-1-ил)бензенсулфонат | 402-660-9 | — | Repr. 1B | Aquatic Chronic 3 | H360D *** H412 | GHS08 | Dgr | H360D *** H412 |   |   |  
607-488-00-X | ethyl (2-acetylamino-5-fluoro-4-isothiocyanatophenoxy)acetate | 414-210-9 | 147379-38-2 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  607-488-00-X | етилов (2-ацетиламино-4-изoтиоцианато-5-флуорофенокси)ацетат | 414-210-9 | 147379-38-2 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
607-489-00-5 | reaction mass of: 2-ethylhexyl linolenate, linoleate and oleate; 2-ethylhexyl epoxyoleate; 2-ethylhexyl diepoxylinoleate; 2-ethylhexyl triepoxylinolenate | 414-890-7 | 71302-79-9 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-489-00-5 | реакционна маса от: 2-етилхексилов линоленат, линолат и олеат;2-етилхексилов епоксиолеат; 2-етилхексилов диепоксилинолат;2-етилхексилов триепоксилиноленат | 414-890-7 | 71302-79-9 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-490-00-0 | N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate | 415-060-7 | — | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  607-490-00-0 | N-[2-хидрокси-3-(C12-16-алкилокси)пропил]-N-метилов глицинат | 415-060-7 | — | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
607-491-00-6 | reaction mass of: diester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2); triester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3) | 427-140-9 | — | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  607-491-00-6 | реакционна маса от: диестер на 4,4′-метиленбис[2-(5-метил-2-хидроксибензил)-3,6-диметилфенола] и 6-диазо-5-оксо-5,6-дихидронафтален-1-сулфоновата киселина (1:2); триестер на 4,4′-метиленбис[2-(5-метил-2-хидроксибензил)-3,6-диметилфенола] и 6-диазо-5-оксо-5,6-дихидронафтален-1-сулфоновата киселина (1:3) | 427-140-9 | — | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  
607-492-00-1 | 2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methyl propyl propanoate | 415-490-5 | 141773-73-1 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-492-00-1 | 2-(1-(3′,3′-диметил-1′-циклохексил)етокси)-2-метилпропилпропанoат | 415-490-5 | 141773-73-1 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-493-00-7 | methyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazole-6-carboxylate | 415-670-3 | 78850-37-0 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-493-00-7 | метилов (3aR,4R,7aR)-2-метил-4-(1S,2R,3-триaцeтоксипропил)-3a,7a-дихидро-4H-пирано[3,4-d]oксазол-6-карбоксилат | 415-670-3 | 78850-37-0 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-494-00-2 | bis(2-ethylhexyl)octylphosphonate | 417-170-0 | 52894-02-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  607-494-00-2 | бис(2-етилхексил)октилфосфонат | 417-170-0 | 52894-02-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
607-495-00-8 | sodium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoate | 417-550-6 | 168151-92-6 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-495-00-8 | натриев 4-сулфофенил-6-((1-оксононил)амино)хексаноат | 417-550-6 | 168151-92-6 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-496-00-3 | 2,2'-methylenebis(4,6-di-tert-butyl-phenyl)-2-ethylhexyl phosphite | 418-310-3 | 126050-54-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-496-00-3 | 2,2′-метилeнбис(4,6-ди-трет-бутилфенил)-2-етилхексилов фосфит | 418-310-3 | 126050-54-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-497-00-9 | cerium oxide isostearate | 419-760-3 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-497-00-9 | цериев изостеарат оксид | 419-760-3 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-498-00-4 | (E)-3,7-dimethyl-2,6-octadienylhexadecanoate | 421-370-3 | 3681-73-0 | Skin Irrit. 2 | Aquatic Chronic 4 | H315 | H413 | GHS07 | Wng | H315 | H413 |   |   |  607-498-00-4 | (E)-3,7-диметил-2,6-октадиенилхексадеканоат | 421-370-3 | 3681-73-0 | Skin Irrit. 2 | Aquatic Chronic 4 | H315 | H413 | GHS07 | Wng | H315 | H413 |   |   |  
607-499-00-X | bis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate) | 421-660-1 | — | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H411 |   |   |  607-499-00-X | бис(диметил(2-хидроксиетил)амониев) 1,2-етандиилбис(2-хексадеценилсукцинат) | 421-660-1 | — | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H411 |   |   |  
607-500-00-3 | calcium 2,2,bis[(5-tetrapropylene-2-hydroxy)phenyl]ethanoate | 421-670-4 | — | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H410 |   |   |  607-500-00-3 | калциев 2,2-бис[(5-тетрапропилен-2-хидрокси)фенил]етaноат | 421-670-4 | — | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H410 |   |   |  
607-501-00-9 | reaction mass of: triphenylthiophosphate and tertiary butylated phenyl derivatives | 421-820-9 | 192268-65-8 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-501-00-9 | реакционна маса от: трифенилтиофосфат и трет-бутилови фенилови производни | 421-820-9 | 192268-65-8 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-502-00-4 | (N-benzyl-N, N,N-tributyl)ammonium 4-dodecylbenzenesulfonate | 422-200-0 | 178277-55-9 | Skin Corr. 1B | Acute Tox. 4 * | Aquatic Chronic 2 | H314 | H302 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H302 | H411 |   |   |  607-502-00-4 | (N-бензил-N, N,N-трибутил)амониев 4-додецилбензенсулфонат | 422-200-0 | 178277-55-9 | Skin Corr. 1B | Acute Tox. 4 * | Aquatic Chronic 2 | H314 | H302 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H302 | H411 |   |   |  
607-503-00-X | 2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinane | 422-210-5 | 68957-94-8 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   |   |  607-503-00-X | 2,4,6-три-n-пропил-2,4,6-триоксо-1,3,5,2,4,6-триoксaтрифосфоринан | 422-210-5 | 68957-94-8 | Skin Corr. 1B | H314 | GHS05 | Dgr | H314 |   |   |  
607-504-00-5 | diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate | 422-670-7 | — | Repr. 2 | Acute Tox. 3 * STOT RE 2 * Aquatic Acute 1 | Aquatic Chronic 1 | H361f | H301 | H373** H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H361f | H301 | H373** H410 |   |   |  607-504-00-5 | диамониев 1-хидрокси-2-(4-(4-карбоксифенилазо)-2,5-диметоскифенилазо)-7-амино-3-нафталенсулфонат | 422-670-7 | — | Repr. 2 | Acute Tox. 3 * | STOT RE 2 * Aquatic Acute 1 | Aquatic Chronic 1 | H361f | H301 | H373** H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H361f | H301 | H373** H410 |   |   |  
607-505-00-0 | pentasodium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chloro-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphtalene-1,3,6-trisulfonate | 422-930-1 |   | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-505-00-0 | пентанатриев 7-(4-(4-(5-амино-4-сулфонато-2-(4-((2-(сулфонатоетокси)сулфонил)фенилазо)фениламино)-6-хлоро-1,3,5-триaзин-2-ил)амино-2-уреидофенилaзо)нафталeн-1,3,6-трисулфонат | 422-930-1 |   | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-506-00-6 | reaction mass of: strontium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate; disodium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate | 422-970-8 |   | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-506-00-6 | реакционна маса от: стронциев (4-хлоро-2-((3-метил-5-оксо-1-(3- сулфонатофенил)-4,5-дихидро-1H-пиразол-4-ил)азо)-5-метил)бензенсулфонат; динатриев (4-хлоро-2-((3-метил-5-оксо-1-(3- сулфонатофенил)-4,5-дихидро-1H-пиразол-4-ил)азо)-5-метил)бензенсулфонат | 422-970-8 |   | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-507-00-1 | potassium, sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate | 422-980-2 | 187026-95-5 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-507-00-1 | калиев натриев 2,4-диамино-3-[4-(2- сулфонатоетоксисулфонил)фенилазо]-5-[4-(2-сулфонатоетоксисулфонил)-2-сулфонатофенилазо]бензенсулфонат | 422-980-2 | 187026-95-5 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-508-00-7 | disodium 3,3'-[iminobis[sulfonyl-4,1-phenylene-(5-hydroxy-3-methylpyrazole-1,4-diyl)azo-4,1-phenylenesulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-phenylenesulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzenesulfonate)] | 423-110-4 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-508-00-7 | динатриев 3,3′-[иминобис[сулфонил-4,1-фенилен(5-хидрокси-3-метил пиразол-1,4-диил)азо-4,1-фениленсулфонилимино(4-амино-6-хидроксипиримидин-2,5-диил)азо-4,1-фениленсулфонилимино(4-амино-6-хидроксипиримидин-2,5-диил)азо]бис(бензенсулфонат)] | 423-110-4 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-509-00-2 | 2-phenoxyethyl 4-aminobenzoate | 430-880-5 | 88938-23-2 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-509-00-2 | 2-феноксиетилов 4-аминобензоат | 430-880-5 | 88938-23-2 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-510-00-8 | (2S, 5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide | 427-200-4 | 76646-91-8 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H302 | H315 | H318 | H317 | GHS05 | GHS07 | Dgr | H302 | H315 | H318 | H317 |   |   |  607-510-00-8 | (2S,5R)-6,6-дибромо-3,3-диметил-7-оксо-4-тиа-1-азабицикло[3.2.0]хептан-2-карбоксилна киселина 4,4-диоксид | 427-200-4 | 76646-91-8 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H302 | H315 | H318 | H317 | GHS05 | GHS07 | Dgr | H302 | H315 | H318 | H317 |   |   |  
607-511-00-3 | reaction mass of: 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxobutyric acid; 4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxobutyric acid | 423-750-4 | — | Eye Irrit. 2 | Aquatic Chronic 2 | H319 | H411 | GHS07 | GHS09 | Wng | H319 | H411 |   |   |  607-511-00-3 | реакционна маса от: 4-[(3-децилоксипропил)(3-изобутокси-1-изобутоксикарбонил-3-оксопропил)амино]-4-оксомаслена киселина; 4-[(3-изобутокси-1-изобутоксикарбонил-3-оксопропил)(3-октилоксипропил)амино]-4-оксомаслена киселина | 423-750-4 | — | Eye Irrit. 2 | Aquatic Chronic 2 | H319 | H411 | GHS07 | GHS09 | Wng | H319 | H411 |   |   |  
607-512-00-9 | trisodium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzenesulfonate | 423-970-0 | 182926-43-8 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-512-00-9 | тринатриев 2,4-диамино-3,5-бис[4-(2-сулфонатoетокси)сулфонил)фенилазо]бензенсулфонат | 423-970-0 | 182926-43-8 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-513-00-4 | reaction mass of: trisodium 4-benzoylamino-6-(6-ethenesulfonyl-1-sulfato-naphthalen-2-ylazo)-5-hydroxynaphthalene-2,7-disulfonate; 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid sodium salt; 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid | 423-200-3 | — | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  607-513-00-4 | реакционна маса от: тринатриев 4-бензоиламино-6-(6-етeнсулфонил-1-сулфатонафтален-2-илазо)-5-хидроксинафтален-2,7-дисулфонат; натриева сол на 5-(бензоиламино)-4-хидрокси-3-((1-сулфо-6-((2-(сулфоокси)етил)сулфонил)-2-нафтил)азо)нафтален-2,7-дисулфоновата киселина; 5-(бензоиламино)-4-хидрокси-3-((1-сулфо-6-((2-(сулфоокси)етил)сулфонил)-2-нафтил)азо)нафтален-2,7-дисулфонова киселина | 423-200-3 | — | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  
607-514-00-X | potassium N-(1-methoxy-1-oxobut-2-en-3-yl)valinate | 427-240-2 | 134841-35-3 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-514-00-X | калиев N-(1-метокси-1-оксобут-2-ен-3-ил)валинат | 427-240-2 | 134841-35-3 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-515-00-5 | reaction mass of: disodium hexyldiphenyl ether disulphonate; disodium dihexyldiphenyl ether disulphonate | 429-650-7 | 147732-60-3 | Eye Irrit. 2 | Aquatic Chronic 2 | H319 | H411 | GHS07 | GHS09 | Wng | H319 | H411 |   |   |  607-515-00-5 | реакционна маса от: динатриев хексилдифенилов етер дисулфонат; динатриев дихексилдифенилов етер дисулфонат | 429-650-7 | 147732-60-3 | Eye Irrit. 2 | Aquatic Chronic 2 | H319 | H411 | GHS07 | GHS09 | Wng | H319 | H411 |   |   |  
607-516-00-0 | N, N'-bis(trifluoroacetyl)-S, S'-bis-L-homocysteine | 429-670-6 | 105996-54-1 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  607-516-00-0 | N, N′-бис(трифлуороацетил)-S,S′-бис-L-хомоцистеин | 429-670-6 | 105996-54-1 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
607-517-00-6 | (S)-α-(acetylthio)benzenepropanoic acid | 430-300-0 | 76932-17-7 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | H302 | H318 | H317 | GHS05 | GHS07 | Dgr | H302 | H318 | H317 |   |   |  607-517-00-6 | (S)-α-(ацетилтио)бензенпропанова киселина | 430-300-0 | 76932-17-7 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | H302 | H318 | H317 | GHS05 | GHS07 | Dgr | H302 | H318 | H317 |   |   |  
607-518-00-1 | 3-oxoandrost-4-ene-17-β-carboxylic acid | 414-990-0 | 302-97-6 | Repr. 2 | Aquatic Chronic 4 | H361f | H413 | GHS08 | Wng | H361f | H413 |   |   |  607-518-00-1 | 3-оксоандрост-4-ен-17-β-карбоксилна киселина | 414-990-0 | 302-97-6 | Repr. 2 | Aquatic Chronic 4 | H361f | H413 | GHS08 | Wng | H361f | H413 |   |   |  
607-519-00-7 | poly-[((4-((4-ethyl-ethylene)amino)phenyl)-((4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)cyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate] | 427-280-0 | 176429-27-9 | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H335 | H315 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H335 | H315 | H318 | H410 |   |   |  607-519-00-7 | поли[((4-((4-етилетилен)амино)фенил)((4-(етил(2-оксиетилен)амино)фенил)метинил)циклохекса-2,5-диенилиден)-N-етил-N-(2-хидроксиетил)амониев ацетат] | 427-280-0 | 176429-27-9 | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H335 | H315 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H335 | H315 | H318 | H410 |   |   |  
607-520-00-2 | reaction mass of: sodium 4,5-dihydro-2-[(propionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate; disodium 4,5-dihydro-2-[(dipropionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate | 427-740-0 | — | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  607-520-00-2 | реакционна маса от: натриев 2-[(пропионато)(C6-18)алкил]-4,5-дихидро-3H-имидазолий-N-етилфосфат; динатриев 2-[(пропионато)(C6-18)алкил]-4,5-дихидро-3H-имидазолий-N-етилфосфат; | 427-740-0 | — | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
607-521-00-8 | tetraethyl N, N'-(methylenedicyclohexane-4,1-diyl)bis-DL-aspartate | 429-270-1 | 136210-30-5 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  607-521-00-8 | тетраетилов N,N′-(метилендициклохексан-4,1-диил)бис-DL-аспартат | 429-270-1 | 136210-30-5 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
607-522-00-3 | sodium salt of the polymer of:sodium 2-methyl-buta-1,3-diene-1-sulfonate with acrylic acid and 2-hydroxyethyl-2-methylacrylate | 429-720-7 | 184246-86-4 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-522-00-3 | натриева сол на полимера на: натриев 2-метилбута-1,3-диен-1-сулфонат с акрилова киселина и 2-хидроксиетил-2-метилакрилат | 429-720-7 | 184246-86-4 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-523-00-9 | reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10'-diamino-6,6',13,13'-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6', 13,13'-tetrachloro-10'[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate | 430-200-7 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  607-523-00-9 | реакционна маса от моно- до тетра(литиев и/или натриев) 3-амино-10-[4-(4-амино-3-сулфонатоанилино)-6-[метил-(2-сулфонатоетил)амино]-1,3,5-триазин-2-иламино]-6,13-дихлоробензо[1,2-B:4,5-B′]ди[1,4]бензоксазин-4,11-дисулфонат; моно- до тетра(литиев и/или натриев) 3-амино-10-[4,6-бис(4-амино-3-сулфонатоанилино)-1,3,5-триазин-2-иламино]-6,13-дихлоробензо[1,2-B:4,5-B′]ди[1,4]бензоксазин-4,11-дисулфонат; моно- до пента(литиев и/или натриев) 10,10′-диамино-6,6′,13,13′-тетрахлоро-3,3′-[6-[метил-(2-сулфонатоетил)амино]-1,3,5-триазин-2,4-диилдиимино]бис[бензо[1,2-B:4,5-B′]ди[1,4]бензоксазин-4,11-дисулфонат; моно- до хепта(литиев и/или натриев) 10-амино-6,6′,13,13′-тетрахлоро-10′-[4-(4-амино-3-сулфонатоанилино)[6-метил-(2-сулфонатоетил)амино]-1,3,5-триазин-2,4-диимино]бис[бензо[1,2-B:4,5-B′]ди[1,4]бензоксазин-4,11-дисулфонат; моно- до хепта(литиев и/или натриев) 10,10′-диамино-6,6′,3,3′-[(2-сулфонато)-1,4-фенилендииминобис[6-метил-(2-сулфонатоетил)амино]-1,3,5-триазин-2,4-диилдиимино]бис[бензо[1,2-B:4,5-B′]ди[1,4]бензоксазин-4,11-дисулфонат | 430-200-7 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
607-524-00-4 | tall oil 2-[(tetrahydro-2H-pyran-2-yl) thio]ethyl esters | 430-310-5 | — | Aquatic Chronic 4 | H413 |   | H413 |   |   |  607-524-00-4 | 2-[(тетрахидро-2H-пиран-2-ил)тио]етилови естери на талово масло | 430-310-5 | — | Aquatic Chronic 4 | H413 |   | H413 |   |   |  
607-525-00-X | (Z)-2-methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid | 431-520-1 | 64485-90-1 | Flam. Sol. 1**** Carc. 2 | Aquatic Chronic 3 | H228 | H351 | H412 | GHS02 | GHS08 | Dgr | H228 | H351 | H412 |   |   |  607-525-00-X | (Z)-2-метоксимино-2-[2-(тритиламино)тиазол-4-ил]оцетна киселина | 431-520-1 | 64485-90-1 | Flam. Sol. 1**** | Carc. 2 | Aquatic Chronic 3 | H228 | H351 | H412 | GHS02 | GHS08 | Dgr | H228 | H351 | H412 |   |   |  
607-526-00-5 | cartap (ISO); 1,3-bis(carbamoylthio)-2-(dimethylamino)propane | — | 15263-53-3 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  607-526-00-5 | картап (ISO); 1,3-бис(карбамоилтио)-2-(диметиламино)пропан | — | 15263-53-3 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
607-527-00-0 | Reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate | 423-180-6 | — | STOT RE 2 * | H373 ** | GHS08 | Wng | H373 ** |   |   |  607-527-00-0 | реакционна маса от: 1-(1′H,1′H,2′H,2′H-тридекафлуорооктил)-12-(1′′H,1′′H,2′′H,2′′H-тридекафлуороoктил)додекандиoат;1-(1′H,1′H,2′H,2′H-тридекафлуорооктил)-12-(1′′H,1′′H,2′′H,2′′H-хептадекафлуородецил)додекандиoат;1-(1′H,1′H,2′H,2′H-тридекафлуорооктил)-12-(1′′H,1′′H,2′′H,2′′H-хеникозафлуорододецил)додекандиоат;1-(1′H,1′H,2′H,2′H-тридекафлуорооктил)-12-(1′′H,1′′H,2′′H,2′′H-пентакозафлуоротетрадецил)додекандиоат; 1-(1′H,1′H,2′H,2′H-хептадекафлуородецил)-12-(1′′H,1′′H,2′′H,2′′H-хептадекафлуородецил)додекандиoaт;1-(1′H,1′H,2′H,2′H-хептадекафлуородецил)-12-(1′′H,1′′H,2′′H,2′′H-хеникозафлуорододецил)додекандиoат | 423-180-6 | — | STOT RE 2 * | H373 ** | GHS08 | Wng | H373 ** |   |   |  
607-528-00-6 | (S)-3-methyl-2-(2-oxotetrahydropyrimidine-1-yl)butyric acid | 430-900-2 | 192725-50-1 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-528-00-6 | (S)-3-метил-2-(2-оксотетрахидропиримидин-1-ил)маслена киселина | 430-900-2 | 192725-50-1 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-529-00-1 | benzyl cis-4-ammonium-4'-toluenesulfonato-1-cyclohexanecarboxylate | 426-070-6 | 67299-45-0 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-529-00-1 | бензилов цис-4-амоний-4′-толуенсулфонато-1-циклохексанкарбоксилат | 426-070-6 | 67299-45-0 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-530-00-7 | reaction mass of isomers of: C7-9-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate | 406-040-9 | 125643-61-0 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-530-00-7 | реакционна маса от изомери на: C7-9-алкилов 3-(3,5-ди-трет-бутил-4-хидроксифенил)пропионат | 406-040-9 | 125643-61-0 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-531-00-2 | methyl 3-amino-4,6-dibromo-2-methyl-benzoate | 425-190-6 | 119916-05-1 | STOT RE 2 * | Aquatic Chronic 2 | H373** H411 | GHS08 | GHS09 | Wng | H373** H411 |   |   |  607-531-00-2 | метилов 3-амино-4,6-дибромо-2-метилбензоат | 425-190-6 | 119916-05-1 | STOT RE 2 * | Aquatic Chronic 2 | H373** H411 | GHS08 | GHS09 | Wng | H373** H411 |   |   |  
607-532-00-8 | (S)-1-[2-tert-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-cyclopentanecarboxylic acid, cyclohexylamine salt | 425-510-4 | 167944-94-7 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-532-00-8 | циклохексиламинова сол на (S)-1-[2-трет-бутоксикарбонил-3-(2-метоксиетокси)пропил]-1-циклопентанкарбоксилната киселина | 425-510-4 | 167944-94-7 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-533-00-3 | pentasodium monohydrogen 6-chloro-3,10-bis[2-[4-chloro-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]phenoxazine-4,11-disulfonate | 414-910-4 | — | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  607-533-00-3 | пентанатриев монохидроген-6-хлоро-3,10-бис[2-[4-хлоро-6-(2,4-дисулфофениламино)-1,3,5-триазин-2-ил-амино]етиламино]-13-етилбензо[5.6][1.4]оксазино[2,3-b]феноксазин-4,11-дисулфонат | 414-910-4 | — | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
607-534-00-9 | ethyl 2-(3-benzoylphenyl)propanoate | 414-920-9 | 60658-04-0 | Acute Tox. 3 * STOT RE 1 | Skin Sens. 1 | Aquatic Chronic 2 | H301 | H372** H317 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H372** H317 | H411 |   |   |  607-534-00-9 | етилов 2-(3-бензоилфенил)пропаноат | 414-920-9 | 60658-04-0 | Acute Tox. 3 * | STOT RE 1 | Skin Sens. 1 | Aquatic Chronic 2 | H301 | H372** | H317 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H372** H317 | H411 |   |   |  
607-535-00-4 | potassium 4-iodo-2-sulfonato-benzoic acid | 426-620-5 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  607-535-00-4 | калиева сол на 4-йодо-2-сулфонатобензоената киселина | 426-620-5 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
607-536-00-X | (2,6-xylyloxy) acetic acid | 430-910-7 | 13335-71-2 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  607-536-00-X | (2,6-ксилилокси)оцетна киселина | 430-910-7 | 13335-71-2 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  
607-537-00-5 | isopropylammonium 2-(3-benzoylphenyl)propionate | 417-970-1 | — | Acute Tox. 3 * Acute Tox. 4 * STOT RE 1 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H312 | H372** H318 | H400 | H410 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H301 | H312 | H372** H318 | H410 |   |   |  607-537-00-5 | изопропиламониев 2-(3-бензоилфенил)пропионат | 417-970-1 | — | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 1 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H312 | H372** H318 | H400 | H410 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H301 | H312 | H372** H318 | H410 |   |   |  
607-539-00-6 | propyl((4-(5-oxo-3-propylisoxazolidin-4-ylidenmethin)phenyl)propoxycarbonylmethyleneamino)acetate | 431-000-2 | 198705-81-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-539-00-6 | пропил((4-(5-оксо-3-пропилизоксазолидин-4-илиденметин)фенил)пропоксикарбонилметиленамино)ацетат | 431-000-2 | 198705-81-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-540-00-1 | 1-(mercaptomethyl)cyclopropylacetic acid | 420-240-3 | 162515-68-6 | Skin Corr. 1B | Acute Tox. 4 * Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H314 | H312 | H302 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H312 | H302 | H317 | H411 |   |   |  607-540-00-1 | 1-(меркаптометил)циклопропилоцетна киселина | 420-240-3 | 162515-68-6 | Skin Corr. 1B | Acute Tox. 4 * | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H314 | H312 | H302 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H312 | H302 | H317 | H411 |   |   |  
607-541-00-7 | [(1-methyl-1,2-ethanediyl)bis[nitrilobis(methylene)]]tetrakis(phosphonic acid) | 421-940-1 | 28698-31-9 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  607-541-00-7 | [(1-метил-1,2-етандиил)бис[нитрилобис(метилен)]]тетракис(фосфонова киселина) | 421-940-1 | 28698-31-9 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  
607-542-00-2 | methyl 2-(4-butanesulfonamidophenoxy)tetradecanoate | 422-110-1 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  607-542-00-2 | метилов 2-(4-бутансулфонамидофенокси)тетрадеканоат | 422-110-1 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
607-543-00-8 | poly-[((4-((4-(ethyl-ethylene)amino)phenyl)-(4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)-3-methylcyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate] | 427-480-8 | 176429-22-4 | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H335 | H315 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H335 | H315 | H318 | H410 |   |   |  607-543-00-8 | поли[((4-((4-(етилетилен)амино)фенил)(4-(етил(2-оксиетилен)амино)фенил)метинил)-3-метилциклохекса-2,5-диенилиден)-N-етил-N-(2-хидроксиетил)амониев ацетат] | 427-480-8 | 176429-22-4 | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H335 | H315 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H335 | H315 | H318 | H410 |   |   |  
607-544-00-3 | ethyl 6,8-difluoro-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazin-1-yl)-4-oxo-quinoline-3-carboxylate | 427-490-2 | 158585-86-5 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-544-00-3 | етилов 6,8-дифлуоро-1-(формилметиламино)-1,4-дихидро-7-(4-метил)пиперазин-1-ил)-4-оксохинолин-3-карбоксилат | 427-490-2 | 158585-86-5 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-545-00-9 | 1,2-dimethyl-3-(1-methylethenyl)cyclopentyl acetate | 424-070-0 | 94346-09-5 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  607-545-00-9 | 1,2-диметил-3-(1-метилетенил)циклопентилов ацетат | 424-070-0 | 94346-09-5 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
607-546-00-4 | reaction mass of: methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]methoxycarbonylmethylamino}acetate; methyl {[5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl]ethoxycarbonylmethylamino}acetate | 424-290-7 | 188070-47-5 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-546-00-4 | реакционна маса от: метилов {[5-ацетиламино-4-(4-нитро-2-хлорофенилазо)фенил]метоксикарбонилметиламино}ацетат; метилов {[5-ацетиламино-4-(4-нитро-2-хлорофенилазо)фенил]етоксикарбонилметиламино}ацетат | 424-290-7 | 188070-47-5 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-547-00-X | 18-methylnonadecyl 2,2-dimethylpropanoate | 424-370-1 | 125496-22-2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 4 | H315 | H317 | H413 | GHS07 | Wng | H315 | H317 | H413 |   |   |  607-547-00-X | 18-метилнонадецилов 2,2-диметилпропаноат | 424-370-1 | 125496-22-2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 4 | H315 | H317 | H413 | GHS07 | Wng | H315 | H317 | H413 |   |   |  
607-548-00-5 | 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone methanesulfonate | 431-010-7 | 154486-26-7 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  607-548-00-5 | 1-(2,4-дихлорофенил)-2-(1H-имидазол-1-ил)етанонметансулфонат | 431-010-7 | 154486-26-7 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  
607-549-00-0 | methyl (E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoate | 424-430-7 | 125778-19-0 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  607-549-00-0 | метилов (E)-2-((3-(1,3-бензодиоксол-5-ил)-2-метил-1-пропенил)амино)бензоат | 424-430-7 | 125778-19-0 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
607-550-00-6 | 2-amino-4-bromo-5-chlorobenzoic acid | 424-700-4 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  607-550-00-6 | 2-амино-4-бромо-5-хлоробензоена киселина | 424-700-4 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
607-551-00-1 | tetrabutylammonium 2-amino-6-iodopurinate | 424-710-9 | 156126-48-6 | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H312 | H302 | H373** H315 | H318 | H317 | H411 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H312 | H302 | H373** H315 | H318 | H317 | H411 |   |   |  607-551-00-1 | тетрабутиламониев 2-амино-6-йодопуринат | 424-710-9 | 156126-48-6 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H312 | H302 | H373** H315 | H318 | H317 | H411 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H312 | H302 | H373** H315 | H318 | H317 | H411 |   |   |  
607-552-00-7 | hexadecyl -amino-4-isopropoxybenzoate | 424-830-1 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-552-00-7 | хексадецилов 3-амино-4-изопропоксибензоат | 424-830-1 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-553-00-2 | 7-amino-4-hydroxy-2-naphthalenesulfonic acid, coupled with 5 (or 8) -amino-8 (or 5)-[[4-[[4-[[4-amino-6(or 7)-sulfo-1-naphthyl]azo]phenyl]amino]-3-sulfophenyl]azo]-2-naphthalenesulfonic acid and 4-hydroxy-7-(phenylamino)-2-naphthalenesulfonic acid, sodium salt | 424-850-0 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-553-00-2 | 7-амино-4-хидрокси-2-нафталенсулфонова киселина, свързана с 5(или 8)-амино-8(или 5)-[[4-[[4-[[4-амино-6(или 7)-сулфо-1-нафтил]азо]фенил]амино]-3-сулфофенил]азо]-2-нафталенсулфонова киселина и натриева сол на 7-(фениламино)-4-хидрокси-2-нафталенсулфоновата киселина | 424-850-0 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-554-00-8 | 2,4-diamino-5-[4-[(2-sulfoxyl ethyl)sulfonyl]phenylazo]benzenesulfonic acid | 424-870-1 | 27624-67-5 | Expl. 1.1 | Eye Dam. 1 | Aquatic Chronic 3 | H201 | H318 | H412 | GHS01 | GHS05 | Dgr | H201 | H318 | H412 |   |   |  607-554-00-8 | 2,4-диамино-5-[4-[(2-сулфоксилетил)сулфонил]фенилазо]бензенсулфонова киселина | 424-870-1 | 27624-67-5 | Expl. 1.1 | Eye Dam. 1 | Aquatic Chronic 3 | H201 | H318 | H412 | GHS01 | GHS05 | Dgr | H201 | H318 | H412 |   |   |  
607-555-00-3 | 1,1,3,3-tetramethylbutylperoxypivalate | 424-980-8 | 22288-41-1 | Flam. Liq. 2 | Org. Perox. D | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H225 | H242 | H315 | H317 | H411 | GHS02 | GHS07 | GHS09 | Dgr | H225 | H242 | H315 | H317 | H411 |   |   |  607-555-00-3 | 1,1,3,3-тетраметилбутилпероксипивалат | 424-980-8 | 22288-41-1 | Flam. Liq. 2 | Org. Perox. D | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H225 | H242 | H315 | H317 | H411 | GHS02 | GHS07 | GHS09 | Dgr | H225 | H242 | H315 | H317 | H411 |   |   |  
607-556-00-9 | 2-acetoxymethylene-4-acetylphenylacetate | 425-160-2 | 24085-06-1 | Acute Tox. 4 * STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373** H318 | H317 | H400 | H410 | GHS05 | GHS08 | GHS07 | GHS09 Dgr | H302 | H373** H318 | H317 | H410 |   |   |  607-556-00-9 | 2-ацетоксиметилен-4-ацетилфенилацетат | 425-160-2 | 24085-06-1 | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373** | H318 | H317 | H400 | H410 | GHS05 | GHS08 | GHS07 | GHS09 Dgr | H302 | H373** H318 | H317 | H410 |   |   |  
607-557-00-4 | salt of: (1S-cis)-1-amino-2,3-dihydro-1H-inden-2-ol and [R-[R*R*]]-2,3-dihydroxybutanedioic acid | 425-210-3 | 169939-84-8 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-557-00-4 | сол на: (1S-цис)-1-амино-2,3-дихидро-1H-инден-2-ола и [R-[R*R*]]-2,3-дихидроксибутандиовата киселина | 425-210-3 | 169939-84-8 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-558-00-X | 2S-isopropyl-5R-methyl-1R-cyclohexyl (2R, 5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1.3]-oxathiolane-2-carboxylate | 425-250-1 | 147027-10-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-558-00-X | 2S-изопропил-5R-метил-1R-циклохексилов (2R,5S)-5-(4-амино-2-оксо-2H-пиримидин-1-ил)[1.3]оксатиолан-2-карбоксилат | 425-250-1 | 147027-10-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-559-00-5 | coconut oil, reaction products with glycerol esters of 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoic acid | 425-400-6 | 179986-09-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-559-00-5 | реакционни продукти на кокосово масло с глицеролови естери на 3,5-бис(1,1-диметилетил)-4-хидроксибензенпропановата киселина | 425-400-6 | 179986-09-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-560-00-0 | (R, S)-2-butyloctanedioic acid | 431-210-4 | 50905-10-7 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-560-00-0 | (R,S)-2-бутилоктандиова киселина | 431-210-4 | 50905-10-7 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-561-00-6 | sodium 4-hydroxy-3-(N'-(2-(2-hydroxyethylenesulfonyl)ethylene)ureido)-5-nitrobenzenesulfonate | 425-460-3 | — | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  607-561-00-6 | натриев 4-хидрокси-3-(N′-(2-(2-хидроксиетиленсулфонил)етилен)уреидо)-5-нитробензенсулфонат | 425-460-3 | — | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
607-562-00-1 | reaction mass of: (2R, 3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate; (2S, 3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate | 425-530-3 | 98769-75-6 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  607-562-00-1 | реакционна маса от: (2R,3R)-3-(2-етоксифенокси)-2-хидрокси-3-фенилпропиламониев метансулфонат; (2S,3S)-3-(2-етоксифенокси)-2-хидрокси-3-фенилпропиламониев метансулфонат | 425-530-3 | 98769-75-6 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  
607-563-00-7 | 5,7-dichloro-4-hydroxyquinoline-3-carboxylic acid | 431-250-2 | 171850-30-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-563-00-7 | 4-хидрокси-5,7-дихлорохинолин-3-карбоксилна киселина | 431-250-2 | 171850-30-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-564-00-2 | 1,6-hexanediammonium, sodium 5-sulfato-1,3-benzenedicarboxylate | 425-730-0 | 51178-75-7 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-564-00-2 | натриев 1,6-хександиамониев 5-сулфато-1,3-бензендикарбоксилат | 425-730-0 | 51178-75-7 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-565-00-8 | 3-ethyl 5 methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate | 425-820-1 | 88150-42-9 | Acute Tox. 3 * STOT RE 2 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H373** H318 | H400 | H410 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H301 | H373** H318 | H410 |   |   |  607-565-00-8 | 3-етилов 5-метилов 2-(2-аминоетоксиметил)-6-метил-1,4-дихидро-4-(2-хлорофенил)-3,5-пиридиндикарбоксилат | 425-820-1 | 88150-42-9 | Acute Tox. 3 * | STOT RE 2 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H373** H318 | H400 | H410 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H301 | H373** H318 | H410 |   |   |  
607-566-00-3 | reaction mass of: dodecylphenyl dodecylhydroxybenzenecarboxylate; bis(dodecylphenyl)dodecyl hydroxybenzenedicarboxylate | 426-140-6 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-566-00-3 | реакционна маса от: додецилфенилов додецилхидроксибензенкарбоксилат; бис(додецилфенил)додецилов хидроксибензендикарбоксилат | 426-140-6 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-567-00-9 | potassium 3-iodo-6-methylbenzenesulfonate | 426-300-5 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-567-00-9 | калиев 3-йодо-6-метилбензенсулфонат | 426-300-5 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-568-00-4 | potassium 2-chloro-3-(benzyloxy)propionate | 426-350-8 | 138666-92-9 | Acute Tox. 4 * STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | H302 | H373** H318 | H317 | GHS05 | GHS08 | GHS07 | Dgr | H302 | H373** H318 | H317 |   |   |  607-568-00-4 | калиев 3-(бензилокси)-2-хлоропропионат | 426-350-8 | 138666-92-9 | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | H302 | H373** H318 | H317 | GHS05 | GHS08 | GHS07 | Dgr | H302 | H373** H318 | H317 |   |   |  
607-569-00-X | reaction mass of: sodium 2-amino-4-(2,6-difluoropyrimidin-4-ylamino)benzenesulfonate; sodium 2-amino-4-(4,6-difluoropyrimidin-4-ylamino)benzenesulfonate | 426-470-0 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-569-00-X | реакционна маса от: натриев 2-амино-4-(2,6-дифлуоропиримидин-4-иламино)бензенсулфонат; натриев 2-амино-4-(4,6-дифлуоропиримидин-4-иламино)бензенсулфонат | 426-470-0 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-570-00-5 | sodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate monohydrate | 426-520-1 | 71420-85-4 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-570-00-5 | натриев (6R-транс)-7-амино-8-оксо-3-[[[1-(сулфометил)-1H-тетразол-5-ил]тио]метил]-5-тиа-1-азабицикло[4.2.0]окт-2-ен-2-карбоксилат монохидрат | 426-520-1 | 71420-85-4 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-571-00-0 | 2-cyclopentene-1-acetic acid, 3-hydroxy-2-pentyl-, methyl ester acetate | 431-400-7 | 57374-49-9 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  607-571-00-0 | метилов [3-(ацетилокси)-2-пентилциклопент-2-ен-1-ил]ацетат | 431-400-7 | 57374-49-9 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
607-572-00-6 | diethyl thiophosphoryl (Z)-(2-aminothiazol-4-yl)methoxyimino acetate | 426-790-0 | 162208-27-7 | Acute Tox. 4 * Acute Tox. 4 * STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H373** H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H312 | H302 | H373** H317 | H410 |   |   |  607-572-00-6 | диетилов тиофосфорилов (Z)-(2-аминотиазол-4-ил)метоксииминоацетат | 426-790-0 | 162208-27-7 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H373** H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H312 | H302 | H373** H317 | H410 |   |   |  
607-573-00-1 | reaction mass of: disodium 7-(2,4-difluoropyrimidin-6-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate; disodium; 7-(4,6-difluoropyrimidin-2-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate | 426-840-1 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-573-00-1 | реакционна маса от: динатриев 7-(2,4-дифлуоропиримидин-6-иламино)-3-(4-метокси-2-сулфонатофенилазо)-4-хидроксинафтален-2-сулфонат; динатриев 7-(4,6-дифлуоропиримидин-2-иламино)-3-(4-метокси-2-сулфонатофенилазо)-4-хидроксинафтален-2-сулфонат | 426-840-1 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-574-00-7 | [1R-(1-α, 2β,5α)]-mono[5-methyl-2-(1-methylethyl)cyclohexyl]butanedioate | 426-890-4 | 77341-67-4 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-574-00-7 | [1R-(1α,2β,5α)]моно[5-метил-2-(1-метилетил)циклохексил]бутандиоат | 426-890-4 | 77341-67-4 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-575-00-2 | 4-(5-(5-[1-(4-carboxyphenyl)hexahydro-2,4,6-trioxopyrimidin-5-ylidene]penta-1,3-dienyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxopyrimidin-1-yl)benzoic acid-triethylamine salt | 426-900-7 | — | STOT SE 3 | Aquatic Chronic 3 | H335 | H412 | GHS07 | Wng | H335 | H412 |   |   |  607-575-00-2 | триетиламинова сол на 4-(5-(5-[1-(4-карбоксифенил)хексахидро-2,4,6-триоксопиримидин-5-илиден]пента-1,3-диенил)-1,2,3,4-тетрахидро-6-хидрокси-2,4-диоксопиримидин-1-ил)бензоената киселина | 426-900-7 | — | STOT SE 3 | Aquatic Chronic 3 | H335 | H412 | GHS07 | Wng | H335 | H412 |   |   |  
607-576-00-8 | branched, octyl 3-[3,5-di(tert-butyl)-4-hydroxyphenyl]propanoate | 427-030-0 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  607-576-00-8 | разклонен октилов 3-[3,5-ди(трет-бутил)-4-хидроксифенил]пропаноат | 427-030-0 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
607-577-00-3 | (2R*, 3S*)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1R)-10-camphorsulfonate | 427-100-0 | — | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H317 | H412 |   |   |  607-577-00-3 | (2R*,3S*)-2-(2,4-дифлуорофенил)-1-(1H-1,2,4-триазол-1-ил)-3-(5-флуоро-4-пиримидинил)бутан-2-олов (1R)-10-камфорсулфонат | 427-100-0 | — | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H317 | H412 |   |   |  
607-578-00-9 | ethyl 4-((4-diethylamino-2-methylphenyl)imino)-4,5-dihydro-1-isopropyl-5-oxo-1H-pyrazole-3-carboxylate | 427-110-5 | — | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 4 | H302 | H373** H413 | GHS08 | GHS07 | Wng | H302 | H373** H413 |   |   |  607-578-00-9 | етилов 4-((4-диетиламино-2-метилфенил)имино)-1-изопропил-5-оксо-4,5-дихидро-1H-пиразол-3-карбоксилат | 427-110-5 | — | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 4 | H302 | H373** H413 | GHS08 | GHS07 | Wng | H302 | H373** H413 |   |   |  
607-579-00-4 | diethyl[(p-ethoxyanilino)methylene]malonate | 431-430-0 | 103976-28-9 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  607-579-00-4 | диетилов [(p-етоксианилино)метилен]малонат | 431-430-0 | 103976-28-9 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
607-580-00-X | ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate | 422-360-1 | 100491-29-0 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  607-580-00-X | етилов 1-(2,4-дифлуорофенил)-4-оксо-6-флуоро-1,4-дихидро-7-хлоро-1,8-нафтиридин-3-карбоксилат | 422-360-1 | 100491-29-0 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
607-581-00-5 | ethyl 2-ethoxy-4-carboxymethylbenzoate | 427-630-2 | 99469-99-5 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-581-00-5 | етилов 2-етокси-4-карбоксиметилбензоат | 427-630-2 | 99469-99-5 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-582-00-0 | reaction mass of: tetrasodium 7-(4-(4-fluoro-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate; tetrasodium 7-(4-(4-hydroxy-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate | 427-650-1 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-582-00-0 | реакционна маса от: тетранатриев 7-(4-(4-флуоро-6-(4-(2-сулфонатоетилсулфонил)фениламино)-1,3,5-триазин-2-иламино)-2-уреидофенилазо)нафтален-1,3,6-трисулфонат; тетранатриев 7-(4-(4-хидрокси-6-(4-(2-сулфонатоетилсулфонил)фениламино)-1,3,5-триазин-2-иламино)-2-уреидофенилазо)нафтален-1,3,6-трисулфонат | 427-650-1 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-583-00-6 | 4-amino-3-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalene sulfonic acid | 427-680-5 | 188907-52-0 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  607-583-00-6 | 4-амино-3-[[4-[[2-(сулфоокси)етил]сулфонил]фенил]азо]-1-нафталенсулфонова киселина | 427-680-5 | 188907-52-0 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  
607-584-00-1 | trisodium 3-[2-acetylamino-4-[4-chloro-6-[4-(2-sulfonatoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalene-1,5-disulfonate | 427-710-7 | 215612-56-9 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  607-584-00-1 | тринатриев 3-[2-ацетиламино-4-[4-хлоро-6-[4-(2-сулфонатоксиетилсулфонил)фениламино]-1,3,5-триазин-2-иламино]фенилазо]нафтален-1,5-дисулфонат | 427-710-7 | 215612-56-9 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  
607-585-00-7 | strontium 2-[(2-hydroxy-6-sulfonato-1-naphthyl)azo]naphthalene-1-sulfonate | 427-930-3 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-585-00-7 | стронциев 2-[(6-сулфонато-2-хидрокси-1-нафтил)азо]нафтален-1-сулфонат | 427-930-3 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-586-00-2 | dodecyl 3-amino-4-chlorobenzoate | 428-020-9 | 6195-20-6 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  607-586-00-2 | додецилов 3-амино-4-хлоробензоат | 428-020-9 | 6195-20-6 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
607-587-00-8 | ethyl cis-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine-1-carboxylate | 428-030-3 | 67914-69-6 | Acute Tox. 4 * STOT RE 2 * Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373** H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373** H410 |   |   |  607-587-00-8 | етилов цис-4-[4-[[2-(2,4-дихлорофенил)-2-(1H-имидазол-1-илметил)-1,3-диоксолан-4-ил]метокси]фенил]пиперазин-1-карбоксилат | 428-030-3 | 67914-69-6 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373** H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373** H410 |   |   |  
607-588-00-3 | reaction mass of: 2-ethylhexyl 2,3,4,5-tetrabromobenzoate; bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate | 428-050-2 | — | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  607-588-00-3 | реакционна маса от: 2-етилхексилов 2,3,4,5-тетрабромобензоат; бис(2-етилхексилов) 3,4,5,6-тетрабромофталат | 428-050-2 | — | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
607-589-00-9 | tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate | 428-070-1 | 91788-83-9 | STOT RE 1 | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H372** H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H372** H302 | H410 |   |   |  607-589-00-9 | тетракис(1,2,2,6,6-пентаметил-4-пиперидил)-1,2,3,4-бутантетракарбоксилат | 428-070-1 | 91788-83-9 | STOT RE 1 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H372** H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H372** H302 | H410 |   |   |  
607-590-00-4 | hexadecyl 3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxovaleramido]-4-isopropoxybenzoate | 428-140-1 | 210706-50-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-590-00-4 | хексадецилов 3-[2-(5,5-диметил-2,4-диоксо-1,3-оксазолидин-3-ил)-4,4-диметил-3-оксовалерамидо]-4-изопропоксибензоат | 428-140-1 | 210706-50-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-591-00-X | reaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate; disodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonate | 428-400-4 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-591-00-X | реакционна маса от: тринатриев 3-(4-(2-сулфооксиетансулфонил)фенилазо)-5-(4-флуоро-6-морфолин-4-ил-1,3,5-триазин-2-иламино)-4-хидроксинафтален-2,7-дисулфонат; динатриев 3-(4-етенсулфонилфенилазо)-5-(4-флуоро-6-морфолин-4-ил-1,3,5-триазин-2-иламино)-4-хидроксинафтален-2,7-дисулфонат | 428-400-4 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-592-00-5 | di(C9-11-alkyl) cyclohexane-1,4-dicarboxylate | 428-870-0 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-592-00-5 | ди(C9-11-алкилов) циклохексан-1,4-дикарбоксилат | 428-870-0 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-593-00-0 | 4-(2-methylacryloyloxy)phenyl4-allyloxybenzoate | 429-000-2 | 159235-16-2 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  607-593-00-0 | 4-(2-метилакрилоилокси)фенилов 4-алилоксибензоат | 429-000-2 | 159235-16-2 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
607-594-00-6 | ethyl (1S, 5R, 6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate | 429-020-1 | 204254-96-6 | STOT RE 2 * | Skin Sens. 1 | H373** H317 | GHS08 | GHS07 | Wng | H373** H317 |   |   |  607-594-00-6 | етилов (1S,5R,6S)-5-(1-етилпропокси)-7-оксабицикло[4.1.0]хепт-3-ен-3-карбоксилат | 429-020-1 | 204254-96-6 | STOT RE 2 * | Skin Sens. 1 | H373** H317 | GHS08 | GHS07 | Wng | H373** H317 |   |   |  
607-595-00-1 | N-amidino-N-methylglycine-2-oxopropionate | 429-120-5 | 208535-04-0 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-595-00-1 | N-амидино-N-метилглицин-2-оксопропионат | 429-120-5 | 208535-04-0 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-596-00-7 | ethyl 2-(4-phenoxyphenyl)lactate | 429-220-9 | 132584-17-9 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  607-596-00-7 | етилов 2-(4-феноксифенил)лактат | 429-220-9 | 132584-17-9 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
607-597-00-2 | tetrasodium 4,4'-bis{4-[4-(2-hydroxyethylamino)-6-(4-sulfonatoanilino)-1,3,5-triazin-2-ylamino]phenylazo}stilbene-2,2'-disulfonate | 429-230-3 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-597-00-2 | тетранатриев 4,4′-бис{4-[6-(4-сулфонатоанилино)-4-(2-хидроксиетиламино)-1,3,5-триазин-2-иламино]фенилазо}стилбен-2,2′-дисулфонат | 429-230-3 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-598-00-8 | trisodium 3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluoro-1,3,5-triazine-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalene-2,7-disulfonate | 429-240-8 | 212652-59-0 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-598-00-8 | тринатриев 3-амино-4-[4-[4-(2-(2-етенилсулфонилетокси)етиламино)-6-флуоро-1,3,5-триазин-2-иламино]-2-сулфофенилазо]-5-хидроксинафтален-2,7-дисулфонат | 429-240-8 | 212652-59-0 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-599-00-3 | 1,1-dimethylpropyl 3,5,5-trimethylperoxyhexanoate | 431-610-9 | 68860-54-8 | Org. Perox. D | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H242 | H317 | H400 | H410 | GHS02 | GHS07 | GHS09 | Dgr | H242 | H317 | H410 |   |   |  607-599-00-3 | 1,1-диметилпропилов 3,5,5-триметилпероксихексаноат | 431-610-9 | 68860-54-8 | Org. Perox. D | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H242 | H317 | H400 | H410 | GHS02 | GHS07 | GHS09 | Dgr | H242 | H317 | H410 |   |   |  
607-600-00-7 | (1S, 1'R)-[1-(3', 3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methyl propanoate | 431-700-8 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-600-00-7 | (1S,1′R)-[1-(3′,3′-диметил-1′-циклохексил)етоксикарбонил]метилов пропаноат | 431-700-8 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-601-00-2 | 1,4-dihydroxy-2,2,6,6-tetramethyl piperidinium-2-hydroxy-1,2,3-propanetricarboxylate | 429-370-5 | 220410-74-2 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  607-601-00-2 | 2,2,6,6-тетраметил-1,4-дихидроксипиперидиниев 2-хидрокси-1,2,3-пропантрикарбоксилат | 429-370-5 | 220410-74-2 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
607-602-00-8 | ethyl (3-cyanomethyl-3,4-dihydro-4-oxophthalazin-1-yl)acetate | 429-680-0 | 122665-86-5 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  607-602-00-8 | етилов (4-оксо-3,4-дихидро-3-цианометилфталазин-1-ил)ацетат | 429-680-0 | 122665-86-5 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
607-603-00-3 | lithium sodium 4,4', 4''-(nitrilotris(ethane-2,1-diylimino(6-chloro-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-(1-sulfonaphthalene-2-ylazo)-2,7-naphthalene)disulfonate | 429-730-1 | 193562-37-7 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  607-603-00-3 | литиев натриев 4,4′,4′′-(нитрилотрис(етан-2,1-диилимино(6-хлоро-1,3,5-триазин-4,2-диил)имино))трис(5-хидрокси-6-(1-сулфонафтален-2-илазо)-2,7-нафтален)дисулфонат | 429-730-1 | 193562-37-7 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
607-604-00-9 | guanidinium benzoate | 429-820-0 | 26739-54-8 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  607-604-00-9 | гуанидиниев бензоат | 429-820-0 | 26739-54-8 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
607-605-00-4 | methyl 4-iodo-2-(3-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)ureidosulfonyl)benzoate | 429-890-2 | 144550-06-1 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  607-605-00-4 | метилов 4-йодо-2-(3-(6-метил-4-метокси-1,3,5-триазин-2-ил)уреидосулфонил)бензоат | 429-890-2 | 144550-06-1 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
607-606-00-X | (Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-enoic acid | 430-100-3 | 86978-24-7 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  607-606-00-X | (Z)-2-(2-t-бутоксикарбониламино-4-тиазолил)пент-2-енова киселина | 430-100-3 | 86978-24-7 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
607-607-00-5 | reaction mass of: calcium bis(C10-14 branched alkyl salicylate); calcium bis(C18-30-alkyl salicylate); calcium C10-14 branched alkylsalicylato-C18-30-alkyl salicylate; calcium bis (C10-14 branched alkyl phenolate); calcium bis (C18-30-alkyl phenolate); calcium C10-14 branched alkylphenolato-C18-30-alkyl phenolate; C10-14 branched alkyl phenol; C18-30-alkyl phenol | 430-180-1 | — | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  607-607-00-5 | реакционна маса от: калциев бис(C10-14-разклонен алкилсалицилат); калциев бис(C18—30-алкилсалицилат); калциев бис(C10—14-разклонен алкилсалицилато-C18—30-алкилсалицилат); калциев бис(C10—14-разклонен алкилфенолат); калциев бис(C18—30-алкилфенолат); калциев C10-14-разклонен алкилфенолато-C18-30-алкилфенолат); C10—14-разклонен алкилфенол; C18—30-алкилфенол | 430-180-1 | — | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
607-608-00-0 | pentapotassium 2-(4-{5-[1-(2,5-disulfophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-(2-pyrrolidinone-1-yl)-1,3-pentadienyl}-3-methylcarbamoyl-5-oxopyrazol-1-yl)benzene-1,4-disulfonate | 430-210-1 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  607-608-00-0 | пентакалиев 2-(4-{5-[1-(2,5-дисулфофенил)-3-метилкарбамоил-5-оксо-4,5-дихидропиразол-4-илиден]-3-(2-пиролидинон-1-ил)-1,3-пентадиенил}-3-метилкарбамоил-5-оксопиразол-1-ил)бензен-1,4-дисулфонат | 430-210-1 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
607-609-00-6 | ethyl (3R)-4-cyano-3-hydroxybutanoate | 430-220-6 | 141942-85-0 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  607-609-00-6 | етилов (3R)-3-хидрокси-4-цианобутаноат | 430-220-6 | 141942-85-0 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
607-610-00-1 | trisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2-sulfonate | 430-280-3 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-610-00-1 | тринатриев 4-хидрокси-6-(сулфонатометиламино)-5-(2-(2-сулфатоетилсулфонил)фенилазо)нафтален-2-сулфонат | 430-280-3 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-611-00-7 | methyl 3-amino-2,2,3-trimethylbutyrate | 431-720-7 | 90886-53-6 | Skin Corr. 1B | Acute Tox. 4 * | Aquatic Chronic 3 | H314 | H302 | H412 | GHS05 | GHS07 | Dgr | H314 | H302 | H412 |   |   |  607-611-00-7 | метилов 3-амино-2,2,3-триметилбутират | 431-720-7 | 90886-53-6 | Skin Corr. 1B | Acute Tox. 4 * | Aquatic Chronic 3 | H314 | H302 | H412 | GHS05 | GHS07 | Dgr | H314 | H302 | H412 |   |   |  
607-612-00-2 | Reaction mass of: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonic acid; ammonium 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonate | 432-190-1 | 182176-52-9 | Acute Tox. 4 * STOT RE 2 * | Eye Dam. 1 | H302 | H373** H318 | GHS05 | GHS08 | GHS07 | Dgr | H302 | H373** H318 |   |   |  607-612-00-2 | реакционна маса от: 3,3,4,4,5,5,6,6,7,7,8,8,8-тридекафлуоро-1-октансулфонова киселина; амониев 3,3,4,4,5,5,6,6,7,7,8,8,8-тридекафлуоро-1-октансулфонат | 432-190-1 | 182176-52-9 | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | H302 | H373** H318 | GHS05 | GHS08 | GHS07 | Dgr | H302 | H373** H318 |   |   |  
607-613-00-8 | reaction mass of: succinic acid; monopersuccinic acid; dipersuccinic acid monomethyl ester of succinic acid monomethyl ester of persuccinic acid dimethyl succinate glutaric acid monoperglutaric acid diperglutaric acid monomethyl ester of glutaric acid monomethyl ester of perglutaric acid dimethyl glutarate adipic acid monoperadipic acid diperadipic acid monomethyl ester of adipic acid monomethyl ester of peradipic aciddimethyl adipate hydrogen peroxide methanolwater | 432-790-1 |   | Acute Tox. 4* Acute Tox. 4* Acute Tox. 4* | Skin Corr. 1B STOT SE 2 | H332 | H312 | H302 | H314 | H371 (eyes) | GHS07 | GHS05 | GHS08 | Dgr | H332 | H312 | H302 | H314 | H371 (eyes) |   |   |  607-613-00-8 | реакционна маса от: янтарна киселина; моноперянтарна киселина; диперянтарна киселина монометилов естер на янтарната киселина монометилов естер на перянтарната киселина диметилов сукцинат глутарова киселина моноперглутарова киселина диперглутарова киселина монометилов естер на глутаровата киселина монометилов естер на перглутаровата киселина диметилов глутарат адипинова киселина моноперадипинова киселина диперадипинова киселина монометилов естер на адипиновата киселина монометилов естер на перадипиновата киселина диметилов адипат водороден пероксид метанол вода | 432-790-1 |   | Acute Tox. 4* | Acute Tox. 4* | Acute Tox. 4* | Skin Corr. 1B | STOT SE 2 | H332 | H312 | H302 | H314 | H371 (очи) | GHS07 | GHS05 | GHS08 | Dgr | H332 | H312 | H302 | H314 | H371 (очи) |   |   |  
607-614-00-3 | 2-(10-oxo-10H-9-oxa-10-phosphaphenanthren-10-ylmethyl)succinic acid | 426-480-5 | 63562-33-4 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  607-614-00-3 | 2-(10-оксо-10H-9-окса-10-фосфафенантрен-10-илметил)янтарна киселина | 426-480-5 | 63562-33-4 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
607-615-00-9 | reaction product of thioglycerol and mercaptoacetic acid consisting mainly of 3-mercapto-1,2-bismercaptoacetoxypropane and oligomers of this substance | 431-120-5 | — | Acute Tox. 3 * Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | H331 | H302 | H319 | H317 | GHS06 | Dgr | H331 | H302 | H319 | H317 |   |   |  607-615-00-9 | реакционен продукт от тиоглицерол и меркаптооцетна киселина, съдържащ главно 3-меркапто-1,2-бисмеркаптоацетоксипропан и олигомери на това вещество | 431-120-5 | — | Acute Tox. 3 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | H331 | H302 | H319 | H317 | GHS06 | Dgr | H331 | H302 | H319 | H317 |   |   |  
607-616-00-4 | 2,4-dichloro-5-fluorobenzoylchloride | 428-390-1 | 86393-34-2 | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H335 | H315 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H335 | H315 | H318 | H317 | H412 |   |   |  607-616-00-4 | 5-флуоро-2,4-дихлоробензоилхлорид | 428-390-1 | 86393-34-2 | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H335 | H315 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H335 | H315 | H318 | H317 | H412 |   |   |  
607-617-00-X | bis(2-ethylhexyl)-4,5-epoxycyclohexane-1,2-dicarboxylate | 430-700-5 | 10138-36-0 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-617-00-X | бис(2-етилхексил)-4,5-епоксициклохексан-1,2-дикарбоксилат | 430-700-5 | 10138-36-0 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-618-00-5 | menadione sodium bisulfite; 2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt | 204-987-0 | 130-37-0 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H315 | H410 |   |   |  607-618-00-5 | менадион натриев бисулфит; натриева сол на 2-метил-1,4-диоксо-1,2,3,4-тетрахидро-2-нафталенсулфоновата киселина | 204-987-0 | 130-37-0 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H315 | H410 |   |   |  
607-619-00-0 | menadione nicotinamide bisulfite; 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonicacid, compound with nicotin-3-amide (1:1) | 277-543-7 | 73581-79-0 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H315 | H410 |   |   |  607-619-00-0 | менадион никотинамид бисулфит; съединение на 2-метил-1,4-диоксо-1,2,3,4-тетрахидронафтален-2-сулфоновата киселина с никотин-3-амид (1:1) | 277-543-7 | 73581-79-0 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H315 | H410 |   |   |  
607-620-00-6 | trisodium nitrilotriacetate | 225-768-6 | 5064-31-3 | Carc. 2 | Acute Tox. 4 * | Eye Irrit. 2 | H351 | H302 | H319 | GHS08 | GHS07 | Wng | H351 | H302 | H319 |   | Carc. 2; H351: C | ≥ 5 % |  607-620-00-6 | тринатриев нитрилотриацетат | 225-768-6 | 5064-31-3 | Carc. 2 | Acute Tox. 4 * | Eye Irrit. 2 | H351 | H302 | H319 | GHS08 | GHS07 | Wng | H351 | H302 | H319 |   | Carc. 2; H351: C | ≥ 5 % |  
607-621-00-1 | milbemectin (ISO); [reaction mass of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)] | — | — | Acute Tox. 4 * | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H302 | H410 |   | M=100 |  607-621-00-1 | милбемектин (ISO); [реакционна маса от милбемицин A3 (CAS № 51596-10-2) и милбемицин A4 (CAS № 51596-11-3) (30:70)] | — | — | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H302 | H410 |   | M=100 |  
607-622-00-7 | 2-ethylhexyl-2-ethylhexanoate | 231-057-1 | 7425-14-1 | Repr. 2 | H361d*** | GHS08 | Wng | H361d*** |   |   |  607-622-00-7 | 2-етилхексилов 2-етилхексаноат | 231-057-1 | 7425-14-1 | Repr. 2 | H361d*** | GHS08 | Wng | H361d*** |   |   |  
607-624-00-8 | perfluorooctane sulfonic acid; heptadecafluorooctane-1-sulfonic acid; [1] potassium perfluorooctanesulfonate; potassium heptadecafluorooctane-1-sulfonate; [2] diethanolamine perfluorooctane sulfonate; [3] ammonium perfluorooctanesulfonate; ammonium heptadecafluorooctanesulfonate; [4] lithium perfluorooctane sulfonate; lithium heptadecafluorooctanesulfonate [5] | 217-179-8 [1] | 220-527-1 [2] | 274-460-8 [3] | 249-415-0 [4] | 249-644-6 [5] | 1763-23-1 [1] | 2795-39-3 [2] | 70225-14-8 [3] | 29081-56-9 [4] | 29457-72-5 [5] | Carc. 2 | Repr. 1B | STOT RE 1 | Acute Tox. 4 * Acute Tox. 4 * | Lact. | Aquatic Chronic 2 | H351 | H360D*** H372** | H332 | H302 | H362 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H351 | H360D*** H372** | H332 | H302 | H362 | H411 |   |   |  607-624-00-8 | перфлуорооктансулфонова киселина; хептадекафлуорооктан-1-сулфонова киселина; [1] калиев перфлуорооктансулфонат; калиев хептадекафлуорооктан-1-сулфонат; [2] диетаноламинов перфлуорооктансулфонат; [3] амониев перфлуорооктансулфонат; амониев хептадекафлуорооктансулфонат; [4] литиев перфлуорооктансулфонат; литиев хептадекафлуорооктансулфонат [5] | 217-179-8 [1] | 220-527-1 [2] | 274-460-8 [3] | 249-415-0 [4] | 249-644-6 [5] | 1763-23-1 [1] | 2795-39-3 [2] | 70225-14-8 [3] | 29081-56-9 [4] | 29457-72-5 [5] | Carc. 2 | Repr. 1B | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Lact. | Aquatic Chronic 2 | H351 | H360D*** H372** | H332 | H302 | H362 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H351 | H360D*** H372** | H332 | H302 | H362 | H411 |   |   |  
607-625-00-3 | clodinafop-propargyl (ISO) | — | 105512-06-9 | Acute Tox. 4 * STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373** H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373** H317 | H410 |   | Skin Sens. 1; H317: C ≥ 0,001  % | M=1 |  607-625-00-3 | клодинафоп-пропаргил (ISO) | — | 105512-06-9 | Acute Tox. 4 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373** H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373** H317 | H410 |   | Skin Sens. 1; H317: C ≥ 0,001  % | M=1 |  
607-626-00-9 | ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate | 401-290-5 | 103112-35-2 | Carc. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H410 |   |   |  607-626-00-9 | етилов 1-(2,4-дихлорофенил)-5-(трихлорометил)-1H-1,2,4-триазол-3-карбоксилат | 401-290-5 | 103112-35-2 | Carc. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H410 |   |   |  
607-627-00-4 | [(4S, 5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate | 416-360-0 | 162221-28-5 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-627-00-4 | (4S,5S)-4-бензил-2-оксо-5-оксазолидинил]метилов 4-нитробензенсулфонат | 416-360-0 | 162221-28-5 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-628-00-X | 4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine | 419-240-6 | 171054-89-0 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-628-00-X | адукт на 4-оксо-4-(p-толил)маслената киселина с 4-етилморфолин | 419-240-6 | 171054-89-0 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-629-00-5 | [[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid | 419-270-1 | 123599-82-6 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  607-629-00-5 | [[2-метил-1-(1-оксопропокси)пропокси](4-фенилбутил)фосфинил]оцетна киселина | 419-270-1 | 123599-82-6 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
607-630-00-0 | acrylic acid, 3-(trimethoxysilyl)propyl ester | 419-560-6 | 4369-14-6 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 3 | H332 | H314 | H317 | H412 | GHS05 | GHS07 | Dgr | H332 | H314 | H317 | H412 |   |   |  607-630-00-0 | (3-(триметоксисилил)пропилов естер на акриловата киселина | 419-560-6 | 4369-14-6 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 3 | H332 | H314 | H317 | H412 | GHS05 | GHS07 | Dgr | H332 | H314 | H317 | H412 |   |   |  
607-631-00-6 | reaction mass of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate; (2-(2-hydroxyethoxy)ethyl)oxo(phenyl)acetate | 442-300-8 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-631-00-6 | реакционна маса от: 2-(2-((оксо(фенил)ацетил)окси)етокси)етилов оксо(фенил)ацетат; 2-(2-хидроксиетокси)етил)оксо(фенил)ацетат | 442-300-8 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-632-00-1 | N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide | 420-210-1 | 111244-14-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-632-00-1 | N-[3-(2,4-ди(1,1-диметилпропил)фенокси)пропил]-1-хидрокси-5-(2-метилпропилоксикарбониламино)нафтамид | 420-210-1 | 111244-14-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-633-00-7 | trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate | 440-480-2 | 341026-59-3 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  607-633-00-7 | тринатриев 5-{[6-(1-нафтиламино)-4-хлоро-1,3,5-триазин-2-ил]амино}-4-хидрокси-3-[(E)-(4-метокси-2-сулфонатофенил)диазенил]-2,7-нафталендисулфонат | 440-480-2 | 341026-59-3 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
607-634-00-2 | (S)-(–)-2-acetoxypropionylchloride; (1S)-2-chloro-1-methyl-2-oxoethyl acetate | 420-610-4 | 36394-75-9 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | H302 | H314 | H317 | GHS05 | GHS07 | Dgr | H302 | H314 | H317 |   |   |  607-634-00-2 | (S)-(–)-2-ацетоксипропионилхлорид; (1S)-1-метил-2-оксо-2-хлороетилов ацетат | 420-610-4 | 36394-75-9 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | H302 | H314 | H317 | GHS05 | GHS07 | Dgr | H302 | H314 | H317 |   |   |  
607-635-00-8 | trisodium N-(3-propionato)-l-aspartate | 422-090-4 | 172737-80-3 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-635-00-8 | тринатриев N-(3-пропионато)-L-аспартат | 422-090-4 | 172737-80-3 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-636-00-3 | 1-bromo-2-methylpropyl propionate | 422-900-6 | 158894-67-8 | Flam. Liq. 3 | Carc. 2 | Skin Corr. 1B | Skin Sens. 1 | H226 | H351 | H314 | H317 | GHS02 | GHS05 | GHS08 | GHS07 | Dgr | H226 | H351 | H314 | H317 |   |   |  607-636-00-3 | 1-бромо-2-метилпропилов пропионат | 422-900-6 | 158894-67-8 | Flam. Liq. 3 | Carc. 2 | Skin Corr. 1B | Skin Sens. 1 | H226 | H351 | H314 | H317 | GHS02 | GHS05 | GHS08 | GHS07 | Dgr | H226 | H351 | H314 | H317 |   |   |  
607-637-00-9 | disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate | 423-730-5 | 250688-43-8 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-637-00-9 | динатриев 8-амино-5-{4-[2-(сулфонатоетокси)сулфонил]фенилазо}нафтален-2-сулфонат | 423-730-5 | 250688-43-8 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-638-00-4 | 2-hydroxybenzoic acid 2-butyloctyl ester | 431-090-3 | 190085-41-7 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-638-00-4 | 2-бутилоктилов естер на 2-хидроксибензоената киселина | 431-090-3 | 190085-41-7 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-639-00-X | 2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate | 431-770-1 | 216698-07-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-639-00-X | 2-(2-оксо-5-(1,1,3,3-тетраметилбутил)-2,3-дихидро-1-бензофуран-3-ил)-4-(1,1,3,3-тетраметилбутил)фенилов ацетат | 431-770-1 | 216698-07-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-641-00-0 | 2-(formylamino)-3-thiophenecarboxylic acid; 2-formamido-3-thiophenecarboxylic acid | 431-930-9 | 43028-69-9 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  607-641-00-0 | 2-(формиламино)-3-тиофенкарбоксилна киселина; 2-формамидо-3-тиофенкарбоксилна киселина | 431-930-9 | 43028-69-9 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  
607-642-00-6 | 3,6,9-trithiaundecamethylene-1,11-dimethacrylate | 432-210-7 | 141631-22-3 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  607-642-00-6 | 3,6,9-тритиаундекаметилен-1,11-диметакрилат | 432-210-7 | 141631-22-3 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
607-643-00-1 | dimethyl (2S)-2-hydroxysuccinate | 432-310-0 | 617-55-0 | Flam. Liq. 3 | Eye Dam. 1 | Skin Sens. 1 | H226 | H318 | H317 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H318 | H317 |   |   |  607-643-00-1 | диметилов (2S)-2-хидроксисукцинат | 432-310-0 | 617-55-0 | Flam. Liq. 3 | Eye Dam. 1 | Skin Sens. 1 | H226 | H318 | H317 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H318 | H317 |   |   |  
607-644-00-7 | methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate | 432-350-9 | 81752-87-6 | Skin Irrit. 2 | H315 | GHS07 | Wng | H315 |   |   |  607-644-00-7 | метилов 2,2-диметил-6-метиленциклохексанкарбоксилат | 432-350-9 | 81752-87-6 | Skin Irrit. 2 | H315 | GHS07 | Wng | H315 |   |   |  
607-645-00-2 | tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate | 432-550-6 | 243858-01-7 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-645-00-2 | тетранатриев 2-(6-(метил-(2-сулфатоетилсулфонил)етил)амино)-4-флуоро-1,3,5-триазин-2-иламино)-6-(4-метил-2-сулфонатофенилазо)-5-хидроксинафтален-1,7-дисулфонат | 432-550-6 | 243858-01-7 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-646-00-8 | D-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester; tert-butyl 2-[(4R, 6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate | 432-960-5 | 124655-09-0 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  607-646-00-8 | 2,4-дидеокси-3,5-O-(1-метилетилиден)-1,1-диметилетилов естер на D-еритрохексановата киселина; трет-бутилов 2-[(4R,6S)-2,2-диметил-6-(хидроксиметил)-1,3-диоксан-4-ил]ацетат | 432-960-5 | 124655-09-0 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
607-647-00-3 | 5-acetoxy-2-(R, S)butyryloxymethyl-1,3-oxathiolane | 433-530-1 | 143446-73-5 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | H302 | H317 | H400 | GHS07 | GHS09 | Wng | H302 | H317 | H400 |   |   |  607-647-00-3 | 5-ацетокси-2-(R,S)-бутирилоксиметил-1,3-оксатиолан | 433-530-1 | 143446-73-5 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | H302 | H317 | H400 | GHS07 | GHS09 | Wng | H302 | H317 | H400 |   |   |  
607-649-00-4 | [3-(chlorocarbonyl)-2-methylphenyl]acetate | 433-690-0 | 167678-46-8 | Skin Corr. 1A | Skin Sens. 1 | H314 | H317 | GHS05 | GHS07 | Dgr | H314 | H317 |   |   |  607-649-00-4 | [2-метил-3-(хлорокарбонил)фенил]ацетат | 433-690-0 | 167678-46-8 | Skin Corr. 1A | Skin Sens. 1 | H314 | H317 | GHS05 | GHS07 | Dgr | H314 | H317 |   |   |  
607-650-00-X | 2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate | 433-910-5 | 145153-52-2 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-650-00-X | 2-метил-1,5-пентандиамин-1,3-бензендикарбоксилат | 433-910-5 | 145153-52-2 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-651-00-5 | sodium 2-(nonanoyloxy)benzenesulfonate | 434-360-9 | 91125-43-8 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  607-651-00-5 | натриев 2-(нонаноилокси)бензенсулфонат | 434-360-9 | 91125-43-8 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
607-652-00-0 | ethyl N2-dodecanoyl-l-argininate hydrochloride | 434-630-6 | 60372-77-2 | Eye Dam. 1 | Aquatic Acute 1 | H318 | H400 | GHS05 | GHS09 | Dgr | H318 | H400 |   |   |  607-652-00-0 | етилов N 2-додеканоил-L-аргининатхидрохлорид | 434-630-6 | 60372-77-2 | Eye Dam. 1 | Aquatic Acute 1 | H318 | H400 | GHS05 | GHS09 | Dgr | H318 | H400 |   |   |  
607-653-00-6 | tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate | 434-840-8 | 225786-91-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-653-00-6 | тетракис(бис(2-хидроксиетил)метиламониев) 3-(4-(7-ацетиламино-3-сулфонато-1-хидроксинафтален-2-илазо)-5-метокси-2-сулфонатофенилазо)-7-(4-амино-3-сулфонатофениламино)-4-хидроксинафтален-2-сулфонат | 434-840-8 | 225786-91-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-654-00-1 | (S)-3-hydroxy-γ-butyrolactone | 434-990-4 | 7331-52-4 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-654-00-1 | (S)-3-хидрокси-γ-бутиролактон | 434-990-4 | 7331-52-4 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-655-00-7 | ethyl 6,8-dichlorooctanoate | 435-080-1 | 1070-64-0 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  607-655-00-7 | етилов 6,8-дихлорооктаноат | 435-080-1 | 1070-64-0 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
607-656-00-2 | sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid | 435-350-7 | 141250-43-3 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  607-656-00-2 | натриева сол на 4-амино-3,6-бис[[5-[[4-хлоро-6-[(2-метил-4-сулфофенил)амино]-1,3,5-триазин-2-ил]амино]-2-сулфофенил]азо]-5-хидрокси-2,7-нафталендисулфоновата киселина | 435-350-7 | 141250-43-3 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
607-657-00-8 | pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate | 436-920-8 | 172399-10-9 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-657-00-8 | пентанатриев 7-(4-(4-(3-(2-сулфатоетансулфонил)фениламино)-6-(4-(2-сулфатоетансулфонил)фениламино)-1,3,5-триазин-2-иламино)-2-уреидофенилазо)нафтален-1,3,6-трисулфонат | 436-920-8 | 172399-10-9 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-658-00-3 | 3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt | 440-770-9 | 371921-63-0 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  607-658-00-3 | литиева калиева натриева сол на 3,10-диамино-6,13-дихлоро-2-((6-(((4-(1,1-диметилетил)фенил)сулфонил)амино)-2-нафталенил)сулфонил)-4,11-трифенодиоксазиндисулфоновата киселина | 440-770-9 | 371921-63-0 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
607-659-00-9 | pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid | 442-030-0 | 321912-47-4 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-659-00-9 | пентанатриева сол на N-[5-[[4-[[3-[(аминокарбонил)амино]-4-[(3,6,8-трисулфонатонафтален-2-ил)азо]фенил]амино]-6-хлоро-1,3,5-триазин-2-ил]амино]-2-сулфонато-4-[[4-[[-2-(оксисулфонато)етил]сулфонил]фенил]азо]фенил]-3-аминопропановата киселина | 442-030-0 | 321912-47-4 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-660-00-4 | 2-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazophenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt | 442-230-8 | 321679-52-1 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  607-660-00-4 | 2-{4-[4-[6-(2-(2-винилсулфонилетокси)етиламино)-4-флуоро-1,3,5-триазин-2-иламино]фенилазофенилазо}нафтален-4,6,8-трисулфонат, тринатриева сол | 442-230-8 | 321679-52-1 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
607-661-00-X | 1,1-dimethylethyl 4'-(bromomethyl)biphenyl-2-carboxylate | 442-850-9 | 114772-40-6 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  607-661-00-X | 1,1-диметилетилов 4′-(бромометил)бифенил-2-карбоксилат | 442-850-9 | 114772-40-6 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
607-662-00-5 | methyl 2-(acetylamino)-3-chloropropionate | 442-860-3 | 87333-22-0 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  607-662-00-5 | мeтилов 2-(ацетамино)-3-хлоропропионат | 442-860-3 | 87333-22-0 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
607-663-00-0 | bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate | 442-980-6 | 127474-91-3 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-663-00-0 | бис(2-етилхексилов) нафтален-2,6-дикарбоксилат | 442-980-6 | 127474-91-3 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-664-00-6 | methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate | 443-120-2 | 393509-79-0 | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  607-664-00-6 | метилов 4-(метансулфониламинометил)-2-хлоросулфонилбензоат | 443-120-2 | 393509-79-0 | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  
607-665-00-1 | trans-methyl-2-ethyl-but-2-enoate | 443-150-6 | 101226-85-1 | Flam. Liq. 3 | H226 | GHS02 | Wng | H226 |   |   |  607-665-00-1 | метилов транс-2-етилбут-2-еноат | 443-150-6 | 101226-85-1 | Flam. Liq. 3 | H226 | GHS02 | Wng | H226 |   |   |  
607-666-00-7 | (2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid | 443-560-5 | 88784-33-2 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  607-666-00-7 | (2S)-5-(бензилокси)-2-(1,3-диоксо-1,3-дихидро-2H-изоиндол-2-ил)-5-оксопентанова киселина | 443-560-5 | 88784-33-2 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
607-667-00-2 | chloro-1-ethylcyclohexyl carbonate | 444-950-8 | 99464-83-2 | Muta. 2 | Skin Sens. 1 | H341 | H317 | GHS08 | GHS07 | Wng | H341 | H317 |   |   |  607-667-00-2 | хлоро-1-етилциклохексилов карбонат | 444-950-8 | 99464-83-2 | Muta. 2 | Skin Sens. 1 | H341 | H317 | GHS08 | GHS07 | Wng | H341 | H317 |   |   |  
607-668-00-8 | trans-2-isopropyl-5-carboxy-1,3-dioxane | 445-770-2 | 42031-28-7 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  607-668-00-8 | транс-2-изопропил-5-карбокси-1,3-диоксан | 445-770-2 | 42031-28-7 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
607-669-00-3 | methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate | 445-990-9 | 376588-17-9 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  607-669-00-3 | метилов (9-ацетокси-3,8,10-триетил-7,8,10-триметил-1,5-диокса-9-азаспиро[5.5]ундец-3-ил)октадеканоат | 445-990-9 | 376588-17-9 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
607-670-00-9 | dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate; (5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate | 448-700-9 | 500791-70-8 | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H373** H318 | H317 | H400 | H410 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H373** H318 | H317 | H410 |   | M=10 |  607-670-00-9 | дибутил-3-(4- (5-амонио-2-бутил)бензофуран-3-ил)карбонил)фенокси)пропиламониев оксалат; (5-амино-2-бутилбензофуран-3-ил)[4- (3-дибутиламинопропокси)фенил]метанон, диоксалат | 448-700-9 | 500791-70-8 | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H373** H318 | H317 | H400 | H410 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H373** H318 | H317 | H410 |   | M=10 |  
607-671-00-4 | diethyl 1,4-cyclohexanedicarboxylate | 417-310-0 | 72903-27-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  607-671-00-4 | диетилов 1,4-циклохександикарбоксилат | 417-310-0 | 72903-27-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
607-672-00-X | reaction mass of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate; 1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate; x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate | 419-000-0 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  607-672-00-X | реакционна маса от: 2-хидрокси-3-(метакрилоилокси)пропилов (2-бензоил)бензоат; 1-хидроксиметил-2-(метакрилоилокси)етилов (2-бензоил)бензоат; x-хидрокси-y-(метакрилоилокси)пропилов(или –етилов) (2-бензоил)бензоат | 419-000-0 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
607-673-00-5 | 1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate | 419-570-0 | — | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  607-673-00-5 | 1-етил-5,6,7,8-тетрахидрохинолиниев тозилат | 419-570-0 | — | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
607-675-00-6 | reaction mass of: cis-9-octadecenedioic acid; cis-9-cis-12-octadecadienedioic acid; hexadecanedioic acid; octadecanedioic acid | 422-260-8 | — | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  607-675-00-6 | реакционна маса от: цис-9-октадецендиова киселина; цис-9-цис-12-октадекадиендиова киселина; хексадекандиова киселина; октадекандиова киселина | 422-260-8 | — | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  
607-676-00-1 | reaction mass of: 2-methylnonanedioic acid; 2,4-dimethyl-4-methoxycarbonylundecanedioic acid; 2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid; 8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid | 423-670-1 | — | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  607-676-00-1 | реакционна маса от: 2-метилнонандиова киселина; 2,4-диметил-4-метоксикарбонилундекандиова киселина; 2,4,6-триметил-4,6-диметоксикарбонилтридекандиова киселина; 8,9-диметил-8,9-диметоксикарбонилхексадекандиова киселина | 423-670-1 | — | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
607-677-00-7 | 2,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazoly]methyl]amino]carbonyl}-L-Valinate | 424-660-8 | — | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | H373** H318 | H317 | GHS05 | GHS08 | GHS07 | Dgr | H373** H318 | H317 |   |   |  607-677-00-7 | 2,5-диоксопиролидин-1-илов N-{[метил[[2-(1-метилетил)-4-тиазолил]метил]амино]карбонил}-L-валинат | 424-660-8 | — | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | H373** H318 | H317 | GHS05 | GHS08 | GHS07 | Dgr | H373** H318 | H317 |   |   |  
607-678-00-2 | reaction mass of: ethyl (2R, 3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate; ethyl (2S, 3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate | 427-090-8 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  607-678-00-2 | реакционна маса от: етилов (2R,3R)-3-изопропилбицикло[2.2.1]хепт-5-ен-2-карбоксилат; етилов (2S,3S)-3-изопропилбицикло[2.2.1]хепт-5-ен-2-карбоксилат | 427-090-8 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
607-679-00-8 | reaction mass of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo[}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate); 3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate); 3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammoniumdi(acetate) | 431-440-5 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  607-679-00-8 | реакционна маса от: 3-{5-[3-(4-{1,6-дихидро-2-хидрокси-4-метил-1-[3-(метиламонио)пропил]-6-оксо-3-пиридилазо}бензамидо)фенилазо]-1,2-дихидро-6-хидрокси-4-метил-2-оксо-1-пиридил}пропил(метил)амониев ди(ацетат); 3-{5-[4-(3-{1,6-дихидро-2-хидрокси-4-метил-1-[3-(метиламонио)пропил]-6-оксо-3-пиридилазо}бензамидо)фенилазо]-1,2-дихидро-6-хидрокси-4-метил-2-оксо-1-пиридил}пропил(диметил)амониев ди(ацетат); 3-{5-[3-(4-{1-[3-(диметиламонио)пропил]-1,6-дихидро-2-хидрокси-4-метил-6-оксо-3-пиридилазо}бензамидо)фенилазо]-1,2-дихидро-6-хидрокси-4-метил-2-оксо-1-пиридил}пропил(диметил)амониев ди(ацетат) | 431-440-5 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  
607-680-00-3 | tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-ylvinyl}(4S, 6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate | 432-810-9 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-680-00-3 | трет-бутилов (6-{2-[4-(4-флуорофенил)-6-изопропил-2-[метил(метилсулфонил)амино]пиримидин-5-илвинил}(4S,6S)-2,2-диметил[1,3]диоксан-4-ил)ацетат | 432-810-9 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-681-00-9 | reaction mass of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid; 9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid; dihexadecyl 9-nonyl-10-octylnonadecandioate; 1-octadecyl, 19-hexadecyl 9-nonyl-10-octylnonadecandioate; dioctadecyl 9-nonyl-10-octylnonadecandioate | 432-910-2 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-681-00-9 | реакционна маса от: 9-нонил-10-октил-19-карбонилоксихексадецилнонадеканова киселина; 9-нонил-10-октил-19-карбонилоксиоктадецилнонадеканова киселина; дихексадецилов 9-нонил-10-октилнонадекандиоат; 1-октадецилов 19-хексадецилов 9-нонил-10-октилнонадекандиоат; диоктадецилов 9-нонил-10-октилнонадекандиоат | 432-910-2 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-682-00-4 | complex reaction mass of Chinese gum rosin post reacted with acrylic acid | 434-230-1 | 144413-22-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-682-00-4 | комплексна реакционна маса от смола от китайски червен бор, реагирала впоследствие с акрилова киселина | 434-230-1 | 144413-22-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-683-00-X | reaction mass of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate; methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80) | 435-450-0 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  607-683-00-X | реакционна маса от: мeтилов 3-((1E)-2-метилпроп-1-енил)-2,2-диметилциклопропанкарбоксилат; мeтилов 3-((1Z)-2-метилпроп-1-енил)-2,2-диметилциклопропанкарбоксилат (20:80) | 435-450-0 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
607-684-00-5 | alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts | 435-660-2 | 243662-67-1 | Skin Irrit. 2 | Skin Sens. 1 | H315 | H317 | GHS07 | Wng | H315 | H317 |   |   |  607-684-00-5 | алкени, C12-14, продукти от хидроформилиране, дестилационни остатъци, С-(хидрогенсулфобутандиоати), динатриеви соли | 435-660-2 | 243662-67-1 | Skin Irrit. 2 | Skin Sens. 1 | H315 | H317 | GHS07 | Wng | H315 | H317 |   |   |  
607-685-00-0 | ammonium 2-cocoyloxyethanesulfonate | 441-050-7 | — | Skin Irrit. 2 | Eye Dam. 1 | H315 | H318 | GHS05 | Dgr | H315 | H318 |   |   |  607-685-00-0 | амониев 2-кокоилоксиетансулфонат | 441-050-7 | — | Skin Irrit. 2 | Eye Dam. 1 | H315 | H318 | GHS05 | Dgr | H315 | H318 |   |   |  
607-686-00-6 | 6,6'-bis(diazo-5,5', 6,6'-tetrahydro-5,5'-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate) | 441-550-5 | — | Self-react. C **** Carc. 2 | H242 | H351 | GHS02 | GHS08 | Dgr | H242 | H351 |   |   |  607-686-00-6 | 6,6′-бис(диазо-5,5′-диоксо-5,5′,6,6′-тетрахидро)[метиленбис(5-(6-диазо-5-оксо-5,6-дихидро-1-нафтилсулфонилокси)-6-метил-2-фенилен]ди(нафтален-1-сулфонат) | 441-550-5 | — | Self-react. C **** Carc. 2 | H242 | H351 | GHS02 | GHS08 | Dgr | H242 | H351 |   |   |  
607-687-00-1 | reaction mass of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl[}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %) | 442-800-6 | — | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  607-687-00-1 | реакционна маса от: 2-{3,6-бис-[(2-етилфенил)метиламино]ксантилий-9-ил}бензенсулфонат (2—10 %); 2-{3,6-бис-[(2,3-диметилфенил)метиламино]ксантилий-9-ил}бензенсулфонат (2-10 %); 2-{3,6-бис-[(2,4-диметилфенил)метиламино]ксантилий-9-ил}бензенсулфонат (2-10 %); 2-{3,6-бис-[(2,5-диметилфенил)метиламино]ксантилий-9-ил}бензенсулфонат (2-10 %); 2-{3-[(2,3-диметилфенил)метиламино]-6-[(2-етилфенил)метиламино]ксантилий-9-ил}бензенсулфонат (7-20 %); 2-{3-[(2,4-диметилфенил)метиламино]-6-[(2-етилфенил)метиламино]ксантилий-9-ил}бензенсулфонат (7-20 %); 2-{3-[(2,5-диметилфенил)метиламино]-6-[(2-етилфенил)метиламино]ксантилий-9-ил}бензенсулфонат (7-20 %); 2-{3-[(2,3-диметилфенил)метиламино]-6-[(2,4-диметилфенил)метиламино]ксантилий-9-ил}бензенсулфонат (7-20 %); 2-{3-[(2,3-диметилфенил)метиламино]-6-[(2,5-диметилфенил)метиламино]ксантилий-9-ил}бензенсулфонат (7-20 %); 2-{3-[(2,4-диметилфенил)метиламино]-6-[(2,5-диметилфенил)метиламино]ксантилий-9-ил}бензенсулфонат (7-20 %) | 442-800-6 | — | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
607-688-00-7 | (R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride | 444-320-2 | — | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  607-688-00-7 | (R)-1-циклохекса-1,4-диенил-1-метоксикарбонилметиламониев хлорид | 444-320-2 | — | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
607-689-00-2 | reaction mass of: methyl 1,4-dimethylcyclohexanecarboxylate (‘para-isomer’ including cis-and trans-isomers); methyl 1,3-dimethylcyclohexanecarboxylate (‘meta-isomer’including cis-and trans-isomers) | 444-920-4 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  607-689-00-2 | реакционна маса от: метилов 1,4-диметилциклохексанкарбоксилат („пара-изомер“ включващ цис- и транс-изомери); метилов 1,3-диметилциклохексанкарбоксилат („мета-изомер“ включващ цис- и транс-изомери) | 444-920-4 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
607-690-00-8 | dimethyl[2S, 2S']-6,6,6'6'-tetramethoxy-2,2'-[N, N'-bis(trifluoracetyl)-S, S'-bi(L-homocysteinyl) diimino]dihexanoate | 432-860-1 | 255387-46-3 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  607-690-00-8 | диметилов [2S,2S′]-6,6,6′6′-тетраметокси-2,2′-[N,N′-бис(трифлуороацетил)-S,S′-би(L-хомоцистеинил)диимино]дихексаноат | 432-860-1 | 255387-46-3 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
607-691-00-3 | magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear | 448-690-6 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-691-00-3 | магнезиеви соли на разклонени и неразклонени мастни киселини с C16-18 и ненаситени с C18 | 448-690-6 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-692-00-9 | zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear | 446-470-4 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-692-00-9 | цинкови соли на разклонени и неразклонени мастни с C16-18 и ненаситени киселини с C18 | 446-470-4 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-693-00-4 | hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate | 443-860-6 | 302776-68-7 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  607-693-00-4 | хексилов 2-(1-(диетиламинохидроксифенил)метаноил)бензоат | 443-860-6 | 302776-68-7 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
607-694-00-X | ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate | 443-870-0 | 163520-33-0 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  607-694-00-X | етилов 5,5-дифенил-2-изоксазолин-3-карбоксилат | 443-870-0 | 163520-33-0 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  
607-696-00-0 | pentyl formate | 211-340-6 | 638-49-3 | Flam. Liq. 3 | Eye Irrit. 2 | STOT SE 3 | H226 | H319 | H335 | GHS02 | GHS07 | Dgr | H226 | H319 | H335 |   |   | C607-696-00-0 | пентилов формат | 211-340-6 | 638-49-3 | Flam. Liq. 3 | Eye Irrit. 2 | STOT SE 3 | H226 | H319 | H335 | GHS02 | GHS07 | Dgr | H226 | H319 | H335 |   |   | C
607-697-00-6 | tert-butyl propionate | — | 20487-40-5 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 |   |   | C607-697-00-6 | трет-бутилов пропионат | — | 20487-40-5 | Flam. Liq. 2 | H225 | GHS02 | Dgr | H225 |   |   | C
607-698-00-1 | 4-tert-butylbenzoic acid | 202-696-3 | 98-73-7 | Repr. 1B | STOT RE 1 | Acute Tox. 4 | H360F H372 | H302 | GHS07 | GHS08 | Dgr | H360F H372 | H302 |   |   |  607-698-00-1 | 4-трет-бутилбензоена киселина | 202-696-3 | 98-73-7 | Repr. 1B | STOT RE 1 | Acute Tox. 4 | H360F H372 | H302 | GHS07 | GHS08 | Dgr | H360F H372 | H302 |   |   |  
607-699-00-7 | bifenthrin (ISO); (2-methylbiphenyl-3-yl)methylrel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate |   | 82657-04-3 | Carc. 2 | Acute Tox. 3 | Acute Tox. 2 | STOT RE 1 | Skin Sens. 1B Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H331 | H300 | H372 (nervous | system) H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H331 | H300 | H372 (nervous | system) H317 | H410 |   | M = 10 000 | M = 100 000 |  607-699-00-7 | бифентрин (ISO); (2-метилбифенил-3-ил)метилов отн-(1R,3R)-3-[(1Z)-3,3,3-трифлуоро-2-хлоропроп-1-ен-1-ил]-2,2-диметилциклопропанкарбоксилат |   | 82657-04-3 | Carc. 2 | Acute Tox. 3 | Acute Tox. 2 | STOT RE 1 | Skin Sens. 1B Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H331 | H300 | H372 (нервна система) H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H331 | H300 | H372 (нервна система) H317 | H410 |   | M = 10 000 | M = 100 000 |  
607-700-00-0 | indoxacarb (ISO); methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [1] reaction mass of (S)-Indoxacarb and (R)-Indoxacarb 75:25; methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2] |   | 173584-44-6 [1] | 144171-61-9 [2] | Acute Tox. 3 | Acute Tox. 4 | STOT RE 1 | Skin Sens. 1B Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H332 | H372 (blood, nervous system, heart) | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H332 | H372 (blood, nervous system, heart) | H317 | H410 |   | M = 1 | M = 1 |  607-700-00-0 | индоксакарб (ISO); метилов (4aS)-7-хлоро-2-{(метоксикарбонил)[4-(трифлуорометокси)фенил]карбамоил}-2,5-дихидроиндено[1,2-e][1,3,4]оксадиазин-4a(3H)-карбоксилат [1] реакционна маса от (S)-индоксакарб и (R)-индоксакарб 75:25; метилов 7-хлоро-2-{(метоксикарбонил)[4-(трифлуорометокси)фенил]карбамоил}-2,5-дихидроиндено[1,2-e][1,3,4]оксадиазин-4a(3H)-карбоксилат [2] |   | 173584-44-6 [1] | 144171-61-9 [2] | Acute Tox. 3 | Acute Tox. 4 | STOT RE 1 | Skin Sens. 1B Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H332 | H372 (кръв, нервна система, сърце) | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H332 | H372 (кръв, нервна система, сърце) | H317 | H410 |   | M = 1 | M = 1 |  
607-702-00-1 | dihexyl phthalate | 201-559-5 | 84-75-3 | Repr. 1B | H360FD | GHS08 | Dgr | H360FD |   |   |  607-702-00-1 | дихексилов фталат | 201-559-5 | 84-75-3 | Repr. 1B | H360FD | GHS08 | Dgr | H360FD |   |   |  
607-703-00-7 | ammoniumpentadeca-fluorooctanoate | 223-320-4 | 3825-26-1 | Carc. 2 | Repr. 1B Lact. | Acute Tox. 4 | Acute Tox. 4 | STOT RE 1 | Eye Dam.1 | H351 | H360D H362 | H332 | H302 | H372 (liver) H318 | GHS08 | GHS07 | GHS05 | Dgr | H351 | H360D H362 | H332 | H302 | H372 (liver) H318 |   |   |  607-703-00-7 | амониев пентадекафлуорооктаноат | 223-320-4 | 3825-26-1 | Carc. 2 | Repr. 1B Lact. | Acute Tox. 4 | Acute Tox. 4 | STOT RE 1 | Eye Dam.1 | H351 | H360D H362 | H332 | H302 | H372 (черен дроб) H318 | GHS08 | GHS07 | GHS05 | Dgr | H351 | H360D H362 | H332 | H302 | H372 (черен дроб) H318 |   |   |  
607-704-00-2 | perfluorooctanoic acid | 206-397-9 | 335-67-1 | Carc. 2 | Repr. 1B Lact. | Acute Tox. 4 | Acute Tox. 4 | STOT RE 1 | Eye Dam. 1 | H351 | H360D H362 | H332 | H302 | H372 (liver) H318 | GHS08 | GHS07 | GHS05 | Dgr | H351 | H360D H362 | H332 | H302 | H372 (liver) H318 |   |   |  607-704-00-2 | перфлуорооктанова киселина | 206-397-9 | 335-67-1 | Carc. 2 | Repr. 1B Lact. | Acute Tox. 4 | Acute Tox. 4 | STOT RE 1 | Eye Dam. 1 | H351 | H360D H362 | H332 | H302 | H372 (черен дроб) H318 | GHS08 | GHS07 | GHS05 | Dgr | H351 | H360D H362 | H332 | H302 | H372 (черен дроб) H318 |   |   |  
607-705-00-8 | benzoic acid | 200-618-2 | 65-85-0 | STOT RE 1 | Skin Irrit. 2 | Eye Dam. 1 | H372 (lungs) (inhalation) H315 | H318 | GHS08 | GHS05 | Dgr | H372 (lungs) (inhalation) H315 | H318 |   |   |  607-705-00-8 | бензоена киселина | 200-618-2 | 65-85-0 | STOT RE 1 | Skin Irrit. 2 | Eye Dam. 1 | H372 (бели дробове) (вдишване) H315 | H318 | GHS08 | GHS05 | Dgr | H372 (бели дробове) (вдишване) H315 | H318 |   |   |  
607-706-00-3 | methyl 2,5-dichlorobenzoate | 220-815-7 | 2905-69-3 | Acute Tox. 4 | STOT SE 3 | Aquatic Chronic 2 | H302 | H336 | H411 | GHS07 | GHS09 | Wng | H302 | H336 | H411 |   |   |  607-706-00-3 | метилов 2,5-дихлоробензoат | 220-815-7 | 2905-69-3 | Acute Tox. 4 | STOT SE 3 | Aquatic Chronic 2 | H302 | H336 | H411 | GHS07 | GHS09 | Wng | H302 | H336 | H411 |   |   |  
608-001-00-3 | acetonitrile; cyanomethane | 200-835-2 | 75-05-8 | Flam. Liq. 2 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | Eye Irrit. 2 | H225 | H332 | H312 | H302 | H319 | GHS02 | GHS07 | Dgr | H225 | H332 | H312 | H302 | H319 |   |   |  608-001-00-3 | ацетонитрил; цианометан | 200-835-2 | 75-05-8 | Flam. Liq. 2 | Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * | Eye Irrit. 2 | H225 | H332 | H312 | H302 | H319 | GHS02 | GHS07 | Dgr | H225 | H332 | H312 | H302 | H319 |   |   |  
608-002-00-9 | trichloroacetonitrile | 208-885-7 | 545-06-2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Chronic 2 | H331 | H311 | H301 | H411 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H411 |   |   |  608-002-00-9 | трихлороацетонитрил | 208-885-7 | 545-06-2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Chronic 2 | H331 | H311 | H301 | H411 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H411 |   |   |  
608-003-00-4 | acrylonitrile | 203-466-5 | 107-13-1 | Flam. Liq. 2 | Carc. 1B | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H225 | H350 | H331 | H311 | H301 | H335 | H315 | H318 | H317 | H411 | GHS02 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H225 | H350 | H331 | H311 | H301 | H335 | H315 | H318 | H317 | H411 |   | * | D608-003-00-4 | акрилонитрил | 203-466-5 | 107-13-1 | Flam. Liq. 2 | Carc. 1B | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H225 | H350 | H331 | H311 | H301 | H335 | H315 | H318 | H317 | H411 | GHS02 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H225 | H350 | H331 | H311 | H301 | H335 | H315 | H318 | H317 | H411 |   | * | D
608-004-00-X | 2-hydroxy-2-methylpropionitrile; 2-cyanopropan-2-ol; acetone cyanohydrin | 200-909-4 | 75-86-5 | Acute Tox. 2 * Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H310 | H300 | H410 |   |   |  608-004-00-X | 2-хидрокси-2-метилпропионитрил; 2-цианопропан-2-ол; ацетон цианохидрин | 200-909-4 | 75-86-5 | Acute Tox. 2 * Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H310 | H300 | H410 |   |   |  
608-005-00-5 | n-butyronitrile | 203-700-6 | 109-74-0 | Flam. Liq. 2 | Acute Tox. 3 * Acute Tox. 3 * | Acute Tox. 3 * | H225 | H331 | H311 | H301 | GHS02 | GHS06 | Dgr | H225 | H331 | H311 | H301 |   |   |  608-005-00-5 | n-бутиронитрил | 203-700-6 | 109-74-0 | Flam. Liq. 2 | Acute Tox. 3 * Acute Tox. 3 * | Acute Tox. 3 * | H225 | H331 | H311 | H301 | GHS02 | GHS06 | Dgr | H225 | H331 | H311 | H301 |   |   |  
608-006-00-0 | bromoxynil (ISO) 3,5-dibromo-4-hydroxybenzonitrile; bromoxynil phenol | 216-882-7 | 1689-84-5 | Repr. 2 | Acute Tox. 2 * Acute Tox. 3 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d *** H330 | H301 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H361d *** H330 | H301 | H317 | H410 |   | M = 10 |  608-006-00-0 | бромоксинил (ISO);3,5-дибромо-4-хидроксибензонитрил; бромоксинил фенол | 216-882-7 | 1689-84-5 | Repr. 2 | Acute Tox. 2 * Acute Tox. 3 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d *** H330 | H301 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H361d *** H330 | H301 | H317 | H410 |   | M = 10 |  
608-007-00-6 | ioxynil (ISO) 4-hydroxy-3,5-diiodobenzonitrile | 216-881-1 | 1689-83-4 | Repr. 2 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d *** H331 | H301 | H312 | H373 ** H319 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H361d *** H331 | H301 | H312 | H373 ** H319 | H410 |   | M = 10 |  608-007-00-6 | йоксинил (ISO);4-хидрокси-3,5-дийодобензонитрил | 216-881-1 | 1689-83-4 | Repr. 2 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 4 * STOT RE 2 * Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d *** H331 | H301 | H312 | H373 ** H319 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H361d *** H331 | H301 | H312 | H373 ** H319 | H410 |   | M = 10 |  
608-008-00-1 | chloroacetonitrile | 203-467-0 | 107-14-2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Chronic 2 | H331 | H311 | H301 | H411 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H411 |   |   |  608-008-00-1 | хлороацетонитрил | 203-467-0 | 107-14-2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Chronic 2 | H331 | H311 | H301 | H411 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H411 |   |   |  
608-009-00-7 | malononitrile | 203-703-2 | 109-77-3 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H410 |   |   |  608-009-00-7 | малононитрил | 203-703-2 | 109-77-3 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H410 |   |   |  
608-010-00-2 | methacrylonitrile; 2-methyl-2-propene nitrile | 204-817-5 | 126-98-7 | Flam. Liq. 2 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * | Skin Sens. 1 | H225 | H331 | H311 | H301 | H317 | GHS02 | GHS06 | Dgr | H225 | H331 | H311 | H301 | H317 |   | * | Skin Sens. 1; H317: C ≥0,2  % | D608-010-00-2 | метакрилонитрил; 2-метил-2-пропеннитрил | 204-817-5 | 126-98-7 | Flam. Liq. 2 | Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * | Skin Sens. 1 | H225 | H331 | H311 | H301 | H317 | GHS02 | GHS06 | Dgr | H225 | H331 | H311 | H301 | H317 |   | * | Skin Sens. 1; H317: C ≥0,2  % | D
608-011-00-8 | oxalonitrile; cyanogen | 207-306-5 | 460-19-5 | Press. Gas | Flam. Gas 1 | Acute Tox. 3 * Aquatic Acute 1 | Aquatic Chronic 1 | H220 | H331 | H400 | H410 | GHS02 | GHS04 | GHS06 | GHS09 | Dgr | H220 | H331 | H410 |   |   | U608-011-00-8 | оксалонитрил; цианоген | 207-306-5 | 460-19-5 | Press. Gas | Flam. Gas 1 | Acute Tox. 3 * Aquatic Acute 1 | Aquatic Chronic 1 | H220 | H331 | H400 | H410 | GHS02 | GHS04 | GHS06 | GHS09 | Dgr | H220 | H331 | H410 |   |   | U
608-012-00-3 | benzonitrile | 202-855-7 | 100-47-0 | Acute Tox. 4 * Acute Tox. 4 * | H312 | H302 | GHS07 | Wng | H312 | H302 |   |   |  608-012-00-3 | бензонитрил | 202-855-7 | 100-47-0 | Acute Tox. 4 * Acute Tox. 4 * | H312 | H302 | GHS07 | Wng | H312 | H302 |   |   |  
608-013-00-9 | 2-chlorobenzonitrile | 212-836-5 | 873-32-5 | Acute Tox. 4 * Acute Tox. 4 * | Eye Irrit. 2 | H312 | H302 | H319 | GHS07 | Wng | H312 | H302 | H319 |   |   |  608-013-00-9 | 2-хлоробензонитрил | 212-836-5 | 873-32-5 | Acute Tox. 4 * Acute Tox. 4 * | Eye Irrit. 2 | H312 | H302 | H319 | GHS07 | Wng | H312 | H302 | H319 |   |   |  
608-014-00-4 | chlorothalonil (ISO); tetrachloroisophthalonitrile | 217-588-1 | 1897-45-6 | Carc. 2 | Acute Tox. 2 * STOT SE 3 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H330 | H335 | H318 | H317 | H400 | H410 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H351 | H330 | H335 | H318 | H317 | H410 |   | M=10 |  608-014-00-4 | хлороталонил (ISO); тетрахлороизофталонитрил | 217-588-1 | 1897-45-6 | Carc. 2 | Acute Tox. 2 * STOT SE 3 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H330 | H335 | H318 | H317 | H400 | H410 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H351 | H330 | H335 | H318 | H317 | H410 |   | M=10 |  
608-015-00-X | dichlobenil (ISO); 2,6-dichlorobenzonitrile | 214-787-5 | 1194-65-6 | Acute Tox. 4 * | Aquatic Chronic 2 | H312 | H411 | GHS07 | GHS09 | Wng | H312 | H411 |   |   |  608-015-00-X | дихлобенил (ISO); 2,6-дихлоробензонитрил | 214-787-5 | 1194-65-6 | Acute Tox. 4 * | Aquatic Chronic 2 | H312 | H411 | GHS07 | GHS09 | Wng | H312 | H411 |   |   |  
608-016-00-5 | 1,4-Dicyano-2,3,5,6-tetra-chloro-benzene | 401-550-8 | 1897-41-2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  608-016-00-5 | 2,3,5,6-тетрахлоро-1,4-дицианобензен | 401-550-8 | 1897-41-2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
608-017-00-0 | bromoxynil octanoate (ISO); 2,6-dibromo-4-cyanophenyl octanoate | 216-885-3 | 1689-99-2 | Repr. 2 | Acute Tox. 3 * Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d *** H331 | H302 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H361d *** H331 | H302 | H317 | H410 |   | M = 10 |  608-017-00-0 | бромоксинил октаноат (ISO); 2,6-дибромо-4-цианофенилов октаноат | 216-885-3 | 1689-99-2 | Repr. 2 | Acute Tox. 3 * Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d *** H331 | H302 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H361d *** H331 | H302 | H317 | H410 |   | M = 10 |  
608-018-00-6 | ioxynil octanoate (ISO); 4-cyano-2,6-diiodophenyl octanoate | 223-375-4 | 3861-47-0 | Repr. 2 | Acute Tox. 3 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d *** H301 | H319 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H361d *** H301 | H319 | H317 | H410 |   | M = 10 |  608-018-00-6 | йоксинил октаноат (ISO); 2,6-дийодо-4-цианофенилов октаноат | 223-375-4 | 3861-47-0 | Repr. 2 | Acute Tox. 3 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d *** H301 | H319 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H361d *** H301 | H319 | H317 | H410 |   | M = 10 |  
608-019-00-1 | 2,2'-dimethyl-2,2'-azodipropiononitrile; ADZN | 201-132-3 | 78-67-1 | Self-react. C | Acute Tox. 4 * | Acute Tox. 4 * Aquatic Chronic 3 | H242 | H332 | H302 | H412 | GHS02 | GHS07 | Dgr | H242 | H332 | H302 | H412 |   |   | T608-019-00-1 | 2,2′-диметил-2,2′-aзодипропиононитрил; ADZN | 201-132-3 | 78-67-1 | Self-react. C | Acute Tox. 4 * | Acute Tox. 4 * Aquatic Chronic 3 | H242 | H332 | H302 | H412 | GHS02 | GHS07 | Dgr | H242 | H332 | H302 | H412 |   |   | T
608-020-00-7 | diphenoxymethylenecyanamide | 427-300-8 | 79463-77-7 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  608-020-00-7 | дифеноксиметиленцианамид | 427-300-8 | 79463-77-7 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
608-021-00-2 | 3-(2-(diaminomethyleneamino)thiazol-4-ylmethylthio)propionitrile | 403-710-2 | 76823-93-3 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  608-021-00-2 | 3-(2-диаминометиленамино)тиазол-4-илметилтио)пропионитрил | 403-710-2 | 76823-93-3 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  
608-022-00-8 | 3,7-dimethyloctanenitrile | 403-620-3 | 40188-41-8 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H315 | H317 | H411 | GHS07 | GHS09 | Wng | H315 | H317 | H411 |   |   |  608-022-00-8 | 3,7-диметилоктаннитрил | 403-620-3 | 40188-41-8 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H315 | H317 | H411 | GHS07 | GHS09 | Wng | H315 | H317 | H411 |   |   |  
608-023-00-3 | fenbuconazole (ISO); 4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile | 406-140-2 | 114369-43-6 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  608-023-00-3 | фенбуконазол (ISO); 4-(4-хлорофенил)-2-фенил-2-[(1H-1,2,4-триазол-1-ил)метил]бутаннитрил | 406-140-2 | 114369-43-6 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
608-024-00-9 | 2-(4-(N-butyl-N-phenethylamino)phenyl)ethylene-1,1,2-tricarbonitrile | 407-650-8 | 97460-76-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  608-024-00-9 | 2-(4-(N-бутил-N-фенетиламино)фенил)eтилен-1,1,2-трикарбонитрил | 407-650-8 | 97460-76-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
608-025-00-4 | 2-nitro-4,5-bis(benzyloxy)phenylacetonitrile | 410-970-0 | 117568-27-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  608-025-00-4 | 2-нитро-4,5-бис(бензилокси)фенилацетонитрил | 410-970-0 | 117568-27-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
608-026-00-X | 3-cyano-3,5,5-trimethylcyclohexanone | 411-490-4 | 7027-11-4 | Acute Tox. 4 * STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H373 ** H317 | H412 | GHS08 | GHS07 | Wng | H302 | H373 ** H317 | H412 |   |   |  608-026-00-X | 3,5,5-триметил-3-цианоциклохексанон | 411-490-4 | 7027-11-4 | Acute Tox. 4 * STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H373 ** H317 | H412 | GHS08 | GHS07 | Wng | H302 | H373 ** H317 | H412 |   |   |  
608-027-00-5 | reaction mass of: 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile; 3-(2-ethylphenyl)-2,2-dimethylpropanenitrile; 3-(3-ethylphenyl)-2,2-dimethylpropanenitrile | 412-660-0 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  608-027-00-5 | реакционна маса от: 3-(4-етилфенил)-2,2-диметилпропаннитрил; 3-(2-етилфенил)-2,2-диметилпропаннитрил; 3-(3-етилфенил)-2,2-диметилпропаннитрил | 412-660-0 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
608-028-00-0 | 4-(2-cyano-3-phenylamino acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate | 413-510-7 | 147374-67-2 | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 2 | H373 ** H317 | H411 | GHS08 | GHS09 | Wng | H373 ** H317 | H411 |   |   |  608-028-00-0 | 4-(3-фениламино-2-цианоакрилоилоксиметил)циклохексилметилов 3-фениламино-2-цианоaкрилат | 413-510-7 | 147374-67-2 | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 2 | H373 ** H317 | H411 | GHS08 | GHS09 | Wng | H373 ** H317 | H411 |   |   |  
608-029-00-6 | 1,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridinecarbonitrile | 411-990-2 | 68612-94-2 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  608-029-00-6 | 4-метил-1-[3-(1-метилетокси)пропил]-2-oксо-1,2-дихидро-6-хидрокси-3-пиридинкарбонитрил | 411-990-2 | 68612-94-2 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
608-030-00-1 | N-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthyazol-5-yl-methylene)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamide | 412-340-0 | 147741-93-3 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  608-030-00-1 | N-ацетил-N-[3-(2-дибутиламино-4-фенилтиазол-5-илметилен)-4-метил-2,6-диоксо-1,2,3,6-тетрахидро-5-цианопиридин-1-ил]бензамид | 412-340-0 | 147741-93-3 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
608-031-00-7 | 2-benzyl-2-methyl-3-butenitrile | 407-870-4 | 97384-48-0 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  608-031-00-7 | 2-бензил-2-метил-3-бутеннитрил | 407-870-4 | 97384-48-0 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
608-032-00-2 | acetamiprid (ISO); | (E)-N 1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine | — | 135410-20-7 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  608-032-00-2 | ацетамиприд (ISO); | (E)-N 1-метил-N 1-[(6-хлоро-3-пиридил)метил]-N 2-цианоацетамидин | — | 135410-20-7 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
608-033-00-8 | N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide | 407-970-8 | 75511-91-0 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  608-033-00-8 | N-бутил-2-метил-3-(4-нитро-2-хлорофенилхидразонo)-1-цианопроп-1-ен-1,3-дикарбоксимид | 407-970-8 | 75511-91-0 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
608-034-00-3 | chlorfenapyr (ISO); 4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile | — | 122453-73-0 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H302 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H302 | H410 |   | M=100 |  608-034-00-3 | хлорфенапир (ISO); 4-бромо-1-етоксиметил-5-трифлуорометил-2-(4-хлорофенил)пирол-3-карбонитрил | — | 122453-73-0 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H302 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H302 | H410 |   | M=100 |  
608-035-00-9 | (±)-α-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorobenzene-aceto-nitrile | 419-290-9 | — | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  608-035-00-9 | (±)-α-[(2-ацетил-5-метилфенил)амино]-2,6-дихлоробензенацетонитрил | 419-290-9 | — | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
608-036-00-4 | 3-(2-{4-[2-(4-cyanophenyl)vinyl]phenyl}vinyl)benzonitrile | 419-060-8 | 79026-02-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  608-036-00-4 | 3-(2-{4-[2-(4-цианофенил)винил]фенил}винил)бензoнитрил | 419-060-8 | 79026-02-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
608-037-00-X | reaction mass of: (E)-2,12-tridecadiennitrile; (E)-3,12-tridecadiennitrile; (Z)-3,12-tridecadiennitrile | 422-190-8 |   | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  608-037-00-X | реакционна маса от: (E)-2,12-тридекадиeннитрил; (E)-3,12-тридекадиeннитрил; (Z)-3,12-тридекадиeннитрил | 422-190-8 |   | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
608-038-00-5 | 2,2,4-trimethyl-4-phenyl-butane-nitrile | 422-580-8 | 75490-39-0 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  608-038-00-5 | 2,2,4-триметил-4-фенилбутаннитрил | 422-580-8 | 75490-39-0 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
608-039-00-0 | 2-phenylhexanenitrile | 423-460-8 | 3508-98-3 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  608-039-00-0 | 2-фенилхексаннитрил | 423-460-8 | 3508-98-3 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
608-040-00-6 | 4,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile) | 423-490-1 | 130755-46-3 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  608-040-00-6 | 4,4′-дитиобис(5-амино-1-(4-(трифлуорометил)-2,6-дихлорофенил)-1H-пиразол-3-карбонитрил) | 423-490-1 | 130755-46-3 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
608-041-00-1 | 4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile | 423-500-4 | 138401-24-8 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  608-041-00-1 | 4′-((2-бутил-4-оксо-1,3-диaзaспиро[4.4]нон-1-ен-3-ил)метил)(1,1′-бифенил)-2-карбонитрил | 423-500-4 | 138401-24-8 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
608-042-00-7 | (S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide | 421-810-4 | 194602-27-2 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H317 | H411 |   |   |  608-042-00-7 | (S)-2,2-дифенил-2-(3-пиролидинил)ацетонитрилхидробромид | 421-810-4 | 194602-27-2 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H317 | H411 |   |   |  
608-043-00-2 | 3-(cis-3-hexenyloxy)propanenitril | 415-220-6 | 142653-61-0 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H302 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H302 | H410 |   |   |  608-043-00-2 | 3-(цис-3-хексенилокси)пропаннитрил | 415-220-6 | 142653-61-0 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H302 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H302 | H410 |   |   |  
608-044-00-8 | 2-cyclohexylidene-2-phenylacetonitrile | 423-740-1 | 10461-98-0 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  608-044-00-8 | 2-циклохексилиден-2-фенилацетонитрил | 423-740-1 | 10461-98-0 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
608-046-00-9 | 5-(4-chloro-2-nitro-phenylazo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-pyridine-3-carbonitrile | 425-310-7 | 77889-90-8 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  608-046-00-9 | 1,4-диметил-5-(2-нитро-4-хлорофенилазо)-2-оксо-1,2-дихидро-6-хидроксипиридин-3-карбонитрил | 425-310-7 | 77889-90-8 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
608-047-00-4 | 2-piperidin-1-yl-benzonitrile | 427-330-1 | 72752-52-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  608-047-00-4 | 2-пиперидин-1-илбензонитрил | 427-330-1 | 72752-52-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
608-048-00-X | 1-(3-cyclopentyloxy-4-methoxyphenyl)-4-oxo-cyclohexanecarbonitrile | 427-450-4 | 152630-47-2 | Acute Tox. 4 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H373** | H317 | H411 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373** | H317 | H411 |   |   |  608-048-00-X | 1-(4-метокси-3-циклопентилоксифенил)-4-оксоциклохексанкарбонитрил | 427-450-4 | 152630-47-2 | Acute Tox. 4 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H373** | H317 | H411 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373** | H317 | H411 |   |   |  
608-049-00-5 | 2-(4-(4-(butyl-(1-methylhexyl)amino)phenyl)-3-cyano-5-oxo-1,5-dihydropyrrol-2-ylidene)propandinitrile | 429-180-2 | 157362-53-3 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  608-049-00-5 | 2-(4-(4-(бутил(1-метилхексил)амино)фенил)-5-оксо-1,5-дихидро-3-цианопирол-2-илиден)пропандинитрил | 429-180-2 | 157362-53-3 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
608-050-00-0 | reaction mass of: 5-(2-cyano-4-nitrophenylazo)-2-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-6-phenylaminonicotinonitrile; | 5-(2-cyano-4-nitrophenylazo)-6-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-2-phenylaminonicotinonitrile | 429-760-5 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  608-050-00-0 | реакционна маса от: 4-метил-5-(4-нитро-2-цианофенилазо)-6-фениламино-2-(2-(2-хидроксиетокси)етиламино)никотинонитрил; | 4-метил-5-(4-нитро-2-цианофенилазо)-2-фениламино-6-(2-(2-хидроксиетокси)етиламино)никотинонитрил | 429-760-5 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
608-051-00-6 | (R)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile | 430-760-2 | 219861-18-4 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  608-051-00-6 | (R)-4-(4-диметиламино-1-(4-флуорофенил)-1-хидроксибутил)-3-(хидроксиметил)бензонитрил | 430-760-2 | 219861-18-4 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  
608-052-00-1 | (S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile | 430-770-7 | 128173-52-4 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  608-052-00-1 | (S)-4-(4-диметиламино-1-(4-флуорофенил)-1-хидроксибутил)-3-(хидроксиметил)бензонитрил | 430-770-7 | 128173-52-4 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  
608-053-00-7 | (R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile | 430-780-1 | 103146-25-4 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  608-053-00-7 | (R,S)-4-(4-диметиламино-1-(4-флуорофенил)-1-хидроксибутил)-3-(хидроксиметил)бензонитрил | 430-780-1 | 103146-25-4 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  
608-054-00-2 | (R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)3-(hydroxymethyl)benzonitrile hemisulfate | 430-790-6 | — | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H317 | H411 |   |   |  608-054-00-2 | (R,S)-4-(4-диметиламино-1-(4-флуорофенил)-1-хидроксибутил)-3-(хидроксиметил)бензонитрилхемисулфат | 430-790-6 | — | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H317 | H411 |   |   |  
608-056-00-3 | N-methyl-N-cyanomethylmorpholiniummethylsulfate | 429-340-1 | — | Acute Tox. 4 * | Eye Dam. 1 | H302 | H318 | GHS05 | GHS07 | Dgr | H302 | H318 |   |   |  608-056-00-3 | N-метил-N-цианометилморфолиниев метилсулфат | 429-340-1 | — | Acute Tox. 4 * | Eye Dam. 1 | H302 | H318 | GHS05 | GHS07 | Dgr | H302 | H318 |   |   |  
608-057-00-9 | 4-(cyanomethyl)-4-methylmorpholin-4-ium hydrogen sulfate | 431-200-1 | 208538-34-5 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | H302 | H318 | H317 | GHS05 | GHS07 | Dgr | H302 | H318 | H317 |   |   |  608-057-00-9 | 4-метил-4-(цианометил)морфолин-4-иев хидрогенсулфат | 431-200-1 | 208538-34-5 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | H302 | H318 | H317 | GHS05 | GHS07 | Dgr | H302 | H318 | H317 |   |   |  
608-058-00-4 | esfenvalerate (ISO); | (S)-α-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate | — | 66230-04-4 | Acute Tox. 3 * | Acute Tox. 3 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H301 | H317 | H410 |   | M = 10000 |  608-058-00-4 | есфенвалерат (ISO); | (S)-3-фенокси-α-цианобензилов (S)-3-метил-2-(4-хлорофенил)бутират | — | 66230-04-4 | Acute Tox. 3 * | Acute Tox. 3 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H301 | H317 | H410 |   | M = 10000 |  
608-059-00-X | 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile | 421-240-6 | 120068-79-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  608-059-00-X | 5-амино-1-(4-(трифлуорометил)-2,6-дихлорофенил)-1H-пиразол-3-карбонитрил | 421-240-6 | 120068-79-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
608-060-00-5 | 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile | 421-300-1 | 138564-59-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  608-060-00-5 | 5-метил-2-[(2-нитрофенил)амино]-3-тиофенкарбонитрил | 421-300-1 | 138564-59-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
608-062-00-6 | 2-fluoro-4-hydroxybenzonitrile | 422-810-7 | 82380-18-5 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  608-062-00-6 | 2-флуоро-4-хидроксибензонитрил | 422-810-7 | 82380-18-5 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  
608-063-00-1 | (S)-α-hydroxy-3-phenoxy-benzeneacetonitrile | 441-070-6 | 61826-76-4 | Acute Tox. 3 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H318 | H317 | H400 | H410 | GHS06 | GHS05 | GHS09 | Dgr | H301 | H318 | H317 | H410 |   |   |  608-063-00-1 | (S)-3-фенокси-α-хидроксибензенацетонитрил | 441-070-6 | 61826-76-4 | Acute Tox. 3 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H318 | H317 | H400 | H410 | GHS06 | GHS05 | GHS09 | Dgr | H301 | H318 | H317 | H410 |   |   |  
608-064-00-7 | cyanomethyltrimethylammoniummethylsulfate | 433-720-2 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  608-064-00-7 | цианометилтриметиламониев метилсулфат | 433-720-2 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
608-065-00-2 | salts of bromoxynil with the exception of those specified elsewhere in this Annex | — | — | Repr. 2 | Acute Tox. 2 * | Acute Tox. 3 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d *** H330 | H301 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H361d *** H330 | H301 | H317 | H410 |   | M = 10 | A608-065-00-2 | соли на бромоксинил, с изключение на тези, посочени другаде в настоящото приложение | — | — | Repr. 2 | Acute Tox. 2 * | Acute Tox. 3 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d *** H330 | H301 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H361d *** H330 | H301 | H317 | H410 |   | M = 10 | A
608-066-00-8 | salts of ioxynil with the exception of those specified elsewhere in this Annex | — | — | Repr. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d *** H331 | H301 | H312 | H373 ** | H319 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H361d *** H331 | H301 | H312 | H373 ** | H319 | H410 |   | M = 10 | A608-066-00-8 | соли на йоксинил, с изключение на тези, посочени другаде в настоящото приложение | — | — | Repr. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d *** H331 | H301 | H312 | H373 ** | H319 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H361d *** H331 | H301 | H312 | H373 ** | H319 | H410 |   | M = 10 | A
609-001-00-6 | 1-nitropropane | 203-544-9 | 108-03-2 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H226 | H332 | H312 | H302 | GHS02 | GHS07 | Wng | H | 226 | H332 | H312 | H302 |   | * |  609-001-00-6 | 1-нитропропан | 203-544-9 | 108-03-2 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H226 | H332 | H312 | H302 | GHS02 | GHS07 | Wng | H | 226 | H332 | H312 | H302 |   | * |  
609-002-00-1 | 2-nitropropane | 201-209-1 | 79-46-9 | Flam. Liq. 3 | Carc. 1B | Acute Tox. 4 * | Acute Tox. 4 * | H226 | H350 | H332 | H302 | GHS02 | GHS08 | GHS07 | Dgr | H226 | H350 | H332 | H302 |   |   |  609-002-00-1 | 2-нитропропан | 201-209-1 | 79-46-9 | Flam. Liq. 3 | Carc. 1B | Acute Tox. 4 * | Acute Tox. 4 * | H226 | H350 | H332 | H302 | GHS02 | GHS08 | GHS07 | Dgr | H226 | H350 | H332 | H302 |   |   |  
609-003-00-7 | nitrobenzene | 202-716-0 | 98-95-3 | Carc. 2. Repr. 1B | Acute Tox. 3 | Acute Tox. 3 | Acute Tox. 3 | STOT RE 1 | Aquatic Chronic 3 | H351 | H360F | H301 | H331 | H311 | H372 (blood) H412 | GHS06 | GHS08 | Dgr | H351 | H360F | H301 | H331 | H311 | H372 (blood) H412 |   |   |  609-003-00-7 | нитробензен | 202-716-0 | 98-95-3 | Carc. 2. Repr. 1B | Acute Tox. 3 | Acute Tox. 3 | Acute Tox. 3 | STOT RE 1 | Aquatic Chronic 3 | H351 | H360F | H301 | H331 | H311 | H372 (кръв) H412 | GHS06 | GHS08 | Dgr | H351 | H360F | H301 | H331 | H311 | H372 (кръв) H412 |   |   |  
609-004-00-2 | dinitrobenzene; [1] | 1,4-dinitrobenzene; [2] | 1,3-dinitrobenzene; [3] | 1,2-dinitrobenzene [4] | 246-673-6 [1] | 202-833-7 [2] | 202-776-8 [3] | 208-431-8 [4] | 25154-54-5 [1] | 100-25-4 [2] | 99-65-0 [3] | 528-29-0 [4] | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H310 | H300 | H373 ** | H410 |   |   |  609-004-00-2 | динитробензен; [1] | 1,4-динитробензен; [2] | 1,3-динитробензен; [3] | 1,2-динитробензен [4] | 246-673-6 [1] | 202-833-7 [2] | 202-776-8 [3] | 208-431-8 [4] | 25154-54-5 [1] | 100-25-4 [2] | 99-65-0 [3] | 528-29-0 [4] | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H310 | H300 | H373 ** | H410 |   |   |  
609-005-00-8 | 1,3,5-trinitrobenzene | 202-752-7 | 99-35-4 | Expl. 1.1 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H201 | H330 | H310 | H300 | H373** | H400 | H410 | GHS01 | GHS06 | GHS08 | GHS09 | Dgr | H201 | H330 | H310 | H300 | H373** | H410 |   |   |  609-005-00-8 | 1,3,5-тринитробензен | 202-752-7 | 99-35-4 | Expl. 1.1 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H201 | H330 | H310 | H300 | H373** | H400 | H410 | GHS01 | GHS06 | GHS08 | GHS09 | Dgr | H201 | H330 | H310 | H300 | H373** | H410 |   |   |  
609-006-00-3 | 4-nitrotoluene | 202-808-0 | 99-99-0 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 2 | H331 | H311 | H301 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H411 |   |   |  609-006-00-3 | 4-нитротолуен | 202-808-0 | 99-99-0 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 2 | H331 | H311 | H301 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H411 |   |   |  
609-007-00-9 | 2,4-dinitrotoluene; [1] | dinitrotoluene [2] | 204-450-0 [1] | 246-836-1 [2] | 121-14-2 [1] | 25321-14-6 [2] | Carc. 1B | Muta. 2 | Repr. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H341 | H361f*** | H331 | H311 | H301 | H373** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H341 | H361f*** | H331 | H311 | H301 | H373** | H410 |   |   |  609-007-00-9 | 2,4-динитротолуен; [1] | динитротолуен [2] | 204-450-0 [1] | 246-836-1 [2] | 121-14-2 [1] | 25321-14-6 [2] | Carc. 1B | Muta. 2 | Repr. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H341 | H361f*** | H331 | H311 | H301 | H373** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H341 | H361f*** | H331 | H311 | H301 | H373** | H410 |   |   |  
609-008-00-4 | 2,4,6-trinitrotoluene; TNT | 204-289-6 | 118-96-7 | Expl. 1.1 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 2 | H201 | H331 | H311 | H301 | H373 ** | H411 | GHS01 | GHS06 | GHS08 | GHS09 | Dgr | H201 | H331 | H311 | H301 | H373 ** | H411 |   |   |  609-008-00-4 | 2,4,6-тринитротолуен; TNT | 204-289-6 | 118-96-7 | Expl. 1.1 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 2 | H201 | H331 | H311 | H301 | H373 ** | H411 | GHS01 | GHS06 | GHS08 | GHS09 | Dgr | H201 | H331 | H311 | H301 | H373 ** | H411 |   |   |  
609-009-00-X | 2,4,6-trinitrophenol; | picric acid | 201-865-9 | 88-89-1 | Expl. 1.1 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H201 | H331 | H311 | H301 | GHS01 | GHS06 | Dgr | H201 | H331 | H311 | H301 |   |   |  609-009-00-X | 2,4,6-тринитрофенол; | пикринова киселина | 201-865-9 | 88-89-1 | Expl. 1.1 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H201 | H331 | H311 | H301 | GHS01 | GHS06 | Dgr | H201 | H331 | H311 | H301 |   |   |  
609-010-00-5 | salts of picric acid | — | — | Unst. Expl | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H201 | H331 | H311 | H301 | GHS01 | GHS06 | Dgr | H201 | H331 | H311 | H301 |   |   | T609-010-00-5 | соли на пикриновата киселина | — | — | Unst. Expl | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H201 | H331 | H311 | H301 | GHS01 | GHS06 | Dgr | H201 | H331 | H311 | H301 |   |   | T
609-011-00-0 | 2,4,6-trinitroanisole | — | 606-35-9 | Expl. 1.1 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 2 | H201 | H332 | H312 | H302 | H411 | GHS01 | GHS07 | GHS09 | Wng | H201 | H332 | H312 | H302 | H411 |   |   |  609-011-00-0 | 2,4,6-тринитроанизол | — | 606-35-9 | Expl. 1.1 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 2 | H201 | H332 | H312 | H302 | H411 | GHS01 | GHS07 | GHS09 | Wng | H201 | H332 | H312 | H302 | H411 |   |   |  
609-012-00-6 | 2,4,6-trinitro-m-cresol | 210-027-1 | 602-99-3 | Expl. 1.1 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H201 | H332 | H312 | H302 | GHS01 | GHS07 | Wng | H201 | H332 | H312 | H302 |   |   |  609-012-00-6 | 2,4,6-тринитро-m-крезол | 210-027-1 | 602-99-3 | Expl. 1.1 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H201 | H332 | H312 | H302 | GHS01 | GHS07 | Wng | H201 | H332 | H312 | H302 |   |   |  
609-013-00-1 | 2,4,6-trinitro-m-xylene | 211-187-5 | 632-92-8 | Expl. 1.1 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | H201 | H332 | H312 | H302 | H373 ** | GHS01 | GHS08 | GHS07 | Wng | H201 | H332 | H312 | H302 | H373 ** |   |   |  609-013-00-1 | 2,4,6-тринитро-m-ксилен | 211-187-5 | 632-92-8 | Expl. 1.1 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | H201 | H332 | H312 | H302 | H373 ** | GHS01 | GHS08 | GHS07 | Wng | H201 | H332 | H312 | H302 | H373 ** |   |   |  
609-015-00-2 | 4-nitrophenol; | p-nitrophenol | 202-811-7 | 100-02-7 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | H332 | H312 | H302 | H373 ** | GHS08 | GHS07 | Wng | H332 | H312 | H302 | H373 ** |   |   |  609-015-00-2 | 4-нитрофенол; | p-нитрофенол | 202-811-7 | 100-02-7 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | H332 | H312 | H302 | H373 ** | GHS08 | GHS07 | Wng | H332 | H312 | H302 | H373 ** |   |   |  
609-016-00-8 | dinitrophenol (reaction mass of isomers); [1] | 2,4(or 2,6)-dinitrophenol [2] | 247-096-2 [1] | 275-732-9 [2] | 25550-58-7 [1] | 71629-74-8 [2] | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H410 |   |   |  609-016-00-8 | динитрофенол (реакционна маса от изомери); [1] | 2,4(или 2,6)-динитрофенол [2] | 247-096-2 [1] | 275-732-9 [2] | 25550-58-7 [1] | 71629-74-8 [2] | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H410 |   |   |  
609-018-00-9 | 2,4,6-trinitroresorcinol; | styphnic acid | 201-436-6 | 82-71-3 | Expl. 1.1 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H201 | H332 | H312 | H302 | GHS01 | GHS07 | Dgr | H201 | H332 | H312 | H302 |   |   |  609-018-00-9 | 2,4,6-тринитрорезорцинол; | стифнинова киселина | 201-436-6 | 82-71-3 | Expl. 1.1 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H201 | H332 | H312 | H302 | GHS01 | GHS07 | Dgr | H201 | H332 | H312 | H302 |   |   |  
609-019-00-4 | lead 2,4,6-trinitro-m-phenylene dioxide; lead 2,4,6-trinitroresorcinoxide; | lead styphnate | 239-290-0 | 15245-44-0 | Unst. Expl | Repr. 1A | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H200 | H360Df | H332 | H302 | H373 ** | H400 | H410 | GHS01 | GHS08 | GHS07 | GHS09 | Dgr | H200 | H360Df | H332 | H302 | H373 ** | H410 |   |   | 1609-019-00-4 | оловен 2,4,6-тринитро-m-фенилендиоксид; оловен 2,4,6-тринитрорезорциноксид; | оловен стифнат | 239-290-0 | 15245-44-0 | Unst. Expl | Repr. 1A | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H200 | H360Df | H332 | H302 | H373 ** | H400 | H410 | GHS01 | GHS08 | GHS07 | GHS09 | Dgr | H200 | H360Df | H332 | H302 | H373 ** | H410 |   |   | 1
609-019-01-1 | lead 2,4,6-trinitro-m-phenylene dioxide; | lead 2,4,6-trinitroresorcinoxide; | lead styphnate (≥ 20 % phlegmatiser) | 239-290-0 | 15245-44-0 | Expl. 1.1 | Repr. 1A | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H201 | H360Df | H332 | H302 | H373 ** | H400 | H410 | GHS01 | GHS08 | GHS07 | GHS09 | Dgr | H201 | H360Df | H332 | H302 | H373 ** | H410 |   |   | 1609-019-01-1 | оловен 2,4,6-тринитро-m-фенилендиоксид; | оловен 2,4,6-тринитрорезорциноксид; | оловен стифнат (≥ 20 % флегматизатор) | 239-290-0 | 15245-44-0 | Expl. 1.1 | Repr. 1A | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H201 | H360Df | H332 | H302 | H373 ** | H400 | H410 | GHS01 | GHS08 | GHS07 | GHS09 | Dgr | H201 | H360Df | H332 | H302 | H373 ** | H410 |   |   | 1
609-020-00-X | DNOC (ISO); | 4,6-dinitro-o-cresol | 208-601-1 | 534-52-1 | Muta. 2 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H330 | H310 | H300 | H315 | H318 | H317 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H341 | H330 | H310 | H300 | H315 | H318 | H317 | H410 | EUH044 |   |  609-020-00-X | DNOC (ISO); | 4,6-динитро-o-крезол | 208-601-1 | 534-52-1 | Muta. 2 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H330 | H310 | H300 | H315 | H318 | H317 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H341 | H330 | H310 | H300 | H315 | H318 | H317 | H410 | EUH044 |   |  
609-021-00-5 | sodium salt of DNOC; | sodium 4,6-dinitro-o-cresolate; [1] | potassium salt of DNOC; potassium 4,6-dinitro-o-cresolate [2] | 219-007-7 [1] | -[2] | 2312-76-7 [1] | 5787-96-2 [2] | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H410 |   |   |  609-021-00-5 | натриева сол на DNOC; | натриев 4,6-динитро-o-крезолат; [1] | калиева сол на DNOC; калиев 4,6-динитро-o-крезолат [2] | 219-007-7 [1] | -[2] | 2312-76-7 [1] | 5787-96-2 [2] | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H410 |   |   |  
609-022-00-0 | ammonium salt of DNOC; ammonium 4,6-dinitro-o-tolyl oxide | 221-037-0 | 2980-64-5 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H310 | H300 | H373 ** | H410 |   |   |  609-022-00-0 | амониева сол на DNOC; амониев 4,6-динитро-о-толилоксид | 221-037-0 | 2980-64-5 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H310 | H300 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H310 | H300 | H373 ** | H410 |   |   |  
609-023-00-6 | dinocap (ISO); | (RS)-2,6-dinitro-4-octylphenyl crotonates and (RS)-2,4-dinitro-6-octylphenyl crotonates in which "octyl" is a reaction mass of 1-methylheptyl, 1-ethylhexyl and 1-propylpentyl groups | 254-408-0 | 39300-45-3 | Repr. 1B | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H360D*** | H332 | H302 | H373** | H315 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H360D*** | H332 | H302 | H373** | H315 | H317 | H410 |   | M=100 |  609-023-00-6 | динокап (ISO); | (RS)-2,6-динитро-4-октилфенилкротонати и (RS)-2,4-динитро-6-октилфенилкротонати, в които „октил“ е реакционна маса от 1-метилхептилови, 1-етилхексилови и 1-пропилпентилови групи | 254-408-0 | 39300-45-3 | Repr. 1B | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H360D*** | H332 | H302 | H373** | H315 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H360D*** | H332 | H302 | H373** | H315 | H317 | H410 |   | M=100 |  
609-024-00-1 | binapacryl (ISO); | 2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate | 207-612-9 | 485-31-4 | Repr. 1B | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H360D *** H312 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H360D *** H312 | H302 | H410 |   |   |  609-024-00-1 | бинапакрил (ISO); | 2-втор-бутил-4,6-динитрофенил-3-метилкротонат | 207-612-9 | 485-31-4 | Repr. 1B | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H360D *** H312 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H360D *** H312 | H302 | H410 |   |   |  
609-025-00-7 | dinoseb (ISO); | 6-sec-butyl-2,4-dinitrophenol | 201-861-7 | 88-85-7 | Repr. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H360Df | H311 | H301 | H319 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H360Df | H311 | H301 | H319 | H410 | EUH044 |   |  609-025-00-7 | диносеб (ISO); | 6-втор-бутил-2,4-динитрофенол | 201-861-7 | 88-85-7 | Repr. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H360Df | H311 | H301 | H319 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H360Df | H311 | H301 | H319 | H410 | EUH044 |   |  
609-026-00-2 | salts and esters of dinoseb, with the exception of those specified elsewhere in this Annex | — | — | Repr. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H360Df | H311 | H301 | H319 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H360Df | H311 | H301 | H319 | H410 | EUH044 |   | A609-026-00-2 | соли и естери на диносеб, с изключение на тези, посочени другаде в настоящото приложение | — | — | Repr. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H360Df | H311 | H301 | H319 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H360Df | H311 | H301 | H319 | H410 | EUH044 |   | A
609-027-00-8 | dinocton; | reaction mass of isomers: | methyl 2-octyl-4,6-dinitrophenyl carbonate, methyl 4-octyl-2,6-dinitrophenyl carbonate | — | 63919-26-6 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  609-027-00-8 | диноктон; | реакционна маса от изомери: | метилов 4,6-динитро-2-октилфенилов карбонат, метилов 2,6-динитро-4-октилфенилов карбонат | — | 63919-26-6 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
609-028-00-3 | dinex (ISO); | 2-cyclohexyl-4,6-dinitrophenol | 205-042-5 | 131-89-5 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H410 |   |   |  609-028-00-3 | динекс (ISO); | 4,6-динитро-2-циклохексилфенол | 205-042-5 | 131-89-5 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H410 |   |   |  
609-029-00-9 | salts and esters of dinex | — | — | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H410 |   |   | A609-029-00-9 | соли и естери на динекс | — | — | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H410 |   |   | A
609-030-00-4 | dinoterb (ISO); | 2-tert-butyl-4,6-dinitrophenol | 215-813-8 | 1420-07-1 | Repr. 1B | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H360D *** H300 | H311 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H360D *** H300 | H311 | H410 | EUH044 |   |  609-030-00-4 | динотерб (ISO); | 2-трет-бутил-4,6-динитрофенол | 215-813-8 | 1420-07-1 | Repr. 1B | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H360D *** H300 | H311 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H360D *** H300 | H311 | H410 | EUH044 |   |  
609-031-00-X | salts and esters of dinoterb | — | — | Repr. 1B | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H360D *** H300 | H311 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H360D *** H300 | H311 | H410 |   |   | A609-031-00-X | соли и естери на динотерб | — | — | Repr. 1B | Acute Tox. 2 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H360D *** H300 | H311 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H360D *** H300 | H311 | H410 |   |   | A
609-032-00-5 | bromofenoxim (ISO); | 3,5-dibromo-4-hydroxybenzaldehyde-O-(2,4-dinitrophenyl)-oxime | 236-129-6 | 13181-17-4 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  609-032-00-5 | бромофеноксим (ISO); | 3,5-дибромо-4-хидроксибензалдехид-О-(2,4-динитрофенил)oксим | 236-129-6 | 13181-17-4 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
609-033-00-0 | dinosam (ISO); | 2-(1-methylbutyl)-4,6-dinitrophenol | — | 4097-36-3 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H410 |   |   |  609-033-00-0 | диносам (ISO); | 2-(1-метилбутил)-4,6-динитрофенол | — | 4097-36-3 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H410 |   |   |  
609-034-00-6 | salts and esters of dinosam | — | — | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H410 |   |   | A609-034-00-6 | соли и естери на диносам | — | — | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H410 |   |   | A
609-035-00-1 | nitroethane | 201-188-9 | 79-24-3 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | H226 | H332 | H302 | GHS02 | GHS07 | Wng | H226 | H332 | H302 |   | * |  609-035-00-1 | нитроетан | 201-188-9 | 79-24-3 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | H226 | H332 | H302 | GHS02 | GHS07 | Wng | H226 | H332 | H302 |   | * |  
609-036-00-7 | nitromethane | 200-876-6 | 75-52-5 | Flam. Liq. 3 | Acute Tox. 4 * | H226 | H302 | GHS02 | GHS07 | Wng | H226 | H302 |   | * |  609-036-00-7 | нитрометан | 200-876-6 | 75-52-5 | Flam. Liq. 3 | Acute Tox. 4 * | H226 | H302 | GHS02 | GHS07 | Wng | H226 | H302 |   | * |  
609-037-00-2 | 5-nitroacenaphthene | 210-025-0 | 602-87-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  609-037-00-2 | 5-нитроаценафтен | 210-025-0 | 602-87-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
609-038-00-8 | 2-nitronaphthalene | 209-474-5 | 581-89-5 | Carc. 1B | Aquatic Chronic 2 | H350 | H411 | GHS08 | GHS09 | Dgr | H350 | H411 |   |   |  609-038-00-8 | 2-нитронафтален | 209-474-5 | 581-89-5 | Carc. 1B | Aquatic Chronic 2 | H350 | H411 | GHS08 | GHS09 | Dgr | H350 | H411 |   |   |  
609-039-00-3 | 4-nitrobiphenyl | 202-204-7 | 92-93-3 | Carc. 1B | Aquatic Chronic 2 | H350 | H411 | GHS08 | GHS09 | Dgr | H350 | H411 |   |   |  609-039-00-3 | 4-нитробифенил | 202-204-7 | 92-93-3 | Carc. 1B | Aquatic Chronic 2 | H350 | H411 | GHS08 | GHS09 | Dgr | H350 | H411 |   |   |  
609-040-00-9 | nitrofen (ISO); | 2,4-dichlorophenyl 4-nitrophenyl ether | 217-406-0 | 1836-75-5 | Carc. 1B | Repr. 1B | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H360D *** H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H360D *** H302 | H410 |   |   |  609-040-00-9 | нитрофен (ISO); | 4-нитрофенил-2,4-дихлорофенилов етер | 217-406-0 | 1836-75-5 | Carc. 1B | Repr. 1B | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H360D *** H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H360D *** H302 | H410 |   |   |  
609-041-00-4 | 2,4-dinitrophenol | 200-087-7 | 51-28-5 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | H331 | H311 | H301 | H373 ** | H400 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H400 |   |   |  609-041-00-4 | 2,4-динитрофенол | 200-087-7 | 51-28-5 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | H331 | H311 | H301 | H373 ** | H400 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H400 |   |   |  
609-042-00-X | pendimethalin (ISO); | N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine | 254-938-2 | 40487-42-1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  609-042-00-X | пендиметалин (ISO); | N-(1-етилпропил)-2,6-динитро-3,4-ксилидин | 254-938-2 | 40487-42-1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
609-043-00-5 | quintozene (ISO); | pentachloronitrobenzene | 201-435-0 | 82-68-8 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  609-043-00-5 | квинтозен (ISO); | нитропентахлоробензен | 201-435-0 | 82-68-8 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
609-044-00-0 | tecnazene (ISO); | 1,2,4,5-tetrachloro-3-nitrobenzene | 204-178-2 | 117-18-0 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  609-044-00-0 | текназен (ISO); | 3-нитро-1,2,4,5-тeтрахлоробензен | 204-178-2 | 117-18-0 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  
609-045-00-6 | reaction mass of: 4,6-dinitro-2-(3-octyl)phenyl methyl carbonate and 4,6-dinitro-2-(4-octyl)phenyl methyl carbonate; dinocton-6 | — | 8069-76-9 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  609-045-00-6 | реакционна маса от: 4,6-динитро-2-(3-октил)фенилов метилов карбонат и 4,6-динитро-2-(4-октил)фенилов метилов карбонат; диноктон-6 | — | 8069-76-9 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
609-046-00-1 | trifluralin (ISO) (containing <0.5 ppm NPDA); | α, α, α-trifluoro-2,6-dinitro-N, N-dipropyl-p-toluidine (containing | < 0,5 ppm NPDA); | 2,6-dinitro-N, N-dipropyl-4-trifluoromethylaniline (containing < 0,5 ppm NPDA); | N, N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0.5 ppm NPDA) | 216-428-8 | 1582-09-8 | Carc. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H317 | H410 |   | M=10 |  609-046-00-1 | трифлуралин (ISO) (съдържащ < 0,5 ppm NPDA); | 2,6-динитро-N,N-дипропил-α, α,α-трифлуоро-p-толуидин (съдържащ | < 0,5 ppm NPDA); | 2,6-динитро-N,N-дипропил-4-трифлуорометиланилин (съдържащ <0,5 ppm NPDA); | N,N-дипропил-2,6-динитро-4-трифлуорометиланилин (съдържащ < 0,5 ppm NPDA) | 216-428-8 | 1582-09-8 | Carc. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H317 | H410 |   | M=10 |  
609-047-00-7 | 2-nitroanisole | 202-052-1 | 91-23-6 | Carc. 1B | Acute Tox. 4 * | H350 | H302 | GHS08 | GHS07 | Dgr | H350 | H302 |   |   |  609-047-00-7 | 2-нитроанизол | 202-052-1 | 91-23-6 | Carc. 1B | Acute Tox. 4 * | H350 | H302 | GHS08 | GHS07 | Dgr | H350 | H302 |   |   |  
609-048-00-2 | sodium 3-nitrobenzenesulphonate | 204-857-3 | 127-68-4 | Eye Irrit. 2 | Skin Sens. 1 | H319 | H317 | GHS07 | Wng | H319 | H317 |   |   |  609-048-00-2 | натриев 3-нитробензенсулфонат | 204-857-3 | 127-68-4 | Eye Irrit. 2 | Skin Sens. 1 | H319 | H317 | GHS07 | Wng | H319 | H317 |   |   |  
609-049-00-8 | 2,6-dinitrotoluene | 210-106-0 | 606-20-2 | Carc. 1B | Muta. 2 | Repr. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 3 | H350 | H341 | H361f *** | H331 | H311 | H301 | H373 ** | H412 | GHS06 | GHS08 | Dgr | H350 | H341 | H361f *** | H331 | H311 | H301 | H373 ** | H412 |   |   |  609-049-00-8 | 2,6-динитротолуен | 210-106-0 | 606-20-2 | Carc. 1B | Muta. 2 | Repr. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 3 | H350 | H341 | H361f *** | H331 | H311 | H301 | H373 ** | H412 | GHS06 | GHS08 | Dgr | H350 | H341 | H361f *** | H331 | H311 | H301 | H373 ** | H412 |   |   |  
609-050-00-3 | 2,3-dinitrotoluene | 210-013-5 | 602-01-7 | Carc. 1B | Muta. 2 | Repr. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H341 | H361f *** | H331 | H311 | H301 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H341 | H361f *** | H331 | H311 | H301 | H373 ** | H410 |   |   |  609-050-00-3 | 2,3-динитротолуен | 210-013-5 | 602-01-7 | Carc. 1B | Muta. 2 | Repr. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H341 | H361f *** | H331 | H311 | H301 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H341 | H361f *** | H331 | H311 | H301 | H373 ** | H410 |   |   |  
609-051-00-9 | 3,4-dinitrotoluene | 210-222-1 | 610-39-9 | Carc. 1B | Muta. 2 | Repr. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 2 | H350 | H341 | H361f *** | H331 | H311 | H301 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H341 | H361f *** | H331 | H311 | H301 | H373 ** | H411 |   |   |  609-051-00-9 | 3,4-динитротолуен | 210-222-1 | 610-39-9 | Carc. 1B | Muta. 2 | Repr. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 2 | H350 | H341 | H361f *** | H331 | H311 | H301 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H341 | H361f *** | H331 | H311 | H301 | H373 ** | H411 |   |   |  
609-052-00-4 | 3,5-dinitrotoluene | 210-566-2 | 618-85-9 | Carc. 1B | Muta. 2 | Repr. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 3 | H350 | H341 | H361f *** | H331 | H311 | H301 | H373 ** | H412 | GHS06 | GHS08 | Dgr | H350 | H341 | H361f *** | H331 | H311 | H301 | H373 ** | H412 |   |   |  609-052-00-4 | 3,5-динитротолуен | 210-566-2 | 618-85-9 | Carc. 1B | Muta. 2 | Repr. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 3 | H350 | H341 | H361f *** | H331 | H311 | H301 | H373 ** | H412 | GHS06 | GHS08 | Dgr | H350 | H341 | H361f *** | H331 | H311 | H301 | H373 ** | H412 |   |   |  
609-053-00-X | hydrazine-trinitromethane | 414-850-9 | — | Expl. 1.1 **** | Self-react. A | Carc. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Skin Sens. 1 | H201 | H240 | H350 | H331 | H301 | H317 | GHS01 | GHS06 | GHS08 | Dgr | H201 | H240 | H350 | H331 | H301 | H317 |   |   |  609-053-00-X | хидразинтринитрометан | 414-850-9 | — | Expl. 1.1 **** | Self-react. A | Carc. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Skin Sens. 1 | H201 | H240 | H350 | H331 | H301 | H317 | GHS01 | GHS06 | GHS08 | Dgr | H201 | H240 | H350 | H331 | H301 | H317 |   |   |  
609-054-00-5 | 2,3-dinitrophenol; [1] | 2,5-dinitrophenol; [2] | 2,6-dinitrophenol; [3] | 3,4-dinitrophenol; [4] | salts of dinitrophenol [5] | 200-628-7 [1] | 206-348-1 [2] | 209-357-9 [3] | 209-415-3 [4]-[5] | 66-56-8 [1] | 329-71-5 [2] | 573-56-8 [3] | 577-71-9 [4]-[5] | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 2 | H331 | H311 | H301 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H411 |   |   |  609-054-00-5 | 2,3-динитрофенол; [1] | 2,5-динитрофенол; [2] | 2,6-динитрофенол; [3] | 3,4-динитрофенол; [4] | соли на динитрофенола [5] | 200-628-7 [1] | 206-348-1 [2] | 209-357-9 [3] | 209-415-3 [4]-[5] | 66-56-8 [1] | 329-71-5 [2] | 573-56-8 [3] | 577-71-9 [4]-[5] | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 2 | H331 | H311 | H301 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H411 |   |   |  
609-055-00-0 | 2,5-dinitrotoluene | 210-581-4 | 619-15-8 | Carc. 1B Muta. 2 | Repr. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 2 | H350 | H341 | H361f *** | H331 | H311 | H301 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H341 | H361f *** | H331 | H311 | H301 | H373 ** | H411 |   |   |  609-055-00-0 | 2,5-динитротолуен | 210-581-4 | 619-15-8 | Carc. 1B | Muta. 2 | Repr. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 2 | H350 | H341 | H361f *** | H331 | H311 | H301 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H341 | H361f *** | H331 | H311 | H301 | H373 ** | H411 |   |   |  
609-056-00-6 | 2,2-dibromo-2-nitroethanol | 412-380-9 | 69094-18-4 | Expl. 1.1 | Carc. 2 | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1A | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H201 | H351 | H302 | H373 ** | H314 | H317 | H400 | H410 | GHS01 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H201 | H351 | H302 | H373 ** | H314 | H317 | H410 |   | * | STOT SE 3; H335: C ≥ 1 % | T609-056-00-6 | 2,2-дибромо-2-нитроетанол | 412-380-9 | 69094-18-4 | Expl. 1.1 | Carc. 2 | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1A | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H201 | H351 | H302 | H373 ** | H314 | H317 | H400 | H410 | GHS01 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H201 | H351 | H302 | H373 ** | H314 | H317 | H410 |   | * | STOT SE 3; H335: C ≥ 1 % | T
609-057-00-1 | 3-chloro-2,4-difluoronitrobenzene | 411-980-8 | 3847-58-3 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H317 | H410 |   |   |  609-057-00-1 | 2,4-дифлуоро-3-хлоронитробензен | 411-980-8 | 3847-58-3 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H317 | H410 |   |   |  
609-058-00-7 | 2-nitro-2-phenyl-1,3-propanediol | 410-360-4 | 5428-02-4 | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H372 ** H312 | H302 | H317 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H372 ** | H312 | H302 | H317 | H411 | EUH070 |   |  609-058-00-7 | 2-нитро-2-фенил-1,3-пропандиол | 410-360-4 | 5428-02-4 | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H372 ** H312 | H302 | H317 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H372 ** | H312 | H302 | H317 | H411 | EUH070 |   |  
609-059-00-2 | 2-chloro-6-(ethylamino)-4-nitrophenol | 411-440-1 | 131657-78-8 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  609-059-00-2 | 6-(етиламино)-4-нитро-2-хлорофенол | 411-440-1 | 131657-78-8 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  
609-060-00-8 | 4-[(3-hydroxypropyl)amino]-3-nitrophenol | 406-305-9 | 92952-81-3 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  609-060-00-8 | 3-нитро-4-[(3-хидроксипропил)aмино]фенол | 406-305-9 | 92952-81-3 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
609-061-00-3 | (E, Z)-4-chlorophenyl(cyclopropyl)ketone O-(4-nitrophenylmethyl)oxime | 406-100-4 | 94097-88-8 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  609-061-00-3 | (E,Z)-4-хлорофенил(циклопропил)кетон-О-(4-нитрофенилметил)oксим | 406-100-4 | 94097-88-8 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
609-062-00-9 | 2-bromo-2-nitropropanol | 407-030-7 | 24403-04-1 | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H311 | H302 | H373 ** | H314 | H317 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H311 | H302 | H373 ** | H314 | H317 | H410 |   |   |  609-062-00-9 | 2-бромо-2-нитропропанол | 407-030-7 | 24403-04-1 | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H311 | H302 | H373 ** | H314 | H317 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H311 | H302 | H373 ** | H314 | H317 | H410 |   |   |  
609-063-00-4 | 2-[(4-chloro-2-nitrophenyl)amino]ethanol | 413-280-8 | 59320-13-7 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  609-063-00-4 | 2-[(2-нитро-4-хлорофенил)амино]eтанол | 413-280-8 | 59320-13-7 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
609-064-00-X | mesotrione(ISO); | 2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione | — | 104206-82-8 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  609-064-00-X | мeсотрион (ISO); | 2-[4-(метилсулфонил)-2-нитробензоил]-1,3-циклохександион | — | 104206-82-8 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
609-065-00-5 | 2-nitrotoluene | 201-853-3 | 88-72-2 | Carc. 1B | Muta. 1B | Repr. 2 | Acute Tox. 4 * | Aquatic Chronic 2 | H350 | H340 | H361f *** H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H340 | H361f *** H302 | H411 |   |   |  609-065-00-5 | 2-нитротолуен | 201-853-3 | 88-72-2 | Carc. 1B | Muta. 1B | Repr. 2 | Acute Tox. 4 * | Aquatic Chronic 2 | H350 | H340 | H361f *** H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H340 | H361f *** H302 | H411 |   |   |  
609-066-00-0 | lithium sodium 3-amino-10-{4-(10-amino-6,13-dichloro-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-3-ylamino)-6-[methyl(2-sulfonato-ethyl)amino]-1,3,5-triazin-2-ylamino}-6,13-dichlorobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate | 418-870-9 | 154212-58-5 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 2 ** | H332 | H312 | H302 | H371 ** | GHS08 | GHS07 | Dgr | H332 | H312 | H302 | H371 ** |   |   |  609-066-00-0 | литиев натриев 3-амино-10-{4-(10-амино-6,13-дихлоро-4,11-дисулфонатобензo[5,6][1,4]oксaзино[2,3-b]феноксазин-3-илaмино)-6-[метил(2-сулфонатоетил)амино]-1,3,5-триазин-2-илaмино}-6,13-дихлоробензо[5,6][1,4]oксазино[2,3-b]феноксазин-4,11-дисулфонат | 418-870-9 | 154212-58-5 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 2 ** | H332 | H312 | H302 | H371 ** | GHS08 | GHS07 | Dgr | H332 | H312 | H302 | H371 ** |   |   |  
609-067-00-6 | sodium and potassium 4-(3-aminopropylamino)-2,6-bis[3(4-methoxy-2-sulfophenylazo)4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazine | 416-280-6 | 156769-97-0 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  609-067-00-6 | натриев и калиев 4-(3-аминопропиламино)-2,6-бис[3-(4-метокси-2-сулфофенилазо)-4-хидрокси-2-сулфо-7-нафтиламино]-1,3,5-триaзин | 416-280-6 | 156769-97-0 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
609-068-00-1 | musk xylene; | 5-tert-butyl-2,4,6-trinitro-m-xylene | 201-329-4 | 81-15-2 | Expl. 1.1 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H201 | H351 | H400 | H410 | GHS01 | GHS08 | GHS09 | Wng | H201 | H351 | H410 |   |   | T609-068-00-1 | мускус-ксилен; | 5-трет-бутил-2,4,6-тринитро-m-ксилен | 201-329-4 | 81-15-2 | Expl. 1.1 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H201 | H351 | H400 | H410 | GHS01 | GHS08 | GHS09 | Wng | H201 | H351 | H410 |   |   | T
609-069-00-7 | musk ketone; | 3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone; | 4'-tert-butyl-2', 6'-dimethyl-3', | 5'-dinitroacetophenone | 201-328-9 | 81-14-1 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   |   |  609-069-00-7 | мускус-кетон: | 3,5-динитро-2,6-диметил-4-трет-бутилацетофенон | 4′-трет-бутил-2′,6′-диметил-3′, | 5′-динитроацетофенон | 201-328-9 | 81-14-1 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   |   |  
609-070-00-2 | 1,4-dichloro-2-(1,1,2,3,3,3-hexafluoropropoxy)-5-nitrobenzene | 415-580-4 | 130841-23-5 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  609-070-00-2 | 5-нитро-2-(1,1,2,3,3,3-хексафлуоропропокси)-1,4-дихлоробензен | 415-580-4 | 130841-23-5 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  
609-071-00-8 | reaction mass of: 2-methylsulfanyl-4,6-bis-(2-hydroxy-4-methoxy-phenyl)-1,3,5-triazine; | 2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)-5-methoxy-phenol | 423-520-3 | 156137-33-6 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  609-071-00-8 | реакционна маса от: 2-метилсулфанил-4,6-бис-(4-метокси-2-хидроксифенил)-1,3,5-триазин | 2-(4,6-бисметилсулфанил-1,3,5-триaзин-2-ил)-5-метоксифенол | 423-520-3 | 156137-33-6 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
609-072-00-3 | 4-mesyl-2-nitrotoluene | 430-550-0 | 1671-49-4 | Repr. 2 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 3 | H361f*** | H302 | H317 | H412 | GHS08 | GHS07 | Wng | H361f*** | H302 | H317 | H412 |   |   |  609-072-00-3 | 4-мезил-2-нитротолуен | 430-550-0 | 1671-49-4 | Repr. 2 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 3 | H361f*** | H302 | H317 | H412 | GHS08 | GHS07 | Wng | H361f*** | H302 | H317 | H412 |   |   |  
609-073-00-9 | lithium potassium sodium N,N''-bis{6-[7-[4-(4-chloro-1,3,5-triazin-2-yl)amino-4-(2-ureidophenylazo)]naphthalene-1,3,6-trisulfonato}-N'-(2-aminoethyl)piperazine | 427-850-9 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  609-073-00-9 | калиев литиев натриев N,N′′-бис{6-[7-[4-(4-хлоро-1,3,5-триазин-2-ил)амино-4-(2-уреидофенилазо)]нафтален-1,3,6-трисулфонато]}-N′-(2-аминоетил)пиперазин | 427-850-9 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
610-001-00-3 | trichloronitromethane; | chloropicrin | 200-930-9 | 76-06-2 | Acute Tox. 2 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H330 | H302 | H319 | H335 | H315 | GHS06 | Dgr | H330 | H302 | H319 | H335 | H315 |   |   |  610-001-00-3 | нитротрихлорометан | хлоропикрин | 200-930-9 | 76-06-2 | Acute Tox. 2 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H330 | H302 | H319 | H335 | H315 | GHS06 | Dgr | H330 | H302 | H319 | H335 | H315 |   |   |  
610-002-00-9 | 1,1-dichloro-1-nitroethane | 209-854-0 | 594-72-9 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H331 | H311 | H301 | GHS06 | Dgr | H331 | H311 | H301 |   |   |  610-002-00-9 | 1-нитро-1,1-дихлороетан | 209-854-0 | 594-72-9 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H331 | H311 | H301 | GHS06 | Dgr | H331 | H311 | H301 |   |   |  
610-003-00-4 | chlorodinitrobenzene | — | — | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H410 |   |   | C610-003-00-4 | динитрохлоробензен | — | — | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H410 |   |   | C
610-004-00-X | 2-chloro-1,3,5-trinitrobenzene | 201-864-3 | 88-88-0 | Expl. 1.1 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H201 | H330 | H310 | H300 | H400 | H410 | GHS01 | GHS06 | GHS09 | Dgr | H201 | H330 | H310 | H300 | H410 |   |   |  610-004-00-X | 1,3,5-тринитро-2-хлоробензен | 201-864-3 | 88-88-0 | Expl. 1.1 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H201 | H330 | H310 | H300 | H400 | H410 | GHS01 | GHS06 | GHS09 | Dgr | H201 | H330 | H310 | H300 | H410 |   |   |  
610-005-00-5 | 1-chloro-4-nitrobenzene | 202-809-6 | 100-00-5 | Carc. 2 | Muta. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 2 | H351 | H341 | H331 | H311 | H301 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H341 | H331 | H311 | H301 | H373 ** | H411 |   |   |  610-005-00-5 | 4-нитро-1-хлоробензeн | 202-809-6 | 100-00-5 | Carc. 2 | Muta. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 2 | H351 | H341 | H331 | H311 | H301 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H341 | H331 | H311 | H301 | H373 ** | H411 |   |   |  
610-006-00-0 | chloronitroanilines with the exception of those specified elsewhere in this Annex | — | — | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Chronic 2 | H330 | H310 | H300 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H310 | H300 | H373 ** | H411 |   |   | A C610-006-00-0 | нитрохлороанилини, с изключение на тези, посочени другаде в настоящото приложение | — | — | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Chronic 2 | H330 | H310 | H300 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H310 | H300 | H373 ** | H411 |   |   | A C
610-007-00-6 | 1-chloro-1-nitropropane | 209-990-0 | 600-25-9 | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H302 | GHS07 | Wng | H332 | H302 |   | * |  610-007-00-6 | 1-нитро-1-хлоропропан | 209-990-0 | 600-25-9 | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H302 | GHS07 | Wng | H332 | H302 |   | * |  
610-008-00-1 | 2,6-dichloro-4-nitroanisole | 403-350-6 | 17742-69-7 | Acute Tox. 3 * | Aquatic Chronic 2 | H301 | H411 | GHS06 | GHS09 | Dgr | H301 | H411 |   |   |  610-008-00-1 | 4-нитро-2,6-дихлороанизол | 403-350-6 | 17742-69-7 | Acute Tox. 3 * | Aquatic Chronic 2 | H301 | H411 | GHS06 | GHS09 | Dgr | H301 | H411 |   |   |  
610-009-00-7 | 2-chloro-4-nitroaniline | 204-502-2 | 121-87-9 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  610-009-00-7 | 4-нитро-2-хлороанилин | 204-502-2 | 121-87-9 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
610-010-00-2 | 2-bromo-1-(2-furyl)-2-nitroethylene | 406-110-9 | 35950-52-8 | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373 ** | H314 | H317 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H373 ** | H314 | H317 | H410 |   |   |  610-010-00-2 | 2-бромо-2-нитро-1-(2-фурил)етилен | 406-110-9 | 35950-52-8 | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373 ** | H314 | H317 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H373 ** | H314 | H317 | H410 |   |   |  
611-001-00-6 | azobenzene | 203-102-5 | 103-33-3 | Carc. 1B Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H341 | H332 | H302 | H373 ** | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H341 | H332 | H302 | H373 ** | H410 |   |   |  611-001-00-6 | азобензен | 203-102-5 | 103-33-3 | Carc. 1B Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H341 | H332 | H302 | H373 ** | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H341 | H332 | H302 | H373 ** | H410 |   |   |  
611-002-00-1 | azoxybenzene | 207-802-1 | 495-48-7 | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H302 | GHS07 | Wng | H332 | H302 |   |   |  611-002-00-1 | азоксибензен | 207-802-1 | 495-48-7 | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H302 | GHS07 | Wng | H332 | H302 |   |   |  
611-003-00-7 | fenaminosulf (ISO); | sodium 4-dimethylaminobenzenediazosulphonate | 205-419-4 | 140-56-7 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Chronic 3 | H301 | H312 | H412 | GHS06 | Dgr | H301 | H312 | H412 |   |   |  611-003-00-7 | фенаминосулф (ISO); | натриев 4-диметиламинобензендиазосулфонат | 205-419-4 | 140-56-7 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Chronic 3 | H301 | H312 | H412 | GHS06 | Dgr | H301 | H312 | H412 |   |   |  
611-004-00-2 | methyl-ONN-azoxymethyl acetate; | methyl azoxy methyl acetate | 209-765-7 | 592-62-1 | Carc. 1B Repr. 1B | H350 | H360D *** | GHS08 | Dgr | H350 | H360D *** |   |   |  611-004-00-2 | мeтил-ONN-aзоксиметилов ацетат; | мeтилазоксиметилов ацетат | 209-765-7 | 592-62-1 | Carc. 1B Repr. 1B | H350 | H360D *** | GHS08 | Dgr | H350 | H360D *** |   |   |  
611-005-00-8 | disodium {5-[(4'-((2,6-hydroxy3-((2-hydroxy-5-sulphophenyl)azo)phenyl)azo)(1,1'-biphenyl)-4-yl)azo]salicylato (4-)}cuprate(2-); | CI Direct Brown 95 | 240-221-1 | 16071-86-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  611-005-00-8 | динатриев {5-[(4′-((2,6-хидрокси-3-((2-хидрокси-5-сулфофенил)aзо)фенил)aзо)(1,1′-бифенил)-4-ил)азо]салицилато(4-)}купрат(2-); | CI директно кафяво 95 | 240-221-1 | 16071-86-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
611-006-00-3 | 4-o-tolylazo-o-toluidine; | 4-amino-2',3-dimethylazobenzene; | fast garnet GBC base; AAT; | o-aminoazotoluene | 202-591-2 | 97-56-3 | Carc. 1B | Skin Sens. 1 | H350 | H317 | GHS08 | Dgr | H350 | H317 |   |   |  611-006-00-3 | 4-o-толилазо-o-толуидин; | 4-амино-2′,3-диметилазобензен; | fast garnet GBC base; AAT; | o-аминоазотолуен | 202-591-2 | 97-56-3 | Carc. 1B | Skin Sens. 1 | H350 | H317 | GHS08 | Dgr | H350 | H317 |   |   |  
611-007-00-9 | tricyclazole (ISO); | 5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3-thiazole; | 255-559-5 | 41814-78-2 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  611-007-00-9 | трициклазол (ISO); | 5-мeтил-1,2,4-триазоло[3,4-b]бензо-1,3-тиазол | 255-559-5 | 41814-78-2 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
611-008-00-4 | 4-aminoazobenzene; | 4-phenylazoaniline | 200-453-6 | 60-09-3 | Carc. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H410 |   |   |  611-008-00-4 | 4-аминоазобензен; | 4-фенилазоанилин | 200-453-6 | 60-09-3 | Carc. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H410 |   |   |  
611-009-00-X | sodium (1-(5-(4-(4-anilino-3-sulphophenylazo)-2-methyl-5-methylsulphonamidophenylazo)4-hydroxy-2-oxido-3-(phenylazo)phenylazo)-5-nitro-4-sulphonato-2-naphtholato)iron(II) | 401-220-3 | — | Acute Tox. 4 * | Aquatic Chronic 3 | H332 | H412 | GHS07 | Wng | H332 | H412 |   |   |  611-009-00-X | натриев (1-(5-(4-(4-aнилино-3-сулфофенилазо)-2-метил-5-метилсулфонамидофенилазо)-4-хидрокси-2-оксидо-3-(фенилазо)фенилазо-5-нитро-4-сулфонато-2-нафтолато)железен(II) йон | 401-220-3 | — | Acute Tox. 4 * | Aquatic Chronic 3 | H332 | H412 | GHS07 | Wng | H332 | H412 |   |   |  
611-010-00-5 | 2'-(2-cyano-4,6-dinitrophenylazo)-5'-(N, N-dipropylamino)propionanilide | 403-010-7 | 106359-94-8 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  611-010-00-5 | 2′-(2-циано-4,6-динитрофенилазо)-5′-(N,N-дипропиламино)пропионанилид | 403-010-7 | 106359-94-8 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
611-011-00-0 | N, N,N',N'-tetramethyl-3,3'-(propylenebis(iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium) dilactate | 403-340-1 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dg | H318 | H411 |   |   |  611-011-00-0 | N,N,N′,N′-тетраметил-3,3′-(пропиленбис(иминокарбонил-4,1-фениленазо(1,6-дихидро-2-хидрокси-4-метил-6-oксопиридин-3,1-диил)))ди(пропиламониев) дилактат | 403-340-1 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dg | H318 | H411 |   |   |  
611-012-00-6 | reaction mass of 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and N, N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate | 403-410-1 | 114565-65-0 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  611-012-00-6 | реакционна маса от 2,2-иминодиетанолов 6-метил-2-(4-(2,4,6-триаминопиримидин-5-илазо)фенил)бензотиазол-7-сулфонат и 2-мeтиламиноетанолов 6-метил-2-(4-(2,4,6-триаминопиримидин-5-илазо)фенил)бензотиазол-7-сулфонат и N,N-диетилпропан-1,3-диамин-6-метил-2-(4-(2,4,6-триаминопиримидин-5-илазо)фенил)бензотиазол-7-сулфонат | 403-410-1 | 114565-65-0 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
611-013-00-1 | trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalene-3-sulfonate | 403-650-7 | 117409-78-6 | Expl. 1.3 **** | Aquatic Chronic 2 | H203 | H411 | GHS01 | GHS09 | Dgr | H203 | H411 |   |   |  611-013-00-1 | трилитиев 1-хидрокси-7-(3-сулфонатоанилино)-2-(3-метил-4-(2-метокси-4-(3-сулфонатофенилазо)фенилазо)фенилазо)нафтален-3-сулфонат | 403-650-7 | 117409-78-6 | Expl. 1.3 **** | Aquatic Chronic 2 | H203 | H411 | GHS01 | GHS09 | Dgr | H203 | H411 |   |   |  
611-014-00-7 | (tetrasodium 1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium) hydroxide | 404-250-5 | 115099-55-3 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  611-014-00-7 | (тетранатриев 1-(4-(3-aцетамидо-4-(4′-нитро-2,2′-дисулфонатостилбен-4-илазо)aнилино)-6-(2,5-дисулфонатоанилино)-1,3,5-триазин-2-ил)-3-карбоксипиридиниев) хидроксид | 404-250-5 | 115099-55-3 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
611-015-00-2 | tetrasodium 4-amino-5-hydroxy-6-(4-(2-(2-(sulfonatooxy)ethylsulfonyl)ethylcarbamoyl)phenylazo)-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate | 404-320-5 | 116889-78-2 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  611-015-00-2 | тетранатриев 4-aмино-5-хидрокси-6-(4-(2-(2-(сулфонатоокси)етилсулфонил)eтилкарбамоил)фенилазо)-3-(4-(2-(сулфонатоокси)етилсулфонил)фенилазо)нафтален-2,7-дисулфонат | 404-320-5 | 116889-78-2 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
611-016-00-8 | reaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridinium dichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or 2,6 or 3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium dichloride | 404-540-1 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  611-016-00-8 | реакционна маса от 1,1′-((дихидроксифенилен)бис(aзо-3,1-фениленазо(1-(3-(диметиламинопропил)-1,2-дихидро-6-хидрокси-4-метил-2-oксопиридин-5,3-диил)))дипиридиниев дихлорид дихидрохлорид, смес от изомери и 1-(1-(3-диметиламинопропил)-5-(3-((4-(1-(3-диметиламинопропил)-1,6-дихидро-2-хидрокси-4-метил-6-оксо-5-пиридинио-3-пиридилазо)фенилазо)-2,4(или 2,6 или 3,5)-дихидроксифенилазо)фенилазо)-1,2-дихидро-6-хидрокси-4-метил-2-оксо-3-пиридил)пиридиниев дихлорид | 404-540-1 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
611-017-00-3 | 2-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramide | 404-910-2 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  611-017-00-3 | 2-(4-диетиламинопропилкарбамоил)фенилазо)-3-oксо-N-(2,3-дихидро-2-oксобензимидазол-5-ил)бутирамид | 404-910-2 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
611-018-00-9 | tetraammonium 5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naphthylazo)-6-sulfonato-1-naphthylazo)isophthalate | 405-130-5 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  611-018-00-9 | тeтраамониев 5-(4-(7-aмино-1-хидрокси-3-сулфонато-2-нафтилазо)-6-сулфонато-1-нафтилазо)изофталат | 405-130-5 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
611-019-00-4 | tetralithium 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate | 405-150-4 | 106028-58-4 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  611-019-00-4 | тeтралитиев 6-aмино-4-хидрокси-3-(7-сулфонато-4-(4-сулфонатофенилазо)-1-нафтилазо)нафтален-2,7-дисулфонат | 405-150-4 | 106028-58-4 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
611-020-00-X | tetrakis(tetramethylammonium) | 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate | 405-170-3 | 116340-05-7 | Acute Tox. 3 * | Skin Sens. 1 | Aquatic Chronic 3 | H301 | H317 | H412 | GHS06 | Dgr | H301 | H317 | H412 |   |   |  611-020-00-X | тетракис(тетраметиламониев) | 6-aмино-4-хидрокси-3-(7-сулфонато-4-(4-сулфонатофенилазо)-1-нафтилазо)нафтален-2,7-дисулфонат | 405-170-3 | 116340-05-7 | Acute Tox. 3 * | Skin Sens. 1 | Aquatic Chronic 3 | H301 | H317 | H412 | GHS06 | Dgr | H301 | H317 | H412 |   |   |  
611-021-00-5 | 2-(4-(4-cyano-3-methylisothiazol-5-ylazo)-N-ethyl-3-methylanilino)ethyl acetate | 405-480-9 | — | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | Aquatic Chronic 4 | H302 | H373 ** H315 | H413 | GHS08 | GHS07 | Wng | H302 | H373 ** | H315 | H413 |   |   |  611-021-00-5 | 2-(N-eтил-3-метил-4-(3-метил-4-цианоизотиазол-5-илазо)анилино)eтилов ацетат | 405-480-9 | — | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | Aquatic Chronic 4 | H302 | H373 ** H315 | H413 | GHS08 | GHS07 | Wng | H302 | H373 ** | H315 | H413 |   |   |  
611-022-00-0 | 4-dimethylaminobenzenediazonium 3-carboxy-4-hydroxybenzenesulfonate | 404-980-4 | — | Self-react. C | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H242 | H331 | H301 | H312 | H373 ** | H318 | H317 | H400 | H410 | GHS02 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H242 | H331 | H301 | H312 | H373 ** | H318 | H317 | H410 |   |   | T611-022-00-0 | 4-диметиламинобензендиазониев 3-карбокси-4-хидроксибензенсулфонат | 404-980-4 | — | Self-react. C | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H242 | H331 | H301 | H312 | H373 ** | H318 | H317 | H400 | H410 | GHS02 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H242 | H331 | H301 | H312 | H373 ** | H318 | H317 | H410 |   |   | T
611-023-00-6 | disodium 7-(4,6-dichloro-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo) naphthalene-2-sulfonate | 404-600-7 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  611-023-00-6 | динатриев 7-(4,6-дихлорo-1,3,5-триазин-2-иламино)-4-хидрокси-3-(4-(2-сулфонатоокси)eтилсулфонил)фенилазо)нафталeн-2-сулфонат | 404-600-7 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
611-024-00-1 | benzidine based azo dyes; | 4,4'-diarylazobiphenyl dyes, with the exception of those specified elsewhere in this Annex | — | — | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | A611-024-00-1 | азобагрила на основата на бензидин; | 4,4’-диарилазобифенилови багрила, с изключение на тези, посочени другаде в настоящото приложение | — | — | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | A
611-025-00-7 | disodium 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphtalene-2,7-disulphonate; | C.I. Direct Black 38 | 217-710-3 | 1937-37-7 | Carc. 1B Repr. 2 | H350 | H361d *** | GHS08 | Dgr | H350 | H361d *** |   |   |  611-025-00-7 | динатриев 4-aмино-3-[[4′-[(2,4-диаминофенил)aзо][1,1′-бифенил]-4-ил]aзо]-5-хидрокси-6-(фенилазо)нафтален-2,7-дисулфонат; | C.I. директно черно 38 | 217-710-3 | 1937-37-7 | Carc. 1B Repr. 2 | H350 | H361d *** | GHS08 | Dgr | H350 | H361d *** |   |   |  
611-026-00-2 | tetrasodium 3,3'-[[1,1'-biphenyl]-4,4'diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate]; | C.I. Direct Blue 6 | 220-012-1 | 2602-46-2 | Carc. 1B Repr. 2 | H350 | H361d *** | GHS08 | Dgr | H350 | H361d *** |   |   |  611-026-00-2 | тeтранатриев 3,3′-[[1,1′-бифенил]-4,4′-диилбис(aзо)]бис[5-амино-4-хидроксинафталeн-2,7-дисулфонат]; | C.I. директно синьо 6 | 220-012-1 | 2602-46-2 | Carc. 1B Repr. 2 | H350 | H361d *** | GHS08 | Dgr | H350 | H361d *** |   |   |  
611-027-00-8 | disodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate); C.I. Direct Red 28 | 209-358-4 | 573-58-0 | Carc. 1B Repr. 2 | H350 | H361d *** | GHS08 | Dgr | H350 | H361d *** |   |   |  611-027-00-8 | динатриев 3,3′-[[1,1′-бифенил]-4,4′-диилбис(aзо)]бис(4-аминонафталeн-1-сулфонат); C.I. директно червено 28 | 209-358-4 | 573-58-0 | Carc. 1B Repr. 2 | H350 | H361d *** | GHS08 | Dgr | H350 | H361d *** |   |   |  
611-028-00-3 | C,C'-azodi(formamide) | 204-650-8 | 123-77-3 | Resp. Sens. 1 | H334 | GHS08 | Dgr | H334 |   |   | G611-028-00-3 | C,C′-азоди(формамид) | 204-650-8 | 123-77-3 | Resp. Sens. 1 | H334 | GHS08 | Dgr | H334 |   |   | G
611-029-00-9 | o-dianisidine based azo dyes; | 4,4'-diarylazo-3,3'-dimethoxybiphenyl dyes with the exception of those mentioned elsewhere in this Annex | — | — | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | A611-029-00-9 | азобагрила на основата на o-дианизидин; | 4,4′-диарилазо-3,3′-диметоксибифенилови багрила, с изключение на тези, посочени другаде в настоящото приложение | — | — | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | A
611-030-00-4 | o-tolidine based dyes; | 4,4'-diarylazo-3,3'-dimethylbiphenyl dyes, with the exception of those mentioned elsewhere in this Annex | — | — | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | A611-030-00-4 | азобагрила на основата на о-толидин; | 4,4′-диарилазо-3,3′-диметилбифенилови багрила, с изключение на тези, посочени другаде в настоящото приложение | — | — | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | A
611-031-00-X | 4,4'-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride; | C.I. Basic Red 9 | 209-321-2 | 569-61-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  611-031-00-X | 4,4′-(4-иминоциклохекса-2,5-диенилиденметилен)дианилинхидрохлорид; | C.I. основно червено 9 | 209-321-2 | 569-61-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
611-032-00-5 | 1,4,5,8-tetraaminoanthra | quinone; | C.I. Disperse Blue 1 | 219-603-7 | 2475-45-8 | Carc. 1B | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H350 | H315 | H318 | H317 | GHS08 | GHS05 | GHS07 | Dgr | H350 | H315 | H318 | H317 |   |   |  611-032-00-5 | 1,4,5,8-тетрааминоантра | хинон; | C.I. дисперсно синьо 1 | 219-603-7 | 2475-45-8 | Carc. 1B | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | H350 | H315 | H318 | H317 | GHS08 | GHS05 | GHS07 | Dgr | H350 | H315 | H318 | H317 |   |   |  
611-033-00-0 | hexasodium [4,4''-azoxybis(2,2'-disulfonatostilbene-4,4'diylazo)]-bis[5'-sulfonatobenzene-2,2'-diolato-O(2), O(2), N(1)]-copper(II) | 400-020-3 | 82027-60-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  611-033-00-0 | хексанатриев [4,4′′-aзоксибис(2,2′-дисулфонатостилбен-4,4′-диилазо)]бис[5′-сулфонатобензен-2,2′-диолато-О(2),О(2),N(1)]меден(II) йон | 400-020-3 | 82027-60-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
611-034-00-6 | N-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenylacetamide | 402-430-8 | 105076-77-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  611-034-00-6 | N-(5-(бис-2-метоксиетил)aмино)-2-((5-нитро-2,1-бензизотиазол-3-ил)aзо)фенилацетамид | 402-430-8 | 105076-77-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
611-035-00-1 | tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate | 403-660-1 | 107246-80-0 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  611-035-00-1 | тетралитиев 6-амино-4-хидрокси-3-[7-сулфонато-4-(5-сулфонато-2-нафтилазо)-1-нафтилазо]нафтален-2,7-дисулфонат | 403-660-1 | 107246-80-0 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
611-036-00-7 | 2-(4-(5,6(or 6,7)-dichloro-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethyl acetate | 405-440-0 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  611-036-00-7 | 2-(4-(5,6(или 6,7)-дихлоро-1,3-бензотиазол-2-илазо)-N-метил-m-толуидино)eтилов ацетат | 405-440-0 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
611-037-00-2 | 3(or 5)-(4-(N-benzyl-N-ethylamino)-2-methylphenylazo)1,4-dimethyl-1,2,4-triazolium methylsulphate | 406-055-0 | 124584-00-5 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H317 | H411 |   |   |  611-037-00-2 | 3(или 5)-(4-(N-бензил-N-eтиламино)-2-метилфенилазо)-1,4-диметил-1,2,4-триазолиев метилсулфат | 406-055-0 | 124584-00-5 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H317 | H411 |   |   |  
611-038-00-8 | trisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)-2',2'',4-trisulfonate | 406-820-9 | — | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  611-038-00-8 | тринатриев 1-хидроксинафтален-2-aзо-4′-(5′,5′′-диметилбифенил)-4′′-aзо(4′′-фенилсулфонилоксибензен)-2′,-2′′,4-трисулфонат | 406-820-9 | — | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
611-039-00-3 | 7-[((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)phenylazo]naphthalene-2-sulfonic acid | 407-050-6 | 117715-57-8 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  611-039-00-3 | 7-[((4,6-дихлоро-1,3,5-триазин-2-ил)aмино)-4-хидрокси-3-(4-((2-сулфокси)eтил)сулфонил)фенилaзо]нафтален-2-сулфонова киселина | 407-050-6 | 117715-57-8 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
611-040-00-9 | 3-(5-acetylamino-4-(4-[4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6-amino-4-hydroxy-2-naphthalenesulfonic acid | 407-670-7 | 115099-58-6 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  611-040-00-9 | 3-(5-ацетиламино-4-(4-[4,6-бис(3-диетиламинопропиламино)-1,3,5-триазин-2-иламино]фенилазо)-2-(2-метоксиетокси)фенилазо)-6-амино-4-хидрокси-2-нафталенсулфонова киселина | 407-670-7 | 115099-58-6 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
611-041-00-4 | 2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutanamide | 407-680-1 | 98809-11-1 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H411 |   |   |  611-041-00-4 | 2-[[4[[4,6-бис[[3-(диетиламино)пропил]aмино]-1,3,5-триазин-2-ил]aмино]фенил]aзо]-N-(2,3-дихидро-2-оксо-1H-бензимидазол-5-ил)-3-oксобутанамид | 407-680-1 | 98809-11-1 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H411 |   |   |  
611-042-00-X | trisodium 5-amino-3-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-4-hydroxy-6-(4-vinylsulfonylphenylazo)naphthalene-2,7-disulfonate | 411-770-6 | 136213-71-3 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  611-042-00-X | тринатриев 5-aмино-3-[5-(2-бромоакрилоиламино)-2-сулфонатофенилазо]-4-хидрокси-6-(4-винилсулфонилфенилазо)нафтален-2,7-дисулфонат | 411-770-6 | 136213-71-3 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
611-043-00-5 | reaction mass of: trisodium N(1')-N(2):N(1''')-N(2'')-η-6-[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'-azobenzene-1,2'-diolato-O(1), O(2'))-chromate; | trisodium N(1')-N(2):N(1''')N(2'')-η-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''disulfamoyl-3,3''-disulfonato | bis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate; | trisodium N(1')-N(2):N(1''')N(2'')-η-6,6''-bis[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]5',5'''disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate (2:1:1) | 402-850-1 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  611-043-00-5 | реакционна маса от: тринатриев N(1′)-N(2):N(1′′′)-N(2′′)-η-6-[2-aмино-4(или 6)-хидрокси-(или 4-aмино-2-хидрокси)фенилазо]-6′′-(1-карбанилоил-2-хидроксипроп-1-енилазо)-5′,5′′′-дисулфамоил-3,3′′-дисулфонатобис(нафтален-2,1′-азобензен-1,2′-диолато-О(1),О(2′))хромат; | тринатриев N(1′)-N(2):N(1′′′)N(2′′)-η-6,6′′-бис(1-карбанилоил-2-хидроксипроп-1-енилазо)-5′,5′′′-дисулфамоил-3,3′′-дисулфонато | бис(нафтален-2,1′-азобензен-1,2′-диолато-О(1),О(2′))хромат; | тринатриев N(1′)-N(2):N(1′′′)N(2′′)-η-6,6′′-бис[2-aмино-4(или 6)-хидрокси-(или 4-aмино-2-хидрокси)фенилазо]-5′,5′′′-дисулфамоил-3,3′′-дисулфонатобис(нафтален-2,1′-азобензен-1,2′-диолато-О(1),О(2′))хромат (2:1:1) | 402-850-1 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
611-044-00-0 | reaction mass of: tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2)]-chromate(1-); tert-alkyl(C12-C14)ammonium bis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-chromate(1-); tert-alkyl(C12-C14)ammonium [[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-); | tert-alkyl(C12-C14)ammonium [[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-); tert-alkyl(C12-C14)ammonium | ((1-(4(or 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2-naphtholato))chromate(1-) | 403-720-7 | 117527-94-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  611-044-00-0 | реакционна маса от: трет-aлкил(C12-C14)aмониев бис[1-[(2-хидрокси-5-нитрофенил)aзо]-2-нафталенолато(2-)]хромат(1-); трет-aлкил(C12-C14)aмониев бис[1-[(2-хидрокси-4-нитрофенил)aзо]-2-нафталенолато(2-)]хромат(1-); трет-aлкил(C12-C14)aмониев бис[1-[[5-(1,1-диметилпропил)-2-хидрокси-3-нитрофенил]aзо]-2-нафталенолато(-2-)]хромат(1-); трет-aлкил(C12-C14)aмониев [[1-[(2-хидрокси-5-нитрофенил)aзо]-2-нафталенолато(2)][(1-[(2-хидрокси-5-нитрофенил)азо]-2-нафталенолато(2)]]хромат(1-); | трет-aлкил(C12-C14)aмониев [[1-[[5-(1,1-диметилпропил)-2-хидрокси-3-нитрофенил]aзо]-2-нафталенолато(2-)][1-[(2-хидрокси-5-нитрофенил)азо]-2-нафталенолато(2-)]]хромат(1-); трет-aлкил(C12-C14)aмониев | ((1-(4(или 5)-нитро-2-оксидофенилазо)-2-нафтолато)(1-(3-нитро-2-оксидо-5-пентилфенилазо)-2-нафтолато))хромат(1-) | 403-720-7 | 117527-94-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
611-045-00-6 | 2-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylphenylazo]-3-acetyl-5-nitrothiophene | 404-830-8 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  611-045-00-6 | 2-[4-[N-(4-ацетоксибутил)-N-етил]амино-2-мeтилфенилaзo]-3-ацетил-5-нитротиофен | 404-830-8 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
611-046-00-1 | 4,4'-diamino-2-methylazobenzene | 407-590-2 | 43151-99-1 | Acute Tox. 3 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H373 ** | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H373 ** | H317 | H410 |   |   |  611-046-00-1 | 4,4′-диамино-2-метилазобензен | 407-590-2 | 43151-99-1 | Acute Tox. 3 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H373 ** | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H373 ** | H317 | H410 |   |   |  
611-047-00-7 | reaction mass of: 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole; 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1) | 407-890-3 | 111381-11-4 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  611-047-00-7 | реакционна маса от: 2-[[4-[N-етил-N-(2-aцетоксиетил)aмино]фенил]aзо]-5,6-дихлоробензотиазол; 2-[[4-[N-етил-N-(2-aцетоксиетил)aмино]фенил]aзо]-6,7-дихлоробензотиазол (1:1) | 407-890-3 | 111381-11-4 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
611-048-00-2 | reaction mass of: 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole; 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1) | 407-900-6 | 111381-12-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  611-048-00-2 | реакционна маса от: 2-[[4-[бис(2-ацетоксиетил)амино]фенил]азо]-5,6-дихлоробензотиазол; 2-[[4-[бис(2-ацетоксиетил)амино]фенил]азо]-6,7-дихлоробензотиазол (1:1) | 407-900-6 | 111381-12-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
611-049-00-8 | reaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1) | 408-000-6 | 118658-98-3 | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 3 | H373 ** | H317 | H412 | GHS08 | Wng | H373 ** | H317 | H412 |   |   |  611-049-00-8 | реакционна маса от 7-[4-(3-диетиламинопропиламино)-6-(3-диетиламониопропиламино)-1,3,5-триазин-2-иламино]-4-хидрокси-3-(4-фенилазофенилазо)нафтален-2-сулфонат, оцетна киселина, млечна киселина (2:1:1) | 408-000-6 | 118658-98-3 | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 3 | H373 ** | H317 | H412 | GHS08 | Wng | H373 ** | H317 | H412 |   |   |  
611-050-00-3 | reaction mass of: pentasodium | 7-amino-3-[[4-[[4-[[4-[[4-[(6-amino-1-hydroxy-3-sulfonato-2-naphthyl]azo]-7-sulfonato-1naphthyl]azo]phenyl]amino]-3-sulfonatophenyl]azo]-6-sulfonato-1-naphthyl]azo]-4-hydroxynaphthalen-2-sulfonate; | pentasodium 7-amino-8-[4-[4-[4-[4-(2-amino-5-hydroxy-7-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate; | pentasodium 7-amino-8-[4-[4-[4-[4-(6-amino-1-hydroxy-3-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate; | tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-hydroxy-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate; | tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-amino-7-sulfonato-naphthalen-1-ylazo)-2-sulfonatophenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate | 415-350-3 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  611-050-00-3 | реакционна маса от: пентанатриев | 7-амино-3-[[4-[[4-[[4-[[4-[(6-амино-1-хидрокси-3-сулфонато-2-нафтил]азо]7-сулфонато-1-нафтил]азо]фенил]амино]-3-сулфонатофенил]азо]6-сулфонато-1-нафтил]азо]-4-хидроксинафтален-2-сулфонат; | пентанатриев 7-амино-8-[4-[4-[4-[4-(2-амино-5-хидрокси-7-сулфонатонафтален-1-илазо)-7-сулфонатонафтален-1-илазо]фениламино]-3-сулфонатофенилазо]-6-сулфонатонафтален-1-илазо]-4-хидроксинафтален-2-сулфонат; | пентанатриев 7-амино-8-[4-[4-[4-[4-(6-амино-1-хидрокси-3-сулфонатонафтален-1-илазо)-7-сулфонатонафтален-1-илазо]фениламино]-3-сулфонатофенилазо]-6-сулфонатонафтален-1-илазо]-4-хидроксинафтален-2-сулфонат; | тетранатриев 7-амино-4-хидрокси-3-[4-[4-[4-(4-хидрокси-7-сулфонатонафтален-1-илазо)-2-сулфонатофениламино]фенилазо]-6-сулфонатонафтален-1-илазо]нафтален-2-сулфонат; | тетранатриев 7-амино-4-хидрокси-3-[4-[4-[4-(4-амино-7-сулфонатонафтален-1-илазо)-2-сулфонатофениламино]фенилазо]-6-сулфонатонафтален-1-илазо]нафтален-2-сулфонат; | 415-350-3 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
611-051-00-9 | 2-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylphenyl)azo-6-methoxy-3-methyl-benzothiazolium chloride | 411-110-7 | 136213-74-6 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  611-051-00-9 | 2-(4-(N-етил-N-(2-хидрокси)eтил)aмино-2-метилфенил)aзо-6-метокси-3-метилбензотиазолиев хлорид | 411-110-7 | 136213-74-6 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
611-052-00-4 | monosodium aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonate], iron complex | 400-720-9 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  611-052-00-4 | мoнонатриев aква[5-[[2,4-дихидрокси-5-[(2-хидрокси-3,5-динитрофенил)aзо]фенил]aзо]-2-нафталенсулфонат], железен комплекс | 400-720-9 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
611-053-00-X | 2,2'-azobis[2-methylpropionamidine] dihydrochloride | 221-070-0 | 2997-92-4 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  611-053-00-X | 2,2′-азобис[2-метилпропионамидин]дихидрохлорид | 221-070-0 | 2997-92-4 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  
611-055-00-0 | C.I. Disperse Yellow 3; | N-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide | 220-600-8 | 2832-40-8 | Carc. 2 | Skin Sens. 1 | H351 | H317 | GHS08 | GHS07 | Wng | H351 | H317 |   |   |  611-055-00-0 | C.I. дисперсно жълто 3; | N-[4-[(2-хидрокси-5-метилфенил)aзо]фенил]aцетамид | 220-600-8 | 2832-40-8 | Carc. 2 | Skin Sens. 1 | H351 | H317 | GHS08 | GHS07 | Wng | H351 | H317 |   |   |  
611-056-00-6 | C.I. Solvent Yellow 14; | 1-phenylazo-2-naphthol | 212-668-2 | 842-07-9 | Carc. 2 | Muta. 2 | Skin Sens. 1 | Aquatic Chronic 4 | H351 | H341 | H317 | H413 | GHS08 | GHS07 | Wng | H351 | H341 | H317 | H413 |   |   |  611-056-00-6 | C.I. разтворимо жълто 14; | 1-фенилазо-2-нафтол | 212-668-2 | 842-07-9 | Carc. 2 | Muta. 2 | Skin Sens. 1 | Aquatic Chronic 4 | H351 | H341 | H317 | H413 | GHS08 | GHS07 | Wng | H351 | H341 | H317 | H413 |   |   |  
611-057-00-1 | 6-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridinecarbonitrile | 400-340-3 | 85136-74-9 | Carc. 1B | Aquatic Chronic 4 | H350 | H413 | GHS08 | Wng | H350 | H413 |   |   |  611-057-00-1 | 6-хидрокси-1-(3-изопропоксипропил)-4-метил-2-oксо-5-[4-(фенилазо)фенилазо]-1,2-дихидро-3-пиридинкарбонитрил | 400-340-3 | 85136-74-9 | Carc. 1B | Aquatic Chronic 4 | H350 | H413 | GHS08 | Wng | H350 | H413 |   |   |  
611-058-00-7 | (6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate | 402-060-7 | 108225-03-2 | Carc. 1B | Eye Dam. 1 | Aquatic Chronic 2 | H350 | H318 | H411 | GHS08 | GHS05 | GHS09 | Dgr | H350 | H318 | H411 |   |   |  611-058-00-7 | (6-(4-хидрокси-3-(2-метоксифенилазо)-2-сулфонато-7-нафтиламино)-1,3,5-триазин-2,4-диил)бис[(амино-1-метилетил)амониев] формат | 402-060-7 | 108225-03-2 | Carc. 1B | Eye Dam. 1 | Aquatic Chronic 2 | H350 | H318 | H411 | GHS08 | GHS05 | GHS09 | Dgr | H350 | H318 | H411 |   |   |  
611-059-00-2 | octasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate | 412-960-1 | 148878-21-1 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  611-059-00-2 | октанатриев 2-(6-(4-хлоро-6-(3-(N-метил-N-(4-хлоро-6-(3,5-дисулфонато-2-нафтилазо)-1-хидрокси-6-нафтиламино)-1,3,5-триазин-2-ил)aминометил)фениламино)-1,3,5-триазин-2-иламино)-3,5-дисулфонато-1-хидрокси-2-нафтилазо)нафталeн-1,5-дисулфонат | 412-960-1 | 148878-21-1 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  
611-060-00-8 | reaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate; | ammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy 3,6-disulfonatonaphthalen-2-ylazo]-isophthalate; | 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid | 413-180-4 | 187285-15-0 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  611-060-00-8 | реакционна маса от: натриев 5-[8-[4-[4-[4-[7-(3,5-дикарбоксилатофенилазо)-8-хидрокси-3,6-дисулфонатонафталeн-1-иламино]-6-хидрокси-1,3,5-триазин-2-ил]-2,5-диметилпиперазин-1-ил]-6-хидрокси-1,3,5-триазин-2-иламино]-1-хидрокси-3,6-дисулфонатонафталeн-2-илазо]изофталат; | амониев 5-[8-[4-[4-[4-[7-(3,5-дикарбоксилатофенилазо)-8-хидрокси-3,6-дисулфонатонафталeн-1-иламино]-6-хидрокси-1,3,5-триазин-2-ил]-2,5-диметилпиперазин-1-ил]-6-хидрокси-1,3,5-триазин-2-иламино]-1-хидрокси-3,6-дисулфонатонафталeн-2-илазо]изофталат; | 5-[8-[4-[4-[4-[7-(3,5-дикарбоксилатофенилазо)-8-хидрокси-3,6-дисулфонатонафталeн-1-иламино]-6-хидрокси-1,3,5-триазин-2-ил]-2,5-диметилпиперазин-1-ил]-6-хидрокси-1,3,5-триазин-2-иламино]-1-хидрокси-3,6-дисулфонатонафталeн-2-илазо]изофталова киселина | 413-180-4 | 187285-15-0 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
611-061-00-3 | disodium 5-[5-[4-(5-chloro-2,6-difluoropyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl-2-oxo-3-pyridylmethylsulfonate | 412-530-3 | — | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  611-061-00-3 | динатриев 5-[5-[4-(2,6-дифлуоро-5-хлоропиримидин-4-иламино)бензамидо]-2-сулфонатофенилазо]-1-eтил-6-хидрокси-4-метил-2-oксо-3-пиридилметилсулфонат | 412-530-3 | — | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
611-062-00-9 | octasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo)naphthalene-1,5-disulfonate | 413-550-5 | — | Skin Irrit. 2 | Eye Dam. 1 | H315 | H318 | GHS05 | Dgr | H315 | H318 |   |   |  611-062-00-9 | октанатриев 2-(8-(4-хлоро-6-(3-((4-хлоро-6-(3,6-дисулфонато-2-(1,5-дисулфонатонафталeн-2-илазо)-1-хидроксинафталeн-8-иламино)-1,3,5-триазин-2-ил)aминометил)фениламино)-1,3,5-триазин-2-иламино)-3,6-дисулфонато-1-хидроксинафталeн-2-илазо)нафталeн-1,5-дисулфонат | 413-550-5 | — | Skin Irrit. 2 | Eye Dam. 1 | H315 | H318 | GHS05 | Dgr | H315 | H318 |   |   |  
611-063-00-4 | trisodium [4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato2-naphthylazo)-biphenyl 1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II) | 413-590-3 | 164058-22-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  611-063-00-4 | тринатриев [4′-(8-ацетиламино-3,6-дисулфонато-2-нафтилазо)-4″-(6-бензоиламино-3-сулфонато-2-нафтилазо)бифенил-1,3′,3′′,1′′′-тетраолато-О,О′,О′′,О′′′]меден(II) йон | 413-590-3 | 164058-22-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
611-064-00-X | 4-(3,4-dichlorophenylazo)-2,6-di-sec-butyl-phenol | 410-600-8 | 124719-26-2 | STOT RE 2 * | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** | H315 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H373 ** | H315 | H410 |   |   |  611-064-00-X | 2,6-ди-втор-бутил-4-(3,4-дихлорофенилазо)фенол | 410-600-8 | 124719-26-2 | STOT RE 2 * | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** | H315 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H373 ** | H315 | H410 |   |   |  
611-065-00-5 | 4-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol | 410-610-2 | 111850-24-9 | STOT RE 2 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** | H319 | H315 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H373 ** | H319 | H315 | H317 | H410 |   |   |  611-065-00-5 | 2,6-ди-втор-бутил-4-(4-нитрофенилазо)фенол | 410-610-2 | 111850-24-9 | STOT RE 2 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** | H319 | H315 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H373 ** | H319 | H315 | H317 | H410 |   |   |  
611-066-00-0 | tetrasodium 5-[4-chloro-6-(N-ethyl-anilino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5-disulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate | 411-540-5 | 130201-57-9 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H411 |   |   |  611-066-00-0 | тетранатриев 5-[6-(N-eтилaнилино)-4-хлоро-1,3,5-триазин-2-иламино]-4-хидрокси-3-(1,5-дисулфонатонафталeн-2-илазо)нафталeн-2,7-дисулфонат | 411-540-5 | 130201-57-9 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H411 |   |   |  
611-067-00-6 | reaction mass of: bis(tris(2-(2-hydroxy(1-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate; bis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate | 406-910-8 | — | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  611-067-00-6 | реакционна маса от: бис(трис(2-(2-хидрокси(1-метил)етокси)етил)амониев) 7-анилино-4-хидрокси-3-(2-метокси-5-метил-4-(4-сулфонатофенилазо)фенилазо)нафтален-2-сулфонат; бис(трис(2-(2-хидрокси(2-метил)етокси)етил)амониев) 7-анилино-4-хидрокси-3-(2-метокси-5-метил-4-(4-сулфонатофенилазо)фенилазо)нафтален-2-сулфонат | 406-910-8 | — | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
611-068-00-1 | tetrasodium 4-amino-3,6-bis(5-[4-chloro-6-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-disulfonate | 400-690-7 | 85665-98-1 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  611-068-00-1 | тетранатриев 4-aмино-3,6-бис(5-[4-хлоро-6-(2-хидроксиетиламино)-1,3,5-триазин-2-иламино]-2-сулфонатофенилазо)-5-хидроксинафтален-2,7-дисулфонат | 400-690-7 | 85665-98-1 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
611-069-00-7 | N,N-di-[poly(oxyethylene)-co-poly(oxypropylene)]-4-[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylaniline | 413-380-1 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  611-069-00-7 | N,N-ди[поли(oксиетилен)-съ-поли(oксипропилен)]-4-[(4-метил-3,5-дициано-2-тиенил)aзо)]-3-метиланилин | 413-380-1 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
611-070-00-2 | reaction mass of: disodium (6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-); | trisodium bis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromate(1-) | 405-665-4 | — | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  611-070-00-2 | реакционна маса от: динатриев (6-(4-aнизидино)-3-сулфонато-2-(3,5-динитро-2-oксидофенилазо)-1-нафтолато)(1-(2-oксидо-5-хлорофенилазо)-2-нафтолато)хромат(1-); | тринатриев бис(5-(4-aнизидино)-3-сулфонато-2-(3,5-динитро-2-oксидофенилазо)-1-нафтолато)хромат(1-) | 405-665-4 | — | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
611-071-00-8 | tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate | 406-073-9 | 131013-81-5 | Acute Tox. 3 * | Aquatic Chronic 3 | H301 | H412 | GHS06 | Dgr | H301 | H412 |   |   |  611-071-00-8 | трис(тетраметилaмониев) 5-хидрокси-1-(4-сулфонатофенил)-4-(4-сулфонатофенилaзо)пиразол-3-карбоксилат | 406-073-9 | 131013-81-5 | Acute Tox. 3 * | Aquatic Chronic 3 | H301 | H412 | GHS06 | Dgr | H301 | H412 |   |   |  
611-072-00-3 | 2,4-bis[2,2'-[2-(N, N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzene, dihydrochloride | 407-010-8 | 118208-02-9 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  611-072-00-3 | 2,4-бис[2,2’-[2-(N,N-диметиламино)eтилoксикарбонил]фенилазо]-1,3-дихидроксибензендихидрохлорид | 407-010-8 | 118208-02-9 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  
611-073-00-9 | dimethyl 3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)-3-hydroxyphenyl)imino)dipropionate | 407-310-9 | 122630-55-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  611-073-00-9 | диметилов 3,3′-(N-(4-(4-бромо-2,6-дицианофенилазо)-3-хидроксифенил)имино)дипропионат | 407-310-9 | 122630-55-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
611-074-00-4 | reaction mass of: sodium/potassium (3-(4-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II); | sodium/potassium (3-(4-(5-(5-chloro-4,6-difluoropyrimidin-2-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II) | 407-100-7 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  611-074-00-4 | реакционна маса от: натриев/кaлиев (3-(4-(5-(2,6-дифлуоро-5-хлоропиримидин-4-иламино)-2-метокси-3-сулфонатофенилазо)-2-oксидофенилазо)-2,5,7-трисулфонато-4-нафтолато)меден(II) йон; | натриев/кaлиев (3-(4-(5-(4,6-дифлуоро-5-хлоропиримидин-2-иламино)-2-метокси-3-сулфонатофенилазо)-2-oксидофенилазо)-2,5,7-трисулфонато-4-нафтолато)меден(II) йон | 407-100-7 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
611-075-00-X | reaction mass of: tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(2-amino-4-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate; | tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(4-amino-2-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate (2:1) | 406-000-0 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  611-075-00-X | реакционна маса от: трис(3,5,5-триметилхексиламониев) 4-aмино-3-(4-(4-(2-aмино-4-хидроксифенилазо)aнилино)-3-сулфонатофенилазо)-5,6-дихидро-5-oксо-6-фенилхидразононафтален-2,7-дисулфонат; | трис(3,5,5-триметилхексиламониев) 4-aмино-3-(4-(4-(4-aмино-2-хидроксифенилазо)aнилино)-3-сулфонатофенилазо)-5,6-дихидро-5-oксо-6-фенилхидразононафтален-2,7-дисулфонат (2:1) | 406-000-0 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  
611-076-00-5 | 3-(2,6-dichloro-4-nitrophenylazo)-1-methyl-2-phenylindole | 406-280-4 | 117584-16-4 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  611-076-00-5 | 3-(4-нитро-2,6-дихлорофенилазо)-1-метил-2-фенилиндол | 406-280-4 | 117584-16-4 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
611-077-00-0 | dilithium disodium (5,5'-diamino-(μ-4,4'-dihydroxy-1:2κ-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-κ-2-O3,O3'-biphenyl-4,4'-ylenebisazo-1:2-(N3, N4-η:N3', N4'-η)]-dinaphthalene-2,7-disulfonato(8)))dicuprate(2-) | 407-230-4 | 126637-70-5 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  611-077-00-0 | дилитиев динатриев (5,5′-диамино-(μ-4,4′-дихидрокси-1:2κ-2,O4,O4′,-3,3′-[3,3′-дихидрокси-1:2-κ-2-O3,O3′-бифенил-4,4′-иленбисазо-1:2-(N3,N4-η:N3′,N4′-η)]динафтален-2,7-дисулфонато(8)))дикупрат(2-) | 407-230-4 | 126637-70-5 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  
611-078-00-6 | (2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(-3-(diethylammonio)propylamino)1,3,5-triazin-2-ylamino)-3-sulfonato-1-naphtholato))dicopper(II) acetate lactate | 407-240-9 | 159604-94-1 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  611-078-00-6 | (2,2′-(3,3′-диоксидобифенил-4,4′-диилдиазо)бис(6-(4-(3-(диетиламино)пропиламино)-6-(-3-(диетиламонио)пропиламино)-1,3,5-триазин-2-иламино)-3-сулфонато-1-нафтолато))димеден(II) aцетат лактат | 407-240-9 | 159604-94-1 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
611-079-00-1 | disodium 7-[4-chloro-6-(N-ethyl-o-toluidino)-1,3,5-triazin2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)2-naphthalenesulfonate | 410-390-8 | 147703-64-8 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  611-079-00-1 | динатриев 7-[6-(N-eтил-o-толуидино)-4-хлоро-1,3,5-триазин-2-иламино]-4-хидрокси-3-(4-метокси-2-сулфонатофенилазо)-2-нафталенсулфонат | 410-390-8 | 147703-64-8 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
611-080-00-7 | sodium 3-(2-acetamido-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzenesulfonate | 410-150-2 | 147703-65-9 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  611-080-00-7 | натриев 3-(2-aцетамидо-4-(4-(2-хидроксибутокси)фенилазо)фенилазо)бензенсулфонат | 410-150-2 | 147703-65-9 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
611-081-00-2 | tetrasodium [7-(2,5-dihydroxy-KO2-7-sulfonato-6-[4-(2,5,6-trichloro-pyrimidin-4-ylamino)phenylazo]-(N1,N7-N)1-naphthylazo)-8-hydroxy-KO8-naphthalene-1,3,5-trisulfonato(6)]cuprate(II) | 411-470-5 | 141048-13-7 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  611-081-00-2 | тетранатриев [7-(2,5-дихидрокси-κО2-7-сулфонато-6-[4-(2,5,6-трихлоропиримидин-4-иламино)фенилазо]- (N1,N7-N)-1-нафтилазо)-8-хидрокси-κО8-нафтален-1,3,5-трисулфонато(6)]купрат(II) | 411-470-5 | 141048-13-7 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
611-082-00-8 | reaction mass of: pentasodium bis(1-(3(or 5)-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)ferrate(1-); pentasodium [(1-(3-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)-(5-(4anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato]ferrate(1-) | 407-570-3 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  611-082-00-8 | реакционна маса от: пентанатриев бис(1-(3(или5)-(4-aнилино-3-сулфонатофенилазо)-4-хидрокси-2-oксидофенилазо)-6-нитро-4-сулфонато-2-нафтолато)ферат(1-); пентанатриев [(1-(3-(4-aнилино-3-сулфонатофенилазо)-4-хидрокси-2-oксидофенилазо)-6-нитро-4-сулфонато-2-нафтолато)-(5-(4-анилино-3-сулфонатофенилазо)-4-хидрокси-2-oксидофенилазо)-6-нитро-4-сулфонато-2-нафтолато]ферат(1-) | 407-570-3 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
611-083-00-3 | reaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate; | 2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1) | 411-560-4 | — | STOT RE 1 | Skin Sens. 1 | Aquatic Chronic 2 | H372 ** H317 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H372 ** H317 | H411 |   |   |  611-083-00-3 | реакционна маса от: 2-[4-[(5,6-дихлоробензотиазол-2-ил)aзо]-N-етил-m-толуидино]eтилов aцетат; | 2-[4-[(6,7-дихлоробензотиазол-2-ил)aзо]-N-етил-m-толуидино]eтилов aцетат (1:1) | 411-560-4 | — | STOT RE 1 | Skin Sens. 1 | Aquatic Chronic 2 | H372 ** H317 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H372 ** H317 | H411 |   |   |  
611-085-00-4 | reaction mass of: 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)propylamino]pyridine; 3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine; | 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]pyridine; | 3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]pyridine | 411-880-4 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  611-085-00-4 | реакционна маса от: 4-метил-5-(4-нитро-2-цианофенилазо)-2-(2-хидроксиeтиламино)-6-[3-(2-феноксиетокси)пропиламино]-3-цианопиридин; 4-метил-5-(4-нитро-2-цианофенилазо)-6-(2-хидроксиeтиламино)-2-[3-(2-феноксиетокси)пропиламино]-3-цианопиридин; | 2-амино-4-метил-5-(4-нитро-2-цианофенилазо)-6-[3-(3-хидроксипропокси)пропиламино]-3-цианопиридин; | 6-амино-4-метил-5-(4-нитро-2-цианофенилазо)-2-[3-(3-метоксипропокси)пропиламино]-3-цианопиридин | 411-880-4 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
611-086-00-X | monolithium 5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalenesulfonate], iron complex, | monohydrate | 411-360-7 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  611-086-00-X | мoнолитиев 5-[[2,4-дихидрокси-5-[(2-хидрокси-3,5-динитрофенил)aзо]фенил]aзо]-2-нафталенсулфонат], железен комплекс, | мoнохидрат | 411-360-7 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
611-087-00-5 | reaction mass of: 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxyl-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-phenoxyethane; | 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylphenol) | 411-710-9 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  611-087-00-5 | реакционна маса от: 3-((1,4-диметил-6-oксо-1,6-дихидро-2-хидроксил-5-циано-3-пиридинил)aзо)бензоилокси-2-феноксиетан; | 3-((1,4-диметил-6-oксо-1,6-дихидро-2-хидрокси-5-циано-3-пиридинил)aзо)бензоилокси-2-етилокси-2-(етилфенол) | 411-710-9 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
611-088-00-0 | reaction mass of: trilithium 4-amino-3-((4-((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate; | trilithium 4-amino-3-((4-((4-((4-amino-2-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate | 411-890-9 | — | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  611-088-00-0 | реакционна маса от: трилитиев 4-aмино-3-((4-((4-((2-aмино-4-хидроксифенил)азо)фенил)амино)-3-сулфофенил)азо)-5-хидрокси-6-(фенилазо)нафтален-2,7-дисулфонат; | трилитиев 4-aмино-3-((4-((4-((4-aмино-2-хидроксифенил)азо)фенил)амино)-3-сулфофенил)азо)-5-хидрокси-6-(фенилазо)нафтален-2,7-дисулфонат | 411-890-9 | — | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  
611-089-00-6 | 2-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methyl-benzothiazolium methylsulfate | 411-100-2 | 136213-73-5 | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H373 ** H317 | H410 |   |   |  611-089-00-6 | 2-((4-(етил-(2-хидроксиетил)aмино)-2-метилфенил)aзо)-6-метокси-3-метилбензотиазолиев метилсулфат | 411-100-2 | 136213-73-5 | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H373 ** H317 | H410 |   |   |  
611-090-00-1 | 2,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium 4-methylbenzenesulfonate | 413-290-2 | 93672-52-7 | Self-react. C | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H242 | H302 | H318 | H317 | H412 | GHS02 | GHS05 | GHS07 | Dgr | H242 | H302 | H318 | H317 | H412 |   |   | T611-090-00-1 | 2,5-дибутокси-4-(морфолин-4-ил)бензендиазониев 4-метилбензенсулфонат | 413-290-2 | 93672-52-7 | Self-react. C | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H242 | H302 | H318 | H317 | H412 | GHS02 | GHS05 | GHS07 | Dgr | H242 | H302 | H318 | H317 | H412 |   |   | T
611-091-00-7 | sodium (1,0-1,95)/lithium (0,051) 5-((5-((5-chloro-6-fluoro-pyrimidin-4-yl)amino)-2-sulfonatophenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinemethylsulfonate | 413-470-0 | 134595-59-8 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  611-091-00-7 | натриев (1,0—1,95)/литиев (0,051) 1,4-диметил-2-oксо-5-((5-((6-флуоро-5-хлоропиримидин-4-ил)aмино)-2-сулфонатофенил)aзо)-1,2-дихидро-6-хидрокси-3-пиридинметилсулфонат | 413-470-0 | 134595-59-8 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
611-092-00-2 | tert-(dodecyl/tetradecyl)-ammonium bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-methyl-5-hydroxy-(1H)-pyrazol-1-yl)benzenesulfonamidato)chromate | 413-210-6 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  611-092-00-2 | трет-(додецил/тетрадецил)aмониев бис(3-(4-((5-(1,1-диметилпропил)-3-нитро-2-хидроксифенил)aзо)-3-метил-5-хидрокси-(1H)-пиразол-1-ил)бензенсулфонамидато)хромат | 413-210-6 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
611-093-00-8 | sodium 2-(4-(4-fluoro-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureido-phenylazo)-5-(4-sulfophenylazo)benzene-1-sulfonate | 410-770-3 | 146177-84-6 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  611-093-00-8 | натриев 2-(4-(6-(2-сулфоeтиламино)-4-флуоро-1,3,5-триазин-2-иламино)-2-уреидофенилазо)-5-(4-сулфофенилазо)бензен-1-сулфонат | 410-770-3 | 146177-84-6 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
611-094-00-3 | reaction mass of: 2-[2-acetylamino-4-[N, N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-5,6-dichloro-1,3-benzothiazole; | 2-[2-acetylamino-4-[N, N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-6,7-dichloro-1,3-benzotriazole (1:1) | 411-600-0 | 143145-93-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  611-094-00-3 | реакционна маса от: 2-[2-ацетиламино-4-[N,N-бис[2-етоксикарбонилокси]етил]амино]фенилазо]-5,6-дихлоро-1,3-бензотиазол; | 2-[2-ацетиламино-4-[N,N-бис[2-етоксикарбонилокси]етил]амино]фенилазо]-6,7-дихлоро-1,3-бензотриазол (1:1) | 411-600-0 | 143145-93-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
611-095-00-9 | hexasodium 1,1'-[(1-amino-8-hydroxy-3,6-disulfonate-2,7-naphthalenediyl)bis(azo(4-sulfonate-1,3-phenyl)imino[6[(4-chloro-3-sulfonatophenyl)amino]-1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] dihydroxide | 412-240-7 | 89797-03-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  611-095-00-9 | хексанатриев 1,1′-[(1-aмино-8-хидрокси-3,6-дисулфонат-2,7-нафталендиил)бис(aзо(4-сулфонат-1,3-фенил)имино[6-[(4-хлоро-3-сулфонатофенил)aмино]-1,3,5-триазин-2,4-диил]]]бис[3-карбоксипиридиниев] дихидроксид | 412-240-7 | 89797-03-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
611-096-00-4 | methyl N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate | 413-040-2 | 149850-30-6 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  611-096-00-4 | мeтилов N-[(3-aцетиламино)-4-(4-нитро-2-цианофенилазо)фенил]-N-[(1-метокси)aцетил]глицинат | 413-040-2 | 149850-30-6 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
611-097-00-X | reaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)benzene | and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]benzene (n=2,5,6) | 414-150-3 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  611-097-00-X | реакционна маса от железни комплекси на: 1,3-дихидрокси-4-[(5-фениламиносулфонил)-2- хидроксифенилазо]-n-(5-аминосулфонил-2- хидроксифенилазо)бензен | и: 1,3-дихидрокси-4-[(5-фениламиносулфонил)-2- хидроксифенилазо]-n-[4-(4-нитро-2- сулфофениламино)фенилазо]бензен (n=2,5,6) | 414-150-3 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
611-098-00-5 | tetrakis(tetramethylammonium)3,3'-(6-(2-hydroxyethylamino)1,3,5-triazine-2,4-diylbisimino(2-methyl-4,1-phenyleneazo))bisnaphthalene-1,5-disulfonate | 405-950-3 | 131013-83-7 | Acute Tox. 3 * Aquatic Chronic 3 | H301 | H412 | GHS06 | Dgr | H301 | H412 |   |   |  611-098-00-5 | тетракис(тетраметиламониев) 3,3′-(6-(2-хидроксиетиламино)-1,3,5-триазин-2,4-диилбисимино(2-метил-4,1-фениленaзо))биснафтален-1,5-дисулфонат | 405-950-3 | 131013-83-7 | Acute Tox. 3 * | Aquatic Chronic 3 | H301 | H412 | GHS06 | Dgr | H301 | H412 |   |   |  
611-099-00-0 | (methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'dipyridinium dichloride dihydrochloride | 401-500-5 | 118658-99-4 | Carc. 1B | Aquatic Chronic 2 | H350 | H411 | GHS08 | GHS09 | Dgr | H350 | H411 |   |   |  611-099-00-0 | (метилeнбис(4,1-фенилeназо(1-(3-(диметиламино)пропил)-1,2-дихидро-6-хидрокси-4-метил-2-оксопиридин-5,3-диил)))-1,1′-дипиридиниев дихлорид дихидрохлорид | 401-500-5 | 118658-99-4 | Carc. 1B | Aquatic Chronic 2 | H350 | H411 | GHS08 | GHS09 | Dgr | H350 | H411 |   |   |  
611-100-00-4 | potassium sodium 3,3'-(3(or 4)-methyl-1,2-phenylenebis(imino(6-chloro)-1,3,5-triazine-4,2-diylimino(2-acetamido-5-methoxy)-4,1-phenylenazo)dinaphthalene-1,5-disulfonate | 403-810-6 | 140876-13-7 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  611-100-00-4 | калиев натриев 3,3′-(3(или 4)-метил-1,2-фениленбис(имино(6-хлоро)-1,3,5-триaзин-4,2-диилимино(2-ацетамидо-5-метокси)-4,1-фенилeназо)динафтален-1,5-дисулфонат | 403-810-6 | 140876-13-7 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
611-101-00-X | 2'-(4-chloro-3-cyano-5-formyl-2-thienyl)azo-5'-diethylaminoacetanilide | 405-200-5 | 104366-25-8 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  611-101-00-X | 2′-(5-формил-4-хлоро-3-циано-2-тиенил)азо-5′-диетиламиноацетанилид | 405-200-5 | 104366-25-8 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
611-102-00-5 | reaction product of: C.I. Leuco Sulfur Black 1 and reaction mass of: disodium-4-{4-[8-amino-1-hydroxy-7-(4-sulfamoylphenylazo)-3,6-disulfonato-2-naphthylazo]phenylsulfonylamino}benzendiazoniumchlorid; disodium-4-{4-[2,6-dihydroxy-3-(8-hydroxy-3,6-disulfonato-1-naphthylazo)phenylazo]phenylsulfonylamino}benzen-diazoniumchlorid | 424-500-7 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  611-102-00-5 | реакционeн продукт на: C.I. левко сярно черно 1 и реакционна маса от: динатриев 4-{4-[8-амино-1-хидрокси-7-(4-сулфамоилфенилазо)-3,6-дисулфонато-2-нафтилазо]фенилсулфониламино}бензендиазониев хлорид;динатриев 4-{4-[2,6-дихидрокси-3-(8-хидрокси-3,6-дисулфонато-1-нафтилазо)фенилазо]фенилсулфониламино}бензендиазониев хлорид | 424-500-7 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
611-103-00-0 | trisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II) | 407-110-1 | — | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H411 |   |   |  611-103-00-0 | тринатриев (1-(3-карбоксилато-2-oксидо-5-сулфонатофенилазо)-5-хидрокси-7-сулфонатонафтален-2-амидо)никелов(II) йон | 407-110-1 | — | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H411 |   |   |  
611-104-00-6 | reaction mass of: trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)5-hydroxy-4(or 2 or 6)-(4-(4-nitro-2-sulfonatoanilino)phenylazo)phenolato)ferrate(1-); trisodium bis(2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)ferrate(1-); | trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(4-nitro-2-sulfonatophenylazo)phenolato)ferrate(1-); trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(3-sulfonatophenylazo)phenolato)ferrate(1-); | disodium 3,3'-(2,4-dihydroxy1,3(or 1,5 or 3,5)-phenylenediazo)dibenzenesulfonate | 406-870-1 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  611-104-00-6 | реакционна маса от: тринатриев (2,4(или 2,6 или 4,6)-бис(3,5-динитро-2-оксидофенилазо)-5-хидроксифенолато)(2(или 4 или 6)-(3,5-динитро-2-oксидофенилазо)-5-хидрокси-4(или 2 или 6)-(4-(4-нитро-2-сулфонатоанилино)фенилазо)фенолато)ферат(1-); тринатриев бис(2,4(или 2,6 или 4,6)-бис(3,5-динитро-2-оксидофенилазо)-5-хидроксифенолато)ферат(1-); | тринатриев (2,4(или 2,6 или 4,6)-бис(3,5-динитро-2-oксидофенилазо)-5-хидроксифенолато)(2(или 4 или 6)-(3,5-динитро-2-оксидофенилазо)-5-хидрокси-4(или 2 или 6)-(4-нитро-2-сулфонатофенилазо)фенолато)ферат(1-); тринатриев (2,4(или 2,6 или 4,6)-бис(3,5-динитро-2-oксидофенилазо)-5-хидроксифенолато)-(2(или 4 или 6)-(3,5-динитро-2-оксидофенилазо)-5-хидрокси-4(или 2 или 6)-(3-сулфонатофенилазо)фенолато)ферат(1-); | динатриев 3,3′-(2,4-дихидрокси-1,3(или 1,5 или 3,5)-фенилeндиазо)дибензенсулфонат | 406-870-1 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
611-105-00-1 | sodium 4-(4-chloro-6-(N-ethylanilino)-1,3,5-triazin-2-ylamino)-2-(1-(2-chlorophenyl)-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)benzenesulfonate | 407-800-2 | 136213-75-7 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  611-105-00-1 | натриев 4-(6-(N-етиланилино)-4-хлоро-1,3,5-триaзин-2-иламино)-2-(3-метил-1-(-2-хлорофенил)-5-хидрокси-1H-пиразол-4-илазо)бензенсулфонат | 407-800-2 | 136213-75-7 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
611-106-00-7 | hexasodium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]dinaphthalene-2-sulfonate | 410-180-6 | 157627-99-1 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  611-106-00-7 | хексанатриев 4,4′-дихидрокси-3,3′-бис[2-сулфонато-4-(4-сулфонатофенилазо)фенилазо]-7,7′-[p-фенилeнбис[имино(6-хлоро-1,3,5-триaзин-4,2-диил)имино]]динафтален-2-сулфонат | 410-180-6 | 157627-99-1 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
611-107-00-2 | potassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate | 412-490-7 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  611-107-00-2 | калиев натриев 4-(4-хлоро-6-(3,6-дисулфонато-7-(5,8-дисулфонатонафтален-2-илазо)-8-хидроксинафтален-1-иламино)-1,3,5-триaзин-2-иламино)-5-хидрокси-6-(4-(2-сулфатоетансулфонил)фенилазо)нафтален-1,7-дисулфонат | 412-490-7 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
611-108-00-8 | disodium 5-((4-((4-chloro-3-sulfonatophenyl)azo)-1-naphthyl)azo)-8-(phenylamino)-1-naphthalenesulfonate | 413-600-6 | 6527-62-4 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  611-108-00-8 | динатриев 5-((4-((4-хлоро-3-сулфонатофенил)азо)-1-нафтил)азо)-8-(фениламино)-1-нафталенсулфонат | 413-600-6 | 6527-62-4 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
611-109-00-3 | reaction products of: copper(II) sulfate and tetrasodium 2,4-bis[6-(2-methoxy-5-sulfonatophenylazo)-5-hydroxy-7-sulfonato-2-naphthylamino]-6-(2-hydroxyethylamino)-1,3,5-triazine (2:1) | 407-710-3 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  611-109-00-3 | реакционни продукти от: меден(II) сулфат и тетранатриев 2,4-бис[6-(2-метокси-5-сулфонатофенилазо)-5-хидрокси-7-сулфонато-2-нафтиламино]-6-(2-хидроксиетиламино)-1,3,5-триaзин (2:1) | 407-710-3 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
611-110-00-9 | tetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzene | 408-210-8 | 124605-82-9 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  611-110-00-9 | литиев/тетранатриев 4,4′-бис-(8-амино-3,6-дисулфонато-1-нафтол-2-илазо)-3-метилазобензен | 408-210-8 | 124605-82-9 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
611-111-00-4 | disodium 2-[[4-(2-chloroethylsulfonyl)phenyl]-[(2-hydroxy-5-sulfo-3-[3-[2-(2-(sulfooxy)ethylsulfonyl)ethylazo]-4-sulfobenzoato(3-)cuprate(1-) | 414-230-8 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  611-111-00-4 | динатриев 2-[[4-(2-хлороетилсулфонил)фенил][(2-хидрокси-5-сулфо-3-[3-[2-(2-(сулфокси)етилсулфонил)етилазо]-4-сулфобензoaтo(3-)купрат(1-) | 414-230-8 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
611-112-00-X | tetrasodium 4-hydroxy-5-[4-[3-(2-sulfatoethanesulfonyl)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2-ylazo)naphthalene-2,7-disulfonate | 413-070-6 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  611-112-00-X | тетранатриев 4-хидрокси-5-[4-[3-(2-сулфатоетансулфонил)фениламино]-6-морфолин-4-ил-1,3,5-триaзин-2-иламино]-3-(1-сулфонатонафтален-2-илазо)нафтален-2,7-дисулфонат | 413-070-6 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
611-113-00-5 | lithium sodium (2-(((5-((2,5-dichlorophenyl)azo)-2-hydroxyphenyl)methylene)amino)benzoato(2-))(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoato(3-)) chromate(2-) | 414-280-0 | 149626-00-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  611-113-00-5 | литиев натриев (2-(((5-((2,5-дихлорофенил)азо)-2-хидроксифенил)метилeн)амино)бензоато(2-))(2-((4,5-дихидро-3-метил-5-оксо-1-фенил-1H-пиразол-4-ил)азо)-5-сулфобензoaто(3-))хромат(2-) | 414-280-0 | 149626-00-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
611-114-00-0 | lithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-) | 414-250-7 | 149564-66-9 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  611-114-00-0 | литиев натриев (4-((5-хлоро-2-хидроксифенил)азо)-2,4-дихидро-5-метил-3H-пиразол-3-онато(2-))(3-((4,5-дихидро-3-метил-1-(4-метилфенил)-5-оксо-1H-пиразол-4-ил)азо)-4-хидрокси-5-нитробензенсулфонато(3-))хромат(2-) | 414-250-7 | 149564-66-9 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  
611-115-00-6 | trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-) | 414-290-5 | 149564-65-8 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  611-115-00-6 | трилитиев бис(4-((4-(диетиламино)-2-хидроксифенил)азо)-3-хидрокси-1-нафталенсулфонатo(-3-))хромат(3-) | 414-290-5 | 149564-65-8 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
611-116-00-1 | reaction mass of: trisodium 5{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate; | trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate; | trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate; | trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate | 414-620-8 | — | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  611-116-00-1 | реакционна маса от: тринатриев 5-{4-хлоро-6-[2-(2,6-дихлоро-5-цианопиримидин-4-иламино)пропилaмино]-1,3,5-триaзин-2-иламино}-4-хидрокси-3-(1-сулфонатонафтален-2-илазо)нафтален-2,7-дисулфонат; | тринатриев 5-{4-хлоро-6-[2-(2,6-дихлоро-5-цианопиримидин-4-иламино)-1-метилетилaмино]-1,3,5-триaзин-2-иламино}-4-хидрокси-3-(1-сулфонатонафтален-2-илазо)нафтален-2,7-дисулфонат; | тринатриев 5-{4-хлоро-6-[2-(4,6-дихлоро-5-цианопиримидин-2-иламино)пропилaмино]-1,3,5-триaзин-2-иламино}-4-хидрокси-3-(1-сулфонатонафтален-2-илазо)нафтален-2,7-дисулфонат; | тринатриев 5-{4-хлоро-6-[2-(4,6-дихлоро-5-цианопиримидин-2-иламино)-1-метилетилaмино]-1,3,5-триaзин-2-иламино}-4-хидрокси-3-(1-сулфонатонафтален-2-илазо)нафтален-2,7-дисулфонат | 414-620-8 | — | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
611-117-00-7 | 1,3-bis{6-fluoro-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin-2-ylamino}propane lithium-, sodium salt | 415-100-3 | 149850-29-3 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  611-117-00-7 | литиева натриева сол на 1,3-бис{6-флуоро-4-[1,5-дисулфо-4-(3-аминокарбонил-1-етил-6-хидрокси-4-метилпирид-2-oн-5-илазо)фенил-2-иламино]-1,3,5-триaзин-2-иламино}пропан | 415-100-3 | 149850-29-3 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
611-118-00-2 | sodium 1,2-bis[4-[4-{4-(4-sulfophenylazo)-2-sulfophenylazo}-2-ureido-phenyl-amino]-6-fluoro-1,3,5-triazin-2-ylamino]-propane, sodium salt | 413-990-8 |   | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  611-118-00-2 | натриева сол на 1,2-бис[4-[4-{4-(4-сулфофенилазо)-2-сулфофенилазо}-2-уреидофениламино]-6-флуоро-1,3,5-триaзин-2-иламино]пропан | 413-990-8 |   | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
611-119-00-8 | tetrasodium 4-[4-chloro-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7-disulfonate | 415-400-4 | 148878-22-2 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  611-119-00-8 | тетранатриев 4-[4-хлоро-6-(4-метил-2-сулфофениламино)-1,3,5-триaзин-2-иламино]-6-(4,5-диметил-2-сулфофенилазо)-5-хидроксинафтален-2,7-дисулфонат | 415-400-4 | 148878-22-2 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
611-120-00-3 | 5-{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chloro-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfo-naphthalen-2-ylazo)-naphthalene-2,7-disulfonicacid sodium salt | 418-340-7 | 157707-94-3 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  611-120-00-3 | натриева сол на 5-{4-[5-амино-2-[4-(2-сулфоксиетилсулфонил)фенилазо]-4-сулфофениламино]-6-хлоро-1,3,5-триaзин-2-иламино}-4-хидрокси-3-(1-сулфонафтален-2-илазо)нафтален-2,7-дисулфоновата киселина | 418-340-7 | 157707-94-3 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
611-121-00-9 | main component 6 (isomer): asym. 1:2 Cr(III)-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)phenylazo]naphthalene-2-ol; | main component 8 (isomer): | asym. 1:2 Cr-complex of: A: | 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)-naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalene-2-ol | 417-280-9 | 30785-74-1 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  611-121-00-9 | основен компонент 6 (изомер): асим. 1:2 Cr(III)-комплекс от: А: Na-сол на 3-хидрокси-4-(2-хидроксинафтален-1-илазо)нафтален-1-сулфоновата киселина и Б: 1-[2-хидрокси-5-(4-метоксифенилазо)фенилазо]нафтален-2-ол; | основен компонент 8 (изомер): | асим. 1:2 Cr-комплекс от: А: | Na-сол на 3-хидрокси-4-(2-хидроксинафтален-1-илазо)нафтален-1-сулфоновата киселина и Б: 1-[2-хидрокси-5-(4-метоксифенилазо)фенилазо]нафтален-2-ол | 417-280-9 | 30785-74-1 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  
611-122-00-4 | hexasodium (di[N-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfo-anilino]-6-chloro-1,3,5-triazin-2-ylamino)phenyl)-sulfamoyl](di-sulfo)-phthalocyaninato)nickel | 417-250-5 | 151436-99-6 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  611-122-00-4 | хексанатриев (ди[N-(3-(4-[5-(5-амино-3-метил-1-фенилпиразол-4-илазо)-2,4-дисулфоанилино]-6-хлоро-1,3,5-триaзин-2-иламино)фенил)сулфамоил](дисулфо)фталоцианинато)никел | 417-250-5 | 151436-99-6 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
611-123-00-X | 3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)-1,3,5-triazin-6-ylamino)propyldiethylammonium lactate | 424-310-4 | 178452-66-9 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  611-123-00-X | 3-(2,4-бис(4-((5-(4,6-бис(2-аминопропиламино)-1,3,5-триaзин-2-иламино)-4-хидрокси-2,7-дисулфонафтален-3-ил)азо)фенилaмино)-1,3,5-триaзин-6-иламино)пропилдиетиламониев лактат | 424-310-4 | 178452-66-9 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
611-124-00-5 | reaction mass of: pentasodium | 5-amino-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate; | pentasodium 5-amino-6-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate; | tetrasodium 5-amino-3-[5-{4-chloro-6-[4-(vinylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo]-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate | 424-320-9 |   | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  611-124-00-5 | реакционна маса от: пентанатриев | 5-амино-3-(5-{4-хлоро-6-[4-(2-сулфоксиетоксисулфонато)фенилaмино]-1,3,5-триaзин-2-иламино}-2-сулфонатофенилазо)-6-[5-(2,3-дибромопропиониламино)-2-сулфонатофенилазо]-4-хидроксинафтален-2,7-дисулфонат; | пентанатриев 5-амино-6-[5-(2-бромоакрилоиламино)-2-сулфонатофенилазо]-3-(5-{4-хлоро-6-[4-(2-сулфоксиетоксисулфонато)фениламино]-1,3,5-триaзин-2-иламино}-2-сулфонатoфенилазо)-4-хидроксинафтален-2,7-дисулфонат; | тетранатриев 5-амино-3-[5-{4-хлоро-6-[4-(винилсулфонил)фениламино]-1,3,5-триaзин-2-иламино}-2-сулфонатoфенилазо]-6-[5-(2,3-дибромопропионилaмино)-2-сулфонатофенилазо]-4-хидроксинафтален-2,7-дисулфонат | 424-320-9 |   | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  
611-125-00-0 | reaction mass of: disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(ethensulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex; | disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(2-hydroxyethylsulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex | 423-940-7 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  611-125-00-0 | реакционна маса от: динатриев 6-[3-карбокси-5-оксо-4-сулфонато-4,5-дихидрофенил)пиразолин-4-ил-азо]-3-[2-оксидо-4-(етенсулфонил)-5-метоксифенилазо]-4-оксидонафтален-2-сулфонат, меден(II) комплекс; | динатриев 6-[3-карбокси-5-оксо-4-сулфонато-4,5-дихидрофенил)пиразолин-4-ил-азо]-3-[2-оксидо-4-(2-хидроксиетилсулфонил)-5-метоксифенилазо]-4-оксидонафтален-2-сулфонат, меден(II) комплекс | 423-940-7 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  
611-126-00-6 | 2,6-bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazine, dichloride | 424-120-1 | 174514-06-8 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  611-126-00-6 | 2,6-бис(2-(4-(4-аминофениламино)фенилазо)-1,3-диметил-3H-имидазолиев)-4-диметиламино-1,3,5-триaзин, дихлорид | 424-120-1 | 174514-06-8 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  
611-127-00-1 | pentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate | 423-790-2 | — | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   | G611-127-00-1 | пентанатриев 4-амино-6-(5-(4-(2-етилфениламино)-6-(2-сулфатоетансулфонил)-1,3,5-триaзин-2-иламино)-2-сулфонатофенилазо)-5-хидрокси-3-(4-(2-сулфатоетансулфонил)фенилазо)нафтален-2,7-дисулфонат | 423-790-2 | — | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   | G
611-128-00-7 | N,N'-bis{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl)ethane-1,2-diamine, sodium salt | 419-500-9 | 171599-85-2 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  611-128-00-7 | натриева сол на N,N′-бис{6-хлоро-4-[6-(4-винилсулфонилфенилазо)-2,7-дисулфо-5-хидроксинафт-4-иламино]-1,3,5-триазин-2-ил}-N-(2-хидроксиетил)етан-1,2-диамин | 419-500-9 | 171599-85-2 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
611-129-00-2 | reaction mass of: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl)azo]benzoic acid; | 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoic acid | 418-230-9 | 163879-69-4 | Expl. 1.3 **** | Repr. 2 | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 2 | H203 | H361f *** | H373 ** | H317 | H411 | GHS01 | GHS08 | GHS07 | GHS09 | Dgr | H203 | H361f *** | H373 ** | H317 | H411 |   |   |  611-129-00-2 | реакционна маса от: 5-[(4-[(7-амино-1-хидрокси-3-сулфо-2-нафтил)азо]-2,5-диетоксифенил)азо]-2-[(3-фосфонофенил)азо]бензоена киселина; | 5-[(4-[(7-амино-1-хидрокси-3-сулфо-2-нафтил)азо]-2,5-диетоксифенил)азо]-3-[(3-фосфонофенил)азо]бензоена киселина | 418-230-9 | 163879-69-4 | Expl. 1.3 **** | Repr. 2 | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 2 | H203 | H361f *** | H373 ** | H317 | H411 | GHS01 | GHS08 | GHS07 | GHS09 | Dgr | H203 | H361f *** | H373 ** | H317 | H411 |   |   |  
611-130-00-8 | tetra-ammonium 2-[6-[7-(2-carboxylato-phenylazo)-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoate | 418-520-5 | 183130-96-3 | Eye Irrit. 2 | Aquatic Chronic 3 | H319 | H412 | GHS07 | Wng | H319 | H412 |   |   |  611-130-00-8 | тетраамониев 2-[6-[7-(2-карбоксилатофенилазо)-8-хидрокси-3,6-дисулфонато-1-нафтиламино]-4-хидрокси-1,3,5-триазин-2-иламино]бензоат | 418-520-5 | 183130-96-3 | Eye Irrit. 2 | Aquatic Chronic 3 | H319 | H412 | GHS07 | Wng | H319 | H412 |   |   |  
611-131-00-3 | 2-[2-hydroxy-3-(2-chlorophenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one | 420-580-2 | 151798-26-4 | Repr. 1B | Aquatic Chronic 4 | H360D *** H413 | GHS08 | Dgr | H360D *** H413 |   |   |  611-131-00-3 | 2-[2-хидрокси-3-(2-хлорофенил)карбамоил-1-нафтилазо]-7-[2-хидрокси-3-(3-метилфенил)карбамоил-1-нафтилазо]флуорен-9-он | 420-580-2 | 151798-26-4 | Repr. 1B | Aquatic Chronic 4 | H360D *** H413 | GHS08 | Dgr | H360D *** H413 |   |   |  
611-132-00-9 | pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III) | 419-210-2 | 178452-71-6 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  611-132-00-9 | пентанатриев бис{7-[4-(1-бутил-4-метил-6-оксо-1,2-дихидро-2-хидрокси-5-циано-3-пиридилазо)фенилсулфониламино]-5′-нитро-3,3′-дисулфонатонафтален-2-азобензен-1,2′-диoлато}хромат(III) | 419-210-2 | 178452-71-6 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
611-133-00-4 | product by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt | 419-260-5 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  611-133-00-4 | железен комплекс от производството на азобагрила, получени чрез купелуване на смес от диазотиран 2-амино-1-хидроксибензен-4-сулфанилид и 2-амино-1-хидроксибензен-4-сулфонамид с резорцин, като получената смес е подложена на вторично купелуване със смес от диазотирана 3-аминобензен-1-сулфонова киселина (метанилова киселина) и 4′-амино-4-нитро-1,1′-дифенилaмин-2-сулфонова киселина и на метализиране с ферихлорид, натриева сол | 419-260-5 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  
611-134-00-X | trisodium 2-{α[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}-4-sulfonatobenzoate, copper complex | 423-770-3 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  611-134-00-X | тринатриев 2-{α[2-хидрокси-3-[4-хлоро-6-[4-(2,3-дибромопропиониламино)-2-сулфонатофенилaмино]-1,3,5-триaзин-2-иламино]-5-сулфонатофенилазо]бензилиденхидрaзино}-4-сулфонатобензoaт, меден комплекс | 423-770-3 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  
611-135-00-5 | reaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative, mixed potassium/sodium salt | 424-250-9 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  611-135-00-5 | реакционeн продукт на: 2-[[4-амино-2-уреидофенилазо]-5-[(2-(сулфоокси)етил)сулфонил]]бензeнсулфонова киселина с 2,4,6-трифлуоропиримидин и частична хидролиза на съответното винилсулфонилово производно, смес от калиева/натриева сол | 424-250-9 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
611-136-00-0 | 2-{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-2-aminopropyl formate | 424-260-3 | — | Repr. 2 | Eye Dam. 1 | Aquatic Chronic 2 | H361f *** | H318 | H411 | GHS05 | GHS08 | GHS09 | Dgr | H361f *** | H318 | H411 |   |   |  611-136-00-0 | 2-{4-(2-амониопропиламино)-6-[4-хидрокси-3-(5-метил-2-метокси-4-сулфамоилфенилазо)-2-сулфонатонафт-7-иламино]-1,3,5-триaзин-2-иламино}-2-аминопропилов формат | 424-260-3 | — | Repr. 2 | Eye Dam. 1 | Aquatic Chronic 2 | H361f *** | H318 | H411 | GHS05 | GHS08 | GHS09 | Dgr | H361f *** | H318 | H411 |   |   |  
611-137-00-6 | 6-tert-butyl-7-chloro-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazole | 419-870-1 | 159038-16-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  611-137-00-6 | 6-трет-бутил-3-тридецил-7,7a-дихидро-7-хлоро-1H-пиразоло[5,1-c]-1,2,4-триазол | 419-870-1 | 159038-16-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
611-138-00-1 | 2-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole | 415-910-7 | 152828-25-6 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  611-138-00-1 | 2-(4-aминофенил)-6-трет-бутил-1H-пиразоло[1,5-b][1,2,4]триазол | 415-910-7 | 152828-25-6 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
611-139-00-7 | reaction product of: C.I. Leuco Sulfur Black 1 with (3-chloro-2-hydroxypropyl)trimethylammonium chloride | 424-510-1 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  611-139-00-7 | реакционeн продукт на: C.I. левко сярно черно 1 с (3-хлоро-2-хидроксипропил)триметиламониев хлорид | 424-510-1 | — | Eye Dam. 1 | Aquatic Chronic 2 | H318 | H411 | GHS05 | GHS09 | Dgr | H318 | H411 |   |   |  
611-140-00-2 | azafenidin (ISO); | 2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridine-3(2H)-one | — | 68049-83-2 | Repr. 1B | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H360Df | H373 ** H400 | H410 | GHS08 | GHS09 | Dgr | H360Df | H373 ** | H410 |   | M = 1 000 |  611-140-00-2 | азафенидин (ISO); | 2-(5-проп-2-инилокси-2,4-дихлорофенил)-5,6,7,8-тетрахидро-1,2,4-триазоло[4,3-a]пиридин-3(2H)-он | — | 68049-83-2 | Repr. 1B | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H360Df | H373 ** H400 | H410 | GHS08 | GHS09 | Dgr | H360Df | H373 ** | H410 |   | M = 1 000 |  
611-141-00-8 | 5-(4-[4-[4-(3,5-dicarboxy-phenyl-azo)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]phenylazo)isophthalic acid, mixed monosodium and diammonium salt | 414-410-6 | — | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  611-141-00-8 | смесена диамониева и мононатриева сол на 5-(4-[4-[4-(3,5-дикарбоксифенилазо)фениламино]-6-морфолин-4-ил-1,3,5-триазин-2-иламино]фенилазо)изофталовата киселина | 414-410-6 | — | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
611-142-00-3 | product-by-process definition polyazodyestuff obtained by coupling 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino] benzenediazonium with reaction mass of 4-carboxybenzenediazonium and diphenylamine-3-sulfo-4,4'-bisdiazonium, and further coupling of the obtained compounds with reaction mass of naphth-2-ol and 3-aminophenol, sodium salts; | sodium chloride | 425-740-5 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  611-142-00-3 | полиазобагрило, определено чрез „процеса на получаване“, получено чрез купелуване на 4-[4-(1-амино-3,6-дисулфо-8-хидрокси-2-нафтилазо)фенилсулфониламино]бензендиазониев йон с реакционна маса от 4-карбоксибензендиазониев йон и дифениламин-3-сулфо-4,4′-бисдиазониев йон, и по-нататъшно купелуване на получените съединения с реакционна маса от нафт-2-ол и 3-аминофенол, натриеви соли; | натриев хлорид | 425-740-5 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
611-143-00-9 | reaction mass of: trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(2,6-difluoropyrimidin-4-ylamino)-4-sulfonatophenolatocuprate (II); trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(4,6-difluoropyrimidin-2-ylamino)-4-sulfonatophenolatocuprate (II) | 428-260-4 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  611-143-00-9 | реакционна маса от: тринатриев 2-(2-[α-(2-карбоксилато-κO-4-сулфонатофенилазо)бензилиден]хидразино-κN′)-6-(2,6-дифлуоропиримидин-4-иламино)-4-сулфонатофенолатокупрат(II); тринатриев 2-(2-[α-(2-карбоксилато-κO-4-сулфонатофенилазо)бензилиден]хидразино-κN′)-6-(4,6-дифлуоропиримидин-2-иламино)-4-сулфонатофенолатокупрат(II); | 428-260-4 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
611-144-00-4 | reaction mas of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt; | 7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt; 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt | 429-070-4 | 214362-06-8 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  611-144-00-4 | реакционна маса от: Na/K сол на 7-амино-3,8-бис[4-(2-сулфоксиетилсулфонил)фенилазо]-4-хидроксинафтален-2-сулфоновата киселина; | Na/K сол на 7-амино-3-[4-(2-сулфоксиетилсулфонил)фенилазо]-4-хидрокси-8-[4-(2-сулфоксиетилсулфонил)-2-сулфофенилазо]нафтален-2-сулфоновата киселина; Na/K сол на 7-амино-8-[4-(2-сулфоксиетилсулфонил)фенилазо]-4-хидрокси-3-[4-(2-сулфоксиетилсулфонил)-2-сулфофенилазо]нафтален-2-сулфоновата киселина; Na/K сол на 7-амино-3,8-бис[4-(2-сулфоксиетилсулфонил)-2сулфофенилазо]-4-хидроксинафтален-2-сулфоновата киселина; | 429-070-4 | 214362-06-8 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
611-145-00-X | reaction mass of: tetrasodium 3-(1,5-disulfonatonaphthalene-2-ylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonate; | 3-(2,5-disulfophenylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino{-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonic acid, sodium salt | 429-440-5 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  611-145-00-X | реакционна маса от: тетранатриев 3-(1,5-дисулфонатонафтален-2-илазо)-7-{6-[4-(2-сулфоксиетилсулфонил)фениламино]-4-хлоро-1,3,5-триазин-2-иламино}-4-хидроксинафтален-2-сулфонат; | натриева сол на 3-(2,5-дисулфофенилазо)-7-{6-[4-(2-сулфоксиетилсулфонил)фениламино]-4-хлоро-1,3,5-триазин-2-иламино}-4-хидроксинафтален-2-сулфоновата киселина | 429-440-5 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
611-146-00-5 | reaction mass of: pentasodium | 3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-(4-sulfonatophenylazo)phenylazo)-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-2-sulfonatophenylamino)phenylazo)-4-hydroxy-6-(2-oxo-1-phenylcarbamoylpropylazo)naphthalene-2-sulfonate; pentasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonatophenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)phenyl)amino)-2-sulfonatophenyl)azo)-4-hydroxynaphthalene2-sulfonate; | pentasodium 6-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-3-((4-((4-((1,7-dihydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate; hexasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate | 430-070-1 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  611-146-00-5 | реакционна маса от: пентанатриев | 3-(4-(4-(7-(2,4-диамино-5-сулфонато-3-(4-сулфонатофенилазо)фенилазо)-1-хидрокси-3-сулфонатонафтален-2-илазо)-2-сулфонатофениламино)фенилазо)-6-(2-оксо-1-фенилкарбамоилпропилазо)-4-хидроксинафтален-2-сулфонат; пентанатриев 6-((2,4-диамино-5-сулфонатофенил)азо)-3-((4-((4-((7-((2,4-диамино-5-сулфонатофенил)азо)-3-сулфонато-1-хидроксинафтален-2-ил)азо)фенил)амино)-2-сулфонатофенил)азо)-4-хидроксинафтален-2-сулфонат; | пентанатриев 6-((2,4-диамино-5-сулфонато-3-((4-сулфонатофенил)азо)фенил)азо)-3-((4-((4-((3-сулфонато-1,7-дихидроксинафтален-2-ил)aзо)-2-сулфонатофенил)амино)фенил)азо)-4-хидроксинафтален-2-сулфонат; хексанатриев 6-((2,4-диамино-5-сулфонатофенил)азо)-3-((4-((4-((7-((2,4-диамино-5-сулфонато-3-((4-сулфонатофенил)азо)фенил)азо)-3-сулфонато-1-хидроксинафтален-2-ил)азо)-2-сулфонатофенил)амино)фенил)азо)-4-хидроксинафтален-2-сулфонат | 430-070-1 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
611-147-00-0 | sodium, potassium, lithium 5-amino-3,6-bis(5-(4-chloro-6-(methyl-(2-methylaminoacetyl)amino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate | 430-090-0 | 205764-96-1 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  611-147-00-0 | калиев литиев натриев 5-амино-3,6-бис(5-(6-(метил-(2-метиламиноацетил)амино)-4-хлоро-1,3,5-триазин-2-иламино)-2-сулфонатофенилазо)-4-хидроксинафтален-2,7-дислуфонат | 430-090-0 | 205764-96-1 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
611-148-00-6 | reaction mass of: 2-(3-(2,6-dichloro-4-nitrophenylazo)carbazol-9-yl)ethanol; | 2-(2-(3-(2,6-dichloro-4-nitro-phenylazo)-carbazol-9-yl)ethoxy)ethanol; | 3-(2,6-dichloro-4-nitrophenylazo)carbazol | 429-590-1 | — | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  611-148-00-6 | реакционна маса от: 2-(3-(4-нитро-2,6-дихлорофенилазо)карбазол-9-ил)етанол; | 2-(2-(3-(4-нитро-2,6-дихлорофенилазо)карбазол-9-ил)етокси)етанол; | 3-(4-нитро-2,6-дихлорофенилазо)карбазол | 429-590-1 | — | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
611-149-00-1 | 2-(2-chloroacetoxy)ethyl 3-((4-(2,5-dichloro-4-fluorosulfonylphenylazo)-3-methylphenyl)ethylamino)propionate | 427-570-7 | 193486-83-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  611-149-00-1 | 2-(2-хлороацетокси)етилов 3-((4-(4-флуоро-2,5-дихлоросулфонилфенилазо)-3-метилфенил)етиламино)пропионат | 427-570-7 | 193486-83-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
611-150-00-7 | tetralithium 2-[6-[7-[2-(carboxylato)phenylazo]-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazine-2-ylamino]benzoate | 440-460-3 | — | Eye Irrit. 2 | Aquatic Chronic 3 | H319 | H412 | GHS07 | Wng | H319 | H412 |   |   |  611-150-00-7 | тетралитиев 2-[6-[7-[2-(карбоксилато)фенилазо]-3,6-дисулфонато-8-хидрокси-1-нафтиламино]-4-хидрокси-1,3,5-триазин-2-иламино]бензоат | 440-460-3 | — | Eye Irrit. 2 | Aquatic Chronic 3 | H319 | H412 | GHS07 | Wng | H319 | H412 |   |   |  
611-151-00-2 | chrysoidine; | 4-(phenylazo)benzene-1,3-diamine | 207-803-7 | 495-54-5 | Muta. 2 | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H302 | H315 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H341 | H302 | H315 | H410 |   |   |  611-151-00-2 | хризоидин; | 4-(фенилазо)бензен-1,3-диамин | 207-803-7 | 495-54-5 | Muta. 2 | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H302 | H315 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H341 | H302 | H315 | H410 |   |   |  
611-152-00-8 | chrysoidine monohydrochloride; | 4-phenylazophenylene-1,3-diamine monohydrochloride; [1] chrysoidine monoacetate; | 4-(phenylazo)benzene-1,3-diamine monoacetate; [2] | chrysoidine acetate; | 4-(phenylazo)benzene-1,3-diamine acetate; [3] | chrysoidine-p-dodecylbenzenesulfonate; dodecylbenzenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1); [4] | chrysoidine dihydrochloride; | 4-(phenylazo)benzene-1,3-diamine dihydrochloride; [5] | chrysoidine sulfate; | bis[4-(phenylazo)benzene-1,3-diamine] sulfate [6] | 208-545-8 [1] | 278-290-5 [2] | 279-116-0 [3] | 264-409-8 [4] | 281-549-5 [5] | 282-432-1 [6] | 532-82-1 [1] | 75660-25-2 [2] | 79234-33-6 [3] | 63681-54-9 [4] | 83968-67-6 [5] | 84196-22-5 [6] | Muta. 2 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H302 | H315 | H318 | H400 | H410 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H341 | H302 | H315 | H318 | H410 |   |   |  611-152-00-8 | хризоидинмонохидрохлорид; | 4-фенилазофенилен-1,3-диаминмонохидрохлорид; [1] хризоидинмоноацетат; | 4-(фенилазо)бензен-1,3-диаминмоноацетат; [2] | хризоидинацетат; | 4-(фенилазо)бензен-1,3-диаминацетат; [3] | хризоидин-p-додецилбензенсулфонат; съединение на додецилбензенсулфонова киселина с 4-(фенилазо)бензен-1,3-диамин (1:1); [4] | хризоидиндихидрохлорид; | 4-(фенилазо)бензен-1,3-диаминдихидрохлорид; [5] | хризоидинсулфат; | бис[4-(фенилазо)бензен-1,3-диамин]сулфат [6] | 208-545-8 [1] | 278-290-5 [2] | 279-116-0 [3] | 264-409-8 [4] | 281-549-5 [5] | 282-432-1 [6] | 532-82-1 [1] | 75660-25-2 [2] | 79234-33-6 [3] | 63681-54-9 [4] | 83968-67-6 [5] | 84196-22-5 [6] | Muta. 2 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H302 | H315 | H318 | H400 | H410 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H341 | H302 | H315 | H318 | H410 |   |   |  
611-153-00-3 | chrysoidine C10-14-alkyl derivatives; | benzenesulfonic acid, mono-C10-14-alkyl derivatives, compounds | with 4-(phenylazo)-1,3-benzenediamine; [1] | chrysoidine compound with dibutylnaphthalene sulfonic acid; | dibutylnaphthalenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1) [2] | 286-946-7 [1] | 304-236-8 [2] | 85407-90-5 [1] | 94247-67-3 [2] | Muta. 2 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | H341 | H302 | H315 | H318 | GHS05 | GHS08 | GHS07 | Dgr | H341 | H302 | H315 | H318 |   |   |  611-153-00-3 | C10-14-алкилови производни на хризоидин; | бензенсулфонова киселина, моно-C10-14-алкилови производни, съединения | с 4-(фенилазо)-1,3-бензендиамин; [1] | съединение на хризоидин с дибутилнафталенсулфонова киселина; | съединение на дибутилнафталенсулфонова киселина с 4-(фенилазо)бензен-1,3-диамин (1:1) [2] | 286-946-7 [1] | 304-236-8 [2] | 85407-90-5 [1] | 94247-67-3 [2] | Muta. 2 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | H341 | H302 | H315 | H318 | GHS05 | GHS08 | GHS07 | Dgr | H341 | H302 | H315 | H318 |   |   |  
611-154-00-9 | trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate | 403-670-6 | 92408-46-3 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  611-154-00-9 | тринатриев 5-бензамидо-3-(4-метил-2-сулфонатофенилазо)-4-хидроксинафтален-2,7-дисулфонат | 403-670-6 | 92408-46-3 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
611-155-00-4 | 4,4'-oxybis(benzenesulfonylazide) | 431-850-4 | 7456-68-0 | Expl. 1.1**** | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H201 | H373** | H400 | H410 | GHS01 | GHS08 | GHS09 | Dgr | H201 | H373** | H410 |   |   |  611-155-00-4 | 4,4′-оксибис(бензенсулфонилазид) | 431-850-4 | 7456-68-0 | Expl. 1.1**** | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H201 | H373** | H400 | H410 | GHS01 | GHS08 | GHS09 | Dgr | H201 | H373** | H410 |   |   |  
611-156-00-X | triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate | 432-270-4 | 221354-37-6 | Repr. 2 | STOT RE 2 * | Aquatic Chronic 2 | H361f*** H373** | H411 | GHS08 | GHS09 | Wng | H361f*** H373** | H411 |   |   |  611-156-00-X | триамониев 4-[4-[7-(4-карбоксилатоанилино)-3-сулфонато-1-хидрокси-2-нафтилазо]-2,5-диметоксифенилазо]бензоат | 432-270-4 | 221354-37-6 | Repr. 2 | STOT RE 2 * | Aquatic Chronic 2 | H361f*** H373** | H411 | GHS08 | GHS09 | Wng | H361f*** H373** | H411 |   |   |  
611-157-00-5 | benzenesulfonic acid, 3,3'-(methylenebis((dihydroxyphenylene)azo)) bis-, potassium sodium salt; | potassium sodium 3-[(E)-(6{3,4-dihydroxy-2-}(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate | 432-590-4 | 243869-48-9 | Eye Irrit. 2 | Aquatic Chronic 3 | H319 | H412 | GHS07 | Wng | H319 | H412 |   |   |  611-157-00-5 | калиева натриева сол на 3,3′-(метиленбис((дихидроксифенилен)азо))бисбензенсулфоновата киселина; | калиев натриев 3-[(E)-(6-{3,4-дихидрокси-2-[(Z)-(3-сулфонатофенил)диазенил]бензил}-2,3-дихидроксифенил)диазенил]бензенсулфонат | 432-590-4 | 243869-48-9 | Eye Irrit. 2 | Aquatic Chronic 3 | H319 | H412 | GHS07 | Wng | H319 | H412 |   |   |  
611-158-00-0 | reaction product of: 2,3,4,2', 3', | 4'-hexahydroxy-5,5'-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride | 421-520-8 | — | **** | Aquatic Chronic 4 | **** H413 | **** | **** H413 |   |   |  611-158-00-0 | реакционeн продукт на: 2,3,4,2′, 3′, | 4′-хексахидрокси-5,5′-диацетилдифенилметан и 6-диазо-5-оксо-5,6-дихидро-1-нафталенсулфонилхлорид и 3-диазо-6-метокси-4-оксо-3,4-дихидро-1-нафталенсулфонилхлорид | 421-520-8 | — | **** | Aquatic Chronic 4 | **** H413 | **** | **** H413 |   |   |  
611-159-00-6 | disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate | 421-880-6 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  611-159-00-6 | динатриев 4-амино-6-((4-((4-(2,4-диаминофенил)азо)фенилсулфамоил)фенил)азо)-3-((4-нитрофенил)азо)-5-хидроксинафтален-2,7-дисулфонат | 421-880-6 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
611-160-00-1 | reaction mass of: 1,1,1-tris(phenyl-4'-(3''-diazo-3'', 4''-dihydro-4''-oxo-naphthalene-1''-sulfonato)ethane; 1,1,1-tris(phenyl-4'-(6''-diazo-5'', | 6''-dihydro-5''-oxo-naphthalene1''-sulfonato)ethane; | reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1); | reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2) | 422-760-6 | — | **** | Aquatic Chronic 4 | **** H413 | **** | **** H413 |   |   |  611-160-00-1 | реакционна маса от: 1,1,1-трис(фенил-4′-(3′′-диазо-4′′-оксо-3′′,4′′-дихидронафтален-1′′-сулфонато)етан; 1,1,1-трис(фенил-4′-(6′′-диазо-5′′-оксо-5′′,6′′-дихидронафтален-1′′-сулфонато)етан; | реакционен продукт от 1,1,1-трис(p-хидроксифенил)етан с 6-диазо-5-оксо-5,6-дихидро-1-нафтилсулфонилхлорид и 3-диазо-4-оксо-3,4-дихидро-1-нафтилсулфонилхлорид (2:1); | реакционен продукт от 1,1,1-трис(p-хидроксифенил)етан с 6-диазо-5-оксо-5,6-дихидро-1-нафтилсулфонилхлорид и 3-диазо-4-оксо-3,4-дихидро-1-нафтилсулфонилхлорид (1:2) | 422-760-6 | — | **** | Aquatic Chronic 4 | **** H413 | **** | **** H413 |   |   |  
611-161-00-7 | trisodium [1,2'-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4'-nitrobenzene)diolato-O, O,N][(Z)-2,2-((phenylcarbamoylprop-1'-enyl)azo)-5-sulfamoylbenzene)diolato-O, O,N]chromate(III) | 423-100-1 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  611-161-00-7 | тринатриев [1,2′-(2-(8-амино-3,5-дисулфонатонафтален)азо)-(4′-нитробензен)диолато-O, O,N][(Z)-2,2-((фенилкарбамоилпроп-1′-енил)азо)-5-сулфамоилбензен)диолато-O, O,N]хромат(III) | 423-100-1 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
611-162-00-2 | 2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate) | 429-600-4 | — | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  611-162-00-2 | 2,4-бис(((2-(диметиламонио)етилокси)карбонил)фен-2-илазо)бензен-1,3-диолбис(метансулфонат) | 429-600-4 | — | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  
611-163-00-8 | 2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate | 429-610-9 | — | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  611-163-00-8 | 2,4-бис(((2-(диметиламонио)етилокси)карбонил)фен-2-илазо)бензен-1,3-диолсулфат | 429-610-9 | — | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 2 | H302 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H411 |   |   |  
611-164-00-3 | reaction mass of: 2,2’-dimethyl-2,2’-azobutanenitrile; | 2-methylpentanenitrile-2-azo-2’-(2’-methylpropanenitrile); | 2,2’-dimethyl-2,2’-azoheptanenitrile; | 2-methylheptanenitrile-2-azo-2’-(2’-methylpropanenitrile); | 2-methylheptanenitrile-2-azo-2’-(2’-methylbutanenitrile) | 429-710-2 | — | Self-react. D | Acute Tox. 4 * | Aquatic Chronic 2 | H242 | H302 | H411 | GHS02 | GHS07 | GHS09 | Dgr | H242 | H302 | H411 |   |   |  611-164-00-3 | реакционна маса от: 2,2′-диметил-2,2′-азобутаннитрил; | 2-метилпентаннитрил-2-азо-2'-(2'-метилпропаннитрил); | 2,2'-диметил-2,2'-азохептаннитрил; | 2-метилхептаннитрил-2-азо-2'-(2'-метилпропаннитрил); | 2-метилхептаннитрил-2-азо-2'-(2'-метилбутаннитрил) | 429-710-2 | — | Self-react. D | Acute Tox. 4 * | Aquatic Chronic 2 | H242 | H302 | H411 | GHS02 | GHS07 | GHS09 | Dgr | H242 | H302 | H411 |   |   |  
611-165-00-9 | reaction mass of: tetrasodium - 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate; tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate | 431-830-5 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  611-165-00-9 | реакционна маса от: тетранатриев 4-амино-6-(5-(2,6-дифлуоропиримидин-4-иламино)-2-сулфонатофенилазо)-3-(4-(сулфатоетилсулфонил)фенилазо)-5-хидроксинафтален-2,7-дисулфонат; тетранатриев 4-амино-6-(5-(4,6-дифлуоропиримидин-2-иламино)-2-сулфонатофенилазо)-3-(4-(2-сулфатоетилсулфонил)фенилазо)-5-хидроксинафтален-2,7-дисулфонат | 431-830-5 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
611-166-00-4 | reaction mass of: pentasodium | 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate; | tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium - 4-amino-5-hydroxy-6-(E)-2-sulfonato-4-}2-(sulfonatooxy)ethylsulfonyl{phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate | 432-100-9 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  611-166-00-4 | реакционна маса от: пентанатриев | 4-амино-3-{(E)-4-[2-(сулфонатоокси)етилсулфонил]фенилазо}-6-{(E)-2-сулфонато-4-[2-(сулфонатоокси)етилсулфонил]фенилазо}-5-хидроксинафтален-2,7-дисулфонат; | тетранатриев 4-амино-3-{(E)-4-[2-(сулфонатоокси)етилсулфонил]фенилазо}-6-[(E)-4-(винилсулфонил)-2-сулфонатофенилазо]-5-хидроксинафтален-2,7-дисулфонат; тетранатриев 4-амино-6-{(E)-2-сулфонато-4-[2-(сулфонатоокси)етилсулфонил]фенилазо}-3-[(E)-4-(винилсулфонил)фенилазо]-5-хидроксинафтален-2,7-дисулфонат | 432-100-9 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
611-167-00-X | sodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4'-(4,8-disulfonato-2-naphthylazo)-5'-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cuprate(II) | 435-240-9 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  611-167-00-X | натриев бис[трис(2-хидроксиетил)амониев] [6-анилино-4′-(4,8-дисулфонато-2-нафтилазо)-5′-метил-3-сулфонатонафтален-2-азобензен-1,2′-диолато]купрат(II) | 435-240-9 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
611-168-00-5 | reaction mass of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2yl]amino]benzoic acid; | 3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid | 435-440-6 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  611-168-00-5 | реакционна маса от: 3-[[4-хлоро-6-[[7-[(1,5-дисулфо-2-нафталенил)азо]-3,6-дисулфо-8-хидрокси-1-нафталенил]амино]-1,3,5-триазин-2-ил]амино]-5-[[4-хлоро-6-[[8-хидрокси-3,6-дисулфо-7-[(2-сулфофенил)azo]-1-нафталенил]амино]-1,3,5-триазин-2-ил]амино]бензоена киселина; | 3,5-бис[[4-хлоро-6-[[7-[(1,5-дисулфо-2-нафталенил)азо]-3,6-дисулфо-8-хидрокси-1-нафталенил]амино]-1,3,5-триазин-2-ил]амино]бензоена киселина | 435-440-6 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
611-169-00-0 | sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate | 435-800-2 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  611-169-00-0 | натриев 5-(2-карбоксифенилазо)-6-хидроксинафтален-2-сулфонат | 435-800-2 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
611-170-00-6 | reaction mas of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)4-sulfonatobenzoate(5-)-κ-O)cuprate(II); | disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate-κ-O-(5))cuprate(II) | 435-880-9 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  611-170-00-6 | реакционна маса от: тринатриев 2-((1-(2-хидрокси-κO-5-(2-сулфонатоетансулфонил)фенилазо-κN 2)-1-фенилметил)азо-κN 1)4-сулфонатобензоат(5-)-κO)купрат(II) | динатриев 2-((1-(5-етенсулфонил-2-хидрокси-κO-фенилазо-κN 2)-1-фенилметил)азо-κN 1)-4-сулфонатобензоат-κO-(5))купрат(II) | 435-880-9 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
611-171-00-1 | reaction mass of trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate; | trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate | 436-890-6 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  611-171-00-1 | реакционна маса от тринатриев 3-(5-(2,6-дифлуоропиримидин-4-иламино)-2-сулфонатофенилазо)-5-(4-флуоро-6-морфолин-4-ил-1,3,5-триазин-2-иламино)-4-хидрокси-2,7-нафталендисулфонат; | тринатриев 3-(5-(4,6-дифлуоропиримидин-2-иламино)-2-сулфонатофенилазо)-5-(4-флуоро-6-морфолин-4-ил-1,3,5-триазин-2-иламино)-4-хидрокси-2,7-нафталендисулфонат | 436-890-6 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
611-172-00-7 | reaction mass of: triammonium | 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate; | diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate | 438-310-7 | — | Self-react. C**** | Repr. 2 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 3 | H242 | H361f*** | H302 | H373** | H412 | GHS02 | GHS08 | GHS07 | Dgr | H242 | H361f*** | H302 | H373** | H412 |   |   |  611-172-00-7 | реакционна маса от: триамониев | 6-амино-3-((2,5-диетокси-4-(3-фосфонофенил)азо)фенил)азо-4-хидрокси-2-нафталенсулфонат; | диамониев 3-((4-((7-амино-3-сулфо-1-хидроксинафтален-2-ил)азо)-2,5-диетоксифенил)азо)бензоат | 438-310-7 | — | Self-react. C**** | Repr. 2 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 3 | H242 | H361f*** | H302 | H373** | H412 | GHS02 | GHS08 | GHS07 | Dgr | H242 | H361f*** | H302 | H373** | H412 |   |   |  
611-173-00-2 | reaction mass of: 3-[3-carbamoyl-5-(5-{4-chloro-6[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt; 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2oxo-1-pyridyl]propanoicacid, disodium salt | 440-510-4 | — | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  611-173-00-2 | реакционна маса от: тринатриева сол на 3-[3-карбамоил-5-(5-{6-[4-(2-сулфонатооксиетилсулфонил)анилино]-4-хлоро-1,3,5-триазин-2-иламино}-2-сулфонатофенилазо)-4-метил-2-оксо-1,2-дихидро-6-хидрокси-1-пиридил]пропановата киселина; динатриева сол на 3-[3-карбамоил-5-(5-{6-[4-(винилсулфонил)анилино]-4-хлоро-1,3,5-триазин-2-иламино}-2-сулфонатофенилазо)-4-метил-2-оксо-1,2-дихидро-6-хидрокси-1-пиридил]пропановата киселина | 440-510-4 | — | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
611-174-00-8 | reaction mass of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino[-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt; | 3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt | 442-290-5 | 457624-86-1 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  611-174-00-8 | реакционна маса от: натриева сол на 3-[5-(4-етенсулфонилбутириламино)-2-сулфофенилазо]-5-{4-хлоро-[6-(4-(3-амино-2,7-дисулфо-5-хидроксинафтален-4-ил)азо)-3-сулфофениламино]-1,3,5-триазин-2-иламино}-4-хидроксинафтален-2,7-дисулфоновата киселина; | натриева сол на 3-[5-(4-(2-хлороетансулфонил)бутириламино)-2-сулфофенилазо]-5-{4-хлоро-[6-(4-(3-амино-2,7-дисулфо-5-хидроксинафтален-4-илазо)-3-сулфофениламино]-1,3,5-триазин-2-иламино}-4-хидроксинафтален-2,7-дисулфоновата киселина | 442-290-5 | 457624-86-1 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
611-175-00-3 | reaction mass of: trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)aniline]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo{naphthalene-2,7-disulfonate; trisodium 5-4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; | disodium 5-4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; | tetrasodium 5-4-chloro-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate | 444-050-5 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  611-175-00-3 | реакционна маса от: тринатриев 3-[4-(винилсулфонил)фенилазо]-5-{6-[N-етил-(3-(2-сулфонатоокси)етилсулфонил)анилино]-4-хлоро-1,3,5-триазин-2-иламино}-4-хидроксинафтален-2,7-дисулфонат; тринатриев 5-{6-[3-(винилсулфонил)-N-етиланилино]-4-хлоро-1,3,5-триазин-2-иламино}-4-хидрокси-3-[4-(2-(сулфонатоокси)етилсулфонил)фенилазо]нафтален-2,7-дисулфонат; | динатриев 5-{6-[3-(винилсулфонил)-N-етиланилино]-4-хлоро-1,3,5-триазин-2-иламино}-4-хидрокси-3-[(4-винилсулфонил)фенилазо]нафтален-2,7-дисулфонат; | тетранатриев 5-{6-[N-етил-3-(2-(сулфонатоокси)етилсулфонил)анилино]-4-хлоро-1,3,5-триазин-2-иламино}-3-[4-(2-(сулфонатоокси)етилсулфонил)фенилазо]-4-хидроксинафтален-2,7-дисулфонат | 444-050-5 | — | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
611-176-00-9 | 2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate | 444-250-2 | — | Self-react. C**** Aquatic Chronic 2 | H242 | H411 | GHS02 | GHS09 | Dgr | H242 | H411 |   |   |  611-176-00-9 | естер на 2,6-бис(2,3,4-трихидроксибензил)-p-крезол с 6-диазо-5-оксо-5,6-дихидро-1-нафталенсулфонат | 444-250-2 | — | Self-react. C**** Aquatic Chronic 2 | H242 | H411 | GHS02 | GHS09 | Dgr | H242 | H411 |   |   |  
611-177-00-4 | reaction mass of: pentasodium bis[6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III); tetrasodium [6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato][6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III); trisodium bis[6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III) | 444-290-0 | 508202-43-5 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  611-177-00-4 | реакционна маса от: пентанатриев бис[6-анилино-3,5′-дисулфонатонафтален-2-азобензен-1,2′-диолато]кобалтат(III); тетранатриев [6-анилино-3,5′-дисулфонатонафтален-2-азобензен-1,2′-диолато][6-анилино-5′-сулфамоил-3-сулфонатонафтален-2-азобензен-1,2′-диолато]кобалтат(III); тринатриев бис[6-анилино-5′-сулфамоил-3-сулфонатонафтален-2-азобензен-1,2′-диолато]кобалтат(III) | 444-290-0 | 508202-43-5 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  
611-178-00-X | reaction mass of: pentasodium | 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate; | tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; | trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; | trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate | 445-280-9 | — | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  611-178-00-X | реакционна маса от: пентанатриев | 4-амино-3-{(E)-4-[2-(сулфонатоокси)етилсулфонил]фенилазо}-6-{(E)-2-сулфонато-4-[2-(сулфонатоокси)етилсулфонил]фенилазо}-5-хидроксинафтален-2,7-дисулфонат; | тетранатриев 4-амино-3-{(E)-4-[2-(сулфонатоокси)етилсулфонил]фенилазо}-6-[(E)-4-(винилсулфонил)-2-сулфонатофенилазо]-5-хидроксинафтален-2,7-дисулфонат; тетранатриев 4-амино-6-{(E)-2-сулфонато-4-[2-(сулфонатоокси)етилсулфонил]фенилазо}-3-[(E)-4-(винилсулфонил)фенилазо]-5-хидроксинафтален-2,7-дисулфонат; тринатриев 4-амино-3-[(E)-4-(винилсулфонил)фенилазо]-6-[(E)-4-(винилсулфонил)-2-сулфонатофенилазо]-5-хидроксинафтален-2,7-дисулфонат; | тринатриев 4-амино-3-[2-(хидроксиетилсулфонил)фенилазо]-6-[(E)-4-(винилсулфонил)-2-сулфонатофенилазо]-5-хидроксинафтален-2,7-дисулфонат; | тринатриев 4-амино-3-[(E)-4-(винилсулфонил)фенилазо]-6-[(E)-4-(2-хидроксиетилсулфонил)-2-сулфонатофенилазо]-5-хидроксинафтален-2,7-дисулфонат | 445-280-9 | — | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  
611-179-00-5 | reaction mass of: pentasodium | 2-[[8-[[4-chloro-6-[[4-(2-sulfonatethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate; | 2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate | 450-010-8 | — | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  611-179-00-5 | реакционна маса от: пентанатриев | 2-[[8-[[4-хлоро-6-[[4-(2-сулфонатоетилсулфонил)]фенил]амино]-1,3,5-триазин-2-ил]амино-1- хидрокси-3,6-дисулфонато-2-нафталенил]азо]нафтален-1,5-дисулфонат; | 2-[[8-[[4-хлоро-6-[[4-[[2-етенил]сулфонил]фенил]амино]-1,3,5-триазин-2-ил]амино]-1- хидрокси-3,6-дисулфонато-2-нафталенил]азо]нафтален-1,5-дисулфонат | 450-010-8 | — | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
611-180-00-0 | iron, complexes with diazotised | 4-aminobenzenesulfonamide, diazotized 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide, diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts | 417-850-7 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  611-180-00-0 | желязо, комплекси с диазотиран | 4-аминобензенсулфонамид, диазотирана 3-аминобензенсулфонова киселина, диазотиран 3-амино-4-хидроксибензенсулфонамид, диазотиран 3-амино-N-фенил-4-хидроксибензенсулфонамид, диазотирана 5-амино-2-(фениламино)бензенсулфонова киселина и резорцинол, натриеви соли | 417-850-7 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
612-001-00-9 | mono-methylamine; [1] | di-methylamine; [2] | tri-methylamine [3] | 200-820-0 [1] | 204-697-4 [2] | 200-875-0 [3] | 74-89-5 [1] | 124-40-3 [2] | 75-50-3 [3] | Flam. Gas 1 | Press. Gas | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | H220 | H332 | H335 | H315 | H318 | GHS02 | GHS04 | GHS05 | GHS07 | Dgr | H220 | H332 | H335 | H315 | H318 |   | * | Skin Irrit. 2; | H315: C ≥ 5 % | Eye Dam. 1; H318: C ≥ 5 % Eye Irrit. 2; | H319: 0,5  % ≤ | C < 5 % | STOT SE 3; H335: C ≥ 5 % | U5612-001-00-9 | монометиламин; [1] | диметиламин; [2] | триметиламин [3] | 200-820-0 [1] | 204-697-4 [2] | 200-875-0 [3] | 74-89-5 [1] | 124-40-3 [2] | 75-50-3 [3] | Flam. Gas 1 | Press. Gas | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | H220 | H332 | H335 | H315 | H318 | GHS02 | GHS04 | GHS05 | GHS07 | Dgr | H220 | H332 | H335 | H315 | H318 |   | * | Skin Irrit. 2; | H315: C ≥ 5 % | Eye Dam. 1; H318: C ≥ 5 % Eye Irrit. 2; | H319: 0,5  % ≤ | C < 5 % | STOT SE 3; H335: C ≥ 5 % | U5
612-001-01-6 | mono-methylamine … %; [1] | di-methylamine … %; [2] | tri-methylamine … % [3] | 200-820-0 [1] | 204-697-4 [2] | 200-875-0 [3] | 74-89-5 [1] | 124-40-3 [2] | 75-50-3 [3] | Flam. Liq. 1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H224 | H332 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H224 | H332 | H302 | H314 |   | * | STOT SE 3; H335: C ≥ 5 % | B612-001-01-6 | монометиламин … %; [1] | диметиламин … %; [2] | триметиламин … % [3] | 200-820-0 [1] | 204-697-4 [2] | 200-875-0 [3] | 74-89-5 [1] | 124-40-3 [2] | 75-50-3 [3] | Flam. Liq. 1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H224 | H332 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H224 | H332 | H302 | H314 |   | * | STOT SE 3; H335: C ≥ 5 % | B
612-002-00-4 | ethylamine | 200-834-7 | 75-04-7 | Flam. Gas 1 | Press. Gas | Eye Irrit. 2 | STOT SE 3 | H220 | H319 | H335 | GHS02 | GHS04 | GHS07 | Dgr | H220 | H319 | H335 |   |   | U612-002-00-4 | етиламин | 200-834-7 | 75-04-7 | Flam. Gas 1 | Press. Gas | Eye Irrit. 2 | STOT SE 3 | H220 | H319 | H335 | GHS02 | GHS04 | GHS07 | Dgr | H220 | H319 | H335 |   |   | U
612-003-00-X | diethylamine | 203-716-3 | 109-89-7 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | H225 | H332 | H312 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H225 | H332 | H312 | H302 | H314 |   | STOT SE 3; H335: C ≥ 1 % |  612-003-00-X | диетиламин | 203-716-3 | 109-89-7 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | H225 | H332 | H312 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H225 | H332 | H312 | H302 | H314 |   | STOT SE 3; H335: C ≥ 1 % |  
612-004-00-5 | triethylamine | 204-469-4 | 121-44-8 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | H225 | H332 | H312 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H225 | H332 | H312 | H302 | H314 |   | STOT SE 3; H335: C ≥ 1 % |  612-004-00-5 | триетиламин | 204-469-4 | 121-44-8 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | H225 | H332 | H312 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H225 | H332 | H312 | H302 | H314 |   | STOT SE 3; H335: C ≥ 1 % |  
612-005-00-0 | butylamine | 203-699-2 | 109-73-9 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | H225 | H332 | H312 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H225 | H332 | H312 | H302 | H314 |   | STOT SE 3; H335: C ≥ 1 % |  612-005-00-0 | бутиламин | 203-699-2 | 109-73-9 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | H225 | H332 | H312 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H225 | H332 | H312 | H302 | H314 |   | STOT SE 3; H335: C ≥ 1 % |  
612-006-00-6 | ethylenediamine; | 1,2-diaminoethane | 203-468-6 | 107-15-3 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Resp. Sens. 1 | Skin Sens. 1 | H226 | H312 | H302 | H314 | H334 | H317 | GHS02 | GHS08 | GHS05 | GHS07 | Dgr | H226 | H312 | H302 | H314 | H334 | H317 |   |   |  612-006-00-6 | етилендиамин; | 1,2-диаминоетан | 203-468-6 | 107-15-3 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Resp. Sens. 1 | Skin Sens. 1 | H226 | H312 | H302 | H314 | H334 | H317 | GHS02 | GHS08 | GHS05 | GHS07 | Dgr | H226 | H312 | H302 | H314 | H334 | H317 |   |   |  
612-007-00-1 | 2-aminopropane; | isopropylamine | 200-860-9 | 75-31-0 | Flam. Liq. 1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H224 | H319 | H335 | H315 | GHS02 | GHS07 | Dgr | H224 | H319 | H335 | H315 |   |   |  612-007-00-1 | 2-аминопропан; | изопропиламин | 200-860-9 | 75-31-0 | Flam. Liq. 1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H224 | H319 | H335 | H315 | GHS02 | GHS07 | Dgr | H224 | H319 | H335 | H315 |   |   |  
612-008-00-7 | niline | 200-539-3 | 62-53-3 | Carc. 2 | Muta. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | H351 | H341 | H331 | H311 | H301 | H372 ** | H318 | H317 | H400 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H351 | H341 | H331 | H311 | H301 | H372 ** | H318 | H317 | H400 |   | * | STOT RE 1; H372: C ≥ 1 % | STOT RE 2; H373: 0,2  % ≤ C < 1 % |  612-008-00-7 | анилин | 200-539-3 | 62-53-3 | Carc. 2 | Muta. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | H351 | H341 | H331 | H311 | H301 | H372 ** | H318 | H317 | H400 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H351 | H341 | H331 | H311 | H301 | H372 ** | H318 | H317 | H400 |   | * | STOT RE 1; H372: C ≥ 1 % | STOT RE 2; H373: 0,2  % ≤ C < 1 % |  
612-009-00-2 | salts of aniline | — | — | Carc. 2 | Muta. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | H351 | H341 | H331 | H311 | H301 | H372 ** | H318 | H317 | H400 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H351 | H341 | H331 | H311 | H301 | H372 ** | H318 | H317 | H400 |   | * | STOT RE 1; H372: C ≥ 1 % STOT RE 2; | H373: 0,2  % ≤ | C < 1 % | A612-009-00-2 | соли на анилина | — | — | Carc. 2 | Muta. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | H351 | H341 | H331 | H311 | H301 | H372 ** | H318 | H317 | H400 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H351 | H341 | H331 | H311 | H301 | H372 ** | H318 | H317 | H400 |   | * | STOT RE 1; H372: C ≥ 1 % STOT RE 2; | H373: 0,2  % ≤ | C < 1 % | A
612-010-00-8 | chloroanilines (with exception of those specified elsewhere in this Annex) | — | — | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H410 |   |   | C612-010-00-8 | хлороанилини (с изключение на тези, посочени другаде в настоящото приложение) | — | — | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H410 |   |   | C
612-011-00-3 | 4-nitrosoaniline | 211-535-6 | 659-49-4 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H312 | H302 | GHS07 | Wng | H332 | H312 | H302 |   |   |  612-011-00-3 | 4-нитрозоанилин | 211-535-6 | 659-49-4 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H312 | H302 | GHS07 | Wng | H332 | H312 | H302 |   |   |  
612-012-00-9 | o-nitroaniline; [1] m-nitroaniline; [2] p-nitroaniline [3] | 201-855-4 [1] | 202-729-1 [2] | 202-810-1 [3] | 88-74-4 [1] | 99-09-2 [2] | 100-01-6 [3] | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 3 | H331 | H311 | H301 | H373 ** | H412 | GHS06 | GHS08 | Dgr | H331 | H311 | H301 | H373 ** | H412 |   |   | C612-012-00-9 | o-нитроанилин; [1] m-нитроанилин; [2] p-нитроанилин [3] | 201-855-4 [1] | 202-729-1 [2] | 202-810-1 [3] | 88-74-4 [1] | 99-09-2 [2] | 100-01-6 [3] | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 3 | H331 | H311 | H301 | H373 ** | H412 | GHS06 | GHS08 | Dgr | H331 | H311 | H301 | H373 ** | H412 |   |   | C
612-013-00-4 | 3-aminobenzene sulphonic acid; | metanilic acid | 204-473-6 | 121-47-1 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H312 | H302 | GHS07 | Wng | H332 | H312 | H302 |   |   |  612-013-00-4 | 3-аминобензенсулфонова киселина; | метанилова киселина | 204-473-6 | 121-47-1 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H312 | H302 | GHS07 | Wng | H332 | H312 | H302 |   |   |  
612-014-00-X | sulphanilic acid; | 4-aminobenzenesulphonic acid | 204-482-5 | 121-57-3 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   |   |  612-014-00-X | сулфанилова киселина; | 4-аминобензенсулфонова киселина | 204-482-5 | 121-57-3 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H315 | H317 | GHS07 | Wng | H319 | H315 | H317 |   |   |  
612-015-00-5 | N-methylaniline | 202-870-9 | 100-61-8 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H410 |   |   |  612-015-00-5 | N-метиланилин | 202-870-9 | 100-61-8 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H410 |   |   |  
612-016-00-0 | N,N-dimethylaniline | 204-493-5 | 121-69-7 | Carc. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Chronic 2 | H351 | H331 | H311 | H301 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H331 | H311 | H301 | H411 |   |   |  612-016-00-0 | N,N-диметиланилин | 204-493-5 | 121-69-7 | Carc. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Chronic 2 | H351 | H331 | H311 | H301 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H331 | H311 | H301 | H411 |   |   |  
612-017-00-6 | N-methyl-N-2,4,6-tetranitroaniline; tetryl | 207-531-9 | 479-45-8 | Expl. 1.1 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 | H201 | H331 | H311 | H301 | H373** | GHS01 | GHS06 | GHS08 | Dgr | H201 | H331 | H311 | H301 | H373** |   |   |  612-017-00-6 | N-метил-N-2,4,6-тетранитроанилин; тетрил | 207-531-9 | 479-45-8 | Expl. 1.1 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 | H201 | H331 | H311 | H301 | H373** | GHS01 | GHS06 | GHS08 | Dgr | H201 | H331 | H311 | H301 | H373** |   |   |  
612-018-00-1 | bis(2,4,6-trinitrophenyl)amine; | hexyl | 205-037-8 | 131-73-7 | Expl. 1.1 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 | Aquatic Chronic 2 | H201 | H330 | H310 | H300 | H373** | H411 | GHS01 | GHS06 | GHS08 | GHS09 | Dgr | H201 | H330 | H310 | H300 | H373** | H411 |   |   |  612-018-00-1 | бис(2,4,6-тринитрофенил)амин; | хексил | 205-037-8 | 131-73-7 | Expl. 1.1 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 | Aquatic Chronic 2 | H201 | H330 | H310 | H300 | H373** | H411 | GHS01 | GHS06 | GHS08 | GHS09 | Dgr | H201 | H330 | H310 | H300 | H373** | H411 |   |   |  
612-019-00-7 | dipicrylamine, ammonium salt | 220-639-0 | 2844-92-0 | Expl. 1.1 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 | Aquatic Chronic 2 | H201 | H330 | H310 | H300 | H373** | H411 | GHS01 | GHS06 | GHS08 | GHS09 | Dgr | H201 | H330 | H310 | H300 | H373** | H411 |   |   |  612-019-00-7 | амониева сол на дипикриламин | 220-639-0 | 2844-92-0 | Expl. 1.1 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 | Aquatic Chronic 2 | H201 | H330 | H310 | H300 | H373** | H411 | GHS01 | GHS06 | GHS08 | GHS09 | Dgr | H201 | H330 | H310 | H300 | H373** | H411 |   |   |  
612-020-00-2 | 1-naphthylamine | 205-138-7 | 134-32-7 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  612-020-00-2 | 1-нафтиламин | 205-138-7 | 134-32-7 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
612-022-00-3 | 2-naphthylamine | 202-080-4 | 91-59-8 | Carc. 1A | Acute Tox. 4 * | Aquatic Chronic 2 | H350 | H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H411 |   | Carc. 1A; H350: C ≥ 0,01  % |  612-022-00-3 | 2-нафтиламин | 202-080-4 | 91-59-8 | Carc. 1A | Acute Tox. 4 * | Aquatic Chronic 2 | H350 | H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H411 |   | Carc. 1A; H350: C ≥ 0,01  % |  
612-023-00-9 | phenylhydrazine; [1] phenylhydrazinium chloride; [2] phenylhydrazine hydrochloride; [3] | phenylhydrazinium sulphate | (2:1) [4] | 202-873-5 [1] | 200-444-7 [2] | 248-259-0 [3] | 257-622-2 [4] | 100-63-0 [1] | 59-88-1 [2] | 27140-08-5 [3] | 52033-74-6 [4] | Carc. 1B | Muta. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | H350 | H341 | H331 | H311 | H301 | H372 ** | H319 | H315 | H317 | H400 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H341 | H331 | H311 | H301 | H372 ** | H319 | H315 | H317 | H400 |   |   |  612-023-00-9 | фенилхидразин; [1] фенилхидразиниев хлорид; [2] фенилхидразинхидрохлорид; [3] | фенилхидразиниев сулфат | (2:1) [4] | 202-873-5 [1] | 200-444-7 [2] | 248-259-0 [3] | 257-622-2 [4] | 100-63-0 [1] | 59-88-1 [2] | 27140-08-5 [3] | 52033-74-6 [4] | Carc. 1B | Muta. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | H350 | H341 | H331 | H311 | H301 | H372 ** | H319 | H315 | H317 | H400 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H341 | H331 | H311 | H301 | H372 ** | H319 | H315 | H317 | H400 |   |   |  
612-024-00-4 | m-toluidine; | 3-aminotoluene | 203-583-1 | 108-44-1 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | H331 | H311 | H301 | H373 ** | H400 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H400 |   |   |  612-024-00-4 | m-тoлуидин; | 3-аминотолуен | 203-583-1 | 108-44-1 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | H331 | H311 | H301 | H373 ** | H400 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H400 |   |   |  
612-025-00-X | nitrotoluidines, with the exception of those specified elsewhere in this Annex | — | — | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 2 | H331 | H311 | H301 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H411 |   |   | C612-025-00-X | нитротолуидини, с изключение на тези, посочени другаде в настоящото приложение | — | — | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 2 | H331 | H311 | H301 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H411 |   |   | C
612-026-00-5 | diphenylamine | 204-539-4 | 122-39-4 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H410 |   |   |  612-026-00-5 | дифениламин | 204-539-4 | 122-39-4 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H373 ** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H410 |   |   |  
612-027-00-0 | xylidines with the exception of those specified elsewhere in this Annex; | dimethyl anilines with the exception of those specified elsewhere in this Annex | — | — | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 2 | H331 | H311 | H301 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H411 |   |   | C612-027-00-0 | ксилидини, с изключение на тези, посочени другаде в настоящото приложение; | диметиланилини, с изключение на тези, посочени другаде в настоящото приложение | — | — | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 2 | H331 | H311 | H301 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H411 |   |   | C
612-028-00-6 | p-phenylenediamine | 203-404-7 | 106-50-3 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H319 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H319 | H317 | H410 |   |   |  612-028-00-6 | p-фенилендиамин | 203-404-7 | 106-50-3 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H319 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H319 | H317 | H410 |   |   |  
612-029-00-1 | benzene-1,4-diamine dihydrochloride; | p-phenylenediamine dihydrochloride | 210-834-9 | 624-18-0 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H319 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H319 | H317 | H410 |   |   |  612-029-00-1 | бензен-1,4-диаминдихидрохлорид; | p-фенилендиаминдихидрохлорид | 210-834-9 | 624-18-0 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H319 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H311 | H301 | H319 | H317 | H410 |   |   |  
612-030-00-7 | 2-methyl-p-phenylenediamine sulphate [1] | 210-431-8 [1] | 228-871-4 [2] | 615-50-9 [1] | 6369-59-1 [2] | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H301 | H332 | H312 | H317 | H411 | GHS06 | GHS09 | Dgr | H301 | H332 | H312 | H317 | H411 |   |   |  612-030-00-7 | 2-мeтил-p-фенилендиаминсулфат [1] | 210-431-8 [1] | 228-871-4 [2] | 615-50-9 [1] | 6369-59-1 [2] | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H301 | H332 | H312 | H317 | H411 | GHS06 | GHS09 | Dgr | H301 | H332 | H312 | H317 | H411 |   |   |  
612-031-00-2 | N,N-dimethylbenzene-1,3-diamine; [1] | 4-amino-N,N-dimethylaniline; | 3-amino-N,N'-dimethylaniline [2] | 220-623-3 [1] | 202-807-5 [2] | 2836-04-6 [1] | 99-98-9 [2] | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H331 | H311 | H301 | GHS06 | Dgr | H331 | H311 | H301 |   |   | C612-031-00-2 | N,N-диметилбензен-1,3-диамин; [1] | 4-амино-N,N-диметиланилин; | 3-амино-N,N′-диметиланилин [2] | 220-623-3 [1] | 202-807-5 [2] | 2836-04-6 [1] | 99-98-9 [2] | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H331 | H311 | H301 | GHS06 | Dgr | H331 | H311 | H301 |   |   | C
612-032-00-8 | N, N,N',N'-tetramethyl-p-phenylenediamine | 202-831-6 | 100-22-1 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H312 | H302 | GHS07 | Wng | H332 | H312 | H302 |   |   |  612-032-00-8 | N, N,N′,N′-тeтраметил-p-фенилендиамин | 202-831-6 | 100-22-1 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H312 | H302 | GHS07 | Wng | H332 | H312 | H302 |   |   |  
612-033-00-3 | 2-aminophenol | 202-431-1 | 95-55-6 | Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | H341 | H332 | H302 | GHS08 | GHS07 | Wng | H341 | H332 | H302 |   |   |  612-033-00-3 | 2-аминофенол | 202-431-1 | 95-55-6 | Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | H341 | H332 | H302 | GHS08 | GHS07 | Wng | H341 | H332 | H302 |   |   |  
612-034-00-9 | 2-amino-4,6-dinitrophenol; | picramic acid | 202-544-6 | 96-91-3 | Expl. 1.1 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 3 | H201 | H332 | H312 | H302 | H412 | GHS01 | GHS07 | Dgr | H201 | H332 | H312 | H302 | H412 |   |   |  612-034-00-9 | 2-амино-4,6-динитрофенол; | пикраминова киселина | 202-544-6 | 96-91-3 | Expl. 1.1 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 3 | H201 | H332 | H312 | H302 | H412 | GHS01 | GHS07 | Dgr | H201 | H332 | H312 | H302 | H412 |   |   |  
612-034-01-6 | 2-amino-4,6-dinitrophenol; | picramic acid; [≥ 20 % water] | 202-544-6 | 96-91-3 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 3 | H332 | H312 | H302 | H412 | GHS07 | Wng | H332 | H312 | H302 | H412 |   |   | G612-034-01-6 | 2-амино-4,6-динитрофенол; | пикраминова киселина; [≥ 20 % вода] | 202-544-6 | 96-91-3 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 3 | H332 | H312 | H302 | H412 | GHS07 | Wng | H332 | H312 | H302 | H412 |   |   | G
612-035-00-4 | 2-methoxyaniline; | o-anisidine | 201-963-1 | 90-04-0 | Carc. 1B Muta. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H350 | H341 | H331 | H311 | H301 | GHS06 | GHS08 | Dgr | H350 | H341 | H331 | H311 | H301 |   |   |  612-035-00-4 | 2-мeтоксианилин; | o-анизидин | 201-963-1 | 90-04-0 | Carc. 1B Muta. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | H350 | H341 | H331 | H311 | H301 | GHS06 | GHS08 | Dgr | H350 | H341 | H331 | H311 | H301 |   |   |  
612-036-00-X | 3,3'-dimethoxybenzidine; | o-dianisidine | 204-355-4 | 119-90-4 | Carc. 1B | Acute Tox. 4 * | H350 | H302 | GHS08 | GHS07 | Dgr | H350 | H302 |   |   |  612-036-00-X | 3,3′-диметоксибензидин; | o-дианизидин | 204-355-4 | 119-90-4 | Carc. 1B | Acute Tox. 4 * | H350 | H302 | GHS08 | GHS07 | Dgr | H350 | H302 |   |   |  
612-037-00-5 | salts of 3,3'-dimethoxybenzidine; salts of o-dianisidine | — | — | Carc. 1B | Acute Tox. 4 * | H350 | H302 | GHS08 | GHS07 | Dgr | H350 | H302 |   |   | A612-037-00-5 | соли на 3,3′-диметоксибензидин; соли на о-дианизидин | — | — | Carc. 1B | Acute Tox. 4 * | H350 | H302 | GHS08 | GHS07 | Dgr | H350 | H302 |   |   | A
612-038-00-0 | 2-nitro-p-anisidine; | 4-methoxy-2-nitroaniline | 202-547-2 | 96-96-8 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Chronic 3 | H330 | H310 | H300 | H373 ** | H412 | GHS06 | GHS08 | Dgr | H330 | H310 | H300 | H373 ** | H412 |   |   |  612-038-00-0 | 2-нитро-p-анизидин; | 4-метокси-2-нитроанилин | 202-547-2 | 96-96-8 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Chronic 3 | H330 | H310 | H300 | H373 ** | H412 | GHS06 | GHS08 | Dgr | H330 | H310 | H300 | H373 ** | H412 |   |   |  
612-039-00-6 | 2-ethoxyaniline; | o-phenetidine | 202-356-4 | 94-70-2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | H331 | H311 | H301 | H373 ** | GHS06 | GHS08 | Dgr | H331 | H311 | H301 | H373 ** |   |   |  612-039-00-6 | 2-етоксианилин; | o-фенетидин | 202-356-4 | 94-70-2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | H331 | H311 | H301 | H373 ** | GHS06 | GHS08 | Dgr | H331 | H311 | H301 | H373 ** |   |   |  
612-040-00-1 | 2,4-dinitroaniline | 202-553-5 | 97-02-9 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Chronic 2 | H330 | H310 | H300 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H310 | H300 | H373 ** | H411 |   |   |  612-040-00-1 | 2,4-динитроанилин | 202-553-5 | 97-02-9 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Chronic 2 | H330 | H310 | H300 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H310 | H300 | H373 ** | H411 |   |   |  
612-041-00-7 | 4,4'-bi-o-toluidine | 204-358-0 | 119-93-7 | Carc. 1B | Acute Tox. 4 * | Aquatic Chronic 2 | H350 | H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H411 |   |   |  612-041-00-7 | 4,4′-би-o-толуидин | 204-358-0 | 119-93-7 | Carc. 1B | Acute Tox. 4 * | Aquatic Chronic 2 | H350 | H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H411 |   |   |  
612-042-00-2 | benzidine; | 1,1'-biphenyl-4,4'-diamine; | 4,4'-diaminobiphenyl; | biphenyl-4,4'-ylenediamine | 202-199-1 | 92-87-5 | Carc. 1A | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H410 |   | Carc. 1A; H350: C ≥ 0,01  % |  612-042-00-2 | бензидин; | 1,1′-бифенил-4,4′-диамин; | 4,4′-диаминобифенил; | бифенил-4,4′-илендиамин | 202-199-1 | 92-87-5 | Carc. 1A | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H410 |   | Carc. 1A; H350: C ≥ 0,01  % |  
612-043-00-8 | N,N'-dimethylbenzidine | — | 2810-74-4 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H312 | H302 | GHS07 | Wng | H332 | H312 | H302 |   |   |  612-043-00-8 | N,N′-диметилбензидин | — | 2810-74-4 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H332 | H312 | H302 | GHS07 | Wng | H332 | H312 | H302 |   |   |  
612-044-00-3 | N,N'-diacetylbenzidine | 210-338-2 | 613-35-4 | Carc. 1B Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H350 | H341 | H332 | H312 | H302 | GHS08 | GHS07 | Dgr | H350 | H341 | H332 | H312 | H302 |   |   |  612-044-00-3 | N,N′-диацетилбензидин | 210-338-2 | 613-35-4 | Carc. 1B Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H350 | H341 | H332 | H312 | H302 | GHS08 | GHS07 | Dgr | H350 | H341 | H332 | H312 | H302 |   |   |  
612-046-00-4 | allylamine | 203-463-9 | 107-11-9 | Flam. Liq. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Chronic 2 | H225 | H331 | H311 | H301 | H411 | GHS02 | GHS06 | GHS09 | Dgr | H225 | H331 | H311 | H301 | H411 |   |   |  612-046-00-4 | алиламин | 203-463-9 | 107-11-9 | Flam. Liq. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Chronic 2 | H225 | H331 | H311 | H301 | H411 | GHS02 | GHS06 | GHS09 | Dgr | H225 | H331 | H311 | H301 | H411 |   |   |  
612-047-00-X | benzylamine | 202-854-1 | 100-46-9 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H312 | H302 | H314 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 |   |   |  612-047-00-X | бензиламин | 202-854-1 | 100-46-9 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H312 | H302 | H314 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 |   |   |  
612-048-00-5 | dipropylamine | 205-565-9 | 142-84-7 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | H225 | H332 | H312 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H225 | H332 | H312 | H302 | H314 |   | STOT SE 3; H335: C ≥ 1 % |  612-048-00-5 | дипропиламин | 205-565-9 | 142-84-7 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | H225 | H332 | H312 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H225 | H332 | H312 | H302 | H314 |   | STOT SE 3; H335: C ≥ 1 % |  
612-049-00-0 | di-n-butylamine; [1] | di-sec-butylamine [2] | 203-921-8 [1] | 210-937-9 [2] | 111-92-2 [1] | 626-23-3 [2] | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H226 | H332 | H312 | H302 | GHS02 | GHS07 | Wng | H226 | H332 | H312 | H302 |   |   |  612-049-00-0 | ди-n-бутиламин; [1] | ди-втор-бутиламин [2] | 203-921-8 [1] | 210-937-9 [2] | 111-92-2 [1] | 626-23-3 [2] | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H226 | H332 | H312 | H302 | GHS02 | GHS07 | Wng | H226 | H332 | H312 | H302 |   |   |  
612-050-00-6 | cyclohexylamine | 203-629-0 | 108-91-8 | Flam. Liq. 3 | Repr. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H226 | H361f*** | H312 | H302 | H314 | GHS02 | GHS05 | GHS08 | GHS07 | Dgr | H226 | H361f*** | H312 | H302 | H314 |   |   |  612-050-00-6 | циклохексиламин | 203-629-0 | 108-91-8 | Flam. Liq. 3 | Repr. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H226 | H361f*** | H312 | H302 | H314 | GHS02 | GHS05 | GHS08 | GHS07 | Dgr | H226 | H361f*** | H312 | H302 | H314 |   |   |  
612-051-00-1 | 4,4'-diaminodiphenylmethane; | 4,4'-methylenedianiline | 202-974-4 | 101-77-9 | Carc. 1B | Muta. 2 | STOT SE 1 | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 2 | H350 | H341 | H370 ** | H373 ** | H317 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H341 | H370 ** | H373 ** | H317 | H411 |   |   |  612-051-00-1 | 4,4′-диаминодифенилметан | 4,4′-метилендианилин | 202-974-4 | 101-77-9 | Carc. 1B | Muta. 2 | STOT SE 1 | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 2 | H350 | H341 | H370 ** | H373 ** | H317 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H341 | H370 ** | H373 ** | H317 | H411 |   |   |  
612-052-00-7 | (S)-sec-butylamine; | (S)-2-aminobutane; [1] (R)-sec-butylamine; | (R)-2-aminobutane; [2] | sec-butylamine; | 2-aminobutane [3] | 208-164-7 [1] | 236-232-6 [2] | 237-732-7 [3] | 513-49-5 [1] | 13250-12-9 [2] | 13952-84-6 [3] | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | Aquatic Acute 1 | H225 | H332 | H302 | H314 | H400 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H225 | H332 | H302 | H314 | H400 |   |   | C612-052-00-7 | (S)-втор-бутиламин; | (S)-2-аминобутан; [1] (R)-втор-бутиламин; | (R)-2-аминобутан; [2] | втор-бутиламин; | 2-аминобутан [3] | 208-164-7 [1] | 236-232-6 [2] | 237-732-7 [3] | 513-49-5 [1] | 13250-12-9 [2] | 13952-84-6 [3] | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | Aquatic Acute 1 | H225 | H332 | H302 | H314 | H400 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H225 | H332 | H302 | H314 | H400 |   |   | C
612-053-00-2 | N-ethylaniline | 203-135-5 | 103-69-5 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | H331 | H311 | H301 | H373 ** | GHS06 | GHS08 | Dgr | H331 | H311 | H301 | H373 ** |   |   |  612-053-00-2 | N-етиланилин | 203-135-5 | 103-69-5 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | H331 | H311 | H301 | H373 ** | GHS06 | GHS08 | Dgr | H331 | H311 | H301 | H373 ** |   |   |  
612-054-00-8 | N,N-diethylaniline | 202-088-8 | 91-66-7 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 2 | H331 | H311 | H301 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H411 |   | * |  612-054-00-8 | N,N-диетиланилин | 202-088-8 | 91-66-7 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 2 | H331 | H311 | H301 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H411 |   | * |  
612-055-00-3 | N-methyl-o-toluidine; [1] N-methyl-m-toluidine; [2] N-methyl-p-toluidine [3] | 210-260-9 [1] | 211-795-0 [2] | 210-769-6 [3] | 611-21-2 [1] | 696-44-6 [2] | 623-08-5 [3] | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 3 | H331 | H311 | H301 | H373 ** | H412 | GHS06 | GHS08 | Dgr | H331 | H311 | H301 | H373 ** | H412 |   |   | C612-055-00-3 | N-метил-o-толуидин; [1] N-метил-m-толуидин; [2] N-метил-p-толуидин [3] | 210-260-9 [1] | 211-795-0 [2] | 210-769-6 [3] | 611-21-2 [1] | 696-44-6 [2] | 623-08-5 [3] | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 3 | H331 | H311 | H301 | H373 ** | H412 | GHS06 | GHS08 | Dgr | H331 | H311 | H301 | H373 ** | H412 |   |   | C
612-056-00-9 | N,N-dimethyl-p-toluidine; [1] N,N-dimethyl-m-toluidine; [2] N,N-dimethyl-o-toluidine [3] | 202-805-4 [1] | 204-495-6 [2] | 210-199-8 [3] | 99-97-8 [1] | 121-72-2 [2] | 609-72-3 [3] | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 3 | H331 | H311 | H301 | H373 ** | H412 | GHS06 | GHS08 | Dgr | H331 | H311 | H301 | H373 ** | H412 |   | * | C612-056-00-9 | N,N-диметил-p-толуидин; [1] N,N-диметил-m-толуидин; [2] N,N-диметил-o-толуидин [3] | 202-805-4 [1] | 204-495-6 [2] | 210-199-8 [3] | 99-97-8 [1] | 121-72-2 [2] | 609-72-3 [3] | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 3 | H331 | H311 | H301 | H373 ** | H412 | GHS06 | GHS08 | Dgr | H331 | H311 | H301 | H373 ** | H412 |   | * | C
612-057-00-4 | piperazine; [solid] | 203-808-3 | 110-85-0 | Repr. 2 | Skin Corr. 1B | Resp. Sens. 1 | Skin Sens. 1 | H361fd | H314 | H334 | H317 | GHS05 | GHS08 | Dgr | H361fd | H314 | H334 | H317 |   |   |  612-057-00-4 | пиперазин; [твърдо агрегатно състояние] | 203-808-3 | 110-85-0 | Repr. 2 | Skin Corr. 1B | Resp. Sens. 1 | Skin Sens. 1 | H361fd | H314 | H334 | H317 | GHS05 | GHS08 | Dgr | H361fd | H314 | H334 | H317 |   |   |  
612-057-01-1 | piperazine; [liquid] | 203-808-3 | 110-85-0 | Repr. 2 | Skin Corr. 1B | Resp. Sens. 1 | Skin Sens. 1 | H361fd | H314 | H334 | H317 | GHS05 | GHS08 | Dgr | H361fd | H314 | H334 | H317 |   |   |  612-057-01-1 | пиперазин; [течност] | 203-808-3 | 110-85-0 | Repr. 2 | Skin Corr. 1B | Resp. Sens. 1 | Skin Sens. 1 | H361fd | H314 | H334 | H317 | GHS05 | GHS08 | Dgr | H361fd | H314 | H334 | H317 |   |   |  
612-058-00-X | 2,2'-iminodiethylamine; | diethylenetriamine | 203-865-4 | 111-40-0 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | H312 | H302 | H314 | H317 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 | H317 |   |   |  612-058-00-X | 2,2′-иминодиетиламин; | диетилентриамин | 203-865-4 | 111-40-0 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | H312 | H302 | H314 | H317 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 | H317 |   |   |  
612-059-00-5 | 3,6-diazaoctanethylenediamin; | triethylenetetramine | 203-950-6 | 112-24-3 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 3 | H312 | H314 | H317 | H412 | GHS05 | GHS07 | Dgr | H312 | H314 | H317 | H412 |   |   |  612-059-00-5 | 3,6-диазаоктанетилендиамин; | триетилентетрамин | 203-950-6 | 112-24-3 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 3 | H312 | H314 | H317 | H412 | GHS05 | GHS07 | Dgr | H312 | H314 | H317 | H412 |   |   |  
612-060-00-0 | 3,6,9-triazaundecamethylenediamine; tetraethylenepentamine | 203-986-2 | 112-57-2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H312 | H302 | H314 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H314 | H317 | H411 |   |   |  612-060-00-0 | 3,6,9-триазаундекаметилендиамин; тетраетиленпентамин | 203-986-2 | 112-57-2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H312 | H302 | H314 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H314 | H317 | H411 |   |   |  
612-061-00-6 | 3-aminopropyldimethylamine; N,N-dimethyl-1,3-diaminopropane | 203-680-9 | 109-55-7 | Flam. Liq. 3 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | H226 | H302 | H314 | H317 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H302 | H314 | H317 |   |   |  612-061-00-6 | 3-аминопропилдиметиламин; N,N-диметил-1,3-диаминопропан | 203-680-9 | 109-55-7 | Flam. Liq. 3 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | H226 | H302 | H314 | H317 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H302 | H314 | H317 |   |   |  
612-062-00-1 | 3-aminopropyldiethylamine; | N,N-diethyl-1,3-diaminopropane | 203-236-4 | 104-78-9 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | H226 | H312 | H302 | H314 | H317 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H312 | H302 | H314 | H317 |   |   |  612-062-00-1 | 3-аминопропилдиетиламин; | N,N-диетил-1,3-диаминопропан | 203-236-4 | 104-78-9 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | H226 | H312 | H302 | H314 | H317 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H312 | H302 | H314 | H317 |   |   |  
612-063-00-7 | 3,3'-iminodi(propylamine); | dipropylenetriamine | 200-261-2 | 56-18-8 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 4 * | Skin Corr. 1A | Skin Sens. 1 | H330 | H311 | H302 | H314 | H317 | GHS06 | GHS05 | Dgr | H330 | H311 | H302 | H314 | H317 |   |   |  612-063-00-7 | 3,3′-иминоди(пропиламин); | дипропилентриамин | 200-261-2 | 56-18-8 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 4 * | Skin Corr. 1A | Skin Sens. 1 | H330 | H311 | H302 | H314 | H317 | GHS06 | GHS05 | Dgr | H330 | H311 | H302 | H314 | H317 |   |   |  
612-064-00-2 | 3,6,9,12-tetra-azatetradecamethylenediamine; pentacthylenehexamine | 223-775-9 | 4067-16-7 | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H317 | H410 |   |   |  612-064-00-2 | 3,6,9,12-тeтраазатетрадекаметилендиамин; пентаетиленхексамин | 223-775-9 | 4067-16-7 | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H317 | H410 |   |   |  
612-065-00-8 | polyethlyenepolyamines with the exception of those specified elsewhere in this Annex | — | — | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H314 | H317 | H410 |   |   |  612-065-00-8 | полиетиленполиамини, с изключение на тези, посочени другаде в настоящото приложение | — | — | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H314 | H317 | H410 |   |   |  
612-066-00-3 | dicyclohexylamine | 202-980-7 | 101-83-7 | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H314 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H410 |   |   |  612-066-00-3 | дициклохексиламин | 202-980-7 | 101-83-7 | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H314 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H410 |   |   |  
612-067-00-9 | 3-aminomethyl-3,5,5-trimethylcyclohexylamine | 220-666-8 | 2855-13-2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 3 | H312 | H302 | H314 | H317 | H412 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 | H317 | H412 |   |   |  612-067-00-9 | 3-аминометил-3,5,5-триметилциклохексиламин | 220-666-8 | 2855-13-2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 3 | H312 | H302 | H314 | H317 | H412 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 | H317 | H412 |   |   |  
612-068-00-4 | 3,3'-dichlorobenzidine; | 3,3'-dichlorobiphenyl-4,4'-ylenediamine | 202-109-0 | 91-94-1 | Carc. 1B | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H312 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H312 | H317 | H410 |   |   |  612-068-00-4 | 3,3′-дихлоробензидин; | 3,3′-дихлоробифенил-4,4′-илендиамин | 202-109-0 | 91-94-1 | Carc. 1B | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H312 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H312 | H317 | H410 |   |   |  
612-069-00-X | salts of 3,3'-dichlorobenzidine; | salts of 3,3'-dichlorobiphenyl-4,4'-ylenediamine | — | — | Carc. 1B | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H312 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H312 | H317 | H410 |   |   | A612-069-00-X | соли на 3,3′-дихлоробензидин; | соли на 3,3′-дихлоробифенил-4,4′-илендиамин | — | — | Carc. 1B | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H312 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H312 | H317 | H410 |   |   | A
612-070-00-5 | salts of benzidine | 208-519-6 | 208-520-1 | 244-236-4 | 252-984-8 | 531-85-1 | 531-86-2 | 21136-70-9 | 36341-27-2 | Carc. 1A | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H410 |   |   | A612-070-00-5 | соли на бензидин | 208-519-6 | 208-520-1 | 244-236-4 | 252-984-8 | 531-85-1 | 531-86-2 | 21136-70-9 | 36341-27-2 | Carc. 1A | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H410 |   |   | A
612-071-00-0 | salts of 2-naphthylamine | 209-030-0 | 210-313-6 | 553-00-4 | 612-52-2 | Carc. 1A | Acute Tox. 4 * | Aquatic Chronic 2 | H350 | H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H411 |   |   | A612-071-00-0 | соли на 2-нафтиламин | 209-030-0 | 210-313-6 | 553-00-4 | 612-52-2 | Carc. 1A | Acute Tox. 4 * | Aquatic Chronic 2 | H350 | H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H411 |   |   | A
612-072-00-6 | biphenyl-4-ylamine; | xenylamine; | 4-aminobiphenyl | 202-177-1 | 92-67-1 | Carc. 1A | Acute Tox. 4 * | H350 | H302 | GHS08 | GHS07 | Dgr | H350 | H302 |   |   |  612-072-00-6 | бифенил-4-иламин; | ксениламин; | 4-аминобифенил | 202-177-1 | 92-67-1 | Carc. 1A | Acute Tox. 4 * | H350 | H302 | GHS08 | GHS07 | Dgr | H350 | H302 |   |   |  
612-073-00-1 | salts of biphenyl-4-ylamine; | salts of xenylamine; | salts of 4-aminobiphenyl | — | — | Carc. 1A | Acute Tox. 4 * | H350 | H302 | GHS08 | GHS07 | Dgr | H350 | H302 |   |   | A612-073-00-1 | соли на бифенил-4-иламин; | соли на ксениламин; | соли на 4-аминобифенил | — | — | Carc. 1A | Acute Tox. 4 * | H350 | H302 | GHS08 | GHS07 | Dgr | H350 | H302 |   |   | A
612-074-00-7 | benzyldimethylamine | 203-149-1 | 103-83-3 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 3 | H226 | H332 | H312 | H302 | H314 | H412 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H332 | H312 | H302 | H314 | H412 |   |   |  612-074-00-7 | бензилдиметиламин | 203-149-1 | 103-83-3 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 3 | H226 | H332 | H312 | H302 | H314 | H412 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H332 | H312 | H302 | H314 | H412 |   |   |  
612-075-00-2 | 2-aminoethyldimethylamine; | 2-dimethylaminoethylamine | 203-541-2 | 108-00-9 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | H225 | H312 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H225 | H312 | H302 | H314 |   |   |  612-075-00-2 | 2-аминоетилдиметиламин | 2-диметиламиноетиламин | 203-541-2 | 108-00-9 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | H225 | H312 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H225 | H312 | H302 | H314 |   |   |  
612-076-00-8 | ethyldimethylamine | 209-940-8 | 598-56-1 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H225 | H332 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H225 | H332 | H302 | H314 |   |   |  612-076-00-8 | етилдиметиламин | 209-940-8 | 598-56-1 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H225 | H332 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H225 | H332 | H302 | H314 |   |   |  
612-077-00-3 | dimethylnitrosoamine; | N-nitrosodimethylamine | 200-549-8 | 62-75-9 | Carc. 1B | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 1 | Aquatic Chronic 2 | H350 | H330 | H301 | H372 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H330 | H301 | H372 ** | H411 |   | Carc. 1B; H350: C ≥ 0,001  % |  612-077-00-3 | диметилнитрозоамин; | N-нитрозодиметиламин | 200-549-8 | 62-75-9 | Carc. 1B | Acute Tox. 2 * | Acute Tox. 3 * | STOT RE 1 | Aquatic Chronic 2 | H350 | H330 | H301 | H372 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H330 | H301 | H372 ** | H411 |   | Carc. 1B; H350: C ≥ 0,001  % |  
612-078-00-9 | 2,2'-dichloro-4,4'-methylenedianiline; | 4,4'-methylene bis(2-chloroaniline) | 202-918-9 | 101-14-4 | Carc. 1B | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H410 |   |   |  612-078-00-9 | 4,4′-метилен-2,2′-дихлородианилин; | 4,4′-метиленбис(2-хлороанилин) | 202-918-9 | 101-14-4 | Carc. 1B | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H410 |   |   |  
612-079-00-4 | salts of 2,2'-dichloro-4,4'-methylenedianiline; | salts of 4,4'-methylenebis(2-chloroaniline) | — | — | Carc. 1B | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H410 |   |   | A612-079-00-4 | соли на 2,2′-дихлоро-4,4′-метилендианилин; | соли на 4,4′-метиленбис(2-хлороанилин) | — | — | Carc. 1B | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H410 |   |   | A
612-080-00-X | 4-amino-N,N-diethylaniline; | N,N-diethyl-p-phenylendiamine | 202-214-1 | 93-05-0 | Acute Tox. 3 * | Skin Corr. 1B | H301 | H314 | GHS06 | GHS05 | Dgr | H301 | H314 |   |   |  612-080-00-X | 4-амино-N,N-диетиланилин; | N,N-диетил-p-фенилендиамин | 202-214-1 | 93-05-0 | Acute Tox. 3 * | Skin Corr. 1B | H301 | H314 | GHS06 | GHS05 | Dgr | H301 | H314 |   |   |  
612-081-00-5 | salts of 4,4'-bi-o-toluidine; | salts of 3,3'-dimethylbenzidine; | salts of o-tolidine | 210-322-5 | 265-294-7 | 277-985-0 | 612-82-8 | 64969-36-4 | 74753-18-7 | Carc. 1B | Acute Tox. 4 * | Aquatic Chronic 2 | H350 | H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H411 |   |   | A612-081-00-5 | соли на 4,4′-би-o-толуидин; | соли на 3,3′-диметилбензидин; | соли на о-толидин | 210-322-5 | 265-294-7 | 277-985-0 | 612-82-8 | 64969-36-4 | 74753-18-7 | Carc. 1B | Acute Tox. 4 * | Aquatic Chronic 2 | H350 | H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H411 |   |   | A
612-082-00-0 | thiourea; | thiocarbamide | 200-543-5 | 62-56-6 | Carc. 2 | Repr. 2 | Acute Tox. 4 * | Aquatic Chronic 2 | H351 | H361d *** H302 | H411 | GHS08 | GHS07 | GHS09 | Wng | H351 | H361d *** H302 | H411 |   |   |  612-082-00-0 | тиоуреа; | тиокарбамид | 200-543-5 | 62-56-6 | Carc. 2 | Repr. 2 | Acute Tox. 4 * | Aquatic Chronic 2 | H351 | H361d *** H302 | H411 | GHS08 | GHS07 | GHS09 | Wng | H351 | H361d *** H302 | H411 |   |   |  
612-083-00-6 | 1-methyl-3-nitro-1-nitrosoguanidine | 200-730-1 | 70-25-7 | Carc. 1B | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 2 | H350 | H332 | H319 | H315 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H332 | H319 | H315 | H411 |   | Carc. 1B; H350: C ≥ 0,01  % |  612-083-00-6 | 1-метил-3-нитро-1-нитрозогуанидин | 200-730-1 | 70-25-7 | Carc. 1B | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 2 | H350 | H332 | H319 | H315 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H332 | H319 | H315 | H411 |   | Carc. 1B; H350: C ≥ 0,01  % |  
612-084-00-1 | dapsone; | 4,4'-diamino diphenyl sulfone | 201-248-4 | 80-08-0 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  612-084-00-1 | дапсон; | 4,4′-диаминодифенилсулфон | 201-248-4 | 80-08-0 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
612-085-00-7 | 4,4'-methylenedi-o-toluidine | 212-658-8 | 838-88-0 | Carc. 1B | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H302 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H317 | H410 |   |   |  612-085-00-7 | 4,4′-мeтиленди-o-толуидин | 212-658-8 | 838-88-0 | Carc. 1B | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H302 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H317 | H410 |   |   |  
612-086-00-2 | amitraz (ISO); | N,N-bis(2,4-xylyliminomethyl) | methylamine | 251-375-4 | 33089-61-1 | Acute Tox. 4 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373 ** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373 ** H317 | H410 |   | M = 10 |  612-086-00-2 | амитраз (ISO); | N,N-бис(2,4-ксилилиминометил) | метиламин | 251-375-4 | 33089-61-1 | Acute Tox. 4 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373 ** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373 ** H317 | H410 |   | M = 10 |  
612-087-00-8 | guazatine (ISO) |   | 108173-90-6 | Acute Tox. 2 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H312 | H302 | H335 | H315 | H318 | H400 | H410 | GHS06 | GHS05 | GHS09 | Dgr | H330 | H312 | H302 | H335 | H315 | H318 | H410 |   |   |  612-087-00-8 | гуазатин (ISO) |   | 108173-90-6 | Acute Tox. 2 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H312 | H302 | H335 | H315 | H318 | H400 | H410 | GHS06 | GHS05 | GHS09 | Dgr | H330 | H312 | H302 | H335 | H315 | H318 | H410 |   |   |  
612-088-00-3 | simazine (ISO); | 6-chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine | 204-535-2 | 122-34-9 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   |   |  612-088-00-3 | симазин (ISO); | N,N′-диетил-6-хлоро-1,3,5-триазин-2,4-диамин | 204-535-2 | 122-34-9 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   |   |  
612-089-00-9 | 1,5-naphthylenediamine | 218-817-8 | 2243-62-1 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   |   |  612-089-00-9 | 1,5-нафтилендиамин | 218-817-8 | 2243-62-1 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   |   |  
612-090-00-4 | 2,2'-(nitrosoimino)bisethanol | 214-237-4 | 1116-54-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  612-090-00-4 | 2,2′-(нитрозоимино)бисетанол | 214-237-4 | 1116-54-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
612-091-00-X | o-toluidine; | 2-aminotoluene | 202-429-0 | 95-53-4 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | Aquatic Acute 1 | H350 | H331 | H301 | H319 | H400 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H331 | H301 | H319 | H400 |   |   |  612-091-00-X | o-тoлуидин; | 2-аминотолуен | 202-429-0 | 95-53-4 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | Aquatic Acute 1 | H350 | H331 | H301 | H319 | H400 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H331 | H301 | H319 | H400 |   |   |  
612-092-00-5 | N, N'-(2,2-dimethylpropylidene)hexamethylenediamine | 401-660-6 | 1000-78-8 | Skin Irrit. 2 | Skin Sens. 1 | H315 | H317 | GHS07 | Wng | H315 | H317 |   |   |  612-092-00-5 | N, N′-(2,2-диметилпропилиден)хексаметилендиамин | 401-660-6 | 1000-78-8 | Skin Irrit. 2 | Skin Sens. 1 | H315 | H317 | GHS07 | Wng | H315 | H317 |   |   |  
612-093-00-0 | 3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline | 401-790-3 | 104147-32-2 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  612-093-00-0 | 4-(1,1,2,2-тетрафлуороетокси)-3,5-дихлороaнилин | 401-790-3 | 104147-32-2 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
612-094-00-6 | 4-(2-chloro-4-trifluoromethyl)phenoxy-2-fluoroaniline hydrochloride | 402-190-4 | 113674-95-6 | STOT RE 1 | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H372** | H302 | H373** | H318 | H317 | H400 | H410 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H372** | H302 | H373** | H318 | H317 | H410 |   |   |  612-094-00-6 | 4-[4-(трифлуорометил)-2-хлорофенокси]-2-флуороанилинхидрохлорид | 402-190-4 | 113674-95-6 | STOT RE 1 | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H372** | H302 | H373** | H318 | H317 | H400 | H410 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H372** | H302 | H373** | H318 | H317 | H410 |   |   |  
612-095-00-1 | benzyl-2-hydroxydodecyldi | methylammonium benzoate | 402-610-6 | 113694-52-3 | Skin Corr. 1B | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H302 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H302 | H410 |   |   |  612-095-00-1 | бензил-2-хидроксидодецилди | метиламониев бензоат | 402-610-6 | 113694-52-3 | Skin Corr. 1B | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H302 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H302 | H410 |   |   |  
612-096-00-7 | 4,4'-carbonimidoylbis[N, N-dimethylaniline] | 207-762-5 | 492-80-8 | Carc. 2 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Chronic 2 | H351 | H302 | H319 | H411 | GHS08 | GHS07 | GHS09 | Wng | H351 | H302 | H319 | H411 |   |   |  612-096-00-7 | 4,4′-карбонимидоилбис[N,N-диметиланилин] | 207-762-5 | 492-80-8 | Carc. 2 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Chronic 2 | H351 | H302 | H319 | H411 | GHS08 | GHS07 | GHS09 | Wng | H351 | H302 | H319 | H411 |   |   |  
612-097-00-2 | salts of 4,4'-carbonimidoylbis[N, N-dimethylaniline] | — | — | Carc. 2 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Chronic 2 | H351 | H302 | H319 | H411 | GHS08 | GHS07 | GHS09 | Wng | H351 | H302 | H319 | H411 |   |   | A612-097-00-2 | соли на 4,4′-карбонимидоилбис[N,N-диметиланилин] | — | — | Carc. 2 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Chronic 2 | H351 | H302 | H319 | H411 | GHS08 | GHS07 | GHS09 | Wng | H351 | H302 | H319 | H411 |   |   | A
612-098-00-8 | nitrosodipropylamine | 210-698-0 | 621-64-7 | Carc. 1B | Acute Tox. 4 * | Aquatic Chronic 2 | H350 | H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H411 |   | Carc. 1B; H350: C ≥ 0,001  % |  612-098-00-8 | нитрозодипропиламин | 210-698-0 | 621-64-7 | Carc. 1B | Acute Tox. 4 * | Aquatic Chronic 2 | H350 | H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H411 |   | Carc. 1B; H350: C ≥ 0,001  % |  
612-099-00-3 | 4-methyl-m-phenylenediamine; | 2,4-toluenediamine | 202-453-1 | 95-80-7 | Carc. 1B | Muta. 2 | Repr. 2 | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 2 | H350 | H341 | H361f*** | H301 | H312 | H373** | H317 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H341 | H361f*** | H301 | H312 | H373** | H317 | H411 |   |   |  612-099-00-3 | 4-метил-m-фенилендиамин; | 2,4-толуендиамин | 202-453-1 | 95-80-7 | Carc. 1B | Muta. 2 | Repr. 2 | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 2 | H350 | H341 | H361f*** | H301 | H312 | H373** | H317 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H341 | H361f*** | H301 | H312 | H373** | H317 | H411 |   |   |  
612-100-00-7 | propylenediamine | 201-155-9 | 78-90-0 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | H226 | H312 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H312 | H302 | H314 |   |   |  612-100-00-7 | пропилендиамин | 201-155-9 | 78-90-0 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A | H226 | H312 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H226 | H312 | H302 | H314 |   |   |  
612-101-00-2 | methenamine; | hexamethylenetetramine | 202-905-8 | 100-97-0 | Flam. Sol. 2 | Skin Sens. 1 | H228 | H317 | GHS02 | GHS07 | Wng | H228 | H317 |   |   |  612-101-00-2 | метенамин; | хексаметилентетрамин | 202-905-8 | 100-97-0 | Flam. Sol. 2 | Skin Sens. 1 | H228 | H317 | GHS02 | GHS07 | Wng | H228 | H317 |   |   |  
612-102-00-8 | N, N-bis(3-aminopropyl)methylamine | 203-336-8 | 105-83-9 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 4 * | Skin Corr. 1B | H331 | H311 | H302 | H314 | GHS06 | GHS05 | Dgr | H331 | H311 | H302 | H314 |   |   |  612-102-00-8 | N, N-бис(3-аминопропил)метиламин | 203-336-8 | 105-83-9 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 4 * | Skin Corr. 1B | H331 | H311 | H302 | H314 | GHS06 | GHS05 | Dgr | H331 | H311 | H302 | H314 |   |   |  
612-103-00-3 | N, N,N',N'-tetramethylethylenediamine | 203-744-6 | 110-18-9 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H225 | H332 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H225 | H332 | H302 | H314 |   |   |  612-103-00-3 | N,N,N′,N′-тeтраметилетилендиамин | 203-744-6 | 110-18-9 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H225 | H332 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H225 | H332 | H302 | H314 |   |   |  
612-104-00-9 | hexamethylenediamine | 204-679-6 | 124-09-4 | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 3 | Skin Corr. 1B | H312 | H302 | H335 | H314 | GHS05 | GHS07 | Dgr | H312 | H302 | H335 | H314 |   |   |  612-104-00-9 | хексаметилендиамин | 204-679-6 | 124-09-4 | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 3 | Skin Corr. 1B | H312 | H302 | H335 | H314 | GHS05 | GHS07 | Dgr | H312 | H302 | H335 | H314 |   |   |  
612-105-00-4 | 2-piperazin-1-ylethylamine | 205-411-0 | 140-31-8 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 3 | H312 | H302 | H314 | H317 | H412 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 | H317 | H412 |   |   |  612-105-00-4 | 2-пиперазин-1-илетиламин | 205-411-0 | 140-31-8 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 3 | H312 | H302 | H314 | H317 | H412 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 | H317 | H412 |   |   |  
612-106-00-X | 2,6-diethylaniline | 209-445-7 | 579-66-8 | Acute Tox. 4 * | H302 | — | H302 |   |   |  612-106-00-X | 2,6-диетиланилин | 209-445-7 | 579-66-8 | Acute Tox. 4 * | H302 | — | H302 |   |   |  
612-107-00-5 | 1-phenylethylamine; [1] | DL-α-methylbenzylamine [2] | 202-706-6 [1] | 210-545-8 [2] | 98-84-0 [1] | 618-36-0 [2] | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H312 | H302 | H314 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 |   |   |  612-107-00-5 | 1-фенилетиламин; [1] | DL-α-мeтилбензиламин [2] | 202-706-6 [1] | 210-545-8 [2] | 98-84-0 [1] | 618-36-0 [2] | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H312 | H302 | H314 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 |   |   |  
612-108-00-0 | 3-aminopropyltriethoxysilane | 213-048-4 | 919-30-2 | Acute Tox. 4 * | Skin Corr. 1B | H302 | H314 | GHS05 | GHS07 | Dgr | H302 | H314 |   |   |  612-108-00-0 | 3-аминопропилтриетоксисилан | 213-048-4 | 919-30-2 | Acute Tox. 4 * | Skin Corr. 1B | H302 | H314 | GHS05 | GHS07 | Dgr | H302 | H314 |   |   |  
612-109-00-6 | bis(2-dimethylaminoethyl)(methyl)amine | 221-201-1 | 3030-47-5 | Acute Tox. 3 * | Acute Tox. 4 * | Skin Corr. 1B | H311 | H302 | H314 | GHS06 | GHS05 | Dgr | H311 | H302 | H314 |   |   |  612-109-00-6 | бис(2-диметиламиноетил)(метил)амин | 221-201-1 | 3030-47-5 | Acute Tox. 3 * | Acute Tox. 4 * | Skin Corr. 1B | H311 | H302 | H314 | GHS06 | GHS05 | Dgr | H311 | H302 | H314 |   |   |  
612-110-00-1 | 2,2'-dimethyl-4,4'-methylenebis(cyclohexylamine) | 229-962-1 | 6864-37-5 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 4 * | Skin Corr. 1A | Aquatic Chronic 2 | H331 | H311 | H302 | H314 | H411 | GHS06 | GHS05 | GHS09 | Dgr | H331 | H311 | H302 | H314 | H411 |   |   |  612-110-00-1 | 2,2′-диметил-4-4′-метиленбис(циклохексиламин) | 229-962-1 | 6864-37-5 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 4 * | Skin Corr. 1A | Aquatic Chronic 2 | H331 | H311 | H302 | H314 | H411 | GHS06 | GHS05 | GHS09 | Dgr | H331 | H311 | H302 | H314 | H411 |   |   |  
612-111-00-7 | 2-methyl-m-phenylenediamine; | 2,6-toluenediamine | 212-513-9 | 823-40-5 | Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H341 | H312 | H302 | H317 | H411 | GHS08 | GHS07 | GHS09 | Wng | H341 | H312 | H302 | H317 | H411 |   |   |  612-111-00-7 | 2-метил-m-фенилендиамин; | 2,6-толуендиамин | 212-513-9 | 823-40-5 | Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H341 | H312 | H302 | H317 | H411 | GHS08 | GHS07 | GHS09 | Wng | H341 | H312 | H302 | H317 | H411 |   |   |  
612-112-00-2 | p-anisidine; | 4-methoxyaniline | 203-254-2 | 104-94-9 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Acute 1 | H330 | H310 | H300 | H373 ** | H400 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H310 | H300 | H373 ** | H400 |   |   |  612-112-00-2 | p-анизидин; | 4-мeтоксианилин | 203-254-2 | 104-94-9 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | STOT RE 2 * | Aquatic Acute 1 | H330 | H310 | H300 | H373 ** | H400 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H310 | H300 | H373 ** | H400 |   |   |  
612-113-00-8 | 6-methyl-2,4-bis(methylthio)phenylene-1,3-diamine | 403-240-8 | 106264-79-3 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  612-113-00-8 | 6-мeтил-2,4-бис(метилтио)фенилен-1,3-диамин | 403-240-8 | 106264-79-3 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  
612-114-00-3 | R, R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamide hydrogen 2,3-bis(benzoyloxy)succinate | 404-390-7 | — | Flam. Sol. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H228 | H317 | H412 | GHS02 | GHS07 | Wng | H228 | H317 | H412 |   |   |  612-114-00-3 | R,R-2-хидрокси-5-(1-хидрокси-2-(4-фенилбут-2-иламино)eтил)бензамид хидроген-2,3-бис(бензоилокси)сукцинат | 404-390-7 | — | Flam. Sol. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H228 | H317 | H412 | GHS02 | GHS07 | Wng | H228 | H317 | H412 |   |   |  
612-115-00-9 | dimethyldioctadecylammonium hydrogen sulfate | 404-050-8 | 123312-54-9 | Eye Irrit. 2 | Aquatic Chronic 4 | H319 | H413 | GHS07 | Wng | H319 | H413 |   |   |  612-115-00-9 | диметилдиоктадециламониев хидрогенсулфат | 404-050-8 | 123312-54-9 | Eye Irrit. 2 | Aquatic Chronic 4 | H319 | H413 | GHS07 | Wng | H319 | H413 |   |   |  
612-116-00-4 | C8-18 alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate | 404-690-8 | 68132-19-4 | Acute Tox. 3 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H314 | H317 | H400 | H410 | GHS06 | GHS05 | GHS09 | Dgr | H331 | H314 | H317 | H410 |   |   |  612-116-00-4 | C8-18-алкилбис(2-хидроксиетил)амониев бис(2-етилхексил)фосфат | 404-690-8 | 68132-19-4 | Acute Tox. 3 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H314 | H317 | H400 | H410 | GHS06 | GHS05 | GHS09 | Dgr | H331 | H314 | H317 | H410 |   |   |  
612-117-00-X | C12-14-tert-alkylamine, methylphosphonic acid salt | 404-750-3 | 119415-07-5 | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 2 | H302 | H314 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H411 |   |   |  612-117-00-X | сол на метилфосфонова киселина и C12-14-трет-алкиламин | 404-750-3 | 119415-07-5 | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 2 | H302 | H314 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H411 |   |   |  
612-118-00-5 | A reaction mass of: (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium 4-toluenesulfonate; (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromide | 405-080-4 | — | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  612-118-00-5 | реакционна маса от: (1,3-диоксо-2H-бенз(de)изохинолин-2-илпропил)хексадецилдиметиламониев 4-толуенсулфонат; (1,3-диоксо-2H-бенз(de)изохинолин-2-илпропил)хексадецилдиметиламониев бромид; | 405-080-4 | — | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  
612-119-00-0 | benzyldimethyloctadecylammonium 3-nitrobenzenesulfonate | 405-330-2 | — | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H315 | H318 | H410 |   |   |  612-119-00-0 | бензилдиметилoктадециламониев 3-нитробензенсулфонат | 405-330-2 | — | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H315 | H318 | H410 |   |   |  
612-120-00-6 | aclonifen (ISO); | 2-chloro-6-nitro-3-phenoxyaniline | 277-704-1 | 74070-46-5 | Carc. 2 | Skin Sens. 1A | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H317 | H400 | H410 | GHS08 | GHS07 | GH09 | Wng | H351 | H317 | H410 |   | M = 100 | M = 10 |  612-120-00-6 | аклонифен (ISO); | 6-нитро-3-фенокси-2-хлороанилин | 277-704-1 | 74070-46-5 | Carc. 2 | Skin Sens. 1A | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H317 | H400 | H410 | GHS08 | GHS07 | GH09 | Wng | H351 | H317 | H410 |   | M = 100 | M = 10 |  
612-121-00-1 | amines, polyethylenepoly-; HEPA | 268-626-9 | 68131-73-7 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H314 | H317 | H410 |   |   |  612-121-00-1 | полиетиленполиамини; HEPA | 268-626-9 | 68131-73-7 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H314 | H317 | H410 |   |   |  
612-122-00-7 | hydroxylamine … % | [> 55 % in aqueous solution] | 232-259-2 | 7803-49-8 | Unst. Expl. Met. Corr. 1 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | H200 | H290 | H351 | H312 | H302 | H373** | H335 | H315 | H318 | H317 | H400 | GHS01 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H200 | H290 | H351 | H312 | H302 | H373** | H335 | H315 | H318 | H317 | H400 |   |   | B612-122-00-7 | хидроксиламин … % | [> 55 % във воден разтвор] | 232-259-2 | 7803-49-8 | Unst. Expl. Met. Corr. 1 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | H200 | H290 | H351 | H312 | H302 | H373** | H335 | H315 | H318 | H317 | H400 | GHS01 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H200 | H290 | H351 | H312 | H302 | H373** | H335 | H315 | H318 | H317 | H400 |   |   | B
612-122-01-4 | hydroxylamine …% [≤ 55 % in aqueous solution] | 232-259-2 | 7803-49-8 | Met. Corr. 1 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | H290 | H351 | H312 | H302 | H373** | H335 | H315 | H318 | H317 | H400 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H290 | H351 | H312 | H302 | H373** | H335 | H315 | H318 | H317 | H400 |   |   | B612-122-01-4 | хидроксиламин … % [≤ 55 % във воден разтвор] | 232-259-2 | 7803-49-8 | Met. Corr. 1 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | H290 | H351 | H312 | H302 | H373** | H335 | H315 | H318 | H317 | H400 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H290 | H351 | H312 | H302 | H373** | H335 | H315 | H318 | H317 | H400 |   |   | B
612-123-00-2 | hydroxylammonium chloride; hydroxylamine hydrochloride; [1] bis(hydroxylammonium) sulfate; | hydroxylamine sulfate (2:1) [2] | 226-798-2 [1] | 233-118-8 [2] | 5470-11-1 [1] | 10039-54-0 [2] | Met. Corr. 1 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | H290 | H351 | H312 | H302 | H373** | H319 | H315 | H317 | H400 | GHS05 | GHS08 | GHS07 | GHS09 | Wng | H290 | H351 | H312 | H302 | H373** | H319 | H315 | H317 | H400 |   |   |  612-123-00-2 | хидроксиламониев хлорид; хидроксиламинхидрохлорид; [1] бис(хидроксиламониев) сулфат; | хидроксиламинсулфат (2:1) [2] | 226-798-2 [1] | 233-118-8 [2] | 5470-11-1 [1] | 10039-54-0 [2] | Met. Corr. 1 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | H290 | H351 | H312 | H302 | H373** | H319 | H315 | H317 | H400 | GHS05 | GHS08 | GHS07 | GHS09 | Wng | H290 | H351 | H312 | H302 | H373** | H319 | H315 | H317 | H400 |   |   |  
612-124-00-8 | N,N,N-trimethylanilinium chloride | 205-319-0 | 138-24-9 | Acute Tox. 3 * | Acute Tox. 3 * | H311 | H301 | GHS06 | Dgr | H311 | H301 |   |   |  612-124-00-8 | N,N,N-триметиланилиниев хлорид | 205-319-0 | 138-24-9 | Acute Tox. 3 * | Acute Tox. 3 * | H311 | H301 | GHS06 | Dgr | H311 | H301 |   |   |  
612-125-00-3 | 2-methyl-p-phenylenediamine; | 2,5-toluenediamine | 202-442-1 | 95-70-5 | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H301 | H332 | H312 | H317 | H411 | GHS06 | GHS09 | Dgr | H301 | H332 | H312 | H317 | H411 |   |   |  612-125-00-3 | 2-метил-p-фенилендиамин; | 2,5-толуендиамин | 202-442-1 | 95-70-5 | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H301 | H332 | H312 | H317 | H411 | GHS06 | GHS09 | Dgr | H301 | H332 | H312 | H317 | H411 |   |   |  
612-126-00-9 | toluene-2,4-diammonium sulphate; | 4-methyl-m-phenylenediamine sulfate | 265-697-8 | 65321-67-7 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H350 | H301 | H312 | H319 | H317 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H301 | H312 | H319 | H317 | H411 |   |   |  612-126-00-9 | тoлуен-2,4-диамониев сулфат; | 4-метил-m-фенилендиаминсулфат | 265-697-8 | 65321-67-7 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H350 | H301 | H312 | H319 | H317 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H301 | H312 | H319 | H317 | H411 |   |   |  
612-127-00-4 | 3-aminophenol | 209-711-2 | 591-27-5 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 2 | H332 | H302 | H411 | GHS07 | GHS09 | Wng | H332 | H302 | H411 |   |   |  612-127-00-4 | 3-аминофенол | 209-711-2 | 591-27-5 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 2 | H332 | H302 | H411 | GHS07 | GHS09 | Wng | H332 | H302 | H411 |   |   |  
612-128-00-X | 4-aminophenol | 204-616-2 | 123-30-8 | Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H332 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H341 | H332 | H302 | H410 |   |   |  612-128-00-X | 4-аминофенол | 204-616-2 | 123-30-8 | Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H332 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H341 | H332 | H302 | H410 |   |   |  
612-129-00-5 | diisopropylamine | 203-558-5 | 108-18-9 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H225 | H332 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H225 | H332 | H302 | H314 |   | STOT SE 3; H335: C ≥ 5 % |  612-129-00-5 | диизопропиламин | 203-558-5 | 108-18-9 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H225 | H332 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H225 | H332 | H302 | H314 |   | STOT SE 3; H335: C ≥ 5 % |  
612-130-00-0 | 2,6-diamino-3,5-diethyltoluene; | 4,6-diethyl-2-methyl-1,3-benzenediamine; [1] | 2,4-diamino-3,5-diethyltoluene; | 2,4-diethyl-6-methyl-1,3-benzenediamine; [2] diethylmethylbenzenediamine [3] | 218-255-3 [1] | 218-256-9 [2] | 270-877-4 [3] | 2095-01-4 [1] | 2095-02-5 [2] | 68479-98-1 [3] | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H373 ** | H319 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H312 | H302 | H373 ** | H319 | H410 |   |   | C612-130-00-0 | 2,6-диамино-3,5-диетилтолуен; | 4,6-диетил-2-метил-1,3-бензендиамин; [1] | 2,4-диамино-3,5-диетилтолуен; | 2,4-диетил-6-метил-1,3-бензендиамин; [2] диетилметилбензендиамин [3] | 218-255-3 [1] | 218-256-9 [2] | 270-877-4 [3] | 2095-01-4 [1] | 2095-02-5 [2] | 68479-98-1 [3] | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H373 ** | H319 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H312 | H302 | H373 ** | H319 | H410 |   |   | C
612-131-00-6 | didecyldimethylammonium chloride | 230-525-2 | 7173-51-5 | Acute Tox. 4 * | Skin Corr. 1B | H302 | H314 | GHS05 | GHS07 | Dgr | H302 | H314 |   |   |  612-131-00-6 | дидецилдиметиламониев хлорид | 230-525-2 | 7173-51-5 | Acute Tox. 4 * | Skin Corr. 1B | H302 | H314 | GHS05 | GHS07 | Dgr | H302 | H314 |   |   |  
612-132-00-1 | N, N'-diphenyl-p-phenylenediamine; | N, N'-diphenyl-1,4-benzenediamine | 200-806-4 | 74-31-7 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  612-132-00-1 | N, N′-дифенил-p-фенилендиамин; | N, N′-дифенил-1,4-бензендиамин | 200-806-4 | 74-31-7 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
612-133-00-7 | (4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate; | 4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenylenediamine sulphate | 247-162-0 | 25646-77-9 | Acute Tox. 3 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H373 ** | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H373 ** | H317 | H410 |   |   |  612-133-00-7 | (4-амонио-m-толил)eтил(2-хидроксиетил)aмониев сулфат; | 4-(N-етил-N-2-хидроксиетил)-2-метилфенилендиаминсулфат | 247-162-0 | 25646-77-9 | Acute Tox. 3 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H373 ** | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H373 ** | H317 | H410 |   |   |  
612-134-00-2 | N-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate; | 4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate | 247-161-5 | 25646-71-3 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  612-134-00-2 | N-(2-(4-амино-N-eтил-m-толуидино)eтил)метансулфонамидсесквисулфат; | 4-(N-етил-N-2-метансулфониламиноетил)-2-метилфенилендиаминсесквисулфат монохидрат | 247-161-5 | 25646-71-3 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  
612-135-00-8 | N-2-naphthylaniline; | N-phenyl-2-naphthylamine | 205-223-9 | 135-88-6 | Carc. 2 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H351 | H319 | H315 | H317 | H411 | GHS08 | GHS07 | GHS09 | Wng | H351 | H319 | H315 | H317 | H411 |   |   |  612-135-00-8 | N-2-нафтиланилин; | N-фенил-2-нафтиламин | 205-223-9 | 135-88-6 | Carc. 2 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H351 | H319 | H315 | H317 | H411 | GHS08 | GHS07 | GHS09 | Wng | H351 | H319 | H315 | H317 | H411 |   |   |  
612-136-00-3 | N-isopropyl-N'-phenyl-p-phenylenediamine | 202-969-7 | 101-72-4 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   | Skin Sens. 1; H317:C ≥0,1  % |  612-136-00-3 | N-изопропил-N′-фенил-p-фенилендиамин | 202-969-7 | 101-72-4 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   | Skin Sens. 1; H317:C ≥0,1  % |  
612-137-00-9 | 4-chloroaniline | 203-401-0 | 106-47-8 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H331 | H311 | H301 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H331 | H311 | H301 | H317 | H410 |   |   |  612-137-00-9 | 4-хлороанилин | 203-401-0 | 106-47-8 | Carc. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H331 | H311 | H301 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H331 | H311 | H301 | H317 | H410 |   |   |  
612-138-00-4 | furalaxyl (ISO); | methyl N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-DL-alaninate | 260-875-1 | 57646-30-7 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  612-138-00-4 | фуралаксил (ISO); | мeтилов N-(2,6-диметилфенил)-N-(2-фурилкарбонил)-DL-aланинат | 260-875-1 | 57646-30-7 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
612-139-00-X | mefenacet (ISO); | 2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide | 277-328-8 | 73250-68-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  612-139-00-X | мефенацет (ISO); | 2-(бензотиазол-2-илокси)-N-метил-N-фенилацетамид | 277-328-8 | 73250-68-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
612-140-00-5 | quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides | 264-151-6 | 63449-41-2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Acute 1 | H312 | H302 | H314 | H400 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H314 | H400 |   |   |  612-140-00-5 | кватернерни амониеви съединения, бензил-C8-18-aлкилдиметил, хлориди | 264-151-6 | 63449-41-2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Acute 1 | H312 | H302 | H314 | H400 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H314 | H400 |   |   |  
612-141-00-0 | 4,4'-methylenebis(2-ethylaniline); | 4,4'-methylenebis(2-ethylbenzeneamine) | 243-420-1 | 19900-65-3 | Carc. 2 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H302 | H410 |   |   |  612-141-00-0 | 4,4′-мeтиленбис(2-eтиланилин); | 4,4′-метиленбис(2-етилбензенамин) | 243-420-1 | 19900-65-3 | Carc. 2 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H302 | H410 |   |   |  
612-142-00-6 | biphenyl-2-ylamine | 201-990-9 | 90-41-5 | Carc. 2 | Acute Tox. 4 * Aquatic Chronic 3 | H351 | H302 | H412 | GHS08 | GHS07 | Wng | H351 | H302 | H412 |   |   |  612-142-00-6 | бифенил-2-иламин | 201-990-9 | 90-41-5 | Carc. 2 | Acute Tox. 4 * Aquatic Chronic 3 | H351 | H302 | H412 | GHS08 | GHS07 | Wng | H351 | H302 | H412 |   |   |  
612-143-00-1 | N5,N5-diethyltoluene-2,5-diamine monohydrochloride; | 4-diethylamino-2-methylaniline monohydrochloride | 218-130-3 | 2051-79-8 | Acute Tox. 3 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H319 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H319 | H317 | H410 |   |   |  612-143-00-1 | N5,N5-диетилтолуен-2,5-диаминмонохидрохлорид; | 4-диетиламино-2-метиланилинмонохидрохлорид | 218-130-3 | 2051-79-8 | Acute Tox. 3 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H319 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H319 | H317 | H410 |   |   |  
612-144-00-7 | flumetralin (ISO); | N-(2-chloro-6-fluorobenzyl)-N-ethyl-α, α,α-trifluoro-2,6-dinitro-p-toluidine | — | 62924-70-3 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H315 | H317 | H410 |   |   |  612-144-00-7 | флуметралин (ISO); | N-етил-2,6-динитро-α, α,α-трифлуоро-N-(6-флуоро-2-хлоробензил)-р-толуидин | — | 62924-70-3 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H315 | H317 | H410 |   |   |  
612-145-00-2 | o-phenylenediamine | 202-430-6 | 95-54-5 | Carc. 2 | Muta. 2 | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H341 | H301 | H332 | H312 | H319 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H341 | H301 | H332 | H312 | H319 | H317 | H410 |   |   |  612-145-00-2 | o-фенилендиамин | 202-430-6 | 95-54-5 | Carc. 2 | Muta. 2 | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H341 | H301 | H332 | H312 | H319 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H341 | H301 | H332 | H312 | H319 | H317 | H410 |   |   |  
612-146-00-8 | o-phenylenediamine dihydrochloride | 210-418-7 | 615-28-1 | Carc. 2 | Muta. 2 | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H341 | H301 | H332 | H312 | H319 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H341 | H301 | H332 | H312 | H319 | H317 | H410 |   |   |  612-146-00-8 | o-фенилендиаминдихидрохлорид | 210-418-7 | 615-28-1 | Carc. 2 | Muta. 2 | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H341 | H301 | H332 | H312 | H319 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H341 | H301 | H332 | H312 | H319 | H317 | H410 |   |   |  
612-147-00-3 | m-phenylenediamine | 203-584-7 | 108-45-2 | Muta. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H331 | H311 | H301 | H319 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H341 | H331 | H311 | H301 | H319 | H317 | H410 |   |   |  612-147-00-3 | m-фенилендиамин | 203-584-7 | 108-45-2 | Muta. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H331 | H311 | H301 | H319 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H341 | H331 | H311 | H301 | H319 | H317 | H410 |   |   |  
612-148-00-9 | m-phenylenediamine dihydrochloride | 208-790-0 | 541-69-5 | Muta. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H331 | H311 | H301 | H319 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H341 | H331 | H311 | H301 | H319 | H317 | H410 |   |   |  612-148-00-9 | m-фенилендиаминдихидрохлорид | 208-790-0 | 541-69-5 | Muta. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H331 | H311 | H301 | H319 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H341 | H331 | H311 | H301 | H319 | H317 | H410 |   |   |  
612-149-00-4 | 1,3-diphenylguanidine | 203-002-1 | 102-06-7 | Repr. 2 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Chronic 2 | H361f *** | H302 | H319 | H335 | H315 | H411 | GHS08 | GHS07 | GHS09 | Wng | H361f *** | H302 | H319 | H335 | H315 | H411 |   |   |  612-149-00-4 | 1,3-дифенилгуанидин | 203-002-1 | 102-06-7 | Repr. 2 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Chronic 2 | H361f *** | H302 | H319 | H335 | H315 | H411 | GHS08 | GHS07 | GHS09 | Wng | H361f *** | H302 | H319 | H335 | H315 | H411 |   |   |  
612-151-00-5 | methyl-phenylene diamine; | diaminotoluene; | [technical product — reaction mass of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)] | — | — | Carc. 1B Muta. 2 | Repr. 2 | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H350 | H341 | H361f*** | H301 | H312 | H373** | H319 | H317 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H341 | H361f*** | H301 | H312 | H373** | H319 | H317 | H411 |   |   |  612-151-00-5 | метилфенилендиамин; | диаминотолуен; | [технически продукт — реакционна маса от 4-метил-m-фенилендиамин (EО № 202-453-1) и 2-метил-m-фенилендиамин (EО № 212-513-9)] | — | — | Carc. 1B Muta. 2 | Repr. 2 | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H350 | H341 | H361f*** | H301 | H312 | H373** | H319 | H317 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H341 | H361f*** | H301 | H312 | H373** | H319 | H317 | H411 |   |   |  
612-152-00-0 | N, N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamine | 406-610-7 | 62478-82-4 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1A | Aquatic Chronic 3 | H226 | H332 | H302 | H373 ** | H314 | H412 | GHS02 | GHS08 | GHS05 | GHS07 | Dgr | H226 | H332 | H302 | H373 ** | H314 | H412 |   |   |  612-152-00-0 | N, N-диетил-N′,N′-диметилпропан-1,3-диилдиамин | 406-610-7 | 62478-82-4 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1A | Aquatic Chronic 3 | H226 | H332 | H302 | H373 ** | H314 | H412 | GHS02 | GHS08 | GHS05 | GHS07 | Dgr | H226 | H332 | H302 | H373 ** | H314 | H412 |   |   |  
612-153-00-6 | 4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzene, monohydrochloride | 407-020-2 | 132885-85-9 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H317 | H412 | GHS07 | Wng | H302 | H317 | H412 |   |   |  612-153-00-6 | 4-[N-етил-N-(2-хидроксиетил)aмино]-1-(2-хидроксиетил)aмино-2-нитробензенмонохидрохлорид | 407-020-2 | 132885-85-9 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H317 | H412 | GHS07 | Wng | H302 | H317 | H412 |   |   |  
612-154-00-1 | 6'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthene] | 410-890-6 | 95235-29-3 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  612-154-00-1 | 6′-(изобутилетиламино)-3′-метил-2′-фениламиноспиро[изобензо-2-oксофуран-7,9′-[9H]-ксантен] | 410-890-6 | 95235-29-3 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
612-155-00-7 | 2'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xanthene | 411-730-8 | 93071-94-4 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  612-155-00-7 | 2′-анилино-6′-((3-етоксипропил)eтиламино)-3′-метилспиро(изобензо-3-oксофуран)-1-(1H)-9′-ксантен | 411-730-8 | 93071-94-4 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
612-156-00-2 | reaction mass of: trihexadecylmethylammonium chloride; dihexadecyldimethylammonium chloride | 405-620-9 | — | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  612-156-00-2 | реакционна маса от: трихексадецилметиламониев хлорид; дихексадецилдиметиламониев хлорид | 405-620-9 | — | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  
612-157-00-8 | (Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride | 410-780-8 | — | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H373 ** | H318 | H317 | H411 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H373 ** | H318 | H317 | H411 |   |   |  612-157-00-8 | (Z)-1-бензо[b]тиен-2-илетаноноксимхидрохлорид | 410-780-8 | — | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H373 ** | H318 | H317 | H411 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H373 ** | H318 | H317 | H411 |   |   |  
612-158-00-3 | reaction mass of: bis(5-dodecyl-2-hydroxybenzald-oximate) copper (II) C12-alkyl group is branched; | 4-dodecylsalicylaldoxime | 410-820-4 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  612-158-00-3 | реакционна маса от: бис(5-додецил-2-хидроксибензалдoксимат)мед(II), C12-алкиловата група е разклонена; | 4-додецилсалицилaлдоксим | 410-820-4 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
612-159-00-9 | reaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine, EINECS listed), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxirane derivatives) and p-toluene-sulfonic acid | 410-880-1 | — | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H314 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H410 |   |   |  612-159-00-9 | реакционни продукти от: триметилхексаметилендиамин (смес от 2,2,4-триметил-1,6-хександиамин и 2,4,4-триметил-1,6-хександиамин, посочени в EINECS), Епоксид 8 (производни на мoно[(C10-C16-aлкилокси)метил]oксиран) и p-тoлуенсулфонова киселина | 410-880-1 | — | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H314 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H410 |   |   |  
612-160-00-4 | p-toluidine; | 4-aminotoluene; [1] | toluidinium chloride; [2] | toluidine sulphate (1:1) [3] | 203-403-1 [1] | 208-740-8 [2] | 208-741-3 [3] | 106-49-0 [1] | 540-23-8 [2] | 540-25-0 [3] | Carc. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | H351 | H331 | H311 | H301 | H319 | H317 | H400 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H331 | H311 | H301 | H319 | H317 | H400 |   |   |  612-160-00-4 | p-тoлуидин; | 4-аминотолуен; [1] | тoлуидиниев хлорид; [2] | тoлуидинсулфат (1:1) [3] | 203-403-1 [1] | 208-740-8 [2] | 208-741-3 [3] | 106-49-0 [1] | 540-23-8 [2] | 540-25-0 [3] | Carc. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | H351 | H331 | H311 | H301 | H319 | H317 | H400 | GHS06 | GHS08 | GHS09 | Dgr | H351 | H331 | H311 | H301 | H319 | H317 | H400 |   |   |  
612-161-00-X | 2,6-xylidine; | 2,6-dimethylaniline | 201-758-7 | 87-62-7 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Aquatic Chronic 2 | H351 | H332 | H312 | H302 | H335 | H315 | H411 | GHS08 | GHS07 | GHS09 | Wng | H351 | H332 | H312 | H302 | H335 | H315 | H411 |   |   |  612-161-00-X | 2,6-ксилидин; | 2,6-диметиланилин | 201-758-7 | 87-62-7 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Aquatic Chronic 2 | H351 | H332 | H312 | H302 | H335 | H315 | H411 | GHS08 | GHS07 | GHS09 | Wng | H351 | H332 | H312 | H302 | H335 | H315 | H411 |   |   |  
612-162-00-5 | dimethyldioctadecylammonium chloride; | DODMAC | 203-508-2 | 107-64-2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  612-162-00-5 | диметилдиоктадециламониев хлорид; | DODMAC | 203-508-2 | 107-64-2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  
612-163-00-0 | metalaxyl-M (ISO); | mefenoxam; | (R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester | — | 70630-17-0 | Acute Tox. 4 * | Eye Dam. 1 | H302 | H318 | GHS05 | GHS07 | Dgr | H302 | H318 |   |   |  612-163-00-0 | мeталаксил-M (ISO); | мeфеноксам; | метилов естер на (R)-2-[(2,6-диметилфенил)метоксиацетиламино]пропионовата киселина | — | 70630-17-0 | Acute Tox. 4 * | Eye Dam. 1 | H302 | H318 | GHS05 | GHS07 | Dgr | H302 | H318 |   |   |  
612-164-00-6 | 2-butyl-2-ethyl-1,5-diaminopentane | 412-700-7 | 137605-95-9 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 3 | H312 | H302 | H373 ** | H314 | H317 | H412 | GHS08 | GHS05 | GHS07 | Dgr | H312 | H302 | H373 ** | H314 | H317 | H412 |   |   |  612-164-00-6 | 2-бутил-2-eтил-1,5-диаминопентан | 412-700-7 | 137605-95-9 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 3 | H312 | H302 | H373 ** | H314 | H317 | H412 | GHS08 | GHS05 | GHS07 | Dgr | H312 | H302 | H373 ** | H314 | H317 | H412 |   |   |  
612-165-00-1 | N,N'-diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine | 413-810-8 | 65181-78-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  612-165-00-1 | N,N′-дифенил-N,N′-бис(3-метилфенил)(1,1′-дифенил)-4,4′-диамин | 413-810-8 | 65181-78-4 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
612-166-00-7 | reaction mass of: cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1); | trans-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1) | 411-830-1 | 114765-88-7 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  612-166-00-7 | реакционна маса от: цис-(5-амоний-1,3,3-триметил)циклохексанметилaмониев фосфат (1:1); | транс-(5-амоний-1,3,3-триметил)циклохексанметилaмониев фосфат (1:1) | 411-830-1 | 114765-88-7 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  
612-167-00-2 | 5-acetyl-3-amino-10,11-dihydro-5H-dibenz[b, f]azepine-hydrochloride | 410-490-1 | — | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H373 ** | H318 | H317 | H411 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H373 ** | H318 | H317 | H411 |   |   |  612-167-00-2 | 5-ацетил-3-амино-10,11-дихидро-5H-дибенз[b, f]азепинхидрохлорид | 410-490-1 | — | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H373 ** | H318 | H317 | H411 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H373 ** | H318 | H317 | H411 |   |   |  
612-168-00-8 | 3,5-dichloro-2,6-difluoropyrdine-4-amine | 220-630-1 | 2840-00-8 | Acute Tox. 4 * | Acute Tox. 4 * Aquatic Chronic 2 | H312 | H302 | H411 | GHS07 | GHS09 | Wng | H312 | H302 | H411 |   |   |  612-168-00-8 | 2,6-дифлуоро-3,5-дихлоропиридин-4-амин | 220-630-1 | 2840-00-8 | Acute Tox. 4 * | Acute Tox. 4 * Aquatic Chronic 2 | H312 | H302 | H411 | GHS07 | GHS09 | Wng | H312 | H302 | H411 |   |   |  
612-169-00-3 | bis(N-methyl-N-phenylhydrazine)sulfate | 423-170-1 | 618-26-8 | Flam. Liq. 2 | STOT RE 1 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H225 | H372** | H302 | H318 | H317 | H400 | H410 | GHS02 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H225 | H372** | H302 | H318 | H317 | H410 |   |   |  612-169-00-3 | бис(N-метил-N-фенилхидразин)сулфат | 423-170-1 | 618-26-8 | Flam. Liq. 2 | STOT RE 1 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H225 | H372** | H302 | H318 | H317 | H400 | H410 | GHS02 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H225 | H372** | H302 | H318 | H317 | H410 |   |   |  
612-170-00-9 | 4-chlorophenyl cyclopropyl ketone O-(4-aminobenzyl)oxime | 405-260-2 | — | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  612-170-00-9 | 4-хлорофенилциклопропилкетон-О-(4-aминобензил)oксим | 405-260-2 | — | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  
612-171-00-4 | N,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane | 410-060-3 | 130728-76-6 | Muta. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H341 | H317 | H411 | GHS08 | GHS09 | Wng | H341 | H317 | H411 |   |   |  612-171-00-4 | N,N,N′,N′-тeтраглицидил-4,4′-диамино-3,3′-диетилдифенилметан | 410-060-3 | 130728-76-6 | Muta. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H341 | H317 | H411 | GHS08 | GHS09 | Wng | H341 | H317 | H411 |   |   |  
612-172-00-X | 4,4'-methylenebis(N,N'-dimethylcyclohexanamine | 412-840-9 | 13474-64-1 | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1A | Aquatic Chronic 3 | H302 | H373 ** | H314 | H412 | GHS08 | GHS05 | GHS07 | Dgr | H302 | H373 ** | H314 | H412 |   |   |  612-172-00-X | 4,4′-метиленбис(N,N′-диметилциклохексанамин) | 412-840-9 | 13474-64-1 | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1A | Aquatic Chronic 3 | H302 | H373 ** | H314 | H412 | GHS08 | GHS05 | GHS07 | Dgr | H302 | H373 ** | H314 | H412 |   |   |  
612-173-00-5 | lithium 1-amino-4-(4-tert-butylanilino)anthraquinone-2-sulfonate | 411-140-0 | 125328-86-1 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H411 |   |   |  612-173-00-5 | литиев 1-aмино-4-(4-трет-бутилaнилино)aнтрахинон-2-сулфонат | 411-140-0 | 125328-86-1 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H411 |   |   |  
612-174-00-0 | 4,4-dimethoxybutylamine | 407-690-6 | 19060-15-2 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H314 | H317 | H412 | GHS05 | GHS07 | Dgr | H302 | H314 | H317 | H412 |   |   |  612-174-00-0 | 4,4-диметоксибутиламин | 407-690-6 | 19060-15-2 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H314 | H317 | H412 | GHS05 | GHS07 | Dgr | H302 | H314 | H317 | H412 |   |   |  
612-175-00-6 | 2-(O-aminooxy)ethylamine dihydrochloride | 412-310-7 | 37866-45-8 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  612-175-00-6 | 2-(О-аминоокси)етиламиндихидрохлорид | 412-310-7 | 37866-45-8 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
612-176-00-1 | polymer of 1,3-dibromopropane and N,N-diethyl-N',N'-dimethyl-1,3-propanediamine | 410-570-6 | 143747-73-3 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  612-176-00-1 | полимер от 1,3-дибромопропан и N,N-диетил-N′,N′-диметил-1,3-пропандиамин | 410-570-6 | 143747-73-3 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
612-177-00-7 | 2-naphthylamino-6-sulfomethylamide | 412-120-4 | 104295-55-8 | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 2 | H373 ** | H317 | H411 | GHS08 | GHS09 | Wng | H373 ** | H317 | H411 |   |   |  612-177-00-7 | 2-нафтиламинo-6-сулфометиламид | 412-120-4 | 104295-55-8 | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 2 | H373 ** | H317 | H411 | GHS08 | GHS09 | Wng | H373 ** | H317 | H411 |   |   |  
612-178-00-2 | 1,4,7,10-tetraazacyclododecane disulfate | 412-080-8 | 112193-77-8 | Acute Tox. 4 * | STOT SE 3 | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H335 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H335 | H318 | H412 |   |   |  612-178-00-2 | 1,4,7,10-тeтраазациклододекандисулфат | 412-080-8 | 112193-77-8 | Acute Tox. 4 * | STOT SE 3 | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H335 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H335 | H318 | H412 |   |   |  
612-179-00-8 | 1-(2-propenyl)pyridinium chloride | 412-740-5 | 25965-81-5 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  612-179-00-8 | 1-(2-пропенил)пиридиниев хлорид | 412-740-5 | 25965-81-5 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  
612-180-00-3 | 3-aminobenzylamine | 412-230-2 | 4403-70-7 | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 2 | H302 | H314 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H411 |   |   |  612-180-00-3 | 3-аминобензиламин | 412-230-2 | 4403-70-7 | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 2 | H302 | H314 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H411 |   |   |  
612-181-00-9 | 2-phenylthioaniline | 413-030-8 | 1134-94-7 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  612-181-00-9 | 2-фенилтиоанилин | 413-030-8 | 1134-94-7 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
612-182-00-4 | 1-ethyl-1-methylmorpholinium bromide | 418-210-1 | 65756-41-4 | Muta. 2 | H341 | GHS08 | Wng | H341 |   |   |  612-182-00-4 | 1-етил-1-метилморфолиниев бромид | 418-210-1 | 65756-41-4 | Muta. 2 | H341 | GHS08 | Wng | H341 |   |   |  
612-183-00-X | 1-ethyl-1-methylpyrrolidinium bromide | 418-200-5 | 69227-51-6 | Muta. 2 | H341 | GHS08 | Wng | H341 |   |   |  612-183-00-X | 1-етил-1-метилпиролидиниев бромид | 418-200-5 | 69227-51-6 | Muta. 2 | H341 | GHS08 | Wng | H341 |   |   |  
612-184-00-5 | 6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one | 403-830-5 | 89331-94-2 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  612-184-00-5 | 6′-(дибутиламино)-3′-метил-2′-(фениламино)спиро[изобензофуран-1(3H),9-(9H)-ксантен]-3-он | 403-830-5 | 89331-94-2 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
612-185-00-0 | 1-[3-[4-((heptadecafluorononyl)oxy)-benzamido]propyl]-N, N,N-trimethylammonium iodide | 407-400-8 | 59493-72-0 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  612-185-00-0 | 1-[3-[4-((хептадекафлуорононил)окси)бензaмидо]пропил]-N,N,N-триметиламониев йодид | 407-400-8 | 59493-72-0 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  
612-186-00-6 | bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate | 406-770-8 | 149057-64-7 | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** | H318 | H317 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H373 ** | H318 | H317 | H410 |   |   |  612-186-00-6 | бис(N-(8-метил-5-фенил-7-хидроксифеназин-3-илиден)диметиламониев) сулфат | 406-770-8 | 149057-64-7 | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** | H318 | H317 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H373 ** | H318 | H317 | H410 |   |   |  
612-187-00-1 | 2,3,4-trifluoroaniline | 407-170-9 | 3862-73-5 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 2 | H312 | H302 | H373 ** | H315 | H318 | H411 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H373 ** | H315 | H318 | H411 |   |   |  612-187-00-1 | 2,3,4-трифлуороанилин | 407-170-9 | 3862-73-5 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 2 | H312 | H302 | H373 ** | H315 | H318 | H411 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H373 ** | H315 | H318 | H411 |   |   |  
612-188-00-7 | 4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline) | 407-560-9 | 107934-68-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  612-188-00-7 | 4,4′-(9H-флуорен-9-илиден)бис(2-хлороанилин) | 407-560-9 | 107934-68-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
612-189-00-2 | 4-amino-2-(aminomethyl)phenol dihydrochloride | 412-510-4 | 135043-64-0 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  612-189-00-2 | 4-амино-2-(аминометил)фенолдихидрохлорид | 412-510-4 | 135043-64-0 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  
612-190-00-8 | 4,4'-methylenebis(2-isopropyl-6-methylaniline) | 415-150-6 | 16298-38-7 | STOT RE 2 * | Aquatic Chronic 2 | H373 ** | H411 | GHS08 | GHS09 | Wng | H373 ** | H411 |   |   |  612-190-00-8 | 4,4′-метилeнбис(2-изопропил-6-метиланилин) | 415-150-6 | 16298-38-7 | STOT RE 2 * | Aquatic Chronic 2 | H373 ** | H411 | GHS08 | GHS09 | Wng | H373 ** | H411 |   |   |  
612-191-00-3 | polymer of allylamine hydrochloride | 415-050-2 | 71550-12-4 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  612-191-00-3 | полимер от алиламинхидрохлорид | 415-050-2 | 71550-12-4 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  
612-192-00-9 | 2-isopropyl-4-(N-methyl)aminomethylthiazole | 414-800-6 | 154212-60-9 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 2 | H312 | H302 | H315 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H315 | H318 | H411 |   |   |  612-192-00-9 | 2-изoпропил-4-(N-метил)аминометилтиазол | 414-800-6 | 154212-60-9 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 2 | H312 | H302 | H315 | H318 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H315 | H318 | H411 |   |   |  
612-193-00-4 | 3-methylaminomethylphenylamine | 414-570-7 | 18759-96-1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H314 | H317 | H410 |   |   |  612-193-00-4 | 3-метиламинометилфенилaмин | 414-570-7 | 18759-96-1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H314 | H317 | H410 |   |   |  
612-194-00-X | 2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propanammonium chloride | 414-670-0 | 141890-30-4 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H410 |   |   |  612-194-00-X | 2-хидрокси-3-[(2-хидроксиетил)-[2-(1-оксотетрадецил)амино]етил]амино]-N,N,N-триметил-1-пропанамониев хлорид | 414-670-0 | 141890-30-4 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H410 |   |   |  
612-195-00-5 | bis[tributyl 4-(methylbenzyl)ammonium] 1,5-naphthalenedisulfonate | 415-210-1 | 160236-81-7 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H302 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H332 | H302 | H318 | H410 |   |   |  612-195-00-5 | бис[трибутил-4-(метилбензил)амониев] 1,5-нафталендисулфонат | 415-210-1 | 160236-81-7 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H302 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H332 | H302 | H318 | H410 |   |   |  
612-196-00-0 | 4-chloro-o-toluidine; [1] | 4-chloro-o-toluidine hydrochloride [2] | 202-441-6[1] | 221-627-8[2] | 95-69-2[1] | 3165-93-3[2] | Carc. 1B | Muta. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H341 | H331 | H311 | H301 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H341 | H331 | H311 | H301 | H410 |   |   |  612-196-00-0 | 4-хлоро-o-толуидин; [1] | 4-хлоро-о-толуидинхидрохлорид [2] | 202-441-6[1] | 221-627-8[2] | 95-69-2[1] | 3165-93-3[2] | Carc. 1B | Muta. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H341 | H331 | H311 | H301 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H341 | H331 | H311 | H301 | H410 |   |   |  
612-197-00-6 | 2,4,5-trimethylaniline; [1] | 2,4,5-trimethylaniline hydrochloride [2] | 205-282-0[1]-[2] | 137-17-7 [1] | 21436-97-5[2] | Carc. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Chronic 2 | H350 | H331 | H311 | H301 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H331 | H311 | H301 | H411 |   |   |  612-197-00-6 | 2,4,5-триметиланилин; [1] | 2,4,5-триметиланилинхидрохлорид [2] | 205-282-0[1]-[2] | 137-17-7 [1] | 21436-97-5[2] | Carc. 1B | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Chronic 2 | H350 | H331 | H311 | H301 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H331 | H311 | H301 | H411 |   |   |  
612-198-00-1 | 4,4'-thiodianiline and its salts | 205-370-9 | 139-65-1 | Carc. 1B | Acute Tox. 4 * | Aquatic Chronic 2 | H350 | H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H411 |   |   |  612-198-00-1 | 4,4′-тиодианилин и негови соли | 205-370-9 | 139-65-1 | Carc. 1B | Acute Tox. 4 * | Aquatic Chronic 2 | H350 | H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H302 | H411 |   |   |  
612-199-00-7 | 4,4'-oxydianiline and its salts; | p-aminophenyl ether | 202-977-0 | 101-80-4 | Carc. 1B Muta. | 1B Repr. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Chronic 2 | H350 | H340 | H361f *** | H331 | H311 | H301 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H340 | H361f *** | H331 | H311 | H301 | H411 |   |   |  612-199-00-7 | 4,4′-оксидианилин и негови соли; | p-аминофенилов етер | 202-977-0 | 101-80-4 | Carc. 1B Muta. | 1B Repr. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Chronic 2 | H350 | H340 | H361f *** | H331 | H311 | H301 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H350 | H340 | H361f *** | H331 | H311 | H301 | H411 |   |   |  
612-200-00-0 | 2,4-diaminoanisole; | 4-methoxy-m-phenylenediamine; [1] | 2,4-diaminoanisole sulphate [2] | 210-406-1 [1] | 254-323-9 [2] | 615-05-4 [1] | 39156-41-7 [2] | Carc. 1B Muta. 2 | Acute Tox. 4 * | Aquatic Chronic 2 | H350 | H341 | H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H341 | H302 | H411 |   |   |  612-200-00-0 | 2,4-диаминоанизол; | 4-метокси-m-фенилендиамин; [1] | 2,4-диаминоанизолсулфат [2] | 210-406-1 [1] | 254-323-9 [2] | 615-05-4 [1] | 39156-41-7 [2] | Carc. 1B Muta. 2 | Acute Tox. 4 * | Aquatic Chronic 2 | H350 | H341 | H302 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H341 | H302 | H411 |   |   |  
612-201-00-6 | N,N,N',N'-tetramethyl-4,4'-methylendianiline | 202-959-2 | 101-61-1 | Carc. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H410 |   |   |  612-201-00-6 | N,N,N′,N′-тетраметил-4,4′-метилендианилин | 202-959-2 | 101-61-1 | Carc. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H410 |   |   |  
612-202-00-1 | 3,4-dichloroaniline | 202-448-4 | 95-76-1 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H318 | H317 | H400 | H410 | GHS06 | GHS05 | GHS09 | Dgr | H331 | H311 | H301 | H318 | H317 | H410 |   |   |  612-202-00-1 | 3,4-дихлороанилин | 202-448-4 | 95-76-1 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H318 | H317 | H400 | H410 | GHS06 | GHS05 | GHS09 | Dgr | H331 | H311 | H301 | H318 | H317 | H410 |   |   |  
612-203-00-7 | C8-10 alkyl dimethyl hydroxyethyl ammoniumchloride (chain < C8: <3 %, chain = C8: 15 %-70 %, chain = C10: 30 %- 85 %, chain > C10: <3 %) | 417-360-3 | — | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | H312 | H302 | H315 | GHS07 | Wng | H312 | H302 | H315 |   |   |  612-203-00-7 | C8-10-алкилдиметилхидроксиетиламониев хлорид (верига < C8: <3 %, верига = C8: 15 %-70 %, верига = C10: 30 %- 85 %, верига > C10: <3 %) | 417-360-3 | — | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | H312 | H302 | H315 | GHS07 | Wng | H312 | H302 | H315 |   |   |  
612-204-00-2 | C.I. Basic Violet 3; | 4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride | 208-953-6 | 548-62-9 | Carc. 2 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H302 | H318 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H351 | H302 | H318 | H410 |   |   |  612-204-00-2 | C.I. основно виолетово 3; | 4-[4,4′-бис(диметиламино)бензхидрилиден]циклохекса-2,5-диeн-1-илиден]диметиламониев хлорид | 208-953-6 | 548-62-9 | Carc. 2 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H302 | H318 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H351 | H302 | H318 | H410 |   |   |  
612-205-00-8 | C.I. Basic Violet 3 with ≥ 0,1 % of Michler's ketone (EC no.202-027-5) | 208-953-6 | 548-62-9 | Carc. 1B | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H302 | H318 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H350 | H302 | H318 | H410 |   |   |  612-205-00-8 | C.I. основно виолетово 3 с ≥ 0,1 % кетон на Михлер (ЕО № 202-027-5) | 208-953-6 | 548-62-9 | Carc. 1B | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H302 | H318 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H350 | H302 | H318 | H410 |   |   |  
612-206-00-3 | famoxadone (ISO); | 3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione | — | 131807-57-3 | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** | H400 | H410 | GHS08 | GHS09 | Wng | H373 ** | H410 |   |   |  612-206-00-3 | фамоксадон (ISO); | 3-анилино-5-метил-5-(4-феноксифенил)-1,3-оксазолидин-2,4-дион | — | 131807-57-3 | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** | H400 | H410 | GHS08 | GHS09 | Wng | H373 ** | H410 |   |   |  
612-207-00-9 | 4-ethoxyaniline; | p-phenetidine | 205-855-5 | 156-43-4 | Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | H341 | H332 | H312 | H302 | H319 | H317 | GHS08 | GHS07 | Wng | H341 | H332 | H312 | H302 | H319 | H317 |   |   |  612-207-00-9 | 4-етоксианилин; | p-фенетидин | 205-855-5 | 156-43-4 | Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | H341 | H332 | H312 | H302 | H319 | H317 | GHS08 | GHS07 | Wng | H341 | H332 | H312 | H302 | H319 | H317 |   |   |  
612-208-00-4 | N-methylbenzene-1,2-diammonium hydrogen phosphate | 424-460-0 | — | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  612-208-00-4 | N-метилбензен-1,2-диамониев хидрогенфосфат | 424-460-0 | — | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  
612-209-00-X | 6-methoxy-m-toluidine; | p-cresidine | 204-419-1 | 120-71-8 | Carc. 1B | Acute Tox. 4 * | H350 | H302 | GHS08 | GHS07 | Dgr | H350 | H302 |   |   |  612-209-00-X | 6-метокси-m-толуидин; | p-крезидин | 204-419-1 | 120-71-8 | Carc. 1B | Acute Tox. 4 * | H350 | H302 | GHS08 | GHS07 | Dgr | H350 | H302 |   |   |  
612-210-00-5 | 5-nitro-o-toluidine; [1] | 5-nitro-o-toluidine hydrochloride [2] | 202-765-8 [1] | 256-960-8 [2] | 99-55-8 [1] | 51085-52-0 [2] | Carc. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Chronic 3 | H351 | H331 | H311 | H301 | H412 | GHS06 | GHS08 | Dgr | H351 | H331 | H311 | H301 | H412 |   |   |  612-210-00-5 | 5-нитро-o-толуидин [1] | 5-нитро-o-толуидинхидрохлорид [2] | 202-765-8 [1] | 256-960-8 [2] | 99-55-8 [1] | 51085-52-0 [2] | Carc. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Aquatic Chronic 3 | H351 | H331 | H311 | H301 | H412 | GHS06 | GHS08 | Dgr | H351 | H331 | H311 | H301 | H412 |   |   |  
612-211-00-0 | N-[(benzotriazole-1-yl)methyl)]4-carboxy-benzenesulfonamide | 416-470-9 | 170292-97-4 | Eye Irrit. 2 | Aquatic Chronic 2 | H319 | H411 | GHS07 | GHS09 | Wng | H319 | H411 |   |   |  612-211-00-0 | N-[(бензoтриазол-1-ил)метил)]-4-карбоксибензенсулфонамид | 416-470-9 | 170292-97-4 | Eye Irrit. 2 | Aquatic Chronic 2 | H319 | H411 | GHS07 | GHS09 | Wng | H319 | H411 |   |   |  
612-212-00-6 | 2,6-dichloro-4-trifluoromethylaniline | 416-430-0 | 24279-39-8 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H302 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H302 | H315 | H317 | H410 |   |   |  612-212-00-6 | 4-(трифлуорометил)-2,6-дихлороанилин | 416-430-0 | 24279-39-8 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H302 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H302 | H315 | H317 | H410 |   |   |  
612-213-00-1 | isobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine | 419-850-2 | 148348-13-4 | Skin Corr. 1B | Aquatic Chronic 3 | H314 | H412 | GHS05 | Dgr | H314 | H412 |   |   |  612-213-00-1 | изoбутилиден-(2-(2-изoпропил-4,4-диметилoксазолидин-3-ил)-1,1-диметилетил)амин | 419-850-2 | 148348-13-4 | Skin Corr. 1B | Aquatic Chronic 3 | H314 | H412 | GHS05 | Dgr | H314 | H412 |   |   |  
612-214-00-7 | 4-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine | 421-390-2 | 89114-90-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  612-214-00-7 | 4-(2,2-дифенилетенил)-N,N-дифенилбензeнамин | 421-390-2 | 89114-90-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
612-215-00-2 | 3-chloro-2-(isopropylthio)aniline | 421-700-6 | 179104-32-6 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  612-215-00-2 | 2-(изoпропилтио)-3-хлороанилин | 421-700-6 | 179104-32-6 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
612-216-00-8 | 1-amino-1-cyanamino-2,2-dicyanoethylene, sodium salt | 425-870-2 | 19450-38-5 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  612-216-00-8 | натриева сол на 1-амино-1-цианамино-2,2-дицианоетилен | 425-870-2 | 19450-38-5 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
612-217-00-3 | 1-methoxy-2-propylamine | 422-550-4 | 37143-54-7 | Flam. Liq. 2 | Skin Corr. 1B | Acute Tox. 4 * | Aquatic Chronic 3 | H225 | H314 | H302 | H412 | GHS02 | GHS05 | GHS07 | Dgr | H225 | H314 | H302 | H412 |   |   |  612-217-00-3 | 1-метокси-2-пропиламин | 422-550-4 | 37143-54-7 | Flam. Liq. 2 | Skin Corr. 1B | Acute Tox. 4 * | Aquatic Chronic 3 | H225 | H314 | H302 | H412 | GHS02 | GHS05 | GHS07 | Dgr | H225 | H314 | H302 | H412 |   |   |  
612-219-00-4 | (2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammonium chloride | 402-200-7 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  612-219-00-4 | (3-(3,4-диметил-9-оксо-10-тиаантрацен-2-илокси)-2-хидроксипропил)триметиламониев хлорид | 402-200-7 | — | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
612-220-00-X | N-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine | 431-060-1 | 153719-38-1 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H317 | H412 | GHS07 | Wng | H302 | H317 | H412 |   |   |  612-220-00-X | N-(3-метил-3,6-дихидро-2H-1,3,5-оксадиазин-4-ил)-N-нитроамин | 431-060-1 | 153719-38-1 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H317 | H412 | GHS07 | Wng | H302 | H317 | H412 |   |   |  
612-221-00-5 | 2-amino-4-(trifluoromethyl)benzenethiol hydrochloride | 429-560-8 | 4274-38-8 | Skin Corr. 1B | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | H314 | H332 | H312 | H302 | H373** | H317 | H400 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H314 | H332 | H312 | H302 | H373** | H317 | H400 |   |   |  612-221-00-5 | 2-амино-4-(трифлуорометил)бензентиолхидрохлорид | 429-560-8 | 4274-38-8 | Skin Corr. 1B | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | H314 | H332 | H312 | H302 | H373** | H317 | H400 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H314 | H332 | H312 | H302 | H373** | H317 | H400 |   |   |  
612-222-00-0 | cis-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinamine | 425-080-8 | 104860-26-6 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H373** | H318 | H400 | H410 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H312 | H302 | H373** | H318 | H410 |   |   |  612-222-00-0 | цис-1-(3-(4-флуорофенокси)пропил)-3-метокси-4-пиперидинамин | 425-080-8 | 104860-26-6 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H373** | H318 | H400 | H410 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H312 | H302 | H373** | H318 | H410 |   |   |  
612-223-00-6 | N-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine | 425-300-2 | 186450-73-7 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  612-223-00-6 | N-бензил-N-етил-(4-(5-нитробензо[c]изотиазол-3-илазо)фенил)амин | 425-300-2 | 186450-73-7 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
612-224-00-1 | N2,N4,N6-tris{4-[(1,4-dimethylpentyl)amino]phenyl}-1,3,5-triazine-2,4,6-triamine | 426-150-0 | 121246-28-4 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  612-224-00-1 | N2,N4,N6-трис{4-[(1,4-диметилпентил)амино]фенил}-1,3,5-триазин-2,4,6-триамин | 426-150-0 | 121246-28-4 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
612-225-00-7 | 1,4,7,10-tetraazacyclododecane | 425-450-9 | 294-90-6 | Skin Corr. 1B | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H312 | H302 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H312 | H302 | H410 |   |   |  612-225-00-7 | 1,4,7,10-тетраазациклододекан | 425-450-9 | 294-90-6 | Skin Corr. 1B | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H312 | H302 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H312 | H302 | H410 |   |   |  
612-226-00-2 | 3-(2'-phenoxyethoxy)propylamine | 427-870-8 | 6903-18-0 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H315 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H315 | H318 | H412 |   |   |  612-226-00-2 | 3-(2′-феноксиетокси)пропиламин | 427-870-8 | 6903-18-0 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H315 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H315 | H318 | H412 |   |   |  
612-227-00-8 | benzyl-N-(2-(2-methoxyphenoxy)ethyl)amine hydrochloride | 428-290-8 | 120606-08-8 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H410 |   |   |  612-227-00-8 | бензил-N-(2-(2-метоксифенокси)етил)аминхидрохлорид | 428-290-8 | 120606-08-8 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H410 |   |   |  
612-228-00-3 | reaction mass of: N-(3-(trimethoxysilyl)propyl)ethylenediamine; | N-benzyl-N-(3-(trimethoxysilyl)propyl)ethylenediamine; N-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine; | N, N'-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine; N, N,N'-tris-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine; | N, N-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine | 414-340-6 | — | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H226 | H332 | H312 | H302 | H371 | H318 | H317 | H412 | GHS02 | GHS05 | GHS08 | GHS07 | Dgr | H226 | H332 | H312 | H302 | H371 | H318 | H317 | H412 |   |   |  612-228-00-3 | реакционна маса от: N-(3-(триметоксисилил)пропил)етилендиамин; | N-бензил-N-(3-(триметоксисилил)пропил)етилендиамин; N-бензил-N′-[3-(триметоксисилил)пропил]етилендиамин; | N,N′-бисбензил-N′-[3-(триметоксисилил)пропил]етилендиамин; N, N,N′-трисбензил-N′-[3-(триметоксисилил)пропил]етилендиамин; | N,N-бисбензил-N′-[3-(триметоксисилил)пропил]етилендиамин | 414-340-6 | — | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT SE 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H226 | H332 | H312 | H302 | H371 | H318 | H317 | H412 | GHS02 | GHS05 | GHS08 | GHS07 | Dgr | H226 | H332 | H312 | H302 | H371 | H318 | H317 | H412 |   |   |  
612-229-00-9 | mepanipyrim; | 4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine | — | 110235-47-7 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   |   |  612-229-00-9 | мепанипирим; | 4-метил-6-(1-пропинил)-N-фенил-2-пиримидинамин | — | 110235-47-7 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   |   |  
612-230-00-4 | N,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide | 431-530-4 | — | Skin Corr. 1A | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H317 | H410 |   |   |  612-230-00-4 | N,N-бис(кокоил-2-оксипропил)-N,N-дибутиламониев бромид | 431-530-4 | — | Skin Corr. 1A | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H317 | H410 |   |   |  
612-231-00-X | 3-((C12-18)-acylamino)-N-(2-((2-hydroxyethyl)amino)-2-oxoethyl)-N,N-dimethyl-1-propanaminium chloride | 427-370-1 | 164288-56-6 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  612-231-00-X | 3-((C12-18)-ациламино)-N-(2-((2-хидроксиетил)амино)-2-оксоетил)-N,N-диметил-1-пропанаминиев хлорид | 427-370-1 | 164288-56-6 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  
612-232-00-5 | reaction mass of: triisopropanolamine salt of 1-amino-4-(3-propionamidoanilino)anthraquinone-2-sulfonic acid; triisopropanolamine salt of 1-amino-4-[3,4-dimethyl-5-(2-hydroxyethylaminosulfonyl)anilino]anthraquinone-2-sulfonic acid | 430-410-9 | 186148-38-9 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  612-232-00-5 | реакционна маса от: сол на триизопропаноламин с 1-амино-4-(3-пропионамидоанилино)антрахинон-2-сулфонова киселина; сол на триизопропаноламин с 1-амино-4-[3,4-диметил-5-(2-хидроксиетиламиносулфонил)анилино]антрахинон-2-сулфонова киселина | 430-410-9 | 186148-38-9 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
612-237-00-2 | hydroxylammonium hydrogensulfate; | hydroxylamine sulfate(1:1); [1] | hydroxylamine phosphate; [2] | hydroxylamine dihydrogenphos | phate; [3] hydroxylamine 4-methylben | zenesulfonate [4] | 233-154-4 [1] | 244-077-0 [2] | 242-818-2 [3] | 258-872-5 [4] | 10046-00-1 [1] | 20845-01-6 [2] | 19098-16-9 [3] | 53933-48-5 [4] | Expl. 1.1 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | H201 | H351 | H312 | H302 | H373** | H319 | H315 | H317 | H400 | GHS01 | GHS08 | GHS07 | GHS09 | Dgr | H201 | H351 | H312 | H302 | H373** | H319 | H315 | H317 | H400 |   |   | T612-237-00-2 | хидроксиламониев хидрогенсулфат; | хидроксиламинсулфат (1:1); [1] | хидроксиламинфосфат; [2] | хидроксиламиндихидрогенфос | фат; [3] хидроксиламин 4-метилбен | зенсулфонат [4] | 233-154-4 [1] | 244-077-0 [2] | 242-818-2 [3] | 258-872-5 [4] | 10046-00-1 [1] | 20845-01-6 [2] | 19098-16-9 [3] | 53933-48-5 [4] | Expl. 1.1 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | H201 | H351 | H312 | H302 | H373** | H319 | H315 | H317 | H400 | GHS01 | GHS08 | GHS07 | GHS09 | Dgr | H201 | H351 | H312 | H302 | H373** | H319 | H315 | H317 | H400 |   |   | T
612-238-00-8 | (3-chloro-2-hydroxypropyl) | trimethylammonium chloride …% | 222-048-3 | 3327-22-8 | Carc. 2 | Aquatic Chronic 3 | H351 | H412 | GHS08 | Wng | H351 | H412 |   |   | B612-238-00-8 | (2-хидрокси-3-хлоропропил) | триметиламониев хлорид …% | 222-048-3 | 3327-22-8 | Carc. 2 | Aquatic Chronic 3 | H351 | H412 | GHS08 | Wng | H351 | H412 |   |   | B
612-239-00-3 | biphenyl-3,3', 4,4'-tetrayltetraamine; | diaminobenzidine | 202-110-6 | 91-95-2 | Carc. 1B Muta. 2 | H350 | H341 | GHS08 | Dgr | H350 | H341 |   |   |  612-239-00-3 | бифенил-3,3′,4,4′-тетраилтетраамин; | диаминобензидин | 202-110-6 | 91-95-2 | Carc. 1B Muta. 2 | H350 | H341 | GHS08 | Dgr | H350 | H341 |   |   |  
612-240-00-9 | pyrimethanil (ISO); | N-(4,6-dimethylpyrimidin-2-yl)aniline | — | 53112-28-0 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  612-240-00-9 | пириметанил (ISO); | N-(4,6-диметилпиримидин-2-ил)анилин | — | 53112-28-0 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
612-241-00-4 | piperazine hydrochloride; [1] piperazine dihydrochloride; [2] piperazine phosphate [3] | 228-042-7 [1] | 205-551-2 [2] | 217-775-8 [3] | 6094-40-2 [1] | 142-64-3 [2] | 1951-97-9 [3] | Repr. 2 | Eye Irrit. 2 | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H361fd | H319 | H315 | H334 | H317 | H412 | GHS08 | Dgr | H361fd | H319 | H315 | H334 | H317 | H412 |   |   |  612-241-00-4 | пиперазинхидрохлорид; [1] пиперазиндихидрохлорид; [2] пиперазинфосфат [3] | 228-042-7 [1] | 205-551-2 [2] | 217-775-8 [3] | 6094-40-2 [1] | 142-64-3 [2] | 1951-97-9 [3] | Repr. 2 | Eye Irrit. 2 | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H361fd | H319 | H315 | H334 | H317 | H412 | GHS08 | Dgr | H361fd | H319 | H315 | H334 | H317 | H412 |   |   |  
612-242-00-X | cyprodinil (ISO); | 4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine | — | 121552-61-2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   | M=10 |  612-242-00-X | ципродинил (ISO); | 6-метил-N-фенил-4-циклопропилпиримидин-2-амин | — | 121552-61-2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   | M=10 |  
612-243-00-5 | (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate | 420-560-3 | 79617-97-3 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   | M=10 |  612-243-00-5 | (1S-цис)-4-(3,4-дихлорофенил)-N-метил-1,2,3,4-тетрахидро-1-нафталенамин-2-хидрокси-2-фенилацетат | 420-560-3 | 79617-97-3 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   | M=10 |  
612-244-00-0 | 3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride | 421-310-6 | 87691-88-1 | Repr. 2 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361f*** | H302 | H319 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H361f*** | H302 | H319 | H317 | H410 |   |   |  612-244-00-0 | 3-(пиперазин-1-ил)-бензо[d]изотиазолхидрохлорид | 421-310-6 | 87691-88-1 | Repr. 2 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361f*** | H302 | H319 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H361f*** | H302 | H319 | H317 | H410 |   |   |  
612-245-00-6 | 2-ethylphenylhydrazine hydrochloride | 421-460-2 | 19398-06-2 | Carc. 2 | STOT RE 1 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H372** | H302 | H318 | H317 | H400 | H410 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H351 | H372** | H302 | H318 | H317 | H410 |   | M=10 |  612-245-00-6 | 2-етилфенилхидразинхидрохлорид | 421-460-2 | 19398-06-2 | Carc. 2 | STOT RE 1 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H372** | H302 | H318 | H317 | H400 | H410 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H351 | H372** | H302 | H318 | H317 | H410 |   | M=10 |  
612-246-00-1 | (2-chloroethyl)(3-hydroxypropyl)ammonium chloride | 429-740-6 | 40722-80-3 | Carc. 1B | Muta. 1B | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 3 | H350 | H340 | H373** | H317 | H412 | GHS08 | GHS07 | Dgr | H350 | H340 | H373** | H317 | H412 |   |   |  612-246-00-1 | (3-хидроксипропил)(2-хлороетил)амониев хлорид | 429-740-6 | 40722-80-3 | Carc. 1B | Muta. 1B | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 3 | H350 | H340 | H373** | H317 | H412 | GHS08 | GHS07 | Dgr | H350 | H340 | H373** | H317 | H412 |   |   |  
612-247-00-7 | N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide | 423-530-8 | 152828-23-4 | STOT RE 1 | Acute Tox. 4 * | Aquatic Chronic 3 | H372** H302 | H412 | GHS08 | GHS07 | Dgr | H372** | H302 | H412 |   |   |  612-247-00-7 | N-[3-(1,1-диметилетил)-1H-пиразол-5-ил]-4-нитро-N′-хидроксибензенкарбоксимидамид | 423-530-8 | 152828-23-4 | STOT RE 1 | Acute Tox. 4 * | Aquatic Chronic 3 | H372** H302 | H412 | GHS08 | GHS07 | Dgr | H372** | H302 | H412 |   |   |  
612-248-00-2 | reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich) | 439-540-0 | — | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 4 | H315 | H317 | H413 | GHS07 | Wng | H315 | H317 | H413 |   |   |  612-248-00-2 | реакционен продукт от дифениламин, фенотиазин и алкени, разклонени (C8-10, богати на C9) | 439-540-0 | — | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 4 | H315 | H317 | H413 | GHS07 | Wng | H315 | H317 | H413 |   |   |  
612-249-00-8 | 4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride | 425-030-5 | 159939-85-2 | Repr. 2 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H361f*** | H302 | H314 | H317 | H411 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H361f*** | H302 | H314 | H317 | H411 |   |   |  612-249-00-8 | 4-[(3-хлорофенил)(1H-имидазол-1-ил)метил]-1,2-бензендиаминдихидрохлорид | 425-030-5 | 159939-85-2 | Repr. 2 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H361f*** | H302 | H314 | H317 | H411 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H361f*** | H302 | H314 | H317 | H411 |   |   |  
612-250-00-3 | chloro-N, N-dimethylformiminium chloride | 425-970-6 | 3724-43-4 | Repr. 1B | Acute Tox. 4 * | Skin Corr. 1A | H360D*** | H302 | H314 | GHS05 | GHS08 | GHS07 | Dgr | H360D*** | H302 | H314 | EUH014 |   |  612-250-00-3 | N, N-диметилхлороформиминиев хлорид | 425-970-6 | 3724-43-4 | Repr. 1B | Acute Tox. 4 * | Skin Corr. 1A | H360D*** | H302 | H314 | GHS05 | GHS08 | GHS07 | Dgr | H360D*** | H302 | H314 | EUH014 |   |  
612-251-00-9 | cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride | 426-020-3 | 51229-78-8 | Flam. Sol. 2 | Repr. 2 | Acute Tox. 4 * | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H228 | H361d*** | H302 | H315 | H317 | H411 | GHS02 | GHS08 | GHS07 | GHS09 | Wng | H228 | H361d*** | H302 | H315 | H317 | H411 |   |   |  612-251-00-9 | цис-1-(3-хлороалил)-3,5,7-триаза-1-азониаадамантанхлорид | 426-020-3 | 51229-78-8 | Flam. Sol. 2 | Repr. 2 | Acute Tox. 4 * | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H228 | H361d*** | H302 | H315 | H317 | H411 | GHS02 | GHS08 | GHS07 | GHS09 | Wng | H228 | H361d*** | H302 | H315 | H317 | H411 |   |   |  
612-252-00-4 | imidacloprid (ISO); | 1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine | 428-040-8 | 138261-41-3 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  612-252-00-4 | имидаклоприд (ISO); | N-нитро-1-(6-хлоропиридин-3-илметил)имидазолидин-2-илиденамин | 428-040-8 | 138261-41-3 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
612-253-00-X | 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing < 0,5 % formamide (EC No 200-842-0)] | 429-400-7 | 199327-61-2 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  612-253-00-X | 7-метокси-6-(3-морфолин-4-илпропокси)-3H-хиназолин-4-он; [съдържащ < 0,5 % формамид (ЕО № 200-842-0)] | 429-400-7 | 199327-61-2 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
612-253-01-7 | 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing ≥ 0,5 % formamide (EC No 200-842-0)] | 429-400-7 | 199327-61-2 | Repr. 1B | Aquatic Chronic 3 | H360D*** | H412 | GHS08 | Dgr | H360D*** | H412 |   |   |  612-253-01-7 | 7-метокси-6-(3-морфолин-4-илпропокси)-3H-хиназолин-4-он; [съдържащ ≥ 0,5 % формамид (EО № 200-842-0)] | 429-400-7 | 199327-61-2 | Repr. 1B | Aquatic Chronic 3 | H360D*** | H412 | GHS08 | Dgr | H360D*** | H412 |   |   |  
612-254-00-5 | reaction products of diisopropanolamine with formaldehyde (1:4) | 432-440-8 | 220444-73-5 | Carc. 2 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H351 | H302 | H314 | H317 | H411 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H351 | H302 | H314 | H317 | H411 |   |   |  612-254-00-5 | реакционни продукти от диизопропаноламин с формалдехид (1:4) | 432-440-8 | 220444-73-5 | Carc. 2 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H351 | H302 | H314 | H317 | H411 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H351 | H302 | H314 | H317 | H411 |   |   |  
612-255-00-0 | 1-(3-methoxypropyl)-4-piperidinamine | 431-950-8 | 179474-79-4 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 3 | H312 | H302 | H314 | H412 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 | H412 |   |   |  612-255-00-0 | 1-(3-метоксипропил)-4-пиперидинамин | 431-950-8 | 179474-79-4 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Chronic 3 | H312 | H302 | H314 | H412 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 | H412 |   |   |  
612-256-00-6 | benzyl(S)-2-[(2'-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate | 427-470-3 | 137864-22-3 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  612-256-00-6 | бензилов (S)-2-[(2′-цианобифенил-4-илметил)пентаноиламино]-3-метилбутират | 427-470-3 | 137864-22-3 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  
612-257-00-1 | tripropylammonium dihydrogenphosphate | 433-700-3 | 35687-90-2 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  612-257-00-1 | трипропиламониев дихидрогенфосфат | 433-700-3 | 35687-90-2 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
612-259-00-2 | N-ethyl-3-trimethoxysilyl-2-methyl-propanamine | 437-720-3 | 227085-51-0 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  612-259-00-2 | N-етил-3-триметоксисилил-2-метилпропанамин | 437-720-3 | 227085-51-0 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
612-261-00-3 | 3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline | 441-190-9 | 121451-05-6 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   | M=10 |  612-261-00-3 | 2-флуоро-4-(1,1,2,3,3,3-хексафлуоропропокси)-3,5-дихлороанилин | 441-190-9 | 121451-05-6 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   | M=10 |  
612-265-00-5 | bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate | 444-360-0 | 191617-13-7 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  612-265-00-5 | бис(2-хидроксиетил)(2-хидроксипропил)амониев ацетат | 444-360-0 | 191617-13-7 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
612-266-00-0 | 3-chloro-4-(3-fluorobenzyloxy)aniline | 445-590-4 | 202197-26-0 | Muta. 2 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H302 | H373** | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H341 | H302 | H373** | H410 |   |   |  612-266-00-0 | 4-(3-флуоробензилокси)-3-хлороанилин | 445-590-4 | 202197-26-0 | Muta. 2 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H302 | H373** | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H341 | H302 | H373** | H410 |   |   |  
612-267-00-6 | bis(hydrogenated tallow C16-18-alkyl)hydroxylamine | 418-370-0 | — | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  612-267-00-6 | бис(хидрогениран C16-18-алкил от лой)хидроксиламин | 418-370-0 | — | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
612-269-00-7 | reaction mass of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole; | 1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole; | reaction mass of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline; | N-[(4-methyl-1H-benzotriazol-1yl)methyl]-4-octyl-N-(4-octylphenyl)aniline | 420-720-2 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  612-269-00-7 | реакционна маса от: 1-[ди(4-октилфенил)аминометил]-5-метил-1H-бензотриазол; | 1-[ди(4-октилфенил)аминометил]-4-метил-1H-бензотриазол; | реакционна маса от: N-[(5-метил-1H-бензотриазол-1-ил)метил]-4-октил-N-(4-октилфенил)анилин; | N-[(4-метил-1H-бензотриазол-1-ил)метил]-4-октил-N-(4-октилфенил)анилин | 420-720-2 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
612-270-00-2 | (S)-azetidine-2-carboxylic acid | 4-cyanobenzylamide hydrochloride | 433-010-2 | — | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H317 | H412 | GHS07 | Wng | H302 | H317 | H412 |   |   |  612-270-00-2 | (S)-азетидин-2-карбоксилна киселина | 4-цианобензиламидхидрохлорид | 433-010-2 | — | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H317 | H412 | GHS07 | Wng | H302 | H317 | H412 |   |   |  
612-271-00-8 | reaction mass of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate; | ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate | 434-970-5 | 160987-57-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  612-271-00-8 | реакционна маса от: етилов 2-((4-(5,6-дихлоробензотиазол-2-илазо)фенил)етиламино)бензоат; | етилов 2-((4-(6,7-дихлоробензотиазол-2-илазо)фенил)етиламино)бензоат | 434-970-5 | 160987-57-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
612-272-00-3 | ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4))iron(3+) monohydrate | 435-210-5 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  612-272-00-3 | амониев (η6-2-(2-(1,2-дикарбоксилатоетиламино)етиламино)бутан-1,4-диоато(4-))железен(3+) йон монохидрат | 435-210-5 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
612-273-00-9 | alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride | 435-650-8 | — | Acute Tox. 4 * | Skin Corr. 1A | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H314 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H410 |   |   |  612-273-00-9 | алкил(рапично масло), бис(2-хидроксиетил)амониев флуорид | 435-650-8 | — | Acute Tox. 4 * | Skin Corr. 1A | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H314 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H410 |   |   |  
612-274-00-4 | (R, S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate | 445-750-3 | — | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H317 | H412 |   |   |  612-274-00-4 | (R,S)-1-[2-амино-1-(4-метоксифенил)етил]циклохексанол ацетат | 445-750-3 | — | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H317 | H412 |   |   |  
612-275-00-X | fatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil | 447-880-6 | 206565-89-1 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H315 | H318 | H317 | H410 |   | M=10 |  612-275-00-X | реакционни продукти на димери на C18-ненаситени мастни киселини с 1-пиперазинетанамин и талово масло | 447-880-6 | 206565-89-1 | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H315 | H318 | H317 | H410 |   | M=10 |  
612-276-00-5 | 1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts | 451-430-4 | 500717-36-2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  612-276-00-5 | реакционни продукти на динатриева сол на 1-амино-4-[(4-амино-2-сулфофенил)амино]-9,10-диоксо-9,10-дихидро-2-антраценсулфоновата киселина с натриеви соли на 2-[[3-[(4,6-дихлоро-1,3,5-триазин-2-ил)етиламино]фенил]сулфонил]етилов хидрогенсулфат | 451-430-4 | 500717-36-2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  
612-277-00-0 | reaction mass of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium; | 4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium | 451-440-9 | 586372-44-3 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  612-277-00-0 | реакционна маса от: 4-амино-3-(4-етенсулфонил-2-сулфонатофенилазо)-5-хидрокси-6-(5-{6-[4-(2-сулфонатооксиетансулфонил)фениламино]-4-хлоро-1,3,5-триазин-2-иламино}-2-сулфонатофенилазо)нафтален-2,7-дисулфонат калий/натрий; | 4-амино-5-хидрокси-6-(5-{6-[4-(2-сулфонатооксиетансулфонил)фениламино]-4-хлоро-1,3,5-триазин-2-иламино}-2-сулфонатофенилазо)-3-(2-сулфонато-4-(2-сулфонатооксиетансулфонил)фенилазо)нафтален-2,7-дисулфонат калий/натрий | 451-440-9 | 586372-44-3 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
612-278-00-6 | ethidium bromide; | 3,8-diamino-1-ethyl-6-phenylphenantridinium bromide | 214-984-6 | 1239-45-8 | Muta. 2 | Acute Tox. 2 * | Acute Tox. 4 * | H341 | H330 | H302 | GHS06 | GHS08 | Dgr | H341 | H330 | H302 |   |   |  612-278-00-6 | етидиев бромид; | 3,8-диамино-1-етил-6-фенилфенантридиниев бромид | 214-984-6 | 1239-45-8 | Muta. 2 | Acute Tox. 2 * | Acute Tox. 4 * | H341 | H330 | H302 | GHS06 | GHS08 | Dgr | H341 | H330 | H302 |   |   |  
612-279-00-1 | (R, S)-2-amino-3,3-dimethylbutane amide | 447-860-7 | 144177-62-8 | Repr. 2 | STOT RE 2 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H361f*** H373** H319 | H315 | H317 | GHS08 | GHS07 | Wng | H361f*** H373** | H319 | H315 | H317 |   |   |  612-279-00-1 | (R,S)-2-амино-3,3-диметилбутанамид | 447-860-7 | 144177-62-8 | Repr. 2 | STOT RE 2 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H361f*** H373** H319 | H315 | H317 | GHS08 | GHS07 | Wng | H361f*** H373** | H319 | H315 | H317 |   |   |  
612-280-00-7 | 3-amino-9-ethyl carbazole; | 9-ethylcarbazol-3-ylamine | 205-057-7 | 132-32-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  612-280-00-7 | 3-амино-9-етилкарбазол; | 9-етилкарбазол-3-иламин | 205-057-7 | 132-32-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
612-281-00-2 | leucomalachite green; N, N,N',N'-tetramethyl-4,4'-benzylidenedianiline | 204-961-9 | 129-73-7 | Carc. 2 | Muta. 2 | H351 | H341 | GHS08 | Wng | H351 | H341 |   |   |  612-281-00-2 | зелен левкомалахит N,N,N′,N′-тетраметил-4,4′-бензилидeндианилин | 204-961-9 | 129-73-7 | Carc. 2 | Muta. 2 | H351 | H341 | GHS08 | Wng | H351 | H341 |   |   |  
612-282-00-8 | octadecylamine | 204-695-3 | 124-30-1 | Asp. Tox. 1 | STOT RE 2 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H304 | H373 (gastrointestinal tract, liver, immune | system) | H315 | H318 | H400 | H410 | GHS05 | GHS08 | GHS09 | Dgr | H304 | H373 (gastrointestinal tract, liver, immune | system) | H315 | H318 | H410 |   | M = 10 | M = 10 |  612-282-00-8 | октадециламин | 204-695-3 | 124-30-1 | Asp. Tox. 1 | STOT RE 2 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H304 | H373 (стомашно-чревен тракт, черен дроб, имунна система) | H315 | H318 | H400 | H410 | GHS05 | GHS08 | GHS09 | Dgr | H304 | H373 (стомашно-чревен тракт, черен дроб, имунна система) | H315 | H318 | H410 |   | M = 10 | M = 10 |  
612-283-00-3 | (Z)-octadec-9-enylamine | 204-015-5 | 112-90-3 | Acute Tox. 4 | Asp Tox. 1 | STOT SE 3 | STOT RE 2 | Skin Corr. 1B Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H304 | H335 | H373 (gastro-intestinal tract, liver, immune system) | H314 | H400 | H410 | GHS05 | GHS07 | GHS08 | GHS09 | Dgr | H302 | H304 | H335 | H373 (gastro-intestinal tract, liver, immune system) | H314 | H410 |   | M = 10 | M = 10 |  612-283-00-3 | (Z)-октадец-9-ениламин | 204-015-5 | 112-90-3 | Acute Tox. 4 | Asp Tox. 1 | STOT SE 3 | STOT RE 2 | Skin Corr. 1B Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H304 | H335 | H373 (стомашно-чревен тракт, черен дроб, имунна система) | H314 | H400 | H410 | GHS05 | GHS07 | GHS08 | GHS09 | Dgr | H302 | H304 | H335 | H373 (стомашно-чревен тракт, черен дроб, имунна система) | H314 | H410 |   | M = 10 | M = 10 |  
612-284-00-9 | amines, hydrogenated tallow alkyl | 262-976-6 | 61788-45-2 | Asp Tox. 1 | STOT RE 2 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H304 | H373 (gastro-intestinal tract, liver, immune system) | H315 | H318 | H400 | H410 | GHS08 | GHS05 | GHS09 | Dgr | H304 | H373 (gastro-intestinal tract, liver, immune system) | H315 | H318 | H410 |   | M = 10 | M = 10 |  612-284-00-9 | хидрогенирани алкиламини от лой | 262-976-6 | 61788-45-2 | Asp Tox. 1 | STOT RE 2 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H304 | H373 (стомашно-чревен тракт, черен дроб, имунна система) | H315 | H318 | H400 | H410 | GHS08 | GHS05 | GHS09 | Dgr | H304 | H373 (стомашно-чревен тракт, черен дроб, имунна система) | H315 | H318 | H410 |   | M = 10 | M = 10 |  
612-285-00-4 | amines, coco alkyl | 262-977-1 | 61788-46-3 | Acute Tox. 4 | Asp. Tox. 1 | STOT SE 3 | STOT RE 2 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H304 | H335 | H373 (gastro-intestinal tract, liver, immune system) | H314 | H400 | H410 | GHS05 | GHS07 | GHS08 | GHS09 | Dgr | H302 | H304 | H335 | H373 (gastro-intestinal tract, liver, immune system) | H314 | H410 |   | M = 10 | M = 10 |  612-285-00-4 | кокосови алкиламини | 262-977-1 | 61788-46-3 | Acute Tox. 4 | Asp. Tox. 1 | STOT SE 3 | STOT RE 2 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H304 | H335 | H373 (стомашно-чревен тракт, черен дроб, имунна система) | H314 | H400 | H410 | GHS05 | GHS07 | GHS08 | GHS09 | Dgr | H302 | H304 | H335 | H373 (стомашно-чревен тракт, черен дроб, имунна система) | H314 | H410 |   | M = 10 | M = 10 |  
612-286-00-X | amines, tallow alkyl | 263-125-1 | 61790-33-8 | Acute Tox. 4 | Asp. Tox. 1 | STOT RE 2 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H304 | H373 (gastro-intestinal tract, liver, immune system) | H314 | H400 | H410 | GHS05 | GHS07 | GHS08 | GHS09 | Dgr | H302 | H304 | H373 (gastro-intestinal tract, liver, immune system) | H314 | H410 |   | M = 10 | M = 10 |  612-286-00-X | алкиламини от лой | 263-125-1 | 61790-33-8 | Acute Tox. 4 | Asp. Tox. 1 | STOT RE 2 | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H304 | H373 (стомашно-чревен тракт, черен дроб, имунна система) | H314 | H400 | H410 | GHS05 | GHS07 | GHS08 | GHS09 | Dgr | H302 | H304 | H373 (стомашно-чревен тракт, черен дроб, имунна система) | H314 | H410 |   | M = 10 | M = 10 |  
612-287-00-5 | fluazinam (ISO); 3-chloro-N-[3- chloro-2,6-dinitro-4-(trifluor omethyl)phenyl]-5-(trifluoromethyl)pyridin-2-amine | — | 79622-59-6 | Repr. 2 | Acute Tox. 4 | Eye Dam. 1 | Skin Sens. 1A | Aquatic Acute 1 | Aquatic Chronic 1 | H361d | H332 | H318 | H317 | H400 | H410 | GHS08 | GHS07 | GHS05 | GHS09 | Dgr | H361d | H332 | H318 | H317 | H410 |   | M = 10 | M = 10 |  612-287-00-5 | флуазинам (ISO); N-[2,6-динитро-4-(трифлуорометил)-3-хлорофенил]-5-(трифлуорометил)-3-хлоропиридин-2-амин | — | 79622-59-6 | Repr. 2 | Acute Tox. 4 | Eye Dam. 1 | Skin Sens. 1A | Aquatic Acute 1 | Aquatic Chronic 1 | H361d | H332 | H318 | H317 | H400 | H410 | GHS08 | GHS07 | GHS05 | GHS09 | Dgr | H361d | H332 | H318 | H317 | H410 |   | M = 10 | M = 10 |  
613-001-00-1 | ethyleneimine; aziridine | 205-793-9 | 151-56-4 | Flam. Liq. 2 | Carc. 1B | Muta. 1B | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Skin Corr. 1B | Aquatic Chronic 2 | H225 | H350 | H340 | H330 | H310 | H300 | H314 | H411 | GHS02 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H225 | H350 | H340 | H330 | H310 | H300 | H314 | H411 |   |   | D613-001-00-1 | етиленимин;азиридин | 205-793-9 | 151-56-4 | Flam. Liq. 2 | Carc. 1B | Muta. 1B | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Skin Corr. 1B | Aquatic Chronic 2 | H225 | H350 | H340 | H330 | H310 | H300 | H314 | H411 | GHS02 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H225 | H350 | H340 | H330 | H310 | H300 | H314 | H411 |   |   | D
613-002-00-7 | pyridine | 203-809-9 | 110-86-1 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H225 | H332 | H312 | H302 | GHS02 | GHS07 | Dgr | H225 | H332 | H312 | H302 |   | * |  613-002-00-7 | пиридин | 203-809-9 | 110-86-1 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H225 | H332 | H312 | H302 | GHS02 | GHS07 | Dgr | H225 | H332 | H312 | H302 |   | * |  
613-003-00-2 | 1,2,3,4-tetranitrocarbazole | — | 6202-15-9 | Expl. 1.1 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H201 | H332 | H312 | H302 | GHS01 | GHS07 | Dgr | H201 | H332 | H312 | H302 |   |   |  613-003-00-2 | 1,2,3,4-тетранитрокарбазол | — | 6202-15-9 | Expl. 1.1 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | H201 | H332 | H312 | H302 | GHS01 | GHS07 | Dgr | H201 | H332 | H312 | H302 |   |   |  
613-004-00-8 | crimidine (ISO);2-chloro-6-methylpyrimidin-4- yldimethylamine | 208-622-6 | 535-89-7 | Acute Tox. 2 * | H300 | GHS06 | Dgr | H300 |   |   |  613-004-00-8 | кримидин (ISO);6-метил-2-хлоропиримидин-4-илдиметиламин | 208-622-6 | 535-89-7 | Acute Tox. 2 * | H300 | GHS06 | Dgr | H300 |   |   |  
613-007-00-4 | desmetryne (ISO);6-isopropylamino-2-methylamino-4-methylthio-1,3,5- triazine | 213-800-1 | 1014-69-3 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   |   |  613-007-00-4 | десметрин (ISO);6-изопропиламино-2-метиламино-4-метилтио-1,3,5-триазин | 213-800-1 | 1014-69-3 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   |   |  
613-008-00-X | dazomet (ISO);tetrahydro-3,5-dimethyl-1,3,5- thiadiazine-2-thione | 208-576-7 | 533-74-4 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H410 |   |   |  613-008-00-X | дазомет (ISO);3,5-диметилтетрахидро-1,3,5-тиадиазин-2-тион | 208-576-7 | 533-74-4 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H410 |   |   |  
613-009-00-5 | 2,4,6-trichloro-1,3,5-triazine; cyanuric chloride | 203-614-9 | 108-77-0 | Acute Tox. 2 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | H330 | H302 | H314 | H317 | GHS06 | GHS05 | Dgr | H330 | H302 | H314 | H317 | EUH014 | STOT SE 3; H335: C ≥ 5 % |  613-009-00-5 | 2,4,6-трихлоро-1,3,5-триазин;циануров хлорид | 203-614-9 | 108-77-0 | Acute Tox. 2 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | H330 | H302 | H314 | H317 | GHS06 | GHS05 | Dgr | H330 | H302 | H314 | H317 | EUH014 | STOT SE 3; H335: C ≥ 5 % |  
613-010-00-0 | ametryn (ISO);N-ethyl-N'-isopropyl-6-(methyl-thio)-1,3,5-triazine-2,4-diamine | 212-634-7 | 834-12-8 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   | M = 100 |  613-010-00-0 | аметрин (ISO);N-етил-N′-изопропил-6-(метилтио)-1,3,5-триазин-2,4-диамин | 212-634-7 | 834-12-8 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   | M = 100 |  
613-011-00-6 | amitrole (ISO);1,2,4-triazol-3-ylamine | 200-521-5 | 61-82-5 | Repr. 2 | STOT RE 2 * | Aquatic Chronic 2 | H361d *** H373 ** | H411 | GHS08 | GHS09 | Wng | H361d *** H373 ** | H411 |   |   |  613-011-00-6 | амитрол (ISO);1,2,4-триазол-3-иламин | 200-521-5 | 61-82-5 | Repr. 2 | STOT RE 2 * | Aquatic Chronic 2 | H361d *** H373 ** | H411 | GHS08 | GHS09 | Wng | H361d *** H373 ** | H411 |   |   |  
613-012-00-1 | bentazone (ISO);3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide | 246-585-8 | 25057-89-0 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H319 | H317 | H412 | GHS07 | Wng | H302 | H319 | H317 | H412 |   |   |  613-012-00-1 | бентазон (ISO);3-изопропил-1,2,3-бензотиадиазин-4-oн-2,2-диоксид | 246-585-8 | 25057-89-0 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H319 | H317 | H412 | GHS07 | Wng | H302 | H319 | H317 | H412 |   |   |  
613-013-00-7 | cyanazine (ISO);2-(4-chloro-6-ethylamino-1,3,5- triazine-2-ylamino)-2-methylpropionitrile | 244-544-9 | 21725-46-2 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  613-013-00-7 | цианазин (ISO);2-(6-eтиламино-4-хлоро-1,3,5-триазин-2-иламино)-2-метилпропионитрил | 244-544-9 | 21725-46-2 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
613-014-00-2 | ethoxyquin (ISO); 6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline | 202-075-7 | 91-53-2 | Acute Tox. 4* | H302 | GHS07 | Wng | H302 |   |   |  613-014-00-2 | етоксихин (ISO); 6-етокси-2,2,4-триметил-1,2-дихидрохинолин | 202-075-7 | 91-53-2 | Acute Tox. 4* | H302 | GHS07 | Wng | H302 |   |   |  
613-015-00-8 | fenazaflor (ISO); phenyl 5,6-dichloro-2-trifluor-omethylbenzimidazole-1-carboxylate | 238-134-9 | 14255-88-0 | Acute Tox. 4* | Acute Tox. 4* | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   |   |  613-015-00-8 | феназафлор (ISO); фенилов 2-трифлуорметил-5,6-дихлоробензимидазол-1-карбоксилат | 238-134-9 | 14255-88-0 | Acute Tox. 4* | Acute Tox. 4* | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   |   |  
613-016-00-3 | fuberidazole (ISO);2-(2-furyl-)-1H-benzimidazole | 223-404-0 | 3878-19-1 | Carc. 2 | Acute Tox. 4 | STOT RE 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H302 | H373 (heart) | H317 | H400 | H410 | GHS07 | GHS08 | GHS09 | Wng | H351 | H302 | H373 (heart) | H317 | H410 |   | M = 1 |  613-016-00-3 | фуберидазол (ISO);2-(2-фурил)-1H-бензимидазол | 223-404-0 | 3878-19-1 | Carc. 2 | Acute Tox. 4 | STOT RE 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H302 | H373 (сърце) | H317 | H400 | H410 | GHS07 | GHS08 | GHS09 | Wng | H351 | H302 | H373 (сърце) | H317 | H410 |   | M = 1 |  
613-017-00-9 | bis(8-hydroxyquinolinium) sulphate | 205-137-1 | 134-31-6 | Acute Tox. 4* | H302 | GHS07 | Wng | H302 |   |   |  613-017-00-9 | бис(8-хидроксихинолиниев) сулфат | 205-137-1 | 134-31-6 | Acute Tox. 4* | H302 | GHS07 | Wng | H302 |   |   |  
613-018-00-4 | morfamquat (ISO); 1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridilium ion |   | 7411-47-4 | Acute Tox. 4* | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Chronic 3 | H302 | H319 | H335 | H315 | H412 | GHS07 | Wng | H302 | H319 | H335 | H315 | H412 |   |   |  613-018-00-4 | морфамкват (ISO); 1,1′-бис(3,5-диметилморфолинокарбонилметил)-4,4′-бипиридилиев йон |   | 7411-47-4 | Acute Tox. 4* | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Chronic 3 | H302 | H319 | H335 | H315 | H412 | GHS07 | Wng | H302 | H319 | H335 | H315 | H412 |   |   |  
613-019-00-X | thioquinox(ISO); 2-thio-1,3-dithiolo(4,5,b)quinoxaline | 202-272-8 | 93-75-4 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  613-019-00-X | тиохинокс (ISO); 2-тио-1,3-дитиоло(4,5-b)хиноксалин | 202-272-8 | 93-75-4 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
613-020-00-5 | tridemorph (ISO); 2,6-dimethyl-4-tridecylmorpholine | 246-347-3 | 24602-86-6 | Repr. 1B | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H360D *** H332 | H302 | H315 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H360D *** H332 | H302 | H315 | H410 |   |   |  613-020-00-5 | тридеморф (ISO); 2,6-диметил-4-тридецилморфолин | 246-347-3 | 24602-86-6 | Repr. 1B | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H360D *** H332 | H302 | H315 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H360D *** H332 | H302 | H315 | H410 |   |   |  
613-021-00-0 | dithianon (ISO); 5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3- dicarbonitrile | 222-098-6 | 3347-22-6 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  613-021-00-0 | дитианон (ISO); 5,10-дихидро-5,10-диоксонафто(2,3-b)-1,4-дитиазин-2,3-дикарбонитрил | 222-098-6 | 3347-22-6 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
613-022-00-6 | pyrethrins including cinerins, with the exception of those specified elsewhere in this Annex | — | — | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   |   | A613-022-00-6 | пиретрини, в това число цинерини, с изключение на тези, посочени другаде в настоящото приложение | — | — | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   |   | A
613-023-00-1 | 2-methyl-4-oxo-3-(penta-2,4- dienyl)cyclopent-2-enyl [1R- [1α[S*(Z)],3β]]-chrysanthemate; pyrethrin I | 204-455-8 | 121-21-1 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   |   |  613-023-00-1 | 2-мeтил-4-oксо-3-(пента-2,4-диенил)циклопент-2-eнилов [1R-[1α[S*(Z)],3β]]хризантемат; пиретрин I | 204-455-8 | 121-21-1 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   |   |  
613-024-00-7 | 2-methyl-4-oxo-3-(penta-2,4- dienyl)cyclopent-2-enyl[1R- [1α[S*(Z)](3β)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2- dimethylcyclopropanecar boxylate; pyrethrin II | 204-462-6 | 121-29-9 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   |   |  613-024-00-7 | 2-мeтил-4-oксо-3-(пента-2,4-диенил)циклопент-2-eнилов [1R- [1α[S*(Z)](3β)]]-3-(2-метил-3-метокси-3-oксопроп-1-енил)-2,2-диметилциклопропанкарбоксилат; пиретрин II | 204-462-6 | 121-29-9 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   |   |  
613-025-00-2 | cinerin I; 3-(but-2-enyl)-2-methyl-4- oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate | 246-948-0 | 25402-06-6 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  613-025-00-2 | цинерин I; 3-(бут-2-eнил)-2-метил-4-оксоциклoпент-2-eнилов 2,2-диметил-3-(2-метилпроп-1-eнил)циклопропанкарбоксилат | 246-948-0 | 25402-06-6 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
613-026-00-8 | cinerin II; 3-(but-2-enyl)-2-methyl-4- oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate | 204-454-2 | 121-20-0 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  613-026-00-8 | цинерин II; 3-(бут-2-eнил)-2-метил-4-оксоциклoпент-2-eнилов 2,2-диметил-3-(2-метил-3-метокси-3-оксопроп-1-eнил)циклопропанкарбоксилат | 204-454-2 | 121-20-0 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
613-027-00-3 | piperidine | 203-813-0 | 110-89-4 | Flam. Liq. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | H225 | H331 | H311 | H314 | GHS02 | GHS06 | GHS05 | Dgr | H225 | H331 | H311 | H314 |   | * |  613-027-00-3 | пиперидин | 203-813-0 | 110-89-4 | Flam. Liq. 2 | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | H225 | H331 | H311 | H314 | GHS02 | GHS06 | GHS05 | Dgr | H225 | H331 | H311 | H314 |   | * |  
613-028-00-9 | morpholine | 203-815-1 | 110-91-8 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H226 | H332 | H312 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dg | H226 | H332 | H312 | H302 | H314 |   |   |  613-028-00-9 | мoрфолин | 203-815-1 | 110-91-8 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H226 | H332 | H312 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dg | H226 | H332 | H312 | H302 | H314 |   |   |  
613-029-00-4 | dichloro-1,3,5-triazinetrione; dichloroisocyanuric acid | 220-487-5 | 2782-57-2 | Ox. Sol. 2 | Acute Tox. 4 * Eye Irrit. 2 | STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H272 | H302 | H319 | H335 | H400 | H410 | GHS03 | GHS07 | GHS09 | Dgr | H272 | H302 | H319 | H335 | H410 | EUH031 |   | T613-029-00-4 | дихлоро-1,3,5-триазинтрион; дихлороизоцианурова киселина | 220-487-5 | 2782-57-2 | Ox. Sol. 2 | Acute Tox. 4 * Eye Irrit. 2 | STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H272 | H302 | H319 | H335 | H400 | H410 | GHS03 | GHS07 | GHS09 | Dgr | H272 | H302 | H319 | H335 | H410 | EUH031 |   | T
613-030-00-X | troclosene potassium; [1] troclosene sodium [2] | 218-828-8 [1] | 220-767-7 [2] | 2244-21-5 [1] | 2893-78-9 [2] | Ox. Sol. 2 | Acute Tox. 4 * Eye Irrit. 2 | STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H272 | H302 | H319 | H335 | H400 | H410 | GHS03 | GHS07 | GHS09 | Dgr | H272 | H302 | H319 | H335 | H410 | EUH031 | * | STOT SE 3; | H335: C ≥ 10 % EUH031: C ≥10 % | G613-030-00-X | троклозен калий; [1] троклозен натрий [2] | 218-828-8 [1] | 220-767-7 [2] | 2244-21-5 [1] | 2893-78-9 [2] | Ox. Sol. 2 | Acute Tox. 4 * Eye Irrit. 2 | STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H272 | H302 | H319 | H335 | H400 | H410 | GHS03 | GHS07 | GHS09 | Dgr | H272 | H302 | H319 | H335 | H410 | EUH031 | * | STOT SE 3; | H335: C ≥ 10 % EUH031: C ≥10 % | G
613-030-01-7 | troclosene sodium, dihydrate | 220-767-7 | 51580-86-0 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H335 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H335 | H410 | EUH031 |   |  613-030-01-7 | троклозен натрий, дихидрат | 220-767-7 | 51580-86-0 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H335 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H335 | H410 | EUH031 |   |  
613-031-00-5 | symclosene; trichloroisocyanuric acid; trichloro-1,3,5-triazinetrion | 201-782-8 | 87-90-1 | Ox. Sol. 2 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H272 | H302 | H319 | H335 | H400 | H410 | GHS03 | GHS07 | GHS09 | Dgr | H272 | H302 | H319 | H335 | H410 | EUH031 |   |  613-031-00-5 | симклозен; трихлороизоцианурова киселина; трихлоро-1,3,5-триазинтрион | 201-782-8 | 87-90-1 | Ox. Sol. 2 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Aquatic Acute 1 | Aquatic Chronic 1 | H272 | H302 | H319 | H335 | H400 | H410 | GHS03 | GHS07 | GHS09 | Dgr | H272 | H302 | H319 | H335 | H410 | EUH031 |   |  
613-032-00-0 | methyl-2,3,5,6-tetrachloro-4- pyridylsulphone;2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine | 236-035-5 | 13108-52-6 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | H312 | H302 | H319 | H317 | GHS07 | Wng | H312 | H302 | H319 | H317 |   |   |  613-032-00-0 | метил-2,3,5,6-тетрахлоро-4-пиридилсулфон;2,3,5,6-тeтрахлоро-4-(метилсулфонил)пиридин | 236-035-5 | 13108-52-6 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | H312 | H302 | H319 | H317 | GHS07 | Wng | H312 | H302 | H319 | H317 |   |   |  
613-033-00-6 | 2-methylaziridine; propyleneimine | 200-878-7 | 75-55-8 | Flam. Liq. 2 | Carc. 1B | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Eye Dam. 1 | Aquatic Chronic 2 | H225 | H350 | H330 | H310 | H300 | H318 | H411 | GHS02 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H225 | H350 | H330 | H310 | H300 | H318 | H411 |   | Carc. 1B; | H350: C ≥ 0,01  % |  613-033-00-6 | 2-мeтилазиридин;пропиленимин | 200-878-7 | 75-55-8 | Flam. Liq. 2 | Carc. 1B | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Eye Dam. 1 | Aquatic Chronic 2 | H225 | H350 | H330 | H310 | H300 | H318 | H411 | GHS02 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H225 | H350 | H330 | H310 | H300 | H318 | H411 |   | Carc. 1B; | H350: C ≥ 0,01  % |  
613-034-00-1 | 1,2-dimethylimidazole | 217-101-2 | 1739-84-0 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | H302 | H315 | H318 | GHS05 | GHS07 | Dgr | H302 | H315 | H318 |   |   |  613-034-00-1 | 1,2-диметилимидазол | 217-101-2 | 1739-84-0 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | H302 | H315 | H318 | GHS05 | GHS07 | Dgr | H302 | H315 | H318 |   |   |  
613-035-00-7 | 1-methylimidazole | 210-484-7 | 616-47-7 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H312 | H302 | H314 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 |   |   |  613-035-00-7 | 1-мeтилимидазол | 210-484-7 | 616-47-7 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1B | H312 | H302 | H314 | GHS05 | GHS07 | Dgr | H312 | H302 | H314 |   |   |  
613-036-00-2 | 2-methylpyridine; 2-picoline | 203-643-7 | 109-06-8 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | H226 | H332 | H312 | H302 | H319 | H335 | GHS02 | GHS07 | Wng | H226 | H332 | H312 | H302 | H319 | H335 |   |   |  613-036-00-2 | 2-мeтилпиридин;2-пиколин | 203-643-7 | 109-06-8 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | H226 | H332 | H312 | H302 | H319 | H335 | GHS02 | GHS07 | Wng | H226 | H332 | H312 | H302 | H319 | H335 |   |   |  
613-037-00-8 | 4-methylpyridine; 4-picoline | 203-626-4 | 108-89-4 | Flam. Liq. 3 | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H226 | H311 | H332 | H302 | H319 | H335 | H315 | GHS02 | GHS06 | Dgr | H226 | H311 | H332 | H302 | H319 | H335 | H315 |   |   |  613-037-00-8 | 4-мeтилпиридин;4-пиколин | 203-626-4 | 108-89-4 | Flam. Liq. 3 | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H226 | H311 | H332 | H302 | H319 | H335 | H315 | GHS02 | GHS06 | Dgr | H226 | H311 | H332 | H302 | H319 | H335 | H315 |   |   |  
613-038-00-3 | 6-phenyl-1,3,5-triazine-2,4- diyldiamine; 6-phenyl-1,3,5-triazine-2,4-diamine; benzoguanamine | 202-095-6 | 91-76-9 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  613-038-00-3 | 6-фенил-1,3,5-триазин-2,4-диилдиамин;6-фенил-1,3,5-триазин-2,4-диамин;бензогуанамин | 202-095-6 | 91-76-9 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
613-039-00-9 | ethylene thiourea; imidazolidine-2-thione; 2-imidazoline-2-thiol | 202-506-9 | 96-45-7 | Repr. 1B | Acute Tox. 4 * | H360D *** H302 | GHS08 | GHS07 | Dgr | H360D *** H302 |   |   |  613-039-00-9 | етилентиоуреа;имидазолидин-2-тион;2-имидазолин-2-тиол | 202-506-9 | 96-45-7 | Repr. 1B | Acute Tox. 4 * | H360D *** H302 | GHS08 | GHS07 | Dgr | H360D *** H302 |   |   |  
613-040-00-4 | azaconazole (ISO);1-{[2-(2,4-dichlorophenyl)-1,3- dioxolan-2-yl]methyl}-1H-1,2.4- triazole | 262-102-3 | 60207-31-0 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  613-040-00-4 | азаконазол (ISO);1-{[2-(2,4-дихлорофенил)-1,3-диоксолан-2-ил]метил}-1H-1,2,4-триазол | 262-102-3 | 60207-31-0 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
613-041-00-X | morpholine-4-carbonyl chloride | 239-213-0 | 15159-40-7 | Carc. 2 | Eye Irrit. 2 | Skin Irrit. 2 | H351 | H319 | H315 | GHS08 | Wng | H351 | H319 | H315 | EUH014 |   |  613-041-00-X | мoрфолин-4-карбонилхлорид | 239-213-0 | 15159-40-7 | Carc. 2 | Eye Irrit. 2 | Skin Irrit. 2 | H351 | H319 | H315 | GHS08 | Wng | H351 | H319 | H315 | EUH014 |   |  
613-043-00-0 | imazalil sulphate (ISO) powder; 1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imid azolium hydrogen sulphate; [1](±)-1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imid azolium hydrogen sulphate [2] | 261-351-5 [1] | 281-291-3 [2] | 58594-72-2 [1] | 83918-57-4 [2] | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  613-043-00-0 | имазалил сулфат (ISO), прахообразен;1-[2-(алилокси)eтил-2-(2,4-дихлорофенил)]-1H-имидазолиев хидрогенсулфат; [1](±)-1-[2-(алилокси)eтил-2-(2,4-дихлорофенил)]-1H-имидазолиев хидрогенсулфат [2] | 261-351-5 [1] | 281-291-3 [2] | 58594-72-2 [1] | 83918-57-4 [2] | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  
613-043-01-8 | imazalil sulphate (ISO), aqueous solution; 1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1] (±)-1-[2-(allyloxy)ethyl-2-(2,4- dichlorophenyl)]-1H-imid azolium hydrogen sulphate [2] | 261-351-5 [1] | 281-291-3 [2] | 58594-72-2 [1] | 83918-57-4 [2] | Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Wng | H302 | H314 | H317 | H410 |   | Skin Corr. 1B; H314: C ≥ 50 % Skin Irrit. 2; H315: 30 % ≤ C < 50 % | Eye Dam. 1; H318: 15 % ≤ C < 50 % | Eye Irrit. 2; H319: 5 % ≤ C < 15 % |  613-043-01-8 | имазалил сулфат (ISO), воден разтвор;1-[2-(алилокси)eтил-2-(2,4-дихлорофенил)]-1H-имидазолиев хидрогенсулфат; [1] (±)-1-[2-(алилокси)eтил-2-(2,4-дихлорофенил)]-1H-имидазолиев хидрогенсулфат [2] | 261-351-5 [1] | 281-291-3 [2] | 58594-72-2 [1] | 83918-57-4 [2] | Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Wng | H302 | H314 | H317 | H410 |   | Skin Corr. 1B; H314: C ≥ 50 % Skin Irrit. 2; H315: 30 % ≤ C < 50 % | Eye Dam. 1; H318: 15 % ≤ C < 50 % | Eye Irrit. 2; H319: 5 % ≤ C < 15 % |  
613-044-00-6 | captan (ISO);1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide | 205-087-0 | 133-06-2 | Carc. 2 | Acute Tox. 3 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | H351 | H331 | H318 | H317 | H400 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H351 | H331 | H318 | H317 | H400 |   | M=10 |  613-044-00-6 | каптан (ISO);N-(трихлорометилтио)-1,2,3,6-тетрахидрофталимид | 205-087-0 | 133-06-2 | Carc. 2 | Acute Tox. 3 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | H351 | H331 | H318 | H317 | H400 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H351 | H331 | H318 | H317 | H400 |   | M=10 |  
613-045-00-1 | folpet (ISO);N-(trichloromethylthio)phthalimide | 205-088-6 | 133-07-3 | Carc. 2 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | H351 | H332 | H319 | H317 | H400 | GHS08 | GHS07 | GHS09 | Wng | H351 | H332 | H319 | H317 | H400 |   | M=10 |  613-045-00-1 | фолпет (ISO);N-(трихлорометилтио)фталимид | 205-088-6 | 133-07-3 | Carc. 2 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | H351 | H332 | H319 | H317 | H400 | GHS08 | GHS07 | GHS09 | Wng | H351 | H332 | H319 | H317 | H400 |   | M=10 |  
613-046-00-7 | captafol (ISO);1,2,3,6-tetrahydro-N-(1,1,2,2- tetrachloroethylthio)phthalimide | 219-363-3 | 2425-06-1 | Carc. 1B Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H317 | H410 |   |   |  613-046-00-7 | каптафол (ISO);N-(1,1,2,2-тетрахлороетилтио)-1,2,3,6-тeтрахидрофталимид | 219-363-3 | 2425-06-1 | Carc. 1B Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H350 | H317 | H400 | H410 | GHS08 | GHS09 | Dgr | H350 | H317 | H410 |   |   |  
613-047-00-2 | 1-dimethylcarbamoyl-5-methyl pyrazol-3-yl dimethylcarbamate; dimetilan (ISO) | 211-420-0 | 644-64-4 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H312 | H410 |   |   |  613-047-00-2 | 1-диметилкарбамоил-5-метилпиразол-3-илов диметилкарбамат; диметилан (ISO) | 211-420-0 | 644-64-4 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H312 | H410 |   |   |  
613-048-00-8 | carbendazim (ISO);methyl benzimidazol-2-ylcarbamate | 234-232-0 | 10605-21-7 | Muta. 1B Repr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H340 | H360FD H400 | H410 | GHS08 | GHS09 | Dgr | H340 | H360FD H410 |   |   |  613-048-00-8 | карбендазим (ISO);мeтилов бензимидазол-2-илкарбамат | 234-232-0 | 10605-21-7 | Muta. 1B Repr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H340 | H360FD H400 | H410 | GHS08 | GHS09 | Dgr | H340 | H360FD H410 |   |   |  
613-049-00-3 | benomyl (ISO);methyl 1-(butylcarbamoyl)benzimidazol-2-ylcarbamate | 241-775-7 | 17804-35-2 | Muta. 1B Repr. 1B STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H340 | H360FD H335 | H315 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H340 | H360FD H335 | H315 | H317 | H410 |   | M = 10 |  613-049-00-3 | беномил (ISO);метилов 1-(бутилкарбамоил)бензимидазол-2-илкарбамат | 241-775-7 | 17804-35-2 | Muta. 1B Repr. 1B STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H340 | H360FD H335 | H315 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H340 | H360FD H335 | H315 | H317 | H410 |   | M = 10 |  
613-050-00-9 | carbadox (INN);methyl 3-(quinoxalin-2-ylmethylene)carbazate 1,4-dioxide; 2-(methoxycarbonylhydrazonomethyl) quinoxaline 1,4-dioxide | 229-879-0 | 6804-07-5 | Flam. Sol. 1 | Carc. 1B | Acute Tox. 4 * | H228 | H350 | H302 | GHS02 | GHS08 | GHS07 | Dgr | H228 | H350 | H302 |   |   | T613-050-00-9 | карбадокс (INN);мeтил 3-(хиноксалин-2-илметилен)карбазат 1,4-диоксид;2-(мeтоксикарбонилхидразонометил)хиноксалинов 1,4-диоксид | 229-879-0 | 6804-07-5 | Flam. Sol. 1 | Carc. 1B | Acute Tox. 4 * | H228 | H350 | H302 | GHS02 | GHS08 | GHS07 | Dgr | H228 | H350 | H302 |   |   | T
613-051-00-4 | molinate (ISO);S-ethyl 1-perhydroazepinecarbothioate; S-ethyl perhydroazepine-1-carbothioate | 218-661-0 | 2212-67-1 | Carc. 2 | Repr. 2 | Acute Tox. 4 * Acute Tox. 4 * | STOT RE 2 * Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H361f *** H332 | H302 | H373 ** H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H361f *** H332 | H302 | H373 ** H317 | H410 |   | M = 100 |  613-051-00-4 | мoлинат (ISO);S-етилов 1-перхидроазепинкарботиоат;S-етилов перхидроазепин-1-карботиоат | 218-661-0 | 2212-67-1 | Carc. 2 | Repr. 2 | Acute Tox. 4 * Acute Tox. 4 * | STOT RE 2 * Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H361f *** H332 | H302 | H373 ** H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H361f *** H332 | H302 | H373 ** H317 | H410 |   | M = 100 |  
613-052-00-X | trifenmorph (ISO);4-tritylmorpholine | 215-812-2 | 1420-06-0 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  613-052-00-X | трифенморф (ISO);4-тритилморфолин | 215-812-2 | 1420-06-0 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
613-053-00-5 | anilazine (ISO);2-chloro-N-(4,6-dichloro-1,3,5- triazin-2-yl)aniline | 202-910-5 | 101-05-3 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H315 | H410 |   |   |  613-053-00-5 | анилазин (ISO);N-(4,6-дихлоро-1,3,5-триазин-2-ил)-2-хлороaнилин | 202-910-5 | 101-05-3 | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H315 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H315 | H410 |   |   |  
613-054-00-0 | thiabendazol (ISO);2-(thiazole-4-yl)benzimidazole | 205-725-8 | 148-79-8 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  613-054-00-0 | тиабендазол (ISO);2-(тиазол-4-ил)бензимидазол | 205-725-8 | 148-79-8 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
613-056-00-1 | 1,2-dimethyl-3,5-diphenylpyra zolium methylsulphate; difenzoquat methyl sulfate | 256-152-5 | 43222-48-6 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS09 | Wng | H302 | H410 |   |   |  613-056-00-1 | 1,2-диметил-3,5-дифенилпиразолиев метилсулфат; дифензокват метилсулфат | 256-152-5 | 43222-48-6 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS09 | Wng | H302 | H410 |   |   |  
613-058-00-2 | permethrin (ISO);m-phenoxybenzyl 3-(2,2-dichorovinyl)-2,2-dimethylcyclopro panecarboxylate | 258-067-9 | 52645-53-1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H302 | H317 | H410 |   | M = 1 000 |  613-058-00-2 | перметрин (ISO);m-феноксибензилов 2,2-диметил-3-(2,2-дихлоровинил)циклопропанкарбоксилат | 258-067-9 | 52645-53-1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H302 | H317 | H410 |   | M = 1 000 |  
613-059-00-8 | profluralin (ISO);N-(cyclopropylmethyl)-α, α,α- trifluoro-2,6-dinitro-N-propyl-p-toluidine | 247-656-6 | 26399-36-0 | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H410 |   |   |  613-059-00-8 | профлуралин (ISO);2,6-динитро-N-пропил-α, α,α-трифлуоро-N-(циклопропилметил)-р-толуидин | 247-656-6 | 26399-36-0 | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H410 |   |   |  
613-060-00-3 | resmethrin (ISO);5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate | 233-940-7 | 10453-86-8 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   | M=1000 |  613-060-00-3 | ресметрин (ISO);5-бензил-3-фурилметилов (±)-цис-транс-хризантемат | 233-940-7 | 10453-86-8 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   | M=1000 |  
613-061-00-9 | 6-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate; ryania | 239-732-2 | 15662-33-6 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   |   |  613-061-00-9 | 6-(1α,5аβ,8aβ,9-пентахидрокси-7β-изопропил-2β,5β,8β -триметилперхидро-8bα,9-eпокси-5,8-eтаноциклопента[1,2-b]инденилов) пирол-2-карбоксилат;риания | 239-732-2 | 15662-33-6 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   |   |  
613-062-00-4 | sabadilla (ISO);veratrine | — | 8051-02-3 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H319 | H335 | H315 | GHS07 | Wng | H319 | H335 | H315 |   |   |  613-062-00-4 | сабадила (ISO);вератрин | — | 8051-02-3 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H319 | H335 | H315 | GHS07 | Wng | H319 | H335 | H315 |   |   |  
613-063-00-X | secbumeton (ISO);2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine | 247-554-1 | 26259-45-0 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H410 |   |   |  613-063-00-X | секбуметон (ISO);2-втор-бутиламино-4-eтиламино-6-метокси-1,3,5-триазин | 247-554-1 | 26259-45-0 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H410 |   |   |  
613-064-00-5 | 5-(3,6,9-trioxa-2-undecy loxy)benzo(d)-1,3-dioxolane; sesamex | — | 51-14-9 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  613-064-00-5 | 5-(3,6,9-триокса-2-ундецилокси)бензо[d]-1,3-диоксолан; сезамекс | — | 51-14-9 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
613-065-00-0 | simetryn (ISO);2,4-bis(ethylamino)-6- methylthio-1,3,5-triazine | 213-801-7 | 1014-70-6 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  613-065-00-0 | симетрин (ISO);2,4-бис(eтиламино)-6-метилтио-1,3,5-триазин | 213-801-7 | 1014-70-6 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
613-066-00-6 | terbumeton (ISO);2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine | 251-637-8 | 33693-04-8 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  613-066-00-6 | тeрбуметон (ISO);2-трет-бутиламино-4-eтиламино-6-метокси-1,3,5-триазин | 251-637-8 | 33693-04-8 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
613-067-00-1 | propazine (ISO);2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine | 205-359-9 | 139-40-2 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   |   |  613-067-00-1 | пропазин (ISO);4,6-бис(изопропиламино)-2-хлоро-1,3,5-триазин | 205-359-9 | 139-40-2 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   |   |  
613-068-00-7 | atrazine (ISO);2-chloro-4-ethylamine-6- isopropylamine-1,3,5-triazine | 217-617-8 | 1912-24-9 | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** H317 | H400 | H410 | GHS08 | GHS09 | Wng | H373 ** H317 | H410 |   |   |  613-068-00-7 | атразин (ISO);4-етиламин-6-изопропиламин-2-хлоро-1,3,5-триазин | 217-617-8 | 1912-24-9 | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** H317 | H400 | H410 | GHS08 | GHS09 | Wng | H373 ** H317 | H410 |   |   |  
613-069-00-2 | ε-caprolactam | 203-313-2 | 105-60-2 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H332 | H302 | H319 | H335 | H315 | GHS07 | Wng | H332 | H302 | H319 | H335 | H315 |   |   |  613-069-00-2 | ε-капролактам | 203-313-2 | 105-60-2 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | H332 | H302 | H319 | H335 | H315 | GHS07 | Wng | H332 | H302 | H319 | H335 | H315 |   |   |  
613-070-00-8 | propylenethiourea | — | 2122-19-2 | Repr. 2 | Acute Tox. 4 * | Aquatic Chronic 3 | H361d *** H302 | H412 | GHS08 | GHS07 | Wng | H361d *** H302 | H412 |   |   |  613-070-00-8 | пропилентиоуреа | — | 2122-19-2 | Repr. 2 | Acute Tox. 4 * | Aquatic Chronic 3 | H361d *** H302 | H412 | GHS08 | GHS07 | Wng | H361d *** H302 | H412 |   |   |  
613-071-00-3 | 2-fluoro-5-trifluoromethylpyridine | 400-290-2 | 69045-82-5 | Flam. Liq. 3 | Skin Sens. 1 | Aquatic Chronic 3 | H226 | H317 | H412 | GHS02 | GHS07 | Wng | H226 | H317 | H412 |   |   |  613-071-00-3 | 2-флуоро-5-трифлуорометилпиридин | 400-290-2 | 69045-82-5 | Flam. Liq. 3 | Skin Sens. 1 | Aquatic Chronic 3 | H226 | H317 | H412 | GHS02 | GHS07 | Wng | H226 | H317 | H412 |   |   |  
613-072-00-9 | N, N-bis(2-ethylhexyl)-((1,2,4- triazol-1-yl)methyl)amine | 401-280-0 | 91273-04-0 | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H314 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H317 | H411 |   |   |  613-072-00-9 | N, N-бис(2-eтилхексил)((1,2,4-триазол-1-ил)метил)амин | 401-280-0 | 91273-04-0 | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H314 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H317 | H411 |   |   |  
613-073-00-4 | N, N-dimethyl-2-(3-(4-chloro phenyl)-4,5-dihydropyrazol-1- ylphenylsulphonyl)ethylamine | 401-410-6 | 10357-99-0 | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 2 | H373 ** H317 | H411 | GHS08 | GHS09 | Wng | H373 ** H317 | H411 |   |   |  613-073-00-4 | N, N-диметил-2-(3-(4-хлорофенил)-4,5-дихидропиразол-1-илфенилсулфонил)eтиламин | 401-410-6 | 10357-99-0 | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 2 | H373 ** H317 | H411 | GHS08 | GHS09 | Wng | H373 ** H317 | H411 |   |   |  
613-074-00-X | 3-(3-methylpent-3-yl)isoxazol-5- ylamine | 401-460-9 | 82560-06-3 | Acute Tox. 3 * | Acute Tox. 3 * | Eye Dam. 1 | Aquatic Chronic 3 | H331 | H301 | H318 | H412 | GHS06 | GHS05 | Dgr | H331 | H301 | H318 | H412 |   |   |  613-074-00-X | 3-(3-мeтилпент-3-ил)изоксазол-5-иламин | 401-460-9 | 82560-06-3 | Acute Tox. 3 * | Acute Tox. 3 * | Eye Dam. 1 | Aquatic Chronic 3 | H331 | H301 | H318 | H412 | GHS06 | GHS05 | Dgr | H331 | H301 | H318 | H412 |   |   |  
613-075-00-5 | 1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione | 401-570-7 | 89415-87-2 | Ox. Sol. 1 **** | Acute Tox. 3 * | Skin Corr. 1B | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | H271 | H331 | H314 | H302 | H317 | H400 | GHS03 | GHS06 | GHS05 | GHS09 | Dgr | H271 | H331 | H314 | H302 | H317 | H400 |   |   |  613-075-00-5 | 5-eтил-5-метил-1,3-дихлороимидазолидин-2,4-дион | 401-570-7 | 89415-87-2 | Ox. Sol. 1 **** | Acute Tox. 3 * | Skin Corr. 1B | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | H271 | H331 | H314 | H302 | H317 | H400 | GHS03 | GHS06 | GHS05 | GHS09 | Dgr | H271 | H331 | H314 | H302 | H317 | H400 |   |   |  
613-076-00-0 | 3-chloro-5-trifluoromethyl-2- pyridylamine | 401-670-0 | 79456-26-1 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  613-076-00-0 | 5-трифлуорометил-3-хлоро-2-пиридиламин | 401-670-0 | 79456-26-1 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
613-077-00-6 | reaction mass of 5-heptyl-1,2,4- triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine | 401-940-8 | — | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Chronic 2 | H302 | H319 | H411 | GHS07 | GHS09 | Wng | H302 | H319 | H411 |   |   |  613-077-00-6 | реакционна маса от 5-хептил-1,2,4-триазол-3-иламин и 5-нонил-1,2,4-триазол-3-иламин | 401-940-8 | — | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Chronic 2 | H302 | H319 | H411 | GHS07 | GHS09 | Wng | H302 | H319 | H411 |   |   |  
613-078-00-1 | N,N,N,N-tetrakis(4,6-bis(butyl- (N-methyl-2,2,6,6-tetramethyl piperidin-4-yl)amino)triazin-2- yl)-4,7-diazadecane-1,10- diamine | 401-990-0 | 106990-43-6 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  613-078-00-1 | N,N,N,N-тeтракис(4,6-бис(бутил(N-метил-2,2,6,6-тетраметилпиперидин-4-ил)aмино)триазин-2-ил)-4,7-диазадекан-1,10-диамин | 401-990-0 | 106990-43-6 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
613-079-00-7 | 4-(1(or 4 or 5 or 6)-methyl-8,9,10-trinorborn-5-en-2- yl)pyridine, reaction mass of isomers | 402-520-7 | — | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H315 | H317 | H410 |   |   |  613-079-00-7 | 4-(1(или 4 или 5 или 6)-мeтил-8,9,10-тринорборн-5-eн-2-ил)пиридин, реакционна маса от изомери | 402-520-7 | — | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H315 | H317 | H410 |   |   |  
613-080-00-2 | 3-(bis(2-ethylhexyl)amino methyl)benzothiazole-2(3H)- thione | 402-540-6 | 105254-85-1 | Skin Corr. 1B Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H317 | H410 |   |   |  613-080-00-2 | 3-(бис(2-eтилхексил)aминометил)бензотиазол-2(3H)-тион | 402-540-6 | 105254-85-1 | Skin Corr. 1B Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H317 | H410 |   |   |  
613-081-00-8 | 1-butyl-2-methylpyridinium bromide | 402-680-8 | 26576-84-1 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  613-081-00-8 | 1-бутил-2-метилпиридиниев бромид | 402-680-8 | 26576-84-1 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
613-082-00-3 | 2-methyl-1-pentylpyridinium bromide | 402-690-2 | — | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 3 | H312 | H302 | H412 | GHS07 | Wng | H312 | H302 | H412 |   |   |  613-082-00-3 | 2-метил-1-пентилпиридиниев бромид | 402-690-2 | — | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 3 | H312 | H302 | H412 | GHS07 | Wng | H312 | H302 | H412 |   |   |  
613-083-00-9 | 2-(4-(3-(4-chlorophenyl)-2-pyra zolin-1-yl)phenylsulfonyl)ethyldimethylammonium formate | 402-120-2 | — | Skin Corr. 1B STOT RE 2 * Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H373 ** H317 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H373 ** H317 | H410 |   |   |  613-083-00-9 | 2-(4-(3-(4-хлорофенил)-2-пиразолин-1-ил)фенилсулфонил)eтилдиметилaмониев формат | 402-120-2 | — | Skin Corr. 1B STOT RE 2 * Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H373 ** H317 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H373 ** H317 | H410 |   |   |  
613-084-00-4 | 2-(4-(3-(4-chlorophenyl)-4,5- dihydropyrazolyl)phenylsulphonyl) ethyldimethylammonium hydrogen phosphonate | 402-490-5 | 106359-93-7 | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H410 |   |   |  613-084-00-4 | 2-(4-(3-(4-хлорофенил)-4,5-дихидропиразолил)фенилсулфонил)eтилдиметилaмониев хидрогенфосфонат | 402-490-5 | 106359-93-7 | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H410 |   |   |  
613-085-00-X | reaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5- oxo-2H-2-furylide namino)benzyl)phenyl)pyrrole-2,5-dione | 401-970-1 | — | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  613-085-00-X | реакционна маса от 1,1′-(мeтиленбис(4,1-фенилен))дипирол-2,5-дион и N-(4-(4-(2,5-диоксопирол-1-ил)бензил)фенил)ацетамид и 1-(4-(4-(5-оксо-2H-2-фурилиденамино)бензил)фенил)пирол-2,5-дион | 401-970-1 | — | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
613-086-00-5 | caffeine | 200-362-1 | 58-08-2 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  613-086-00-5 | кофеин | 200-362-1 | 58-08-2 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
613-087-00-0 | tetrahydrothiophene | 203-728-9 | 110-01-0 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 3 | H225 | H332 | H312 | H302 | H319 | H315 | H412 | GHS02 | GHS07 | Dgr | H225 | H332 | H312 | H302 | H319 | H315 | H412 |   |   |  613-087-00-0 | тeтрахидротиофен | 203-728-9 | 110-01-0 | Flam. Liq. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 3 | H225 | H332 | H312 | H302 | H319 | H315 | H412 | GHS02 | GHS07 | Dgr | H225 | H332 | H312 | H302 | H319 | H315 | H412 |   |   |  
613-088-00-6 | 1,2-benzisothiazol-3(2H)-one;1,2-benzisothiazolin-3-one | 220-120-9 | 2634-33-5 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | H302 | H315 | H318 | H317 | H400 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H315 | H318 | H317 | H400 |   | Skin Sens. 1; H317: C≥0,05  % |  613-088-00-6 | 1,2-бензизотиазол-3(2H)-oн;1,2-бензизотиазолин-3-oн | 220-120-9 | 2634-33-5 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | H302 | H315 | H318 | H317 | H400 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H315 | H318 | H317 | H400 |   | Skin Sens. 1; H317: C≥0,05  % |  
613-089-00-1 | diquat dibromide; [1]diquat dichloride; [2]6,7-dihydrodipyrido[1,2-α:2',1'- c]pyrazinediylium dihydroxide [3] | 201-579-4 [1] | 223-714-6 [2] | 301-467-6 [3] | 85-00-7 [1] | 4032-26-2 [2] | 94021-76-8 [3] | Acute Tox. 2 * STOT RE 1 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H372 ** H302 | H319 | H335 | H315 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H372 ** H302 | H319 | H335 | H315 | H317 | H410 |   |   |  613-089-00-1 | дикват дибромид; [1]дикват дихлорид; [2]6,7-дихидродипиридо[1,2-α:2′,1′-c]пиразиндиилиев дихидроксид [3] | 201-579-4 [1] | 223-714-6 [2] | 301-467-6 [3] | 85-00-7 [1] | 4032-26-2 [2] | 94021-76-8 [3] | Acute Tox. 2 * STOT RE 1 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H372 ** H302 | H319 | H335 | H315 | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H372 ** H302 | H319 | H335 | H315 | H317 | H410 |   |   |  
613-090-00-7 | paraquat dichloride;1,1-dimethyl-4,4'-bipyridinium dichloride; [1]paraquat dimethylsulfate;1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate [2] | 217-615-7 [1] | 218-196-3 [2] | 1910-42-5 [1] | 2074-50-2 [2] | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H311 | H301 | H372 ** H319 | H335 | H315 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H311 | H301 | H372 ** H319 | H335 | H315 | H410 |   |   |  613-090-00-7 | паракват дихлорид;1,1-диметил-4,4′-бипиридиниев дихлорид; [1]паракват диметилсулфат;1,1-диметил-4,4′-бипиридиниев диметилсулфат [2] | 217-615-7 [1] | 218-196-3 [2] | 1910-42-5 [1] | 2074-50-2 [2] | Acute Tox. 2 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H311 | H301 | H372 ** H319 | H335 | H315 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H311 | H301 | H372 ** H319 | H335 | H315 | H410 |   |   |  
613-091-00-2 | morfamquat dichloride; [1]morfamquat sulfate [2] | 225-062-8 [1] [2] | 4636-83-3 [1] | 29873-36-7 [2] | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Chronic 3 | H302 | H319 | H335 | H315 | H412 | GHS07 | Wng | H302 | H319 | H335 | H315 | H412 |   |   |  613-091-00-2 | мoрфамкват дихлорид; [1]мoрфамкват сулфат [2] | 225-062-8 [1] [2] | 4636-83-3 [1] | 29873-36-7 [2] | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Chronic 3 | H302 | H319 | H335 | H315 | H412 | GHS07 | Wng | H302 | H319 | H335 | H315 | H412 |   |   |  
613-092-00-8 | 1,10-phenanthroline | 200-629-2 | 66-71-7 | Acute Tox. 3 * Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H410 |   |   |  613-092-00-8 | 1,10-фенантролин | 200-629-2 | 66-71-7 | Acute Tox. 3 * Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H410 |   |   |  
613-093-00-3 | hexasodium 6,13-dichloro-3,10- bis((4-(2,5-disulfonatoanilino)-6- fluoro-1,3,5-triazin-2- ylamino)prop-3-ylamino)-5,12- dioxa-7,14-diazapentacene-4,11- disulfonate | 400-050-7 | 85153-92-0 | Resp. Sens. 1 | Skin Sens. 1 | H334 | H317 | GHS08 | Dgr | H334 | H317 |   |   |  613-093-00-3 | хексанатриев 3,10-бис((4-(2,5-дисулфонатоанилино)-6-флуоро-1,3,5-триазин-2-иламино)проп-3-иламино)-6,13-дихлоро-5,12-диокса-7,14-диазапентацен-4,11-дисулфонат | 400-050-7 | 85153-92-0 | Resp. Sens. 1 | Skin Sens. 1 | H334 | H317 | GHS08 | Dgr | H334 | H317 |   |   |  
613-094-00-9 | 4-methoxy-N,6-dimethyl-1,3,5- triazin-2-ylamine | 401-360-5 | 5248-39-5 | Acute Tox. 4 * STOT RE 2 * | H302 | H373 ** | GHS08 | GHS07 | Wng | H302 | H373 ** |   |   |  613-094-00-9 | N,6-диметил-4-мeтокси-1,3,5-триазин-2-иламин | 401-360-5 | 5248-39-5 | Acute Tox. 4 * STOT RE 2 * | H302 | H373 ** | GHS08 | GHS07 | Wng | H302 | H373 ** |   |   |  
613-095-00-4 | sodium 3-(2H-benzotriazol-2- yl)-5-sec-butyl-4-hydroxyben zenesulfonate | 403-080-9 | 92484-48-5 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  613-095-00-4 | натриев 3-(2H-бензотриазол-2-ил)-5-втор-бутил-4-хидроксибензенсулфонат | 403-080-9 | 92484-48-5 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
613-096-00-X | 2-amino-6-ethoxy-4-methylamino-1,3,5-triazine | 403-580-7 | 62096-63-3 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  613-096-00-X | 2-амино-6-eтокси-4-метиламино-1,3,5-триазин | 403-580-7 | 62096-63-3 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
613-097-00-5 | 7-amino-3-((5-carboxymethyl-4- methyl-1,3-thiazol-2- ylthio)methyl)-8-oxo-5-thia-1- azabicyclo(4.2.0)oct-2-ene-2- carboxylic acid | 403-690-5 | 111298-82-9 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H334 | H317 | H412 | GHS08 | Dgr | H334 | H317 | H412 |   |   |  613-097-00-5 | 7-амино-3-((5-карбоксиметил-4-метил-1,3-тиазол-2-илтио)метил)-8-oксо-5-тиа-1-азабицикло[4.2.0]окт-2-eн-2-карбоксилна киселина | 403-690-5 | 111298-82-9 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H334 | H317 | H412 | GHS08 | Dgr | H334 | H317 | H412 |   |   |  
613-098-00-0 | N-(n-octyl)-2-pyrrolidone | 403-700-8 | 2687-94-7 | Skin Corr. 1B Aquatic Chronic 2 | H314 | H411 | GHS05 | GHS09 | Dgr | H314 | H411 |   |   |  613-098-00-0 | N-(n-октил)-2-пиролидoн | 403-700-8 | 2687-94-7 | Skin Corr. 1B Aquatic Chronic 2 | H314 | H411 | GHS05 | GHS09 | Dgr | H314 | H411 |   |   |  
613-099-00-6 | 1-dodecyl-2-pyrrolidone | 403-730-1 | 2687-96-9 | Skin Corr. 1B Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H317 | H410 |   |   |  613-099-00-6 | 1-додецил-2-пиролидон | 403-730-1 | 2687-96-9 | Skin Corr. 1B Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H317 | H410 |   |   |  
613-100-00-X | 2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridine-7,14-dione | 404-230-6 | — | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  613-100-00-X | 2,9-бис(3-(диетиламино)пропилсулфамоил)хино[2,3-b]акридин-7,14-дион | 404-230-6 | — | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
613-101-00-5 | N—tert-pentyl-2-benzothiazolesulfenamide | 404-380-2 | 110799-28-5 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  613-101-00-5 | N-трет-пентил-2-бензотиазолсулфенамид | 404-380-2 | 110799-28-5 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
613-102-00-0 | dimethomorph (ISO);4-(3-(4-chlorophenyl)-3-(3,4- dimethoxyphenyl)acryloyl)morpholine | 404-200-2 | 110488-70-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  613-102-00-0 | диметоморф (ISO);4-(3-(3,4-диметоксифенил)-3-(4-хлорофенил)aкрилоил)морфолин | 404-200-2 | 110488-70-5 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
613-103-00-6 | sodium 5-n-butylbenzotriazole | 404-450-2 | 118685-34-0 | Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 | Aquatic Chronic 2 | H302 | H314 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H317 | H411 |   |   |  613-103-00-6 | натриев 5-n-бутилбензотриазол | 404-450-2 | 118685-34-0 | Acute Tox. 4 * Skin Corr. 1B Skin Sens. 1 | Aquatic Chronic 2 | H302 | H314 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H317 | H411 |   |   |  
613-104-00-1 | 5-tert-butyl-3-isoxazolylamine hydrochloride | 404-840-2 | — | Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 | Aquatic Chronic 3 | H302 | H373 ** H318 | H412 | GHS08 | GHS05 | GHS07 | Dgr | H302 | H373 ** H318 | H412 |   |   |  613-104-00-1 | 5-трет-бутил-3-изоксазолиламинхидрохлорид | 404-840-2 | — | Acute Tox. 4 * STOT RE 2 * Eye Dam. 1 | Aquatic Chronic 3 | H302 | H373 ** H318 | H412 | GHS08 | GHS05 | GHS07 | Dgr | H302 | H373 ** H318 | H412 |   |   |  
613-105-00-7 | hexakis(tetramethylammonium) 4,4'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6- morpholino-1,3,5-triazine-4,2- diyl)imino)bis(5-hydroxy-6-phenylazonaphthalene-2,7- disulfonate) | 405-160-9 | 124537-30-0 | Acute Tox. 3 * Skin Sens. 1 | Aquatic Chronic 3 | H301 | H317 | H412 | GHS06 | Dgr | H301 | H317 | H412 |   |   |  613-105-00-7 | хексакис(тетраметиламониев) 4,4′-виниленбис((3-сулфонато-4,1-фенилен)имино(6-морфолино-1,3,5-триазин-4,2-диил)имино)бис(5-хидрокси-6-фенилазонафтален-2,7-дисулфонат) | 405-160-9 | 124537-30-0 | Acute Tox. 3 * Skin Sens. 1 | Aquatic Chronic 3 | H301 | H317 | H412 | GHS06 | Dgr | H301 | H317 | H412 |   |   |  
613-106-00-2 | tetrapotassium 2-(4-(5-(1-(2,5- disulfonatophenyl)-3-ethoxycar bonyl-5-hydroxypyrazol-4- yl)penta-2,4-dienylidene)-3- ethoxycarbonyl-5-oxo-2-pyra zolin-1-yl)benzene-1,4- disulfonate | 405-240-3 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  613-106-00-2 | тeтракалиев 2-(4-(5-(1-(2,5-дисулфонатофенил)-3-eтоксикарбонил-5-хидроксипиразол-4-ил)пента-2,4-диенилиден)-3-eтоксикарбонил-5-oксо-2-пиразолин-1-ил)бензен-1,4-дисулфонат | 405-240-3 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
613-107-00-8 | hexasodium 2,2'-vinylenebis((3- sulfonato-4,1-pheny lene)imino(6-(N-cyanoethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2-diyl)imino)dibenzene-1,4-disulfonate | 405-280-1 | 76508-02-6 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  613-107-00-8 | хексантриев 2,2′-виниленбис((3-сулфонато-4,1-фенилен)имино(6-(N-(2-хидроксипропил)-N-цианоетилaмино)-1,3,5-триазин-4,2-диил)имино)дибензен-1,4-дисулфонат | 405-280-1 | 76508-02-6 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
613-108-00-3 | benzothiazole-2-thiol | 205-736-8 | 149-30-4 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  613-108-00-3 | бензотиазол-2-тиол | 205-736-8 | 149-30-4 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
613-109-00-9 | bis(piperidinothiocarbonyl) disulphide | 202-328-1 | 94-37-1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H335 | H315 | H317 | GHS07 | Wng | H319 | H335 | H315 | H317 |   |   |  613-109-00-9 | бис(пиперидинотиокарбонил)дисулфид | 202-328-1 | 94-37-1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | H319 | H335 | H315 | H317 | GHS07 | Wng | H319 | H335 | H315 | H317 |   |   |  
613-110-00-4 | dimepiperate (ISO);S-(1-methyl-1-phenylethyl) piperidine-1-carbothioate | 262-784-2 | 61432-55-1 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  613-110-00-4 | димепиперат (ISO);S-(1-мeтил-1-фенилетилов) пиперидин-1-карботиоат | 262-784-2 | 61432-55-1 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
613-111-00-X | 1,2,4-triazole | 206-022-9 | 288-88-0 | Repr. 2 | Acute Tox. 4 * | Eye Irrit. 2 | H361d *** H302 | H319 | GHS08 | GHS07 | Wng | H361d *** H302 | H319 |   |   |  613-111-00-X | 1,2,4-триазол | 206-022-9 | 288-88-0 | Repr. 2 | Acute Tox. 4 * | Eye Irrit. 2 | H361d *** H302 | H319 | GHS08 | GHS07 | Wng | H361d *** H302 | H319 |   |   |  
613-112-00-5 | octhilinone (ISO);2-octyl-2H-isothiazol-3-one | 247-761-7 | 26530-20-1 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H302 | H314 | H317 | H400 | H410 | GHS06 | GHS05 | GHS09 | Dgr | H331 | H311 | H302 | H314 | H317 | H410 |   | Skin Sens. 1; H317: C≥0,05  % |  613-112-00-5 | октилинон (ISO);2-октил-2H-изотиазол-3-он | 247-761-7 | 26530-20-1 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H302 | H314 | H317 | H400 | H410 | GHS06 | GHS05 | GHS09 | Dgr | H331 | H311 | H302 | H314 | H317 | H410 |   | Skin Sens. 1; H317: C≥0,05  % |  
613-113-00-0 | 2-(morpholinothio)benzothiazole | 203-052-4 | 102-77-2 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H319 | H315 | H317 | H411 | GHS07 | GHS09 | Wng | H319 | H315 | H317 | H411 |   |   |  613-113-00-0 | 2-(мoрфолинотио)бензотиазол | 203-052-4 | 102-77-2 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H319 | H315 | H317 | H411 | GHS07 | GHS09 | Wng | H319 | H315 | H317 | H411 |   |   |  
613-114-00-6 | 2,2',2''-(hexahydro-1,3,5- triazine-1,3,5-triyl)triethanol;1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine | 225-208-0 | 4719-04-4 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   | Skin Sens. 1; H317: C ≥ | 0,1  % |  613-114-00-6 | 2,2′,2′′-(хексахидро-1,3,5-триазин-1,3,5-триил)триетанол;1,3,5-трис(2-хидроксиетил)хексахидро-1,3,5-триазин | 225-208-0 | 4719-04-4 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   | Skin Sens. 1; H317: C ≥ | 0,1  % |  
613-115-00-1 | hymexazol (ISO);3-hydroxy-5-methylisoxazole | 233-000-6 | 10004-44-1 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  613-115-00-1 | химексазол (ISO);3-хидрокси-5-метилизоксазол | 233-000-6 | 10004-44-1 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  
613-116-00-7 | tolylfluanid (ISO);dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;[containing ≥0.1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | 211-986-9 | 731-27-1 | Acute Tox. 2 * STOT RE 1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | H330 | H372** H319 | H335 | H315 | H317 | H400 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H372** H319 | H335 | H315 | H317 | H400 |   | M=10 |  613-116-00-7 | толилфлуанид (ISO);N-[(диметиламино)сулфонил]-N-(p-толил)флуородихлорометансулфенамид;[съдържащ ≥ 0,1 % (w/w) частици с аеродинамичен диаметър по-малък от 50 μm] | 211-986-9 | 731-27-1 | Acute Tox. 2 * STOT RE 1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | H330 | H372** H319 | H335 | H315 | H317 | H400 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H372** H319 | H335 | H315 | H317 | H400 |   | M=10 |  
613-116-01-4 | tolylfluanid (ISO);dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | 211-986-9 | 731-27-1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | H319 | H335 | H315 | H317 | H400 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H317 | H400 |   | M=10 |  613-116-01-4 | толилфлуанид (ISO);N-[(диметиламино)сулфонил]-N-(p-толил)флуородихлорометансулфенамид;[съдържащ < 0,1 % (w/w) частици с аеродинамичен диаметър по-малък от 50 μm] | 211-986-9 | 731-27-1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | H319 | H335 | H315 | H317 | H400 | GHS07 | GHS09 | Wng | H319 | H335 | H315 | H317 | H400 |   | M=10 |  
613-117-00-2 | diniconazole (ISO);(E)-β-[(2,4-dichlorophenyl)methylene]-α-(1,1-dimethylethyl)-1H—1,2,4-triazol-1- ethanol;(E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H—1,2,4- triazol-1-yl)pent-1-en-3-ol | — | 76714-88-0 | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  613-117-00-2 | диниконазол (ISO);(E)-α-(1,1-диметилетил)-β-[(2,4-дихлорофенил)метилен]-1H-1,2,4-триазол-1-eтанол;(E)-(RS)-4,4-диметил-1-(2,4-дихлорофенил)-2-(1H-1,2,4-триазол-1-ил)пент-1-eн-3-oл | — | 76714-88-0 | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
613-118-00-8 | flubenzimine (ISO);N-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2- ylidene]aniline | 253-703-1 | 37893-02-0 | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H410 |   |   |  613-118-00-8 | флубензимин (ISO);N-[4,5-бис[(трифлуорметил)имино]3-фенилтиазолидин-2-илиден]aнилин | 253-703-1 | 37893-02-0 | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H319 | H400 | H410 | GHS07 | GHS09 | Wng | H319 | H410 |   |   |  
613-119-00-3 | (benzothiazol-2-ylthio)methyl thiocyanate; TCMTB | 244-445-0 | 21564-17-0 | Acute Tox. 2 * Acute Tox. 4 * Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H302 | H319 | H315 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H302 | H319 | H315 | H317 | H410 |   |   |  613-119-00-3 | (бензотиазол-2-илтио)метилов тиоцианат;TCMTB | 244-445-0 | 21564-17-0 | Acute Tox. 2 * Acute Tox. 4 * Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H302 | H319 | H315 | H317 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H302 | H319 | H315 | H317 | H410 |   |   |  
613-120-00-9 | bioresmethrin (ISO);(5-benzyl-3-furyl)methyl (1R)-2,2-dimethyl-3-(2-methylprop-1- en-1-yl)cyclopropanecarboxylate | 249-014-0 | 28434-01-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M = 1000 |  613-120-00-9 | биоресметрин (ISO);(5-бензил-3-фурил)метилов (1R)-2,2-диметил-3-(2-метилпроп-1-ен-1-ил)циклопропанкарбоксилат | 249-014-0 | 28434-01-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M = 1000 |  
613-122-00-X | diclobutrazole (ISO);(R*, R*)-(±)-β-[(2,4-dichlorop henyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol; (2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2- (1H—1,2,4-triazol-1yl)pentan-3-ol | — | 75736-33-3 | Eye Irrit. 2 | Aquatic Chronic 2 | H319 | H411 | GHS07 | GHS09 | Wng | H319 | H411 |   |   |  613-122-00-X | диклобутразол (ISO);(R*,R*)-(±)-β-[(2,4-дихлорофенил)метил]-α-(1,1-диметилетил)-1H-1,2,4-триазол-1-етанол; (2RS,3RS)-4,4-диметил-1-(2,4-дихлорофенил)-2-(1H-1,2,4-триазол-1ил)пентан-3-ол | — | 75736-33-3 | Eye Irrit. 2 | Aquatic Chronic 2 | H319 | H411 | GHS07 | GHS09 | Wng | H319 | H411 |   |   |  
613-123-00-5 | 5,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole-3-thione; etem | 251-684-4 | 33813-20-6 | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  613-123-00-5 | 5,6-дихидро-3H-имидазо[2,1-c]-1,2,4-дитиазол-3-тион;етем | 251-684-4 | 33813-20-6 | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
613-124-00-0 | fenpropimorph (ISO);cis-4-[3-(p-tert-butylphenyl)-2- methylpropyl]-2,6-dimethylmorpholine | 266-719-9 | 67564-91-4 | Repr. 2 | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Chronic 2 | H361d *** H302 | H315 | H411 | GHS08 | GHS07 | GHS09 | Wng | H361d *** H302 | H315 | H411 |   |   |  613-124-00-0 | фенпропиморф (ISO);цис-4-[3-(p-трет-бутилфенил)-2-метилпропил]-2,6-диметилморфолин | 266-719-9 | 67564-91-4 | Repr. 2 | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Chronic 2 | H361d *** H302 | H315 | H411 | GHS08 | GHS07 | GHS09 | Wng | H361d *** H302 | H315 | H411 |   |   |  
613-125-00-6 | hexythiazox(ISO);trans-5-(4-chlorophenyl)-N- cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide | — | 78587-05-0 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  613-125-00-6 | хекситиазокс (ISO);транс-4-метил-5-(4-хлорофенил)-N-циклохексил-2-оксо-3-тиазолидинкарбоксамид | — | 78587-05-0 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
613-126-00-1 | imazapyr (ISO);2-[4,5-dihydro-4-methyl-4-(1- methylethyl)-5-oxo-1H- imidazol-2-yl]-3-pyridine carboxylate | — | 81334-34-1 | Eye Irrit. 2 | Aquatic Chronic 3 | H319 | H412 | GHS07 | Wng | H319 | H412 |   |   |  613-126-00-1 | имазапир (ISO);2-[4,5-дихидро-4-метил-4-(1-метилетил)-5-оксо-1H-имидазол-2-ил]-3-пиридинкарбоксилат | — | 81334-34-1 | Eye Irrit. 2 | Aquatic Chronic 3 | H319 | H412 | GHS07 | Wng | H319 | H412 |   |   |  
613-127-00-7 | 1,1-dimethylpiperidinium chloride; mepiquat chloride | 246-147-6 | 24307-26-4 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  613-127-00-7 | 1,1-диметилпиперидиниев хлорид;мепикват хлорид | 246-147-6 | 24307-26-4 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
613-128-00-2 | prochloraz (ISO);N-propyl-N-[2-(2,4,6-trichlorop henoxy)ethyl]-1H-imidazole-1- carboxamide | 266-994-5 | 67747-09-5 | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  613-128-00-2 | прохлораз (ISO);N-пропил-N-[2-(2,4,6-трихлорофенокси)eтил]-1H-имидазол-1-карбоксамид; | 266-994-5 | 67747-09-5 | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
613-129-00-8 | metamitron (ISO);4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one | 255-349-3 | 41394-05-2 | Acute Tox. 4 * | Aquatic Acute 1 | H302 | H400 | GHS07 | GHS09 | Wng | H302 | H400 |   |   |  613-129-00-8 | метамитрон (ISO);4-амино-3-метил-6-фенил-1,2,4-триазин-5-oн | 255-349-3 | 41394-05-2 | Acute Tox. 4 * | Aquatic Acute 1 | H302 | H400 | GHS07 | GHS09 | Wng | H302 | H400 |   |   |  
613-131-00-9 | pyroquilon (ISO);1,2,5,6-tetrahydropyrrolo[3,2,1- ij]quinolin-4-one | — | 57369-32-1 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  613-131-00-9 | пирохилон (ISO);1,2,5,6-тетрахидропироло[3,2,1-ij]хинолин-4-он | — | 57369-32-1 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
613-132-00-4 | hexazinone (ISO);3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione | 257-074-4 | 51235-04-2 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H410 |   |   |  613-132-00-4 | хексазинон (ISO);6-диметиламино-1-метил-3-циклохексил-1,2,3,4-тетрахидро-1,3,5-триазин-2,4-дион | 257-074-4 | 51235-04-2 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H410 |   |   |  
613-134-00-5 | myclobutanil(ISO);2-(4-chlorophenyl)-2-(1H-1,2,4- triazol-1-ylmethyl)hexanenitrile | — | 88671-89-0 | Repr. 2 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Chronic 2 | H361d *** H302 | H319 | H411 | GHS08 | GHS07 | GHS09 | Wng | H361d *** H302 | H319 | H411 |   |   |  613-134-00-5 | миклобутанил (ISO);2-(4-хлорофенил)-2-(1Н-1,2,4-триазол-1-илметил)хексаннитрил | — | 88671-89-0 | Repr. 2 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Chronic 2 | H361d *** H302 | H319 | H411 | GHS08 | GHS07 | GHS09 | Wng | H361d *** H302 | H319 | H411 |   |   |  
613-135-00-0 | di(benzothiazol-2-yl) disulphide | 204-424-9 | 120-78-5 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 | EUH031 |   |  613-135-00-0 | ди(бензотиазол-2-ил)дисулфид | 204-424-9 | 120-78-5 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 | EUH031 |   |  
613-136-00-6 | N-cyclohexylbenzothiazole-2- sulphenamide | 202-411-2 | 95-33-0 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  613-136-00-6 | N-циклохексилбензотиазол-2-сулфенамид | 202-411-2 | 95-33-0 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
613-137-00-1 | methabenzthiazuron (ISO);1-(1,3-benzothiazol-2-yl)1,3- dimethylurea | 242-505-0 | 18691-97-9 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  613-137-00-1 | мeтабензтиазурон (ISO);1-(1,3-бензотиазол-2-ил)-1,3-диметилуреа | 242-505-0 | 18691-97-9 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
613-138-00-7 | quinoxyfen (ISO);5,7-dichloro-4-(4-fluorophenoxy)quinoline | — | 124495-18-7 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  613-138-00-7 | хиноксифен (ISO);4-(4-флуорофенокси)-5,7-дихлорохинолин | — | 124495-18-7 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
613-139-00-2 | metsulfuron-methyl (ISO); methyl-2-{[(4-methoxy-6- methyl-1,3,5-triazin-2-yl)carbamoyl]sulfamoyl}benzoate | — | 74223-64-6 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M = 1000 |  613-139-00-2 | метсулфурон-метил (ISO); метилов 2-{[(6-метил-4-метокси-1,3,5-триазин-2-ил)карбамоил]сулфамоил}бензоат | — | 74223-64-6 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M = 1000 |  
613-140-00-8 | cycloheximide (ISO);4-{(2R)-2-[(1S,3S,5S)-3,5- dimethyl-2-oxocyclohexyl]-2- hydroxyethyl}piperidine-2,6- dione | 200-636-0 | 66-81-9 | Muta. 2 | Repr. 1B | Acute Tox. 2 * | Aquatic Chronic 2 | H341 | H360D *** H300 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H341 | H360D *** H300 | H411 |   |   |  613-140-00-8 | циклохексимид (ISO);4-{(2R)-2-[(1S,3S,5S)-3,5-диметил-2-оксоциклохексил]-2-хидроксиетил}пиперидин-2,6-дион | 200-636-0 | 66-81-9 | Muta. 2 | Repr. 1B | Acute Tox. 2 * | Aquatic Chronic 2 | H341 | H360D *** H300 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H341 | H360D *** H300 | H411 |   |   |  
613-141-00-3 | 1,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinone | 401-470-3 | 93686-63-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  613-141-00-3 | 1,4-диамино-2-(2-бутилтетразол-5-ил)-3-цианоантрахинон | 401-470-3 | 93686-63-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
613-142-00-9 | trans—N-methyl-2-styryl-[4'- aminomethine-(1-acetyl-1-(2- methoxyphenyl)acetamido)]py ridinium acetate | 405-860-4 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  613-142-00-9 | транс-N-мeтил-2-стирил-[4′-aминометин(1-aцетил-1-(2-метоксифенил)aцетамидо)]пиридиниев ацетат | 405-860-4 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
613-143-00-4 | 1-(3-phenylpropyl)-2-methylpyridinium bromide | 405-930-4 | 10551-42-5 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Chronic 3 | H302 | H319 | H412 | GHS07 | Wng | H302 | H319 | H412 |   |   |  613-143-00-4 | 2-метил-1-(3-фенилпропил)пиридиниев бромид | 405-930-4 | 10551-42-5 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Chronic 3 | H302 | H319 | H412 | GHS07 | Wng | H302 | H319 | H412 |   |   |  
613-144-00-X | reaction products of: poly(vinyl acetate), partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4- dimethylthiazoliummethylsulfate | 406-460-2 | 125139-08-4 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  613-144-00-X | реакционни продукти от: поли(винилацетат), частично хидролизиран, с (E)-2-(4-формилстирил)-3,4-диметилтиазолиев метилсулфат | 406-460-2 | 125139-08-4 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
613-145-00-5 | (S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium 4-methylbenzenesulfonate | 406-960-0 | 77497-97-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  613-145-00-5 | (S)-3-бензилоксикарбонил-1,2,3,4-тетрахидроизохинолиниев 4-метилбензенсулфонат | 406-960-0 | 77497-97-3 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
613-146-00-0 | N-ethyl-N-methylpiperidinium iodide | 407-780-5 | 4186-71-4 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  613-146-00-0 | N-етил-N-метилпиперидиниев йодид | 407-780-5 | 4186-71-4 | Acute Tox. 4 * | Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
613-147-00-6 | 4-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholine | 407-940-4 | 111681-72-2 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  613-147-00-6 | 4-(2-(1-мeтил-2-(4-морфолинил)eтокси)eтил]морфолин | 407-940-4 | 111681-72-2 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
613-148-00-1 | tetrasodium 1,2-bis(4-fluoro-6- [5-(1-amino-2-sulfonatoanthra chinon-4-ylamino)-2,4,6- trimethyl-3-sulfonatopheny lamino]-1,3,5-triazin-2- ylamino)ethane | 411-240-4 | 143683-23-2 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  613-148-00-1 | тетранатриев 1,2-бис(6-[5-(1-aмино-2-сулфонатоантрахинон-4-иламино)-2,4,6-триметил-3-сулфонатофениламино]-4-флуоро-1,3,5-триазин-2-иламино)eтан | 411-240-4 | 143683-23-2 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
613-150-00-2 | 2,2'-[3,3'-(piperazine-1,4-diyl)di propyl]bis(1H-benzimidazo[2,1—b]benzo[l, m,n][3,8]phenanthroline-1,3,6-trione | 406-295-6 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  613-150-00-2 | 2,2′-[3,3′-(пиперазин-1,4-диил)дипропил]бис(1H-бензимидазо[2,1-b]бензо[l,m,n][3,8]фенантролин-1,3,6-трион | 406-295-6 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
613-151-00-8 | 1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine | 406-360-9 | 104218-44-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  613-151-00-8 | 1-(3-мeзилокси-5-тритилоксиметил-2-D-треофурил)тимин | 406-360-9 | 104218-44-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
613-152-00-3 | phenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate | 406-600-2 | 89392-03-0 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  613-152-00-3 | фенилов N-(4,6-диметоксипиримидин-2-ил)карбамат | 406-600-2 | 89392-03-0 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
613-153-00-9 | 2,3,5-trichloropyridine | 407-270-2 | 16063-70-0 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  613-153-00-9 | 2,3,5-трихлоропиридин | 407-270-2 | 16063-70-0 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
613-154-00-4 | 2-amino-4-chloro-6-methoxypyrimidine | 410-050-9 | 5734-64-5 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  613-154-00-4 | 2-амино-6-метокси-4-хлоропиримидин | 410-050-9 | 5734-64-5 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
613-155-00-X | 5-chloro-2,3-difluoropyridine | 410-090-7 | 89402-43-7 | Flam. Liq. 3 | Acute Tox. 4 * | Aquatic Chronic 3 | H226 | H302 | H412 | GHS02 | GHS07 | Wng | H226 | H302 | H412 |   |   |  613-155-00-X | 2,3-дифлуоро-5-хлоропиридин | 410-090-7 | 89402-43-7 | Flam. Liq. 3 | Acute Tox. 4 * | Aquatic Chronic 3 | H226 | H302 | H412 | GHS02 | GHS07 | Wng | H226 | H302 | H412 |   |   |  
613-156-00-5 | 2-butyl-4-chloro-5-formylimidazole | 410-260-0 | 83857-96-9 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  613-156-00-5 | 2-бутил-5-формил-4-хлороимидазол | 410-260-0 | 83857-96-9 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
613-157-00-0 | 2,4-diamino-5-methoxymethylpyrimidine | 410-330-0 | 54236-98-5 | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | H302 | H373 ** H319 | GHS08 | GHS07 | Wng | H302 | H373 ** H319 |   |   |  613-157-00-0 | 2,4-диамино-5-метоксиметилпиримидин | 410-330-0 | 54236-98-5 | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | H302 | H373 ** H319 | GHS08 | GHS07 | Wng | H302 | H373 ** H319 |   |   |  
613-158-00-6 | 2,3-dichloro-5-trifluoromethyl- pyridine | 410-340-5 | 69045-84-7 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H332 | H302 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H332 | H302 | H318 | H317 | H411 |   |   |  613-158-00-6 | 5-трифлуоро-2,3-дихлорометилпиридин | 410-340-5 | 69045-84-7 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H332 | H302 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H332 | H302 | H318 | H317 | H411 |   |   |  
613-159-00-1 | fenazaquin (ISO);4-[2-[4-(1,1-dimethylethyl)phenyl]-ethoxy]quinazoline | 410-580-0 | 120928-09-8 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H332 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H332 | H410 |   |   |  613-159-00-1 | феназахин (ISO);4-[2-[4-(1,1-диметилетил)фенил]eтокси]хиназолин | 410-580-0 | 120928-09-8 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H332 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H332 | H410 |   |   |  
613-160-00-7 | (1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptanes dihydrobromide | 411-000-9 | 125224-62-6 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  613-160-00-7 | (1S)-2-мeтил-2,5-диазобицикло[2.2.1]хептандихидробромид | 411-000-9 | 125224-62-6 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
613-161-00-2 | (2,4-diaminopteridin-6-yl)methanol hydrobromide | 430-620-0 | 76145-91-0 | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 3 | H373** H317 | H412 | GHS08 | GHS07 | Wng | H373** H317 | H412 |   |   |  613-161-00-2 | (2,4-диаминоптеридин-6-ил)метанолхидробромид | 430-620-0 | 76145-91-0 | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 3 | H373** H317 | H412 | GHS08 | GHS07 | Wng | H373** H317 | H412 |   |   |  
613-162-00-8 | (6R-trans)-1-((7-ammonio-2- carboxylato-8-oxo-5-thia-1- azabicyclo-[4.2.0]oct-2-en-3- yl)methyl)pyridinium iodide | 423-260-0 | 100988-63-4 | Muta. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H341 | H317 | H411 | GHS08 | GHS07 | GHS09 | Wng | H341 | H317 | H411 |   |   |  613-162-00-8 | (6R-транс)-1-((7-амонио-2-карбоксилато-8-оксо-5-тиа-1-азабицикло[4.2.0]окт-2-ен-3-ил)метил)пиридиниев йодид | 423-260-0 | 100988-63-4 | Muta. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H341 | H317 | H411 | GHS08 | GHS07 | GHS09 | Wng | H341 | H317 | H411 |   |   |  
613-163-00-3 | azimsulfuron (ISO);1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H- tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea | — | 120162-55-2 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M=1000 |  613-163-00-3 | азимсулфурон (ISO);1-(4,6-димeтоксипиримидин-2-ил)-3-[1-метил-4-(2-метил-2H-тетразол-5-ил)пиразол-5-илсулфонил]уреа | — | 120162-55-2 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M=1000 |  
613-164-00-9 | flufenacet (ISO);N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide | — | 142459-58-3 | Acute Tox. 4 * STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373** H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373** H317 | H410 |   | M=100 |  613-164-00-9 | флуфенацет (ISO);N-изопропил-2-(5-трифлуорометил[1,3,4]тиадиазол-2-илокси)-N-(4-флуорофенил)ацетамид | — | 142459-58-3 | Acute Tox. 4 * STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373** H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373** H317 | H410 |   | M=100 |  
613-165-00-4 | flupyrsulfuron-methyl-sodium(ISO);methyl 2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluoromethyl]nicotinate, monosodium salt | — | 144740-54-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M=100 |  613-165-00-4 | флупирсулфурон-метил-натрий (ISO);мононатриева сол на метилов 2-[[(4,6-диметоксипиримидин-2-илкарбамоил)сулфамоил]-6-трифлуорометил]никотинат | — | 144740-54-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M=100 |  
613-167-00-5 | reaction mass of: 5-chloro-2- methyl-4-isothiazolin-3-one [EC no. 247-500-7]and 2-methyl-2H -isothiazol-3- one [EC no. 220-239-6] (3:1); reaction mass of: 5-chloro-2- methyl-4-isothiazolin-3-one [EC no. 247-500-7]and 2-methyl-4-isothiazolin-3- one [EC no. 220-239-6] (3:1) | — | 55965-84-9 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H314 | H317 | H400 | H410 | GHS06 | GHS05 | GHS09 | Dgr | H331 | H311 | H301 | H314 | H317 | H410 |   | Skin Corr. 1B; H314: C ≥0,6  % | Skin Irrit. 2; H315: 0,06  % ≤ C < 0,6  % | Eye Irrit. 2; H319: 0,06  % ≤ C < 0,6  % | Skin Sens. 1; H317: C ≥ 0,0015  % |  613-167-00-5 | реакционна маса от: 2-метил-5-хлоро-4-изотиазолин-3-oн [EС № 247-500-7] и 2-мeтил-2Н-изотиазол-3-он [EС № 220-239-6] (3:1); реакционна маса от: 2-метил-5-хлоро-4-изотиазолин-3-oн [EС № 247-500-7] и 2-мeтил-4-изотиазолин-3-он [EС № 220-239-6] (3:1) | — | 55965-84-9 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H311 | H301 | H314 | H317 | H400 | H410 | GHS06 | GHS05 | GHS09 | Dgr | H331 | H311 | H301 | H314 | H317 | H410 |   | Skin Corr. 1B; H314: C ≥0,6  % | Skin Irrit. 2; H315: 0,06  % ≤ C < 0,6  % | Eye Irrit. 2; H319: 0,06  % ≤ C < 0,6  % | Skin Sens. 1; H317: C ≥ 0,0015  % |  
613-168-00-0 | 1-vinyl-2-pyrrolidone | 201-800-4 | 88-12-0 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * STOT RE 2 * | STOT SE 3 | Eye Dam. 1 | H351 | H332 | H312 | H302 | H373 ** H335 | H318 | GHS06 | GHS05 | GHS09 | Dgr | H351 | H332 | H312 | H302 | H373 ** H335 | H318 |   |   | D613-168-00-0 | 1-винил-2-пиролидон | 201-800-4 | 88-12-0 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * STOT RE 2 * | STOT SE 3 | Eye Dam. 1 | H351 | H332 | H312 | H302 | H373 ** H335 | H318 | GHS06 | GHS05 | GHS09 | Dgr | H351 | H332 | H312 | H302 | H373 ** H335 | H318 |   |   | D
613-169-00-6 | 9-vinylcarbazole | 216-055-0 | 1484-13-5 | Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H312 | H302 | H315 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H341 | H312 | H302 | H315 | H317 | H410 |   | M=100 |  613-169-00-6 | 9-винилкарбазол | 216-055-0 | 1484-13-5 | Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H341 | H312 | H302 | H315 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H341 | H312 | H302 | H315 | H317 | H410 |   | M=100 |  
613-170-00-1 | 2,2-ethylmethylthiazolidine | 404-500-3 | 694-64-4 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H317 | H411 |   |   |  613-170-00-1 | 2,2-етилметилтиазолидин | 404-500-3 | 694-64-4 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H317 | H411 |   |   |  
613-171-00-7 | hexaconazole (ISO);(RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2- ol | 413-050-7 | 79983-71-4 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  613-171-00-7 | хексаконазол (ISO);(RS)-2-(2,4-дихлорофенил)-1-(1H-1,2,4-триазол-1-ил)хексан-2-oл | 413-050-7 | 79983-71-4 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  
613-172-00-2 | 5-chloro-1,3-dihydro-2H-indol-2-one | 412-200-9 | 17630-75-0 | Repr. 2 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 3 | H361f *** H302 | H317 | H412 | GHS08 | GHS07 | Wng | H361f *** H302 | H317 | H412 |   |   |  613-172-00-2 | 5-хлоро-1,3-дихидро-2H-индол-2-oн | 412-200-9 | 17630-75-0 | Repr. 2 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 3 | H361f *** H302 | H317 | H412 | GHS08 | GHS07 | Wng | H361f *** H302 | H317 | H412 |   |   |  
613-173-00-8 | fluquinconazole (ISO);3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one | 411-960-9 | 136426-54-5 | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H372 ** H312 | H315 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H301 | H372 ** H312 | H315 | H410 |   |   |  613-173-00-8 | флухинконазол (ISO);3-(2,4-дихлорофенил)-2-(1H-1,2,4-триазол-1-ил)-6-флуорохиназолин-4-(3H)-oн | 411-960-9 | 136426-54-5 | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H372 ** H312 | H315 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H301 | H372 ** H312 | H315 | H410 |   |   |  
613-174-00-3 | tetraconazole (ISO); | (±) 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether | 407-760-6 | 112281-77-3 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 2 | H332 | H302 | H411 | GHS07 | GHS09 | Wng | H332 | H302 | H411 |   |   |  613-174-00-3 | тетраконазол (ISO); | (±)-2-(2,4-дихлорофенил)-3-(1H-1,2,4-триазол-1-ил)пропил-1,1,2,2-тетрафлуороетилов етер | 407-760-6 | 112281-77-3 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 2 | H332 | H302 | H411 | GHS07 | GHS09 | Wng | H332 | H302 | H411 |   |   |  
613-175-00-9 | epoxiconazole (ISO); (2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane | 406-850-2 | 133855-98-8 | Carc. 2 | Repr. 1B | Aquatic Chronic 2 | H351 | H360Df | H411 | GHS08 | GHS09 | Dgr | H351 | H360Df | H411 |   |   |  613-175-00-9 | епоксиконазол (ISO); (2RS,3SR)-[(1H-1,2,4-триазол-1-ил)метил]-2-(4-флуорофенил)-3-(2-хлорофенил)oксиран | 406-850-2 | 133855-98-8 | Carc. 2 | Repr. 1B | Aquatic Chronic 2 | H351 | H360Df | H411 | GHS08 | GHS09 | Dgr | H351 | H360Df | H411 |   |   |  
613-176-00-4 | 2-methyl-2-azabicyclo[2.2.1]heptane | 404-810-9 | 4524-95-2 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | H226 | H312 | H302 | H373 ** | H314 | GHS02 | GHS08 | GHS05 | GHS07 | Dgr | H226 | H312 | H302 | H373 ** | H314 |   |   |  613-176-00-4 | 2-мeтил-2-aзабицикло[2.2.1]хептан | 404-810-9 | 4524-95-2 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | H226 | H312 | H302 | H373 ** | H314 | GHS02 | GHS08 | GHS05 | GHS07 | Dgr | H226 | H312 | H302 | H373 ** | H314 |   |   |  
613-177-00-X | 8-amino-7-methylquinoline | 412-760-4 | 5470-82-6 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H312 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H312 | H302 | H317 | H411 |   |   |  613-177-00-X | 8-амино-7-метилхинолин | 412-760-4 | 5470-82-6 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H312 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H312 | H302 | H317 | H411 |   |   |  
613-178-00-5 | 4-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine | 410-470-2 | 137796-06-6 | Skin Corr. 1B | Skin Sens. 1 | H314 | H317 | GHS05 | GHS07 | Dgr | H314 | H317 |   | STOT SE 3; H335: C ≥ 5 % |  613-178-00-5 | 4-етил-2-метил-2-изопентил-1,3-oксазолидин | 410-470-2 | 137796-06-6 | Skin Corr. 1B | Skin Sens. 1 | H314 | H317 | GHS05 | GHS07 | Dgr | H314 | H317 |   | STOT SE 3; H335: C ≥ 5 % |  
613-179-00-0 | lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide | 411-690-1 | 111337-53-2 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H314 | H317 | H411 | GHS05 | GHS07 | Dgr | H302 | H314 | H317 | H411 |   |   |  613-179-00-0 | литиев 3-оксо-1,2(2Н)-бензизотиазол-2-ид | 411-690-1 | 111337-53-2 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H314 | H317 | H411 | GHS05 | GHS07 | Dgr | H302 | H314 | H317 | H411 |   |   |  
613-180-00-6 | N-(1,1-dimethylethyl)bis(2-benzothiazolesulfen)amide | 407-430-1 | 3741-80-8 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  613-180-00-6 | N-(1,1-диметилетил)бис(2-бензотиазолсулфен)aмид | 407-430-1 | 3741-80-8 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
613-181-00-1 | 5,5-dimethyl-perhydro-pyrimidin-2-one α-(4-trifluoromethylstyryl)-α-(4-trifluoromethyl)cinnamylidenehydrazone | 405-090-9 | 67485-29-4 | STOT RE 1 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H372 ** | H302 | H319 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H372 ** | H302 | H319 | H410 |   |   |  613-181-00-1 | 5,5-диметилперхидропиримидин-2-он α-(4-трифлуорометилстирил)-α-(4-трифлуорометил)цинамилиденхидразон | 405-090-9 | 67485-29-4 | STOT RE 1 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H372 ** | H302 | H319 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H372 ** | H302 | H319 | H410 |   |   |  
613-182-00-7 | 1-(1-naphthylmethyl)quinolinium chloride | 406-220-7 | 65322-65-8 | Carc. 2 | Muta. 2 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H351 | H341 | H302 | H315 | H318 | H412 | GHS08 | GHS05 | GHS07 | Dgr | H351 | H341 | H302 | H315 | H318 | H412 |   |   |  613-182-00-7 | 1-(1-нафтилметил)хинолиниев хлорид | 406-220-7 | 65322-65-8 | Carc. 2 | Muta. 2 | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H351 | H341 | H302 | H315 | H318 | H412 | GHS08 | GHS05 | GHS07 | Dgr | H351 | H341 | H302 | H315 | H318 | H412 |   |   |  
613-183-00-2 | reaction mass of: 5-(N-methylperfluorooctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one; 5-(N-methylperfluoroheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one | 413-640-4 | — | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** | H400 | H410 | GHS08 | GHS09 | Wng | H373 ** | H410 |   |   |  613-183-00-2 | реакционна маса от: 5-(N-метилперфлуорооктилсулфонамидо)метил-3-октадецил-1,3-oксaзолидин-2-он; 5-(N-метилперфлуорохептилсулфонамидо)метил-3-октадецил-1,3-oксaзолидин-2-он | 413-640-4 | — | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** | H400 | H410 | GHS08 | GHS09 | Wng | H373 ** | H410 |   |   |  
613-184-00-8 | nitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate | 413-670-8 | — | Eye Irrit. 2 | Skin Sens. 1 | H319 | H317 | GHS07 | Wng | H319 | H317 |   |   |  613-184-00-8 | нитрилотриетиленамониопропан-2-ол 2-етилхексаноат | 413-670-8 | — | Eye Irrit. 2 | Skin Sens. 1 | H319 | H317 | GHS07 | Wng | H319 | H317 |   |   |  
613-185-00-3 | 2,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazol-3-one | 407-630-9 | 82633-79-2 | Acute Tox. 3 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H318 | H317 | H400 | H410 | GHS06 | GHS05 | GHS09 | Dgr | H301 | H318 | H317 | H410 |   |   |  613-185-00-3 | 2-метил-2,3,5,6-тетрахидро-2H-циклопента[d]-1,2-тиазол-3-он | 407-630-9 | 82633-79-2 | Acute Tox. 3 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H318 | H317 | H400 | H410 | GHS06 | GHS05 | GHS09 | Dgr | H301 | H318 | H317 | H410 |   |   |  
613-186-00-9 | (2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-yl acetate | 408-050-9 | 76855-69-1 | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H319 | H317 | H411 | GHS07 | GHS09 | Wng | H319 | H317 | H411 |   |   |  613-186-00-9 | (2R,3R)-3-((R)-1-(трет-бутилдиметилсилокси)етил)-4-оксоазетидин-2-илов ацетат | 408-050-9 | 76855-69-1 | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H319 | H317 | H411 | GHS07 | GHS09 | Wng | H319 | H317 | H411 |   |   |  
613-187-00-4 | 5-(2-amino-5-cyano-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-3-methyl-2,4-dicarbonitrilethiophene | 410-530-8 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  613-187-00-4 | 5-(2-амино-4-метил-6-[2-(2-хидроксиетокси)етиламино]-5-цианопиридин-3-илазо)-3-метил-2,4-дикарбонитрилтиофен | 410-530-8 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
613-188-00-X | 1-(3-(4-fluorophenoxy)propyl)3-methoxy-4-piperidinone | 411-500-7 | 116256-11-2 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H317 | H411 |   |   |  613-188-00-X | 1-(3-(4-флуорофенокси)пропил)-3-метокси-4-пиперидинон | 411-500-7 | 116256-11-2 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H317 | H411 |   |   |  
613-189-00-5 | 1,4,7,10-tetrakis(p-toluensulfonyl)-1,4,7,10-tetraazacyclododecane | 414-030-0 | 52667-88-6 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  613-189-00-5 | 1,4,7,10-тетракис(p-толуенсулфонил)-1,4,7,10-тетраaзaциклододекан | 414-030-0 | 52667-88-6 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
613-190-00-0 | disodium 1-amino-4-(2-(5-chloro-6-fluoro-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracene-2-sulfonate | 414-040-5 | 149530-93-8 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  613-190-00-0 | динатриев 1-амино-4-(2-(6-флуоро-5-хлоропиримидин-4-иламинометил)-4-метил-6-сулфофениламино)-9,10-диоксо-9,10-дихидроантрацен-2-сулфонат | 414-040-5 | 149530-93-8 | Acute Tox. 4 * | Skin Sens. 1 | H302 | H317 | GHS07 | Wng | H302 | H317 |   |   |  
613-191-00-6 | 3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine | 421-150-7 | 143860-04-2 | Repr. 1B | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H360F *** H314 | H400 | H410 | GHS08 | GHS05 | GHS09 | Dgr | H360F *** H314 | H410 |   |   |  613-191-00-6 | 3-етил-2-метил-2-(3-метилбутил)-1,3-оксазолидин | 421-150-7 | 143860-04-2 | Repr. 1B | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H360F *** H314 | H400 | H410 | GHS08 | GHS05 | GHS09 | Dgr | H360F *** H314 | H410 |   |   |  
613-192-00-1 | 3-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexane | 426-750-2 | 151860-15-0 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  613-192-00-1 | 3-бензил-екзо-6-нитро-2,4-диоксо-3-аза-цис-бицикло[3.1.0]хексан | 426-750-2 | 151860-15-0 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
613-193-00-7 | pentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane-1,11-diyldisulfamoyl)di[phthalocyaninecopper(II)]] heptalactate | 414-930-3 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  613-193-00-7 | пентакис[3-(диметиламонио)пропилсулфамоил][(4,4,8,8-тетраметил-6-хидрокси-4,8-диазониаундекан-1,11-диилдисулфамоил)ди[фталоцианинмеден(II)]] хепталактат | 414-930-3 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
613-194-00-2 | 6,13-dichloro-3,10-bis{2-[4-fluoro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium-, sodium salt | 418-000-8 | 163062-28-0 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  613-194-00-2 | литиева натриева сол на 6,13-дихлоро-3,10-бис{2-[6-(2-сулфофениламино)-4-флуоро-1,3,5-триaзин-2-иламино]пропилaмино}бензo[5,6][1,4]oксазино[2,3-b]феноксазин-4,11-дисулфоновата киселина | 418-000-8 | 163062-28-0 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
613-195-00-8 | 2,2-(1,4-phenylene)bis((4H—3,1-benzoxazine-4-one) | 418-280-1 | 18600-59-4 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  613-195-00-8 | 2,2-(1,4-фенилeн)бис(4H-3,1-бензoксазин-4-он) | 418-280-1 | 18600-59-4 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
613-196-00-3 | 5-[[4-chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphtalene-2,7-disulfonic acid, sodium salt | 418-380-5 | 168113-78-8 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  613-196-00-3 | натриева сол на 5-[[4-хлоро-6-[[2-[[4-флуоро-6-[[5-хидрокси-6-[(4-метокси-2-сулфофенил)азо]-7-сулфо-2-нафталенил]амино]-1,3,5-триaзин-2-ил]амино]-1-метилетил]амино]-1,3,5-триазин-2-ил]амино]-3-[[4-(етенилсулфонил)фенил]азо]-4-хидроксинафтален-2,7-дисулфоновата киселина | 418-380-5 | 168113-78-8 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
613-197-00-9 | reaction mass of: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine; | 2,4,6-tri(methylcarbamoyl)-1,3,5-triazine; | [(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine; | [(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine | 420-390-1 | 187547-46-2 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  613-197-00-9 | реакционна маса от: 2,4,6-три(бутилкарбамоил)-1,3,5-триазин; | 2,4,6-три(метилкарбамоил)-1,3,5-триазин | [(2-бутил-4,6-диметил)трикарбамоил]-1,3,5-триазин; | [(2,4-дибутил-6-метил)трикарбамоил]-1,3,5-триазин | 420-390-1 | 187547-46-2 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
613-198-00-4 | 2-amino-4-dimethylamino-6-trifluoroethoxy-1,3,5-triazine | 415-500-8 | 145963-84-4 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 3 | H302 | H373** | H412 | GHS08 | GHS07 | Wng | H302 | H373** | H412 |   |   |  613-198-00-4 | 2-амино-4-диметиламино-6-трифлуороетокси-1,3,5-триазин | 415-500-8 | 145963-84-4 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 3 | H302 | H373** | H412 | GHS08 | GHS07 | Wng | H302 | H373** | H412 |   |   |  
613-199-00-X | reaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6 trione; | reaction mass of oligomers of | 3,5-bis(3-aminomethylphenyl)1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5(1H,3H,5H)-triazine-2,4,6-trione | 421-550-1 | — | Carc. 1B | Repr. 1B | Skin Sens. 1 | Aquatic Chronic 3 | H350 | H360D *** H317 | H412 | GHS08 | Dgr | H350 | H360D *** H317 | H412 |   |   |  613-199-00-X | реакционна маса от: 1,3,5-трис(3-аминометилфенил)-1,3,5-(1H,3H,5H)-триазин-2,4,6-триoн; | реакционна маса от олигомери на | 3,5-бис(3-аминометилфенил)-1-поли[3,5-бис(3-аминометилфенил)-2,4,6-триоксо-1,3,5-(1H,3H,5H)-триазин-1-ил]-1,3,5(1H,3H,5H)-триазин-2,4,6-трион | 421-550-1 | — | Carc. 1B | Repr. 1B | Skin Sens. 1 | Aquatic Chronic 3 | H350 | H360D *** H317 | H412 | GHS08 | Dgr | H350 | H360D *** H317 | H412 |   |   |  
613-200-00-3 | reaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts | 420-980-7 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  613-200-00-3 | реакционeн продукт на: (29H,31H-фталоцианинато(2-)-N29,N30,N31,N32)мед, хлоросярна киселина и 3-(2-сулфооксиетилсулфонил)анилин, натриеви соли | 420-980-7 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
613-201-00-9 | (R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole | 422-390-5 | 143322-57-0 | Repr. 2 | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361f *** H372 ** | H332 | H302 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H361f *** H372 ** | H332 | H302 | H317 | H410 | EUH070 |   |  613-201-00-9 | (R)-5-бромо-3-(1-метил-2-пиролидинилметил)-1H-индол | 422-390-5 | 143322-57-0 | Repr. 2 | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361f *** H372 ** | H332 | H302 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Dgr | H361f *** H372 ** | H332 | H302 | H317 | H410 | EUH070 |   |  
613-202-00-4 | pymetrozine (ISO); | (E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one | — | 123312-89-0 | Carc. 2 | Aquatic Chronic 3 | H351 | H412 | GHS08 | Wng | H351 | H412 |   |   |  613-202-00-4 | пиметрозин (ISO); | (E)-6-метил-4-(3-пиридилметилeнамино)-4,5-дихидро-1,2,4-триазин-3(2H)-он | — | 123312-89-0 | Carc. 2 | Aquatic Chronic 3 | H351 | H412 | GHS08 | Wng | H351 | H412 |   |   |  
613-203-00-X | pyraflufen-ethyl (ISO); | 2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid ethyl ester; [1] pyraflufen (ISO); | 2-chloro-5-(4-chloro-5-difluoromethoxy-1-methylpyrazol-3-yl)-4-fluorophenoxyacetic acid [2] | -[1] | -[2] | 129630-19-9 [1] | 129630-17-7 [2] | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M=1000 |  613-203-00-X | пирафлуфен-етил (ISO); | етилов естер на 5-(1-метил-5-дифлуорометокси-4-хлоропиразол-3-ил)-4-флуоро-2-хлорофеноксиоцетната киселина; [1] пирафлуфен (ISO); | 5-(1-метил-5-дифлуорометокси-4-хлоропиразол-3-ил)-4-флуоро-2-хлорофеноксиоцетна киселина [2] | -[1] | -[2] | 129630-19-9 [1] | 129630-17-7 [2] | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M=1000 |  
613-204-00-5 | oxadiargyl (ISO); | 3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one | 254-637-6 | 39807-15-3 | Repr. 2 | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H361d*** H373** | H400 | H410 | GHS08 | GHS09 | Wng | H361d*** H373** | H410 |   | M = 1000 |  613-204-00-5 | оксадиаргил (ISO); | 5-(1,1-диметилетил)-3-[5-(2-пропинилокси)-2,4-дихлорофенил]-1,3,4-оксадиазол-2(3H)-он | 254-637-6 | 39807-15-3 | Repr. 2 | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H361d*** H373** | H400 | H410 | GHS08 | GHS09 | Wng | H361d*** H373** | H410 |   | M = 1000 |  
613-205-00-0 | propiconazole(ISO); | (±) 1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H—1,2,4-triazole | 262-104-4 | 60207-90-1 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  613-205-00-0 | пропиконазол (ISO); | (±)-1-[2-(2,4-дихлорофенил)-4-пропил-1,3-диоксолан-2-илметил]-1Н-1,2,4-триазол | 262-104-4 | 60207-90-1 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  
613-206-00-6 | fenamidone (ISO); | (S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one | — | 161326-34-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  613-206-00-6 | фенамидон (ISO); | (S)-5-метил-2-метилтио-5-фенил-3-фениламино-3,5-дихидроимидазол-4-он | — | 161326-34-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
613-208-00-7 | imazamox (ISO); | (RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid | — | 114311-32-9 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  613-208-00-7 | имазамокс (ISO); | (RS)-2-(4-изопропил-4-метил-5-оксо-2-имидазолин-2-ил)-5-метоксиметилникотинова киселина | — | 114311-32-9 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
613-209-00-2 | cis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride | 417-430-3 | 63645-17-0 | Acute Tox. 3 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 2 | H301 | H373 ** | H317 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H373 ** | H317 | H411 |   |   |  613-209-00-2 | цис-2,6-диметил-1-(3-хлоропропил)пиперидинхидрохлорид | 417-430-3 | 63645-17-0 | Acute Tox. 3 * | STOT RE 2 * | Skin Sens. 1 | Aquatic Chronic 2 | H301 | H373 ** | H317 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H373 ** | H317 | H411 |   |   |  
613-210-00-8 | 2-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane | 417-650-1 | 88128-57-8 | STOT RE 2 * | Aquatic Chronic 3 | H373 ** | H412 | GHS08 | Wng | H373 ** | H412 |   |   |  613-210-00-8 | 2,5,5-триметил-2-(3-хлоропропил)-1,3-диoксaн | 417-650-1 | 88128-57-8 | STOT RE 2 * | Aquatic Chronic 3 | H373 ** | H412 | GHS08 | Wng | H373 ** | H412 |   |   |  
613-211-00-3 | N-methyl-4-(p-formylstyryl)pyridinium methylsulfate | 418-240-3 | 74401-04-0 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  613-211-00-3 | N-метил-4-(p-формилстирил)пиридиниев метилсулфат | 418-240-3 | 74401-04-0 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
613-212-00-9 | 4-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinane-1,1-dioxide) | 418-320-8 | 133467-41-1 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  613-212-00-9 | 4-[4-(2-етилхексилокси)фенил](1,4-тиазинан-1,1-диoксид) | 418-320-8 | 133467-41-1 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
613-213-00-4 | cis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline | 416-040-0 | 120807-02-5 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  613-213-00-4 | цис-1-бензоил-4-[(4-метилсулфонил)окси]-L-пролин | 416-040-0 | 120807-02-5 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
613-214-00-X | N, N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-quinolylidene)-1,3-dioxoindan-5-carboxamide | 416-260-7 | 147613-95-4 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  613-214-00-X | N, N-ди-n-бутил-2-(6-изoпропил-1,2-дихидро-3-хидрокси-2-хинолилиден)-1,3-диоксоиндан-5-карбоксамид | 416-260-7 | 147613-95-4 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
613-215-00-5 | 2-chloromethyl-3,4-dimethoxypyridinium chloride | 416-440-5 | 72830-09-2 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H312 | H302 | H373 ** | H315 | H318 | H317 | H411 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H373 ** | H315 | H318 | H317 | H411 |   |   |  613-215-00-5 | 3,4-диметокси-2-хлорометилпиридиниев хлорид | 416-440-5 | 72830-09-2 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H312 | H302 | H373 ** | H315 | H318 | H317 | H411 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H312 | H302 | H373 ** | H315 | H318 | H317 | H411 |   |   |  
613-216-00-0 | 6-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazole | 416-490-8 | 162208-01-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  613-216-00-0 | 6-трет-бутил-7-(6-диетиламино-2-метил-3-пиридилимино)-3-(3-метилфенил)пиразоло[3,2-c][1,2,4]триазол | 416-490-8 | 162208-01-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
613-217-00-6 | 4-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidine | 416-770-1 | 73754-27-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  613-217-00-6 | 4-[3-(3,5-ди-трет-бутил-4-хидроксифенил)пропионилокси]-1-[2-[3-(3,5-ди-трет-бутил-4-хидрофенил)пропионилокси]етил]-2,2,6,6-тетраметилпиперидин | 416-770-1 | 73754-27-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
613-218-00-1 | 6-hydroxyindole | 417-020-4 | 2380-86-1 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H317 | H411 |   |   |  613-218-00-1 | 6-хидроксииндол | 417-020-4 | 2380-86-1 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H317 | H411 |   |   |  
613-219-00-7 | 7a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazole | 417-140-7 | 79185-77-6 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  613-219-00-7 | 7a-етил-3,5-бис(1-метилетил)-2,3,4,5-тетрахидроoксазолo[3,4-c]-2,3,4,5-тетрахидроoксазол | 417-140-7 | 79185-77-6 | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
613-220-00-2 | trans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide | 417-290-3 | 147086-81-5 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  613-220-00-2 | транс-(4S,6S)-5,6-дихидро-6-метил-4H-тиено[2,3-b]тиопиран-4-ол-7,7-диoксид | 417-290-3 | 147086-81-5 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
613-221-00-8 | 2-chloro-5-methyl-pyridine | 418-050-0 | 18368-64-4 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Chronic 3 | H312 | H302 | H315 | H412 | GHS07 | Wng | H312 | H302 | H315 | H412 |   |   |  613-221-00-8 | 5-метил-2-хлоропиридин | 418-050-0 | 18368-64-4 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Aquatic Chronic 3 | H312 | H302 | H315 | H412 | GHS07 | Wng | H312 | H302 | H315 | H412 |   |   |  
613-222-00-3 | 4-(1-oxo-2-propenyl)-morpholine | 418-140-1 | 5117-12-4 | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | H302 | H373 ** | H318 | H317 | GHS08 | GHS05 | GHS07 | Dgr | H302 | H373 ** | H318 | H317 |   |   |  613-222-00-3 | 4-(1-оксо-2-пропенил)морфолин | 418-140-1 | 5117-12-4 | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | H302 | H373 ** | H318 | H317 | GHS08 | GHS05 | GHS07 | Dgr | H302 | H373 ** | H318 | H317 |   |   |  
613-223-00-9 | N-isopropyl-3-(4-fluorophenyl)-1H-indole | 418-790-4 | 93957-49-4 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  613-223-00-9 | N-изoпропил-3-(4-флуорофенил)-1H-индол | 418-790-4 | 93957-49-4 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
613-224-00-4 | 2,5-dimercaptomethyl-1,4-dithiane | 419-770-8 | 136122-15-1 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H317 | H410 |   |   |  613-224-00-4 | 2,5-димеркаптометил-1,4-дитиан | 419-770-8 | 136122-15-1 | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H317 | H410 |   |   |  
613-225-00-X | reaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine; | 2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine. | 421-290-9 | — | STOT RE 2 * | Aquatic Chronic 4 | H373 ** | H413 | GHS08 | Wng | H373 ** | H413 |   |   |  613-225-00-X | реакционна маса от: [2-(антрахинон-1-иламино)-6-[(5-бензоиламино)антрахинон-1-иламино]-4-фенил]-1,3,5-триaзин; | 2,6-бис[(5-бензоиламино)антрахинон-1-иламино]-4-фенил-1,3,5-триазин | 421-290-9 | — | STOT RE 2 * | Aquatic Chronic 4 | H373 ** | H413 | GHS08 | Wng | H373 ** | H413 |   |   |  
613-226-00-5 | 1-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl)-pyridinium dichloride | 420-950-3 | 163831-67-2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  613-226-00-5 | 1-(2-(етил(4-(4-(4-(4-(етил(2-пиридиноетил)амино)-2-метилфенилазо)бензоиламино)фенилазо)-3-метилфенил)амино)етил)пиридиниев дихлорид | 420-950-3 | 163831-67-2 | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  
613-227-00-0 | (±)-[(R*,R*) and (R*,S*)]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran | 419-600-2 | 99199-90-3 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  613-227-00-0 | (±)-[(R*,R*) и (R*,S*)]-6-флуоро-3,4-дихидро-2-оксиранил-2H-1-бензoпиран | 419-600-2 | 99199-90-3 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
613-228-00-6 | (±)-(R*,S*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran | 419-630-6 | 793669-26-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  613-228-00-6 | (±)-(R*,S*)-6-флуоро-3,4-дихидро-2-оксиранил-2H-1-бензoпиран | 419-630-6 | 793669-26-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
613-229-00-1 | 1-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidine | 411-930-5 | 106917-31-1 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H317 | H410 |   |   |  613-229-00-1 | 1-ацетил-4-(3-додецил-2,5-диоксо-1-пиролидинил)-2,2,6,6-тетраметилпиперидин | 411-930-5 | 106917-31-1 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H317 | H410 |   |   |  
613-230-00-7 | florasulam (ISO); | 2',6',8-trifluoro-5-methoxy-5-triazolo[1,5-c]; | pyrimidine-2-sulfonanilide | — | 145701-23-1 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  613-230-00-7 | флорасулам (ISO); | 2′,6′,8-трифлуоро-5-метокси-5-триазоло[1,5-c] | пиримидин-2-сулфонанилид | — | 145701-23-1 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
613-231-00-2 | 2,6-diamino-3-((pyridine-3-yl)azo)pyridine | 421-430-9 | 28365-08-4 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 2 | H302 | H373** | H411 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373** | H411 |   |   |  613-231-00-2 | 2,6-диамино-3-((пиридин-3-ил)азо)пиридин | 421-430-9 | 28365-08-4 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 2 | H302 | H373** | H411 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373** | H411 |   |   |  
613-232-00-8 | 3-(benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-oxide | 431-030-6 | 163269-30-5 | Acute Tox. 3 * | STOT RE 2 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H373** | H318 | H400 | H410 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H331 | H373** | H318 | H410 |   |   |  613-232-00-8 | 3-(бензо[b]тиен-2-ил)-1,4,2-окса-5,6-дихидротиазин-4-оксид | 431-030-6 | 163269-30-5 | Acute Tox. 3 * | STOT RE 2 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H373** | H318 | H400 | H410 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H331 | H373** | H318 | H410 |   |   |  
613-233-00-3 | 4,4'-(oxy-(bismethylene))-bis-1,3-dioxolane | 423-230-7 | 56552-15-9 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  613-233-00-3 | 4,4′-(окси(бисметилeн))бис-1,3-диоксолан | 423-230-7 | 56552-15-9 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
613-234-00-9 | imidazo[1,2-b]pyridazin hydrochloride | 431-510-5 | 18087-70-2 | Acute Tox. 4 * | Eye Irrit. 2 | H302 | H319 | GHS07 | Wng | H302 | H319 |   |   |  613-234-00-9 | имидазо[1,2-b]пиридазинхидрохлорид | 431-510-5 | 18087-70-2 | Acute Tox. 4 * | Eye Irrit. 2 | H302 | H319 | GHS07 | Wng | H302 | H319 |   |   |  
613-235-00-4 | 2,3-dihydro-2,2-dimethyl-1H-perimidine | 424-060-6 | 6364-17-6 | Acute Tox. 4* | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373** | H317 | H410 |   |   |  613-235-00-4 | 2,2-диметил-2,3-дихидро-1H-перимидин | 424-060-6 | 6364-17-6 | Acute Tox. 4* | STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373** | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373** | H317 | H410 |   |   |  
613-236-00-X | 2-chloro-3-trifluoromethylpyridine | 424-520-6 | 65753-47-1 | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | Skin Corr. 1B | Aquatic Chronic 3 | H311 | H301 | H372** | H314 | H412 | GHS06 | GHS05 | GHS08 | Dgr | H311 | H301 | H372** | H314 | H412 |   |   |  613-236-00-X | 3-(трифлуорометил)-2-хлоропиридин | 424-520-6 | 65753-47-1 | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 1 | Skin Corr. 1B | Aquatic Chronic 3 | H311 | H301 | H372** | H314 | H412 | GHS06 | GHS05 | GHS08 | Dgr | H311 | H301 | H372** | H314 | H412 |   |   |  
613-237-00-5 | 6-tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3.4b][1,3,4]thiadiazine | 424-950-4 | 133949-92-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  613-237-00-5 | 6-трет-бутил-3-(3-додецилсулфонил)пропил-7H-1,2,4-триазоло[3.4b][1,3,4]тиадиазин | 424-950-4 | 133949-92-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
613-238-00-0 | sodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]phenyl]sulfonyl]ethyl sulfate | 430-890-1 | 81992-66-7 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  613-238-00-0 | натриев 2-[[4-[(4,6-дихлоро-1,3,5-триазин-2-ил)амино]фенил]сулфонил]етилов сулфат | 430-890-1 | 81992-66-7 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
613-239-00-6 | 2-[3-(methylamino)propyl]-1H-benzimidazole | 425-760-4 | 64137-52-6 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  613-239-00-6 | 2-[3-(метиламино)пропил]-1H-бензимидазол | 425-760-4 | 64137-52-6 | Eye Dam. 1 | Aquatic Chronic 3 | H318 | H412 | GHS05 | Dgr | H318 | H412 |   |   |  
613-241-00-7 | 3-(2H-tetrazol-5-yl)pyridine | 426-810-8 | 3250-74-6 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  613-241-00-7 | 3-(2H-тетразол-5-ил)пиридин | 426-810-8 | 3250-74-6 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
613-242-00-2 | reaction products of 3,10-bis((2-aminopropyl)amino)-6,13-dichloro-4,11-triphenodioxazinedisulfonic acid with 2-amino-1,4-benzenedisulfonic acid, 2-((4-aminophenyl)sulfonyl)ethyl hydrogen sulfate and 2,4,6-trifluoro-1,3,5-triazine, sodium salts | 426-860-0 | 191877-09-5 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  613-242-00-2 | реакционни продукти от 3,10-бис((2-аминопропил)амино)-6,13-дихлоро-4,11-трифенодиоксазиндисулфонова киселина с 2-амино-1,4-бензендисулфонова киселина, 2-((4-аминофенил)сулфонил)етилов хидрогенсулфат и 2,4,6-трифлуоро-1,3,5-триазин, натриеви соли | 426-860-0 | 191877-09-5 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
613-243-00-8 | 4,4'-(1,6-hexamethylenebis(formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidine) | 427-350-0 | 182235-14-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  613-243-00-8 | 4,4′-(1,6-хексаметиленбис(формилимино))бис(2,2,6,6-тетраметил-1-оксилпиперидин) | 427-350-0 | 182235-14-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
613-244-00-3 | 5,7-dichloro-4-hydroxyquinoline | 427-420-0 | 21873-52-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  613-244-00-3 | 4-хидрокси-5,7-дихлорохинолин | 427-420-0 | 21873-52-9 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
613-245-00-9 | 2-fluoro-6-trifluoromethylpyridine | 428-100-3 | 94239-04-0 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 3 | H226 | H332 | H302 | H412 | GHS02 | GHS07 | Wng | H226 | H332 | H302 | H412 |   |   |  613-245-00-9 | 6-(трифлуорометил)-2-флуоропиридин | 428-100-3 | 94239-04-0 | Flam. Liq. 3 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 3 | H226 | H332 | H302 | H412 | GHS02 | GHS07 | Wng | H226 | H332 | H302 | H412 |   |   |  
613-246-00-4 | 2-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine | 428-200-7 | 103577-66-8 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  613-246-00-4 | 3-метил-4-(2,2,2-трифлуороетокси)-2-хидроксиметилпиридин | 428-200-7 | 103577-66-8 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
613-247-00-X | 3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroindole | 428-910-7 | 107786-36-7 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  613-247-00-X | 3-(2-метокси-4-метоксикарбоксибензил)-5-нитроиндол | 428-910-7 | 107786-36-7 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
613-248-00-5 | 3,4-dimethyl-1H-pyrazole | 429-130-1 | 2820-37-3 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  613-248-00-5 | 3,4-диметил-1H-пиразол | 429-130-1 | 2820-37-3 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  
613-249-00-0 | 1-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfate | 429-300-3 | 155601-30-2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H411 |   |   |  613-249-00-0 | 1-(2-хидроксиетил)-1H-пиразол-4,5-диилдиамониев сулфат | 429-300-3 | 155601-30-2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H411 |   |   |  
613-250-00-6 | reaction mass of: carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidine; | methyl carbonato-N-ethyl-2-isopropyl-1,3-oxazolidine; | 2-isopropyl-N-hydroxyethyl 1,3-oxazolidine | 429-990-6 | — | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  613-250-00-6 | реакционна маса от: карбонатобис-N-етил-2-изопропил-1,3-оксазолидин; | метилкарбонато-N-етил-2-изопропил-1,3-оксазолидин; | 2-изопропил-N-хидроксиетил-1,3-оксазолидин | 429-990-6 | — | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H318 | H317 | H412 |   |   |  
613-251-00-1 | (R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethenyl]-1H-indole | 430-560-5 | 180637-89-2 | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | H302 | H373** | H318 | H317 | GHS05 | GHS08 | GHS07 | Dgr | H302 | H373** | H318 | H317 |   |   |  613-251-00-1 | (R)-3-[(1-метилпиролидин-2-ил)метил]-5-[2-(фенилсулфонил)етенил]-1H-индол | 430-560-5 | 180637-89-2 | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | H302 | H373** | H318 | H317 | GHS05 | GHS08 | GHS07 | Dgr | H302 | H373** | H318 | H317 |   |   |  
613-253-00-2 | 2,2-dialkyl-4-hydroxymethyl1,3-dioxolane; | reaction products with ethylene oxide (alkyl is C1-12 and the sum to C13, average degree of ethoxylation is 3,5) | 430-580-4 | — | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 | EUH019 |   |  613-253-00-2 | 2,2-диалкил-4-хидроксиметил-1,3-диоксолан; | реакционни продукти с етиленов оксид (алкилът е C1-12, а сумарно достига C13, средната степен на етоксилиране е 3,5) | 430-580-4 | — | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 | EUH019 |   |  
613-254-00-8 | forchlorfenuron (ISO); | 1-(2-chloro-4-pyridyl)-3-phenylurea | — | 68157-60-8 | Carc. 2 | Aquatic Chronic 2 | H351 | H411 | GHS08 | GHS09 | Wng | H351 | H411 |   |   |  613-254-00-8 | форхлорфенурон (ISO); | 1-(2-хлоро-4-пиридил)-3-фенилуреа | — | 68157-60-8 | Carc. 2 | Aquatic Chronic 2 | H351 | H411 | GHS08 | GHS09 | Wng | H351 | H411 |   |   |  
613-255-00-3 | reaction mass of isomers of: sodium [(2-hydroxyethylsulfamoyl){][}2-(2-piperazin-1-ylethylamino)ethylsulfamoyl][2-(4-aminoethylpiperazine-1-yl)ethylsulfamoyl{](sulfamoyl)[}(sulfonatophthalocyaninato)]copper(II) | 424-270-8 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  613-255-00-3 | реакционна маса от изомери на: натриев [(2-хидроксиетилсулфамоил){[2-(2-пиперазин-1-илетиламино)етилсулфамоил][2-(4-аминоетилпиперазин-1-ил)етилсулфамоил](сулфамоил)}(сулфонатофталоцианинато)]меден(II) йон | 424-270-8 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
613-256-00-9 | 3'5'-anhydro thymidine | 425-810-5 | 38313-48-3 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  613-256-00-9 | 3′5′-анхидротимидин | 425-810-5 | 38313-48-3 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
613-257-00-4 | 2-phthalimidoethyl N-[4-(2-cyano-4-nitrophenylazo)phenyl]-N-methyl-β-alaninate | 426-400-9 | 170222-39-6 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  613-257-00-4 | 2-фталимидоетилов N-метил-N-[4-(4-нитро-2-цианофенилазо)фенил]-β-аланинат | 426-400-9 | 170222-39-6 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
613-258-00-X | reaction mass of: 4-chloro-7-methylbenzotriazole sodium salt; | 4-chloro-5-methylbenzotriazole sodium salt; | 5-chloro-4-methylbenzotriazole sodium salt | 427-730-6 | 202420-04-0 | Skin Corr. 1B | Aquatic Chronic 3 | H314 | H412 | GHS05 | Dgr | H314 | H412 |   |   |  613-258-00-X | реакционна маса от: натриева сол на 7-метил-4-хлоробензотриазол; | натриева сол на 5-метил-4-хлоробензотриазол; | натриева сол на 4-метил-5-хлоробензотриазол | 427-730-6 | 202420-04-0 | Skin Corr. 1B | Aquatic Chronic 3 | H314 | H412 | GHS05 | Dgr | H314 | H412 |   |   |  
613-259-00-5 | reaction mass of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate; | [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate | 428-790-6 | 72963-72-5 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  613-259-00-5 | реакционна маса от: [2,4-диоксо-(2-пропин-1-ил)имидазолидин-3-ил]метилов (1R)-цис-хризантемат; | [2,4-диоксо-(2-пропин-1-ил)имидазолидин-3-ил]метилов (1R)-транс-хризантемат | 428-790-6 | 72963-72-5 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
613-260-00-0 | (±)-4-(3-chlorophenyl)-6-[(4-chlorophenyl)hydroxy(1-methyl-1H-imidazol-5-yl)methyl]-1-methyl-2(1H)-quinolin | 430-730-9 | — | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  613-260-00-0 | (±)-1-метил-4-(3-хлорофенил)-6-[(4-хлорофенил)хидрокси(1-метил-1H-имидазол-5-ил)метил]-2(1H)хинолин | 430-730-9 | — | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H400 | H410 | GHS05 | GHS09 | Dgr | H318 | H410 |   |   |  
613-261-00-6 | pyrazole-1-carboxamidine monohydrochloride | 429-520-1 | 4023-02-3 | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H373** H318 | H317 | H412 | GHS05 | GHS08 | GHS07 | Dgr | H302 | H373** | H318 | H317 | H412 |   |   |  613-261-00-6 | пиразол-1-карбоксамидинмонохидрохлорид | 429-520-1 | 4023-02-3 | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H373** H318 | H317 | H412 | GHS05 | GHS08 | GHS07 | Dgr | H302 | H373** | H318 | H317 | H412 |   |   |  
613-262-00-1 | disodium (E)-1,2-bis-(4-(4-methylamino-6-(4-methylcarbamoylphenylamino)-1,3,5-triazin-2-ylamino)phenyl-2-sulfonato)ethene | 427-310-2 | 180850-95-7 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  613-262-00-1 | динатриев (E)-1,2-бис(4-(4-метиламино-6-(4-метилкарбамоилфениламино)-1,3,5-триазин-2-иламино)фенил-2-сулфонато)етен | 427-310-2 | 180850-95-7 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
613-263-00-7 | monosodium 3-cyano-5-fluoro-6-hydroxypyridine-2-olate | 429-570-2 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  613-263-00-7 | мононатриев 5-флуоро-6-хидрокси-3-цианопиридин-2-олат | 429-570-2 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
613-266-00-3 | 2-chloro-5-chloromethylthiazole | 429-830-5 | 105827-91-6 | Acute Tox. 3 * | Skin Corr. 1B | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H311 | H314 | H302 | H317 | H411 | GHS06 | GHS05 | GHS09 | Dgr | H311 | H314 | H302 | H317 | H411 |   |   |  613-266-00-3 | 2-хлоро-5-хлорометилтиазол | 429-830-5 | 105827-91-6 | Acute Tox. 3 * | Skin Corr. 1B | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H311 | H314 | H302 | H317 | H411 | GHS06 | GHS05 | GHS09 | Dgr | H311 | H314 | H302 | H317 | H411 |   |   |  
613-267-00-9 | thiamethoxam (ISO); | 3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine | 428-650-4 | 153719-23-4 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   | M=10 |  613-267-00-9 | тиаметоксам (ISO); | 3-(2-хлоротиазол-5-илметил)-5-метил[1,3,5]оксадиазинан-4-илиден-N-нитроамин | 428-650-4 | 153719-23-4 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   | M=10 |  
613-268-00-4 | (4aS-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine | 425-930-8 | 151213-39-7 | Skin Corr. 1B | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 2 | H314 | H332 | H302 | H373** | H411 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H314 | H332 | H302 | H373** | H411 |   |   |  613-268-00-4 | (4aS-цис)-6-бензилоктахидропироло[3,4-b]пиридин | 425-930-8 | 151213-39-7 | Skin Corr. 1B | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 2 | H314 | H332 | H302 | H373** | H411 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H314 | H332 | H302 | H373** | H411 |   |   |  
613-269-00-X | 2-thiazolidinylidenecyanamide | 427-720-1 | 26364-65-8 | Acute Tox. 4* | STOT RE 2 * | Aquatic Chronic 3 | H302 | H373** | H412 | GHS08 | GHS07 | Wng | H302 | H373** | H412 |   |   |  613-269-00-X | 2-тиазолидинилиденцианамид | 427-720-1 | 26364-65-8 | Acute Tox. 4* | STOT RE 2 * | Aquatic Chronic 3 | H302 | H373** | H412 | GHS08 | GHS07 | Wng | H302 | H373** | H412 |   |   |  
613-270-00-5 | 5-amino-N-(2,6-dichloro-3-methylphenyl)-1H-1,2,4-triazole-3-sulfonamide | 428-150-6 | 113171-13-4 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  613-270-00-5 | 5-амино-N-(3-метил-2,6-дихлорофенил)-1H-1,2,4-триазол-3-сулфонамид | 428-150-6 | 113171-13-4 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
613-271-00-0 | tritosulfuron (ISO) (containing ≤0,02 % AMTT); | 1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02 % AMTT) | — | 142469-14-5 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   | M=10 |  613-271-00-0 | тритосулфурон (ISO) (съдържащ ≤ 0,02 % AMTT); | 1-[4-метокси-6-(трифлуорометил)-1,3,5-триазин-2-ил]-3-[2-(трифлуорометил)бензенсулфонил]уреа (съдържащ ≤ 0,02 % AMTT) | — | 142469-14-5 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   | M=10 |  
613-272-00-6 | pyraclostrobin (ISO); | methyl N-{2-[1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl]phenyl}(N-methoxy)carbamate | — | — | Acute Tox. 3 * | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H315 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H315 | H410 |   | M=100 |  613-272-00-6 | пираклостробин (ISO); | метилов N-{2-[1-(4-хлорофенил)-1H-пиразол-3-илоксиметил]фенил}(N-метокси)карбамат | — | — | Acute Tox. 3 * | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H315 | H400 | H410 | GHS06 | GHS09 | Dgr | H331 | H315 | H410 |   | M=100 |  
613-273-00-1 | tetrahydro-3-methyl-5-((2-phenylthio)thiazol-5-ylmethyl)-[4H]-1,3,5-oxadiazinan-4-ylidene-N-nitroamine | 427-600-9 | 192439-46-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  613-273-00-1 | тетрахидро-3-метил-5-((2-фенилтио)тиазол-5-илметил)-[4H]-1,3,5-оксадиазинан-4-илиден-N-нитроамин | 427-600-9 | 192439-46-6 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
613-274-00-7 | 2,6-dichloro-1-fluoropyridiniumtetrafluoroborate | 427-400-1 | 140623-89-8 | Skin Corr. 1B | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H302 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H302 | H317 | H410 |   |   |  613-274-00-7 | 1-флуоро-2,6-дихлоропиридиниев тетрафлуороборат | 427-400-1 | 140623-89-8 | Skin Corr. 1B | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H314 | H302 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H314 | H302 | H317 | H410 |   |   |  
613-275-00-2 | 3-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a] pyrimidin-4-one monohydrochloride | 424-530-0 | 93076-03-0 | Acute Tox. 3 * | STOT SE 2 | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H301 | H371** | H373** | H318 | H317 | H411 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H301 | H371** | H373** | H318 | H317 | H411 |   |   |  613-275-00-2 | 2-метил-6,7,8,9-тетрахидро-3-(2-хлороетил)-4H-пиридо[1,2-а]пиримидин-4-онмонохидрохлорид | 424-530-0 | 93076-03-0 | Acute Tox. 3 * | STOT SE 2 | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H301 | H371** | H373** | H318 | H317 | H411 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H301 | H371** | H373** | H318 | H317 | H411 |   |   |  
613-276-00-8 | 1-(2-chlorophenyl)-1,2-dihydro-5H-tetrazol-5-one | 426-110-2 | 98377-35-6 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  613-276-00-8 | 1-(2-хлорофенил)-1,2-дихидро-5H-тетразол-5-он | 426-110-2 | 98377-35-6 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
613-277-00-3 | (4-(6-diethylamino-2-methylpyridin-3-yl)imino-4,5-dihydro-3-methyl-1-(4-methylphenyl)-1H-pyrazol-5-one | 427-070-9 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  613-277-00-3 | (4-(6-диетиламино-2-метилпиридин-3-ил)имино-3-метил-1-(4-метилфенил)-4,5-дихидро-1H-пиразол-5-он | 427-070-9 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
613-278-00-9 | (3-aminophenyl)pyridin-3-ylmethanone | 428-230-0 | 79568-06-2 | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H373** | H400 | H410 | GHS08 | GHS09 | Wng | H373** | H410 |   |   |  613-278-00-9 | (3-аминофенил)пиридин-3-илметанон | 428-230-0 | 79568-06-2 | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H373** | H400 | H410 | GHS08 | GHS09 | Wng | H373** | H410 |   |   |  
613-279-00-4 | 2-ethyl-2,3-dihydro-2-methyl-1H-perimidine | 424-380-6 | 43057-68-7 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373** | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373** | H410 |   |   |  613-279-00-4 | 2-етил-2-метил-2,3-дихидро-1H-перимидин | 424-380-6 | 43057-68-7 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373** | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373** | H410 |   |   |  
613-280-00-X | tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one; | dimethyl propyleneurea | 230-625-6 | 7226-23-5 | Repr. 2 | Acute Tox. 4 * | Eye Dam. 1 | H361f*** | H302 | H318 | GHS05 | GHS08 | GHS07 | Dgr | H361f*** | H302 | H318 |   |   |  613-280-00-X | 1,3-диметилтетрахидро-1H-пиримидин-2-он | диметилпропиленуреа | 230-625-6 | 7226-23-5 | Repr. 2 | Acute Tox. 4 * | Eye Dam. 1 | H361f*** | H302 | H318 | GHS05 | GHS08 | GHS07 | Dgr | H361f*** | H302 | H318 |   |   |  
613-281-00-5 | quinoline | 202-051-6 | 91-22-5 | Carc. 1B Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 2 | H350 | H341 | H312 | H302 | H319 | H315 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H341 | H312 | H302 | H319 | H315 | H411 |   |   |  613-281-00-5 | хинолин | 202-051-6 | 91-22-5 | Carc. 1B Muta. 2 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 2 | H350 | H341 | H312 | H302 | H319 | H315 | H411 | GHS08 | GHS07 | GHS09 | Dgr | H350 | H341 | H312 | H302 | H319 | H315 | H411 |   |   |  
613-282-00-0 | triticonazole (ISO); | (RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol | — | 131983-72-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  613-282-00-0 | тритиконазол (ISO); | (RS)-(E)-2,2-диметил-1-(1H-1,2,4-триазол-1-метил)-5-(4-хлоробензилиден)циклопентанол | — | 131983-72-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
613-283-00-6 | ketoconazole; | 1-[4-[4-[[(2SR, 4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone | 265-667-4 | 65277-42-1 | Repr. 1B | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H360F*** | H301 | H373** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H360F*** | H301 | H373** | H410 |   |   |  613-283-00-6 | кетоконазол; | 1-[4-[4-[[(2SR,4RS)-2-(имидазол-1-илметил)-2-(2,4-дихлорофенил)-1,3-диоксолан-4-ил]метокси]фенил]пиперазин-1-ил]етанон | 265-667-4 | 65277-42-1 | Repr. 1B | Acute Tox. 3 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H360F*** | H301 | H373** | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H360F*** | H301 | H373** | H410 |   |   |  
613-284-00-1 | metconazole (ISO); | (1RS, 5RS;1RS, 5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol | — | 125116-23-6 | Repr. 2 | Acute Tox. 4 * | Aquatic Chronic 2 | H361d*** | H302 | H411 | GHS08 | GHS07 | GHS09 | Wng | H361d*** | H302 | H411 |   |   |  613-284-00-1 | мeтконазол (ISO); | (1RS,5RS;1RS,5SR)-2,2-диметил-1-(1H-1,2,4-триазол-1-илметил)-5-(4-хлоробензил)циклопентанол | — | 125116-23-6 | Repr. 2 | Acute Tox. 4 * | Aquatic Chronic 2 | H361d*** | H302 | H411 | GHS08 | GHS07 | GHS09 | Wng | H361d*** | H302 | H411 |   |   |  
613-285-00-7 | 1-hydroxybenzotriazole, anhydrous; [1] | 1-hydroxybenzotriazole, monohydrated [2] | 219-989-7 [1] | 219-989-7 [2] | 2592-95-2 [1] | 123333-53-9 [2] | Expl. 1.3 | H203 | GHS01 | Dgr | H203 |   |   |  613-285-00-7 | 1-хидроксибензотриазол, безводен; [1] | 1-хидроксибензотриазол, монохидрат [2] | 219-989-7 [1] | 219-989-7 [2] | 2592-95-2 [1] | 123333-53-9 [2] | Expl. 1.3 | H203 | GHS01 | Dgr | H203 |   |   |  
613-286-00-2 | potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate; | [containing < 0,5 % N, N-dimethylformamide (EC no | 200-679-5)] | 418-260-2 | 183196-57-8 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  613-286-00-2 | калиев 1-метил-3-морфолинокарбонил-4-[3-(1-метил-3-морфолинокарбонил-5-оксо-2-пиразолин-4-илиден)-1-пропенил]пиразол-5-олат; | [съдържащ < 0,5 % N,N-диметилформамид (ЕО № | 200-679-5)] | 418-260-2 | 183196-57-8 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
613-286-01-X | potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate; | [containing ≥ 0,5 % N, N-dimethylformamide (EC No 200-679-5)] | 418-260-2 | 183196-57-8 | Repr. 1B | Skin Sens. 1 | H360D*** H317 | GHS08 | GHS07 | Dgr | H360D*** H317 |   |   |  613-286-01-X | калиев 1-метил-3-морфолинокарбонил-4-[3-(1-метил-3-морфолинокарбонил-5-оксо-2-пиразолин-4-илиден)-1-пропенил]пиразол-5-олат; | [съдържащ ≥ 0,5 % N,N-диметилформамид (ЕО № 200-679-5)] | 418-260-2 | 183196-57-8 | Repr. 1B | Skin Sens. 1 | H360D*** H317 | GHS08 | GHS07 | Dgr | H360D*** H317 |   |   |  
613-287-00-8 | 1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole | 419-540-7 | 160194-26-3 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  613-287-00-8 | 1-(3-йодо-4-аминобензил)-1H-1,2,4-триазол | 419-540-7 | 160194-26-3 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  
613-288-00-3 | 1,3-bis(dimethylcarbamoyl)-imidazolium chloride | 420-930-4 | 135756-61-5 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  613-288-00-3 | 1,3-бис(диметилкарбамоил)имидазолиев хлорид | 420-930-4 | 135756-61-5 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  
613-289-00-9 | 3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole | 432-020-4 | 142623-48-1 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  613-289-00-9 | 3-(5-метил-2-флуоро-4-хлорофенил)-1-метил-5-(трифлуорометил)-1H-пиразол | 432-020-4 | 142623-48-1 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
613-290-00-4 | 4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride | 432-470-1 | 189012-93-9 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H410 |   |   |  613-290-00-4 | 4-хидрокси-7-(2-аминоетил)-1,3-бензотиазол-2(3H)-онхидрохлорид | 432-470-1 | 189012-93-9 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H410 |   |   |  
613-291-00-X | 2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one | 434-820-9 | 106461-41-0 | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H373** | H400 | H410 | GHS08 | GHS09 | Wng | H373** | H410 |   |   |  613-291-00-X | 2,4-дихидро-4-(4-(4-(4-хидроксифенил)-1-пиперазинил)фенил)-2-(1-метилпропил)-3H-1,2,4-триазол-3-он | 434-820-9 | 106461-41-0 | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H373** | H400 | H410 | GHS08 | GHS09 | Wng | H373** | H410 |   |   |  
613-292-00-5 | N, N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine | 435-010-8 | 26157-73-3 | Muta. 2 | Aquatic Chronic 3 | H341 | H412 | GHS08 | Wng | H341 | H412 |   |   |  613-292-00-5 | N,N′,N′′-трис(2-метил-2,3-епоксипропил)перхидро-2,4,6-оксо-1,3,5-триазин | 435-010-8 | 26157-73-3 | Muta. 2 | Aquatic Chronic 3 | H341 | H412 | GHS08 | Wng | H341 | H412 |   |   |  
613-293-00-0 | 2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonyl | methyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester | 448-050-6 | 444065-11-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  613-293-00-0 | 2,6-ди-трет-бутил-4-метилциклохексилов естер на 2-(4-трет-бутилфенил)-6-циано-5-[бис(етоксикарбонил | метил)карбамоилокси]-1H-пироло[1,2-b][1,2,4]триазол-7-карбоксилната киселина | 448-050-6 | 444065-11-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
613-294-00-6 | 2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester | 448-260-8 | 379268-96-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  613-294-00-6 | [4-(6-трет-бутил-7-хлоро-1H-пиразоло[1,5-b][1,2,4]триазол-2-ил)фенилкарбамоил]метилов естер на 2-хексилдекановата киселина | 448-260-8 | 379268-96-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
613-295-00-1 | 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c, f][1,2]thiazepine hydrochloride | 448-720-8 | 363138-44-7 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  613-295-00-1 | 11-амино-3-хлоро-6,11-дихидро-5,5-диоксо-6-метилдибензо[c,f][1,2]тиазепинхидрохлорид | 448-720-8 | 363138-44-7 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  
613-296-00-7 | pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1yl)benzene-1,4-disulfonate | 418-270-7 | — | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  613-296-00-7 | пентакалиев 2-(4-(5-[1-(2,5-дисулфонатофенил)-4,5-дихидро-3-метилкарбамоил-5-оксопиразол-4-илиден]-3-метил-1,3-пентадиенил)-3-метилкарбамоил-5-оксопиразол-1-ил)бензен-1,4-дисулфонат | 418-270-7 | — | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
613-297-00-2 | 5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole | 420-820-6 | — | Flam. Liq. 3 | Acute Tox. 4 * | Aquatic Chronic 2 | H226 | H302 | H411 | GHS02 | GHS07 | GHS09 | Wng | H226 | H302 | H411 |   |   |  613-297-00-2 | 5-(2-бромофенил)-2-трет-бутил-2H-тетразол | 420-820-6 | — | Flam. Liq. 3 | Acute Tox. 4 * | Aquatic Chronic 2 | H226 | H302 | H411 | GHS02 | GHS07 | GHS09 | Wng | H226 | H302 | H411 |   |   |  
613-298-00-8 | bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate | 421-560-6 | — | STOT RE 2 * | Eye Dam. 1 | Aquatic Chronic 2 | H373** | H318 | H411 | GHS05 | GHS08 | GHS09 | Dgr | H373** | H318 | H411 |   |   |  613-298-00-8 | бис(6-хидрокси-4-метил-5-(3-метилимидазолий-1-ил)-3-(4-фенилазо)-1H-пиридин-2-он)етилен дилактат | 421-560-6 | — | STOT RE 2 * | Eye Dam. 1 | Aquatic Chronic 2 | H373** | H318 | H411 | GHS05 | GHS08 | GHS09 | Dgr | H373** | H318 | H411 |   |   |  
613-299-00-3 | main component 1 (isomer 1): | 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; | main component 1 (isomer 2): | 2-{6-fluoro-4-[3-(2,5-disulfophenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; | main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; | main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt | 422-610-1 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  613-299-00-3 | основна съставка 1 (изомер 1): | 2-{6-флуоро-4-[3-(2,5-дисулфофенилазо)-4-хидрокси-2-сулфонафт-7-иламино]-1,3,5-триазин-2-иламино}-3-{6-флуоро-4-[3-(1,5-дисулфонафт-2-илазо)-4-хидрокси-2-сулфонафт-7-иламино]-1,3,5-триазин-2-иламино}пропан, натриева сол; | основна съставка 1 (изомер 2): | 2-{6-флуоро-4-[3-(2,5-дисулфофенилазо)-4-хидрокси-2-сулфонафт-7-иламино]-1,3,5-триазин-2-иламино}-3-{6-флуоро-4-[3-(2,5-дисулфофенилазо)-4-хидрокси-2-сулфонафт-7-иламино]-1,3,5-триазин-2-иламино}пропан, натриева сол; | основна съставка 2: 2,3-бис{6-флуоро-4-[3-(2,5-дисулфофенилазо)-4-хидрокси-2-сулфонафт-7-иламино]-1,3,5-триазин-2-иламино}пропан, натриева сол; | основна съставка 3: 2,3-бис{6-флуоро-4-[3-(1,5-дисулфонафт-2-илазо)-4-хидрокси-2-сулфонафт-7-иламино]-1,3,5-триазин-2-иламино}пропан, натриева сол; | 422-610-1 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
613-300-00-7 | 1-imidazol-1-yl-octadecan-2-ol | 434-120-3 | — | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  613-300-00-7 | 1-имидазол-1-илоктадекан-2-ол | 434-120-3 | — | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
613-301-00-2 | dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate | 443-910-7 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  613-301-00-2 | диметил-1-{[2-метокси-5-(2-метилбутоксикарбонил)фенилкарбамоил][2-октадецил-1,1-диоксо-1,2,4-бензотиадиазин-3-ил]метил}имидазол-4,5-дикарбоксилат | 443-910-7 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
613-302-00-8 | disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate | 432-980-4 | 243858-60-8 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  613-302-00-8 | динатриев 2-(1-етил-5-карбамоил-4-метил-6-оксо-1,6-дихидро-2-хидроксипиридин-3-илазо)-4-(4-флуоро-6-(4-(2-сулфонилоксиетилсулфонил)фениламино)-1,3,5-триазин-2-иламино)бензенсулфонат | 432-980-4 | 243858-60-8 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
613-303-00-3 | 2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine | 429-800-1 | 95737-68-1 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  613-303-00-3 | 2-(1-метил-2-(4-феноксифенокси)етокси)пиридин | 429-800-1 | 95737-68-1 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
613-304-00-9 | 5,6-dihydroxy-2,3-dihydro-1H-indolium bromide | 421-170-6 | 138937-28-7 | Acute Tox. 4 * | Eye Dam. 1 | H302 | H318 | GHS05 | GHS07 | Dgr | H302 | H318 |   |   |  613-304-00-9 | 5,6-дихидрокси-2,3-дихидро-1H-индолиев бромид | 421-170-6 | 138937-28-7 | Acute Tox. 4 * | Eye Dam. 1 | H302 | H318 | GHS05 | GHS07 | Dgr | H302 | H318 |   |   |  
613-305-00-4 | 2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole | 448-630-9 | 3147-77-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  613-305-00-4 | 2-(4-октилокси-2-хидроксифенил)-2H-бензотриазол | 448-630-9 | 3147-77-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
613-306-00-X | (2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate | 433-520-5 | 82911-69-1 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  613-306-00-X | (2,5-диоксопиролидин-1-ил)-9H-флуорен-9-илметилкарбонат | 433-520-5 | 82911-69-1 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H317 | H411 |   |   |  
613-307-00-5 | clothianidin (ISO); | 3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine | — | 210880-92-5 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   | M=10 |  613-307-00-5 | клотианидин (ISO); | 2-метил-1-нитро-3-[(2-хлоро-1,3-тиазол-5-ил)метил]гуанидин | — | 210880-92-5 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   | M=10 |  
613-308-00-0 | 2-amino-5-methylthiazole | 423-800-5 | 7305-71-7 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373** | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373** | H410 |   |   |  613-308-00-0 | 2-амино-5-метилтиазол | 423-800-5 | 7305-71-7 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373** | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373** | H410 |   |   |  
613-309-00-6 | 1-methyl-3-phenyl-1-piperazine | 431-180-2 | 5271-27-2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H312 | H302 | H315 | H318 | H412 | GHS05 | GHS07 | Dgr | H312 | H302 | H315 | H318 | H412 |   |   |  613-309-00-6 | 1-метил-3-фенил-1-пиперазин | 431-180-2 | 5271-27-2 | Acute Tox. 4 * | Acute Tox. 4 * | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 3 | H312 | H302 | H315 | H318 | H412 | GHS05 | GHS07 | Dgr | H312 | H302 | H315 | H318 | H412 |   |   |  
613-310-00-1 | (-)(3S, 4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride | 432-360-3 | 105813-13-6 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  613-310-00-1 | (-)(3S,4R)-3-(3,4-метилендиоксифеноксиметил)-4-(4-флуорофенил)-N-бензилпиперидинхидрохлорид | 432-360-3 | 105813-13-6 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  
613-311-00-7 | methyl-5-nitrophenyl-guanidine | 435-500-1 | 152460-07-6 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H319 | H317 | H412 | GHS07 | Wng | H302 | H319 | H317 | H412 |   |   |  613-311-00-7 | метил-5-нитрофенилгуанидин | 435-500-1 | 152460-07-6 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H319 | H317 | H412 | GHS07 | Wng | H302 | H319 | H317 | H412 |   |   |  
613-312-00-2 | 2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride | 420-200-5 | — | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H317 | H412 |   |   |  613-312-00-2 | 2-(4-метил-2-фенил-1-пиперазинил)бензенметанолмонохидрохлорид | 420-200-5 | — | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H317 | H412 |   |   |  
613-313-00-8 | 2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione | 442-780-9 | 173838-67-0 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  613-313-00-8 | 2-(4-(4-(3-пиридинил)-1H-имидазол-1-ил)бутил)-1H-изоиндол-1,3(2H)-дион | 442-780-9 | 173838-67-0 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
613-314-00-3 | 4-decyloxazolidin-2-one; | 4-decyl-1,3-oxazolidin-2-one | 443-770-7 | 7693-82-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  613-314-00-3 | 4-дециклоксазолидин-2-он; | 4-децил-1,3-оксазолидин-2-он | 443-770-7 | 7693-82-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
613-315-00-9 | tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate | 430-390-1 | — | Acute Tox. 4 * | Aquatic Chronic 3 | H332 | H412 | GHS07 | Wng | H332 | H412 |   |   |  613-315-00-9 | тетракалиев 4-[5-[3-карбоксилато-5-оксо-1-(4-сулфонатофенил)-4,5-дихидропиразол-4-илиден]-3-(пиперидинокарбонил)пента-1,3-диенилиден]-1-(4-сулфонатофенил)-5-хидроксипиразол-3-карбоксилат | 430-390-1 | — | Acute Tox. 4 * | Aquatic Chronic 3 | H332 | H412 | GHS07 | Wng | H332 | H412 |   |   |  
613-316-00-4 | trimethylopropane tri(3-aziridinylpropanoate); | (TAZ) | 257-765-0 | 52234-82-9 | Muta. 2 | Eye Dam. 1 | Skin Sens. 1 | H341 | H318 | H317 | GHS05 | GHS08 | GHS07 | Dgr | H341 | H318 | H317 |   |   |  613-316-00-4 | триметилопропанов три(3-азиридинилпропаноат); | (TAZ) | 257-765-0 | 52234-82-9 | Muta. 2 | Eye Dam. 1 | Skin Sens. 1 | H341 | H318 | H317 | GHS05 | GHS08 | GHS07 | Dgr | H341 | H318 | H317 |   |   |  
613-317-00-X | penconazole (ISO); 1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole | 266-275-6 | 66246-88-6 | Repr. 2 | Acute Tox. 4 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H361d | H302 | H410 |   | M = 1 | M = 1 |  613-317-00-X | пенконазол (ISO); 1-[2-(2,4-дихлорофенил)пентил]-1H-1,2,4-триазол | 266-275-6 | 66246-88-6 | Repr. 2 | Acute Tox. 4 | Aquatic Acute 1 | Aquatic Chronic 1 | H361d | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H361d | H302 | H410 |   | M = 1 | M = 1 |  
614-002-00-X | salts of nicotine | — | — | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Chronic 2 | H330 | H310 | H300 | H411 | GHS06 | GHS09 | Dgr | H330 | H310 | H300 | H411 |   |   | A614-002-00-X | соли на никотина | — | — | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Chronic 2 | H330 | H310 | H300 | H411 | GHS06 | GHS09 | Dgr | H330 | H310 | H300 | H411 |   |   | A
614-003-00-5 | strychnine | 200-319-7 | 57-24-9 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   |   |  614-003-00-5 | стрихнин | 200-319-7 | 57-24-9 | Acute Tox. 1 | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H310 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H310 | H300 | H410 |   |   |  
614-004-00-0 | salts of strychnine | — | — | Acute Tox. 2 * | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H300 | H410 |   |   | A614-004-00-0 | соли на стрихнина | — | — | Acute Tox. 2 * | Acute Tox. 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H300 | H400 | H410 | GHS06 | GHS09 | Dgr | H330 | H300 | H410 |   |   | A
614-005-00-6 | colchicine | 200-598-5 | 64-86-8 | Muta. 1B | Acute Tox. 2 * | H340 | H300 | GHS06 | GHS08 | Dgr | H340 | H300 |   |   |  614-005-00-6 | колхицин | 200-598-5 | 64-86-8 | Muta. 1B | Acute Tox. 2 * | H340 | H300 | GHS06 | GHS08 | Dgr | H340 | H300 |   |   |  
614-006-00-1 | brucine; | 2,3-dimethoxystrychnine | 206-614-7 | 357-57-3 | Acute Tox. 2 * | Acute Tox. 2 * | Aquatic Chronic 3 | H330 | H300 | H412 | GHS06 | Dgr | H330 | H300 | H412 |   |   |  614-006-00-1 | бруцин; | 2,3-диметоксистрихнин | 206-614-7 | 357-57-3 | Acute Tox. 2 * | Acute Tox. 2 * | Aquatic Chronic 3 | H330 | H300 | H412 | GHS06 | Dgr | H330 | H300 | H412 |   |   |  
614-007-00-7 | brucine sulphate; [1] | brucine nitrate; [2] | strychnidin-10-one, 2,3-dimethoxy-, mono[(R)-1-methylheptyl 1,2-benzenedicarboxylate]; [3] | strychnidin-10-one, 2,3-dimethoxy-, compd.with (S) mono(1-methylheptyl)-1,2-benzenedicarboxylate (1:1) [4] | 225-432-9 [1] | 227-317-9 [2] | 269-439-5 [3] | 269-710-8 [4] | 4845-99-2 [1] | 5786-97-0 [2] | 68239-26-9 [3] | 68310-42-9 [4] | Acute Tox. 2 * | Acute Tox. 2 * | Aquatic Chronic 3 | H330 | H300 | H412 | GHS06 | Dgr | H330 | H300 | H412 |   |   | A614-007-00-7 | бруцин сулфат; [1] | бруцин нитрат; [2] | 2,3-диметоксистрихнидин-10-oн, мoно[(R)-1-метилхептилов 1,2-бензендикарбоксилат]; [3] | 2,3-диметоксистрихнидин-10-oн, съединение с (S)-мoно(1-метилхептил)-1,2-бензендикарбоксилат (1:1) [4] | 225-432-9 [1] | 227-317-9 [2] | 269-439-5 [3] | 269-710-8 [4] | 4845-99-2 [1] | 5786-97-0 [2] | 68239-26-9 [3] | 68310-42-9 [4] | Acute Tox. 2 * | Acute Tox. 2 * | Aquatic Chronic 3 | H330 | H300 | H412 | GHS06 | Dgr | H330 | H300 | H412 |   |   | A
614-008-00-2 | aconitine | 206-121-7 | 302-27-2 | Acute Tox. 2 * | Acute Tox. 2 * | H330 | H300 | GHS06 | Dgr | H330 | H300 |   |   |  614-008-00-2 | аконитин | 206-121-7 | 302-27-2 | Acute Tox. 2 * | Acute Tox. 2 * | H330 | H300 | GHS06 | Dgr | H330 | H300 |   |   |  
614-009-00-8 | salts of aconitine | — | — | Acute Tox. 2 * | Acute Tox. 2 * | H330 | H300 | GHS06 | Dgr | H330 | H300 |   |   | A614-009-00-8 | соли на аконитина | — | — | Acute Tox. 2 * | Acute Tox. 2 * | H330 | H300 | GHS06 | Dgr | H330 | H300 |   |   | A
614-010-00-3 | atropine | 200-104-8 | 51-55-8 | Acute Tox. 2 * | Acute Tox. 2 * | H330 | H300 | GHS06 | Dgr | H330 | H300 |   |   |  614-010-00-3 | атропин | 200-104-8 | 51-55-8 | Acute Tox. 2 * | Acute Tox. 2 * | H330 | H300 | GHS06 | Dgr | H330 | H300 |   |   |  
614-011-00-9 | salts of atropine | — | — | Acute Tox. 2 * | Acute Tox. 2 * | H330 | H300 | GHS06 | Dgr | H330 | H300 |   |   | A614-011-00-9 | соли на атропина | — | — | Acute Tox. 2 * | Acute Tox. 2 * | H330 | H300 | GHS06 | Dgr | H330 | H300 |   |   | A
614-012-00-4 | hyoscyamine | 202-933-0 | 101-31-5 | Acute Tox. 2 * | Acute Tox. 2 * | H330 | H300 | GHS06 | Dgr | H330 | H300 |   |   |  614-012-00-4 | хиосциамин | 202-933-0 | 101-31-5 | Acute Tox. 2 * | Acute Tox. 2 * | H330 | H300 | GHS06 | Dgr | H330 | H300 |   |   |  
614-013-00-X | salts of hyoscyamine | — | — | Acute Tox. 2 * | Acute Tox. 2 * | H330 | H300 | GHS06 | Dgr | H330 | H300 |   |   | A614-013-00-X | соли на хиосциамина | — | — | Acute Tox. 2 * | Acute Tox. 2 * | H330 | H300 | GHS06 | Dgr | H330 | H300 |   |   | A
614-014-00-5 | hyoscine | 200-090-3 | 51-34-3 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | H330 | H310 | H300 | GHS06 | Dgr | H330 | H310 | H300 |   |   |  614-014-00-5 | хиосцин | 200-090-3 | 51-34-3 | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | H330 | H310 | H300 | GHS06 | Dgr | H330 | H310 | H300 |   |   |  
614-015-00-0 | salts of hyoscine | — | — | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | H330 | H310 | H300 | GHS06 | Dgr | H330 | H310 | H300 |   |   | A614-015-00-0 | соли на хиосцина | — | — | Acute Tox. 2 * | Acute Tox. 1 | Acute Tox. 2 * | H330 | H310 | H300 | GHS06 | Dgr | H330 | H310 | H300 |   |   | A
614-016-00-6 | pilocarpine | 202-128-4 | 92-13-7 | Acute Tox. 2 * | Acute Tox. 2 * | H330 | H300 | GHS06 | Dgr | H330 | H300 |   |   |  614-016-00-6 | пилокарпин | 202-128-4 | 92-13-7 | Acute Tox. 2 * | Acute Tox. 2 * | H330 | H300 | GHS06 | Dgr | H330 | H300 |   |   |  
614-017-00-1 | salts of pilocarpine | — | — | Acute Tox. 2 * | Acute Tox. 2 * | H330 | H300 | GHS06 | Dgr | H330 | H300 |   |   | A614-017-00-1 | соли на пилокарпина | — | — | Acute Tox. 2 * | Acute Tox. 2 * | H330 | H300 | GHS06 | Dgr | H330 | H300 |   |   | A
614-018-00-7 | papaverine | 200-397-2 | 58-74-2 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  614-018-00-7 | папаверин | 200-397-2 | 58-74-2 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
614-019-00-2 | salts of papaverine | — | — | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   | A614-019-00-2 | соли на папаверина | — | — | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   | A
614-020-00-8 | physostigmine | 200-332-8 | 57-47-6 | Acute Tox. 2 * | Acute Tox. 2 * | H330 | H300 | GHS06 | Dgr | H330 | H300 |   |   |  614-020-00-8 | физостигмин | 200-332-8 | 57-47-6 | Acute Tox. 2 * | Acute Tox. 2 * | H330 | H300 | GHS06 | Dgr | H330 | H300 |   |   |  
614-021-00-3 | salts of physostigmine | — | — | Acute Tox. 2 * | Acute Tox. 2 * | H330 | H300 | GHS06 | Dgr | H330 | H300 |   |   | A614-021-00-3 | соли на физостигмина | — | — | Acute Tox. 2 * | Acute Tox. 2 * | H330 | H300 | GHS06 | Dgr | H330 | H300 |   |   | A
614-022-00-9 | digitoxin | 200-760-5 | 71-63-6 | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | H331 | H301 | H373 ** | GHS06 | GHS08 | Dgr | H331 | H301 | H373 ** |   |   |  614-022-00-9 | дигитоксин | 200-760-5 | 71-63-6 | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | H331 | H301 | H373 ** | GHS06 | GHS08 | Dgr | H331 | H301 | H373 ** |   |   |  
614-023-00-4 | ephedrine | 206-080-5 | 299-42-3 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  614-023-00-4 | ефедрин | 206-080-5 | 299-42-3 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
614-024-00-X | salts of ephedrine | — | — | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   | A614-024-00-X | соли на ефедрина | — | — | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   | A
614-025-00-5 | ouabain | 211-139-3 | 630-60-4 | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | H331 | H301 | H373 ** | GHS06 | GHS08 | Dgr | H331 | H301 | H373 ** |   |   |  614-025-00-5 | уабаин | 211-139-3 | 630-60-4 | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | H331 | H301 | H373 ** | GHS06 | GHS08 | Dgr | H331 | H301 | H373 ** |   |   |  
614-026-00-0 | strophantin-K | 234-239-9 | 11005-63-3 | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | H331 | H301 | H373 ** | GHS06 | GHS08 | Dgr | H331 | H301 | H373 ** |   |   |  614-026-00-0 | строфантин-K | 234-239-9 | 11005-63-3 | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | H331 | H301 | H373 ** | GHS06 | GHS08 | Dgr | H331 | H301 | H373 ** |   |   |  
614-027-00-6 | bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(β-D-glucopyranosyloxy)-8,14-dihydroxy-, (3β, 6β)-; | red squill; | scilliroside | 208-077-4 | 507-60-8 | Acute Tox. 2 * | H300 | GHS06 | Dgr | H300 |   |   |  614-027-00-6 | (3β,6β)-6-(ацетилокси)-3-(β-D- глюкопиранозилокси)-8,14-дихидроксибуфа-4,20,22-триенолид; | морски лук; | сцилирозид | 208-077-4 | 507-60-8 | Acute Tox. 2 * | H300 | GHS06 | Dgr | H300 |   |   |  
614-028-00-1 | reaction mass of: 2-ethylhexyl mono-D-glucopyranoside; | 2-ethylhexyl di-D-glucopyranoside | 414-420-0 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  614-028-00-1 | реакционна маса от: 2-етилхексилов моно-D-глюкопиранозид; | 2-етилхексилов ди-D-глюкопиранозид | 414-420-0 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
614-029-00-7 | constitutional isomers of penta-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside; | constitutional isomers of hexa-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside; | constitutional isomers of hepta-O-allyl-β-D-fructofuransoyl-α-D-glucopyranoside | 419-640-0 | 68784-14-5 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  614-029-00-7 | конституционни изомери на пента-O-алил-β-D-фруктофуранозил-α-D-глюкопиранозид; | конституционни изомери на хекса-O-алил-β-D-фруктофуранозил-α-D-глюкопиранозид; | конституционни изомери на хепта-O-алил-β-D-фруктофуранозил-α-D-глюкопиранозид | 419-640-0 | 68784-14-5 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
615-001-00-7 | methyl isocyanate | 210-866-3 | 624-83-9 | Flam. Liq. 2 | Repr. 2 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 3 * | Resp. Sens. 1 | Skin Sens. 1 | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | H225 | H361d*** H330 | H311 | H301 | H334 | H317 | H335 | H315 | H318 | GHS02 | GHS06 | GHS05 | GHS08 | Dgr | H225 | H361d*** H330 | H311 | H301 | H334 | H317 | H335 | H315 | H318 |   |   |  615-001-00-7 | метилов изоцианат | 210-866-3 | 624-83-9 | Flam. Liq. 2 | Repr. 2 | Acute Tox. 2 * | Acute Tox. 3 * | Acute Tox. 3 * | Resp. Sens. 1 | Skin Sens. 1 | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | H225 | H361d*** H330 | H311 | H301 | H334 | H317 | H335 | H315 | H318 | GHS02 | GHS06 | GHS05 | GHS08 | Dgr | H225 | H361d*** H330 | H311 | H301 | H334 | H317 | H335 | H315 | H318 |   |   |  
615-002-00-2 | methyl isothiocyanate | 209-132-5 | 556-61-6 | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H314 | H317 | H400 | H410 | GHS06 | GHS05 | GHS09 | Dgr | H331 | H301 | H314 | H317 | H410 |   |   |  615-002-00-2 | метилов изотиоцианат | 209-132-5 | 556-61-6 | Acute Tox. 3 * | Acute Tox. 3 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H301 | H314 | H317 | H400 | H410 | GHS06 | GHS05 | GHS09 | Dgr | H331 | H301 | H314 | H317 | H410 |   |   |  
615-003-00-8 | thiocyanic acid | 207-337-4 | 463-56-9 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 3 | H332 | H312 | H302 | H412 | GHS07 | Wng | H332 | H312 | H302 | H412 | EUH032 |   |  615-003-00-8 | тиоцианова киселина | 207-337-4 | 463-56-9 | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 3 | H332 | H312 | H302 | H412 | GHS07 | Wng | H332 | H312 | H302 | H412 | EUH032 |   |  
615-004-00-3 | salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex | — | — | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 3 | H332 | H312 | H302 | H412 | GHS07 | Wng | H332 | H312 | H302 | H412 | EUH032 |   | A615-004-00-3 | соли на тиоциановата киселина, с изключение на тези, посочени другаде в настоящото приложение | — | — | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 3 | H332 | H312 | H302 | H412 | GHS07 | Wng | H332 | H312 | H302 | H412 | EUH032 |   | A
615-005-00-9 | 4,4'-methylenediphenyl diisocyanate; diphenylmethane-4,4'-diisocyanate; [1] | 2,2'-methylenediphenyl diisocyanate; diphenylmethane-2,2'-diisocyanate; [2] | o-(p-isocyanatobenzyl)phenyl isocyanate; | diphenylmethane-2,4'-diisocyanate; [3] | methylenediphenyl diisocyanate [4] | 202-966-0 [1] | 219-799-4 [2] | 227-534-9 [3] | 247-714-0 [4] | 101-68-8 [1] | 2536-05-2 [2] | 5873-54-1 [3] | 26447-40-5 [4] | Carc. 2 | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | H351 | H332 | H373** | H319 | H335 | H315 | H334 | H317 | GHS08 | GHS07 | Dgr | H351 | H332 | H373** | H319 | H335 | H315 | H334 | H317 |   | Eye Irrit. 2; H319: | C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % Resp. Sens. 1; H334: C ≥ 0,1  % | STOT SE 3; H335: C ≥ 5 % | C2615-005-00-9 | 4,4′-метилендифенилов диизоцианат; дифенилметан-4,4′-диизоцианат; [1] | 2,2′-метилендифенилов диизоцианат; дифенилметан-2,2′-диизоцианат; [2] | o-(p-изоцианатобензил)фенилов изоцианат; | дифенилметан-2,4′-диизоцианат; [3] | метилендифенилов диизоцианат [4] | 202-966-0 [1] | 219-799-4 [2] | 227-534-9 [3] | 247-714-0 [4] | 101-68-8 [1] | 2536-05-2 [2] | 5873-54-1 [3] | 26447-40-5 [4] | Carc. 2 | Acute Tox. 4 * | STOT RE 2 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | H351 | H332 | H373** | H319 | H335 | H315 | H334 | H317 | GHS08 | GHS07 | Dgr | H351 | H332 | H373** | H319 | H335 | H315 | H334 | H317 |   | Eye Irrit. 2; H319: | C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % Resp. Sens. 1; H334: C ≥ 0,1  % | STOT SE 3; H335: C ≥ 5 % | C2
615-006-00-4 | 2-methyl-m-phenylene diisocyanate; | toluene-2,4-di-isocyanate; [1] | 4-methyl-m-phenylene diisocyanate; | toluene-2,6-di-isocyanate; [2] | m-tolylidene diisocyanate; | toluene-diisocyanate [3] | 202-039-0 [1] | 209-544-5 [2] | 247-722-4 [3] | 91-08-7 [1] | 584-84-9 [2] | 26471-62-5 [3] | Carc. 2 | Acute Tox. 2 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H351 | H330 | H319 | H335 | H315 | H334 | H317 | H412 | GHS06 | GHS08 | Dgr | H351 | H330 | H319 | H335 | H315 | H334 | H317 | H412 |   | Resp. Sens. 1; H334: C ≥ | 0,1  % | C615-006-00-4 | 2-мeтил-m-фениленов диизоцианат; | толуен-2,4-диизоцианат; [1] | 4-мeтил-m-фениленов диизоцианат; | толуен-2,6-диизоцианат; [2] | m-тoлилиденов диизоцианат; | толуенов диизоцианат [3] | 202-039-0 [1] | 209-544-5 [2] | 247-722-4 [3] | 91-08-7 [1] | 584-84-9 [2] | 26471-62-5 [3] | Carc. 2 | Acute Tox. 2 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H351 | H330 | H319 | H335 | H315 | H334 | H317 | H412 | GHS06 | GHS08 | Dgr | H351 | H330 | H319 | H335 | H315 | H334 | H317 | H412 |   | Resp. Sens. 1; H334: C ≥ | 0,1  % | C
615-007-00-X | 1,5-naphthylene diisocyanate | 221-641-4 | 3173-72-6 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | Aquatic Chronic 3 | H332 | H319 | H335 | H315 | H334 | H412 | GHS08 | GHS07 | Dgr | H332 | H319 | H335 | H315 | H334 | H412 |   |   |  615-007-00-X | 1,5-нафтиленов диизоцианат | 221-641-4 | 3173-72-6 | Acute Tox. 4 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | Aquatic Chronic 3 | H332 | H319 | H335 | H315 | H334 | H412 | GHS08 | GHS07 | Dgr | H332 | H319 | H335 | H315 | H334 | H412 |   |   |  
615-008-00-5 | 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate; isophorone di-isocyanate | 223-861-6 | 4098-71-9 | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H331 | H319 | H335 | H315 | H334 | H317 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H319 | H335 | H315 | H334 | H317 | H411 |   | * | Resp. Sens. 1; H334: C ≥0,5  % | Skin Sens.1; H317: C ≥0,5  % | 2615-008-00-5 | 3-изоцианатометил-3,5,5-триметилциклохексилов изоцианат; изофорондиизоцианат | 223-861-6 | 4098-71-9 | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H331 | H319 | H335 | H315 | H334 | H317 | H411 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H319 | H335 | H315 | H334 | H317 | H411 |   | * | Resp. Sens. 1; H334: C ≥0,5  % | Skin Sens.1; H317: C ≥0,5  % | 2
615-009-00-0 | 4,4'-methylenedi(cyclohexyl isocyanate); dicyclohexylmethane-4,4'-di-isocyanate | 225-863-2 | 5124-30-1 | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | H331 | H319 | H335 | H315 | H334 | H317 | GHS06 | GHS08 | Dgr | H331 | H319 | H335 | H315 | H334 | H317 |   | * | Resp. Sens. 1; H334: C ≥0,5  % | Skin Sens. 1; H317: C ≥0,5  % | 2615-009-00-0 | 4,4′-мeтиленди(циклохексилов изоцианат); дициклохексилметан-4,4′-диизоцианат | 225-863-2 | 5124-30-1 | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | H331 | H319 | H335 | H315 | H334 | H317 | GHS06 | GHS08 | Dgr | H331 | H319 | H335 | H315 | H334 | H317 |   | * | Resp. Sens. 1; H334: C ≥0,5  % | Skin Sens. 1; H317: C ≥0,5  % | 2
615-010-00-6 | 2,2,4-trimethylhexamethylene-1,6-di-isocyanate; [1] | 2,4,4-trimethylhexamethylene-1,6-di-isocyanate [2] | 241-001-8 [1] | 239-714-4 [2] | 16938-22-0 [1] | 15646-96-5 [2] | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H331 | H319 | H335 | H315 | H334 | GHS06 | GHS08 | Dgr | H331 | H319 | H335 | H315 | H334 |   | * | Resp. Sens. 1; H334: C ≥0,5  % | Skin Sens. 1; H317: C ≥0,5  % | C2615-010-00-6 | 2,2,4-триметилхексаметилен-1,6-диизоцианат; [1] | 2,4,4-триметилхексаметилен-1,6-диизоцианат [2] | 241-001-8 [1] | 239-714-4 [2] | 16938-22-0 [1] | 15646-96-5 [2] | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H331 | H319 | H335 | H315 | H334 | GHS06 | GHS08 | Dgr | H331 | H319 | H335 | H315 | H334 |   | * | Resp. Sens. 1; H334: C ≥0,5  % | Skin Sens. 1; H317: C ≥0,5  % | C2
615-011-00-1 | hexamethylene-di-isocyanate | 212-485-8 | 822-06-0 | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | H331 | H319 | H335 | H315 | H334 | H317 | GHS06 | GHS08 | Dgr | H331 | H319 | H335 | H315 | H334 | H317 |   | * | Resp. Sens. 1; H334: C ≥ | 0,5  % | Skin Sens. 1; H317: C ≥0,5  % | 2615-011-00-1 | хексаметилендиизоцианат | 212-485-8 | 822-06-0 | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | Skin Sens. 1 | H331 | H319 | H335 | H315 | H334 | H317 | GHS06 | GHS08 | Dgr | H331 | H319 | H335 | H315 | H334 | H317 |   | * | Resp. Sens. 1; H334: C ≥ | 0,5  % | Skin Sens. 1; H317: C ≥0,5  % | 2
615-012-00-7 | 4-isocyanatosulphonyltoluene; | tosyl isocyanate | 223-810-8 | 4083-64-1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H319 | H335 | H315 | H334 | GHS08 | GHS07 | Dgr | H319 | H335 | H315 | H334 | EUH014 | Eye Irrit.; | H319: C ≥ 5 % | STOT SE 3; H335: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % |  615-012-00-7 | 4-изоцианатосулфонилтолуен; | тoзилов изоцианат | 223-810-8 | 4083-64-1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H319 | H335 | H315 | H334 | GHS08 | GHS07 | Dgr | H319 | H335 | H315 | H334 | EUH014 | Eye Irrit.; | H319: C ≥ 5 % | STOT SE 3; H335: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % |  
615-014-00-8 | tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate | — | 7276-58-6 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  615-014-00-8 | tris(1-додецил-3-метил-2-фенилбензимидазолиев) хексацианоферат | — | 7276-58-6 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
615-015-00-3 | 1,7,7-trimethylbicyclo(2,2,1)hept-2-yl thiocyanatoacetate; | isobornyl thiocyanoacetate | 204-081-5 | 115-31-1 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  615-015-00-3 | 1,7,7-триметилбицикло[2.2.1]хепт-2-илов тиоцианатоацетат; | изоборнилов тиоцианоацетат | 204-081-5 | 115-31-1 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
615-016-00-9 | potassium cyanate | 209-676-3 | 590-28-3 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  615-016-00-9 | калиев цианат | 209-676-3 | 590-28-3 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
615-017-00-4 | calcium cyanamide | 205-861-8 | 156-62-7 | Acute Tox. 4 * | STOT SE 3 | Eye Dam. 1 | H302 | H335 | H318 | GHS05 | GHS07 | Dgr | H302 | H335 | H318 |   |   |  615-017-00-4 | калциев цианамид | 205-861-8 | 156-62-7 | Acute Tox. 4 * | STOT SE 3 | Eye Dam. 1 | H302 | H335 | H318 | GHS05 | GHS07 | Dgr | H302 | H335 | H318 |   |   |  
615-018-00-X | 2-(2-butoxyethoxy)ethyl thiocyanate | 203-985-7 | 112-56-1 | Flam. Liq. 3 | Acute Tox. 3 * | Acute Tox. 3 * | H226 | H311 | H301 | GHS02 | GHS06 | Dgr | H226 | H311 | H301 |   |   |  615-018-00-X | 2-(2-бутоксиетокси)eтилов тиоцианат | 203-985-7 | 112-56-1 | Flam. Liq. 3 | Acute Tox. 3 * | Acute Tox. 3 * | H226 | H311 | H301 | GHS02 | GHS06 | Dgr | H226 | H311 | H301 |   |   |  
615-019-00-5 | dicyclohexylcarbodiimide | 208-704-1 | 538-75-0 | Acute Tox. 3 * | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | H311 | H302 | H318 | H317 | GHS06 | GHS05 | Dgr | H311 | H302 | H38 | H317 |   |   |  615-019-00-5 | дициклохексилкарбодиимид | 208-704-1 | 538-75-0 | Acute Tox. 3 * | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | H311 | H302 | H318 | H317 | GHS06 | GHS05 | Dgr | H311 | H302 | H38 | H317 |   |   |  
615-020-00-0 | methylene dithiocyanate | 228-652-3 | 6317-18-6 | Acute Tox. 2 * | Acute Tox. 3 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | H330 | H301 | H314 | H317 | H400 | GHS06 | GHS05 | GHS09 | Dgr | H330 | H301 | H314 | H317 | H400 |   |   |  615-020-00-0 | мeтиленов дитиоцианат | 228-652-3 | 6317-18-6 | Acute Tox. 2 * | Acute Tox. 3 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | H330 | H301 | H314 | H317 | H400 | GHS06 | GHS05 | GHS09 | Dgr | H330 | H301 | H314 | H317 | H400 |   |   |  
615-021-00-6 | 1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione; | TGIC | 219-514-3 | 2451-62-9 | Muta. 1B | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H340 | H331 | H301 | H373 ** | H318 | H317 | H412 | GHS06 | GHS08 | GHS05 | Dgr | H340 | H331 | H301 | H373 ** | H318 | H317 | H412 |   |   |  615-021-00-6 | 1,3,5-трис(оксиранилметил)-1,3,5-триазин-2,4,6(1H,3H,5H)-трион; | TGIC | 219-514-3 | 2451-62-9 | Muta. 1B | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H340 | H331 | H301 | H373 ** | H318 | H317 | H412 | GHS06 | GHS08 | GHS05 | Dgr | H340 | H331 | H301 | H373 ** | H318 | H317 | H412 |   |   |  
615-022-00-1 | methyl 3-isocyanatosulfonyl-2-thiophene-carboxylate | 410-550-7 | 79277-18-2 | STOT RE 2 * | Resp. Sens. 1 | Skin Sens. 1 | H373** | H334 | H317 | GHS08 | Dgr | H373** | H334 | H317 | EUH014 |   |  615-022-00-1 | метилов 3-изоцианатосулфонил-2-тиофенкарбоксилат | 410-550-7 | 79277-18-2 | STOT RE 2 * | Resp. Sens. 1 | Skin Sens. 1 | H373** | H334 | H317 | GHS08 | Dgr | H373** | H334 | H317 | EUH014 |   |  
615-023-00-7 | 2-(isocyanatosulfonylmethyl)benzoic acid methyl ester; (alt.):methyl 2-(isocyanatosulfonylmethyl)benzoate | 410-900-9 | 83056-32-0 | Flam. Liq. 3 | Muta. 2 | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Resp. Sens. 1 | H226 | H341 | H332 | H373 ** | H318 | H334 | GHS02 | GHS08 | GHS05 | GHS07 | Dgr | H226 | H341 | H332 | H373 ** | H318 | H334 | EUH014 |   |  615-023-00-7 | метилов естер на 2-(изоцианатосулфонилметил)бензоената киселина; (алт.):метилов 2-(изоцианатосулфонилметил)бензоат | 410-900-9 | 83056-32-0 | Flam. Liq. 3 | Muta. 2 | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Resp. Sens. 1 | H226 | H341 | H332 | H373 ** | H318 | H334 | GHS02 | GHS08 | GHS05 | GHS07 | Dgr | H226 | H341 | H332 | H373 ** | H318 | H334 | EUH014 |   |  
615-024-00-2 | 2-phenylethylisocyanate | 413-080-0 | 1943-82-4 | Acute Tox. 3 * | Acute Tox. 4 * | Skin Corr. 1A | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H331 | H302 | H314 | H334 | H317 | H411 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H331 | H302 | H314 | H334 | H317 | H411 |   |   |  615-024-00-2 | 2-фенилетилизоцианат | 413-080-0 | 1943-82-4 | Acute Tox. 3 * | Acute Tox. 4 * | Skin Corr. 1A | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H331 | H302 | H314 | H334 | H317 | H411 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H331 | H302 | H314 | H334 | H317 | H411 |   |   |  
615-025-00-8 | 4,4'-ethylidenediphenyl dicyanate | 405-740-1 | 47073-92-7 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H302 | H373 ** | H318 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H332 | H302 | H373 ** | H318 | H410 |   |   |  615-025-00-8 | 4,4′-етилидендифенилов дицианат | 405-740-1 | 47073-92-7 | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H302 | H373 ** | H318 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H332 | H302 | H373 ** | H318 | H410 |   |   |  
615-026-00-3 | 4,4'-methylenebis(2,6-dimethylphenyl cyanate) | 405-790-4 | 101657-77-6 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  615-026-00-3 | 4,4′-мeтиленбис(2,6-диметилфенилов цианат) | 405-790-4 | 101657-77-6 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
615-028-00-4 | ethyl 2-(isocyanatosulfonyl)benzoate | 410-220-2 | 77375-79-2 | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H302 | H373** | H318 | H334 | H317 | GHS05 | GHS08 | GHS07 | Dgr | H302 | H373** | H318 | H334 | H317 | EUH014 |   |  615-028-00-4 | етилов 2-(изоцианатосулфонил)бензоат | 410-220-2 | 77375-79-2 | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Resp. Sens. 1 | Skin Sens. 1 | H302 | H373** | H318 | H334 | H317 | GHS05 | GHS08 | GHS07 | Dgr | H302 | H373** | H318 | H334 | H317 | EUH014 |   |  
615-029-00-X | 2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptane | 411-280-2 | — | Acute Tox. 2 * | Acute Tox. 4 * | Skin Corr. 1B | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H330 | H302 | H314 | H334 | H317 | H412 | GHS06 | GHS08 | GHS05 | Dgr | H330 | H302 | H314 | H334 | H317 | H412 |   |   |  615-029-00-X | 2,5-бисизоцианатометилбицикло[2.2.1]хептан | 411-280-2 | — | Acute Tox. 2 * | Acute Tox. 4 * | Skin Corr. 1B | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H330 | H302 | H314 | H334 | H317 | H412 | GHS06 | GHS08 | GHS05 | Dgr | H330 | H302 | H314 | H334 | H317 | H412 |   |   |  
615-030-00-5 | alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex | — | — | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 3 | H332 | H312 | H302 | H412 | GHS07 | Wng | H332 | H312 | H302 | H412 |   |   | A615-030-00-5 | алкални соли и алкалоземни соли на тиоциановата киселина, с изключение на тези, посочени другаде в настоящото приложение | — | — | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Chronic 3 | H332 | H312 | H302 | H412 | GHS07 | Wng | H332 | H312 | H302 | H412 |   |   | A
615-031-00-0 | thallium thiocyanate | 222-571-7 | 3535-84-0 | Acute Tox. 2 * | Acute Tox. 2 * | Acute Tox. 4 * | STOT RE 2 | Aquatic Chronic 2 | H330 | H300 | H312 | H373** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H300 | H312 | H373** | H411 |   |   |  615-031-00-0 | талиев тиоцианат | 222-571-7 | 3535-84-0 | Acute Tox. 2 * | Acute Tox. 2 * | Acute Tox. 4 * | STOT RE 2 | Aquatic Chronic 2 | H330 | H300 | H312 | H373** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H330 | H300 | H312 | H373** | H411 |   |   |  
615-032-00-6 | metal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex | — | — | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   |   | A615-032-00-6 | метални соли на тиоциановата киселина, с изключение на тези, посочени другаде в настоящото приложение | — | — | Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H332 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H332 | H312 | H302 | H410 |   |   | A
615-033-00-1 | reaction product of diphenylmethanediisocyanate, octylamine, oleylamine and cyclohexylamine (1:1.58:0.32:0097) | 430-980-9 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  615-033-00-1 | реакционен продукт от дифенилметандиизоцианат, октиламин, олеиламин и циклохексиламин (1:1,58:0,32:0,097) | 430-980-9 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
615-034-00-7 | reaction product of diphenylmethanediisocyanate, octylamine, | 4-ethoxyaniline and ethylenediamine (1:0,37:1,53:0,05) | 430-750-8 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  615-034-00-7 | реакционен продукт от дифенилметандиизоцианат, октиламин, | 4-етоксианилин и етилендиамин (1:0,37:1,53:0,05) | 430-750-8 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
615-035-00-2 | reaction product of diphenylmethanediisocyanate, octylamine and oleylamine (molar ratio | 1:1.86:0.14) | 430-930-6 | 122886-55-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  615-035-00-2 | реакционен продукт от дифенилметандиизоцианат, октиламин и олеиламин (моларно съотношение | 1:1.86:0.14) | 430-930-6 | 122886-55-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
615-036-00-8 | reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction of isomers: | 65 % 2,4-and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 4:1:7:1:2) | 430-940-0 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  615-036-00-8 | реакционен продукт от дифенилметандиизоцианат, толуендиизоцианат (реакционна маса от изомери: | 65 % 2,4-диизоцианат и 35 % 2,6-диизоцианат), октиламин, олеиламин и 4-етоксианилин (моларно съотношение 4:1:7:1:2) | 430-940-0 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
615-037-00-3 | reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4-and 35 % 2,6-diisocyanate), octylamine and oleylamine (molar ratio 4:1:9:1) | 430-950-5 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  615-037-00-3 | реакционен продукт от дифенилметандиизоцианат, толуендиизоцианат (реакционна маса от изомери: 65 % 2,4-диизоцианат и 35 % 2,6-диизоцианат), октиламин и олеиламин (моларно съотношение 4:1:9:1) | 430-950-5 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
615-038-00-9 | reaction product of toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate) and aniline | (molarratio 1:2) | 430-960-1 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  615-038-00-9 | реакционен продукт от толуендиизоцианат (реакционна маса от изомери: 65 % 2,4-диизоцианат и 35 % 2,6-диизоцианат) и анилин | (моларно съотношение 1:2) | 430-960-1 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
615-039-00-4 | reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4-and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 3.88:1:6.38:0.47:2.91) | 430-970-4 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  615-039-00-4 | реакционен продукт от дифенилметандиизоцианат, толуендиизоцианат (реакционна маса от изомери: 65 % 2,4-диизоцианат и 35 % 2,6-диизоцианат), октиламин, олеиламин и 4-етоксианилин (моларно съотношение 3,88:1:6,38:0,47:2,91) | 430-970-4 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
615-044-00-1 | 4-chlorophenylisocyanate | 203-176-9 | 104-12-1 | Acute Tox. 2 * | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Resp. Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H302 | H335 | H315 | H318 | H334 | H400 | H410 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H330 | H302 | H335 | H315 | H318 | H334 | H410 |   |   |  615-044-00-1 | 4-хлорофенилизоцианат | 203-176-9 | 104-12-1 | Acute Tox. 2 * | Acute Tox. 4 * | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Resp. Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H330 | H302 | H335 | H315 | H318 | H334 | H400 | H410 | GHS06 | GHS05 | GHS08 | GHS09 | Dgr | H330 | H302 | H335 | H315 | H318 | H334 | H410 |   |   |  
615-045-00-7 | 4,4'-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate) | 420-530-1 | — | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Chronic 4 | H334 | H317 | H413 | GHS08 | Dgr | H334 | H317 | H413 |   |   |  615-045-00-7 | 4,4′-метиленов бис(2,6-диетил-3-хлорофенилизоцианат) | 420-530-1 | — | Resp. Sens. 1 | Skin Sens. 1 | Aquatic Chronic 4 | H334 | H317 | H413 | GHS08 | Dgr | H334 | H317 | H413 |   |   |  
616-001-00-X | N, N-dimethylformamide; | dimethyl formamide | 200-679-5 | 68-12-2 | Repr. 1B | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | H360D *** H332 | H312 | H319 | GHS08 | GHS07 | Dgr | H360D *** H332 | H312 | H319 |   |   |  616-001-00-X | N, N-диметилформамид; | диметилформамид | 200-679-5 | 68-12-2 | Repr. 1B | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | H360D *** H332 | H312 | H319 | GHS08 | GHS07 | Dgr | H360D *** H332 | H312 | H319 |   |   |  
616-002-00-5 | 2-fluoroacetamide | 211-363-1 | 640-19-7 | Acute Tox. 2 * | Acute Tox. 3 * | H300 | H311 | GHS06 | Dgr | H300 | H311 |   |   |  616-002-00-5 | 2-флуороацетамид | 211-363-1 | 640-19-7 | Acute Tox. 2 * | Acute Tox. 3 * | H300 | H311 | GHS06 | Dgr | H300 | H311 |   |   |  
616-003-00-0 | acrylamide; | prop-2-enamide | 201-173-7 | 79-06-1 | Carc. 1B | Muta. 1B Repr. 2 | Acute Tox. 3 * | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H350 | H340 | H361f *** H301 | H372 ** | H332 | H312 | H319 | H315 | H317 | GHS06 | GHS08 | Dgr | H350 | H340 | H361f *** H301 | H372 ** | H332 | H312 | H319 | H315 | H317 |   |   | D616-003-00-0 | акриламид; | проп-2-енамид | 201-173-7 | 79-06-1 | Carc. 1B | Muta. 1B Repr. 2 | Acute Tox. 3 * | STOT RE 1 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | H350 | H340 | H361f *** H301 | H372 ** | H332 | H312 | H319 | H315 | H317 | GHS06 | GHS08 | Dgr | H350 | H340 | H361f *** H301 | H372 ** | H332 | H312 | H319 | H315 | H317 |   |   | D
616-004-00-6 | allidochlor (ISO); | N,N-diallylchloroacetamide | 202-270-7 | 93-71-0 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 2 | H312 | H302 | H319 | H315 | H411 | GHS07 | GHS09 | Wng | H312 | H302 | H319 | H315 | H411 |   |   |  616-004-00-6 | алидохлор (ISO); | N,N-диалилхлороацетамид | 202-270-7 | 93-71-0 | Acute Tox. 4 * | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 2 | H312 | H302 | H319 | H315 | H411 | GHS07 | GHS09 | Wng | H312 | H302 | H319 | H315 | H411 |   |   |  
616-005-00-1 | chlorthiamid (ISO); | 2,6-dichloro (thiobenzamide) | 217-637-7 | 1918-13-4 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  616-005-00-1 | хлортиамид (ISO); | 2,6-дихлоро(тиобензамид) | 217-637-7 | 1918-13-4 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
616-007-00-2 | diphenamid (ISO); | N, N-dimethyl-2,2-diphenylacetamide | 213-482-4 | 957-51-7 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  616-007-00-2 | дифенамид (ISO); | N, N-диметил-2,2-дифенилацетамид | 213-482-4 | 957-51-7 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
616-008-00-8 | propachlor (ISO); | 2-chloro-N-isopropylacetanilide; | α-chloro-N-isopropylacetanilide | 217-638-2 | 1918-16-7 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H317 | H410 |   |   |  616-008-00-8 | пропахлор (ISO); | N-изопропил-2-хлороацетанилид; | N-изопропил-α-хлороацетанилид | 217-638-2 | 1918-16-7 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H319 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H319 | H317 | H410 |   |   |  
616-009-00-3 | propanil (ISO); | 3',4'-dichloropropionanilide | 211-914-6 | 709-98-8 | Acute Tox. 4 * | Aquatic Acute 1 | H302 | H400 | GHS07 | GHS09 | Wng | H302 | H400 |   | M=10 |  616-009-00-3 | пропанил (ISO); | 3′,4′-дихлоропропионанилид | 211-914-6 | 709-98-8 | Acute Tox. 4 * | Aquatic Acute 1 | H302 | H400 | GHS07 | GHS09 | Wng | H302 | H400 |   | M=10 |  
616-010-00-9 | tosylchloramide sodium | 204-854-7 | 127-65-1 | Acute Tox. 4 * | Skin Corr. 1B | Resp. Sens. 1 | H302 | H314 | H334 | GHS08 | GHS05 | GHS07 | Dg | H302 | H314 | H334 | EUH031 |   |  616-010-00-9 | тoзилхлорамид натрий | 204-854-7 | 127-65-1 | Acute Tox. 4 * | Skin Corr. 1B | Resp. Sens. 1 | H302 | H314 | H334 | GHS08 | GHS05 | GHS07 | Dg | H302 | H314 | H334 | EUH031 |   |  
616-012-00-X | N-(dichlorofluoromethylthio)phthalimide; | N-(fluorodichloromethylthio)phthalimide | 211-952-3 | 719-96-0 | Skin Irrit. 2 | H315 | GHS07 | Wng | H315 |   |   |  616-012-00-X | N-(дихлорофлуорометилтио)фталимид; | N-(флуородихлорометилтио)фталимид | 211-952-3 | 719-96-0 | Skin Irrit. 2 | H315 | GHS07 | Wng | H315 |   |   |  
616-013-00-5 | butyraldehyde oxime | 203-792-8 | 110-69-0 | Acute Tox. 3 * | Acute Tox. 4 * | Eye Irrit. 2 | H311 | H302 | H319 | GHS06 | Dgr | H311 | H302 | H319 |   |   |  616-013-00-5 | бутиралдехидоксим | 203-792-8 | 110-69-0 | Acute Tox. 3 * | Acute Tox. 4 * | Eye Irrit. 2 | H311 | H302 | H319 | GHS06 | Dgr | H311 | H302 | H319 |   |   |  
616-014-00-0 | 2-butanone oxime; | ethyl methyl ketoxime; | ethyl methyl ketone oxime | 202-496-6 | 96-29-7 | Carc. 2 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | H351 | H312 | H318 | H317 | GHS08 | GHS05 | GHS07 | Dgr | H351 | H312 | H318 | H317 |   |   |  616-014-00-0 | 2-бутаноноксим; | етилметилкетоксим; | етилметилкетоноксим | 202-496-6 | 96-29-7 | Carc. 2 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | H351 | H312 | H318 | H317 | GHS08 | GHS05 | GHS07 | Dgr | H351 | H312 | H318 | H317 |   |   |  
616-015-00-6 | alachlor (ISO); | 2-chloro-2',6'-diethyl-N-(methoxymethyl)acetanilide | 240-110-8 | 15972-60-8 | Carc. 2 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H302 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H302 | H317 | H410 |   | M=10 |  616-015-00-6 | алахлор (ISO); | 2′,6′-диетил-N-(метоксиметил)-2-хлороацетанилид | 240-110-8 | 15972-60-8 | Carc. 2 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H302 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H302 | H317 | H410 |   | M=10 |  
616-016-00-1 | 1-(3,4-dichlorophenylimino) | thiosemicarbazide | — | 5836-73-7 | Acute Tox. 2 * | H300 | GHS06 | Dgr | H300 |   |   |  616-016-00-1 | 1-(3,4-дихлорофенилимино) | тиосемикарбазид | — | 5836-73-7 | Acute Tox. 2 * | H300 | GHS06 | Dgr | H300 |   |   |  
616-017-00-7 | cartap hydrochloride | 239-309-2 | 15263-52-2 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   |   |  616-017-00-7 | картап хидрохлорид | 239-309-2 | 15263-52-2 | Acute Tox. 4 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H312 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H312 | H302 | H410 |   |   |  
616-018-00-2 | N,N-diethyl-m-toluamide; | deet | 205-149-7 | 134-62-3 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 3 | H302 | H319 | H315 | H412 | GHS07 | Wng | H302 | H319 | H315 | H412 |   |   |  616-018-00-2 | N,N-диетил-m-толуамид; | DEET | 205-149-7 | 134-62-3 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 3 | H302 | H319 | H315 | H412 | GHS07 | Wng | H302 | H319 | H315 | H412 |   |   |  
616-019-00-8 | perfluidone (ISO); | 1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide; | 253-718-3 | 37924-13-3 | Acute Tox. 4 * | Eye Irrit. 2 | H302 | H319 | GHS07 | Wng | H302 | H319 |   |   |  616-019-00-8 | перфлуидон (ISO); | N-(4-фенилсулфонил-o-толил)-1,1,1-трифлуорометансулфонамид; | 253-718-3 | 37924-13-3 | Acute Tox. 4 * | Eye Irrit. 2 | H302 | H319 | GHS07 | Wng | H302 | H319 |   |   |  
616-020-00-3 | tebuthiuron (ISO); | 1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea | 251-793-7 | 34014-18-1 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  616-020-00-3 | тебутиурон (ISO); | 1-(5-трет-бутил-1,3,4-тиадиазол-2-ил)-1,3-диметилуреа | 251-793-7 | 34014-18-1 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
616-021-00-9 | thiazafluron (ISO); | 1,3-dimethyl-1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)urea | 246-901-4 | 25366-23-8 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  616-021-00-9 | тиазафлурон (ISO); | 1,3-диметил-1-(5-трифлуорометил-1,3,4-тиадиазол-2-ил)уреа | 246-901-4 | 25366-23-8 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
616-022-00-4 | acetamide | 200-473-5 | 60-35-5 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  616-022-00-4 | ацетамид | 200-473-5 | 60-35-5 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  
616-023-00-X | N-hexadecyl(or octadecyl)-N-hexadecyl (or octadecyl)benzamide | 401-980-6 | — | Skin Irrit. 2 | Skin Sens. 1 | H315 | H317 | GHS07 | Wng | H315 | H317 |   |   |  616-023-00-X | N-хексадецил(или октадецил)-N-хексадецил(или октадецил)бензамид | 401-980-6 | — | Skin Irrit. 2 | Skin Sens. 1 | H315 | H317 | GHS07 | Wng | H315 | H317 |   |   |  
616-024-00-5 | 2-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilide | 402-260-4 | 54942-74-4 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-024-00-5 | 2-(4,4-диметил-2,5-диоксооксазолидин-1-ил)-2-хлоро-5-(2-(2,4-ди-трет-пентилфенокси)бутирамидо)-4,4-диметил-3-oксовалеранилид | 402-260-4 | 54942-74-4 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-025-00-0 | valinamide | 402-840-7 | 20108-78-5 | Repr. 2 | Eye Irrit. 2 | Skin Sens. 1 | H361f *** H319 | H317 | GHS08 | Wng | H361f *** H319 | H317 |   |   |  616-025-00-0 | валинамид | 402-840-7 | 20108-78-5 | Repr. 2 | Eye Irrit. 2 | Skin Sens. 1 | H361f *** H319 | H317 | GHS08 | Wng | H361f *** H319 | H317 |   |   |  
616-026-00-6 | thioacetamide | 200-541-4 | 62-55-5 | Carc. 1B | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 3 | H350 | H302 | H319 | H315 | H412 | GHS08 | GHS07 | Dgr | H350 | H302 | H319 | H315 | H412 |   |   |  616-026-00-6 | тиоацетамид | 200-541-4 | 62-55-5 | Carc. 1B | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 3 | H350 | H302 | H319 | H315 | H412 | GHS08 | GHS07 | Dgr | H350 | H302 | H319 | H315 | H412 |   |   |  
616-027-00-1 | tris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate | 403-760-5 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  616-027-00-1 | трис(2-(2-хидроксиетокси)етил)амониев 3-aцетоацетамидо-4-метоксибензенсулфонат | 403-760-5 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
616-028-00-7 | N-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide | 403-790-9 | 108673-51-4 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  616-028-00-7 | N-(3-хидрокси-4-(-3-(4-цианофенил)уреидо)фенил)-2-(2,4-ди-трет-пентилфенокси)oктанамид | 403-790-9 | 108673-51-4 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
616-029-00-2 | N, N'-ethylenebis(vinylsulfonylacetamide) | 404-790-1 | 66710-66-5 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  616-029-00-2 | N,N′-етиленбис(винилсулфонилацетамид) | 404-790-1 | 66710-66-5 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
616-030-00-8 | ethidimuron (ISO); | 1-(5-ethylsulphonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea | 250-010-6 | 30043-49-3 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  616-030-00-8 | етидимурон (ISO); | 1-(5-етилсулфонил-1,3,4-тиадиазол-2-ил)-1,3-диметилуреа | 250-010-6 | 30043-49-3 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
616-031-00-3 | dimethachlor (ISO); | 2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamide; | 256-625-6 | 50563-36-5 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  616-031-00-3 | диметахлор (ISO); | N-(2,6-диметилфенил)-N-(2-метоксиетил)-2-хлороацетамид; | 256-625-6 | 50563-36-5 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  
616-032-00-9 | diflufenican (ISO); | N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide | — | 83164-33-4 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  616-032-00-9 | дифлуфеникан (ISO); | N-(2,4-дифлуорофенил)-2-[3-(трифлуорометил)фенокси]-3-пиридинкарбоксамид | — | 83164-33-4 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
616-033-00-4 | cyprofuram (ISO); | N-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide | 274-050-9 | 69581-33-5 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H312 | H410 |   |   |  616-033-00-4 | ципрофурам (ISO); | N-(тетрахидро-2-oксо-3-фурил)-N-(3-хлорофенил)циклопропанкарбоксамид | 274-050-9 | 69581-33-5 | Acute Tox. 3 * | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H312 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H312 | H410 |   |   |  
616-034-00-X | pyracarbolid; (ISO); | 3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide | 246-419-4 | 24691-76-7 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  616-034-00-X | пиракарболид (ISO); | 6-метил-3,4-дихидро-2Н-пиран-5-карбоксанилид | 246-419-4 | 24691-76-7 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
616-035-00-5 | cymoxanil (ISO); | 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide | 261-043-0 | 57966-95-7 | Repr. 2 | Acute Tox. 4 | STOT RE 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361fd | H302 | H373 (blood, thymus) | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H361fd | H302 | H373 (blood, thymus) | H317 | H410 |   | M = 1 | M = 1 |  616-035-00-5 | цимоксанил (ISO); | N-[(eтиламино)карбонил]-2-(метоксиимино)-2-цианоaцетамид | 261-043-0 | 57966-95-7 | Repr. 2 | Acute Tox. 4 | STOT RE 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361fd | H302 | H373 (кръв, тимус) | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H361fd | H302 | H373 (кръв, тимус) | H317 | H410 |   | M = 1 | M = 1 |  
616-036-00-0 | 2-chloracetamide | 201-174-2 | 79-07-2 | Repr. 2 | Acute Tox. 3 * | Skin Sens. 1 | H361f *** H301 | H317 | GHS06 | GHS08 | Dgr | H361f *** H301 | H317 |   | Skin Sens. 1; H317: C ≥ 0,1  % |  616-036-00-0 | 2-хлороацетамид | 201-174-2 | 79-07-2 | Repr. 2 | Acute Tox. 3 * | Skin Sens. 1 | H361f *** H301 | H317 | GHS06 | GHS08 | Dgr | H361f *** H301 | H317 |   | Skin Sens. 1; H317: C ≥ 0,1  % |  
616-038-00-1 | (4-aminophenyl)-N-methylmethylensulfonamide hydrochloride | 406-010-5 | 88918-84-7 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H411 |   |   |  616-038-00-1 | (4-аминофенил)-N-метилметиленсулфонамидхидрохлорид | 406-010-5 | 88918-84-7 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H318 | H317 | H411 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H411 |   |   |  
616-039-00-7 | 3',5'-dichloro-4'-ethyl-2'-hydroxypalmitanilide | 406-200-8 | 117827-06-2 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  616-039-00-7 | 4′-eтил-2′-хидрокси-3′,5′-дихлоропалмитанилид | 406-200-8 | 117827-06-2 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
616-040-00-2 | potassium N-(4-toluenesulfonyl)-4-toluenesulfonamide | 406-650-5 | 97888-41-0 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  616-040-00-2 | калиев N-(4-толуенсулфонил)-4-толуенсулфонамид | 406-650-5 | 97888-41-0 | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
616-041-00-8 | 3',5'-dichloro-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxyhexananilide | 406-840-8 | 101664-25-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-041-00-8 | 2-(2,4-ди-трет-пентилфенокси)-4′-eтил-2′-хидрокси-3′,5′-дихлорохексананилид | 406-840-8 | 101664-25-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-042-00-3 | N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide | 407-070-5 | 142859-67-4 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  616-042-00-3 | N-(2-(6-етил-7-(4-метилфенокси)-1H-пиразоло[1,5-b][1,2,4]триазол-2-ил)пропил)-2-oктадецилоксибензамид | 407-070-5 | 142859-67-4 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
616-043-00-9 | isoxaben (ISO); | N-[3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl]-2,6-dimethoxybenzamide | 407-190-8 | 82558-50-7 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-043-00-9 | изоксабен (ISO); | N-[3-(1-етил-1-метилпропил)-1,2-oксазол-5-ил]-2,6-диметоксибензамид | 407-190-8 | 82558-50-7 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-044-00-4 | N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)-butanamide | 402-510-2 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  616-044-00-4 | N-(4-eтил-2-хидрокси-3,5-дихлорофенил)-2-(3-пентадецилфенокси)бутанамид | 402-510-2 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
616-045-00-X | 2'-(4-chloro-3-cyano-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilide | 405-190-2 | 122371-93-1 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  616-045-00-X | 2′-(5-формил-4-хлоро-3-циано-2-тиенилазо)-5′-диетиламино-2-метоксиацетанилид | 405-190-2 | 122371-93-1 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
616-046-00-5 | N-(2-(6-chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamide | 406-390-2 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  616-046-00-5 | N-(2-(7-метил-6-хлоропиразоло[1,5-b]-1,2,4-триазол-4-ил)пропил)-2-(2,4-ди-трет-пентилфенокси)октанамид | 406-390-2 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
616-047-00-0 | reaction mass of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N, N-di(C16)alkylacetamide; | 2,2',2'',2'''-(ethylenedinitrilotetrakis-N, N-di(C18)alkylacetamide | 406-640-0 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  616-047-00-0 | реакционна маса от: 2,2′,2′′,2′′′-(етилендинитрилотетракис-N, N-ди(C16)-aлкилацетамид; | 2,2′,2′′,2′′′-(етилендинитрилотетракис-N, N-ди(C18)-aлкилацетамид; | 406-640-0 | — | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
616-048-00-6 | 3'-trifluoromethylisobutyranilide | 406-740-4 | 1939-27-1 | STOT RE 2 * | Aquatic Chronic 2 | H373 ** | H411 | GHS08 | GHS09 | Wng | H373 ** | H411 |   |   |  616-048-00-6 | 3′-трифлуорометилизобутиранилид | 406-740-4 | 1939-27-1 | STOT RE 2 * | Aquatic Chronic 2 | H373 ** | H411 | GHS08 | GHS09 | Wng | H373 ** | H411 |   |   |  
616-049-00-1 | 2-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-hexanamide | 408-150-2 | 99141-89-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-049-00-1 | 2-(2,4-бис(1,1-диметилетил)фенокси)-N-(4-eтил-2-хидрокси-3,5-дихлорофенил)хексанамид | 408-150-2 | 99141-89-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-050-00-7 | lufenuron (ISO); | N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide | 410-690-9 | 103055-07-8 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  616-050-00-7 | луфенурон (ISO); | 2,6-дифлуоро-N-[4-(1,1,2,3,3,3-хексафлуоропропокси)-2,5-дихлорофениламинокарбонил]бензамид | 410-690-9 | 103055-07-8 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
616-051-00-2 | reaction mass of: 2,4 -bis(N'-(4-methylphenyl)-ureido)-toluene; | 2,6 -bis(N'-(4-methylphenyl)-ureido)-toluene | 411-070-0 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-051-00-2 | реакционна маса от: 2,4-бис(N′-(4-метилфенил)уреидо)толуен; | 2,6-бис(N′-(4-метилфенил)уреидо)толуен; | 411-070-0 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-052-00-8 | formamide | 200-842-0 | 75-12-7 | Repr. 1B | H360D *** | GHS08 | Dgr | H360D *** |   |   |  616-052-00-8 | формамид | 200-842-0 | 75-12-7 | Repr. 1B | H360D *** | GHS08 | Dgr | H360D *** |   |   |  
616-053-00-3 | N-methylacetamide | 201-182-6 | 79-16-3 | Repr. 1B | H360D *** | GHS08 | Dgr | H360D *** |   |   |  616-053-00-3 | N-мeтилацетамид | 201-182-6 | 79-16-3 | Repr. 1B | H360D *** | GHS08 | Dgr | H360D *** |   |   |  
616-054-00-9 | iprodione (ISO); | 3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide | 253-178-9 | 36734-19-7 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   |   |  616-054-00-9 | ипродион (ISO); | 3-(3,5-дихлорофенил)-2,4-диоксо-N-изопропилимидазолидин-1-карбоксамид | 253-178-9 | 36734-19-7 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   |   |  
616-055-00-4 | propyzamide (ISO); | 3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide | 245-951-4 | 23950-58-5 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   |   |  616-055-00-4 | пропизамид (ISO); | N-(1,1-диметилпроп-2-инил)-3,5-дихлоробензамид | 245-951-4 | 23950-58-5 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   |   |  
616-056-00-X | N-methylformamide | 204-624-6 | 123-39-7 | Repr. 1B | Acute Tox. 4 * | H360D *** H312 | GHS08 | GHS07 | Dg | H360D *** H312 |   |   |  616-056-00-X | N-метилформамид | 204-624-6 | 123-39-7 | Repr. 1B | Acute Tox. 4 * | H360D *** H312 | GHS08 | GHS07 | Dg | H360D *** H312 |   |   |  
616-057-00-5 | reaction mass of: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide; | N-[2,3-bis-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide; methacrylamide; | 2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide; | N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide | 412-790-8 | — | Carc. 1B | Muta. 2 | STOT RE 2 * | H350 | H341 | H373 ** | GHS08 | Dgr | H350 | H341 | H373 ** |   |   |  616-057-00-5 | реакционна маса от: N-[3-хидрокси-2-(2-метилaкрилоиламинометокси)пропоксиметил]-2-метилaкриламид; | N-[2,3-бис(2-метилaкрилоиламинометокси)пропоксиметил]-2-метилакриламид; мeтакриламид; | 2-мeтил-N-(2-метилакрилоиламинометоксиметил)aкриламид; | N-(2,3-дихидроксипропоксиметил)-2-метилакриламид | 412-790-8 | — | Carc. 1B | Muta. 2 | STOT RE 2 * | H350 | H341 | H373 ** | GHS08 | Dgr | H350 | H341 | H373 ** |   |   |  
616-058-00-0 | 1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene | 412-570-1 | 119462-56-5 | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** | H318 | H317 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H373 ** | H318 | H317 | H410 |   |   |  616-058-00-0 | 1,3-бис(3-метил-2,5-диоксо-1Н-пиролинилметил)бензен | 412-570-1 | 119462-56-5 | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** | H318 | H317 | H400 | H410 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H373 ** | H318 | H317 | H410 |   |   |  
616-059-00-6 | 4-((4-(diethylamino)-2-ethoxyphenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide | 412-650-6 | 121487-83-0 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-059-00-6 | 4-((4-(диетиламино)-2-eтоксифенил)имино)-1-oксо-N-пропил-1,4-дихидро-2-нафталенкарбоксамид | 412-650-6 | 121487-83-0 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-060-00-1 | condensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily | amino-ethyl-piperazine and triethylenetetramine) | 413-770-1 | — | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H317 | H410 |   |   |  616-060-00-1 | кoндензационен продукт на: 3-(7-карбоксихепт-1-ил)-6-хексил-4-циклохексен-1,2-дикарбоксилна киселина и полиамини (основно | аминоетилпиперазин и триетилентетрамин) | 413-770-1 | — | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H314 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H314 | H317 | H410 |   |   |  
616-061-00-7 | N,N'—1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide | 413-610-0 | 124172-53-8 | Eye Irrit. 2 | Aquatic Chronic 3 | H319 | H412 | GHS07 | Wng | H319 | H412 |   |   |  616-061-00-7 | N,N′-1,6-хександиилбис(N-(2,2,6,6-тетраметилпиперидин-4-ил)формамид | 413-610-0 | 124172-53-8 | Eye Irrit. 2 | Aquatic Chronic 3 | H319 | H412 | GHS07 | Wng | H319 | H412 |   |   |  
616-062-00-2 | N-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide | 411-590-8 | 70693-57-1 | Skin Corr. 1B | Aquatic Chronic 3 | H314 | H412 | GHS05 | Dgr | H314 | H412 |   |   |  616-062-00-2 | N-[3-[(2-ацетилокси)етил](фенилметил)амино]-4-метоксифенилацетамид | 411-590-8 | 70693-57-1 | Skin Corr. 1B | Aquatic Chronic 3 | H314 | H412 | GHS05 | Dgr | H314 | H412 |   |   |  
616-063-00-8 | 3-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)-yl)-2,5-pyrrolidindione | 411-920-0 | 106917-30-0 | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1A | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H302 | H373 ** | H314 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H331 | H302 | H373 ** | H314 | H410 |   |   |  616-063-00-8 | 3-додецил-(1-(1,2,2,6,6-пентаметил-4-пиперидин)ил)-2,5-пиролидиндион | 411-920-0 | 106917-30-0 | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1A | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H302 | H373 ** | H314 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H331 | H302 | H373 ** | H314 | H410 |   |   |  
616-064-00-3 | N—tert-butyl-3-methylpicolinamide | 406-720-5 | 32998-95-1 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  616-064-00-3 | N-трет-бутил-3-метилпиколинамид | 406-720-5 | 32998-95-1 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
616-065-00-9 | 3'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurea | 411-970-3 | 79881-89-3 | Acute Tox. 4 * | STOT RE 2 * | H302 | H373 ** | GHS08 | GHS07 | Wng | H302 | H373 ** |   |   |  616-065-00-9 | 3′-(3-ацетил-4-хидроксифенил)-1,1-диетилуреа | 411-970-3 | 79881-89-3 | Acute Tox. 4 * | STOT RE 2 * | H302 | H373 ** | GHS08 | GHS07 | Wng | H302 | H373 ** |   |   |  
616-066-00-4 | 5,6,12,13-tetrachloroanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone | 405-100-1 | 115662-06-1 | Repr. 2 | H361f *** | GHS08 | Wng | H361f *** |   |   |  616-066-00-4 | 5,6,12,13-тeтрахлороантра[2,1,9-def:6,5,10-d′e′f′]диизохинолин-1,3,8,10(2H,9H)-тетрон | 405-100-1 | 115662-06-1 | Repr. 2 | H361f *** | GHS08 | Wng | H361f *** |   |   |  
616-067-00-X | dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorobenzoate | 407-300-4 | 92683-20-0 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-067-00-X | додецилов 3-(2-(3-бензил-4-eтокси-2,5-диоксоимидазолидин-1-ил)-4,4-диметил-3-oксовалерамидо)-4-хлоробензоат | 407-300-4 | 92683-20-0 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-068-00-5 | potassium 4-(11-methacrylamidoundecanamido)benzenesulfonate | 406-500-9 | 174393-75-0 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  616-068-00-5 | калиев 4-(11-метакриламидоундеканамидо)бензенсулфонат | 406-500-9 | 174393-75-0 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
616-069-00-0 | 1-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamide | 406-210-2 | 110560-22-0 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-069-00-0 | 1-хидрокси-5-(2-метилпропилоксикарбониламино)-N-(3-додецилоксипропил)-2-нафтоамид | 406-210-2 | 110560-22-0 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-070-00-6 | reaction mass of: 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea; | 3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urea; | 3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea | 406-530-2 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-070-00-6 | реакционна маса от: 3,3′-дициклохексил-1,1′-метиленбис(4,1-фенилен)диуреа; | 1-(4-(4-(3-oктадецилуреидо)бензил)фенил)-3-циклохексилуреа; | 3,3′-диоктадецил-1,1′-метиленбис(4,1-фенилен)диуреа | 406-530-2 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-071-00-1 | reaction mass of: bis(N-cyclohexyl-N'-phenyleneureido)methylene; | bis(N-octadecyl-N'-phenyleneureido)methylene; | bis(N-dicyclohexyl-N'-phenyleneureido)methylene (1:2:1) | 406-550-1 | — | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  616-071-00-1 | реакционна маса от: бис(N′-фенилен-N-циклохексилуреидо)метилен; | бис-(N-октадецил-N′-фениленуреидо)метилен; | бис(N′-фенилен-N-дициклохексилуреидо)метилен (1:2:1) | 406-550-1 | — | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
616-072-00-7 | 1-(2-deoxy-5-O-trityl-β-D-threopentofuranosyl)thymine | 407-120-6 | 55612-11-8 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-072-00-7 | 1-(2-деокси-5-О-тритил-β-D-треопентофуранозил)тимин | 407-120-6 | 55612-11-8 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-073-00-2 | 4'-ethoxy-2-benzimidazoleanilide | 407-600-5 | 120187-29-3 | Muta. 2 | Aquatic Chronic 4 | H341 | H413 | GHS08 | Wng | H341 | H413 |   |   |  616-073-00-2 | 4′-етокси-2-бензимидазолaнилид | 407-600-5 | 120187-29-3 | Muta. 2 | Aquatic Chronic 4 | H341 | H413 | GHS08 | Wng | H341 | H413 |   |   |  
616-074-00-8 | N-butyl-2-(4-morpholinylcarbonyl)benzamide | 407-730-2 | 104958-67-0 | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H319 | H317 | H412 | GHS07 | Wng | H319 | H317 | H412 |   |   |  616-074-00-8 | N-бутил-2-(4-морфолинилкарбонил)бензамид | 407-730-2 | 104958-67-0 | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H319 | H317 | H412 | GHS07 | Wng | H319 | H317 | H412 |   |   |  
616-075-00-3 | D, L-(N,N-diethyl-2-hydroxy-2-phenylacetamide) | 408-120-9 | 65197-96-8 | Acute Tox. 4 * | Eye Dam. 1 | H302 | H318 | GHS05 | GHS07 | Dgr | H302 | H318 |   |   |  616-075-00-3 | D, L-(N,N-диетил-2-фенил-2-хидроксиацетамид) | 408-120-9 | 65197-96-8 | Acute Tox. 4 * | Eye Dam. 1 | H302 | H318 | GHS05 | GHS07 | Dgr | H302 | H318 |   |   |  
616-076-00-9 | tebufenozide (ISO); | N-tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide | 412-850-3 | 112410-23-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  616-076-00-9 | тебуфенозид (ISO); | N-трет-бутил-N′-(4-eтилбензоил)-3,5-диметилбензохидразид | 412-850-3 | 112410-23-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
616-077-00-4 | reaction mass of: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfonic acid; | potassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfate | 411-310-4 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  616-077-00-4 | реакционна маса от: 2-(9-мeтил-1,3,8,10-тетраоксо-2,3,9,10-тетрахидро-(1H,8H)-антра[2,1,9-def: 6,5,10-d′e′f′]диизохинолин-2-илeтансулфонова киселина; | калиев 2-(9-мeтил-1,3,8,10-тетраоксо-2,3,9,10-тетрахидро-(1H,8H)-антра[2,1,9-def: 6,5,10-d′e′f′]диизохинолин-2-илeтансулфонат | 411-310-4 | — | Eye Dam. 1 | H318 | GHS05 | Dgr | H318 |   |   |  
616-078-00-X | 2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)hexanamide | 411-330-3 | 104541-33-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-078-00-X | 2-[2,4-бис(1,1-диметилетил)фенокси]-N-(5-метил-2-хидроксифенил)хексанамид | 411-330-3 | 104541-33-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-079-00-5 | 1,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate | 411-700-4 | 140921-24-0 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  616-079-00-5 | 1,6-хександиилбис(2-(2-(1-eтилпентил)-3-oксазолидинил)eтил)карбамат | 411-700-4 | 140921-24-0 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
616-080-00-0 | 4-(2-((3-ethyl-4-methyl-2-oxo-pyrrolin-1-yl)carboxamido)ethyl)benzenesulfonamide) | 411-850-0 | 119018-29-0 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  616-080-00-0 | 4-(2-((3-етил-4-метил-2-oксопиролин-1-ил)карбоксамидо)eтил)бензенсулфонамид | 411-850-0 | 119018-29-0 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
616-081-00-6 | 5-bromo-8-naphtholactam | 413-480-5 | 24856-00-6 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  616-081-00-6 | 5-бромо-8-нафтолактам | 413-480-5 | 24856-00-6 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   |   |  
616-082-00-1 | N-(5-chloro-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)benzamide | 413-200-1 | 129604-78-0 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  616-082-00-1 | N-(3-((4-(диетиламино)-2-метилфенил)имино)-4-метил-6-oксо-5-хлоро-1,4-циклохексадиен-1-ил)бензамид | 413-200-1 | 129604-78-0 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
616-083-00-7 | [2-[(4-nitrophenyl)amino]ethyl]urea | 410-700-1 | 27080-42-8 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  616-083-00-7 | [2-[(4-нитрофенил)aмино]eтил]уреа | 410-700-1 | 27080-42-8 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
616-084-00-2 | 2,4-bis[N'-(4-methylphenyl)ureido]toluene | 411-790-5 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  616-084-00-2 | 2,4-бис[N′-(4-метилфенил)уреидо]толуен | 411-790-5 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
616-085-00-8 | 3-(2,4-dichlorophenyl)-6-fluoro-quinazoline-2,4(1H,3H)-dione | 412-190-6 | 168900-02-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  616-085-00-8 | 3-(2,4-дихлорофенил)-6-флуорохиназолин-2,4(1H,3H)-дион | 412-190-6 | 168900-02-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
616-086-00-3 | 2-acetylamino-6-chloro-4-[(4-diethylamino)2-methylphenyl-imino]-5-methyl-1-oxo-2,5-cyclohexadiene | 412-250-1 | 102387-48-4 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-086-00-3 | 2-ацетиламино-4-[(4-диетиламино)-2-метилфенилимино]-5-метил-1-оксо-6-хлоро-2,5-циклохексадиен | 412-250-1 | 102387-48-4 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-087-00-9 | reaction mass of: 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecane-1,16-diyl-prop-2-enoate; | 7,7,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecane-1,16-diyl-prop-2-enoate | 412-260-6 | 52658-19-2 | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H319 | H317 | H411 | GHS07 | GHS09 | Wng | H319 | H317 | H411 |   |   |  616-087-00-9 | реакционна маса от: 7,9,9-триметил-3,14-диокса-4,13-диоксо-5,12-диазахексадекан-1,16-диилпроп-2-eноат; | 7,7,9-триметил-3,14-диокса-4,13-диоксо-5,12-диазахексадекан-1,16-диилпроп-2-eноат | 412-260-6 | 52658-19-2 | Eye Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H319 | H317 | H411 | GHS07 | GHS09 | Wng | H319 | H317 | H411 |   |   |  
616-088-00-4 | 2-aminosulfonyl-N, N-dimethylnicotinamide | 413-440-7 | 112006-75-4 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  616-088-00-4 | 2-аминосулфонил-N, N-диметилникотинамид | 413-440-7 | 112006-75-4 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
616-089-00-X | 5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethyltetrahydrofuran | 415-360-8 | 41107-56-6 | Muta. 2 | H341 | GHS08 | Wng | H341 |   |   |  616-089-00-X | 5-(2,4-диоксо-1,2,3,4-тетрахидропиримидин)-3-флуоро-2-хидроксиметилтетрахидрофуран | 415-360-8 | 41107-56-6 | Muta. 2 | H341 | GHS08 | Wng | H341 |   |   |  
616-090-00-5 | 1-(1,4-benzodioxan-2-ylcarbonyl)piperazine hydrochloride | 415-660-9 | 70918-74-0 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 2 | H331 | H311 | H301 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H411 |   |   |  616-090-00-5 | 1-(1,4-бензодиоксан-2-илкарбонил)пиперазинхидрохлорид | 415-660-9 | 70918-74-0 | Acute Tox. 3 * | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Aquatic Chronic 2 | H331 | H311 | H301 | H373 ** | H411 | GHS06 | GHS08 | GHS09 | Dgr | H331 | H311 | H301 | H373 ** | H411 |   |   |  
616-091-00-0 | 1,3,5-tris-[(2S and 2R)-2,3-epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione | 423-400-0 | 59653-74-6 | Muta. 1B | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | H340 | H331 | H302 | H373 ** | H318 | H317 | GHS06 | GHS08 | GHS05 | Dgr | H340 | H331 | H302 | H373 ** | H318 | H317 |   |   |  616-091-00-0 | 1,3,5-трис[(2S и 2R)-2,3-eпоксипропил]-1,3,5-триaзин-2,4,6-(1H,3H,5H)-триoн | 423-400-0 | 59653-74-6 | Muta. 1B | Acute Tox. 3 * | Acute Tox. 4 * | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | H340 | H331 | H302 | H373 ** | H318 | H317 | GHS06 | GHS08 | GHS05 | Dgr | H340 | H331 | H302 | H373 ** | H318 | H317 |   |   |  
616-092-00-6 | polymeric reaction product of bicyclo[2.2.1]hepta-2,5-diene, ethene, 1,4-hexadiene, 1-propene with N, N-di-2-propenylformamide | 404-035-6 | — | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  616-092-00-6 | полимерен реакционен продукт от бицикло[2.2.1]хепта-2,5-диeн, етeн, 1,4-хексадиeн, 1-пропен с N,N-ди-2-пропенилформамид | 404-035-6 | — | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
616-093-00-1 | reaction products of: aniline-terephthalaldehyde-o-toluidine condensate with maleic anhydride | 406-620-1 | 129217-90-9 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  616-093-00-1 | реакционни продукти от: анилинтерефталалдехид-o-толуидин кондензат с малеинов анхидрид | 406-620-1 | 129217-90-9 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
616-095-00-2 | 3,3'-dioctadecyl-1,1'-methylene | bis(4,1-phenylene)diurea | 406-690-3 | 43136-14-7 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-095-00-2 | 3,3′-диоктадецил-1,1′-метилен | бис(4,1-фенилен)диуреа | 406-690-3 | 43136-14-7 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-096-00-8 | N-(3-hexadecyloxy-2-hydroxyprop-1-yl)-N-(2-hydroxyethyl)palmitamide | 408-110-4 | 110483-07-3 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-096-00-8 | N-(3-хексадецилокси-2-хидроксипроп-1-ил)-N-(2-хидроксиетил)палмитамид | 408-110-4 | 110483-07-3 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-097-00-3 | N,N'-1,4-phenylenebis(2-((2-methoxy-4-nitrophenyl)azo)-3-oxobutanamide | 411-840-6 | 83372-55-8 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-097-00-3 | N,N′-1,4-фенилeнбис(2-((2-метокси-4-нитрофенил)азо)-3-оксобутанамид | 411-840-6 | 83372-55-8 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-098-00-9 | 1-[4-chloro-3-((2,2,3,3,3-pentafluoropropoxy)methyl)phenyl]-5-phenyl-1H-1,2,4-triazole-3-carboxamide | 411-750-7 | 119126-15-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  616-098-00-9 | 1-[3-((2,2,3,3,3-пентафлуоропропокси)метил)-4-хлорофенил]-5-фенил-1H-1,2,4-триазол-3-карбоксамид | 411-750-7 | 119126-15-7 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
616-099-00-4 | 2-[4-[(4-hydroxyphenyl)sulfonyl]phenoxy]-4,4-dimethyl-N-[5-[(methylsulfonyl)amino]-2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]phenyl]-3-oxopentanamide | 414-170-2 | 135937-20-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-099-00-4 | 2-[4-[(4-хидроксифенил)сулфонил]фенокси]-4,4-диметил-N-[5-[(метилсулфонил)амино]-2-[4-(1,1,3,3-тетраметилбутил)фенокси]фенил]-3-оксопентанамид | 414-170-2 | 135937-20-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-100-00-8 | 1,3-dimethyl-1,3-bis(trimethylsilyl)urea | 414-180-7 | 10218-17-4 | Acute Tox. 4 * | Skin Irrit. 2 | H302 | H315 | GHS07 | Wng | H302 | H315 |   |   |  616-100-00-8 | 1,3-диметил-1,3-бис(триметилсилил)уреа | 414-180-7 | 10218-17-4 | Acute Tox. 4 * | Skin Irrit. 2 | H302 | H315 | GHS07 | Wng | H302 | H315 |   |   |  
616-101-00-3 | (S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide | 414-600-9 | 149182-72-9 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  616-101-00-3 | (S)-N-трет-бутил-1,2,3,4-тетрахидро-3-изохинолинкарбоксамид | 414-600-9 | 149182-72-9 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
616-102-00-9 | reaction mass of: α-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl]-ω-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyloxy]-poly-(oxyethylene-co-oxypropylene); | 1,2-(or 1,3-)bis[α-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl)-ω-oxy-poly(oxyethylene-co-oxypropylene)]-3-(or 2-)propanol; | 1,2,3-tris[α-(3-mercaptopropanoxycarbonyl-amino)methylphenylaminocarbonyl)-ω-oxy-poly-(oxyethylene-co-oxypropylene)]propane] | 415-870-0 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  616-102-00-9 | реакционна маса от: α-[3-(3-меркаптопропаноксикарбониламино)метилфениламинокарбонил]-ω-[3-(3-меркаптопропанoксикарбониламино)метилфенилaминокарбонилокси]поли(оксиетилeн-съ-оксипропилeн); | 1,2(или 1,3)-бис[α-(3-меркаптопропаноксикарбониламино)метилфениламинокарбонил)-ω-оксиполи(оксиетилeн-съ-оксипропилeн)]-3(или 2)-пропанoл; | 1,2,3-трис[α-(3-меркаптопропаноксикарбониламино)метилфениламинокарбонил)-ω-оксиполи(оксиетилeн-съ-оксипропилeн)]пропан] | 415-870-0 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
616-103-00-4 | (S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamide | 415-030-3 | 120298-38-6 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  616-103-00-4 | (S,S)-транс-4-(ацетиламино)-6-метил-7,7-диоксо-5,6-дихидро-4H-тиенo[2,3-b]тиопиран-2-сулфонамид | 415-030-3 | 120298-38-6 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   |   |  
616-104-00-X | benalaxyl (ISO); | methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)-DL-alaninate | 275-728-7 | 71626-11-4 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  616-104-00-X | беналаксил (ISO); | метилов N-(2,6-диметилфенил)-N-(фенилацетил)-DL-аланинат | 275-728-7 | 71626-11-4 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
616-105-00-5 | chlorotoluron (ISO); | 3-(3-chloro-p-tolyl)-1,1-dimethylurea | 239-592-2 | 15545-48-9 | Carc. 2 | Repr. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H361d *** H400 | H410 | GHS08 | GHS09 | Wng | H351 | H361d *** H410 |   |   |  616-105-00-5 | хлоротолурон (ISO); | 3-(3-хлоро-p-толил)-1,1-диметилуреа | 239-592-2 | 15545-48-9 | Carc. 2 | Repr. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H361d *** H400 | H410 | GHS08 | GHS09 | Wng | H351 | H361d *** H410 |   |   |  
616-106-00-0 | phenmedipham (ISO); | methyl 3-(3-methylcarbaniloyloxy)carbanilate | 237-199-0 | 13684-63-4 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  616-106-00-0 | фенмедифам (ISO); | метилов 3-(3-метилкарбанилoилокси)карбанилат | 237-199-0 | 13684-63-4 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
616-107-00-6 | cinidon ethyl (ISO); | ethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate | — | 142891-20-1 | Carc. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H317 | H410 |   |   |  616-107-00-6 | цинидон етил (ISO); | етилов (Z)-2-хлоро-3-[2-хлоро-5-(циклохекс-1-ен-1,2-дикарбоксимидо)фенил]акрилат | — | 142891-20-1 | Carc. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H317 | H410 |   |   |  
616-108-00-1 | iodosulfuron-methyl-sodium; sodium ({[5-iodo-2-(methoxycarbonyl)phenyl]sulfonyl}carbamoyl)(4-methoxy-6-methyl-1,3,5-triazin-2-yl)azanide | — | 144550-36-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  616-108-00-1 | йодосулфурон-метил-натрий; натриев ({[5-йодо-2-(метоксикарбонил)фенил]сулфонил}карбамоил)(6-метил-4-метокси-1,3,5-триазин-2-ил)азанид | — | 144550-36-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
616-109-00-7 | sulfosulfuron (ISO); | 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea | — | 141776-32-1 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  616-109-00-7 | сулфосулфурон (ISO); | 1-(4,6-диметоксипиримидин-2-ил)-3-(2-етилсулфонилимидазо[1,2-a]пиридин-3-ил)сулфонилуреа | — | 141776-32-1 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
616-110-00-2 | cyclanilide (ISO); | 1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid | 419-150-7 | 113136-77-9 | Acute Tox. 4 * Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  616-110-00-2 | цикланилид (ISO); | 1-(2,4-дихлороанилинокарбонил)циклопропанкарбоксилна киселина | 419-150-7 | 113136-77-9 | Acute Tox. 4 * Aquatic Chronic 2 | H302 | H411 | GHS07 | GHS09 | Wng | H302 | H411 |   |   |  
616-111-00-8 | fenhexamid (ISO); | N-(2,3-dichlor-4-hydroxyphenyl)-1-methylcyclohexancarboxamid | 422-530-5 | 126833-17-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  616-111-00-8 | фенхексамид (ISO); | 1-метил-N-(4-хидрокси-2,3-дихлорофенил)циклохексанкарбоксамид | 422-530-5 | 126833-17-8 | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
616-112-00-3 | oxasulfuron (ISO); | oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate | — | 144651-06-9 | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** | H400 | H410 | GHS08 | GHS09 | Wng | H373 ** | H410 |   |   |  616-112-00-3 | оксасулфурон (ISO); | oксeтан-3-илов 2-[(4,6-диметилпиримидин-2-ил)карбамоилсулфамоил]бензoaт | — | 144651-06-9 | STOT RE 2 * | Aquatic Acute 1 | Aquatic Chronic 1 | H373 ** | H400 | H410 | GHS08 | GHS09 | Wng | H373 ** | H410 |   |   |  
616-113-00-9 | desmedipham (ISO); | ethyl 3-phenylcarbamoyloxyphenylcarbamate | 237-198-5 | 13684-56-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M=10 |  616-113-00-9 | десмедифам (ISO); | етилов 3-фенилкарбамоилоксифенилкарбамат | 237-198-5 | 13684-56-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M=10 |  
616-114-00-4 | dodecanamide, N,N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo(1,1'-bianthracene)-4,4'-diyl)bis- | 418-010-2 | 136897-58-0 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-114-00-4 | N,N′-(9,9′,10,10′-тетрахидро-9,9′,10,10′-тетраоксо(1,1′-биантрацен)-4,4′-диил)бисдодеканамид | 418-010-2 | 136897-58-0 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-115-00-X | N-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide | 416-150-9 | 136450-06-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-115-00-X | N-(3-ацетил-2-хидроксифенил)-4-(4-фенилбутокси)бензамид | 416-150-9 | 136450-06-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-116-00-5 | N-(4-dimethylaminopyridinium)-3-methoxy-4-(1-methyl-5-nitroindol-3-ylmethyl)-N-(o-tolylsulfonyl)benzamidate | 416-790-9 | 143052-96-4 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-116-00-5 | N-(4-диметиламинопиридиниев) 4-(1-метил-5-нитроиндол-3-илметил)-3-метокси-N-(o-толилсулфонил)бензaмидат | 416-790-9 | 143052-96-4 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-117-00-0 | N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide | 416-860-9 | 777891-21-1 | Repr. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361f *** H317 | H400 | H410 | GHS08 | GHS09 | Wng | H361f *** H317 | H410 |   |   |  616-117-00-0 | N-[2-(3-ацетил-5-нитротиофен-2-илазо)-5-диетиламинофенил]ацетамид | 416-860-9 | 777891-21-1 | Repr. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H361f *** H317 | H400 | H410 | GHS08 | GHS09 | Wng | H361f *** H317 | H410 |   |   |  
616-118-00-6 | N-(2',6'-dimethylphenyl)-2-piperidinecarboxamide hydrochloride | 417-950-0 | 65797-42-4 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  616-118-00-6 | N-(2′,6′-диметилфенил)-2-пиперидинкарбоксамидхидрохлорид | 417-950-0 | 65797-42-4 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
616-119-00-1 | 2-(1-butyl-3,5-dioxo-2-phenyl-(1,2,4)-triazolidin-4-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1-sulfonyl))propionylamino)-phenyl)-pentanamide | 418-060-5 | 118020-93-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-119-00-1 | 2-(1-бутил-3,5-диоксо-2-фенил-1,2,4-триазолидин-4-ил)-4,4-диметил-3-оксо-N-(2-метокси-5-(2-(додецил-1-сулфонил))пропиониламино)фенил)пентанамид | 418-060-5 | 118020-93-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-120-00-7 | reaction mass of: N-(3-dimethylamino-4-methyl-phenyl)-benzamide; | N-(3-dimethylamino-2-methyl-phenyl)-benzamide; | N-(3-dimethylamino-3-methyl-phenyl)-benzamide | 420-600-1 | — | STOT RE 2 * | Aquatic Chronic 2 | H373 ** | H411 | GHS08 | GHS09 | Wng | H373 ** | H411 |   |   |  616-120-00-7 | реакционна маса от: N-(3-диметиламино-4-метилфенил)бензамид; | N-(3-диметиламино-2-метилфенил)бензамид; | N-(3-диметиламино-3-метилфенил)бензамид | 420-600-1 | — | STOT RE 2 * | Aquatic Chronic 2 | H373 ** | H411 | GHS08 | GHS09 | Wng | H373 ** | H411 |   |   |  
616-121-00-2 | 2,4-dihydroxy-N-(2-methoxyphenyl)benzamide | 419-090-1 | 129205-19-2 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  616-121-00-2 | N-(2-метоксифенил)-2,4-дихидроксибензамид | 419-090-1 | 129205-19-2 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
616-122-00-8 | methyl neodecanamide | 414-460-9 | 105726-67-8 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  616-122-00-8 | метилов неодеканамид | 414-460-9 | 105726-67-8 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
616-123-00-3 | N-[3-[[4-(diethylamino)-2-methylphenyl]imino]-6-oxo-1,4-cyclohexadienyl]acetamide | 414-740-0 | 96141-86-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  616-123-00-3 | N-[3-[[4-(диетиламино)-2-метилфенил]имино]-6-оксо-1,4-циклохексадиенил]ацетамид | 414-740-0 | 96141-86-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
616-124-00-9 | lithium bis(trifluoromethylsulfonyl)imide | 415-300-0 | 90076-65-6 | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Skin Corr. 1B | Aquatic Chronic 3 | H311 | H301 | H373** | H314 | H412 | GHS06 | GHS05 | GHS08 | Dgr | H311 | H301 | H373** | H314 | H412 |   |   |  616-124-00-9 | литиев бис(трифлуорометилсулфонил)имид | 415-300-0 | 90076-65-6 | Acute Tox. 3 * | Acute Tox. 3 * | STOT RE 2 * | Skin Corr. 1B | Aquatic Chronic 3 | H311 | H301 | H373** | H314 | H412 | GHS06 | GHS05 | GHS08 | Dgr | H311 | H301 | H373** | H314 | H412 |   |   |  
616-125-00-4 | 3-cyano-N-(1,1-dimethylethyl)androsta-3,5-diene-17-β-carboxamide | 415-730-9 | 151338-11-3 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | 410 |   |   |  616-125-00-4 | N-(1,1-диметилетил)-3-цианоандроста-3,5-диен-17-β- карбоксамид | 415-730-9 | 151338-11-3 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | 410 |   |   |  
616-126-00-X | 1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide | 423-960-6 | 139756-01-7 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 3 | H302 | H373** | H412 | GHS08 | GHS07 | Wng | H302 | H373** | H412 |   |   |  616-126-00-X | 1-метил-4-нитро-3-пропил-1H-пиразол-5-карбоксамид | 423-960-6 | 139756-01-7 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 3 | H302 | H373** | H412 | GHS08 | GHS07 | Wng | H302 | H373** | H412 |   |   |  
616-127-00-5 | reaction mass of: N, N'-Ethane-1,2-diylbis(decanamide); | 12-Hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamide; | N, N'-Ethane-1,2-diylbis(12hydroxyoctadecanamide) | 430-050-2 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  616-127-00-5 | реакционна маса от: N,N′-етан-1,2-диилбис(деканамид); | N-[2-[1-оксидецил)амино]етил]-12-хидроксиоктадеканамид; | N,N′-етан-1,2-диилбис(12-хидроксиоктадеканамид) | 430-050-2 | — | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
616-128-00-0 | N-(2-(1-allyl-4,5-dicyanoimidazol-2-ylazo)-5-(dipropylamino)phenyl)-acetamide | 417-530-7 | 123590-00-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-128-00-0 | N-(2-(1-алил-4,5-дицианоимидазол-2-илазо)-5-(дипропиламино)фенил)ацетамид | 417-530-7 | 123590-00-1 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-129-00-6 | N,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamide | 419-710-0 | 42774-15-2 | Acute Tox. 4 * | Eye Irrit. 2 | H302 | H319 | GHS07 | Wng | H302 | H319 |   |   |  616-129-00-6 | N,N′-бис(2,2,6,6-тетраметил-4-пиперидил)изофталамид | 419-710-0 | 42774-15-2 | Acute Tox. 4 * | Eye Irrit. 2 | H302 | H319 | GHS07 | Wng | H302 | H319 |   |   |  
616-130-00-1 | N-(3-(2-(4,4-dimethyl-2,5-dioxo-imidazolin-1-yl)-4,4-dimethyl-3-oxo-pentanoylamino)-4-methoxy-phenyl)-octadecanamide | 421-780-2 | 150919-56-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-130-00-1 | N-(3-(2-(4,4-диметил-2,5-диоксоимидазолин-1-ил)-4,4-диметил-3-оксопентанoиламино)-4-метоксифенил)октадеканамид | 421-780-2 | 150919-56-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-131-00-7 | 1-aminocyclopentanecarboxamide | 422-950-9 | 17193-28-1 | STOT RE 1 | Acute Tox. 4 * | Eye Dam. 1 | H372** | H302 | H318 | GHS05 | GHS08 | GHS07 | Dgr | H372** | H302 | H318 |   |   |  616-131-00-7 | 1-аминоциклопентанкарбоксамид | 422-950-9 | 17193-28-1 | STOT RE 1 | Acute Tox. 4 * | Eye Dam. 1 | H372** | H302 | H318 | GHS05 | GHS08 | GHS07 | Dgr | H372** | H302 | H318 |   |   |  
616-132-00-2 | N-[4-(4-cyano-2-furfurylidene-2,5-dihydro-5-oxo-3-furyl)phenyl]butane-1-sulfonamide | 423-250-6 | 130016-98-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  616-132-00-2 | N-[4-(4-циано-2-фурфурилиден-2,5-дихидро-5-оксо-3-фурил)фенил]бутан-1-сулфонамид | 423-250-6 | 130016-98-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
616-133-00-8 | N-cyclohexyl-S, S-dioxo | benzo[b]tiophene-2-carboxamide | 423-990-1 | 149118-66-1 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H410 |   |   |  616-133-00-8 | N-циклохексил-S, S-диоксо | бензo[b]тиофен-2-карбоксамид | 423-990-1 | 149118-66-1 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H410 |   |   |  
616-134-00-3 | 3,3'-bis(dioctyloxyphosphinothioylthio)-N, N'-oxybis(methylene)dipropionamide | 401-820-5 | 793710-14-2 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  616-134-00-3 | 3,3′-бис(диoктилоксифосфинотиоилтио)-N,N′-оксибис(метилeн)дипропионамид | 401-820-5 | 793710-14-2 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
616-135-00-9 | (3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline-3-carboxamide | 430-230-0 | 136522-17-3 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  616-135-00-9 | (3S,4aS,8aS)-2-[(2R,3S)-3-амино-2-хидрокси-4-фенилбутил]-N-трет-бутилдекахидроизохинолин-3-карбоксамид | 430-230-0 | 136522-17-3 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
616-136-00-4 | reaction product of cocoalkyldiethanolamides and cocoalkylmonoglycerides and molybdenumtrioxide (1.75-2.2: 0.75-1.0:0.1-1.1) | 430-380-7 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  616-136-00-4 | реакционен продукт от кокоалкилдиетаноламиди и кокоалкилмоноглицериди и молибденов триоксид (1,75-2,2: 0.75-1.0:0.1-1.1) | 430-380-7 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
616-137-00-X | 4-dichloroacetyl-1-oxa-4-azaspiro[4.5]decane | 401-130-4 | 71526-07-3 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  616-137-00-X | 4-дихлороацетил-1-окса-4-азаспиро[4.5]декан | 401-130-4 | 71526-07-3 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
616-138-00-5 | benzoic acid, N-tert-butyl-N'-(4-chlorobenzoyl)hydrazide | 431-600-4 | 112226-61-6 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  616-138-00-5 | бензоена киселина, N-трет-бутил-N′-(4-хлоробензоил)хидразид | 431-600-4 | 112226-61-6 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
616-139-00-0 | (3S, 4aS, 8aS)-N-tert-butyldecahydro-3-isoquinolinecarboxamide | 420-380-5 | 136465-81-1 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  616-139-00-0 | (3S,4aS,8aS)-N-трет-бутилдекахидро-3-изохинолинкарбоксамид | 420-380-5 | 136465-81-1 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Chronic 3 | H302 | H318 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H412 |   |   |  
616-140-00-6 | N, N''-(methylenedi-4,1-phenylene)bis[N'-(4-methylphenyl)urea] | 429-380-1 | 133336-92-2 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  616-140-00-6 | N,N′′-(метиленди-4,1-фенилен)бис[N′-(4-метилфенил)уреа] | 429-380-1 | 133336-92-2 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
616-141-00-1 | zoxamide (ISO); | (RS)-3,5-dichloro-N-(3-chloro-1-ethyl-1-methyl-2-oxopropyl)-p-toluamide | — | 156052-68-5 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   | M=10 |  616-141-00-1 | зоксамид (ISO); | (RS)-N-(1-етил-1-метил-2-оксо-3-хлоропропил)-3,5-дихлоро-p-толуамид | — | 156052-68-5 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H317 | H410 |   | M=10 |  
616-142-00-7 | 1,3-bis(vinylsulfonylacetamido)propane | 428-350-3 | 93629-90-4 | Muta. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H341 | H318 | H317 | H412 | GHS08 | GHS05 | GHS07 | Dgr | H341 | H318 | H317 | H412 |   |   |  616-142-00-7 | 1,3-бис(винилсулфонилацетамидо)пропан | 428-350-3 | 93629-90-4 | Muta. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H341 | H318 | H317 | H412 | GHS08 | GHS05 | GHS07 | Dgr | H341 | H318 | H317 | H412 |   |   |  
616-143-00-2 | N,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide | 422-560-9 | 149591-38-8 | Repr. 2 | Eye Irrit. 2 | Aquatic Chronic 4 | H361f *** H319 | H413 | GHS08 | Wng | H361f *** H319 | H413 |   |   |  616-143-00-2 | N,N′-дихексадецил-N,N′-бис(2-хидроксиетил)пропандиамид | 422-560-9 | 149591-38-8 | Repr. 2 | Eye Irrit. 2 | Aquatic Chronic 4 | H361f *** H319 | H413 | GHS08 | Wng | H361f *** H319 | H413 |   |   |  
616-144-00-8 | 3,4-dichloro-N-[5-chloro-4-[2-[4-dodecyloxyphenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide | 431-130-1 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-144-00-8 | N-[4-[2-[4-додецилоксифенилсулфонил]бутирамидо]-2-хидрокси-5-хлорофенил]-3,4-дихлоробензамид | 431-130-1 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-145-00-3 | pethoxamide (ISO); | 2-chloro-N-(2-ethoxyethyl)-N-(2-methyl-1-phenylprop-1enyl)acetamide | — | 106700-29-2 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   | M=100 |  616-145-00-3 | петоксамид (ISO); | N-(2-етоксиетил)-N-(2-метил-1-фенилпроп-1-енил)-2-хлороацетамид | — | 106700-29-2 | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H317 | H410 |   | M=100 |  
616-146-00-9 | N-(2-methoxy-5-octadecanoylaminophenyl)-2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxopentanoic acidamide | 431-330-7 | 142776-95-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-146-00-9 | амид на N-(2-метокси-5-октадеканоиламинофенил)-2-(3-бензил-2,5-диоксоимидазолидин-1-ил)-4,4-диметил-3-оксопентановата киселина | 431-330-7 | 142776-95-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-147-00-4 | 1-methyl-4-(2-methyl-2H-tetrazol-5-yl)-1H-pyrazole-5-sulfonamide | 424-160-1 | 139481-22-4 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  616-147-00-4 | 1-метил-4-(2-метил-2H-тетразол-5-ил)-1H-пиразол-5-сулфонамид | 424-160-1 | 139481-22-4 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
616-148-00-X | N-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide | 424-550-1 | 84245-12-5 | Carc. 1B | Muta. 1B | Repr. 1B | H350 | H340 | H360FD | GHS08 | Dgr | H350 | H340 | H360FD |   |   |  616-148-00-X | N-[6-оксо-6,9-дихидро-9-[[2-хидрокси-1-(хидроксиметил)етокси]метил]-1H-пурин-2-ил]ацетамид | 424-550-1 | 84245-12-5 | Carc. 1B | Muta. 1B | Repr. 1B | H350 | H340 | H360FD | GHS08 | Dgr | H350 | H340 | H360FD |   |   |  
616-150-00-0 | (2R,3S)-N-(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzenesulfonamide hydrochloride | 425-260-6 | — | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H373** | H318 | H317 | H411 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H373** | H318 | H317 | H411 |   |   |  616-150-00-0 | (2R,3S)-N-(3-амино-4-фенил-2-хидроксибутил)-N-изобутил-4-нитробензенсулфонамидхидрохлорид | 425-260-6 | — | STOT RE 2 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H373** | H318 | H317 | H411 | GHS05 | GHS08 | GHS07 | GHS09 | Dgr | H373** | H318 | H317 | H411 |   |   |  
616-151-00-6 | N-(2-amino-4,6-dichloropyrimidin-5-yl)formamide | 425-650-6 | 171887-03-9 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H317 | H412 |   |   |  616-151-00-6 | N-(2-амино-4,6-дихлоропиримидин-5-ил)формамид | 425-650-6 | 171887-03-9 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 3 | H302 | H318 | H317 | H412 | GHS05 | GHS07 | Dgr | H302 | H318 | H317 | H412 |   |   |  
616-152-00-1 | 4-(4-fluorophenyl)-2-(2-methyl-1-oxopropyl)-4-oxo-3,N-diphenylbutanamide | 425-850-3 | 125971-96-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-152-00-1 | 2-(2-метил-1-оксопропил)-4-оксо-3,N-дифенил-4-(4-флуорофенил)бутанамид | 425-850-3 | 125971-96-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-153-00-7 | 4-methyl-3-oxo-N-phenyl-2-(phenylmethylene)pentanamide | 425-860-8 | 125971-57-5 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  616-153-00-7 | 4-метил-3-оксо-N-фенил-2-(фенилметилен)пентанамид | 425-860-8 | 125971-57-5 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
616-154-00-2 | 3,4-dichloro-N-[5-chloro-4-[2-[4-(hexadecyloxy)phenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide | 431-110-0 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-154-00-2 | N-[4-[2-[4-(хексадецилокси)фенилсулфонил]бутирамидо]-2-хидрокси-5-хлорофенил]-3,4-дихлоробензамид | 431-110-0 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-155-00-8 | N,N,N',N'-tetracyclohexyl-1,3-benzenedicarboxamide | 431-040-0 | 104560-40-9 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  616-155-00-8 | N,N,N′,N′-тетрациклохексил-1,3-бензендикарбоксамид | 431-040-0 | 104560-40-9 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
616-156-00-3 | 6-(2-chloro-6-cyano-4-nitrophenylazo)-4-methoxy-3-[N-(methoxycarbonylmethyl)-N-(1-methoxycarbonylethyl)amino]acetanilide | 430-500-8 | 204277-61-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-156-00-3 | 4-метокси-3-[N-(метоксикарбонилметил)-N-(1-метоксикарбонилетил)амино]-6-(4-нитро-2-хлоро-6-цианофенилазо)ацетанилид | 430-500-8 | 204277-61-2 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-157-00-9 | 3-amino-4-hydroxy-N-(3-isopropoxypropyl)benzenesulfonamide hydrochloride | 427-780-9 | 114565-70-7 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H410 |   |   |  616-157-00-9 | 3-амино-N-(3-изопропоксипропил)-4-хидроксибензенсулфонамидхидрохлорид | 427-780-9 | 114565-70-7 | Acute Tox. 4 * | Eye Dam. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H318 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H302 | H318 | H410 |   |   |  
616-158-00-4 | N-[4-cyano-3-trifluoromethylphenyl]methacrylamide | 427-880-2 | 90357-53-2 | STOT RE 2 * | Aquatic Chronic 2 | H373** | H411 | GHS08 | GHS09 | Wng | H373** | H411 |   |   |  616-158-00-4 | N-[3-трифлуорометил-4-цианофенил]метакриламид | 427-880-2 | 90357-53-2 | STOT RE 2 * | Aquatic Chronic 2 | H373** | H411 | GHS08 | GHS09 | Wng | H373** | H411 |   |   |  
616-160-00-5 | 2,2'-azobis[N-(2-hydroxyethyl)2-methylpropionamide] | 429-090-3 | 61551-69-7 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  616-160-00-5 | 2,2′-азобис[2-метил-N-(2-хидроксиетил)пропионамид] | 429-090-3 | 61551-69-7 | Skin Sens. 1 | Aquatic Chronic 3 | H317 | H412 | GHS07 | Wng | H317 | H412 |   |   |  
616-161-00-0 | 2,4-dichloro-5-hydroxyacetanilide | 429-110-0 | 67669-19-6 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  616-161-00-0 | 5-хидрокси-2,4-дихлороацетанилид | 429-110-0 | 67669-19-6 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
616-162-00-6 | isostearic acid monoisopropanolamide | 431-540-9 | — | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  616-162-00-6 | моноизопропаноламид на изостеариновата киселина | 431-540-9 | — | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
616-163-00-1 | 4,4'-methylenebis[N-(4-chlorophenyl)-3-hydroxynaphthalene-2-carboxamide] | 430-350-3 | 192463-88-0 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-163-00-1 | 4,4′-метиленбис[3-хидрокси-N-(4-хлорофенил)нафтален-2-карбоксамид] | 430-350-3 | 192463-88-0 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-164-00-7 | dimoxystrobin (ISO); | (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide | — | 149961-52-4 | Carc. 2 | Repr. 2 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H361d*** | H332 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H361d*** | H332 | H410 |   | M=10 |  616-164-00-7 | димоксистробин (ISO); | (E)-2-(метоксиимино)-N-метил-2-[α-(2,5-ксилилокси)-o-толил]ацетамид | — | 149961-52-4 | Carc. 2 | Repr. 2 | Acute Tox. 4 * | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H361d*** | H332 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H361d*** | H332 | H410 |   | M=10 |  
616-165-00-2 | beflubutamid (ISO); | (RS)-N-benzyl-2-(α, α, α, 4-tetrafluoro-m-tolyoxy)butyramide | — | 113614-08-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M=100 |  616-165-00-2 | бефлубутамид (ISO); | (RS)-N-бензил-2-(α, α,α,4-тетрафлуоро-m-толилокси)бутирамид | — | 113614-08-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M=100 |  
616-166-00-8 | cyazofamid (ISO); | 4-chloro-2-cyano-N, N-dimethyl-5-p-tolylimidazole-1-sulfonamide | — | 120116-88-3 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M=10 |  616-166-00-8 | циазофамид (ISO); | N,N-диметил-4-хлоро-2-циано-5-p-толилимидазол-1-сулфонамид | — | 120116-88-3 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M=10 |  
616-167-00-3 | N, N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide | 418-290-6 | 168612-06-4 | Eye Irrit. 2 | Skin Sens. 1 | H319 | H317 | GHS07 | Wng | H319 | H317 |   |   |  616-167-00-3 | N, N-дибутил-(5-тиоксо-2,5-дихидро-1H-тетразол-1-ил)ацетамид | 418-290-6 | 168612-06-4 | Eye Irrit. 2 | Skin Sens. 1 | H319 | H317 | GHS07 | Wng | H319 | H317 |   |   |  
616-168-00-9 | 1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium | 418-440-0 | 136997-71-2 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  616-168-00-9 | 1-диметилкарбамоил-4-(2-сулфонатоетил)пиридиниев йон | 418-440-0 | 136997-71-2 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
616-169-00-4 | 4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one | 420-220-4 | 92771-56-7 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  616-169-00-4 | 4-[4-(2,2-диметилпропанамидо)]фенилазо-3-(2-хлоро-5-(2-(3-пентадецилфенокси)бутиламидо)анилино)-1-(2,4,6-трихлорофенил)-2-пиразолин-5-он | 420-220-4 | 92771-56-7 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
616-170-00-X | (2R)-2-amino-2-phenylacetamide | 420-370-0 | 6485-67-2 | Eye Irrit. 2 | Skin Sens. 1 | H319 | H317 | GHS07 | Wng | H319 | H317 |   |   |  616-170-00-X | (2R)-2-амино-2-фенилацетамид | 420-370-0 | 6485-67-2 | Eye Irrit. 2 | Skin Sens. 1 | H319 | H317 | GHS07 | Wng | H319 | H317 |   |   |  
616-171-00-5 | 2-(para-chlorophenyl)glycineamide | 420-830-0 | 102333-75-5 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  616-171-00-5 | 2-(пара-хлорофенил)глицинамид | 420-830-0 | 102333-75-5 | Eye Dam. 1 | Skin Sens. 1 | H318 | H317 | GHS05 | GHS07 | Dgr | H318 | H317 |   |   |  
616-172-00-0 | N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide; | (4-acetamido-2,2,6,6-tetra | methyl-1-piperidinyl)oxidanyl | 423-840-3 | 14691-89-5 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  616-172-00-0 | N-(2,2,6,6,-тетраметил-1-оксилпиперидин-4-ил)ацетамид; | (4-ацетамидо-2,2,6,6-тетра | метил-1-пиперидинил)оксиданил | 423-840-3 | 14691-89-5 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
616-174-00-1 | 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride | 424-560-4 | 151257-01-1 | Acute Tox. 4 * | Eye Irrit. 2 | H302 | H319 | GHS07 | Wng | H302 | H319 |   |   |  616-174-00-1 | 2-бутил-1,3-диазаспиро[4.4]нон-1-ен-4-онхидрохлорид | 424-560-4 | 151257-01-1 | Acute Tox. 4 * | Eye Irrit. 2 | H302 | H319 | GHS07 | Wng | H302 | H319 |   |   |  
616-175-00-7 | 2-(2-hexyldecyloxy)benzamide | 431-230-3 | 202483-62-3 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-175-00-7 | 2-(2-хексилдецилокси)бензамид | 431-230-3 | 202483-62-3 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-176-00-2 | 3-N, N-bis(methoxyethyl)aminoacetanilide | 432-530-7 | 24294-01-7 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  616-176-00-2 | 3-N, N-бис(метоксиетил)аминоацетанилид | 432-530-7 | 24294-01-7 | Acute Tox. 4 * | Aquatic Chronic 3 | H302 | H412 | GHS07 | Wng | H302 | H412 |   |   |  
616-177-00-8 | (3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide; | N-[3-({4-[(2-{]butyl[}(4methylphenyl)sulfonyl{]amino[}phenyl)thio{]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3yl[}amino)-4-chlorophenyl]tetradecanamide | 432-970-1 | 217324-98-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-177-00-8 | (3-(4-(2-(бутил(4-метилфенилсулфонил)амино)фенилтио)-5-оксо-1-(2,4,6-трихлорофенил)-4,5-дихидро-1H-пиразол-3-иламино)-4-хлорофенил)тетрадеканамид; | N-[3-({4-[(2-{бутил[(4-метилфенил)сулфонил]амино}фенил)тио]-5-оксо-1-(2,4,6-трихлорофенил)-4,5-дихидро-1H-пиразол-3-ил}амино)-4-хлорофенил]тетрадеканамид | 432-970-1 | 217324-98-6 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-178-00-3 | N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide | 434-500-9 | 52583-35-4 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-178-00-3 | N-(5-(бис(2-метоксиетил)амино)-2-((4,6-динитро-2-цианофенил)азо)фенил)ацетамид | 434-500-9 | 52583-35-4 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-179-00-9 | 2-chloro-N-(4-methylphenyl)acetamide | 435-170-9 | 16634-82-5 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H410 |   |   |  616-179-00-9 | N-(4-метилфенил)-2-хлороацетамид | 435-170-9 | 16634-82-5 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H318 | H317 | H410 |   |   |  
616-180-00-4 | N, N-(dimethylamino)thioacetamide hydrochloride | 435-470-1 | 27366-72-9 | Repr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H360D*** H400 | H410 | GHS08 | GHS09 | Dgr | H360D*** H410 |   |   |  616-180-00-4 | N,N-(диметиламино)тиоацетамидхидрохлорид | 435-470-1 | 27366-72-9 | Repr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H360D*** H400 | H410 | GHS08 | GHS09 | Dgr | H360D*** H410 |   |   |  
616-181-00-X | 4'-methyldodecane-1-sulfonanilide | 435-490-9 | 17417-32-2 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  616-181-00-X | 4′-метилдодекан-1-сулфонанилид | 435-490-9 | 17417-32-2 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
616-182-00-5 | N'-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide | 435-860-1 | 214417-91-1 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  616-182-00-5 | N′-(1,3-диметилбутилиден)-3-хидрокси-2-нафтохидразид | 435-860-1 | 214417-91-1 | Skin Sens. 1 | Aquatic Chronic 2 | H317 | H411 | GHS07 | GHS09 | Wng | H317 | H411 |   |   |  
616-183-00-0 | N-dodecyl-4-methoxybenzamide | 442-340-6 | 1854-15-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-183-00-0 | N-додецил - 4-метоксибензамид | 442-340-6 | 1854-15-5 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-184-00-6 | 3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide | 442-560-2 | 105043-55-8 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-184-00-6 | 3-метил-N-(5,8,14-триоксо-5,8,13,14-тетрахидронафт[2,3-c]акридин-6-ил)бензамид | 442-560-2 | 105043-55-8 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-186-00-7 | N, N'-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide) | 443-010-4 | 53641-10-4 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  616-186-00-7 | N,N′-(2-хлоро-1,4-фенилен)бис(3-оксобутанамид) | 443-010-4 | 53641-10-4 | Aquatic Chronic 3 | H412 | — | H412 |   |   |  
616-188-00-8 | 2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide | 443-980-9 | 221215-20-9 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  616-188-00-8 | амид на 2-(5,5-диметил-2,4-диоксооксазолидин-3-ил)-4,4-диметил-3-оксо-N-(2-метокси-5-октадеканоиламинофенил)пентановата киселина | 443-980-9 | 221215-20-9 | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
616-189-00-3 | N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide | 444-780-4 | 452962-97-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-189-00-3 | N-[5-(бис(2-метоксиетил)амино]-2-(6-бромо-2-метил-1,3-диоксо-2,3-дихидро-1H-изоиндол-5-илазо)фенил]ацетамид | 444-780-4 | 452962-97-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-190-00-9 | N-decyl-4-nitrobenzamide | 445-880-0 | 64026-19-3 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-190-00-9 | N-децил-4-нитробензамид | 445-880-0 | 64026-19-3 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-191-00-4 | 2-ethyl-N-methyl-N-(3-methylphenyl)butanamide | 446-190-2 | 406488-30-0 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H319 | H315 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H319 | H315 | H317 | H411 |   |   |  616-191-00-4 | 2-етил-N-метил-N-(3-метилфенил)бутанамид | 446-190-2 | 406488-30-0 | Acute Tox. 4 * | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H302 | H319 | H315 | H317 | H411 | GHS07 | GHS09 | Wng | H302 | H319 | H315 | H317 | H411 |   |   |  
616-192-00-X | 2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5'-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2'-[(2-ethylhexyl)thio]acetanilide | 448-060-0 | 727678-39-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-192-00-X | 2-[2-(3-бутоксипропил)-1,1-диоксо-1,2,4-бензотиадиазин-3-ил]-5′-трет-бутил-2-(5,5-диметил-2,4-диоксо-1,3-оксазолидин-3-ил)-2′-[(2-етилхексил)тио]ацетанилид | 448-060-0 | 727678-39-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-193-00-5 | N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide | 449-940-7 | 368450-39-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-193-00-5 | N-[2-(2-бутил-1,3-диоксо-2,3-дихидро-4,6-дициано-1H-изоиндол-5-илазо)-5-диетиламинофенил]ацетамид | 449-940-7 | 368450-39-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-194-00-0 | 2,2-diethoxy-N, N-dimethylacetamide | 449-950-1 | 34640-92-1 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  616-194-00-0 | 2,2-диетокси-N, N-диметилацетамид | 449-950-1 | 34640-92-1 | Eye Irrit. 2 | H319 | GHS07 | Wng | H319 |   |   |  
616-196-00-1 | disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide | 419-990-4 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  616-196-00-1 | динатриева сол на 1-хидрокси-4-(β-(4-(1-хидрокси-3,6-дисулфо-8-ацетиламино-2-нафтилазо)фенокси)етокси)-N-додецил-2-нафтамид | 419-990-4 | — | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
616-197-00-7 | reaction mass of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate; N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane | sulfonamide | 422-500-1 | — | STOT RE 2 * | H373** | GHS08 | Wng | H373** |   |   |  616-197-00-7 | реакционна маса от: калиев N-[3-(диметилоксидоамино)пропил]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-хептадекафлуорооктансулфонамидат; N-[3-(диметилоксидоамино)пропил]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-хептадекафлуорооктан | сулфонамид | 422-500-1 | — | STOT RE 2 * | H373** | GHS08 | Wng | H373** |   |   |  
616-198-00-2 | 1,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene | 423-300-7 | — | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  616-198-00-2 | 1,3-бис[12-хидроксиоктадекамид-N-метилен]бензен | 423-300-7 | — | Skin Sens. 1 | Aquatic Chronic 4 | H317 | H413 | GHS07 | Wng | H317 | H413 |   |   |  
616-200-00-1 | reaction mass of N, N’-ethane1,2-diylbis(hexanamide) and 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide and N, N’-ethane-1,2-diylbis(12-hydroxyoctadecan amide) | 432-430-3 |   | Aquatic Chronic 4 | H413 |   | H413 |   |   |  616-200-00-1 | реакционна маса от N,N′-етан-1,2-диилбис(хексанамид) и 12-хидрокси-N-[2-[(1-оксихексил)амино]етил]октадеканамид и N,N′-етан-1,2-диилбис(12-хидроксиоктадеканамид) | 432-430-3 |   | Aquatic Chronic 4 | H413 |   | H413 |   |   |  
616-201-00-7 | 12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine | 432-840-2 | 220926-97-6 | Acute Tox. 4 * | Aquatic Chronic 4 | H332 | H413 | GHS07 | Wng | H332 | H413 |   |   |  616-201-00-7 | 12-хидроксиоктадеканова киселина, реакционни продукти с 1,3-бензендиметанамин и хексаметилендиамин | 432-840-2 | 220926-97-6 | Acute Tox. 4 * | Aquatic Chronic 4 | H332 | H413 | GHS07 | Wng | H332 | H413 |   |   |  
616-202-00-2 | reaction mass of: 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide; | 2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide; | 2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide | 434-330-5 | — | Carc. 2 | Skin Sens. 1 | Aquatic Chronic 4 | H351 | H317 | H413 | GHS08 | GHS07 | Wng | H351 | H317 | H413 |   |   |  616-202-00-2 | реакционна маса от: 2,2′-[(3,3′-дихлоро[1,1′-бифенил]-4,4′-диил)бис(азо)]бис[N-(2,4-диметилфенил)]-3-оксобутанамид; | 2-[[3,3′-дихлоро-4′-[[1[[(2,4-диметилфенил)амино]карбонил]-2-оксопропил]азо][1,1′-бифенил]-4-ил]азо]-N-(2-метилфенил)-3-оксобутанамид; | 2-[[3,3′-дихлоро-4′-[[1[[(2,4-диметилфенил)амино]карбонил]-2-оксопропил]азо][1,1′-бифенил]-4-ил]азо]-N-(2-карбоксилфенил)-3-оксобутанамид; | 434-330-5 | — | Carc. 2 | Skin Sens. 1 | Aquatic Chronic 4 | H351 | H317 | H413 | GHS08 | GHS07 | Wng | H351 | H317 | H413 |   |   |  
616-203-00-8 | reaction mass of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide; | N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol5-ylazo)5-diethylaminophenyl]acetamide | 442-280-0 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-203-00-8 | реакционна маса от: N-[5-(бис(2-метоксиетил)амино]-2-(2-бутил-1,3-диоксо-2,3-дихидро-4,6-дициано-1H-изоиндол-5-илазо)фенил]ацетамид; | N-[2-(2-бутил-1,3-диоксо-2,3-дихидро-4,6-дициано-1H-изоиндол-5-илазо)-5-диетиламинофенил]ацетамид | 442-280-0 | — | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-204-00-3 | N, N''-(methylenedi-4,1-phenylene)bis[N'-octylurea] | 451-060-3 | 122886-55-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  616-204-00-3 | N,N′′-(метиленди-4,1-фенилен)бис(N′-октилуреа) | 451-060-3 | 122886-55-9 | Aquatic Chronic 4 | H413 | — | H413 |   |   |  
616-205-00-9 | metazachlor (ISO); | 2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)-acetamide | 266-583-0 | 67129-08-2 | Skin Sens. 1B | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H351 | H400 | H410 | GHS07 | GHS08 | GHS09 | Wng | H317 | H351 | H410 |   | M = 100 | M = 100 |  616-205-00-9 | метазахлор (ISO); | N-(2,6-диметилфенил)-N-(1H-пиразол-1-илметил)-2-хлороацетамид | 266-583-0 | 67129-08-2 | Skin Sens. 1B | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H317 | H351 | H400 | H410 | GHS07 | GHS08 | GHS09 | Wng | H317 | H351 | H410 |   | M = 100 | M = 100 |  
616-206-00-4 | flufenoxuron (ISO); | 1-(4-(2-cloro-α, α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea | 417-680-3 | 101463-69-8 | Lact. | Aquatic Acute 1 | Aquatic Chronic 1 | H362 | H400 | H410 | GHS09 | Wng | H362 | H410 |   | M = 10 000 | M = 10 000 |  616-206-00-4 | флуфеноксурон (ISO); | 1-(4-(α, α,α-p-трифлуоро-2-хлоротолилокси)-2-флуорофенил)-3-(2,6-дифлуоробензолил)уреа | 417-680-3 | 101463-69-8 | Lact. | Aquatic Acute 1 | Aquatic Chronic 1 | H362 | H400 | H410 | GHS09 | Wng | H362 | H410 |   | M = 10 000 | M = 10 000 |  
616-208-00-5 | N-ethyl-2-pyrrolidone; | 1-ethylpyrrolidin-2-one | 220-250-6 | 2687-91-4 | Repr. 1B | H360D | GHS08 | Dgr | H360D |   |   |  616-208-00-5 | N-етил-2-пиролидон; | 1-етилпиролидин-2-он | 220-250-6 | 2687-91-4 | Repr. 1B | H360D | GHS08 | Dgr | H360D |   |   |  
616-209-00-0 | amidosulfuron (ISO); | 3-(4,6-dimethoxypyrimidin-2-yl)-1-((N-methyl-N-methylsulfonylamino)sulfonyl)urea | 407-380-0 | 120923-37-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M = 100 | M = 100 |  616-209-00-0 | амидосулфурон (ISO); | 3-(4,6-диметоксипиримидин-2-ил)-1-((N-метил-N-метилсулфониламино)сулфонил)уреа | 407-380-0 | 120923-37-7 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   | M = 100 | M = 100 |  
616-210-00-6 | tebufenpyrad (ISO); | N-(4-tertbutylbenzyl)-4-chloro-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide |   | 119168-77-3 | Acute Tox. 3 | Acute Tox. 4 | STOT RE 2 | Skin Sens. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H332 | H373 (gastro-intestinal tract) (Oral) | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H332 | H373 (gastro-intestinal tract) (Oral) | H317 | H410 |   | M = 10 | M = 10 |  616-210-00-6 | тебуфенпирад (ISO); | N-(4-трет-бутилбензил)-3-етил-1-метил-4-хлоро-1H-пиразол-5-карбоксамид |   | 119168-77-3 | Acute Tox. 3 | Acute Tox. 4 | STOT RE 2 | Skin Sens. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H332 | H373 (стомашно-чревен тракт) (поглъщане) | H317 | H400 | H410 | GHS06 | GHS08 | GHS09 | Dgr | H301 | H332 | H373 (стомашно-чревен тракт) (поглъщане) | H317 | H410 |   | M = 10 | M = 10 |  
616-211-00-1 | proquinazid (ISO); | 6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one |   | 189278-12-4 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   | M = 1 | M = 10 |  616-211-00-1 | прохиназид (ISO); | 6-йодо-3-пропил-2-пропоксихиназолин-4(3H)-он |   | 189278-12-4 | Carc. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H400 | H410 | GHS08 | GHS09 | Wng | H351 | H410 |   | M = 1 | M = 10 |  
616-212-00-7 | 3-iodo-2-propynyl butylcarbamate; 3-iodoprop-2-yn-1-yl butylcarbamate | 259-627-5 | 55406-53-6 | Acute Tox. 3 | Acute Tox. 4 | STOT RE 1 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H302 | H372 (larynx) H318 | H317 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H331 | H302 | H372 (larynx) H318 | H317 | H410 |   | M = 10 | M = 1 |  616-212-00-7 | 3-йодо-2-пропинилов бутилкарбамат 3-йодопроп-2-ин-1-илов бутилкарбамат | 259-627-5 | 55406-53-6 | Acute Tox. 3 | Acute Tox. 4 | STOT RE 1 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H331 | H302 | H372 (ларинкс) H318 | H317 | H400 | H410 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H331 | H302 | H372 (ларинкс) H318 | H317 | H410 |   | M = 10 | M = 1 |  
617-001-00-2 | di-tert-butyl peroxide | 203-733-6 | 110-05-4 | Org. Perox. E Flam. Liq. 2 Muta. 2 | H242 | H225 | H341 | GHS02 | GHS08 | Dgr | H242 | H225 | H341 |   |   |  617-001-00-2 | ди-трет-бутилпероксид | 203-733-6 | 110-05-4 | Org. Perox. E Flam. Liq. 2 Muta. 2 | H242 | H225 | H341 | GHS02 | GHS08 | Dgr | H242 | H225 | H341 |   |   |  
617-002-00-8 | α, α-dimethylbenzyl hydroperoxide; | cumene hydroperoxide | 201-254-7 | 80-15-9 | Org. Perox. E | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | Aquatic Chronic 2 | H242 | H331 | H312 | H302 | H373 ** | H314 | H411 | GHS02 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H242 | H331 | H312 | H302 | H373 ** | H314 | H411 |   | Skin Corr. 1B; H314: C ≥ 10 % Skin Irrit. 2; H315: 3 % ≤ C | < 10 % | Eye Dam. 1; H318: 3 % ≤ C | < 10 % | Eye Irrit. 2; H319: 1 % ≤ C | < 3 % | STOT SE 3; H335: C < 10 % |  617-002-00-8 | α, α-диметилбензилхидропероксид; | куменхидропероксид | 201-254-7 | 80-15-9 | Org. Perox. E | Acute Tox. 3 * | Acute Tox. 4 * | Acute Tox. 4 * | STOT RE 2 * | Skin Corr. 1B | Aquatic Chronic 2 | H242 | H331 | H312 | H302 | H373 ** | H314 | H411 | GHS02 | GHS06 | GHS08 | GHS05 | GHS09 | Dgr | H242 | H331 | H312 | H302 | H373 ** | H314 | H411 |   | Skin Corr. 1B; H314: C ≥ 10 % Skin Irrit. 2; H315: 3 % ≤ C | < 10 % | Eye Dam. 1; H318: 3 % ≤ C | < 10 % | Eye Irrit. 2; H319: 1 % ≤ C | < 3 % | STOT SE 3; H335: C < 10 % |  
617-003-00-3 | dilauroyl peroxide | 203-326-3 | 105-74-8 | Org. Perox. D | H242 | GHS02 | Dgr | H242 |   |   |  617-003-00-3 | дилауроилпероксид | 203-326-3 | 105-74-8 | Org. Perox. D | H242 | GHS02 | Dgr | H242 |   |   |  
617-004-00-9 | 1,2,3,4-tetrahydro-1-naphthyl hydroperoxide | 212-230-0 | 771-29-9 | Org. Perox. D | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H242 | H302 | H314 | H400 | H410 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H242 | H302 | H314 | H410 |   | STOT SE 3; H335: C ≥ 5 % |  617-004-00-9 | 1,2,3,4-тeтрахидро-1-нафтилхидропероксид | 212-230-0 | 771-29-9 | Org. Perox. D | Acute Tox. 4 * | Skin Corr. 1B | Aquatic Acute 1 | Aquatic Chronic 1 | H242 | H302 | H314 | H400 | H410 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H242 | H302 | H314 | H410 |   | STOT SE 3; H335: C ≥ 5 % |  
617-006-00-X | bis(α, α-dimethylbenzyl) | peroxide | 201-279-3 | 80-43-3 | Org. Perox. F | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 2 | H242 | H319 | H315 | H411 | GHS02 | GHS07 | GHS09 | Wng | H242 | H319 | H315 | H411 |   |   |  617-006-00-X | бис(α, α-диметилбензил) | пероксид | 201-279-3 | 80-43-3 | Org. Perox. F | Eye Irrit. 2 | Skin Irrit. 2 | Aquatic Chronic 2 | H242 | H319 | H315 | H411 | GHS02 | GHS07 | GHS09 | Wng | H242 | H319 | H315 | H411 |   |   |  
617-007-00-5 | tert-butyl α, α-dimethylbenzyl peroxide | 222-389-8 | 3457-61-2 | Org. Perox. E | Skin Irrit. 2 | Aquatic Chronic 2 | H242 | H315 | H411 | GHS02 | GHS07 | GHS09 | Wng | H242 | H315 | H411 |   |   |  617-007-00-5 | трет-бутил-α, α-диметилбензилпероксид | 222-389-8 | 3457-61-2 | Org. Perox. E | Skin Irrit. 2 | Aquatic Chronic 2 | H242 | H315 | H411 | GHS02 | GHS07 | GHS09 | Wng | H242 | H315 | H411 |   |   |  
617-008-00-0 | dibenzoyl peroxide; | benzoyl peroxide | 202-327-6 | 94-36-0 | Org. Perox. B | Eye Irrit. 2 | Skin Sens. 1 | H241 | H319 | H317 | GHS01 | GHS02 | GHS07 | Dgr | H241 | H319 | H317 |   |   |  617-008-00-0 | дибензоилпероксид; | бензоилпероксид | 202-327-6 | 94-36-0 | Org. Perox. B | Eye Irrit. 2 | Skin Sens. 1 | H241 | H319 | H317 | GHS01 | GHS02 | GHS07 | Dgr | H241 | H319 | H317 |   |   |  
617-010-00-1 | 1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1] | 1,1’-dioxybiscyclohexan-1-ol; [2] | cyclohexylidene hydroperoxide; [3] | cyclohexanone, peroxide [4] | 201-091-1 [1] | 219-306-2 [2] | 220-279-4 [3] | 235-527-7 [4] | 78-18-2 [1] | 2407-94-5 [2] | 2699-11-8 [3] | 12262-58-7 [4] | Org. Perox. A | Skin Corr. 1B | Acute Tox. 4 * | H240 | H314 | H302 | GHS01 | GHS05 | GHS07 | Dgr | H240 | H314 | H302 |   | STOT SE 3; H335: C ≥ 5 % | C617-010-00-1 | 1-хидропероксициклохексил-1-хидроксициклохексилпероксид; [1] | 1,1′-диоксибисциклохексан-1-ол; [2] | циклохексилиденхидропероксид; [3] | циклохексанон, пероксид [4] | 201-091-1 [1] | 219-306-2 [2] | 220-279-4 [3] | 235-527-7 [4] | 78-18-2 [1] | 2407-94-5 [2] | 2699-11-8 [3] | 12262-58-7 [4] | Org. Perox. A | Skin Corr. 1B | Acute Tox. 4 * | H240 | H314 | H302 | GHS01 | GHS05 | GHS07 | Dgr | H240 | H314 | H302 |   | STOT SE 3; H335: C ≥ 5 % | C
617-010-01-9 | 1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1] | 1,1'-dioxybiscyclohexan-1-ol; [2] | cyclohexylidene hydroperoxide; | [3] cyclohexanone, peroxide [4] [≤ 91 % solution] | 201-091-1 [1] | 219-306-2 [2] | 220-279-4 [3] | 235-527-7 [4] | 78-18-2 [1] | 2407-94-5 [2] | 2699-11-8 [3] | 12262-58-7 [4] | Org. Perox. C | Acute Tox. 4 * | Skin Corr. 1B | H242 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H242 | H302 | H314 |   | STOT SE 3; H335: C ≥ 5 % | C T617-010-01-9 | 1-хидропероксициклохексил-1-хидроксициклохексилпероксид; [1] | 1,1′-диоксибисциклохексан-1-ол; [2] | циклохексилиденхидропероксид; | [3] циклохексанонпероксид [4] [≤ 91 % разтвор] | 201-091-1 [1] | 219-306-2 [2] | 220-279-4 [3] | 235-527-7 [4] | 78-18-2 [1] | 2407-94-5 [2] | 2699-11-8 [3] | 12262-58-7 [4] | Org. Perox. C | Acute Tox. 4 * | Skin Corr. 1B | H242 | H302 | H314 | GHS02 | GHS05 | GHS07 | Dgr | H242 | H302 | H314 |   | STOT SE 3; H335: C ≥ 5 % | C T
617-012-00-2 | 8-p-menthyl hydroperoxide; | p-menthane hydroperoxide | 201-281-4 | 80-47-7 | Org. Perox. D | Skin Corr. 1B | Acute Tox. 4 * | H242 | H314 | H332 | GHS02 | GHS05 | GHS07 | Dgr | H242 | H314 | H332 |   | STOT SE 3; H335: C ≥ 5 % |  617-012-00-2 | 8-p-мeнтилхидропероксид; | р-ментанхидропероксид | 201-281-4 | 80-47-7 | Org. Perox. D | Skin Corr. 1B | Acute Tox. 4 * | H242 | H314 | H332 | GHS02 | GHS05 | GHS07 | Dgr | H242 | H314 | H332 |   | STOT SE 3; H335: C ≥ 5 % |  
617-013-00-8 | O, O-tert-butyl O-docosyl monoperoxyoxalate | 404-300-6 | 116753-76-5 | Org. Perox. C **** Aquatic Acute 1 | Aquatic Chronic 1 | H242 | H400 | H410 | GHS02 | GHS09 | Dgr | H242 | H410 |   |   |  617-013-00-8 | О,О-трет-бутилов O-докозилов монопероксиоксалат | 404-300-6 | 116753-76-5 | Org. Perox. C **** Aquatic Acute 1 | Aquatic Chronic 1 | H242 | H400 | H410 | GHS02 | GHS09 | Dgr | H242 | H410 |   |   |  
617-014-00-3 | 6-(nonylamino)-6-oxo-peroxyhexanoic acid | 406-680-9 | 104788-63-8 | Org. Perox. C **** Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | H242 | H318 | H317 | H400 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H242 | H318 | H317 | H400 |   |   |  617-014-00-3 | 6-(нониламино)-6-oксопероксихексанова киселина | 406-680-9 | 104788-63-8 | Org. Perox. C **** Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | H242 | H318 | H317 | H400 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H242 | H318 | H317 | H400 |   |   |  
617-015-00-9 | bis(4-methylbenzoyl)peroxide | 407-950-9 | 895-85-2 | Org. Perox. B **** Aquatic Acute 1 | Aquatic Chronic 1 | H241 | H400 | H410 | GHS01 | GHS02 | GHS09 | Dgr | H241 | H410 |   |   |  617-015-00-9 | бис(4-метилбензоил)пероксид | 407-950-9 | 895-85-2 | Org. Perox. B **** | Aquatic Acute 1 | Aquatic Chronic 1 | H241 | H400 | H410 | GHS01 | GHS02 | GHS09 | Dgr | H241 | H410 |   |   |  
617-016-00-4 | 3-hydroxy-1,1-dimethylbutyl 2-ethyl-2-methylheptaneperoxoate | 413-910-1 | — | Org. Perox. C **** Flam. Liq. 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H242 | H226 | H315 | H400 | H410 | GHS02 | GHS07 | GHS09 | Dgr | H242 | H226 | H315 | H410 |   |   |  617-016-00-4 | 1,1-диметил-3-хидроксибутилов 2-етил-2-метилхептанпероксоат | 413-910-1 | — | Org. Perox. C **** | Flam. Liq. 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H242 | H226 | H315 | H400 | H410 | GHS02 | GHS07 | GHS09 | Dgr | H242 | H226 | H315 | H410 |   |   |  
617-017-00-X | reaction mass of: 2,2'-bis(tert-pentylperoxy)-p-diisopropylbenzene; | 2,2'-bis(tert-pentylperoxy)-m-diisopropylbenzene | 412-140-3 | 32144-25-5 | Org. Perox. D | Aquatic Chronic 4 | H242 | H413 | GHS02 | Dgr | H242 | H413 |   |   | T617-017-00-X | реакционна маса от: 2,2′-бис(трет-пентилперокси)-p-диизопропилбензен; | 2,2′-бис(трет-пентилперокси)-m-диизопропилбензен; | 412-140-3 | 32144-25-5 | Org. Perox. D | Aquatic Chronic 4 | H242 | H413 | GHS02 | Dgr | H242 | H413 |   |   | T
617-018-00-5 | reaction mass of: 1-methyl-1-(3-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, | 63 % by weight; | 1-methyl-1-(4-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 31 % by weight | 410-840-3 | 71566-50-2 | Org. Perox. C **** Aquatic Chronic 2 | H242 | H411 | GHS02 | GHS09 | Dgr | H242 | H411 |   |   | T617-018-00-5 | реакционна маса от: 1-метил-1-(3-(1-метилетил)фенил)етил-1-метил-1-фенилетилпероксид, | 63 % тегловни; | 1-метил-1-(4-(1-метилетил)фенил)етил-1-метил-1-фенилетилпероксид, 31 % тегловни | 410-840-3 | 71566-50-2 | Org. Perox. C **** | Aquatic Chronic 2 | H242 | H411 | GHS02 | GHS09 | Dgr | H242 | H411 |   |   | T
617-019-00-0 | 6-(phthalimido)peroxyhexanoic acid | 410-850-8 | 128275-31-0 | Org. Perox. D | Eye Dam. 1 | Aquatic Acute 1 | H242 | H318 | H400 | GHS02 | GHS05 | GHS09 | DgDgr | H242 | H318 | H400 |   |   | T617-019-00-0 | 6-(фталимидо)пероксихексанова киселина | 410-850-8 | 128275-31-0 | Org. Perox. D | Eye Dam. 1 | Aquatic Acute 1 | H242 | H318 | H400 | GHS02 | GHS05 | GHS09 | DgDgr | H242 | H318 | H400 |   |   | T
617-020-00-6 | 1,3-di(prop-2,2-diyl)benzene bis(neodecanoylperoxide) | 420-060-5 | 117663-11-3 | Flam. Liq. 3 | Org. Perox. D **** Aquatic Chronic 2 | H226 | H242 | H411 | GHS02 | GHS09 | Dgr | H226 | H242 | H411 |   |   |  617-020-00-6 | 1,3-ди(проп-2,2-диил)бензенбис(неодеканоилпероксид) | 420-060-5 | 117663-11-3 | Flam. Liq. 3 | Org. Perox. D **** | Aquatic Chronic 2 | H226 | H242 | H411 | GHS02 | GHS09 | Dgr | H226 | H242 | H411 |   |   |  
617-021-00-1 | methylethylketone peroxide trimer | 429-320-2 | — | Org. Perox. B**** | Asp. Tox. 1 | Skin Irrit. 2 | Skin Sens. 1 | H241 | H304 | H315 | H317 | GHS01 | GHS02 | GHS08 | GHS07 | Dgr | H241 | H304 | H315 | H317 |   |   |  617-021-00-1 | тример на етилметилкетонпероксид | 429-320-2 | — | Org. Perox. B**** | Asp. Tox. 1 | Skin Irrit. 2 | Skin Sens. 1 | H241 | H304 | H315 | H317 | GHS01 | GHS02 | GHS08 | GHS07 | Dgr | H241 | H304 | H315 | H317 |   |   |  
617-022-00-7 | reaction mass of: 1,2-dimethylpropylidene dihydroperoxide; dimethyl 1,2-benzenedicarboxylate | 442-480-8 | — | Org. Perox. C | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H242 | H302 | H314 | H317 | H411 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H242 | H302 | H314 | H317 | H411 |   |   |  617-022-00-7 | реакционна маса от: 1,2-диметилпропилидендихидропероксид; диметилов 1,2-бензендикарбоксилат | 442-480-8 | — | Org. Perox. C | Acute Tox. 4 * | Skin Corr. 1B | Skin Sens. 1 | Aquatic Chronic 2 | H242 | H302 | H314 | H317 | H411 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H242 | H302 | H314 | H317 | H411 |   |   |  
647-001-00-8 | glucosidase, β- | 232-589-7 | 9001-22-3 | Resp. Sens. 1 | H334 | GHS08 | Dgr | H334 |   |   |  647-001-00-8 | β-глюкозидаза | 232-589-7 | 9001-22-3 | Resp. Sens. 1 | H334 | GHS08 | Dgr | H334 |   |   |  
647-002-00-3 | cellulase | 232-734-4 | 9012-54-8 | Resp. Sens. 1 | H334 | GHS08 | Dgr | H334 |   |   |  647-002-00-3 | целулаза | 232-734-4 | 9012-54-8 | Resp. Sens. 1 | H334 | GHS08 | Dgr | H334 |   |   |  
647-003-00-9 | cellobiohydrolase, exo- | 253-465-9 | 37329-65-0 | Resp. Sens. 1 | H334 | GHS08 | Dgr | H334 |   |   |  647-003-00-9 | eкзо-целобиохидролаза | 253-465-9 | 37329-65-0 | Resp. Sens. 1 | H334 | GHS08 | Dgr | H334 |   |   |  
647-004-00-4 | cellulases with the exception of those specified elsewhere in this Annex | — | — | Resp. Sens. 1 | H334 | GHS08 | Dgr | H334 |   |   | A647-004-00-4 | целулази, с изключение на тези, посочени другаде в настоящото приложение | — | — | Resp. Sens. 1 | H334 | GHS08 | Dgr | H334 |   |   | A
647-005-00-X | bromelain, juice | 232-572-4 | 9001-00-7 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H319 | H335 | H315 | H334 | GHS08 | GHS07 | Dgr | H319 | H335 | H315 | H334 |   |   |  647-005-00-X | бромелаин, сок | 232-572-4 | 9001-00-7 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H319 | H335 | H315 | H334 | GHS08 | GHS07 | Dgr | H319 | H335 | H315 | H334 |   |   |  
647-006-00-5 | ficin | 232-599-1 | 9001-33-6 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H319 | H335 | H315 | H334 | GHS08 | GHS07 | Dgr | H319 | H335 | H315 | H334 |   |   |  647-006-00-5 | фицин | 232-599-1 | 9001-33-6 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H319 | H335 | H315 | H334 | GHS08 | GHS07 | Dgr | H319 | H335 | H315 | H334 |   |   |  
647-007-00-0 | papain | 232-627-2 | 9001-73-4 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H319 | H335 | H315 | H334 | GHS08 | GHS07 | Dgr | H319 | H335 | H315 | H334 |   |   |  647-007-00-0 | папаин | 232-627-2 | 9001-73-4 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H319 | H335 | H315 | H334 | GHS08 | GHS07 | Dgr | H319 | H335 | H315 | H334 |   |   |  
647-008-00-6 | pepsin A | 232-629-3 | 9001-75-6 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H319 | H335 | H315 | H334 | GHS08 | GHS07 | Dgr | H319 | H335 | H315 | H334 |   |   |  647-008-00-6 | пепсин A | 232-629-3 | 9001-75-6 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H319 | H335 | H315 | H334 | GHS08 | GHS07 | Dgr | H319 | H335 | H315 | H334 |   |   |  
647-009-00-1 | rennin | 232-645-0 | 9001-98-3 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H319 | H335 | H315 | H334 | GHS08 | GHS07 | Dgr | H319 | H335 | H315 | H334 |   |   |  647-009-00-1 | ренин | 232-645-0 | 9001-98-3 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H319 | H335 | H315 | H334 | GHS08 | GHS07 | Dgr | H319 | H335 | H315 | H334 |   |   |  
647-010-00-7 | trypsin | 232-650-8 | 9002-07-7 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H319 | H335 | H315 | H334 | GHS08 | GHS07 | Dgr | H319 | H335 | H315 | H334 |   |   |  647-010-00-7 | трипсин | 232-650-8 | 9002-07-7 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H319 | H335 | H315 | H334 | GHS08 | GHS07 | Dgr | H319 | H335 | H315 | H334 |   |   |  
647-011-00-2 | chymotrypsin | 232-671-2 | 9004-07-3 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H319 | H335 | H315 | H334 | GHS08 | GHS07 | Dgr | H319 | H335 | H315 | H334 |   |   |  647-011-00-2 | химотрипсин | 232-671-2 | 9004-07-3 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H319 | H335 | H315 | H334 | GHS08 | GHS07 | Dgr | H319 | H335 | H315 | H334 |   |   |  
647-012-00-8 | subtilisin | 232-752-2 | 9014-01-1 | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Resp. Sens. 1 | H335 | H315 | H318 | H334 | GHS08 | GHS05 | GHS07 | Dgr | H335 | H315 | H318 | H334 |   |   |  647-012-00-8 | субтилизин | 232-752-2 | 9014-01-1 | STOT SE 3 | Skin Irrit. 2 | Eye Dam. 1 | Resp. Sens. 1 | H335 | H315 | H318 | H334 | GHS08 | GHS05 | GHS07 | Dgr | H335 | H315 | H318 | H334 |   |   |  
647-013-00-3 | proteinase, microbial neutral | 232-966-6 | 9068-59-1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H319 | H335 | H315 | H334 | GHS08 | GHS07 | Dgr | H319 | H335 | H315 | H334 |   |   |  647-013-00-3 | неутрална протеиназа от микроорганизми | 232-966-6 | 9068-59-1 | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H319 | H335 | H315 | H334 | GHS08 | GHS07 | Dgr | H319 | H335 | H315 | H334 |   |   |  
647-014-00-9 | proteases with the exception of those specified elsewhere in this Annex | — | — | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H319 | H335 | H315 | H334 | GHS08 | GHS07 | Dgr | H319 | H335 | H315 | H334 |   |   |  647-014-00-9 | протеази, с изключение на тези, посочени другаде в настоящото приложение | — | — | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Resp. Sens. 1 | H319 | H335 | H315 | H334 | GHS08 | GHS07 | Dgr | H319 | H335 | H315 | H334 |   |   |  
647-015-00-4 | amylase, α- | 232-565-6 | 9000-90-2 | Resp. Sens. 1 | H334 | GHS08 | Dgr | H334 |   |   |  647-015-00-4 | α-амилаза | 232-565-6 | 9000-90-2 | Resp. Sens. 1 | H334 | GHS08 | Dgr | H334 |   |   |  
647-016-00-X | amylases with the exception of those specified elsewhere in this Annex | — | — | Resp. Sens. 1 | H334 | GHS08 | Dgr | H334 |   |   |  647-016-00-X | амилази, с изключение на тези, посочени другаде в настоящото приложение | — | — | Resp. Sens. 1 | H334 | GHS08 | Dgr | H334 |   |   |  
647-017-00-5 | laccase | 420-150-4 | 80498-15-3 | Resp. Sens. 1 | H334 | GHS08 | Dgr | H334 |   |   |  647-017-00-5 | лаказа | 420-150-4 | 80498-15-3 | Resp. Sens. 1 | H334 | GHS08 | Dgr | H334 |   |   |  
648-001-00-0 | Distillates (coal tar), benzole fraction; | Light Oil; [A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists of hydrocarbons having carbon numbers primarily in the range of C4 to C10 and distilling in the approximate range of 80oC to 160 oC (175oF to 320oF).] | 283-482-7 | 84650-02-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  648-001-00-0 | Дестилати (каменовъглен катран), бензенова фракция; | леко масло; [Сложна комбинация от въглеводороди, получени чрез дестилация на каменовъглен катран. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C4 до C10 и дестилира в приблизителния температурен интервал от 80 oC до 160 oC (175 oF до 320 oF)]. | 283-482-7 | 84650-02-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
648-002-00-6 | Tar oils, brown-coal; Light Oil; | [The distillate from lignite tar boiling in the range of approximately 80 o C to 250 o C (176oF to 482 oF). Composed primarily of aliphatic and aromatic hydrocarbons and monobasic phenols.] | 302-674-4 | 94114-40-6 | Carc. 1B | Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-002-00-6 | Катранени масла, кафяви въглища; леко масло; | [Дестилат от лигнитен катран с интервал на кипене приблизително 80 oC—250 oC (176 oF—482 oF). Състои сe основно от алифатни и ароматни въглеводороди и моноосновни феноли.] | 302-674-4 | 94114-40-6 | Carc. 1B | Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-003-00-1 | Benzol forerunnings (coal); Light Oil Redistillate, low boiling; | [The distillate from coke oven light oil having an approximate distillation range below 100 o C (212 oF). Composed primarily of C4 to C6 aliphatic hydrocarbons.] | 266-023-5 | 65996-88-5 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-003-00-1 | Първични бензенови (въглищни) дестилати; редестилат на леко масло, с ниска точка на кипене; | [Дестилат от леки масла, получени от коксови пещи с приблизителна област на дестилация под 100 oC (212 oF). Състоят се основно от алифатни въглеводороди с дължина на въглеродната верига C4—C6.] | 266-023-5 | 65996-88-5 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-004-00-7 | Distillates (coal tar), benzole fraction, BTX-rich; | Light Oil Redistillate, low boiling; | [A residue from the distillation of crude benzole to remove benzole fronts. Composed primarily of benzene, toluene and xylenes boiling in the range of approximately 75 oC to 200 oC (167 oF to 392 oF).] | 309-984-9 | 101896-26-8 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-004-00-7 | Дестилати (каменовъглен катран), бензенова фракция, богати на BTX (бензен, толуен, ксилен); | редестилат на леко масло, с ниска точка на кипене; | [Остатък от дестилацията на суров бензен, за да се отстранят леките бензенови продукти. Съставен основно от бензен, толуен и ксилени с точка на кипене приблизително в интервала 75 oC —200 oC (167 oF- 392 oF).] | 309-984-9 | 101896-26-8 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-005-00-2 | Aromatic hydrocarbons, C6-10, C8-rich; Light Oil Redistillate, low boiling | 292-697-5 | 90989-41-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-005-00-2 | Ароматни въглеводороди, C6-10, богати на C8; редестилат на леко масло, с ниска точка на кипене; | 292-697-5 | 90989-41-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-006-00-8 | Solvent naphtha (coal), light; Light Oil Redistillate, low boiling | 287-498-5 | 85536-17-0 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-006-00-8 | Солвент-нафта (въглищна), лека; редестилат на леко масло, с ниска точка на кипене; | 287-498-5 | 85536-17-0 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-007-00-3 | Solvent naphtha (coal), xylene-styrene cut; Light Oil Redistillate, intermediate boiling | 287-502-5 | 85536-20-5 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-007-00-3 | Солвент-нафта (въглищна), ксилен-стиренова фракция; Редестилат на лека фракция, с междинна температура на кипене | 287-502-5 | 85536-20-5 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-008-00-9 | Solvent naphtha (coal), coumarone-styrene contg.; Light Oil Redistillate, intermediate boiling | 287-500-4 | 85536-19-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-008-00-9 | Солвент-нафта (въглищна), съдържаща кумарон-стирен; Редестилат на леко масло, с междинна температура на кипене | 287-500-4 | 85536-19-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-009-00-4 | Naphtha (coal), distn. residues; | Light Oil Redistillate, high boiling; | [The residue remaining from the distillation of recovered naphtha. Composed primarily of naphthalene and condensation products of indene and styrene.] | 292-636-2 | 90641-12-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-009-00-4 | Нафта (въглищна), остатъци от дестилация; | редестилат на леко масло, с висока точка на кипене; | [Остатък от дестилацията на повторно извлечена нафта. Състои се основно от нафтален и кондезационни продукти на инден и стирен.] | 292-636-2 | 90641-12-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-010-00-X | Aromatic hydrocarbons, C8; Light Oil Redistillate, high boiling | 292-694-9 | 90989-38-1 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-010-00-X | Ароматни въглеводороди, C8; редестилат на леко масло, с висока точка на кипене; | 292-694-9 | 90989-38-1 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-012-00-0 | Aromatic hydrocarbons, C8-9, hydrocarbon resin polymn. by-product; | Light Oil Redistillate, high boiling; | [A complex combination of hydrocarbons obtained from the evaporation of solven under vacuum from polymerized hydrocarbon resin. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C9 and boiling in the range of approximately 120 o C to 215 o C (248 oF to 419 oF).] | 295-281-1 | 91995-20-9 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-012-00-0 | Ароматни въглеводороди, C8—9, страничен продукт при полимеризация на въглеводородни смоли; | редестилат на леко масло, с висока точка на кипене; | [Сложна комбинация от въглеводороди, получена от изпаряването във вакуум на разтворител от полимеризирана въглеводородна смола. Състои се предимно от ароматни въглеводороди с дължина на въглеродната верига основно в интервала C8—C9, с точка на кипене в интервала приблизително 120 oC—215 oC (248 oF—419 oF).] | 295-281-1 | 91995-20-9 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-013-00-6 | Aromatic hydrocarbons, C9-12, benzene distn.; | Light Oil Redistillate, high boiling | 295-551-9 | 92062-36-7 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-013-00-6 | Ароматни въглеводороди, C9—12, бензенови дестил.; | редестилат на леко масло, с висока точка на кипене; | 295-551-9 | 92062-36-7 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-014-00-1 | Extract residues (coal), benzole fraction alk., acid ext.; | Light Oil Extract Residues, low boiling; | [The redistillate from the distillate, freed of tar acids and tar bases, from bituminous coal high temperature tar boiling in the approximate range of 90o C to 160 o C (194oF to 320 oF). It consists predomi nantly of benzene, toluene and xylenes.] | 295-323-9 | 91995-61-8 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-014-00-1 | Остатъци от екстракция (въглищни), алкална бензенова фракция, екстракция с киселина; | остатъци от екстракция на леко масло, с ниска точка на кипене; | [Редестилат от дестилата, освободен от катранени киселини и основи, на високотемпературен катран от битуминозни въглища, с точка на кипене в интервала приблизително 90 oC—160 oC (194 oF- 320 oF). Състои се предимно от бензен, толуен и ксилени.] | 295-323-9 | 91995-61-8 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-015-00-7 | Extract residues (coal tar), benzole fraction alk., acid ext.; Light Oil Extract Residues, low boiling; | [A complex combination of hydrocarbons obtained by the redistillation of the distillate of high temperature coal tar (tar acid and tar base free). It consists predominantly of unsubstituted and substituted mononuclear aromatic hydrocarbons boiling in the range of 85 oC to 195o C (185oF to 383oF).] | 309-868-8 | 101316-63-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-015-00-7 | Остатъци от екстракция (каменовъглен катран), алкална бензенова фракция, екстракция с киселина; остатъци от екстракция на леко масло, с ниска точка на кипене; | [Сложна комбинация от въглеводороди, получена от редестилация на дестилат на високотемпературен каменовъглен катран (без съдържание на катранени киселини и катранени основи). Състои се предимно от незаместени и заместени еднопръстенни ароматни въглеводороди с точка на кипене в интервала 85 oC—195 oC (185 oF—383 oF).] | 309-868-8 | 101316-63-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-016-00-2 | Extract residues (coal), benzole fraction acid; | Light Oil Extract Residues, low boiling; | [An acid sludge by-product of the sulfuric acid refining of crude high temperature coal. Composed primarily of sulfuric acid and organic compounds.] | 298-725-2 | 93821-38-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-016-00-2 | Остатъци от екстракция (въглищни), кисели бензенови фракции; | остатъци от екстракция на леко масло, с ниска точка на кипене; | [Кисели утайки, вторични продукти от обогатяването на сурови високотемпературни въглища със сярна киселина. Съставени основно от сярна киселина и органични съединения.] | 298-725-2 | 93821-38-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-017-00-8 | Extract residues (coal), light oil alk., distn. overheads; | Light Oil Extract Residues, low boiling; | [The first fraction from the distillation of aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oil boiling substantially below 145o C (293 oF). | Composed primarily of C7 and C8 aliphatic and aromatic hydrocarbons.] | 292-625-2 | 90641-02-4 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-017-00-8 | Остатъци от екстракция (въглищни), алкални леки масла, дестилация горни фракции; | остатъци от екстракция на леко масло, с ниска точка на кипене; | [Първа фракция от дестилацията на дънните фракции в предварителната ректификационна колона на ароматни въглеводороди, богати на кумарон, нафтален и инден, или промито карболово масло, с точка на кипене значително под 145 oC (293 oF). | Съставена основно от C7 и C8 алифатни и ароматни въглеводороди.] | 292-625-2 | 90641-02-4 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-018-00-3 | Extract residues (coal), light oil alk., acid ext., indene fraction; | Light Oil Extract Residues, intermediate boiling | 309-867-2 | 101316-62-5 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-018-00-3 | Остатъци от екстракция (въглищни), алкални леки масла, кисели екстракти; инденова фракция; | остатъци от екстракция на леко масло, с междинна температура на кипене | 309-867-2 | 101316-62-5 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-019-00-9 | Extract residues (coal), light oil alk., indene naphtha fraction; Light Oil Extract Residues, high boiling; | [The distillate from aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed Carbolic oils, having an approximate boiling range of 155o C to 180o C (311 oF to 356 oF). Composed primarily of indene, indan and trimethylbenzenes.] | 292-626-8 | 90641-03-5 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-019-00-9 | Остатъци от екстракция (въглищни), алкални леки масла, инденова нафтена фракция; остатъци от екстракция на леко масло, с висока точка на кипене; | [Дестилат от дънните фракции в предварителната ректификационна колона на ароматни въглеводороди, богати на кумарон, нафтален и инден, или промити карболови масла с точка на кипене в интервала приблизително 155 oC—180 oC (311 oF—356 oF). Съставен основно от инден, индан и триметилбензени.] | 292-626-8 | 90641-03-5 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-020-00-4 | Solvent naphtha (coal); | Light Oil Extract Residues, high boiling; | [The distillate from either high temperature coal tar, coke oven light oil, or coal tar oil alkaline extract residue having an approximate distillation range of 130o C to 210o C (266oF to 410oF). Composed primarily of indene and other polycyclic ring systems containing a single aromatic ring. May contain phenolic compounds and aromatic nitrogen bases.] | 266-013-0 | 65996-79-4 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-020-00-4 | Солвент-нафта (въглищна); | остатъци от екстракция на леко масло, с висока точка на кипене; | [Дестилат от леко масло от коксова пещ на високотемпературен каменовъглен катран или от остатъка от алкална екстракция на масло от каменовъглен катран с приблизителен интервал на дестилация 130 oC—210 oC (266 oF—410 oF). Съставен основно от инден и други полициклични пръстенни системи, съдържащи единичен ароматен пръстен. Може да съдържа фенолни съединения и ароматни азотни основи.] | 266-013-0 | 65996-79-4 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-021-00-X | Distillates (coal tar), light oils, neutral fraction; Light Oil Extract Residues, high boiling; [A distillate from the fractional distillation of high temperature coal tar. Composed primarily of alkyl-substituted one ring aromatic hydrocarbons boiling in the range of approximately 135o C to 210o C (275oF to 410oF). May also include unsaturated hydrocarbons such as indene and coumarone.] | 309-971-8 | 101794-90-5 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-021-00-X | Дестилати (каменовъглен катран), леки масла, неутрална фракция; остатъци от екстракция на леко масло, с висока точка на кипене; [Дестилат от фракционна дестилация на високотемпературен каменовъглен катран. Съставен основно от алкилзаместени еднопръстенни ароматни въглеводороди с точка на кипене в интервала приблизително 135 oC—210 oC (275 oF—410 oF). Може също да съдържа ненаситени въглеводороди като инден и кумарон.] | 309-971-8 | 101794-90-5 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-022-00-5 | Distillates (coal tar), light oils, acid exts.; Light Oil Extract Residues, high boiling; | [This oil is a complex reaction mass of aromatic hydrocarbons, primarily indene, naphthalene, coumarone, phenol, and o-, m-and p-cresol and boiling in the range of 140o C to 215o C (284 oF to 419 oF).] | 292-609-5 | 90640-87-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-022-00-5 | Дестилати (каменовъглен катран), леки масла, кисели екстракти; остатъци от екстракция на леко масло, с висока точка на кипене; | [Това масло е комплексна реакционна маса от ароматни въглеводороди, основно от инден, нафтален, кумарон, фенол и о-, m- и p-крезол, с температура на кипене в интервала от 140 oС до 215oС (284 oF до 419 oF).] | 292-609-5 | 90640-87-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-023-00-0 | Distillates (coal tar), light oils; Carbolic Oil; | [A complex combination of hydrocarbons obtained by distillation of coal tar. It consists of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills at the approximate range of 150 o C to 210 o C (302 oF to 410 oF).] | 283-483-2 | 84650-03-3 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-023-00-0 | Дестилати (каменовъглен катран), леки масла; карболово масло; | [Сложна комбинация от въглеводороди, получени при дестилация на каменовъглен катран. Състои се от ароматни и други въглеводороди, фенолни съединения и ароматни азотни съединения и дестилира в интервала приблизително 150 oC—210 oC (302 oF—410 oF).] | 283-483-2 | 84650-03-3 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-024-00-6 | Tar oils, coal; Carbolic Oil; | [The distillate from high temperature coal tar having an approximate distillation range of 130 o C to 250 o C (266 oF to 410 oF). Composed primarily of naphthalene, alkylnaphthalenes, phenolic compounds, and aromatic nitrogen bases.] | 266-016-7 | 65996-82-9 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-024-00-6 | Катранени масла, въглищни; карболово масло; | [Дестилат от високотемпературен каменовъглен катран с приблизителен интервал на дестилация 130 oC—250 oC (266 oF—410 oF). Съставен основно от нафтален, алкилнафталени, фенолни съединения и ароматни азотни основи.] | 266-016-7 | 65996-82-9 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-026-00-7 | Extract residues (coal), light oil alk., acid ext.; | Carbolic Oil Extract Residue; [The oil resulting from the acid washing of alkali-washed carbolic oil to remove the minor amounts of basic compounds (tar bases). | Composed primarily of indene, indan and alkylbenzenes.] | 292-624-7 | 90641-01-3 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-026-00-7 | Остатъци от екстракция (въглищни), алкално леко масло, кисел екстракт; | остатък от екстракция на карболово масло; [Масло, получено чрез киселинно промиване на алкално промито карболово масло за отстраняване на незначителни количества основни съединения (катранени основи). | Съставено основно от инден, индан и алкилбензени.] | 292-624-7 | 90641-01-3 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-027-00-2 | Extract residues (coal), tar oil alk.; | Carbolic Oil Extract Residue; [The residue obtained from coal tar oil by an alkaline wash such as aqueous sodium hydroxide after the removal of crude coal tar acids. Composed primarily of naphthalenes and aromatic nitrogen bases.] | 266-021-4 | 65996-87-4 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-027-00-2 | Остатъци от екстракция (въглищни), алкално катранено масло; | остатък от екстракция на карболово масло; [Остатък, получен от масло от каменовъглен катран чрез алкално промиване, напр. с воден разтвор на натриев хидроксид, след отстраняването на суровите каменовъглени катранени киселини. Съставен основно от нафталени и ароматни азотни основи.] | 266-021-4 | 65996-87-4 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-028-00-8 | Extract oils (coal), light oil; Acid Extract; | [The aqueous extract produced by an acidic wash of alkali-washed carbolic oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.] | 292-622-6 | 90640-99-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-028-00-8 | Екстрактни масла (въглищни), леко масло; киселинен екстракт; | [Воден екстракт, получен чрез киселинно промиване на алкално промито карболово масло. Съставен основно от кисели соли на различни ароматни азотни основи, включително пиридин, хинолин и техните алкилови производни.] | 292-622-6 | 90640-99-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-029-00-3 | Pyridine, alkyl derivs.; Crude Tar Bases; | [The complex combination of polyalkylated pyridines derived from coal tar distillation or as high-boiling distillates approxi mately above 150o C (302oF) from the reaction of ammonia with acetaldehyde, formaldehyde or paraformaldehyde.] | 269-929-9 | 68391-11-7 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-029-00-3 | Пиридин, алкилови производни; сурови катранени основи; | [Сложна комбинация от полиалкилирани пиридини, получена от дестилация на каменовъглен катран или на също така висококипящи дестилати с температура на кипене приблизително над 150 oC (302oF), получени при реакцията на амоняк с ацеталдехид, формалдехид или параформалдехид.] | 269-929-9 | 68391-11-7 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-030-00-9 | Tar bases, coal, picoline fraction; | Distillate Bases; | [Pyridine bases boiling in the range of approximately 125o C to 160o C (257oF 320oF) obtained by distillation of neutralized acid extract of the base-containing tar fraction obtained by the distillation of bituminous coal tars. Composed chiefly of lutidines and picolines.] | 295-548-2 | 92062-33-4 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-030-00-9 | Катранени основи, въглищни, пиколинова фракция; | дестилатни основи; | [Пиридинови основи с точка на кипене в интервала приблизително 125 oC—160 oC (257 oF—320 oF), получени при дестилацията на неутрализирани кисели екстракти на основасъдържаща катранена фракция от дестилацията на битумни каменовъглени катрани. Съставени главно от лутидини и пиколини.] | 295-548-2 | 92062-33-4 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-031-00-4 | Tar bases, coal, lutidine fraction; | Distillate Bases | 293-766-2 | 91082-52-9 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-031-00-4 | Катранени основи, въглищни, лутидинова фракция; | дестилатни основи | 293-766-2 | 91082-52-9 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-032-00-X | Extract oils (coal), tar base, collidine fraction; | Distillate Bases; | [The extract produced by the acidic extraction of bases from crude coal tar aromatic oils, neutralization, and distillation of the bases. Composed primarily of collidines, aniline, toluidines, lutidines, xylidines.] | 273-077-3 | 68937-63-3 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-032-00-X | Екстрактни масла (въглищни), катранена основа, колидинова фракция; | дестилатни основи; | [Екстракт, получен от киселинна екстракция на основи от ароматни масла на суров въглищен катран, неутрализация и дестилация на основите. Съставен основно от колидини, анилин, толуидини, лутидини, ксилидини.] | 273-077-3 | 68937-63-3 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-033-00-5 | Tar bases, coal, collidine fraction; | Distillate Bases; | [The distillation fraction boiling in the range of approximately 181 o C to 186 o C (356 oF to 367 oF) from the crude bases obtained from the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of bituminous coal tar. It contains chiefly aniline and collidines.] | 295-543-5 | 92062-28-7 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-033-00-5 | Катранени основи, въглищни, колидинова фракция; | дестилатни основи; | [Дестилатна фракция с точка на кипене в интервала приблизително 181 oC—186 oC (356 oF—367 oF) от сурови основи, получени от неутрализирани, основасъдържащи катранени фракции след кисела екстракция, получени от дестилация на битумни каменовъглени катрани. Съдържа главно анилин и колидини.] | 295-543-5 | 92062-28-7 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-034-00-0 | Tar bases, coal, aniline fraction; Distillate Bases; | [The distillation fraction boiling in the range of approximately 180o C to 200o C (356 oF to 392 oF) from the crude bases obtained by dephenolating and debasing the carbolated oil from the distillation of coal tar. | It contains chiefly aniline, collidines, lutidines and toluidines.] | 295-541-4 | 92062-27-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-034-00-0 | Катранени основи, въглищни, анилинова фракция; дестилатни основи; | [Дестилатна фракция с точка на кипене в интервала приблизително 180 oC—200 oC (356 oF—392 oF) от сурови основи, получени след отстраняване на фенолите и основите от карболираното масло от дестилацията на каменовъглен катран. | Съдържа главно анилин, колидини, лутидини и толуидини.] | 295-541-4 | 92062-27-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-035-00-6 | Tar bases, coal, toluidine fraction; | Distillate Bases | 293-767-8 | 91082-53-0 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-035-00-6 | Катранени основи, въглищни, толуидинова фракция; | дестилатни основи | 293-767-8 | 91082-53-0 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-036-00-1 | Distillates (petroleum), alkene-alkyne manuf. pyrolysis oil, mixed with high-temp. coal tar, indene fraction; | Redistillates; | [A complex combination of hydrocarbons obtained as a redistillate from the fractional distillation of bituminous coal high temperature tar and residual oils that are obtained by the pyrolytic production of alkenes and alkynes from petroleum products or natural gas. It consists predominantly of indene and boils in a range of approximately160 o C to 190 o C (320 oF to 374 oF).] | 295-292-1 | 91995-31-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-036-00-1 | Дестилати (нефтени) от алкеновото и алкиновото производство на пиролизно масло, смесено с високотемпературен каменовъглен катран, инденова фракция; | редестилати; | [Сложна комбинация от въглеводороди, получена като редестилат от фракционна дестилация на високотемпературен битумен каменовъглен катран и остатъчни масла, получени при пиролизното производство на алкени и алкини от нефтени продукти или природен газ. Състои се предимно от инден и има точка на кипене в интервала приблизително 160 oC—190 oC (320 oF—374 oF).] | 295-292-1 | 91995-31-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-037-00-7 | Distillates (coal), coal tar-residual pyrolysis oils, naphthalene oils; | Redistillates; | [The redistillate obtained from the fractional distillation of bituminous coal high temperature tar and pyrolysis residual oils and boiling in the range of approximately 190o C to 270o C (374oF to 518oF). Composed primarily of substituted dinuclear aromatics.] | 295-295-8 | 91995-35-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-037-00-7 | Дестилати (въглищни), остатъчни масла от пиролизата на каменовъглен катран, нафталенови масла; | редестилати; | [Редестилат, получен от фракционната дестилация на високотемпературен битумен каменовъглен катран и пиролизни остатъчни масла, и с точка на кипене в интервала приблизително 190 oC—270 oC (374 oF—518 oF). Съставен основно от заместени двупръстенни ароматни съединения.] | 295-295-8 | 91995-35-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-038-00-2 | Extract oils (coal), coal tar-residual pyrolysis oils, naph thalene oil, redistillate; Redistillates; | [The redistillate from the fractional distillation of dephe nolated and debased methylnaphthalene oil obtained from bituminous coal high temperature tar and pyrolysis residual oils boiling in the approximate range of 220o C to 230o C (428oF to 446oF). It consists predominantly of unsubstituted and substituted dinuclear aromatic hydrocarbons.] | 295-329-1 | 91995-66-3 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-038-00-2 | Екстрактни масла (въглищни), остатъчни масла от пиролизата на каменовъглен катран, нафталеново масло, редестилат; редестилати; | [Редестилат от фракционната дестилация на метилнафталеново масло след отстраняване на фенолите и основите, получено от високотемпературен битумен каменовъглен катран и остатъчни масла от пиролиза, с точка на кипене в интервала приблизително 220 oC—230 oC (428 oF—446 oF). Състои се предимно от незаместени и заместени двупръстенни ароматни въглеводороди.] | 295-329-1 | 91995-66-3 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-039-00-8 | Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oils; | Redistillates; | [A neutral oil obtained by debasing and dephenolating the oil obtained from the distillation of high temperature tar and pyrolysis residual oils which has a boiliing range of 225o C to 255o C (437oF to 491oF). Composed primarily of substituted dinuclear aromatic hydrocarbons.] | 310-170-0 | 122070-79-5 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-039-00-8 | Екстрактни масла (въглищни), остатъчни масла от пиролизата на каменовъглен катран, нафталенови масла; | редестилати; | [Неутрално масло, получено чрез отстраняване на фенолите и основите от масло, получено от дестилация на високотемпературен катран и пиролизни остатъчни масла, с точка на кипене в интервала 225 oC—255 oC (437 oF—491 oF). Състои се основно от заместени двупръстенни ароматни въглеводороди.] | 310-170-0 | 122070-79-5 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-040-00-3 | Extract oils (coal), coal tar residual pyrolysis oils, naph thalene oil, distn. residues; Redistillates; | [Residue from the distillation of dephenolated and debased methylnaphthalene oil (from bituminous coal tar and pyrolysis residual oils) with a boiling range of 240 o C to 260o C (464oF to 500oF). Composed primarily of substituted dinuclear aromatic and heterocyclic hydrocarbons.] | 310-171-6 | 122070-80-8 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-040-00-3 | Екстрактни масла (въглищни), остатъчни масла от пиролизата на каменовъглен катран, нафталеново масло, остатъци от дестилация; редестилати; | [Остатък от дестилацията на получено чрез отстраняване на фенолите и основите метилнафталeново масло, (от битумен каменовъглен катран и пиролизни остатъчни масла), с точка на кипене в интервала 240 oC—260 oC (464 oF—500 oF). Съставен основно от субституирани двуядрени заместени двупръстенни ароматни и хетероциклени въглеводороди.] | 310-171-6 | 122070-80-8 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-041-00-9 | Absorption oils, bicyclo arom. and heterocyclic hydrocarbon fraction; | Wash Oil Redistillate; | [A complex combination of hydrocarbons obtained as a redistillate from the distillation of wash oil. It consists predominantly of 2-ringed aromatic and heterocyclic hydrocarbons boiling in the range of approximately 260 oC to 290 oC (500oF to 554oF).] | 309-851-5 | 101316-45-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-041-00-9 | Абсорбционни масла, бицикло ароматна фракция и хетероциклена въглеводородна фракция; | редестилат на промивно масло; | [Сложна комбинация от въглеводороди, получена като редестилат от дестилацията на промивно масло. Състои се предимно от двупръстенни ароматни и хетероциклени въглеводороди, с точка на кипене в интервал приблизително 260 oC до 290 oC (500 oF до 554 oF).] | 309-851-5 | 101316-45-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-042-00-4 | Distillates (coal tar), upper, fluorene-rich; | Wash Oil Redistillate; | [A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists af aromatic and polycyclic hydrocarbons primarily fluorene and some acenaphthene.] | 284-900-0 | 84989-11-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-042-00-4 | Дестилати (каменовъглен катран), горни, богати на флуорен; | редестилат на промивно масло; | [Сложна комбинация от въглеводороди, получена чрез кристализацията на катранено масло. Състои се от ароматни и многопръстенни въглеводороди, основно флуорен и малко количество аценафтен.] | 284-900-0 | 84989-11-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-043-00-X | Creosote oil, acenaphthene fraction, acenaphthene-free; Wash Oil Redistillate; | [The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.] | 292-606-9 | 90640-85-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-043-00-X | Креозотно масло, аценафтенова фракция, без съдържание на аценафтен; редестилат на промивно масло; | [Масло, оставащо след отстраняване на аценафтена чрез кристализационен процес от аценафтеновото масло, получено от каменовъглен катран. Състои се основно от нафтален и алкилнафталени.] | 292-606-9 | 90640-85-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-044-00-5 | Distillates (coal tar), heavy oils; Heavy Anthracene Oil; [Distillate from the fractional distillation of coal tar of bituminous coal, with boiling range of 240oC to 400oC (464oF to 752 oF). Composed primarily of tri-and polynuclear hydrocarbons and heterocyclic compounds.] | 292-607-4 | 90640-86-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  648-044-00-5 | Дeстилати (каменовъглен катран), тежки масла; Тежко антраценово масло; [Дестилат от фракционната дестилация на каменовъглен катран от битумни въглища, с точка на кипене в интервала от 240 oC до 400 oC (464 oF до 752 oF). Състои се основно от трипръстенни и многопръстенни въглеводороди и хетероциклени съединения.] | 292-607-4 | 90640-86-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
648-045-00-0 | Distillates (coal tar), upper; Heavy Anthracene Oil; | [The distillate from coal tar having an approximate distillation range of 220oC to 450oC (428oF to 842oF). Composed primarily of three to four membered condensed ring aromatic hydrocarbons and other hydrocarbons.] | 266-026-1 | 65996-91-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-045-00-0 | Дестилати (каменовъглен катран), горна фракция; Тежко антраценово масло; | [Дестилат от каменовъглен катран, имащ приблизителен дестилационен обхват от 220 oC до 450 oC (428 oF до 842 oF). Състои се основно от ароматни въглеводороди с три до четири кондензирани пръстена и от други въглеводороди.] | 266-026-1 | 65996-91-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-046-00-6 | Anthracene oil, acid ext.; Anthracene Oil Extract Residue; [A complex combination of hydrocarbons from the base-freed fraction obtained from the distillation of coal tar and boiling in the range of approxi mately 325 oC to 365 oC (617 oF to 689 oF). It contains predominantly anthracene and phenanthrene and their alkyl derivatives.] | 295-274-3 | 91995-14-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-046-00-6 | Антраценово масло, кисел екстракт; остатък от екстракцията на антраценово масло; [Сложна комбинация от въглеводороди от освободената от основи фракция, получена от дестилацията на каменовъглен катран и кипяща в обхвата от около 325 oC до 365 oC (617 oF до 689 oF). Съдържа главно антрацен и фенантрен и техни алкилови производни.] | 295-274-3 | 91995-14-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-047-00-1 | Distillates (coal tar); Heavy Anthracene Oil; | [The distillate from coal tar having an approximate distil lationrange of 100oC to 450oC (212oF to 842oF). Composed primarily of two to four membered condensed ring aromatic hydrocarbons, phenolic compounds, and aromatic nitrogen bases.] | 266-027-7 | 65996-92-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-047-00-1 | Дестилати (каменовъглен катран); Тежко антраценово масло; | [Дестилат от каменовъглен катран, имащ приблизителен дестилационен обхват от 100 oC до 450 oC (212 oF до 842 oF). Състои се главно от ароматни въглеводороди с два до четири кондензирани пръстена, фенолни съединения и ароматни азотни бази.] | 266-027-7 | 65996-92-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-048-00-7 | Distillates (coal tar), pitch, heavy oils; | Heavy Anthracene Oil; | [The distillate from the distillation of the pitch obtained from bituminous high temperature tar. Composed primarily of tri-and polynuclear aromatic hydrocarbons and boiling in the range of approximately 300 oC to 470 oC (572 oF to 878 oF). The product may also contain heteroatoms.] | 295-312-9 | 91995-51-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-048-00-7 | Дестилати (каменовъглен катран), смола, тежки масла; | Тежко антраценово масло; | [Дестилат от дестилацията на смола, получена от битумен високотемпературен катран. Съставен главно от основно от трипръстенни и многопръстенни въглеводороди с точка на кипене в интервал приблизително 300 oC до 470 oC (572 oF до 878 oF). Продуктът може да съдържа и хетероатоми.] | 295-312-9 | 91995-51-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-049-00-2 | Distillates (coal tar), pitch; Heavy Anthracene Oil; | [The oil obtained from condensation of the vapors from the heat treatment of pitch. | Composed primarily of two-to four-ring aromatic compounds boiling in the range of 200 oC to greater than 400 oC (392 oF to greater than 752 oF).] | 309-855-7 | 101316-49-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-049-00-2 | Дестилати (каменовъглен катран), смола; Тежко антраценово масло; | [Масло, получено от кондензирането на изпарения от термичната обработка на смола. | Състои се основно от двупръстенни до четирипръстенни ароматни съединения, кипящи в обхвата от 200 oC до повече от 400 oC (392 oF до повече от 752 oF).] | 309-855-7 | 101316-49-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-050-00-8 | Distillates (coal tar), heavy oils, pyrene fraction; | Heavy Anthracene Oil Redistillate; | [The redistillate obtained from the fractional distillation of pitch distillate boiling in the range of approximately 350 oC to 400 oC (662 oF to 752 oF). Consists predominantly of tri-and polynuclear aromatics and heterocyclic hydrocarbons.] | 295-304-5 | 91995-42-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-050-00-8 | Дестилати (каменовъглен катран), тежки масла, пиренова фракция; | Редестилат на тежко антраценово масло; | [редестилат, получен от фракционната дестилация на смолен дестилат, кипящ в обхватa от около 350 oC до 400 oC (662 oF до 752 oF). Състои се основно от трипръстенни и многопръстенни ароматни съединения и хетероциклени въглеводороди.] | 295-304-5 | 91995-42-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-051-00-3 | Distillates (coal tar), pitch, pyrene fraction; | Heavy Anthracene Oil Redistillate; | [The redistillate obtained from the fractional distillation of pitch distillate and boiling in the range of approximately 380 oC to 410 oC (7160 to 770 oF). Composed primarily of tri-and polynuclear aromatic hydrocarbons and heterocyclic compounds.] | 295-313-4 | 91995-52-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-051-00-3 | Дестилати (каменовъглен катран), смола, пиренова фракция; | Редестилат на тежко антраценово масло; | [редестилат, получен от фракционната дестилация на смолен дестилат, кипящ в обхвата от около 380 oC до 410 oC (716 oF до 770 oF). Състои се основно от трипръстенни и многопръстенни ароматни въглеводороди и хетероциклени съединения.] | 295-313-4 | 91995-52-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-052-00-9 | Paraffin waxes (coal), brown-coal high-temp. tar, carbon-treated; | Coal Tar Extract; [A complet combination of hydrocarbons obtained by the treatment of lignite carbon ization tar with activated carbon for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] | 308-296-6 | 97926-76-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-052-00-9 | Парафинови восъци (каменни въглища), високотемпературни катрани от кафяви въглища, обработени с активен въглен; | Екстракт от каменовъглен катран; [Сложна комбинация от въглеводороди, получена от обработката на катран от коксуване на лигнит с активен въглен за отстраняването на следи от съставки и онечиствания. Състои се основно от наситени въглеводороди с неразклонена и разклонена верига и брой на въглеродните атоми предимно по-голям от C12.] | 308-296-6 | 97926-76-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-053-00-4 | Paraffin waxes (coal), brown-coal high-temp tar, clay-treated; Coal Tar Extract; | [A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with bentonite for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] | 308-297-1 | 97926-77-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-053-00-4 | Парафинови восъци (каменни въглища), високотемпературни катрани от кафяви въглища, обработени с глина; Екстракт от каменовъглен катран; | [сложна комбинация от въглеводороди, получени от обработката на катран от коксуване на лигнит с бентонит за отстраняването на следи от съставки и онечиствания. Състои се основно от наситени въглеводороди с неразклонена и разклонена верига и брой на въглеродните атоми предимно по-голям от C12.] | 308-297-1 | 97926-77-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-054-00-X | Pitch; Pitch | 263-072-4 | 61789-60-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-054-00-X | Смола; Смола | 263-072-4 | 61789-60-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-055-00-5 | Pitch, coal tar, high-temp.; Pitch; [The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 oC to 180 oC (86oF to 356oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.] | 266-028-2 | 65996-93-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  648-055-00-5 | Смола, каменовъглен катран, високотемпературен; Смола; [Остатъкът от дестилацията на високотемпературен каменовъглен катран. Твърд черен продукт с точка на размекване приблизително в интервала от 30 oC до 180 oC (86 oF до 356oF). Съставен главно от сложна смес от ароматни въглеводороди с три или повече кондензирани пръстена.] | 266-028-2 | 65996-93-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
648-056-00-0 | Pitch, coal tar, high-temp., heat-treated; Pitch; [The heat treated residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 80oC to180 oC (176 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.] | 310-162-7 | 121575-60-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-056-00-0 | Смола, каменовъглен катран, високотемпературен, термично обработен; Смола; [Топлинно обработен остатък от дестилацията на високотемпературен каменовъглен катран. Твърд черен продукт с приблизителна температура на омекване в интервала от 80 oС до 180 oС (176oF до 356oF). Съставена главно от сложна смес от ароматни въглеводороди с три или повече кондензирани пръстена.] | 310-162-7 | 121575-60-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-057-00-6 | Pitch, coal tar, high-temp., secondary; | Pitch Redistillate; [The residue obtained during the distillation of high boiling fractions from bituminous coal high temperature tar and/or pitch coke oil, with a softening point of 140 oC to 170 oC (284 oF to 392 oF) according to DIN 52025. Composed primarily of tri-and polynuclear aromatic compounds which also contain heteroatoms.] | 302-650-3 | 94114-13-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-057-00-6 | Смола, каменовъглен катран, високотемпературен, вторична; | Смолен редестилат; [Остатък, получен по време на дестилацията на фракции с висока точка на кипене от битумен каменовъглен високотемпературен катран и/или смолно коксово масло, с точка на омекване от 140 oC до 170 oC (284 oF до 392 oF) по DIN 52025. Състои се основно от ароматни съединения с пръстени с три или повече атома, които съдържат и хетероатоми.] | 302-650-3 | 94114-13-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-058-00-1 | Residues (coal tar), pitch distn.; Pitch Redistillate; | [Residue from the fractional distillation of pitch distillate boiling in the range of approximately 400oC to 470oC (752 oF to 846 oF). Composed primarily of polynuclear aromatic hydrocarbons, and heterocyclic compounds.] | 295-507-9 | 92061-94-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-058-00-1 | Остатъчни продукти (каменовъглен катран), дестилация на смола; Смолен редестилат; | [Остатък от фракционната дестилация на смолен дестилат, кипящ в обхвата от около 400 oC до 470 oC (752 oF до 846 oF). Състои се основно от многопръстенни ароматни въглеводороди и хетероциклени съединения.] | 295-507-9 | 92061-94-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-059-00-7 | Tar, coal, high-temp., distn. and storage residues; | Coal Tar Solids Residue; | [Coke-and ash-containing solid residues that separate on distillation and thermal treatment of bituminous coal high temperature tar in distillation installations and storage vessels. Consists predominantly of carbon and contains a small quantity of hetero compounds as well as ash components.] | 295-535-1 | 92062-20-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-059-00-7 | Катран, каменни въглища, високотемпературен, остатъчни продукти от дестилация и съхранение; | Остатъчен твърд продукт от каменовъглен катран; | [Твърди остатъци, съдържащи кокс и пепел, които се отделят при дестилация и термична обработка на битумен каменовъглен високотемпературен катран в дестилационни инсталации и бункери за съхранение. Състои се предимно от въглерод и съдържа малко количество хетеросъединения, както и пепелни компоненти.] | 295-535-1 | 92062-20-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-060-00-2 | Tar, coal, storage residues; Coal Tar Solids Residue; | [The deposit removed from crude coal tar storages. Composed primarily of coal tar and carbonaceous particulate matter.] | 293-764-1 | 91082-50-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-060-00-2 | Катран, каменни въглища, остатъчни продукти от съхранение; Остатъчен твърд продукт от каменовъглен катран; | [Утайка, отделена от бункери за суров каменовъглен катран. Състои се главно от каменовъглен катран и маса от въглеродсъдържащи частици.] | 293-764-1 | 91082-50-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-061-00-8 | Tar, coal, high-temp., residues; Coal Tar Solids Residue; | [Solids formed during the coking of bituminous coal to produce crude bituminous coal high temperature tar. Composed primarily of coke and coal particles, highly aromatized compounds and mineral substances.] | 309-726-5 | 100684-51-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-061-00-8 | Катран, каменни въглища, високотемпературен, остатъчни продукти; Остатъчен твърд продукт от каменовъглен катран; | [Твърди вещества, образувани по време на коксуването на битумни въглища за производството на суров битумен каменовъглен високотемпературен катран. Състои се основно от кокс и въглищни частици, високоароматизирани съединения и минерални вещества.] | 309-726-5 | 100684-51-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-062-00-3 | Tar, coal, high-temp., high-solids; | Coal Tar Solids Residue; | [The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons with a high solid content of coal-type materials.] | 273-615-7 | 68990-61-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-062-00-3 | Катран, каменни въглища, високотемпературен, с високо съдържание на твърди вещества; | Остатъчен твърд продукт от каменовъглен катран; | [Кондезационен продукт, получен при охлаждане приблизително до температурата на обкръжаващата среда, на газа, отделен при високотемпературна (по-висока от 700oС (1292oF) деструктивна дестилация на въглища. Състои се основно от комплексна смес на ароматни въглеводороди с кондензирани пръстени, с високо съдържание на твърди подобни на въглища материали.] | 273-615-7 | 68990-61-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-063-00-9 | Waste solids, coal-tar pitch coking; | Coal Tar Solids Residue; | [The combination of wastes formed by the coking of bituminous coal tar pitch. It consists predominantly of carbon.] | 295-549-8 | 92062-34-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-063-00-9 | Твърди отпадъци, каменовъглен катран от коксуване на смола; | Остатъчен твърд продукт от каменовъглен катран; | [Комбинация от отпадъчни продукти, образувани при коксуването на битуминозна смола от каменовъглен катран. Състои се основно от въглерод.] | 295-549-8 | 92062-34-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-064-00-4 | Extract residues (coal), brown; Coal Tar Extract; | [The residue from extraction of dried coal.] | 294-285-0 | 91697-23-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-064-00-4 | Остатъци от екстракция (въглищни), кафяви; Екстракт от каменовъглен катран; | [Остатъчен продукт от екстракцията на изсушени въглища.] | 294-285-0 | 91697-23-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-065-00-X | Paraffin waxes (coal), brown-coal-high-temp. tar; | Coal Tar Extract; [A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.] | 295-454-1 | 92045-71-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-065-00-X | Парафинови восъци (каменни въглища), високотемпературни катрани от кафяви въглища; | Екстракт от каменовъглен катран; [Сложна комбинация от въглеводороди, получени от катран от коксуване на лигнит, чрез кристализация с разтворител (обезмасляване с разтворител), чрез обезмасляване или процес на образуване на адукти. Състои се главно от наситени въглеводороди с неразклонена и разклонена верига с брой на въглеродните атоми предимно по-голям от C12.] | 295-454-1 | 92045-71-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-066-00-5 | Paraffin waxes (coal), brown-coal-high-temp. tar, hydrotreated; | Coal Tar Extract; [A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process treated with hydrogen in the presence of a catalyst. It consists predomi nantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.] | 295-455-7 | 92045-72-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-066-00-5 | Парафинови восъци (каменни въглища), високотемпературни катрани от кафяви въглища, обработени с водород (хидротретирани); | Екстракт от каменовъглен катран; [Сложна комбинация от въглеводороди, получени от катран от коксуване на лигнит, чрез кристализация с разтворител (обезмасляване с разтворител), чрез обезмасляване или процес на образуване на адукти, третирани с водород в присъствието на катализтор. Състои се основно от наситени въглеводороди с неразклонена и разклонена верига и брой на въглеродните атоми предимно по-голям от C12.] | 295-455-7 | 92045-72-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-067-00-0 | Paraffin waxes (coal), brown-coal high-temp tar, silicic acid-treated; | Coal Tar Extract; | [A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with silicic acid for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] | 308-298-7 | 97926-78-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-067-00-0 | Парафинови восъци (каменни въглища), високотемпературни катрани от кафяви въглища, обработени със със силициева киселина; | Екстракт от каменовъглен катран; | [Сложна комбинация от въглеводороди, получени чрез обработката на катран от коксуване на лигнит със силициева киселина за отстраняването на следи от съставки и онечиствания. Състои се основно от наситени въглеводороди с неразклонена и разклонена верига и брой на въглеродните атоми предимно по-голям от C12.] | 308-298-7 | 97926-78-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-068-00-6 | Tar, coal, low-temp, distn. residues; | Tar Oil, intermediate boiling; [Residues from fractional distillation of low temperature coal tar to remove oils that boil in a range up to approximately 300 oC (572 oF). Composed primarily of aromatic compounds.] | 309-887-1 | 101316-85-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-068-00-6 | Остатъци от дестилация на нискотемпературен каменовъглен катран; | Катранено масло с междинна температура на кипене; [Остатъци от фракционната дестилация на нискотемпературен каменовъглен катран за отстраняване на масла, кипящи в обхват до около 300 oC (572 oF). Състои се главно от ароматни съединения.] | 309-887-1 | 101316-85-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-069-00-1 | Pitch, coal tar, low-temp; Pitch Residue; | [A complex black solid or semi-solid obtained from the distillation of a low temperature coal tar. It has a softening point within the approximate range of 40 oC to 180 oC (104oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.] | 292-651-4 | 90669-57-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-069-00-1 | Смола от нискотемпературен каменовъглен катран; Смолен остатък; | [Сложен черен твърд или полутвърд продукт, получен от дестилацията на нискотемпературен каменовъглен катран. С точка на размекване приблизително в интервала от 40 oC до 180 oC (104oF до 356 oF). Състои се основно от сложна смес от въглеводороди.] | 292-651-4 | 90669-57-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-070-00-7 | Pitch, coal tar, low-temp., oxidized; | Pitch Residue, oxidised; | [The product obtained by air-blowing, at elevated temperature, low-temperature coal tar pitch. It has a softening-point within the approximate range of 70 oC to 180 oC (158 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.] | 292-654-0 | 90669-59-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-070-00-7 | Окислена смола от нискотемпературен каменовъглен катран | Окислен смолен остатък; | [Продукт, получен чрез продухване с въздух на смола от нискотемпературен каменовъглен катран. Точката на размекване е в приблизителния обхват от 70 oC до 180 oC (158 oF до 356 oF). Състои се основно от сложна смес от въглеводороди.] | 292-654-0 | 90669-59-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-071-00-2 | Pitch, coal tar, low-temp., heat-treated; | Pitch Residue, oxidised; Pitch Residue, heat-treated; | [A complex black solid obtained by the heat treatment of low temperature coal tar pitch. It has a softening point within the approximate range of 50 oC to 140 oC (122oF to 284oF). Composed primarily of a complex mixture of aromatic compounds.] | 292-653-5 | 90669-58-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-071-00-2 | Термично обработена смола от нискотемпературен каменовъглен катран; | Окислен смолен остатък; Термично обработен смолен остатък; | [Сложен твърд продукт с черен цвят, получен при термично обработване на смола от нискотемпературен каменовъглен катран. Има температура на размекване в интервала от 50 oС до 140 oС (122oF до 284oF). Състои се основно от сложна смес на ароматни съединения.] | 292-653-5 | 90669-58-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-072-00-8 | Distillates (coal-petroleum), condensed-ring arom; | Distillates; | [The distillate from a mixture of coal and tar and aromatic petroleum streams having an approximate distillation range of 220 oC to 450 oC (428oF to 842oF). Composed primarily of 3-to 4-membered condensed ring aromatic hydrocarbons.] | 269-159-3 | 68188-48-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-072-00-8 | Дестилати (каменни въглища и нефт), ароматни въглеводороди с кондензирани пръстени; | Дестилати; | [Дестилат от смес от въглища и катран и ароматни нефтени фракции с приблизителен интервал на дестилация от 220 oC до 450 oC (428 oF до 842 oF). Съставен главно от ароматни въглеводороди с 3 до 4 кондензирани пръстена.] | 269-159-3 | 68188-48-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-073-00-3 | Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene-polypropylene pyrolysis-derived; Pyrolysis Products; | [A complex combination hydrocarbons obtained from mixed coal tar pitch-polyethylene-polypropylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212oF to 428oF) according to DIN 52025.]; | 309-956-6 | 101794-74-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-073-00-3 | Ароматни въглеводороди, C20-C28, многопръстенни, получени чрез пиролиза на смес смола от каменовъглен катран-полиетилен-полипропилен; Пиролизни продукти; | [Сложна комбинация от въглеводороди, получена от пиролизата на смес смола от каменовъглен катран-полиетилен-полипропилен. Състои се главно от многопръстенни ароматни въглеводороди с брой на въглеродните атоми предимно в интервала от C20 до C28 и точка на размекване от 100 oC до 220 oC (212 oF до 428 oF) по DIN 52025.]; | 309-956-6 | 101794-74-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-074-00-9 | Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene pyrolysis-derived; | Pyrolysis Products; | [A complex combination of hydrocarbonsobtained from mixed coal tar pitch-polyethylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numberspredominantly in the range of C20 through C28 and having a softening pointof 100oC to 220oC (212oF to 428oF) according to DIN 52025.] | 309-957-1 | 101794-75-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-074-00-9 | Ароматни въглеводороди, C20-C28, многопръстенни, получени чрез пиролиза на смес смола от каменовъглен катран-полиетилен; | Пиролизни продукти; | [Сложна комбинация от въглеводороди, получени чрез пиролиза на смес смола от каменовъглен катран-полиетилен. Състои се главно от многопръстенни ароматни въглеводороди с брой на въглеродните атоми предимно в интервала от C20 до C28 и точка на размекване от 100 oC до 220 oC (212 oF до 428 oF) по DIN 52025.] | 309-957-1 | 101794-75-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-075-00-4 | Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polystyrene pyrolysis-derived; | Pyrolysis Products; | [A complex combination of hydrocarbons obtained from mixed coal tar pitch-polystyrene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100oC to 220oC (212oF to 428oF) according to DIN 52025.] | 309-958-7 | 101794-76-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-075-00-4 | Ароматни въглеводороди, C20-C28, многопръстенни, получени чрез пиролиза на смес смола от каменовъглен катран-полистирен; | Пиролизни продукти; | [Сложна комбинация от въглеводороди, получени чрез пиролиза на смес смола от каменовъглен катран-полистирен. Състои се главно от многопръстенни ароматни въглеводороди с брой на въглеродните атоми предимно в интервала от C20 до C28 и точка на размекване от 100 oC до 220 oC (212 oF до 428 oF) по DIN 52025.] | 309-958-7 | 101794-76-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-076-00-X | Pitch, coal tar-petroleum; Pitch Residues; | [The residue from the distillation of a mixture of coal tar and aromatic petroleum streams. A solid with a softening point from 40oC to 180oC (140oF to 356oF). Composed; primarily of a complex combination of three or more membered condensed ring aromatic hydrocarbons.] | 269-109-0 | 68187-57-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-076-00-X | Смола от каменовъглен катран — нефт; Смолни остатъци; | [Остатък от дестилацията на смес от каменовъглен катран и ароматни нефтени фракции. Твърд продукт с температура на размекване в интервала от 40 oС до 180 oС (140oF до 356oF). Съставен главно от сложна комбинация от ароматни въглеводороди с три или повече кондензирани пръстена.] | 269-109-0 | 68187-57-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-077-00-5 | Phenanthrene, distn. residues; Heavy Anthracene Oi Redistillate; | [Residue from the distillation of crude phenanthrene boiling in the approximate range of 340 oC to 420 oC (644oF to 788oF). It consists predominantly of phenanthrene, anthracene and carbazole.] | 310-169-5 | 122070-78-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-077-00-5 | Фенантрен, остатъци от дестилация; Редестилат на тежко антраценово масло; | [Остатък от фракционната дестилация на суров фенантрен с точка на кипене в интервала приблизително 340 oC—420 oC (644 oF—788 oF). Състои се основно от фенантрен, антрацен и карбазол.] | 310-169-5 | 122070-78-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-078-00-0 | Distillates (coal tar), upper, fluorene-free; Wash Oil Redistillate; | [A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists of aromatic polycyclic hydrocarbons, primarily diphenyl, dibenzofuran and acenaphthene.] | 284-899-7 | 84989-10-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-078-00-0 | Дестилати (каменовъглен катран), горни, без съдържание на флуорен; редестилат на промивно масло; | [Сложна комбинация от въглеводороди, получена чрез кристализацията на катранено масло. Състои се от ароматни многопръстенни въглеводороди, главно дифенил, дибензофуран и аценафтен.] | 284-899-7 | 84989-10-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-079-00-6 | Anthracene oil; Anthracene oil; | [A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300 oC to 400 oC (572oF to 752oF). Composed primarily of phenanthrene, anthracene and carbazole.] | 292-602-7 | 90640-80-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-079-00-6 | Aнтраценово масло; Aнтраценово масло; | [Сложна комбинация от многопръстенни ароматни въглеводороди, получени от каменовъглен катран, с интервал на дестилация приблизително от 300o до 400oС (572oF до 752oF). Състои се основно от фенантрен, антрацен и карбазол.] | 292-602-7 | 90640-80-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-080-00-1 | Residues (coal tar), creosote oil distn.; Wash Oil Redistillate; | [The residue from the fractional distillation of wash oil boiling in the approximate range of 270 o C to 330 o C (518 oF to 626 oF). It consists predomi nantly of dinuclear aromatic and heterocyclic hydrocarbons.] | 295-506-3 | 92061-93-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-080-00-1 | Остатъци (каменовъглен катран), дестилация на креозотно масло; редестилат на промивно масло; | [Остатък от фракционна дестилация на промивно масло, с точка на кипене в интервала приблизително 270 oC—330 oC (518 oF—626 oF). Състои се предимно от двупръстенни ароматни и хетероциклени въглеводороди.] | 295-506-3 | 92061-93-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-081-00-7 | Tar, coal; Coal tar; | [The by-product from the destructive distillation of coal. Almost black semisolid. A complex combination of aromatic hydrocarbons, phenolic compounds, nitrogen bases and thiophene.] | 232-361-7 | 8007-45-2 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  648-081-00-7 | Катран, каменни въглища; Каменовъглен катран; | [Вторичен продукт от сухата дестилация на въглища. Почти черен полутвърд продукт. Сложна комбинация от ароматни въглеводороди, фенолни съединения, азотни бази и тиофен.] | 232-361-7 | 8007-45-2 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  
648-082-00-2 | Tar, coal, high-temp.; Coal tar; [The condensation product obtained by cooling, to approxi mately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons. May contain minor amounts of phenolic compounds and aromatic nitrogen bases.] | 266-024-0 | 65996-89-6 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  648-082-00-2 | Високотемпературен катран от каменни въглища; Каменовъглен катран; [Кондезационен продукт, получен при охлаждане приблизително до температурата на обкръжаващата среда, на газ, отделен при високотемпературна (по-висока от 700oС (1292oF) суха дестилация на въглища. Черна вискозна течност, по-плътна от водата. Състои се основно от сложна смес от ароматни въглеводороди с кондензирани пръстени. Може да съдържа минимални количества от фенолни съединения и ароматни азотни основи.] | 266-024-0 | 65996-89-6 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  
648-083-00-8 | Tar, coal, low-temp.; Coal oil; | [The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in low temperature (less than 700 oC (1292oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of condensed ring aromatic hydrocarbons, phenolic compounds, aromatic nitrogen bases, and their alkyl derivatives.] | 266-025-6 | 65996-90-9 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  648-083-00-8 | Нискотемпературен катран от каменни въглища; Каменовъглен катран; | [Кондезационен продукт, получен при охлаждане приблизително до температурата на обкръжаващата среда, на газ, отделен при нискотемпературна (по-малко от 700 oC (1292oF)) суха дестилация на въглища. Черна вискозна течност, по-плътна от водата. Състои се главно от ароматни въглеводороди с кондензирани пръстени, фенолни съединения, ароматни азотни основи и техните алкилови производни.] | 266-025-6 | 65996-90-9 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  
648-084-00-3 | Distillates (coal), coke-oven light oil, naphthalene cut; Naphthalene Oil; | [The complex combination of hydrocarbons obtained from prefractionation (continuous distillation) of coke oven light oil. It consists predominantly of naphthalene, coumarone and indene and boils above 148 oC (298oF).] | 285-076-5 | 85029-51-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-084-00-3 | Дестилати (въглищни), леко масло от коксови пещи, нафталенова фракция; нафталеново масло; | [Сложна комбинация от въглеводороди, получена при префракциониране (продължителна дестилация) на леко масло от коксови пещи. Състои се предимно от нафтален, кумарон и инден и има точка на кипене над 148 oC (298 oF).] | 285-076-5 | 85029-51-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-085-00-9 | Distillates (coal tar), naphthalene oils; Naphthalene Oil; | [A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic and other hydrocarbons, phenolic compound and aromatic nitrogen compounds and distills in the approximate range of 200 oC to 250 oC (392oF to 482oF).]- | 283-484-8 | 84650-04-4 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-085-00-9 | Дестилати (каменовъглен катран), нафталенови масла; нафталеново масло; | [Сложна комбинация от въглеводороди, получени чрез дестилация на каменовъглен катран. Състои се основно от ароматни и други въглеводороди, фенолни съединения и ароматни азотни съединения и дестилира в интервала приблизително 200 oC—250 oC (392 oF—482 oF).] | 283-484-8 | 84650-04-4 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-086-00-4 | Distillates (coal tar), naph thalene oils, naphthalene-low; Naphthalene Oil Redistillate; [A complex combination of hydrocarbons obtained by crys tallization of naphthalene oil. Composed primarily of naphthalene, alkyl naphthalenes and phenolic compounds.] | 284-898-1 | 84989-09-3 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-086-00-4 | Дестилати (каменовъглен катран), нафталенови масла с ниско съдържание на нафтален; редестилат на нафталеново масло; [Сложна комбинация от въглеводороди, получени при кристализация на нафталеново масло. Състои се основно от нафтален, алкилнафталени и фенолни съединения.] | 284-898-1 | 84989-09-3 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-087-00-X | Distillates (coal tar), naphthalene oil crystn. mother liquor; Naphthalene Oil Redistillate; | [A complex combination of organic compounds obtained as a filtrate from the crystallization of the naphthalene fraction from coal tar and boiling in the range of approximately 200 oC to 230 oC (392oF to 446oF). Contains chiefly naphthalene, thionaphthene and alkylnaphthalenes.] | 295-310-8 | 91995-49-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-087-00-X | Дестилати (каменовъглен катран), кристализация на нафталеново масло, първична луга; редестилат на нафталеново масло; | [Сложна комбинация от органични съединения, получена като филтрат от кристализацията на нафталеновата фракция от каменовъглен катран и с точка на кипене в интервала приблизително 200 oC—230 oC (392 oF—446 oF). Съдържа главно нафтален, тионафтен и алкилнафталени.] | 295-310-8 | 91995-49-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-088-00-5 | Extract residues (coal), naphthalene oil, alk.; Naphthalene Oil Extract Residue; | [A complex combination of hydrocarbons obtained from the alkali washing of naphthalene oil to remove phenolic compounds (tar acids). It is composed of naphthalene and alkyl naphthalenes.] | 310-166-9 | 121620-47-1 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-088-00-5 | Остатъци от екстракция (въглищни), нафталеново масло, алкални; Остатък от екстракция на нафталеново масло; | [Сложна комбинация от въглеводороди, получена от алкално промиване на нафталеново масло за отстраняване на фенолни съединения (катранени киселини). Състои се от нафтален и алкилнафталени.] | 310-166-9 | 121620-47-1 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-089-00-0 | Extract residues (coal), naphthalene oil, alk., naphthalene-low; | Naphthalene Oil Extract Residue; | [A complex combination of hydrocarbons remaining after the removal of naphthalene from alkali-washed naphthalene oil by a crystallization process. It is composed primarily of naphthalene and alkyl naphthalenes.] | 310-167-4 | 121620-48-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-089-00-0 | Остатъци от екстракция (въглищни), нафталеново масло, алкални, с ниско съдържание на нафтален; | Остатък от екстракция на нафталеново масло; | [Сложна комбинация от въглеводороди, останала след отстраняването на нафталена от алкално промитото нафталеново масло чрез кристализационен процес. Състои се основно от нафтален и алкилнафталени.] | 310-167-4 | 121620-48-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-090-00-6 | Distillates (coal tar), naphthalene oils, naphthalene-free, alk. exts.; | Naphthalene Oil Extract Residue; | [The oil remaining after the removal of phenolic compounds (tar acids) from drained naphthalene oil by an alkali wash. Composed primarily of naphthalene and alkyl naphthalenes.] | 292-612-1 | 90640-90-7 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-090-00-6 | Дестилати (каменовъглен катран), нафталенови масла, без съдържание на нафтален, алкални екстракти; | Остатък от екстракция на нафталеново масло; | [Масло, оставащо след отстраняването на фенолните съединения (катранени киселини) от отделеното нафталеново масло чрез алкално промиване. Състои се основно от нафтален и алкилнафталени.] | 292-612-1 | 90640-90-7 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-091-00-1 | Extract residues (coal), naphthalene oil alk., distn. overheads; | Naphthalene Oil Extract Residue; | [The distillate from alkali-washed naphthalene oil having an approximate distillation range of 180 oC to 220 oC (356oF to 428 oF). Composed primarily of naphthalene, alkylbenzenes, indene and indan.] | 292-627-3 | 90641-04-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-091-00-1 | Остатъци от екстракция (въглищни), алкално нафталеново масло, дестилация горни фракции; | Остатък от екстракция на нафталеново масло; | [Дестилат от алкално промито нафталеново масло с приблизителен интервал на дестилация 180 oC—220 oC (356 oF—428 oF). Съставен основно от нафтален, алкилбензени, инден и индан.] | 292-627-3 | 90641-04-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-092-00-7 | Distillates (coal tar), naphthalene oils, methylnaphthalene fraction; | Methylnaphthalene Oil; | [A distillate from the fractional distillation of high temperature coal tar. Composed primarily of substituted two ring aromatic hydrocarbons and aromatic nitrogen bases boiling in the range of approximately 225 oC to 255 oC (437oF to 491 oF).] | 309-985-4 | 101896-27-9 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-092-00-7 | Дестилати (каменовъглен катран), нафталенови масла, метилнафталенова фракция; | метилнафталеново масло; | [Дестилат от фракционна дестилация на високотемпературен каменовъглен катран. Съставен основно от заместени двупръстенни ароматни въглеводороди и ароматни азотни основи, с точка на кипене в интервала приблизително 225 oC—255 oC (437 oF—491 oF).] | 309-985-4 | 101896-27-9 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-093-00-2 | Distillates (coal tar), naphthalene oils, indole-methylnaphthalene fraction; Methylnaphthalene Oil; | [A distillate from the fractional distillation of high temperature coal tar. Composed primarily of indole and methylnaphthalene boiling in the range of approximately 235 oC to 255 oC (455 oF to 491 oF).] | 309-972-3 | 101794-91-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-093-00-2 | Дестилати (каменовъглен катран), нафталенови масла, индол-метилнафталенова фракция; метилнафталеново масло; | [Дестилат от фракционна дестилация на високотемпературен каменовъглен катран. Съставен основно от индол и метилнафтален, с точка на кипене в интервала приблизително 235 oC—255 oC (455 oF—491 oF).] | 309-972-3 | 101794-91-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-094-00-8 | Distillates (coal tar), naphthalene oils, acid exts.; Methylnaphthalene Oil Extract Residue; | [A complex combination of hydrocarbons obtained by debasing the methylnaphthalene fraction obtained by the distillation of coal tar and boiling in the range of approximately 230 oC to 255 oC (446oF to 491oF). Contains chiefly 1(2)-methylnaphthalene, naphthalene, dimethylnaphthalene and biphenyl.] | 295-309-2 | 91995-48-1 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-094-00-8 | Дестилати (каменовъглен катран), нафталенови масла, кисели екстракти; Остатък от екстракцията на метилнафталеново масло; | [Сложна комбинация от въглеводороди, получена след отстраняване на основите от метилнафталеновата фракция, получена при дестилация на каменовъглен катран, и с точка на кипене в интервала приблизително 230 oC—255 oC (446 oF—491 oF). Състои се главно от 1(2)-метилнафтален, нафтален, диметилнафтален и бифенил.] | 295-309-2 | 91995-48-1 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-095-00-3 | Extract residues (coal), naphthalene oil alk., distn. residues; Methylnaphthalene Oil Extract Residue; [The residue from the distillation of alkali-washed naphthalene oil having an approximate distillation range of 220 oC to 300 oC (428oF to 572oF). Composed primarily of naphthalene, alkylnaphthalenes and aromatic nitrogen bases.] | 292-628-9 | 90641-05-7 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-095-00-3 | Остатъци от екстракция (въглищни), алкално нафталеново масло, остатъци от дестилация; Остатък от екстракцията на метилнафталеново масло; [Остатък от дестилация на алкално промито нафталеново масло, с интервал на дестилация приблизително 220 oC—300 oC (428 oF—572 oF). Съставен основно от нафтален, алкилнафталени и ароматни азотни основи.] | 292-628-9 | 90641-05-7 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-096-00-9 | Extract oils (coal), acidic, tar-base free; | Methylnaphthalene Oil Extract Residue; [The extract oil boiling in the range of approximately 220 oC to 265 oC (428oF to 509oF) from coal tar alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove tar bases. Composed primarily of alkylnaphthalenes.] | 284-901-6 | 84989-12-8 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-096-00-9 | Екстрактни масла (въглищни), кисели, без съдържание на катранени основи; | Остатък от екстракцията на метилнафталеново масло; [Екстрактно масло с точка на кипене в интервала приблизително 220 oC—265 oC (428 oF—509 oF) от остатъка от алкален екстракт на каменовъглен катран, получен чрез промиване с киселина, като воден разтвор на сярна киселина, след дестилация за отстраняване на катранените основи. Съставено основно от алкилнафталени.] | 284-901-6 | 84989-12-8 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-097-00-4 | Distillates (coal tar), benzole fraction, distn. residues; | Wash Oil; | [A complex combination of hydrocarbons obtained from the distillation of crude benzole (high temperature coal tar). It may be a liquid with the approximate distillation range of 150o C to 300 oC (302oF to 572oF) or a semi-solid or solid with a melting point up to 70 oC (158oF). It is composed primarily of naphthalene and alkyl naphthalenes.] | 310-165-3 | 121620-46-0 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-097-00-4 | Дестилати (каменовъглен катран), бензенова фракция, остатъци от дестилация; | промивно масло; | [Сложна комбинация от въглеводороди, получена от дестилацията на суров бензен (високотемпературен каменовъглен катран). Може да бъде течност с интервал на дестилация приблизително 150 oC—300 oC (302 oF- 572 oF) или полутвърд или твърд продукт с точка на топене до 70 oC (158 oF). Състои се основно от нафтален и алкилнафталени.] | 310-165-3 | 121620-46-0 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-098-00-X | Creosote oil, acenaphthene fraction; | Wash Oil; [A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240 o C to 280 o C (464oF to 536 oF). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.] | 292-605-3 | 90640-84-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-098-00-X | Креозотно масло, аценафтенова фракция; | промивно масло; [Сложна комбинация от въглеводороди, получени чрез дестилация на каменовъглен катран и с точка на кипене в интервала приблизително 240 oC—280 oC (464 oF—536 oF). Състои се основно от аценафтен, нафтален и алкилнафтален.] | 292-605-3 | 90640-84-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-099-00-5 | Creosote oil; | [A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200 oC to 325 oC (392oF to 617oF).] | 263-047-8 | 61789-28-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-099-00-5 | Креозотно масло; | [Сложна комбинация от въглеводороди, получени чрез дестилация на каменовъглен катран. Състои се основно от ароматни въглеводороди и може да съдържа измерими количества катранени киселини и катранени основи. Дестилира в интервала приблизително 200 oC—325 oC (392 oF—617 oF).] | 263-047-8 | 61789-28-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-100-00-9 | Creosote oil, high-boiling distillate; | Wash Oil; | [The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5 oC (41oF).] | 274-565-9 | 70321-79-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-100-00-9 | Креозотно масло, дестилат с висока точка на кипене; | промивно масло; | [Дестилационна фракция с висока точка на кипене, получена при високотемпературно коксуване на битуминозни въглища, допълнително рафинирана за отстраняване на излишъка от кристални соли. Състои се основно от креозотно масло, като някои от нормално съдържащите се като компонент в дестилати на каменовъглен катран многопръстенни ароматни соли, са отстранени. Не съдържа кристали при приблизително 5 oC (41 oF).] | 274-565-9 | 70321-79-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-101-00-4 | Creosote; | [The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.] | 232-287-5 | 8001-58-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  648-101-00-4 | Креозот; | [Дестилат от каменовъглен катран, получен от високотемпературно коксуване на битуминозни въглища. Състои се основно от ароматни въглеводороди, катранени киселини и катранени основи.] | 232-287-5 | 8001-58-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
648-102-00-X | Extract residues (coal), creosote oil acid; | Wash Oil Extract Residue; | [A complex combination of hydrocarbons from the base-freed fraction from the distillation of coal tar, boiling in the range of approximately 250 oC to 280 oC (482oF to 536oF). It consists predominantly of biphenyl and isomeric diphenylnaphthalenes.] | 310-189-4 | 122384-77-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-102-00-X | Кисели остатъци от екстракция (въглищни), креозотно масло; | остатък от екстракция на промивно масло; | [Сложна комбинация от въглеводороди, получени от фракция без съдържание на основи от дестилация на каменовъглен катран, с точка на кипене в интервала приблизително 250 oC —280 oC (482 oF—536 oF). Състои се предимно от бифенил и изомерни дифенилнафталени.] | 310-189-4 | 122384-77-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-103-00-5 | Anthracene oil, anthracene paste; | Anthracene Oil Fraction; | [The anthracene-rich solid obtained by the crystallization and centrifuging of anthracene oil. It is composed primarily of anthracene, carbazole and phenanthrene.] | 292-603-2 | 90640-81-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-103-00-5 | Антраценово масло, антраценова паста; | фракция антраценово масло; | [Богат на антрацен твърд продукт, получен чрез кристализация и центрофугиране на антраценово масло. Състои се основно от антрацен, карбазол и фенантрен.] | 292-603-2 | 90640-81-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-104-00-0 | Anthracene oil, anthracene-low; Anthracene Oil Fraction; | [The oil remaining after the removal, by a crystallization process, of an anthracene-rich solid (anthracene paste) from anthracene oil. It is composed primarily of two, three and four membered aromatic compounds.] | 292-604-8 | 90640-82-7 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-104-00-0 | Антраценово масло с ниско съдържание на антрацен; фракция антраценово масло; | [Масло, оставащо след отстраняване чрез кристализационен процес от антраценовото масло на богат на антрацен твърд продукт (антраценова паста). Състои се основно от ароматни съединения с два, три и четири пръстена.] | 292-604-8 | 90640-82-7 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-105-00-6 | Residues (coal tar), anthracene oil distn.; Anthracene Oil Fraction; | [The residue from the fraction distillation of crude anthracene boiling in the approximate range of 340 oC to 400 oC (644oF to 752oF). It consists predominantly of tri-and polynuclear aromatic and heterocyclic hydrocarbons.] | 295-505-8 | 92061-92-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-105-00-6 | Остатъци (каменовъглен катран), дестилация на антраценово масло; фракция антраценово масло; | [Остатък от фракционната дестилация на суров антрацен, с точка на кипене в интервала приблизително 340 oC—400 oC (644 oF—752 oF). Състои се основно от трипръстенни и многопръстенни ароматни и хетероциклени въглеводороди.] | 295-505-8 | 92061-92-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-106-00-1 | Anthracene oil, anthracene paste, anthracene fraction; Anthracene Oil Fraction; | [A complex combination of hydrocarbons from the distillation of anthracene obtained by the crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of 330 oC to 350 oC (626oF to 662oF). It contains chiefly anthracene, carbazole and phenanthrene.] | 295-275-9 | 91995-15-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-106-00-1 | Антраценово масло, антраценова паста, антраценова фракция; фракция антраценово масло; | [Сложна комбинация от въглеводороди от дестилацията на антрацен, получена чрез кристализацията на антраценово масло от битумни високотемпературни катрани, с точка на кипене в интервала приблизително 330 oC—350 oC (626 oF—662 oF). Състои се главно от антрацен, карбазол и фенантрен.] | 295-275-9 | 91995-15-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-107-00-7 | Anthracene oil, anthracene paste, carbazole fraction; Anthracene Oil Fraction; | [A complex combination of hydrocarbons from the distil lation of anthracene obtained by crystallization of anthracene oil from bituminous coal high temperature tar and boiling in the approximate range of 350 oC to 360 oC (662oF to 680 oF). It contains chiefly anthracene, carbazole and phenanthrene.] | 295-276-4 | 91995-16-3 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-107-00-7 | Антраценово масло, антраценова паста; карбазолова фракция; фракция антраценово масло; | [Сложна комбинация от въглеводороди от дестилацията на антрацен, получена чрез кристализация на антраценово масло от битумни високотемпературни каменовъглени катрани с точка на кипене в интервала приблизително 350 oC—360 oC (662 oF—680 oF). Състои се главно от антрацен, карбазол и фенантрен.] | 295-276-4 | 91995-16-3 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-108-00-2 | Anthracene oil, anthracene paste, distn. lights; | Anthracene Oil Fraction; | [A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of approximately 290 oC to 340 oC (554oF to 644 oF). It contains chiefly trinuclear aromatics and their dihydro derivatives.] | 295-278-5 | 91995-17-4 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-108-00-2 | Антраценово масло, антраценова паста, леки дестилати; | фракция антраценово масло; | [Сложна комбинация от въглеводороди от дестилацията на антрацен, получена чрез кристализацията на антраценово масло от битумен високотемпературен катран и с точка на кипене в интервала приблизително 290 oC—340 oC (554 oF—644 oF). Състои се главно от трипръстенни ароматни съединения и техните дихидропроизводни.] | 295-278-5 | 91995-17-4 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-109-00-8 | Tar oils, coal, low-temp.; Tar Oil, high boiling; | [A distillate from low-temperature coal tar. Composed primarily of hydrocarbons, phenolic compounds and aromatic nitrogen bases boiling in the range of approximately 160 oC to 340 oC (320oF to 644oF).] | 309-889-2 | 101316-87-4 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-109-00-8 | Катранени масла, въглищни, нискотемпературни; катранено масло с висока температура на кипене; | [Дестилат от нискотемпературен каменовъглен катран. Състои се основно от въглеводороди, фенолни съединения и ароматни азотни основи, с точка на кипене в интервала приблизително 160 oC—340 oC (320 oF—644 oF).] | 309-889-2 | 101316-87-4 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-110-00-3 | Extract residues (coal), low temp. coal atar alk.; | [The residue from low temperature coal tar oils after an alkaline wash, such as aqueous sodium hydroxide, to remove crude coal tar acids. Composed primarily of hydrocarbons and aromatic nitrogen bases.] | 310-191-5 | 122384-78-5 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-110-00-3 | Остатъци от екстракция (каменни въглища), ниско температурни, каменовъглен катран, алкални; | [Остатък от нискотемпературни масла от каменовъглен катран след алкално промиване, например с воден разтвор на натриев хидроксид, за отстраняване на сурови каменовъглени катранени киселини. Съставен основно от въглеводороди и ароматни азотни основи.] | 310-191-5 | 122384-78-5 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-111-00-9 | Phenols, ammonia liquor ext.; Alkaline Extract; | [The combination of phenols extracted, using isobutyl acetate, from the ammonia liquor condensed from the gas evolved in low-temperature (less than 700 oC (1292oF)) destructive distillation of coal. It consists predominantly of a reaction mass of monohydric and dihydric phenols.] | 284-881-9 | 84988-93-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-111-00-9 | Феноли, екстракт от амонячен разтвор; алкален екстракт; | [Комбинация от феноли, екстрахирани с помощта на изобутилацетат от течен амоняк, кондензирал от газа при нискотемпературна (под 700 oC (1292oF) суха дестилация на въглища. Състои се предимно от реакционна маса на феноли с една и две хидроксилни групи.] | 284-881-9 | 84988-93-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-112-00-4 | Distillates (coal tar), light oils, alk. exts.; | Alkaline Extract; | [The aqueous extract from carbolic oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.] | 292-610-0 | 90640-88-3 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-112-00-4 | Дестилати (каменовъглен катран), леки масла, алкални екстракти; | алкален екстракт; | [Воден екстракт от карболово масло, получен при алкално промиване, напр. с воден разтвор на натриев хидроксид. Съставен основно от алкални соли на различни фенолни съединения.] | 292-610-0 | 90640-88-3 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-113-00-X | Extracts, coal tar oil alk.; Alkaline Extract; | [The extract from coal tar oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.] | 266-017-2 | 65996-83-0 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-113-00-X | Екстракти, масло от каменовъглен катран, алкални; алкален екстракт; | [Екстракт от масло от каменовъглен катран, получен чрез алкално промиване, напр. с воден разтвор на натриев хидроксид. Съставен основно от алкални соли на различни фенолни съединения.] | 266-017-2 | 65996-83-0 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-114-00-5 | Distillates (coal tar), naphthalene oils, alk. exts.; Alkaline Extract; | [The aqueous extract from naphthalene oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.] | 292-611-6 | 90640-89-4 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-114-00-5 | Дестилати (каменовъглен катран), нафталенови масла, алкални екстракти; алкален екстракт; | [Воден екстракт от нафталеново масло, получен чрез алкално промиване, напр. с воден разтвор на натриев хидроксид. Съставен основно от алкални соли на различни фенолни съединения.] | 292-611-6 | 90640-89-4 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-115-00-0 | Extract residues (coal), tar oil alk., carbonated, limed; | Crude Phenols; [The product obtained by treatment of coal tar oil alkaline extract with CO2 and CaO. Composed primarily of CaCO3, Ca(OH)2, Na2CO3 and other organic and inorganic impurities.] | 292-629-4 | 90641-06-8 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-115-00-0 | Остатъци от екстракция (въглищни), алкално катранено масло, карбонизирано, обработено с вар; | Сурови феноли; [[Продукт, получен при обработване на алкален екстракт от масло от каменовъглен катран с СО2 и СаО. Състои се основно от CaCO3, Ca(OH)2, Na2CO3 и други органични и неорганични онечиствания.] | 292-629-4 | 90641-06-8 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-116-00-6 | Tar acids, coal, crude; Crude Phenols; | [The reaction product obtained by neutralizing coal tar oil alkaline extract with an acidic solution, such as aqueous sulfuric acid, or gaseous carbon dioxide, to obtain the free acids. Composed primarily of tar acids such as phenol, cresols, and xylenols.] | 266-019-3 | 65996-85-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-116-00-6 | Катранени киселини, въглищни, сурови; Сурови феноли; | [Реакционен продукт, получен при неутрализация на алкален екстракт на масло от каменовъглен катран с кисел разтвор, като воден разтвор на сярна киселина, или с газообразен въглероден диоксид, за получаване на свободните киселини. Съставен основно от катранени киселини като фенол, крезоли и ксиленоли.] | 266-019-3 | 65996-85-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-117-00-1 | Tar acids, brown-coal, crude; Crude Phenols; | [An acidified alkaline extract of brown coal tar distillate. | Composed primarily of phenol and phenol homologs.] | 309-888-7 | 101316-86-3 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-117-00-1 | Катранени киселини, кафяви въглища, сурови; Сурови феноли; | [Подкиселен алкален екстракт от дестилат на катран от кафяви въглища. | Съставен основно от фенол и хомолози на фенола.] | 309-888-7 | 101316-86-3 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-118-00-7 | Tar acids, browncoal gasification; | Crude Phenols; | [A complex combination of organic compounds obtained from brown coal gasification. Composed primarily of C6-10 hydroxy aromatic phenols and their homologs.] | 295-536-7 | 92062-22-1 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-118-00-7 | Катранени киселини от газификация на кафяви въглища; | Сурови феноли; | [Сложна комбинация от органични съединения, получени от газификация на кафяви въглища. Съставена основно от C6-10 хидроксиароматни феноли и техни хомолози.] | 295-536-7 | 92062-22-1 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-119-00-2 | Tar acids, distn. residues; Distillate Phenols; | [A residue from the distillation of crude phenol from coal. It consists predominantly of phenols having carbon numbers in the range of C8 through C10 with a softening point of 60 oC to 80 oC (140oF to 176oF).] | 306-251-5 | 96690-55-0 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-119-00-2 | Катранени киселини, остатъци от дестилация; фенолни дестилати; | [Остатък от дестилацията на суров фенол от въглища. Състои се предимно от феноли с брой на въглеродните атоми в интервала C8—C10 с точка на размекване 60 oC—80 oC (140 oF—176 oF).] | 306-251-5 | 96690-55-0 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-120-00-8 | Tar acids, methylphenol fraction; | Distillate Phenols; | [The fraction of tar acid rich in 3-and 4-methylphenol, recovered by distillation of low-temperature coal tar crude tar acids.] | 284-892-9 | 84989-04-8 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-120-00-8 | Катранени киселини, метилфенолна фракция; | фенолни дестилати; | [Фракция на катранени киселини, богата на 3- и 4-метилфенол, извлечена от дестилация на сурови катранени киселини от нискотемпературен каменовъглен катран.] | 284-892-9 | 84989-04-8 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-121-00-3 | Tar acids, polyalkylphenol fraction; | Distillate Phenols; | [The fraction of tar acids, recovered by distillation of low-temperature coal tar crude tar acids, having an approximate boiling range of 225 oC to 320 oC (437oF to 608oF). Composed primarily of polyalkylphenols.] | 284-893-4 | 84989-05-9 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-121-00-3 | Катранени киселини, полиалкилфенолна фракция; | фенолни дестилати; | [Фракция на катранени киселини, извлечена чрез дестилация на сурови катранени киселини от нискотемпературен каменовъглен катран, с точка на кипене приблизително в интервала 225 oC—320 oC (437 oF—608 oF). Съставена основно от полиалкилфеноли.] | 284-893-4 | 84989-05-9 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-122-00-9 | Tar acids, xylenol fraction; Distillate Phenols; | [The fraction of tar acids, rich in 2,4-and 2,5-dimethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.] | 284-895-5 | 84989-06-0 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-122-00-9 | Катранени киселини, ксиленолна фракция; фенолни дестилати; | [Фракция на катранени киселини, богата на 2,4- и 2,5-диметилфенол, извлечена чрез дестилация на сурови катранени киселини от нискотемпературен каменовъглен катран.] | 284-895-5 | 84989-06-0 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-123-00-4 | Tar acids, ethylphenol fraction; Distillate Phenols; | [The fraction of tar acids, rich in 3-and 4-ethylphenol, recovered by distillation of low-temperature coal tar rude tar acids.] | 284-891-3 | 84989-03-7 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-123-00-4 | Катранени киселини, етилфенолна фракция; фенолни дестилати; | [Фракция на катранени киселини, богата на 3- и 4-етилфенол, получена при дестилация на сурови катранени киселини от нискотемпературен каменовъглен катран.] | 284-891-3 | 84989-03-7 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-124-00-X | Tar acids, 3,5-xylenol fraction; Distillate Phenols; | [The fraction of tar acids, rich in 3,5-dimethylphenol, recovered by distillation of low-temperature coal tar acids.] | 284-896-0 | 84989-07-1 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-124-00-X | Катранени киселини, 3,5-ксиленолна фракция; фенолни дестилати; | [Фракция на катранени киселини, богата на 3,5-диметилфенол, извлечена чрез дестилация на катранени киселини от нискотемпературен каменовъглен катран.] | 284-896-0 | 84989-07-1 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-125-00-5 | Tar acids, residues, distillates, first-cut; | Distillate Phenols; | [The residue from the distillation in the range of 235 oC to 355 oC (481oF to 697oF) of light carbolic oil.] | 270-713-1 | 68477-23-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-125-00-5 | Катранени киселини, остатъци, дестилати, първа фракция; | фенолни дестилати; | [Остатък от дестилация в интервала от 235 до 355oС (от 481oF до 697oF) на леко карболово масло.] | 270-713-1 | 68477-23-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-126-00-0 | Tar acids, cresylic, residues; Distillate Phenols; | [The residue from crude coal tar acids after removal of phenol, cresols, xylenols and any higher boiling phenols. A black solid with a melting point approximately 80 oC (176oF). Composed primarily of polyalkylphenols, resin gums, and inorganic salts.] | 271-418-0 | 68555-24-8 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-126-00-0 | Катранени киселини, крезилни, остатъци; фенолни дестилати; | [Остатък от сурови киселини от каменовъглен катран след отстраняване на фенола, крезолите, ксиленолите и всички феноли с по-висока точка на кипене. Черен твърд материал с точка на топене приблизително 80 oC (176 oF). Състои се основно от полиалкилфеноли, смолисти клейове и неорганични соли.] | 271-418-0 | 68555-24-8 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-127-00-6 | Phenols, C9-11; Distillate Phenols | 293-435-2 | 91079-47-9 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-127-00-6 | Феноли, C9-11; фенолни дестилати | 293-435-2 | 91079-47-9 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-128-00-1 | Tar acids, cresylic; Distillate Phenols; | [A complex combination of organic compounds obtained from brown coal and boiling in the range of approximately 200 oC to 230 oC (392oF to 446oF). It contains chiefly phenols and pyridine bases.] | 295-540-9 | 92062-26-5 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-128-00-1 | Катранени киселини, крезилни; фенолни дестилати; | [Сложна комбинация от органични съединения, получена от кафяви въглища, с точка на кипене в интервала приблизително 200 oC—230 oC (392 oF—446 oF). Състои се главно от феноли и пиридинови основи.] | 295-540-9 | 92062-26-5 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-129-00-7 | Tar acids, brown-coal, C2-alkylphenol fraction; | Distillate Phenols; | [The distillate from the acidification of alkaline washed lignite tar distillate boiling in the range of approximately 200 oC to 230 oC (392oF to 446oF). Composed primarily of m-and p-ethylphenol as well as cresols and xylenols.] | 302-662-9 | 94114-29-1 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-129-00-7 | Катранени киселини, кафяви въглища, C2-алкилфенолна фракция; | фенолни дестилати; | [Дестилат от подкиселяването на алкално промит дестилат на лигнитен катран, с точка на кипене в интервала приблизително 200 oC—230 oC (392 oF—446 oF). Съставен основно от m- и p-етилфенол, а също и крезоли и ксиленоли.] | 302-662-9 | 94114-29-1 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-130-00-2 | Extract oils (coal), naphthalene oils; | Acid Extract; | [The aqueous extract produced by an acidic wash of alkali- washed naphthalene oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.] | 292-623-1 | 90641-00-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-130-00-2 | Екстрактни масла (въглищни), нафталенови масла; | киселинен екстракт; | [Воден екстракт, получен от киселинно промиване на алкално промито нафталеново масло. Съставен основно от кисели соли на различни ароматни азотни основи, включително пиридин, хинолин и техните алкилови производни.] | 292-623-1 | 90641-00-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-131-00-8 | Tar bases, quinoline derivs.; Distillate Bases | 271-020-7 | 68513-87-1 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-131-00-8 | Катранени основи, хинолинови производни; дестилатни основи | 271-020-7 | 68513-87-1 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-132-00-3 | Tar bases, coal, quinoline derivs. fraction; | Distillate Bases | 274-560-1 | 70321-67-4 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-132-00-3 | Катранени основи, въглищни, фракция на хинолинови производни; | дестилатни основи | 274-560-1 | 70321-67-4 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-133-00-9 | Tar bases, coal, distn. residues; Distillate Bases; | [The distillation residue remaining after the distillation of the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of oal tars. I contains chiefly aniline, collidines, quinoline and quinoline derivatives and toluidines.] | 295-544-0 | 92062-29-8 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-133-00-9 | Катранени основи, въглищни, остатъци от дестилация; дестилатни основи; | [Остатък от дестилация на неутрализирани, извлечени с киселина основасъдържащи катранени фракции, получени от дестилация на каменовъглени катрани. Състои се главно от анилин, колидини, хинолин и хинолинови производни и толуидини.] | 295-544-0 | 92062-29-8 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-134-00-4 | Hydrocarbon oils, arom., mixed with polyethylene and polypropylene, pyrolyzed, light oil fraction; | Heat Treatment Products; [The oil obtained from the heat treatment of a polyethylene/ polypropylene reaction mass with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 oC to 120 oC (158 oF to 248 oF).] | 309-745-9 | 100801-63-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-134-00-4 | Въглеводородни масла, ароматни, смесени с полиетилен и полипропилен, пиролизирани, фракция леко масло; | продукти от топлинна обработка; [Масло, получено от топлинната обработка на реакционна маса от полиетилен/полипропилен и смола от каменовъглен катран или ароматни масла. Състои се предимно от бензен и неговите хомолози, с точка на кипене в интервала приблизително 70 oC—120 oC (158 oF—248 oF).] | 309-745-9 | 100801-63-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-135-00-X | Hydrocarbon oils, arom., mixed with polyethylene, pyrolyzed, light oil fraction; | Heat Treatment Products; | [The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of 70 oC to 120 oC (158oF to 248oF).] | 309-748-5 | 100801-65-8 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-135-00-X | Въглеводородни масла, ароматни, смесени с полиетилен, пиролизирани, фракция леко масло; | продукти от топлинна обработка; | [Масло, получено от топлинната обработка на полиетилен със смола от каменовъглен катран или ароматни масла. Състои се предимно от бензен и неговите хомолози, с точка на кипене в интервала 70 oC—120 oC (158 oF—248 oF).] | 309-748-5 | 100801-65-8 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-136-00-5 | Hydrocarbon oils, arom., mixed with polystyrene, pyrolyzed, light oil fraction; | Heat Treatment Products; | [The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils. | It consists predominantly of benzene and its homologs boiling in a range of approximately 70 oC to 210 oC (158 oF to 410oF).] | 309-749-0 | 100801-66-9 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-136-00-5 | Въглеводородни масла, ароматни, смесени с полистирен, пиролизирани, фракция леко масло; | продукти от топлинна обработка; | [Масло, получено от топлинната обработка на смес от полистирен и смола от каменовъглен катран или ароматни масла. | Състои се предимно от бензен и неговите хомолози, с точка на кипене в интервала приблизително 70 oC—210 oC (158 oF—410 oF).] | 309-749-0 | 100801-66-9 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-137-00-0 | Extract residues (coal), tar oil alk., naphthalene distn. residues; Naphthalene Oil Extract Residue; | [The residue obtained from chemical oil extracted after the removal of naphthalene by distillation composed primarily of two to four membered condensed ring aromatic hydrocarbons and aromatic nitrogen bases.] | 277-567-8 | 73665-18-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-137-00-0 | Остатъци от екстракция (въглищни), алкално катранено масло, остатъци от дестилация на нафтален; Остатък от екстракция на нафталеново масло; | [Остатък, получен от екстракцията на синтетично масло след отстраняването на нафталена чрез дестилация, съставен основно от ароматни въглеводороди с два до четири кондензирани пръстена и от ароматни азотни основи.] | 277-567-8 | 73665-18-6 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-138-00-6 | Creosote oil, low-boiling distillate; | Wash Oil; | [The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38 o C (100 oF).] | 274-566-4 | 70321-80-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-138-00-6 | Креозотно масло, дестилат с ниска точка на кипене; | промивно масло; | [Дестилационна фракция с ниска точка на кипене, получена чрез високотемпературно коксуване на битуминозни въглища, допълнително рафинирана за отстраняване на излишъка от кристални соли. Състои се основно от креозотно масло, като някои от нормално съдържащите се като компонент в дестилати на каменовъглен катран многопръстенни ароматни соли, са отстранени. Не съдържа кристали при приблизително 38 oC (100 oF).] | 274-566-4 | 70321-80-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-139-00-1 | Tar acids, cresylic, sodium salts, caustic solns.; Alkaline Extract | 272-361-4 | 68815-21-4 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-139-00-1 | Катранени киселини, крезилни, натриеви соли, разяждащи разтвори; алкален екстракт | 272-361-4 | 68815-21-4 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-140-00-7 | Extract oils (coal), tar base; Acid Extract; | [The extract from coal tar oil alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove naphthalene. Composed primarily of the acid salts of various aromatic nitrogen bases including pyridine, quinoline, and their alkyl derivatives.] | 266-020-9 | 65996-86-3 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-140-00-7 | Екстрактни масла (въглищни), катранена основа; киселинен екстракт; | [Екстракт от остатъка от алкална екстракция на масло от каменовъглен катран, получен от киселинно промиване, например с воден разтвор на сярна киселина, след дестилация за отстраняване на нафталена. Съставен основно от кисели соли на различни ароматни азотни основи, включително пиридин, хинолин и техните алкилови производни.] | 266-020-9 | 65996-86-3 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-141-00-2 | Tar bases, coal, crude; Crude Tar Bases; | [The reaction product obtained by neutralizing coal tar base extract oil with an alkaline solution, such as aqueous sodium hydroxide, to obtain the free bases. Composed primarily of such organic bases as acridine, phenanthridine, pyridine, quinoline and their alkyl derivatives.] | 266-018-8 | 65996-84-1 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM648-141-00-2 | Катранени основи, въглищни, сурови; сурови катранени основи; | [Продукт от реакцията на неутрализация на масло от основен екстракт от каменовъглен катран с алкален разтвор, например воден разтвор на натриев хидроксид, за получаване на свободни основи. Съставен основно от органични основи като акридин, фенантридин, пиридин, хинолин и техните алкилови производни.] | 266-018-8 | 65996-84-1 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | JM
648-142-00-8 | Residues (coal), liq. solvent extn.; | [A cohesive powder composed of coal mineral matter and undissolved coal remaining after extraction of coal by a liquid solvent.] | 302-681-2 | 94114-46-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-142-00-8 | Остатъци (каменовъглени) от екстракция с течен разтворител; | [Кохезивен прах, съдържащ минерални продукти от каменни въглища и неразтворени каменни въглища, след екстракция на въглища с течен разтворител.] | 302-681-2 | 94114-46-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-143-00-3 | Coal liquids, liq. solvent extn. soln.; | [The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. A black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydro-genated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.] | 302-682-8 | 94114-47-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-143-00-3 | Каменовъглени течни фракции, разтвор за екстракция с течен разтворител; | [Продукт, получен чрез филтруване на минерални продукти от каменни въглища и неразтворени каменни въглища от разтвора за екстракция на каменни въглища, получен чрез разтваряне на въглища в течен разтворител. Черна, вискозна, много сложна течна комбинация, състояща се главно от ароматни и частично хидрогенирани ароматни въглеводороди, ароматни азотни съединения, ароматни серни съединения, фенолни и други ароматни кислородни съединения и техните алкилови производни.] | 302-682-8 | 94114-47-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-144-00-9 | Coal liquids, liq. solvent extn.; [The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. A black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.] | 302-683-3 | 94114-48-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M648-144-00-9 | Каменовъглени течни фракции, екстракция с течен разтворител; [Продукт, практически без съдържание на разтворител, получен при дестилация на разтворителя от филтруван каменовъглен екстрактен разтвор, получен при разтваряне на каменни въглища с течен разтворител. Черен, полутвърд продукт, който се състои основно от сложна комбинация от ароматни въглеводороди с кондензирани пръстени, ароматни азотсъдържащи съединения, ароматни сярасъдържащи съединения, фенолни съединения и други ароматни кислородсъдържащи съединения, както и техните алкилови производни.] | 302-683-3 | 94114-48-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | M
648-145-00-4 | Tar brown-coal; | [An oil distilled from brown-coal tar. Composed primarily of aliphatic, naphthenic and one-to three-ring aromatic hydrocarbons, their alkyl derivates, heteroaromatics and one-and two-ring phenols boiling in the range of approximately 150oC to 360 oC (302oF to 680oF).] | 309-885-0 | 101316-83-0 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  648-145-00-4 | Катран, кафяви въглища; | [Дестилирано масло от катран от кафяви въглища. Състои се главно от алифатни, нафтенови и ароматни въглеводороди с един до три пръстена, техните алкилови производни, хетероароматни съединения и феноли с един и два пръстена, кипящи в обхвата от около 150 oС до 360 oС (302 oF до 680 oF).] | 309-885-0 | 101316-83-0 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  
648-146-00-X | Tar, brown-coal, low-temp.; | [A tar obtained from low temperature carbonization and low temperature gasification of brown coal. Composed primarily of aliphatic, naphthenic and cyclic aromatic hydrocarbons, heteroaromatic hydrocarbons and cyclic phenols.] | 309-886-6 | 101316-84-1 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  648-146-00-X | Катран, кафяви въглища, нискотемпературен; | [Катран, получен от нискотемпературна суха дестилация и нискотемпературна газификация на кафяви каменни въглища. Състои се главно от алифатни, нафтенови и циклични ароматни въглеводороди, хетероароматни въглеводороди и циклични феноли.] | 309-886-6 | 101316-84-1 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  
648-147-00-5 | Light oil (coal), coke-oven; Crude benzole; | [The volatile organic liquid extracted from the gas evolved in the high temperature (greater than 700 oC (1 292 oF)) destructive distillation of coal. Composed primarily of benzene, toluene, and xylenes. May contain other minor hydrocarbon constituents.] | 266-012-5 | 65996-78-3 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-147-00-5 | Леко масло (въглищно), коксови пещи; суров бензен; | [Летлива органична течност, екстрахирана от газ, получен при високотемпературна суха дестилация на въглища (над 700 oC (1292 oF). Съставен основно от бензен, толуен и ксилени. Възможно е да съдържа други въглеводородни съставки в незначителни количества.] | 266-012-5 | 65996-78-3 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-148-00-0 | Distillates (coal), liq. solvent extn., primary; | [The liquid product of condensation of vapors emitted during the digestion of coal in a liquid solvent and boiling in the range of approximately 30 oC to 300 oC 86 oF to 572 oF). | Composed primarily of partly hydrogenated condensed-ring aromatic hydrocarbons, aromatic compounds containing nitrogen, oxygen and sulfur, and their alkyl derivatives having carbon numbers predominantly in the range of C4 through C14.] | 302-688-0 | 94114-52-0 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-148-00-0 | Дестилати (въглищни), екстракция с течен разтворител, първични; | [Течен продукт от кондензацията на пари, отделени при разтварянето на въглища с течен разтворител и с температура на кипене в интервала приблизително от 30 oC до 300oС (86oF до 572oF). | Съставен основно от частично хидрогенирани ароматни въглеводороди с кондензирани пръстени, ароматни съединения, съдържащи азот, кислород и сяра, и техните алкилови производни с брой на въглеродните атоми предимно в интервала C4—C14.] | 302-688-0 | 94114-52-0 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-149-00-6 | Distillates (coal), solvent extn., hydrocracked; | [Distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 300o C (86 oF to 572 oF). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 through C14. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.] | 302-689-6 | 94114-53-1 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-149-00-6 | Дестилати (въглищни), екстракция с разтворител, хидрокрекирани; | [Дестилат, получен от хидрокрекинг на въглищен екстракт или разтвор, получен чрез процес на екстракция с течен разтворител или на газова екстракция в свръхкритични условия, с точка на кипене в интервала приблизително на 30 oC—300 oC (86 oF—572 oF). Съставен основно от ароматни, хидрогенирани ароматни и нафтенови съединения, техните алкилови производни и алкани с брой на въглеродните атоми предимно в интервала C4—C14. Присъстват също и азот-, сяра- и кислородсъдържащи ароматни и хидрогенирани ароматни съединения.] | 302-689-6 | 94114-53-1 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-150-00-1 | Naphtha (coal), solvent extn., hydrocracked; | [Fraction of the distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86oF to 356oF). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 to C9. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.] | 302-690-1 | 94114-54-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-150-00-1 | Нафта (въглищна), екстракция с разтворител, хидрокрекирана; | [Фракция на дестилат, получен при хидрокрекинг на каменовъглен екстракт или разтвор, получен при екстракция с течен разтворител или от процес на газова екстракция в свръхкритични условия, кипяща в интервала приблизително от 30 oC до 180 oC (86oF до 356oF). Съставена основно от ароматни, хидрогенирани ароматни и нафтенови съединения, техните алкилови производни и алкани с брой на въглеродните атоми предимно в интервала C4—C9. Присъстват също и азот-, сяра- и кислородсъдържащи ароматни и хидрогенирани ароматни съединения.] | 302-690-1 | 94114-54-2 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-151-00-7 | Gasoline, coal solvent extn., hydrocracked naphtha; | [Motor fuel produced by the reforming of the refined naphtha fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86 oF to 356oF). Composed primarily of aromatic and naphthenic hydrocarbons, their alkyl derivatives and alkyl hydrocarbons having carbon numbers in the range of C4 through C9.] | 302-691-7 | 94114-55-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  648-151-00-7 | Бензин, екстракция на каменни въглища с разтворител, хидрокрекинг на нафта; | [Моторно гориво, получено чрез риформинг процес на рафинираната нафтена фракция от продуктите от хидрокрекинг на екстракта на каменни въглища или разтвор, получен при екстракция с течен разтворител или чрез процес на газова екстракция в свръхкритични условия с температура на кипене в интервала приблизително от 30 oC до 180 oC (86oF до 356oF). Състои се главно от ароматни и нафтенови въглеводороди, техните алкилови производни и алкилови въглеводороди с брой на въглеродните атоми предимно в обхвата от C4 до C9.] | 302-691-7 | 94114-55-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
648-152-00-2 | Distillates (coal), solvent extn., hydrocracked middle; | [Distillate obtained from the hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 o C to 300 oC (356oF to 572oF. Composed primarily of two-ring aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes having carbon numbers predominantly in the range of C9 through C14. Nitrogen, sulfur and oxygen-containing compounds are also present.] | 302-692-2 | 94114-56-4 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-152-00-2 | Дестилати (въглищни), екстракция с разтворител, хидрокрекирани средни; | [Дестилат, получен при хидрокрекинг на каменовъглен екстракт или разтвор, получен чрез екстракция с течен разтворител или чрез процес на газова екстракция в свръхкритични условия, с температура на кипене в интервала приблизително от 180 oC до 300 oC (356 oF до 572 oF). Състои се основно от ароматни двупръстенни съединения, хидрогенирани ароматни и нафтенови съединения, техните алкилови производни и алкани с брой на въглеродните атоми преобладаващо в интервала от C9 до C14. Присъстват също и азот-, сяра- и кислородсъдържащи ароматни и хидрогенирани ароматни съединения.] | 302-692-2 | 94114-56-4 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-153-00-8 | Distillates (coal), solvent extn., hydrocracked hydrogenated middle; | [Distillate from the hydroge nation of hydrocracked middle distillate from coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 280 oC (356 F to 536oF). Composed primarily of hydrogenated two-ring carbon compounds and their alkyl derivatives having carbon numbers predominantly in the range of C9 through C14.] | 302-693-8 | 94114-57-5 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-153-00-8 | Дестилати (въглищни), екстракция с разтворител, хидрокрекирани хидрогенирани средни; | [Дестилат от хидрогениране на хидрокрекиран среден дестилат от каменовъглен екстракт или разтвор, получен при екстракция с течен разтворител или при процес на газова екстракция в свръхкритични условия, с температура на кипене в интервала приблизително от 180 oC до 280 oC (356 oF до 536 oF). Състои се главно от хидрогенирани двупръстенни въглеродни съединения и техните алкилови производни с брой на въглеродните атоми предимно в обхвата от C9 до C14.] | 302-693-8 | 94114-57-5 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
648-154-00-3 | Fuels, jet aircraft, coal solvent extn.,hydrocracked hydro genated; | [Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180oC to 225oC (356oF to 473oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C10 through C12.] | 302-694-3 | 94114-58-6 | Carc. 2 | H351 | GHS08 | Wng | H350 |   |   |  648-154-00-3 | Горива, реактивен двигател, екстракция на въглища с разтворител, от хидрокрекинг, хидрогенирани; | [Гориво за реактивен двигател, получено при хидрогениране на средната дестилатна фракция от продуктите от хидрокрекинга на каменовъглен екстракт или разтвор, получен чрез екстракция с течен разтворител или чрез процес на газова екстракция в свръхкритични условия, с температура на кипене в интервала приблизително от 180oС до 225oС (от 356oF до 473oF). Състои се основно от хидрогенирани двупръстенни въглеводороди и техните алкилови производни с брой на въглеродните атоми преобладаващо от C10 до C12.] | 302-694-3 | 94114-58-6 | Carc. 2 | H351 | GHS08 | Wng | H350 |   |   |  
648-155-00-9 | Fuels, diesel, coal solvent extn., hydrocracked hydrogenated; [Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200oC to 280oC (392oF to 536oF). Composed primarily of hydrogenated two-ring hydrocarbons andtheir alkylderivatives having carbon numbers predominantly in the range of C11 through C14.] | 302-695-9 | 94114-59-7 | Carc. 2 | H351 | GHS08 | Wng | H350 |   |   |  648-155-00-9 | Горива, дизелови, за дизелов двигател, екстракция на въглища с течен разтворител, от хидрокрекинг, хидрогенирани; [Гориво за дизелов двигател, получено при хидрогениране на средната дестилатна фракция от продуктите от хидрокрекинга на каменовъглен екстракт или разтвор, получен чрез екстракция с течен разтворител или чрез процес на газова екстракция в свръхкритични условия, с температура на кипене в интервала приблизително от 200 oC до 280oС (392oF до 536oF). Състои се основно от хидрогенирани двупръстенни въглеводороди и техните алкилови производни с брой на въглеродните атоми преобладаващо от C11 до C14.] | 302-695-9 | 94114-59-7 | Carc. 2 | H351 | GHS08 | Wng | H350 |   |   |  
648-156-00-4 | Light oil (coal), semi-coking process; Fresh oil; [The volatile organic liquid condensed from the gasevolved in the low-temperature (less than 700 oC (1 292 oF)) destructive distillation of coal. Composed primarily of C6-10 hydrocarbons.] | 292-635-7 | 90641-11-5 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J648-156-00-4 | Леко масло (въглищно), процес на полукоксуване; свежо масло; [Летлива органична течност, кондензирала от газа, получен при нискотемпературна (под 700 oС (1292 oF) суха дестилация на въглища. Съставена основно от C6—10 въглеводороди.] | 292-635-7 | 90641-11-5 | Carc. 1B Muta. 1B | H350 | H340 | GHS08 | Dgr | H350 | H340 |   |   | J
649-001-00-3 | Extracts (petroleum), light naphthenic distillate solvent | 265-102-1 | 64742-03-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-001-00-3 | Екстракти (нефт), лек нафтенов дестилатен разтворител | 265-102-1 | 64742-03-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-002-00-9 | Extracts (petroleum), heavy paraffinic distillate solvent | 265-103-7 | 64742-04-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-002-00-9 | Екстракти (нефт), тежък парафинов дестилатен разтворител | 265-103-7 | 64742-04-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-003-00-4 | Extracts (petroleum), light paraffinic distillate solvent | 265-104-2 | 64742-05-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-003-00-4 | Екстракти (нефт), лек парафинов дестилатен разтворител | 265-104-2 | 64742-05-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-004-00-X | Extracts (petroleum), heavy naphthenic distillate solvent | 265-111-0 | 64742-11-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-004-00-X | Екстракти (нефт), тежък нафтенов дестилатен разтворител | 265-111-0 | 64742-11-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-005-00-5 | Extracts (petroleum), light vacuum gas oil solvent | 295-341-7 | 91995-78-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-005-00-5 | Екстракти (нефт), разтворител от лек вакуумен газьол | 295-341-7 | 91995-78-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-006-00-0 | hydrocarbons C26-55, arom-rich | 307-753-7 | 97722-04-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-006-00-0 | въглеводороди C26-55, богати на ароматни въглеводороди | 307-753-7 | 97722-04-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-007-00-6 | fatty acids, tall-oil, reaction products with iminodiethanol and boric acid | 400-160-5 | — | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  649-007-00-6 | мастни киселини, тaлово масло, реакционни продукти с иминодиетанол и борна киселина | 400-160-5 | — | Skin Irrit. 2 | Aquatic Chronic 2 | H315 | H411 | GHS07 | GHS09 | Wng | H315 | H411 |   |   |  
649-008-00-1 | Residues (petroleum), atm. tower; | Heavy Fuel oil; | [A complex residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approxi mately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] | 265-045-2 | 64741-45-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-008-00-1 | Остатъци (нефт), от атмосферна колона за дестилация на нефт; | Тежко горивно масло; | [Сложен остатък от атмосферна дестилация на суров нефт. Състои се от въглеводороди с брой въглеродни атоми, предимно по-големи от C20 и кипящ над около 350 oC (662 oF). Тази фракция вероятно съдържа 5 или повече тегловни процента ароматни въглеводороди с 4 до 6 кондензирани пръстена.] | 265-045-2 | 64741-45-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-009-00-7 | Gas oils (petroleum), heavy vacuum; | Heavy Fuel oil; | [A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] | 265-058-3 | 64741-57-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-009-00-7 | Газьоли (нефт); тежки вакуумни; | Тежко горивно масло; | [Сложна комбинация от въглеводороди, получени при вакуумна дестилация на остатъка от атмосферната дестилация на суров нефт. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C20 до C50 и кипи в приблизителния температурен интервал от 350 oC до 600 oC (662 oF до 1112 oF)]. Тази фракция вероятно съдържа 5 или повече тегловни процента ароматни въглеводороди с 4 до 6 кондензирани пръстена.] | 265-058-3 | 64741-57-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-010-00-2 | Distillates (petroleum), heavy catalytic cracked; | Heavy Fuel oil; | [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260oC to 500oC (500oF to 932oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] | 265-063-0 | 64741-61-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-010-00-2 | Дестилати (нефт), тежки от каталитичен крекинг; | Тежко горивно масло; | [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от процес на каталитичен крекинг. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C15 до C35 и кипи в приблизителния температурен интервал от 260 oC до 500oС (500oF до 932oF). Тази фракция вероятно съдържа 5 или повече тегловни процента ароматни въглеводороди с 4 до 6 кондензирани пръстена.] | 265-063-0 | 64741-61-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-011-00-8 | Clarified oils (petroleum), catalytic cracked; | Heavy Fuel oil; | [A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350oC (662oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] | 265-064-6 | 64741-62-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-011-00-8 | Пречистени масла (нефтени), каталитично крекирани; | Тежко горивно масло; | [Комплексна комбинация от въглеводороди, получена като остатъчна фракция при дестилация на продукти от процес на каталитичен крекинг. Състои се от въглеводороди с брой въглеродни атоми, предимно по-голям от C20 и кипи над около 350 oC (662 oF). Тази фракция вероятно съдържа 5 или повече тегловни процента ароматни въглеводороди с 4 до 6 кондензирани пръстена.] | 265-064-6 | 64741-62-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-012-00-3 | Residues (petroleum), hydrocracked; Heavy Fuel oil; | [A complex combination of hydrocarbons produced as the residual fraction from distillation of the products of a hydrocracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approxi mately 350oC (662 oF).] | 265-076-1 | 64741-75-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-012-00-3 | Остатъци (нефт), от хидрокрекинг процес; Тежко горивно масло; | [Сложна комбинация от въглеводороди, получени като остатъчна фракция от дестилация на продуктите от процес на хидрокрекинг. Състои се от въглеводороди с брой въглеродни атоми, предимно по-голям от C20 и кипи над около 350 oC (662 oF).] | 265-076-1 | 64741-75-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-013-00-9 | Residues (petroleum), thermal cracked; Heavy Fuel oil; | [A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] | 265-081-9 | 64741-80-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-013-00-9 | Остатъци (нефт), от термичен крекинг; Тежко горивно масло; | [Сложна комбинация от въглеводороди, получени като остатъчна фракция от дестилация на продукта от процес на термичен крекинг. Състои се основно от ненаситени въглеводороди с брой въглеродни атоми, предимно по-голям от C20, и кипи над около 350 oC (662 oF). Тази фракция вероятно съдържа 5 или повече тегловни процента ароматни въглеводороди с 4 до 6 кондензирани пръстена.] | 265-081-9 | 64741-80-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-014-00-4 | Distillates (petroleum), heavy thermal cracked; | Heavy Fuel oil; | [A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C15 through C36 and boiling in the range of approximately 260oC to 480 oC (500 oF to 896 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] | 265-082-4 | 64741-81-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-014-00-4 | Дестилати (нефт), тежки от термичен крекинг; | Тежко горивно масло; | [Сложна комбинация от въглеводороди, получена при дестилацията на продукти от процес на термичен крекинг. Състои се основно от ненаситени въглеводороди с брой на въглеродните атоми основно в интервала от C15 до C36 и кипи в приблизителния температурен интервал от 260 oC до 480 oС (500oF до 896 oF). Тази фракция вероятно съдържа 5 или повече тегловни процента ароматни въглеводороди с 4 до 6 кондензирани пръстена.] | 265-082-4 | 64741-81-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-015-00-X | Gas oils (petroleum), hydro-treated vacuum; Heavy Fuel oil; | [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C50 and boiling in the range of approximately 230oC to 600oC (446 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] | 265-162-9 | 64742-59-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-015-00-X | Газьоли (нефт), обработени с водород, вакуумни; Тежко горивно масло; | [Сложна комбинация от въглеводороди, получена при обработване на нефтена фракция с водород в присъствие на катализатор. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C13 до C50 и кипи в приблизителния температурен интервал от 230 oC до 600 oC (446oF до 1112oF). Тази фракция вероятно съдържа 5 или повече тегловни процента ароматни въглеводороди с 4 до 6 кондензирани пръстена.] | 265-162-9 | 64742-59-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-016-00-5 | Residues (petroleum), hydrodesulfurized atmospheric tower; Heavy Fuel oil; | [A complex combination of hydrocarbons obtained by treating an atmospheric tower residuum with hydrogen in the presence of a catalyst under conditions primarily to remove organic sulfur compounds. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] | 265-181-2 | 64742-78-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-016-00-5 | Остатъци (нефт), хидродесулфурирани от атмосферна колона; Тежко горивно масло; | [Сложна комбинация от въглеводороди, получени от третирането на остатъка от атмосферна кула с водород в присъствието на катализатор при условия, главно насочени за отстраняването на сярасъдържащи органични съединения. Състои се основно от въглеводороди с брой въглеродни атоми, предимно по-голям от C20, и кипи над около 350 oC (662 oF). Тази фракция вероятно съдържа 5 или повече тегловни процента ароматни въглеводороди с 4 до 6 кондензирани пръстена.] | 265-181-2 | 64742-78-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-017-00-0 | Gas oils (petroleum), hydrodesulfurized heavy vacuum; Heavy Fuel oil; [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oC). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] | 265-189-6 | 64742-86-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-017-00-0 | Газьоли (нефт), хидродесулфурирани тежки вакуумни; Тежко горивно масло; [Сложна комбинация от въглеводороди, получена чрез процес на каталитична хидродесулфурация. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C20 до C50 и кипи в приблизителния температурен интервал от 350 oC до 600 oC (662 oF до 1112 oF). Тази фракция вероятно съдържа 5 или повече тегловни процента ароматни въглеводороди с 4 до 6 кондензирани пръстена.] | 265-189-6 | 64742-86-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-018-00-6 | Residues (petroleum), steam-cracked; | Heavy Fuel oil; | [A complex combination of hydrocarbons obtained as the residual fraction from the distillation of the products of a steam cracking process (including steam cracking to produce ethylene). It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C14 and boiling above approximately 260 oC (500 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-memberedcondensed ring aromatic hydrocarbons.] | 265-193-8 | 64742-90-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-018-00-6 | Остатъци (нефт), от паров крекинг процес; | Тежко горивно масло; | [Сложна комбинация от въглеводороди, получена като остатъчна фракция от дестилацията на продукти от процес на паров крекинг (включително и паров крекинг за производство на етилен). Състои се основно от ненаситени въглеводороди с брой въглеродни атоми, предимно по-голям от C14, и кипи над около 260 oC (500 oF). Тази фракция вероятно съдържа 5 или повече тегловни процента ароматни въглеводороди с 4 до 6 кондензирани пръстена.] | 265-193-8 | 64742-90-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-019-00-1 | Residues (petroleum), atmospheric; | Heavy Fuel oil; | [A complex residuum from atmospheric distillation of crude oil. | It consists of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approxi mately 200oC (392 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] | 269-777-3 | 68333-22-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-019-00-1 | Oстатъци (нефт), от атмосферна дестилация; | Тежко горивно масло; | [Сложен остатък от атмосферната дестилация на суров нефт. | Състои се от въглеводороди с брой въглеродни атоми, предимно по-голям от C11, и кипи над около 200 oC (392 oF). Тази фракция вероятно съдържа 5 или повече тегловни процента ароматни въглеводороди с 4 до 6 кондензирани пръстена.] | 269-777-3 | 68333-22-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-020-00-7 | Clarified oils (petroleum), hydrodesulfurized catalytic cracked; | Heavy Fuel oil; | [A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] | 269-782-0 | 68333-26-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-020-00-7 | Пречистени масла (нефт), хидродесулфурирани от каталитичен крекинг; | Тежко горивно масло; | [Сложна комбинация от въглеводороди, получена при обработката на каталитично крекирано пречистено масло с водород, с цел превръщане на органичната сяра във водороден сулфид, който след това се отстранява. Състои се от въглеводороди с брой въглеродни атоми, предимно по-голям от C20, и кипи над около 350 oC (662 oF). Тази фракция вероятно съдържа 5 или повече тегловни процента ароматни въглеводороди с 4 до 6 кондензирани пръстена.] | 269-782-0 | 68333-26-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-021-00-2 | Distillates (petroleum), hydrodesulfurized intermediate catalytic cracked; | Heavy Fuel oil; | [A complex combination of hydrocarbons obtained by treating intermediate catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.] | 269-783-6 | 68333-27-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-021-00-2 | Дестилати (нефт), хидродесулфурирани, междинни, от каталитичен крекинг; | Тежко горивно масло; | [Сложна комбинация от въглеводороди, получена при обработката на междинни каталитично крекирани дестилати с водород за превръщане на органичната сяра във водороден сулфид, който след това се отстранява. Състои се главно от въглеводороди с брой въглеродни атоми предимно в обхвата от C11 до C30 и кипи в обхвата от около 205 oC до 450 oC (401 oF до 842 oF). Съдържа от относително голямо количество трипръстенни ароматни въглеводороди.] | 269-783-6 | 68333-27-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-022-00-8 | Distillates (petroleum), hydrodesulfurized heavy catalytic cracked; | Heavy Fuel oil; | [A complex combination of hydrocarbons obtained by treatment of heavy catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260oC to 500 oC (500oF to 932oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] | 269-784-1 | 68333-28-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-022-00-8 | Дестилати (нефт), хидродесулфурирани, тежки, от каталитичен крекинг; | Тежко горивно масло; | [Сложна комбинация от въглеводороди, получена при обработката на тежки каталитично крекирани дестилати с водород за превръщане на органичната сяра във водороден сулфид, който след това се отстранява. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C15 до C35 и кипи в приблизителния температурен интервал от 260 oC до 500oС (500oF до 932oF). Тази фракция вероятно съдържа 5 или повече тегловни процента ароматни въглеводороди с 4 до 6 кондензирани пръстена.] | 269-784-1 | 68333-28-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-023-00-3 | Fuel oil, residues-straight-run gas oils, high-sulfur; | Heavy Fuel oil | 270-674-0 | 68476-32-4 | Carc. 1B | H350 | HS08 | Dgr | H350 |   |   |  649-023-00-3 | Горивно масло, остатъци, газьоли от пряка дестилация с високо съдържание на сяра; | Тежко горивно масло; | 270-674-0 | 68476-32-4 | Carc. 1B | H350 | HS08 | Dgr | H350 |   |   |  
649-024-00-9 | Fuel oil, residual; Heavy Fuel oil; | [The liquid product from various refinery streams, usually residues. The composition is complex and varies with the source of the crude oil.] | 270-675-6 | 68476-33-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-024-00-9 | Горивно масло, остатък; Тежко горивно масло; | [Течен продукт от различни фракции от рафиниране, обичайно остатъци. Съставът е сложен и варира в зависимост от източника на суровия нефт.] | 270-675-6 | 68476-33-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-025-00-4 | Residues (petroleum), catalytic reformer fractionator residue distn.; | Heavy Fuel oil; | [A complex residuum from the distillation of catalytic reformer fractionator residue. It boils approximately above 399oC (750oF).] | 270-792-2 | 68478-13-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-025-00-4 | Остатъци (нефтени), дестилация на остатъка от фракционатора на каталитичен риформинг; | Тежко горивно масло; | [Сложен остатък от дестилацията на остатъка от фракционатора на каталитичен риформинг. Има температура на кипене приблизително над 399oС (750oF).] | 270-792-2 | 68478-13-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-026-00-X | Residues,(petroleum), heavy coker gas oil and vacuum gas oil; | Heavy Fuel oil; | [A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and vacuum gas oil. It predomi nantly consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).] | 270-796-4 | 68478-17-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-026-00-X | Остатъци (нефт), тежък газьол от коксуване и вакуумен газьол; | Тежко горивно масло; | [Сложна комбинация от въглеводороди, получени като остатъчна фракция при дестилацията на тежък коксов газьол и вакуумен газьол. Състои се основно от въглеводороди с брой въглеродни атоми, предимно по-голям от C13, и кипи над около 230 oC (446oF).] | 270-796-4 | 68478-17-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-027-00-5 | Residues (petroleum), heavy coker and light vacuum; | Heavy Fuel oil; | [A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and light vacuum gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).] | 270-983-0 | 68512-61-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-027-00-5 | Остатъци (нефт), тежък газьол от коксуване и лек вакуумен газьол; | Тежко горивно масло; | [Сложна комбинация от въглеводороди, получени като остатъчна фракция при дестилацията на тежък газьол от коксуване и лек вакуумен газьол. Състои се основно от въглеводороди с брой въглеродни атоми, предимно по-голям от C13, и кипи над около 230 oC (446oF).] | 270-983-0 | 68512-61-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-028-00-0 | Residues(petroleum), light vacuum; | Heavy Fuel oil; [A complex residuum from the vacuum distillation of the residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).] | 270-984-6 | 68512-62-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-028-00-0 | Остатъци (нефт), леки вакуумни; | Тежко горивно масло; [Сложен остатък от вакуумната дестилация на остатъка от атмосферната дестилация на суров нефт. Състои се главно от въглеводороди с брой въглеродни атоми предимно по-голям от C13 и кипи над около 230 oC (446 oF)] | 270-984-6 | 68512-62-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-029-00-6 | Residues (petroleum), steam-cracked light; | Heavy Fuel oil; | [A complex residuum from the distillation of the products from a steam-cracking process. It consists predominantly of aromatic and unsaturated hydrocarbons having carbon numbers greater than C7 and boiling in the range of approximately 101oC to 555 oC (214 oF to 1030oF).] | 271-013-9 | 68513-69-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-029-00-6 | Остатъци (нефт), от паров крекинг, леки; | Тежко горивно масло; | [Сложен остатък от дестилация на продукти от процес на паров крекинг. Състои се главно от ароматни и ненаситени въглеводороди с брой въглеродни атоми по-голям от C7 и кипи в обхвата от около 101 oC до 555 oC (214 oF до 1030 oF).] | 271-013-9 | 68513-69-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-030-00-1 | Fuel oil, No 6; Heavy Fuel oil; | [A distillate oil having a minimum viscosity of 900 SUS at 37.7 oC (100 oF) to a maximum of 9000 SUS at 37.7 oC (100 oF).] | 271-384-7 | 68553-00-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-030-00-1 | Горивно масло, № 6; Тежко горивно масло; | [Маслен дестилат с минимален вискозитет 900 SUS при 37,7 oC (100oF) до максимален вискозитет 9000 SUS при 37,7 oC (100oF).] | 271-384-7 | 68553-00-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-031-00-7 | Residues (petroleum), topping plant, low-sulfur; | Heavy Fuel oil; | [A low-sulfur complex combination of hydrocarbons produced as the residual fraction from the topping plant distillation of crude oil. It is the residuum after the straight-run gasoline cut, kerosene cut and gas oil cut have been removed.] | 271-763-7 | 68607-30-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-031-00-7 | Остатъци (нефт), от инсталация за отбензинване на нефта, ниско съдържание на сяра; | Тежко горивно масло; | [Сложна комбинация от въглеводороди с ниско съдържание на сяра, получени като остатъчната фракция от дестилация на суров нефт в инсталация за обезбензинване. Това е отатъкът след отстраняването на бензиновата, керосиновата и газьоловата фракция от пряката дестилация.] | 271-763-7 | 68607-30-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-032-00-2 | Gas oils (petroleum), heavy atmospheric; | Heavy Fuel oil; | [A complex combination of hydrocarbons obtained by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C35 and boiling in the range of approximately 121oC to 510 oC (250 oF to 950oF).] | 272-184-2 | 68783-08-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-032-00-2 | Газьоли (нефт), тежки, от атмосферна дестилация; | Тежко горивно масло; | [Сложна комбинация от въглеводороди, получени от дестилацията на суров нефт. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C7 до C35 и кипи в приблизителния температурен интервал от 121 oC до 510 oC (250oF до 950oF).] | 272-184-2 | 68783-08-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-033-00-8 | Residues(petroleum), coker scrubber, Condensed-ring-arom.-contg.; Heavy Fuel oil; [A very complex combination of hydrocarbons produced as the residual fraction from the distillation of vaccum residuum and the products from a thermal cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt.% or more of 4-to 6-membered condensed rind aromatic hydrocarbons.] | 272-187-9 | 68783-13-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-033-00-8 | Остатъци (нефт), коксов скрубер, съдържащи ароматни съединения с кондензирани пръстени; Тежко горивно масло; [Много сложна комбинация от въглеводороди, получени като остатъчна фракция при дестилацията на вакуумни остатъци и продукти от термично крекиране. Състои се основно от въглеводороди с брой въглеродни атоми, предимно по-голям от C20, и кипи над около 350 oC (662 oF). Тази фракция вероятно съдържа 5 или повече тегловни процента ароматни въглеводороди с 4 до 6 кондензирани пръстена.] | 272-187-9 | 68783-13-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-034-00-3 | Distillates (petroleum), petroleum residues vacuum; Heavy Fuel oil; | [A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from the atmospheric distillation of crude oil.] | 273-263-4 | 68955-27-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-034-00-3 | Дестилати (нефт), вакуумни нефтени остатъци; Тежко горивно масло; | [Сложна комбинация от въглеводороди, получена при вакуумната дестилация на остатъка от атмосферната дестилация на суров нефт.] | 273-263-4 | 68955-27-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-035-00-9 | Residues (petroleum), steam-cracked, resinous; | Heavy Fuel oil; | [A complex residuum from the distillation of steam-cracked petroleum residues.] | 273-272-3 | 68955-36-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-035-00-9 | Остатъци (нефт), от паров крекинг, смолообразни | Тежко горивно масло; | [Сложен остатък от дестилацията на нефтени остатъци от паров крекинг.] | 273-272-3 | 68955-36-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-036-00-4 | Distillates (petroleum), intermediate vacuum; | Heavy Fuel oil; | [A complex combination of hydrocarbons produced by the vacuum, distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C14 through C42 and boiling in the range of approximately 250oC to 545oC (482oF to 1013oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] | 274-683-0 | 70592-76-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-036-00-4 | Дестилати (нефт), междинни вакуумни; | Тежко горивно масло; | [Сложна комбинация от въглеводороди, получени при вакуумна дестилация на остатъка от атмосферната дестилация на суров нефт. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C14 до C42 и с температура на кипене приблизително в интервала от 250 до 545 oC (482oF до 1013oF). Тази фракция вероятно съдържа 5 или повече тегловни процента ароматни въглеводороди с 4 до 6 кондензирани пръстена.] | 274-683-0 | 70592-76-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-037-00-X | Distillates (petroleum), light vacuum; | Heavy Fuel oil; | [A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C35 and boiling in the range of approximately 250 oC to 545oC (482oF to 1013 oF).] | 274-684-6 | 70592-77-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-037-00-X | Дестилати (нефт), леки вакуумни; | Тежко горивно масло; | [Сложна комбинация от въглеводороди, получени при вакуумна дестилация на остатъка от атмосферната дестилация на суров нефт. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C11 до C35 и кипи в обхвата от около 250 oC до 545 oC (482 oF до 1013 oF).] | 274-684-6 | 70592-77-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-038-00-5 | Distillates (petroleum), vacuum; Heavy Fuel oil; | [A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having numbers predominantly in the range of C15 through C50 and boiling in the range of approximately 270 oC to 600 oC (518oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] | 274-685-1 | 70592-78-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-038-00-5 | Дестилати (нефт), вакуумни; Тежко горивно масло; | [Сложна комбинация от въглеводороди, получени при вакуумна дестилация на остатъка от атмосферната дестилация на суров нефт. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C15 до C50 и с температура на кипене приблизително в интервала от 270 oC до 600 oC (518oF до 1112oF). Тази фракция вероятно съдържа 5 или повече тегловни процента ароматни въглеводороди с 4 до 6 кондензирани пръстена.] | 274-685-1 | 70592-78-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-039-00-0 | Gas oils (petroleum), hydrodesulfurized coker heavy vacuum; Heavy Fuel oil; | [A complex combination of hydrocarbons obtained by hydrodesulfurization of heavy coker distillate stocks, It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C18 to C44 and boiling in the range of approximately 304oC to 548oC (579oF to 1018oF). Likely to contain 5 % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] | 285-555-9 | 85117-03-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-039-00-0 | Газьоли (нефт), хидродесулфурирани тежки вакуумни, от коксуване; Тежко горивно масло; | [Сложна комбинация от въглеводороди, получени чрез хидродесулфурация на тежки дестилатни остатъци от коксови пещи. Състои се основно от въглеводороди с брой на въглеродните атоми основно в интервала от C18 до C44 и с температура на кипене приблизително в интервала от 304 oC до 548 oC (579oF до 1018oF). Може да съдържа 5 или повече тегловни процента ароматни въглеводороди с 4 до 6 кондензирани пръстена.] | 285-555-9 | 85117-03-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-040-00-6 | Residues (petroleum), steam-cracked, distillates; | Heavy Fuel oil; | [A complex combination of hydrocarbons obtained during the production of refined petroleum tar by the distillation of steam cracked tar. It consists predominantly of aromatic and other hydrocarbons and organic sulfur compounds.] | 292-657-7 | 90669-75-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-040-00-6 | Остатъци (нефтени), дестилати от крекинг с пара; | Тежко горивно масло; | [Сложна комбинация от въглеводороди, получена при производството на обогатени нефтени катрани чрез дестилация на катран, обработен чрез паров крекинг. Състои се основно от ароматни и други въглеводороди и органични серни съединения.] | 292-657-7 | 90669-75-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-041-00-1 | Residues (petroleum), vacuum, light; | Heavy Fuel oil; | [A complex residuum from the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C24 and boiling above approximately 390 oC (734 oF).] | 292-658-2 | 90669-76-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-041-00-1 | Остатъци (нефтени) леки вакуумни; | Тежко горивно масло; | [Сложен остатък от вакуумната дестилация на остатъци от атмосферна дестилация на суров нефт. Състои се основно от въглеводороди с брой въглеродни атоми предимно по-голям от C24, и кипи над около 390 oC (734 oF).] | 292-658-2 | 90669-76-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-042-00-7 | Fuel oil, heavy, high-sulfur; Heavy Fuel oil; | [A complex combination of hydrocarbons obtained by the distillation of crude petroleum. It consists predominantly of aliphatic, aromatic and cycloaliphatic hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).] | 295-396-7 | 92045-14-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-042-00-7 | Тежки горивни масла с високо съдържание на сяра; Тежко горивно масло; | [Сложна комбинация от въглеводороди, получена при дестилация на суров нефт. Състои се основно от алифатни, ароматни и циклоалифатни въглеводороди с брой въглеродни атоми предимно по-голям от C25, с точка на кипене над 400 oC (752oF).] | 295-396-7 | 92045-14-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-043-00-2 | Residues (petroleum), catalytic cracking; | Heavy Fuel oil; | [A complex combination of hydrocarbons produced as the residual fraction from the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200oC (392oF).] | 295-511-0 | 92061-97-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-043-00-2 | Остатъци (нефтени) от каталитичен крекинг; | Тежко горивно масло; | [Сложна комбинация от въглеводороди, получени като остатъчна фракция от дестилацията на продукти, получени при каталитичен крекинг. Състои се основно от въглеводороди с брой въглеродни атоми предимно по-голям от C11, и кипи над около 200 oC (392oF).] | 295-511-0 | 92061-97-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-044-00-8 | Distillates (petroleum), intermediate catalytic cracked, thermally degraded; | Heavy Fuel oil; | [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 220 oC to 450 C (428 oF to 842 oF). This stream is likely to contain organic sulfur compounds.] | 295-990-6 | 92201-59-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-044-00-8 | Дестилати (нефтени), междинни, от каталитичен крекинг, термично разградени; | Тежко горивно масло; | [Сложна комбинация от въглеводороди, получени чрез дестилация на продукти от каталитичен крекинг процес, използвани като топлопреносен флуид. Състои се главно от въглеводороди, кипящи в обхвата от около 220 oC до 450 oC (428 oF до 842 oF). Тази фракция вероятно съдържа органични серни съединения.] | 295-990-6 | 92201-59-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-045-00-3 | Residual oils (petroleum); Heavy Fuel oil; | [A complex combination of hydrocarbons, sulfur compounds and metal-containing organic compounds obtained as the residue from refinery fractionation cracking processes. It produces a finished oil with a viscosity above 2cSt. at 100 oC.] | 298-754-0 | 93821-66-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-045-00-3 | Остатъчни масла (нефт); Тежко горивно масло; | [Сложна комбинация от въглеводороди, серни съединения и металсъдържащи органични съединения, получени като остатък от крекинг процеси в рафинерийни фракционатори. Получава се крайно масло с вискозитет над 2 cSt. при 100 oC).] | 298-754-0 | 93821-66-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-046-00-9 | Residues, steam cracked, thermally treated; | Heavy Fuel oil; | [A complex combination of hydrocarbons obtained by the treatment and distillation of raw steam-cracked naphtha. It consists predominantly of unsaturated hydrocarbons boiling in the range above approximately 180oC (356oF).] | 308-733-0 | 98219-64-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-046-00-9 | Термично обработени, крекирани с пара остатъци; | Тежко горивно масло; | [Сложна комбинация от въглеводороди, получени от обработката и дестилацията на сурова крекирана с пара нафта. Състои се главно от ненаситени въглеводороди, кипящи в обхвата над около 180 oC (356 oF).] | 308-733-0 | 98219-64-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-047-00-4 | Distillates (petroleum), hydrodesulfurized full-range middle; Heavy Fuel oil; | [A complex combination of hydrocarbons obtained by treating a petroleum stock with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150oC to 400oC (302 oF to 752 oF).] | 309-863-0 | 101316-57-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-047-00-4 | Дестилати (нефт), хидродесулфурирани, кипящи в широк обхват, средни; Тежко горивно масло; | [Сложна комбинация от въглеводороди, получени от обработката на нефтена суровина с водород. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C9 до C25, и с температура на кипене приблизително в интервала от 150 oC до 400 oC (302oF до 752oF).] | 309-863-0 | 101316-57-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-048-00-X | Residues (petroleum), catalytic reformer fractionator; | Heavy Fuel oil; | [A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C25 and boiling in the range of approximately 160 oC to 400oC (320 oF to 725 oF). This stream is likely to contain 5 wt. % or more of 4-or 6-membered condensed ring aromatic hydrocarbons.] | 265-069-3 | 64741-67-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-048-00-X | Остатъци (нефт), от дестилационната колона (фракционатор) на каталитичен риформинг; | Тежко горивно масло; | [Сложна комбинация от въглеводороди, получени като остатъчна фракция от дестилация на продукти чрез каталитичен риформинг. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C10 до C25, с температура на кипене приблизително в интервала от 160 oC до 400 oC (320oF до 725oF). Тази фракция вероятно съдържа 5 или повече тегловни процента ароматни въглеводороди с 4 или 6 кондензирани пръстена.] | 265-069-3 | 64741-67-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-049-00-5 | Petroleum; Crude oil; | [A complex combination of hydrocarbons, It consists predominantly of aliphatic, alicyclic and aromatic hydrocarbons. It may also contain small amounts of nitrogen, oxygen and sulfur compounds. This category encompasses light, medium, and heavy petroleums, as well as the oils extended from tar sands. Hydrocarbonaceous materials requiring major chemical changes for their recovery or conversion to petroleum refinery feedstocks such as crude shale oils; upgraded shale oils and liquid coal fuels are not included in this definition.] | 232-298-5 | 8002-05-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-049-00-5 | Нефт; Суров нефт; | [Сложна комбинация от въглеводороди. Състои се основно от алифатни, алициклични и ароматни въглеводороди. Възможно е да съдържа малки количества от азотни, кислородни и серни съединения. Тази категория включва леки, средни и тежки нефтени, а също и екстрактни масла от катрани. Материали, съдържащи въглеводороди и изискващи основни химически промени за тяхното извличане или преобразуване до суровини за нефтена рафинерия, като сурови шистови масла; подобрените шистови масла и течните каменовъглени горива не се включват в това определение.] | 232-298-5 | 8002-05-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-050-00-0 | Distillates (petroleum), light paraffinic; | Unrefined or mildly refined baseoil; | [A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons normally present in this distillation range of crude oil.] | 265-051-5 | 64741-50-0 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  649-050-00-0 | Дестилати (нефт), леки парафинови; | Нерафинирано базово масло или базово масло, рафинирано при меки условия; | [Сложна комбинация от въглеводороди, получени при вакуумна дестилация на остатък от атмосферна дестилация на суров нефт. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C15 до C30, като от нея се получава крайно масло с вискозитет по-нисък от 100 SUS при 100 oF (19cSt при 40 oC). Съдържа относително голяма част наситени алифатни въглеводороди, нормално налични в този дестилационен обхват на суровия нефт.] | 265-051-5 | 64741-50-0 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  
649-051-00-6 | Distillates(petroleum), heavy paraffinic; | Unrefined ormildly refined baseoil; [A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons.] | 265-052-0 | 64741-51-1 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  649-051-00-6 | Дестилати (нефт), тежки парафинови; | Нерафинирано базово масло или базово масло, рафинирано при меки условия; [Сложна комбинация от въглеводороди, получени при вакуумна дестилация на остатък от атмосферна дестилация на суров нефт. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C20 до C50, като от нея се получава крайно масло с вискозитет не по-нисък 100 SUS при 100oF (19cSt при 40 oC). Съдържа относително голяма част от наситени алифатни въглеводороди.] | 265-052-0 | 64741-51-1 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  
649-052-00-1 | Distillates (petroleum), light naphthenic; | Unrefined or mildly refined baseoil; | [A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-053-6 | 64741-52-2 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  649-052-00-1 | Дестилати (нефт), леки нафтенови; | Нерафинирано базово масло или базово масло, рафинирано при меки условия; | [Сложна комбинация от въглеводороди, получени при вакуумна дестилация на остатък от атмосферна дестилация на суров нефт. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C15 до C30, като от нея се получава крайно масло с вискозитет по-нисък от 100 SUS при 100 oF (19cSt при 40 oC). Съдържа относително малко количество нормални парафини.] | 265-053-6 | 64741-52-2 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  
649-053-00-7 | Distillates (petroleum), heavy naphthenic; | Unrefined or mildly refined baseoil; | [A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-054-1 | 64741-53-3 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  649-053-00-7 | Дестилати (нефт), тежки нафтенови; | Нерафинирано базово масло или базово масло, рафинирано при меки условия; | [Сложна комбинация от въглеводороди, получени при вакуумна дестилация на остатък от атмосферна дестилация на суров нефт. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C20 до C50, като от нея се получава крайно масло с вискозитет не по-нисък 100 SUS при 100oF (19cSt при 40 oC). Съдържа относително малко количество нормални парафини.] | 265-054-1 | 64741-53-3 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  
649-054-00-2 | Distillates (petroleum), acid-treated heavy naphthenic; Unrefined or mildly refined baseoil; | [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-117-3 | 64742-18-3 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  649-054-00-2 | Дестилати (нефт), обработени с киселина, тежки нафтенови; Нерафинирано базово масло или базово масло, рафинирано при меки условия; | [Сложна комбинация от въглеводороди, получена като рафинат от процес на обработване със сярна киселина. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C20 до C50, като от нея се получава крайно масло с вискозитет не по-нисък 100 SUS при 100oF (19cSt при 40 oC). Съдържа относително малко количество нормални парафини.] | 265-117-3 | 64742-18-3 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  
649-055-00-8 | Distillates (petroleum), acid-treated light naphthenic; Unrefined or mildly refined baseoil; | [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-118-9 | 64742-19-4 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  649-055-00-8 | Дестилати (нефт), обработени с киселина, леки нафтенови; Нерафинирано базово масло или базово масло, рафинирано при меки условия; | [Сложна комбинация от въглеводороди, получена като рафинат от процес на обработване със сярна киселина. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C15 до C30, като от нея се получава крайно масло с вискозитет по-нисък от 100 SUS при 100 oF (19cSt при 40 oC). Съдържа относително малко количество нормални парафини.] | 265-118-9 | 64742-19-4 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  
649-056-00-3 | Distillates (petroleum), acid-treated heavy paraffinic; Unrefined or mildly refined baseoil; | [A complex combination of hydrocarbons btained as a raffinate from a sulfuric acid process. It consists predomi nantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of a least 100 SUS at 100oF (19cSt at 40 oC).] | 265-119-4 | 64742-20-7 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  649-056-00-3 | Дестилати (нефт), обработени с киселина, тежки парафинови; Нерафинирано базово масло или базово масло, рафинирано при меки условия; | [Сложна комбинация от въглеводороди, получена като рафинат от обработка със сярна киселина. Състои се основно от наситени въглеводороди с брой на въглеродните атоми основно в интервала от C20 до C50, като от нея се получава крайно масло с вискозитет не по-нисък 100 SUS при 100oF (19cSt при 40 oC).] | 265-119-4 | 64742-20-7 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  
649-057-00-9 | Distillates (petroleum), acid-treated light paraffinic; Unrefined or mildly refined baseoil; | [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oi having aviscosity of less than 100 SUS at 100 oF (19cSt at 40oC).] | 265-121-5 | 64742-21-8 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  649-057-00-9 | Дестилати (нефт), обработени с киселина, леки парафинови; Нерафинирано базово масло или базово масло, рафинирано при меки условия; | [Сложна комбинация от въглеводороди, получена като рафинат от процес на обработване със сярна киселина. Състои се основно от наситени въглеводороди с брой на въглеродните атоми основно в интервала от C15 до C30, като от нея се получава крайно масло с вискозитет по-нисък от 100 SUS при 100 oF (19cSt при 40 oC).] | 265-121-5 | 64742-21-8 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  
649-058-00-4 | Distillates (petroleum), chemically neutralized heavy paraffinic; | Unrefined or mildly refined baseoil; | [A complex combination of hydrocarbons obtained from a treating proces to remove acidic materials. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of aliphatic hydrocarbons.] | 265-127-8 | 64742-27-4 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  649-058-00-4 | Дестилати (нефт), химично неутрализирани, тежки парафинови; | Нерафинирано базово масло или базово масло, рафинирано при меки условия; | [Сложна комбинация от въглеводороди, получена вследствие използване на метод за отстраняване на киселинните материали. Състои се основно от въглеводороди с брой на въглеродните атоми основно в интервала от C20 до C50, като от нея се получава крайно масло с вискозитет не по-нисък 100 SUS при 100oF (19cSt при 40 oC). Съдържа относително голяма част алифатни въглеводороди.] | 265-127-8 | 64742-27-4 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  
649-059-00-X | Distillates (petroleum), chemically neutralized light paraffinic; | Unrefined or mildly refined baseoil; | [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC).] | 265-128-3 | 64742-28-5 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  649-059-00-X | Дестилати (нефт), химично неутрализирани, леки парафинови; | Нерафинирано базово масло или базово масло, рафинирано при меки условия; | [Сложна комбинация от въглеводороди, получена при процес на обработване за отстраняване на киселинните материали. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C15 до C30, като от нея се получава крайно масло с вискозитет по-нисък от 100 SUS при 100 oF (19cSt при 40 oC).] | 265-128-3 | 64742-28-5 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  
649-060-00-5 | Distillates (petroleum), chemically neutralized heavy naphthenic; | Unrefined or mildly refined baseoil; | [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-135-1 | 64742-34-3 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  649-060-00-5 | Дестилати (нефт), химично неутрализирани тежки нафтенови; | Нерафинирано базово масло или базово масло, рафинирано при меки условия; | [Сложна комбинация от въглеводороди, получена при процес на обработване за отстраняване на киселинните материали. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C20 до C50, като от нея се получава крайно масло с вискозитет не по-нисък 100 SUS при 100oF (19cSt при 40 oC). Съдържа относително малко количество нормални парафини.] | 265-135-1 | 64742-34-3 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  
649-061-00-0 | Distillates (petroleum), chemically neutralized light naphthenic; | Unrefined or mildly refined baseoil; | [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS a 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-136-7 | 64742-35-4 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  649-061-00-0 | Дестилати (нефт), химично неутрализирани леки нафтенови; | Нерафинирано базово масло или базово масло, рафинирано при меки условия; | [Сложна комбинация от въглеводороди, получена при процес на обработване за отстраняване на киселинните материали. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C15 до C30, като от нея се получава крайно масло с вискозитет по-нисък от 100 SUS при 100 oF (19cSt при 40 oC). Съдържа относително малко количество нормални парафини.] | 265-136-7 | 64742-35-4 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  
649-062-00-6 | Gases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free; Petroleum gas; | [A complex combination of hydrocarbons obtained from fractionation of catalytic cracked hydrocarbons and treated to remove acidic impurities. It consists of hydrocarbons having carbon numbers in the range of C2 through C4, predominantly C3.] | 270-755-0 | 68477-73-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-062-00-6 | Газове (нефтени), горната фракция от депропанатор за каталитично крекирана нафта, богати на C3, без съдържание на киселини; нефтен газ; | [Сложна комбинация от въглеводороди, получена чрез фракциониране на каталитично крекирани въглеводороди и обработена за отстраняване на киселинните онечиствания. Състои се от въглеводороди с брой въглеродни атоми в интервала от C2 до C4, с преобладаване на C3.] | 270-755-0 | 68477-73-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-063-00-1 | Gases (petroleum), catalytic cracker; | Petroleum gas; | [A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 270-756-6 | 68477-74-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-063-00-1 | Газове (нефтени), от каталитичен крекинг | нефтен газ; | [Сложна комбинация от въглеводороди, получени при дестилация на продукти от процес на каталитичен крекинг. Състои се основно от алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C6.] | 270-756-6 | 68477-74-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-064-00-7 | Gases (petroleum), catalytic cracker, C1-5-rich; | Petroleum gas; | [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of aliphatic hydro carbons having carbon numbers in the range of C1 through C6, predominantly C1 through C5.] | 270-757-1 | 68477-75-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-064-00-7 | Газове (нефтени), от каталитичен крекинг, богати на C1-5; | нефтен газ; | [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от процес на каталитичен крекинг. Състои се от алифатни въглеводороди с брой на въглеродните атоми в интервала от C1 до C6, основно от C1 до C5.] | 270-757-1 | 68477-75-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-065-00-2 | Gases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich; | Petroleum gas; | [A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic polymerized naphtha. It consists of aliphatic hydrocarbons having carbon numbers in the range of C2 through C6, predominantly C2 through C4.] | 270-758-7 | 68477-76-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-065-00-2 | Газове (нефтени), каталитично полимеризирана горна фракция от стабилизатор за нафта, богати на C2-4; | нефтен газ; | [Сложна комбинация от въглеводороди, получени от стабилизация чрез фракциониране на каталитично полимеризирана нафта. Състои се от алифатни въглеводороди с брой на въглеродните атоми в интервала от C2 до C6, основно от C2 до C4.] | 270-758-7 | 68477-76-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-066-00-8 | Gases (petroleum), catalytic reformer, C1-4-rich; | Petroleum gas; | [A complex combination of hydrocarbons produced by distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C4.] | 270-760-8 | 68477-79-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-066-00-8 | Газове (нефтени), от каталитичен риформинг, богати на C1-4; | нефтен газ; | [Сложна комбинация от въглеводороди, получени при дестилация на продукти от процес на каталитичен риформинг. Състои се от въглеводороди с брой на въглеродните атоми в интервала от C1 до C6, основно от C1 до C4.] | 270-760-8 | 68477-79-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-067-00-3 | Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed; Petroleum gas; | [A complex combination of olefinic and paraffinic hydrocarbons having carbon numbers in the range of C3 through C5 which are used as alkylation feed. Ambient temperatures normally exceed the critical temperature of these combinations.] | 270-765-5 | 68477-83-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-067-00-3 | Газове (нефтени), захранване на алкилирането с олефинови-парафинови C3-5; нефтен газ; | [Сложна комбинация от олефинови и парафинови въглеводороди с брой на въглеродните атоми в интервала от C3 до C5, които се използват като захранване на алкилирането. Температурата на обкръжаващата среда обикновено превишава критичната температура на тези комбинации.] | 270-765-5 | 68477-83-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-068-00-9 | Gases (petroleum), C4-rich; Petroleum gas; | [A complex combination of hydrocarbons produced by distillation of products from a catalytic fractionation process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.] | 270-767-6 | 68477-85-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-068-00-9 | Газове (нефтени), богати на C4; нефтен газ; | [Сложна комбинация от въглеводороди, получени при дестилация на продукти от процес на каталитично фракциониране. Състои се от алифатни въглеводороди с брой на въглеродните атоми в интервала от C3 до C5, основно C4.] | 270-767-6 | 68477-85-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-069-00-4 | Gases (petroleum), deethanizer overheads; | Petroleum gas; | [A complex combination of hydrocarbons produced from distillation of the gas and gasoline fractions from the catalytic cracking process. It contains predominantly ethane and ethylene.] | 270-768-1 | 68477-86-1 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-069-00-4 | Газове (нефтени), от горната част на колоната за деетанизация; | нефтен газ; | [Сложна комбинация от въглеводороди, получени при дестилация на фракции от газ и лек бензин при процес на каталитичен крекинг. Състои се предимно от етан и етилен.] | 270-768-1 | 68477-86-1 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-070-00-X | Gasespetroleum),deisobutanizer tower overheads; Petroleum gas; | [A complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydro carbons having carbon numbers predominantly in the range of C3 through C4.] | 270-769-7 | 68477-87-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-070-00-X | Газове (нефтени), от горната част на колоната за деизобутанизация; нефтен газ; | [Сложна комбинация от въглеводороди, получена чрез атмосферна дестилация на бутан-бутиленова фракция. Състои се от алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C3 до C4.] | 270-769-7 | 68477-87-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-071-00-5 | Gases (petroleum), depropanizer dry, propene-rich; | Petroleum gas; | [A complex combination of hydrocarbons produced by the distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists predominantly of propylene withsome ethane and propane.] | 270-772-3 | 68477-90-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-071-00-5 | Газове (нефтени), от колоната за депропанизация, сухи, богати на пропен; | нефтен газ; | [Сложна комбинация от въглеводороди, получени при дестилация на фракции от газ и лек бензин при процес на каталитичен крекинг. Състои се предимно от пропилен с малки количества от етан и пропан.] | 270-772-3 | 68477-90-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-072-00-0 | Gases (petroleum), depropanizer overheads; | Petroleum gas; | [A complex combination of hydrocarbons produced by distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] | 270-773-9 | 68477-91-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-072-00-0 | Газове (нефтени), от горна част на колоната за депропанизация; | нефтен газ; | [Сложна комбинация от въглеводороди, получени при дестилация на фракции от газ и лек бензин при процес на каталитичен крекинг. Състои се от алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C2 до C4.] | 270-773-9 | 68477-91-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-073-00-6 | Gases (petroleum), gas recovery plant depropanizer overheads; Petroleum gas; | [A complex combination of hydrocarbons obtained by fractionation of miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4, predominantly propane.] | 270-777-0 | 68477-94-1 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-073-00-6 | Газове (нефтени), от горна част на колоната за депропанизация в инсталация за газоулавяне; нефтен газ; | [Сложна комбинация от въглеводороди, получена чрез фракциониране на различни въглеводородни фракции. Състои се основно от алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C4, основно пропан.] | 270-777-0 | 68477-94-1 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-074-00-1 | Gases (petroleum), Girbotol unit feed; | Petroleum gas; | [A complex combination of hydrocarbons that is used as the feed into the Girbatol unit to remove hydrogen sulfide. It consists of aliphatic hydro carbons having carbon numbers predominantly in the range of C2 through C4.] | 270-778-6 | 68477-95-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-074-00-1 | Газове (нефтени), захранване в Гирбатол-инсталация; | нефтен газ; | [Сложна комбинация от въглеводороди, която се използва за захранване на Гирбатол-инсталация за отстраняване на водороден сулфид. Състои се от алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C2 до C4.] | 270-778-6 | 68477-95-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-075-00-7 | Gases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free; | Petroleum gas | 270-782-8 | 68477-99-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-075-00-7 | Газове (нефтени) от фракционатор за изомеризирана нафта, богати на C4, без съдържание на водороден сулфид; | Нефтен газ | 270-782-8 | 68477-99-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-076-00-2 | Tail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum; | Petroleum gas; | [A complex combination of hydrocarbons obtained from fractionation of catalytic cracked clarified oil and thermal cracked vacuum residue. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 270-802-5 | 68478-21-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-076-00-2 | Остатъчен газ (нефтен), фракциониране на каталитично крекиранo пречистено масло и термично крекиран вакуумен остатък, приемник след дефлегматор; | нефтен газ; | [Сложна комбинация от въглеводороди, получени при фракционирането на каталитично крекиранo пречистено масло и термично крекиран вакуумен остатък. Състои се основно от алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C6.] | 270-802-5 | 68478-21-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-077-00-8 | Tail gas (petroleum), catalytic cracked naphtha stabilization absorber; | Petroleum gas; | [A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists predomi nantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 270-803-0 | 68478-22-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-077-00-8 | Остатъчен газ (нефтен), стабилизиращ абсорбер за каталитично крекирана нафта; | нефтен газ; | [Сложна комбинация от въглеводороди, получена от стабилизиране на каталитично крекирана нафта. Състои се основно от алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C6.] | 270-803-0 | 68478-22-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-078-00-3 | Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater; Petroleum gas; | [A complex combination of hydrocarbons obtained from the fractionation of products from catalytic cracking, catalytic reforming and hydrodesulfurizing processes treated to remove acidic impurities. It consists predominantly of hydrocarbons having cabon numbers predominantly in the range of C1 through C5.] | 270-804-6 | 68478-24-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-078-00-3 | Остатъчен газ (нефтен), от комбинирана колона за фракциониране на продукти от каталитичен крекинг, каталитичен риформинг и процес за хидродесулфурация; нефтен газ; | [Сложна комбинация от въглеводороди, получени от фракционирането на продукти от процеси на каталитичен крекинг, каталитичен риформинг и хидродесулфурация, обработени за отстраняване на киселинните онечиствания. Състои се основно от алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C5.] | 270-804-6 | 68478-24-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-079-00-9 | Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer; | Petroleum gas; | [A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic reformed naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] | 270-806-7 | 68478-26-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-079-00-9 | Остатъчен газ (нефтен), от колона за стабилизация чрез фракциониране на нафта от каталитичен риформинг; | нефтен газ; | [Сложна комбинация от въглеводороди, получени от фракционното стабилизиране на нафта от каталитичен риформинг. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C4.] | 270-806-7 | 68478-26-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-080-00-4 | Tail gas (petroleum), saturate gas plant mixed stream, C4-rich; Petroleum gas; | [A complex combination of hydrocarbons obtained from the fractionation stabilization of straight-run naphtha, distillation tail gas and catalytic reformed naphtha stabilizer tail gas. It consists of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly butane and isobutane.] | 270-813-5 | 68478-32-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-080-00-4 | Остатъчен газ (нефтен), смесена фракция от инсталация за обработване на наситени газове, богат на C4; нефтен газ; | [Сложна комбинация от въглеводороди, получена от стабилизация чрез фракциониране на първичен нафтен дестилат, дестилат от остатъчен газ и остатъчен газ от стабилизатор на нафта от каталитичен риформинг. Състои се от въглеводороди с брой въглеродни атоми в интервала от C3 до C6, с преобладаване на бутан и изобутан.] | 270-813-5 | 68478-32-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-081-00-X | Tail gas (petroleum), saturate gas recovery plant, C1-2-rich; Petroleum gas; | [A complex combination of hydrocarbons obtained from fractionation of distillate tail gas, straight-run naphtha, catalytic reformed naphtha stabilizer tail gas. It consists predominantly of hydrocarbons having carbon numbers in the range of C1through C5, Predominantly methane and ethane.] | 270-814-0 | 68478-33-1 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-081-00-X | Остатъчен газ (нефтен), от инсталация за извличане на наситени газове, богат на C1-2; нефтен газ; | [Сложна комбинация от въглеводороди, получена чрез фракциониране на дестилат от остатъчен газ, първичен нафтен дестилат, остатъчен газ от стабилизатор на нафта от каталитичен риформинг. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C5, основно метан и етан.] | 270-814-0 | 68478-33-1 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-082-00-5 | Tail gas (petroleum), vacuum residues thermal cracker; Petroleum gas; | [A complex combination of hydrocarbons obtained from the thermal cracking of vacuum residues. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 270-815-6 | 68478-34-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-082-00-5 | Остатъчен газ (нефтен), вакуумни остатъци от термичен крекинг, нефтен газ; | [Сложна комбинация от въглеводороди, получени от термичен крекинг на вакуумни остатъци. Състои се от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C5.] | 270-815-6 | 68478-34-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-083-00-0 | Hydrocarbons, C3-4-rich, petroleum distillate; | Petroleum gas; | [A complex combination of hydrocarbons produced by distillation and condensation of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C3 through C4.] | 270-990-9 | 68512-91-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-083-00-0 | Въглеводороди, богати на C3-4, нефтен дестилат; | нефтен газ; | [Сложна комбинация от въглеводороди, получени при дестилация и кондензация на суров нефт. Състои се от въглеводороди с брой на въглеродните атоми в интервала от C3 до C5, преобладаващо от C3 до C4.] | 270-990-9 | 68512-91-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-084-00-6 | Gases (petroleum), full-range straight-run naphtha dehexanizer off; petroleum gas; [A complex combination of hydrocarbons obtained by the fractionation of the full-range straight-run naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] | 271-000-8 | 68513-15-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-084-00-6 | Газове (нефтени), от дехексанизатор на нафта от пряка дестилация, кипяща в широк обхват; нефтен газ; [Сложна комбинация от въглеводороди, получени при фракционирането на нафта от пряка дестилация, кипяща в широк обхват. Състои се от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C2 до C6.] | 271-000-8 | 68513-15-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-085-00-1 | Gases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich; | Petroleum gas; | [A complex combination of hydrocarbon produced by the distillation of products from a hydrocracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4. It may also contain small amounts of hydrogen and hydrogen sulfide.] | 271-001-3 | 68513-16-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-085-00-1 | Газове (нефтени), на изход от колоната за депропанизация на хидрокрекинг процес, богати на въглеводороди; | нефтен газ; | [Сложна комбинация от въглеводороди, получени при дестилация на продукти от процес на хидрокрекинг. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C4. Може да съдържа малки количества водород и водороден сулфид.] | 271-001-3 | 68513-16-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-086-00-7 | Gases (petroleum), light straight-run naphtha stabilizer off; | Petroleum gas; | [A complex combination of hydrocarbons obtained by the stabilization of light straight-run naphtha. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] | 271-002-9 | 68513-17-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-086-00-7 | Газове (нефтени), на изход от стабилизатора за лека нафта от пряка дестилация; | нефтен газ; | [Сложна комбинация от въглеводороди, получени при стабилизацията на лека нафта от пряка дестилация. Състои се от наситени алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C2 до C6.] | 271-002-9 | 68513-17-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-087-00-2 | Residues (petroleum), alkylation splitter, C4-rich; | Petroleum gas; | [A complex residuum from the distillation of streams various refinery operations. It consists of hydrocarbons having carbon numbers in the range of C4 through C5, predominantly butane and boiling in the range of approximately - 11.7 o C to 27.8 o C (11 oF to 82 oF).] | 271-010-2 | 68513-66-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-087-00-2 | Остатъци (нефт), от разделителна колона в инсталация за алкилиране, богати на C4; | нефтен газ; | [Сложен остатък от дестилацията на фракции от различни операции в рафинерията. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C4 до C5, преобладаващо бутан, и с температура на кипене приблизително в интервала от –11,7 oC до 27,8 oC. (11oF до 82oF).] | 271-010-2 | 68513-66-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-088-00-8 | Hydrocarbons, C1-4; Petroleum gas; | [A complex combination of hydrocarbons provided by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus164 o C to minus 0.5 o C (– 263 oF to 31 oF).] | 271-032-2 | 68514-31-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-088-00-8 | Въглеводороди, C1-4; нефтен газ; | [Сложна комбинация от въглеводороди, получени при термичен крекинг и абсорбиращи операции и също така при дестилация на суров нефт. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C1 до C4, с температура на кипене приблизително в интервала от –164 oC до –0,5 oC (–263oF до 31oF).] | 271-032-2 | 68514-31-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-089-00-3 | Hydrocarbons, C1-4, sweetened; Petroleum gas; | [A complex combination of hydrocarbons obtaine by subjectin hydrocarbon gases to a sweetening process to convert mercaptans o to remove acidc impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately – | 164o C to - 0.5 oC (– 263 oF to 31 oF).] | 271-038-5 | 68514-36-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-089-00-3 | Въглеводороди, C1-4, десулфурирани; нефтен газ; | [Сложна комбинация от въглеводороди, получени при подлагане на въглеводородни газове на обработка за превръщане на меркаптани или за отстраняване на киселинни онечиствания. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C1 до C4, с температура на кипене приблизително в интервала от минус | 164 oC до –0,5 oC (–263oF до 31oF).] | 271-038-5 | 68514-36-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-090-00-9 | Hydrocarbons, C1-3; Petroleum gas; | [A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approxi mately minus 164 o C to minus 42 oC (– 263 oF to - 44 oF).] | 271-259-7 | 68527-16-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-090-00-9 | Въглеводороди, C1-3; нефтен газ; | [Сложна комбинация от въглеводороди с брой на въглеродните атоми предимно в интервала от C1 до C3, с температура на кипене приблизително в интервала от –164 oC до –42 oC (–263oF до –44 oF).] | 271-259-7 | 68527-16-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-091-00-4 | Hydrocarbons, C1-4, debutanizer fraction; | Petroleum gas | 271-261-8 | 68527-19-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-091-00-4 | Въглеводороди, C1-4, фракция от колоната за дебутанизация; | Нефтен газ | 271-261-8 | 68527-19-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-092-00-X | Gases (petroleum), C1-5, wet; Petroleum gas; | [A complex combination of hydrocarbons produced by the distillation of crude oil and/or the cracking of tower gas oil. | It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 271-624-0 | 68602-83-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-092-00-X | Газове (нефтени), C1-5, влажни; нефтен газ; | [Сложна комбинация от въглеводороди, получена чрез дестилация на суров нефт и/или чрез крекинг на газьол от върха на колоната. | Състои се от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C5.] | 271-624-0 | 68602-83-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-093-00-5 | Hydrocarbons, C2-4; Petroleum gas | 271-734-9 | 68606-25-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-093-00-5 | Въглеводороди, C2-4; Нефтен газ | 271-734-9 | 68606-25-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-094-00-0 | Hydrocarbons, C3; Petroleum gas | 271-735-4 | 68606-26-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-094-00-0 | Въглеводороди, C3; Нефтен газ | 271-735-4 | 68606-26-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-095-00-6 | Gases (petroleum), alkylation feed; | Petroleum gas; | [A complex combination of hydrocarbons produced by the catalytic cracking of gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C4.] | 271-737-5 | 68606-27-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-095-00-6 | Газове (нефтени), захранване на алкилирането | нефтен газ; | [Сложна комбинация от въглеводороди, получени при каталитичен крекинг на газьол. Състои се от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C3 до C4.] | 271-737-5 | 68606-27-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-096-00-1 | Gases (petroleum), depropanizer bottoms fractionation off; Petroleum gas; | [A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists predominantly of butane, isobutane and butadiene.] | 271-742-2 | 68606-34-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-096-00-1 | Газове (нефтени), фракциониране на дънни фракции от колоната за депропанизация; нефтен газ; | [Сложна комбинация от въглеводороди, получена чрез фракциониране на дънните фракции от колоната за депропанизация. Състои се предимно от бутан, изобутан и бутадиен.] | 271-742-2 | 68606-34-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-097-00-7 | Gases (petroleum), refinery blend; | Petroleum gas; | [A complex combination obtained from various processes. | It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 272-183-7 | 68783-07-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-097-00-7 | Газове (нефтени), бленда от рафинерията; | нефтен газ; | [Сложна комбинация, получена чрез различни процеси. | Състои се от водород, водороден сулфид и въглеводороди с брой на въглеродните атоми предимно в интервала от C1 до C5.] | 272-183-7 | 68783-07-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-098-00-2 | Gases (petroleum), catalytic cracking; | Petroleum gas; | [A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C3 through C5.] | 272-203-4 | 68783-64-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-098-00-2 | Газове (нефтени), каталитичен крекинг | нефтен газ; | [Сложна комбинация от въглеводороди, получени при дестилация на продукти от процес на каталитичен крекинг. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C3 до C5.] | 272-203-4 | 68783-64-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-099-00-8 | Gases (petroleum), C2-4, sweetened; | Petroleum gas; | [A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C2 through C4 and boiling in the range of approximately - 51 oC to - 34 oC (– 60oF to - 30oF).] | 272-205-5 | 68783-65-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-099-00-8 | Газове (нефтени), C2-4, десулфурирани; | нефтен газ; | [Сложна комбинация от въглеводороди, получена при подлагане на десулфурация на нефтен дестилат за превръщане на меркаптаните или за отстраняване на киселинните онечиствания. Състои се основно от наситени и ненаситени въглеводороди с брой на въглеродните атоми в интервала от C2 до C4, с температура на кипене в интервала от –51 oC до –34 oC (–60oF до –30oF).] | 272-205-5 | 68783-65-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-100-00-1 | Gases (petroleum), crude oil fractionation off; | Petroleum gas; | [A complex combination of hydrocarbons produced by the fractionation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 272-871-7 | 68918-99-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-100-00-1 | Газове (нефтени), от фракциониране на суров нефт; | нефтен газ; | [Сложна комбинация от въглеводороди, получена чрез фракциониране на суров нефт. Състои се от наситени алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C5.] | 272-871-7 | 68918-99-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-101-00-7 | Gases (petroleum), dehexanizer off; | Petroleum gas; | [A complex combination of hydrocarbons obtained by the Fractionation of combined naphtha streams. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 272-872-2 | 68919-00-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-101-00-7 | Газове (нефтени), на изход от колоната за дехексанизация; | нефтен газ; | [Сложна комбинация от въглеводороди, получени при фракционирането на комбинирани нафтени фракции. Състои се от наситени алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C5.] | 272-872-2 | 68919-00-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-102-00-2 | Gases (petroleum), light straight run gasoline fractionation stabilizer off; | Petroleum gas; | [A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 272-878-5 | 68919-05-1 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-102-00-2 | Газове (нефтени), от колона за стабилизация чрез фракциониране на лек бензин от пряка дестилация; | нефтен газ; | [Сложна комбинация от въглеводороди, получена чрез фракциониране на лек бензин от пряка дестилация. Състои се от наситени алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C5.] | 272-878-5 | 68919-05-1 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-103-00-8 | Gases (petroleum), naphtha unifiner desulfurization stripper off; | Petroleum gas; | [A complex combination of hydrocarbons produced by a naphtha unifiner desulfurization process and stripped from the naphtha product. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] | 272-879-0 | 68919-06-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-103-00-8 | Газове (нефтени), от разделителна колона от процес „Unifiner“ за десулфурация на нафта; | нефтен газ; | [Сложна комбинация от въглеводороди, получени от процес „Unifiner“ за десулфурация на нафта и разделени от нафтения продукт. Състои се от наситени алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C4.] | 272-879-0 | 68919-06-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-104-00-3 | Gases (petroleum), straight-run naphtha catalytic reforming off; Petroleum gas; | [A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and fractionation of the total effluent. It consists of methane, ethane, and propane.] | 272-882-7 | 68919-09-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-104-00-3 | Газове (нефтени), на изход от каталитичен риформинг на нафта от пряка дестилация; нефтен газ; | [Сложна комбинация от въглеводороди, получени при каталитичен риформинг на нафта от пряка дестилация и фракциониране на общия изходящ поток. Състои се от метан, етан и пропан.] | 272-882-7 | 68919-09-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-105-00-9 | Gases(petroleum), fluidized catalytic cracker splitter overheads; Petroleum gas; | [A complex combination of hydrocarbons produced by the fractionation of the charge to the C3-C4 splitter. It consists predominantly of C3 hydrocarbons.] | 272-893-7 | 68919-20-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-105-00-9 | Газове (нефтени), втечнени горни фракции от върха на разделителната колона на каталитичен крекинг; нефтен газ; | [Сложна комбинация от въглеводороди, получена при фракциониране на захранващия поток на разделителната колона за C3-C4. Състои се основно от C3 въглеводороди.] | 272-893-7 | 68919-20-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-106-00-4 | Gases (petroleum), straight-run stabilizer off; | Petroleum gas; | [A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] | 272-883-2 | 68919-10-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-106-00-4 | Газове (нефтени), на изход от прякодестилатния стабилизатор; | нефтен газ; | [Сложна комбинация от въглеводороди, получени при фракционирането на течност от първата колона, използвана при дестилацията на суров нефт. Състои се от наситени алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C4.] | 272-883-2 | 68919-10-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-107-00-X | Gases (petroleum), catalytic cracked naphtha debutanizer; Petroleum gas; | [A complex combination of hydrocarbons obtained from fractionation of catalytic cracked naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] | 273-169-3 | 68952-76-1 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-107-00-X | Газове (нефтени), от колоната за дебутанизация на нафта от каталитичен крекинг; нефтен газ; | [Сложна комбинация от въглеводороди, получена чрез фракциониране на каталитично крекирана нафта. Състои се от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C4.] | 273-169-3 | 68952-76-1 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-108-00-5 | Tail gas (petroleum), catalytic cracked distillate and naphtha stabilizer; | Petroleum gas; | [A complex combination of hydrocarbons obtained by the fractionation of catalytic cracked naphtha and distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] | 273-170-9 | 68952-77-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-108-00-5 | Остатъчен газ (нефтен), от стабилизатора за каталитично крекиран дестилат и нафта; | нефтен газ; | [Сложна комбинация от въглеводороди, получени при фракционирането на каталитично крекирана нафта и дестилат. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C4.] | 273-170-9 | 68952-77-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-109-00-0 | Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber; | petroleum gas; | [A complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil. It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 273-175-6 | 68952-81-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-109-00-0 | Остатъчен газ (нефтен), дестилат, газьол и нафта от термичен крекинг, абсорбер; | нефтен газ; | [Сложна комбинация от въглеводороди, получени при разделянето на термично крекирани дестилати, нафта и газьол. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C6.] | 273-175-6 | 68952-81-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-110-00-6 | Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking; | Petroleum gas; | [A complex combination of hydrocarbons obtained from the fractionation stabilization of thermal cracked hydrocarbons from petroleum coking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 273-176-1 | 68952-82-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-110-00-6 | Остатъчен газ (нефтен), от колона за стабилизация чрез фракциониране на термично крекирани въглеводороди, коксуване на нефт; | нефтен газ; | [Сложна комбинация от въглеводороди, получени при стабилизация чрез фракциониране на термично крекирани въглеводороди при коксуване на нефт. Състои се от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C6.] | 273-176-1 | 68952-82-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-111-00-1 | Gases (petroleum, light steam-cracked, butadiene conc.; Petroleum gas; | [A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists of hydrocarbons having a carbon number predominantly of C4.] | 273-265-5 | 68955-28-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-111-00-1 | Газове (нефтени), леки от паров крекинг, бутадиенов концентрат; нефтен газ; | [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от процес на термичен крекинг. Състои се от въглеводороди с брой на въглеродните атоми преобладаващо C4.] | 273-265-5 | 68955-28-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-112-00-7 | Gases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead; | Petroleum gas; | [A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and the frac tionation of the total effluent. | It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] | 273-270-2 | 68955-34-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-112-00-7 | Газове (нефтени), фракция от горната част на стабилизатора в инсталацията за каталитичен риформинг на нафта от пряка дестилация; | нефтен газ; | [Сложна комбинация от въглеводороди, получени при каталитичен риформинг на нафта от пряка дестилация и фракциониране на общия изходящ поток. | Състои се от наситени алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C2 до C4.] | 273-270-2 | 68955-34-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-113-00-2 | Hydrocarbons, C4; Petroleum gas | 289-339-5 | 87741-01-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-113-00-2 | Въглеводороди, C4; Нефтен газ | 289-339-5 | 87741-01-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-114-00-8 | Alkanes, C1-4, C3-rich; Petroleum gas | 292-456-4 | 90622-55-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-114-00-8 | Алкани, C1-4, богати на C3; Нефтен газ | 292-456-4 | 90622-55-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-115-00-3 | Gases (petroleum), steam-cracker C3-rich; | Petroleum gas; | [A complex combination of hydrocarbons produced by the distillation of products from a steam cracking process. It consists predominantly of propylene with some propane and boils in the range of approximately - 70 oC to 0 oC (– 94oF to 32oF).] | 295-404-9 | 92045-22-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-115-00-3 | Газове (нефтени), инсталация за крекинг с водна пара, богати на C3; | нефтен газ; | [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от крекинг с водна пара. Състои се основно от пропилен и малко пропан, с точка на кипене приблизително в интервала от –70 oC до 0 oC (–94oF до 32oF).] | 295-404-9 | 92045-22-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-116-00-9 | Hydrocarbons, C4, steam-cracker distillate; | Petroleum gas; | [A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12 o C to 5 o C (10.4 oF to 41oF).] | 295-405-4 | 92045-23-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-116-00-9 | Въглеводороди, C4, дестилат от паров крекинг; | нефтен газ; | [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от паров крекинг. Състои се основно от въглеводороди с брой на въглеродните атоми C4, преобладаващо 1-бутен и 2-бутен, съдържа също бутан и изобутен, и с температура на кипене приблизително в интервала от –12 oC до 5 oC (10,4oF до 41oF).] | 295-405-4 | 92045-23-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-117-00-4 | Petroleum gases, liquefied, sweetened, C4 fraction; Petroleum gas; | [A complex combination of hydrocarbons obtained by subjecting a liquified petroleum gas mix to a sweetening process to oxidize mercaptans or to remove acidic impurities. It consists predominantly of C4 saturated and unsaturated hydrocarbons.] | 295-463-0 | 92045-80-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K S U649-117-00-4 | Нефтени газове, втечнени, десулфурирани, C4 фракция нефтен газ; | [Сложна комбинация от въглеводороди, получена чрез подложен на десулфурация втечнен продукт от смесване на нефтени газове за окисляване на меркаптани или за отделяне на киселинни примеси. Състои се предимно от C4 наситени и ненаситени въглеводороди.] | 295-463-0 | 92045-80-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K S U
649-118-00-X | Hydrocarbons, C4, 1,3-butadiene-and isobutene-free; Petroleum gas | 306-004-1 | 95465-89-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-118-00-X | Въглеводороди, C4, без съдържание на 1,3-бутадиен и изобутен; Нефтен газ | 306-004-1 | 95465-89-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-119-00-5 | Raffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free; Petroleum gas | 307-769-4 | 97722-19-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-119-00-5 | Рафинати (нефтени), парокрекирана C4 фракция, екстракция с амониев меден ацетат, C3-5 и C3-5 ненаситени, без съдържание на бутадиен; Нефтен газ | 307-769-4 | 97722-19-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-120-00-0 | Gases (petroleum), amine system feed; | Refinery gas; | [The feed gas to the amine system for removal of hydrogen sulfide. It consists of hydrogen. Carbon monoxide, carbon dioxide, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 may also be present.] | 270-746-1 | 68477-65-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-120-00-0 | Газове (нефтени), захранване на система за третиране с амини | нефтозаводски газ; | [газ за захранване на система за третиране с амини за отстраняване на водороден сулфид. Състои се от водород. Може да съдържа въглероден моноксид, въглероден диоксид, водороден сулфид и алифатни въглеводороди с брой на въглеродните атоми основно в интервала C1—C5.] | 270-746-1 | 68477-65-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-121-00-6 | Gases (petroleum), benzene unit hydrodesulfurizer off; | Refinery gas; | [Off gases produced by the benzene unit. It consists primarily of hydrogen. Carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6, including benzene, may also be present.] | 270-747-7 | 68477-66-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-121-00-6 | Газове (нефтени), на изход от колоната за хидродесулфурация на бензен; | нефтозаводски газ; | [Изходящи газове, получени от инсталацията за производство на бензен. Състоят се основно от водород. Може да съдържа въглероден моноксид и въглеводороди с брой на въглеродните атоми основно в интервала C1—C6, включително бензен.] | 270-747-7 | 68477-66-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-122-00-1 | Gases (petroleum), benzene unit recycle, hydrogen-rich; | Refinery gas; | [A complex combination of hydrocarbons obtained by recycling the gases of the benzene unit. It consists primarily of hydrogen with various small amounts of carbon monoxide and hydro carbons having carbon numbers in the range of C1 through C6.] | 270-748-2 | 68477-67-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-122-00-1 | Газове (нефтени), рециркулат от инсталацията за бензен, богати на водород; | нефтозаводски газ; | [Сложна комбинация от въглеводороди, получена чрез рециклиране на газове от бензеновата инсталация. Състои се основно от водород с различни малки количества въглероден моноксид и въглеводороди с брой на въглеродните атоми в интервала C1—C6.] | 270-748-2 | 68477-67-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-123-00-7 | Gases (petroleum), blend oil, hydrogen-nitrogen-rich; | Refinery gas; | [A complex combination of hydrocarbons obtained by distillation of a blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide, and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 270-749-8 | 68477-68-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-123-00-7 | Газове (нефтени), от блендиран нефт, богати на водород-азот; | нефтозаводски газ; | [Сложна комбинация от въглеводороди, получена чрез дестилация на блендирано масло. Състои се основно от водород и азот с различни малки количества от въглероден оксид, въглероден диоксид и алифатни въглеводороди с брой въглеродни атоми главно в интервала от C1 до C5.] | 270-749-8 | 68477-68-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-124-00-2 | Gases (petroleum), catalytic reformed naphtha stripper overheads; | Refinery gas; | [A complex combination of hydrocarbons obtained from stabilization of catalytic reformed naphtha. Its consists of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] | 270-759-2 | 68477-77-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-124-00-2 | Газове (нефтени), фракции от горната част на разделителната колона на нафта от каталитичен риформинг; | нефтозаводски газ; | [Сложна комбинация от въглеводороди, получени чрез стабилизция на нафта от каталитичен риформинг. Състои се от водород и наситени въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C4.] | 270-759-2 | 68477-77-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-125-00-8 | Gases (petroleum), C6-8 catalytic reformer recycle; | Refinery gas; | [A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed and recycled to conserve hydrogen. It consists primarily of hydrogen. It may also contain various small amounts of carbon monoxide, carbon dioxide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 270-761-3 | 68477-80-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-125-00-8 | Газове (нефтени), C6-8 рециркулат от каталитичен риформинг; | нефтозаводски газ; | [Сложна комбинация от въглеводороди, получени при дестилацията на продукти от каталитичен риформинг на захранване от C6-C8 и рециклирани за запазване на водорода. Състои се основно от водород. Може да съдържа различни малки количества въглероден моноксид, въглероден диоксид, азот и въглеводороди с брой на въглеродните атоми основно в интервала C1—C6.] | 270-761-3 | 68477-80-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-126-00-3 | Gases (petroleum), C6-8 catalytic reformer; | Refinery gas; | [A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8feed. It consists of hydrocarbons having carbon numbers in the range of C1 through C5 and hydrogen.] | 270-762-9 | 68477-81-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-126-00-3 | Газове (нефтени), C6-8 каталитичен риформинг; | нефтозаводски газ; | [Сложна комбинация от въглеводороди, получени при дестилацията на продукти от каталитичен риформинг на захранване от C6-C8. Състои се от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C5, и от водород.] | 270-762-9 | 68477-81-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-127-00-9 | Gases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich; Refinery gas | 270-763-4 | 68477-82-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-127-00-9 | Газове (нефтени), C6-8 рециркулат от каталитичен риформинг, богати на водород; нефтозаводски газ | 270-763-4 | 68477-82-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-128-00-4 | Gases (petroleum), C2-return stream; | Refinery gas; | [A complex combination of hydrocarbons obtained by the extraction of hydrogen from a gas stream which consists primarily of hydroge with small amounts of nitrogen, carbon monoxide, methane, ethane, and ethylene. It contain predominantly hydrocarbons such as methane, ethane, and ethylene with small amounts of hydrogen, nitrogen and carbon monoxide.] | 270-766-0 | 68477-84-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-128-00-4 | Газове (нефтени), C2-възвратен поток; | нефтозаводски газ; | [Сложна комбинация от въглеводороди, получени при екстракция на водород от газов поток, който съдържа основно водород с малки количества от азот, въглероден моноксид, метан, етан и етилен. Състои се главно от въглеводороди, като метан, етан и етилен с малки количества от водород, азот и въглероден моноксид.] | 270-766-0 | 68477-84-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-129-00-X | Gases (petroleum), dry sour, gas-concn.-unit-off; | Refinery gas; | [The complex combination of dry gase from a gas concentration unit. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] | 270-774-4 | 68477-92-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-129-00-X | Газове (нефтени), сухи сярасъдържащи, от инсталация за концентриране на газа; | нефтозаводски газ; | [Сложна комбинация от сухи газове от инсталация за концентриране на газа. Състои се от водород, водороден сулфид и въглеводороди с брой на въглеродните атоми предимно в интервала от C1 до C3.] | 270-774-4 | 68477-92-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-130-00-5 | Gases (petroleum), gas concn. reabsorber distn.; | Refinery gas; | [A complex combination of hydrocarbons produced by distillation of products from combined gas streams in a gas concentration reabsorber. It consists predominantly of hydrogen, carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide and hydrocarbons having carbon numbers in the range of C1 through C3.] | 270-776-5 | 68477-93-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-130-00-5 | Газове (нефтени), от дестилат от реабсорбера на инсталацията за концентриране на газа; | нефтозаводски газ; | [Сложна комбинация от въглеводороди, получени при дестилация на продукти от комбинирани газови потоци в реабсорбер за концентрирани газове. Състои се основно от водород, въглероден моноксид, въглероден диоксид, азот, водороден сулфид и въглеводороди с брой на въглеродните атоми в интервала C1—C3.] | 270-776-5 | 68477-93-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-131-00-0 | Gases (petroleum), hydrogen absorber off; | Refinery gas; | [A complex combination obtained by absorbing hydrogen from a hydrogen rich stream. It consists of hydrogen, carbon monoxide, nitrogen, and methane with small amounts of C2 hydrocarbons.] | 270-779-1 | 68477-96-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-131-00-0 | Газове (нефтени), на изхода от абсорбера за водород; | нефтозаводски газ; | [Сложна комбинация, получена при абсорбирането на водород от богата на водород фракция. Състои се от водород, въглероден оксид, азот и метан с малки количества от C2 въглеводороди.] | 270-779-1 | 68477-96-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-132-00-6 | Gases (petroleum), hydrogen-rich; | Refinery gas; | [A complex combination separated as a gas from hydrocarbon gases by chilling. It consists primarily of hydrogen with various small amounts of carbon monoxide, nitrogen, methane, and C2 hydrocarbons.] | 270-780-7 | 68477-97-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-132-00-6 | Газове (нефтени), богати на водород | нефтозаводски газ; | [Сложна комбинация, разделена като газ от въглеводородни газове чрез охлаждане. Състои се основно от водород с различни малки количества от въглероден моноксид, азот, метан и C2 въглеводороди.] | 270-780-7 | 68477-97-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-133-00-1 | Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich; | Refinery gas; | [A complex combination obtained from recycled hydrotreated blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 270-781-2 | 68477-98-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-133-00-1 | Газове (нефтени), от рециркулат на блендиран нефт от инсталация за обработване с водород, богати на водород и азот; | нефтозаводски газ; | [Сложна комбинация, получена от рециклирано блендирано масло след третиране с водород. Състои се основно от водород и азот с различни малки количества от въглероден моноксид, въглероден диоксид и въглеводороди с брой въглеродни атоми главно в интервала от C1 до C5.] | 270-781-2 | 68477-98-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-134-00-7 | Gases (petroleum), recycle, hydrogen-rich; | Refinery gas; | [A complex combination obtained from recycled reactor gases. It consists primarily of hydrogen with various small amounts of carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.] | 270-783-3 | 68478-00-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-134-00-7 | Газове (нефтени), от рециркулат, богати на водород; | нефтозаводски газ; | [Сложна комбинация, получена от рециклирани реакторни газове. Състои се основно от водород с различни малки количества от въглероден моноксид, въглероден диоксид, азот, водороден сулфид и наситени алифатни въглеводороди с брой въглеродни атоми в интервала от C1 до C5.] | 270-783-3 | 68478-00-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-135-00-2 | Gases (petroleum), reformer make-up, hydrogen-rich; Refinery gas; | [Acomplex combination obtained from the reformers. It consists primarily of hydrogen with variou smal amount of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 270-784-9 | 68478-01-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-135-00-2 | Газове (нефтени), свежи газове от инсталация за риформинг, богати на водород; нефтозаводски газ; | [Сложна комбинация, получена от инсталации за риформинг. Състои се основно от водород с различни малки количества въглероден моноксид и алифатни въглеводороди с брой на въглеродните атоми предимно в интервала C1—C5.] | 270-784-9 | 68478-01-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-136-00-8 | Gases (petroleum), reforming hydrotreater; | Refinery gas; | [A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen, methane, and ethane with various small amounts of hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.] | 270-785-4 | 68478-02-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-136-00-8 | Газове (нефтени), от инсталация за обработване с водород в риформинга; | нефтозаводски газ; | [Сложна комбинация, получена от процеса на обработване с водород в риформинга. Състои се основно от водород с различни малки количества водороден сулфид и алифатни въглеводороди с брой на въглеродните атоми предимно в интервала C3—C5.] | 270-785-4 | 68478-02-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-137-00-3 | Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich; | Refinery gas; | [A complex combination obtained fromthe reforming hydrotreating process. It consists primarily of hydrogen and methane with various small amounts of carbon monoxide, carbon dioxide, nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C5.] | 270-787-5 | 68478-03-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-137-00-3 | Газове (нефтени), от инсталация за обработване с водород в риформинга, богати на водород и метан; | нефтозаводски газ; | [Сложна комбинация, получена от процеса на обработване с водород в риформинга. Състои се основно от водород и метан с различни малки количества от въглероден моноксид, въглероден диоксид, азот и наситени алифатни въглеводороди с брой въглеродни атоми главно в интервала от C2 до C5.] | 270-787-5 | 68478-03-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-138-00-9 | Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich; | Refinery gas; | [A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 270-788-0 | 68478-04-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-138-00-9 | Газове (нефтени), от кондициониране (дообработване) в инсталация за обработване с водород в риформинга, богати на водород; | нефтозаводски газ; | [Сложна комбинация, получена от процеса на обработване с водород в риформинга. Състои се основно от водород с различни малки количества въглероден моноксид и алифатни въглеводороди с брой на въглеродните атоми предимно в интервала C1—C5.] | 270-788-0 | 68478-04-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-139-00-4 | Gases (petroleum), thermal cracking distn.; | Refinery gas; | [A complex combination produced by distillation of products from a thermal cracking process. It consists of hydrogen, hydrogen sulfide, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 270-789-6 | 68478-05-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-139-00-4 | Газове (нефтени), дестилация от термичен крекинг; | нефтозаводски газ; | [Сложна комбинация, получена при дестилация на продукти от процес на термичен крекинг. Състои се от водород, водороден сулфид, въглероден моноксид, въглероден диоксид и въглеводороди с брой на въглеродните атоми предимно в интервала от C1 до C6.] | 270-789-6 | 68478-05-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-140-00-X | Tail gas (petroleum), catalytic cracker refractionation absorber; Refinery gas; | [A complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] | 270-805-1 | 68478-25-1 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-140-00-X | Остатъчен газ (нефтен), абсорбер за рефракциониране след каталитичен крекинг; нефтозаводски газ; | [Сложна комбинация от въглеводороди, получени при рефракциониране на продукти от процес на каталитичен крекинг. Състои се от водород и въглеводороди с брой на въглеродните атоми предимно в интервала от C1 до C3.] | 270-805-1 | 68478-25-1 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-141-00-5 | Tail gas (petroleum), catalytic reformed naphtha separator; Refinery gas; | [A complex combination of hydrocarbons obtained from the catalytic reforming of straight run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 270-807-2 | 68478-27-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-141-00-5 | Остатъчен газ (нефтен), от сепаратор за нафта от каталитичен риформинг; нефтозаводски газ; | [Сложна комбинация от въглеводороди, получена чрез каталитичен риформинг на първичен нафтен дестилат. Състои се от водород и въглеводороди с брой на въглеродните атоми предимно в интервала от C1 до C6.] | 270-807-2 | 68478-27-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-142-00-0 | Tail gas (petroleum), catalytic reformed naphtha stabilizer; Refinery gas; | [A complex combination of hydrocarbons obtained from the stabilization of catalytic reformed naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 270-808-8 | 68478-28-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-142-00-0 | Остатъчен газ (нефтен), от стабилизатор за нафта от каталитичен риформинг; нефтозаводски газ; | [Сложна комбинация от въглеводороди, получена чрез стабилизация на нафта от каталитичен риформинг. Състои се от водород и въглеводороди с брой на въглеродните атоми предимно в интервала от C1 до C6.] | 270-808-8 | 68478-28-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-143-00-6 | Tail gas (petroleum), cracked distillate hydrotreater separator; Refinery gas; [A complex combination of hydrocarbons obtained by treating cracked distillates with hydrogen in the presence of a catalyst. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 270-809-3 | 68478-29-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-143-00-6 | Остатъчен газ (нефтен), дестилат от крекинг процес, инсталация за обработване с водород, сепаратор; нефтозаводски газ; [Сложна комбинация от въглеводороди, получена чрез обработване на крекирани дестилати с водород в присъствие на катализатор. Състои се от водород и наситени алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C5.] | 270-809-3 | 68478-29-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-144-00-1 | Tail gas (petroleum), hydrodesulfurized straight-run naphtha separator; | Refinery gas; | [A complex combination of hydrocarbons obtained from hydrodesulfurization of straight-run naphtha. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 270-810-9 | 68478-30-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-144-00-1 | Остатъчен газ (нефтен), от сепаратор на хидродесулфурирана нафта от пряка дестилация; | нефтозаводски газ; | [Сложна комбинация от въглеводороди, получени при хидродесулфурация на нафта от пряка дестилация. Състои се от водород и наситени алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C6.] | 270-810-9 | 68478-30-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-145-00-7 | Gases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads; | Refinery gas; | [A complex combination of hydrocarbons obtained from the catalytic reforming of straight-run naphtha followed by fractionation of the total effluent. It consists of hydrogen, methane, ethane and propane.] | 270-999-8 | 68513-14-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-145-00-7 | Газове (нефтeни), фракции от горната част на стабилизатор на прякодестилатна нафта от каталитичен риформинг; | нефтозаводски газ; | [Сложна комбинация от въглеводороди, получени при каталитичен риформинг на нафта от пряка дестилация, последвано от фракционирането на общия изходящ поток. Състои се от водород, метан, етан и пропан.] | 270-999-8 | 68513-14-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-146-00-2 | Gases (petroleum), reformer effluent high-pressure flash drum off; | Refinery gas; | [A complex combination produced by the high-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.] | 271-003-4 | 68513-18-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-146-00-2 | Газове (нефтени), от изпарителен барабан за изпаряване при високо налягане на изходящ поток от риформинга; | нефтозаводски газ; | [Сложна комбинация, получена от изпаряване при високо налягане на изходящ поток от реактора за риформинг. Състои се основно от водород с различни малки количества метан, етан и пропан.] | 271-003-4 | 68513-18-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-147-00-8 | Gases (petroleum), reformer effluent low-pressure flash drum off; | Refinery gas; | [A complex combination produced by low-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.] | 271-005-5 | 68513-19-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-147-00-8 | Газове (нефтени), от изпарителен барабан за изпаряване при ниско налягане на изходящ поток от риформинга; | нефтозаводски газ; | [Сложна комбинация, получена от изпаряване при ниско налягане на изходящ поток от реактора за риформинг. Състои се основно от водород с различни малки количества метан, етан и пропан.] | 271-005-5 | 68513-19-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-148-00-3 | Gases (petroleum), oil refinery gas distn. off; | Refinery gas; | [A complex combination separatedby distillation of a gas stream containing hydrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers in the range of C1 through C6 or obtained by cracking ethane and propane. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C2, hydrogen, nitrogen, and carbon monoxide.] | 271-258-1 | 68527-15-1 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-148-00-3 | Газове (нефтени), от дестилация на нефтозаводски газ; | нефтозаводски газ; | [Сложна комбинация, разделена при дестилация на газова фракция, съдържаща водород, въглероден моноксид, въглероден диоксид и въглеводороди с брой въглеродни атоми в интервала от C1 до C6 или получени чрез крекинг на етан и пропан. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала C1—C2, водород, азот и въглероден моноксид.] | 271-258-1 | 68527-15-1 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-149-00-9 | Gases (petroleum), benzene unit hydrotreater depentanizer overheads; Refinery gas; | [A complex combination produced by treating the feed from the benzene unit with hydrogen in the presence of a catalyst followed by depentanizing. It consists primarily of hydrogen, ethane and propane with various small amounts of nitrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6. It may contain trace amounts of benzene.] | 271-623-5 | 68602-82-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-149-00-9 | Газове (нефтени), фракциии от горната част на колоната за депентанизация на инсталация за обработване с водород в инсталацията за бензен; нефтозаводски газ; | [Сложна комбинация, получена чрез обработване на захранването от бензенова инсталация с водород в присъствие на катализатор, последвано от депентанизация. Състои се основно от водород, етан и пропан с различни малки количества азот, въглероден моноксид, въглероден диоксид и въглеводороди с брой на въглеродните атоми основно в интервала от C1 до C6.] Също може да съдържа и следи от бензен.] | 271-623-5 | 68602-82-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-150-00-4 | Gases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator; Refinery gas; | [A complex combination produced by the fractionation of the overhead products from the catalyticcracking process in the fluidized catalytic cracker. It consists of hydrogen, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] | 271-625-6 | 68602-84-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-150-00-4 | Газове (нефтени), горни фракции на изход от вторичния абсорбер, от горната част на фракционатор на каталитичен крекинг в кипящ слой; нефтозаводски газ; | [Сложна комбинация, получена при фракционирането на продукти от горната част в инсталация за каталитичен крекинг в кипящ слой. Състои се от водород, азот и въглеводороди с брой на въглеродните атоми предимно в интервала от C1 до C3.] | 271-625-6 | 68602-84-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-151-00-X | Petroleum products, refinery gases; | Refinery gas; [A complex combination which consists primarily of hydrogen with various small amounts of methane, ethane, and propane.] | 271-750-6 | 68607-11-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-151-00-X | Нефтени продукти, нефтозаводски газове; | нефтозаводски газ; [Сложна комбинация, съдържаща основно водород с различни малки количества метан, етан и пропан.] | 271-750-6 | 68607-11-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-152-00-5 | Gases (petroleum), hydrocracking low-pressure separator; Refinery gas; | [A complex combination obtained by the liquid-vapor separation of the hydrocracking process reactor effluent. It consists predominantly of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] | 272-182-1 | 68783-06-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-152-00-5 | Газове (нефтени), от сепаратор за ниско налягане на хидрокрекинг; нефтозаводски газ; | [Сложна комбинация, получена при течно-парно разделяне на изходящия поток от реактора на процес на хидрокрекинг. Състои се предимно от водород и наситени въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C3.] | 272-182-1 | 68783-06-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-153-00-0 | Gases (petroleum), refinery; Refinery gas; | [A complex combination obtained from various petroleum refining operations. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] | 272-338-9 | 68814-67-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-153-00-0 | Газове (нефтени), рафинерия нефтозаводски газ; | [Сложна комбинация, получена от различни операции по рафиниране на нефт. Състои се от водород и въглеводороди с брой на въглеродните атоми предимно в интервала от C1 до C3.] | 272-338-9 | 68814-67-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-154-00-6 | Gases (petroleum), platformer products separator off; | Refinery gas; | [A complex combination obtained from the chemical reforming of naphthenes to aromatics. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] | 272-343-6 | 68814-90-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-154-00-6 | Газове (нефтени), от сепаратор на продукти от инсталация за платформинг; | нефтозаводски газ; | [Сложна комбинация, получена чрез химичен риформинг на нафтени до ароматни съединения. Състои се от водород и наситени алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C2 до C4.] | 272-343-6 | 68814-90-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-155-00-1 | Gases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off; | Refinery gas; | [The complex combination obtained from the depentanizer stabilization of hydrotreated kerosine. It consists primarily of hydrogen, methane, ethane, and propane with various small amounts of nitrogen, hydrogen sulfide, carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C4 through C5.] | 272-775-5 | 68911-58-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-155-00-1 | Газове (нефтени), от колона за стабилизация за депентанизация на инсталацията за обработване с водород на сярасъдържащ керосин; | нефтозаводски газ; | [Сложна комбинация, получена от стабилизираща колона за депентанизация на керосин, обработен с водород. Състои се основно от водород, метан, етан и пропан с различни малки количества азот, водороден сулфид, въглероден моноксид и въглеводороди с брой на въглеродните атоми основно в интервала от C4 до C5.] | 272-775-5 | 68911-58-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-156-00-7 | Gases (petroleum), hydrotreated sour kerosine flash drum; Refinery gas; | [A complex combination obtained from the flash drum of the unit treating sour kerosine with hydrogen in the presence of a catalyst. It consists primarily of hydrogen and methane with various small amounts of nitrogen, carbon monoxide, and hydrocarbons having carbon numbers predominantly in the range of C2 through C5.] | 272-776-0 | 68911-59-1 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-156-00-7 | Газове (нефтени), от изпарителен барабан на инсталация за обработване с водород на сярасъдържащ керосин; нефтозаводски газ; | [Сложна комбинация, получена от изпарителен барабан на инсталация за обработване с водород на сярасъдържащ керосин в присъствие на катализатор. Състои се основно от водород и метан с различни малки количества от азот, въглероден моноксид и въглеводороди с брой въглеродни атоми главно в интервала от C2 до C5.] | 272-776-0 | 68911-59-1 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-157-00-2 | Gases (petroleum), distillate unifiner desulfurization stripper off; | Refinery gas; | [A complex combination stripped from the liquid product of the unifiner desulfurization process. It consists of hydrogen sulfide, methane, ethane, and propane.] | 272-873-8 | 68919-01-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-157-00-2 | Газове (нефтени), от разделителна колона от процес „Unifiner“ за десулфурация на дестилат; | нефтозаводски газ; | [Сложна комбинация, отделена от течния продукт от процес „Unifiner“ за десулфурация. Състои се от водороден сулфид, метан, етан и пропан.] | 272-873-8 | 68919-01-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-158-00-8 | Gases (petroleum), fluidized catalytic cracker fractionation off; | Refinery gas; | [A complex combination produced by the fractionation of the overhead product of the fluidized catalytic cracking process. It consists of hydrogen, hydrogen sulfide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 272-874-3 | 68919-02-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-158-00-8 | Газове (нефтени), от фракционираща колона на инсталация за каталитичен крекинг в кипящ слой; | нефтозаводски газ; | [Сложна комбинация, получена от фракциониране на продукти от горната част в инсталация за каталитичен крекинг в кипящ слой. Състои се от водород, водороден сулфид, азот и въглеводороди с брой на въглеродните атоми предимно в интервала от C1 до C5.] | 272-874-3 | 68919-02-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-159-00-3 | Gases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off; | Refinery gas; | [A complex combination produced by scrubbing the overhead gas from the fluidized catalytic cracker. It consists of hydrogen, nitrogen, methane, ethane and propane.] | 272-875-9 | 68919-03-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-159-00-3 | Газове (нефтени), от скрубера за вторична абсорбция след каталитичен крекинг в кипящ слой; | нефтозаводски газ; | [Сложна комбинация, получена при пречистването на газ от горната част при каталитичен крекинг в кипящ слой. Състои се от водород, азот, метан, етан и пропан.] | 272-875-9 | 68919-03-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-160-00-9 | Gases (petroleum), heavy distillate hydrotreater desulfurization stripper off; | Refinery gas; | [A complex combination stripped from the liquid product of the heavy distillate hydrotreater desulfurization process. It consists of hydrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 272-876-4 | 68919-04-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-160-00-9 | Газове (нефтени), от тежък дестилат от разделителната колона на процес на десулфурация в инсталация за обработване с водород | нефтозаводски газ; | [Сложна комбинация, отделена от течния продукт на тежък дестилат от процес на десулфурация в инсталация за обработване с водород. Състои се от водород, водороден сулфид и алифатни въглеводороди с брой на въглеродните атоми предимно в интервала от C1 до C5.] | 272-876-4 | 68919-04-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-161-00-4 | Gases (petroleum), platformer stabilizer off, light ends fractionation; | Refinery gas; | [A complex combination obtained by the fractionation of the light ends of the platinum reactors of the platformer unit. It consists of hydrogen, methane, ethane and propane.] | 272-880-6 | 68919-07-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-161-00-4 | Газове (нефтени), от стабилизатор на инсталация за платформинг, фракциониране на леки остатъчни фракции; | нефтозаводски газ; | [Сложна комбинация, получена при фракциониране на леки фракции от платинови реактори на инсталация за платформинг. Състои се от водород, метан, етан и пропан.] | 272-880-6 | 68919-07-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-162-00-X | Gases (petroleum), preflash tower off, crude distn.; | Refinery gas; | [A complex combination produced from the first tower used in the distillation of crude oil. It consists of nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 272-881-1 | 68919-08-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-162-00-X | Газове (нефтени), от колоната за предварително изпаряване от инсталацията за дестилация на суров нефт; | нефтозаводски газ; | [Сложна комбинация, получена от първата колона при дестилация на суров нефт. Състои се от азот и наситени алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C5.] | 272-881-1 | 68919-08-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-163-00-5 | Gases (petroleum), tar stripper off; | Refinery gas; | [A complex combination obtained by the fractionation of reduced crude oil. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] | 272-884-8 | 68919-11-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-163-00-5 | Газове (нефтени), от катраноотделител; | нефтозаводски газ; | [Сложна комбинация, получена при фракционирането на суров нефт с отстранени леки фракции. Състои се от водород и въглеводороди с брой на въглеродните атоми предимно в интервала от C1 до C4.] | 272-884-8 | 68919-11-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-164-00-0 | Gases (petroleum), unifiner stripper off; | Refinery gas; | [A combination of hydrogen and methane obtained by fractionation of the products from the unifiner unit.] | 272-885-3 | 68919-12-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-164-00-0 | Газове (нефтени), от разделителна колона от процес „Unifiner“; | нефтозаводски газ; | [Комбинация от водород и метан, получена при фракциониране на продукти от инсталация за процес „Unifiner“.] | 272-885-3 | 68919-12-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-165-00-6 | Tail gas (petroleum), catalytic hydrodesulfurized naphtha separator; | Refinery gas; | [A complex combination of hydrocarbons obtained from the hydrodesulfurization of naphtha. It consists of hydrogen, methane, ethane, and propane.] | 273-173-5 | 68952-79-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-165-00-6 | Остатъчен газ (нефтен), от сепаратор за каталитично хидродесулфурирана нафта; | нефтозаводски газ; | [Сложна комбинация от въглеводороди, получени при хидродесулфурация на нафта. Състои се от водород, метан, етан и пропан.] | 273-173-5 | 68952-79-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-166-00-1 | Tail gas (petroleum), straight-run naphtha hydrodesulfurizer; Refinery gas; | [A complex combination obtained from the hydrodesulfurization of straight-run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 273-174-0 | 68952-80-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-166-00-1 | Остатъчен газ (нефтен), от хидродесулфурация на нафта от пряка дестилация; нефтозаводски газ; | [Сложна комбинация, получена при хидродесулфурация на нафта от пряка дестилация. Състои се от водород и въглеводороди с брой на въглеродните атоми предимно в интервала от C1 до C5.] | 273-174-0 | 68952-80-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-167-00-7 | Gases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation; | Refinery gas; | [A complex combination obtained by the fractionation of products from the fluidized catalytic cracker and gas oil desulfurizer. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] | 273-269-7 | 68955-33-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-167-00-7 | Газове (нефтени), от абсорбер с порест материал, фракциониране на горни фракции при каталитичен крекинг в кипящ слой и десулфурация на газьол; | нефтозаводски газ; | [Сложна комбинация, получена при фракционирането на продукти от каталитичен крекинг в кипящ слой и от десулфурация на газьол. Състои се от водород и въглеводороди с брой на въглеродните атоми предимно в интервала от C1 до C4.] | 273-269-7 | 68955-33-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-168-00-2 | Gases (petroleum), crude distn. and catalytic cracking; | Refinery gas; | [A complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen, carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 273-563-5 | 68989-88-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-168-00-2 | Газове (нефтени), от дестилация на суров нефт и каталитичен крекинг; | нефтозаводски газ; | [Сложна комбинация, получена при процеси на дестилация на суров нефт и на каталитичен крекинг. Състои се от водород, водороден сулфид, въглероден моноксид и парафинови и олефинови въглеводороди с брой на въглеродните атоми предимно в интервала от C1 до C6.] | 273-563-5 | 68989-88-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-169-00-8 | Gases (petroleum), gas oil diethanolamine scrubber off; Refinery gas; | [A complex combination produced by desulfurization of gas oils with diethanolamine. It consists predominantly of hydrogen sulfide, hydrogen and aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.] | 295-397-2 | 92045-15-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-169-00-8 | Газове (нефтени), от диетаноламинов скрубер на газьол; нефтозаводски газ; | [Сложна комбинация, получена при десулфурация на газьоли с диетаноламин. Състои се от водороден сулфид, водород и наситени алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C5.] | 295-397-2 | 92045-15-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-170-00-3 | Gases (petroleum), gas oil hydrodesulfurization effluent; Refinery gas; | [A complex combination obtained by separation of the liquid phase from the effluent from the hydrogenation reaction. It consists predominantly of hydrogen, hydrogen sulfide and aliphatic hydro carbons having carbon numbers predominantly in the range of C1 through C3.] | 295-398-8 | 92045-16-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-170-00-3 | Газове (нефтени), изходящ поток от хидродесулфурация на газьол; нефтозаводски газ; | [Сложна комбинация, получена при разделянето на течната фаза от изходящия поток от реакцията на хидрогениране. Състои се предимно от водород, водороден сулфид и алифатни въглеводороди с брой на въглеродните атоми предимно в интервала от C1 до C3.] | 295-398-8 | 92045-16-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-171-00-9 | Gases (petroleum), gas oil hydrodesulfurization purge; Refinery gas; | [A complex combination of gases obtained from the reformer and from the purges from the hydrogenation reactor. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] | 295-399-3 | 92045-17-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-171-00-9 | Газове (нефтени), от продухване при хидродесулфурация на газьол; нефтозаводски газ; | [Сложна комбинация от газове, получена от инсталацията за риформинг и от продухването на реактора за хидрогениране. Състои се основно от водород и алифатни въглеводороди с брой на въглеродните атоми основно в интервала от C1 до C4.] | 295-399-3 | 92045-17-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-172-00-4 | Gases (petroleum), hydrogenator effluent flash drum off; | Refinery gas; | [A complex combination of gases obtained from flash of the effluents after the hydroge nation reaction. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 295-400-7 | 92045-18-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-172-00-4 | Газове (нефтени), от изходящия поток от изпарителния барабан на инсталацията за хидрогениране; | нефтозаводски газ; | [Сложна комбинация от газове, получена при изпаряване на изходящия поток след реакцията на хидрогениране. Състои се предимно от водород и алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C6.] | 295-400-7 | 92045-18-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-173-00-X | Gases (petroleum), naphtha steam cracking high-pressure residual; | Refinery gas; | [A complex combination obtained as a reaction mass of the non-condensable portions from the product of a naphtha steam cracking process as well as residual gases obtained during the preparation of subsequent products. It consists predominantly of hydrogen and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 with which natural gas may also be mixed.] | 295-401-2 | 92045-19-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-173-00-X | Газове (нефтени), остатък от паров крекинг на нафта при високо налягане; | нефтозаводски газ; | [Сложна комбинация, получена като реакционна маса от некондензиращите части на продукта от процес на паров крекинг на нафта, както и от остатъчни газове, получени при подготовка на следващи продукти. Състои се основно от водород и парафинови и олефинови въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C5, с които също е възможно да бъде смесен и природен газ.] | 295-401-2 | 92045-19-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-174-00-5 | Gases (petroleum), residue visbaking off; | Refinery gas; | [A complex combination obtained from viscosity reduction of residues in a furnace. It consists predominantly of hydrogen sulfide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 295-402-8 | 92045-20-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-174-00-5 | Газове (нефтени), от висбрекинг на остатъци; | нефтозаводски газ; | [Сложна комбинация, получена при понижаване на вискозитета на остатъци в пещ. Състои се основно от водороден сулфид и парафинови и олефинови въглеводороди с брой на въглеродните атоми предимно в интервала от C1 до C5.] | 295-402-8 | 92045-20-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-175-00-0 | Foots oil (petroleum), acid-treated; | Foots oil; | [A complex combination of hydrocarbons obtained by treatment of Foot's oil with sulfuric acid. It consists predominantly of branched-chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.] | 300-225-7 | 93924-31-3 | Flam. Gas 1 | Press. Gas | Carc. 1B | H220 | H350 | H340 | GHS02 | GHS04 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-175-00-0 | Масло, което се отделя при топенето на парафин (нефтено), обработено с киселина; | масло, което се отделя при топенето на парафин; | [Сложна комбинация от въглеводороди, получена от обработката със сярна киселина на масло, което се отделя при топенето на парафин. Състои се основно от въглеводороди с разклонена верига с брой на въглеродните атоми преобладаващо в интервала от C20 до C50.] | 300-225-7 | 93924-31-3 | Flam. Gas 1 | Press. Gas | Carc. 1B | H220 | H350 | H340 | GHS02 | GHS04 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-176-00-6 | Foots oil (petroleum), clay-treated; | Foots oil; | [A complex combination of hydrocarbons obtained by treatment of Foot's oil with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predomi nantly of branched chain hydro carbons with carbon numbers predominantly in the range of C20 through C50.] | 300-226-2 | 93924-32-4 | Flam. Gas 1 | Press. Gas | Carc. 1B | H220 | H350 | H340 | GHS02 | GHS04 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-176-00-6 | Масло, което се отделя при топенето на парафин (нефтено), обработено с глина; | масло, което се отделя при топенето на парафин; | [Сложна комбинация от въглеводороди, получена при обработване на масло, което се отделя при топенето на парафин, с природна или модифицирана глина, при контактен или перколационен процес, за отстраняване на следи от налични полярни съединения и онечиствания. Състои се основно от въглеводороди с разклонена верига с брой на въглеродните атоми преобладаващо в интервала от C20 до C50.] | 300-226-2 | 93924-32-4 | Flam. Gas 1 | Press. Gas | Carc. 1B | H220 | H350 | H340 | GHS02 | GHS04 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-177-00-1 | Gases (petroleum), C3-4; Petroleum gas; [A complex combination of hydrocarbons produced by distillation of products from the cracking of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C4, predominantly of propane and propylene, and boiling in the range of approximately - 51 oC to - 1 oC (– 60 oF to 30 oF.)] | 268-629-5 | 68131-75-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-177-00-1 | Газове (нефтени), C3-4; нефтен газ; [Сложна комбинация от въглеводороди, получена при дестилация на продукти от крекинг на суров нефт. Състои се от въглеводороди с брой на въглеродните атоми в интервала от C3 до C4, основно пропан и пропилен, и с температура на кипене приблизително в интервала от –51 oC до –1 oC (–60oF до 30oF).] | 268-629-5 | 68131-75-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-178-00-7 | Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber; Petroleum gas; | [The complex combination of hydrocarbons from the distillation of the products from catalytic cracked distillates and catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.] | 269-617-2 | 68307-98-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-178-00-7 | Остатъчен газ (нефтен), дестилат от каталитичен крекинг и нафта от каталитичен крекинг, фракциониращ абсорбер; нефтен газ; | [Сложна комбинация от въглеводороди, получена при дестилация на продуктите, получени от каталитично крекирани дестилати и от каталитично крекирана нафта. Състои се основно от въглеводороди с брой на въглеродните атоми в интервала от C1 до C4.] | 269-617-2 | 68307-98-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-179-00-2 | Tail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer; Petroleum gas; | [A complex combination of hydrocarbons from the fractionation stabilization products | from polymerization of naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.] | 269-618-8 | 68307-99-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-179-00-2 | Остатъчен газ (нефтен), от колона за стабилизация чрез фракциониране на каталитично полимеризирана нафта; нефтен газ; | [Сложна комбинация от въглеводороди от продукти от стабилизация чрез фракциониране | от полимеризирането на нафта. Състои се основно от въглеводороди с брой на въглеродните атоми в интервала от C1 до C4.] | 269-618-8 | 68307-99-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-180-00-8 | Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free; | Petroleum gas; | [A complex combination of hydrocarbons obtained from fractionation stabilization of catalytic reformed naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predomi nantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] | 269-619-3 | 68308-00-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-180-00-8 | Остатъчен газ (нефтен), от колона за стабилизация чрез фракциониране на нафта от каталитичен риформинг, без съдържание на водороден сулфид; | нефтен газ; | [Сложна комбинация от въглеводороди, получени при стабилизация чрез фракциониране на нафта от каталитичен риформинг, от които водородният сулфид е бил отстранен чрез обработване с амини. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C4.] | 269-619-3 | 68308-00-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-181-00-3 | Tail gas (petroleum), cracked distillate hydrotreater stripper; | Petroleum gas; | [A complex combination of hydrocarbons obtained by treating thermal cracked distillates with hydrogen in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 269-620-9 | 68308-01-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-181-00-3 | Остатъчен газ (нефтен), крекинг дестилат от разделителната колона на инсталацията за обработване с водород; | нефтен газ; | [Сложна комбинация от въглеводороди, получена при обработване на дестилати от термичен крекинг с водород в присъствие на катализатор. Състои се основно от наситени въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C6.] | 269-620-9 | 68308-01-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-182-00-9 | Tail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free; Petroleum gas; | [A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of straight run distillates and from which hydrogen sulfide has been removed by amine treatment. It consists predomi nantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] | 269-630-3 | 68308-10-1 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-182-00-9 | Остатъчен газ (нефтен), дестилат от пряка дестилация от хидродесулфуратор, без съдържание на водороден сулфид; нефтен газ; | [Сложна комбинация от въглеводороди, получена при каталитична хидродесулфурация на дестилати от пряка дестилация, от която водородният сулфид е бил отстранен чрез обработване с амини. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C4.] | 269-630-3 | 68308-10-1 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-183-00-4 | Tail gas (petroleum), gas oil catalytic cracking absorber; | Petroleum gas; | [A complex combination of hydrocarbons obtained from the distillation of products from the catalytic cracking of gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 269-623-5 | 68308-03-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-183-00-4 | Остатъчен газ (нефтен), каталитичен крекинг на газьол, абсорбер; | нефтен газ; | [Сложна комбинация от въглеводороди, получена при дестилация на продукти от каталитичен крекинг на газьол. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C5.] | 269-623-5 | 68308-03-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-184-00-X | Tail gas (petroleum), gas recovery plant; | Petroleum gas; | [A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 269-624-0 | 68308-04-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-184-00-X | Остатъчен газ (нефтен), от инсталация за извличане на газ; | нефтен газ; | [Сложна комбинация от въглеводороди, получена при дестилация на продукти от различни въглеводородни фракции. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C5.] | 269-624-0 | 68308-04-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-185-00-5 | Tail gas (petroleum), gas recovery plant deethanizer; | Petroleum gas; | [A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] | 269-625-6 | 68308-05-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-185-00-5 | Остатъчен газ (нефтен), от колона за деетанизация на инсталация за извличане на газ; | нефтен газ; | [Сложна комбинация от въглеводороди, получена при дестилация на продукти от различни въглеводородни фракции. Състои се от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C4.] | 269-625-6 | 68308-05-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-186-00-0 | Tail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free; | Petroleum gas; | [A complex combination of hydrocarbons obtained from fractionation of hydrodesul furized naphtha and distillate | hydrocarbon streams and treated to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 269-626-1 | 68308-06-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-186-00-0 | Остатъчен газ (нефтен), от фракционираща колона на хидродесулфуриран дестилат и хидродесулфурирана нафта, без съдържание на киселини; | нефтен газ; | [Сложна комбинация от въглеводороди, получени при фракционирането на въглеводородни фракции от хидродесулфурирани нафта и дестилат,обработени за отстраняване на киселинни онечиствания. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C5.] | 269-626-1 | 68308-06-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-187-00-6 | Tail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free; | Petroleum gas; | [A complex combination of hydrocarbons obtained from stripping stabilization of catalytic hydrodesulfurized vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 269-627-7 | 68308-07-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-187-00-6 | Остатъчен газ (нефтен), от разделителната колона за хидродесулфуриран вакуумен газьол, без съдържание на водороден сулфид; | нефтен газ; | [Сложна комбинация от въглеводороди, получена при стабилизация чрез ректификация на каталитично хидродесулфуриран вакуумен газьол, от която водородният сулфид е бил отстранен чрез обработване с амини. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C6.] | 269-627-7 | 68308-07-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-188-00-1 | Tail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free; | Petroleum gas; | [A complex combination of hydrocarbons obtained from fractionation stabilization of light straight run naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 269-629-8 | 68308-09-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-188-00-1 | Остатъчен газ (нефтен), стабилизатор на лека нафта от пряка дестилация без съдържание на водороден сулфид; | нефтен газ; | [Сложна комбинация от въглеводороди, получена при стабилизация чрез фракциониране на лека нафта от пряка дестилация, от която водородният сулфид е бил отстранен чрез обработване с амини. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C5.] | 269-629-8 | 68308-09-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-189-00-7 | Tail gas (petroleum), propane-propylene alkylation feed prep deethanizer; | Petroleum gas; | [A complex combination of hydrocarbons obtained from the distillation of the reaction products of propane with propylene. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] | 269-631-9 | 68308-11-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-189-00-7 | Остатъчен газ (нефтен), подготовка на захранването за алкилиране пропан-пропилен, колона за деетанизация; | нефтен газ; | [Сложна комбинация от въглеводороди, получена при дестилация на реакционните продукти на пропан с пропилен. Състои се от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C4.] | 269-631-9 | 68308-11-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-190-00-2 | Tail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free; | Petroleum gas; | [A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] | 269-632-4 | 68308-12-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-190-00-2 | Остатъчен газ (нефтен), хидродесулфуратор на вакуумен газьол, без съдържание на водороден сулфид; | нефтен газ; | [Сложна комбинация от въглеводороди, получена при каталитична хидродесулфурация на вакуумен газьол, от която водородният сулфид е бил отстранен чрез обработване с амини. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C6.] | 269-632-4 | 68308-12-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-191-00-8 | Gases (petroleum), catalytic cracked overheads; Petroleum gas; | [A complex combination of hydrocarbons produced by the distillation of products from the catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C5 and boiling in the range of approximately –48 oC to 32 oC (– 54 oF to 90oF).] | 270-071-2 | 68409-99-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-191-00-8 | Газове (нефтени), каталитично крекирани фракции от горната част; нефтен газ; | [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от каталитичен крекинг. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C3 до C5, с температура на кипене приблизително в интервала от –48 oC до 32 oC (–54 oF до 90oF).] | 270-071-2 | 68409-99-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-193-00-9 | Alkanes, C1-2; Petroleum gas | 270-651-5 | 68475-57-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-193-00-9 | Алкани, C1-2; Нефтен газ | 270-651-5 | 68475-57-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-194-00-4 | Alkanes, C2-3; Petroleum gas | 270-652-0 | 68475-58-1 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-194-00-4 | Алкани, C2-3; Нефтен газ | 270-652-0 | 68475-58-1 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-195-00-X | Alkanes, C3-4; | petroleum gas | 270-653-6 | 68475-59-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-195-00-X | Алкани, C3-4; | нефтен газ | 270-653-6 | 68475-59-2 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-196-00-5 | Alkanes, C4-5; Petroleum gas | 270-654-1 | 68475-60-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-196-00-5 | Алкани, C4-5; Нефтен газ | 270-654-1 | 68475-60-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-197-00-0 | Fuel gases; Petroleum gas; | [A combination of light gases. It consists predominantly of hydrogen and/or low molecular weight hydrocarbons.] | 270-667-2 | 68476-26-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-197-00-0 | Горивни газове нефтен газ; | [Комбинация от леки газове. Състои се основно от водород и/или въглеводороди с ниско молекулно тегло.] | 270-667-2 | 68476-26-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-198-00-6 | Fuel gases, crude oil of distillates; | Petroleum gas; | [A complex combination of light gases produced by distil lation of crude oil and by catalytic reforming of naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately - 217o C to - 12 o C (– 423 oF to 10 oF).] | 270-670-9 | 68476-29-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-198-00-6 | Горивни газове, дестилати на суров нефт | нефтен газ; | [Сложна комбинация от леки газове, получени чрез дестилация на суров нефт и чрез каталитичен риформинг на нафта. Състои се от водород и въглеводороди с брой на въглеродните атоми предимно в интервала от C1 до C4, с температура на кипене приблизително в интервала от –217o C до –12 o C (–423 oF до 10 oF).] | 270-670-9 | 68476-29-9 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-199-00-1 | Hydrocarbons, C3-4; Petroleum gas | 270-681-9 | 68476-40-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-199-00-1 | Въглеводороди, C3-4; Нефтен газ | 270-681-9 | 68476-40-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-200-00-5 | Hydrocarbons, C4-5; Petroleum gas | 270-682-4 | 68476-42-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-200-00-5 | Въглеводороди, C4-5; Нефтен газ | 270-682-4 | 68476-42-6 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-201-00-0 | Hydrocarbons, C2-4, C3-rich; Petroleum gas | 270-689-2 | 68476-49-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-201-00-0 | Въглеводороди, C2-4, богати на C3; Нефтен газ | 270-689-2 | 68476-49-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-202-00-6 | Petroleum gases, liquefied; Petroleum gas; | [A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately – | 40 oC to 80 oC (– 40oF to 176oF).] | 270-704-2 | 68476-85-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K S U649-202-00-6 | Нефтени газове, втечнени; нефтен газ; | [Сложна комбинация от въглеводороди, получена чрез дестилация на суров нефт. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C3 до C7, с температура на кипене приблизително в интервала от | –40 oC до 80 oC (–40oF до 176oF).] | 270-704-2 | 68476-85-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K S U
649-203-00-1 | Petroleum gases, liquefied, sweetened; | Petroleum gas; | [A complex combination of hydrocarbons obtained by subjecting liquefied petroleum gas mix to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately–40 o C to 80 o C (– 40 oF to176 oF).] | 270-705-8 | 68476-86-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K S U649-203-00-1 | Газове (нефтени), втечнени, десулфурирани; | нефтен газ; | [Сложна комбинация от въглеводороди, получена чрез подлагане на десулфурация на микс от втечнени нефтени газове за превръщане на меркаптани или за отстраняване на киселинни онечиствания. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от от C3 до C7, с температура на кипене приблизително в интервала от –40 oC до 80 oC (–40oF до 176oF).] | 270-705-8 | 68476-86-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K S U
649-204-00-7 | Gases (petroleum), C3-4, isobutane-rich; | Petroleum gas; | [A complex combination of hydrocarbons from the distillation of saturated and unsaturated hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly butane and isobutane. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C4, predominantly isobutane.] | 270-724-1 | 68477-33-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-204-00-7 | Газове (нефтени), C3-4, богати на изобутан; | нефтен газ; | [Сложна комбинация от въглеводороди, получена при дестилация на наситени и ненаситени въглеводороди, обикновено с брой на въглеродните атоми от C3 до C6, основно бутан и изобутан. Състои се от наситени и ненаситени въглеводороди, с брой на въглеродните атоми в интервала от C3 до C4, основно изобутан.] | 270-724-1 | 68477-33-8 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-205-00-2 | Distillates (petroleum), C3-6, piperylene-rich; | Petroleum gas; | [A complex combination of hydrocarbons from the distillation of saturated and unsaturated aliphatic hydrocarbons usually ranging in the carbon numbers C3 through C6. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C6, predominantly piperylenes.] | 270-726-2 | 68477-35-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-205-00-2 | Дестилати (нефтени), C3-6, богати на пиперилен; | нефтен газ; | [Сложна комбинация от въглеводороди, получена при дестилация на наситени и ненаситени алифатни въглеводороди, основно с брой на въглеродните атоми от C3 до C6. Състои се от наситени и ненаситени въглеводороди, с брой на въглеродните атоми в интервала от C3 до C6, основно пиперилени.] | 270-726-2 | 68477-35-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-206-00-8 | Gases (petroleum), butane splitter overheads; | Petroleum gas; | [A complex combination of hydrocarbons obtained from the distillation of the butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.] | 270-750-3 | 68477-69-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-206-00-8 | Газове (нефтени), фракции от горната част на дестилационна колона за бутан; | нефтен газ; | [Сложна комбинация от въглеводороди, получена при дестилация на бутановата фракция. Състои се от алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C3 до C4.] | 270-750-3 | 68477-69-0 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-207-00-3 | Gases (petroleum), C2-3-; Petroleum gas; | [A complex combination of hydrocarbons produced by the distillation of products from a catalytic fractionation process. It contains predominantly ethane, ethylene, propane, and propylene.] | 270-751-9 | 68477-70-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-207-00-3 | Газове (нефтени), C2-3; нефтен газ; | [Сложна комбинация от въглеводороди, получена при дестилация на продукти от каталитично фракциониране. Състои се основно от етан, етилен, пропан и пропилен.] | 270-751-9 | 68477-70-3 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-208-00-9 | Gases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free; | Petroleum gas; | [A complex combination of hydrocarbons obtained from fractionation of catalytic cracked gas oil hydrocarbon | stream and treated to remove hydrogen sulfide and other acidic components. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.] | 270-752-4 | 68477-71-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-208-00-9 | Газове (нефтени), дънни фракции от депропанизатор на газьол от каталитичен крекинг, богати на C4, | без съдържание на киселини; | нефтен газ; | [Сложна комбинация от въглеводороди, получена чрез фракциониране на каталитично крекирана въглеводородна | фракция от газьол и обработена за отстраняване на водородния сулфид и други киселинни компоненти. Състои се от въглеводороди с брой на въглеродните атоми в интервала от C3 до C5, основно C4.] | 270-752-4 | 68477-71-4 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-209-00-4 | Gases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich; | Petroleum gas; | [A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.] | 270-754-5 | 68477-72-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-209-00-4 | Газове (нефтени), дънни фракции от дебутанизатор на нафта от каталитичен крекинг, богати на C3-5; | нефтен газ; | [Сложна комбинация от въглеводороди, получена от стабилизиране на каталитично крекирана нафта. Състои се от алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C3 до C5.] | 270-754-5 | 68477-72-5 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-210-00-X | Tail gas (petroleum), isomerized naphtha fractionation stabilizer; | Petroleum gas; | [A complex combination of hydrocarbons obtained from the fractionation stabilization products from isomerized naphtha. It consists predomi nantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] | 269-628-2 | 68308-08-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U649-210-00-X | Остатъчен газ (нефтен), от колона за стабилизация чрез фракциониране на изомеризирана нафта; | нефтен газ; | [Сложна комбинация от въглеводороди, получени от фракциониране на продукти от стабилизация от изомеризирана нафта. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C4.] | 269-628-2 | 68308-08-7 | Press. Gas | Flam. Gas 1 | Carc. 1A Muta. 1B | H220 | H350 | H340 | GHS04 | GHS02 | GHS08 | Dgr | H220 | H350 | H340 |   |   | K U
649-211-00-5 | Foots oil (petroleum), carbon-treated; | Foots oil; | [A complex combination of hydrocarbons obtained by the treatment of Foots oil with activated carbon for the removal of trace constituents and impurities. It consists predominantly of saturated straight chain hydrocarbons having carbon numbers predominantly greater than C12.] | 308-126-0 | 97862-76-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-211-00-5 | Масло, което се отделя при топенето на парафин (нефтено), обработено с активен въглен; | масло, което се отделя при топенето на парафин; | [Сложна комбинация от въглеводороди, получена при обработване с активен въглен на масло, което се отделя при топенето на парафин, за отстраняване на следи от съставки и на онечиствания. Състои се основно от наситени въглеводороди с неразклонена верига и брой на въглеродните атоми предимно по-голям от C12.] | 308-126-0 | 97862-76-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-212-00-0 | Distillates (petroleum), sweetened middle; | Gasoil — unspecified; | [A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150oC to 345oC (302 o F to 653oF).] | 265-088-7 | 64741-86-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-212-00-0 | Дестилати (нефтени), десулфурирани, средни; | Газьол — неспецифициран; | [Сложна комбинация от въглеводороди, получена при подлагане на десулфурация на нефтен дестилат за превръщане на меркаптаните или за отстраняване на киселинните онечиствания. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C9 до C20, и с температура на кипене приблизително в интервала от 150 oC до 345 oC (302oF до 653oF).] | 265-088-7 | 64741-86-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-213-00-6 | Gas oils (petroleum), solvent-refined; | Gasoil — unspecified; | [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205oC to 400oC (401oF to 752oF).] | 265-092-9 | 64741-90-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-213-00-6 | Газьоли (нефтени), рафинирани с разтворител; | Газьол — неспецифициран; | [Сложна комбинация от въглеводороди, получена като рафинат от екстракция с разтворител. Състои се основно от алифатни въглеводороди с брой на въглеродните атоми в интервала от C11 до C25, с температура на кипене приблизително в интервала от 205 oC до 400 oC (401oF до 752oF).] | 265-092-9 | 64741-90-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-214-00-1 | Distillates (petroleum), solvent-refined middle; | Gasoil — unspecified; | [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150oC to 345oC (302oF to 653 oF).] | 265-093-4 | 64741-91-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-214-00-1 | Дестилати (нефтени), рафинирани с разтворител, средни; | Газьол — неспецифициран; | [Сложна комбинация от въглеводороди, получена като рафинат от екстракция с разтворител. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C9 до C20, с температура на кипене приблизително в интервала от 150 oC до 345 oC (302oF до 653oF).] | 265-093-4 | 64741-91-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-215-00-7 | Gas oils (petroleum), acid-treated; | Gasoil — unspecified; | [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230oC to 400oC (446oF to 752 oF).] | 265-112-6 | 64742-12-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-215-00-7 | Газьоли (нефтени), обработени с киселина; | Газьол — неспецифициран; | [Сложна комбинация от въглеводороди, получена като рафинат от процес на обработване със сярна киселина. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C13 до C25, с температура на кипене приблизително в интервала от 230 oC до 400 oC (446oF до 752oF).] | 265-112-6 | 64742-12-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-216-00-2 | Distillates (petroleum), acid-treated middle; | Gasoil — unspecified; | [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).] | 265-113-1 | 64742-13-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-216-00-2 | Дестилати (нефтени), обработени с киселина, средни; | Газьол — неспецифициран; | [Сложна комбинация от въглеводороди, получена като рафинат от процес на обработване със сярна киселина. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C11 до C20, с температура на кипене приблизително в интервала от 205 oC до 345 oC (401oF до 653oF).] | 265-113-1 | 64742-13-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-217-00-8 | Distillates (petroleum), acid-treated light; | Gasoil — unspecified; | [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150oC to 290oC (302oF to 554oF).] | 265-114-7 | 64742-14-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-217-00-8 | Дестилати (нефтени), обработени с киселина, леки, | Газьол — неспецифициран; | [Сложна комбинация от въглеводороди, получена като рафинат от процес на обработване със сярна киселина. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C9 до C16, с температура на кипене приблизително в интервала от 150 oC до 290 oC (302oF до 554oF).] | 265-114-7 | 64742-14-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-218-00-3 | Gas oils (petroleum), chemically neutralized; | Gasoil — unspecified; | [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446oF to 752 oF).] | 265-129-9 | 64742-29-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-218-00-3 | Газьоли (нефтени), химично неутрализирани; | Газьол — неспецифициран; | [Сложна комбинация от въглеводороди, получена при процес на обработване за отстраняване на киселинните материали. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C13 до C25, и с температура на кипене приблизително в интервала от 230 oC до 400 oC (446oF до 752oF).] | 265-129-9 | 64742-29-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-219-00-9 | Distillates (petroleum), chemically neutralized middle; | Gasoil — unspecified; | [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205oC to 345oC (401oF to 653oF).] | 265-130-4 | 64742-30-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-219-00-9 | Дестилати (нефтени), химично неутрализирани, средни; | Газьол — неспецифициран; | [Сложна комбинация от въглеводороди, получена при процес на обработване за отстраняване на киселинните материали. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C11 до C20, и с температура на кипене приблизително в интервала от 205 oC до 345 oC (401oF до 653oF).] | 265-130-4 | 64742-30-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-220-00-4 | Distillates (petroleum), clay-treated middle; | Gasoil — unspecified; | [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150oC to 345oC (302oF to 653oF).] | 265-139-3 | 64742-38-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-220-00-4 | Дестилати (нефтени), обработени с глина, средни; | Газьол — неспецифициран; | [Сложна комбинация от въглеводороди, получена при обработване на нефтена фракция с природна или модифицирана глина, обичайно при перколационен процес, за отстраняване на следи от налични полярни съединения и онечиствания. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C9 до C20, и с температура на кипене приблизително в интервала от 150 oC до 345 oC (302oF до 653oF).] | 265-139-3 | 64742-38-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-221-00-X | Distillates (petroleum), hydrotreated middle; | Gasoil — unspecified; | [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately | 205oC to 400oC (401 oF to 752 oF).] | 265-148-2 | 64742-46-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-221-00-X | Дестилати (нефтени), обработени с водород, средни; | Газьол — неспецифициран; | [Сложна комбинация от въглеводороди, получена при обработване на нефтена фракция с водород в присъствие на катализатор. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C11 до C25 и с температура на кипене приблизително в интервала от | 205 oC до 400 oC (401oF до 752oF).] | 265-148-2 | 64742-46-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-222-00-5 | Gas oils (petroleum), hydrodesulfurized; | Gasoil — unspecified; | [A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230oC to 400oC (446oF to 752 oF).] | 265-182-8 | 64742-79-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-222-00-5 | Дестилати (нефтени), хидродесулфурирани; | Газьол — неспецифициран; | [Сложна комбинация от въглеводороди, получена при обработване на нефтена суровина с водород за превръщане на органичната сяра във водороден сулфид, който се отстранява. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C13 до C25, и с температура на кипене приблизително в интервала от 230 oC до 400 oC (446oF до 752oF).] | 265-182-8 | 64742-79-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-223-00-0 | Distillates (petroleum), hydrodesulfurized middle; | Gasoil — unspecified; | [A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205oC to 400oC (401oF to 752oF).] | 265-183-3 | 64742-80-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-223-00-0 | Дестилати (нефтени), хидродесулфурирани, средни; | Газьол — неспецифициран; | [Сложна комбинация от въглеводороди, получена при обработване на нефтена суровина с водород за превръщане на органичната сяра във водороден сулфид, който се отстранява. Състои се от въглеводороди с брой на въглеродните атоми основно от C11 до C25, и с температура на кипене приблизително в интервала от 205 oC до 400 oC (401oF до 752oF).] | 265-183-3 | 64742-80-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-224-00-6 | Fuels, diesel; | Gasoil — unspecified; | [A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 163oC to 357oC (325oF to 675oF).] | 269-822-7 | 68334-30-5 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   | N649-224-00-6 | Горива, дизелови; | Газьол — неспецифициран; | [Сложна комбинация от въглеводороди, получена чрез дестилация на суров нефт. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C9 до C20 и с температура на кипене в интервала приблизително от 163 oC до 357 oC (325oF до 675oF).] | 269-822-7 | 68334-30-5 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   | N
649-225-00-1 | Fuel oil, No 2; | Gasoil — unspecified; | [A distillate oil having a minimum viscosity of 32,6 SUS at 37,7oC (100oF) to a maximum of 37,9 SUS at 37,7oC (100 oF).] | 270-671-4 | 68476-30-2 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  649-225-00-1 | Горивно масло, № 2; | Газьол — неспецифициран; | [Маслен дестилат с минимален вискозитет 32,6 SUS при 37,7 oC (100oF) до максимален вискозитет 37,9 SUS при 37,7 oC (100oF).] | 270-671-4 | 68476-30-2 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  
649-226-00-7 | Fuel oil, No 4; | Gasoil — unspecified; | [A distillate oil having a minimum viscosity of 45 SUS at 37,7oC (100oF) to a maximum of 125 SUS at 37,7 oC (100 oF).] | 270-673-5 | 68476-31-3 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  649-226-00-7 | Горивно масло, № 4; | Газьол — неспецифициран; | [Маслен дестилат с минимален вискозитет 45 SUS при 37,7 oC (100oF) до максимален вискозитет 125 SUS при 37,7 oC (100oF).] | 270-673-5 | 68476-31-3 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  
649-227-00-2 | Fuels, diesel, No 2; Gasoil — unspecified; | [A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF).] | 270-676-1 | 68476-34-6 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  649-227-00-2 | Горива, дизелови, № 2; Газьол — неспецифициран; | [Нефтен дестилат с минимален вискозитет 32,6 SUS при 37,7 oC (100oF).] | 270-676-1 | 68476-34-6 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  
649-228-00-8 | Distillates (petroleum), catalytic reformer fractionator residue, high-boiling; | Gasoil — unspecified; | [A complex combination of hydrocarbons from the distillation of catalytic reformer fracftionator residue. It boils in the range of approximately 343 oC to 99oC (650oF to 750 oF).] | 270-719-4 | 68477-29-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-228-00-8 | Дестилати (нефтени), остатъци от ректификационна колона на каталитичен риформинг, висококипящи; | Газьол — неспецифициран; | [Сложна комбинация от въглеводороди от остатъци от ректификационна колона на каталитичен риформинг. Кипи в обхвата от около 343 oC до 399 oC (650 oF до 750 oF).] | 270-719-4 | 68477-29-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-229-00-3 | Distillates (petroleum), catalytic reformer fractionator residue, intermediate-boiling; | Gasoil — unspecified; | [A complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils in the range of approximately 288oC to 371oC (550oF to 700oF).] | 270-721-5 | 68477-30-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-229-00-3 | Дестилати (нефтени), остатъци от ректификационна колона на каталитичен риформинг, с междинна температура на кипене; | Газьол — неспецифициран; | [Сложна комбинация от въглеводороди от дестилация на остатъци от ректификационна колона на каталитичен риформинг. Кипи в обхвата от около 288 oC до 371 oC (550 oF до 700 oF).] | 270-721-5 | 68477-30-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-230-00-9 | Distillates (petroleum), catalytic reformer fractionator residue, low-boiling; | Gasoil — unspecified; | [The complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils approximately below 288 oC (550oF).] | 270-722-0 | 68477-31-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-230-00-9 | Дестилати (нефтени), остатъци от ректификационна колона на каталитичен риформинг, нискокипящи; | Газьол — неспецифициран; | [Сложна комбинация от въглеводороди от дестилацията на остатъци от ректификационна колона на каталитичен риформинг. Има температура на кипене приблизително под 288 oC (550oF).] | 270-722-0 | 68477-31-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-231-00-4 | Distillates (petroleum), highly refined middle; | Gasoil — unspecified; | [A complex combination of hydrocarbons obtained by the subjection of a petroleum fraction to several of the following steps: filtration, centrifugation, atmospheric distillation, vacuum distillation, acidification, neutralization and clay treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C20.] | 292-615-8 | 90640-93-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-231-00-4 | Дестилати (нефтени), високо рафинирани, средни; | Газьол — неспецифициран; | [Сложна комбинация от въглеводороди от подлагането на нефтена фракция на няколко от следните етапи: филтруване, центрофугиране, атмосферна дестилация, вакуумна дестилация, подкиселяване, неутрализация и обработка с глина. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C10 до C20.] | 292-615-8 | 90640-93-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-232-00-X | Distillates (petroleum) catalytic reformer, heavy arom. conc.; Gasoil — unspecified; [A complex combination of hydrocarbons obtained from the distillation of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C16 and boiling in the range of approximately 200oC to 300oC (392 oF to 572 oF).] | 295-294-2 | 91995-34-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-232-00-X | Дестилати (нефтени) от каталитичен риформинг, с висока концентрация на тежки ароматни въглеводороди; Газьол — неспецифициран; [Сложна комбинация от въглеводороди, получена от дестилацията на нефтена фракция от каталитичен риформинг. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C10 до C16, и с температура на кипене приблизително в интервала от 200 oC до 300 oC (392oF до 572oF).] | 295-294-2 | 91995-34-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-233-00-5 | Gas oils, paraffinic; Gasoil — unspecified; | [A distillate obtained from the redistillation of a complex combination of hydrocarbons obtained by the distillation of the effluents from a severe catalytic hydrotreatment of paraffins. It boils in the range of approximately 190oC to 330oC (374oF to 594oF).] | 300-227-8 | 93924-33-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-233-00-5 | Газьоли, парафинови; Газьол — неспецифициран; | [Дестилат, получен от редестилацията на сложна комбинация от въглеводороди, получени от дестилацията на изходящите потоци от каталитична обработка на парафини с водород в твърд режим. Кипи в обхвата от около 190 oC до 330 oC (374 oF до 594 oF).] | 300-227-8 | 93924-33-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-234-00-0 | Naphtha (petroleum), solvent-refined hydrodesulfurized heavy; | Gasoil — unspecified | 307-035-3 | 97488-96-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-234-00-0 | Нафта (нефтена), рафинирана с разтворители, хидродесулфурирана, тежка; | Газьол — неспецифициран | 307-035-3 | 97488-96-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-235-00-6 | Hydrocarbons, C16-20, hydrotreated middle distillate, distn. lights; | Gasoil — unspecified; [A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a middle distillate with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 290 oC to 350 oC (554 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).] | 307-659-6 | 97675-85-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-235-00-6 | Въглеводороди, C16-20, обработени с водород средни дестилати, леки;; | Газьол — неспецифициран; [Сложна комбинация от въглеводороди, получени като първи поток от вакуумна дестилация на изходящи потоци от обработката на среден дестилат с водород. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C16 до C20, с температура на кипене приблизително в интервала от 290 oC до 350 oC (554oF до 662oF).] От нея се получава крайно масло с вискозитет от 2 cSt. при 100 oC (212oF).] | 307-659-6 | 97675-85-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-236-00-1 | Hydrocarbons, C12-20, hydrotreated paraffinic, distn. lights; | Gasoil — unspecified; | [A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluent from the treatment of heavy paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C20 and boiling in the range of approximately 230 oC to 350 oC (446 oF to 662 oF). It produces a finished oil having viscosity of 2cSt at 100oC (212oF).] | 307-660-1 | 97675-86-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-236-00-1 | Въглеводороди, C12-20, обработени с водород, парафинови, леки дестилати; | Газьол — неспецифициран; | [Сложна комбинация от въглеводороди, получени като първи поток от вакуумна дестилация на изходящ поток от обработката на тежки парафини с водород в присъствие на катализатор. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C12 до C20, и с температура на кипене приблизително в интервала от 230 oC до 350 oC (446oF до 662oF).] От нея се получава крайно масло с вискозитет от 2 cSt. при 100 oC (212oF).] | 307-660-1 | 97675-86-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-237-00-7 | Hydrocarbons, C11-17, solvent-extd. light naphthenic; | Gasoil — unspecified; | [A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a visciosity of 2.2 cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 200oC to 300oC (392oF to 572 oF).] | 307-757-9 | 97722-08-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-237-00-7 | Въглеводороди, C11-17, екстрахирани с разтворител, леки нафтенови; | Газьол — неспецифициран; | [Сложна комбинация от въглеводороди, получени от екстракцията на ароматните съединения от лек нафтенов дестилат, с вискозитет от 2,2 cSt при 40 oC (104 oF). Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C11 до C17 и с температура на кипене приблизително в интервала от 200 oC до 300 oC (392oF до 572oF).] | 307-757-9 | 97722-08-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-238-00-2 | Gas oils, hydrotreated; Gasoil — unspecified; | [A complex combination of hydrocarbons obtained from the redistillation of the effluents from the treatment of paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C27 and boiling in the range of approximately 330oC to 340oC (626oF to 644oF).] | 308-128-1 | 97862-78-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-238-00-2 | Газьоли, обработени с водород; Газьол — неспецифициран; | [Сложна комбинация от въглеводороди, получена от редестилация на изходящи потоци от обработка на парафини с водород в присъствието на катализатор. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C17 до C27, с температура на кипене приблизително в интервала от 330 oC до 340 oC (626oF до 644oF).] | 308-128-1 | 97862-78-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-239-00-8 | Distillates (petroleum), carbon-treated light paraffinic; | Gasoil — unspecified; | [A complex combination of hydrocarbons obtained by the treatment of a petroleum oil fraction with activated charcoal for the removal of traces of polar constituents and impur ities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C28.] | 309-667-5 | 100683-97-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-239-00-8 | Дестилати (нефтени), обработени с активен въглен леки парафинови; | Газьол — неспецифициран; | [Сложна комбинация от въглеводороди, получени от обработката на фракция от нефтено масло с активен въглен за отстраняването на следи от полярни съставки и онечиствания. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C12 до C28.] | 309-667-5 | 100683-97-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-240-00-3 | Distillates (petroleum), intermediate paraffinic, carbon-treated; | Gasoil — unspecified; | [A complex combination of hydrocarbons obtained by the treatment of petroleum with activated charcoal for the removal of trace polar consti tuents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.] | 309-668-0 | 100683-98-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-240-00-3 | Дестилати (нефтени), обработени с активен въглен, междинни парафинови; | Газьол — неспецифициран; | [Сложна комбинация от въглеводороди, получена от обработката на нефт с активен въглен, за отстраняването на следи от полярни съставки и онечиствания. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C16 до C36.] | 309-668-0 | 100683-98-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-241-00-9 | Distillates (petroleum), intermediate paraffinic, clay-treated; Gasoil — unspecified; [A complex combination of hydrocarbons obtained by the treatment of petroleum with bleaching earth for the removal of trace polar constituents and impurities. It consists predomi nantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.] | 309-669-6 | 100683-99-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-241-00-9 | Дестилати (нефтени), междинни парафинови, обработени с глина; Газьол — неспецифициран; [Сложна комбинация от въглеводороди, получена от обработката на нефт с избелваща пръст за отстраняването на следи от полярни съставки и онечиствания. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C16 до C36.] | 309-669-6 | 100683-99-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-242-00-4 | Alkanes, C12-26-branched and linear | 292-454-3 | 90622-53-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-242-00-4 | Алкани, C12-26, с неразклонена и разклонена верига | 292-454-3 | 90622-53-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-243-00-X | Lubricating greases; Grease; | [A complex combination of hydrocarbons having carbon numbers predominantly in the range of C12 through C50. May contain organic salts of alkali metals, alkaline earth metals, and/or aluminium compounds.] | 278-011-7 | 74869-21-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-243-00-X | Смазочни греси; Грес; | [Сложна комбинация от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C12 до C50.] Може да съдържа органични соли на алкални метали, алкалоземни метали и/или алуминиеви съединения.] | 278-011-7 | 74869-21-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-244-00-5 | Slack wax (petroleum); Slack wax; | [A complex combination of hydrocarbons obtained from a petroleum fraction by solvent crystallization (solvent dewaxing) or as a distillation fraction from a very waxy crude. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.] | 265-165-5 | 64742-61-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-244-00-5 | Суров парафин (нефт); Суров парафин; | [Сложна комбинация от въглеводороди, получени от нефтена фракция чрез кристализация с разтворител (депарафиниране с разтворител) или като дестилационна фракция от суров нефт с много високо съдържание на парафин. Състои се основно от наситени въглеводороди с неразклонена и разклонена верига и брой на въглеродните атоми предимно по-голям от C20.] | 265-165-5 | 64742-61-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-245-00-0 | Slack wax (petroleum), acid-treated; | Slack wax; | [A complex combination of hydrocarbons obtained as a raffinate by treatment of a petroleum slack wax fraction with sulfuric acid treating process. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.] | 292-659-8 | 90669-77-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-245-00-0 | Суров парафин (нефтен), обработен с киселина; | Суров парафин; | [Сложна комбинация от въглеводороди, получени като рафинат чрез обработката на нефтена фракция на суров парафин със сярна киселина. Състои се основно от наситени въглеводороди с неразклонена и разклонена верига и брой на въглеродните атоми предимно по-голям от C20.] | 292-659-8 | 90669-77-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-246-00-6 | Slack wax (petroleum), clay-treated; | Slack wax; | [A complex combination of hydrocarbons obtained by treatment of a petroleum slack wax fraction with natural or modified clay in either a contacting or percolation process. It consists predomi nantly of saturated straight and branched hydrocarbons having carbon numbers predominantly greater than C20.] | 292-660-3 | 90669-78-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-246-00-6 | Суров парафин (нефтен), обработен с глина; | Суров парафин; | [Сложна комбинация от въглеводороди, получени чрез обработката на нефтена фракция на суров парафин с природна или модифицирана глина при контактен или перколационен процес. Състои се основно от наситени въглеводороди с неразклонена и разклонена верига и брой на въглеродните атоми предимно по-голям от C20.] | 292-660-3 | 90669-78-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-247-00-1 | Slack wax (petroleum), hydrotreated; | Slack wax; | [A complex combination of hydrocarbons obtained by treating slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.] | 295-523-6 | 92062-09-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-247-00-1 | Суров парафин (нефтен), обработен с водород; | Суров парафин; | [Сложна комбинация от въглеводороди, получена от обработване на суров парафин с водород в присъствие на катализатор. Състои се основно от наситени въглеводороди с неразклонена и разклонена верига и брой на въглеродните атоми предимно по-голям от C20.] | 295-523-6 | 92062-09-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-248-00-7 | Slack wax (petroleum), low-melting; | Slack wax; | [A complex combination of hydrocarbons obtained from a petroleum fraction by solvent deparaffination. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] | 295-524-1 | 92062-10-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-248-00-7 | Суров парафин (нефтен), нискотопим; | Суров парафин; | [Сложна комбинация от въглеводороди, получени от нефтена фракция чрез депарафиниране с разтворител. Състои се основно от наситени въглеводороди с неразклонена и разклонена верига и брой на въглеродните атоми предимно по-голям от C12.] | 295-524-1 | 92062-10-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-249-00-2 | Slack wax (petroleum), low-melting, hydrotreated; | Slack wax; | [A complex combination of hydrocarbons obtained by treatment of low-melting petroleum slack wax with hydrogen in the presence of a catalyst. It consists predomi nantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] | 295-525-7 | 92062-11-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-249-00-2 | Суров парафин (нефтен), нискотопим, обработен с водород; | Суров парафин; | [Сложна комбинация от въглеводороди, получени от обработката с водород на нефтен суров парафин с ниска точка на топене в присъствието на катализатор. Състои се основно от наситени въглеводороди с неразклонена и разклонена верига и брой на въглеродните атоми предимно по-голям от C12.] | 295-525-7 | 92062-11-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-250-00-8 | Slack wax (petroleum), low-melting, carbon-treated; | Slack wax; | [A complex combination of hydrocarbons obtained by the treatment of low-melting slack wax with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] | 308-155-9 | 97863-04-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-250-00-8 | Суров парафин (нефтен), нискотопим, обработен с активен въглен; | Суров парафин; | [Сложна комбинация от въглеводороди, получена от обработката с активен въглен на нискотопим суров парафин за отстраняване на следи от полярни съставки и онечиствания. Състои се основно от наситени въглеводороди с неразклонена и разклонена верига и брой на въглеродните атоми предимно по-голям от C12.] | 308-155-9 | 97863-04-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-251-00-3 | Slack wax (petroleum), low-melting, clay-treated; | Slack wax; | [A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with bentonite for removal of trace polar constituents and impur ities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] | 308-156-4 | 97863-05-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-251-00-3 | Суров парафин (нефтен), нискотопим, обработен с глина; | Суров парафин; | [Сложна комбинация от въглеводороди, получени от обработката с бентонит на нефтен суров парафин с ниска точка на топене за отстраняването на следи от полярни съставки и примеси. Състои се основно от наситени въглеводороди с неразклонена и разклонена верига и брой на въглеродните атоми предимно по-голям от C12.] | 308-156-4 | 97863-05-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-252-00-9 | Slack wax (petroleum), low-melting, silicic acid-treated; Slack wax; [A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] | 308-158-5 | 97863-06-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-252-00-9 | Суров парафин (нефтен), нискотопим, обработен със силициева киселина; Суров парафин; [Сложна комбинация от въглеводороди, получена от обработката със силициева киселина на нискотопим нефтен суров парафин за отстраняване на следи от полярни съставки и онечиствания. Състои се основно от наситени въглеводороди с неразклонена и разклонена верига и брой на въглеродните атоми предимно по-голям от C12.] | 308-158-5 | 97863-06-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-253-00-4 | Slack wax (petroleum), carbon-treated; | Slack wax; | [A complex combination of hydrocarbons obtained by treatment of petroleum slack wax with activated charcoal for the removal of trace polar constituents and impurities.] | 309-723-9 | 100684-49-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-253-00-4 | Суров парафин (нефтен), обработен с активен въглен; | Суров парафин; | [Сложна комбинация от въглеводороди, получена при обработване на нефтен суров парафин с активен въглен за отстраняване на следи от полярни съставки и онечиствания.] | 309-723-9 | 100684-49-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-254-00-X | Petrolatum; Petrolatum; | [A complex combination of hydrocarbons obtained as a semi-solid from dewaxing paraffinic residual oil. It consists predominantly of saturated crystalline and liquid hydrocarbons having carbon numbers predominantly greater than C25.] | 232-373-2 | 8009-03-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-254-00-X | Петролатум; Петролатум; | [Сложна комбинация от въглеводороди, получени като полутвърд продукт от депарафинирането на остатъчно парафиново масло. Състои се основно от наситени кристални и течни въглеводороди с брой на въглеродните атоми предимно по-голям от C25.] | 232-373-2 | 8009-03-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-255-00-5 | Petrolatum (petroleum), oxidized; | Petrolatum; | [A complex combination of organic compounds, predominantly high molecular weight carboxylic acids, obtained by the air oxidation of petrolatum.] | 265-206-7 | 64743-01-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-255-00-5 | Петролатум (нефтен), окислен; | Петролатум; | [Сложна комбинация от органични съединения, основно карбоксилни киселини с високо молекулно тегло, получена при окисление на петролатум в присъствие на въздух.] | 265-206-7 | 64743-01-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-256-00-0 | Petrolatum (petroleum), alumina-treated; | Petrolatum; | [A complex combination of hydrocarbons obtained when petrolatum is treated with Al2O3 to remove polar components and impurities. It consists predominantly of saturated, crystalline, and liquid hydrocarbons having carbon numbers predominantly greater than C25.] | 285-098-5 | 85029-74-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-256-00-0 | Петролатум (нефтен), обработен с диалуминиев триоксид; | Петролатум; | [[Сложна комбинация от въглеводороди, получена при обработване на петролатум с Al2O3 за отстраняване на полярни съставки и онечиствания. Състои се основно от наситени, кристални и течни въглеводороди с брой на въглеродните атоми предимно по-голям от C25.] | 285-098-5 | 85029-74-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-257-00-6 | Petrolatum (petroleum), hydrotreated; | Petrolatum; | [A complex combination of hydrocarbons obtained as a semi-solid from dewaxed paraffinic residual oil treated with hydrogen in the presence of a catalyst. It consists predominantly of saturated microcrystalline and liquid hydrocarbons having carbon numbers predominantly greater than C20.] | 295-459-9 | 92045-77-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-257-00-6 | Петролатум (нефтен), обработен с водород; | Петролатум; | [Сложна комбинация от въглеводороди, получени като полутвърд продукт от депарафинирането на остатъчно парафиново масло, обработено с водород в присъствието на катализатор. Състои се основно от наситени микрокристални и течни въглеводороди с брой на въглеродните атоми предимно по-голям от C20.] | 295-459-9 | 92045-77-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-258-00-1 | Petrolatum (petroleum), carbon-treated; | Petrolatum; | [A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with activated carbon for the removal of trace polar constituents and impur ities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.] | 308-149-6 | 97862-97-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-258-00-1 | Петролатум (нефтен), обработен с активен въглен; | Петролатум; | [Сложна комбинация от въглеводороди, получени от обработката на нефтен петролатум с активен въглен за отстраняването на следи от полярни съставки и онечиствания. Състои се основно от наситени въглеводороди с брой на въглеродните атоми предимно по-голям от C20.] | 308-149-6 | 97862-97-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-259-00-7 | Petrolatum (petroleum), silicic acid-treated; | Petrolatum; | [A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.] | 308-150-1 | 97862-98-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-259-00-7 | Петролатум (нефтен), обработен със силициева киселина; | Петролатум; | [Сложна комбинация от въглеводороди, получени от обработката на нефтен петролатум със силициева киселина за отстраняването на следи от полярни съставки и онечиствания. Състои се основно от наситени въглеводороди с брой на въглеродните атоми предимно по-голям от C20.] | 308-150-1 | 97862-98-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-260-00-2 | Petrolatum (petroleum), clay-treated; | Petrolatum; [A complex combination of hydrocarbons obtained by treatment of petrolatum with bleaching earth for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of greater than C25.] | 309-706-6 | 100684-33-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N649-260-00-2 | Петролатум (нефтен), обработен с глина; | Петролатум; [Сложна комбинация от въглеводороди, получени от обработката на петролатум с избелваща пръст за отстраняването на следи от полярни съставки и онечиствания. Състои се основно от въглеводороди с брой на въглеродните атоми по- голям от C25.] | 309-706-6 | 100684-33-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | N
649-261-00-8 | Gasoline, natural; | Low boiling point naphtha; | [A complex combination of hydrocarbons separated from natural gas by processes such as refrigeration or absorption. It consists predominantly of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 20 oC to 120 oC (– 4oF to 248oF).] | 232-349-1 | 8006-61-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-261-00-8 | Бензин, отделен от природен газ; | Нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, отделена от природен газ чрез процеси като охлаждане или абсорбция. Състои се основно от наситени алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C4 до C8 и с температура на кипене приблизително в интервала от –20 oC до 120 oC (–4oF до 248oF).] | 232-349-1 | 8006-61-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-262-00-3 | Naphtha; | Low boiling point naphtha; [Refined, partly refined, or unrefined petroleum products produced by the distillation of natural gas. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 100o C to 200o C (212oF to 392oF).] | 232-443-2 | 8030-30-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-262-00-3 | Нафта с ниска температура на кипене; | Нафта с ниска температура на кипене; [Рафинирани, частично рафинирани или нерафинирани нефтени продукти, получени чрез дестилация на природен газ. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C5 до C6, с температура на кипене приблизително в интервала от 100 oC до 200 oC (212oF до 392oF).] | 232-443-2 | 8030-30-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-263-00-9 | Ligroine; | Low boiling point naphtha; | [A complex combination of hydrocarbons obtained by the fractional distillation of petroleum. This fraction boils in a range of approximately 20 oC to 135 oC (58oF to 275oF).] | 232-453-7 | 8032-32-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-263-00-9 | Лигроин; | Нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез фракционна дестилация на нефт. Тази фракция кипи в интервал приблизително 20 oC—135 oC (58 oF—275 oF).] | 232-453-7 | 8032-32-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-264-00-4 | Naphtha (petroleum), heavy straight-run; Low boiling point naphtha; [A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (149oF to 446oF).] | 265-041-0 | 64741-41-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-264-00-4 | Нафта (нефтена), тежка прякодестилатна; Нафта с ниска температура на кипене; [Сложна комбинация от въглеводороди, получена чрез дестилация на суров нефт. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C6 до C12, с температура на кипене приблизително в интервала от 65 oC до 230 oC (149 oF до 446oF).] | 265-041-0 | 64741-41-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-265-00-X | Naphtha (petroleum), full-range straight-run; | Low boiling point naphtha; | [A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 220 oC (– 4 oF to 428oF).] | 265-042-6 | 64741-42-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-265-00-X | Нафта (нефтена), от пряка дестилация, кипяща в широк обхват; | Нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез дестилация на суров нефт. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C4 до C11, с температура на кипене приблизително в интервала от –20 oC до 220 oC (–4oF до 428oF).] | 265-042-6 | 64741-42-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-266-00-5 | Naphtha (petroleum), light straight-run; | Low boiling point naphtha; | [A complex combination of hydrocarbons produced by distillation of crude oil. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately - 20 oC to 180 oC (– 4oF to 356oF).] | 265-046-8 | 64741-46-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-266-00-5 | Нафта (нефтена), лека, от пряка дестилация; | Нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез дестилация на суров нефт. Състои се основно от алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C4 до C10, с температура на кипене приблизително в интервала от –20 oC до 180 oC (–4oF до 356 oF).] | 265-046-8 | 64741-46-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-267-00-0 | Solvent naphtha (petroleum), light aliph.; | Low boiling point naphtha; | [A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 35o C to 160o C (95oF to 320oF).] | 265-192-2 | 64742-89-8 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-267-00-0 | Солвент нафта (нефтена), лека алифатна; | Нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез дестилация на суров нефт и бензин от природен газ. Състои се предимно от наситени въглеводороди с брой на въглеродните атоми предимно в интервала от C5 до C10, с температура на кипене приблизително в интервала от 35 oC до 160 oC (95oF до 320oF).] | 265-192-2 | 64742-89-8 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-268-00-6 | Distillates (petroleum), straight-run light; | Low boiling point naphtha; | [A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C7 and boiling in the range of approximately– 88 oC to 99o C (– 127oF to 210oF).] | 270-077-5 | 68410-05-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-268-00-6 | Дестилати (нефтени), леки, от пряка дестилация; | Нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез дестилация на суров нефт. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C2 до C7, с температура на кипене приблизително в интервала от –88 oC до 99 oC (–127oF до 210oF).] | 270-077-5 | 68410-05-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-269-00-1 | Gasoline, vapor-recovery; Low boiling point naphtha; | [A complex combination of hydrocarbons separated from the gases from vapor recovery systems by cooling. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 196 oC (– 4oF to 384oF).] | 271-025-4 | 68514-15-8 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-269-00-1 | Бензин, извлечен от пари; Нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена при разделяне от газовете от системата за извличане на пари чрез охлаждане. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C4 до C11, с температура на кипене приблизително в интервала от –20 oC до 196 oC (–4oF до 384 oF).] | 271-025-4 | 68514-15-8 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-270-00-7 | Gasoline, straight-run, topping-plant; Low boiling point naphtha; | [A complex combination of hydrocarbons produced from the topping plant by the distillation of crude oil. It boils in the range of approximately 36,1 oC to 193,3 oC (97oF to 380oF).] | 271-727-0 | 68606-11-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-270-00-7 | Бензин, прякодестилатен, от инсталация за отбензинване на нефта; Нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена от инсталация за отбензинване на нефта при дестилация на суров нефт. Има точка на кипене в интервала приблизително 36,1 oC—193,3 oC (97 oF—380 oF).] | 271-727-0 | 68606-11-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-271-00-2 | Naphtha (petroleum), unsweetened; Low boiling point naphtha; [A complex combination of hydrocarbons produced from the distillation of naphtha streams from various refinery processes. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 0 oC to 230 oC (25oF to 446oF).] | 272-186-3 | 68783-12-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-271-00-2 | Нафта (нефтена), не десулфурирана; Нафта с ниска температура на кипене; [Сложна комбинация от въглеводороди, получена от дестилация на нафтени фракции по различни методи за рафиниране. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C5 до C12, с температура на кипене приблизително в интервала от 0 oC до 230 oC (25 oF до 446oF).] | 272-186-3 | 68783-12-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-272-00-8 | Distillates (petroleum), light straight-run gasoline frac tionation stabilizer overheads; Low boiling point naphtha; | [A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in he range of C3 through C6.] | 272-931-2 | 68921-08-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-272-00-8 | Дестилати (нефтени), компоненти от горната част на стабилизатор при фракциониране на лек бензин от пряка дестилация; Нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез фракциониране на лек бензин от пряка дестилация. Състои се от наситени алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C3 до C6.] | 272-931-2 | 68921-08-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-273-00-3 | Naphtha (petroleum), heavy straight run, arom.-contg.; | Low boiling point naphtha; | [A complex combination of hydrocarbons obtained from a distillation process of crude petroleum. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 oC to 210 oC (266oF to 410oF).] | 309-945-6 | 101631-20-3 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-273-00-3 | Нафта (нефтена), тежка прякодестилатна фракция, съдържаща ароматни съединения; | Нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена от процес на дестилация на суров нефт. Състои се основно от въглеводороди с брой на въглеродните атоми предимно в интервала от C8 до C12, с температура на кипене приблизително в интервала от 130 oC до 210 oC (266oF до 410oF).] | 309-945-6 | 101631-20-3 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-274-00-9 | Naphtha (petroleum), full-range alkylate; | Low boiling point modified naphtha; | [A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5 It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 220 oC (194oF to 428oF).] | 265-066-7 | 64741-64-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-274-00-9 | Нафта (нефтена), кипяща в широк обхват, алкилат; | Модифицирана нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена при дестилация на реакционните продукти от изобутан с моноолефинови въглеводороди, обикновено с брой на въглеродните атоми от C3 до C5. Състои се основно от наситени въглеводороди с разклонена верига с брой на въглеродните атоми преобладаващо в интервала от C7 до C12, с температура на кипене приблизително в интервала от 90 oC до 220 oC (194oF до 428oF).] | 265-066-7 | 64741-64-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-275-00-4 | Naphtha (petroleum), heavy alkylate; | Low boiling point modified naphtha; [A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 to C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 150 oC to 220 oC (302oF to 428oF).] | 265-067-2 | 64741-65-7 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-275-00-4 | Нафта (нефтена), тежка, алкилат; | Модифицирана нафта с ниска температура на кипене; [Сложна комбинация от въглеводороди, получена при дестилация на реакционните продукти от изобутан с моноолефинови въглеводороди, обикновено с брой на въглеродните атоми от C3 до C5. Състои се основно от наситени въглеводороди с разклонена верига с брой на въглеродните атоми предимно в интервала от C9 до C12, с температура на кипене приблизително в интервала от 150 oC до 220 oC (302 oF до 428 oF).] | 265-067-2 | 64741-65-7 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-276-00-X | Naphtha (petroleum), light alkylate; | Low boiling point modified naphtha; | [A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 90 oC to 160 oC (194oF to 320 oF).] | 265-068-8 | 64741-66-8 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-276-00-X | Нафта (нефтена), лека, алкилат; | Модифицирана нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена при дестилация на реакционните продукти от изобутан с моноолефинови въглеводороди, обикновено с брой на въглеродните атоми от C3 до C5. Състои се основно от наситени въглеводороди с разклонена верига с брой на въглеродните атоми предимно в интервала от C7 до C10, с температура на кипене приблизително в интервала от 90 oC до 160 oC (194oF до 320oF).] | 265-068-8 | 64741-66-8 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-277-00-5 | Naphtha (petroleum), isomerization; | Low boiling point modified naphtha; | [A complex combination of hydrocarbons obtained from catalytic isomerization of straight chain paraffinic C4 through C6 hydrocarbons. It consists predominantly of saturated hydrocarbons such as isobutane, isopentane, 2,2-dimethylbutane, 2-methylpentane, and 3-methylpentane.] | 265-073-5 | 64741-70-4 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-277-00-5 | Нафта (нефтена), изомеризация; | Модифицирана нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получени от каталитичната изомеризация на парафинови въглеводороди с неразклонена верига с C4 до C6. Състои се предимно от наситени въглеводороди като изобутан, изопентан, 2,2-диметилбутан, 2-метилпентан и 3-метилпентан.] | 265-073-5 | 64741-70-4 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-278-00-0 | Naphtha (petroleum), solvent-refined light; | Low boiling point modified naphtha; | [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approxi mately 35 oC to 190 oC (95oF to 374oF).] | 265-086-6 | 64741-84-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-278-00-0 | Нафта (нефтена), рафинирана с разтворител, лека; | Модифицирана нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена като рафинат от екстрационен процес с разтворител. Състои се основно от алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C5 до C11, с температура на кипене приблизително в интервала от 35 oC до 190 oC (95oF до 374oF).] | 265-086-6 | 64741-84-0 | Carc. 1B Muta. 1B Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-279-00-6 | Naphtha (petroleum), solvent-refined heavy; | Low boiling point modified naphtha; | [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194oF to 446oF).] | 265-095-5 | 64741-92-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-279-00-6 | Нафта (нефтена), рафинирана с разтворител, тежка; | Модифицирана нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена като рафинат от екстрационен процес с разтворител. Състои се основно от алифатни въглеводороди с брой на въглеродните атоми предимно в интервала от C7 до C12, с температура на кипене приблизително в интервала от 90 oC до 230 oC (194 oF до 446 oF).] | 265-095-5 | 64741-92-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-280-00-1 | Raffinates (petroleum), catalytic reformer ethylene glycol-water countercurrent exts.; | Low boiling point modified naphtha; | [A complex combination of hydrocarbons obtained as the raffinate from the UDEX extraction process on the catalytic reformer stream. It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C9.] | 270-088-5 | 68410-71-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-280-00-1 | Рафинати (нефтени), каталитичен риформинг, противотокова екстракция с етиленгликол-вода; | Модифицирана нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена като рафинат от процес на екстракция „UDEX“, приложен към поток от каталитичен риформинг. Състои се от наситени въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C6 до C9.] | 270-088-5 | 68410-71-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-281-00-7 | Raffinates (petroleum), reformer, Lurgi unit-sepd.; | Low boiling point modified naphtha; | [The complex combination of hydrocarbons obtained as a raffinate from a Lurgi separation unit. It consists predominantly of non-aromatic hydrocarbons with various small amounts of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8.] | 270-349-3 | 68425-35-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-281-00-7 | Рафинати (нефтени), от риформинг, разделени с инсталация „Lurgi“; | Модифицирана нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена като рафинат от инсталация за разделяне „Lurgi“. Състои се главно от неароматни въглеводороди с различни малки количества ароматни въглеводороди с брой на въглеродните атоми предимно в обхвата от C6 до C8.] | 270-349-3 | 68425-35-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-28-00-2 | Naphtha (petroleum), full-range alkylate, butane-contg.; | Low boiling point modified naphta; | [A complex combination of hydrocarbons produced by the distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 with some butanes and boiling in the range of approximately 35 oC to 200 oC (95 oF to 428 oF).] | 271-267-0 | 68527-27-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-28-00-2 | Нафта (нефтена), кипяща в широк обхват, алкилат, съдържаща бутан; | Модифицирана нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена при дестилация на реакционните продукти от изобутан с моноолефинови въглеводороди, обикновено с брой на въглеродните атоми от C3 до C5. Състои се основно от наситени въглеводороди с разклонена верига с брой на въглеродните атоми предимно в интервала от C7 до C12, с някои бутани, с температура на кипене приблизително в интервала от 35 oC до 200 oC (95 oF до 428 oF).] | 271-267-0 | 68527-27-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-283-00-8 | Distillates (petroleum), naphtha steam cracking-derived, solvent-refined light hydrotreated; | Low boiling point modified naphtha; | [A complex combination of hydrocarbons obtained as the raffinates from a solvent extraction process of hydrotreated light distillate from steam-cracked naphtha.] | 295-315-5 | 91995-53-8 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-283-00-8 | Дестилати (нефтени), от паров крекинг на нафта, рафинирани с разтворител, леки, обработени с водород; | Модифицирана нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена като рафинати от екстракционен процес с разтворител на обработен с водород лек дестилат от крекирана с пара нафта] | 295-315-5 | 91995-53-8 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-284-00-3 | Naphtha (petroleum),C4-12, butane-alkylate, isooctane-rich; Low boiling point modified naphtha; | [A complex combination of hydrocarbons obtained by alkylation of butanes. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12, rich in isooctane, and boiling in the range of approximately 35 oC to 210 oC (95oF to 410oF).] | 295-430-0 | 92045-49-3 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-284-00-3 | Нафта (нефтена), C4-12, бутанови алкилати, богата на изооктан; Модифицирана нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез алкилиране на бутани. Състои се основно от въглеводороди с брой на въглеродните атоми предимно в интервала от C4 до C12, богата на изооктан, с температура на кипене приблизително в интервала от 35 oC до 210 oC (95 oF до 410 oF).] | 295-430-0 | 92045-49-3 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-285-00-9 | Hydrocarbons, hydrotreated light naphtha distillates, solvent-refined; | Low boiling point modified naphtha; [A combination of hydrocarbons obtained from the distillation of hydrotreated naphtha followed by a solvent extraction and distillation process. It consists predominantly of saturated hydrocarbons boiling in the range of approximately 94 o C to 99 o C (201 oF to 210 oF).] | 295-436-3 | 92045-55-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-285-00-9 | Въглеводороди, обработени с водород леки нафтени дестилати, рафинирани с разтворител | Модифицирана нафта с ниска температура на кипене; [Комбинация от въглеводороди, получена от дестилация на обработена с водород нафта, с последващ процес на екстракция с разтворител и дестилация. Състои се предимно от наситени въглеводороди с точка на кипене в интервала приблизително 94 oC—99 oC (201 oF—210 oF).] | 295-436-3 | 92045-55-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-286-00-4 | Naphtha (petroleum), isomerisation, C6-fraction; | Low boiling point modified naphtha; | [A complex combination of hydrocarbons obtained by distillation of a gasoline which has been catalyticall isomerized. It consists predominantly of hexane isomers boiling in the range of approximately 60 oC to 66 oC (140oF to 151oF).] | 295-440-5 | 92045-58-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-286-00-4 | Нафта (нефтена), изомеризирана, C6-фракция; | Модифицирана нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез дестилация на каталитично изомеризиран бензин. Състои се предимно от изомери на хексан с точка на кипене в интервала приблизително 60 oC—66 oC (140 oF—151 oF).] | 295-440-5 | 92045-58-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-287-00-X | Hydrocarbons, C6-7, naphtha-cracking, solvent-refined; | Low boiling point modified naphtha; | [A complex combination of hydrocarbons obtained by the sorption of benzene from a catalytically fully hydrogenated benzene-rich hydrocarbon cut that was distillatively obtained from prehydrogenated cracked naphtha. It consists predomi nantly of paraffinic and naphthenic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 70 oC to 100 oC (158oF to 212oF).] | 295-446-8 | 92045-64-2 | Carc. 1B | muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-287-00-X | Въглеводороди, C6-7, от крекинг процес на нафта, рафинирани с разтворител; | Модифицирана нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез сорбция на бензен от богата на бензен каталитично напълно хидрогенирана въглеводородна фракция, получена чрез дестилация на предварително хидрогенирана крекирана нафта. Състои се основно от парфинови и нафтенови въглеводороди с брой на въглеродните атоми предимно в интервала от C6 до C7, с температура на кипене приблизително в интервала от 70 oC до 100 oC (158 oF до 212 oF).] | 295-446-8 | 92045-64-2 | Carc. 1B | muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-288-00-5 | Hydrocarbons, C6-rich, hydrotreated light naphtha distillates, solvent-refined; | Low boiling point modified naphtha; | [A complex combination of hydrocarbons obtained by distillation of hydrotreated naphtha followed by solvent extraction. It consists predominantly of saturated hydrocarbons and boiling in the range of approximately 65o C to 70o C (149oF to 158oF).] | 309-871-4 | 101316-67-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-288-00-5 | Въглеводороди, богати на C6, леки дестилати на обработена с водород нафта, рафинирани с разтворител;; | Модифицирана нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез дестилация на обработена с водород нафта, последвана от екстракция с разтворител. Състои се предимно от наситени въглеводороди с точка на кипене в интервала приблизително 65o C до 70o C (149oF до 158oF).] | 309-871-4 | 101316-67-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-289-00-0 | Naphtha (petroleum), heavy catalytic cracked; | Low boiling point cat-cracked naphtha; | [A complex combination of hydrocarbons produced by a distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (148oF to 446 oF). It contains a relatively large proportion of unsaturated hydrocarbons.] | 265-055-7 | 64741-54-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-289-00-0 | Нафта (нефтена), тежка от каталитичен крекинг; | Каталитично крекирана нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от процес на каталитичен крекинг. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C6 до C12, с температура на кипене приблизително в интервала от 65 oC до 230 oC (148 oF до 446 oF).] Съдържа относително голяма пропорция ненаситени въглеводороди.] | 265-055-7 | 64741-54-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-290-00-6 | Naphtha (petroleum), light catalytic cracked; | Low boiling point cat-cracked naphtha; | [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 190 oC (– 4 oF to 374 oF). It contains a relatively large proportion of unsaturated hydrocarbons.] | 265-056-2 | 64741-55-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-290-00-6 | Нафта (нефтена), лека от каталитичен крекинг; | Каталитично крекирана нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от процес на каталитичен крекинг. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C4 до C11, с температура на кипене приблизително в интервала от –20 oC до 190 oC (–4oF до 374 oF).] Съдържа относително голяма пропорция ненаситени въглеводороди.] | 265-056-2 | 64741-55-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-291-00-1 | Hydrocarbons, C3-11, catalytic cracker distillates; | Low boiling point cat-cracked naphtha; | [A complex combination of hydrocarbons produced by the distillations of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C11 and boiling in a range approximately up to 204 oC (400oF).] | 270-686-6 | 68476-46-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-291-00-1 | Въглеводороди, C3-11, дестилати от каталитичен крекинг; | Каталитично крекирана нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от процес на каталитичен крекинг. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C3 до C11, с температура на кипене приблизително до 204 oC (400 oF).] | 270-686-6 | 68476-46-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-292-00-7 | Naphtha (petroleum), catalytic cracked light distd.; | Low boiling point cat-cracked naphtha; | [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] | 272-185-8 | 68783-09-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-292-00-7 | Нафта (нефтена), лека от каталитичен крекинг, дестилат; | Каталитично крекирана нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от процес на каталитичен крекинг. Състои се от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C1 до C5.] | 272-185-8 | 68783-09-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-293-00-2 | Distillates (petroleum), naphtha steam cracking-derived, hydro-treated light arom.; | Low boiling point cat-cracked naphtha.; | [A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predominantly of aromatic hydrocarbons.] | 295-311-3 | 91995-50-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-293-00-2 | Дестилати (петролни), от парен крекинг на нафта; обработени с водород, леки ароматни; | Каталитично крекирана нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез обработване на лек дестилат от парокрекирана нафта. Състои се предимно от ароматни въглеводороди.] | 295-311-3 | 91995-50-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-294-00-8 | Naphtha (petroleum), heavy catalytic cracked, sweetened; Low boiling point cat-cracked naphtha; | [A complex combination of hydrocarbons obtained by subjecting a catalytic cracked petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 60 oC to200 oC (140oF to 392oF).] | 295-431-6 | 92045-50-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-294-00-8 | Нафта (нефтена), тежка от каталитичен крекинг, десулфурирана; Каталитично крекирана нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез подлагане на каталитично крекиран нефтен дестилат на процес на десулфурация за преобразуване на меркаптани или за отстраняване на киселинни онечиствания. Състои се основно от въглеводороди с брой на въглеродните атоми предимно в интервала от C6 до C12, с температура на кипене приблизително в интервала от 60 oC до 200 oC (140 oF до 392 oF).] | 295-431-6 | 92045-50-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-295-00-3 | Naphtha (petroleum), light catalytic cracked sweetened; Low boiling point cat-cracked naphtha; | [A complex combination of hydrocarbons obtained by subjecting naphtha from a catalytic cracking process to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predomi nantly of hydrocarbons boiling in a range of approximately 35 oC to 210 oC (95oF to 410oF).] | 295-441-0 | 92045-59-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-295-00-3 | Нафта (нефтена), лека от каталитичен крекинг, десулфурирана; Каталитично крекирана нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез подлагане на нафта от каталитичен крекинг на процес на десулфурация за преобразуване на меркаптани или за отстраняване на киселинни онечиствания. Състои се предимно от въглеводороди с точка на кипене в интервала приблизително 35 oC- 210 oC (95 oF—410 oF).] | 295-441-0 | 92045-59-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-296-00-9 | Hydrocarbons, C8-12, catalytic-cracking, chem. neutralized; | Low boiling point cat-cracked naphtha; | [A complex combination of hydrocarbons produced by the distillation of a cut from the catalytic cracking process, having undergone an alkaline washing. It consists predomi nantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 oC to 210 oC (266oF to 410oF).] | 295-794-0 | 92128-94-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-296-00-9 | Въглеводороди, C8-12, от каталитичен крекинг, химично неутрализирани; | Каталитично крекирана нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез дестилацията на фракция от каталитичен крекинг, преминала алкално промиване. Състои се основно от въглеводороди с брой на въглеродните атоми предимно в интервала от C8 до C12, с температура на кипене приблизително в интервала от 130 oC до 210 oC (266oF до 410oF).] | 295-794-0 | 92128-94-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-297-00-4 | Hydrocarbons, C8-12, catalytic cracker distillates; | Low boiling point cat-cracked naphtha; | [A complex combination of hydrocarbons obtained by distillation of products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C12 and boiling in the range of approxi mately 140 oC to 210 oC (284oF to 410oF).] | 309-974-4 | 101794-97-2 | Carc. 1B | Muta. 1B A | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-297-00-4 | Въглеводороди, C8-12, дестилати от каталитичен крекинг; | Каталитично крекирана нафта с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от каталитичен крекинг. Състои се основно от въглеводороди с брой на въглеродните атоми предимно в интервала от C8 до C12, с температура на кипене приблизително в интервала от 140 oC до 210 oC (284 oF до 410oF).] | 309-974-4 | 101794-97-2 | Carc. 1B | Muta. 1B A | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-298-00-X | Hydrocarbons, C8-12, catalytic cracking, chem. neutralized, sweetened; Low boiling point cat-cracked naphtha | 309-987-5 | 101896-28-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-298-00-X | Въглеводороди, C8-12, от каталитичен крекинг, химично неутрализирани, десулфурирани; Каталитично крекирана нафта с ниска температура на кипене; | 309-987-5 | 101896-28-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-299-00-5 | Naphtha (petroleum), light catalytic reformed; | Low boiling point cat-reformed naphtha; | [A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 190o C (95oF to 374oF). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol.% or more benzene.] | 265-065-1 | 64741-63-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-299-00-5 | Нафта (нефтена), лека от каталитичен риформинг; | Нафта от каталитичен риформинг с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от каталитичен риформинг. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C5 до C11, с температура на кипене приблизително в интервала от 35 oC до 190 oC (95 oF до 374 oF).] Съдържа относително голяма пропорция ароматни въглеводороди и въглеводороди с разклонена верига. Тази фракция може да съдържа 10 обемни % или повече бензен.] | 265-065-1 | 64741-63-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-300-00-9 | Naphtha (petroleum), heavy catalytic reformed; | Low boiling point cat-reformed naphtha; [A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194oF to 446oF).] | 265-070-9 | 64741-68-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-300-00-9 | Нафта (нефтена), тежка от каталитичен риформинг; | Нафта от каталитичен риформинг с ниска температура на кипене; [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от каталитичен риформинг. Състои се основно от ароматни въглеводороди с брой на въглеродните атоми предимно в интервала от C7 до C12, с температура на кипене приблизително в интервала от 90 oC до 230 oC (194 oF до 446 oF).] | 265-070-9 | 64741-68-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-301-00-4 | Distillates (petroleum), catalytic reformed depentanizer; | Low boiling point cat-reformed naphtha; | [A complex combination of hydrocarbons from the distillation of products from a catalytic reforming process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 49 oC to 63 oC (–57oF to 145oF).] | 270-660-4 | 68475-79-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-301-00-4 | Дестилати (нефтени), от колона за депентанизация на каталитичен риформинг; | Нафта от каталитичен риформинг с ниска температура на кипене; | [Сложна комбинация от въглеводороди, от дестилация на продукти от каталитичен риформинг. Състои се основно от алифатни въглеводороди с брой на въглеродните атоми предимно в интервала от C3 до C6, с температура на кипене приблизително в интервала от –49 oC до 63 oC (–57oF до 145oF).] | 270-660-4 | 68475-79-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-302-00-X | Hydrocarbons, C2-6, C6-8 catalytic reformer; | Low boiling point cat-reformed naphtha | 270-687-1 | 68476-47-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-302-00-X | Въглеводороди, C2-6, C6-8 каталитичен риформинг; | Нафта от каталитичен риформинг с ниска температура на кипене; | 270-687-1 | 68476-47-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-303-00-5 | Residues (petroleum), C6-8 catalytic reformer; | Low boiling point cat-reformed naphtha; | [A complex residuum from the catalytic reforming of C6-8 feed. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] | 270-794-3 | 68478-15-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-303-00-5 | Остатъци (нефтени), C6-8 каталитичен риформинг; | Нафта от каталитичен риформинг с ниска температура на кипене; | [Комплексен остатък от каталитичен риформинг на C6-8 захранване. Състои се от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C2 до C6.] | 270-794-3 | 68478-15-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-304-00-0 | Naphtha (petroleum), light catalytic reformed, arom.-free; Low boiling point cat-reformed naphtha; | [A complex combination of hydrocarbons obtained from distillation of products from a catalytic reforming process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approxi mately 35o C to 120o C (95 oF to 248 oF). It contains a relatively large proportion of branched chain hydrocarbons with the aromatic components removed.] | 270-993-5 | 68513-03-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-304-00-0 | Нафта (нефтена), от каталитичен риформинг, лека, без съдържание на ароматни съединения; Нафта от каталитичен риформинг с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена от дестилация на продукти от каталитичен риформинг. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C5 до C8, с температура на кипене приблизително в интервала от 35 oC до 120 oC (95 oF до 248 oF).] Съдържа сравнително голяма пропорция от въглеводороди с разклонена верига, като ароматните съставки са отстранени.] | 270-993-5 | 68513-03-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-305-00-6 | Distillates (petroleum), catalytic reformed straight-run naphtha overheads; | Low boiling point cat-reformed naphtha; | [A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha followed by the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] | 271-008-1 | 68513-63-3 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-305-00-6 | Дестилати (нефтени), горни фракции от прякодестилатна нафта от каталитичен риформинг; | Нафта от каталитичен риформинг с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез каталитичен риформинг на нафта от пряка дестилация, следван от фракциониране на общия изходящ поток. Състои се от наситени алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C2 до C6.] | 271-008-1 | 68513-63-3 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-306-00-1 | Petroleum products, hydrofiner-powerformer reformates; | Low boiling point cat-reformed naphtha; | [The complex combination of hydrocarbons obtained in a hydrofiner-powerformer process and boiling in a range of approximately 27 oC to 210 oC (80oF to 410oF).] | 271-058-4 | 68514-79-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-306-00-1 | Нефтени продукти, продукти от процес „Hydrofining-Powerforming“; | Нафта от каталитичен риформинг с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена при процес „Hydrofining-Powerforming“, с температура на кипене в интервала приблизително от 27 oC до 210 oC (80oF до 410oF).] | 271-058-4 | 68514-79-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-307-00-7 | Naphtha (petroleum), full-range reformed; | Low boiling point cat-reformed naphtha; | [A complex combination of hydrocarbons produced by the distillation of the products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35o C to 230 oC (95oF to 446oF).] | 272-895-8 | 68919-37-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-307-00-7 | Нафта (нефтена), кипяща в широк обхват, от риформинг; | Нафта от каталитичен риформинг с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получени при дестилация на продукти от процес на каталитичен крекинг. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C5 до C12, с температура на кипене приблизително в интервала от 35 oC до 230 oC (95 oF до 446oF).] | 272-895-8 | 68919-37-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-308-00-2 | Naphtha (petroleum), catalytic reformed; | Low boiling point cat-reformed naphtha; | [A complex combination of hydrocarbons produced by the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 oC to 220 oC (90oF to 430oF). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.] | 273-271-8 | 68955-35-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-308-00-2 | Нафта (нефтена), от каталитичен риформинг; | Нафта от каталитичен риформинг с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от процес на каталитичен крекинг. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C4 до C12, с температура на кипене приблизително в интервала от 30 oC до 220 oC (90 oF до 430 oF).] Съдържа относително голяма пропорция ароматни въглеводороди и въглеводороди с разклонена верига. Тази фракция може да съдържа 10 обемни % или повече бензен.] | 273-271-8 | 68955-35-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-309-00-8 | Distillates (petroleum), catalytic reformed hydrotreated light, C8-12 arom. fraction;-Low boiling point cat-reformed naphtha; | [A complex combination of alkylbenzenes obtained by the catalytic reforming of petroleum naphtha. It consists predominantly of alkylbenzenes having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 160 oC to 180 oC (320oF to 356oF).] | 285-509-8 | 85116-58-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-309-00-8 | Дестилати (нефтени), от каталитичен риформинг, обработени с водород, леки, C8-12 ароматна фракция;Нафта от каталитичен риформинг с ниска температура на кипене; | [Сложна комбинация от алкилбензени, получена чрез каталитичен риформинг на нефтена нафта. Състои се основно от алкилбензени с брой на въглеродните атоми предимно в интервала от C8 до C10, с температура на кипене приблизително в интервала от 160 oC до 180 oC (320 oF до 356 oF).] | 285-509-8 | 85116-58-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-310-00-3 | Aromatic hydrocarbons, C8, catalytic reforming-derived; | Low boiling point cat-reformed naphtha | 295-279-0 | 91995-18-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-310-00-3 | Ароматни въглеводороди, C8, получени от каталитичен риформинг; | Нафта от каталитичен риформинг с ниска температура на кипене; | 295-279-0 | 91995-18-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-311-00-9 | Aromatic hydrocarbons, C7-12, C8-rich; | Low boiling point cat-reformed naphtha; | [A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 (primarily C8) and can contain nonaromatic hydrocarbons, both boiling in the range of approximately 130 oC to 200 oC (266oF to 392oF).] | 297-401-8 | 93571-75-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-311-00-9 | Ароматни въглеводороди, C7-12, богати на C8; | Нафта от каталитичен риформинг с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез разделяне от фракцията, съдържаща продукт от платформинг. Състои се основно от ароматни въглеводороди с брой на въглеродните атоми предимно в интервала от C7 до C12 (главно C8) и може да съдържа неароматни въглеводороди, като и ароматните, и неароматните въглеводороди са с температура на кипене приблизително в интервала от 130 oC до 200 oC (266oF до 392oF).] | 297-401-8 | 93571-75-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-312-00-4 | Gasoline, C5-11, high-octane stabilised reformed; | Low boiling point cat-reformed naphtha; - | [A complex high octane combination of hydrocarbons obtained by the catalytic dehydrogenation of a predominantly naphthenic naphtha. It consists predominantly of aromatics and non-aromatics having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approxi mately 45 oC to 185 oC (113oF to 365 oF).] | 297-458-9 | 93572-29-3 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-312-00-4 | Бензин, C5-11, високооктанов, стабилизиран, от риформинг; | Нафта от каталитичен риформинг с ниска температура на кипене; - | [Сложна високооктанова комбинация от въглеводороди, получена чрез каталитично дехидрогениране на предимно нафтенова нафта. Състои се основно от ароматни и неароматни въглеводороди с брой на въглеродните атоми предимно в интервала от C5 до C11, с температура на кипене приблизително в интервала от 45 oC до 185 oC (113 oF до 365 oF).] | 297-458-9 | 93572-29-3 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-313-00-X | Hydrocarbons, C7-12, C≥9-arom.-rich, reforming heavy fraction; Low boiling point cat-reformed naphtha; | [A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 120 oC to 210 oC (248oF to380oF) and C9 and higher aromatic hydrocarbons.] | 297-465-7 | 93572-35-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-313-00-X | Въглеводороди, C7-12, богати на ароматни въглеводороди с C≥9, тежка фракция от риформинг; Нафта от каталитичен риформинг с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез разделяне от фракцията, съдържаща продукт от платформинг. Състои се основно от неароматни въглеводороди с брой на въглеродните атоми предимно в интервала от C7 до C12, с температура на кипене приблизително в интервала от 120 oC до 210 oC (248 oF до 380 oF), и от ароматни въглеводороди с C9 и повече.] | 297-465-7 | 93572-35-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-314-00-5 | Hydrocarbons, C5-11, nonaroms.-rich, reforming light fraction; | Low boiling point cat-reformed naphtha; | [A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 125 oC (94oF to 257oF), benzene and toluene.] | 297-466-2 | 93572-36-2 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-314-00-5 | Въглеводороди, C5-11, богати на неароматни съединения, лека фракция от каталитичен риформинг; | Нафта от каталитичен риформинг с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез разделяне от фракцията, съдържаща продукт от платформинг. Състои се основно от неароматни въглеводороди с брой на въглеродните атоми предимно в интервала от C5 до C11, с температура на кипене приблизително в интервала от 35 oC до 125 oC (94 oF до 257 oF), бензен и толуен.] | 297-466-2 | 93572-36-2 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-315-00-0 | Foots oil (petroleum), silicic acid-treated; | Foots oil; | [A complex combination of hydrocarbons obtained by the treatment of Foots oil with silicic acid for removal of trace constituents and impurities. It consists predominantly of straight chain hydrocarbons having carbon numbers predominantly greater than C12.] | 308-127-6 | 97862-77-6 | Carc. 1B | H350 | H304 | GHS08 | Dgr | H350 | H304 |   |   | L649-315-00-0 | Масло, което се отделя при топенето на парафин (нефтено), обработено със силициева киселина; | масло, което се отделя при топенето на парафин; | [Сложна комбинация от въглеводороди, получена от обработката на масло, което се отделя при топенето на парафин, със силициева киселина за отстраняването на следи от съставки и онечиствания. Състои се основно от въглеводороди с неразклонена верига и брой на въглеродните атоми предимно по-голям от C12.] | 308-127-6 | 97862-77-6 | Carc. 1B | H350 | H304 | GHS08 | Dgr | H350 | H304 |   |   | L
649-316-00-6 | Naphtha (petroleum), light thermal cracked; | Low boiling point thermally cracked naphtha; | [A complexcombination of hydrocarbons from distillation of products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately - 10 oC to 130 oC (14oF to 266oF).] | 265-075-6 | 64741-74-8 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-316-00-6 | Нафта (нефтена), лека, от термичен крекинг; | Нафта от термичен крекинг с ниска температура на кипене; | [Сложна комбинация от въглеводороди от дестилация на продукти от термичен крекинг. Състои се основно от ненаситени въглеводороди с брой на въглеродните атоми предимно в интервала от C4 до C8, с температура на кипене приблизително в интервала от –10 oC до 130 oC (14oF до 266oF).] | 265-075-6 | 64741-74-8 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-317-00-1 | Naphtha (petroleum), heavy thermal cracked; | Low boiling point thermally cracked naphtha; | [A complex combination of hydrocarbons from distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65o C to 220 oC (148oF to 428oF).] | 265-085-0 | 64741-83-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-317-00-1 | Нафта (нефтена), тежка, от термичен крекинг; | Нафта от термичен крекинг с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена при дестилацията на продукти от процес на термичен крекинг. Състои се основно от ненаситени въглеводороди с брой на въглеродните атоми предимно в интервала от C6 до C12, с температура на кипене приблизително в интервала от 65 oC до 220 oC (148oF до 428oF).] | 265-085-0 | 64741-83-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-318-00-7 | Distillates (petroleum), heavy arom.; | Low boiling point thermally cracked naphtha; | [The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This higher boiling fraction consists predominantly of C5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having carbon number predominantly of C5. This stream may contain benzene.] | 267-563-4 | 67891-79-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-318-00-7 | Дестилати (нефтени), тежки ароматни; | Нафта от термичен крекинг с ниска температура на кипене; | [Сложна комбинация от въглеводороди от дестилация на продукти от термичен крекинг на етан и пропан. Тази фракция с по-висока точка на кипене се състои предимно от ароматни въглеводороди с C5-7 и някои ненаситени алифатни въглеводороди с брой на въглеродните атоми предимно C5. Тази фракция може да съдържа бензен.] | 267-563-4 | 67891-79-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-319-00-2 | Distillates (petroleum), light arom.; | Low boiling point thermally cracked naphtha; [The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This lower boiling fraction consists predominantly of C5-7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having a carbon number predominantly of C5. This stream may contain benzene.] | 267-565-5 | 67891-80-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | HS08 | Dgr | H350 | H340 | H304 |   |   | P649-319-00-2 | Дестилати (нефтени), леки ароматни; | Нафта от термичен крекинг с ниска температура на кипене; [Сложна комбинация от въглеводороди от дестилация на продукти от термичен крекинг на етан и пропан. Тази фракция с по-ниска точка на кипене се състои предимно от ароматни въглеводороди с C5-7 и някои ненаситени алифатни въглеводороди с брой на въглеродните атоми предимно C5. Тази фракция може да съдържа бензен.] | 267-565-5 | 67891-80-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | HS08 | Dgr | H350 | H340 | H304 |   |   | P
649-320-00-8 | Distillates (petroleum), naphtha-raffinate pyrolyzate-derived, gasoline-blending; | Low boiling point thermally cracked naphtha; [The complex combination of hydrocarbons obtained by the pyrolysis fractionation at 816o C (1 500 oF) of naphtha and raffinate. It consists predominantly of hydrocarbons having a carbon number of C9 and boiling at approximately 204 oC (400oF).] | 270-344-6 | 68425-29-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-320-00-8 | Дестилати (нефт), от пиролизат от нафтен рафинат, блендиран бензин; | Нафта от термичен крекинг с ниска температура на кипене; [Сложна комбинация от въглеводороди, получена чрез пиролизно фракциониране при 816 oC (1500 oF) на нафта и рафинат. Състои се предимно от въглеводороди с брой на въглеродните атоми C9 и с точка на кипене приблизително 204 oC (400 oF).] | 270-344-6 | 68425-29-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-321-00-3 | Aromatic hydrocarbons, C6-8, naphtha-raffinate pyrolyzate-derived; Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons obtained by the fractionation pyrolysis at 816 o C (1 500 oF) of naphtha and raffinate. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8, including benzene.] | 270-658-3 | 68475-70-7 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-321-00-3 | Ароматни въглеводороди, C6-8, от пиролизат на нафтен рафинат; Нафта от термичен крекинг с ниска температура на кипене; [Сложна комбинация от въглеводороди, получена чрез пиролизно фракциониране при 816 oC (1500 oF) на нафта и рафинат. Състои се основно от ароматни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C6 до C8, включително бензен.] | 270-658-3 | 68475-70-7 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-322-00-9 | Distillates (petroleum), thermal cracked naphtha and gas oil; Low boiling point thermally cracked naphtha; | [A complex combination of hydrocarbons produced by distillation of thermally cracked naphtha and/or gas oil. It consists predominantly of olefinic hydrocarbons having a carbon number of C5 and boiling in the range of approxi mately 33 o C to 60 o C (91 oF to 140 oF).] | 271-631-9 | 68603-00-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-322-00-9 | Дестилати (нефтени), термично крекирани нафта и газьол; Нафта от термичен крекинг с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез дестилация на термично крекирана нафта и/или газьол. Състои се основно от олефинови въглеводороди с брой на въглеродните атоми C5, с температура на кипене приблизително в интервала от 33 o C до 60 o C (91 oF до 140 oF).] | 271-631-9 | 68603-00-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-323-00-4 | Distillates (petroleum), thermal cracked naphtha and gas oil, C5-dimer-contg.; | Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists predominantly of hydrocarbons having a carbon number of C5 with some dimerized C5 olefins and boiling in the range of approximately 33o C to 184 o C (91oF to 363 oF).] | 271-632-4 | 68603-01-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-323-00-4 | Дестилати (нефтени), термично крекирани нафта и газьол; със съдържание на C5-димери; | Нафта от термичен крекинг с ниска температура на кипене; [Сложна комбинация от въглеводороди, получена чрез екстракционна дестилация на термично крекирана нафта и/или термично крекиран газьол. Състои се предимно от въглеводороди с брой на въглеродните атоми C5, с някои димеризирани C5 олефини, с точка на кипене в интервала приблизително 33 oC—184 oC (91 oF—363 oF).] | 271-632-4 | 68603-01-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-324-00-X | Distillates (petroleum), thermal cracked naphtha and gas oil, extractive; | Low boiling point thermally cracked naphtha; | [A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists of paraffinic and olefinic hydrocarbons, predomi nantly isoamylenes such as 2-methyl-1-buteneand 2-methyl-2-butene and boiling in the rangeof approximately 31o C to 40o C (88oF to 104oF).] | 271-634-5 | 68603-03-2 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-324-00-X | Дестилати (нефтени), термично крекирани нафта и газьол, екстракционна дестилация; | Нафта от термичен крекинг с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез екстракционна дестилация на термично крекирана нафта и/или термично крекиран газьол. Състои се от парафинови и олефинови въглеводороди, преобладаващо изоамилени като 2-метил-1-бутен и 2-метил-2-бутен, с температура на кипене приблизително в интервала от 31 oC до 40 oC (88oF до 104oF).] | 271-634-5 | 68603-03-2 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-325-00-5 | Distillates (petroleum), light thermal cracked, debutanized arom.; | Low boiling point thermally cracked naphtha; [A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists predominantly of aromatic hydrocarbons, primarily benzene.] | 273-266-0 | 68955-29-3 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-325-00-5 | Дестилати (нефтени), леки термично крекирани, дебутанизирани ароматни; | Нафта от термичен крекинг с ниска температура на кипене; [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от процес на термичен крекинг. Състои се предимно от ароматни въглеводороди, основно бензен.] | 273-266-0 | 68955-29-3 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-326-00-0 | Naphtha (petroleum), light thermal cracked, sweetened; | Low boiling point thermally cracked naphtha; | [A complex combination of hydrocarbons obtained by subjecting a petroleum distillate From the high temperature thermal cracking of heavy oil fractions to a sweetening process to convert mercaptans. It consists predominantly of aromatics, olefins and saturated hydrocarbons boiling in the range of approximately 20 oC to 100 o C (68 oF to 212 oF).] | 295-447-3 | 92045-65-3 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-326-00-0 | Нафта (нефтена), лека от термичен крекинг, десулфурирана; | Нафта от термичен крекинг с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез подлагане на нефтен дестилат от високотемпературен термичен крекинг на фракции на тежко масло на десулфурация за превръщане на меркаптани. Състои се предимно от ароматни съединения, олефини и наситени въглеводороди, с точка на кипене в интервал приблизително 20 oC—100 oC (68 oF—212 oF).] | 295-447-3 | 92045-65-3 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-327-00-6 | Naphtha (petroleum), hydrotreated heavy; | Low boiling point ydrogen treated naphtha; [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C13 and boiling in the range of approximately 65o C to 230o C (149oF to 446oF).] | 265-150-3 | 64742-48-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-327-00-6 | Нафта (нефтена), обработена с водород, тежка; | Нафта, обработена с водород, с ниска температура на кипене; [Сложна комбинация от въглеводороди, получена при обработване на нефтена фракция с водород в присъствие на катализатор. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C6 до C13, с температура на кипене приблизително в интервала от 65o C до 230o C (149oF до 446oF).] | 265-150-3 | 64742-48-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-328-00-1 | Naphtha (petroleum), hydrotreated light; | Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by treating a petroleum fraction With hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20o C to 190o C (– 4oF to 374oF).] | 265-151-9 | 64742-49-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-328-00-1 | Нафта (нефтена), обработена с водород, лека; | Нафта, обработена с водород, с ниска температура на кипене; [Сложна комбинация от въглеводороди, получена при обработване на нефтена фракция с водород в присъствие на катализатор. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C4 до C11, с температура на кипене приблизително в интервала от –20 o C до 190 o C (–4 oF до 374 oF).] | 265-151-9 | 64742-49-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-329-00-7 | Naphtha (petroleum), hydrodesulfurized light; | Low boiling point hydrogen treated naphtha; | [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in The range of approximately - 20o C to 190o C (– 4oF to 374oF).] | 265-178-6 | 64742-73-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-329-00-7 | Нафта (нефтена), хидродесулфурирана, лека; | Нафта, обработена с водород, с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез процес на каталитична хидродесулфурация. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C4 до C11, с температура на кипене приблизително в интервала от –20 o C до 190 o C (–4 oF до 374 oF).] | 265-178-6 | 64742-73-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-330-00-2 | naphtha (petroleum), hydrodesulphurized heavy; | Low boiling point hydrogen treated naphtha; | [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90o C to 230o C (194oF to 446 oF).] | 265-185-4 | 64742-82-1 | Carc. 1B | Muta. 1B | STOT RE 1 | Asp. Tox. 1 | H350 | H340 | H372 (central nervous system) | H304 | GHS08 | Dgr | H350 | H340 | H372 (central nervous system) | H304 |   |   | P649-330-00-2 | Нафта (нефтена), хидродесулфурирана, тежка; | Нафта, обработена с водород, с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез процес на каталитична хидродесулфурация. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C7 до C12, с температура на кипене приблизително в интервала от 90 o C до 230o C (194 oF до 446 oF).] | 265-185-4 | 64742-82-1 | Carc. 1B | Muta. 1B | STOT RE 1 | Asp. Tox. 1 | H350 | H340 | H372 (централна нервна система) | H304 | GHS08 | Dgr | H350 | H340 | H372 (централна нервна система) | H304 |   |   | P
649-331-00-8 | Distillates (petroleum), hydrotreated middle, intermediate boiling; | Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained by the distillation of products from a middle distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 127o C to 188o C (262oF to 370oF).] | 270-092-7 | 68410-96-8 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-331-00-8 | Дестилати (нефтени), обработени с водород, средни, с междинна температура на кипене; | Нафта, обработена с водород, с ниска температура на кипене; [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от процес на обработка с водород на средни дестилати. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C5 до C10, с температура на кипене приблизително в интервала от 127 o C до 188 o C (262 oF до 370 oF).] | 270-092-7 | 68410-96-8 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-332-00-3 | Distillates (petroleum), light distillate hydrotreating process, low-boiling; | Low boiling point hydrogen treated naphtha; | [A complex combination of hydrocarbons obtained by the distillation of products from the light distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C9 and boiling in the range of approximately 3 o C to 194 o C (37 oF to 382 oF).] | 270-093-2 | 68410-97-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-332-00-3 | Дестилати (нефтени), обработване с водород на лек дестилат, с ниска температура на кипене; | Нафта, обработена с водород, с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от процес на обработване с водород на лек дестилат. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C6 до C9, с температура на кипене приблизително в интервала от 3 o C до 194 o C (37 oF до 382 oF).] | 270-093-2 | 68410-97-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-333-00-9 | Distillates (petroleum), hydrotreated heavy naphtha, deisohexanizer overheads; | Low boiling point hydrogen treated naphtha; | [A complex combination of hydrocarbons obtained by distillation of the products from a heavy naphtha hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 49 oC to 68 oC (– 57oF to 155oF).] | 270-094-8 | 68410-98-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-333-00-9 | Дестилати (нефт), от обработена с водород тежка нафта, фракции от горната част на колоната за деизохексанизация; | Нафта, обработена с водород, с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от процес на обработване с водород на тежка нафта. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C3 до C6, с температура на кипене приблизително в интервала от –49 oC до 68 oC (–57oF до 155oF).] | 270-094-8 | 68410-98-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-334-00-4 | Solvent naphtha (petroleum), light arom., hydrotreated; | Low boiling point hydrogen treated naphtha; | [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approxi mately 135 oC to 210 oC (275oF to 410oF).] | 270-988-8 | 68512-78-7 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-334-00-4 | Солвент нафта (нефтена), лека, ароматна, обработена с водород; | Нафта, обработена с водород, с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена при обработване на нефтена фракция с водород в присъствие на катализатор. Състои се основно от въглеводороди с брой на въглеродните атоми предимно в интервала от C8 до C10, с температура на кипене приблизително в интервала от 135 oC до 210 oC (275 oF до 410oF).] | 270-988-8 | 68512-78-7 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-335-00-X | Naphtha (petroleum), hydrodesulfurized thermal cracked light; Low boiling point hydrogen treated naphtha; | [A complex combination of hydrocarbons obtained by fractionation of hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 oC to 195 oC (73oF to 383oF).] | 285-511-9 | 85116-60-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-335-00-X | Нафта (нефтена), хидродесулфурирана, термично крекирана, лека; Нафта, обработена с водород, с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена при фракциониране на хидродесулфуриран дестилат от термичен крекинг. Състои се основно от въглеводороди с брой на въглеродните атоми предимно в интервала от C5 до C11, с температура на кипене приблизително в интервала от 23 oC до 195 oC (73 oF до 383 oF).] | 285-511-9 | 85116-60-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-336-00-5 | Naphtha (petroleum), hydrotreated light, cycloalkane-contg.; Low boiling point hydrogen treated naphtha; | [A complex combination of hydrocarbons obtained from the distillation of a petroleum fraction. It consists predominantly of alkanes and cycloalkanes boiling in the range of approximately - 20o C to 190 oC (– 4oF to 374oF).] | 285-512-4 | 85116-61-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-336-00-5 | Нафта (нефтена), обработена с водород, лека, съдържаща циклоалкани; Нафта, обработена с водород, с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена от дестилация на нефтена фракция. Състои се предимно от алкани и циклоалкани, с точка на кипене в интервала приблизително от –20 oC до 190 oC (–4 oF до 374 oF).] | 285-512-4 | 85116-61-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-337-00-0 | Naphtha (petroleum),heavy steam-cracked, hydrogenated; Low boiling point hydrogen treated naphtha | 295-432-1 | 92045-51-7 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-337-00-0 | Нафта (нефтена), тежка от парен крекинг, хидрогенирана; Нафта, обработена с водород, с ниска температура на кипене; | 295-432-1 | 92045-51-7 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-338-00-6 | Naphtha (petroleum), hydrodesulfurized full-range; | Low boiling point hydrogen treated naphtha; | [A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 oC to 250 oC (86oF to 482oF).] | 295-433-7 | 92045-52-8 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-338-00-6 | Нафта (нефтена), хидродесулфурирана, кипяща в широк обхват; | Нафта, обработена с водород, с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез процес на каталитична хидродесулфурация. Състои се основно от въглеводороди с брой на въглеродните атоми предимно в интервала от C4 до C11, с температура на кипене приблизително в интервала от 30 oC до 250 oC (86 oF до 482 oF).] | 295-433-7 | 92045-52-8 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-339-00-1 | Naphtha (petroleum), hydrotreated light steam-cracked; | Low boiling point hydrogen treated naphtha; | [A complex combination of hydrocarbons obtained by treating a petroleum fraction, derived from a pyrolysis process, with hydrogen in the presence of a catalyst. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35o C to 190 oC (95oF to 374oF).] | 295-438-4 | 92045-57-3 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-339-00-1 | Нафта (нефтена), обработена с водород, тежка от паров крекинг; | Нафта, обработена с водород, с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез обработване на нефтена фракция от пиролизен процес с водород в присъствието на катализатор. Състои се основно от ненаситени въглеводороди с брой на въглеродните атоми предимно в интервала от C5 до C11, с температура на кипене приблизително в интервала от 35 oC до 190 oC (95 oF до 374 oF).] | 295-438-4 | 92045-57-3 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-340-00-7 | Hydrocarbons, C4-12, naphtha-cracking, hydrotreated; | Low boiling point hydrogen treated naphtha; | [A complex combination of hydrocarbons obtained by distallation from the product of a naphtha steam cracking process and subsequent catalytic selective hydrogenation of gum formers. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 oC to 230o C (86oF to 446oF).] | 295-443-1 | 92045-61-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-340-00-7 | Въглеводороди, C4-12, от крекинг процес на нафта, обработени с водород; | Нафта, обработена с водород, с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез дестилация на продукт от процес на паров крекинг на нафта с последващо селективно каталитично хидрогениране на материали, образуващи клейове. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C4 до C12, с температура на кипене приблизително в интервала от 30 oC до 230 oC (86 oF до 446 oF).] | 295-443-1 | 92045-61-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-341-00-2 | Solvent naphtha (petroleum), hydrotreated light naphthenic; Low boiling point hydrogen treated naphtha; | [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of cycloparaffinic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approxi mately 73o C to 85o C (163 oF to 185 oF).] | 295-529-9 | 92062-15-2 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-341-00-2 | Солвент нафта (нефтена), обработена с водород, лека нафтенова фракция; Нафта, обработена с водород, с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена при обработване на нефтена фракция с водород в присъствие на катализатор. Състои се основно от циклопарафинови въглеводороди с брой на въглеродните атоми предимно в интервала от C6 до C7, с температура на кипене приблизително в интервала от 73 oC до 85 oC (163 oF до 185 oF).] | 295-529-9 | 92062-15-2 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-342-00-8 | Naphtha (petroleum), light steam-cracked, hydrogenated; Low boiling point hydrogen treated naphtha; | [A complex combination of hydrocarbons produced from the separation and subsequent Hydrogenation of the products of a steam-cracking process to produce ethylene. It consists predominantly of saturated and unsaturated paraffins, cyclic paraffins and cyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately 50o C to 200o C (122 oF to 392 oF). The proportion of benzene hydrocarbons may vary up to 30 wt. % and the stream may also contain small amounts ofsulfur and oxygenated compounds.] | 296-942-7 | 93165-55-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-342-00-8 | Нафта (нефтена), лека от паров крекинг, хидрогенирана; Нафта, обработена с водород, с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена чрез разделяне и последващо хидрогениране на продукти от паров крекинг за получаване на етилен. Състои се основно от наситени и ненаситени парафини, пръстенни парафини и пръстенни ароматни въглеводороди, с брой на въглеродните атоми преобладаващо в интервала от C4 до C10, с температура на кипене приблизително в интервала от 50 oC до 200 oC (122 oF до 392 oF). Делът на бензеновите въглеводороди може да варира до 30 % тегловни, а фракцията може да съдържа също малки количества сяра и окислени съединения.] | 296-942-7 | 93165-55-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-343-00-3 | Hydrocarbons, C6-11, hydrotreated, dearomatized; | Low boiling point hydrogen treated naphtha; | [A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.] | 297-852-0 | 93763-33-8 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-343-00-3 | Въглеводороди, C6-11, обработени с водород, деароматизирани; | Нафта, обработена с водород, с ниска температура на кипене; | [Сложна комбинация от въглеводороди, получена като разтворители, които са били подложени на обработване с водород, за превръщане на ароматните съединения в нафтени чрез каталитично хидрогениране.] | 297-852-0 | 93763-33-8 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-344-00-9 | Hydrocarbons, C9-12, hydrotreated, dearomatized; | Low boiling point hydrogen treated naphtha; [A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.] | 297-853-6 | 93763-34-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-344-00-9 | Въглеводороди, C9-12, обработени с водород, деароматизирани; | Нафта, обработена с водород, с ниска температура на кипене; [Сложна комбинация от въглеводороди, получена като разтворители, които са били подложени на обработване с водород, за превръщане на ароматните съединения в нафтени чрез каталитично хидрогениране.] | 297-853-6 | 93763-34-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-345-00-4 | stoddard solvent; | Low boiling point naphtha — | unspecified; | [A colourless, refined petroleum distillate that is free from rancid or objectionable odours and that boils in a range of approximately 148,8 oC to 204,4 o C (300oF to 400oF).] | 232-489-3 | 8052-41-3 | Carc. 1B | Muta. 1B | STOT RE 1 | Asp. Tox. 1 | H350 | H340 | H372 (central nervous system) | H304 | GHS08 | Dgr | H350 | H340 | H372 (central nervous system) | H304 |   |   | P649-345-00-4 | Разтворител Стодард (Stoddard); | Нафта с ниска температура на кипене — | неспецифицирана; | [Безцветен, рафиниран нефтен дестилат, който не е с гранив или неприятен мирис и има температура на кипене приблизително в интервала от 148,8 oC до 204,4 oC (300 oF до 400 oF).] | 232-489-3 | 8052-41-3 | Carc. 1B | Muta. 1B | STOT RE 1 | Asp. Tox. 1 | H350 | H340 | H372 (централна нервна система) | H304 | GHS08 | Dgr | H350 | H340 | H372 (централна нервна система) | H304 |   |   | P
649-346-00-X | Natural gas condensates (petroleum); | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons separated as a liquid from natural gas in a surface separator by retrograde condensation. It consists mainly of hydrocarbons having carbon numbers predominantly in the range of C2 to C20. It is a liquid at atmospheric temperature and pressure.] | 265-047-3 | 64741-47-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-346-00-X | Кондензати от природен газ (нефтени) | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, разделена като течност от природен газ в повърхностен сепаратор чрез ретроградна кондензация. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C2 до C20. Представлява течност при атмосферна температура и налягане.] | 265-047-3 | 64741-47-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-347-00-5 | Natural gas (petroleum), raw liq. mix; Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons separated as a liquid from natural gas in a gas recycling plant by processes such as refrigeration or absorption. It consists mainly of saturated aliphatic hydrocarbons having carbon numbers in the range of C2 through C8.] | 265-048-9 | 64741-48-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-347-00-5 | Природен газ (нефтен), течен необработен микс; Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, разделена като течност от природен газ в инсталация за рециклиране на газ чрез процеси като охлаждане или абсорбция. Състои се основно от наситени алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C2 до C8.] | 265-048-9 | 64741-48-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-348-00-0 | Naphtha (petroleum), light hydrocracked; | Low boiling naphtha — unspecified; | [A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C4 through C10, and boiling in the range of approxi mately - 20 o C to 180 o C (– 4 oF to 356 oF).] | 265-071-4 | 64741-69-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-348-00-0 | Нафта (нефтена), лека от хидрокрекинг; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди от дестилация на продукти от процес на хидрокрекинг. Състои се основно от наситени въглеводороди с брой на въглеродните атоми предимно в интервала от C4 до C10, с температура на кипене приблизително в интервала от –20 oC до 180 oC (–4 oF до 356 oF).] | 265-071-4 | 64741-69-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-349-00-6 | Naphtha (petroleum), heavy hydrocracked; | Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12, and boiling in the range of approximately 65 oC to 230 oC (148oF to 446oF).] | 265-079-8 | 64741-78-2 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-349-00-6 | Нафта (нефтена), тежка от хидрокрекинг; | Нафта с ниска температура на кипене — неспецифицирана; [Сложна комбинация от въглеводороди от дестилация на продукти от процес на хидрокрекинг. Състои се основно от въглеводороди с брой на въглеродните атоми предимно в интервала от C6 до C12, с температура на кипене приблизително в интервала от 65 oC до 230 oC (148 oF до 446 oF).] | 265-079-8 | 64741-78-2 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-350-00-1 | Naphtha (petroleum) sweetened; | Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately - 10o C to 230o C (14oF to 446oF).] | 265-089-2 | 64741-87-3 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-350-00-1 | Нафта (нефтена), десулфурирана; | Нафта с ниска температура на кипене — неспецифицирана; [Сложна комбинация от въглеводороди, получена от нефтена нафта, подложена на десулфурация за превръщане на меркаптаните или за отстраняване на киселинни онечиствания. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C4 до C12, с температура на кипене приблизително в интервала от –10 o C до 230o C (14 oF до 446oF).] | 265-089-2 | 64741-87-3 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-351-00-7 | Naphtha(petroleum), acid-treated; | Low boilingpoint naphtha -unspecified; [A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 o C to 230 o C (194 oF to 446 oF).] | 265-115-2 | 64742-15-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-351-00-7 | Нафта (нефтена), обработена с киселина; | Нафта с ниска температура на кипене — неспецифицирана; [Сложна комбинация от въглеводороди, получена като рафинат от процес на обработване със сярна киселина. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C7 до C12, с температура на кипене приблизително в интервала от 90 o C до 230 o C (194 oF до 446 oF).] | 265-115-2 | 64742-15-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-352-00-2 | Naphtha (petroleum), chemically neutralized heavy; | Low boilingpoint naphtha — unspecified; | [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65o C to 230o C (149oF to 446oF).] | 265-122-0 | 64742-22-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-352-00-2 | Нафта (нефтена), химически неутрализирана, тежка; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена при процес на обработване за отстраняване на киселинните материали. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C6 до C12, с температура на кипене приблизително в интервала от 65 o C до 230 o C (149 oF до 446 oF).] | 265-122-0 | 64742-22-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-353-00-8 | Naphtha (petroleum), chemically neutralized light; | Low boilingpoint naphtha -unspecified; [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 190o C (–4 oF to 374 oF).] | 265-123-6 | 64742-23-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-353-00-8 | Нафта (нефтена), химично неутрализирана, лека; | Нафта с ниска температура на кипене — неспецифицирана; [Сложна комбинация от въглеводороди, получена при процес на обработване за отстраняване на киселинните материали. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C4 до C11, с температура на кипене приблизително в интервала от –20 oC до 190 oC (–4 oF до 374 oF).] | 265-123-6 | 64742-23-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-354-00-3 | Naphtha (petroleum), catalytic dewaxed; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons obtained from the catalytic dewaxing of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35o C to 230 oC (95oF to 446oF).] | 265-170-2 | 64742-66-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-354-00-3 | Нафта (нефтена), каталитично депарафинирана; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена от каталитично депарафиниране на нефтена фракция. Състои се основно от въглеводороди с брой на въглеродните атоми предимно в интервала от C5 до C12, с температура на кипене приблизително в интервала от 35 oC до 230 oC (95 oF до 446oF).] | 265-170-2 | 64742-66-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-355-00-9 | Naphtha (petroleum), light steam-cracked; | Low boiling point naphtha -unspecified; [A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (– 4oF to 374oF). This stream is likely to contain 10 vol.% or more benzene.] | 265-187-5 | 64742-83-2 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-355-00-9 | Нафта (нефтена), лека от паров крекинг; | Нафта с ниска температура на кипене — неспецифицирана; [Сложна комбинация от въглеводороди, получена от дестилация на продукти от процес на паров крекинг. Състои се основно от ненаситени въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C4 до C11, с температура на кипене приблизително в интервала от –20 oC до 190 oC (–4oF до 374 oF).] Тази фракция вероятно съдържа 10 обемни % или повече бензен.] | 265-187-5 | 64742-83-2 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-356-00-4 | Solvent naphtha (petroleum), light arom.; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 oC to 210 oC (275oF to 410oF).] | 265-199-0 | 64742-95-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-356-00-4 | Солвент нафта (нефтена), лека, ароматна; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена от дестилация на ароматни фракции. Състои се основно от ароматни въглеводороди с брой на въглеродните атоми предимно в интервала от C8 до C10, с температура на кипене приблизително в интервала от 135 oC до 210 oC (275 oF до 410 oF).] | 265-199-0 | 64742-95-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-357-00-X | Aromatic hydrocarbons, C6-10, acid-treated, neutralized; | Low boiling point naphtha — unspecified | 268-618-5 | 68131-49-7 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-357-00-X | Ароматни въглеводороди, C6-10, обработени с киселина, неутрализирани; | Нафта с ниска температура на кипене — неспецифицирана; | 268-618-5 | 68131-49-7 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-358-00-5 | Distillates (petroleum), C3-5, 2-methyl-2-butene-rich; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons from the distil lation of hydrocarbons usually ranging in carbon numbers from C3 through C5, predominantly isopentane and 3-methyl-1-butene. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C5, predominantly 2-methyl-2-butene.] | 270-725-7 | 68477-34-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-358-00-5 | Дестилати (нефтени), C3-5, богати на 2-метил-2-бутен; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди от дестилацията на въглеводороди, с брой на въглеродните атоми обичайно в интервала от C3 до C5, предимно изопентан и 3-метил-1-бутен. Състои се от наситени и ненаситени въглеводороди, с брой на въглеродните атоми в интервала от C3 до C5, основно 2-метил-2-бутен.] | 270-725-7 | 68477-34-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-359-00-0 | Distillates (petroleum), polymd. steam-cracked petroleum distillates, C5-12 fraction; | Low boiling point naphtha- unspecified; | [A complex combination of hydrocarbons obtained from the distillation of polymerized steam-cracked petroleum distillate. It consists predomi nantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12.] | 270-735-1 | 68477-50-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-359-00-0 | Дестилати (нефтени), полимеризирани нефтени дестилати от паров крекинг, фракция с C5-12; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена от дестилация на полимеризиран нефтен дестилат от паров крекинг. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C5 до C12.] | 270-735-1 | 68477-50-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-360-00-6 | Distillates (petroleum), steam-cracked, C5-12 fraction; | Low boiling point naphtha -unspecified; | [A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C12.] | 270-736-7 | 68477-53-2 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-360-00-6 | Дестилати (нефтени), от паров крекинг, фракция с C5-12; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от органични съединения, получена чрез дестилация на продукти от процес на паров крекинг. Състои се от ненаситени въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C5 до C12.] | 270-736-7 | 68477-53-2 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-361-00-1 | Distillates (petroleum), steam-cracked, C5-10 fraction, mixed with light steam-cracked petroleum naphtha C5 fraction; Low boiling point naphtha -unspecified | 270-738-8 | 68477-55-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-361-00-1 | Дестилати (нефтени), от паров крекинг, фракция с C5-10, смесена с фракция с C5 лека нефтена нафта от паров крекинг; Нафта с ниска температура на кипене — неспецифицирана; | 270-738-8 | 68477-55-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-362-00-7 | Extracts (petroleum), cold-acid, C4-6; Low boiling point naphtha — unspecified; [A complex combination of organic compounds produced by cold acid unit extraction of saturated and unsaturated aliphatic hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly pentanes and amylenes. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.] | 270-741-4 | 68477-61-2 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-362-00-7 | Екстракти (нефтени), нискотемпературна киселинна екстракция, C4-6; Нафта с ниска температура на кипене — неспецифицирана; [Сложна комбинация от органични съединения, получени чрез инсталация за нискотемпературна киселинна екстракция на наситени и ненаситени алифатни въглеводороди, с брой на въглеродните атоми обичайно в интервала от C3 до C6, предимно пентани и амилени. Състои се основно от наситени и ненаситени въглеводороди, с брой на въглеродните атоми в интервала от C4 до C6, основно C5.] | 270-741-4 | 68477-61-2 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-363-00-2 | Distillates (petroleum), depentanizer overheads; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons obtained from a catalytic cracked gas stream. It consists of aliphatic hydro carbons having carbon numbers predominantly in the range of C4 through C6.] | 270-771-8 | 68477-89-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-363-00-2 | Дестилати (нефтени), фракции от горната част на колона за депетанизация; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена от каталитично крекирана газова фракция. Състои се от алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C4 до C6.] | 270-771-8 | 68477-89-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-364-00-8 | Residues (petroleum), butane splitter bottoms; | Low boiling point naphtha -unspecified; | [A complex residuum from the distillation of butane stream. It consists of aliphatic hydro carbons having carbon numbers predominantly in the range of C4 through C6.] | 270-791-7 | 68478-12-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-364-00-8 | Остатъци (нефтени), от дъното на дестилационна колона за бутан; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложен остатък от дестилация на бутанова фракция. Състои се от алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C4 до C6.] | 270-791-7 | 68478-12-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-365-00-3 | Residual oils (petroleum), deisobutanizer tower; | Low boiling point naphtha -unspecified; | [A complex residuum from the atmospheric distillation of the butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.] | 270-795-9 | 68478-16-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-365-00-3 | Остатъци (нефтени), от колона за деизобутанизация; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложен остатък от атмосферна дестилация на бутан-бутиленов поток. Състои се от алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C4 до C6.] | 270-795-9 | 68478-16-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-366-00-9 | Naphtha (petroleum), full-range coker; | Low boiling point naphtha — unspecified; | [A complex combination of hydrocarbons produced by the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C15 and boiling in the range of approximately 43o C to 250o C (110oF-500oF).] | 270-991-4 | 68513-02-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-366-00-9 | Нафта (нефтена), кипяща в широк обхват, от коксуване; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от инсталация за коксуване в кипящ слой. Състои се основно от ненаситени въглеводороди с брой на въглеродните атоми предимно в интервала от C4 до C15, с температура на кипене приблизително в интервала от 43 oC до 250 oC (110 oF до 500 oF).] | 270-991-4 | 68513-02-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-367-00-4 | Naphtha (petroleum), steam-cracked middle arom.; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons produced by the distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 130o C to 220o C (266oF to 428oF).] | 271-138-9 | 68516-20-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-367-00-4 | Нафта (нефтена), от паров крекинг, средна, съдържаща ароматни съединения; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получени при дестилация на продукти от процес на паров крекинг. Състои се предимно от ароматни въглеводороди с брой на въглеродните атоми предимно в интервала от C7 до C12, с температура на кипене приблизително в интервала от 130 o C до 220 o C (266 oF до 428 oF).] | 271-138-9 | 68516-20-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-368-00-X | Naphtha (petroleum), clay-treated full-range straight-run; Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons resulting from treatment of full-range straight- run naphtha with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20o C to 220o C (– 4oF to 429oF).] | 271-262-3 | 68527-21-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-368-00-X | Нафта (нефтена), обработена с глина, кипяща в широк обхват, от пряка дестилация; Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена при обработване на кипяща в широк обхват нафта от пряка дестилация с природна или модифицирана глина, обичайно при перколационен процес, за отстраняване на следи от налични полярни съединения и онечиствания. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C4 до C11, с температура на кипене приблизително в интервала от –20 o C до 220 o C (–4 oF до 429 oF).] | 271-262-3 | 68527-21-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-369-00-5 | Naphtha (petroleum), clay-treated light straight-run; | Low boiling point naphtha — unspecified; | [A complex combination of hydrocarbons resulting from treatment of light straight-run naphtha with a natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 93 oC to 180 oC (200oF to 356oF).] | 271-263-9 | 68527-22-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-369-00-5 | Нафта (нефтена), обработена с глина, лека, от пряка дестилация; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена от обработка с природна или модифицирана глина на лека нафта от пряка дестилация, обикновено с перколационен процес, за отстраняване на следи от налични полярни съединения и онечиствания. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C7 до C10, с температура на кипене приблизително в интервала от 93 oC до 180 oC (200 oF до 356 oF).] | 271-263-9 | 68527-22-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-370-00-0 | Naphtha (petroleum), light steam-cracked arom.; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C9 and boiling in the range of approximately 110o C to 165 o C (230 oF to 329 oF).] | 271-264-4 | 68527-23-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-370-00-0 | Нафта (нефтена), от паров крекинг, лека, съдържаща ароматни съединения; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получени при дестилация на продукти от процес на паров крекинг. Състои се предимно от ароматни въглеводороди с брой на въглеродните атоми предимно в интервала от C7 до C9, с температура на кипене приблизително в интервала от 110 o C до 165 o C (230 oF до 329 oF).] | 271-264-4 | 68527-23-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-371-00-6 | Naphtha (petroleum),light steam-cracked, debenzenized; Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 80o C to 218o C (176oF to 424oF).] | 271-266-5 | 68527-26-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-371-00-6 | Нафта (нефтена), от паров крекинг, лека, без съдържание на бензен; Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получени при дестилация на продукти от процес на паров крекинг. Състои се основно от въглеводороди с брой на въглеродните атоми предимно в интервала от C4 до C12, с температура на кипене приблизително в интервала от 80 o C до 218 o C (176 oF до 424 oF).] | 271-266-5 | 68527-26-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-372-00-1 | Naphtha (petroleum), arom.-contg.; | Low boilingpoint naphtha — unspecified | 271-635-0 | 68603-08-7 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-372-00-1 | Нафта (нефтена), съдържаща ароматни съединения; | Нафта с ниска температура на кипене — неспецифицирана; | 271-635-0 | 68603-08-7 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-373-00-7 | Gasoline, pyrolysis, debutanizer bottoms; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists of hydrocarbons having carbon numbers predominantly greater than C5.] | 271-726-5 | 68606-10-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-373-00-7 | Бензин, пиролизен, дънни продукти от колона за дебутанизация; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена чрез фракциониране на дънните продукти от колоната за депропанизация. Състои се от въглеводороди с брой на въглеродните атоми предимно по-голям от C5.] | 271-726-5 | 68606-10-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-374-00-2 | Naphtha (petroleum), light, sweetened; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydro carbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 20o C to 100o C (– 4oF to 212 oF).] | 272-206-0 | 68783-66-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-374-00-2 | Нафта (нефтена), лека, десулфурирана; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена при подлагане на десулфурация на нефтен дестилат за превръщане на меркаптаните или за отстраняване на киселинните онечиствания. Състои се основно от наситени и ненаситени въглеводороди с брой на въглеродните атоми предимно в интервала от C3 до C6, с температура на кипене приблизително в интервала от –20 o C до 100 o C (–4 oF до 212 oF).] | 272-206-0 | 68783-66-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-375-00-8 | Natural gas condensates; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons separated and/or condensed from natural gas during transportation and collected at the wellhead and/or from the production, gathering, transmission, and distribution pipelines in deeps, scrubbers, etc. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C2 through C8.] | 272-896-3 | 68919-39-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-375-00-8 | Кондензати от природен газ; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, разделена и/или кондензирана от природен газ по време на транспортиране и събрана в сондата за добиване и/или в производствени, събирателни, транзитни и разпределителни тръбопроводи в шахти, скрубери и т.н. Състои се основно от въглеводороди с брой на въглеродните атоми в интервала от C2 до C8.] | 272-896-3 | 68919-39-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-376-00-3 | Distillates (petroleum), naphtha unifiner stripper; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons produced by stripping the products from the naphtha unifiner. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] | 272-932-8 | 68921-09-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-376-00-3 | Дестилати (нефтени), разделителна колона от процес „Unifiner“ за нафта; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена от разделяне на продукти от разделителна колона от процес „Unifiner“ за нафта. Състои се от наситени алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C2 до C6.] | 272-932-8 | 68921-09-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-377-00-9 | Naphtha (petroleum), catalytic reformed light, arom.-free fraction; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons remaining after removal of aromatic compounds from catalytic reformed light naphtha in a selective absorption process. It consists predominantly of paraffinic and cyclic compounds having carbon numbers predominantly in the range of C5 to C8 and boiling in the range of approximately 66o C to 121o C (151oF to250oF).] | 285-510-3 | 85116-59-2 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-377-00-9 | Нафта (нефтена), от каталитичен риформинг, лека, фракция без съдържание на ароматни съединения; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, останала след отстраняване на ароматни съединения от лека нафта от каталитичен риформинг чрез процес на селективна абсорбция. Състои се основно от парафинови и пръстенни съединения с брой на въглеродните атоми предимно в интервала от C5 до C8, с температура на кипене приблизително в интервала от 66 oC до 121 oC (151 oF до 250 oF).] | 285-510-3 | 85116-59-2 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-378-00-4 | Gasoline; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons consisting primarily of paraffins, cycloparaffins, aromatic and olefinic hydrocarbons having carbon numbers predominantly greater than C3 and boiling in the range of 30 oC to 260o C (86oF to 500oF).] | 289-220-8 | 86290-81-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-378-00-4 | Бензин; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, състояща се основно от парафини, циклопарафини, ароматни и олефинови въглеводороди с брой на въглеродните атоми преобладаващо по-големи от C3, с температура на кипене приблизително в интервала от 30 oC до 260 oC (86oF до 500oF).] | 289-220-8 | 86290-81-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-379-00-X | Aromatic hydrocarbons, C7-8, dealkylation products, distn. residues; | Low boiling point naphtha — unspecified | 292-698-0 | 90989-42-7 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-379-00-X | Ароматни въглеводороди, C7-8, продукти от процес на деалкилиране, остатъци от дестилация; | Нафта с ниска температура на кипене — неспецифицирана; | 292-698-0 | 90989-42-7 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-380-00-5 | Hydrocarbons, C4-6, depentanizer lights, arom. hydrotreater; Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons obtained as first runnings from the depentanizer column before hydrotreatment of the aromatic charges. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C6, predominantly pentanes and pentenes and boiling in the range of approximately 25 oC to 40 o C (77oF to 104oF).] | 295-298-4 | 91995-38-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-380-00-5 | Въглеводороди, C4-6, леки фракции от колона за депентанизация, инсталация за обработване с водород на ароматни фракции; Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена като първа фракция от колона за депентанизация преди обработката с водород на ароматните фракции. Състои се основно от въглеводороди с брой на въглеродните атоми предимно в интервала от C4 до C6, преобладаващо пентани и пентени, и с температура на кипене в интервала приблизително от 25 oC до 40 oC (77oF до 104oF).] | 295-298-4 | 91995-38-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-381-00-0 | Distillates (petroleum), heat-soaked steam-cracked naphtha, C5-rich; | Low boiling point naphtha — unspecified; | [A complex combination of hydrocarbons obtained by distillation of heat-soaked steam- cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.] | 295-302-4 | 91995-41-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-381-00-0 | Дестилати (нефтени), от сокинг, нафта от паров крекинг, богати на C5; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена чрез дестилация на обработена чрез сокинг нафта от паров крекинг. Състои се основно от въглеводороди с брой на въглеродните атоми в интервала от C4 до C6, основно C5.] | 295-302-4 | 91995-41-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-382-00-6 | Extracts (petroleum), catalytic reformed light naphtha solvent; Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons obtained as the extract from the solvent extraction of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C8 and boiling in the range of approximately 100 oC to 200 oC (212oF to 392oF).] | 295-331-2 | 91995-68-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-382-00-6 | Екстракти (нефтени), от лека нафта от каталитичен риформинг, обработена с разтворител; Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена като екстракт от екстракция с разтворител на нефтена фракция от каталитичен риформинг. Състои се основно от ароматни въглеводороди с брой на въглеродните атоми предимно в интервала от C7 до C8, с температура на кипене приблизително в интервала от 100 oC до 200 oC (212 oF до 392 oF).] | 295-331-2 | 91995-68-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-383-00-1 | Naphtha (petroleum), hydrodesulfurized light, dearomatized; Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons obtained by distillation of hydrodesulfurized and dearomatized light petroleum fractions. It consists predominantly of C7 paraffins and cycloparaffins boiling in a range of approximately 90o C to 100o C (194oF to 212oF).] | 295-434-2 | 92045-53-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-383-00-1 | Нафта (нефтена), хидродесулфурирана, лека, деароматизирана; Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена чрез дестилация на хидродесулфурирани и деароматизирани леки нефтени фракции. Състои се предимно от парафини и циклопарафини с C7, с точка на кипене в интервала приблизително 90 o C до 100 o C (194 oF до 212 oF).] | 295-434-2 | 92045-53-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-384-00-7 | Naphtha (petroleum), light, C5-rich, sweetened; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C5, predominantly C5, and boiling in the range of approximately minus 10 oC to 35o C (14oF to 95oF).] | 295-442-6 | 92045-60-8 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-384-00-7 | Нафта (нефтена), лека, богата на C5, десулфурирана; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена от нефтена нафта, подложена на десулфурация за превръщане на меркаптаните или за отстраняване на киселинни онечиствания. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C4 до C5, основно C5, с температура на кипене приблизително в интервала от –10 oC до 35 oC (14 oF до 95 oF).] | 295-442-6 | 92045-60-8 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-385-00-2 | Hydrocarbons, C8-11, naphtha-cracking, toluene cut; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons obtained by distillation from prehydrogenated cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C11 and boiling in the range of approximately 130o C to 205o C (266oF to 401oF).] | 295-444-7 | 92045-62-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-385-00-2 | Въглеводороди, C8-11, крекинг на нафта, толуенова фракция; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена при дестилация на предварително хидрогенирана крекирана нафта. Състои се основно от въглеводороди с брой на въглеродните атоми предимно в интервала от C8 до C11, с температура на кипене приблизително в интервала от 130 oC до 205 oC (266 oF до 401 oF).] | 295-444-7 | 92045-62-0 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-386-00-8 | Hydrocarbons, C4-11, naphtha-cracking, arom.-free; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons obtained from prehydrogenated cracked naphtha after distillative separation of benzene-and toluene-containing hydrocarbon cuts and a higher boiling fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 o C to 205 o C (86 oF to 401 oF).] | 295-445-2 | 92045-63-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-386-00-8 | Въглеводороди, C4-11, нафта от крекинг процес, без съдържание на ароматни съединения; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена от предварително хидрогенирана крекирана нафта след дестилационно разделяне на бензенсъдържащи и толуенсъдържащи въглеводородни фракции и фракция с по-висока температура на кипене. Състои се основно от въглеводороди с брой на въглеродните атоми предимно в интервала от C4 до C11, с температура на кипене приблизително в интервала от 30 o C до 205 o C (86 oF до 401 oF).] | 295-445-2 | 92045-63-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-387-00-3 | Naphtha (petroleum), light heat-soaked, steam-cracked; | Low boiling point naphtha — unspecified; | [A complex combination of hydrocarbons obtained by the fractionation of steam cracked naphtha after recovery from a heat soaking process. It consists predominantly of hydrocarbons having a carbon number predominantly in the range of C4 through C6 and boiling in the range of approxi mately 0o C to 80o C (32oF to 176oF).] | 296-028-8 | 92201-97-3 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-387-00-3 | Нафта (нефтена), лека, от сокинг, от паров крекинг; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена при фракциониране на нафта от паров крекинг след извличане чрез сокинг. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C4 до C6, с температура на кипене приблизително в интервала от 0 oC до 80 oC (32oF до 176oF).] | 296-028-8 | 92201-97-3 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-388-00-9 | Distillates (petroleum), C6-rich; Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons obtained from the distillation of a petroleum feedstock. It consists predominantly of hydrocarbons having carbon numbers of C5 through C7, rich in C6, and boiling in the range of approximately 60o C to70o C (140 oF to 158 oF).] | 296-903-4 | 93165-19-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-388-00-9 | Дестилати (нефтени), богати на C6; Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена от дестилация на нефтена суровина. Състои се основно от въглеводороди с брой на въглеродните атоми предимно в интервала от C5 до C7, богати на C6, с температура на кипене приблизително в интервала от 60 oC до 70 oC (140oF до 158oF).] | 296-903-4 | 93165-19-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-389-00-4 | Gasoline, pyrolysis, hydrogenated; | Low boiling point naphtha-unspecified; | [A distillation fraction from the hydrogenation of pyrolysis gasoline boiling in the range of approximately 20o C to 200o C (68oF to 392oF).] | 302-639-3 | 94114-03-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-389-00-4 | Бензин, пиролизен, хидрогениран; | Нафта с ниска температура на кипене — неспецифицирана; | [Дестилационна фракция от хидрогениране на пиролизен бензин с температура на кипене приблизително в интервала от 20 oC до 200 oC (68oF до 392oF).] | 302-639-3 | 94114-03-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-390-00-X | Distillates (petroleum), steam-cracked, C8-12 fraction, polymd., distn. lights; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons obtained by distillation of the polymerized C8 through C12 fraction from steam-cracked petroleum distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C12.] | 305-750-5 | 95009-23-7 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-390-00-X | Дестилати (нефтени), от паров крекинг, фракция с C8-12, полимеризирани леки дестилати; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена при дестилация на полимеризирана фракция с C8—C12 от нефтени дестилати от паров крекинг. Състои се основно от алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C8 до C12.] | 305-750-5 | 95009-23-7 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-391-00-5 | Extracts (petroleum) heavy naphtha solvent, clay-treated; Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons obtained by the treatment of heavy naphthic solvent petroleum extract with bleaching earth. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C10 and boiling in the range of approximately 80 o C to 180 o C (175 oF to 356 oF).] | 308-261-5 | 97926-43-7 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-391-00-5 | Екстракти (нефтени), тежък нафтен разтворител, обработени с глина; Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена при обработване с избелваща глина на нефтен екстракт с тежък нафтен разтворител. Състои се основно от въглеводороди с брой на въглеродните атоми предимно в интервала от C6 до C10, с температура на кипене приблизително в интервала от 80 o C до 180 o C (175 oF до 356 oF).] | 308-261-5 | 97926-43-7 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-392-00-0 | Naphtha (petroleum), light steam-cracked, debenzenized, thermally treated; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons obtained by the treatment and distillation of debenzenized light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 95 oC to 200o C (203oF to 392oF).] | 308-713-1 | 98219-46-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-392-00-0 | Нафта (нефтена), от паров крекинг, лека, без съдържание на бензен, термично обработена; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена при обработване и дестилация на очистена от бензен лека нефтена нафта от паров крекинг. Състои се основно от въглеводороди с брой на въглеродните атоми предимно в интервала от C7 до C12, с температура на кипене приблизително в интервала от 95 oC до 200 oC (203 oF до 392 oF).] | 308-713-1 | 98219-46-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-393-00-6 | Naphtha (petroleum), light steam-cracked, thermally treated; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons obtained by the treatment and distillation of light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 35 o C to 80 o C (95 oF to 176 oF).] | 308-714-7 | 98219-47-7 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-393-00-6 | Нафта (нефтена), от паров крекинг, лека, термично обработена; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена при обработване и дестилация на лека нефтена нафта от паров крекинг. Състои се основно от въглеводороди с брой на въглеродните атоми предимно в интервала от C5 до C6, с температура на кипене приблизително в интервала от 35 o C до 80 o C (95 oF до 176 oF).] | 308-714-7 | 98219-47-7 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-394-00-1 | Distillates (petroleum), C7-9, C8-rich, hydrodesulfurized dearomatized; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons obtained by the distillation of petroleum light fraction, hydrodesulfurized and dearomatized. It consists predominantly of hydrocarbons having carbon numbers in the range of C7 through C9, predominantly C8 paraffins and cycloparaffins, boiling in the range of approximately 120 o C to 130 o C (248 oF to 266 oF).] | 309-862-5 | 101316-56-7 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-394-00-1 | Дестилати (нефтeни), C7-9, богати на C8, хидродесулфурирани, деароматизирани; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена при дестилация на лека нефтена фракция, хидродесулфурирана и деароматизирана. Състои се основно от въглеводороди с брой на въглеродните атоми предимно в интервала от C7 до C9, преобладаващо C8, парафини и циклопарафини, с температура на кипене приблизително в интервала от 120 oС до 130 oС (248oF до 266oF).] | 309-862-5 | 101316-56-7 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-395-00-7 | Hydrocarbons, C6-8, hydrogenated sorption-dearomatized, toluene raffination; | Low boiling point naphtha — unspecified; | [A complex combination of hydrocarbons obtained during the sorptions of toluene from a hydrocarbon fraction from cracked gasoline treated with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C8 and boiling in the range of approximately 80o C to 135o C (176oF to 275oF).] | 309-870-9 | 101316-66-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-395-00-7 | Въглеводороди, C6-8, хидрогенирани, деароматизирани чрез сорбция, рафиниране на толуен; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена по време на сорбция на толуен от въглеводородна фракция от крекиран бензин, обработена с водород в присъствие на катализатор. Състои се основно от въглеводороди с брой на въглеродните атоми предимно в интервала от C6 до C8, с температура на кипене приблизително в интервала от 80 o C до 135 o C (176 oF до 275 oF).] | 309-870-9 | 101316-66-9 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-396-00-2 | Naphtha (petroleum), hydrodesulfurised full-range coker; | Low boiling point naphtha -unspecified; | [A complex ombination of hydrocarbons obtained by fractionation from hydrodesulfurised coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 oC to 196 o C (73 oF to 385 oF).] | 309-879-8 | 101316-76-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-396-00-2 | Нафта (нефтена), хидродесулфурирана, кипяща в широк обхват, от коксуване; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена при фракциониране от хидродесулфуриран дестилат от коксуване. Състои се основно от въглеводороди с брой на въглеродните атоми предимно в интервала от C5 до C11, с температура на кипене приблизително в интервала от 23 oC до 196 oC (73 oF до 385 oF).] | 309-879-8 | 101316-76-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-397-00-8 | Naphtha (petroleum), sweetened light; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 20 o C to 130 o C (68 oF to 266 oF).] | 309-976-5 | 101795-01-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-397-00-8 | Нафта (нефтена), лека, десулфурирана; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена от нефтена нафта, подложена на десулфурация за превръщане на меркаптаните или за отстраняване на киселинни онечиствания. Състои се основно от въглеводороди с брой на въглеродните атоми предимно в интервала от C5 до C8, с температура на кипене приблизително в интервала от 20 o C до 130 o C (68 oF до 266 oF).] | 309-976-5 | 101795-01-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-398-00-3 | Hydrocarbons, C3-6, C5-rich, steam-cracked naphtha; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons obtained by distillation of steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly C5.] | 310-012-0 | 102110-14-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-398-00-3 | Въглеводороди, C3-6, богати на C5, нафта от паров крекинг; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена от дестилацията на нафта от паров крекинг. Състои се основно от въглеводороди с брой на въглеродните атоми в интервала от C3 до C6, основно C5.] | 310-012-0 | 102110-14-5 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-399-00-9 | Hydrocarbons, C5-rich, dicyclopentadiene-contg.; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons obtained by distillation of the products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers of C5 and dicyclopentadiene and boiling in the range of approximately 30o C to 170o C (86oF to 338oF).] | 310-013-6 | 102110-15-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-399-00-9 | Въглеводороди, богати на C5, съдържащи дициклопентадиен; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена от дестилацията на продукти от паров крекинг. Състои се предимно от въглеводороди с брой на въглеродните атоми C5 и дициклопентадиен, с точка на кипене в интервала приблизително 30 oC—170 oC (86 oF—338 oF).] | 310-013-6 | 102110-15-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-400-00-2 | Residues (petroleum), steam-cracked light, arom.; | Low boiling point naphtha -unspecified; | [A complex combination of hydrocarbons obtained by the distillation of the products of steamcracking or similar processes after taking off the very light products resulting in a residue starting with hydrocarbons having carbon numbers greater than C5. It consists predominantly of aromatic hydrocarbons having carbon numbers greater than C5 and boiling above approximately 40o C (104oF).] | 310-057-6 | 102110-55-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-400-00-2 | Остатъци (нефтени), леки, от паров крекинг, ароматни; | Нафта с ниска температура на кипене — неспецифицирана; | [Сложна комбинация от въглеводороди, получена чрез дестилация на продуктите от паров крекинг или подобни процеси след отстраняването на много леките продукти, като в резултат се получава остатък, започващ с въглеводороди с брой на въглеродните атоми по-голям от C5. Състои се главно от ароматни въглеводороди с брой въглеродни атоми по-голям от C5, с точка на кипене над около 40 oC (104 oF)] | 310-057-6 | 102110-55-4 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-401-00-8 | Hydrocarbons, C≥5, C5-6-rich; Low boiling point naphtha -unspecified | 270-690-8 | 68476-50-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-401-00-8 | Въглеводороди, C ≥ 5, богати на C5-6; Нафта с ниска температура на кипене — неспецифицирана; | 270-690-8 | 68476-50-6 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-402-00-3 | Hydrocarbons, C5-rich; | Low boiling point naphtha — unspecified | 270-695-5 | 68476-55-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-402-00-3 | Въглеводороди, богати на C5; | Нафта с ниска температура на кипене — неспецифицирана; | 270-695-5 | 68476-55-1 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-403-00-9 | Aromatic hydrocarbons, C8-10; Low boiling point naphtha -unspecified | 292-695-4 | 90989-39-2 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P649-403-00-9 | Ароматни въглеводороди, C8-10; Нафта с ниска температура на кипене — неспецифицирана; | 292-695-4 | 90989-39-2 | Carc. 1B | Muta. 1B | Asp. Tox. 1 | H350 | H340 | H304 | GHS08 | Dgr | H350 | H340 | H304 |   |   | P
649-404-00-4 | Kerosine (petroleum); Straight run kerosine; | [A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150oC to 290oC (320oF to 554oF).] | 232-366-4 | 8008-20-6 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-404-00-4 | Керосин (нефтен); Керосин от пряка дестилация; | [Сложна комбинация от въглеводороди, получена чрез дестилация на суров нефт. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C9 до C16, с температура на кипене приблизително в интервала от 150 oC до 290 oC (320oF до 554oF).] | 232-366-4 | 8008-20-6 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-405-00-X | solvent naphtha (petroleum), medium aliph.; | Straight run kerosine; | [A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140o C to 220o C (284oF to 428oF).] | 265-191-7 | 64742-88-7 | STOT RE 1 | Asp. Tox. 1 | H372 (central nervous system) | H304 | GHS08 | Dgr | H372 (central nervous system) | H304 |   |   |  649-405-00-X | Солвент нафта (нефтена), средна алифатна.; | Керосин от пряка дестилация; | [Сложна комбинация от въглеводороди, получена чрез дестилация на суров нефт или бензин от природен газ. Състои се от въглеводороди с брой на въглеродните атоми предимно в интервала от C9 до C12, с температура на кипене приблизително в интервала от 140 o C до 220 o C (284 oF до 428 oF).] | 265-191-7 | 64742-88-7 | STOT RE 1 | Asp. Tox. 1 | H372 (централна нервна система) | H304 | GHS08 | Dgr | H372 (централна нервна система) | H304 |   |   |  
649-406-00-5 | Solvent naphtha (petroleum) heavy aliph.; | Straight run kerosine; | [A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C11 through C16 and boiling in the range of approximately 190 oC to 290 oC (374 oF to 554 oF).] | 265-200-4 | 64742-96-7 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-406-00-5 | Солвент нафта (нефтена), тежка, алифатна; | Керосин от пряка дестилация; | [Сложна комбинация от въглеводороди, получена чрез дестилация на суров нефт или бензин от природен газ. Състои се основно от наситени въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C11 до C16, с температура на кипене приблизително в интервала от 190 oC до 290 oC (374oF до 554oF).] | 265-200-4 | 64742-96-7 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-407-00-0 | Kerosine (petroleum), straight-run wide-cut; | Straight run kerosine; | [A complex combination of hydrocarbons obtained as a wide cut hydrocarbon fuel cut from atmospheric distillation and boiling in the range of approximately 70 oC to 220 oC (158 oF to 428 oF).] | 295-418-5 | 92045-37-9 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-407-00-0 | Керосин (нефтен), широка фракция, от пряка дестилация; | Керосин от пряка дестилация; | [Сложна комбинация от въглеводороди, получена като широка фракция от въглеводородни горива от атмосферна дестилация, с температура на кипене приблизително в интервала от 70 oC до 220 oC (158oF до 428oF).] | 295-418-5 | 92045-37-9 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-408-00-6 | Distillates (petroleum), steam-cracked; | Cracked kerosine; | [A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C7 through C16 and boiling in the range of approximately 90 oC to 290 oC (190 oF to 554 oF).] | 265-194-3 | 64742-91-2 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-408-00-6 | Дестилати (нефтени), от паров крекинг; | Крекиран керосин; | [Сложна комбинация от въглеводороди, получена от дестилация на продукти от процес на паров крекинг. Състои се основно от ненаситени въглеводороди с брой на въглеродните атоми основно в интервала от C7 до C16, с температура на кипене приблизително в интервала от 90 oC до 290 oC (190oF до 554oF).] | 265-194-3 | 64742-91-2 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-409-00-1 | Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C8-10 fraction; | Cracked kerosine; | [A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists of hydrocarbons having carbon numbers in the range of C8 through C10 and boiling in the range of approximately 129oC to 194oC (264 oF to 382 oF).] | 270-728-3 | 68477-39-4 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-409-00-1 | Дестилати (нефтени), крекирани нефтени дестилати от разделителна колона от паров крекинг, фракция с C8-10; | Крекиран керосин; | [Сложна комбинация от въглеводороди, получена от дестилацията на крекирани дестилати от разделителна колона от паров крекинг. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C8 до C10, с температура на кипене приблизително в интервала от 129 oC до 194 oC (264oF до 382oF).] | 270-728-3 | 68477-39-4 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-410-00-7 | Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C10-12 fraction; | Cracked kerosine; | [A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C10 through C12.] | 270-729-9 | 68477-40-7 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-410-00-7 | Дестилати (нефтени), крекирани нефтени дестилати от разделителна колона от паров крекинг, фракция с C10-12; | Крекиран керосин; | [Сложна комбинация от въглеводороди, получена от дестилацията на крекирани дестилати от разделителна колона от паров крекинг. Състои се основно от ароматни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C10 до C12.] | 270-729-9 | 68477-40-7 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-411-00-2 | Distillates (petroleum), steam-cracked, C8-12 fraction; | Cracked kerosine; | [A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C8 through C12.] | 270-737-2 | 68477-54-3 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-411-00-2 | Дестилати (нефтени), от паров крекинг, фракция с C8-12; | Крекиран керосин; | [Сложна комбинация от органични съединения, получена чрез дестилация на продукти от процес на паров крекинг. Състои се основно от ненаситени въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C8 до C12.] | 270-737-2 | 68477-54-3 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-412-00-8 | Kerosine (petroleum), hydrodesulfurized thermal cracked; Cracked kerosine; | [A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized thermal cracker distillate. It consists predomi nantly of hydrocarbons predominantly in the range of C8 to C16 and boiling in the range of approximately 120oC to 283oC (284oF to 541oF).] | 285-507-7 | 85116-55-8 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-412-00-8 | Керосин (нефтен), хидродесулфуриран, от термичен крекинг; Крекиран керосин; | [Сложна комбинация от въглеводороди, получена при фракциониране на хидродесулфуриран дестилат от термичен крекинг. Състои се главно от въглеводороди с брой на въглеродните атоми основно в интервала от C8 до C16, с температура на кипене приблизително в интервала от 120 oC до 283 oC (284oF до 541oF).] | 285-507-7 | 85116-55-8 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-413-00-3 | Aromtic hydrocarbons, C≥10, steam-cracking, hydrotreated; Cracked kerosine; | [A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly greater than C10 and boiling in the range of approximately 150 oC to 320 oC (302 oF to 608 oF).] | 292-621-0 | 90640-98-5 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-413-00-3 | Ароматни въглеводороди, C ≥ 10, паров крекинг, обработени с водород; Крекиран керосин; | [Сложна комбинация от въглеводороди, получена при дестилация на продукти от паров крекинг, обработени с водород в присъствие на катализатор. Състои се основно от ароматни въглеводороди с брой на въглеродните атоми преобладаващо над C10, с температура на кипене приблизително в интервала от 150 oC до 320 oC (302 oF до 608 oF).] | 292-621-0 | 90640-98-5 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-414-00-9 | Naphtha (petroleum), steam-cracked, hydrotreated, C9-10-arom.-rich; Cracked kerosine; | [A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process thereafter treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C9 through C10 and boiling in the range of approximately 140oC to 200oC (284oF to 392oF).] | 292-637-8 | 90641-13-7 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-414-00-9 | Нафта (нефтена), от паров крекинг, обработена с водород, богата на ароматни съединения с C9-10; Крекиран керосин; | [Сложна комбинация от въглеводороди, получена при дестилация на продукти от паров крекинг, обработена впоследствие с водород в присъствие на катализатор. Състои се основно от ароматни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C9 до C10, с температура на кипене приблизително в интервала от 140 oC до 200 oC (284oF до 392oF).] | 292-637-8 | 90641-13-7 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-415-00-4 | Distillates (petroleum), thermal-cracked, alkylarom. hydrocarbon-rich; | Cracked kerosine; | [A complex combination of hydrocarbons obtained by distillation of thermal-cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250oC (212oF to 482oF.] | 309-866-7 | 101316-61-4 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-415-00-4 | Дестилати (нефтени), термично крекирани, богати на алкилароматни въглеводороди; | Крекиран керосин; | [Сложна комбинация от въглеводороди, получени при дестилация на термично крекирани тежки катранени фракции. Състои се основно от високоалкилирани ароматни въглеводороди с температура на кипене приблизително в интервала от 100 oC до 250 oC (212oF до 482oF).] | 309-866-7 | 101316-61-4 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-416-00-X | Distillates (petroleum), catalytic cracked heavy tar light; | Cracked kerosine; | [A complex combination of hydrocarbons obtained by distillation of catalytic cracking heavy tars. It consists predomi nantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).] | 309-938-8 | 101631-13-4 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-416-00-X | Дестилати (нефт), леки, от каталитично крекирани тежки катранени фракции; | Крекиран керосин; | [Сложна комбинация от въглеводороди, получени при дестилация на каталитично крекирани тежки катранени фракции. Състои се основно от високоалкилирани ароматни въглеводороди с температура на кипене приблизително в интервала от 100 oC до 250 oC (212oF до 482oF).] | 309-938-8 | 101631-13-4 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-417-00-5 | Solvent naphtha (petroleum), hydrocracked heavy arom.; Cracked kerosine; | [A complex combination of hydrocarbons obtained by the distillation of hydrocracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 235 oC to 290 oC (455 oF to 554 oF).] | 309-881-9 | 101316-80-7 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-417-00-5 | Солвент нафта (нефтена), от хидрокрекинг, тежка ароматна; Крекиран керосин; | [Сложна комбинация от въглеводороди, получена при дестилация на нефтен дестилат от хидрокрекинг. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C9 до C16, с температура на кипене приблизително в интервала от 235 oC до 290 oC (455oF до 554oF).] | 309-881-9 | 101316-80-7 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-418-00-0 | Distillates (petroleum), steam-cracked heavy tar light; | Cracked kerosine; | [A complex combination of hydrocarbons obtained by distillation of steam cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).] | 309-940-9 | 101631-15-6 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-418-00-0 | Дестилати (нефтени), леки, от паров крекинг на тежки катранени фракции; | Крекиран керосин; | [Сложна комбинация от въглеводороди, получена при дестилация на тежки катранени фракции от паров крекинг. Състои се основно от високоалкилирани ароматни въглеводороди с температура на кипене приблизително в интервала от 100 oC до 250 oC (212oF до 482oF).] | 309-940-9 | 101631-15-6 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-419-00-6 | Distillates (petroleum), alkylate; Kerosine — unspecified; | [A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 205oC to 320oC (401oF to 608oF).] | 265-074-0 | 64741-73-7 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-419-00-6 | Дестилати (нефтени), алкилат; Керосин — неспецифициран; | [Сложна комбинация от въглеводороди, получена при дестилация на реакционните продукти от изобутан с моноолефинови въглеводороди, обикновено с брой на въглеродните атоми от C3 до C5. Състои се от въглеводороди с брой на въглеродните атоми основно от C11 до C17, с температура на кипене приблизително в интервала от 205 oC до 320 oC (401oF до 608oF).] | 265-074-0 | 64741-73-7 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-420-00-1 | Extracts (petroleum), heavy naphtha solvent; | Kerosine — unspecified; | [A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predomi nantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90oC to 220oC (194 oF to 428 oF).] | 265-099-7 | 64741-98-6 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-420-00-1 | Екстракти (нефтени), тежък нафтен разтворител; | Керосин — неспецифициран; | [Сложна комбинация от въглеводороди, получена като екстракт от екстракционен процес с разтворител. Състои се основно от ароматни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C7 до C12, с температура на кипене приблизително в интервала от 90 oC до 220 oC (194oF до 428oF).] | 265-099-7 | 64741-98-6 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-421-00-7 | Distillates (petroleum), chemically neutralized light; Kerosine — unspecified; | [A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).] | 265-132-5 | 64742-31-0 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-421-00-7 | Дестилати (нефтени), химически неутрализирани, леки; Керосин — неспецифициран; | [Сложна комбинация от въглеводороди, получена при процес на обработване за отстраняване на киселинните материали. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C9 до C16, с температура на кипене приблизително в интервала от 150 oC до 290 oC (302oF до 554oF).] | 265-132-5 | 64742-31-0 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-422-00-2 | Distillates (petroleum), hydro- treated light; | Kerosine — unspecified; | [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approxi mately 150 oC to 290 oC (302 oF to 554 oF).] | 265-149-8 | 64742-47-8 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-422-00-2 | Дестилати (нефтени), обработени с водород, леки; | Керосин — неспецифициран; | [Сложна комбинация от въглеводороди, получена при обработване на нефтена фракция с водород в присъствие на катализатор. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C9 до C16, с температура на кипене приблизително в интервала от 150 oC до 290 oC (302oF до 554oF).] | 265-149-8 | 64742-47-8 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-423-00-8 | Kerosine (petroleum), hydrodesulfurized; Kerosine — unspecified; | [A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).] | 265-184-9 | 64742-81-0 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-423-00-8 | Керосин (нефтен), хидродесулфуриран; Керосин — неспецифициран; | [Сложна комбинация от въглеводороди, получена при обработване на нефтена суровина с водород за превръщане на органичната сяра във водороден сулфид, който се отстранява. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C9 до C16, с температура на кипене приблизително в интервала от 150 oC до 290 oC (302oF до 554oF).] | 265-184-9 | 64742-81-0 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-424-00-3 | Solvent naphtha (petroleum), heavy arom.; | Kerosine — unspecified; | [A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 165 oC to 290 oC (330 oF to 554 oF).] | 265-198-5 | 64742-94-5 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-424-00-3 | Солвент нафта (нефтена), тежка ароматна; | Керосин — неспецифициран; | [Сложна комбинация от въглеводороди, получена от дестилация на ароматни потоци. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C9 до C16, с температура на кипене приблизително в интервала от 165 oC до 290 oC (330oF до 554oF).] | 265-198-5 | 64742-94-5 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-425-00-9 | Naphtha (petroleum), heavy coker; | Kerosine — unspecified; | [A complex combination of hydrocarbons from the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons | having carbon numbers predominantly in the range of C6 through C15 and boiling in the range of approximately 157 oC to 288 oC (315 oF to 550 oF).] | 269-778-9 | 68333-23-3 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-425-00-9 | Нафта (нефтена), тежка от коксуване; | Керосин — неспецифициран; | [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от инсталация за коксуване в кипящ слой. Състои се предимно от ненаситени въглеводороди | с брой на въглеродните атоми основно в интервала от C6 до C15, с температура на кипене приблизително в интервала от 157 oC до 288 oC (315oF до 550oF).] | 269-778-9 | 68333-23-3 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-426-00-4 | Naphtha (petroleum), catalytic reformed hydrodesulfurized heavy, arom. fraction; | Kerosine — unspecified; | [A complex combination of hydrocarbons produced by fractionation from catalytically reformed hydrodesulfurized naphtha. It consists predominantly of aromatic hydrocarbons having carbon numbers predominently in the range of C7 to C 13 and boiling in the range of approximately 98oC to 218oC (208oF to 424oF).] | 285-508-2 | 85116-57-0 | Asp. Tox. 1 | H304 | GHS08-Dgr | H304 |   |   |  649-426-00-4 | Нафта (нефтена), от каталитичен риформинг, хидродесулфурирана, тежка, ароматна фракция; | Керосин — неспецифициран; | [Сложна комбинация от въглеводороди, получена при фракциониране на хидродесулфурирана нафта от каталитичен риформинг. Състои се основно от ароматни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C7 до C13, с температура на кипене приблизително в интервала от 98 oC до 218 oC (208oF до 424oF).] | 285-508-2 | 85116-57-0 | Asp. Tox. 1 | H304 | GHS08-Dgr | H304 |   |   |  
649-427-00-X | Kerosine (petroleum), sweetened; | Kerosine — unspecified; | [A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of 130 oC to 290 oC (266 oF to 554 oF).] | 294-799-5 | 91770-15-9 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-427-00-X | Керосин (нефтен), десулфуриран; | Керосин — неспецифициран; | [Сложна комбинация от въглеводороди, получена при подлагане на десулфурация на нефтен дестилат за превръщане на меркаптаните или за отстраняване на киселинните онечиствания. Състои се основно от въглеводороди с брой на въглеродните атоми основно в интервала от C9 до C16, с температура на кипене приблизително в интервала от 130 oC до 290 oC (266 oF до 554oF).] | 294-799-5 | 91770-15-9 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-428-00-5 | Kerosine (petroleum), solvent-refined sweetened; | Kerosine — unspecified; | [A complex combination of hydrocarbons obtained from a petroleum stock by solvent refining and sweetening and boiling in the range of approximately 150 oC to 260 oC (302 oF to 500 oF).] | 295-416-4 | 92045-36-8 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-428-00-5 | Керосин (нефтен), рафиниран с разтворител, десулфуриран; | Керосин — неспецифициран; | [Сложна комбинация от въглеводороди, получена от нефтена суровина при рафиниране с разтворител и десулфурация, с температура на кипене приблизително в интервала от 150 oC до 260 oC (302oF до 500oF).] | 295-416-4 | 92045-36-8 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-429-00-0 | Hydrocarbons, C9-16, hydrotreated, dearomatized; | Kerosine — unspecified; | [A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.] | 297-854-1 | 93763-35-0 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-429-00-0 | Въглеводороди, C9-16, обработени с водород, деароматизирани; | Керосин — неспецифициран; | [Сложна комбинация от въглеводороди, получена като разтворители, които са били подложени на обработване с водород, за превръщане на ароматните съединения в нафтени чрез каталитично хидрогениране.] | 297-854-1 | 93763-35-0 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-430-00-6 | Kerosine (petroleum), solvent-refined hydrodesulfurized; Kerosine — unspecified | 307-033-2 | 97488-94-3 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-430-00-6 | Керосин (нефтен), рафиниран с разтворител, хидродесулфуриран; Керосин — неспецифициран; | 307-033-2 | 97488-94-3 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-431-00-1 | Distillates (petroleum), hydrodesulfurized full-range middle coker; | Kerosine — unspecified; | [A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon | numbers predominantly in the range of C8 through C16 and boiling in the range of approximately 120 oC to 283 oC (248 oF to 541 oF).] | 309-864-6 | 101316-58-9 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-431-00-1 | Дестилати (нефтени), хидродесулфурирани, кипящи в широк обхват, средни, от коксуване; | Керосин — неспецифициран; | [Сложна комбинация от въглеводороди, получена при фракциониране от хидродесулфуриран дестилат от коксуване. Състои се основно от въглеводороди с брой въглеродни | атоми основно в интервала от C8 до C16, с температура на кипене приблизително в интервала от 120 oC до 283 oC (248 oF до 541 oF).] | 309-864-6 | 101316-58-9 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-432-00-7 | Solvent naphtha (petroleum), hydrodesulfurized heavy arom.; Kerosine — unspecified; | [A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 180 oC to 240 oC (356 oF to 464 oF).] | 309-882-4 | 101316-81-8 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-432-00-7 | Солвент нафта (нефтена), хидродесулфурирана, тежка ароматна; Керосин — неспецифициран; | [Сложна комбинация от въглеводороди, получена от каталитична хидродесулфурация на нефтена фракция. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C10 до C13, с температура на кипене приблизително в интервала от 180 oC до 240 oC (356oF до 464oF).] | 309-882-4 | 101316-81-8 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-433-00-2 | Solvent naphtha (petroleum), hydrodesulfurized medium; Kerosine — unspecified; | [A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 175 oC to 220 oC (347 oF to 428 oF).] | 309-884-5 | 101316-82-9 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-433-00-2 | Солвент нафта (нефт), хидродесулфурирана, средна; Керосин — неспецифициран; | [Сложна комбинация от въглеводороди, получена от каталитична хидродесулфурация на нефтена фракция. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C10 до C13, с температура на кипене приблизително в интервала от 175 oC до 220 oC (347oF до 428oF).] | 309-884-5 | 101316-82-9 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-434-00-8 | Kerosine (petroleum), hydrotreated; | Kerosine — unspecified; | [A complex combination of hydrocarbons obtained from the distillation of petroleum and subsequent hydrotreatment. It consists predominantly of alkanes, cycloalkanes and alkylbenzenes having carbon numbers predominantly in the range of C12 through C16 and boiling in the range of approximately 230 oC to 270 oC (446 oF to 518 oF).] | 309-944-0 | 101631-19-0 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  649-434-00-8 | Керосин (нефтен), обработен с водород; | Керосин — неспецифициран; | [Сложна комбинация от въглеводороди, получена от дестилация на нефт и последващо обработване с водород. Състои се основно от алкани, циклоалкани и алкилбензени с брой на въглеродните атоми преобладаващо в интервала от C12 до C16, с температура на кипене приблизително в интервала от 230 oC до 270 oC (446oF до 518oF).] | 309-944-0 | 101631-19-0 | Asp. Tox. 1 | H304 | GHS08 | Dgr | H304 |   |   |  
649-435-00-3 | Distillates (petroleum), light catalytic cracked; | Cracked gasoil; | [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.] | 265-060-4 | 64741-59-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-435-00-3 | Дестилати (нефтени), леки от каталитичен крекинг; | Крекиран газьол; | [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от процес на каталитичен крекинг. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C9 до C25, с температура на кипене приблизително в интервала от 150 oC дo 400 oC (302oF дo 752oF). Съдържа от относително голям дял двупръстенни ароматни въглеводороди.] | 265-060-4 | 64741-59-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-436-00-9 | Distillates (petroleum), intermediate catalytic cracked; Cracked gasoil; | [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.] | 265-062-5 | 64741-60-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-436-00-9 | Дестилати (нефтени), междинни, от каталитичен крекинг; Крекиран газьол; | [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от процес на каталитичен крекинг. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C11 до C30 и кипи в обхвата от около 205 oC до 450 oC (401 oF до 842 oF). Съдържа от относително голям дял трипръстенни ароматни въглеводороди.] | 265-062-5 | 64741-60-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-437-00-4 | Distillates (petroleum), light hydrocracked; | Cracked gasoil; | [A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C10 through C18 and boiling in the range of approxi mately 160oC to 320oC (320 oF to 608 oF).] | 265-078-2 | 64741-77-1 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  649-437-00-4 | Дестилати (нефтени), леки, от хидрокрекинг; | Крекиран газьол; | [Сложна комбинация от въглеводороди от дестилация на продукти от процес на хидрокрекинг. Състои се основно от наситени въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C10 до C18, с температура на кипене приблизително в интервала от 160 oC до 320 oC (320oF до 608oF).] | 265-078-2 | 64741-77-1 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  
649-438-00-X | Distillates (petroleum), light thermal cracked; | Cracked gasoil; | [A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C10 through C22 and boiling in the range of approximately 160oC to 370 oC (320oF to 698oF).] | 265-084-5 | 64741-82-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-438-00-X | Дестилати (нефтени), леки от термичен крекинг; | Крекиран газьол; | [Сложна комбинация от въглеводороди, получена при дестилацията на продукти от процес на термичен крекинг. Състои се основно от ненаситени въглеводороди с брой на въглеродните атоми основно в интервала от C10 до C22, с температура на кипене приблизително в интервала от 160 oC до 370 oC (320 oF до 698 oF).] | 265-084-5 | 64741-82-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-439-00-5 | Distillates (petroleum), hydrodesulfurized light catalytic cracked; | Cracked gasoil; | [A complex combination of hydrocarbons obtained by treating light catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.] | 269-781-5 | 68333-25-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-439-00-5 | Дестилати (нефтени), хидродесулфурирани леки от каталитичен крекинг; | Крекиран газьол; | [Сложна комбинация от въглеводороди, получена при обработката на леки каталитично крекирани дестилати с водород за превръщане на органичната сяра във водороден сулфид, който след това се отстранява. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C9 до C25, с температура на кипене приблизително в интервала от 150 oC дo 400 oC (302oF дo 752oF). Съдържа от относително голям дял двупръстенни ароматни въглеводороди.] | 269-781-5 | 68333-25-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-440-00-0 | Distillates (petroleum),light steam-cracked naphtha; | Cracked gasoil; | [A complex combination of hydrocarbons from the multiple distillation of products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C10 through C18.] | 270-662-5 | 68475-80-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-440-00-0 | Дестилати (нефтени), лека нафта от паров крекинг; | Крекиран газьол; | [Сложна комбинация от въглеводороди, получена от многократната дестилация на продукти от парен крекинг. Състои се от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C10 до C18.] | 270-662-5 | 68475-80-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-441-00-6 | Distillates (petroleum), cracked steam-cracked petroleum distillates; | Cracked gasoil; | [A complex combination of hydrocarbons produced by distilling cracked steam cracked distillate and/or its fractionation products. It consists of hydrocarbons having carbon numbers predominently in the range of C10 to low molecular weight polymers.] | 270-727-8 | 68477-38-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-441-00-6 | Дестилати (нефтени), крекирани нефтени дестилати от паров крекинг; | Крекиран газьол; | [Сложна комбинация от въглеводороди, получени чрез дестилиране на крекиран нефтен дестилат от паров крекинг и/или на продуктите от фракционирането му. Състои се въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C10 до нискомолекулни полимери.] | 270-727-8 | 68477-38-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-442-00-1 | Gas oils (petroleum), steam-cracked; | Cracked gasoil; | [A complex combination of hydrocarbons produced by distillation of the products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C9 and boiling in the range of from approximately 205 oC to 400 oC (400 oF to 752 oF).] | 271-260-2 | 68527-18-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-442-00-1 | Газьоли (нефтени), от паров крекинг; | Крекиран газьол; | [Сложна комбинация от въглеводороди, получена от дестилация на продукти от паров крекинг. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо над C9, с температура на кипене приблизително в интервала от 205 oC до 400 oC (400oF до 752oF).] | 271-260-2 | 68527-18-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-443-00-7 | Distillates (petroleum), hydrodesulfurized thermal cracked middle; | Cracked gasoil; | [A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized themal cracker distillate stocks. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 to C25 and boiling in the range of approximately 205 oC to 400ooC (401oF to 752oF).] | 285-505-6 | 85116-53-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-443-00-7 | Дестилати (нефтени), хидродесулфурирани, от термичен крекинг, средни; | Крекиран газьол; | [Сложна комбинация от въглеводороди, получена при фракциониране на дестилатни хидродесулфурирани суровини от термичен крекинг. Състои се основно от въглеводороди с брой на въглеродните атоми в интервала от C11 до C25, с температура на кипене приблизително в интервала от 205 oC до 400 oC (401oF до 752oF).] | 285-505-6 | 85116-53-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-444-00-2 | Gas oils (petroleum), thermal-cracked, hydrodesulfurized; Cracked gasoil | 295-411-7 | 92045-29-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-444-00-2 | Газьоли (нефтени), от термичен крекинг, хидродесулфурирани; Крекиран газьол; | 295-411-7 | 92045-29-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-445-00-8 | Residues (petroleum), hydrogenated steam-cracked naphtha; Cracked gasoil; | [A complex combination of hydrocarbons obtained as a residual fraction from the distillation of hydrotreated steam-cracked naphtha. It consists predominantly of hydrocarbons boiling in the range of approximately 200oC to 350oC (32 oF to 662 oF).] | 295-514-7 | 92062-00-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-445-00-8 | Остатъци (нефтени), хидрогенирана нафта от паров крекинг; Крекиран газьол; | [Сложна комбинация от въглеводороди, получена като остатъчна фракция от дестилацията на обработена с водород нафта от паров крекинг. Състои се главно от въглеводороди, кипящи в обхвата от около 200 oC до 350 oC (392 oF до 662 oF).] | 295-514-7 | 92062-00-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-446-00-3 | Residues (petroleum), steam-cracked naphtha distn.; | Cracked gasoil; | [A complex combination of hydrocarbons obtained as a column bottom from the separation of effluents from steam cracking naphtha at a high temperature. It boils in the range of approximately 147 oC to 300 oC (297 oF to 572 oF) and produces a finished oil having a viscosity of 18cSt at 50 oC.] | 295-517-3 | 92062-04-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-446-00-3 | Остатъци (нефтени), дестилация на нафта от паров крекинг; | Крекиран газьол; | [Сложна комбинация от въглеводороди, получена като дънен продукт от колона при разделянето на изходящи потоци от нафта от паров крекинг при висока температура. Има температура на кипене в интервала приблизително от 147 oC до 300 oC (297oF до 572oF) и се получава крайно масло с вискозитет 18cSt при 50 oC.] | 295-517-3 | 92062-04-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-447-00-9 | Distillates (petroleum), light catalytic cracked, thermally degraded; | Cracked gasoil; | [A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 190oC to 340oC (374oF to 644oF). This stream is likely to contain organic sulfur compounds.] | 295-991-1 | 92201-60-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-447-00-9 | Дестилати (нефтени), леки, от каталитичен крекинг, термично разградени; | Крекиран газьол; | [Сложна комбинация от въглеводороди, получена чрез дестилация на продукти от каталитичен крекинг процес, използвана като топлопреносен флуид. Състои се главно от въглеводороди, кипящи в обхвата от около 190 oC до 340 oC (374 oF до 644 oF). Тази фракция вероятно съдържа органосерни съединения.] | 295-991-1 | 92201-60-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-448-00-4 | Residues (petroleum), steam-cracked heat-soaked naphtha; Cracked gasoil; | [A complex combination of hydrocarbons obtained as residue from the distillation of steam cracked heat soaked naphtha and boiling in the range of approximately 150 oC to 350 oC (302 oF to 662 oF).] | 297-905-8 | 93763-85-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-448-00-4 | Остатъци (нефтени), обработена чрез сокинг нафта от паров крекинг; Крекиран газьол; | [Сложна комбинация от въглеводороди, получена като остатък от дестилацията на паров крекинг на нафта в сокинг камера, с температура на кипене приблизително в интервала от 150 oC до 350 oC (302oF до 662oF).] | 297-905-8 | 93763-85-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-449-00-X | Hydrocarbons, C16-20, solvent-dewaxed hydrocracked paraffinic distn. residue; | Cracked gasoil; | [A complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 360 oC to 500 oC (680 oF to 932 oF). It produces a finished oil having a viscosity of 4,5 cSt at approximately 100 oC (212 oF).] | 307-662-2 | 97675-88-2 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  649-449-00-X | Въглеводороди, C16-20, депарафиниран с разтворител хидрокрекиран парафинов остатък от дестилация; | Крекиран газьол; | [Сложна комбинация от въглеводороди, получена чрез депарафиниране с разтворител на остатък от дестилация от хидрокрекиран парафинов дестилат. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C16 до C20, с температура на кипене приблизително в интервала от 360 oC до 500 oC (680oF до 932oF). От нея се получава крайно масло с вискозитет от 4,5 cSt при около 100 oC (212oF).] | 307-662-2 | 97675-88-2 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  
649-450-00-5 | Gas oils (petroleum), light vacuum, thermal-cracked hydrodesulfurized; | Cracked gasoil; | [A complex combination of hydrocarbons obtained by catalytic dehydrosulfurization of thermal-cracked light vacuum petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C20 and boiling in the range of approximately 270 oC to 370 oC (518 oF to 698 oF).] | 308-278-8 | 97926-59-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-450-00-5 | Газьоли (нефтени), леки вакуумни, от термичен крекинг, хидродесулфурирани; | Крекиран газьол; | [Сложна комбинация от въглеводороди, получени чрез каталитична хидродесулфурация на лек вакуумен нефтен газьол от термичен крекинг. Състои се основно от въглеводороди с брой на въглеродните атоми основно в интервала от C14 до C20, с температура на кипене приблизително в интервала от 270 oC до 370 oC (518oF до 698oF).] | 308-278-8 | 97926-59-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-451-00-0 | Distillates (petroleum), hydrodesulfurized middle coker; Cracked gasoil; | [A complex combination of hydrocarbons by fractionation from hydrodesulfurised coker distillate stocks. Is consists of hydrocarbons having carbon numbers predominantly in the range of C12 through C21 and boiling in the range of approximately 200 oC to 360 oC (392 oF to 680 oF).] | 309-865-1 | 101316-59-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-451-00-0 | Дестилати (нефтени), хидродесулфурирани средни от коксуване; Крекиран газьол; | [Сложна комбинация от въглеводороди, получена при фракциониране на суровини от хидродесулфуриран дестилат от коксуване. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C12 до C21, с температура на кипене приблизително в интервала от 200 oC до 360 oC (392oF до 680oF).] | 309-865-1 | 101316-59-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-452-00-6 | Distillates (petroleum), heavy steam-cracked; | Cracked gasoil; | [A complex combination of hydrocarbons obtained by distillation of steam cracking heavy residues. It consists predominantly of highly alkylated heavy aromatic hydrocarbons boiling in the range of approximately 250 oC to 400 oC (482 oF to 752 oF).] | 309-939-3 | 101631-14-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  649-452-00-6 | Дестилати (нефтени), тежки, от паров крекинг; | Крекиран газьол; | [Сложна комбинация от въглеводороди, получена при дестилация на тежки остатъци от паров крекинг. Състои се основно от тежки високоалкилирани ароматни въглеводороди с температура на кипене приблизително в интервала от 250 oC до 400 oC (482oF до 752oF).] | 309-939-3 | 101631-14-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   |  
649-453-00-1 | Distillates (petroleum), heavy hydrocracked; | Baseoil — unspecified; | [A complex combination of hydrocarbons from the distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers in the range of C15-C39 and boiling in the range of approximately 260 oC to 600 oC (500 oF to 1112 oF).] | 265-077-7 | 64741-76-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-453-00-1 | Дестилати (нефтени), тежки, от хидрокрекинг; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди от дестилация на продукти от процес на хидрокрекинг. Състои се основно от наситени въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C15 до C39, с температура на кипене приблизително в интервала от 260oС до 600oС (500oF до 1112oF).] | 265-077-7 | 64741-76-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-454-00-7 | Distillates (petroleum), solvent-refined heavy paraffinic; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).] | 265-090-8 | 64741-88-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-454-00-7 | Дестилати (нефтени), рафинирани с разтворител тежки парафинови; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена като рафинат от екстрационен процес с разтворител. Състои се основно от наситени въглеводороди с брой на въглеродните атоми основно в интервала от C20 до C50, като от нея се получава крайно масло с вискозитет не по-нисък 100 SUS при 100oF (19cSt при 40 oC).] | 265-090-8 | 64741-88-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-455-00-2 | Distillates (petroleum), solvent-refined light paraffinic; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).] | 265-091-3 | 64741-89-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-455-00-2 | Дестилати (нефтени), рафинирани с разтворител леки парафинови; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена като рафинат от екстракция с разтворител. Състои се основно от въглеводороди с брой на въглеродните атоми основно в интервала от C15 до C30, като от нея се получава крайно масло с вискозитет по-нисък от 100 SUS при 100 oF (19cSt при 40 oC).] | 265-091-3 | 64741-89-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-456-00-8 | Residual oils (petroleum), solvent deasphalted; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained as the solvent soluble fraction from C3-C4 solvent deasphalting of a residuum. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).] | 265-096-0 | 64741-95-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-456-00-8 | Остатъци (нефтени), деасфалтирани с разтворител; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получени като разтворима в разтворител фракция от деасфалтирането на остатък с разтворител с C3-4. Състои се от въглеводороди с брой въглеродни атоми, предимно по-голям от C25, и кипи над около 400 oC (752 oF).] | 265-096-0 | 64741-95-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-457-00-3 | Distillates (petroleum), solvent-refined heavy naphthenic; Baseoil — unspecified; | [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt a 40 oC). It contains relatively few normal paraffins.] | 265-097-6 | 64741-96-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-457-00-3 | Дестилати (нефтени), рафинирани с разтворител тежки нафтенови; Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена като рафинат от екстракция с разтворител. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C20 до C50, като от нея се получава крайно масло с вискозитет не по-нисък 100 SUS при 100oF (19cSt при 40 oC). Съдържа относително малко количество нормални парафини.] | 265-097-6 | 64741-96-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-458-00-9 | Distillates (petroleum), solvent-refined light naphthenic; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-098-1 | 64741-97-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-458-00-9 | Дестилати (нефтени), рафинирани с разтворител леки нафтенови; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена като рафинат от екстракция с разтворител. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C15 до C30, като от нея се получава крайно масло с вискозитет по-нисък от 100 SUS при 100 oF (19cSt при 40 oC). Съдържа относително малко количество нормални парафини.] | 265-098-1 | 64741-97-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-459-00-4 | Residual oils (petroleum,) solvent-refined; | Baseoil — unspecified; | [A complex combination by hydrocarbons obtained as the solvent insoluble fraction from solvent refining of a residuum using a polar organic solvent such as phenol or furfural. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400oC (752oF).] | 265-101-6 | 64742-01-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-459-00-4 | Остатъчни масла (нефтени), рафинирани с разтворител; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена като неразтворима в разтворител фракция от рафиниране с разтворител на остатък с полярен органичен разтворител като фенол или фурфурал. Състои се от въглеводороди с брой въглеродни атоми, предимно по-голям от C25, и кипи над около 400 oC (752 oF).] | 265-101-6 | 64742-01-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-460-00-X | Distillates (petroleum), clay-treated paraffinic; | Baseoil — unspecified; | [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] | 265-137-2 | 64742-36-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-460-00-X | Дестилати (нефтени), обработени с глина, парафинови; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена чрез обработката на нефтена фракция с природна или модифицирана глина при контактен или перколационен метод, за отстраняване на следи от налични полярни съединения и онечиствания. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C20 до C50, като от нея се получава крайно масло с вискозитет не по-нисък 100 SUS при 100oF (19cSt при 40 oC). Съдържа относително голям дял наситени въглеводороди.] | 265-137-2 | 64742-36-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-461-00-5 | Distillates (petroleum), clay-treated light paraffinic; | Baseoil — unspecified; | [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] | 265-138-8 | 64742-37-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-461-00-5 | Дестилати (нефтени), обработени с глина, леки парафинови; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена чрез обработката на нефтена фракция с природна или модифицирана глина при контактен или перколационен метод, за отстраняване на следи от налични полярни съединения и онечиствания. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C15 до C30, като от нея се получава крайно масло с вискозитет по-нисък от 100 SUS при 100 oF (19cSt при 40 oC). Съдържа относително голям дял наситени въглеводороди.] | 265-138-8 | 64742-37-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-462-00-0 | Residual oils (petroleum), clay-treated; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by treatment of a residual oil with a natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydro-carbons having carbon numbers predominantly higher than C25 and boiling above approximately 400oC (752 oF).] | 265-143-5 | 64742-41-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-462-00-0 | Остатъчни масла (нефтени), обработени с глина; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена при обработване на остатъчно масло с природна или модифицирана глина, при контактен или перколационен процес, за отстраняване на следи от налични полярни съединения и онечиствания. Състои се от въглеводороди с брой въглеродни атоми, предимно по-голям от C25, и кипи над около 400 oC (752 oF).] | 265-143-5 | 64742-41-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-463-00-6 | Distillates (petroleum), clay-treated heavy naphthenic; Baseoil — unspecified; [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-146-1 | 64742-44-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-463-00-6 | Дестилати (нефтени), обработени с глина, тежки нафтенови; Базово масло — неспецифицирано; [Сложна комбинация от въглеводороди, получена чрез обработката на нефтена фракция с природна или модифицирана глина при контактен или перколационен процес, за отстраняване на следи от налични полярни съединения и онечиствания. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C20 до C50, като от нея се получава крайно масло с вискозитет не по-нисък 100 SUS при 100oF (19cSt при 40 oC). Съдържа относително малко количество нормални парафини.] | 265-146-1 | 64742-44-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-464-00-1 | Distillates (petroleum), clay-treated light naphthenic; | Baseoil — unspecified; | [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-147-7 | 64742-45-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-464-00-1 | Дестилати (нефтени), обработени с глина, леки, нафтенови; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена чрез обработката на нефтена фракция с природна или модифицирана глина при контактен или перколационен процес, за отстраняване на следи от налични полярни съединения и онечиствания. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C15 до C30, като от нея се получава крайно масло с вискозитет по-нисък от 100 SUS при 100 oF (19cSt при 40 oC). Съдържа относително малко количество нормални парафини.] | 265-147-7 | 64742-45-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-465-00-7 | Distillates (petroleum), hydrotreated heavy naphthenic; Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-155-0 | 64742-52-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-465-00-7 | Дестилати (нефтени), обработени с водород, тежки, нафтенови; Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена при обработване на нефтена фракция с водород в присъствие на катализатор. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C20 до C50, като от нея се получава крайно масло с вискозитет не по-нисък 100 SUS при 100oF (19cSt при 40 oC). Съдържа относително малко количество нормални парафини.] | 265-155-0 | 64742-52-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-466-00-2 | Distillates (petroleum), hydrotreated light naphthenic; Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-156-6 | 64742-53-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-466-00-2 | Дестилати (нефтени), обработени с водород, леки, нафтенови; Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена при обработване на нефтена фракция с водород в присъствие на катализатор. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C15 до C30, като от нея се получава крайно масло с вискозитет по-нисък от 100 SUS при 100 oF (19cSt при 40 oC). Съдържа относително малко количество нормални парафини.] | 265-156-6 | 64742-53-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-467-00-8 | Distillates (petroleum), hydrotreated heavy paraffinic; Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] | 265-157-1 | 64742-54-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-467-00-8 | Дестилати (нефтени), обработени с водород, тежки, парафинови; Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена при обработване на нефтена фракция с водород в присъствие на катализатор. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C20 до C50, като от нея се получава крайно масло с вискозитет не по-нисък 100 SUS при 100oF (19cSt при 40 oC). Съдържа относително голям дял наситени въглеводороди.] | 265-157-1 | 64742-54-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-468-00-3 | Distillates (petroleum), hydrotreated light paraffinic; Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] | 265-158-7 | 64742-55-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-468-00-3 | Дестилати (нефтени), обработени с водород, леки, парафинови; Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена при обработване на нефтена фракция с водород в присъствие на катализатор. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C15 до C30, като от нея се получава крайно масло с вискозитет по-нисък 100 SUS при 100oF (19cSt при 40 oC). Съдържа относително голям дял наситени въглеводороди.] | 265-158-7 | 64742-55-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-469-00-9 | Distillates (petroleum), solvent-dewaxed light paraffinic; | Baseoil — unspecified; | [A complex comination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).] | 265-159-2 | 64742-56-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-469-00-9 | Дестилати (нефтени), депарафинирани с разтворител, леки парафинови; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена от отстраняването на нормални парафини от нефтена фракция чрез кристализация с разтворител. Състои се основно от въглеводороди с брой на въглеродните атоми основно в интервала от C15 до C30, като от нея се получава крайно масло с вискозитет по-нисък от 100 SUS при 100 oF (19cSt при 40 oC).] | 265-159-2 | 64742-56-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-470-00-4 | Residual oils (petroleum), hydrotreated; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).] | 265-160-8 | 64742-57-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-470-00-4 | Остатъчни масла (нефтени), обработени с водород; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена при обработване на нефтена фракция с водород в присъствие на катализатор. Състои се основно от въглеводороди с брой въглеродни атоми, предимно по-голям от C25, и кипи над около 400 oC (752 oF).] | 265-160-8 | 64742-57-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-471-00-X | Residual oils (petroleum), solvent-dewaxed; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by removal of ong, branched chain hydrocarbons from a residual oil by solvent crystalli zation. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approxi mately 400 oC (752 oF).] | 265-166-0 | 64742-62-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-471-00-X | Остатъчни масла (нефтени), депарафинирани с разтворител; | Базово масло — неспецифицирано; | [Комплексна комбинация от въглеводороди, получена чрез отстраняването на въглеводороди с дълга разклонена верига от остатъчно масло чрез кристализация от разтворител. Състои се от въглеводороди с брой въглеродни атоми, предимно по-голям от C25, и кипи над около 400 oC (752 oF).] | 265-166-0 | 64742-62-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-472-00-5 | Distillates (petroleum), solvent-dewaxed heavy naphthenic; Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 . through C50 and produces a finished oil of not less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-167-6 | 64742-63-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-472-00-5 | Дестилати (нефтени), депарафинирани с разтворител, тежки, нафтенови; Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена от отстраняването на нормални парафини от нефтена фракция чрез кристализация от разтворител. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C20 до C50, като от нея се получава крайно масло с вискозитет не по-нисък 100 SUS при 100oF (19cSt при 40 oC). Съдържа относително малко количество нормални парафини.] | 265-167-6 | 64742-63-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-473-00-0 | Distillates (petroleum), solvent-dewaxed light naphthenic; Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-168-1 | 64742-64-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-473-00-0 | Дестилати (нефтени), депарафинирани с разтворител, леки, нафтенови; Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена от отстраняването на нормални парафини от нефтена фракция чрез кристализация с разтворител. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C15 до C30, като от нея се получава крайно масло с вискозитет по-нисък от 100 SUS при 100 oF (19cSt при 40 oC). Съдържа относително малко количество нормални парафини.] | 265-168-1 | 64742-64-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-474-00-6 | Distillates (petroleum), solvent-dewaxed heavy paraffinic; Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity not less than 100 SUS at 100 oF (19cSt at 40 oC).] | 265-169-7 | 64742-65-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-474-00-6 | Дестилати (нефтени), депарафинирани с разтворител, тежки, парафинови; Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена от отстраняването на нормални парафини от нефтена фракция чрез кристализация с разтворител. Състои се основно от въглеводороди с брой на въглеродните атоми основно в интервала от C20 до C50, като се получава крайно масло с вискозитет не по-нисък от 100 SUS при 100oF (19cSt при 40 oC).] | 265-169-7 | 64742-65-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-475-00-1 | Naphthenic oils (petroleum), catalytic dewaxed heavy; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-172-3 | 64742-68-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-475-00-1 | Нафтенови масла (нефтени), каталитично депарафинирани, тежки; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена чрез процес на каталитично депарафиниране. Състои се основно от въглеводороди с брой на въглеродните атоми основно в интервала от C20 до C50, като от нея се получава крайно масло с вискозитет не по-нисък 100 SUS при 100oF (19cSt при 40 oC). Съдържа относително малко количество нормални парафини.] | 265-172-3 | 64742-68-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-476-00-7 | Naphthenic oils (petroleum), catalytic dewaxed light; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-173-9 | 64742-69-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-476-00-7 | Нафтенови масла (нефтени), каталитично депарафинирани, леки; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена чрез процес на каталитично депарафиниране. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C15 до C30, като от нея се получава крайно масло с вискозитет по-нисък от 100 SUS при 100 oF (19cSt при 40 oC). Съдържа относително малко количество нормални парафини.] | 265-173-9 | 64742-69-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-477-00-2 | Paraffin oils (petroleum), catalytic dewaxed heavy; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).] | 265-174-4 | 64742-70-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-477-00-2 | Парафинови масла (нефтени), каталитично депарафинирани, тежки; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена чрез процес на каталитично депарафиниране. Състои се основно от въглеводороди с брой на въглеродните атоми основно в интервала от C20 до C50, като от нея се получава крайно масло с вискозитет не по-нисък 100 SUS при 100oF (19cSt при 40 oC).] | 265-174-4 | 64742-70-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-478-00-8 | Paraffin oils (petroleum), catalytic dewaxed light; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained from a catalytic dewxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).] | 265-176-5 | 64742-71-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-478-00-8 | Парафинови масла (нефтени), каталитично депарафинирани, леки; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена чрез процес на каталитично депарафиниране. Състои се основно от въглеводороди с брой на въглеродните атоми основно в интервала от C15 до C30, като от нея се получава крайно масло с вискозитет по-нисък от 100 SUS при 100 oF (19cSt при 40 oC).] | 265-176-5 | 64742-71-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-479-00-3 | Naphthenic oils (petroleum), complex dewaxed heavy; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by removing straight chain | paraffin hydrocarbons as a solid by treatment with an agent such as urea. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-179-1 | 64742-75-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-479-00-3 | Нафтенови масла (нефтени), комплексно депарафинирани, тежки; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена чрез отстраняване на парафиновите | въглеводороди с неразклонена верига като твърд продукт чрез обработка с реактив като например уреа. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C20 до C50, като от нея се получава крайно масло с вискозитет не по-нисък 100 SUS при 100oF (19cSt при 40 oC). Съдържа относително малко количество нормални парафини.] | 265-179-1 | 64742-75-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-480-00-9 | Naphthenic oils (petroleum), complex dewaxed light; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 265-180-7 | 64742-76-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-480-00-9 | Нафтенови масла (нефтени), комплексно депарафинизирани, леки; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена чрез процес на каталитично депарафиниране. Състои се от въглеводороди с брой на въглеродните атоми основно в интервала от C15 до C30, като от нея се получава крайно масло с вискозитет по-нисък от 100 SUS при 100 oF (19cSt при 40 oC). Съдържа относително малко количество нормални парафини.] | 265-180-7 | 64742-76-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-481-00-4 | Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based, high-viscosity; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil, and | solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of approximately 112cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.] | 276-736-3 | 72623-85-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-481-00-4 | Смазочни масла (нефт), C20-50, обработени с водород, на база неутрално масло, с висок вискозитет; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена при обработване с водород на лек вакуумен газьол, тежък вакуумен газьол и | деасфалтирано с разтворител остатъчно масло в присъствие на катализатор в двуфазен процес, като процесът на депарафиниране се извършва между двете фази. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C20 до C50, като от нея се получава крайно масло с вискозитет около 112cSt при 40 oC. Съдържа относително голям дял наситени въглеводороди.] | 276-736-3 | 72623-85-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-482-00-X | Lubricating oils (petroleum), C15-30, hydrotreated neutral oil-based; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by treating light vacuum gas oil and heavy vacuum gas oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of approximately 15cSt at 40 oC. It contains a relatively large proportion of saturated hydrocabons.] | 276-737-9 | 72623-86-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-482-00-X | Смазочни масла (нефтени), C15-30, обработени с водород, на база неутрално масло; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена при обработване с водород на лек вакуумен газьол и тежък вакуумен газьол в присъствие на катализатор в двуфазен процес, като процесът на депарафиниране се извършва между двете фази. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C15 до C30, като се получава крайно масло с вискозитет около 15cSt при 40 oC. Съдържа относително голям дял наситени въглеводороди.] | 276-737-9 | 72623-86-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-483-00-5 | Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of approximately 32cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.] | 276-738-4 | 72623-87-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-483-00-5 | Смазочни масла (нефтени), C20-50, обработени с водород, на база неутрално масло; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена при обработката на лек вакуумен газьол, тежък вакуумен газьол и деасфалтирано с разтворител остатъчно масло в присъствие на катализатор в двуфазен процес, като процесът на депарафиниране се извършва между двете фази. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C20 до C50, като от нея се получава крайно масло с вискозитет около 32cSt при 40 oC. Съдържа относително голям дял наситени въглеводороди.] | 276-738-4 | 72623-87-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-484-00-0 | Lubricating oils; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C15 through C50.] | 278-012-2 | 74869-22-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-484-00-0 | Смазочни масла; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена от процесите на екстракция с разтворител и депарафиниране. Състои се основно от наситени въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C15 до C50.] | 278-012-2 | 74869-22-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-485-00-6 | Distillates (petroleum), complex dewaxed heavy paraffinci; Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by dewaxing heavy paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of equal to or greater than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 292-613-7 | 90640-91-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-485-00-6 | Дестилати (нефтени), комплексно депарафинирани, тежки, парафинови; Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена при депарафиниране на тежки, парафинови дестилати. Състои се основно от въглеводороди с брой на въглеродните атоми основно в интервала от C20 до C50, като от нея се получава крайно масло с вискозитет равен на 100 SUS при 100 oF (19cSt при 40 oC) или по-висок. Съдържа относително малко количество нормални парафини.] | 292-613-7 | 90640-91-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-486-00-1 | Distillates (petroleum), complex dewaxed light paraffinic; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by dewaxing light paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] | 292-614-2 | 90640-92-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-486-00-1 | Дестилати (нефт), комплексно депарафинирани, леки, парафинови; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена при депарафиниране на лек парафинов дестилат. Състои се основно от въглеводороди с брой на въглеродните атоми основно в интервала от C12 до C30, като от нея се получава крайно масло с вискозитет по-нисък от 100 SUS при 100 oF (19cSt при 40 oC). Съдържа относително малко количество нормални парафини.] | 292-614-2 | 90640-92-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-487-00-7 | Distillates (petroleum), solvent dewaxed heavy paraffinic, clay-treated; Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by treating dewaxed heavy paraffinic distillate with neutral or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] | 292-616-3 | 90640-94-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-487-00-7 | Дестилати (нефтени), депарафинирани с разтворител, тежки, парафинови, обработени с глина; Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена при обработката на депарафиниран тежък парафинов дестилат с природна или модифицирана глина при контактен или перколационен процес. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C20 до C50.] | 292-616-3 | 90640-94-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-488-00-2 | Hydrocarbons, C20-50, solvent dewaxed heavy paraffinic, hydrotreated; | Baseoil — unspecified; | [A complex combination of hydrocarbons produced by treating dewaxed heavy paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] | 292-617-9 | 90640-95-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-488-00-2 | Въглеводороди, C20-50, депарафинирани с разтворител, тежки, парафинови, обработени с водород; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получени чрез обработката на депарафиниран тежък парафинов дестилат с водород в присъствието на катализатор. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C20 до C50.] | 292-617-9 | 90640-95-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-489-00-8 | Distillates (petroleum), solvent dewaxed light paraffinic, clay-treated; | Baseoil — unspecified; | [A complex combination of hydrocarbons resulting from treatment of dewaxed light paraffinic distillate with natural or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.] | 292-618-4 | 90640-96-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-489-00-8 | Дестилати (нефтени), депарафинирани с разтворител, леки, парафинови, обработени с глина; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена при обработката на депарафиниран лек парафинов дестилат с природна или модифицирана глина при контактен или перколационен процес. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C15 до C30.] | 292-618-4 | 90640-96-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-490-00-3 | Distillates (petroleum), solvent dewaxed light paraffinic, hydrotreated; | Baseoil — unspecified; | [A complex combination of hydrocarbons produced by Treating a dewaxed light paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.] | 292-620-5 | 90640-97-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-490-00-3 | Дестилати (нефтени), депарафинирани с разтворител, леки, парафинови, обработени с водород; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получени чрез обработката на депарафиниран лек парафинов дестилат с водород в присъствието на катализатор. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C15 до C30.] | 292-620-5 | 90640-97-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-491-00-9 | Residual oils (petroleum), hydrotreated solvent dewaxed; Baseoil — unspecified | 292-656-1 | 90669-74-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-491-00-9 | Остатъчни масла (нефтени), обработени с водород, депарафинирани с разтворител; Базово масло — неспецифицирано; | 292-656-1 | 90669-74-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-492-00-4 | Residual oils (petroleum), catalytic dewaxed; | Baseoil — unspecified | 294-843-3 | 91770-57-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-492-00-4 | Остатъчни масла (нефтени), каталитично депарафинирани; | Базово масло — неспецифицирано; | 294-843-3 | 91770-57-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-493-00-X | Distillates (petroleum), dewaxed heavy paraffinic, hydrotreated; Baseoil — unspecified; | [A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C25 through C39 and produces a finished oil with a viscosity of approximately 44 cSt at 50 oC.] | 295-300-3 | 91995-39-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-493-00-X | Дестилати (нефтени), депарафинирани, тежки, парафинови, обработени с водород; Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена при интензивно обработване на депарафиниран дестилат чрез хидрогениране в присъствие на катализатор. Състои се предимно от наситени въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C25 до C39, като от нея се получава крайно масло с вискозитет приблизително 44 cSt при 50 oC.] | 295-300-3 | 91995-39-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-494-00-5 | Distillates (petroleum), dewaxed light paraffinic, hydrotreated; Baseoil — unspecified; | [A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C21 through C29 and produces a finished oil with a viscosity of approximately 13 cSt at 50 oC.] | 295-301-9 | 91995-40-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-494-00-5 | Дестилати (нефтени), депарафинирани, леки, парафинови, обработени с водород; Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена при интензивно обработване на депарафиниран дестилат чрез хидрогениране в присъствие на катализатор. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C21 до C29, като от нея се получава крайно масло с вискозитет около 13 cSt при 50 oC.] | 295-301-9 | 91995-40-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-495-00-0 | Distillates (petroleum), hydrocracked solvent-refined, dewaxed; | Baseoil — unspecified; [A complex combination of liquid hydrocarbons obtained by recrystallization of dewaxed hydrocracked solvent-refined petroleum distillates.] | 295-306-6 | 91995-45-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-495-00-0 | Дестилати (нефтени), от хидрокрекинг, рафинирани с разтворител, депарафинирани; | Базово масло — неспецифицирано; [Сложна комбинация от течни въглеводороди, получени при рекристализация на депарафинирани нефтени дестилати от хидрокрекинг, рафинирани с разтворител.] | 295-306-6 | 91995-45-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-496-00-6 | Distillates (petroleum), solvent-refined light naphthenic, hydrotreated; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst and removing the aromatic hydrocarbons by solvent extraction. It consists predominantly of naphthenic hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of between 13-15cSt at 40 oC.] | 295-316-0 | 91995-54-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-496-00-6 | Дестилати (нефтени), рафинирани с разтворител, леки, нафтенови, обработени с водород; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получени от обработката на нефтена фракция с водород в присъствието на катализатор и отстраняването на ароматните въглеводороди чрез екстракция с разтворител. Състои се основно от нафтенови въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C15 до C30, като от нея се получава крайно масло с вискозитет между 13-15cSt при 40 oC.] | 295-316-0 | 91995-54-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-497-00-1 | Lubricating oils (petroleum), C17-35, solvent-extd., dewaxed, hydrotreated; | Baseoil — unspecified | 295-423-2 | 92045-42-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-497-00-1 | Смазочни масла (нефтени), C17-35, екстрахирани с разтворител, депарафинирани, обработени с водород; | Базово масло — неспецифицирано; | 295-423-2 | 92045-42-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-498-00-7 | Lubricating oils (petroleum), hydrocracked nonarom. solvent-deparaffined; | Baseoil — unspecified | 295-424-8 | 92045-43-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-498-00-7 | Смазочни масла (нефтени), от хидрокрекинг, неароматни, депарафинирани с разтворител; | Базово масло — неспецифицирано; | 295-424-8 | 92045-43-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-499-00-2 | Residual oils (petroleum), hydrocracked acid-treated solvent-dewaxed; | Baseoil — unspecified; | [A complex combination of hydrocarbons produced by solvent removal of paraffins from the residue of the distil lation of acid-treated, hydrocracked heavy paraffins and boiling approximately above 380 oC (716 oF).] | 295-499-7 | 92061-86-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-499-00-2 | Остатъчни масла (нефтени), от хидрокрекинг, обработени с киселина, депарафинирани с разтворител; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена при депарафиниране с разтворител на парафини от остатъка от дестилацията на обработени с киселина тежки парафини от хидрокрекинг, с температура на кипене приблизително над 380 oС (716oF).] | 295-499-7 | 92061-86-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-500-00-6 | Paraffin oils (petroleum), solvent-refined dewaxed heavy; Baseoil — unspecified; | [A complex combination of hydrocarbons obtained from sulfur-containing paraffinic crude oil. It consists predominantly of a solvent refined deparaffinated lubricating oil with a viscosity of 65cSt at 50 oC.] | 295-810-6 | 92129-09-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-500-00-6 | Парафинови масла (нефтени), рафинирани с разтворител, депарафинирани, тежки; Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получени от сярасъдържащ парафинов суров нефт. Състои се предимно от рафинирано с разтворител депарафинирано смазочно масло с вискозитет 65 cSt при 50 oC.] | 295-810-6 | 92129-09-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-501-00-1 | Lubricating oils (petroleum), base oils, paraffinic; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by refining of crude oil. It consists predominantly of aromatics, naphthenics and paraffinics and produces a finished oil with a viscosity of 120 SUS at 100 oF (23cSt at 40 oC).] | 297-474-6 | 93572-43-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-501-00-1 | Смазочни масла (нефтени), базови масла, парафинови; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена от рафиниране на суров нефт. Състои се предимно от ароматни, нафтенови и парафинови въглеводороди и от нея се произвежда крайно масло с вискозитет 120 SUS при 100 oF (23 cSt при 40 oC).] | 297-474-6 | 93572-43-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-502-00-7 | Hydrocarbons, hydrocracked paraffinic distn. residues, solvent-dewaxed; | Baseoil — unspecified | 297-857-8 | 93763-38-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-502-00-7 | Въглеводороди, от хидрокрекинг, остатъци от дестилация на парафинови продукти, депарафинирани с разтворител; | Базово масло — неспецифицирано; | 297-857-8 | 93763-38-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-503-00-2 | Hydrocarbons, C20-50, residual oil hydrogenation vacuum distillate; | Baseoil — unspecified | 300-257-1 | 93924-61-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-503-00-2 | Въглеводороди, C20-50, вакуумен дестилат от хидрогениране на остатъчно масло; | Базово масло — неспецифицирано; | 300-257-1 | 93924-61-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-504-00-8 | Distillates (petroleum), solvent-refined hydrotreated heavy; hydrogenated; | Baseoil — unspecified | 305-588-5 | 94733-08-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-504-00-8 | Дестилати (нефтени), рафинирани с разтворител, тежки, обработени с водород; хидрогенирани; | Базово масло — неспецифицирано; | 305-588-5 | 94733-08-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-505-00-3 | Distillates (petroleum), solvent-refined hydrocracked light; Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by solvent dearomatization of the residue of hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370oC to 450oC (698oF to 842oF).] | 305-589-0 | 94733-09-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-505-00-3 | Дестилати (нефтени), рафинирани с разтворител, леки, от хидрокрекинг; Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена чрез деароматизиране с разтворител на остатъка от хидрокрекиран нефт. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C18 до C27, с температура на кипене приблизително в интервала от 370 oC до 450 oC (698 oF до 842 oF).] | 305-589-0 | 94733-09-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-506-00-9 | Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrocracked distillate-based; | Baseoil — unspecified; [A complex combination of hydrocarbons obtained by solvent deparaffination of the distillation residue from hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370oC to 550 oC (698 oF to 1022oF).] | 305-594-8 | 94733-15-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-506-00-9 | Смазочни масла (нефтени), C18-40, депарафинирани с разтворител, на основата на дестилат от хидрокрекинг; | Базово масло — неспецифицирано; [Сложна комбинация от въглеводороди, получена чрез депарафиниране с разтворител на остатък от дестилация от хидрокрекиран нефт. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C18 до C40, с температура на кипене приблизително в интервала от 370 oС до 550 oС (698oF до 1022oF).] | 305-594-8 | 94733-15-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-507-00-4 | Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrogenated raffinate-based; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by solvent deparaffination of the hydrogenated raffinate obtained by solvent extraction of a hydrotreated petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).] | 305-595-3 | 94733-16-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-507-00-4 | Смазочни масла (нефтени), C18-40, депарафинирани с разтворител, на основата на дестилат от хидрокрекинг; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена чрез депарафиниране с разтворител на хидрогениран рафинат, получен от екстракция с разтворител на обработен с водород нефтен дестилат. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C18 до C40, с температура на кипене приблизително в интервала от 370 oС до 550 oС (698oF до 1022oF).] | 305-595-3 | 94733-16-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-508-00-X | Hydrocarbons, C13-30, arom.-rich, solvent-extd. naphthenic distillate; | Baseoil — unspecified | 305-971-7 | 95371-04-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-508-00-X | Въглеводороди, C13-30, богати на ароматни съединения, екстрахирани с разтворител, нафтенов дестилат; | Базово масло — неспецифицирано; | 305-971-7 | 95371-04-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-509-00-5 | Hydrocarbons, C16-32, arom. rich, solvent-extd. naphthenic distillate; | Baseoil — unspecified | 305-972-2 | 95371-05-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-509-00-5 | Въглеводороди, C16-32, богати на ароматни съединения, екстрахирани с разтворител, нафтенов дестилат; | Базово масло — неспецифицирано; | 305-972-2 | 95371-05-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-510-00-0 | Hydrocarbons, C37-68, dewaxed deasphalted hydrotreated vacuum distn. residues; | Baseoil — unspecified | 305-974-3 | 95371-07-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-510-00-0 | Въглеводороди, C37-68, депарафинирани, деасфалтирани, обработени с водород остатъци от вакуумна дестилация; | Базово масло — неспецифицирано; | 305-974-3 | 95371-07-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-511-00-6 | Hydrocarbons, C37-65, hydrotreated deasphalted vacuum distn. residues; | Baseoil — unspecified | 305-975-9 | 95371-08-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-511-00-6 | Въглеводороди, C37-65, обработени с водород деасфалтирани остатъци от вакуумна дестилация; | Базово масло — неспецифицирано; | 305-975-9 | 95371-08-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-512-00-1 | Distillates (petroleum), hydrocracked solvent-refined light; Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by the solvent treatment of a distillate from hydrocracked petroleum distillates. It consists predomiantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450oC (698 oF to 842 oF.] | 307-010-7 | 97488-73-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-512-00-1 | Дестилати (нефтени), от хидрокрекинг, рафинирани с разтворител, леки; Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена чрез обработката с разтворител на дестилат от хидрокрекирани нефтени дестилати. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C18 до C27, с температура на кипене приблизително в интервала от 370 oС до 450 oС (698oF до 842oF.] | 307-010-7 | 97488-73-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-513-00-7 | Distillates (petroleum), solvent-refined hydrogenated heavy; Baseoil — unspecified; [A complex combination of hydrocarbons, obtained by the treatment of a hydrogenated petroleum distillate with a solvent. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C19 through C40 and boiling in the range of approximately 390 oC to 550 oC (734 oF to 1022 oF).] | 307-011-2 | 97488-74-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-513-00-7 | Дестилати (нефтени), рафинирани с разтворител, тежки, хидрогенирани; Базово масло — неспецифицирано; [Сложна комбинация от въглеводороди, получена чрез обработката с разтворител на хидрогениран нефтен дестилат. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C19 до C40, с температура на кипене приблизително в интервала от 390 oС до 550 oС (734 oF до 1022 oF).] | 307-011-2 | 97488-74-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-514-00-2 | Lubricating oils (petroleum), C18-27, hydrocracked solvent-dewaxed; | Baseoil — unspecified | 307-034-8 | 97488-95-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-514-00-2 | Смазочни масла (нефтени), C18-27, депарафинирани с разтворител, от хидрокрекинг; | Базово масло — неспецифицирано; | 307-034-8 | 97488-95-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-515-00-8 | Hydrocarbons, C17-30, hydrotreated solvent-deasphalted atm. distn. residue, distn. lights; Baseoil — unspecified; | [A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a solvent deasphalted short residue with hydrogen in the presence of a catalyst. It consists predomi nantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C30 and boiling in the range of approximately 300 oC to 400 oC (572 oF to 752 oF). It produces a finished oil having a viscosity of 4cSt at approximately 100 oC (212 oF).] | 307-661-7 | 97675-87-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-515-00-8 | Въглеводороди, C17-30, обработени с водород, деасфалтирани с разтворител, остатък от атмосферна дестилация, лек дестилат; Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена като първа фракция от вакуумна дестилация на изходящи потоци от обработката с водород, в присъствието на катализатор, на деасфалтиран с разтворител вакуумен остатък. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C17 до C30, с температура на кипене приблизително в интервала от 300oС до 400oС (572oF до 752oF). От нея се получава крайно масло с вискозитет от 4 cSt. при приблизително 100 oC (212oF).] | 307-661-7 | 97675-87-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-516-00-3 | Hydrocarbons, C17-40, hydrotreated solvent-deasphalted distn. residue, vacuum distn. lights; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the catalytic hydrotreatment of a solvent deasphalted short residue having a viscosity of 8cSt at approximately 100 oC (212 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C40 and boiling in the range of approximately 300 oC to 500 oC (592 oF to 932 oF).] | 307-755-8 | 97722-06-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-516-00-3 | Въглеводороди, C17-40, обработени с водород, деасфалтирани с разтворител, остатък от дестилация, леки вакуумни дестилати; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена като първа фракция от вакуумна дестилация на изходящи продукти от каталитична обработка с водород на деасфалтиран с разтворител остатък от вакуумна дестилация на остатъци от атмосферна дестилация с вискозитет 8 cSt при около 100 oC (212 oF). Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C17 до C40, с температура на кипене приблизително в интервала от 300oС до 500oС (592oF до 932oF).] | 307-755-8 | 97722-06-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-517-00-9 | Hydrocarbons, C13-27, solvent-extd. light naphthenic; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 9.5cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C27 and boiling in the range of approximately 240 oC to 400 oC (464 oF to 752 oF).] | 307-758-4 | 97722-09-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-517-00-9 | Въглеводороди, C13-27, екстрахирани с разтворител, леки нафтенови; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена от екстракцията на ароматните съединения от лек нафтенов дестилат, с вискозитет от 9,5 cSt при 40 oC (104 oF). Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C13 до C27, с температура на кипене приблизително в интервала от 240 oC до 400 oC (464oF до 752oF).] | 307-758-4 | 97722-09-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-518-00-4 | Hydrocarbons, C14-29, solvent-extd. light naphthenic; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 16cSt at 40oC (104oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C29 and boiling in the range of approximately 250 oC to 425 oC (482 oF to 797 oF).] | 307-760-5 | 97722-10-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-518-00-4 | Въглеводороди, C14-29, екстрахирани с разтворител, леки нафтенови; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена от екстракцията на ароматните съединения от лек нафтенов дестилат, с вискозитет от 16 cSt при 40 oC (104 oF). Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C14 до C29, с температура на кипене приблизително в интервала от 250 oС до 425 oС (482oF до 797oF).] | 307-760-5 | 97722-10-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-519-00-X | Hydrocarbons, C27-42, dearomatized; | Baseoil — unspecified | 308-131-8 | 97862-81-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-519-00-X | Въглеводороди, C27-42, деароматизирани; | Базово масло — неспецифицирано; | 308-131-8 | 97862-81-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-520-00-5 | Hydrocarbons, C17-30, hydrotreated distillates, distn. lights; Baseoil — unspecified | 308-132-3 | 97862-82-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-520-00-5 | Въглеводороди, C17-30, обработени с водород дестилати, леки дестилати; Базово масло — неспецифицирано; | 308-132-3 | 97862-82-3 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-521-00-0 | Hydrocarbons, C27-45, naphthenic vacuum distn.; | Baseoil — unspecified | 308-133-9 | 97862-83-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-521-00-0 | Въглеводороди, C27-45, нафтенови, вакуумна дестилация; | Базово масло — неспецифицирано; | 308-133-9 | 97862-83-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-522-00-6 | Hydrocarbons, C27-45, dearomatized; | Baseoil — unspecified | 308-287-7 | 97926-68-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-522-00-6 | Въглеводороди, C27-45, деароматизирани; | Базово масло — неспецифицирано; | 308-287-7 | 97926-68-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-523-00-1 | Hydrocarbons, C20-58, hydrotreated; | Baseoil — unspecified | 308-289-8 | 97926-70-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-523-00-1 | Въглеводороди, C20-58, обработени с водород; | Базово масло — неспецифицирано; | 308-289-8 | 97926-70-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-524-00-7 | Hydrocarbons, C27-42, naphthenic; | Baseoil — unspecified | 308-290-3 | 97926-71-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-524-00-7 | Въглеводороди, C27-42, нафтенови; | Базово масло — неспецифицирано; | 308-290-3 | 97926-71-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-525-00-2 | Residual oils (petroleum), carbon-treated solvent-dewaxed; Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by the treatment of solvent-dewaxed petroleum residual oils with activated charcoal for the removal of trace polar constituents and impurities.] | 309-710-8 | 100684-37-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-525-00-2 | Остатъчни масла (нефтени), обработени с активен въглен, депарафинирани с разтворител; Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена при обработване с активен въглен на депарафинирани с разтворител нефтени остатъчни масла за отстраняване на следи от полярни съставки и онечиствания.] | 309-710-8 | 100684-37-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-526-00-8 | Residual oils (petroleum), clay-treated solvent-dewaxed; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by treatment of solvent-dewaxed petroleum residual oils with bleaching earth for the removal of trace polar constituents and impurities.] | 309-711-3 | 100684-38-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-526-00-8 | Остатъчни масла (нефтени), обработени с глина, депарафинирани с разтворител; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена при обработване с белилна пръст на депарафинирани с разтворител нефтени остатъчни масла, за отстраняване на следи от полярни съставки и онечиствания.] | 309-711-3 | 100684-38-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-527-00-3 | Lubricating oils (petroleum), C>25, solvent-extd., deasphalted, dewaxed, hydrogenated; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C25 and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100 oC (212 oF).] | 309-874-0 | 101316-69-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-527-00-3 | Смазочни масла (нефтени), C > 25, екстрахирани с разтворител, деасфалтирани, депарафинирани, хидрогенирани; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена чрез екстракция с разтворител и хидрогениране на остатъци от вакуумна дестилация. Състои се основно от въглеводороди с брой на въглеродните атоми по-голям от C25, като от нея се получава крайно масло с вискозитет в интервала от 32cSt до 37cSt при 100 oC (212oF).] | 309-874-0 | 101316-69-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-528-00-9 | Lubricating oils (petroleum), C17-32, solvent-extd., dewaxed, hydrogenated; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C32 and produced a finished oil with a viscosity in the order of 17cSt to 23cSt at 40 oC (104 oF.] | 309-875-6 | 101316-70-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-528-00-9 | Смазочни масла (нефтени), C17-32, екстрахирани с разтворител, депарафинирани, хидрогенирани; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена чрез екстракция с разтворител и хидрогениране на остатъци от атмосферна дестилация. Състои се основно от въглеводороди с брой на въглеродните атоми от C17 до C32, като от нея се получава крайно масло с вискозитет в интервала от 17cSt до 23cSt при 40 oC (104oF).] | 309-875-6 | 101316-70-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-529-00-4 | Lubricating oils (petroleum), C20-35, solvent-extd., dewaxed, hydrogenated; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C35 and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40 oC (104 oF).] | 309-876-1 | 101316-71-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-529-00-4 | Смазочни масла (нефтени), C20-35, екстрахирани с разтворител, депарафинирани, хидрогенирани; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена чрез екстракция с разтворител и хидрогениране на остатъци от атмосферна дестилация. Състои се основно от въглеводороди с брой на въглеродните атоми от C20 до C35, като от нея се получава крайно масло с вискозитет в интервала от 37cSt до 44cSt при 40 oC (104oF).] | 309-876-1 | 101316-71-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-530-00-X | Lubricating oils (petroleum), C24-50, solvent-extd., dewaxed, hydrogenated; | Baseoil — unspecified; | [A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C24 through C50 and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40 oC (104 oF).] | 309-877-7 | 101316-72-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-530-00-X | Смазочни масла (нефтени), C24-50, екстрахирани с разтворител, депарафинирани, хидрогенирани; | Базово масло — неспецифицирано; | [Сложна комбинация от въглеводороди, получена чрез екстракция с разтворител и хидрогениране на остатъци от атмосферна дестилация. Състои се основно от въглеводороди с брой на въглеродните атоми от C24 до C50, като от нея се получава крайно масло с вискозитет в интервала от 16cSt до 75cSt при 40 oC (104oF).] | 309-877-7 | 101316-72-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-531-00-5 | Extracts (petroleum), heavy naphthenic distillate solvent, arom. conc.; | Distillate aromatic extract (treated); | [An aromatic concentrate produced by adding water to heavy naphthenic distillate solvent extract and extraction solvent.] | 272-175-3 | 68783-00-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-531-00-5 | Екстракти (нефтени), разтворител на тежък нафтенов дестилат, концентрат от ароматни съединения; | Ароматен екстракт от дестилат (обработен); | [Концентрат от ароматни съединения, получен чрез добавяне на вода към екстракт с разтворител на тежък нафтенов дестилат и разтворител за екстракция.] | 272-175-3 | 68783-00-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-532-00-0 | Extracts (petroleum), solvent-refined heavy paraffinic distillate solvent; | Distillate aromaticextract (treated); [A complex combination of hydrocarbons obtained as the extractfrom the re-extraction of solvent-refined heavy paraffinic distillate. It consists of saturated and aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] | 272-180-0 | 68783-04-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-532-00-0 | Екстракти (нефтени), разтворител, рафиниран с разтворител тежък парафинов дестилат; | Ароматен екстракт от дестилат (обработен); [Сложна комбинация от въглеводороди, получена като екстракт от реекстракцията на рафиниран с разтворител тежък парафинов дестилат. Състои се от наситени и ароматни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C20 до C50.] | 272-180-0 | 68783-04-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-533-00-6 | Extracts (petroleum), heavy paraffinic distillates, solvent-deasphalted; | Distillate aromatic extract (treated); | [A complex combination of hydrocarbons obtained as the extract from a solvent extraction of heavy paraffinic distillate.] | 272-342-0 | 68814-89-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-533-00-6 | Екстракти (нефтени), тежки, парафинови дестилати, деасфалтирани с разтворител; | Ароматен екстракт от дестилат (обработен); | [Сложна комбинация от въглеводороди, получена като екстракт от екстракция с разтворител на тежък парафинов дестилат.] | 272-342-0 | 68814-89-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-534-00-1 | Extracts (petroleum), heavy naphthenic distillate solvent, hydrotreated; | Distillate aromatic extract (treated); | [A complex combination of hydrocarbons obtained by treating a heavy naphthenic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predomi nantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 19cSt at 40 oC (100 SUS at 100 oF).] | 292-631-5 | 90641-07-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-534-00-1 | Екстракти (нефтени), разтворител на тежък нафтенов дестилат, обработени с водород; | Ароматен екстракт от дестилат (обработен); | [Сложна комбинация от въглеводороди, получена при обработване с водород, в присъствието на катализатор, на екстракт с разтворител на тежък нафтенов дестилат. Състои се основно от ароматни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C20 до C50, като от нея се получава крайно масло с вискозитет не по-нисък от 19cSt при 40 oC (100 SUS при 100oF).] | 292-631-5 | 90641-07-9 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-535-00-7 | Extracts (petroleum), heavy paraffinic distillate solvent, hydrotreated; | Distillate aromatic extract (treated); | [A complex combination of hydrocarbons produced by treating a heavy paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C21 through C33 and boiling in the range of approximately 350oC to 480oC (662oF to 896oF). | 292-632-0 | 90641-08-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-535-00-7 | Екстракти (нефтени), разтворител на тежък парафинов дестилат, обработен с водород; | Ароматен екстракт от дестилат (обработен); | [Сложна комбинация от въглеводороди, получена при обработване с водород, в присъствието на катализатор, на екстракт с разтворител на тежък парафинов дестилат. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C21 до C33, с температура на кипене приблизително в интервала от 350oС до 480oС (662oF до 896oF).] | 292-632-0 | 90641-08-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-536-00-2 | Extracts (petroleum), light paraffinic distillate solvent, hydrotreated; | Distillate aromatic extract (treated); | [A complex combination of hydrocarbons produced by treating a lightparaffinic distillate solvent extract with hydrogen in the presence of acatalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C26 and boiling in the range of approximately 280oC to 400oC (536 oF to 752 oF).] | 292-633-6 | 90641-09-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-536-00-2 | Екстракти (нефтени), разтворител на лек парафинов дестилат, обработен с водород; | Ароматен екстракт от дестилат (обработен); | [Сложна комбинация от въглеводороди, получена при обработване с водород, в присъствието на катализатор, на екстракт с разтворител на лек парафинов дестилат. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C17 до C26, с температура на кипене приблизително в интервала от 280oС до 400oС (536 oF до 752 oF).] | 292-633-6 | 90641-09-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-537-00-8 | Extracts (petroleum), hydrotreated light paraffinic distillate solvent; | Distillate aromatic extract (treated); | [A complex combination of hydrocarbons obtained as the extract from solvent extraction of intermediate paraffinic top solvent distillate that is treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C36.] | 295-335-4 | 91995-73-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-537-00-8 | Екстракти (нефтени), разтворител на лек парафинов дестилат, обработен с водород; | Ароматен екстракт от дестилат (обработен); | [Сложна комбинация от въглеводороди, получени като екстракт от екстракцията с разтворител на междинен парафинов дестилат от горната част на разтворителя, обработен с водород в присъствието на катализатор. Състои се основно от ароматни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C16 до C36.] | 295-335-4 | 91995-73-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-538-00-3 | Extracts (petroleum), light naphthenic distillate solvent, hydrodesulfurized; | Distillate aromatic extract (treated); | [A complex combination of hydrocarbons obtained by treating the extract, obtained from a solvent extraction process, with hydrogen in the presence of a catalyst under conditions primarily to remove sulfur compounds. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C15 through C30. This stream is likely to contain 5 wt.% or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] | 295-338-0 | 91995-75-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-538-00-3 | Екстракти (нефтени), разтворител на лек нафтенов дестилат, хидродесулфуриран; | Ароматен екстракт от дестилат (обработен); | [Сложна комбинация от въглеводороди, получена чрез обработката на екстракт, получен чрез екстракция с разтворител, с водород в присъствие на катализатор, в условия главно за отстраняване на серни съединения. Състои се основно от ароматни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C15 до C30.] Тази фракция вероятно съдържа 5 или повече тегловни процента ароматни въглеводороди с 4 до 6 кондензирани пръстена.] | 295-338-0 | 91995-75-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-539-00-9 | Extracts(petroleum), light paraffinic distillate solvent, acid-treated; | Distillate aromatic extract (treated); | [A complex combination of hydrocarbons obtained as a fraction of the distillation of an extract from the solvent extraction of light paraffinic top petroleum distillates that is subjected to a sulfuric acid refining. It consists predomi nantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.] | 295-339-6 | 91995-76-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-539-00-9 | Екстракти (нефтени), разтворител на лек парафинов дестилат, обработен с киселина; | Ароматен екстракт от дестилат (обработен); | [Сложна комбинация от въглеводороди, получена като фракция от дестилацията на екстракт от екстракция с разтворител на леки парафинови нефтени дестилати от горната част, която се подлага на рафиниране със сярна киселина. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C16 до C32.] | 295-339-6 | 91995-76-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-540-00-4 | Extracts (petroleum), light paraffinic distillate solvent, hydrodesulfurized; | Distillate aromatic extract (treated); | [A complex combination of hydrocarbons obtained by solvent extraction of a light paraffin distillate and treated with hydrogen to convert the organic sulfur to hydrogen sulfide which is eliminated. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C40 and produces a finished oil with a viscosity of greater than 10cSt at 40 oC.] | 295-340-1 | 91995-77-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-540-00-4 | Екстракти (нефтени), разтворител на лек парафинов дестилат, хидродесулфуриран; | Ароматен екстракт от дестилат (обработен); | [Сложна комбинация от въглеводороди, получена чрез екстракция с разтворител на лек парафинов дестилат и обработена с водород за превръщане на органичната сяра във водороден сулфид, който се отстранява. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C15 до C40, като от нея се получава крайно масло с вискозитет по-висок от 10cSt при 40 oC.] | 295-340-1 | 91995-77-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-541-00-X | Extracts (petroleum), light vacuum gas oil solvent, hydrotreated; | Distillate aromatic extract (treated); | [A complex combination of hydrocarbons, obtained by solvent extraction from light vacuum petroleum gas oils and treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.] | 295-342-2 | 91995-79-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-541-00-X | Екстракти (нефтени), разтворител на лек вакуумен газьол, обработен с водород; | Ароматен екстракт от дестилат (обработен); | [Сложна комбинация от въглеводороди, получени чрез екстракция с разтворител от леки вакуумни нефтени газьоли и обработена с водород в присъствието на катализатор. Състои се основно от ароматни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C13 до C30.] | 295-342-2 | 91995-79-8 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-542-00-5 | Extracts (petroleum), heavy paraffinic distillate solvent, clay-treated; | Distillate aromatic extract (treated); | [A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contact or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50. This stream is likely to contain 5 wt.% or more 4-6 membered ring aromatic hydrocarbons.] | 296-437-1 | 92704-08-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-542-00-5 | Екстракти (нефтени), разтворител на тежък парафинов дестилат, обработен с глина; | Ароматен екстракт от дестилат (обработен); | [Сложна комбинация от въглеводороди, получена чрез обработката на нефтена фракция с природна или модифицирана глина при контактен или перколационен процес, за отстраняване на следи от налични полярни съединения и онечиствания. Състои се основно от ароматни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C20 до C50.] Тази фракция вероятно съдържа 5 или повече тегловни процента ароматни въглеводороди с 4 до 6 кондензирани пръстена.] | 296-437-1 | 92704-08-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-543-00-0 | Extracts (petroleum), heavy naphthenic distillate solvent, hydrodesulfurized; | Distillate aromatic extract (treated); | [A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.] | 297-827-4 | 93763-10-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-543-00-0 | Екстракти (нефтени), разтворител на тежък нафтенов дестилат, хидродесулфуриран; | Ароматен екстракт от дестилат (обработен); | [Сложна комбинация от въглеводороди, получена при обработване на нефтена суровина с водород за превръщане на органичната сяра във водороден сулфид, който се отстранява. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C15 до C50, като от нея се получава крайно масло с вискозитет по-висок от 19cSt при 40 oC.] | 297-827-4 | 93763-10-1 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-544-00-6 | Extracts (petroleum), solvent-dewaxed heavy paraffinic distillate solvent, hydrodesulfurized; | Distillate aromatic extract (treated); | [A complex combination of hydrocarbons obtained from a solvent dewaxed petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.] | 297-829-5 | 93763-11-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-544-00-6 | Екстракти (нефт), депарафинирани с разтворител, разтворител на тежък парафинов дестилат, хидродесулфуриран; | Ароматен екстракт от дестилат (обработен); | [Сложна комбинация от въглеводороди, получена при обработване на депарафинирана с разтворител нефтена суровина с водород за превръщане на органичната сяра във водороден сулфид, който се отстранява. Състои се основно от въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C15 до C50, като от нея се получава крайно масло с вискозитет по-висок от 19cSt при 40 oC.] | 297-829-5 | 93763-11-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-545-00-1 | Extracts (petroleum), light paraffinic distillate solvent, carbon-treated; | Distillate aromatic extract (treated); | [A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillate treated with activated charcoal to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.] | 309-672-2 | 100684-02-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-545-00-1 | Екстракти (нефтени), разтворител на лек парафинов дестилат, обработен с активен въглен; | Ароматен екстракт от дестилат (обработен); | [Сложна комбинация от въглеводороди, получени като фракция от дестилацията на екстракт, извлечен чрез екстракция с разтворител на лек парафинов нефтен дестилат от горната част, обработен с активен въглен за отстраняване на следи от полярни компоненти и онечиствания. Състои се основно от ароматни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C16 до C32.] | 309-672-2 | 100684-02-4 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-546-00-7 | Extracts (petroleum), light paraffinic distillate solvent, clay-treated; | Distillate aromatic extract (treated); | [A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillates treated with bleaching earth to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.] | 309-673-8 | 100684-03-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-546-00-7 | Екстракти (нефтени), разтворител на лек парафинов дестилат, обработен с глина; | Ароматен екстракт от дестилат (обработен); | [Сложна комбинация от въглеводороди, получена като фракция от дестилацията на екстракт, извлечен чрез екстракция с разтворител на леки парафинови нефтени дестилати от горната част, обработен с избелваща пръст за отстраняване на следи от полярни компоненти и онечиствания. Състои се основно от ароматни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C16 до C32.] | 309-673-8 | 100684-03-5 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-547-00-2 | Extracts (petroleum), light vacuum, gas oil solvent, carbon-treated; | Distillate aromatic extract (treated); | [A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oil treated with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.] | 309-674-3 | 100684-04-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-547-00-2 | Екстракти (нефтени), разтворител на лек вакуумен газьол, обработен с активен въглен; | Ароматен екстракт от дестилат (обработен); | [Сложна комбинация от въглеводороди, получена чрез екстракция с разтворител от лек вакуумен нефтен газьол, обработен с активен въглен за отстраняване на следи от полярни компоненти и онечиствания. Състои се основно от ароматни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C13 до C30.] | 309-674-3 | 100684-04-6 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-548-00-8 | Extracts (petroleum), light vacuum gas oil solvent, clay-treated; | Distillate aromatic extract (treated); | [A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oils treated with bleaching earth for removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.] | 309-675-9 | 100684-05-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-548-00-8 | Екстракти (нефтени), разтворител на лек вакуумен газьол, обработен с глина; | Ароматен екстракт от дестилат (обработен); | [Сложна комбинация от въглеводороди, получена чрез екстракция с разтворител от леки вакуумни нефтени газьоли, обработени с избелваща пръст за отстраняване на следи от полярни компоненти и онечиствания. Състои се основно от ароматни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от C13 до C30.] | 309-675-9 | 100684-05-7 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-549-00-3 | Foots oil (petroleum); Foots oil; | [A complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process. It consists predomi nantly of branched chain hydro carbons having carbon numbers predominantly in the range of C20 through C50.] | 265-171-8 | 64742-67-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-549-00-3 | Масло, което се отделя при топенето на парафин (нефтено); масло, което се отделя при топенето на парафин; | [Сложна комбинация от въглеводороди, получена като маслената фракция от обезмасляване с разтворител или восъчна стопилка. Състои се основно от въглеводороди с разклонена верига с брой на въглеродните атоми преобладаващо в интервала от C20 до C50.] | 265-171-8 | 64742-67-2 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
649-550-00-9 | Foots oil (petroleum), hydrotreated; Foots oil | 295-394-6 | 92045-12-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L649-550-00-9 | Масло, което се отделя при топенето на парафин (нефтено), обработено с водород; Масло, което се отделя при топенето на парафин; | 295-394-6 | 92045-12-0 | Carc. 1B | H350 | GHS08 | Dgr | H350 |   |   | L
650-002-00-6 | turpentine, oil | 232-350-7 | 8006-64-2 | Flam. Liq. 3 | Acute Tox. 4 * Acute Tox. 4 * | Acute Tox. 4 * | Asp. Tox. 1 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H226 | H332 | H312 | H302 | H304 | H319 | H315 | H317 | H411 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H226 | H332 | H312 | H302 | H304 | H319 | H315 | H317 | H411 |   |   |  650-002-00-6 | тeрпентиново масло | 232-350-7 | 8006-64-2 | Flam. Liq. 3 | Acute Tox. 4 * Acute Tox. 4 * | Acute Tox. 4 * | Asp. Tox. 1 | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 2 | H226 | H332 | H312 | H302 | H304 | H319 | H315 | H317 | H411 | GHS02 | GHS08 | GHS07 | GHS09 | Dgr | H226 | H332 | H312 | H302 | H304 | H319 | H315 | H317 | H411 |   |   |  
650-003-00-1 | fenson (ISO); | 4-chlorophenyl benzenesulphonate; | 201-274-6 | 80-38-6 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Chronic 2 | H302 | H319 | H411 | GHS07 | GHS09 | Wng | H302 | H319 | H411 |   |   |  650-003-00-1 | фенсон (ISO); | 4-хлорoфенилбензенсулфонат; | 201-274-6 | 80-38-6 | Acute Tox. 4 * | Eye Irrit. 2 | Aquatic Chronic 2 | H302 | H319 | H411 | GHS07 | GHS09 | Wng | H302 | H319 | H411 |   |   |  
650-004-00-7 | norbormide (ISO); | 5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)bicycle [2.2.1] hept-5-ene-2,3-dicarboximide | 213-589-6 | 991-42-4 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  650-004-00-7 | норбормид (ISO); | 5-(α-хидрокси- α - 2-пиридилбензил)-7-(α-2-пиридилбензилиден)бицикло[2.2.1]хепт-5-eн-2,3-дикарбоксимид | 213-589-6 | 991-42-4 | Acute Tox. 4 * | H302 | GHS07 | Wng | H302 |   |   |  
650-005-00-2 | (2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one, rotenone | 201-501-9 | 83-79-4 | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H319 | H335 | H315 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H319 | H335 | H315 | H410 |   |   |  650-005-00-2 | (2R,6aS,12aS)-1,2,6,6a,12,12a-хексахидро-2-изопропенил-8,9-диметоксихромено[3,4-b]фуро[2,3-h]хромен-6-oн, ротенон | 201-501-9 | 83-79-4 | Acute Tox. 3 * | Eye Irrit. 2 | STOT SE 3 | Skin Irrit. 2 | Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H319 | H335 | H315 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H319 | H335 | H315 | H410 |   |   |  
650-006-00-8 | benquinox (ISO); | p-benzoquinone 1-benzoylhydrazone 4-oxime | 207-807-9 | 495-73-8 | Acute Tox. 3 * Acute Tox. 4 * | H301 | H312 | GHS06 | Dgr | H301 | H312 |   |   |  650-006-00-8 | бенхинокс (ISO); | p-бензохинон-1-бензоилхидразон-4-oксим | 207-807-9 | 495-73-8 | Acute Tox. 3 * Acute Tox. 4 * | H301 | H312 | GHS06 | Dgr | H301 | H312 |   |   |  
650-007-00-3 | chlordimeform (ISO); | N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine | 228-200-5 | 6164-98-3 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H312 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H312 | H302 | H410 |   |   |  650-007-00-3 | хлордимеформ (ISO); | N 2-(4-хлоро-o-толил)-N 1,N 1-диметилформамидин | 228-200-5 | 6164-98-3 | Carc. 2 | Acute Tox. 4 * | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H312 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H312 | H302 | H410 |   |   |  
650-008-00-9 | drazoxolon (ISO); | 4-(2-chlorophenylhydrazone)-3-methyl-5-isoxazolone | 227-197-8 | 5707-69-7 | Acute Tox. 3 * Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H410 |   |   |  650-008-00-9 | дразоксолон (ISO); | 4-(2-хлорофенилхидразон)-3-метил-5-изоксазолон | 227-197-8 | 5707-69-7 | Acute Tox. 3 * Aquatic Acute 1 | Aquatic Chronic 1 | H301 | H400 | H410 | GHS06 | GHS09 | Dgr | H301 | H410 |   |   |  
650-009-00-4 | chlordimeform hydrochloride; N'-(4-chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride; | N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine hydorchloride | 243-269-1 | 19750-95-9 | Carc. 2 | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H302 | H410 |   |   |  650-009-00-4 | хлордимеформ хидрохлорид; N′-(4-хлоро-o-толил)-N,N-диметилформамидинмонохидрохлорид; | N 2-(4-хлоро-o-толил)-N 1,N 1-диметилформамидинхидрохлорид | 243-269-1 | 19750-95-9 | Carc. 2 | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H351 | H302 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H351 | H302 | H410 |   |   |  
650-010-00-X | benzyl violet 4B; | α-[4-(4-dimethylamino-α-{4-[ethyl(3-sodiosulphonato benzyl)amino] phenyl}benzylidene)cyclohexa-2,5-dienylidene(ethyl)ammonio]toluene-3-sulphonate | 216-901-9 | 1694-09-3 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  650-010-00-X | бензил виолет 4B; | α[4-(4-диметиламино-α-{4-[eтил(3-натриосулфонатобензил)aмино]фенил}бензилиден)циклохексa-2,5-диенилиден(eтил)aмонио]толуен-3-сулфонат | 216-901-9 | 1694-09-3 | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   |  
650-012-00-0 | erionite | — | 12510-42-8 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  650-012-00-0 | eрионит | — | 12510-42-8 | Carc. 1A | H350 | GHS08 | Dgr | H350 |   |   |  
650-013-00-6 | asbestos | — | — | — | — | — | — | — | 12001-28-4 | 132207-32-0 | 12172-73-5 | 77536-66-4 | 77536-68-6 | 77536-67-5 | 12001-29-5 | Carc. 1A | STOT RE 1 | H350 | H372 ** | GHS08 | Dgr | H350 | H372 ** |   |   |  650-013-00-6 | азбест | — | — | — | — | — | — | — | 12001-28-4 | 132207-32-0 | 12172-73-5 | 77536-66-4 | 77536-68-6 | 77536-67-5 | 12001-29-5 | Carc. 1A | STOT RE 1 | H350 | H372 ** | GHS08 | Dgr | H350 | H372 ** |   |   |  
650-014-00-1 | diethyl 2,4-dihydroxycyclodisiloxane-2,4-diylbis(trimethylene)diphosphonate, tetrasodium salt, reaction products with disodium metasilicate | 401-770-4 | — | Skin Corr. 1B | Acute Tox. 4 * | H314 | H302 | GHS05 | GHS07 | Dgr | H314 | H302 |   |   |  650-014-00-1 | диетилов 2,4-дихидроксициклодисилоксан-2,4-диилбис(триметилен)дифосфонат, тетранатриева сол, реакционни продукти с динатриев метасиликат | 401-770-4 | — | Skin Corr. 1B | Acute Tox. 4 * | H314 | H302 | GHS05 | GHS07 | Dgr | H314 | H302 |   |   |  
650-015-00-7 | rosin; | colophony | 232-475-7 | 232-484-6 | 277-299-1 | 8050-09-7 | 8052-10-6 | 73138-82-6 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  650-015-00-7 | дървесна смола; | колофон | 232-475-7 | 232-484-6 | 277-299-1 | 8050-09-7 | 8052-10-6 | 73138-82-6 | Skin Sens. 1 | H317 | GHS07 | Wng | H317 |   |   |  
650-016-00-2 | Mineral wool, with the exception of those specified elsewhere in this Annex; | [Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight] | — | — | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   | AQR650-016-00-2 | Минералнa ватa, с изключение на тези, посочени другаде в настоящото приложение | [Изкуствени стъкловлакна (силикатни) с произволна ориентация със съдържание на алкални оксиди и алкалоземни оксиди (Na2O+K2O+CaO+MgO+BaO)) по-високо от 18 тегловни %] | — | — | Carc. 2 | H351 | GHS08 | Wng | H351 |   |   | AQR
650-017-00-8 | Refractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex; | [Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight] | — | — | Carc. 1B | H350i | GHS08 | Dgr | H350i |   |   | AR650-017-00-8 | Огнеупорни керамични влакна, влакна със специално предназначение, с изключение на тези, посочени другаде в настоящото приложение | [Изкуствени стъкловлакна (силикатни) с произволна ориентация със съдържание на алкални оксиди и алкалоземни оксиди (Na2O+K2O+CaO+MgO+BaO)) по-малко или равно на 18 тегловни %] | — | — | Carc. 1B | H350i | GHS08 | Dgr | H350i |   |   | AR
650-018-00-3 | Reaction product of: acetophenone, formaldehyde, cyclohexylamine, methanol and acetic acid | 406-230-1 | — | Flam. Liq. 3 | Carc. 2 | Skin Corr. 1B | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H226 | H351 | H314 | H332 | H317 | H400 | H410 | GHS02 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H226 | H351 | H314 | H332 | H317 | H410 |   |   |  650-018-00-3 | Реакционен продукт от: ацетофенон, формалдехид, циклохексиламин, мeтанол и оцетна киселина | 406-230-1 | — | Flam. Liq. 3 | Carc. 2 | Skin Corr. 1B | Acute Tox. 4 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H226 | H351 | H314 | H332 | H317 | H400 | H410 | GHS02 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H226 | H351 | H314 | H332 | H317 | H410 |   |   |  
650-031-00-4 | bis(4-hydroxy-N-methylanilinium) sulphate | 200-237-1 | 55-55-0 | Acute Tox. 4 * STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373 ** H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373 ** H317 | H410 |   |   |  650-031-00-4 | бис(N-метил-4-хидроксианилиниев) сулфат | 200-237-1 | 55-55-0 | Acute Tox. 4 * STOT RE 2 * | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H373 ** H317 | H400 | H410 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373 ** H317 | H410 |   |   |  
650-041-00-9 | triasulfuron (ISO); | 1-[2-(2-chloroethoxy)phenylsulfonyl]-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea | — | 82097-50-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  650-041-00-9 | триасулфурон (ISO); | 3-(6-метил-4-метокси-1,3,5-триазин-2-ил)-1-[2-(2-хлороетокси)фенилсулфонил]уреа | — | 82097-50-5 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  
650-042-00-4 | Reaction product of: polyethylene-polyamine-(C16-C18)-alkylamides with monothio-(C2)-alkyl phosphonates | 417-450-2 | — | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H319 | H315 | H317 | H412 | GHS07 | Wng | H319 | H315 | H317 | H412 |   |   |  650-042-00-4 | Реакционен продукт от: полиетилeн-полиамин-(C16-C18)-алкиламиди с монотио-(C2)-алкилфосфонати | 417-450-2 | — | Eye Irrit. 2 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Chronic 3 | H319 | H315 | H317 | H412 | GHS07 | Wng | H319 | H315 | H317 | H412 |   |   |  
650-043-00-X | reaction product of: 3,5-bis-tert-butylsalicylic acid and aluminiumsulfate | 420-310-3 | — | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  650-043-00-X | реакционeн продукт на: 3,5-бис-трет-бутилсалицилова киселина и алуминиев сулфат | 420-310-3 | — | Acute Tox. 4 * Aquatic Acute 1 | Aquatic Chronic 1 | H302 | H400 | H410 | GHS07 | GHS09 | Wng | H302 | H410 |   |   |  
650-044-00-5 | mixed linear and branched C14-15 alcohols ethoxylated, reaction product with epichlorohydrin | 420-480-9 | 158570-99-1 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H317 | H410 |   |   |  650-044-00-5 | смесени C14-15 етоксилирани алкохоли с неразклонени и разклонени вериги, реакционен продукт с епихлорохидрин | 420-480-9 | 158570-99-1 | Skin Irrit. 2 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H317 | H400 | H410 | GHS07 | GHS09 | Wng | H315 | H317 | H410 |   |   |  
650-045-00-0 | Reaction product of: 1,2,3-propanetricarboxylic acid, 2-hydroxy, diethyl ester, 1-propanol and zirconium tetra-n-propanolate | 417-110-3 | — | Flam. Liq. 2 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 2 | H225 | H315 | H318 | H411 | GHS02 | GHS05 | GHS09 | Dgr | H225 | H315 | H318 | H411 |   |   |  650-045-00-0 | Реакционен продукт от: диетилов естер на 2-хидрокси-1,2,3-пропантрикарбоксиловата киселина, 1-пропанoл и циркониев тетра-n-пропанoлат | 417-110-3 | — | Flam. Liq. 2 | Skin Irrit. 2 | Eye Dam. 1 | Aquatic Chronic 2 | H225 | H315 | H318 | H411 | GHS02 | GHS05 | GHS09 | Dgr | H225 | H315 | H318 | H411 |   |   |  
650-046-00-6 | di(tetramethylammonium)(29H,31H-phthalocyanin-N29,N30,N31,N32)disulfonamide disulfonate, cuprate(2-)complex, derivates | 416-180-2 | 12222-04-7 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 2 | H302 | H373 ** H411 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373 ** H411 |   |   |  650-046-00-6 | ди(тетраметиламониев) (29H,31H-фталоцианин-N29,N30,N31,N32)дисулфонамид дисулфонат, купрат(2-) комплекс, производни | 416-180-2 | 12222-04-7 | Acute Tox. 4 * | STOT RE 2 * | Aquatic Chronic 2 | H302 | H373 ** H411 | GHS08 | GHS07 | GHS09 | Wng | H302 | H373 ** H411 |   |   |  
650-047-00-1 | dibenzylphenylsulfonium hexafluoroantimonate | 417-760-8 | 134164-24-2 | STOT RE 1 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H372 ** H302 | H318 | H317 | H411 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H372 ** | H302 | H318 | H317 | H411 |   |   |  650-047-00-1 | дибензилфенилсулфониев хексафлуороантимонат | 417-760-8 | 134164-24-2 | STOT RE 1 | Acute Tox. 4 * | Eye Dam. 1 | Skin Sens. 1 | Aquatic Chronic 2 | H372 ** H302 | H318 | H317 | H411 | GHS08 | GHS05 | GHS07 | GHS09 | Dgr | H372 ** | H302 | H318 | H317 | H411 |   |   |  
650-048-00-7 | reaction product of: borax, hydrogen peroxide, acetic acid anhydride and acetic acid | 420-070-1 | — | Org. Perox. D **** Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A Aquatic Acute 1 | H242 | H332 | H312 | H302 | H314 | H400 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H242 | H332 | H312 | H302 | H314 | H400 |   |   |  650-048-00-7 | реакционeн продукт на: боракс, водороден пероксид, оцетен анхидрид и оцетна киселина | 420-070-1 | — | Org. Perox. D **** Acute Tox. 4 * | Acute Tox. 4 * | Acute Tox. 4 * | Skin Corr. 1A Aquatic Acute 1 | H242 | H332 | H312 | H302 | H314 | H400 | GHS02 | GHS05 | GHS07 | GHS09 | Dgr | H242 | H332 | H312 | H302 | H314 | H400 |   |   |  
650-049-00-2 | 2-alkoyloxyethyl hydrogen maleate, where alkoyl represents (by weight 70 to 85 % unsaturated octadecoyl, 0.5 to 10 % saturated octadecoyl, and 2 to 18 % saturated hexadecoyl | 417-960-5 | — | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H315 | H318 | H317 | H410 |   |   |  650-049-00-2 | 2-алкоилоксиетилов хидрогенмалеат, в който „алкоил“ представлява (тегловни 70 до 85 % ненаситен октадекоил, 0,5 до 10 % наситен октадекоил и 2 до18 % наситен хексадекоил) | 417-960-5 | — | Skin Irrit. 2 | Eye Dam. 1 | Skin Sens. 1 | Aquatic Acute 1 | Aquatic Chronic 1 | H315 | H318 | H317 | H400 | H410 | GHS05 | GHS07 | GHS09 | Dgr | H315 | H318 | H317 | H410 |   |   |  
650-050-00-8 | reaction mass of: 1-methyl-3-hydroxypropyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydro-cinnamate and/or 3-hydroxybutyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydrocinnamate; | 1,3-butanediol bis[3-(3'-(1,1-dimethylethyl)4'-hydroxy-phenyl)propionate] isomers; | 1,3-butanediol bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyphenyl)propionate] isomers | 423-600-8 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  650-050-00-8 | реакционна маса от: 1-метил-3-хидроксипропилов 3,5-[1,1-диметилетил]-4-хидроксидихидроцинамат и/или 3-хидроксибутилов 3,5-[1,1-диметилетил]-4-хидроксидихидроцинамат; | изомери на 1,3-бутандиолбис[3-(3′-(1,1-диметилетил)-4′-хидроксифенил)пропионат]; | изомери на 1,3-бутандиoлбис[3-(3′,5′-(1,1-диметилетил)-4′-хидроксифенил)пропионат] | 423-600-8 | — | Aquatic Chronic 2 | H411 | GHS09 | H411 |   |   |  
650-055-00-5 | silver sodium zirconium hydrogenphosphate | 422-570-3 | 155925-27-2 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |  650-055-00-5 | натриев сребърен циркониев хидрогенфосфат | 422-570-3 | 155925-27-2 | Aquatic Acute 1 | Aquatic Chronic 1 | H400 | H410 | GHS09 | Wng | H410 |   |   |